data_2kue_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kue _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 122.69 1.233 . . . . 73.400000000000006 108.637 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 54.3 mt-30 -94.48 140.11 30.26 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.33 -1.759 . . . . 72.420000000000002 108.949 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpp180 -120.87 152.35 38.55 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.827 -1.175 . . . . 73.120000000000005 107.827 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.36 140.88 32.16 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 124.091 0.87 . . . . 64.129999999999995 109.775 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -89.98 122.76 67.46 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 109.33 -0.619 . . . . 73.019999999999996 109.33 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.45 141.14 94.94 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.597 2.198 . . . . 72.030000000000001 112.581 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.41 24.13 4.12 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.35 -0.841 . . . . 73.099999999999994 110.891 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.5 -7.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.047 0.927 . . . . 74.430000000000007 109.024 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 13.2 m -62.74 -36.32 82.66 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.472 -1.24 . . . . 73.120000000000005 110.097 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.42 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 18.1 p -62.11 -26.6 68.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.25 -1.341 . . . . 70.109999999999999 110.839 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.472 ' C ' ' HG1' ' A' ' 436' ' ' THR . 59.9 mt -83.71 -44.62 14.29 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.041 -0.527 . . . . 65.219999999999999 110.586 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.472 ' HG1' ' C ' ' A' ' 435' ' ' LEU . 22.3 m -160.87 145.61 14.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.671 -0.492 . . . . 75.219999999999999 109.671 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -54.92 -42.37 72.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.478 0.711 . . . . 72.310000000000002 110.92 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 436' ' ' THR . . . -57.55 -44.39 85.16 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.888 -0.596 . . . . 74.349999999999994 110.579 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.66 -43.61 98.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.369 -0.832 . . . . 73.120000000000005 111.256 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -59.76 -51.73 68.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.443 -0.799 . . . . 62.119999999999997 110.978 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.1 -47.55 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.869 -0.605 . . . . 73.340000000000003 112.333 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -64.78 -47.15 79.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.7 -0.4 . . . . 75.239999999999995 111.65 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.89 -40.33 83.51 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.633 -0.427 . . . . 71.140000000000001 111.984 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.487 HD22 ' CE2' ' A' ' 452' ' ' PHE . 19.4 tp -68.89 -33.64 74.11 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.363 0.601 . . . . 73.299999999999997 110.261 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.6 m -64.06 -41.63 97.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.62 -0.718 . . . . 73.040000000000006 109.59 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.57 62.79 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.798 -0.637 . . . . 74.099999999999994 110.82 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.4 -13.47 52.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.063 0.459 . . . . 74.129999999999995 110.077 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.77 -2.36 27.43 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.567 -0.825 . . . . 75.129999999999995 113.844 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 95.6 m-85 -83.56 136.49 34.23 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 117.303 0.552 . . . . 75.439999999999998 111.671 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.21 4.82 4.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.549 -0.751 . . . . 73.120000000000005 112.451 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.426 ' NE ' ' HB ' ' A' ' 483' ' ' VAL . 77.2 ttt180 -111.29 115.56 29.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.702 -0.851 . . . . 75.340000000000003 108.702 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.487 ' CE2' HD22 ' A' ' 444' ' ' LEU . 65.2 m-85 -130.82 156.9 44.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.024 -0.534 . . . . 74.430000000000007 111.12 -173.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -139.41 121.82 16.09 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 104.615 -2.365 . . . . 74.230000000000004 104.615 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -110.65 135.19 51.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.744 0.307 . . . . 71.409999999999997 111.397 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.3 156.56 46.4 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.987 -1.116 . . . . 65.230000000000004 107.987 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -136.09 143.06 44.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.219999999999999 107.732 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.8 m -130.99 139.19 34.83 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 109.501 -0.555 . . . . 63.520000000000003 109.501 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -64.41 123.07 11.21 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.292 1.995 . . . . 74.439999999999998 110.326 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 68.0 m -151.81 -179.51 7.52 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.087 -1.079 . . . . 61.039999999999999 108.087 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 2.8 t -33.97 108.53 0.32 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 125.787 1.635 . . . . 61.240000000000002 112.625 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.33 -29.75 78.06 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 124.139 3.226 . . . . 73.409999999999997 115.274 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -71.98 -6.91 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.583 0.586 . . . . 75.030000000000001 112.583 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 78.8 mt -111.3 13.81 21.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.006 0.432 . . . . 74.219999999999999 110.936 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.82 133.62 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.826 -0.625 . . . . 72.319999999999993 112.008 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.86 79.55 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 121.037 -0.602 . . . . 70.329999999999998 113.793 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 434' ' ' THR . 11.1 pttp -101.67 162.26 13.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.761 -1.2 . . . . 73.409999999999997 107.761 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 486' ' ' ILE . 53.3 t -81.46 133.21 29.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.851 -1.166 . . . . 74.319999999999993 107.851 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.6 pt -102.11 -6.73 9.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.593 -0.443 . . . . 73.239999999999995 110.819 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.5 143.69 4.05 Favored Glycine 0 N--CA 1.423 -2.224 0 C-N-CA 120.237 -0.983 . . . . 74.409999999999997 112.864 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.4 p -119.35 147.46 44.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.837 -1.171 . . . . 73.329999999999998 107.837 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.49 -51.38 42.2 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 119.394 -0.336 . . . . 73.219999999999999 111.595 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.12 127.81 13.99 Favored 'Trans proline' 0 C--N 1.361 1.223 0 N-CA-C 108.012 -1.572 . . . . 71.430000000000007 108.012 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.27 158.22 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.893 1.729 . . . . 63.009999999999998 113.102 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.429 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.08 -17.0 51.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.842 0.829 . . . . 74.109999999999999 109.981 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -96.87 -25.92 15.27 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.389 -0.823 . . . . 64.530000000000001 111.537 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.11 156.68 17.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.889 -0.411 . . . . 73.349999999999994 109.889 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.5 p -90.57 140.83 29.38 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.183 -0.673 . . . . 70.019999999999996 109.183 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.1 m -126.7 142.6 51.49 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.752 -0.832 . . . . 60.439999999999998 108.752 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.43 140.17 57.35 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.226 -0.657 . . . . 53.030000000000001 109.226 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.21 -9.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.98 0.895 . . . . 70.030000000000001 111.616 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -81.94 -3.29 53.96 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.613 -0.721 . . . . 73.140000000000001 109.185 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.43 147.38 28.78 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 121.983 -0.448 . . . . 73.040000000000006 110.644 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.426 ' HB ' ' NE ' ' A' ' 451' ' ' ARG . 5.1 p -85.66 124.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.837 -1.171 . . . . 74.099999999999994 107.837 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.94 118.12 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.285 -0.966 . . . . 75.140000000000001 108.588 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.65 115.11 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.785 -1.561 . . . . 75.310000000000002 106.785 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.06 124.18 69.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.24 -0.891 . . . . 74.319999999999993 109.377 -176.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.59 123.17 61.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.303 -0.628 . . . . 73.329999999999998 109.303 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.21 141.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.314 -0.624 . . . . 74.450000000000003 109.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -76.92 113.51 3.8 Favored Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.526 -1.429 . . . . 75.010000000000005 109.526 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -102.19 130.04 48.73 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.618 -0.512 . . . . 71.030000000000001 109.618 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.981 0 N-CA-C 109.024 -1.63 . . . . 73.349999999999994 109.024 177.711 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.179 0 N-CA-C 107.171 -1.418 . . . . 73.430000000000007 107.171 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 8.8 p -119.89 151.26 39.16 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.167 -0.924 . . . . 71.439999999999998 109.738 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -146.65 149.47 33.56 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.114 0.483 . . . . 72.25 111.432 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 543' ' ' THR . 9.1 p-10 -82.6 134.48 35.18 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.381 -1.281 . . . . 74.340000000000003 107.602 173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 540' ' ' PRO . 0.2 OUTLIER -75.62 122.73 87.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 119.622 -0.831 . . . . 65.329999999999998 109.091 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.9 170.53 9.87 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.403 2.069 . . . . 74.510000000000005 112.712 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.02 116.62 29.08 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.817 -0.629 . . . . 71.150000000000006 109.948 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.84 17.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 122.621 1.2 . . . . 72.030000000000001 107.942 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 147.55 48.57 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.325 -1.307 . . . . 74.209999999999994 109.45 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.13 -6.48 53.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 111.363 -0.695 . . . . 55.340000000000003 111.363 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.47 177.28 4.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.3 m -77.47 156.35 31.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.248 -0.649 . . . . 72.219999999999999 109.248 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.62 -44.03 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 123.448 0.468 . . . . 73.099999999999994 111.598 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.3 -42.68 79.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.031 0.382 . . . . 72.439999999999998 112.031 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.07 -35.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.651 -0.819 . . . . 70.430000000000007 111.121 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.45 81.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.698 -0.683 . . . . 61.100000000000001 111.094 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.66 -38.22 84.15 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.395 0.434 . . . . 74.409999999999997 110.538 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.1 tttm -63.7 -52.01 62.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.654 -0.703 . . . . 71.129999999999995 110.27 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -65.02 -41.61 95.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.969 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.25 -39.39 89.47 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.616 -0.72 . . . . 64.310000000000002 109.762 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -59.02 -41.57 88.07 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.186 0.594 . . . . 71.230000000000004 112.427 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.1 t -59.02 -35.35 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 111.088 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -112.28 4.31 17.64 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.024 -0.67 . . . . 75.5 111.398 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.93 -100.25 0.29 Allowed Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 118.036 -2.031 . . . . 61.219999999999999 117.625 -168.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 60.9 m-85 -120.08 161.47 20.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.404 -0.398 . . . . 74.120000000000005 111.295 -164.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 m -119.01 -13.96 9.39 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.527 0.68 . . . . 64.319999999999993 110.782 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -107.97 115.49 30.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.422 -0.955 . . . . 71.409999999999997 108.422 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -120.97 156.64 31.67 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.542 0.687 . . . . 72.140000000000001 111.318 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.7 m -139.99 155.75 46.96 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.518 -1.66 . . . . 75.219999999999999 106.518 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -121.28 138.46 54.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.038 0.447 . . . . 74.120000000000005 110.007 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.94 131.75 56.05 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.545 -0.909 . . . . 73.530000000000001 108.545 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 36.1 m -88.61 123.17 32.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.572 0.545 . . . . 73.519999999999996 109.677 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 35.3 m -121.61 162.64 20.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.768 -1.197 . . . . 73.230000000000004 107.768 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 11.1 m-20 -78.06 133.3 37.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.095 0.474 . . . . 75.150000000000006 110.79 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.509 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 11.0 m -95.95 105.42 21.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.732 -1.122 . . . . 54.049999999999997 111.563 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 2.4 Cg_endo -81.16 -77.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 121.701 1.6 . . . . 64.209999999999994 109.506 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -95.24 -58.47 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 120.325 -0.55 . . . . 75.439999999999998 109.892 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 527' ' ' SER . 36.6 Cg_endo -65.34 144.62 80.97 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.945 1.763 . . . . 72.340000000000003 112.309 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -151.37 132.73 14.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.837 -0.801 . . . . 63.240000000000002 108.837 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.86 -24.66 5.79 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-O 121.922 0.735 . . . . 65.519999999999996 112.075 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.15 150.38 24.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 C-N-CA 124.372 1.069 . . . . 73.340000000000003 111.492 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.18 128.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.081 -0.963 . . . . 74.230000000000004 110.018 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -92.25 -22.23 19.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.255 -1.339 . . . . 72.540000000000006 109.733 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.96 33.67 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.156 -0.777 . . . . 61.020000000000003 111.156 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.9 p -117.94 160.33 21.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.643 -0.873 . . . . 75.219999999999999 108.643 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -64.13 -58.5 14.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.338 -0.363 . . . . 73.129999999999995 111.035 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.49 148.81 43.32 Favored 'Trans proline' 0 C--N 1.373 1.862 0 N-CA-C 109.17 -1.127 . . . . 62.229999999999997 109.17 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . 0.437 ' O ' HD13 ' A' ' 497' ' ' ILE . 32.1 Cg_exo -60.46 140.06 89.58 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.069 1.846 . . . . 54.200000000000003 110.661 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.39 131.94 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.618 0.367 . . . . 73.109999999999999 110.847 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.22 40.7 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.363 -0.922 . . . . 74.25 112.274 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 60.3 m -67.44 126.47 29.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.144 -0.687 . . . . 75.010000000000005 109.144 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 13.2 m -94.33 122.86 37.32 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.942 -0.762 . . . . 63.539999999999999 108.942 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.03 161.0 66.37 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.282 -0.636 . . . . 75.219999999999999 109.282 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.83 134.93 63.59 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.468 2.112 . . . . 62.399999999999999 111.355 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.513 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 20.0 m -65.94 -19.85 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.244 0.545 . . . . 72.340000000000003 111.263 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -77.67 -10.27 59.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.647 -0.706 . . . . 70.430000000000007 111.516 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.0 t -85.39 161.13 19.58 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 74.349999999999994 108.922 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.32 130.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.012 0.434 . . . . 74.049999999999997 111.278 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.9 tt -101.6 132.84 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.071 0.462 . . . . 74.310000000000002 110.011 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.59 127.45 51.01 Favored 'General case' 0 N--CA 1.399 -2.999 0 N-CA-C 108.73 -0.841 . . . . 75.310000000000002 108.73 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.5 tp -104.19 133.58 48.88 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.944 -1.025 . . . . 74.510000000000005 108.854 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -94.46 109.23 21.12 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.708 -1.219 . . . . 74.230000000000004 107.708 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.71 138.51 44.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 121.177 0.513 . . . . 74.200000000000003 112.187 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -68.09 114.95 7.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.722 -0.844 . . . . 62.130000000000003 108.722 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 61.9 pttt . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 115.802 -0.636 . . . . 74.25 110.702 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 480' ' ' ILE . 12.4 pt-20 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.77 0.319 . . . . 73.319999999999993 111.491 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 478' ' ' SER . 68.6 mt-30 -90.84 119.14 30.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.291 -0.564 . . . . 72.219999999999999 110.018 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -120.18 160.24 23.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.462 -1.31 . . . . 71.540000000000006 107.462 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.09 141.39 29.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.385 0.428 . . . . 63.130000000000003 111.4 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.1 130.72 68.63 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.597 -0.89 . . . . 73.310000000000002 108.597 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.34 142.93 78.54 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.319 2.68 . . . . 74.319999999999993 114.426 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.46 -7.5 50.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.314 -0.857 . . . . 75.549999999999997 111.091 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 32.4 m -80.38 1.05 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.6 0.714 . . . . 70.230000000000004 110.801 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.3 m -63.77 -28.05 69.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.091 -0.959 . . . . 44.039999999999999 109.476 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -62.07 -28.4 69.58 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.587 -1.188 . . . . 72.519999999999996 111.186 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.414 ' C ' ' HG1' ' A' ' 436' ' ' THR . 63.9 mt -83.37 -45.27 13.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.089 -0.505 . . . . 74.319999999999993 110.572 -172.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.465 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.5 m -165.69 149.06 7.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.655 -0.869 . . . . 73.5 108.655 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.08 -45.41 75.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.407 0.683 . . . . 75.219999999999999 110.655 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.41 -44.7 76.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.038 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.465 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 31.2 mm-40 -64.32 -37.89 89.1 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.014 -0.539 . . . . 74.420000000000002 110.935 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.79 -51.33 68.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 74.329999999999998 110.477 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.41 -46.03 97.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.221 -0.9 . . . . 75.310000000000002 112.309 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -63.03 -44.55 95.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.561 0.22 . . . . 74.25 111.319 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.34 -38.44 84.85 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.04 0.385 . . . . 72.209999999999994 112.04 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.1 tp -68.53 -34.26 75.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.516 0.674 . . . . 74.040000000000006 109.938 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.2 m -65.66 -40.74 92.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.418 -0.81 . . . . 73.040000000000006 109.305 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -16.57 62.71 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.315 0.578 . . . . 72.010000000000005 110.419 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.78 -14.14 49.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.222 0.534 . . . . 71.120000000000005 109.589 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.39 50.16 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.884 -0.674 . . . . 64.25 113.616 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.438 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.0 m-85 -92.29 121.36 33.72 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.177 0.489 . . . . 62.210000000000001 110.123 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.21 5.02 21.87 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 111.197 -0.761 . . . . 73.099999999999994 111.197 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -102.86 116.46 32.6 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.326 -0.62 . . . . 74.530000000000001 109.326 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.434 ' CE2' HD21 ' A' ' 444' ' ' LEU . 73.8 m-85 -130.4 144.79 51.61 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.281 0.563 . . . . 73.120000000000005 111.075 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 485' ' ' ILE . 22.3 tptm -131.02 121.84 25.75 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.897 -2.26 . . . . 73.519999999999996 104.897 167.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -105.32 134.99 47.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.695 -0.483 . . . . 75.099999999999994 109.695 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -139.93 150.32 44.4 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.695 -0.854 . . . . 71.120000000000005 108.695 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -125.73 148.74 48.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.762 -1.199 . . . . 75.230000000000004 107.762 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.2 m -143.17 144.79 30.0 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 109.115 -0.698 . . . . 74.239999999999995 109.115 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.44 123.05 10.91 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.608 2.206 . . . . 72.109999999999999 112.571 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.8 t -137.17 -179.13 5.54 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.699 -1.963 . . . . 74.129999999999995 105.699 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.435 ' CG2' HD23 ' A' ' 463' ' ' LEU . 6.9 t -61.88 141.64 95.3 Favored Pre-proline 0 N--CA 1.423 -1.791 0 N-CA-C 109.944 -0.391 . . . . 73.340000000000003 109.944 178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.76 -29.66 34.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.108 3.205 . . . . 74.140000000000001 112.32 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.05 -20.65 65.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.999 0.74 . . . . 73.299999999999997 112.999 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 460' ' ' THR . 4.5 mm? -106.33 11.47 30.97 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.107 -0.371 . . . . 75.120000000000005 111.964 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.92 128.99 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.156 0.503 . . . . 75.329999999999998 111.419 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.29 -9.58 77.01 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.655 -0.783 . . . . 73.430000000000007 112.49 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -100.55 155.35 17.9 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.175 -1.046 . . . . 74.310000000000002 108.175 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.96 129.75 36.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.901 -1.148 . . . . 73.200000000000003 107.901 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.2 pt -98.55 -16.04 7.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.42 -0.512 . . . . 74.519999999999996 110.799 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 176.32 149.1 7.36 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.675 -0.693 . . . . 73.310000000000002 111.738 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.3 p -116.82 152.85 33.56 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.606 -1.257 . . . . 74.409999999999997 107.606 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.477 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.1 t-20 -68.03 -51.94 25.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 C-N-CA 120.502 -0.479 . . . . 75.219999999999999 110.714 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.9 Cg_exo -79.13 130.59 9.38 Favored 'Trans proline' 0 C--N 1.371 1.751 0 N-CA-C 107.952 -1.595 . . . . 74.439999999999998 107.952 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.88 157.15 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.791 1.661 . . . . 72.450000000000003 112.845 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.19 -6.75 57.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.358 1.075 . . . . 72.150000000000006 109.109 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 -40.32 14.29 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.14 -1.391 . . . . 75.239999999999995 111.048 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.77 167.13 10.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 74.340000000000003 110.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 p -101.57 133.56 46.06 Favored 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 108.708 -0.849 . . . . 74.230000000000004 108.708 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.2 m -118.9 148.6 42.75 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.379 -0.6 . . . . 65.329999999999998 109.379 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.25 51.78 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.282 0.364 . . . . 71.439999999999998 111.403 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.8 mm -57.7 -28.51 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.708 1.203 . . . . 74.409999999999997 111.147 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.1 t -76.56 -7.36 55.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.73 -0.668 . . . . 73.540000000000006 110.876 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.99 142.22 28.1 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 122.074 -0.391 . . . . 60.140000000000001 110.435 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.96 126.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.786 -0.82 . . . . 74.219999999999999 108.786 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.19 119.37 36.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.137 -0.69 . . . . 74.5 109.137 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.453 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.9 mp -92.94 119.65 40.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.182 -1.414 . . . . 74.329999999999998 107.182 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.06 125.91 74.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 109.53 -0.545 . . . . 74.099999999999994 109.53 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.3 mp -104.43 119.18 52.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.538 -0.542 . . . . 75.040000000000006 109.538 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.21 144.12 10.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.98 -0.748 . . . . 64.120000000000005 108.98 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -77.71 122.21 6.0 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 111.823 -0.511 . . . . 73.25 111.823 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.9 t -118.45 131.93 56.25 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.16 -1.793 . . . . 63.219999999999999 106.16 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.673 0 C-N-CA 119.672 -1.251 . . . . 72.349999999999994 111.12 -177.567 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.61 0 N-CA-C 106.864 -1.532 . . . . 71.430000000000007 106.864 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.434 ' HB ' HG21 ' A' ' 544' ' ' THR . 40.6 p -125.21 152.79 44.07 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.88 -0.6 . . . . 75.239999999999995 110.119 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.466 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -133.67 135.6 44.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.31 -0.405 . . . . 72.019999999999996 109.939 -177.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.7 p-10 -83.28 130.54 35.08 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.454 -0.943 . . . . 74.439999999999998 108.454 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.8 pt -81.52 131.99 56.62 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 115.991 -0.55 . . . . 73.230000000000004 110.423 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -84.36 152.62 12.16 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.518 2.145 . . . . 74.340000000000003 112.111 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.56 101.22 2.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.533 0.683 . . . . 73.340000000000003 109.95 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.06 1.81 8.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.278 -0.874 . . . . 71.329999999999998 109.484 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.85 122.95 19.25 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.999 -1.0 . . . . 64.349999999999994 110.679 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.94 -29.73 3.87 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.607 -0.597 . . . . 60.450000000000003 111.607 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -88.87 -175.48 4.88 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.109 -0.701 . . . . 74.049999999999997 109.109 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 70.0 p -80.49 157.38 26.17 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.637 -0.825 . . . . 70.349999999999994 110.644 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.01 -41.6 80.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.452 0.644 . . . . 73.140000000000001 109.333 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.71 -43.28 89.57 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.259 -0.882 . . . . 65.549999999999997 112.504 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.58 -34.68 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 119.945 -0.702 . . . . 60.210000000000001 110.585 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.12 77.94 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.803 -0.635 . . . . 75.140000000000001 110.834 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.24 -41.74 97.41 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.638 0.586 . . . . 74.120000000000005 110.203 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 514' ' ' VAL . 56.0 mtmt -65.16 -51.73 59.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 113.203 0.816 . . . . 73.299999999999997 113.203 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -63.48 -40.93 98.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.912 0.386 . . . . 73.040000000000006 110.725 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.53 -39.51 88.64 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 115.626 -0.716 . . . . 71.230000000000004 110.796 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.77 -37.66 87.51 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.891 0.377 . . . . 73.239999999999995 110.654 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 510' ' ' LYS . 47.7 t -69.16 -30.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.965 -0.561 . . . . 60.009999999999998 111.476 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.92 18.83 7.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 120.201 -0.6 . . . . 71.319999999999993 111.748 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -150.06 -110.75 0.53 Allowed Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 118.869 -1.634 . . . . 72.319999999999993 115.135 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.27 164.25 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.373 -0.414 . . . . 72.409999999999997 110.214 -168.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -105.57 -7.98 18.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.426 -0.806 . . . . 75.230000000000004 109.916 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.417 ' HZ1' ' HB3' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -118.71 119.27 33.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 75.25 111.544 -174.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.79 155.95 42.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.149 -0.932 . . . . 73.040000000000006 109.711 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 72.7 m -135.03 148.18 49.86 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.135 -1.432 . . . . 65.099999999999994 107.135 170.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -122.23 128.2 50.87 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.264 -0.643 . . . . 65.319999999999993 109.264 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.411 ' HB2' ' OE1' ' A' ' 554' ' ' GLN . . . -119.75 131.48 55.37 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.319 -0.993 . . . . 72.519999999999996 108.319 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -88.69 126.69 35.43 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.447 0.641 . . . . 55.43 111.425 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.02 162.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.228 -1.397 . . . . 72.329999999999998 107.228 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.423 ' HA ' ' HE2' ' A' ' 557' ' ' LYS . 5.9 p-10 -79.36 129.26 34.29 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.795 0.807 . . . . 71.299999999999997 112.426 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 556' ' ' SER . 10.9 p -92.94 122.25 64.11 Favored Pre-proline 0 N--CA 1.416 -2.152 0 CA-C-N 114.272 -1.331 . . . . 75.150000000000006 108.712 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.82 -67.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.472 2.114 . . . . 70.140000000000001 111.882 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.1 -52.08 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 123.704 0.802 . . . . 74.420000000000002 109.473 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.6 150.14 89.21 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.215 1.276 . . . . 75.140000000000001 110.196 168.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.62 139.89 16.63 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.469 -0.567 . . . . 61.200000000000003 109.469 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.64 10.92 Favored Glycine 0 C--O 1.242 0.607 0 C-N-CA 120.905 -0.665 . . . . 52.25 111.775 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.4 OUTLIER -87.14 147.02 25.81 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.933 0.397 . . . . 71.25 110.626 177.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.62 122.71 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 108.219 -1.03 . . . . 74.409999999999997 108.219 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.41 -25.59 59.56 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.296 -0.865 . . . . 73.430000000000007 109.571 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.79 -156.3 26.8 Favored Glycine 0 N--CA 1.424 -2.115 0 N-CA-C 110.299 -1.12 . . . . 73.129999999999995 110.299 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.0 p -130.0 160.54 33.32 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.379 -0.971 . . . . 72.439999999999998 108.379 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.58 -56.35 36.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 123.461 0.476 . . . . 74.209999999999994 110.751 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.26 146.92 28.82 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.009 1.139 . . . . 72.319999999999993 109.96 170.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -73.3 156.07 50.98 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.363 2.042 . . . . 72.120000000000005 112.465 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.8 136.99 58.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.075 0.55 . . . . 74.209999999999994 111.351 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -17.45 56.52 Favored Glycine 0 C--N 1.312 -0.765 0 C-N-CA 120.85 -0.69 . . . . 53.520000000000003 112.004 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.5 m -71.54 132.48 44.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.397 -0.594 . . . . 73.239999999999995 109.397 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -99.25 122.77 42.88 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.023 -1.103 . . . . 74.310000000000002 108.023 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.85 154.95 73.53 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.486 -0.931 . . . . 74.109999999999999 108.486 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' HG21 ' A' ' 494' ' ' THR . 31.8 Cg_exo -59.91 141.99 97.65 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.229 1.952 . . . . 73.099999999999994 111.621 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.8 -19.28 25.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 121.797 0.808 . . . . 74.140000000000001 111.575 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -87.31 2.73 49.34 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.982 -1.008 . . . . 75.549999999999997 109.541 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -103.45 149.06 25.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.351 -0.84 . . . . 62.130000000000003 108.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.36 130.13 42.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.008 0.433 . . . . 74.120000000000005 110.721 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.1 tt -95.38 130.84 43.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 75.209999999999994 110.6 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.99 121.7 43.1 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.209 0.528 . . . . 70.239999999999995 110.581 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.04 133.76 39.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.824 -1.08 . . . . 75.120000000000005 110.087 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.411 ' OE1' ' HB2' ' A' ' 523' ' ' ALA . 12.4 mm-40 -90.18 109.57 20.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.523 -1.658 . . . . 75.439999999999998 106.523 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.47 133.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.119 0.414 . . . . 74.150000000000006 112.119 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 527' ' ' SER . 14.5 m -70.47 114.48 8.62 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.247 -1.39 . . . . 71.540000000000006 107.247 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 526' ' ' ASP 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 117.903 -1.519 . . . . 74.510000000000005 111.77 -176.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.295 0.569 . . . . 73.129999999999995 110.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -83.37 126.92 33.23 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.463 -1.31 . . . . 71.030000000000001 107.463 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -130.05 162.32 29.02 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.845 -1.169 . . . . 74.239999999999995 107.845 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.32 141.53 29.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.257 0.465 . . . . 62.020000000000003 112.257 -173.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -82.39 129.2 64.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 107.285 -1.376 . . . . 72.409999999999997 107.285 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.34 141.19 96.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.056 1.837 . . . . 75.129999999999995 112.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -94.24 4.17 54.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.862 -0.608 . . . . 73.120000000000005 109.809 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.96 -2.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.201 -0.909 . . . . 70.5 109.955 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 15.1 m -60.52 -33.64 72.93 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.441 -1.254 . . . . 73.540000000000006 110.181 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.3 t -64.91 -25.61 67.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.051 -0.977 . . . . 73.540000000000006 110.607 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.8 mt -81.4 -45.74 15.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.691 -0.404 . . . . 75.409999999999997 110.279 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.9 m -163.37 142.33 8.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.707 -0.849 . . . . 72.439999999999998 108.707 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -54.75 -45.11 74.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.045 0.538 . . . . 73.400000000000006 110.898 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.91 -42.95 76.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.067 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.35 -42.91 99.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 116.031 -0.532 . . . . 75.519999999999996 111.782 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.63 -51.73 68.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.516 -0.765 . . . . 73.430000000000007 111.324 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.35 -47.58 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.368 -0.833 . . . . 65.319999999999993 111.956 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.34 -46.21 81.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.975 0.417 . . . . 74.340000000000003 110.948 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.251 59.5 mttp -67.28 -37.9 84.17 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 113.08 0.77 . . . . 72.349999999999994 113.08 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.405 HD23 ' CE2' ' A' ' 452' ' ' PHE . 41.5 tp -67.77 -36.78 81.11 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.143 0.497 . . . . 74.349999999999994 109.728 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.3 m -60.65 -42.69 97.5 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 51.439999999999998 109.294 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.7 -19.65 62.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.414 -0.812 . . . . 74.329999999999998 111.336 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.21 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.275 0.56 . . . . 60.219999999999999 110.218 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.32 29.36 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.767 -0.73 . . . . 72.129999999999995 113.437 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.93 130.96 35.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.883 0.341 . . . . 74.209999999999994 110.597 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 30.4 4.27 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.11 -0.796 . . . . 72.340000000000003 111.11 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -132.58 115.9 16.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.551 -0.907 . . . . 74.340000000000003 108.551 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.405 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.9 m-85 -133.39 148.09 51.8 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.177 -0.919 . . . . 63.399999999999999 110.306 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.476 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.2 tppp? -138.97 122.64 17.49 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.202 -1.777 . . . . 73.439999999999998 106.202 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -103.1 135.22 45.17 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.874 0.369 . . . . 74.099999999999994 111.321 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.91 152.34 43.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.696 -1.594 . . . . 70.129999999999995 106.696 172.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.67 150.74 48.82 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.879 -0.786 . . . . 73.019999999999996 108.879 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.4 m -140.22 150.25 60.86 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 109.11 -0.7 . . . . 75.109999999999999 109.11 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.2 Cg_exo -65.39 132.44 31.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.325 2.017 . . . . 71.129999999999995 111.218 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.2 m -146.8 177.12 9.35 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.229 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.0 t -62.54 144.49 95.69 Favored Pre-proline 0 N--CA 1.432 -1.347 0 C-N-CA 123.852 0.861 . . . . 61.200000000000003 110.015 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.15 -31.72 37.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.966 3.111 . . . . 73.239999999999995 113.067 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.99 -12.04 60.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 120.027 -0.669 . . . . 75.019999999999996 111.754 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.5 mt -109.61 -4.45 16.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.7 -0.227 . . . . 73.099999999999994 111.528 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.8 t -61.2 127.5 20.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.567 -0.531 . . . . 74.409999999999997 109.567 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.42 75.33 Favored Glycine 0 C--O 1.25 1.101 0 C-N-CA 121.082 -0.58 . . . . 53.439999999999998 111.738 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 95.5 mttt -125.27 159.22 32.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.405 -0.961 . . . . 75.310000000000002 108.405 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 486' ' ' ILE . 39.1 t -82.75 133.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 109.329 -0.619 . . . . 75.219999999999999 109.329 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.72 -7.59 9.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 120.462 -0.495 . . . . 74.219999999999999 110.342 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.16 165.08 18.48 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.995 -0.842 . . . . 63.420000000000002 110.995 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.1 p -120.0 145.45 46.79 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.25 -0.648 . . . . 42.43 109.25 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.471 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.1 t-20 -57.4 -50.58 87.37 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 118.981 -0.533 . . . . 64.450000000000003 111.886 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.3 Cg_exo -76.7 131.82 12.69 Favored 'Trans proline' 0 C--N 1.37 1.709 0 N-CA-C 108.377 -1.432 . . . . 75.549999999999997 108.377 171.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.65 138.56 70.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.429 2.086 . . . . 73.209999999999994 112.037 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.49 1.77 50.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.133 0.968 . . . . 54.32 110.484 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.03 -27.78 15.45 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.798 -1.092 . . . . 73.340000000000003 109.639 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -109.89 164.85 12.19 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.848 -0.614 . . . . 71.319999999999993 109.455 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 15.5 p -90.61 136.86 32.79 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 120.736 0.303 . . . . 70.109999999999999 111.247 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.7 m -120.1 142.03 49.26 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.69 -0.856 . . . . 71.319999999999993 108.69 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.97 39.35 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.932 0.345 . . . . 74.329999999999998 111.932 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.81 -23.54 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.044 0.937 . . . . 74.219999999999999 111.282 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -80.67 -8.94 59.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.549 -0.75 . . . . 75.219999999999999 110.9 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 140.63 43.3 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.921 0.391 . . . . 71.030000000000001 112.04 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.3 122.89 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.942 -1.133 . . . . 74.0 107.942 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.95 118.84 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.223 -1.029 . . . . 74.409999999999997 108.223 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.476 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.6 mp -92.74 117.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.064 -1.828 . . . . 75.430000000000007 106.064 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.56 120.57 62.36 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 CA-C-N 115.566 -0.743 . . . . 73.409999999999997 109.429 -174.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.66 121.45 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.645 0.736 . . . . 75.439999999999998 111.242 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 142.72 13.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.778 -1.101 . . . . 74.409999999999997 109.386 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.38 118.99 4.9 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 109.024 -1.63 . . . . 63.420000000000002 109.024 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.6 t -122.79 155.6 36.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.557 -0.905 . . . . 65.010000000000005 108.557 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.947 0 N-CA-C 109.602 -1.399 . . . . 62.32 109.602 178.514 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 CA-C-O 122.123 0.963 . . . . 73.209999999999994 110.448 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 546' ' ' PRO . 8.9 p -140.41 153.86 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.735 -1.12 . . . . 73.120000000000005 109.053 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.96 146.96 36.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.328 -0.249 . . . . 74.239999999999995 110.328 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.41 135.53 41.71 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.613 -0.884 . . . . 75.140000000000001 108.613 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.99 137.7 28.01 Favored Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 115.919 -0.582 . . . . 72.319999999999993 111.526 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.19 -172.09 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.224 1.949 . . . . 74.540000000000006 110.25 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.1 128.58 35.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.169 0.509 . . . . 72.25 110.487 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.39 4.16 2.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.845 0.831 . . . . 64.340000000000003 109.435 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.67 144.06 26.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.489 -0.778 . . . . 62.039999999999999 110.279 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 95.3 13.09 53.25 Favored Glycine 0 CA--C 1.498 -1.007 0 N-CA-C 111.081 -0.808 . . . . 61.240000000000002 111.081 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -118.88 176.18 5.4 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.056 -1.09 . . . . 75.349999999999994 108.056 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 m -86.58 155.41 20.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.715 -1.217 . . . . 62.219999999999999 107.715 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 10.3 p -54.87 -41.51 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 123.383 0.427 . . . . 73.450000000000003 111.968 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.25 -42.53 83.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.138 0.422 . . . . 72.150000000000006 112.138 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.52 -34.38 24.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 119.884 -0.726 . . . . 70.200000000000003 110.646 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.431 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -61.14 -47.66 85.2 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.078 -0.964 . . . . 74.209999999999994 111.017 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.2 mt-30 -62.75 -38.3 89.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.631 0.582 . . . . 73.549999999999997 110.002 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 514' ' ' VAL . 44.7 mmtm -63.03 -52.82 61.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.529 0.518 . . . . 74.439999999999998 111.911 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.57 -42.78 99.76 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 110.939 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.09 -43.33 95.72 Favored 'General case' 0 C--O 1.197 -1.698 0 CA-C-N 115.641 -0.709 . . . . 75.519999999999996 109.939 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.99 -38.61 79.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.41 0.684 . . . . 70.340000000000003 111.383 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.8 t -62.03 -40.52 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.291 -0.413 . . . . 71.519999999999996 111.63 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -101.29 -36.4 8.91 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.505 -0.878 . . . . 72.200000000000003 110.863 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -89.6 -115.77 1.55 Allowed Glycine 0 N--CA 1.415 -2.739 0 CA-C-N 114.435 -1.257 . . . . 74.209999999999994 115.783 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 17.3 m-85 -125.15 -175.29 3.26 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.194 -0.503 . . . . 73.409999999999997 110.235 -167.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.3 p -113.2 -7.71 13.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.305 0.483 . . . . 74.219999999999999 112.305 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.65 120.86 43.69 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 120.617 -0.433 . . . . 63.5 110.147 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -125.67 155.97 40.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.42 -0.809 . . . . 72.120000000000005 109.284 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 154.82 45.61 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.842 -1.54 . . . . 75.450000000000003 106.842 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -120.97 128.42 52.71 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.229 -0.588 . . . . 72.239999999999995 110.193 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.07 131.19 57.01 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.086 -1.079 . . . . 61.409999999999997 108.086 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.3 p -88.78 131.41 35.07 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.745 -0.661 . . . . 74.430000000000007 111.184 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.4 m -121.96 162.0 21.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.803 -1.184 . . . . 75.439999999999998 107.803 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -79.8 123.75 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.254 0.549 . . . . 75.140000000000001 111.733 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 7.2 m -85.15 149.75 53.44 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.203 -0.908 . . . . 63.200000000000003 108.567 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.599 1.532 . . . . 75.450000000000003 109.285 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -122.97 -58.46 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.802 -0.618 . . . . 74.400000000000006 111.003 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.34 148.4 54.96 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.823 1.33 . . . . 65.230000000000004 111.522 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.71 175.68 9.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.045 -0.724 . . . . 54.420000000000002 109.045 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 86.51 -15.85 48.51 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 121.256 -0.497 . . . . 54.229999999999997 111.927 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.92 147.83 25.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.657 0.741 . . . . 73.400000000000006 111.598 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.431 HG23 ' CB ' ' A' ' 508' ' ' ALA . 69.7 t -81.46 123.7 38.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 114.991 -1.004 . . . . 71.219999999999999 109.614 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.9 m -86.13 -26.45 25.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.733 -1.122 . . . . 72.120000000000005 109.242 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.13 -153.27 23.72 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 111.019 -0.832 . . . . 74.310000000000002 111.019 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -134.81 161.29 35.63 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.954 -0.758 . . . . 74.340000000000003 108.954 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -54.69 -54.44 49.08 Favored Pre-proline 0 CA--C 1.561 1.374 0 O-C-N 123.291 0.369 . . . . 70.319999999999993 110.615 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.35 149.4 14.96 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.103 1.202 . . . . 75.420000000000002 110.191 171.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -67.64 154.13 74.26 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.317 2.011 . . . . 62.119999999999997 113.024 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.78 129.56 40.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.18 -0.674 . . . . 43.350000000000001 109.18 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.59 46.46 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 111.862 -0.495 . . . . 54.109999999999999 111.862 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 93.2 m -78.06 137.36 38.2 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.986 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 25.6 m -94.56 123.89 38.26 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.727 -0.669 . . . . 74.540000000000006 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.9 155.0 78.27 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 110.092 -0.336 . . . . 75.200000000000003 110.092 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.419 ' HA ' HG23 ' A' ' 494' ' ' THR . 26.4 Cg_exo -64.03 139.72 68.75 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.242 2.628 . . . . 74.25 112.482 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.542 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 16.3 m -67.75 -21.19 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.785 0.803 . . . . 72.239999999999995 111.114 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.12 -10.92 59.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.646 -1.161 . . . . 75.400000000000006 110.349 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.8 t -93.24 155.1 17.64 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.927 -0.768 . . . . 72.209999999999994 108.927 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.68 130.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.937 -0.764 . . . . 71.150000000000006 108.937 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 18.7 tt -93.64 135.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.539 0.685 . . . . 75.319999999999993 111.377 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -102.74 124.49 48.37 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.65 -0.705 . . . . 75.120000000000005 109.485 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 28.4 tp -96.72 132.78 42.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.893 -1.048 . . . . 74.310000000000002 109.204 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -96.33 106.66 18.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.414 -1.328 . . . . 71.219999999999999 107.414 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.62 137.0 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 111.125 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.464 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 50.2 m -65.83 115.65 6.17 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.025 -1.102 . . . . 72.510000000000005 108.025 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 C--N 1.314 -0.955 0 O-C-N 123.643 0.589 . . . . 73.540000000000006 109.773 -176.345 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.238 0.479 0 N-CA-C 109.516 -0.55 . . . . 74.340000000000003 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 66.2 mt-30 -83.83 138.74 33.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.842 -0.617 . . . . 62.539999999999999 112.435 -171.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -130.18 154.73 47.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.852 -1.907 . . . . 75.420000000000002 105.852 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.15 28.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 117.737 0.244 . . . . 74.329999999999998 110.727 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.2 mp -79.69 129.98 69.25 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 108.493 -0.928 . . . . 74.030000000000001 108.493 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.61 141.14 54.05 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.938 1.759 . . . . 75.510000000000005 111.062 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.39 67.23 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.267 1.032 . . . . 74.209999999999994 109.844 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.39 -2.55 9.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.556 -1.646 . . . . 74.040000000000006 106.556 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 8.2 m -60.96 -41.22 95.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.394 -1.73 . . . . 74.200000000000003 111.373 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 13.9 t -58.15 -26.29 62.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.6 -0.727 . . . . 74.400000000000006 111.623 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.93 -44.53 18.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.318 -0.553 . . . . 73.430000000000007 110.916 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.474 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.5 m -164.64 145.2 7.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.695 -0.854 . . . . 74.519999999999996 108.695 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.38 -43.65 79.45 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.787 0.835 . . . . 72.310000000000002 110.77 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.17 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.695 0.76 . . . . 74.209999999999994 110.704 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.9 mm-40 -70.42 -38.78 74.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.663 -0.699 . . . . 72.439999999999998 110.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -59.84 -50.95 71.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.472 -0.786 . . . . 73.5 111.036 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.4 t -59.37 -46.32 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 111.571 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -65.13 -44.79 87.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.744 -0.383 . . . . 75.200000000000003 111.139 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -63.4 -44.69 93.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.259 -0.428 . . . . 75.209999999999994 111.821 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.591 HD21 ' CE2' ' A' ' 452' ' ' PHE . 29.4 tp -67.26 -40.11 86.17 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.329 -0.396 . . . . 75.140000000000001 110.295 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.2 m -60.44 -44.15 96.12 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 110.468 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.08 -18.05 62.56 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.784 -0.644 . . . . 74.310000000000002 111.431 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.62 57.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.092 0.472 . . . . 70.450000000000003 110.825 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.9 -6.03 37.17 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.368 -0.92 . . . . 72.430000000000007 112.675 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.7 130.84 35.2 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.098 -0.704 . . . . 74.510000000000005 109.098 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.62 2.03 6.47 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.47 -0.872 . . . . 71.439999999999998 113.129 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -104.37 115.35 30.22 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.126 -1.065 . . . . 73.109999999999999 108.126 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.591 ' CE2' HD21 ' A' ' 444' ' ' LEU . 27.0 m-85 -123.28 144.89 49.12 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.318 0.58 . . . . 75.439999999999998 110.8 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -135.26 122.62 21.79 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.77 -1.567 . . . . 72.329999999999998 106.77 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -93.89 121.75 35.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.045 0.45 . . . . 64.349999999999994 109.881 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.02 151.68 45.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.929 -1.138 . . . . 75.030000000000001 107.929 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -132.03 134.35 45.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.331 -0.618 . . . . 74.329999999999998 109.331 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.4 m -119.04 137.53 25.2 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 107.979 -1.119 . . . . 74.120000000000005 107.979 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.07 121.63 9.17 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.458 1.438 . . . . 74.310000000000002 109.606 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -138.93 179.22 6.62 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.121 -1.437 . . . . 73.530000000000001 107.121 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.3 t -56.43 126.24 68.65 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-O 121.659 0.742 . . . . 72.409999999999997 110.164 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.51 -28.91 29.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 125.25 3.966 . . . . 63.020000000000003 115.739 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.69 -15.96 62.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.66 0.615 . . . . 73.510000000000005 112.66 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 73.3 mt -87.69 4.74 42.89 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 72.140000000000001 112.149 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.5 p -60.25 130.08 23.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 121.023 0.439 . . . . 61.25 110.172 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.51 68.54 Favored Glycine 0 C--N 1.307 -1.04 0 C-N-CA 120.631 -0.795 . . . . 61.200000000000003 111.656 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.88 144.33 42.62 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.138 0.494 . . . . 73.450000000000003 109.914 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.441 HG22 HD11 ' A' ' 486' ' ' ILE . 46.0 t -82.13 135.82 24.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.376 -0.972 . . . . 73.219999999999999 108.376 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.3 pt -97.96 -29.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 119.84 -0.744 . . . . 71.140000000000001 110.417 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -174.28 161.17 31.11 Favored Glycine 0 N--CA 1.424 -2.162 0 C-N-CA 120.395 -0.907 . . . . 74.209999999999994 111.639 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.0 p -118.7 152.81 35.44 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.194 -0.669 . . . . 73.140000000000001 109.194 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.473 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 16.7 t-20 -62.76 -54.56 46.34 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-O 119.156 -0.45 . . . . 73.219999999999999 111.416 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -75.81 134.16 16.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 N-CA-C 108.529 -1.374 . . . . 63.43 108.529 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.89 143.65 73.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.854 2.37 . . . . 72.439999999999998 113.206 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -88.89 -7.57 55.86 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.442 1.115 . . . . 60.32 109.437 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.91 -33.01 17.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.449 -1.25 . . . . 75.230000000000004 110.06 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -114.91 175.67 5.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.597 -0.729 . . . . 75.150000000000006 110.681 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 18.0 p -92.42 139.98 30.04 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 116.338 -0.392 . . . . 72.0 109.99 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 53.4 m -130.1 147.07 51.8 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.883 -0.784 . . . . 74.420000000000002 108.883 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.468 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.98 150.37 48.76 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.521 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.38 -24.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.626 -0.715 . . . . 72.319999999999993 110.025 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -81.14 2.27 28.24 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.807 -0.633 . . . . 70.209999999999994 111.085 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.37 145.66 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.924 -0.398 . . . . 71.5 109.924 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.4 p -86.35 120.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.265 -1.013 . . . . 71.420000000000002 108.265 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.44 117.23 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 C-N-CA 118.233 -1.387 . . . . 73.120000000000005 107.456 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.473 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.4 mt -97.97 112.21 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 105.438 -2.06 . . . . 74.109999999999999 105.438 175.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.85 120.4 51.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 N-CA-C 108.346 -0.983 . . . . 73.430000000000007 108.346 -175.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 120.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.328 0.585 . . . . 74.049999999999997 110.124 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.72 138.83 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.887 -1.153 . . . . 73.019999999999996 107.887 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.9 104.66 2.23 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 108.753 -1.739 . . . . 71.439999999999998 108.753 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.5 t -105.63 139.73 39.78 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.815 -1.18 . . . . 72.150000000000006 107.815 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.953 0 N-CA-C 108.902 -1.679 . . . . 74.230000000000004 108.902 177.168 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.888 0 N-CA-C 108.965 -0.754 . . . . 73.230000000000004 108.965 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 546' ' ' PRO . 46.1 p -121.68 158.96 27.56 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.813 -1.085 . . . . 74.310000000000002 108.379 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -150.0 148.53 29.17 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.087 -0.338 . . . . 74.340000000000003 110.087 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.5 p-10 -80.36 131.6 35.65 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.45 0.643 . . . . 60.0 110.322 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.3 pt -75.4 131.29 77.98 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.177 -0.919 . . . . 75.450000000000003 111.461 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -92.14 119.64 0.5 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 122.639 2.226 . . . . 74.409999999999997 111.753 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.75 122.28 28.89 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.675 -1.232 . . . . 75.010000000000005 107.675 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.44 43.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.829 1.299 . . . . 72.129999999999995 110.631 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.72 145.97 43.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.358 -1.292 . . . . 72.340000000000003 112.242 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.0 -12.64 31.83 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.134 -0.555 . . . . 73.109999999999999 113.012 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.518 ' O ' HG11 ' A' ' 534' ' ' VAL . 25.5 mt-30 -108.17 -170.9 1.76 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 121.048 -0.261 . . . . 75.319999999999993 111.311 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.1 m -85.07 156.36 21.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.498 -1.297 . . . . 73.109999999999999 107.498 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.99 -41.19 90.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.576 0.626 . . . . 72.239999999999995 111.232 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.82 -42.06 97.73 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 116.492 -0.322 . . . . 65.319999999999993 111.424 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.8 -34.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 119.194 -1.003 . . . . 74.430000000000007 111.018 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.78 86.66 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.873 -0.603 . . . . 74.430000000000007 110.247 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -61.91 -42.27 98.89 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 123.255 0.347 . . . . 72.030000000000001 110.097 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.25 -48.36 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.342 -0.614 . . . . 73.310000000000002 109.342 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 -38.9 92.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.540000000000006 110.771 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.29 -43.68 73.34 Favored 'General case' 0 C--O 1.186 -2.263 0 CA-C-N 115.352 -0.84 . . . . 73.310000000000002 110.185 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.36 -46.55 86.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.433 0.635 . . . . 74.329999999999998 111.435 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.04 -18.65 21.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 74.310000000000002 111.316 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -129.87 18.41 5.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.932 -0.766 . . . . 75.0 108.932 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -162.61 -110.74 0.25 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.111 -1.042 . . . . 44.539999999999999 114.691 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -123.31 167.74 13.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.856 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 9.3 p -104.68 7.03 34.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.829 0.678 . . . . 73.310000000000002 112.829 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.0 OUTLIER -131.04 123.01 27.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.775 0.321 . . . . 73.230000000000004 110.781 -178.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.76 152.15 48.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 74.099999999999994 110.528 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 47.8 t -127.51 147.83 50.32 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.818 -1.919 . . . . 70.0 105.818 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -121.53 127.51 51.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 110.258 -0.275 . . . . 74.439999999999998 110.258 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 135.29 48.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.8 -0.637 . . . . 73.409999999999997 109.741 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 2.7 p -88.47 130.1 35.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.71 -0.677 . . . . 74.140000000000001 109.551 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.605 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.44 159.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.639 -0.504 . . . . 73.239999999999995 109.639 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.32 115.95 17.53 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.962 0.887 . . . . 73.400000000000006 109.795 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.9 m -95.26 157.3 36.61 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.883 -1.508 . . . . 71.230000000000004 110.68 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.72 -142.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.641 2.227 . . . . 73.439999999999998 108.817 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.578 ' HA ' ' NE ' ' A' ' 529' ' ' ARG . 4.3 mmp_? -58.35 -49.78 91.69 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 113.481 0.919 . . . . 73.510000000000005 113.481 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.82 149.0 47.17 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.269 1.313 . . . . 73.109999999999999 111.455 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.86 145.97 26.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.254 -1.017 . . . . 74.109999999999999 108.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.48 -53.07 0.74 Allowed Glycine 0 N--CA 1.437 -1.274 0 C-N-CA 120.683 -0.77 . . . . 74.299999999999997 112.431 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.06 149.56 48.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.127 0.571 . . . . 52.109999999999999 111.965 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -73.49 127.65 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 121.486 0.66 . . . . 73.230000000000004 109.584 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -24.65 44.55 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.717 -1.128 . . . . 74.329999999999998 109.642 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.09 -146.38 16.63 Favored Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 111.311 -0.716 . . . . 64.420000000000002 111.311 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -116.19 160.07 20.91 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.487 -0.931 . . . . 72.439999999999998 108.487 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -53.74 -54.24 48.56 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 111.813 0.301 . . . . 71.319999999999993 111.813 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.4 Cg_endo -92.56 167.67 2.73 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.253 1.969 . . . . 65.109999999999999 110.179 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.95 155.6 57.35 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.466 2.11 . . . . 71.450000000000003 111.538 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 137.88 58.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.757 -0.46 . . . . 75.25 109.757 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.43 -19.11 34.62 Favored Glycine 0 C--N 1.294 -1.751 0 C-N-CA 120.023 -1.084 . . . . 75.310000000000002 111.717 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -65.64 123.14 18.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.484 -0.932 . . . . 74.510000000000005 108.484 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 16.8 m -94.87 122.48 37.55 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.703 -0.48 . . . . 75.420000000000002 109.703 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.74 159.19 69.48 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.662 -0.866 . . . . 72.129999999999995 108.662 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.404 ' HA ' HG21 ' A' ' 494' ' ' THR . 32.2 Cg_exo -61.39 139.25 81.47 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.074 1.849 . . . . 72.519999999999996 111.339 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.63 -18.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.302 -0.863 . . . . 75.340000000000003 112.481 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.58 -9.55 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.16 -0.927 . . . . 74.519999999999996 109.78 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 45.1 m -92.34 152.1 19.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.217 -0.901 . . . . 54.200000000000003 110.795 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.5 t -88.38 133.53 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.869 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.2 tt -98.49 139.27 20.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.513 -0.551 . . . . 74.239999999999995 109.513 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.82 125.83 49.71 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 109.902 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.82 133.7 42.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.453 -0.943 . . . . 71.25 108.453 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -97.51 111.19 23.56 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.035 -1.098 . . . . 72.439999999999998 108.035 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.21 137.71 41.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 C-N-CA 120.532 -0.467 . . . . 75.430000000000007 111.996 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.2 m -68.02 117.67 10.18 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.353 -1.351 . . . . 73.200000000000003 107.353 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 8.1 ptmm? . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 118.516 -0.754 . . . . 75.530000000000001 112.341 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 121.164 0.507 . . . . 74.420000000000002 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -83.9 147.21 27.64 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 119.683 -0.807 . . . . 74.430000000000007 109.384 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 7.9 tpp85 -143.26 161.16 39.03 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.137 -1.06 . . . . 75.120000000000005 108.137 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.23 140.29 33.76 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 123.582 0.753 . . . . 64.010000000000005 112.018 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -96.67 126.89 41.47 Favored Pre-proline 0 N--CA 1.424 -1.735 0 N-CA-C 104.607 -2.368 . . . . 74.439999999999998 104.607 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.62 141.34 90.82 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.35 2.034 . . . . 73.209999999999994 114.381 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -100.76 -5.22 26.67 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.845 -1.07 . . . . 52.420000000000002 108.492 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.43 -4.68 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 122.542 1.163 . . . . 73.439999999999998 108.524 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 10.0 m -58.51 -31.98 68.4 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.922 -1.49 . . . . 75.340000000000003 109.283 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -57.14 -27.51 61.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.538 -1.21 . . . . 70.099999999999994 110.642 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.1 mt -89.99 -44.47 9.84 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.008 -0.677 . . . . 74.439999999999998 111.724 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 24.5 m -158.34 143.55 16.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.326 -0.859 . . . . 74.519999999999996 109.947 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.27 -45.92 79.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.848 0.459 . . . . 63.420000000000002 110.006 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.73 -35.27 65.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.901 -0.591 . . . . 75.349999999999994 111.782 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.468 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.0 mm-40 -70.79 -43.59 68.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.412 -0.358 . . . . 72.329999999999998 111.154 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.07 -51.22 70.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.363 -0.835 . . . . 73.099999999999994 110.554 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.87 -47.62 88.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 115.493 -0.776 . . . . 73.030000000000001 112.125 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -64.81 -42.91 94.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.677 -0.409 . . . . 74.25 111.629 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -66.44 -45.49 79.65 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.096 0.474 . . . . 74.299999999999997 110.176 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 34.6 tp -68.58 -37.35 79.78 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.767 -0.651 . . . . 73.349999999999994 111.065 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.9 m -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 109.846 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.9 -15.45 62.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.967 -0.56 . . . . 74.409999999999997 110.921 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -81.14 -14.83 57.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.211 0.529 . . . . 73.230000000000004 110.098 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.31 58.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.298 -0.954 . . . . 73.400000000000006 113.652 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 90.6 m-85 -72.58 146.02 46.98 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.911 -0.774 . . . . 74.5 108.911 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.25 -7.01 2.31 Favored Glycine 0 C--N 1.303 -1.275 0 C-N-CA 120.006 -1.092 . . . . 74.439999999999998 112.656 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 0.0 OUTLIER -102.5 115.42 30.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.859 -1.534 . . . . 75.150000000000006 106.859 -178.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.08 149.37 50.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.175 0.512 . . . . 75.150000000000006 110.722 -173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 485' ' ' ILE . 17.6 tppt? -138.64 123.02 18.3 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.537 -1.283 . . . . 74.349999999999994 107.537 169.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -102.74 134.85 45.45 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.331 0.586 . . . . 75.129999999999995 111.114 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.14 158.42 44.49 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.183 -1.043 . . . . 75.129999999999995 108.183 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -135.2 146.91 49.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.231 -1.026 . . . . 74.019999999999996 108.231 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.1 t -133.6 131.3 21.23 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.352 -0.981 . . . . 63.539999999999999 108.352 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -65.87 120.89 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.775 1.65 . . . . 73.519999999999996 109.989 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.0 m -140.79 179.48 6.68 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 106.735 -1.58 . . . . 74.319999999999993 106.735 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -52.49 133.82 44.18 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.341 0.401 . . . . 70.420000000000002 111.581 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG11 ' A' ' 464' ' ' VAL . 86.9 Cg_exo -50.45 -26.51 16.45 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 125.071 3.847 . . . . 72.319999999999993 113.05 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -57.27 -33.22 67.39 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.304 0.642 . . . . 53.520000000000003 110.568 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 93.9 mt -103.83 11.07 36.17 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.567 0.58 . . . . 74.120000000000005 112.567 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 461' ' ' PRO . 12.3 p -61.21 128.15 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 119.927 -0.709 . . . . 75.400000000000006 110.595 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.13 77.69 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 120.887 -0.673 . . . . 64.209999999999994 112.163 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.7 mptp? -100.31 148.69 24.4 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.685 -0.857 . . . . 74.120000000000005 108.685 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.93 125.35 39.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.758 -1.201 . . . . 70.129999999999995 107.758 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.92 -10.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 120.852 0.358 . . . . 74.200000000000003 111.386 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.22 149.04 8.06 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.176 -1.012 . . . . 71.239999999999995 112.193 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -119.03 140.48 49.97 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.494 -1.299 . . . . 74.120000000000005 107.494 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.6 t-20 -62.59 -53.83 53.56 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-O 118.963 -0.541 . . . . 75.420000000000002 111.765 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.1 Cg_exo -74.34 146.0 34.99 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 108.583 -1.353 . . . . 74.519999999999996 108.583 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.7 134.28 46.45 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.415 2.077 . . . . 72.200000000000003 112.918 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.63 6.44 47.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.481 1.134 . . . . 74.409999999999997 109.529 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.37 -21.87 13.75 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.279 -1.328 . . . . 63.130000000000003 109.278 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.7 155.54 39.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 111.413 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.7 p -83.99 123.91 30.49 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.653 -0.703 . . . . 74.140000000000001 109.516 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.8 m -115.59 150.74 36.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.716 -0.846 . . . . 62.310000000000002 108.716 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.99 151.21 46.51 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.24 0.216 . . . . 71.409999999999997 111.338 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.96 -17.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.83 0.852 . . . . 75.010000000000005 112.215 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.4 t -72.04 -6.05 39.55 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 116.44 -0.345 . . . . 72.519999999999996 110.851 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.95 131.1 35.75 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 122.633 0.373 . . . . 73.239999999999995 111.996 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.79 123.57 38.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.867 -1.16 . . . . 72.200000000000003 107.867 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.34 118.18 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 C-N-CA 119.067 -1.053 . . . . 74.510000000000005 109.322 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -97.21 112.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.685 -1.969 . . . . 73.129999999999995 105.685 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.42 121.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 115.908 -0.587 . . . . 73.310000000000002 109.559 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.97 120.45 52.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.183 0.516 . . . . 75.400000000000006 109.894 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.0 t -96.05 140.32 17.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-N 115.694 -0.684 . . . . 74.209999999999994 109.19 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.31 114.03 3.85 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.368 -1.093 . . . . 72.049999999999997 110.368 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 40.6 t -98.84 133.56 42.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.013 -1.106 . . . . 63.119999999999997 108.013 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.528 0 N-CA-C 110.915 -0.874 . . . . 75.400000000000006 110.915 -178.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 108.259 -1.015 . . . . 75.409999999999997 108.259 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.7 p -131.55 143.9 50.71 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.429 -0.35 . . . . 74.239999999999995 110.534 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.84 164.59 27.23 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.07 -0.715 . . . . 72.349999999999994 109.07 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.17 134.02 35.77 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.06 -1.459 . . . . 74.200000000000003 107.06 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -76.65 132.49 71.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.67 -0.412 . . . . 74.109999999999999 110.251 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -91.42 178.46 1.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.763 2.309 . . . . 75.329999999999998 113.217 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.68 135.95 36.71 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.928 -1.138 . . . . 74.5 107.928 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.85 16.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.991 0.9 . . . . 61.020000000000003 109.407 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' A' ' 534' ' ' VAL . . . -68.06 132.43 47.24 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.899 -1.046 . . . . 62.420000000000002 111.801 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 117.91 -24.65 8.8 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.429 -0.891 . . . . 72.400000000000006 112.023 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.57 173.75 7.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.945 -0.761 . . . . 74.049999999999997 108.945 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 9.8 p -80.01 156.94 26.92 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.486 -0.486 . . . . 75.140000000000001 111.504 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.76 -42.26 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 O-C-N 123.838 0.712 . . . . 71.209999999999994 112.181 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.64 -39.44 80.71 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 121.017 -0.273 . . . . 73.439999999999998 111.592 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 83.8 t -71.1 -44.04 75.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.442 0.639 . . . . 73.319999999999993 110.827 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.08 -47.83 81.23 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 74.209999999999994 111.628 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.81 -35.62 81.68 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 121.042 -0.263 . . . . 71.310000000000002 110.579 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 514' ' ' VAL . 0.7 OUTLIER -65.14 -51.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.206 -0.664 . . . . 72.349999999999994 109.206 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.7 -37.8 87.92 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.96 -0.564 . . . . 74.420000000000002 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.67 -45.47 71.64 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.818 -0.628 . . . . 74.420000000000002 109.451 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.29 -41.27 88.53 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.033 0.753 . . . . 75.209999999999994 113.033 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 510' ' ' LYS . 90.3 t -64.23 -31.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 111.655 -177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.81 15.91 11.8 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.993 -0.283 . . . . 74.340000000000003 110.72 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.8 -98.08 0.2 Allowed Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 117.281 -2.39 . . . . 52.130000000000003 117.426 -169.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.646 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 78.1 m-85 -121.89 152.83 39.19 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.145 0.497 . . . . 74.549999999999997 111.791 -164.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.9 m -96.19 -27.48 15.01 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.02 -0.991 . . . . 73.430000000000007 111.871 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.75 134.66 51.16 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.156 -0.34 . . . . 75.129999999999995 110.09 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.77 145.53 51.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.347 0.594 . . . . 75.329999999999998 111.009 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.3 m -141.11 144.6 34.98 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.873 -1.529 . . . . 71.450000000000003 106.873 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.603 ' OE1' ' HB2' ' A' ' 553' ' ' LEU . 13.2 mm-40 -121.26 127.41 51.36 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.119 -1.067 . . . . 75.030000000000001 108.119 -172.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.427 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -114.28 133.45 55.64 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.991 -1.114 . . . . 73.030000000000001 107.991 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.7 m -88.55 130.81 35.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.165 0.507 . . . . 43.539999999999999 110.718 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.25 162.82 21.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 105.033 -2.21 . . . . 72.409999999999997 105.033 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.75 131.9 36.04 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 118.872 0.76 . . . . 61.149999999999999 111.991 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 66.4 p -77.04 150.38 80.88 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.946 -1.025 . . . . 75.400000000000006 109.215 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.52 -47.4 7.52 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.021 1.814 . . . . 71.5 110.512 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -163.2 -58.83 0.01 OUTLIER Pre-proline 0 C--O 1.222 -0.348 0 C-N-CA 127.316 2.246 . . . . 74.209999999999994 109.411 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 527' ' ' SER . 30.5 Cg_endo -66.85 135.96 39.99 Favored 'Trans proline' 0 C--N 1.36 1.137 0 N-CA-C 109.091 -1.157 . . . . 62.409999999999997 109.091 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.34 157.85 38.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.297 0.373 . . . . 73.109999999999999 110.145 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 115.13 -18.67 15.89 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 121.131 -0.557 . . . . 72.519999999999996 112.192 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.3 OUTLIER -87.36 148.46 25.02 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.253 0.549 . . . . 74.329999999999998 111.336 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 501' ' ' ALA . 11.4 p -81.26 128.87 38.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.822 -0.807 . . . . 73.430000000000007 108.822 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -78.44 -31.2 47.95 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.775 -0.824 . . . . 65.239999999999995 108.775 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.09 -157.29 28.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.16 -1.176 . . . . 52.329999999999998 110.16 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.4 p -117.56 160.77 20.7 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.154 -1.054 . . . . 72.030000000000001 108.154 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 64.4 t30 -58.67 -51.26 83.09 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 119.979 -0.688 . . . . 71.109999999999999 111.167 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.3 Cg_exo -81.53 155.73 18.68 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 121.33 1.353 . . . . 70.230000000000004 109.835 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.64 149.98 56.05 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.373 2.049 . . . . 71.230000000000004 112.025 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.18 129.89 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.353 0.661 . . . . 72.340000000000003 110.045 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -7.06 36.33 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.573 -0.822 . . . . 72.409999999999997 111.834 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.1 m -77.13 133.92 38.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.451 -0.574 . . . . 71.420000000000002 109.451 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.9 t -100.81 127.33 47.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.251 0.548 . . . . 73.430000000000007 110.312 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 517' ' ' PHE . 11.2 m -138.76 162.08 54.84 Favored Pre-proline 0 C--O 1.248 1.018 0 N-CA-C 109.331 -0.618 . . . . 72.140000000000001 109.331 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.84 135.03 46.23 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.483 2.122 . . . . 72.239999999999995 112.373 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.646 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 11.3 m -67.29 -21.12 27.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.699 0.762 . . . . 73.310000000000002 112.381 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.27 -7.96 55.95 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.602 -1.181 . . . . 64.010000000000005 109.324 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -92.14 179.0 5.69 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.432 -0.804 . . . . 72.439999999999998 110.764 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.31 124.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.84 -0.618 . . . . 64.340000000000003 112.365 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.3 tp -94.1 123.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 106.476 -1.676 . . . . 72.310000000000002 106.476 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.64 116.74 32.91 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-O 120.894 0.378 . . . . 74.109999999999999 110.082 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.603 ' HB2' ' OE1' ' A' ' 522' ' ' GLN . 6.1 mp -98.72 134.37 41.73 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.169 -0.923 . . . . 73.450000000000003 110.621 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.427 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 9.0 mm-40 -92.06 109.84 21.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.66 -1.978 . . . . 73.450000000000003 105.66 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.3 m -105.73 137.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 112.515 0.561 . . . . 74.519999999999996 112.515 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 49.5 m -72.72 114.53 10.96 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.577 0.703 . . . . 74.400000000000006 110.312 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 557' ' ' LYS . 7.3 tmtm? . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.046 -1.464 . . . . 75.519999999999996 107.046 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.992 0.901 . . . . 72.200000000000003 108.724 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.3 mt-30 -87.53 120.97 29.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.111 -0.95 . . . . 74.439999999999998 110.862 -174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -120.66 166.38 13.76 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.698 0.761 . . . . 73.209999999999994 110.536 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -84.38 140.3 31.66 Favored 'General case' 0 C--N 1.266 -3.053 0 CA-C-N 113.628 -1.623 . . . . 75.319999999999993 109.421 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.22 126.81 78.38 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 106.791 -1.559 . . . . 63.399999999999999 106.791 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.13 141.74 70.97 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.493 2.129 . . . . 71.219999999999999 112.399 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -112.41 70.64 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.532 1.158 . . . . 71.549999999999997 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.51 6.74 4.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 123.886 1.803 . . . . 65.5 106.226 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 0.7 OUTLIER -62.71 -30.97 71.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.32 -2.218 . . . . 73.109999999999999 109.308 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.0 m -58.37 -28.24 64.96 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 125.821 1.649 . . . . 64.25 110.642 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.5 -45.3 9.04 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.449 -0.501 . . . . 71.219999999999999 112.107 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.7 m -163.65 150.66 12.23 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.754 -0.832 . . . . 73.209999999999994 108.754 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.415 ' CZ ' HG22 ' A' ' 441' ' ' VAL . 32.7 t80 -53.08 -54.89 28.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.539 0.524 . . . . 75.549999999999997 110.704 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.7 -36.57 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 112.117 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -61.48 -45.77 92.83 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 112.313 0.486 . . . . 72.150000000000006 112.313 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -65.3 -44.58 87.49 Favored 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 123.68 0.613 . . . . 73.329999999999998 109.727 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.415 HG22 ' CZ ' ' A' ' 437' ' ' TYR . 90.8 t -59.02 -46.82 91.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.436 0 CA-C-N 115.368 -0.833 . . . . 74.019999999999996 111.629 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 442' ' ' LYS . 10.9 mmpt? -60.28 -47.03 87.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.824 0.284 . . . . 75.019999999999996 110.966 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.72 -38.95 87.71 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.937 -0.305 . . . . 63.549999999999997 111.244 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.8 tp -67.04 -41.27 86.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.16 0.505 . . . . 75.519999999999996 110.092 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.9 m -61.07 -45.27 95.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.998 -1.001 . . . . 73.219999999999999 109.022 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.96 62.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.68 -0.691 . . . . 74.129999999999995 111.718 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.28 -13.12 57.49 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.193 0.521 . . . . 74.530000000000001 110.724 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.93 20.35 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 120.665 -0.779 . . . . 65.230000000000004 112.3 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -69.23 118.08 11.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.53 -0.545 . . . . 74.239999999999995 109.53 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -106.72 -15.71 16.09 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.63 -0.714 . . . . 74.230000000000004 111.483 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -109.45 114.01 27.29 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.954 0.883 . . . . 74.25 110.344 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.7 154.46 40.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.665 -1.152 . . . . 75.209999999999994 111.208 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -131.33 125.45 32.76 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.16 -0.681 . . . . 73.349999999999994 109.16 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -88.69 121.02 30.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.981 0.419 . . . . 75.400000000000006 110.744 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.39 153.5 32.95 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 71.549999999999997 107.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.48 147.62 49.8 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.775 -0.824 . . . . 75.219999999999999 108.775 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.4 t -137.21 138.24 24.79 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 108.816 -0.809 . . . . 74.519999999999996 108.816 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.81 122.16 9.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 74.439999999999998 110.182 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -137.52 179.75 6.22 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.929 -1.137 . . . . 63.32 107.929 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.6 t -65.27 144.03 98.92 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.047 -0.723 . . . . 75.409999999999997 109.047 174.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.36 -28.03 25.82 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.571 3.514 . . . . 75.450000000000003 112.464 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -59.01 -34.44 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 123.393 0.677 . . . . 73.420000000000002 111.442 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.98 4.75 49.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.066 1.135 . . . . 75.430000000000007 114.066 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 79.5 t -60.5 130.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.152 0.501 . . . . 75.430000000000007 112.325 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.94 84.72 Favored Glycine 0 CA--C 1.504 -0.644 0 CA-C-N 115.252 -0.886 . . . . 72.129999999999995 112.646 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.07 151.62 38.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.838 -0.43 . . . . 75.420000000000002 109.838 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 486' ' ' ILE . 46.7 t -81.93 134.25 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.687 -0.857 . . . . 71.230000000000004 108.687 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.46 -24.36 4.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.59 -0.444 . . . . 70.140000000000001 111.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.85 168.05 38.17 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.684 -0.77 . . . . 74.209999999999994 111.952 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.3 p -121.03 153.13 37.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.668 -0.493 . . . . 72.209999999999994 109.668 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.467 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 23.2 t-20 -68.49 -52.74 19.17 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 119.299 -0.381 . . . . 73.019999999999996 111.272 174.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.76 129.64 10.08 Favored 'Trans proline' 0 C--N 1.365 1.418 0 CA-C-N 120.202 1.108 . . . . 75.439999999999998 109.605 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.41 ' HB2' ' NE2' ' A' ' 476' ' ' GLN . 28.9 Cg_endo -64.67 129.89 24.83 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.323 2.015 . . . . 75.230000000000004 112.25 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 0.71 30.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 111.605 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.99 -1.004 . . . . 55.329999999999998 109.165 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.584 HE21 ' N ' ' A' ' 476' ' ' GLN . 0.0 OUTLIER -129.79 157.84 41.08 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.109 -1.071 . . . . 71.430000000000007 108.109 177.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 37.4 p -86.72 123.67 32.13 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.997 -0.371 . . . . 74.230000000000004 109.997 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 50.4 m -108.58 145.18 35.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.395 -0.594 . . . . 71.439999999999998 109.395 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.26 153.2 43.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.152 -0.477 . . . . 71.219999999999999 110.781 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.87 -21.83 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.729 0.811 . . . . 74.540000000000006 110.7 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -76.66 9.09 3.0 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 116.037 -0.529 . . . . 74.209999999999994 111.944 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -98.6 145.83 26.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.378 0.271 . . . . 65.120000000000005 111.151 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.52 119.52 35.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.876 -1.157 . . . . 71.25 107.876 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 71.0 t -87.62 118.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 118.992 -1.083 . . . . 71.200000000000003 108.617 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.467 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 66.0 mt -94.86 114.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.795 -1.557 . . . . 74.239999999999995 106.795 176.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.27 128.36 59.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 115.656 -0.702 . . . . 75.310000000000002 109.488 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 38.1 mt -106.53 118.97 55.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 116.08 -0.509 . . . . 65.439999999999998 110.549 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.63 145.87 8.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.752 -0.658 . . . . 73.010000000000005 109.548 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -87.76 123.49 6.68 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.069 -0.812 . . . . 72.0 111.069 176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.8 m -123.6 137.61 54.71 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.414 -0.958 . . . . 62.509999999999998 108.414 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.681 0 C-N-CA 120.541 -0.838 . . . . 70.209999999999994 112.827 -175.593 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.193 0 CA-C-O 121.851 0.834 . . . . 72.040000000000006 111.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -134.67 154.39 51.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.206 -0.906 . . . . 74.409999999999997 110.85 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.49 149.6 30.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.869 -0.419 . . . . 75.409999999999997 109.869 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -90.58 139.14 30.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.654 -0.499 . . . . 74.450000000000003 109.654 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -96.19 138.44 21.59 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.777 -0.647 . . . . 73.310000000000002 112.019 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.25 171.26 11.46 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.522 2.148 . . . . 55.009999999999998 111.037 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -85.53 132.99 34.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.202 0.525 . . . . 74.010000000000005 110.174 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.73 11.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.962 0.887 . . . . 75.230000000000004 109.182 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.37 155.24 22.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.786 -0.643 . . . . 71.310000000000002 110.192 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 97.71 -13.26 64.08 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.539 -1.425 . . . . 63.140000000000001 109.539 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -94.53 179.65 5.2 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.438 -1.319 . . . . 75.109999999999999 107.438 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.0 m -83.67 155.28 23.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.718 -1.216 . . . . 73.019999999999996 107.718 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.8 -42.95 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.38 0.511 . . . . 73.230000000000004 112.38 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.24 -42.55 75.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.058 0.392 . . . . 70.129999999999995 112.058 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -75.08 -35.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.551 -0.86 . . . . 74.530000000000001 111.036 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.18 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.273 -0.876 . . . . 75.140000000000001 111.354 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.44 -34.74 78.89 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 121.249 -0.18 . . . . 75.0 110.969 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -64.67 -49.1 72.31 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.111 -0.329 . . . . 74.319999999999993 110.111 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.77 -46.52 81.79 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.242 0.544 . . . . 65.409999999999997 110.377 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.8 -36.58 81.53 Favored 'General case' 0 C--O 1.181 -2.551 0 CA-C-N 115.113 -0.949 . . . . 72.5 110.855 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.98 -39.28 81.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.246 0.546 . . . . 73.219999999999999 110.4 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.33 -34.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.496 -0.775 . . . . 73.420000000000002 111.336 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -111.27 11.3 21.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.566 0.698 . . . . 74.439999999999998 111.802 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.87 -111.97 1.33 Allowed Glycine 0 N--CA 1.417 -2.593 0 CA-C-N 115.412 -0.813 . . . . 75.519999999999996 111.893 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 37.1 m-85 -133.16 -177.15 4.39 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.542 -0.54 . . . . 72.439999999999998 109.542 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -106.98 -7.95 16.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.647 0.737 . . . . 72.530000000000001 109.729 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -108.11 115.99 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.863 -0.608 . . . . 63.329999999999998 110.061 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -126.25 151.49 47.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.785 0.802 . . . . 75.239999999999995 112.366 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.8 m -136.87 151.67 49.36 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.202 -1.407 . . . . 75.219999999999999 107.202 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.528 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.7 mm-40 -121.33 131.14 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.38 -0.6 . . . . 74.010000000000005 109.38 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.5 130.96 56.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.374 -0.602 . . . . 75.140000000000001 109.374 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 15.3 m -93.55 120.82 34.29 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.99 -0.745 . . . . 60.530000000000001 108.99 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.5 m -122.01 162.29 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 74.129999999999995 108.157 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . 0.262 13.8 m-20 -82.39 141.85 32.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.943 1.46 . . . . 74.439999999999998 114.943 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 2.7 m -97.55 144.03 27.24 Favored Pre-proline 0 C--N 1.28 -2.45 0 CA-C-N 113.425 -1.716 . . . . 73.430000000000007 109.016 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.94 -69.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 107.939 -1.6 . . . . 73.219999999999999 107.939 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -118.39 -59.4 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 118.494 -0.765 . . . . 75.329999999999998 112.291 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 527' ' ' SER . 54.7 Cg_endo -69.15 136.79 35.56 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 121.454 1.436 . . . . 71.439999999999998 111.811 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.08 123.03 16.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.861 -0.792 . . . . 65.319999999999993 108.861 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.08 -18.45 6.58 Favored Glycine 0 C--N 1.296 -1.662 0 N-CA-C 109.388 -1.485 . . . . 55.140000000000001 109.388 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -79.09 147.42 32.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.245 -0.977 . . . . 72.329999999999998 109.542 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.16 115.54 17.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 107.971 -1.122 . . . . 74.200000000000003 107.971 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 16.9 m -78.26 -24.83 46.68 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.65 -0.704 . . . . 75.409999999999997 109.544 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.54 -175.39 43.16 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.84 -0.904 . . . . 72.319999999999993 110.84 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.3 p -119.69 158.55 26.24 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.013 -1.477 . . . . 73.439999999999998 107.013 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.451 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -59.43 -53.14 68.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.292 -0.563 . . . . 73.450000000000003 111.609 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.6 Cg_endo -86.81 147.71 8.25 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.21 1.273 . . . . 64.219999999999999 109.172 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.63 153.01 65.2 Favored 'Trans proline' 0 C--O 1.245 0.825 0 C-N-CA 122.022 1.815 . . . . 73.129999999999995 112.279 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 129.49 40.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.87 -0.605 . . . . 72.319999999999993 109.488 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.34 -19.08 37.73 Favored Glycine 0 C--N 1.304 -1.225 0 C-N-CA 121.122 -0.561 . . . . 75.420000000000002 111.744 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 87.5 m -75.03 132.42 41.31 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.915 0.388 . . . . 71.030000000000001 110.386 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 29.1 m -91.05 123.72 34.73 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.79 -0.819 . . . . 75.519999999999996 108.79 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.67 160.98 63.76 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.159 -0.682 . . . . 74.530000000000001 109.159 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.39 134.69 49.64 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.275 1.983 . . . . 74.340000000000003 112.356 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 15.7 m -67.56 -19.87 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 122.434 1.111 . . . . 74.120000000000005 110.56 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.76 -13.71 58.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.599 -1.637 . . . . 64.430000000000007 109.307 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 64.1 m -93.25 169.43 10.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.074 -0.966 . . . . 75.409999999999997 111.865 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.35 133.48 44.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.964 -0.562 . . . . 71.439999999999998 110.188 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.8 tt -102.87 137.25 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.208 0.528 . . . . 74.400000000000006 110.015 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.79 129.71 51.24 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 116.076 -0.511 . . . . 72.140000000000001 110.355 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.528 ' HB3' ' OE1' ' A' ' 522' ' ' GLN . 6.4 tt -102.41 127.09 49.58 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.255 -1.387 . . . . 75.420000000000002 107.255 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -104.07 106.98 17.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.778 0.799 . . . . 71.299999999999997 109.28 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.62 138.02 37.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 114.831 -1.077 . . . . 75.430000000000007 111.793 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.485 ' HB2' ' OG ' ' A' ' 527' ' ' SER . 13.5 p -65.03 122.56 17.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 72.439999999999998 109.997 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 524' ' ' SER . 22.6 pttp . . . . . 0 C--O 1.259 1.564 0 CA-C-N 116.466 -0.334 . . . . 75.430000000000007 111.779 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 10.6 pt-20 . . . . . 0 CA--C 1.499 -1.007 0 CA-C-O 121.7 0.762 . . . . 75.219999999999999 109.935 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -114.28 133.04 55.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.552 -1.204 . . . . 74.549999999999997 109.022 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.562 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -120.51 161.51 21.17 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 108.109 -1.071 . . . . 74.010000000000005 108.109 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.84 141.6 32.15 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.369 0.668 . . . . 73.540000000000006 110.301 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.68 130.9 66.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 106.825 -1.546 . . . . 71.200000000000003 106.825 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.47 140.95 63.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.097 2.531 . . . . 71.340000000000003 113.931 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.53 -2.78 57.91 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.021 -0.99 . . . . 73.230000000000004 110.258 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.84 8.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.766 0.793 . . . . 72.209999999999994 110.832 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 4.3 p -61.39 -42.23 98.39 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.536 1.534 . . . . 75.140000000000001 110.832 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 7.1 p -66.34 -25.59 66.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.742 -1.117 . . . . 74.239999999999995 111.867 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.37 -46.31 17.86 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.26 -0.576 . . . . 73.530000000000001 110.297 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.9 m -169.59 147.15 3.47 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.058 -1.09 . . . . 74.140000000000001 108.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 441' ' ' VAL . 25.5 t80 -50.75 -49.13 58.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.657 0.783 . . . . 74.230000000000004 110.296 171.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -57.53 -35.86 70.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.652 -0.704 . . . . 53.509999999999998 111.871 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.495 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.6 mm-40 -70.66 -40.38 73.04 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.095 0.474 . . . . 75.420000000000002 110.857 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -46.38 90.09 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.169 -0.923 . . . . 70.230000000000004 110.364 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 437' ' ' TYR . 90.1 t -58.64 -47.41 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.45 -0.796 . . . . 74.340000000000003 111.961 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 61.7 mttp -62.91 -48.84 77.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.822 0.344 . . . . 74.409999999999997 110.439 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -68.27 -38.44 81.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.579 -0.737 . . . . 75.040000000000006 111.259 -176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 35.4 tp -68.47 -40.33 81.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.15 0.5 . . . . 74.329999999999998 109.983 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 38.6 m -60.93 -45.81 93.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.442 -0.799 . . . . 72.099999999999994 109.884 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.97 62.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.712 -0.676 . . . . 72.129999999999995 111.226 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.75 59.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.648 0.261 . . . . 64.120000000000005 110.358 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.25 -5.29 49.03 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.347 -0.93 . . . . 65.329999999999998 114.203 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 76.7 m-85 -62.96 139.12 58.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.866 0.333 . . . . 74.140000000000001 111.226 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.45 -2.93 9.66 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.39 -0.91 . . . . 73.530000000000001 113.37 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -119.31 115.63 24.54 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.527 -0.916 . . . . 75.319999999999993 108.527 -177.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -132.45 151.12 52.01 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.943 0.401 . . . . 74.400000000000006 110.161 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.46 ' HB3' HG13 ' A' ' 485' ' ' ILE . 61.8 tttp -139.6 122.62 16.75 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.251 -1.759 . . . . 74.209999999999994 106.251 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.84 135.08 42.85 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.88 -0.328 . . . . 73.519999999999996 110.244 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.95 155.17 50.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.494 -0.928 . . . . 61.420000000000002 108.494 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.42 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.5 p30 -133.9 138.53 45.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.679 -1.23 . . . . 73.219999999999999 107.679 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 t -134.98 143.54 46.56 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 108.849 -0.797 . . . . 73.030000000000001 108.849 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.68 122.19 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.142 1.895 . . . . 71.409999999999997 109.114 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -133.3 179.64 6.07 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.309 -0.86 . . . . 61.119999999999997 109.491 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -61.07 135.16 93.21 Favored Pre-proline 0 N--CA 1.417 -2.117 0 C-N-CA 123.755 0.822 . . . . 73.099999999999994 108.935 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 89.3 Cg_exo -50.64 -29.98 27.11 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.097 3.198 . . . . 65.209999999999994 115.123 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -75.76 -22.8 56.13 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.728 -0.789 . . . . 73.340000000000003 112.501 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.14 4.89 51.04 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.598 0.592 . . . . 75.319999999999993 112.598 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 15.0 p -61.2 127.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 C-N-CA 120.097 -0.641 . . . . 73.319999999999993 109.874 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.52 -6.05 77.53 Favored Glycine 0 C--N 1.308 -0.989 0 CA-C-N 115.595 -0.729 . . . . 73.319999999999993 113.169 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -110.0 157.14 19.61 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.61 -0.885 . . . . 75.209999999999994 108.61 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 48.9 t -82.26 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.844 -1.169 . . . . 75.349999999999994 107.844 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 34.9 pt -97.74 -20.41 5.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.21 -0.596 . . . . 71.430000000000007 109.688 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.54 155.24 14.64 Favored Glycine 0 N--CA 1.409 -3.132 0 C-N-CA 120.015 -1.088 . . . . 74.0 112.425 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.9 p -119.56 154.28 34.13 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.263 -1.754 . . . . 71.430000000000007 106.263 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.456 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 41.7 t-20 -65.12 -55.0 29.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 C-N-CA 119.975 -0.69 . . . . 62.140000000000001 110.625 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.73 126.94 9.21 Favored 'Trans proline' 0 C--N 1.365 1.428 0 N-CA-C 108.947 -1.213 . . . . 61.329999999999998 108.947 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.46 143.46 76.05 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.464 2.109 . . . . 65.310000000000002 112.264 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.533 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.27 4.58 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.183 0.992 . . . . 74.239999999999995 110.692 -176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -101.4 -9.28 21.27 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.456 -1.247 . . . . 74.030000000000001 109.471 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -122.27 167.48 13.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.517 -0.92 . . . . 74.409999999999997 108.517 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 30.6 p -98.03 143.43 28.59 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 109.619 -0.511 . . . . 72.019999999999996 109.619 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.6 m -128.98 147.41 50.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.016 -0.735 . . . . 73.349999999999994 109.016 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -54.52 153.39 5.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.586 0.958 . . . . 71.109999999999999 113.586 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.59 -32.29 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 110.241 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 36.39 4.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.779 1.276 . . . . 73.430000000000007 110.222 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.33 145.63 25.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 105.028 -2.212 . . . . 74.400000000000006 105.028 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.88 111.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.55 -1.26 . . . . 73.510000000000005 111.074 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.45 118.51 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.993 -1.114 . . . . 73.0 107.993 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.5 mp -95.23 112.69 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 74.239999999999995 106.286 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.79 118.39 50.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 109.481 -0.562 . . . . 74.120000000000005 109.481 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -100.07 121.68 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.393 -0.595 . . . . 72.0 109.393 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 134.02 35.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 109.087 -0.709 . . . . 75.340000000000003 109.087 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.36 115.73 5.21 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 109.82 -1.312 . . . . 71.099999999999994 109.82 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 456' ' ' ASN . 12.1 m -113.07 130.2 56.24 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.208 -0.664 . . . . 75.319999999999993 109.208 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.0 0 CA-C-O 119.198 -0.779 . . . . 70.140000000000001 111.398 -177.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 122.254 1.026 . . . . 73.439999999999998 108.696 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.5 p -132.58 157.33 45.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.815 -1.084 . . . . 71.420000000000002 109.901 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 140.1 22.86 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.336 -0.987 . . . . 73.230000000000004 108.336 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.3 p-10 -89.78 136.08 33.25 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.305 -1.368 . . . . 72.099999999999994 107.305 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 541' ' ' ALA . 29.2 pt -81.97 134.99 48.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 116.071 -0.513 . . . . 73.219999999999999 112.367 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.54 -175.39 1.26 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.965 2.443 . . . . 74.420000000000002 112.08 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -91.22 95.39 10.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.289 0.566 . . . . 70.510000000000005 109.895 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.26 -3.86 10.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.828 0.823 . . . . 62.100000000000001 108.996 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.56 55.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.162 -1.381 . . . . 71.319999999999993 110.036 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.22 -16.72 38.29 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 111.001 -0.84 . . . . 64.430000000000007 111.001 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -97.92 -175.35 3.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.557 -0.905 . . . . 75.319999999999993 108.557 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.9 m -79.17 155.01 28.84 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.724 -0.843 . . . . 64.439999999999998 108.724 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.527 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 6.9 p -53.71 -45.65 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 123.608 0.568 . . . . 71.329999999999998 112.116 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.9 -41.96 77.54 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.76 0.652 . . . . 73.219999999999999 112.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.7 -37.41 35.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 119.946 -0.702 . . . . 73.219999999999999 111.788 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.05 91.25 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.082 -0.508 . . . . 71.299999999999997 111.202 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -65.26 -35.51 81.25 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.795 -0.362 . . . . 73.409999999999997 110.68 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 514' ' ' VAL . 19.5 mmtp -59.83 -50.49 73.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.165 0.432 . . . . 73.120000000000005 112.165 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -62.37 -38.66 90.42 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.915 0.388 . . . . 64.540000000000006 110.91 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.09 -46.28 71.42 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.632 -0.713 . . . . 74.310000000000002 109.906 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.3 t-20 -59.15 -48.03 83.1 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 124.025 0.93 . . . . 71.340000000000003 112.066 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 510' ' ' LYS . 98.3 t -60.89 -28.67 43.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.822 -0.626 . . . . 75.340000000000003 112.031 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.72 13.15 9.96 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.477 -0.889 . . . . 74.299999999999997 111.366 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -154.01 -88.78 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.44 0 C-N-CA 117.581 -2.247 . . . . 72.120000000000005 117.276 -170.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 55.7 m-85 -117.96 151.27 37.77 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.494 -0.353 . . . . 74.540000000000006 111.008 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 8.6 m -107.52 -25.72 11.25 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.081 -0.509 . . . . 74.230000000000004 110.673 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.3 126.29 52.66 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.32 -0.622 . . . . 75.349999999999994 109.32 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -128.4 144.11 51.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 110.853 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.4 m -121.79 153.59 38.1 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.005 -1.48 . . . . 74.450000000000003 107.005 172.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -127.2 129.36 47.67 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.116 -0.634 . . . . 63.020000000000003 110.833 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -117.57 144.03 45.52 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.225 -1.398 . . . . 74.230000000000004 107.225 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -101.86 135.36 43.54 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.971 0.415 . . . . 72.0 111.379 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 18.5 m -121.94 149.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.71 -1.219 . . . . 75.439999999999998 107.71 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.25 118.5 20.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.42 -0.585 . . . . 74.319999999999993 109.42 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 82.7 p -90.98 162.85 31.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 113.58 0.956 . . . . 74.209999999999994 113.58 -170.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -71.8 -138.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.548 2.832 . . . . 74.409999999999997 109.468 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -68.87 -53.45 14.85 Favored Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 113.082 0.771 . . . . 75.129999999999995 113.082 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.6 150.88 36.22 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 121.451 1.434 . . . . 73.530000000000001 112.062 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -149.9 145.69 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.682 -0.858 . . . . 50.409999999999997 108.682 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.11 -20.77 5.89 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 111.28 -0.728 . . . . 75.439999999999998 111.28 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 148.75 25.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.069 -0.345 . . . . 72.439999999999998 110.069 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.7 t -74.57 115.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.596 -1.631 . . . . 74.129999999999995 106.596 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.2 m -72.0 -33.27 67.96 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 109.824 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.93 -165.04 36.62 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 110.59 -1.004 . . . . 74.010000000000005 110.59 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.9 p -125.0 160.83 28.08 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 107.777 -1.194 . . . . 70.099999999999994 107.777 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.414 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 63.8 t30 -59.82 -51.13 82.96 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 119.757 -0.777 . . . . 74.129999999999995 111.27 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.1 Cg_exo -77.52 145.2 23.27 Favored 'Trans proline' 0 C--N 1.367 1.512 0 N-CA-C 108.832 -1.257 . . . . 73.030000000000001 108.832 171.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -70.54 152.09 65.05 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.188 1.925 . . . . 74.120000000000005 111.9 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.45 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -55.38 137.07 48.78 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.028 0.531 . . . . 71.329999999999998 110.765 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.68 -20.34 46.63 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 121.102 -0.57 . . . . 44.420000000000002 112.023 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 29.6 m -73.44 135.4 44.14 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.841 -0.211 . . . . 74.239999999999995 110.566 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 35.5 m -96.98 123.36 40.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.581 -0.525 . . . . 64.129999999999995 109.581 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.4 164.17 43.01 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 109.209 -0.663 . . . . 74.209999999999994 109.209 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -71.92 133.55 21.89 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 73.310000000000002 111.27 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.53 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.6 m -68.8 -20.88 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 74.340000000000003 111.141 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.8 -16.72 60.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.408 -1.269 . . . . 64.200000000000003 110.501 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.2 t -97.08 161.17 13.94 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.005 -0.739 . . . . 72.109999999999999 109.005 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.47 134.89 26.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.259 -0.645 . . . . 63.409999999999997 109.259 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -105.19 141.01 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.011 0.434 . . . . 53.350000000000001 110.577 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -103.08 121.56 42.86 Favored 'General case' 0 N--CA 1.406 -2.63 0 C-N-CA 123.525 0.73 . . . . 72.120000000000005 110.433 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.01 134.27 42.09 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 124.211 1.004 . . . . 62.409999999999997 110.015 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -92.27 108.25 19.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.859 -1.163 . . . . 71.209999999999994 107.859 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.82 138.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.798 -0.637 . . . . 72.120000000000005 110.33 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 6.2 p -65.91 119.55 11.5 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.129 0.966 . . . . 74.049999999999997 113.585 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 29.1 tttm . . . . . 0 C--O 1.262 1.763 0 C-N-CA 125.691 1.596 . . . . 74.209999999999994 108.431 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.281 0 CA-C-O 122.271 1.034 . . . . 70.239999999999995 108.443 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -107.69 137.92 44.84 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.986 -1.461 . . . . 73.219999999999999 109.662 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.15 156.12 40.62 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.947 -1.131 . . . . 73.209999999999994 107.947 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.08 141.89 31.68 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 123.524 0.73 . . . . 63.32 111.393 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -85.2 121.17 73.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.431 -0.951 . . . . 64.299999999999997 108.431 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.22 143.36 39.51 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.033 1.822 . . . . 74.340000000000003 112.253 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.66 32.24 0.59 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.778 0.799 . . . . 74.239999999999995 111.851 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.06 -12.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.863 -1.162 . . . . 74.120000000000005 107.863 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 11.6 m -60.49 -36.66 78.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.168 -1.378 . . . . 62.420000000000002 109.265 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -57.03 -27.74 61.9 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.217 -1.356 . . . . 75.209999999999994 110.465 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.59 -46.64 12.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.626 -0.43 . . . . 75.510000000000005 110.688 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 438' ' ' ALA . 40.5 m -166.47 149.05 6.81 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.201 -0.666 . . . . 74.439999999999998 109.201 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.54 -46.88 63.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.217 1.007 . . . . 73.25 110.374 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 73.340000000000003 111.365 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.49 -36.92 74.09 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.99 -0.55 . . . . 75.150000000000006 111.764 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -61.45 -52.37 64.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 124.342 1.026 . . . . 72.510000000000005 110.435 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 67.3 t -66.8 -50.64 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 115.129 -0.942 . . . . 73.329999999999998 111.808 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.405 ' HZ3' ' HB2' ' A' ' 442' ' ' LYS . 10.1 mtmp? -62.49 -45.37 93.34 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.767 0.654 . . . . 72.200000000000003 112.767 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -68.5 -40.81 80.74 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.873 -0.731 . . . . 74.329999999999998 110.933 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.51 -33.87 74.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.055 0.455 . . . . 73.329999999999998 109.813 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 37.1 m -59.68 -45.04 93.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.465 -0.789 . . . . 75.420000000000002 109.215 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -16.81 62.61 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.159 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.16 -13.78 54.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 110.452 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -18.18 9.1 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 120.308 -0.949 . . . . 61.149999999999999 113.178 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.95 130.59 42.61 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.889 -0.411 . . . . 75.540000000000006 109.889 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -118.92 -1.31 14.68 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.285 -0.959 . . . . 55.420000000000002 112.879 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.42 115.34 20.78 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.367 0.603 . . . . 74.140000000000001 109.961 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -125.62 154.87 41.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.895 -1.15 . . . . 75.120000000000005 107.895 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.438 ' HB3' HG12 ' A' ' 485' ' ' ILE . 28.0 tptp -133.98 122.97 23.83 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.569 -1.271 . . . . 73.25 107.569 174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -91.18 120.84 32.45 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.472 0.654 . . . . 60.140000000000001 110.662 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.08 155.62 28.96 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.212 -1.773 . . . . 74.099999999999994 106.212 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -138.15 144.3 40.71 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.288 -0.634 . . . . 75.409999999999997 109.288 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 t -134.59 140.32 35.19 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 107.616 -1.253 . . . . 72.310000000000002 107.616 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_exo -65.13 122.63 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.045 1.83 . . . . 71.420000000000002 110.634 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.6 t -144.05 179.91 6.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.587 -1.635 . . . . 52.219999999999999 106.587 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -63.55 145.32 97.41 Favored Pre-proline 0 N--CA 1.414 -2.262 0 O-C-N 123.316 0.385 . . . . 73.430000000000007 110.026 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -50.61 -28.07 21.17 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.734 3.623 . . . . 70.349999999999994 112.236 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.75 -24.1 65.46 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.923 0.889 . . . . 74.109999999999999 112.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.9 5.7 33.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.852 0.686 . . . . 64.109999999999999 112.852 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 98.8 t -61.06 128.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.975 0.416 . . . . 75.400000000000006 111.269 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.47 84.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.499 -0.773 . . . . 75.099999999999994 111.91 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -111.19 146.79 36.28 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.234 -1.025 . . . . 74.340000000000003 108.234 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.8 t -81.39 129.37 37.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.101 -1.074 . . . . 73.230000000000004 108.101 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.7 pt -98.75 -9.8 8.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 72.239999999999995 111.418 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.33 163.02 24.62 Favored Glycine 0 CA--C 1.482 -2.005 0 C-N-CA 119.547 -1.311 . . . . 73.299999999999997 110.863 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.8 p -116.73 146.13 43.0 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.779 -0.822 . . . . 63.509999999999998 108.779 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.5 t30 -57.72 -50.04 90.34 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 123.315 0.384 . . . . 73.319999999999993 110.531 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_endo -85.01 137.91 6.54 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 N-CA-C 107.838 -1.639 . . . . 75.239999999999995 107.838 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 475' ' ' ASN . 6.3 Cg_exo -61.27 141.01 91.62 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.343 1.362 . . . . 73.239999999999995 111.029 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.66 10.72 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.377 1.084 . . . . 72.340000000000003 109.905 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 473' ' ' PRO . 65.1 t30 -95.12 -29.91 14.32 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 113.84 -1.527 . . . . 65.450000000000003 108.398 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 473' ' ' PRO . 3.4 pt20 -98.86 170.78 8.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.779 -0.646 . . . . 64.230000000000004 109.93 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.7 p -98.49 134.02 42.05 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 116.036 -0.529 . . . . 71.129999999999995 109.886 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.0 m -114.0 145.53 41.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.462 -0.57 . . . . 72.219999999999999 109.462 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -59.39 148.11 33.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.974 0.416 . . . . 72.319999999999993 111.992 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.51 -30.74 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 123.537 0.735 . . . . 74.340000000000003 111.514 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -101.39 17.24 23.17 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.284 0.564 . . . . 65.510000000000005 110.549 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -88.56 139.3 30.62 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.785 -1.191 . . . . 72.319999999999993 107.785 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.95 111.08 16.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.642 0.734 . . . . 64.109999999999999 109.363 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.89 118.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.515 -0.92 . . . . 74.310000000000002 108.515 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 46.8 mt -99.25 111.55 29.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.501 -1.296 . . . . 74.239999999999995 107.501 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.466 ' O ' HD13 ' A' ' 486' ' ' ILE . 0.0 OUTLIER -103.7 129.97 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-O 121.075 0.464 . . . . 74.420000000000002 110.16 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.71 116.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.233 -1.025 . . . . 64.439999999999998 108.233 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.42 140.07 18.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.966 -0.561 . . . . 73.25 109.568 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.71 118.15 6.93 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.454 -1.058 . . . . 74.349999999999994 110.454 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.3 m -119.96 132.72 55.6 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.846 -0.798 . . . . 73.209999999999994 108.846 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.329 0 N-CA-C 109.991 -1.243 . . . . 72.150000000000006 109.991 -177.083 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.643 0 N-CA-C 108.12 -1.067 . . . . 75.120000000000005 108.12 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 35.6 p -124.66 156.92 36.75 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.077 -0.965 . . . . 70.239999999999995 108.956 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.05 150.29 31.53 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 75.510000000000005 107.779 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 544' ' ' THR . 6.7 p-10 -99.46 138.22 36.86 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 120.948 0.404 . . . . 74.530000000000001 110.282 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.419 HG13 ' HA ' ' A' ' 541' ' ' ALA . 31.5 pt -88.15 133.91 36.02 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.556 -0.747 . . . . 74.299999999999997 111.985 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.3 177.0 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.603 2.202 . . . . 72.349999999999994 110.877 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.07 115.45 27.34 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.635 -0.426 . . . . 74.209999999999994 110.295 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.2 14.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.514 1.15 . . . . 74.140000000000001 108.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.49 143.23 46.68 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.09 -0.959 . . . . 75.340000000000003 110.48 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.7 -24.71 10.09 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.056 -0.592 . . . . 70.030000000000001 111.631 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -91.89 177.62 6.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.183 -0.673 . . . . 74.340000000000003 109.183 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.6 m -75.85 155.47 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.628 -0.508 . . . . 74.219999999999999 109.628 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.51 -49.1 14.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 123.719 0.637 . . . . 73.140000000000001 112.614 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.42 -42.51 74.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.259 0.466 . . . . 64.319999999999993 112.259 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -39.48 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 119.786 -0.766 . . . . 75.129999999999995 111.861 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.56 83.66 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.785 -0.643 . . . . 65.319999999999993 111.365 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.75 -35.52 80.96 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 120.219 -0.592 . . . . 74.109999999999999 110.5 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 513' ' ' ASN . 59.9 tttp -63.11 -48.9 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.462 0.648 . . . . 73.099999999999994 110.139 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -68.84 -38.24 79.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.264 -0.88 . . . . 70.129999999999995 111.453 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.03 -35.94 81.01 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 108.969 -0.752 . . . . 70.420000000000002 108.969 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 510' ' ' LYS . 2.5 t-20 -57.28 -38.8 74.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 75.430000000000007 110.115 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.06 -44.28 97.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 110.632 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -103.23 16.46 26.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 65.209999999999994 111.235 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.1 -117.9 1.28 Allowed Glycine 0 N--CA 1.414 -2.792 0 C-N-CA 120.766 -0.731 . . . . 71.430000000000007 112.421 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 16.7 m-85 -122.01 173.4 7.56 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 110.263 -0.273 . . . . 72.0 110.263 -171.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 19.5 p -96.23 -14.26 22.83 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.752 -0.658 . . . . 75.209999999999994 111.409 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.18 115.69 29.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.559 -0.291 . . . . 75.340000000000003 111.448 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -120.98 151.34 39.85 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.278 0.561 . . . . 74.319999999999993 111.095 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.2 m -135.64 152.21 51.0 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.892 -1.892 . . . . 75.209999999999994 105.892 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -119.39 123.55 44.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.634 -0.876 . . . . 74.439999999999998 108.634 -170.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.84 121.24 42.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.451 -0.574 . . . . 72.5 109.451 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.4 p -87.88 116.27 25.92 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.115 0.484 . . . . 73.420000000000002 110.099 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.53 162.14 21.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 115.533 -0.758 . . . . 75.439999999999998 110.16 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.69 121.44 24.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.152 0.977 . . . . 72.430000000000007 109.967 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 556' ' ' SER . 2.6 p -144.9 101.77 4.52 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 114.189 -1.369 . . . . 72.450000000000003 109.967 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.61 -57.35 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.559 2.839 . . . . 71.25 114.481 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.434 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 57.1 mtt180 -80.04 -49.43 1.27 Allowed Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 113.06 0.763 . . . . 75.150000000000006 113.06 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 39.6 Cg_exo -62.03 134.94 52.2 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.739 1.626 . . . . 72.25 112.306 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.07 74.36 0.97 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.646 -0.872 . . . . 65.230000000000004 108.646 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.89 3.68 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 110.747 -0.941 . . . . 73.5 110.747 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -86.19 149.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.256 0.55 . . . . 75.030000000000001 111.147 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 87.7 t -73.71 124.7 31.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.345 -0.843 . . . . 64.25 109.079 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.6 m -76.23 -28.95 57.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.592 -1.185 . . . . 73.349999999999994 110.252 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.77 -159.66 31.2 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.03 -1.228 . . . . 73.219999999999999 110.03 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.5 p -127.18 157.38 39.92 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.261 -1.015 . . . . 65.219999999999999 108.261 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.5 t30 -66.81 -54.65 20.56 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.086 -0.645 . . . . 75.310000000000002 110.613 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.5 Cg_exo -71.7 131.59 18.82 Favored 'Trans proline' 0 C--N 1.377 2.033 0 N-CA-C 108.113 -1.534 . . . . 64.129999999999995 108.113 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.4 147.46 90.69 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.463 2.108 . . . . 71.120000000000005 113.075 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.419 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -63.26 142.82 58.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.988 -0.551 . . . . 53.299999999999997 110.56 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.99 64.0 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.519 -0.632 . . . . 61.210000000000001 111.519 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.1 m -79.65 132.39 36.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.582 -0.525 . . . . 71.510000000000005 109.582 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 496' ' ' ASP . 41.2 m -97.91 122.23 40.77 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.308 -0.997 . . . . 73.329999999999998 108.308 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.52 165.25 37.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.472 -0.936 . . . . 74.030000000000001 108.472 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 137.58 78.7 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.493 2.129 . . . . 72.519999999999996 113.69 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.653 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -67.3 -19.69 25.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.157 -0.929 . . . . 75.540000000000006 112.259 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.76 -3.67 58.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.674 -1.148 . . . . 65.439999999999998 109.667 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.7 m -95.7 152.24 18.64 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 115.371 -0.831 . . . . 65.209999999999994 110.559 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.9 t -88.71 134.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.688 -0.687 . . . . 75.209999999999994 110.433 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.53 141.96 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 109.551 -0.537 . . . . 75.409999999999997 109.551 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -103.02 122.37 44.49 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.814 -0.809 . . . . 72.420000000000002 108.814 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.22 128.85 44.9 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.031 -0.986 . . . . 74.129999999999995 108.751 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -88.2 106.31 18.11 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.82 -0.807 . . . . 71.230000000000004 108.82 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 524' ' ' SER . 29.7 m -105.56 139.11 27.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 115.662 -0.699 . . . . 74.120000000000005 110.429 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.429 ' HA ' ' OG ' ' A' ' 527' ' ' SER . 22.3 p -57.16 120.76 8.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.537 -0.756 . . . . 73.109999999999999 112.139 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 524' ' ' SER . 57.4 tttm . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 109.31 -0.626 . . . . 74.310000000000002 109.31 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.858 0 CA-C-O 121.504 0.668 . . . . 74.510000000000005 109.552 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 60.0 mt-30 -109.69 125.54 52.74 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.561 -1.2 . . . . 74.230000000000004 108.926 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -123.12 160.44 26.44 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.169 -1.048 . . . . 73.430000000000007 108.169 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.97 141.64 28.46 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.635 -0.505 . . . . 73.099999999999994 109.635 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.59 119.41 76.76 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.73 -0.841 . . . . 74.209999999999994 108.73 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.94 144.51 43.19 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.275 1.983 . . . . 65.209999999999994 111.99 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.97 59.44 5.63 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.164 1.459 . . . . 74.409999999999997 109.17 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.14 -5.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 106.333 -1.728 . . . . 73.409999999999997 106.333 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.472 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 1.3 p -63.25 -32.37 73.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.864 -1.971 . . . . 71.209999999999994 109.704 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.6 t -63.02 -26.79 69.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.332 -1.304 . . . . 63.109999999999999 111.103 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.54 -46.7 10.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.02 -1.072 . . . . 75.299999999999997 111.488 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.442 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 1.8 m -171.88 150.6 2.63 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.172 -1.047 . . . . 75.319999999999993 108.172 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -52.63 -48.27 66.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.224 0.61 . . . . 74.420000000000002 110.631 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.78 66.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.731 -0.668 . . . . 54.210000000000001 111.968 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.4 mm-40 -70.98 -42.85 69.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.285 -0.416 . . . . 75.439999999999998 111.126 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.6 -47.06 87.89 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.199 -0.909 . . . . 73.450000000000003 110.75 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.54 -48.78 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.663 -0.699 . . . . 71.450000000000003 111.227 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -62.29 -44.65 96.02 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.024 0.379 . . . . 72.430000000000007 112.024 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 443' ' ' LYS . 6.5 mmpt? -66.56 -42.68 86.72 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.76 -0.376 . . . . 73.409999999999997 111.673 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.3 tp -69.41 -32.97 72.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.274 0.559 . . . . 71.219999999999999 110.106 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.6 m -64.45 -41.55 96.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.847 -0.615 . . . . 74.019999999999996 109.405 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.23 -16.22 63.02 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.168 0.508 . . . . 73.120000000000005 110.942 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.65 -13.06 46.66 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.099 -0.5 . . . . 73.349999999999994 110.086 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.54 -9.31 24.08 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.002 -0.618 . . . . 72.319999999999993 113.95 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -71.85 143.72 49.32 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.889 0.344 . . . . 73.299999999999997 111.194 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -149.0 16.54 1.19 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.69 -0.767 . . . . 64.310000000000002 112.319 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -120.97 115.77 23.82 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.987 -1.486 . . . . 72.519999999999996 106.987 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.36 160.64 39.7 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 113.514 0.931 . . . . 74.200000000000003 113.514 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -142.33 134.08 26.93 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.197 1.799 . . . . 75.239999999999995 107.012 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -103.65 132.03 50.27 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.62 -0.511 . . . . 73.420000000000002 109.62 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.53 139.24 53.37 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.767 -0.827 . . . . 75.409999999999997 108.767 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -114.17 130.19 56.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.607 -0.886 . . . . 62.350000000000001 108.607 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.1 m -120.63 138.17 27.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.517 -0.311 . . . . 74.349999999999994 110.433 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.85 122.61 9.26 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.357 2.038 . . . . 74.319999999999993 111.007 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -144.75 179.07 7.55 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.039 -1.467 . . . . 74.510000000000005 107.039 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.557 ' OG1' ' HD2' ' A' ' 461' ' ' PRO . 6.6 t -70.76 144.2 90.56 Favored Pre-proline 0 N--CA 1.433 -1.322 0 N-CA-C 109.039 -0.726 . . . . 74.299999999999997 109.039 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.557 ' HD2' ' OG1' ' A' ' 460' ' ' THR . 2.0 Cg_endo -48.8 -27.88 12.0 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 125.165 3.91 . . . . 72.209999999999994 115.476 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.72 -13.22 61.98 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.29 -1.364 . . . . 54.420000000000002 112.343 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.23 -0.14 44.64 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.831 -0.543 . . . . 71.129999999999995 111.364 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 84.9 t -61.51 128.14 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.799 -0.445 . . . . 75.430000000000007 109.799 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.79 -16.73 60.15 Favored Glycine 0 C--O 1.244 0.773 0 C-N-CA 121.099 -0.572 . . . . 73.109999999999999 111.996 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -92.77 142.66 27.1 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.894 -0.78 . . . . 74.150000000000006 108.894 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 60.2 t -82.85 124.85 39.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.628 -1.619 . . . . 75.150000000000006 106.628 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.16 -5.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 118.667 -1.213 . . . . 75.010000000000005 111.803 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.14 160.14 27.84 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 119.775 -1.202 . . . . 55.119999999999997 112.666 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.4 p -134.42 145.33 48.79 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.196 -1.409 . . . . 71.510000000000005 107.196 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.441 ' OD1' ' HB ' ' A' ' 485' ' ' ILE . 12.5 m120 -64.4 -51.08 63.11 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 120.364 -0.534 . . . . 75.129999999999995 112.202 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.55 123.38 11.35 Favored 'Trans proline' 0 C--O 1.253 1.252 0 N-CA-C 108.716 -1.302 . . . . 70.420000000000002 108.716 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.38 139.19 37.52 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.217 1.945 . . . . 71.299999999999997 112.185 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.24 2.14 37.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.724 0.773 . . . . 73.5 110.608 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.24 -32.92 24.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.877 -1.056 . . . . 55.140000000000001 110.094 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.67 178.37 4.42 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.155 -1.054 . . . . 74.109999999999999 108.155 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 32.5 p -97.04 126.54 42.26 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-O 121.277 0.561 . . . . 70.409999999999997 110.547 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -106.77 147.05 30.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.479 -0.934 . . . . 60.310000000000002 108.479 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.5 147.58 41.75 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 120.9 0.381 . . . . 72.310000000000002 111.584 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.85 -21.9 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.31 1.044 . . . . 75.5 111.26 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -94.85 1.78 55.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.417 -0.811 . . . . 71.329999999999998 110.103 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -78.83 144.6 34.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.971 -0.751 . . . . 74.030000000000001 108.971 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 38.7 t -82.13 112.49 20.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.558 -1.275 . . . . 75.0 107.558 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.69 119.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 N-CA-C 109.176 -0.676 . . . . 71.519999999999996 109.176 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.441 ' HB ' ' OD1' ' A' ' 471' ' ' ASN . 3.3 mp -97.68 119.48 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.463 -2.051 . . . . 74.219999999999999 105.463 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.19 128.43 65.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.95 -0.568 . . . . 72.439999999999998 109.981 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 58.5 mt -103.65 112.51 37.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-N 115.299 -0.864 . . . . 74.430000000000007 110.52 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.16 140.57 17.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 115.517 -0.765 . . . . 73.530000000000001 109.585 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.68 129.3 9.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.237 -1.145 . . . . 33.119999999999997 110.237 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.5 p -135.58 152.03 50.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.842 -0.429 . . . . 62.520000000000003 109.842 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 109.986 -1.245 . . . . 54.140000000000001 109.986 178.271 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 121.743 0.783 . . . . 62.420000000000002 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -138.72 162.81 33.76 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.197 -0.911 . . . . 72.200000000000003 110.476 -172.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.484 ' HB3' ' CE1' ' A' ' 517' ' ' PHE . 48.0 tptt -146.61 139.85 25.63 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.267 -0.424 . . . . 73.439999999999998 110.318 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -80.61 137.73 36.39 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.214 1.005 . . . . 72.450000000000003 109.023 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.6 pt -97.34 133.29 24.04 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 120.041 -0.663 . . . . 75.299999999999997 110.674 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.22 178.22 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.512 2.141 . . . . 74.200000000000003 110.296 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.0 122.53 38.92 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.153 -0.619 . . . . 73.239999999999995 110.045 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.36 6.02 5.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.652 -0.704 . . . . 72.230000000000004 110.102 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.446 ' HA ' HG11 ' A' ' 534' ' ' VAL . . . -74.01 147.2 43.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.553 -0.749 . . . . 73.019999999999996 110.712 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.46 -14.23 56.63 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.051 -0.82 . . . . 72.439999999999998 111.051 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -99.58 -170.04 1.84 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.583 -0.525 . . . . 61.130000000000003 109.583 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.1 m -82.08 155.77 24.91 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.667 -1.234 . . . . 74.430000000000007 107.667 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.76 -42.09 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.712 0.292 . . . . 74.409999999999997 111.537 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 31.9 t70 -68.19 -43.46 78.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.197 0.443 . . . . 61.0 112.197 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.26 -34.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.77 -0.772 . . . . 73.120000000000005 110.839 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.73 -49.18 78.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.728 . . . . 74.319999999999993 110.752 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.61 -34.66 78.76 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 120.669 -0.412 . . . . 73.129999999999995 111.009 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 12.7 mmmm -57.36 -53.16 61.29 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.166 0.291 . . . . 73.310000000000002 111.148 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -62.84 -40.63 98.04 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.38 0.61 . . . . 75.239999999999995 110.285 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.91 -38.51 91.21 Favored 'General case' 0 C--O 1.191 -2.02 0 CA-C-N 115.081 -0.963 . . . . 74.420000000000002 110.928 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.13 -37.96 84.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.163 0.585 . . . . 75.230000000000004 111.54 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.24 -29.8 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 73.299999999999997 110.697 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.66 31.21 6.36 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.166 -0.334 . . . . 74.430000000000007 110.363 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -160.39 -108.7 0.24 Allowed Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 119.009 -1.567 . . . . 51.420000000000002 113.759 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 495' ' ' LYS . 18.3 m-85 -137.69 177.26 8.01 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.876 -0.787 . . . . 75.129999999999995 108.876 -172.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 m -112.13 6.5 19.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 122.296 1.046 . . . . 71.340000000000003 108.725 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -108.52 115.75 30.69 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.647 -0.872 . . . . 72.219999999999999 108.647 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -128.16 150.87 49.81 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.293 0.371 . . . . 72.420000000000002 110.222 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.8 m -130.8 155.7 46.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.572 -1.27 . . . . 73.129999999999995 107.572 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -121.91 122.25 38.96 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.998 0.428 . . . . 75.329999999999998 110.001 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.47 56.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.777 -0.823 . . . . 62.399999999999999 108.777 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -90.07 118.9 29.96 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.575 -0.898 . . . . 75.319999999999993 108.575 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.6 152.23 25.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.584 -0.895 . . . . 74.409999999999997 108.584 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.64 123.04 25.53 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.606 1.193 . . . . 54.329999999999998 111.098 -169.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.5 m -128.49 101.04 21.63 Favored Pre-proline 0 N--CA 1.416 -2.138 0 CA-C-N 113.795 -1.548 . . . . 65.420000000000002 109.102 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.26 -57.15 1.19 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.032 2.488 . . . . 74.040000000000006 112.538 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -88.33 -49.41 0.43 Allowed Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 113.349 0.87 . . . . 74.239999999999995 113.349 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.59 146.52 95.38 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 121.883 1.722 . . . . 71.329999999999998 112.701 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.11 85.04 0.32 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.395 1.078 . . . . 75.310000000000002 108.381 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.0 -35.05 2.44 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 110.543 -1.023 . . . . 72.319999999999993 110.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -85.31 147.21 26.65 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.155 0.502 . . . . 71.420000000000002 109.91 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 501' ' ' ALA . 4.4 p -75.07 126.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.499 -0.926 . . . . 74.030000000000001 108.499 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.2 m -72.11 -36.57 69.48 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.331 -0.85 . . . . 63.32 109.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 172.46 -167.44 40.35 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.258 -0.972 . . . . 60.039999999999999 111.728 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.1 p -118.71 160.62 21.53 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.525 -0.917 . . . . 71.099999999999994 108.525 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.6 t-20 -61.58 -53.39 61.91 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.93 -0.308 . . . . 74.030000000000001 111.33 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -87.81 144.93 6.5 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 108.912 -1.226 . . . . 73.239999999999995 108.912 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.13 150.83 72.52 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 121.816 1.677 . . . . 73.340000000000003 111.447 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.09 135.83 36.72 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.674 0.79 . . . . 74.420000000000002 111.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.98 -26.51 20.52 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.228 -0.749 . . . . 61.439999999999998 111.228 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 88.2 m -65.68 133.69 51.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.501 . . . . 72.439999999999998 111.184 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.3 m -101.99 122.87 44.88 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.271 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.44 155.55 71.65 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.639 -0.504 . . . . 73.010000000000005 109.639 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.86 138.98 88.82 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.664 2.243 . . . . 70.450000000000003 112.944 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.464 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 21.4 m -67.04 -19.7 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 122.344 1.069 . . . . 71.549999999999997 110.344 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.31 -2.67 39.14 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.956 -1.475 . . . . 73.219999999999999 110.453 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -108.43 172.38 6.87 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.751 -0.833 . . . . 74.25 108.751 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.58 136.34 50.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.872 -0.788 . . . . 74.519999999999996 108.872 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.51 138.88 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 120.063 -0.655 . . . . 74.409999999999997 110.531 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -102.17 124.01 47.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-O 121.241 0.543 . . . . 74.310000000000002 110.032 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.98 131.2 46.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.233 -1.765 . . . . 73.099999999999994 106.233 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -107.12 105.95 16.2 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.717 0.77 . . . . 75.040000000000006 110.234 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.03 139.83 16.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.134 -1.394 . . . . 75.420000000000002 111.487 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.1 p -56.33 114.71 2.1 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 63.200000000000003 112.903 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.358 -1.719 . . . . 73.120000000000005 106.358 174.129 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 122.67 1.224 . . . . 75.299999999999997 107.79 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HB3' ' C ' ' A' ' 477' ' ' THR . 96.0 mt-30 -110.1 135.67 50.54 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.004 -1.453 . . . . 74.129999999999995 109.962 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -126.29 158.53 35.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.036 0.446 . . . . 74.549999999999997 111.436 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.92 141.99 30.0 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.789 -1.096 . . . . 75.430000000000007 110.532 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.27 129.93 70.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.721 -0.844 . . . . 73.219999999999999 108.721 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.89 141.8 65.6 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.671 2.914 . . . . 72.319999999999993 114.792 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.26 -3.05 48.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.918 -1.037 . . . . 74.150000000000006 111.271 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.8 m -85.68 3.39 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.603 0.716 . . . . 71.400000000000006 110.812 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.453 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 14.8 m -61.48 -29.57 70.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.823 -1.08 . . . . 71.319999999999993 110.196 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.494 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 18.2 p -62.44 -27.87 69.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.102 -0.953 . . . . 75.409999999999997 111.524 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.409 ' C ' ' HG1' ' A' ' 436' ' ' THR . 65.4 mt -78.6 -45.44 21.63 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.925 -0.398 . . . . 74.549999999999997 109.925 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.486 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 16.1 m -166.79 148.27 6.13 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.717 -0.846 . . . . 71.540000000000006 108.717 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.401 ' O ' HG22 ' A' ' 441' ' ' VAL . 53.1 t80 -53.27 -43.01 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.925 0.89 . . . . 74.239999999999995 111.301 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.75 -41.16 85.88 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.483 -0.326 . . . . 63.32 111.24 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.486 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.5 mm-40 -63.69 -40.61 97.23 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.248 0.547 . . . . 74.519999999999996 110.099 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -50.96 71.54 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.982 -1.008 . . . . 73.010000000000005 110.595 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 437' ' ' TYR . 92.7 t -59.42 -45.84 93.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.37 -0.832 . . . . 71.230000000000004 111.819 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 67.7 mttm -63.05 -47.28 83.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.695 0.283 . . . . 74.109999999999999 111.591 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -67.78 -38.81 83.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.312 -0.404 . . . . 74.25 111.399 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.55 -37.98 83.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.235 0.54 . . . . 74.230000000000004 109.88 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.2 m -59.47 -47.87 83.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.425 -0.807 . . . . 73.109999999999999 109.784 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.45 -15.83 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.011 -0.541 . . . . 62.530000000000001 111.933 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.0 -13.73 59.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.242 0.544 . . . . 75.530000000000001 110.433 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.88 -17.62 24.88 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.421 -0.895 . . . . 62.130000000000003 113.11 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -64.05 126.95 29.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.109 0.481 . . . . 74.450000000000003 111.082 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.485 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -110.12 -1.89 29.91 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.385 -0.825 . . . . 73.109999999999999 111.277 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 3.0 mpt_? -123.73 114.87 20.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.227 0.536 . . . . 71.519999999999996 110.187 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -147.68 146.81 29.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.429 -0.805 . . . . 74.25 110.361 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -131.13 126.51 35.9 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.363 -0.606 . . . . 74.319999999999993 109.363 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -84.0 122.35 28.64 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 111.191 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.36 149.86 41.12 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.069 -1.456 . . . . 61.219999999999999 107.069 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -127.92 146.82 50.51 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.785 -0.45 . . . . 74.420000000000002 109.785 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 44.5 m -124.57 131.45 24.16 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.791 -0.818 . . . . 75.120000000000005 108.791 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.51 123.81 11.61 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.461 2.107 . . . . 71.510000000000005 111.056 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.472 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 49.7 m -147.02 -179.72 7.01 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.444 -0.947 . . . . 65.450000000000003 108.444 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -49.75 136.35 19.24 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.896 0.878 . . . . 73.310000000000002 110.66 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.491 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 9.1 Cg_endo -50.66 -36.5 50.83 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.666 3.578 . . . . 75.349999999999994 114.786 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -77.58 -8.75 58.32 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.261 0.837 . . . . 73.230000000000004 113.261 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 18.0 tp -84.39 -11.82 55.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.003 0.43 . . . . 73.140000000000001 110.433 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.3 p -56.72 135.91 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.443 -0.799 . . . . 72.329999999999998 112.028 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.04 55.21 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 121.06 -0.59 . . . . 74.420000000000002 114.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 434' ' ' THR . 14.3 ptmm? -107.85 148.18 29.92 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.919 -1.112 . . . . 74.450000000000003 110.396 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.46 ' CG2' HD11 ' A' ' 486' ' ' ILE . 61.0 t -81.39 131.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.719 -0.474 . . . . 75.439999999999998 109.719 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 33.8 pt -101.04 -10.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.992 -0.549 . . . . 73.120000000000005 111.529 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.98 172.42 33.31 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.213 -0.755 . . . . 74.340000000000003 111.213 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 159.07 37.63 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.099 -0.704 . . . . 75.299999999999997 109.099 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.3 t-20 -60.6 -56.17 37.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 119.16 -0.448 . . . . 72.310000000000002 111.58 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.7 Cg_endo -85.88 146.15 9.05 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 121.192 1.261 . . . . 73.319999999999993 109.486 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.534 ' HG2' ' HG2' ' A' ' 476' ' ' GLN . 14.2 Cg_exo -62.88 149.8 90.33 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.693 1.595 . . . . 73.319999999999993 111.637 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.7 -11.66 60.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.654 0.74 . . . . 72.319999999999993 109.798 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -96.2 -12.19 25.0 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.222 -0.899 . . . . 71.129999999999995 112.012 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.534 ' HG2' ' HG2' ' A' ' 473' ' ' PRO . 0.0 OUTLIER -96.11 155.07 16.91 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 119.435 -0.906 . . . . 65.239999999999995 108.845 176.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.404 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 34.7 p -101.2 120.68 40.6 Favored 'General case' 0 N--CA 1.395 -3.185 0 N-CA-C 108.372 -0.974 . . . . 74.540000000000006 108.372 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 24.6 m -105.1 140.05 38.86 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.203 -0.666 . . . . 71.329999999999998 109.203 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -61.63 146.78 47.94 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.953 -0.388 . . . . 73.319999999999993 109.953 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.39 -23.0 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 123.597 0.759 . . . . 75.439999999999998 111.965 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.6 t -77.84 -8.02 57.47 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.355 -0.384 . . . . 62.43 111.299 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -74.87 136.2 41.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 120.909 0.385 . . . . 72.450000000000003 110.833 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.66 113.85 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 0 N-CA-C 106.588 -1.634 . . . . 74.209999999999994 106.588 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 63.0 t -86.63 119.93 35.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.136 -0.69 . . . . 71.430000000000007 109.136 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.84 111.86 24.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.885 -1.524 . . . . 75.319999999999993 106.885 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.68 128.11 55.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.68 -1.146 . . . . 74.439999999999998 108.719 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 54.8 mt -104.52 114.04 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.614 0.721 . . . . 75.140000000000001 110.988 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.55 130.33 45.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.471 -0.786 . . . . 71.010000000000005 109.421 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.31 114.51 4.98 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 107.81 -2.116 . . . . 62.310000000000002 107.81 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.1 m -120.54 129.37 53.77 Favored 'General case' 0 N--CA 1.412 -2.347 0 C-N-CA 120.163 -0.615 . . . . 74.409999999999997 109.525 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.409 -3.155 0 N-CA-C 110.218 -1.153 . . . . 60.340000000000003 110.218 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.9 p -133.5 152.26 51.88 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.678 -1.147 . . . . 74.239999999999995 109.467 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.82 143.75 27.69 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.717 -0.475 . . . . 75.25 109.717 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 543' ' ' THR . 7.3 p-10 -93.0 138.32 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.681 -0.859 . . . . 70.299999999999997 108.681 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.406 ' CG2' ' HE1' ' A' ' 517' ' ' PHE . 0.2 OUTLIER -93.82 121.04 65.29 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 114.849 1.426 . . . . 71.420000000000002 114.849 -176.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.75 136.27 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 106.294 -2.233 . . . . 73.120000000000005 106.294 164.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.37 139.86 56.64 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.796 0.807 . . . . 74.439999999999998 111.866 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.27 27.88 3.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.854 -1.535 . . . . 72.439999999999998 106.854 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.87 137.63 33.59 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.963 -1.471 . . . . 61.439999999999998 110.583 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.07 -48.23 0.93 Allowed Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.572 -0.823 . . . . 53.020000000000003 112.612 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.6 -168.69 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 111.877 0.325 . . . . 75.120000000000005 111.877 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.9 p -82.58 162.24 22.01 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 112.898 0.703 . . . . 75.530000000000001 112.898 -170.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.8 t -48.11 -52.5 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 O-C-N 124.839 1.337 . . . . 74.420000000000002 110.16 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 1.8 m-20 -68.04 -42.18 80.98 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.855 -1.066 . . . . 73.409999999999997 112.753 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.28 -35.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 119.214 -0.994 . . . . 73.329999999999998 111.497 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.58 96.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.754 -0.657 . . . . 72.439999999999998 111.021 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 79.4 mt-30 -61.4 -43.36 98.99 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.989 -0.375 . . . . 75.010000000000005 109.989 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.8 mptp? -61.74 -49.31 76.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.79 -0.641 . . . . 75.219999999999999 111.883 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -62.58 -47.78 82.3 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 123.205 0.315 . . . . 75.329999999999998 110.66 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.11 -43.29 99.1 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.938 -0.574 . . . . 73.150000000000006 110.719 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.38 -37.22 74.82 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.717 0.807 . . . . 71.140000000000001 111.75 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 510' ' ' LYS . 77.1 t -63.44 -42.48 96.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 116.282 -0.417 . . . . 74.120000000000005 111.869 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -108.21 -18.45 13.77 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.944 -1.102 . . . . 74.209999999999994 111.856 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -102.98 -100.47 2.57 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 115.079 0.792 . . . . 65.450000000000003 115.079 -171.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 49.0 m-85 -127.56 172.69 10.51 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.916 0.389 . . . . 74.420000000000002 111.183 -168.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.8 p -106.27 -25.73 11.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.485 -0.78 . . . . 71.430000000000007 111.047 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.73 121.65 45.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.871 -0.604 . . . . 74.120000000000005 109.72 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -128.46 143.4 50.98 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.591 . . . . 73.239999999999995 112.204 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.8 m -115.15 152.48 32.51 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.732 -1.951 . . . . 60.439999999999998 105.732 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -123.39 134.06 54.02 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.175 -0.61 . . . . 73.120000000000005 111.586 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.71 121.89 39.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.81 -0.811 . . . . 64.439999999999998 108.81 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.5 m -88.24 118.05 27.57 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.626 -1.62 . . . . 74.200000000000003 106.626 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.659 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.0 m -119.97 149.5 22.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.263 -1.384 . . . . 75.109999999999999 107.263 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.33 133.75 37.57 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.39 1.091 . . . . 73.219999999999999 112.579 -167.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 5.8 m -94.61 129.08 37.52 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 112.962 -1.926 . . . . 71.409999999999997 109.165 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.13 -71.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 121.073 1.182 . . . . 71.409999999999997 109.072 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.405 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 24.5 mmm180 -111.57 -55.05 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.036 -0.507 . . . . 74.310000000000002 112.165 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 527' ' ' SER . 10.7 Cg_exo -73.18 134.48 21.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.306 1.338 . . . . 74.319999999999993 111.339 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.51 159.46 43.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.436 -0.95 . . . . 65.299999999999997 108.436 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.91 -21.81 25.28 Favored Glycine 0 C--N 1.319 -0.402 0 CA-C-O 121.611 0.562 . . . . 65.019999999999996 111.862 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.52 147.77 25.2 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.245 0.545 . . . . 70.049999999999997 110.728 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.88 124.88 34.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.975 -0.75 . . . . 74.239999999999995 108.975 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -33.21 52.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.315 -0.857 . . . . 71.200000000000003 109.44 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.78 -147.18 15.19 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.333 -0.707 . . . . 72.340000000000003 111.333 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.0 p -121.79 160.41 24.68 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.955 -0.757 . . . . 71.329999999999998 108.955 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -62.55 -52.61 64.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 121.007 -0.277 . . . . 74.040000000000006 110.368 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.41 146.2 34.96 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 120.919 1.079 . . . . 75.340000000000003 109.791 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.67 154.25 70.35 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.197 1.931 . . . . 73.439999999999998 111.9 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.45 132.88 53.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.024 -0.535 . . . . 74.25 109.964 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.49 -10.84 56.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.113 -0.565 . . . . 63.299999999999997 111.824 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 71.5 m -77.46 129.3 35.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.616 -0.513 . . . . 73.030000000000001 109.616 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 7.0 t -93.85 122.6 36.5 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.476 0.655 . . . . 63.210000000000001 110.148 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.27 158.81 70.13 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.685 -0.857 . . . . 71.049999999999997 108.685 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.86 134.29 42.8 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.032 1.821 . . . . 75.230000000000004 112.081 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 17.2 m -67.61 -22.61 28.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.886 0.851 . . . . 73.540000000000006 110.849 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.15 0.73 52.89 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.353 -1.294 . . . . 75.319999999999993 111.685 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.8 t -98.02 -177.55 3.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.971 -0.751 . . . . 74.439999999999998 108.971 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.8 t -109.41 134.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.857 -1.164 . . . . 74.430000000000007 107.857 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -115.08 146.0 20.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.498 -0.556 . . . . 75.409999999999997 109.498 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.43 130.96 49.36 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-O 121.46 0.647 . . . . 72.209999999999994 110.454 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.75 130.96 48.27 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.68 -1.145 . . . . 73.450000000000003 108.624 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -94.8 115.33 27.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.959 -1.497 . . . . 75.310000000000002 106.959 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.74 135.2 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-N 116.525 -0.307 . . . . 72.310000000000002 111.089 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.5 m -74.23 114.39 12.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 109.04 -0.726 . . . . 72.549999999999997 109.04 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 11.5 ptmm? . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 114.795 -1.093 . . . . 72.439999999999998 110.919 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.4 pt-20 . . . . . 0 N--CA 1.438 -1.074 0 CA-C-O 122.411 1.1 . . . . 74.439999999999998 111.041 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 95.7 mt-30 -111.02 130.18 55.67 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.315 -1.311 . . . . 74.439999999999998 108.774 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -125.06 150.44 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.322 -0.854 . . . . 73.25 110.354 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 140.7 32.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 111.575 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -84.26 126.63 69.13 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 108.244 -1.021 . . . . 75.510000000000005 108.244 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.8 140.85 36.18 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.311 1.34 . . . . 73.439999999999998 110.517 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -105.81 69.37 0.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.457 1.122 . . . . 63.229999999999997 109.973 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.11 6.32 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 105.937 -1.875 . . . . 75.329999999999998 105.937 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.522 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.2 m -57.92 -30.05 65.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.031 -2.35 . . . . 73.430000000000007 110.399 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 3.2 m -61.76 -27.83 69.01 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.852 1.261 . . . . 72.400000000000006 110.856 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.0 -46.34 9.92 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 118.763 -1.175 . . . . 74.040000000000006 111.323 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.486 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.8 m -167.88 151.97 6.34 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -52.14 -49.29 64.02 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.266 1.026 . . . . 75.25 109.507 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.97 76.7 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.256 -0.883 . . . . 74.519999999999996 111.412 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.486 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 26.3 mm-40 -61.85 -46.06 91.07 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.239 0.337 . . . . 74.120000000000005 110.95 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -63.15 -47.25 83.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.629 -0.714 . . . . 63.229999999999997 110.463 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.25 -45.37 98.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.658 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -60.8 -47.58 85.67 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 122.197 0.199 . . . . 72.209999999999994 111.453 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -67.79 -39.14 84.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.381 -0.527 . . . . 72.430000000000007 112.34 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.4 tp -68.05 -37.06 80.88 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.319 0.58 . . . . 72.450000000000003 109.898 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -65.13 -41.81 94.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.509 -0.769 . . . . 75.319999999999993 109.4 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.75 -21.44 63.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.845 -0.616 . . . . 70.319999999999993 110.768 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.86 -13.33 59.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.335 0.588 . . . . 64.450000000000003 109.767 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.98 16.07 61.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.693 -0.685 . . . . 72.129999999999995 113.61 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.24 133.39 52.7 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.123 0.487 . . . . 72.209999999999994 111.141 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -90.39 -48.93 3.37 Favored Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.505 -0.771 . . . . 74.299999999999997 113.059 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -110.38 116.0 30.66 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.306 -0.958 . . . . 75.049999999999997 111.905 -172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.66 146.36 30.35 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.891 -0.595 . . . . 73.019999999999996 110.448 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -131.75 131.83 43.32 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.281 -0.637 . . . . 74.439999999999998 109.281 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -89.25 129.82 35.75 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.752 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.99 144.68 48.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.432 -1.321 . . . . 72.109999999999999 107.432 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -123.09 144.56 49.23 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.906 -0.718 . . . . 73.430000000000007 110.258 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.9 m -137.75 131.28 16.98 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.114 -0.494 . . . . 63.509999999999998 110.211 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.47 123.41 11.1 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.6 2.2 . . . . 72.239999999999995 111.218 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.5 p -142.78 179.25 7.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.991 -0.55 . . . . 71.420000000000002 110.476 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.2 t -56.38 143.38 66.0 Favored Pre-proline 0 N--CA 1.429 -1.485 0 C-N-CA 124.116 0.967 . . . . 70.549999999999997 109.987 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.58 -29.23 24.33 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.047 3.164 . . . . 75.409999999999997 113.01 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.06 -35.7 81.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.568 0.581 . . . . 74.049999999999997 112.568 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.87 -9.38 46.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 111.584 0.216 . . . . 74.549999999999997 111.584 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 61.4 t -61.5 127.02 20.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 109.88 -0.415 . . . . 75.420000000000002 109.88 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.3 71.4 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.562 -0.745 . . . . 75.209999999999994 111.798 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 434' ' ' THR . 4.3 mptp? -98.88 145.49 26.95 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.344 0.658 . . . . 75.409999999999997 109.475 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 94.9 t -82.12 126.61 39.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.378 -1.712 . . . . 74.340000000000003 106.378 173.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.24 -5.39 9.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.815 -0.754 . . . . 73.040000000000006 111.641 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.04 13.33 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.103 -1.046 . . . . 54.240000000000002 112.997 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 31.7 p -116.91 141.46 48.2 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.607 -1.257 . . . . 70.349999999999994 107.607 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 28.1 t-20 -57.16 -53.52 64.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-O 119.105 -0.474 . . . . 73.540000000000006 111.914 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.67 144.54 17.6 Favored 'Trans proline' 0 C--N 1.36 1.143 0 CA-C-N 120.459 1.2 . . . . 74.230000000000004 109.087 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.26 147.85 93.49 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.536 2.158 . . . . 75.129999999999995 111.536 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.85 -21.56 26.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.026 0.441 . . . . 45.520000000000003 111.625 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.85 -30.72 59.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.7 0.762 . . . . 52.530000000000001 109.717 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.25 152.93 17.94 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.539 -0.755 . . . . 74.420000000000002 110.036 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.2 p -85.19 117.68 24.28 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 115.945 -0.571 . . . . 71.329999999999998 110.593 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.2 m -100.79 146.63 27.03 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.573 -1.269 . . . . 73.150000000000006 107.573 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -71.31 150.79 44.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 118.078 0.399 . . . . 74.549999999999997 110.502 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.56 -25.06 23.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 124.316 1.046 . . . . 75.030000000000001 110.83 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -100.55 0.17 38.92 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.514 -0.766 . . . . 72.310000000000002 111.278 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -77.35 151.81 34.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.205 -1.406 . . . . 73.230000000000004 107.205 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.34 111.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 119.211 -0.995 . . . . 74.430000000000007 110.495 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.31 118.72 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.235 -1.024 . . . . 75.400000000000006 108.235 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 69.2 mt -95.18 119.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.345 -1.354 . . . . 74.329999999999998 107.345 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.99 119.67 55.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 109.361 -0.607 . . . . 75.549999999999997 109.361 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 487' ' ' ILE . 3.2 mp -99.03 119.67 47.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 109.68 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.65 136.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.299 -0.864 . . . . 75.030000000000001 109.995 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.97 112.47 3.81 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 107.595 -2.202 . . . . 72.319999999999993 107.595 172.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.5 m -114.27 158.41 21.44 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.705 -0.48 . . . . 74.230000000000004 109.705 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.408 0 C-N-CA 120.673 -0.775 . . . . 74.099999999999994 111.345 -178.323 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.7 0 CA-C-O 122.12 0.962 . . . . 74.439999999999998 110.131 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -137.31 156.31 48.4 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.756 -1.201 . . . . 72.099999999999994 107.756 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -149.85 157.04 42.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.632 0.604 . . . . 73.420000000000002 112.632 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.42 130.6 34.61 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 125.344 1.458 . . . . 75.519999999999996 110.219 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -87.27 129.23 52.33 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.397 -0.521 . . . . 75.430000000000007 111.402 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.04 162.34 23.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.66 2.24 . . . . 71.040000000000006 111.552 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.27 114.55 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.047 -0.524 . . . . 74.329999999999998 110.041 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.84 -0.02 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 112.305 0.483 . . . . 73.209999999999994 112.305 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.87 143.21 54.58 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.407 0.442 . . . . 74.329999999999998 110.398 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 90.38 11.61 62.4 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.406 -0.902 . . . . 75.150000000000006 111.027 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -122.43 -170.16 2.03 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.841 -0.8 . . . . 75.019999999999996 108.841 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.8 m -91.21 155.44 18.58 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.366 -1.346 . . . . 74.329999999999998 107.366 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.22 -41.35 80.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.266 0.354 . . . . 73.010000000000005 111.606 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.5 m-20 -66.08 -42.98 88.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 111.463 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.5 -36.38 28.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 119.757 -0.777 . . . . 73.5 110.988 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -63.53 -46.4 86.21 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.477 -0.783 . . . . 75.329999999999998 111.382 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.8 -35.72 82.02 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 120.447 -0.501 . . . . 52.210000000000001 110.084 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG22 ' A' ' 514' ' ' VAL . 33.6 mmtp -65.52 -50.69 64.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.552 -0.295 . . . . 73.349999999999994 111.516 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.24 -40.51 96.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.289 -0.414 . . . . 71.540000000000006 110.936 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.3 -42.61 75.21 Favored 'General case' 0 C--O 1.183 -2.441 0 N-CA-C 109.225 -0.658 . . . . 74.540000000000006 109.225 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.18 -40.01 84.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.943 0.497 . . . . 63.009999999999998 111.607 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 510' ' ' LYS . 84.6 t -67.01 -29.66 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 112.455 0.539 . . . . 74.530000000000001 112.455 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -118.55 -5.11 10.76 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.406 -0.918 . . . . 70.219999999999999 111.699 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -108.71 1.94 Allowed Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 115.402 -0.817 . . . . 61.119999999999997 113.497 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 31.3 m-85 -130.3 174.41 9.87 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.461 -0.495 . . . . 70.019999999999996 111.279 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -103.82 -5.13 22.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.403 -0.817 . . . . 73.019999999999996 111.096 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.439 ' HG3' ' HA ' ' A' ' 550' ' ' VAL . 14.8 ptpt -113.82 121.04 42.82 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.029 -0.532 . . . . 72.140000000000001 110.782 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -126.27 148.54 49.49 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.681 0.753 . . . . 74.239999999999995 111.766 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.9 m -127.81 154.94 44.85 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.851 -1.907 . . . . 64.340000000000003 105.851 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -121.81 143.21 49.54 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.722 -0.791 . . . . 75.5 109.848 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.73 123.0 48.83 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.933 -1.506 . . . . 74.510000000000005 106.933 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.3 m -88.76 116.45 27.03 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.437 -0.801 . . . . 71.209999999999994 109.779 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 29.9 m -121.14 156.92 24.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.179 -1.415 . . . . 62.409999999999997 107.179 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.39 124.04 27.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.252 0.549 . . . . 74.439999999999998 110.438 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 18.3 m -72.15 151.69 92.48 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.631 -1.168 . . . . 75.329999999999998 112.626 -173.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.62 -144.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.848 2.366 . . . . 73.040000000000006 107.441 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.83 -49.57 68.15 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 121.554 -0.716 . . . . 73.549999999999997 111.926 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.95 152.25 36.25 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 121.168 1.245 . . . . 60.020000000000003 111.111 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.13 149.66 43.3 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 101.03 -10.45 58.49 Favored Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.97 -0.633 . . . . 62.539999999999999 111.907 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.32 148.81 24.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.315 0.579 . . . . 74.200000000000003 111.701 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.521 HG23 ' CB ' ' A' ' 508' ' ' ALA . 95.5 t -75.75 120.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.271 -0.877 . . . . 72.420000000000002 109.133 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -82.1 -31.39 30.74 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.121 -0.945 . . . . 74.5 108.751 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 170.62 -169.64 42.5 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.284 -0.726 . . . . 72.030000000000001 111.284 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 32.7 p -123.69 149.46 45.46 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.221 -1.77 . . . . 64.439999999999998 106.221 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.6 t-20 -56.21 -58.32 17.25 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.978 -0.534 . . . . 74.310000000000002 112.069 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.8 Cg_exo -80.5 145.16 16.4 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.343 1.362 . . . . 74.230000000000004 108.784 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.1 147.56 73.56 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.898 1.732 . . . . 72.349999999999994 112.226 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.51 129.57 32.88 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.728 0.811 . . . . 73.129999999999995 110.267 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.68 -7.79 36.58 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.624 -0.798 . . . . 63.350000000000001 111.51 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.8 m -82.73 126.87 32.86 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.791 -0.448 . . . . 70.409999999999997 109.791 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 87.9 m -93.3 123.18 36.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.037 -1.098 . . . . 75.120000000000005 108.037 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.97 158.55 68.38 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 109.113 -0.699 . . . . 61.439999999999998 109.113 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 494' ' ' THR . 34.6 Cg_exo -61.09 145.66 98.63 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 122.664 2.242 . . . . 71.510000000000005 112.129 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 18.5 m -67.4 -19.24 25.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 122.144 0.974 . . . . 72.329999999999998 109.221 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.13 3.78 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 71.200000000000003 109.998 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 36.3 t -112.71 141.83 46.04 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.783 -1.192 . . . . 70.040000000000006 107.783 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.439 ' HA ' ' HG3' ' A' ' 519' ' ' LYS . 21.9 t -91.34 136.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.306 -0.627 . . . . 73.439999999999998 109.306 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.1 tp -91.32 135.02 28.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 110.078 -0.341 . . . . 74.409999999999997 110.078 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.86 117.64 35.08 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-O 121.573 0.701 . . . . 74.120000000000005 110.7 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.51 118.88 33.95 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.897 -1.52 . . . . 74.129999999999995 106.897 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -94.56 106.67 18.66 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.616 -1.253 . . . . 64.340000000000003 107.616 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.23 138.56 46.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-N 114.957 -1.02 . . . . 75.329999999999998 112.029 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.451 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 31.8 m -61.02 121.1 11.59 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.037 -0.983 . . . . 63.329999999999998 109.392 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 22.5 pttp . . . . . 0 C--O 1.254 1.305 0 CA-C-N 115.754 -0.657 . . . . 73.140000000000001 110.588 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.1 pt-20 . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.808 0.813 . . . . 74.219999999999999 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -83.61 123.57 29.91 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.319 -0.855 . . . . 71.319999999999993 109.571 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -120.26 164.45 16.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.788 -1.189 . . . . 74.319999999999993 107.788 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.42 141.61 32.62 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 123.247 0.619 . . . . 64.230000000000004 112.323 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -85.06 131.46 48.6 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 105.33 -2.1 . . . . 64.200000000000003 105.33 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.34 141.5 97.78 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.994 1.796 . . . . 75.430000000000007 113.041 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -102.34 -13.03 17.49 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.411 -0.813 . . . . 64.239999999999995 108.913 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.61 8.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.046 -0.979 . . . . 73.450000000000003 110.331 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 7.1 m -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.798 -1.092 . . . . 74.430000000000007 108.865 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 p -59.29 -27.62 66.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.133 -1.394 . . . . 75.049999999999997 111.115 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.42 -45.08 23.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.609 -0.515 . . . . 71.25 109.609 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.7 m -163.69 144.49 8.85 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.148 -1.056 . . . . 74.129999999999995 108.148 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 441' ' ' VAL . 30.1 t80 -59.29 -41.38 88.8 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.75 0.42 . . . . 73.140000000000001 110.465 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.69 74.27 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.19 0.306 . . . . 73.519999999999996 111.176 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 40.7 mm-40 -61.87 -44.43 96.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 116.237 -0.438 . . . . 72.540000000000006 110.31 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.23 -47.71 84.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.351 -0.84 . . . . 54.329999999999998 110.708 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 437' ' ' TYR . 88.7 t -58.7 -50.55 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 O-C-N 123.704 0.628 . . . . 74.049999999999997 110.79 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -38.0 84.7 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.789 0.662 . . . . 75.439999999999998 112.789 -177.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -66.47 -43.29 85.89 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 120.739 0.305 . . . . 72.409999999999997 110.719 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.79 -36.88 78.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 74.430000000000007 110.313 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.4 m -63.63 -41.28 98.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.995 -0.743 . . . . 74.109999999999999 108.995 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.16 -18.67 62.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.987 -0.551 . . . . 63.32 111.239 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.47 -14.65 51.99 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.677 -0.49 . . . . 74.349999999999994 109.677 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 480' ' ' ILE . . . 85.98 8.73 78.62 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.953 -0.567 . . . . 63.149999999999999 114.33 172.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.49 124.54 20.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.213 0.506 . . . . 74.420000000000002 111.834 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -63.4 -55.41 25.79 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.054 -0.975 . . . . 52.229999999999997 114.285 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.544 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 0.4 OUTLIER -121.81 130.95 53.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.282 -0.567 . . . . 74.209999999999994 110.761 -174.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.77 144.59 31.25 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.805 -0.634 . . . . 75.140000000000001 109.304 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -131.34 141.5 49.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.456 -0.572 . . . . 74.409999999999997 109.456 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.63 136.4 34.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.878 0.736 . . . . 74.129999999999995 110.813 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.63 52.44 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.55 -2.018 . . . . 72.120000000000005 105.55 171.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -138.59 150.47 46.34 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 119.012 0.823 . . . . 72.310000000000002 110.138 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 25.6 m -131.94 145.7 58.56 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 108.627 -0.879 . . . . 55.409999999999997 108.627 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.63 134.8 26.93 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.505 2.137 . . . . 71.120000000000005 112.04 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.3 p -152.15 179.74 8.24 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.866 0.866 . . . . 64.099999999999994 109.207 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -59.68 142.3 87.98 Favored Pre-proline 0 N--CA 1.432 -1.339 0 C-N-CA 123.741 0.817 . . . . 44.450000000000003 111.411 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.486 ' O ' HG12 ' A' ' 464' ' ' VAL . 54.0 Cg_exo -52.57 -28.13 35.43 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.421 3.414 . . . . 74.140000000000001 113.428 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.98 -10.34 59.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.344 0.498 . . . . 74.530000000000001 112.344 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 9.5 mp -107.29 0.73 23.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.446 0.535 . . . . 75.5 112.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.1 p -61.29 128.81 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.286 0.565 . . . . 70.120000000000005 112.191 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.82 69.7 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 120.896 -0.669 . . . . 74.030000000000001 112.427 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 23.5 mtpp -109.91 146.17 35.62 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.318 -0.993 . . . . 72.510000000000005 108.318 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 486' ' ' ILE . 63.1 t -81.86 124.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.29 -0.633 . . . . 73.340000000000003 109.29 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.1 pt -101.68 -2.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.923 -0.58 . . . . 73.409999999999997 111.639 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.99 156.67 11.79 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.119 -0.562 . . . . 50.43 112.324 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 35.0 p -128.5 148.73 50.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.415 -0.957 . . . . 74.319999999999993 108.415 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.52 -56.18 20.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.273 -0.394 . . . . 75.109999999999999 110.477 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -82.2 131.37 6.72 Favored 'Trans proline' 0 C--N 1.364 1.369 0 CA-C-N 120.152 1.09 . . . . 75.200000000000003 109.473 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -72.69 152.61 53.49 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.976 1.784 . . . . 63.240000000000002 113.119 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.47 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 6.35 11.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.395 1.078 . . . . 73.140000000000001 111.232 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.23 -28.64 13.99 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.796 -0.638 . . . . 75.239999999999995 111.108 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -115.45 161.47 18.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.211 -0.663 . . . . 73.239999999999995 109.211 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 33.3 p -95.35 140.8 29.72 Favored 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 120.483 -0.487 . . . . 72.239999999999995 109.875 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' SER . . . . . 0.459 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . 23.4 m -120.88 147.94 44.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.452 -0.573 . . . . 62.219999999999999 109.452 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 482' ' ' ASN . . . -57.12 151.32 15.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.352 0.871 . . . . 64.239999999999995 113.352 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.1 mm -58.07 -32.98 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.049 0.939 . . . . 74.140000000000001 110.368 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.2 t -81.4 3.25 25.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.251 -0.886 . . . . 64.510000000000005 111.979 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 479' ' ' ALA . 0.8 OUTLIER -74.33 158.42 34.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.275 0.559 . . . . 70.010000000000005 112.349 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 451' ' ' ARG . 60.4 t -106.97 114.31 45.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.027 -1.101 . . . . 73.519999999999996 108.027 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 88.6 t -94.61 119.91 43.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.237 0.541 . . . . 74.510000000000005 110.439 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 71.9 mt -96.31 112.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.484 -1.673 . . . . 74.040000000000006 106.484 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.461 HD12 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.19 128.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 116.167 -0.47 . . . . 71.120000000000005 110.533 -176.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.93 115.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.599 0.714 . . . . 75.239999999999995 111.069 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.53 142.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.547 -0.752 . . . . 74.349999999999994 109.55 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.27 113.71 3.77 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.091 -1.204 . . . . 62.25 110.091 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 35.1 t -95.8 129.81 42.92 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 106.748 -1.575 . . . . 72.120000000000005 106.748 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.593 0 C-N-CA 119.754 -1.212 . . . . 73.420000000000002 112.029 -177.695 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 109.027 -0.731 . . . . 60.100000000000001 109.027 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 546' ' ' PRO . 66.6 p -124.92 164.93 19.02 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.25 -0.887 . . . . 74.319999999999993 109.123 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 517' ' ' PHE . 6.4 mmpt? -139.62 144.18 37.57 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.686 -0.857 . . . . 74.340000000000003 108.686 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 27.6 t70 -90.59 130.34 36.63 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.788 -0.819 . . . . 54.420000000000002 108.788 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 20.4 pt -96.12 121.39 60.77 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.268 -0.573 . . . . 73.109999999999999 112.525 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.23 169.96 4.93 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.915 1.743 . . . . 74.140000000000001 109.316 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.88 129.71 34.84 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.491 -0.884 . . . . 75.439999999999998 109.574 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.35 14.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 123.278 1.513 . . . . 73.420000000000002 107.093 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.436 ' HA ' HG11 ' A' ' 534' ' ' VAL . . . -71.61 138.57 48.82 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.546 -1.661 . . . . 60.409999999999997 110.293 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.09 -4.57 41.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.648 -0.787 . . . . 72.510000000000005 111.822 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -106.09 176.63 5.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.844 -1.539 . . . . 73.450000000000003 106.844 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 71.1 p -80.41 157.87 26.13 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.448 -0.901 . . . . 72.349999999999994 108.963 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.46 -43.14 86.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.495 0.664 . . . . 65.0 110.19 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.86 -42.8 85.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.77 -1.105 . . . . 73.310000000000002 111.812 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.18 -36.84 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 119.431 -0.908 . . . . 73.430000000000007 111.243 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.49 73.4 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.908 -0.587 . . . . 71.439999999999998 111.282 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.3 -35.97 82.62 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 120.318 -0.553 . . . . 71.349999999999994 110.614 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -61.37 -53.69 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.505 0.503 . . . . 75.239999999999995 110.775 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.11 -41.85 94.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.788 -0.642 . . . . 73.439999999999998 110.673 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.4 HD13 HD11 ' A' ' 551' ' ' ILE . 4.9 tt -66.36 -40.66 89.91 Favored 'General case' 0 C--O 1.186 -2.257 0 CA-C-N 115.404 -0.816 . . . . 75.510000000000005 109.246 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.1 t-20 -58.54 -38.29 77.46 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.387 0.675 . . . . 65.109999999999999 111.621 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.57 -40.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.726 -0.67 . . . . 72.129999999999995 112.032 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -107.4 -23.28 12.26 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.037 -0.665 . . . . 74.239999999999995 112.197 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -103.59 -100.16 2.58 Favored Glycine 0 N--CA 1.413 -2.861 0 CA-C-N 115.262 -0.881 . . . . 41.43 113.683 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 46.0 m-85 -131.23 166.86 20.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.331 0.586 . . . . 72.150000000000006 111.185 -171.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.452 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 4.7 p -102.8 -4.12 25.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.943 -1.026 . . . . 74.400000000000006 110.295 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -109.95 116.29 31.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.705 . . . . 73.209999999999994 109.763 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -128.94 145.84 51.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.332 0.587 . . . . 75.109999999999999 110.911 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 59.2 m -135.64 145.63 47.02 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.988 -1.486 . . . . 73.510000000000005 106.988 172.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -125.55 143.25 51.09 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.393 -0.523 . . . . 73.450000000000003 111.95 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.45 129.23 52.85 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.596 -1.261 . . . . 65.439999999999998 107.596 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -88.35 127.74 35.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.207 0.527 . . . . 73.209999999999994 110.422 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.1 m -121.54 162.53 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.287 -1.005 . . . . 75.420000000000002 108.287 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.78 140.51 38.23 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.937 -0.705 . . . . 73.409999999999997 110.065 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 8.3 m -90.08 114.17 59.9 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.377 -1.283 . . . . 74.219999999999999 110.825 -174.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.85 -83.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.729 1.619 . . . . 75.230000000000004 109.661 173.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -90.9 -54.8 0.27 Allowed Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-O 118.805 -0.616 . . . . 72.329999999999998 111.14 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 527' ' ' SER . 21.9 Cg_endo -61.61 153.26 68.2 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.99 1.794 . . . . 64.409999999999997 111.359 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.46 82.43 0.27 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.853 0.861 . . . . 71.310000000000002 108.993 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.31 -31.12 2.64 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.482 -1.047 . . . . 75.5 110.482 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -86.12 149.55 25.05 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.259 -0.471 . . . . 72.209999999999994 110.17 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' A' ' 501' ' ' ALA . 5.3 p -73.85 123.11 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.318 -0.993 . . . . 64.530000000000001 108.318 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -71.87 -41.58 67.86 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.872 -1.058 . . . . 75.400000000000006 110.874 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -174.26 -160.35 22.3 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.407 -0.902 . . . . 71.120000000000005 111.189 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.0 p -131.74 159.98 36.86 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.66 -0.867 . . . . 74.140000000000001 108.66 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 48.8 t30 -69.02 -55.36 10.53 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-O 118.937 -0.554 . . . . 72.530000000000001 110.512 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.0 Cg_endo -81.48 146.94 15.59 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.05 1.167 . . . . 74.329999999999998 109.533 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.04 147.73 43.66 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.943 1.762 . . . . 74.340000000000003 112.444 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.11 138.23 58.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.824 -0.626 . . . . 75.340000000000003 110.017 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.74 -5.75 60.16 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 111.173 -0.771 . . . . 65.430000000000007 111.173 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -88.78 126.04 35.16 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.593 -0.521 . . . . 73.519999999999996 109.593 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.1 m -90.51 123.13 33.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.802 -1.184 . . . . 63.530000000000001 107.802 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.74 154.74 75.8 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.82 -0.437 . . . . 75.510000000000005 109.82 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.473 ' HA ' HG21 ' A' ' 494' ' ' THR . 27.0 Cg_exo -64.72 147.71 89.91 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.945 2.43 . . . . 73.510000000000005 113.55 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.522 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.6 m -67.05 -19.42 25.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.163 0.982 . . . . 73.299999999999997 111.995 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.62 -8.03 59.03 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.688 -1.142 . . . . 55.299999999999997 109.365 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 41.4 m -97.44 149.91 21.62 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 115.165 -0.925 . . . . 71.120000000000005 109.204 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.87 136.57 26.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.94 -0.573 . . . . 74.040000000000006 110.309 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 512' ' ' LEU . 15.5 tt -98.93 129.01 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.665 0.745 . . . . 74.430000000000007 109.963 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 521' ' ' SER . 31.8 tt0 -103.74 129.67 51.15 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 115.696 -0.684 . . . . 72.349999999999994 110.379 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.72 134.5 48.74 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.419 1.088 . . . . 74.319999999999993 110.672 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.06 108.53 19.79 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.276 -1.75 . . . . 72.209999999999994 106.276 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.09 137.62 38.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 112.089 0.403 . . . . 75.200000000000003 112.089 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.7 m -60.42 122.02 13.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.668 -1.604 . . . . 73.010000000000005 106.668 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.836 -0.602 . . . . 70.140000000000001 111.863 -172.789 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.041 0.924 . . . . 74.409999999999997 111.319 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 96.2 mt-30 -102.93 130.22 49.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.81 -1.086 . . . . 72.329999999999998 108.758 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -128.23 158.85 36.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.206 -1.035 . . . . 73.329999999999998 108.206 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -82.66 141.5 32.43 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 123.254 0.622 . . . . 75.030000000000001 110.365 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 474' ' ' ALA . 2.8 mp -85.09 130.01 53.79 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.052 -0.721 . . . . 74.450000000000003 109.052 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.01 145.19 99.42 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.979 2.453 . . . . 75.129999999999995 112.333 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.24 11.72 35.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.433 1.111 . . . . 74.439999999999998 110.14 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.91 -9.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.581 1.182 . . . . 74.5 108.562 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.8 m -59.26 -33.75 71.41 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.916 -1.493 . . . . 65.299999999999997 110.292 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 4.2 m -60.68 -27.34 67.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.505 -1.225 . . . . 73.400000000000006 110.375 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.79 -44.25 17.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 119.991 -0.683 . . . . 74.510000000000005 110.959 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 91.5 m -162.0 144.61 11.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 109.394 -0.595 . . . . 71.319999999999993 109.394 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -52.68 -49.42 65.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.016 0.926 . . . . 73.510000000000005 111.227 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.69 -40.77 80.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 71.519999999999996 111.22 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.499 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 19.9 mm-40 -61.42 -41.42 97.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.827 -0.624 . . . . 73.450000000000003 111.101 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.05 -51.82 67.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 123.915 0.759 . . . . 71.439999999999998 110.718 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.77 -46.68 95.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 CA-C-N 115.114 -0.948 . . . . 75.019999999999996 111.994 -174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 75.6 mmtt -60.84 -47.89 84.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 110.028 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -68.26 -45.29 73.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.351 -0.84 . . . . 74.510000000000005 111.431 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.507 HD22 ' CE2' ' A' ' 452' ' ' PHE . 21.8 tp -69.07 -38.53 79.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.063 0.459 . . . . 72.140000000000001 110.845 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.6 m -64.16 -39.66 94.48 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.838 -0.619 . . . . 73.239999999999995 109.459 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -18.98 62.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.932 -0.577 . . . . 64.319999999999993 110.442 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.16 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.087 0.47 . . . . 70.439999999999998 110.124 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.84 -23.71 9.93 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.617 -0.802 . . . . 75.109999999999999 113.175 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.69 134.29 56.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.741 0.305 . . . . 74.439999999999998 110.783 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -130.13 -8.17 3.41 Favored Glycine 0 N--CA 1.428 -1.886 0 C-N-CA 119.811 -1.185 . . . . 70.019999999999996 112.898 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -102.69 115.4 30.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.548 -0.908 . . . . 74.239999999999995 108.548 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.507 ' CE2' HD22 ' A' ' 444' ' ' LEU . 42.3 m-85 -129.19 154.88 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.294 -0.866 . . . . 74.230000000000004 110.394 -175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.406 ' HB3' HG12 ' A' ' 485' ' ' ILE . 0.7 OUTLIER -138.86 122.92 17.93 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.37 -2.455 . . . . 75.420000000000002 104.37 169.239 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -105.17 134.61 47.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 110.904 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.13 153.3 47.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.497 -0.927 . . . . 73.340000000000003 108.497 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.35 146.49 50.02 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 70.430000000000007 109.396 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 53.4 m -139.89 135.21 16.37 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 116.555 -0.293 . . . . 74.209999999999994 110.373 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.72 122.39 10.23 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.386 2.057 . . . . 72.209999999999994 111.374 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.7 m -140.54 -179.91 6.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.81 -1.181 . . . . 71.409999999999997 107.81 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.8 t -50.2 142.99 13.46 Favored Pre-proline 0 C--O 1.25 1.131 0 C-N-CA 123.168 0.587 . . . . 73.349999999999994 110.795 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.12 -29.32 28.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.088 3.192 . . . . 73.109999999999999 112.986 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.52 -18.86 63.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.467 0.543 . . . . 71.040000000000006 112.467 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -100.97 6.8 43.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.978 0.732 . . . . 75.230000000000004 112.978 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.6 p -61.01 127.69 21.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.406 -0.518 . . . . 70.530000000000001 110.546 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.48 12.73 84.26 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.801 -0.714 . . . . 60.539999999999999 112.439 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 94.6 mttt -121.18 154.87 35.68 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.693 -0.854 . . . . 75.239999999999995 108.693 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 486' ' ' ILE . 40.5 t -82.06 126.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.174 -0.676 . . . . 75.329999999999998 109.174 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.4 pt -98.17 -13.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.462 -0.495 . . . . 63.299999999999997 110.358 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.45 160.82 19.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.595 -0.812 . . . . 73.319999999999993 111.684 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.5 p -120.86 146.72 46.28 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.546 -0.909 . . . . 71.329999999999998 108.546 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.549 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.3 t-20 -58.49 -57.93 22.81 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-O 119.128 -0.463 . . . . 73.310000000000002 111.042 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.34 129.55 14.04 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 108.737 -1.294 . . . . 73.450000000000003 108.737 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.7 133.08 37.72 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 74.209999999999994 112.254 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.436 ' CB ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.6 -5.7 46.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.939 0.876 . . . . 72.340000000000003 110.673 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.81 -28.44 28.08 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.224 -1.353 . . . . 74.319999999999993 109.4 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.91 165.21 11.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.041 -0.726 . . . . 74.109999999999999 109.041 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.5 p -87.84 120.83 29.56 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 109.094 -0.706 . . . . 75.150000000000006 109.094 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 19.8 m -104.39 147.98 26.93 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.359 -0.978 . . . . 74.409999999999997 108.359 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.81 148.58 44.38 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.752 0.31 . . . . 71.430000000000007 110.94 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.36 -21.9 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.869 0.842 . . . . 75.109999999999999 110.549 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 t -94.32 -0.56 54.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.228 -0.896 . . . . 71.219999999999999 110.566 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.9 142.13 38.63 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.345 -0.983 . . . . 71.430000000000007 108.345 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.63 112.0 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.702 -0.851 . . . . 70.519999999999996 108.702 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.77 118.41 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 108.389 -0.967 . . . . 71.040000000000006 108.389 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.4 mt -92.44 112.01 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 106.018 -1.845 . . . . 75.450000000000003 106.018 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.55 121.56 56.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.121 -0.945 . . . . 74.409999999999997 108.633 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.93 118.85 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.748 -0.66 . . . . 73.209999999999994 109.608 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.25 139.16 19.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.011 -1.107 . . . . 72.129999999999995 108.011 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.02 127.08 7.79 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 109.975 -1.25 . . . . 62.439999999999998 109.975 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 24.6 p -108.38 131.72 54.47 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.749 -0.834 . . . . 70.230000000000004 108.749 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.089 0 N-CA-C 109.939 -1.264 . . . . 74.209999999999994 109.939 179.524 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.338 0 N-CA-C 107.353 -1.351 . . . . 74.319999999999993 107.353 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 41.5 p -135.51 166.36 23.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.854 -1.066 . . . . 74.400000000000006 109.583 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 27.6 mmtm -140.13 137.63 34.61 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.052 0.453 . . . . 73.430000000000007 111.802 173.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.78 126.46 31.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.626 -1.17 . . . . 72.519999999999996 108.058 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.9 pt -96.34 131.01 29.39 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.73 -0.788 . . . . 75.439999999999998 110.619 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.76 -177.95 1.03 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.356 2.037 . . . . 74.319999999999993 110.472 174.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.91 93.8 3.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.07 0.462 . . . . 74.349999999999994 110.232 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.19 -0.6 10.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.84 -1.541 . . . . 72.319999999999993 106.84 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.46 143.69 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.459 -1.7 . . . . 75.230000000000004 109.565 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.22 -15.45 25.36 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.477 -0.868 . . . . 62.130000000000003 111.52 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.64 -170.15 1.95 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.28 -0.568 . . . . 74.450000000000003 110.249 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.5 157.52 21.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.894 -1.15 . . . . 74.239999999999995 107.894 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 42.4 t -56.62 -49.62 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.416 0.627 . . . . 74.209999999999994 111.14 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.27 -41.96 80.3 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.282 -0.872 . . . . 75.200000000000003 111.129 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.32 -44.67 94.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.828 -1.078 . . . . 74.150000000000006 110.632 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.05 96.47 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.003 -0.544 . . . . 74.109999999999999 110.957 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.21 -40.17 95.19 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.89 -0.411 . . . . 73.450000000000003 109.89 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -44.03 89.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.832 -0.622 . . . . 75.140000000000001 110.6 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.65 -44.51 73.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.039 0.447 . . . . 73.140000000000001 110.519 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.15 -36.8 85.37 Favored 'General case' 0 C--O 1.191 -2.004 0 CA-C-N 115.565 -0.743 . . . . 71.409999999999997 109.54 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 26.2 t-20 -57.85 -37.96 74.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.263 0.625 . . . . 72.5 111.597 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.46 -43.16 91.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.585 -0.734 . . . . 74.409999999999997 111.675 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -110.85 13.29 22.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.521 -0.472 . . . . 71.450000000000003 110.549 -171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.9 -103.01 0.31 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.408 -1.377 . . . . 60.229999999999997 115.108 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 46.9 m-85 -127.04 177.56 6.56 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.005 0.431 . . . . 74.109999999999999 112.143 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 m -120.74 -14.52 8.54 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.739 -0.664 . . . . 65.439999999999998 110.949 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -108.23 119.68 40.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.431 -0.581 . . . . 75.239999999999995 109.431 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.72 147.57 44.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.714 -0.675 . . . . 73.010000000000005 111.001 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 44.3 m -137.5 151.64 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.756 -1.572 . . . . 73.099999999999994 106.756 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -121.53 137.83 54.56 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 118.339 0.518 . . . . 74.319999999999993 111.381 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -126.17 122.62 36.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.353 -1.351 . . . . 70.299999999999997 107.353 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 5.2 p -89.33 132.7 34.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.777 0.322 . . . . 71.099999999999994 111.5 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.76 149.31 24.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.183 -1.414 . . . . 72.109999999999999 107.183 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.88 136.3 37.25 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.133 -0.627 . . . . 74.010000000000005 110.972 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.1 m -133.64 160.5 68.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.065 -0.97 . . . . 73.549999999999997 109.982 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -70.19 -142.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.38 2.72 . . . . 75.420000000000002 111.964 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -51.39 81.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 113.888 1.07 . . . . 73.120000000000005 113.888 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.24 133.02 31.38 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 121.043 1.408 . . . . 72.109999999999999 109.799 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -168.78 125.49 0.98 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.303 0.641 . . . . 74.109999999999999 109.518 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.9 -23.53 1.45 Allowed Glycine 0 C--N 1.301 -1.413 0 N-CA-C 109.841 -1.304 . . . . 63.130000000000003 109.841 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.55 29.92 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.447 -0.946 . . . . 74.430000000000007 108.447 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 75.0 t -74.05 119.39 21.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.6 -0.889 . . . . 72.129999999999995 108.6 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.0 m -68.5 -40.36 80.89 Favored 'General case' 0 N--CA 1.427 -1.595 0 O-C-N 124.529 1.143 . . . . 74.140000000000001 109.642 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.61 -152.87 20.63 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.506 -0.854 . . . . 54.200000000000003 111.541 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -134.04 161.76 33.96 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.744 -1.206 . . . . 62.200000000000003 107.744 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -56.32 -65.3 1.67 Allowed Pre-proline 0 N--CA 1.474 0.76 0 CA-C-O 118.891 -0.576 . . . . 65.230000000000004 110.65 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.88 147.92 27.66 Favored 'Trans proline' 0 C--N 1.367 1.509 0 CA-C-N 120.633 1.262 . . . . 74.25 109.248 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.86 163.05 40.08 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.927 1.751 . . . . 71.109999999999999 111.528 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.76 58.66 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.187 -0.46 . . . . 73.420000000000002 110.21 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.49 -12.76 61.51 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.936 -0.865 . . . . 72.219999999999999 110.936 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.7 m -86.04 124.22 32.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 109.07 -0.715 . . . . 73.25 109.07 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.1 t -90.6 123.38 34.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.96 -1.126 . . . . 74.540000000000006 107.96 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.443 HG21 ' CZ ' ' A' ' 517' ' ' PHE . 19.4 m -123.64 156.27 64.93 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 109.671 -0.492 . . . . 74.230000000000004 109.671 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 135.08 65.29 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.213 2.609 . . . . 71.329999999999998 114.23 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.518 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.5 m -67.28 -20.78 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.274 -0.876 . . . . 64.120000000000005 111.518 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.11 -0.23 55.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 111.12 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 17.4 t -100.42 151.04 22.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.236 -1.024 . . . . 75.310000000000002 108.236 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.58 136.41 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 N-CA-C 108.022 -1.103 . . . . 73.409999999999997 108.022 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.6 tt -97.52 143.28 12.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 120.036 -0.665 . . . . 75.430000000000007 110.858 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -102.45 118.37 36.72 Favored 'General case' 0 N--CA 1.408 -2.547 0 C-N-CA 123.471 0.709 . . . . 64.239999999999995 109.404 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.0 tp -97.05 129.25 44.51 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.729 -1.123 . . . . 70.5 108.689 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -90.05 112.95 24.56 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.364 -0.976 . . . . 71.329999999999998 108.364 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.8 137.88 33.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.006 -0.543 . . . . 73.099999999999994 111.955 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.5 m -68.76 126.08 28.61 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 115.64 -0.709 . . . . 73.349999999999994 111.65 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 115.308 -0.86 . . . . 72.409999999999997 108.803 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 122.559 1.171 . . . . 65.209999999999994 110.191 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.427 ' C ' ' HB ' ' A' ' 477' ' ' THR . 26.7 mt-30 -101.64 125.7 48.35 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.006 -1.452 . . . . 55.43 108.755 175.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -121.04 153.44 37.38 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.407 -0.36 . . . . 74.439999999999998 110.341 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.02 141.39 28.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 110.889 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.4 mp -85.09 128.33 60.53 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 107.47 -1.307 . . . . 75.319999999999993 107.47 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.8 147.05 61.78 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.561 2.174 . . . . 74.340000000000003 112.55 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -83.54 29.31 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.956 -0.565 . . . . 72.439999999999998 110.762 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.9 m -85.84 7.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.001 0.905 . . . . 72.019999999999996 109.784 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.559 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 2.3 p -58.0 -35.02 70.62 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 125.999 1.719 . . . . 72.230000000000004 109.982 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.52 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.6 t -60.47 -26.04 66.48 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.718 -1.583 . . . . 74.129999999999995 111.496 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.81 -47.81 10.01 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 118.953 -1.099 . . . . 73.420000000000002 111.05 -174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.4 m -174.41 153.99 2.03 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.736 -1.209 . . . . 73.420000000000002 107.736 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.468 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 29.2 t80 -50.37 -54.72 19.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.293 1.037 . . . . 71.219999999999999 110.656 171.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.18 -41.23 75.18 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.912 -0.586 . . . . 75.040000000000006 111.936 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 443' ' ' LYS . 66.2 mm-40 -61.51 -46.56 89.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.156 0.428 . . . . 74.129999999999995 112.156 -178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.83 58.64 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.603 0.594 . . . . 74.140000000000001 112.603 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.74 -47.6 88.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 70.430000000000007 110.958 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.62 -35.21 79.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.304 0.242 . . . . 71.019999999999996 110.973 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 439' ' ' GLU . 2.6 tmtm? -66.26 -47.61 73.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.155 -1.054 . . . . 75.340000000000003 108.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.1 tp -68.86 -32.66 72.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.723 -0.671 . . . . 72.209999999999994 110.519 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 96.9 m -60.89 -43.99 97.72 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.51 -0.768 . . . . 64.239999999999995 109.308 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -20.02 62.45 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.077 -0.51 . . . . 71.340000000000003 111.148 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.54 -10.9 59.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.997 -0.547 . . . . 71.310000000000002 110.414 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.51 -8.43 8.33 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 119.927 -1.13 . . . . 74.120000000000005 113.956 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 445' ' ' THR . 92.5 m-85 -86.17 133.37 33.86 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 117.306 0.553 . . . . 73.319999999999993 110.773 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.41 -13.96 3.04 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.886 -0.673 . . . . 53.229999999999997 112.692 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -103.06 116.29 32.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.41 0.605 . . . . 71.040000000000006 110.87 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.04 158.03 40.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.826 -0.625 . . . . 75.010000000000005 111.231 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.4 tppp? -134.61 135.7 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.042 -2.207 . . . . 63.149999999999999 105.042 172.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -115.95 135.09 54.3 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.535 0.607 . . . . 74.120000000000005 111.236 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.24 140.86 45.58 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.348 -0.982 . . . . 64.299999999999997 108.348 175.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.86 142.12 46.5 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.862 -0.792 . . . . 74.140000000000001 108.862 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.5 t -140.58 146.74 46.19 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 108.605 -0.887 . . . . 74.329999999999998 108.605 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.2 Cg_exo -65.08 140.17 64.31 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.846 1.698 . . . . 74.0 109.926 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 71.1 m -150.72 179.77 7.93 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.747 -0.835 . . . . 64.510000000000005 108.747 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -56.09 133.67 74.5 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.94 -0.763 . . . . 75.450000000000003 108.94 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 79.3 Cg_exo -50.1 -29.59 22.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.142 3.228 . . . . 74.409999999999997 115.117 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.81 -10.31 59.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.234 0.828 . . . . 75.109999999999999 113.234 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.8 mt -102.53 11.61 37.61 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.784 -0.366 . . . . 73.099999999999994 111.731 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -61.14 128.05 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.999 0.428 . . . . 73.540000000000006 110.737 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.8 3.99 90.39 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.996 -0.547 . . . . 73.329999999999998 112.292 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 434' ' ' THR . 93.5 mttt -112.23 159.69 18.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.371 -0.974 . . . . 72.319999999999993 108.371 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.559 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 46.0 t -82.67 129.07 38.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.557 -0.905 . . . . 63.5 108.557 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.33 -20.52 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.361 0.601 . . . . 65.230000000000004 109.764 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.75 170.2 33.09 Favored Glycine 0 N--CA 1.416 -2.688 0 N-CA-C 110.471 -1.052 . . . . 74.420000000000002 110.471 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.2 p -120.02 157.62 28.49 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.452 -0.573 . . . . 72.349999999999994 109.452 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.567 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 25.6 t-20 -60.21 -49.28 91.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 119.238 -0.41 . . . . 73.420000000000002 111.49 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.0 Cg_exo -83.14 155.88 14.82 Favored 'Trans proline' 0 C--N 1.365 1.402 0 N-CA-C 107.821 -1.646 . . . . 73.319999999999993 107.821 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.36 146.65 81.26 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 121.697 1.598 . . . . 64.439999999999998 109.887 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.94 -37.4 29.56 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 121.059 0.457 . . . . 73.329999999999998 111.166 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . 0.271 18.8 m-80 -85.41 -8.33 58.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.719 1.377 . . . . 73.400000000000006 114.719 -172.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.39 152.28 18.54 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.773 -1.195 . . . . 74.120000000000005 107.773 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.427 ' HB ' ' C ' ' A' ' 426' ' ' GLN . 33.1 p -79.51 121.63 25.46 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.272 0.558 . . . . 73.239999999999995 110.738 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.6 m -104.59 140.83 37.43 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.357 -0.979 . . . . 65.25 108.357 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 145.67 52.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.733 0.302 . . . . 72.319999999999993 111.635 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.0 mm -59.59 -21.89 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.472 0.709 . . . . 73.439999999999998 111.27 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.8 t -83.49 0.08 47.94 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.924 -0.485 . . . . 72.25 111.473 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.08 154.77 20.49 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.967 0.413 . . . . 75.219999999999999 110.605 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.25 124.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.17 -1.418 . . . . 74.150000000000006 107.17 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.41 118.7 37.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 C-N-CA 119.19 -1.004 . . . . 75.040000000000006 109.405 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.567 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.96 113.15 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.029 -1.841 . . . . 75.200000000000003 106.029 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.34 128.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 115.923 -0.58 . . . . 75.530000000000001 109.595 -175.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 31.5 mt -104.5 119.96 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.277 -0.874 . . . . 72.030000000000001 109.286 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.59 137.76 23.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.279 -0.873 . . . . 73.0 108.885 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -85.05 123.49 6.32 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 110.943 -0.863 . . . . 62.350000000000001 110.943 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 27.4 t -111.07 129.46 55.91 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.67 -1.604 . . . . 72.109999999999999 106.67 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.612 0 N-CA-C 109.291 -1.523 . . . . 63.229999999999997 109.291 179.163 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.36 0 N-CA-C 107.69 -1.226 . . . . 73.299999999999997 107.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 23.8 p -134.76 160.71 37.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.348 -0.842 . . . . 74.319999999999993 110.66 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -150.45 142.24 23.74 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.714 0.806 . . . . 73.329999999999998 109.052 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.6 p-10 -88.75 134.01 34.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.479 . . . . 75.120000000000005 107.008 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.95 124.92 88.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 CA-C-N 115.489 -0.778 . . . . 72.019999999999996 111.867 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.06 150.15 1.65 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.533 2.155 . . . . 72.230000000000004 111.212 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -87.64 107.55 18.66 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.345 1.069 . . . . 63.539999999999999 110.053 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.53 42.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 106.925 -1.509 . . . . 73.209999999999994 106.925 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.42 159.89 25.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.406 -1.27 . . . . 73.230000000000004 112.629 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.15 -16.09 46.37 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.216 -0.753 . . . . 72.319999999999993 111.216 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -89.93 -173.08 3.75 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.195 0.522 . . . . 74.510000000000005 111.696 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.6 m -90.85 156.56 17.93 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.403 -1.332 . . . . 74.109999999999999 107.403 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 19.2 t -55.05 -48.97 75.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 123.721 0.638 . . . . 73.239999999999995 111.08 -172.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.34 -41.62 80.46 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.619 0.6 . . . . 75.120000000000005 112.619 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.88 -34.86 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.507 -0.877 . . . . 75.540000000000006 111.234 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.78 89.22 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.727 -0.67 . . . . 75.310000000000002 110.216 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.1 mt-30 -62.73 -42.74 99.81 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 123.448 0.467 . . . . 73.109999999999999 110.481 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.67 99.44 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 112.897 0.703 . . . . 73.299999999999997 112.897 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -66.99 -48.11 69.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.53 -0.468 . . . . 65.400000000000006 110.094 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.427 HD23 HD12 ' A' ' 551' ' ' ILE . 41.8 tp -60.2 -41.17 92.44 Favored 'General case' 0 C--O 1.198 -1.614 0 CA-C-N 115.512 -0.767 . . . . 75.340000000000003 110.144 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.8 t-20 -59.21 -48.05 83.05 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.856 0.862 . . . . 74.200000000000003 111.29 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.88 -18.89 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.318 0.488 . . . . 75.150000000000006 112.318 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -118.96 8.66 11.7 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.778 -0.769 . . . . 74.150000000000006 110.229 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -149.84 -95.83 0.14 Allowed Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.02 -1.562 . . . . 65.530000000000001 115.836 -170.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 59.6 m-85 -123.11 170.18 10.47 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.221 0.534 . . . . 74.430000000000007 111.736 -165.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 20.4 p -97.11 -35.9 10.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.276 -0.874 . . . . 73.409999999999997 112.352 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -117.77 142.61 47.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.127 0.489 . . . . 71.530000000000001 112.075 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -127.6 156.99 41.4 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.735 -1.12 . . . . 75.099999999999994 110.404 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.4 t -129.73 141.99 50.79 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.845 -2.28 . . . . 74.530000000000001 104.845 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -121.28 129.78 53.31 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.944 -0.761 . . . . 75.209999999999994 108.944 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.03 136.96 51.0 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 123.601 0.563 . . . . 75.439999999999998 109.736 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 51.9 m -88.56 131.61 34.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.31 -0.859 . . . . 63.130000000000003 109.491 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 557' ' ' LYS . 34.4 m -122.24 149.53 25.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.734 -0.469 . . . . 72.109999999999999 109.734 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.93 111.45 16.27 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.74 0.781 . . . . 73.239999999999995 110.195 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 7.2 p -107.58 119.81 49.37 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.615 -1.175 . . . . 70.519999999999996 109.818 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -51.49 1.54 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.449 2.099 . . . . 74.120000000000005 111.527 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -102.78 -50.93 0.15 Allowed Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 114.186 1.18 . . . . 75.239999999999995 114.186 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.75 153.45 36.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.904 1.736 . . . . 74.420000000000002 112.373 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.89 108.01 0.86 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 122.918 0.487 . . . . 70.329999999999998 110.968 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.75 -24.08 33.19 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 120.935 -0.65 . . . . 74.420000000000002 114.336 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.24 23.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 2.7 p -73.68 120.16 22.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.945 -0.761 . . . . 73.439999999999998 108.945 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -71.73 -40.39 69.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.991 -1.004 . . . . 74.230000000000004 110.174 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.84 -149.81 13.81 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.488 -0.645 . . . . 73.5 111.488 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.5 p -117.9 160.03 22.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.277 -1.008 . . . . 73.230000000000004 108.277 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -74.3 -56.05 2.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.018 -1.073 . . . . 71.329999999999998 110.181 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.87 149.33 89.71 Favored 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 120.741 0.961 . . . . 72.450000000000003 109.614 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.8 152.36 80.66 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.525 2.15 . . . . 72.0 112.549 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.38 132.64 52.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.795 -0.817 . . . . 74.530000000000001 108.795 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.63 40.83 Favored Glycine 0 C--N 1.298 -1.574 0 C-N-CA 120.272 -0.966 . . . . 71.120000000000005 111.958 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.8 m -67.44 120.96 14.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.871 -0.789 . . . . 64.120000000000005 108.871 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.4 m -90.18 122.75 33.41 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.556 -0.905 . . . . 74.109999999999999 108.556 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.01 157.63 77.7 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 108.095 -1.076 . . . . 70.25 108.095 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.81 144.3 98.53 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.182 1.922 . . . . 75.319999999999993 111.577 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -65.03 -18.55 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.18 0.991 . . . . 72.420000000000002 110.786 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.32 -17.73 53.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.883 -1.508 . . . . 74.329999999999998 109.83 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 172.4 13.79 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.985 -1.007 . . . . 72.409999999999997 113.644 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.03 124.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.358 -1.292 . . . . 75.150000000000006 109.42 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.427 HD12 HD23 ' A' ' 512' ' ' LEU . 13.1 tt -100.46 136.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.558 -0.534 . . . . 72.099999999999994 109.558 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.29 122.6 45.13 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-O 121.435 0.636 . . . . 72.120000000000005 111.126 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 12.7 tp -101.39 133.83 45.4 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.203 1.401 . . . . 73.319999999999993 109.356 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -104.01 114.56 28.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.157 -0.682 . . . . 73.129999999999995 109.157 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 137.84 34.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 111.496 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 10.4 m -64.11 115.06 4.6 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 106.94 -1.504 . . . . 65.549999999999997 106.94 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.543 ' OXT' ' HD2' ' A' ' 557' ' ' LYS 0.306 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 N-CA-C 114.828 1.418 . . . . 64.450000000000003 114.828 -172.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.554 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.894 0.854 . . . . 65.219999999999999 110.445 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -83.43 137.69 33.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.355 -0.839 . . . . 64.230000000000004 111.87 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.439 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 21.6 tpp180 -129.51 157.38 42.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.351 -0.981 . . . . 73.099999999999994 108.351 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.43 141.92 28.79 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 123.332 0.653 . . . . 72.120000000000005 111.279 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -85.15 130.49 51.79 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 108.109 -1.071 . . . . 73.310000000000002 108.109 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.97 158.38 34.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.546 2.83 . . . . 71.0 115.393 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -113.3 16.32 19.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.917 -1.038 . . . . 65.549999999999997 110.309 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.98 -2.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.244 1.021 . . . . 64.299999999999997 109.224 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 4.1 m -61.22 -38.87 88.17 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.977 -1.465 . . . . 75.25 110.828 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 9.4 t -59.03 -26.82 64.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.607 -0.724 . . . . 74.540000000000006 111.672 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.414 ' C ' ' HG1' ' A' ' 436' ' ' THR . 89.4 mt -76.9 -45.54 27.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 120.063 -0.655 . . . . 74.340000000000003 110.097 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.463 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 14.3 m -168.82 147.49 4.06 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.301 -1.0 . . . . 72.239999999999995 108.301 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -51.64 -44.47 62.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.607 0.763 . . . . 74.219999999999999 111.112 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.75 -35.41 66.16 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.984 0.514 . . . . 74.010000000000005 111.6 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.463 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 10.7 mm-40 -70.52 -42.29 71.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.796 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.34 -50.77 72.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.358 -0.837 . . . . 65.340000000000003 110.113 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.0 t -58.55 -49.19 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.214 -0.903 . . . . 75.439999999999998 112.015 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.66 -46.83 83.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.839 -0.344 . . . . 73.019999999999996 111.622 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.78 -41.62 87.35 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 75.420000000000002 110.122 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.3 tp -68.48 -43.21 77.43 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.916 -0.584 . . . . 72.420000000000002 110.155 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 39.5 m -59.51 -44.68 93.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.676 -0.693 . . . . 75.420000000000002 109.804 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.69 62.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.906 -0.588 . . . . 64.510000000000005 111.395 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -80.93 -13.72 58.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.132 0.492 . . . . 72.530000000000001 110.152 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.65 -5.78 26.15 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.126 -1.035 . . . . 70.230000000000004 112.794 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 97.3 m-85 -82.65 111.54 18.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.576 -0.527 . . . . 73.129999999999995 109.576 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.25 41.32 Favored Glycine 0 N--CA 1.427 -1.918 0 CA-C-N 115.476 -0.784 . . . . 75.019999999999996 111.836 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.51 114.63 26.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.264 0.554 . . . . 71.109999999999999 111.239 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.82 156.83 43.14 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.322 -0.854 . . . . 72.530000000000001 112.366 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 123.06 29.31 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.176 -1.416 . . . . 75.099999999999994 107.176 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -94.0 125.71 38.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.858 -0.61 . . . . 73.450000000000003 109.873 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.04 147.15 50.5 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.327 -1.36 . . . . 72.420000000000002 107.327 176.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -122.57 139.88 53.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.344 -0.543 . . . . 73.010000000000005 109.652 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.4 m -126.44 140.85 38.35 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 109.259 -0.645 . . . . 74.420000000000002 109.259 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -64.77 121.91 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.597 1.531 . . . . 75.310000000000002 109.842 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.5 m -133.67 179.99 5.88 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.761 -1.57 . . . . 70.549999999999997 106.761 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.0 t -60.56 136.98 92.56 Favored Pre-proline 0 N--CA 1.419 -2.003 0 N-CA-C 109.136 -0.69 . . . . 71.120000000000005 109.136 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 85.2 Cg_exo -49.86 -28.96 19.38 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.464 3.443 . . . . 73.150000000000006 114.829 -173.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.18 -18.43 61.86 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.07 0.767 . . . . 74.129999999999995 113.07 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.28 7.96 44.59 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.934 -0.479 . . . . 74.540000000000006 111.983 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -60.96 128.36 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 120.968 0.414 . . . . 73.209999999999994 110.505 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.13 89.31 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.77 -0.728 . . . . 73.510000000000005 111.97 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -113.65 148.22 36.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.646 -1.242 . . . . 74.140000000000001 107.646 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 44.8 t -82.36 140.43 16.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.534 -0.913 . . . . 74.239999999999995 108.534 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.8 pt -96.96 -23.37 4.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.448 0.642 . . . . 73.409999999999997 109.402 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.39 175.48 38.62 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 109.062 -1.615 . . . . 75.030000000000001 109.062 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.6 p -116.49 154.36 30.51 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.879 -0.785 . . . . 74.010000000000005 108.879 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.7 t30 -61.09 -46.65 96.23 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 123.56 0.537 . . . . 74.230000000000004 110.165 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.4 Cg_exo -83.36 137.07 7.97 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.036 1.158 . . . . 74.329999999999998 109.391 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.442 ' HG2' ' CG ' ' A' ' 476' ' ' GLN . 9.8 Cg_endo -62.56 140.19 80.08 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.266 1.977 . . . . 73.230000000000004 112.051 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.53 -8.08 55.17 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 122.134 0.969 . . . . 75.109999999999999 111.153 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -94.65 -3.98 48.47 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.603 -1.18 . . . . 70.409999999999997 110.399 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.442 ' CG ' ' HG2' ' A' ' 473' ' ' PRO . 31.3 mm-40 -109.94 159.98 16.8 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 109.081 -0.711 . . . . 73.109999999999999 109.081 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.1 p -101.8 115.21 30.03 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.34 -1.356 . . . . 74.109999999999999 107.34 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 48.8 m -100.59 140.97 34.1 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.795 -0.446 . . . . 75.049999999999997 109.795 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.58 145.66 54.65 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.036 -0.529 . . . . 74.230000000000004 110.61 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.1 mm -67.24 -9.16 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 122.085 0.945 . . . . 73.109999999999999 110.752 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -77.51 -5.91 51.7 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.613 -0.679 . . . . 74.030000000000001 109.894 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.05 158.09 16.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.706 -0.621 . . . . 73.200000000000003 111.742 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.98 125.77 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.013 -1.847 . . . . 74.400000000000006 106.013 169.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.71 120.53 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.813 -0.755 . . . . 75.540000000000006 110.609 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.81 114.84 29.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.098 -1.445 . . . . 74.219999999999999 107.098 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.63 121.52 61.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 109.016 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.11 120.26 51.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.9 0.857 . . . . 73.230000000000004 112.446 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.0 t -96.56 146.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.588 -1.187 . . . . 73.319999999999993 108.955 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -82.83 123.41 6.09 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.026 -1.23 . . . . 50.420000000000002 110.026 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 28.8 t -110.95 143.83 40.99 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.167 -1.42 . . . . 75.400000000000006 107.167 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.874 0 C-N-CA 120.33 -0.938 . . . . 72.209999999999994 111.308 -177.505 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.915 0.864 . . . . 74.239999999999995 109.813 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 32.6 p -137.32 160.06 40.15 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.75 -1.114 . . . . 74.150000000000006 108.957 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -141.47 143.06 33.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.33 0.394 . . . . 74.340000000000003 110.371 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.1 t70 -89.96 119.2 30.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.231 -1.396 . . . . 61.420000000000002 107.231 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.4 pt -81.9 123.42 80.1 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 112.473 0.546 . . . . 75.010000000000005 112.473 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.96 177.44 2.07 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.381 2.054 . . . . 72.519999999999996 109.287 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -85.57 138.12 32.4 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.026 -1.07 . . . . 73.409999999999997 109.526 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.67 19.01 4.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.561 -1.644 . . . . 74.140000000000001 106.561 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.01 153.37 34.56 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.167 -1.833 . . . . 75.129999999999995 111.657 -174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.08 58.71 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.91 -0.662 . . . . 71.540000000000006 111.79 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG13 ' A' ' 534' ' ' VAL . 21.0 mt-30 -121.47 -176.26 3.26 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 74.409999999999997 108.877 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.3 m -81.18 155.7 26.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 119.386 -0.925 . . . . 73.219999999999999 108.576 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.16 -41.45 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 111.619 0.229 . . . . 73.219999999999999 111.619 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.93 -42.25 85.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.378 -0.374 . . . . 75.239999999999995 111.46 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.7 p -76.04 -35.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.646 -0.822 . . . . 74.109999999999999 111.501 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.02 76.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.582 -0.736 . . . . 52.43 111.106 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.09 -38.52 91.02 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.959 -0.564 . . . . 74.329999999999998 110.355 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 514' ' ' VAL . 39.5 ttmt -63.53 -52.37 61.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 123.509 0.506 . . . . 75.239999999999995 110.866 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -62.9 -44.92 94.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 123.209 0.318 . . . . 65.420000000000002 110.302 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 31.0 tp -64.89 -36.88 85.79 Favored 'General case' 0 C--O 1.188 -2.149 0 CA-C-N 116.08 -0.509 . . . . 74.230000000000004 110.542 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.9 t-20 -59.61 -42.92 93.73 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.198 0.599 . . . . 74.409999999999997 110.492 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.9 t -67.7 -30.31 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.799 . . . . 72.140000000000001 111.443 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.18 15.09 14.05 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 121.679 -0.638 . . . . 74.140000000000001 110.785 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -155.12 -99.9 0.17 Allowed Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 118.248 -1.93 . . . . 64.310000000000002 116.637 -169.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 51.2 m-85 -115.31 161.84 17.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.264 . . . . 74.040000000000006 110.633 -168.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.2 p -102.51 -27.88 12.52 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.482 0.549 . . . . 70.109999999999999 112.482 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 9.3 mmpt? -108.79 128.46 54.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 120.589 0.233 . . . . 72.329999999999998 110.722 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 93.9 m-85 -125.18 145.21 50.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.512 -0.767 . . . . 74.400000000000006 110.375 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.1 t -115.71 159.57 21.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.137 -1.431 . . . . 60.399999999999999 107.137 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -121.18 129.09 53.07 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.744 -0.465 . . . . 74.329999999999998 109.744 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.55 129.75 44.85 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.221 -1.029 . . . . 61.130000000000003 108.221 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 9.2 m -89.21 130.68 35.58 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.041 -0.726 . . . . 70.530000000000001 109.041 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.37 157.57 26.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.339 -0.986 . . . . 74.040000000000006 108.339 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -79.69 142.21 35.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.229 0.537 . . . . 75.420000000000002 110.984 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 22.2 p -102.35 110.22 62.27 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.992 -1.004 . . . . 72.409999999999997 112.649 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -76.95 -51.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 121.644 1.562 . . . . 73.519999999999996 110.155 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.6 -64.25 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 112.38 0.511 . . . . 74.530000000000001 112.38 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.47 149.06 34.33 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.671 1.58 . . . . 63.229999999999997 112.969 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.93 138.81 25.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.575 -0.528 . . . . 62.420000000000002 109.575 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 87.79 -26.69 7.19 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 122.004 0.78 . . . . 50.130000000000003 111.816 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.57 150.0 23.98 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.614 -0.793 . . . . 73.129999999999995 111.826 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 503' ' ' GLN . 2.8 p -74.41 125.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.433 -0.803 . . . . 63.450000000000003 110.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 14.3 p -88.97 -22.0 23.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.799 -0.637 . . . . 63.100000000000001 109.899 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.44 -159.13 30.95 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.205 -0.758 . . . . 74.519999999999996 111.205 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -118.39 161.04 20.62 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.27 -1.011 . . . . 75.140000000000001 108.27 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.431 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 15.1 t-20 -54.94 -55.3 40.27 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 119.216 -0.421 . . . . 72.409999999999997 111.877 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.8 Cg_exo -80.47 143.58 15.42 Favored 'Trans proline' 0 C--N 1.366 1.499 0 N-CA-C 108.374 -1.433 . . . . 65.329999999999998 108.374 170.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.71 157.36 52.24 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.306 2.004 . . . . 73.019999999999996 113.405 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.41 131.33 50.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.329 -0.85 . . . . 73.299999999999997 109.541 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.52 -6.95 36.32 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 110.765 -0.934 . . . . 53.409999999999997 110.765 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 36.0 m -88.45 129.33 35.46 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.543 -0.54 . . . . 73.239999999999995 109.543 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.0 m -96.75 123.22 40.38 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.195 -1.039 . . . . 54.219999999999999 108.195 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.62 158.37 72.17 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 110.179 -0.304 . . . . 75.200000000000003 110.179 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.7 137.2 53.06 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.823 2.349 . . . . 74.120000000000005 111.654 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.495 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.5 m -67.48 -20.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.469 0.652 . . . . 54.43 111.808 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.69 2.1 46.69 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 74.040000000000006 111.319 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -93.09 167.78 11.55 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.292 -1.003 . . . . 75.329999999999998 108.292 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.43 116.61 44.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.133 -0.692 . . . . 74.450000000000003 109.133 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 15.4 tt -88.71 132.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.191 0.52 . . . . 72.450000000000003 109.99 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -102.91 131.07 50.1 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-O 121.489 0.661 . . . . 72.420000000000002 111.747 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 554' ' ' GLN . 1.8 tm? -99.78 135.3 41.41 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.951 1.3 . . . . 72.540000000000006 109.304 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.408 ' N ' HD13 ' A' ' 553' ' ' LEU . 25.9 mm-40 -94.69 106.44 18.42 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.489 -0.778 . . . . 74.400000000000006 108.91 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.07 122.33 47.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 109.427 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 25.6 p -76.52 115.35 16.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 108.779 -0.822 . . . . 74.140000000000001 108.779 -176.468 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 109.56 -0.533 . . . . 75.010000000000005 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.1 mt-30 -90.15 119.51 30.53 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.321 -0.4 . . . . 74.010000000000005 109.933 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.6 mmp_? -121.27 156.21 33.0 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 110.932 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.17 141.79 28.39 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.387 -0.824 . . . . 73.319999999999993 109.917 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -84.9 119.36 72.56 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.856 -1.164 . . . . 71.150000000000006 107.856 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 25.8 Cg_exo -68.47 142.28 53.6 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.265 1.977 . . . . 73.219999999999999 112.197 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 434' ' ' THR . 10.6 m-20 -84.95 37.57 0.67 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.696 0.76 . . . . 73.109999999999999 111.458 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.9 p -87.26 -6.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.609 1.195 . . . . 75.5 108.086 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 3.3 p -59.02 -36.47 75.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.664 1.586 . . . . 73.430000000000007 110.47 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 431' ' ' ASP . 14.7 t -61.69 -26.71 68.21 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.0 -1.0 . . . . 65.099999999999994 110.789 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.47 -46.5 13.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.31 -0.956 . . . . 75.239999999999995 111.407 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 85.7 m -169.73 149.72 3.86 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.788 -0.819 . . . . 63.32 108.788 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.405 ' O ' HG21 ' A' ' 441' ' ' VAL . 54.4 t80 -52.75 -49.4 65.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.928 0.491 . . . . 75.299999999999997 111.309 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.19 -39.87 73.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 64.239999999999995 111.589 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.472 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.7 mm-40 -62.97 -43.78 97.85 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.935 -0.575 . . . . 73.319999999999993 111.01 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.11 -44.06 95.13 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.269 -0.878 . . . . 72.420000000000002 109.932 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 437' ' ' TYR . 88.5 t -60.01 -49.53 83.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 115.999 -0.546 . . . . 75.230000000000004 111.142 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.0 mmtp -60.62 -47.67 85.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.045 0.45 . . . . 74.400000000000006 110.485 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 30.6 mmmt -67.93 -41.39 82.66 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.798 0.666 . . . . 74.450000000000003 112.798 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.48 -38.8 81.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 64.420000000000002 109.736 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.2 m -59.28 -46.04 89.62 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.266 -0.879 . . . . 70.209999999999994 109.278 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.28 -20.17 63.91 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.522 -0.763 . . . . 64.120000000000005 111.692 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.4 -13.61 59.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.306 0.574 . . . . 61.25 109.986 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.23 -9.13 42.21 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.983 -0.627 . . . . 74.030000000000001 113.232 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.38 115.59 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.941 0.371 . . . . 75.519999999999996 110.011 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.09 2.06 40.81 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.467 -0.873 . . . . 64.120000000000005 111.619 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -126.75 113.19 16.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.3 0.572 . . . . 75.129999999999995 109.553 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -148.73 165.15 32.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.539 -0.755 . . . . 74.0 112.188 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -140.4 131.7 26.68 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.828 -0.804 . . . . 73.140000000000001 108.828 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -93.21 135.31 34.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 123.425 0.453 . . . . 75.549999999999997 110.053 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -142.7 162.47 35.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.336 -1.357 . . . . 72.319999999999993 107.336 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.84 150.68 51.89 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 118.146 0.43 . . . . 74.030000000000001 110.636 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.0 m -138.03 146.75 53.49 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 107.963 -1.125 . . . . 71.310000000000002 107.963 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.98 130.01 22.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.733 1.622 . . . . 74.510000000000005 111.143 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -143.66 -179.72 6.62 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.579 -1.637 . . . . 61.039999999999999 106.579 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.06 142.61 85.37 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 123.004 0.522 . . . . 71.409999999999997 111.32 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 464' ' ' VAL . 75.9 Cg_exo -51.68 -29.13 32.12 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.259 3.306 . . . . 75.129999999999995 111.66 174.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.1 -29.36 67.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.512 -0.767 . . . . 72.299999999999997 111.054 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.46 13.42 24.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.409 0.522 . . . . 71.120000000000005 112.409 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 461' ' ' PRO . 15.0 p -60.47 128.02 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.075 -0.65 . . . . 74.239999999999995 110.468 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.18 11.46 83.53 Favored Glycine 0 C--O 1.249 1.069 0 C-N-CA 120.941 -0.647 . . . . 60.119999999999997 111.789 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -122.97 154.44 38.41 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.083 -1.08 . . . . 73.25 108.083 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 46.2 t -82.43 141.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.275 -0.639 . . . . 74.200000000000003 109.275 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.2 pt -97.49 -29.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.456 -0.498 . . . . 73.510000000000005 110.339 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.62 -179.01 47.05 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.531 -1.028 . . . . 62.509999999999998 110.531 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -124.23 152.17 43.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.512 -0.551 . . . . 61.210000000000001 109.512 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.0 t-20 -60.91 -49.95 86.99 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 112.285 0.476 . . . . 74.010000000000005 112.285 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.1 Cg_exo -78.16 142.69 19.48 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.154 1.236 . . . . 72.0 109.361 171.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.49 132.98 40.53 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.697 2.265 . . . . 63.140000000000001 111.897 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.72 -12.73 59.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.025 0.917 . . . . 65.140000000000001 110.706 -175.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.93 11.55 37.06 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.902 -1.045 . . . . 64.109999999999999 109.713 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -125.57 169.96 11.94 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 106.527 -1.657 . . . . 74.439999999999998 106.527 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.2 p -107.11 115.3 29.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 N-CA-C 108.031 -1.099 . . . . 74.310000000000002 108.031 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 30.3 m -102.03 138.81 38.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.407 -0.59 . . . . 74.150000000000006 109.407 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.415 ' HB1' ' ND2' ' A' ' 482' ' ' ASN . . . -66.67 137.16 56.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.614 -0.513 . . . . 71.25 109.614 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.23 -25.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 124.543 1.137 . . . . 61.210000000000001 113.074 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.3 t -71.44 -7.01 44.59 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 120.996 0.427 . . . . 71.140000000000001 111.76 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.415 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 32.7 m-80 -90.11 145.5 25.01 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 116.519 -0.309 . . . . 65.329999999999998 110.966 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.08 117.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.347 0.594 . . . . 70.109999999999999 109.759 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.79 118.86 34.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.707 -0.849 . . . . 75.530000000000001 108.707 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -92.63 113.23 27.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.247 -1.39 . . . . 65.409999999999997 107.247 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.51 119.82 53.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.337 -0.847 . . . . 75.049999999999997 109.397 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -104.11 123.79 58.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.718 0.77 . . . . 75.319999999999993 112.252 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.18 144.29 10.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 114.802 -1.09 . . . . 74.140000000000001 108.724 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.74 120.72 5.54 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 111.345 -0.702 . . . . 70.030000000000001 111.345 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.8 t -101.46 129.49 47.51 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.909 -1.885 . . . . 73.340000000000003 105.909 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.431 0 C-N-CA 120.271 -0.966 . . . . 74.219999999999999 113.089 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 108.503 -0.925 . . . . 73.439999999999998 108.503 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.402 HG21 ' HA ' ' A' ' 546' ' ' PRO . 16.6 p -136.99 154.67 50.35 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.821 -1.081 . . . . 74.519999999999996 109.232 -176.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.01 142.49 36.27 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.368 0.418 . . . . 72.349999999999994 109.982 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -80.82 132.2 35.46 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.262 -1.385 . . . . 72.409999999999997 107.262 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.69 129.88 80.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.998 -0.546 . . . . 75.420000000000002 110.059 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -87.07 160.79 8.67 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.565 2.177 . . . . 72.329999999999998 110.948 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.69 135.69 33.55 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.588 -0.845 . . . . 71.340000000000003 109.434 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.6 16.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 122.507 1.146 . . . . 63.219999999999999 108.416 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.63 40.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.726 -1.125 . . . . 64.439999999999998 109.719 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.68 -26.9 11.06 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.973 -1.251 . . . . 70.409999999999997 109.973 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -91.01 176.36 6.62 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.668 -1.234 . . . . 72.310000000000002 107.668 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.3 p -81.57 157.24 24.84 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.167 -0.613 . . . . 74.310000000000002 110.15 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.61 -41.73 38.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.601 0.563 . . . . 72.230000000000004 112.28 -177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.25 -43.08 78.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.574 0.583 . . . . 73.540000000000006 112.574 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.29 -36.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 118.837 -1.145 . . . . 75.150000000000006 111.519 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.36 77.48 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.136 -0.938 . . . . 71.209999999999994 111.39 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.94 -35.01 79.8 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 123.238 0.336 . . . . 75.129999999999995 110.513 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.424 ' O ' HG21 ' A' ' 514' ' ' VAL . 53.4 tttp -60.98 -51.61 68.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 123.244 0.34 . . . . 73.430000000000007 110.13 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.66 -44.77 95.42 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.726 -0.67 . . . . 73.409999999999997 110.376 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.08 -43.21 95.67 Favored 'General case' 0 C--O 1.179 -2.606 0 CA-C-N 115.404 -0.816 . . . . 75.340000000000003 109.999 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 24.6 t-20 -59.05 -39.54 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.508 0.723 . . . . 73.420000000000002 112.146 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.94 -0.573 . . . . 73.140000000000001 111.626 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.75 -39.28 7.91 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.311 -0.956 . . . . 74.349999999999994 110.165 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -95.09 -101.19 1.79 Allowed Glycine 0 N--CA 1.412 -2.945 0 CA-C-N 113.954 -1.475 . . . . 52.229999999999997 115.3 -170.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 16.9 m-85 -133.53 172.17 13.09 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.911 -167.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 18.7 m -109.84 -1.95 17.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.593 -0.73 . . . . 72.120000000000005 110.073 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.36 116.39 31.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.125 -0.488 . . . . 74.349999999999994 109.899 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.35 151.27 49.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.005 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -140.98 158.53 43.8 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.142 -1.429 . . . . 75.109999999999999 107.142 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -121.77 152.11 39.83 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.416 0.627 . . . . 72.140000000000001 111.818 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 554' ' ' GLN . . . -134.29 125.74 28.31 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.747 -1.205 . . . . 72.219999999999999 107.747 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.9 m -88.68 131.36 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.33 -1.359 . . . . 73.349999999999994 107.33 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.3 150.52 24.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.236 -0.586 . . . . 72.430000000000007 109.921 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.07 133.6 36.78 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.014 -0.735 . . . . 70.450000000000003 109.014 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.6 m -143.59 138.85 15.71 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.049 -0.722 . . . . 73.540000000000006 109.049 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.12 -58.51 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.2 . . . . 74.340000000000003 113.178 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 -41.26 0.07 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 118.586 -0.721 . . . . 74.420000000000002 112.943 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -55.83 149.73 49.38 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 121.688 1.592 . . . . 73.239999999999995 112.972 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.95 113.16 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.813 -1.18 . . . . 74.030000000000001 107.813 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.04 -34.05 4.63 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.385 -0.912 . . . . 61.109999999999999 112.192 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -85.17 147.96 26.35 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-O 121.579 0.704 . . . . 74.319999999999993 111.813 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.23 125.51 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.877 -1.157 . . . . 71.129999999999995 107.877 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.2 m -86.18 -33.95 20.65 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.677 -0.692 . . . . 73.420000000000002 109.596 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -179.94 -176.63 47.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.78 -0.928 . . . . 63.109999999999999 110.78 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.7 p -117.88 160.12 21.95 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 107.585 -1.265 . . . . 64.239999999999995 107.585 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.2 t-20 -60.23 -53.84 61.01 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.532 -0.467 . . . . 72.129999999999995 111.348 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 75.2 Cg_endo -88.41 146.73 6.2 Favored 'Trans proline' 0 C--N 1.369 1.613 0 CA-C-N 120.103 1.072 . . . . 73.530000000000001 110.116 171.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.39 159.53 52.63 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.174 1.916 . . . . 72.519999999999996 111.335 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 135.02 57.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.625 0.37 . . . . 74.439999999999998 110.729 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.88 48.62 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.678 -0.772 . . . . 63.5 111.933 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.7 m -71.39 121.7 19.03 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.442 -0.577 . . . . 75.540000000000006 109.442 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.4 t -83.61 126.7 33.11 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.5 0.5 . . . . 74.25 109.825 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.91 156.57 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.801 -0.814 . . . . 74.310000000000002 108.801 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' HG21 ' A' ' 494' ' ' THR . 32.4 Cg_exo -59.47 144.71 99.34 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.436 2.09 . . . . 74.409999999999997 111.741 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.9 m -66.15 -20.54 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.327 0.492 . . . . 71.099999999999994 112.327 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.81 3.51 54.23 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.067 -0.515 . . . . 74.019999999999996 111.196 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -84.68 146.14 27.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.57 -0.529 . . . . 70.409999999999997 109.57 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.83 118.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.057 -1.09 . . . . 74.120000000000005 108.057 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.1 tt -94.32 145.91 7.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 120.962 0.411 . . . . 73.140000000000001 110.398 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -102.62 127.91 49.52 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-O 121.203 0.525 . . . . 75.200000000000003 109.932 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.05 115.19 29.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.49 -1.232 . . . . 62.350000000000001 107.867 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 523' ' ' ALA . 77.3 mt-30 -92.48 108.01 19.65 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.456 0.646 . . . . 74.319999999999993 109.468 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.0 p -113.78 139.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.056 -0.974 . . . . 75.239999999999995 111.368 -174.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 m -57.81 128.66 38.2 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.928 -1.138 . . . . 51.439999999999998 107.928 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 65.8 pttt . . . . . 0 C--O 1.264 1.868 0 N-CA-C 113.619 0.97 . . . . 74.430000000000007 113.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 123.143 1.449 . . . . 73.400000000000006 109.059 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.4 mt-30 -111.09 153.88 25.05 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.48 -1.691 . . . . 72.230000000000004 111.886 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.05 149.74 52.16 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.365 -0.834 . . . . 74.0 110.364 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -95.14 140.57 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 74.420000000000002 108.129 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.47 122.0 82.06 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 122.912 0.133 . . . . 75.209999999999994 110.69 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 142.49 33.43 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.014 2.476 . . . . 73.099999999999994 111.908 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -99.46 78.03 2.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.425 1.107 . . . . 75.400000000000006 110.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.1 m -112.44 5.34 8.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 N-CA-C 106.061 -1.829 . . . . 74.140000000000001 106.061 171.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.447 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -59.62 -38.69 82.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.684 -2.053 . . . . 72.310000000000002 110.611 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -26.34 68.46 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.283 -1.326 . . . . 72.420000000000002 112.166 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.22 -46.01 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.847 -0.427 . . . . 65.340000000000003 109.847 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 175.49 158.3 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.671 1.188 . . . . 65.430000000000007 111.335 175.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.424 ' O ' HG22 ' A' ' 441' ' ' VAL . 58.1 t80 -51.54 -43.69 62.43 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.91 1.284 . . . . 74.109999999999999 110.78 172.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.88 83.03 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.743 0.652 . . . . 44.530000000000001 111.036 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 19.4 mm-40 -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.692 -0.686 . . . . 70.230000000000004 109.903 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.53 85.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.197 -0.91 . . . . 73.019999999999996 111.352 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 437' ' ' TYR . 98.8 t -59.37 -48.47 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 123.433 0.458 . . . . 72.409999999999997 111.371 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 442' ' ' LYS . 10.5 mmpt? -63.86 -47.11 82.01 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.09 0.244 . . . . 73.430000000000007 111.283 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.7 mptp? -67.29 -38.52 85.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.488 0.551 . . . . 74.049999999999997 112.488 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 tp -68.02 -39.62 83.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.459 0.647 . . . . 72.219999999999999 109.44 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.24 -41.16 99.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.522 -0.763 . . . . 75.25 109.376 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.42 62.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.475 -0.784 . . . . 64.200000000000003 111.216 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.46 -13.81 53.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 74.239999999999995 109.431 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.92 56.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-N 115.702 -0.681 . . . . 75.430000000000007 113.862 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.93 133.04 46.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.157 0.503 . . . . 74.030000000000001 111.893 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.98 18.34 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.409 -0.814 . . . . 74.129999999999995 112.109 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -123.92 116.36 22.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.74 0.781 . . . . 73.200000000000003 112.044 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -143.06 147.19 34.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.225 -0.898 . . . . 75.120000000000005 110.181 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -131.02 133.9 46.17 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.688 -1.227 . . . . 75.420000000000002 107.688 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -95.47 121.43 37.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.204 0.526 . . . . 74.329999999999998 110.779 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.23 141.45 48.28 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.386 -0.968 . . . . 74.329999999999998 108.386 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -126.72 144.15 51.02 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.535 -0.543 . . . . 75.150000000000006 109.535 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.8 p -144.52 149.9 45.6 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.988 -0.551 . . . . 72.319999999999993 109.997 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.3 Cg_exo -65.54 140.55 63.32 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.258 1.972 . . . . 72.510000000000005 111.114 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.2 t -152.27 179.39 8.57 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.765 -1.198 . . . . 73.109999999999999 107.765 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.4 t -66.65 144.55 98.67 Favored Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 123.705 0.802 . . . . 63.409999999999997 110.589 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.42 -29.34 30.7 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.41 3.407 . . . . 73.340000000000003 112.623 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -68.51 -32.13 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.804 -0.634 . . . . 75.140000000000001 111.823 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.91 9.01 39.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.551 0.575 . . . . 74.409999999999997 112.551 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.76 127.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.822 -0.436 . . . . 74.319999999999993 109.822 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.45 -12.28 64.91 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.627 -0.797 . . . . 64.349999999999994 111.946 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.2 146.73 23.48 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.313 -0.625 . . . . 75.319999999999993 109.313 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 64.9 t -82.67 124.79 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 N-CA-C 106.649 -1.611 . . . . 75.340000000000003 106.649 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 25.5 pt -97.85 -2.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 120.9 0.381 . . . . 65.329999999999998 111.579 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.96 164.93 20.26 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 120.236 -0.983 . . . . 63.140000000000001 111.788 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.4 p -120.77 142.71 49.32 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.725 -1.583 . . . . 73.239999999999995 106.725 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.465 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 6.1 t30 -63.97 -45.01 80.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 123.544 0.527 . . . . 75.230000000000004 110.494 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.99 139.8 12.23 Favored 'Trans proline' 0 C--N 1.375 1.938 0 CA-C-N 120.347 1.16 . . . . 74.120000000000005 109.912 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.9 144.08 63.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.697 2.264 . . . . 62.229999999999997 112.338 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.94 15.9 4.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.069 0.938 . . . . 73.299999999999997 110.483 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.02 -28.74 12.56 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.863 -1.062 . . . . 74.409999999999997 111.576 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.02 154.09 31.53 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.118 -0.697 . . . . 73.439999999999998 109.118 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.3 p -81.59 135.27 35.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.973 -0.558 . . . . 73.439999999999998 110.566 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.3 m -111.9 138.24 48.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.832 -0.803 . . . . 72.310000000000002 108.832 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -61.02 150.41 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.272 0.358 . . . . 63.509999999999998 110.824 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.58 -28.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.449 0.7 . . . . 72.209999999999994 111.041 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -88.07 0.87 55.46 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.686 -0.688 . . . . 70.230000000000004 111.439 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.08 148.99 27.18 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.002 -0.74 . . . . 75.120000000000005 109.002 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 30.9 t -92.14 111.49 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.746 -0.835 . . . . 74.540000000000006 108.746 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 86.0 t -91.0 118.82 37.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.131 -0.692 . . . . 64.230000000000004 109.131 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.8 mt -93.8 114.25 30.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.745 -0.835 . . . . 74.040000000000006 108.745 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.6 124.97 54.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.271 -0.64 . . . . 75.120000000000005 109.271 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.48 116.25 49.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.354 0.597 . . . . 73.129999999999995 111.073 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.98 140.72 16.91 Favored 'Isoleucine or valine' 0 C--O 1.252 1.225 0 CA-C-N 115.824 -0.626 . . . . 74.340000000000003 110.288 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.69 117.23 4.6 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.546 -1.422 . . . . 61.539999999999999 109.546 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.8 m -125.03 135.68 52.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.684 -0.488 . . . . 64.540000000000006 109.684 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.739 0 N-CA-C 110.006 -1.238 . . . . 75.109999999999999 110.006 -179.468 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.279 -1.008 . . . . 74.430000000000007 108.279 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 544' ' ' THR . 13.2 p -128.29 155.29 44.84 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.79 -1.095 . . . . 64.120000000000005 109.842 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -142.65 149.98 39.63 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 71.510000000000005 109.35 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -85.35 138.07 32.53 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.47 -1.307 . . . . 73.140000000000001 107.47 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -83.1 120.39 75.87 Favored Pre-proline 0 C--N 1.291 -1.937 0 C-N-CA 119.808 -0.757 . . . . 75.420000000000002 110.028 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.76 158.48 21.49 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.737 1.625 . . . . 73.209999999999994 109.431 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.42 101.91 2.07 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.064 0.935 . . . . 75.319999999999993 110.977 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.36 -1.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.72 119.91 15.56 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 113.822 -1.536 . . . . 63.520000000000003 107.962 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.37 -27.65 5.74 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.439 -1.464 . . . . 72.140000000000001 109.439 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -83.94 178.41 7.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.021 -0.733 . . . . 75.400000000000006 109.021 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.3 m -91.12 155.87 18.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.978 . . . . 72.219999999999999 108.361 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 -47.85 56.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 112.55 0.574 . . . . 72.319999999999993 112.55 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.403 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 20.6 m-20 -69.46 -41.38 76.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.538 0.57 . . . . 72.420000000000002 112.538 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.26 -35.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.445 -0.902 . . . . 63.509999999999998 111.55 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.67 -48.95 77.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.44 -0.8 . . . . 63.149999999999999 111.322 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.42 -37.02 85.7 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 120.194 -0.602 . . . . 62.119999999999997 110.608 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 2.1 mptm? -65.94 -52.13 52.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.136 0.791 . . . . 73.219999999999999 113.136 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . 0.253 33.3 p30 -69.08 -37.59 78.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.761 0.652 . . . . 74.450000000000003 112.761 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.28 -36.8 83.89 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-O 120.516 0.198 . . . . 74.310000000000002 110.742 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.5 t-20 -58.28 -37.53 75.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.59 0.756 . . . . 75.010000000000005 111.724 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.88 -38.72 83.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.717 -0.674 . . . . 73.200000000000003 111.53 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -105.51 -13.86 15.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.764 -0.774 . . . . 64.519999999999996 110.695 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -125.12 -97.74 1.15 Allowed Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 117.067 1.587 . . . . 74.530000000000001 117.067 -166.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 2.7 m-85 -127.59 153.69 46.1 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.04 0.448 . . . . 72.450000000000003 110.161 -163.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.4 m -106.31 -6.43 18.37 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.196 -0.911 . . . . 73.319999999999993 109.436 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -108.23 115.02 29.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.838 -0.619 . . . . 74.340000000000003 109.973 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.42 156.25 37.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.212 -0.904 . . . . 73.420000000000002 111.482 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 65.7 m -138.09 152.94 49.25 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.036 -1.839 . . . . 43.329999999999998 106.036 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -119.77 131.19 55.27 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.829 -0.804 . . . . 75.239999999999995 108.829 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.48 140.43 49.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.442 -0.947 . . . . 70.329999999999998 108.442 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.1 m -104.36 119.47 39.03 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.165 -0.68 . . . . 73.209999999999994 109.165 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.4 153.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.968 -0.753 . . . . 74.319999999999993 108.968 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.7 135.4 36.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.039 -0.664 . . . . 74.400000000000006 110.041 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 m -146.26 136.31 11.94 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 107.242 -1.392 . . . . 73.109999999999999 107.242 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.12 150.97 66.76 Favored 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.365 2.043 . . . . 73.129999999999995 112.156 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HB2' ' HD3' ' A' ' 530' ' ' PRO 0.406 75.8 mtm180 37.64 -89.49 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 118.166 2.654 . . . . 73.340000000000003 118.166 179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 50.7 Cg_exo -57.56 148.53 72.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.15 1.9 . . . . 61.219999999999999 113.743 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.05 160.09 40.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.906 -0.776 . . . . 71.120000000000005 108.906 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 105.3 -21.28 35.66 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 120.523 -0.846 . . . . 63.030000000000001 112.695 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.65 148.29 25.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.282 0.563 . . . . 73.340000000000003 111.215 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.53 119.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 74.340000000000003 108.676 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.0 m -88.21 -25.52 22.86 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.58 0.705 . . . . 65.420000000000002 109.836 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.24 178.66 47.09 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.212 -0.755 . . . . 61.329999999999998 111.212 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.2 p -118.57 160.4 21.85 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.123 -1.065 . . . . 74.120000000000005 108.123 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.4 t-20 -60.49 -54.67 52.62 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-O 119.146 -0.454 . . . . 72.510000000000005 112.057 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.2 Cg_endo -86.17 153.0 9.53 Favored 'Trans proline' 0 C--N 1.365 1.413 0 CA-C-N 120.461 1.2 . . . . 75.129999999999995 109.549 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.68 150.87 85.9 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.032 1.822 . . . . 73.219999999999999 111.577 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.64 58.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.604 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.99 54.1 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 121.095 -0.574 . . . . 51.439999999999998 112.0 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.8 m -69.55 129.17 38.93 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.776 -0.25 . . . . 74.150000000000006 110.332 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -93.86 122.95 36.87 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.5 161.42 60.82 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.449 -0.796 . . . . 73.239999999999995 109.07 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.61 136.25 65.85 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.569 2.18 . . . . 74.409999999999997 111.381 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 29.2 m -67.07 -21.36 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 74.099999999999994 111.494 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -86.34 -1.81 57.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.762 -0.654 . . . . 72.310000000000002 110.863 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.1 t -85.85 168.38 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.322 0.582 . . . . 74.340000000000003 110.419 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.9 t -97.61 136.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.34 -0.846 . . . . 75.109999999999999 108.804 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.0 tt -112.84 144.26 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.723 -0.473 . . . . 75.109999999999999 109.723 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 26.6 tt0 -103.53 122.71 45.5 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 108.815 -0.809 . . . . 75.129999999999995 108.815 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.4 tp -100.68 117.82 35.56 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.045 -1.094 . . . . 75.030000000000001 108.045 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.3 mt-30 -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.987 0.899 . . . . 74.409999999999997 110.325 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.33 141.21 23.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.085 -1.416 . . . . 74.239999999999995 111.872 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -55.78 122.84 12.37 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.618 -0.719 . . . . 73.0 110.208 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.147 -1.057 . . . . 72.140000000000001 108.147 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.142 0.496 . . . . 74.450000000000003 110.808 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.85 156.33 26.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.057 . . . . 75.510000000000005 108.145 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -150.95 155.41 39.04 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.404 -1.332 . . . . 74.510000000000005 107.404 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.36 141.1 28.89 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 110.061 -0.348 . . . . 73.439999999999998 110.061 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 474' ' ' ALA . 2.9 mp -78.39 130.21 72.35 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.005 -1.109 . . . . 73.340000000000003 108.005 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.64 144.19 93.75 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.572 2.182 . . . . 74.239999999999995 112.839 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.16 20.4 11.43 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.238 0.542 . . . . 65.120000000000005 111.342 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 8.7 p -83.29 -1.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.408 1.099 . . . . 73.019999999999996 108.435 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 2.8 p -60.09 -34.23 73.19 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.178 1.391 . . . . 54.310000000000002 110.097 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -59.33 -27.84 66.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.253 -1.339 . . . . 73.019999999999996 111.27 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 70.5 mt -90.77 -47.19 7.78 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 119.204 -0.998 . . . . 64.319999999999993 112.041 -175.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 6.4 m -159.9 148.28 17.21 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.386 -0.598 . . . . 73.200000000000003 109.386 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.414 ' O ' HG22 ' A' ' 441' ' ' VAL . 26.7 t80 -56.42 -47.85 78.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.022 0.529 . . . . 71.010000000000005 110.396 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -56.81 -44.28 81.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.944 -0.571 . . . . 65.430000000000007 111.165 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.6 mm-40 -63.82 -41.6 97.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.929 -0.578 . . . . 74.010000000000005 110.945 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -59.92 -46.33 89.7 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.361 -0.836 . . . . 65.519999999999996 110.673 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 437' ' ' TYR . 87.4 t -60.95 -46.31 96.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 O-C-N 123.792 0.683 . . . . 72.109999999999999 111.361 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 66.7 mttm -60.62 -48.53 81.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.06 0.457 . . . . 74.200000000000003 110.38 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -67.65 -38.94 84.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.676 -0.693 . . . . 75.329999999999998 112.85 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.5 tp -68.54 -38.48 80.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.284 0.564 . . . . 72.430000000000007 109.574 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -61.82 -43.38 98.97 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.354 -0.839 . . . . 73.040000000000006 109.226 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.3 -16.0 62.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.73 -0.668 . . . . 71.540000000000006 111.736 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.84 -14.16 51.93 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 121.328 0.585 . . . . 75.420000000000002 109.539 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.93 55.88 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.616 -0.72 . . . . 71.25 113.891 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -59.62 131.1 49.9 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.391 0.595 . . . . 75.049999999999997 112.419 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -80.28 -43.77 9.3 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.214 -0.903 . . . . 73.200000000000003 114.183 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -129.62 132.77 46.84 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.793 0.806 . . . . 74.230000000000004 112.531 -175.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -140.73 150.38 43.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.814 -1.084 . . . . 65.349999999999994 109.991 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -130.31 130.69 44.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.059 -0.719 . . . . 74.140000000000001 109.059 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.92 132.42 37.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.274 0.559 . . . . 71.409999999999997 111.321 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.48 148.94 50.31 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.946 -1.501 . . . . 62.100000000000001 106.946 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.6 148.07 48.09 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.174 -0.611 . . . . 71.420000000000002 110.091 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.6 m -142.75 142.55 22.95 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.988 -0.745 . . . . 74.450000000000003 108.988 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.5 Cg_exo -67.06 128.57 18.87 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.436 2.091 . . . . 73.109999999999999 111.57 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.9 m -140.28 179.22 6.77 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.757 -0.46 . . . . 74.450000000000003 109.757 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.8 t -54.88 139.87 61.61 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 123.885 0.874 . . . . 73.030000000000001 111.439 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.01 -31.28 43.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.112 3.208 . . . . 70.310000000000002 113.387 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.34 -12.7 60.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.039 0.447 . . . . 73.319999999999993 111.847 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 30.8 tp -113.17 1.27 15.2 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.227 0.537 . . . . 74.010000000000005 110.29 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.35 127.23 20.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.102 0.477 . . . . 73.019999999999996 110.722 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.18 -6.86 66.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 116.011 -0.54 . . . . 65.430000000000007 112.281 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.5 mptp? -99.87 157.3 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.786 -0.82 . . . . 73.030000000000001 108.786 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.426 HG22 HD12 ' A' ' 486' ' ' ILE . 59.0 t -81.94 131.5 33.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 73.340000000000003 107.944 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.4 pt -98.57 -4.53 9.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.43 -0.508 . . . . 75.099999999999994 111.425 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.92 154.18 7.29 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.461 -0.791 . . . . 55.409999999999997 111.493 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 18.4 p -116.76 146.37 42.87 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.135 -0.691 . . . . 74.540000000000006 109.135 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -59.1 -49.66 91.92 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.086 -0.483 . . . . 75.519999999999996 111.654 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.9 Cg_exo -82.86 144.07 12.03 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.443 1.429 . . . . 75.140000000000001 110.305 172.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -75.65 135.92 18.49 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.325 2.016 . . . . 75.319999999999993 111.871 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 429' ' ' ILE . . . -77.96 -0.29 27.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.837 0.827 . . . . 74.329999999999998 111.058 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.61 -27.01 34.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.64 -1.164 . . . . 65.340000000000003 110.418 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -113.88 175.03 5.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.291 -0.413 . . . . 74.530000000000001 110.578 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -98.68 115.37 28.54 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 108.534 -0.913 . . . . 73.349999999999994 108.534 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.2 m -100.44 144.19 29.72 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.906 -0.775 . . . . 63.32 108.906 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.496 ' HB2' ' ND2' ' A' ' 482' ' ' ASN . . . -62.11 135.08 57.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 74.099999999999994 111.388 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.4 mm -57.11 -27.09 26.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.062 1.745 . . . . 75.439999999999998 112.524 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -75.27 -11.01 59.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.969 -0.56 . . . . 75.010000000000005 111.046 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 43.9 m-80 -78.08 150.24 33.77 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 112.797 0.666 . . . . 72.540000000000006 112.797 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.4 t -86.36 114.93 26.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.632 -1.247 . . . . 74.25 107.632 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.0 119.4 35.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.879 -0.785 . . . . 72.349999999999994 108.879 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -92.86 118.75 39.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.413 -1.328 . . . . 75.209999999999994 107.413 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.29 123.27 68.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.725 -0.67 . . . . 71.329999999999998 109.544 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 487' ' ' ILE . 3.1 mp -104.87 124.53 59.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.137 0.494 . . . . 73.230000000000004 110.005 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.21 140.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.728 -0.669 . . . . 72.310000000000002 110.064 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 120.51 5.17 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.521 -1.432 . . . . 74.319999999999993 109.521 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.0 t -118.33 160.45 21.63 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.411 -0.959 . . . . 73.319999999999993 108.411 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.378 0 C-N-CA 120.418 -0.896 . . . . 61.43 111.796 -178.27 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 122.066 0.936 . . . . 72.030000000000001 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 546' ' ' PRO . 10.4 p -135.26 159.21 42.28 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.872 -1.058 . . . . 74.340000000000003 109.498 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -146.28 141.79 27.69 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.352 -0.61 . . . . 75.310000000000002 109.352 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.8 p-10 -89.14 138.13 31.7 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.961 -0.755 . . . . 74.099999999999994 108.961 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.3 pt -93.86 137.54 23.07 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 116.197 -0.456 . . . . 72.519999999999996 111.93 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.53 171.83 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.935 2.423 . . . . 74.219999999999999 112.112 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -82.84 110.57 17.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.588 0.709 . . . . 73.230000000000004 111.115 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.55 8.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.389 -0.823 . . . . 73.420000000000002 110.053 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.02 140.27 32.81 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.044 -0.525 . . . . 74.010000000000005 109.744 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.09 -13.44 58.8 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.126 -1.19 . . . . 71.010000000000005 110.126 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.446 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 17.2 mt-30 -93.96 178.3 5.7 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.264 -1.013 . . . . 73.430000000000007 108.264 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.2 p -85.54 157.5 20.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.145 -0.687 . . . . 74.540000000000006 109.145 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.41 -42.21 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.481 0.488 . . . . 74.019999999999996 112.092 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.01 -41.99 81.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.128 -0.629 . . . . 74.209999999999994 111.354 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 7.1 p -76.9 -36.42 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 118.577 -1.249 . . . . 73.0 111.125 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.84 -48.77 75.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.874 -0.603 . . . . 74.109999999999999 111.315 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.51 -35.15 80.02 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 123.293 0.37 . . . . 64.25 110.072 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.414 ' O ' HG22 ' A' ' 514' ' ' VAL . 50.4 tptt -63.49 -51.72 64.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.342 0.401 . . . . 71.120000000000005 110.248 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -61.89 -41.53 98.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.164 0.506 . . . . 75.430000000000007 110.126 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.35 -47.77 78.07 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 110.171 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.87 -41.21 91.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.811 0.444 . . . . 74.329999999999998 111.919 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 510' ' ' LYS . 91.3 t -63.87 -34.09 66.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.326 0.491 . . . . 64.420000000000002 112.326 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.27 -19.23 11.37 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.003 -1.079 . . . . 75.519999999999996 112.274 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -99.93 -103.5 2.52 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.71 -0.677 . . . . 71.549999999999997 114.541 -173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 11.5 m-85 -135.77 -178.59 5.2 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 110.265 -0.272 . . . . 65.319999999999993 110.265 -169.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -115.56 3.95 14.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.135 0.493 . . . . 55.200000000000003 111.106 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -108.12 115.54 30.31 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.658 -0.867 . . . . 74.510000000000005 108.658 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.63 151.5 50.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.757 0.789 . . . . 74.409999999999997 111.518 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.0 m -134.69 151.08 50.74 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.623 -1.621 . . . . 74.329999999999998 106.623 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -120.77 122.6 40.71 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.582 -1.266 . . . . 73.049999999999997 107.582 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.97 117.15 30.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.748 -1.204 . . . . 73.329999999999998 107.748 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.9 p -88.75 124.52 34.21 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 108.304 -0.999 . . . . 71.329999999999998 108.304 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.98 153.53 26.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.857 -0.794 . . . . 73.010000000000005 108.857 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.8 115.63 17.7 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.631 -1.248 . . . . 73.540000000000006 107.631 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.2 m -119.89 168.77 9.59 Favored Pre-proline 0 C--N 1.282 -2.356 0 CA-C-N 114.515 -1.22 . . . . 70.430000000000007 110.663 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.9 -166.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 123.031 2.487 . . . . 75.340000000000003 112.165 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -50.67 -51.86 61.64 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 115.272 1.582 . . . . 73.5 115.272 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.24 133.71 36.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 CA-C-N 120.706 1.288 . . . . 75.120000000000005 111.495 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.418 ' HA ' ' OG ' ' A' ' 556' ' ' SER . . . -142.61 157.79 44.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.32 -0.622 . . . . 74.430000000000007 109.32 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 99.86 -24.89 30.39 Favored Glycine 0 C--N 1.313 -0.696 0 N-CA-C 110.389 -1.084 . . . . 63.240000000000002 110.389 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.95 148.04 25.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.346 -0.927 . . . . 75.140000000000001 110.154 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.83 119.12 23.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.109 -0.496 . . . . 72.129999999999995 111.038 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 24.0 m -73.16 -35.1 66.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.942 -1.026 . . . . 73.209999999999994 109.046 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.46 -161.58 35.31 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 111.084 -0.807 . . . . 74.319999999999993 111.084 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -130.34 160.8 32.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.524 -0.917 . . . . 74.329999999999998 108.524 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.5 t-20 -53.22 -57.87 14.88 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.493 0.496 . . . . 73.310000000000002 111.398 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.3 Cg_endo -89.2 147.42 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 CA-C-N 120.797 1.32 . . . . 74.349999999999994 109.11 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.75 155.64 69.61 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.692 1.595 . . . . 72.239999999999995 111.811 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.6 137.46 58.17 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 122.62 0.368 . . . . 65.140000000000001 110.118 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.26 -6.0 61.28 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.988 -0.625 . . . . 53.32 111.834 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.9 m -86.79 134.56 33.55 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.67 -0.312 . . . . 73.530000000000001 110.863 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.7 m -92.49 123.78 36.05 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.5 -0.926 . . . . 75.420000000000002 108.5 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.03 158.2 75.86 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.452 -0.573 . . . . 75.019999999999996 109.452 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.422 ' HA ' HG23 ' A' ' 494' ' ' THR . 47.2 Cg_exo -58.74 144.33 98.19 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.825 2.35 . . . . 70.310000000000002 112.162 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.577 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 34.4 m -67.48 -20.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.664 0.616 . . . . 75.299999999999997 112.664 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.23 4.41 54.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.209 -0.451 . . . . 73.209999999999994 110.683 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -77.33 140.97 40.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.08 -1.081 . . . . 63.549999999999997 108.08 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.5 t -88.31 112.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.488 -1.301 . . . . 74.150000000000006 107.488 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 19.8 tt -86.57 133.73 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.743 0.782 . . . . 72.450000000000003 111.399 -176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 21.0 tt0 -102.81 125.67 49.65 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.145 -0.934 . . . . 75.409999999999997 109.437 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.59 131.82 44.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.901 -1.148 . . . . 74.310000000000002 107.901 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -92.67 105.02 17.25 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 107.74 -1.207 . . . . 74.019999999999996 107.74 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.8 p -100.29 132.81 45.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.31 0.576 . . . . 75.439999999999998 110.145 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 531' ' ' ALA . 26.7 p -66.87 128.02 34.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.441 -0.8 . . . . 52.340000000000003 111.895 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 108.036 -1.098 . . . . 74.409999999999997 108.036 176.836 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.633 0.73 . . . . 72.109999999999999 109.658 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 77.0 mt-30 -101.22 130.98 47.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.076 -0.965 . . . . 74.439999999999998 110.298 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.63 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.3 mmp_? -123.92 155.59 37.85 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 110.955 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -84.77 141.55 30.44 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.782 -0.645 . . . . 75.510000000000005 111.596 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -79.25 131.18 66.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.626 -0.716 . . . . 74.319999999999993 109.551 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.43 152.32 65.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.962 2.441 . . . . 75.120000000000005 112.774 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.85 8.38 43.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.427 0.632 . . . . 65.219999999999999 110.142 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.7 -12.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 122.542 1.163 . . . . 74.120000000000005 108.293 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.5 m -58.79 -38.39 78.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.855 -1.52 . . . . 73.230000000000004 110.804 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.2 m -60.21 -26.5 66.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.696 -1.138 . . . . 73.430000000000007 111.167 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.35 -45.45 12.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.812 -0.355 . . . . 72.109999999999999 111.108 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 28.3 m -161.86 143.78 11.34 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.031 -0.729 . . . . 72.450000000000003 109.031 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -52.51 -44.72 65.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.792 0.837 . . . . 74.400000000000006 111.455 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.37 90.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.159 -0.473 . . . . 72.349999999999994 111.19 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 8.4 mm-40 -69.2 -37.34 78.06 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.731 -0.668 . . . . 73.420000000000002 110.202 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.91 -51.92 67.62 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.092 -0.958 . . . . 72.329999999999998 111.349 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.84 -40.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.425 -0.807 . . . . 75.349999999999994 111.777 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -66.08 -44.86 83.21 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.768 -0.373 . . . . 71.340000000000003 111.08 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.52 -40.57 89.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.643 0.259 . . . . 73.420000000000002 111.624 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 30.3 tp -68.94 -34.75 75.87 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.25 0.548 . . . . 60.420000000000002 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.1 m -64.48 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.381 -0.6 . . . . 74.430000000000007 109.381 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.07 62.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.72 -0.673 . . . . 71.409999999999997 110.398 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.8 -13.63 53.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.724 -0.472 . . . . 71.219999999999999 109.724 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.32 -13.11 18.91 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.785 -0.643 . . . . 74.099999999999994 113.831 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.401 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 66.6 m-85 -71.09 138.94 50.16 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 111.143 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -138.38 10.63 3.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.156 -1.021 . . . . 73.099999999999994 113.149 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -120.74 115.01 22.47 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.278 -1.008 . . . . 73.439999999999998 108.278 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.17 153.83 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.847 0.356 . . . . 73.420000000000002 110.559 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -131.42 122.35 26.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.002 -1.481 . . . . 75.200000000000003 107.002 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -94.36 115.78 28.05 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.177 0.513 . . . . 64.219999999999999 110.193 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -118.53 154.61 32.28 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.997 -1.112 . . . . 72.400000000000006 107.997 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.21 148.22 52.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.365 -0.606 . . . . 73.129999999999995 109.365 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.6 m -135.63 147.21 60.57 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 109.06 -0.718 . . . . 63.0 109.06 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.9 Cg_exo -65.07 122.72 10.58 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.428 2.086 . . . . 74.219999999999999 110.933 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.9 t -148.88 179.4 7.89 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.017 -1.105 . . . . 75.239999999999995 108.017 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.84 139.83 90.1 Favored Pre-proline 0 N--CA 1.427 -1.593 0 C-N-CA 124.333 1.053 . . . . 64.329999999999998 110.662 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -50.87 -29.87 28.19 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.311 3.341 . . . . 74.329999999999998 113.141 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.78 -29.73 69.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.097 -0.502 . . . . 74.25 111.818 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.31 -2.13 49.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.033 -0.531 . . . . 71.409999999999997 111.68 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.7 t -61.28 127.04 20.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.23 -0.656 . . . . 75.329999999999998 109.23 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.93 -3.54 82.87 Favored Glycine 0 C--N 1.307 -1.065 0 C-N-CA 121.067 -0.587 . . . . 71.120000000000005 112.121 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.7 154.29 26.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.545 -0.909 . . . . 74.400000000000006 108.545 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.468 HG23 HD12 ' A' ' 486' ' ' ILE . 43.3 t -82.12 125.36 39.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.844 -0.798 . . . . 75.219999999999999 108.844 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.8 pt -98.45 -7.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.141 0.496 . . . . 72.219999999999999 110.415 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.46 150.2 5.92 Favored Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.631 -0.713 . . . . 75.030000000000001 111.487 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 10.4 p -116.47 158.32 23.77 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.481 -1.303 . . . . 74.030000000000001 107.481 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.94 -55.11 14.22 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 119.059 -1.056 . . . . 73.040000000000006 110.609 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.26 116.33 4.46 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 108.574 -1.356 . . . . 64.129999999999995 108.574 170.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 158.79 41.56 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.566 2.177 . . . . 73.230000000000004 113.413 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.413 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.33 7.25 9.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.307 -0.86 . . . . 75.340000000000003 110.401 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.16 -40.8 11.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.356 -0.838 . . . . 73.549999999999997 110.802 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -118.73 165.27 14.21 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.589 -0.523 . . . . 73.239999999999995 109.589 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 23.9 p -84.06 142.79 30.17 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.459 -0.337 . . . . 74.549999999999997 110.682 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.3 m -124.3 150.77 45.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.883 -1.154 . . . . 65.340000000000003 107.883 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.63 146.22 42.61 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.534 0.606 . . . . 74.510000000000005 111.328 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.71 -23.09 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.44 1.096 . . . . 75.239999999999995 111.014 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -95.5 1.18 53.86 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.784 -1.098 . . . . 70.219999999999999 110.428 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -80.67 155.45 26.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.13 121.23 38.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.889 -0.782 . . . . 73.329999999999998 108.889 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.85 118.89 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.926 -0.768 . . . . 75.219999999999999 108.926 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.44 117.43 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 106.157 -1.794 . . . . 75.340000000000003 106.157 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.468 HD12 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.92 124.24 65.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.701 -0.851 . . . . 62.140000000000001 108.701 -176.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.14 118.53 49.12 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 CA-C-O 121.396 0.617 . . . . 74.310000000000002 109.608 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.54 141.49 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.294 -0.866 . . . . 75.540000000000006 108.915 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.98 128.48 11.95 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 108.516 -1.833 . . . . 64.420000000000002 108.516 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.8 m -140.91 150.72 43.53 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.141 -0.623 . . . . 72.019999999999996 109.513 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.166 0 N-CA-C 109.689 -1.364 . . . . 73.310000000000002 109.689 179.197 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 121.788 0.804 . . . . 75.239999999999995 109.084 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 546' ' ' PRO . 47.0 p -131.87 160.58 35.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.356 -0.979 . . . . 72.129999999999995 108.356 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 544' ' ' THR . 67.8 mttm -135.59 147.22 48.61 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.215 -0.291 . . . . 75.219999999999999 110.215 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.28 126.51 36.39 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.593 -0.892 . . . . 74.150000000000006 108.593 175.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 541' ' ' ALA . 38.1 pt -81.95 137.41 46.76 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.524 -0.762 . . . . 63.539999999999999 112.358 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.43 175.47 6.25 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.563 2.175 . . . . 75.140000000000001 111.224 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.45 121.61 31.85 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 75.030000000000001 110.27 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.66 9.8 6.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.35 -0.841 . . . . 64.209999999999994 109.378 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.17 147.6 40.29 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.342 -0.844 . . . . 73.519999999999996 112.191 -172.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.64 69.46 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.178 -0.769 . . . . 64.239999999999995 111.178 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -117.32 -167.82 1.38 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.984 -0.747 . . . . 75.549999999999997 108.984 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.4 m -90.67 155.66 18.68 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.299 -0.961 . . . . 72.319999999999993 109.608 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.76 -43.93 57.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.196 0.598 . . . . 74.349999999999994 112.141 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.15 -42.2 80.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 111.906 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.59 -34.23 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.894 -0.722 . . . . 74.109999999999999 111.09 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.47 -47.28 86.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.534 -0.757 . . . . 72.409999999999997 110.736 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.89 -37.37 87.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 123.257 0.348 . . . . 73.049999999999997 110.632 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 514' ' ' VAL . 60.4 tttp -62.39 -53.67 51.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.64 -0.709 . . . . 75.409999999999997 110.062 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.07 -42.76 96.87 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.344 -0.844 . . . . 74.219999999999999 110.676 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.6 -41.12 96.98 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 115.592 -0.731 . . . . 74.150000000000006 109.715 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.18 -40.08 84.59 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.82 0.448 . . . . 74.430000000000007 110.708 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.2 t -67.18 -36.88 78.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.848 -0.615 . . . . 72.299999999999997 111.71 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -113.84 9.17 17.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.135 -0.626 . . . . 71.400000000000006 111.025 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -140.38 -107.5 0.7 Allowed Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.156 -1.497 . . . . 73.439999999999998 115.198 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.7 m-85 -127.6 -176.59 3.8 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.06 0.392 . . . . 74.239999999999995 112.06 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.87 -14.34 10.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.623 0.725 . . . . 74.120000000000005 110.559 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -108.14 115.72 30.65 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.246 -0.65 . . . . 75.120000000000005 109.246 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -124.29 155.59 38.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.298 -0.41 . . . . 75.25 110.347 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.3 m -140.86 158.29 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.447 -1.686 . . . . 75.439999999999998 106.447 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -121.95 144.12 49.06 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.735 -0.468 . . . . 73.129999999999995 109.735 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.31 134.91 54.65 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.208 -0.664 . . . . 73.329999999999998 109.208 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.4 m -90.26 119.9 30.96 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.606 -0.887 . . . . 70.019999999999996 108.606 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.51 163.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.626 -1.25 . . . . 73.129999999999995 107.626 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.43 129.18 35.42 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.642 0.734 . . . . 71.430000000000007 109.488 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 11.2 p -77.27 132.48 69.92 Favored Pre-proline 0 N--CA 1.419 -2.015 0 CA-C-N 114.682 -1.144 . . . . 72.349999999999994 110.576 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . 0.446 ' O ' ' HD2' ' A' ' 529' ' ' ARG . 11.9 Cg_endo -63.69 -75.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.524 1.482 . . . . 73.129999999999995 109.579 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.486 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 10.9 mmm180 -121.17 -57.7 0.03 OUTLIER Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.663 -0.495 . . . . 65.200000000000003 109.663 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 2.7 Cg_exo -77.36 153.15 31.01 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.305 2.004 . . . . 73.310000000000002 111.609 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.98 149.28 52.47 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.785 -0.82 . . . . 73.239999999999995 108.785 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 103.82 -22.08 36.49 Favored Glycine 0 C--O 1.249 1.035 0 N-CA-C 111.156 -0.778 . . . . 61.399999999999999 111.156 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.09 148.09 25.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.579 0.704 . . . . 64.099999999999994 111.674 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 3.8 p -75.8 125.16 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.977 -1.011 . . . . 74.239999999999995 110.15 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 8.4 m -77.45 -37.08 52.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.262 -1.014 . . . . 74.299999999999997 108.262 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.43 35.2 Favored Glycine 0 N--CA 1.417 -2.603 0 N-CA-C 109.665 -1.374 . . . . 73.140000000000001 109.665 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.3 p -117.74 159.88 22.27 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.209 -1.404 . . . . 62.32 107.209 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -56.75 -57.15 25.81 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 123.489 0.493 . . . . 73.129999999999995 110.716 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.26 142.84 21.77 Favored 'Trans proline' 0 C--N 1.368 1.588 0 N-CA-C 109.125 -1.144 . . . . 74.239999999999995 109.125 171.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.22 151.02 86.78 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.282 1.988 . . . . 74.409999999999997 111.804 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.421 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -58.92 138.45 57.38 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.747 0.308 . . . . 62.340000000000003 110.196 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.78 -21.13 43.36 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 111.309 -0.716 . . . . 74.239999999999995 111.309 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 46.2 m -70.75 132.35 45.22 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.105 0.478 . . . . 75.450000000000003 110.394 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 m -96.67 122.66 39.86 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.397 -0.819 . . . . 74.400000000000006 108.82 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.16 159.63 71.35 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.398 -0.593 . . . . 74.540000000000006 109.398 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.452 ' HA ' HG21 ' A' ' 494' ' ' THR . 39.2 Cg_exo -61.03 142.26 96.84 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.217 2.611 . . . . 73.420000000000002 114.584 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.488 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 30.9 m -67.43 -19.32 25.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.95 0.881 . . . . 73.510000000000005 111.146 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.9 -10.12 55.79 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.22 -1.354 . . . . 74.409999999999997 109.747 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 59.9 p -92.3 171.76 8.85 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.866 -0.606 . . . . 71.329999999999998 112.03 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.25 136.39 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.261 -1.014 . . . . 74.310000000000002 108.261 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.0 tt -113.76 142.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 120.895 0.379 . . . . 74.420000000000002 110.538 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -102.99 128.3 49.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 122.968 0.507 . . . . 75.200000000000003 111.606 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.3 122.01 42.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.135 -1.431 . . . . 75.510000000000005 107.135 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -104.32 110.13 22.25 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.606 -0.887 . . . . 72.129999999999995 108.606 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.36 139.13 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.461 -0.791 . . . . 73.519999999999996 112.944 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 69.6 m -64.76 115.05 4.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.484 -0.78 . . . . 71.340000000000003 109.581 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 106.46 -1.682 . . . . 73.219999999999999 106.46 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 122.296 1.046 . . . . 73.209999999999994 111.617 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -121.75 131.03 53.85 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.222 -1.354 . . . . 72.219999999999999 108.122 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -122.72 151.56 41.44 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.154 -0.684 . . . . 75.450000000000003 109.154 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -93.74 142.16 27.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.266 -0.879 . . . . 74.239999999999995 110.082 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 474' ' ' ALA . 2.9 mp -79.13 125.11 84.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.858 -0.793 . . . . 75.540000000000006 108.858 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.43 141.79 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.727 1.618 . . . . 74.219999999999999 111.332 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.65 52.19 1.85 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.728 0.775 . . . . 73.140000000000001 110.652 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 440' ' ' ALA . 14.8 p -102.39 -2.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.018 -1.475 . . . . 74.109999999999999 107.018 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.492 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 1.7 p -59.11 -41.44 88.16 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.998 -1.91 . . . . 72.030000000000001 110.703 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.3 p -61.71 -26.37 68.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.9 -1.045 . . . . 72.140000000000001 112.807 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.3 -46.48 13.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 119.077 -1.049 . . . . 73.439999999999998 111.575 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.6 m -170.39 147.36 3.0 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.942 -0.762 . . . . 75.319999999999993 108.942 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -50.82 -48.91 59.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.507 1.123 . . . . 71.200000000000003 110.581 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.76 75.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.204 -0.453 . . . . 75.450000000000003 111.579 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 25.0 mm-40 -69.59 -44.68 70.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.088 0.47 . . . . 70.349999999999994 110.363 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.44 -51.18 70.55 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.045 -0.979 . . . . 63.100000000000001 111.704 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.01 -45.95 89.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 CA-C-N 115.737 -0.665 . . . . 75.549999999999997 111.511 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.19 -47.91 80.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -67.79 -39.52 84.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.31 -0.556 . . . . 74.200000000000003 110.668 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 452' ' ' PHE . 20.9 tp -69.7 -34.78 74.37 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.252 0.548 . . . . 75.409999999999997 110.716 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 27.1 m -62.06 -43.31 99.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.651 -0.704 . . . . 71.329999999999998 109.64 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.87 62.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.626 -0.715 . . . . 75.310000000000002 110.836 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.65 59.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.049 0.452 . . . . 72.200000000000003 110.454 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.92 6.95 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.329 -0.938 . . . . 75.340000000000003 113.171 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 445' ' ' THR . 97.1 m-85 -80.85 130.93 35.31 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.69 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -136.22 14.74 4.0 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.184 -1.166 . . . . 60.109999999999999 110.184 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -116.95 115.3 25.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.978 -1.49 . . . . 75.239999999999995 106.978 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 87.7 m-85 -139.04 156.43 47.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.301 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.432 ' HB2' HG13 ' A' ' 485' ' ' ILE . 68.8 mttm -133.55 122.97 24.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.114 -1.809 . . . . 74.120000000000005 106.114 167.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -93.79 120.02 33.51 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.763 -0.775 . . . . 75.040000000000006 112.027 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.31 43.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.232 -1.025 . . . . 74.530000000000001 108.232 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.89 150.75 33.19 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.915 -1.143 . . . . 63.409999999999997 107.915 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.1 p -134.6 138.21 29.4 Favored Pre-proline 0 C--N 1.277 -2.575 0 N-CA-C 108.964 -0.754 . . . . 61.43 108.964 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.57 123.6 11.64 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.086 1.857 . . . . 74.409999999999997 110.042 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 179.31 7.55 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 108.43 -0.952 . . . . 60.100000000000001 108.43 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -67.92 137.89 92.54 Favored Pre-proline 0 N--CA 1.418 -2.065 0 C-N-CA 123.467 0.707 . . . . 72.150000000000006 110.461 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.78 -29.21 25.45 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 124.669 3.579 . . . . 64.519999999999996 113.596 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.65 -21.53 61.81 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 111.401 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.422 HD11 ' HD2' ' A' ' 466' ' ' LYS . 23.0 tp -105.15 2.92 29.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 74.140000000000001 110.683 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.46 128.03 20.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 111.013 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.31 -2.55 56.37 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.717 -0.674 . . . . 64.129999999999995 111.676 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.422 ' HD2' HD11 ' A' ' 463' ' ' LEU . 96.6 mttt -112.21 145.05 40.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.38 -0.6 . . . . 75.109999999999999 109.38 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.75 134.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.193 -0.669 . . . . 74.310000000000002 109.193 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.7 pt -98.28 -20.09 5.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.484 -0.886 . . . . 72.219999999999999 110.08 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.927 -0.654 . . . . 54.210000000000001 111.565 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.2 p -116.77 161.0 19.95 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.518 -0.919 . . . . 65.349999999999994 108.518 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.522 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.4 t-20 -65.69 -52.43 43.06 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-O 119.012 -0.518 . . . . 75.319999999999993 111.568 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.5 Cg_exo -75.02 135.81 19.52 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 120.359 1.164 . . . . 62.009999999999998 109.116 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.57 136.26 53.42 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.614 2.209 . . . . 75.030000000000001 111.351 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 429' ' ' ILE . . . -77.0 -17.68 58.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.822 -0.626 . . . . 72.239999999999995 111.964 -172.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -76.49 -31.87 58.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.386 0.612 . . . . 72.049999999999997 109.71 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -95.34 164.87 12.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.456 -0.793 . . . . 64.540000000000006 110.836 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -97.63 127.1 43.33 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.525 -0.761 . . . . 62.439999999999998 110.449 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.4 m -110.06 139.68 44.92 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.283 -1.006 . . . . 64.129999999999995 108.283 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.452 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -57.89 150.39 20.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.075 0.398 . . . . 74.239999999999995 112.075 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.1 -25.71 38.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.847 -0.615 . . . . 75.120000000000005 110.82 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -86.71 5.29 36.95 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 116.146 -0.479 . . . . 75.239999999999995 111.363 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.13 157.52 24.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 120.909 0.385 . . . . 64.450000000000003 111.031 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.05 123.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.034 -1.099 . . . . 73.530000000000001 108.034 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 62.1 t -94.18 119.01 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 C-N-CA 119.069 -1.053 . . . . 73.5 108.844 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.522 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.1 mp -92.65 118.35 38.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 105.308 -2.108 . . . . 71.420000000000002 105.308 174.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 tt -102.13 124.35 55.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 116.347 -0.388 . . . . 74.409999999999997 109.967 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.95 108.46 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.395 -0.965 . . . . 75.439999999999998 108.395 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.67 139.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.005 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.07 123.89 6.53 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.484 -1.446 . . . . 55.509999999999998 109.484 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.3 m -135.85 149.74 49.15 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 41.439999999999998 108.286 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.164 0 C-N-CA 119.746 -1.216 . . . . 73.099999999999994 110.768 -176.852 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 106.471 -1.678 . . . . 65.129999999999995 106.471 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 546' ' ' PRO . 37.2 p -127.96 161.29 29.47 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 114.519 -1.218 . . . . 74.420000000000002 109.858 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 544' ' ' THR . 96.0 mttt -143.31 156.33 44.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.835 -0.431 . . . . 74.319999999999993 109.835 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -92.78 135.87 33.74 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.952 -0.758 . . . . 74.120000000000005 108.952 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 541' ' ' ALA . 23.2 pt -78.14 136.67 61.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.998 -0.546 . . . . 75.239999999999995 110.926 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.83 -172.49 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.577 2.184 . . . . 74.219999999999999 110.339 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -99.41 136.35 39.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.454 -0.943 . . . . 71.040000000000006 108.454 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 m -128.66 16.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 120.887 0.375 . . . . 72.519999999999996 110.835 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -72.0 116.45 12.42 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.915 -0.584 . . . . 65.109999999999999 111.367 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 116.69 -19.33 12.57 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.811 -0.709 . . . . 64.439999999999998 112.103 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -81.76 177.7 8.74 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.845 -0.342 . . . . 72.319999999999993 110.153 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.3 m -91.4 156.29 17.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.553 -1.277 . . . . 74.329999999999998 107.553 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.96 -43.47 75.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.921 0.391 . . . . 73.109999999999999 112.054 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.59 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 5.9 p-10 -68.51 -42.08 79.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 111.897 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.94 -34.63 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.142 -1.023 . . . . 73.319999999999993 111.141 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -62.0 -48.89 78.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.448 -0.796 . . . . 70.319999999999993 111.364 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.4 -36.77 84.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.404 0.44 . . . . 71.030000000000001 110.746 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.59 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.6 mptp? -64.01 -47.58 79.72 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.123 0.264 . . . . 74.5 111.56 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -65.13 -42.91 93.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.975 0.417 . . . . 75.349999999999994 110.318 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.74 -37.26 85.88 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 115.762 -0.653 . . . . 73.219999999999999 109.655 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -62.25 -37.9 87.21 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 122.762 0.425 . . . . 70.239999999999995 110.714 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 510' ' ' LYS . 61.0 t -72.44 -27.21 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.089 0.471 . . . . 74.329999999999998 110.637 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.77 36.54 4.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.552 -0.295 . . . . 65.239999999999995 110.23 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -169.33 -100.92 0.14 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 117.106 -2.473 . . . . 75.25 116.613 -173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 545' ' ' VAL . 61.3 m-85 -127.63 162.36 26.69 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 115.212 -0.494 . . . . 62.130000000000003 111.312 -162.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.2 m -104.37 -17.37 14.82 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.225 -0.898 . . . . 65.319999999999993 110.869 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -109.98 123.93 50.52 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.92 -0.488 . . . . 71.049999999999997 109.804 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.97 151.28 45.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.473 0.654 . . . . 75.109999999999999 111.666 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -141.6 152.03 43.67 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.121 -1.437 . . . . 74.409999999999997 107.121 169.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.23 128.12 50.77 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 120.741 0.305 . . . . 75.140000000000001 110.233 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.58 127.34 52.04 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.878 -0.786 . . . . 73.519999999999996 108.878 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -91.29 143.07 27.03 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.117 -0.697 . . . . 62.43 109.117 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.87 159.45 26.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.375 -0.972 . . . . 73.299999999999997 108.375 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.32 134.43 36.61 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.362 0.601 . . . . 73.120000000000005 109.432 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 8.1 t -129.81 162.3 54.28 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 108.021 -1.103 . . . . 63.509999999999998 108.021 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 122.519 2.146 . . . . 72.450000000000003 110.079 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.17 -46.52 62.19 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 118.986 -1.086 . . . . 71.040000000000006 113.315 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.67 134.65 38.75 Favored 'Trans proline' 0 C--N 1.365 1.401 0 CA-C-N 120.383 1.172 . . . . 71.140000000000001 109.897 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -153.71 176.33 12.23 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.682 -0.859 . . . . 73.230000000000004 108.682 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.93 7.15 62.88 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 111.049 -0.82 . . . . 74.409999999999997 111.049 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.9 141.1 28.99 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 107.633 -1.247 . . . . 74.299999999999997 107.633 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 95.8 t -77.12 115.76 19.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 104.781 -2.303 . . . . 70.109999999999999 104.781 165.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.8 m -76.1 -26.73 56.72 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.739 -0.837 . . . . 73.140000000000001 108.739 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.43 -149.43 21.2 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.291 -0.868 . . . . 61.329999999999998 111.023 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -118.09 161.67 19.46 Favored 'General case' 0 C--N 1.279 -2.498 0 C-N-CA 123.522 0.729 . . . . 71.0 109.108 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.6 t-20 -52.33 -51.96 67.42 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 123.427 0.454 . . . . 65.420000000000002 111.636 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.3 Cg_endo -91.6 161.16 3.53 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.473 1.449 . . . . 73.430000000000007 109.845 171.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.95 150.58 61.19 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.154 1.902 . . . . 72.120000000000005 112.194 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -50.94 131.02 26.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.102 0.961 . . . . 74.420000000000002 111.422 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -17.29 36.69 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.773 -0.648 . . . . 72.010000000000005 112.099 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 48.6 m -67.86 128.01 34.93 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.567 -0.372 . . . . 70.439999999999998 110.301 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 27.8 m -97.59 123.36 41.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.761 -0.459 . . . . 74.519999999999996 109.761 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 517' ' ' PHE . 9.5 m -134.14 162.26 58.76 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.264 -0.643 . . . . 71.209999999999994 109.264 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.431 ' HA ' HG23 ' A' ' 494' ' ' THR . 31.2 Cg_exo -61.93 136.21 60.06 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.104 2.536 . . . . 75.420000000000002 113.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.57 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 33.2 m -66.73 -22.82 30.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.663 -0.699 . . . . 73.150000000000006 112.343 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.97 -2.13 57.74 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.134 -0.939 . . . . 73.120000000000005 110.011 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -93.97 173.19 7.79 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.087 -0.709 . . . . 72.319999999999993 109.087 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.99 127.65 44.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 111.827 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.15 130.13 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.825 -1.176 . . . . 73.310000000000002 107.825 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.04 127.19 50.38 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-O 121.268 0.556 . . . . 75.430000000000007 110.111 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.6 tp -95.28 132.58 40.13 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.979 -1.009 . . . . 63.439999999999998 109.06 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -100.18 113.34 25.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.425 -0.954 . . . . 74.329999999999998 108.425 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.81 137.67 44.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-O 120.627 0.251 . . . . 75.329999999999998 111.24 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 58.6 p -83.39 124.49 30.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 109.785 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 108.829 -0.804 . . . . 74.109999999999999 108.829 -177.368 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.512 -0.509 0 CA-C-O 121.908 0.861 . . . . 75.530000000000001 109.916 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 153.5 34.13 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.222 -1.399 . . . . 63.329999999999998 107.222 174.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -145.85 152.62 39.79 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.292 -1.744 . . . . 73.319999999999993 106.292 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.41 140.94 30.34 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.503 0.668 . . . . 73.430000000000007 112.503 -177.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.49 131.04 69.44 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 107.51 -1.293 . . . . 73.409999999999997 107.51 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.0 140.6 94.54 Favored 'Trans proline' 0 C--O 1.243 0.734 0 C-N-CA 122.664 2.242 . . . . 73.439999999999998 113.346 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -96.47 -5.25 40.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.025 -0.989 . . . . 65.319999999999993 109.84 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.18 5.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.947 0.879 . . . . 64.319999999999993 110.703 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -62.63 -30.45 71.37 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.869 1.268 . . . . 71.519999999999996 109.918 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.5 t -57.65 -26.76 62.1 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.42 -1.263 . . . . 75.25 111.077 176.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.57 -44.96 15.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 120.788 -0.365 . . . . 75.319999999999993 110.422 -175.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.502 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 3.7 m -164.1 149.44 10.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.702 -0.851 . . . . 72.099999999999994 108.702 175.381 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -54.71 -44.02 73.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.783 0.833 . . . . 72.239999999999995 110.768 174.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.63 -43.56 76.26 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.305 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.0 mm-40 -61.67 -42.43 98.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 123.514 0.509 . . . . 74.409999999999997 110.44 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.47 77.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.157 -0.929 . . . . 71.5 110.097 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.96 -47.61 92.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 CA-C-N 115.788 -0.642 . . . . 74.549999999999997 112.101 -177.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.5 mmtp -60.96 -48.6 81.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.035 0.445 . . . . 74.510000000000005 110.452 -176.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 443' ' ' LYS . 10.3 mmpt? -68.2 -39.19 82.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.899 -0.591 . . . . 75.409999999999997 111.843 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 452' ' ' PHE . 23.4 tp -68.54 -40.25 80.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.195 0.521 . . . . 75.329999999999998 110.044 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 42.8 m -59.41 -45.85 90.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.249 -0.887 . . . . 73.409999999999997 109.461 176.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -17.28 62.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.63 -0.714 . . . . 75.219999999999999 111.473 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.59 -13.92 57.4 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 110.861 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.9 -11.81 22.67 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.15 -1.024 . . . . 74.340000000000003 113.519 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.5 138.55 47.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.976 0.417 . . . . 70.150000000000006 110.857 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 -12.74 3.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.591 -0.814 . . . . 75.340000000000003 113.599 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -103.38 114.99 29.7 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.095 -0.706 . . . . 74.219999999999999 109.095 -178.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.53 ' CE2' HD22 ' A' ' 444' ' ' LEU . 37.1 m-85 -120.03 153.27 36.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.369 -0.832 . . . . 72.340000000000003 109.696 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 485' ' ' ILE . 16.3 tppt? -143.73 122.33 12.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 105.566 -2.013 . . . . 72.230000000000004 105.566 170.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -104.2 125.4 50.46 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 120.862 0.363 . . . . 71.439999999999998 110.732 -176.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.93 49.04 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.231 -1.026 . . . . 74.409999999999997 108.231 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -124.02 149.35 46.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.543 -0.91 . . . . 63.009999999999998 108.543 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.2 m -140.42 140.65 23.4 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 108.97 -0.752 . . . . 70.109999999999999 108.97 176.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.7 Cg_exo -65.76 122.0 9.51 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.965 1.777 . . . . 75.129999999999995 109.946 177.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.4 m -151.99 -179.54 7.57 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.756 -1.201 . . . . 71.319999999999993 107.756 -178.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -24.98 100.24 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.51 0 C-N-CA 126.563 1.945 . . . . 73.239999999999995 112.83 177.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.437 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 73.8 Cg_exo -51.53 -38.09 63.89 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 124.499 3.466 . . . . 64.099999999999994 115.973 -170.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.45 -11.33 59.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.191 0.811 . . . . 74.209999999999994 113.191 -176.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.65 14.15 31.71 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.692 0.282 . . . . 71.219999999999999 111.186 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.1 p -52.86 128.73 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.335 176.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.49 -3.06 56.27 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.826 -0.702 . . . . 72.209999999999994 111.506 -179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -103.48 146.01 29.15 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.316 -0.624 . . . . 73.519999999999996 109.316 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.443 HG22 HD12 ' A' ' 486' ' ' ILE . 46.9 t -81.78 132.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.477 -0.564 . . . . 72.219999999999999 109.477 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.5 -21.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.624 -0.43 . . . . 72.150000000000006 110.625 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.96 159.92 23.54 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 111.106 -0.798 . . . . 73.510000000000005 111.106 177.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -122.63 152.32 40.6 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.326 -0.99 . . . . 74.140000000000001 108.326 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 66.0 t30 -64.44 -50.59 65.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.499 -0.481 . . . . 75.540000000000006 111.058 177.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.3 Cg_exo -79.59 147.83 20.06 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 120.371 1.168 . . . . 75.129999999999995 109.104 172.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -71.37 140.89 37.71 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.142 1.894 . . . . 75.310000000000002 113.463 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.11 6.67 28.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.115 0.96 . . . . 73.420000000000002 109.183 176.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.1 -26.83 13.55 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.667 -1.151 . . . . 73.420000000000002 111.988 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -137.85 174.96 10.01 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.279 -0.569 . . . . 75.150000000000006 110.263 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.7 p -86.94 147.71 25.64 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.238 0.542 . . . . 71.519999999999996 112.368 -176.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.4 m -133.83 150.1 51.39 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.393 -1.336 . . . . 70.400000000000006 107.393 174.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 482' ' ' ASN . . . -55.48 142.24 33.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.617 0.599 . . . . 65.230000000000004 112.617 -176.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.02 -29.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.563 1.145 . . . . 63.299999999999997 111.532 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -94.08 12.26 27.02 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.527 -0.469 . . . . 74.120000000000005 111.577 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.95 146.32 35.55 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 122.14 -0.35 . . . . 73.010000000000005 110.365 176.652 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.2 122.98 36.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.632 -0.877 . . . . 71.200000000000003 108.632 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.82 118.51 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 108.039 -1.097 . . . . 75.200000000000003 108.039 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.0 mp -96.99 114.47 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 106.194 -1.78 . . . . 75.150000000000006 106.194 175.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.443 HD12 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.88 125.68 59.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 108.901 -0.777 . . . . 74.109999999999999 108.901 -177.713 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.46 116.47 49.31 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 CA-C-O 121.693 0.758 . . . . 70.230000000000004 109.988 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.41 136.83 25.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.22 -0.9 . . . . 72.420000000000002 109.461 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.91 112.1 3.53 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.783 -2.127 . . . . 62.420000000000002 107.783 174.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.4 t -115.3 145.37 42.54 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 119.873 -0.731 . . . . 74.430000000000007 109.787 -176.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.406 -3.301 0 N-CA-C 107.965 -2.054 . . . . 71.430000000000007 107.965 176.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 108.503 -0.925 . . . . 75.299999999999997 108.503 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.6 p -136.27 157.56 46.51 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.543 -1.208 . . . . 62.43 108.268 -175.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 28.9 mtpp -143.94 157.36 44.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.666 -0.864 . . . . 75.129999999999995 108.666 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.0 t70 -91.36 130.92 37.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.677 -1.231 . . . . 75.120000000000005 107.677 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 23.8 pt -77.15 126.11 85.73 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 112.366 0.506 . . . . 64.400000000000006 112.366 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 55.2 Cg_endo -94.07 114.46 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.32 2.013 . . . . 75.219999999999999 112.886 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.67 124.36 29.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.422 -0.955 . . . . 64.319999999999993 108.422 175.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.4 t -114.53 45.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.154 -1.054 . . . . 75.109999999999999 108.154 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.29 130.73 45.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.848 -1.069 . . . . 65.150000000000006 111.381 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 129.99 -32.04 3.22 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.316 -0.945 . . . . 72.540000000000006 113.29 176.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.481 ' O ' HG12 ' A' ' 534' ' ' VAL . 23.7 mt-30 -94.7 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.691 -0.485 . . . . 71.340000000000003 109.691 -177.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 157.38 19.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.178 -1.009 . . . . 74.150000000000006 109.564 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.5 t -55.92 -44.14 77.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.593 0.558 . . . . 72.310000000000002 111.151 -176.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.442 ' CG ' ' HZ3' ' A' ' 510' ' ' LYS . 19.8 t70 -67.61 -41.75 83.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.693 -0.685 . . . . 74.219999999999999 111.921 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -36.26 27.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 118.884 -1.126 . . . . 74.450000000000003 110.654 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.58 87.25 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.53 -0.759 . . . . 73.219999999999999 110.959 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -64.82 -35.17 80.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 123.307 0.38 . . . . 75.010000000000005 110.041 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.442 ' HZ3' ' CG ' ' A' ' 506' ' ' ASP . 52.5 mttp -61.42 -47.48 85.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 123.127 0.267 . . . . 73.329999999999998 111.517 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -68.84 -43.12 76.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.376 -0.375 . . . . 73.200000000000003 111.006 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 520' ' ' PHE . 5.8 tt -64.27 -37.54 87.86 Favored 'General case' 0 C--O 1.173 -2.947 0 CA-C-N 115.928 -0.578 . . . . 63.549999999999997 109.537 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.33 -37.44 75.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.929 0.491 . . . . 71.420000000000002 110.362 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.88 -39.86 75.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.73 -0.668 . . . . 74.340000000000003 111.122 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -94.99 -10.83 29.76 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.431 0.634 . . . . 74.239999999999995 110.384 -174.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -117.25 -117.54 2.9 Favored Glycine 0 N--CA 1.411 -2.978 0 CA-C-N 115.243 -0.889 . . . . 73.319999999999993 113.139 -172.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.674 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 35.9 m-85 -136.46 -175.41 4.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.459 -0.571 . . . . 74.319999999999993 109.459 -169.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 m -99.37 -18.5 17.48 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.719 -0.673 . . . . 74.120000000000005 111.811 -178.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -107.29 115.87 30.93 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.876 -0.729 . . . . 71.109999999999999 111.54 -175.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . 0.435 ' CE2' HD23 ' A' ' 512' ' ' LEU . 19.7 m-85 -120.84 142.57 49.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.578 -1.192 . . . . 74.140000000000001 108.543 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.5 p -115.62 145.28 42.84 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 104.936 -2.246 . . . . 72.200000000000003 104.936 171.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -121.82 138.3 54.43 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.829 -1.148 . . . . 73.040000000000006 111.09 -174.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.6 139.91 52.92 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.782 -0.822 . . . . 54.039999999999999 108.782 178.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.0 m -101.75 125.18 48.37 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.998 -1.112 . . . . 75.140000000000001 107.998 177.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.15 160.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.972 -0.751 . . . . 73.310000000000002 108.972 -176.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 8.4 p-10 -78.55 132.68 37.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.445 0.641 . . . . 71.510000000000005 109.901 -175.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 p -95.51 106.12 24.72 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 114.568 -1.197 . . . . 72.129999999999995 111.963 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 4.3 Cg_exo -76.55 -66.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.34 2.027 . . . . 73.219999999999999 110.986 177.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -108.72 -52.19 0.07 OUTLIER Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 118.977 -0.535 . . . . 75.450000000000003 111.879 178.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.96 134.19 17.57 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 120.4 1.178 . . . . 74.510000000000005 110.635 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.76 128.54 14.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.259 -0.274 . . . . 74.230000000000004 110.259 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.42 23.38 Favored Glycine 0 CA--C 1.502 -0.726 0 N-CA-C 110.185 -1.166 . . . . 65.030000000000001 110.185 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.59 149.19 23.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.276 -0.962 . . . . 65.430000000000007 109.529 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.7 p -73.18 127.07 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.175 -1.046 . . . . 74.549999999999997 108.175 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.6 m -73.5 -25.75 60.58 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.208 -1.36 . . . . 74.530000000000001 109.841 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.18 20.36 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 110.767 -0.933 . . . . 54.109999999999999 110.767 175.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -120.27 159.4 25.05 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.147 -1.427 . . . . 72.329999999999998 107.147 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -63.05 -54.54 45.28 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 119.942 -0.703 . . . . 75.239999999999995 110.56 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.4 Cg_endo -93.07 134.05 1.06 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.225 1.283 . . . . 72.340000000000003 109.665 171.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -72.91 164.0 36.8 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.717 2.278 . . . . 74.329999999999998 113.429 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -54.1 145.07 17.88 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-N 115.486 -0.779 . . . . 61.310000000000002 109.372 173.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.62 34.01 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.832 -1.707 . . . . 73.450000000000003 108.832 -172.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.0 m -88.62 119.85 29.47 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.816 -0.809 . . . . 65.430000000000007 108.816 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 86.5 m -101.77 127.43 48.56 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.147 -0.686 . . . . 74.430000000000007 109.147 176.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.84 160.21 64.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.647 -0.871 . . . . 75.319999999999993 108.647 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 494' ' ' THR . 42.9 Cg_exo -58.46 152.74 52.5 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.394 2.062 . . . . 62.149999999999999 111.773 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.674 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.9 m -65.98 -20.78 27.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.239 0.543 . . . . 73.030000000000001 112.39 -177.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.14 3.73 54.87 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.645 -0.707 . . . . 75.230000000000004 110.83 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.7 t -79.67 167.95 20.0 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.939 -0.393 . . . . 74.420000000000002 109.939 -177.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.19 120.64 62.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 109.757 -0.46 . . . . 75.120000000000005 109.757 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.4 tt -92.52 138.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.962 -0.385 . . . . 75.329999999999998 109.962 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -101.82 121.76 42.71 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 121.479 0.656 . . . . 74.150000000000006 110.654 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.94 134.91 41.12 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.98 1.312 . . . . 75.099999999999994 109.24 -177.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.27 108.68 20.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.625 -0.716 . . . . 74.349999999999994 110.017 -176.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.9 131.76 42.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 124.066 0.946 . . . . 74.219999999999999 110.008 -179.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 45.6 p -69.05 125.01 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.289 0.566 . . . . 74.140000000000001 110.769 175.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 105.875 -1.898 . . . . 75.340000000000003 105.875 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 108.961 -0.755 . . . . 62.009999999999998 108.961 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 478' ' ' SER . 21.0 mp0 -82.67 125.21 30.96 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.266 -0.879 . . . . 63.450000000000003 109.979 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.527 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 18.9 tpp180 -120.7 155.87 32.96 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.68 -0.859 . . . . 73.409999999999997 108.68 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 142.02 28.83 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.207 1.003 . . . . 74.400000000000006 111.691 -174.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -86.0 128.7 57.0 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 109.524 -0.547 . . . . 75.409999999999997 109.524 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.72 160.1 47.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.161 2.574 . . . . 73.310000000000002 112.332 176.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.52 24.68 9.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.945 0.498 . . . . 71.510000000000005 111.257 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.7 t -76.4 -2.98 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.8 1.286 . . . . 73.129999999999995 109.281 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.472 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 3.1 m -52.37 -34.27 46.96 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.444 2.298 . . . . 75.109999999999999 111.323 177.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.9 t -60.97 -28.01 68.69 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.851 -0.613 . . . . 75.219999999999999 112.014 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.4 -47.51 8.72 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 118.874 -1.13 . . . . 64.349999999999994 111.836 -172.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 18.9 m -172.1 154.11 3.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.071 -1.085 . . . . 72.400000000000006 108.071 -178.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -51.91 -54.82 24.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 75.450000000000003 110.463 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.04 73.05 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 123.467 0.479 . . . . 70.25 111.91 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.04 -45.84 93.12 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.722 0.639 . . . . 50.109999999999999 111.327 -178.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -71.27 -43.75 66.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.016 -0.538 . . . . 71.230000000000004 110.774 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.23 -48.36 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.965 -0.561 . . . . 72.420000000000002 111.985 -178.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.94 -40.1 96.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 71.530000000000001 110.344 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -66.57 -43.06 86.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.075 -0.512 . . . . 73.420000000000002 111.005 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 452' ' ' PHE . 22.8 tp -68.69 -33.41 73.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.396 0.617 . . . . 74.439999999999998 109.611 179.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.3 m -62.42 -41.29 98.58 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.485 -0.78 . . . . 73.209999999999994 109.212 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.02 63.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.75 -0.659 . . . . 71.530000000000001 110.991 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.18 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.193 0.521 . . . . 75.510000000000005 110.02 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.98 -6.88 17.31 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.78 -0.724 . . . . 43.310000000000002 113.423 175.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.527 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 85.7 m-85 -75.28 136.8 40.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.084 0.772 . . . . 73.540000000000006 113.084 -176.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.57 25.93 3.73 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.169 -1.172 . . . . 71.510000000000005 110.169 175.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.61 115.19 15.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.821 -1.178 . . . . 75.340000000000003 107.821 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CE2' HD22 ' A' ' 444' ' ' LEU . 67.8 m-85 -140.18 150.06 43.73 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.894 -0.41 . . . . 74.230000000000004 109.894 -175.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.401 ' HB3' HG13 ' A' ' 485' ' ' ILE . 15.1 tppt? -133.67 122.91 24.11 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 106.42 -1.696 . . . . 74.439999999999998 106.42 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -95.31 123.6 38.91 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 110.278 -0.267 . . . . 74.329999999999998 110.278 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.26 151.67 51.71 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.542 -1.281 . . . . 73.400000000000006 107.542 176.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.14 143.64 40.42 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.085 -0.646 . . . . 73.329999999999998 110.232 178.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.3 m -124.04 149.32 59.87 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 109.242 -0.651 . . . . 64.349999999999994 109.242 -178.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.03 122.88 10.52 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.171 1.914 . . . . 74.439999999999998 110.238 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 t -134.2 179.81 6.03 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.601 -0.889 . . . . 75.409999999999997 108.601 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.1 t -65.56 141.43 97.91 Favored Pre-proline 0 N--CA 1.423 -1.825 0 C-N-CA 123.74 0.816 . . . . 74.310000000000002 110.793 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.72 -29.23 32.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.389 3.393 . . . . 74.430000000000007 112.62 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.48 -23.92 61.9 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.626 -0.716 . . . . 74.299999999999997 112.049 -177.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.551 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 11.2 mp -108.49 8.7 27.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.449 0.537 . . . . 72.420000000000002 112.449 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.7 133.4 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.967 0.413 . . . . 74.409999999999997 110.963 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.57 -16.21 57.94 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 120.9 -0.666 . . . . 75.019999999999996 113.438 175.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 463' ' ' LEU . 0.2 OUTLIER -103.82 166.22 10.55 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.538 -0.865 . . . . 74.319999999999993 109.588 178.671 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 59.3 t -82.13 130.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.429 -1.322 . . . . 74.329999999999998 107.429 176.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.1 pt -98.43 -0.87 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.17 -0.612 . . . . 74.230000000000004 110.937 -178.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.0 162.84 11.83 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 115.621 -0.718 . . . . 74.019999999999996 112.069 174.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.5 p -116.47 149.77 38.95 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.679 -1.23 . . . . 70.200000000000003 107.679 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.47 -52.02 55.91 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 120.298 -0.561 . . . . 72.409999999999997 110.874 177.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.88 136.46 22.94 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 119.912 1.004 . . . . 72.400000000000006 109.854 172.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.505 2.136 . . . . 73.200000000000003 112.165 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -85.92 0.15 53.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.398 1.095 . . . . 74.329999999999998 109.053 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -91.07 -32.07 16.02 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.67 -1.605 . . . . 73.239999999999995 110.358 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.06 168.52 9.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.446 -0.501 . . . . 74.349999999999994 110.575 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 25.0 p -98.69 137.15 37.73 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.345 -0.389 . . . . 54.32 111.047 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 478' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.5 m -116.36 148.82 40.23 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.406 -0.59 . . . . 72.019999999999996 109.406 179.141 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.539 ' HB1' ' ND2' ' A' ' 482' ' ' ASN . . . -69.64 157.63 36.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.742 0.246 . . . . 74.140000000000001 111.32 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.7 mm -70.35 -25.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.896 0.855 . . . . 75.230000000000004 110.199 -175.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.9 t -95.62 2.21 54.03 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.347 -0.842 . . . . 74.040000000000006 110.337 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.539 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -80.82 139.59 35.91 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 108.267 -1.012 . . . . 73.340000000000003 108.267 176.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.34 111.99 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.006 -0.739 . . . . 64.430000000000007 109.006 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.57 118.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.865 -1.161 . . . . 70.209999999999994 107.865 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -93.87 122.05 45.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.777 -1.194 . . . . 75.430000000000007 107.777 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.19 126.0 68.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.232 -1.025 . . . . 74.209999999999994 108.232 -179.11 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.4 mp -104.09 120.93 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.392 0.615 . . . . 64.450000000000003 110.125 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.09 145.34 8.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.646 -0.706 . . . . 73.310000000000002 109.281 -177.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.6 106.73 3.29 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.83 -0.908 . . . . 73.430000000000007 110.83 176.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.0 m -108.2 138.56 44.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.149 -1.056 . . . . 73.030000000000001 108.149 177.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.124 0 C-N-CA 119.875 -1.155 . . . . 71.219999999999999 111.705 -177.587 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.273 0 N-CA-C 107.67 -1.233 . . . . 54.409999999999997 107.67 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 43.4 p -134.89 162.78 31.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.012 -0.995 . . . . 71.439999999999998 110.766 -173.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.432 ' HG2' ' HA2' ' A' ' 516' ' ' GLY . 0.3 OUTLIER -142.83 132.0 23.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.21 -1.033 . . . . 74.239999999999995 108.21 178.007 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.9 p-10 -80.73 138.33 36.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.436 -0.949 . . . . 61.100000000000001 108.436 173.144 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.415 HG13 ' HA ' ' A' ' 541' ' ' ALA . 42.8 pt -98.61 137.58 20.65 Favored Pre-proline 0 C--N 1.292 -1.902 0 C-N-CA 120.433 -0.507 . . . . 75.099999999999994 111.742 -177.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.69 -176.97 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.472 2.115 . . . . 73.239999999999995 110.11 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -77.02 125.95 30.17 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.402 -0.962 . . . . 74.209999999999994 108.402 176.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 7.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.139 0.971 . . . . 74.040000000000006 110.264 -177.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -93.05 160.44 14.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.628 -0.714 . . . . 71.030000000000001 110.844 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 94.96 -7.98 70.18 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 109.691 -1.364 . . . . 63.32 109.691 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -102.04 -180.0 4.16 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.32 -0.94 . . . . 75.439999999999998 108.665 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 38.4 m -88.2 155.64 19.65 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.909 -1.145 . . . . 61.399999999999999 107.909 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.79 -42.78 53.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 122.879 0.472 . . . . 75.040000000000006 112.15 -177.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.09 -42.04 85.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.857 -0.611 . . . . 73.319999999999993 111.287 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.0 p -76.6 -35.65 26.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.401 -0.92 . . . . 73.439999999999998 110.798 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.31 -48.51 77.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.184 -0.916 . . . . 71.219999999999999 111.186 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.12 -35.69 81.59 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 123.039 0.212 . . . . 75.340000000000003 110.973 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -64.65 -53.24 50.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.592 0.558 . . . . 71.329999999999998 109.882 179.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.92 -42.94 99.96 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.007 -0.542 . . . . 64.400000000000006 110.525 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.33 -37.99 89.47 Favored 'General case' 0 C--O 1.184 -2.362 0 CA-C-N 116.061 -0.518 . . . . 71.319999999999993 110.638 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.96 -46.57 89.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.842 0.353 . . . . 73.099999999999994 110.791 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -27.63 37.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 73.25 111.422 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -120.16 24.4 10.46 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.078 -0.649 . . . . 75.310000000000002 109.956 -175.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 495' ' ' LYS . . . -164.51 -110.26 0.23 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 118.507 -1.806 . . . . 54.240000000000002 116.244 -173.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.4 m-85 -116.15 176.73 4.97 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.039 0.447 . . . . 73.230000000000004 111.243 -164.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.7 m -118.63 -17.42 9.27 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.562 -0.745 . . . . 64.310000000000002 110.495 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.84 115.64 30.51 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.758 -0.777 . . . . 73.530000000000001 110.968 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -120.77 135.28 55.19 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.436 -1.257 . . . . 75.219999999999999 108.676 -177.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.0 t -115.86 152.39 33.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.9 -2.259 . . . . 72.549999999999997 104.9 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -121.46 128.72 52.42 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.996 -0.682 . . . . 73.049999999999997 110.809 -175.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.172 -1.418 . . . . 71.099999999999994 107.172 177.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 41.0 m -88.75 125.91 35.09 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.821 -0.627 . . . . 74.109999999999999 109.784 -177.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.88 156.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 176.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -79.55 118.35 21.32 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 113.588 0.959 . . . . 65.519999999999996 113.588 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 12.7 m -60.75 136.56 92.96 Favored Pre-proline 0 N--CA 1.427 -1.606 0 CA-C-N 113.288 -1.778 . . . . 75.209999999999994 110.631 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -78.08 -88.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 108.505 -1.383 . . . . 71.120000000000005 108.505 172.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.434 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 92.7 mtt180 -102.54 -55.99 0.11 Allowed Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 118.788 -0.625 . . . . 74.329999999999998 111.548 171.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 4.3 Cg_exo -75.81 149.96 34.16 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.376 1.384 . . . . 70.400000000000006 110.967 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.61 128.24 38.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.139 -1.06 . . . . 62.25 108.139 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.95 -7.31 17.11 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 110.705 -0.958 . . . . 73.400000000000006 110.705 -178.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.68 147.1 27.11 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.067 -0.716 . . . . 75.120000000000005 109.067 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.26 115.63 20.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.567 -1.642 . . . . 73.420000000000002 106.567 173.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 31.4 m -89.65 -27.45 20.14 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 115.634 -0.712 . . . . 73.409999999999997 109.775 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -177.2 -173.99 43.21 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.959 -1.115 . . . . 72.430000000000007 111.766 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.3 p -134.81 160.32 38.57 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.657 -1.238 . . . . 74.510000000000005 107.657 176.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.53 -54.55 42.34 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.22 0.325 . . . . 74.040000000000006 110.608 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.64 138.45 8.37 Favored 'Trans proline' 0 C--N 1.365 1.403 0 N-CA-C 109.314 -1.071 . . . . 75.219999999999999 109.314 169.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 159.48 46.6 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 121.766 1.644 . . . . 62.539999999999999 111.82 178.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.415 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -60.76 135.1 57.67 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.436 -0.347 . . . . 71.239999999999995 110.27 177.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.65 -29.05 10.91 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 111.038 -0.825 . . . . 65.439999999999998 111.038 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.6 m -73.28 136.84 44.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.048 0.451 . . . . 71.319999999999993 110.863 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -100.78 122.36 43.26 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.478 -0.783 . . . . 74.019999999999996 109.265 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.06 157.59 69.05 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.585 -0.28 . . . . 70.129999999999995 110.474 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.92 134.21 42.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.936 2.424 . . . . 70.340000000000003 113.488 -178.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.7 m -68.06 -21.29 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 111.434 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.22 0.57 51.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.393 -0.821 . . . . 75.420000000000002 110.738 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.4 t -103.52 161.84 13.54 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.45 130.54 44.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.062 -1.088 . . . . 73.209999999999994 108.062 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -95.04 145.95 7.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 110.023 -0.362 . . . . 75.319999999999993 110.023 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -102.64 116.54 32.79 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.57 -0.53 . . . . 75.219999999999999 109.57 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 25.4 tp -95.74 125.04 40.04 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.74 -1.578 . . . . 71.540000000000006 106.74 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -103.94 102.53 12.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.076 0.941 . . . . 74.140000000000001 108.507 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.0 138.19 30.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 114.418 -1.264 . . . . 74.010000000000005 110.368 -173.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 30.2 p -61.88 118.33 7.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.625 -0.88 . . . . 75.540000000000006 108.625 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 107.809 -1.182 . . . . 75.129999999999995 107.809 -176.409 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 121.628 0.728 . . . . 74.329999999999998 109.675 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -82.8 145.45 29.51 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 114.901 -1.045 . . . . 75.549999999999997 109.577 -172.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -131.23 153.24 49.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.38 -0.97 . . . . 74.450000000000003 108.38 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.28 141.27 28.77 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 123.079 0.552 . . . . 63.520000000000003 111.153 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.8 mp -81.12 130.39 63.16 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.728 -0.841 . . . . 74.530000000000001 108.728 175.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.45 160.43 48.59 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.644 2.229 . . . . 74.030000000000001 113.89 -177.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -102.02 0.22 34.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.013 -0.994 . . . . 73.510000000000005 109.971 -179.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.05 1.51 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.775 0.797 . . . . 73.310000000000002 110.665 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.8 m -63.93 -30.31 71.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.793 -1.094 . . . . 62.020000000000003 109.455 177.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.9 t -62.21 -26.57 68.44 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.064 -0.971 . . . . 72.349999999999994 110.316 176.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.18 -46.29 20.92 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.926 -0.71 . . . . 71.049999999999997 109.998 -175.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.429 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 22.7 m -165.59 147.37 7.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.855 -0.794 . . . . 71.209999999999994 108.855 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -50.62 -49.06 57.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.17 0.988 . . . . 74.209999999999994 111.44 174.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.43 -43.9 75.78 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 123.407 0.442 . . . . 74.25 111.363 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.429 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 16.2 mm-40 -61.57 -41.38 97.31 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.143 -0.48 . . . . 74.129999999999995 111.766 -178.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.66 -51.58 68.79 Favored 'General case' 0 CA--C 1.508 -0.662 0 O-C-N 123.898 0.749 . . . . 74.519999999999996 110.216 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.75 -48.36 86.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 114.65 -1.159 . . . . 74.310000000000002 112.087 -175.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.6 mmtp -60.42 -45.43 93.63 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 117.874 0.306 . . . . 74.299999999999997 110.726 -176.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -66.51 -46.23 76.91 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.695 -0.684 . . . . 74.140000000000001 110.502 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.2 tp -69.21 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.22 0.533 . . . . 71.310000000000002 111.476 -177.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.61 -42.89 98.19 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.131 -0.692 . . . . 73.439999999999998 109.131 176.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -18.25 62.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 61.140000000000001 110.801 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.24 59.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.222 0.534 . . . . 74.450000000000003 110.145 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.48 -9.16 15.03 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 120.142 -1.028 . . . . 65.549999999999997 113.702 174.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -77.56 131.78 38.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.898 0.38 . . . . 75.519999999999996 111.169 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.87 12.6 5.34 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.713 -0.955 . . . . 53.240000000000002 110.713 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -118.65 115.97 25.62 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.709 -1.219 . . . . 74.340000000000003 107.709 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -134.91 154.3 51.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.494 0.664 . . . . 75.329999999999998 111.557 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.437 ' HB3' HG13 ' A' ' 485' ' ' ILE . 63.5 tttp -143.04 123.03 13.55 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 106.447 -1.686 . . . . 74.310000000000002 106.447 170.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -91.62 132.79 36.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.545 -0.462 . . . . 71.120000000000005 110.319 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.33 143.84 50.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.674 -0.862 . . . . 71.530000000000001 108.674 176.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -119.79 144.18 47.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.264 -0.643 . . . . 71.120000000000005 109.264 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -141.34 134.97 14.65 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 107.133 -1.432 . . . . 73.030000000000001 107.133 177.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_endo -65.53 122.19 9.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.758 1.639 . . . . 73.540000000000006 109.715 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.4 m -124.72 174.63 7.76 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 116.064 -0.516 . . . . 61.109999999999999 110.269 -176.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -62.81 142.85 97.17 Favored Pre-proline 0 N--CA 1.416 -2.171 0 N-CA-C 107.801 -1.185 . . . . 75.109999999999999 107.801 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.42 -30.93 28.71 Favored 'Trans proline' 0 N--CA 1.473 0.295 0 C-N-CA 123.85 3.033 . . . . 72.120000000000005 113.377 -176.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.8 -27.01 65.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.586 -0.279 . . . . 71.200000000000003 111.429 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.78 -0.53 29.18 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.613 0.598 . . . . 74.329999999999998 112.613 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -61.37 127.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 109.96 -0.385 . . . . 74.430000000000007 109.96 176.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.85 -4.36 71.81 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 112.019 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -114.46 154.21 28.59 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.57 -0.9 . . . . 73.329999999999998 108.57 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.11 134.3 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.122 -0.696 . . . . 74.040000000000006 109.122 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.3 pt -98.08 -20.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.55 -0.46 . . . . 73.439999999999998 110.538 -178.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 166.17 28.76 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.666 -0.778 . . . . 74.329999999999998 111.676 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 37.6 p -120.94 156.23 32.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.716 -0.475 . . . . 75.450000000000003 109.716 178.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -71.59 -48.35 12.12 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.303 -0.408 . . . . 60.119999999999997 111.326 175.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.3 Cg_exo -71.59 140.26 35.72 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 109.04 -1.177 . . . . 72.420000000000002 109.04 170.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.81 142.92 90.68 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.02 2.48 . . . . 73.319999999999993 114.294 -174.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.4 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -91.16 -6.97 52.75 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 74.340000000000003 109.386 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -99.52 -27.98 13.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.578 -0.737 . . . . 73.450000000000003 111.41 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.48 151.33 38.75 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.744 0.306 . . . . 71.409999999999997 110.358 -179.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 55.3 p -74.83 131.48 40.8 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.683 -0.69 . . . . 63.310000000000002 110.538 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.2 m -106.87 151.31 25.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.139 -0.689 . . . . 72.109999999999999 109.139 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.84 152.58 40.2 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.0 -0.741 . . . . 72.219999999999999 109.0 -175.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.52 -17.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.888 0.851 . . . . 62.149999999999999 110.563 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -93.11 7.03 45.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.553 -0.749 . . . . 75.099999999999994 110.008 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.45 140.21 32.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.681 -0.859 . . . . 63.200000000000003 108.681 176.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.03 121.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.895 -1.52 . . . . 61.450000000000003 106.895 176.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.46 117.92 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 C-N-CA 118.976 -1.09 . . . . 72.019999999999996 109.37 -179.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.7 mp -96.49 111.81 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 106.091 -1.818 . . . . 75.030000000000001 106.091 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 123.56 59.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 109.041 -0.725 . . . . 74.239999999999995 109.041 -177.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.19 115.98 46.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.582 -0.736 . . . . 71.310000000000002 109.946 -173.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 30.0 t -96.86 137.98 23.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.659 -0.701 . . . . 73.530000000000001 109.547 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.23 107.6 2.22 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 107.685 -2.166 . . . . 64.319999999999993 107.685 172.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -111.39 150.97 29.03 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.219 0.533 . . . . 63.130000000000003 110.797 -172.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.263 0 N-CA-C 110.146 -1.182 . . . . 75.510000000000005 110.146 177.673 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 121.255 0.55 . . . . 75.239999999999995 109.992 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.1 p -124.89 155.99 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.813 -0.631 . . . . 75.349999999999994 109.808 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -140.89 148.95 41.27 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.09 0.556 . . . . 72.450000000000003 109.805 176.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.62 125.01 29.47 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.944 -1.502 . . . . 53.43 106.944 178.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.0 pt -79.46 132.37 62.36 Favored Pre-proline 0 C--N 1.301 -1.501 0 C-N-CA 120.182 -0.607 . . . . 62.439999999999998 110.738 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -87.22 -171.27 0.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 122.13 1.887 . . . . 71.430000000000007 111.448 177.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.92 99.39 11.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.519 -0.919 . . . . 71.329999999999998 108.519 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.4 t -99.51 -5.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.906 0.86 . . . . 64.540000000000006 108.752 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.84 146.51 49.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.83 -1.077 . . . . 73.510000000000005 110.779 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.5 -20.07 23.35 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 119.888 -1.149 . . . . 74.209999999999994 112.08 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -92.09 -171.44 2.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.456 -0.942 . . . . 74.219999999999999 108.456 177.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 m -84.95 155.22 21.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.124 -1.806 . . . . 73.430000000000007 106.124 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.4 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 10.1 p -64.11 -40.77 90.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 118.514 0.597 . . . . 65.230000000000004 110.984 -177.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 9.4 t70 -64.08 -43.19 96.15 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.403 -0.817 . . . . 65.430000000000007 111.611 178.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.94 -34.98 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.634 -0.826 . . . . 65.319999999999993 111.03 -178.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.62 76.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 73.239999999999995 111.256 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -65.41 -36.77 84.94 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 116.096 -0.502 . . . . 72.129999999999995 110.638 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.5 mptp? -62.7 -49.24 75.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.264 0.352 . . . . 74.109999999999999 111.946 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -63.67 -47.96 79.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.718 -0.393 . . . . 74.120000000000005 110.413 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.8 tp -62.27 -37.05 83.99 Favored 'General case' 0 C--O 1.192 -1.96 0 CA-C-N 115.759 -0.655 . . . . 64.319999999999993 111.313 -176.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.3 t-20 -59.01 -41.26 87.28 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.516 0.726 . . . . 61.409999999999997 110.294 177.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.1 -32.09 31.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.802 -0.635 . . . . 74.219999999999999 111.347 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.08 12.11 25.32 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.006 -0.678 . . . . 71.540000000000006 109.949 -174.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.33 -98.52 0.13 Allowed Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 117.735 -2.174 . . . . 71.239999999999995 117.29 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.657 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 67.2 m-85 -103.13 155.32 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 112.716 0.636 . . . . 74.030000000000001 112.716 -161.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 15.3 p -99.65 -36.19 9.58 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.991 -1.004 . . . . 72.25 112.151 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -108.22 131.93 54.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.269 0.557 . . . . 75.040000000000006 110.365 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.7 147.88 51.53 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.596 -0.729 . . . . 65.040000000000006 110.405 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.86 158.79 43.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.886 -1.153 . . . . 62.240000000000002 107.886 171.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.02 150.23 42.39 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.295 0.569 . . . . 72.200000000000003 111.48 -174.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.59 135.91 53.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.441 -1.689 . . . . 73.540000000000006 106.441 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 1.6 p -88.39 126.8 35.39 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 120.927 0.394 . . . . 73.409999999999997 111.369 -175.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.62 160.92 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 109.934 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.86 113.52 19.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.921 0.867 . . . . 63.530000000000001 112.892 -175.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.8 m -114.54 117.39 42.75 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.386 -1.338 . . . . 75.409999999999997 107.386 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.93 -39.05 15.03 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.96 2.44 . . . . 73.430000000000007 115.331 -171.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.417 ' HG3' ' HD3' ' A' ' 530' ' ' PRO 0.446 7.4 ptm180 -122.19 -88.22 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 115.095 1.516 . . . . 75.349999999999994 115.095 -175.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.417 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 10.9 Cg_exo -75.22 153.51 40.78 Favored 'Trans proline' 0 C--N 1.372 1.768 0 CA-C-N 123.123 2.151 . . . . 65.140000000000001 111.072 173.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -134.94 159.41 41.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 73.349999999999994 108.073 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.33 -17.46 7.01 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.962 -0.855 . . . . 74.109999999999999 110.962 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.495 ' OE2' ' HB3' ' A' ' 556' ' ' SER . 4.3 pm0 -81.95 147.44 29.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 110.1 -0.333 . . . . 71.340000000000003 110.1 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 4.2 p -77.07 115.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 106.839 -1.541 . . . . 75.530000000000001 106.839 173.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.1 m -79.71 -21.21 44.88 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.243 -0.89 . . . . 74.230000000000004 110.529 -174.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.83 -168.69 34.48 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.856 -0.687 . . . . 72.319999999999993 112.101 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.1 p -117.85 160.31 21.62 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.372 -0.974 . . . . 73.129999999999995 108.372 176.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -61.82 -52.91 65.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 121.058 -0.257 . . . . 71.230000000000004 111.404 177.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.5 Cg_exo -83.95 152.75 12.85 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.077 1.185 . . . . 74.510000000000005 109.023 173.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.8 158.55 46.55 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.115 1.877 . . . . 73.349999999999994 112.417 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.41 130.52 46.62 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.131 0.491 . . . . 73.549999999999997 110.243 176.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -14.68 37.55 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 115.92 -0.582 . . . . 72.25 112.063 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 89.8 m -80.6 131.26 35.48 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.606 -0.349 . . . . 72.109999999999999 110.434 177.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.1 t -98.33 127.87 44.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.386 -0.598 . . . . 62.140000000000001 109.386 178.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 517' ' ' PHE . 7.9 m -135.2 158.45 74.66 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.759 -0.83 . . . . 73.209999999999994 108.759 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.1 133.15 34.41 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.819 1.679 . . . . 75.439999999999998 112.41 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.657 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 21.6 m -68.57 -25.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.783 -1.099 . . . . 72.439999999999998 112.306 -176.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.06 -6.35 59.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.926 -1.034 . . . . 74.510000000000005 109.882 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.8 t -92.95 -172.84 3.11 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.673 -0.694 . . . . 73.439999999999998 110.267 -175.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.02 113.23 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.668 -0.696 . . . . 75.319999999999993 110.513 -174.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.7 tt -96.2 142.61 13.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.748 -0.834 . . . . 74.150000000000006 108.748 176.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.01 124.17 48.54 Favored 'General case' 0 N--CA 1.399 -2.986 0 CA-C-O 121.125 0.488 . . . . 74.299999999999997 110.929 -175.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.66 136.03 38.61 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.054 -0.975 . . . . 74.430000000000007 111.719 176.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -91.62 109.41 20.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.599 -1.63 . . . . 73.150000000000006 106.599 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.89 135.6 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.399 0.619 . . . . 74.040000000000006 111.295 -174.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.495 ' HB3' ' OE2' ' A' ' 533' ' ' GLU . 1.8 p -62.58 117.97 6.96 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 124.792 1.237 . . . . 62.420000000000002 112.388 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.427 -1.622 0 N-CA-C 108.746 -0.835 . . . . 75.430000000000007 108.746 178.473 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 480' ' ' ILE . 9.7 pt-20 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.998 0.428 . . . . 75.439999999999998 111.829 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -96.91 122.94 40.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.97 0.414 . . . . 65.400000000000006 110.813 -176.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -120.89 146.85 46.17 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.87 -0.605 . . . . 74.439999999999998 111.97 -179.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.1 141.76 28.31 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.86 -1.064 . . . . 74.010000000000005 109.791 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.35 119.64 77.71 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.414 -0.587 . . . . 75.400000000000006 109.414 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.69 142.48 35.94 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.917 2.412 . . . . 75.129999999999995 111.522 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -88.81 78.47 7.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.811 1.291 . . . . 52.240000000000002 113.494 -176.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.55 4.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.469 -2.048 . . . . 70.299999999999997 105.469 167.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.461 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.0 m -62.16 -41.3 98.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 112.355 -2.202 . . . . 71.150000000000006 109.057 178.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 42.4 m -58.07 -27.01 63.25 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.407 -1.27 . . . . 74.230000000000004 111.243 176.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.09 -46.31 11.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.233 -0.587 . . . . 74.319999999999993 111.035 -174.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.7 m -170.16 154.17 4.87 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.926 -0.768 . . . . 63.439999999999998 108.926 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -51.82 -49.84 62.01 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.255 1.022 . . . . 73.099999999999994 110.05 169.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.97 84.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.288 -0.869 . . . . 64.450000000000003 111.772 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 17.5 mm-40 -61.28 -46.09 91.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.993 -177.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -68.0 -49.47 61.4 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.765 -0.652 . . . . 75.310000000000002 111.34 -178.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.15 -48.2 90.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 123.537 0.523 . . . . 72.040000000000006 111.779 -176.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.14 -45.88 89.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.747 0.308 . . . . 73.109999999999999 111.023 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -67.22 -40.55 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.388 -0.369 . . . . 72.329999999999998 111.364 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.81 -33.03 73.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.189 0.519 . . . . 64.420000000000002 109.876 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 41.1 m -60.12 -44.17 95.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.56 -0.746 . . . . 73.0 109.232 173.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.11 64.4 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.602 -0.726 . . . . 75.439999999999998 111.298 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.15 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.241 0.543 . . . . 74.140000000000001 110.219 178.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.78 -18.66 5.94 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.748 -0.739 . . . . 62.030000000000001 113.308 176.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 445' ' ' THR . 96.3 m-85 -74.35 136.11 42.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 110.584 -177.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.19 -12.61 1.24 Allowed Glycine 0 C--N 1.296 -1.68 0 CA-C-N 115.754 -0.657 . . . . 74.219999999999999 112.356 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -102.51 115.38 30.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.351 -0.611 . . . . 75.329999999999998 109.351 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -128.0 165.18 20.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.703 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 1.9 tmtp? -146.68 124.99 12.24 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.884 -2.265 . . . . 74.540000000000006 104.884 172.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -94.54 128.75 41.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.433 0.635 . . . . 75.420000000000002 111.173 -177.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.78 154.29 45.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.225 -1.028 . . . . 74.439999999999998 108.225 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.31 151.29 47.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.968 -0.382 . . . . 70.319999999999993 109.968 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 54.5 m -140.56 148.41 53.2 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.62 -0.882 . . . . 75.5 108.62 174.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.74 129.32 21.92 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.209 1.94 . . . . 75.519999999999996 111.346 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.8 t -141.46 173.48 11.45 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.74 -0.837 . . . . 74.140000000000001 108.74 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.4 t -66.34 146.64 99.05 Favored Pre-proline 0 N--CA 1.412 -2.332 0 C-N-CA 123.757 0.823 . . . . 74.420000000000002 109.141 177.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.23 -28.88 21.32 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.497 3.465 . . . . 73.120000000000005 113.061 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.854 -0.612 . . . . 74.319999999999993 111.176 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.35 -3.17 29.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.255 0.465 . . . . 74.319999999999993 112.255 -176.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 93.9 t -61.11 127.68 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 177.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.93 -12.0 68.99 Favored Glycine 0 C--N 1.314 -0.681 0 N-CA-C 111.49 -0.644 . . . . 73.019999999999996 111.49 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -101.74 159.5 15.27 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.644 -0.873 . . . . 74.109999999999999 108.644 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 54.6 t -82.32 132.11 32.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 74.409999999999997 108.812 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.9 pt -102.95 -23.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.966 -0.693 . . . . 75.049999999999997 111.69 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.89 157.54 22.74 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 111.564 -0.614 . . . . 61.439999999999998 111.564 178.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.2 p -124.62 147.82 48.27 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.646 -0.501 . . . . 62.539999999999999 109.646 177.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.488 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.6 t-20 -64.48 -50.15 67.52 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.054 -0.498 . . . . 73.230000000000004 110.56 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.0 Cg_exo -72.63 124.99 10.2 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.198 -1.501 . . . . 75.239999999999995 108.198 170.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.21 139.32 65.61 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.646 2.231 . . . . 64.140000000000001 112.874 -175.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.06 -16.26 41.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.857 0.837 . . . . 64.310000000000002 109.508 177.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -78.74 -31.97 46.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.325 -1.307 . . . . 74.129999999999995 109.358 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -108.98 172.44 6.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.536 -0.913 . . . . 74.510000000000005 108.536 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.6 p -98.54 133.72 42.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.549999999999997 108.85 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.2 m -116.16 140.87 48.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.38 -0.6 . . . . 74.120000000000005 109.38 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.07 145.39 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 74.230000000000004 111.659 -178.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -58.52 -31.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 110.643 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.5 t -77.44 8.85 3.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 111.705 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.54 144.64 25.42 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 122.058 -0.401 . . . . 65.040000000000006 110.16 178.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.55 122.32 35.55 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 N-CA-C 108.367 -0.975 . . . . 71.329999999999998 108.367 175.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.4 t -87.87 117.52 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 C-N-CA 119.277 -0.969 . . . . 75.129999999999995 108.722 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.488 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 54.4 mt -99.38 111.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.595 -2.002 . . . . 74.409999999999997 105.595 175.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 125.34 58.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 109.099 -0.704 . . . . 73.140000000000001 109.099 -175.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.5 mp -99.86 116.91 44.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 N-CA-C 109.187 -0.672 . . . . 75.430000000000007 109.187 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.18 143.15 12.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 64.319999999999993 109.061 -177.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.8 114.01 3.96 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.163 -1.975 . . . . 63.439999999999998 108.163 172.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -116.11 153.49 31.66 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.69 -0.855 . . . . 75.310000000000002 108.69 -176.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.218 0 C-N-CA 120.485 -0.864 . . . . 65.019999999999996 111.215 -179.08 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.129 0 CA-C-O 122.002 0.905 . . . . 74.400000000000006 110.691 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 546' ' ' PRO . 25.3 p -131.79 159.81 37.42 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.602 -1.258 . . . . 72.099999999999994 107.602 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -147.61 145.04 28.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.834 -0.747 . . . . 75.340000000000003 110.837 177.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.64 113.11 19.42 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.035 -1.468 . . . . 74.400000000000006 107.035 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 30.7 pt -75.83 127.91 84.55 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 113.112 0.782 . . . . 74.540000000000006 113.112 -173.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -101.21 112.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 122.982 2.455 . . . . 73.530000000000001 111.324 171.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.69 132.11 34.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.219 -0.659 . . . . 74.140000000000001 109.219 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.04 59.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 107.582 -1.266 . . . . 72.349999999999994 107.582 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -57.51 140.6 50.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.156 -1.838 . . . . 72.030000000000001 110.616 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.48 -11.29 30.68 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.673 -0.775 . . . . 41.32 111.264 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.512 ' O ' HG12 ' A' ' 534' ' ' VAL . 26.6 mt-30 -97.5 -171.15 2.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.103 -0.332 . . . . 65.349999999999994 110.103 177.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 12.1 m -84.86 156.75 21.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.842 -1.169 . . . . 75.340000000000003 107.842 -177.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -41.97 93.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.78 0.324 . . . . 74.219999999999999 110.608 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.49 -42.04 95.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.707 -0.679 . . . . 73.019999999999996 110.821 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.88 -34.98 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 119.638 -0.825 . . . . 63.530000000000001 110.721 -177.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.76 85.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.367 -0.833 . . . . 65.430000000000007 111.029 178.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -62.76 -45.95 90.29 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.487 0.492 . . . . 75.129999999999995 109.916 178.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -61.9 -54.03 47.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.603 -0.726 . . . . 72.120000000000005 112.053 -173.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.88 -38.33 88.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.544 -0.463 . . . . 73.010000000000005 110.919 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.71 -43.22 72.86 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 109.422 -0.584 . . . . 75.329999999999998 109.422 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.92 -45.8 89.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.351 0.661 . . . . 74.219999999999999 111.815 -178.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.72 -30.85 49.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 72.25 111.418 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.26 22.44 12.88 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 122.059 -0.401 . . . . 74.239999999999995 110.415 -174.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.74 -101.82 0.17 Allowed Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 117.165 -2.445 . . . . 72.030000000000001 116.514 -172.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 23.3 m-85 -109.6 156.37 20.26 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.513 -0.844 . . . . 72.430000000000007 110.601 -165.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.5 m -107.92 -24.27 11.7 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.762 -0.654 . . . . 71.400000000000006 111.426 -174.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -107.93 115.55 30.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.841 0.353 . . . . 71.400000000000006 110.143 -176.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -117.04 154.54 30.77 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.745 -0.661 . . . . 74.409999999999997 110.383 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.29 155.58 45.96 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.481 -1.674 . . . . 61.520000000000003 106.481 171.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.465 HE22 HD21 ' A' ' 553' ' ' LEU . 11.7 mm100 -119.96 148.3 43.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.294 -1.002 . . . . 74.340000000000003 108.294 -174.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.12 128.5 30.23 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.223 -0.658 . . . . 74.420000000000002 109.223 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -88.02 122.44 31.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.444 -1.317 . . . . 74.209999999999994 107.444 176.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.72 153.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 109.169 -175.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.34 114.59 18.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.436 1.112 . . . . 74.409999999999997 110.883 -175.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.9 p -117.17 120.52 33.51 Favored Pre-proline 0 N--CA 1.408 -2.535 0 CA-C-N 113.799 -1.546 . . . . 72.120000000000005 109.769 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.95 -55.12 3.18 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.766 2.311 . . . . 72.109999999999999 112.818 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.434 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 23.8 mtp180 -99.92 -54.4 0.17 Allowed Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 114.081 1.141 . . . . 75.239999999999995 114.081 177.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 32.1 Cg_exo -60.21 153.27 60.28 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.138 1.892 . . . . 74.329999999999998 113.798 -176.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.05 133.74 9.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.604 -1.258 . . . . 63.399999999999999 107.604 176.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 84.23 -45.16 3.44 Favored Glycine 0 C--N 1.312 -0.754 0 C-N-CA 121.258 -0.496 . . . . 75.450000000000003 113.516 177.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.22 149.68 48.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.248 1.019 . . . . 75.140000000000001 111.406 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 503' ' ' GLN . 9.3 p -75.17 127.35 36.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.193 0.52 . . . . 75.310000000000002 111.073 -174.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -82.19 -22.21 36.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.518 -0.765 . . . . 73.420000000000002 109.226 -178.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 140.67 -149.5 20.99 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.901 -1.28 . . . . 65.150000000000006 109.901 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.0 p -116.94 157.26 26.02 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.766 -1.198 . . . . 74.019999999999996 107.766 176.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.414 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 52.1 t30 -59.44 -53.48 65.48 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.39 -0.338 . . . . 75.200000000000003 111.734 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.9 Cg_exo -77.19 138.84 18.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 108.386 -1.428 . . . . 75.340000000000003 108.386 172.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.07 155.43 69.68 Favored 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 121.958 1.772 . . . . 64.319999999999993 111.948 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -59.09 143.42 48.67 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 110.695 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 94.02 -9.27 72.89 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 120.944 -0.646 . . . . 75.430000000000007 111.853 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 29.5 m -80.16 128.22 33.26 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.218 -0.66 . . . . 75.010000000000005 109.218 177.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 1.8 m -84.88 122.68 29.53 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.712 -1.218 . . . . 73.239999999999995 107.712 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.11 154.72 81.76 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.626 -0.509 . . . . 75.450000000000003 109.626 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.443 ' HA ' HG23 ' A' ' 494' ' ' THR . 21.4 Cg_exo -67.42 133.95 31.79 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.428 2.085 . . . . 75.209999999999994 111.813 -178.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 19.5 m -67.69 -20.48 26.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.166 0.507 . . . . 75.200000000000003 112.08 -177.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.67 -3.04 55.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.83 -0.623 . . . . 73.329999999999998 110.444 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.7 t -95.19 164.99 12.62 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.361 -0.607 . . . . 73.150000000000006 109.361 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.73 136.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.604 -0.517 . . . . 73.340000000000003 109.604 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.5 tt -110.65 138.47 38.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 120.936 0.398 . . . . 74.340000000000003 109.937 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -103.4 127.43 50.76 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 122.771 0.428 . . . . 65.219999999999999 109.85 -178.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.465 HD21 HE22 ' A' ' 522' ' ' GLN . 18.4 tp -100.63 132.96 45.75 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.485 -0.78 . . . . 63.310000000000002 108.899 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -88.88 113.66 24.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.115 -0.698 . . . . 74.319999999999993 109.115 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 47.8 t -103.96 124.16 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 108.542 -0.91 . . . . 64.430000000000007 108.542 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 16.0 m -61.58 121.84 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.302 -0.999 . . . . 55.549999999999997 108.302 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 60.2 tttm . . . . . 0 N--CA 1.42 -1.96 0 CA-C-O 118.462 -0.78 . . . . 74.129999999999995 110.745 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.5 pt-20 . . . . . 0 N--CA 1.442 -0.838 0 CA-C-O 122.116 0.96 . . . . 72.450000000000003 108.641 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -83.53 121.88 27.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.802 -1.09 . . . . 74.109999999999999 109.946 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -121.07 156.92 31.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.096 -1.076 . . . . 71.230000000000004 108.096 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -83.43 140.84 32.13 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 109.844 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -84.71 127.88 63.36 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.318 -0.993 . . . . 70.510000000000005 108.318 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.3 141.59 63.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.887 1.724 . . . . 63.240000000000002 111.93 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -111.31 70.22 0.71 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 122.669 1.224 . . . . 73.230000000000004 108.781 -177.124 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.96 5.92 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 113.779 -1.555 . . . . 65.329999999999998 107.812 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 2.3 m -57.34 -34.62 68.97 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.872 -1.967 . . . . 54.130000000000003 112.428 -177.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.0 t -60.3 -27.06 67.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.156 0.582 . . . . 70.319999999999993 111.557 178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.45 -45.97 18.39 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 120.127 -0.629 . . . . 71.099999999999994 110.21 -172.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.4 m -170.3 149.08 3.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.494 -1.298 . . . . 73.25 107.494 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -53.22 -45.86 68.84 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.555 0.535 . . . . 74.019999999999996 110.389 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.13 74.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.52 -0.764 . . . . 71.420000000000002 111.867 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -61.35 -44.87 96.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.269 -0.423 . . . . 72.420000000000002 111.048 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -62.79 -51.05 68.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.831 -0.622 . . . . 61.329999999999998 110.766 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -62.95 -48.86 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.662 -0.699 . . . . 75.200000000000003 111.97 -175.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.06 -41.49 90.7 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 121.107 -0.237 . . . . 75.420000000000002 111.353 -177.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.445 ' HZ1' ' HB2' ' A' ' 443' ' ' LYS . 0.0 OUTLIER -66.65 -39.12 88.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.244 0.545 . . . . 72.239999999999995 109.887 -179.434 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.51 -40.32 80.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.671 -0.695 . . . . 74.319999999999993 109.904 177.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.4 m -59.47 -46.5 88.62 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.637 -0.71 . . . . 71.430000000000007 109.107 176.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.34 65.9 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.443 -0.799 . . . . 72.239999999999995 111.437 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.61 -14.01 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 74.450000000000003 111.023 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.03 -14.92 21.3 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.108 -1.044 . . . . 64.430000000000007 113.046 175.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -69.81 130.15 41.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.608 -0.516 . . . . 74.420000000000002 109.608 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.19 -23.92 6.48 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.894 -0.669 . . . . 61.229999999999997 111.704 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -103.01 115.79 31.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.831 0.824 . . . . 73.349999999999994 112.458 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -146.83 141.74 26.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.405 -1.27 . . . . 74.329999999999998 110.112 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -131.39 123.22 27.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.548 -0.751 . . . . 71.519999999999996 109.089 -174.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -85.78 135.35 33.76 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.003 -0.544 . . . . 74.239999999999995 110.576 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.68 147.7 52.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.396 -1.705 . . . . 74.310000000000002 106.396 171.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -114.4 149.2 36.53 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.438 -0.505 . . . . 70.349999999999994 109.808 -178.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -140.63 133.49 14.63 Favored Pre-proline 0 N--CA 1.422 -1.862 0 N-CA-C 108.01 -1.107 . . . . 72.310000000000002 108.01 -178.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.0 125.09 14.06 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.656 2.237 . . . . 74.030000000000001 111.93 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 31.4 t -139.26 179.5 6.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 -178.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.4 t -57.64 140.37 80.59 Favored Pre-proline 0 N--CA 1.432 -1.336 0 C-N-CA 123.213 0.605 . . . . 65.540000000000006 110.327 177.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.58 -29.61 25.57 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 124.312 3.342 . . . . 74.310000000000002 113.573 -178.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.58 -10.59 59.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.58 0.585 . . . . 70.049999999999997 112.58 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.6 8.11 35.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.525 0.565 . . . . 74.319999999999993 112.525 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.4 p -60.68 128.1 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.796 0.331 . . . . 72.409999999999997 110.453 179.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.54 87.62 Favored Glycine 0 C--O 1.252 1.26 0 C-N-CA 120.847 -0.692 . . . . 73.409999999999997 112.214 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -113.61 146.06 40.31 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.19 -1.041 . . . . 74.219999999999999 108.19 177.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 45.8 t -81.94 144.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.943 -0.391 . . . . 64.120000000000005 109.943 -176.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.6 pt -98.21 -19.0 6.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.142 0.496 . . . . 74.239999999999995 110.503 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.24 178.36 37.67 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 111.191 -0.764 . . . . 72.219999999999999 111.191 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 27.8 p -119.59 145.99 45.91 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.415 -0.587 . . . . 73.409999999999997 109.415 178.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.88 -52.1 74.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 123.266 0.353 . . . . 70.519999999999996 111.103 178.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.68 143.41 23.9 Favored 'Trans proline' 0 C--N 1.366 1.493 0 N-CA-C 108.89 -1.235 . . . . 73.319999999999993 108.89 170.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.94 153.11 79.49 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 122.459 2.106 . . . . 71.040000000000006 112.355 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -87.15 -20.07 27.55 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.424 -0.807 . . . . 72.340000000000003 110.262 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 -32.12 15.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.089 -0.959 . . . . 74.519999999999996 112.117 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -94.57 145.57 24.72 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.234 -0.986 . . . . 72.200000000000003 108.613 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 28.6 p -83.87 128.71 34.74 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 116.327 -0.397 . . . . 71.209999999999994 110.513 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 m -114.03 145.11 42.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.073 -1.084 . . . . 63.340000000000003 108.073 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.412 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.46 142.0 58.31 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.663 0.268 . . . . 55.450000000000003 111.542 -176.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 425' ' ' GLU . 50.2 mm -57.75 -25.84 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.779 0.832 . . . . 74.109999999999999 110.578 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -79.56 3.61 18.33 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.971 -0.559 . . . . 74.439999999999998 111.226 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.412 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -95.52 157.77 15.75 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.975 -0.453 . . . . 74.409999999999997 110.241 179.272 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.39 122.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.962 -1.125 . . . . 71.540000000000006 107.962 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.25 119.38 36.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.616 -0.512 . . . . 71.549999999999997 109.616 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.31 121.81 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.588 -1.264 . . . . 74.209999999999994 107.588 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.95 121.29 66.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 115.626 -0.715 . . . . 75.450000000000003 109.277 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.73 118.36 49.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 121.808 0.813 . . . . 75.540000000000006 112.511 -178.283 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.77 145.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.883 -1.053 . . . . 73.530000000000001 109.1 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.77 117.31 4.63 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 110.477 -1.049 . . . . 71.129999999999995 110.477 176.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 7.3 p -99.57 128.66 45.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 107.486 -1.302 . . . . 64.299999999999997 107.486 174.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 C-N-CA 120.213 -0.994 . . . . 71.519999999999996 112.057 -174.93 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.827 0 N-CA-C 107.44 -1.318 . . . . 73.0 107.44 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.9 p -122.61 158.77 29.23 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 115.538 -0.755 . . . . 75.540000000000006 109.847 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -135.65 141.63 45.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.323 -0.398 . . . . 75.349999999999994 110.76 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.07 127.1 32.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.723 -1.214 . . . . 75.209999999999994 107.723 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.97 129.79 80.0 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 115.87 -0.605 . . . . 74.239999999999995 111.863 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -94.26 124.28 0.43 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.769 2.313 . . . . 55.030000000000001 112.471 173.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.18 135.43 36.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 174.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 t -125.28 33.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.754 0.787 . . . . 75.510000000000005 108.928 -176.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -61.28 116.16 4.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 72.140000000000001 110.771 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.57 -23.92 5.01 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.651 -0.785 . . . . 72.299999999999997 112.244 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.31 -179.17 3.87 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.712 -0.847 . . . . 65.540000000000006 108.712 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 25.7 m -84.09 155.7 22.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 119.928 -0.709 . . . . 71.230000000000004 109.652 -172.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.06 -41.31 68.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.787 0.435 . . . . 74.109999999999999 111.199 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.64 -42.06 87.3 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.535 -0.757 . . . . 75.349999999999994 111.59 -178.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.06 -36.37 56.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 118.952 -1.099 . . . . 75.129999999999995 110.631 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.16 74.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.942 -1.026 . . . . 74.120000000000005 111.56 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.35 -35.24 79.74 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 123.116 0.26 . . . . 63.109999999999999 110.676 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -63.54 -49.15 74.61 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.332 0.395 . . . . 75.209999999999994 111.918 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -68.88 -38.27 79.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.897 0.379 . . . . 72.319999999999993 110.472 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.4 -44.67 95.89 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 115.84 -0.618 . . . . 74.0 110.065 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.0 t-20 -59.54 -47.69 84.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.413 0.685 . . . . 71.0 111.989 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.69 -20.0 17.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.169 -0.469 . . . . 63.310000000000002 112.04 -175.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -116.61 4.02 13.14 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 120.034 -0.666 . . . . 73.040000000000006 111.13 -178.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.73 -96.64 0.2 Allowed Glycine 0 N--CA 1.41 -3.089 0 C-N-CA 118.806 -1.664 . . . . 75.420000000000002 115.763 -169.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 9.6 m-85 -129.74 158.4 39.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.278 -0.461 . . . . 72.439999999999998 110.292 -165.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -104.95 -2.21 24.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.609 -0.885 . . . . 65.329999999999998 108.609 177.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.73 115.61 30.41 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 72.040000000000006 109.462 -175.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -126.24 152.42 46.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.603 0.716 . . . . 72.230000000000004 111.786 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -133.59 148.82 51.62 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.629 -1.619 . . . . 75.319999999999993 106.629 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.27 123.25 42.72 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.691 -1.226 . . . . 72.420000000000002 107.691 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.86 126.53 54.92 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.78 -1.192 . . . . 74.219999999999999 107.78 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -91.92 120.45 32.6 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.019 -0.734 . . . . 74.150000000000006 109.019 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.39 151.51 24.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.568 -1.271 . . . . 74.319999999999993 107.568 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.473 ' HA ' ' OXT' ' A' ' 557' ' ' LYS . 12.6 m-20 -79.05 128.22 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.024 0.916 . . . . 70.310000000000002 113.411 -170.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.4 m -143.4 111.7 5.47 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.84 -1.541 . . . . 74.230000000000004 106.84 177.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -56.17 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.048 2.498 . . . . 62.420000000000002 114.568 -174.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -82.34 -44.78 0.98 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 114.715 1.376 . . . . 73.140000000000001 114.715 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 533' ' ' GLU . 72.6 Cg_exo -57.07 133.76 59.94 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.352 1.368 . . . . 72.230000000000004 110.803 174.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -143.09 127.21 17.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.587 -0.279 . . . . 74.129999999999995 110.652 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.0 -11.28 55.2 Favored Glycine 0 N--CA 1.469 0.858 0 CA-C-O 121.372 0.429 . . . . 62.450000000000003 113.024 175.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 530' ' ' PRO . 11.4 pt-20 -86.78 150.89 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.505 0.722 . . . . 74.319999999999993 110.976 178.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 47.8 t -74.71 124.64 32.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.226 -1.028 . . . . 75.129999999999995 108.226 178.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 28.8 m -83.38 -33.64 25.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 71.519999999999996 108.44 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.05 -167.12 39.92 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.834 -0.621 . . . . 65.120000000000005 111.655 177.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.5 p -118.97 160.38 22.1 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.579 -0.897 . . . . 72.400000000000006 108.579 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.516 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.9 t-20 -57.8 -56.77 31.13 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 119.274 -0.394 . . . . 74.239999999999995 111.95 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.3 Cg_endo -89.38 166.05 5.37 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.833 1.688 . . . . 62.450000000000003 109.506 174.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.28 152.55 55.75 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.295 1.996 . . . . 70.5 111.974 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.14 135.94 57.73 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.862 0.465 . . . . 65.230000000000004 110.351 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.47 37.16 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.99 -0.624 . . . . 72.129999999999995 111.564 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.6 m -67.89 131.56 45.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.483 -0.562 . . . . 74.230000000000004 109.483 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.3 t -100.02 123.72 44.58 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.994 0.902 . . . . 75.140000000000001 110.971 -177.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.69 158.93 60.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 73.040000000000006 108.465 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.62 143.78 98.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.237 1.958 . . . . 74.439999999999998 110.894 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.32 -21.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.246 0.461 . . . . 73.329999999999998 112.246 -176.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.97 -2.77 58.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.325 -0.398 . . . . 75.329999999999998 111.034 178.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -81.21 152.58 27.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.18 -0.674 . . . . 52.219999999999999 109.18 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.06 125.5 42.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.312 -0.625 . . . . 73.150000000000006 109.312 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.2 tt -97.25 139.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.122 -0.325 . . . . 74.439999999999998 110.122 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -102.85 120.27 40.3 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 120.902 0.382 . . . . 65.239999999999995 110.119 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 tt -100.89 130.18 46.86 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.423 -1.325 . . . . 73.25 107.423 176.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.8 mt-30 -101.21 109.51 21.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.661 0.743 . . . . 75.340000000000003 110.186 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.18 139.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.448 -1.251 . . . . 75.120000000000005 111.598 -175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -57.14 121.05 9.13 Favored 'General case' 0 C--O 1.25 1.108 0 C-N-CA 123.825 0.85 . . . . 70.010000000000005 112.973 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.473 ' OXT' ' HA ' ' A' ' 526' ' ' ASP . 28.4 ttpp . . . . . 0 N--CA 1.432 -1.367 0 C-N-CA 124.951 1.301 . . . . 72.5 108.362 175.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 107.866 -1.161 . . . . 63.229999999999997 107.866 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.422 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 96.6 mt-30 -83.47 149.09 26.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.649 -1.614 . . . . 74.409999999999997 108.396 178.472 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.464 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 17.6 tpp180 -120.92 155.33 34.44 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.528 -1.286 . . . . 74.329999999999998 107.528 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.39 141.48 31.7 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.49 -0.93 . . . . 72.239999999999995 108.49 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -80.07 127.4 77.03 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.018 -1.475 . . . . 65.430000000000007 107.018 177.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.27 139.93 32.99 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 109.431 -1.027 . . . . 74.140000000000001 109.431 175.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -115.28 72.04 0.78 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.889 1.328 . . . . 73.319999999999993 109.93 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.14 14.68 7.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 113.552 -1.658 . . . . 74.340000000000003 107.1 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.508 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.3 m -52.39 -41.29 63.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 127.637 2.375 . . . . 75.219999999999999 110.395 178.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.3 t -56.43 -26.71 54.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.003 1.321 . . . . 74.510000000000005 112.017 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.4 mt -85.85 -46.92 10.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.118 -1.033 . . . . 63.200000000000003 111.048 -174.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 20.1 m -174.23 153.7 2.05 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.535 -0.913 . . . . 75.420000000000002 108.535 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.487 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 40.3 t80 -50.55 -50.68 52.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.142 0.977 . . . . 74.340000000000003 111.009 171.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.48 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.757 0.661 . . . . 64.420000000000002 111.461 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -61.49 -45.98 91.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.317 -0.402 . . . . 73.430000000000007 111.463 -178.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -63.38 -48.36 78.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.87 -0.605 . . . . 65.439999999999998 110.967 -178.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.18 -46.59 90.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.894 -0.594 . . . . 72.430000000000007 112.238 -176.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -66.55 -41.55 88.49 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.488 0.181 . . . . 71.400000000000006 111.488 -178.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.08 -38.99 86.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.458 -0.497 . . . . 75.219999999999999 111.179 176.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.516 HD21 ' CE2' ' A' ' 452' ' ' PHE . 33.5 tp -67.11 -36.61 82.29 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.251 0.548 . . . . 75.120000000000005 110.041 178.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.2 m -59.49 -44.72 93.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.459 -0.791 . . . . 73.239999999999995 109.582 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.68 -18.65 62.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.44 -0.8 . . . . 73.329999999999998 111.181 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.16 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.228 0.537 . . . . 72.439999999999998 110.903 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.06 -25.77 9.74 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.813 -0.708 . . . . 60.009999999999998 113.454 174.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 96.2 m-85 -57.42 130.7 47.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.038 0.535 . . . . 72.319999999999993 112.0 -176.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.0 26.29 4.79 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.398 -0.906 . . . . 72.439999999999998 112.849 -178.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -132.91 115.59 15.43 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.235 -1.024 . . . . 75.010000000000005 108.235 178.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.516 ' CE2' HD21 ' A' ' 444' ' ' LEU . 27.6 m-85 -128.93 150.11 50.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.575 0.702 . . . . 71.420000000000002 111.731 -174.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.484 ' HB2' HG13 ' A' ' 485' ' ' ILE . 36.3 mmtm -136.24 130.62 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.646 -1.983 . . . . 75.540000000000006 105.646 169.374 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -108.26 124.72 50.74 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.703 -0.799 . . . . 74.519999999999996 110.83 -175.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.05 145.01 48.56 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.934 -0.575 . . . . 63.119999999999997 109.547 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -118.88 134.54 55.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.436 -1.32 . . . . 70.540000000000006 107.436 175.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.1 t -122.29 137.23 27.3 Favored Pre-proline 0 C--N 1.283 -2.284 0 N-CA-C 108.479 -0.934 . . . . 75.409999999999997 108.479 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.11 122.17 9.86 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.847 1.698 . . . . 72.040000000000006 110.801 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 40.5 m -134.07 178.7 6.76 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.353 -0.98 . . . . 74.400000000000006 108.353 -177.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.7 t -74.0 151.26 88.39 Favored Pre-proline 0 N--CA 1.403 -2.804 0 N-CA-C 107.651 -1.24 . . . . 74.329999999999998 107.651 176.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.493 ' O ' HG13 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -50.42 -28.91 22.44 Favored 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 124.121 3.214 . . . . 74.0 112.718 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.97 -26.25 68.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.121 -0.49 . . . . 74.049999999999997 111.344 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.34 -0.42 35.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.81 1.041 . . . . 75.530000000000001 113.81 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -60.81 128.13 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 119.962 -0.695 . . . . 74.140000000000001 110.696 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.24 -12.77 67.8 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 121.12 -0.562 . . . . 74.400000000000006 112.654 177.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.27 139.72 38.35 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.732 -0.47 . . . . 73.209999999999994 109.732 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 61.6 t -82.49 128.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.767 -0.651 . . . . 75.219999999999999 109.628 -178.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.47 -6.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.937 0.399 . . . . 74.450000000000003 112.019 -176.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.29 160.92 15.43 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.939 -1.125 . . . . 75.400000000000006 112.829 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.0 p -118.95 142.29 47.91 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.255 -1.017 . . . . 71.519999999999996 108.255 176.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.7 t-20 -54.74 -51.58 77.68 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 112.387 0.514 . . . . 72.129999999999995 112.387 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.5 Cg_exo -77.2 124.13 7.05 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 N-CA-C 108.158 -1.516 . . . . 75.140000000000001 108.158 169.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.32 142.17 65.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.326 2.017 . . . . 75.120000000000005 112.037 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.504 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.21 -14.65 61.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.144 0.973 . . . . 45.43 110.697 -177.152 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.27 -9.98 55.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.731 -1.577 . . . . 71.409999999999997 111.33 -176.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -120.84 151.06 40.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.945 -0.761 . . . . 64.230000000000004 108.945 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 10.7 p -84.44 132.7 34.54 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 108.807 -0.812 . . . . 73.109999999999999 108.807 176.513 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.6 m -122.2 145.71 47.94 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.358 -0.608 . . . . 73.409999999999997 109.358 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.402 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -59.55 154.64 16.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.439 . . . . 74.530000000000001 111.001 179.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.1 -25.42 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.796 0.807 . . . . 74.349999999999994 110.603 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.4 t -94.54 11.48 30.79 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.014 -0.994 . . . . 71.109999999999999 110.921 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.74 141.35 39.34 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 121.697 -0.627 . . . . 72.530000000000001 109.853 176.47 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.57 117.33 25.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.609 0.719 . . . . 74.540000000000006 110.075 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.44 118.61 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.734 -0.839 . . . . 74.140000000000001 108.734 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.495 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 2.5 mp -96.5 117.83 41.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 105.411 -2.07 . . . . 71.129999999999995 105.411 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.72 119.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 109.068 -0.715 . . . . 73.540000000000006 109.068 -176.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.53 114.26 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.942 -0.572 . . . . 75.540000000000006 110.528 -175.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 17.5 t -95.99 136.59 26.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.688 -0.856 . . . . 63.539999999999999 108.688 -178.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.44 125.08 6.8 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.815 -1.714 . . . . 73.150000000000006 108.815 175.072 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -128.63 129.84 46.44 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 109.12 -0.696 . . . . 73.409999999999997 109.12 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.85 0 N-CA-C 109.104 -1.598 . . . . 74.0 109.104 178.361 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.165 0 CA-C-O 122.147 0.975 . . . . 70.129999999999995 109.591 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 546' ' ' PRO . 17.9 p -137.1 154.11 50.38 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.644 -1.243 . . . . 74.340000000000003 107.644 -176.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -138.64 150.0 45.78 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.562 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.36 113.73 26.7 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.02 -1.104 . . . . 74.109999999999999 108.02 -179.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.6 134.84 21.37 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 113.443 0.905 . . . . 71.239999999999995 113.443 -174.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.4 -178.15 1.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.767 2.311 . . . . 70.129999999999995 109.04 170.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.69 153.64 18.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.091 -0.707 . . . . 70.150000000000006 109.091 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.65 33.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 104.937 -2.246 . . . . 72.430000000000007 104.937 175.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.89 147.45 33.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.794 -1.548 . . . . 72.439999999999998 111.327 -173.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 103.65 -12.98 53.96 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.64 -0.984 . . . . 43.539999999999999 110.64 -177.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.12 179.92 4.08 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.72 156.15 26.4 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.647 -0.421 . . . . 64.239999999999995 109.941 -170.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.1 p -54.3 -43.7 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.383 0.512 . . . . 75.299999999999997 112.383 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.64 -41.91 78.74 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.332 0.493 . . . . 64.340000000000003 112.332 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.83 -38.9 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 119.47 -0.892 . . . . 75.25 111.524 -174.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.38 80.93 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.61 -0.723 . . . . 71.530000000000001 111.39 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -64.82 -34.68 78.93 Favored 'General case' 0 C--O 1.205 -1.282 0 O-C-N 123.214 0.321 . . . . 71.519999999999996 110.394 -177.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -59.5 -52.48 65.4 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.495 -0.557 . . . . 74.329999999999998 109.495 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -66.86 -44.72 80.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.457 -0.792 . . . . 72.099999999999994 110.704 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.47 -37.0 82.03 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 115.915 -0.584 . . . . 71.510000000000005 110.531 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.81 -38.15 77.98 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.552 0.741 . . . . 74.5 110.942 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -37.62 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.718 -0.674 . . . . 74.430000000000007 111.267 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -122.74 33.83 5.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.713 0.768 . . . . 72.430000000000007 111.455 -176.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -153.39 -128.52 1.29 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.98 -1.009 . . . . 62.240000000000002 111.553 -178.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 44.7 m-85 -105.66 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.053 0.454 . . . . 71.239999999999995 110.319 -173.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.6 p -110.03 -3.63 16.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.577 -0.738 . . . . 74.230000000000004 110.902 178.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 550' ' ' VAL . 28.2 mtpp -113.77 115.73 28.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.84 -0.8 . . . . 74.239999999999995 108.84 -177.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.83 156.46 43.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.152 0.501 . . . . 74.209999999999994 111.456 -175.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -140.99 156.62 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.017 -1.475 . . . . 75.219999999999999 107.017 171.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -121.75 124.87 45.24 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.385 -0.598 . . . . 74.409999999999997 109.385 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.82 140.63 48.78 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.529 -0.915 . . . . 75.230000000000004 108.529 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 20.0 m -88.18 124.81 34.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.974 -0.557 . . . . 60.549999999999997 110.704 -176.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.562 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 33.2 m -121.17 156.8 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.954 -1.128 . . . . 74.450000000000003 107.954 176.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.88 142.4 38.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.999 0.904 . . . . 72.209999999999994 112.048 -170.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 p -118.17 135.29 23.43 Favored Pre-proline 0 N--CA 1.413 -2.294 0 CA-C-N 114.264 -1.334 . . . . 72.439999999999998 110.187 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.55 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.275 0 N-CA-C 109.075 -1.163 . . . . 64.519999999999996 109.075 171.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.494 ' HG3' ' HD3' ' A' ' 530' ' ' PRO . 23.2 ptt180 -127.43 -47.07 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 114.72 1.378 . . . . 74.450000000000003 114.72 176.572 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.494 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 84.7 Cg_endo -76.54 135.89 16.8 Favored 'Trans proline' 0 C--N 1.385 2.45 0 CA-C-N 121.763 1.665 . . . . 73.120000000000005 112.107 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -137.32 145.44 43.41 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.955 -0.387 . . . . 73.519999999999996 109.955 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 100.21 -18.83 54.97 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.899 -0.48 . . . . 74.329999999999998 111.899 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.43 148.4 24.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.638 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.73 122.45 28.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.289 -0.869 . . . . 75.340000000000003 109.472 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.3 m -92.68 -10.01 38.78 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.788 -1.096 . . . . 75.140000000000001 109.348 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -159.12 27.98 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 110.774 -0.931 . . . . 75.430000000000007 110.774 177.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -134.36 157.75 45.59 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.698 -1.223 . . . . 71.5 107.698 177.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -52.68 -58.72 10.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.861 -0.59 . . . . 52.350000000000001 110.908 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.51 140.53 15.13 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 120.464 1.202 . . . . 63.100000000000001 109.063 170.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.47 155.8 65.9 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 121.935 1.757 . . . . 73.239999999999995 112.193 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.53 136.14 57.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.944 -0.571 . . . . 73.340000000000003 109.914 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -5.36 57.04 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.088 -1.053 . . . . 62.299999999999997 111.815 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 16.7 m -89.2 137.72 32.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.446 -0.575 . . . . 74.319999999999993 109.446 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 26.7 m -98.8 123.04 42.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.244 -1.021 . . . . 63.049999999999997 108.244 175.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.74 161.96 57.97 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 110.054 -0.351 . . . . 71.519999999999996 110.054 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.401 ' HA ' HG23 ' A' ' 494' ' ' THR . 20.7 Cg_exo -66.33 137.79 48.57 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.02 2.48 . . . . 61.009999999999998 113.995 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.538 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 15.0 m -67.86 -20.45 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.005 0.907 . . . . 72.040000000000006 111.248 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.45 -5.15 58.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.446 -1.252 . . . . 73.400000000000006 110.456 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -103.72 152.25 22.05 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.69 -1.226 . . . . 74.049999999999997 107.69 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 519' ' ' LYS . 38.8 t -88.71 136.2 23.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.859 -0.423 . . . . 73.510000000000005 109.859 -177.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.0 tt -95.88 135.49 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.352 0.596 . . . . 73.200000000000003 109.408 176.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.59 120.61 40.59 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.379 -0.971 . . . . 74.409999999999997 108.379 -177.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.0 tp -95.5 126.58 40.89 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.811 -1.086 . . . . 72.0 108.472 -177.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -89.53 105.64 17.93 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.632 -0.877 . . . . 75.310000000000002 108.632 -177.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.48 134.49 47.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 120.789 0.328 . . . . 72.310000000000002 110.667 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.7 p -66.35 121.46 15.3 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.044 -0.525 . . . . 75.310000000000002 109.743 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 20.6 pttp . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 115.557 -0.747 . . . . 75.510000000000005 110.626 -177.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.775 0.797 . . . . 64.239999999999995 109.521 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -101.39 147.89 25.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.162 -1.051 . . . . 62.420000000000002 108.162 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 18.4 tpt180 -120.72 158.82 26.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.966 0.413 . . . . 75.400000000000006 110.166 -175.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.3 141.47 29.22 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.149 0.979 . . . . 75.340000000000003 110.41 -176.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.0 mp -87.85 121.49 70.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.617 -1.623 . . . . 74.200000000000003 106.617 173.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.74 141.83 55.86 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.091 1.861 . . . . 73.420000000000002 112.898 -175.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.58 11.64 23.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.74 -0.663 . . . . 74.430000000000007 110.767 -178.192 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.416 HG22 ' HG3' ' A' ' 443' ' ' LYS . 21.5 m -73.27 -9.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.701 -0.851 . . . . 74.209999999999994 108.701 176.177 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.518 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 18.0 m -57.23 -38.2 73.44 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.329 -1.305 . . . . 75.129999999999995 109.866 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.1 m -60.02 -27.56 67.0 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.779 -1.1 . . . . 70.239999999999995 110.647 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.8 mt -79.85 -47.63 14.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.382 -0.927 . . . . 74.430000000000007 109.975 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 49.8 m -166.01 145.77 6.27 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.682 -0.858 . . . . 74.5 108.682 177.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -55.29 -44.5 75.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.468 0.707 . . . . 72.439999999999998 111.914 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.19 -43.29 78.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.447 . . . . 74.120000000000005 110.881 177.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.9 mm-40 -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 71.439999999999998 110.534 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -59.54 -51.39 70.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.98 -1.009 . . . . 72.409999999999997 110.95 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.31 -48.52 88.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 114.851 -1.068 . . . . 73.129999999999995 111.784 -176.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.16 -46.11 90.43 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.154 0.428 . . . . 74.120000000000005 112.154 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.416 ' HG3' HG22 ' A' ' 432' ' ' VAL . 74.5 mmtt -66.98 -42.71 84.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.847 0.356 . . . . 75.129999999999995 111.267 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.81 80.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 75.109999999999999 111.026 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 49.2 m -62.35 -45.57 92.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.204 -0.665 . . . . 70.109999999999999 109.204 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.88 62.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.593 -0.73 . . . . 62.149999999999999 111.054 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -79.33 -13.8 59.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.010000000000005 110.2 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.91 -9.82 15.84 Favored Glycine 0 CA--C 1.494 -1.229 0 C-N-CA 120.072 -1.061 . . . . 75.049999999999997 113.209 173.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -80.35 136.6 36.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.58 -0.526 . . . . 73.340000000000003 109.58 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.04 -1.82 6.71 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 120.405 -0.903 . . . . 53.420000000000002 112.603 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -112.65 115.96 29.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.523 -0.918 . . . . 74.349999999999994 108.523 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -131.0 152.08 50.7 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.319 -0.4 . . . . 74.230000000000004 110.173 -174.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -135.8 122.59 21.11 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.457 -1.312 . . . . 71.310000000000002 107.457 170.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -97.68 133.37 42.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.151 0.501 . . . . 75.530000000000001 110.21 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.31 138.96 54.33 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.264 -1.384 . . . . 74.109999999999999 107.264 175.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.09 136.64 53.16 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.695 -0.854 . . . . 72.200000000000003 108.695 177.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.1 p -128.2 144.49 51.93 Favored Pre-proline 0 C--N 1.289 -2.048 0 N-CA-C 109.779 -0.452 . . . . 61.219999999999999 109.779 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -64.93 123.46 11.65 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.12 1.88 . . . . 75.239999999999995 109.85 175.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.7 m -142.06 178.16 7.72 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.5 -0.926 . . . . 74.519999999999996 108.5 -177.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -58.76 141.71 84.74 Favored Pre-proline 0 C--O 1.253 1.272 0 C-N-CA 123.295 0.638 . . . . 75.519999999999996 111.431 178.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.46 -28.58 28.4 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.982 3.788 . . . . 73.129999999999995 113.382 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -75.39 -11.26 60.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.785 0.661 . . . . 73.25 112.785 -178.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 83.4 mt -111.0 6.36 20.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.978 0.362 . . . . 71.329999999999998 111.978 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 49.1 t -61.21 127.34 20.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 121.125 -0.23 . . . . 74.099999999999994 110.804 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.24 87.75 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 116.11 -0.496 . . . . 73.030000000000001 112.467 176.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 28.4 mtpp -106.75 142.13 36.89 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.113 -1.069 . . . . 73.219999999999999 108.113 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.428 HG23 HD12 ' A' ' 486' ' ' ILE . 60.8 t -81.76 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.408 -0.59 . . . . 72.230000000000004 109.408 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 20.2 pt -98.25 -10.08 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.085 -0.507 . . . . 75.040000000000006 111.652 -176.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 162.15 21.34 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.64 -0.79 . . . . 75.049999999999997 112.153 177.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 25.4 p -130.09 150.31 51.41 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.021 -1.103 . . . . 75.239999999999995 108.021 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.61 -52.9 61.6 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 119.325 -0.369 . . . . 74.310000000000002 111.855 176.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.99 140.81 38.85 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 120.836 1.024 . . . . 63.439999999999998 110.073 173.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.02 145.69 85.81 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.253 2.636 . . . . 71.0 113.248 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -90.95 -17.39 26.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.331 1.062 . . . . 71.450000000000003 109.122 178.15 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -92.92 -19.14 21.94 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.616 -1.175 . . . . 74.439999999999998 110.114 -176.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -118.97 150.94 39.07 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.14 -0.482 . . . . 64.340000000000003 110.378 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.7 p -85.99 127.2 34.59 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.513 -0.312 . . . . 74.420000000000002 111.226 -178.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.0 m -111.27 151.24 28.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.475 0.71 . . . . 75.540000000000006 109.777 -176.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.489 ' HB1' ' ND2' ' A' ' 482' ' ' ASN . . . -60.43 142.92 54.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 72.129999999999995 111.811 -178.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.89 -30.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.765 1.226 . . . . 73.049999999999997 111.275 -176.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -83.95 0.75 46.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.073 -0.512 . . . . 74.329999999999998 111.604 -175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.489 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -73.44 145.08 46.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 112.465 0.543 . . . . 74.510000000000005 112.465 -177.843 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.7 p -84.46 125.78 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.627 -0.879 . . . . 73.120000000000005 108.627 172.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.0 118.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 109.032 -0.729 . . . . 74.510000000000005 109.032 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.72 115.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 105.804 -1.924 . . . . 75.230000000000004 105.804 174.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.428 HD12 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.39 125.46 70.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.408 -0.815 . . . . 64.439999999999998 109.932 -174.234 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.33 120.75 55.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.083 0.468 . . . . 75.140000000000001 110.107 -177.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.8 t -102.84 140.39 21.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 CA-C-N 115.642 -0.708 . . . . 74.040000000000006 109.67 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.0 122.73 5.84 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 109.238 -1.545 . . . . 75.219999999999999 109.238 173.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.4 p -122.29 137.27 54.91 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.109 -0.7 . . . . 53.439999999999998 109.109 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.412 ' N ' HG21 ' A' ' 464' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.803 0 C-N-CA 120.141 -1.028 . . . . 74.140000000000001 111.464 -176.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.695 0 N-CA-C 107.939 -1.134 . . . . 71.530000000000001 107.939 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.5 p -125.33 166.05 17.26 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.335 -0.848 . . . . 74.519999999999996 111.242 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -149.57 147.13 27.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.741 0.817 . . . . 75.5 110.191 176.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 30.4 t70 -96.08 127.05 41.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.137 -1.06 . . . . 72.310000000000002 108.137 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.49 121.81 83.14 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 112.231 0.456 . . . . 74.340000000000003 112.231 -175.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.19 146.29 14.1 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.995 1.797 . . . . 65.439999999999998 110.437 175.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.81 121.01 17.25 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.362 -0.607 . . . . 75.299999999999997 109.362 179.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.01 19.09 3.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.68 1.228 . . . . 74.129999999999995 108.249 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.21 112.25 19.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.421 -1.263 . . . . 74.140000000000001 109.525 -176.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.98 -28.39 1.71 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.66 -0.976 . . . . 73.5 110.66 -178.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -86.46 178.57 7.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.425 -0.954 . . . . 71.450000000000003 108.425 177.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 155.95 28.55 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.154 -1.054 . . . . 55.119999999999997 108.154 -174.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.8 p -51.76 -45.9 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.608 0.595 . . . . 61.329999999999998 112.608 -176.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 510' ' ' LYS . 25.4 t70 -67.57 -42.76 82.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.22 0.325 . . . . 65.140000000000001 111.545 -178.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.92 -39.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 119.537 -0.865 . . . . 74.019999999999996 111.678 -175.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.3 71.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.465 -0.789 . . . . 63.25 112.284 179.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.02 -35.6 81.71 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 120.138 -0.625 . . . . 74.510000000000005 110.333 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 510' ' ' LYS . 33.1 ttmt -60.67 -48.15 83.07 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.951 0.782 . . . . 75.409999999999997 109.331 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -62.62 -43.7 98.14 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.438 -0.801 . . . . 72.530000000000001 110.689 178.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.25 -43.06 92.54 Favored 'General case' 0 C--O 1.188 -2.16 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 109.45 -178.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -58.74 -37.71 76.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.037 0.935 . . . . 72.510000000000005 111.76 -178.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 510' ' ' LYS . 98.0 t -66.05 -37.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 112.512 0.56 . . . . 73.349999999999994 112.512 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -112.19 -15.4 13.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.24 -0.584 . . . . 75.230000000000004 111.896 -173.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -106.14 -110.31 3.48 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 115.541 -0.754 . . . . 74.040000000000006 113.324 -175.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.535 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 21.0 m-85 -123.94 175.43 6.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.092 0.472 . . . . 73.120000000000005 110.992 -172.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.9 p -109.42 -3.45 17.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.362 -0.835 . . . . 74.219999999999999 110.477 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.42 115.72 30.64 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.008 -0.738 . . . . 74.25 109.008 -176.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.78 149.28 50.79 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 123.576 0.547 . . . . 63.409999999999997 110.846 -176.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.6 m -136.36 143.54 44.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.21 -1.774 . . . . 73.310000000000002 106.21 171.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -121.78 136.78 54.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 118.019 0.372 . . . . 73.319999999999993 110.157 -177.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.409 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -126.48 131.02 51.73 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.445 -0.946 . . . . 64.510000000000005 108.445 177.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.3 p -88.88 133.6 34.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.094 0.473 . . . . 72.030000000000001 112.167 -176.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.16 163.1 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.95 -1.5 . . . . 75.200000000000003 106.95 175.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.499 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 10.9 p-10 -78.29 137.32 38.02 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.047 0.451 . . . . 75.430000000000007 109.829 -175.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 8.2 m -97.94 108.23 45.14 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.157 -172.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 30.0 Cg_endo -90.92 -90.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 122.449 2.099 . . . . 73.219999999999999 110.332 172.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -84.18 -48.63 0.68 Allowed Pre-proline 0 N--CA 1.439 -1.008 0 C-N-CA 120.177 -0.609 . . . . 74.030000000000001 111.518 171.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.536 ' HA ' ' OE2' ' A' ' 533' ' ' GLU . 78.4 Cg_exo -58.74 134.1 58.36 Favored 'Trans proline' 0 C--N 1.374 1.918 0 CA-C-N 120.19 1.104 . . . . 75.019999999999996 110.488 169.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.46 116.26 3.87 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 123.192 0.308 . . . . 72.340000000000003 110.796 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.17 -15.16 35.03 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 121.997 0.776 . . . . 73.219999999999999 111.64 178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.536 ' OE2' ' HA ' ' A' ' 530' ' ' PRO . 13.9 pt-20 -87.55 150.04 23.96 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 125.315 1.446 . . . . 74.430000000000007 110.939 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.2 t -73.15 122.4 25.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 107.68 -1.23 . . . . 70.230000000000004 107.68 178.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.8 m -87.8 -24.68 23.67 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.007 -0.997 . . . . 74.439999999999998 110.593 -174.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.01 -163.28 37.02 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.906 -0.878 . . . . 64.420000000000002 110.906 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.9 p -140.7 160.22 40.51 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 72.519999999999996 107.964 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.45 -60.27 11.11 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 119.243 -0.408 . . . . 75.510000000000005 110.786 178.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.13 139.86 19.39 Favored 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 120.189 1.103 . . . . 72.540000000000006 109.265 172.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.12 153.94 52.0 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.976 1.784 . . . . 75.049999999999997 112.229 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.71 131.77 51.28 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.475 -0.565 . . . . 74.200000000000003 109.475 176.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.25 -5.77 36.12 Favored Glycine 0 C--N 1.299 -1.49 0 N-CA-C 110.464 -1.054 . . . . 71.299999999999997 110.464 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -88.41 125.33 34.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.517 -0.549 . . . . 71.420000000000002 109.517 174.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.1 m -101.6 123.49 45.69 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.426 -0.953 . . . . 74.219999999999999 108.426 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.31 164.49 42.95 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.636 -0.505 . . . . 73.510000000000005 109.636 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.65 147.84 85.31 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.605 2.203 . . . . 75.299999999999997 111.436 176.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.535 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.2 m -66.86 -19.19 25.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.624 0.601 . . . . 74.319999999999993 112.624 -178.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.67 3.51 44.4 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.899 -0.591 . . . . 73.120000000000005 110.968 176.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.0 t -80.89 139.65 35.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.965 -0.754 . . . . 73.019999999999996 108.965 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.77 115.93 29.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.138 -0.689 . . . . 74.409999999999997 109.138 -179.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.4 tt -88.0 134.53 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.61 0.719 . . . . 75.219999999999999 111.039 -177.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.72 122.12 43.32 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 107.43 -1.322 . . . . 64.040000000000006 107.43 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.18 127.42 55.58 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.636 -1.165 . . . . 75.25 108.648 -175.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 5.7 mm-40 -92.41 109.53 20.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.963 -0.754 . . . . 74.209999999999994 108.963 -174.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.95 138.38 26.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 74.040000000000006 111.572 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 p -71.53 125.25 26.57 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.935 -1.505 . . . . 73.540000000000006 106.935 171.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.264 1.867 0 CA-C-N 115.646 -0.706 . . . . 74.109999999999999 111.246 -172.845 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 480' ' ' ILE . 11.1 pt-20 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 122.014 0.912 . . . . 73.310000000000002 109.657 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -121.12 134.73 55.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.548 -1.279 . . . . 74.209999999999994 107.548 175.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -125.15 158.93 32.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.353 -0.61 . . . . 72.299999999999997 109.353 -176.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.64 142.49 30.76 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 123.715 0.806 . . . . 74.400000000000006 109.581 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -79.59 130.06 69.28 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 107.876 -1.157 . . . . 73.329999999999998 107.876 178.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 149.52 49.87 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.912 1.742 . . . . 73.030000000000001 111.967 178.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -114.9 72.96 0.81 Allowed 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 122.054 0.93 . . . . 74.549999999999997 110.355 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.6 4.67 5.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.119 -1.808 . . . . 73.409999999999997 106.119 175.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.01 -32.89 74.35 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 112.754 -2.021 . . . . 70.450000000000003 110.93 -176.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 t -61.44 -27.23 68.41 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.415 -0.812 . . . . 51.210000000000001 111.122 176.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.13 -46.32 15.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.159 -1.416 . . . . 72.420000000000002 110.416 -174.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 9.5 m -166.01 147.36 6.83 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.662 -0.866 . . . . 74.239999999999995 108.662 177.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.25 -45.54 65.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.954 0.902 . . . . 74.310000000000002 111.154 172.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.0 74.6 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.909 0.484 . . . . 73.209999999999994 110.869 178.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.555 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 12.2 mm-40 -66.29 -41.19 90.15 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.511 -0.768 . . . . 72.120000000000005 110.611 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.61 -50.12 75.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.913 -0.585 . . . . 64.310000000000002 110.407 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.56 -48.21 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.541 -0.754 . . . . 74.319999999999993 111.554 -176.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -60.95 -46.67 89.76 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.473 0.546 . . . . 74.230000000000004 112.473 -177.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.6 mptp? -67.38 -38.92 85.48 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 121.029 -0.269 . . . . 72.209999999999994 111.489 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -39.74 86.59 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.244 0.545 . . . . 74.150000000000006 109.889 178.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -59.4 -45.76 90.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.286 -0.87 . . . . 73.25 109.41 176.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.28 62.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.76 -0.654 . . . . 72.109999999999999 111.689 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -13.08 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 71.420000000000002 110.265 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.14 -16.1 25.22 Favored Glycine 0 CA--C 1.494 -1.253 0 C-N-CA 120.842 -0.694 . . . . 52.009999999999998 113.039 173.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.97 121.18 14.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.156 0.503 . . . . 74.340000000000003 111.035 -177.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.6 -2.73 40.48 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.411 -0.813 . . . . 75.109999999999999 111.6 178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -120.85 114.93 22.31 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.202 0.525 . . . . 75.109999999999999 110.176 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -148.26 148.36 30.38 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.321 -0.854 . . . . 73.319999999999993 111.083 178.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.503 ' HZ2' ' HB2' ' A' ' 453' ' ' LYS . 5.1 ttmp? -131.09 129.18 41.57 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.326 -0.99 . . . . 75.530000000000001 108.326 -178.022 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -93.33 124.82 37.58 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.417 0.448 . . . . 72.340000000000003 110.656 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 150.56 42.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.465 -1.309 . . . . 61.140000000000001 107.465 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.87 141.17 49.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.508 -0.923 . . . . 75.349999999999994 108.508 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 13.4 t -127.96 137.67 31.3 Favored Pre-proline 0 N--CA 1.416 -2.158 0 N-CA-C 109.007 -0.738 . . . . 55.399999999999999 109.007 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.97 123.66 11.93 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.488 2.125 . . . . 72.519999999999996 111.045 179.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 m -138.94 179.47 6.47 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.846 -1.539 . . . . 75.230000000000004 106.846 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 15.4 t -60.53 141.81 91.57 Favored Pre-proline 0 N--CA 1.422 -1.85 0 N-CA-C 108.385 -0.969 . . . . 61.229999999999997 108.385 175.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.85 -29.29 26.12 Favored 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 124.176 3.251 . . . . 74.400000000000006 113.721 -176.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -75.5 -13.97 60.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.708 0.632 . . . . 75.540000000000006 112.708 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.42 2.38 55.69 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 122.157 -0.34 . . . . 64.409999999999997 111.845 179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -60.75 128.43 21.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.258 0.551 . . . . 72.239999999999995 110.436 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.26 -12.94 67.61 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 120.834 -0.698 . . . . 75.329999999999998 111.774 178.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -98.76 139.97 33.65 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 60.7 t -82.27 138.89 18.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.119 -1.067 . . . . 75.129999999999995 108.119 176.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 32.3 pt -98.38 -29.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 120.033 -0.667 . . . . 74.439999999999998 111.227 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.82 168.76 40.89 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.345 -1.407 . . . . 63.200000000000003 112.502 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 34.2 p -117.64 143.32 46.26 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.27 -0.641 . . . . 73.010000000000005 109.27 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.472 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.3 t-20 -60.16 -49.77 89.28 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.578 0.584 . . . . 71.25 112.578 177.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.4 Cg_exo -81.97 144.59 13.61 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.03 1.153 . . . . 73.340000000000003 109.203 172.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.55 145.01 41.32 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.34 2.026 . . . . 74.219999999999999 111.237 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.422 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -79.86 -18.25 51.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.522 -0.763 . . . . 75.109999999999999 110.09 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -77.4 -27.44 52.42 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.931 -1.031 . . . . 75.150000000000006 113.019 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -100.76 160.89 13.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.222 -1.029 . . . . 72.219999999999999 108.222 175.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.2 p -97.94 126.04 43.15 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 109.414 -0.587 . . . . 65.329999999999998 109.414 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 142.82 34.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.491 -0.929 . . . . 62.109999999999999 108.491 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -56.49 153.22 10.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.568 0.581 . . . . 75.409999999999997 112.568 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.2 mm -61.51 -30.02 47.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.434 0.635 . . . . 74.450000000000003 110.149 178.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 8.31 39.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 65.409999999999997 111.128 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.09 149.4 26.93 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.148 -1.056 . . . . 71.450000000000003 108.148 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.38 117.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.845 0.831 . . . . 73.439999999999998 111.382 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.1 t -92.44 119.92 40.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.359 -0.837 . . . . 62.420000000000002 109.545 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.472 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.61 116.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.766 -1.568 . . . . 74.129999999999995 106.766 175.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.13 126.16 58.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.715 -0.675 . . . . 72.120000000000005 109.327 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 26.7 mt -104.49 115.61 46.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.776 -0.647 . . . . 74.420000000000002 110.224 -173.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.14 136.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.231 -0.655 . . . . 73.310000000000002 109.231 -177.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.43 124.67 6.56 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 109.096 -1.602 . . . . 72.439999999999998 109.096 175.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.5 m -135.31 140.78 45.39 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.138 -0.69 . . . . 71.099999999999994 109.138 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.866 0 C-N-CA 120.162 -1.018 . . . . 35.140000000000001 110.651 179.261 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.252 0 CA-C-O 122.081 0.944 . . . . 71.219999999999999 109.493 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.407 HG23 ' HA ' ' A' ' 546' ' ' PRO . 46.6 p -136.02 152.93 51.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.705 -1.134 . . . . 74.239999999999995 108.165 -177.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -141.22 153.4 45.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.085 -0.339 . . . . 74.25 110.085 177.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -93.91 138.54 31.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.123 -0.489 . . . . 72.120000000000005 110.128 179.083 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.0 pt -94.79 129.19 36.82 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 116.123 -0.49 . . . . 74.299999999999997 111.049 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.1 174.12 13.33 Favored 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.355 2.037 . . . . 73.540000000000006 110.779 172.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.97 128.86 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 71.200000000000003 111.123 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.45 -9.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.502 0.668 . . . . 71.200000000000003 110.275 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.56 136.23 47.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.514 -0.766 . . . . 73.510000000000005 112.142 -174.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.5 -16.1 29.33 Favored Glycine 0 CA--C 1.492 -1.363 0 C-N-CA 120.784 -0.722 . . . . 73.540000000000006 111.578 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.16 177.99 7.02 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 110.149 -0.315 . . . . 75.230000000000004 110.149 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.1 155.84 18.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.709 -1.219 . . . . 75.540000000000006 107.709 -177.068 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.69 -46.69 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.086 0.773 . . . . 72.109999999999999 113.086 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.85 -41.82 74.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.28 0.474 . . . . 74.299999999999997 112.28 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.52 -34.4 29.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.608 -0.837 . . . . 74.329999999999998 110.737 -175.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.62 85.06 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.928 -1.033 . . . . 51.020000000000003 110.134 177.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.37 -35.99 82.68 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.084 -0.507 . . . . 74.329999999999998 111.456 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.76 -51.54 61.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.834 -0.346 . . . . 75.340000000000003 110.776 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 514' ' ' VAL . 62.2 m-20 -68.3 -39.7 81.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 109.978 -177.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.59 -37.31 87.13 Favored 'General case' 0 C--O 1.181 -2.527 0 CA-C-N 116.277 -0.42 . . . . 75.109999999999999 110.142 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -58.94 -39.85 82.85 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.039 0.536 . . . . 62.520000000000003 111.535 -178.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 511' ' ' ASN . 7.7 p -74.18 -31.28 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 120.149 -0.62 . . . . 62.229999999999997 112.197 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.73 -33.76 9.72 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.982 0.896 . . . . 74.409999999999997 110.897 -175.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -92.74 -112.74 2.07 Favored Glycine 0 N--CA 1.416 -2.645 0 CA-C-N 114.301 -1.318 . . . . 65.230000000000004 113.933 -172.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 57.5 m-85 -130.61 175.97 8.57 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.759 -0.46 . . . . 74.099999999999994 109.759 -170.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 m -98.03 -25.71 14.86 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.233 -0.439 . . . . 72.209999999999994 112.076 -173.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.66 123.16 48.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.871 -0.732 . . . . 72.310000000000002 110.839 -177.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.74 146.09 34.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.153 -0.931 . . . . 70.519999999999996 109.867 -176.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.5 m -126.88 149.5 49.73 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.323 -1.732 . . . . 65.209999999999994 106.323 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.51 131.37 54.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.623 -0.51 . . . . 74.209999999999994 109.623 -174.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.3 52.27 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.969 -1.123 . . . . 71.329999999999998 107.969 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.7 m -103.45 129.35 50.56 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.854 0.359 . . . . 71.329999999999998 110.708 -176.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.0 m -122.47 156.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 110.145 178.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.95 142.48 27.76 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.755 . . . . 63.399999999999999 109.422 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 37.9 t -137.13 140.34 30.91 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 106.556 -1.646 . . . . 74.340000000000003 106.556 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.12 -72.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.815 2.343 . . . . 75.310000000000002 113.167 -176.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 529' ' ' ARG 0.285 30.9 mmt180 -116.47 -54.97 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.653 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 178.19 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.59 133.84 56.97 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.174 1.249 . . . . 65.030000000000001 110.855 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.93 4.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.698 -0.482 . . . . 71.439999999999998 109.698 -178.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.48 -25.52 2.98 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.439 -1.064 . . . . 74.510000000000005 110.439 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.63 150.27 23.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.633 0.773 . . . . 73.409999999999997 110.454 177.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.13 120.0 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 106.879 -1.526 . . . . 75.540000000000006 106.879 175.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 21.2 m -70.04 -27.59 64.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.976 -1.011 . . . . 75.019999999999996 109.851 -175.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.68 24.88 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 110.297 -1.121 . . . . 73.310000000000002 110.297 177.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.2 p -129.87 161.33 31.05 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 107.753 -1.203 . . . . 74.219999999999999 107.753 178.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.1 t-20 -61.64 -52.58 68.34 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 120.654 -0.418 . . . . 75.120000000000005 110.131 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_exo -79.85 127.35 6.99 Favored 'Trans proline' 0 C--N 1.364 1.351 0 N-CA-C 108.459 -1.4 . . . . 72.0 108.459 170.041 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.06 154.45 73.99 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.151 1.901 . . . . 65.120000000000005 112.229 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -52.03 132.6 32.85 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.078 0.551 . . . . 75.209999999999994 111.282 179.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.85 -25.29 21.24 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 111.05 -0.82 . . . . 74.310000000000002 111.05 -176.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.1 m -65.7 135.59 55.17 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.21 0.528 . . . . 72.219999999999999 110.73 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.7 m -94.97 123.61 38.54 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.239 -1.393 . . . . 73.430000000000007 107.239 177.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 517' ' ' PHE . 20.5 t -123.22 152.21 63.49 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 107.012 -1.477 . . . . 72.129999999999995 107.012 -176.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 494' ' ' THR . 51.9 Cg_exo -59.87 140.03 91.11 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 73.430000000000007 112.077 174.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.493 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 23.8 m -67.62 -21.34 27.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.397 0.617 . . . . 51.350000000000001 111.685 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -88.89 3.59 50.81 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.027 -0.988 . . . . 73.109999999999999 110.756 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -97.25 154.23 17.53 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.267 -0.642 . . . . 75.430000000000007 109.267 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.77 137.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.838 -0.801 . . . . 74.010000000000005 108.838 177.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.7 tp -93.16 129.89 43.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.48 -0.563 . . . . 75.239999999999995 109.48 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -103.0 116.57 32.8 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 122.798 0.439 . . . . 74.420000000000002 110.712 -176.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.31 134.28 39.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.323 -0.853 . . . . 65.349999999999994 111.111 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -96.97 108.51 21.25 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 73.25 107.529 178.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.67 138.37 29.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 120.428 0.156 . . . . 74.319999999999993 111.223 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.7 p -72.64 119.8 17.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.338 -0.615 . . . . 65.439999999999998 109.338 179.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 C--N 1.294 -1.836 0 CA-C-N 115.87 -0.605 . . . . 75.140000000000001 109.539 -177.033 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 122.032 0.92 . . . . 75.019999999999996 109.042 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.416 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 92.5 mt-30 -83.11 152.08 25.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.546 -1.206 . . . . 75.400000000000006 110.734 -176.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -127.56 157.62 39.66 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.458 -1.312 . . . . 75.530000000000001 107.458 177.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.45 141.55 31.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 123.588 0.555 . . . . 74.430000000000007 110.13 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.9 mp -79.66 130.83 66.3 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.097 -1.075 . . . . 75.450000000000003 108.097 177.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -64.61 141.0 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.833 1.688 . . . . 74.349999999999994 112.314 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.59 9.01 43.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.583 -0.735 . . . . 75.349999999999994 110.362 -177.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.41 7.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.016 0.913 . . . . 74.25 110.656 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.492 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 3.2 p -60.72 -38.7 85.96 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 125.324 1.45 . . . . 64.319999999999993 110.514 177.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.1 t -60.7 -26.66 67.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.124 -0.943 . . . . 75.310000000000002 111.278 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 51.8 mt -81.88 -46.42 14.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.11 -0.636 . . . . 73.299999999999997 110.224 -174.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 21.0 m -167.94 150.21 5.56 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.819 -1.178 . . . . 74.129999999999995 107.819 177.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.37 -48.71 68.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.139 173.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.61 71.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.626 0.77 . . . . 75.120000000000005 112.094 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -61.68 -45.72 92.79 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.297 -0.411 . . . . 74.230000000000004 111.584 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -66.62 -45.74 78.13 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.92 -47.53 89.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.832 0 O-C-N 123.822 0.701 . . . . 64.299999999999997 112.388 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.09 -47.42 86.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.617 0.246 . . . . 73.209999999999994 111.661 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.62 -42.31 86.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.408 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.65 -38.38 80.42 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 75.010000000000005 110.562 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 46.8 m -63.26 -42.5 99.17 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.865 -0.607 . . . . 72.540000000000006 109.578 175.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.11 -18.48 64.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.044 -0.526 . . . . 74.049999999999997 110.561 177.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.92 -13.96 58.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.1 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.99 -14.05 26.46 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.851 -0.69 . . . . 71.120000000000005 112.991 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.59 130.08 41.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.71 0.291 . . . . 72.200000000000003 110.525 -178.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.38 11.11 6.81 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.236 -0.746 . . . . 73.140000000000001 111.236 178.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.04 115.43 29.44 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.052 -1.462 . . . . 75.0 107.052 -178.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -136.76 147.49 46.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.662 -0.415 . . . . 73.340000000000003 111.043 -174.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -132.14 122.75 25.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.254 -1.387 . . . . 75.329999999999998 107.254 169.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -103.72 128.94 51.03 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.866 -0.42 . . . . 63.439999999999998 109.866 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -129.86 144.04 51.11 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.187 -1.412 . . . . 74.519999999999996 107.187 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.03 135.79 53.63 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.447 -0.946 . . . . 73.109999999999999 108.447 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.3 m -116.44 138.57 24.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.669 -0.863 . . . . 64.310000000000002 108.669 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.9 122.31 10.09 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.063 1.842 . . . . 63.43 110.416 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.454 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 25.1 t -143.66 -179.18 6.29 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 105.914 -1.884 . . . . 71.099999999999994 105.914 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.1 t -66.07 132.99 94.66 Favored Pre-proline 0 N--CA 1.416 -2.175 0 CA-C-O 121.071 0.462 . . . . 71.129999999999995 109.886 176.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.73 -28.51 30.29 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.917 3.078 . . . . 71.340000000000003 112.039 176.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.87 -17.33 63.06 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.738 -0.665 . . . . 74.010000000000005 112.103 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.65 13.39 19.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.177 -0.327 . . . . 73.510000000000005 111.698 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.9 p -57.47 128.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 73.209999999999994 111.572 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.47 -12.92 59.92 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.626 -0.797 . . . . 61.140000000000001 112.131 177.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -92.84 139.78 30.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.179 -0.675 . . . . 62.329999999999998 109.179 176.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 61.5 t -82.47 134.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.992 -0.744 . . . . 72.019999999999996 108.992 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.0 pt -97.31 -7.41 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.251 -0.58 . . . . 73.510000000000005 110.73 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 167.81 25.86 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.656 -0.783 . . . . 53.32 111.651 175.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.5 p -120.43 149.47 42.33 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.893 -1.151 . . . . 74.109999999999999 107.893 176.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.425 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -65.05 -52.94 45.3 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-O 119.248 -0.406 . . . . 73.230000000000004 111.079 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.6 Cg_exo -73.93 139.58 27.52 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 108.8 -1.269 . . . . 71.099999999999994 108.8 172.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.47 141.31 66.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.578 2.185 . . . . 65.0 112.63 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.32 -11.86 55.63 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.204 -0.907 . . . . 54.140000000000001 110.164 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -94.56 -24.77 17.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 111.458 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.86 174.16 5.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.08 -0.648 . . . . 73.230000000000004 109.538 177.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.416 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 19.1 p -101.18 144.33 30.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.967 -0.561 . . . . 75.209999999999994 109.776 178.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.3 m -127.85 148.8 50.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.708 -0.849 . . . . 73.049999999999997 108.708 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 152.29 42.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 110.061 -0.348 . . . . 74.340000000000003 110.061 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.03 -12.74 16.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.859 0.838 . . . . 74.219999999999999 111.213 -173.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -90.18 1.12 56.79 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.844 -0.616 . . . . 74.349999999999994 110.923 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.52 141.76 41.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.01 0.433 . . . . 71.019999999999996 111.977 -177.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.76 115.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.79 -1.189 . . . . 72.120000000000005 107.79 176.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.48 119.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.587 -0.845 . . . . 75.420000000000002 108.931 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.5 mp -99.4 123.23 51.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.239 -1.763 . . . . 74.430000000000007 106.239 175.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.38 123.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 109.327 -0.62 . . . . 74.450000000000003 109.327 -177.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -103.52 117.54 49.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 CA-C-O 121.76 0.79 . . . . 71.519999999999996 111.802 178.749 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 20.1 t -96.61 140.47 17.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.872 -1.058 . . . . 74.219999999999999 109.335 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.42 116.8 4.38 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.29 -1.524 . . . . 70.420000000000002 109.29 174.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -126.64 129.95 49.5 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 107.36 -1.348 . . . . 73.129999999999995 107.36 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.418 -2.526 0 C-N-CA 119.464 -1.35 . . . . 65.400000000000006 111.373 -178.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.874 0.845 . . . . 75.439999999999998 109.545 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 546' ' ' PRO . 14.5 p -137.94 157.55 46.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.693 -1.14 . . . . 64.400000000000006 108.735 -177.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.25 147.48 32.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.949 0.404 . . . . 72.040000000000006 110.652 178.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.6 p-10 -84.71 131.82 34.53 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.161 -0.927 . . . . 74.439999999999998 108.54 175.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.9 pt -76.47 134.7 69.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.712 -0.676 . . . . 73.140000000000001 110.843 -177.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.13 167.43 9.38 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.565 2.177 . . . . 74.420000000000002 109.778 173.088 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.02 141.88 28.34 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.631 -1.248 . . . . 74.340000000000003 107.631 176.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.62 13.84 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-O 121.986 0.898 . . . . 73.299999999999997 110.492 -174.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.58 147.52 29.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.398 -0.819 . . . . 71.209999999999994 111.649 -175.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 91.48 11.81 60.41 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 111.099 -0.8 . . . . 71.030000000000001 111.099 177.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.469 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 22.5 mt-30 -119.89 178.42 4.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.8 0.334 . . . . 75.209999999999994 111.831 -176.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.679 -1.23 . . . . 75.209999999999994 107.679 -176.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.05 -41.65 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 117.833 0.288 . . . . 73.040000000000006 111.381 -177.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.04 -42.51 80.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.549 0.574 . . . . 65.400000000000006 112.549 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 11.2 p -73.67 -34.94 42.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 118.98 -1.088 . . . . 75.530000000000001 110.16 -176.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -63.36 -49.9 72.06 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.941 -1.027 . . . . 61.219999999999999 111.157 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -65.13 -37.5 87.63 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 116.264 -0.426 . . . . 75.299999999999997 110.642 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -65.59 -53.6 39.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.107 0.41 . . . . 74.450000000000003 112.107 178.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -62.42 -39.0 91.86 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.078 0.466 . . . . 71.340000000000003 110.596 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.59 -47.66 62.77 Favored 'General case' 0 C--O 1.187 -2.192 0 CA-C-N 115.884 -0.598 . . . . 71.349999999999994 110.575 178.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.38 -41.19 98.79 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.448 0.536 . . . . 74.040000000000006 112.448 -176.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.05 -29.11 43.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.335 0.495 . . . . 74.109999999999999 112.335 -177.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.88 -26.37 6.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.204 -0.998 . . . . 73.230000000000004 111.798 -174.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.65 -98.92 2.38 Favored Glycine 0 N--CA 1.41 -3.065 0 CA-C-N 115.26 -0.882 . . . . 73.049999999999997 114.533 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 50.1 m-85 -133.68 160.11 38.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.761 0.315 . . . . 61.32 110.487 -167.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 p -103.63 -7.9 20.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.586 -0.734 . . . . 73.129999999999995 112.004 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.48 119.92 40.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.725 -0.472 . . . . 75.329999999999998 109.725 -176.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -126.3 153.47 44.77 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.595 0.712 . . . . 71.209999999999994 111.533 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.5 m -141.16 153.71 45.49 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.928 -1.508 . . . . 64.239999999999995 106.928 169.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -121.65 132.31 54.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 118.28 0.491 . . . . 74.409999999999997 110.956 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.14 136.14 53.44 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.068 -1.456 . . . . 72.409999999999997 107.068 174.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 25.9 m -98.53 133.49 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.948 0.404 . . . . 62.219999999999999 110.491 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.13 163.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.42 -0.955 . . . . 53.119999999999997 108.42 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.17 140.08 38.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.262 0.553 . . . . 70.239999999999995 110.213 -174.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.0 p -103.17 118.23 58.43 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.402 -0.817 . . . . 73.150000000000006 113.015 -172.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -80.62 -75.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.829 1.686 . . . . 74.540000000000006 109.226 172.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -107.79 -52.73 0.07 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.751 -0.642 . . . . 74.439999999999998 112.472 171.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.81 134.21 45.74 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 120.644 1.266 . . . . 73.430000000000007 111.355 175.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.62 126.53 7.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.066 -1.087 . . . . 74.510000000000005 108.066 178.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.21 -29.33 7.72 Favored Glycine 0 C--N 1.308 -0.979 0 N-CA-C 111.372 -0.691 . . . . 73.439999999999998 111.372 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.93 149.78 26.84 Favored 'General case' 0 C--O 1.255 1.361 0 C-N-CA 123.232 0.613 . . . . 74.310000000000002 110.044 176.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 508' ' ' ALA . 80.4 t -74.31 126.92 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.891 0 CA-C-O 121.527 0.68 . . . . 73.010000000000005 109.554 -173.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.6 m -92.15 -12.65 32.28 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 110.136 -175.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.73 -150.77 19.99 Favored Glycine 0 N--CA 1.425 -2.069 0 C-N-CA 120.1 -1.048 . . . . 65.150000000000006 112.815 174.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 17.9 p -118.16 161.5 19.77 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 124.591 1.156 . . . . 75.319999999999993 109.254 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.9 t-20 -61.33 -57.12 27.69 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 119.298 -0.382 . . . . 72.510000000000005 111.094 176.217 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.2 Cg_exo -83.41 156.29 14.38 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.224 1.282 . . . . 74.209999999999994 109.852 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.14 158.83 48.61 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.042 1.828 . . . . 74.109999999999999 112.196 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.89 133.81 54.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.204 0.601 . . . . 75.230000000000004 111.045 178.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.98 -19.64 32.4 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.805 -0.712 . . . . 51.119999999999997 111.676 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.0 m -65.56 123.84 20.76 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.676 -0.49 . . . . 53.409999999999997 109.676 177.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 41.6 m -94.03 123.81 37.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 109.944 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.8 157.01 72.84 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 70.129999999999995 108.978 177.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 494' ' ' THR . 51.4 Cg_exo -58.7 146.01 93.71 Favored 'Trans proline' 0 CA--C 1.519 -0.24 0 C-N-CA 122.929 2.419 . . . . 64.239999999999995 111.619 177.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 32.4 m -66.75 -20.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.434 0.635 . . . . 75.209999999999994 111.767 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -91.11 3.85 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.345 -0.843 . . . . 61.340000000000003 111.38 176.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -83.06 152.06 25.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.939 -0.763 . . . . 74.109999999999999 108.939 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.58 119.2 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.02 -1.104 . . . . 72.140000000000001 108.02 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -89.83 141.64 14.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.189 0.518 . . . . 74.329999999999998 110.139 -177.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.0 121.78 43.25 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 121.618 0.723 . . . . 75.319999999999993 110.228 -176.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.7 134.54 39.83 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.207 1.403 . . . . 74.409999999999997 108.954 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -103.83 115.91 31.32 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.246 -0.888 . . . . 62.009999999999998 109.244 -177.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.18 129.83 75.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 116.107 -0.497 . . . . 74.200000000000003 111.061 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 68.2 m -74.52 116.67 15.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.347 -0.983 . . . . 72.430000000000007 108.347 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.446 -0.797 . . . . 73.510000000000005 108.955 -175.988 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.599 0.714 . . . . 74.439999999999998 110.023 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 78.2 mt-30 -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 114.95 -1.023 . . . . 74.209999999999994 110.577 -177.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -129.88 156.76 43.87 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.078 -1.082 . . . . 74.430000000000007 108.078 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.43 143.16 27.37 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.167 0.432 . . . . 73.040000000000006 112.167 -178.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.53 130.67 73.38 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.875 -0.602 . . . . 65.319999999999993 111.413 -174.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.1 148.95 37.57 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.887 3.724 . . . . 74.129999999999995 115.524 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -94.64 -5.24 46.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.437 -0.801 . . . . 63.530000000000001 110.125 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.5 p -74.95 -5.99 7.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.256 1.027 . . . . 73.420000000000002 109.679 -176.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.428 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 5.5 m -63.61 -26.69 68.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.409 -1.268 . . . . 71.439999999999998 109.119 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.1 p -58.51 -27.67 64.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.816 -1.083 . . . . 73.310000000000002 111.341 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.6 mt -86.75 -47.35 9.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.709 -0.796 . . . . 74.230000000000004 110.978 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 25.6 m -167.01 150.17 6.5 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 109.533 -0.543 . . . . 74.140000000000001 109.533 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -51.63 -46.56 63.7 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.116 1.366 . . . . 75.129999999999995 111.199 174.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.21 85.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.998 -0.546 . . . . 72.319999999999993 111.277 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.69 -44.11 97.58 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.668 -0.696 . . . . 73.299999999999997 110.827 178.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -50.79 72.35 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.093 -0.958 . . . . 71.209999999999994 110.399 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -46.58 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.799 -0.637 . . . . 74.219999999999999 112.129 -176.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -63.31 -48.01 79.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.476 0.179 . . . . 72.439999999999998 110.984 -177.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -68.25 -39.47 82.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.071 -0.513 . . . . 74.329999999999998 111.63 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.514 HD22 ' CE2' ' A' ' 452' ' ' PHE . 28.9 tp -67.44 -37.49 83.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 109.686 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 -44.13 95.94 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.326 -0.852 . . . . 71.340000000000003 109.722 175.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.76 62.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.606 -0.725 . . . . 74.450000000000003 111.442 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.91 -12.96 54.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 72.510000000000005 111.047 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.61 -18.74 10.74 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.536 -0.84 . . . . 73.200000000000003 112.693 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.456 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 81.5 m-85 -75.69 136.51 40.37 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.663 0.268 . . . . 75.409999999999997 110.301 -176.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -137.99 26.0 2.89 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.721 -0.951 . . . . 74.420000000000002 110.721 177.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -124.52 116.03 21.82 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.374 -1.343 . . . . 73.319999999999993 107.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 444' ' ' LEU . 64.0 m-85 -130.18 146.5 51.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.301 0.572 . . . . 75.430000000000007 110.903 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -140.86 123.29 15.92 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.807 -1.553 . . . . 75.230000000000004 106.807 169.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.93 130.07 37.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.16 0.505 . . . . 74.409999999999997 111.306 -177.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -130.03 141.94 50.68 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.37 -1.344 . . . . 73.319999999999993 107.37 175.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.15 149.09 45.01 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.199 -0.601 . . . . 53.329999999999998 110.791 -177.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 457' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 56.0 m -132.49 134.27 24.62 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-N 115.475 -0.784 . . . . 70.439999999999998 108.889 177.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 27.3 Cg_exo -65.58 127.51 18.18 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.627 2.218 . . . . 74.430000000000007 112.243 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 38.6 m -146.94 -179.94 7.16 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 125.498 1.519 . . . . 72.230000000000004 107.077 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.4 t -50.51 114.56 4.67 Favored Pre-proline 0 CA--C 1.584 2.269 0 C-N-CA 124.135 0.974 . . . . 74.400000000000006 110.14 177.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.11 -28.91 34.8 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.736 3.624 . . . . 63.509999999999998 116.425 -171.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.97 -20.83 64.2 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.956 -0.698 . . . . 73.340000000000003 112.077 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.37 14.37 22.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.485 0.55 . . . . 73.109999999999999 112.485 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.09 128.09 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.386 0.613 . . . . 75.0 110.697 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.3 1.77 55.72 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.677 -0.692 . . . . 54.32 112.783 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -91.79 138.49 31.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.623 -1.251 . . . . 74.030000000000001 107.623 176.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 486' ' ' ILE . 50.7 t -82.96 124.82 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.212 -0.995 . . . . 73.400000000000006 108.39 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -99.51 -14.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 120.221 -0.592 . . . . 72.400000000000006 111.272 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.04 39.17 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.602 -0.809 . . . . 63.240000000000002 111.203 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.6 p -132.19 147.78 52.43 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.683 -0.858 . . . . 74.310000000000002 108.683 177.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.7 t-20 -64.02 -51.93 59.71 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 119.167 -0.444 . . . . 72.420000000000002 111.272 176.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.2 Cg_exo -74.12 145.18 34.76 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.334 1.356 . . . . 73.120000000000005 109.74 173.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.78 146.01 58.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.696 2.264 . . . . 73.400000000000006 112.995 -177.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -101.77 -9.7 20.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.544 -0.753 . . . . 73.109999999999999 110.196 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.475 -0.935 . . . . 70.420000000000002 108.475 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -117.77 175.56 5.6 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.164 -0.926 . . . . 71.439999999999998 108.531 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 27.4 p -88.3 148.74 24.15 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 116.648 -0.251 . . . . 62.25 111.592 -177.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.6 m -126.05 148.61 49.28 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.781 -1.192 . . . . 73.230000000000004 107.781 175.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 147.13 53.52 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-O 120.611 0.243 . . . . 75.040000000000006 111.331 -177.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.01 -28.14 41.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 75.5 111.311 179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.0 t -85.48 7.48 22.66 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.717 -0.674 . . . . 75.420000000000002 110.399 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.97 144.68 27.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.346 -0.613 . . . . 64.340000000000003 109.346 -177.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.68 111.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.346 -0.983 . . . . 75.310000000000002 108.346 179.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.22 118.23 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 C-N-CA 118.925 -1.11 . . . . 75.420000000000002 108.424 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 58.5 mt -100.43 113.94 37.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.345 -1.724 . . . . 75.329999999999998 106.345 176.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.46 128.12 52.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 CA-C-N 115.652 -0.703 . . . . 61.340000000000003 109.458 -174.706 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 30.9 mm -97.59 109.9 24.34 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-O 121.361 0.6 . . . . 74.209999999999994 109.484 -176.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.69 133.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.543 -0.753 . . . . 74.299999999999997 110.143 -177.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.71 115.91 4.91 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.146 -1.982 . . . . 65.540000000000006 108.146 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.0 m -127.44 160.39 31.61 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.084 -1.08 . . . . 63.329999999999998 108.084 -176.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.783 0 C-N-CA 119.207 -1.473 . . . . 70.299999999999997 111.064 -178.073 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.259 0 CA-C-O 121.938 0.875 . . . . 74.129999999999995 109.042 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 17.2 p -136.45 166.35 23.7 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.909 -1.041 . . . . 65.129999999999995 110.009 -174.064 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -150.6 151.05 31.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.142 0.977 . . . . 72.030000000000001 108.908 175.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -95.65 133.11 40.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.399 -1.334 . . . . 73.430000000000007 107.399 173.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 43.6 pt -84.32 134.84 42.27 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 120.534 -0.466 . . . . 75.129999999999995 111.638 -175.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.04 170.37 7.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.621 2.214 . . . . 75.409999999999997 111.509 175.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -85.61 133.13 34.06 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.933 -0.576 . . . . 75.310000000000002 110.638 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.71 13.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.63 -0.714 . . . . 73.140000000000001 110.526 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.76 137.47 40.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.099 -0.5 . . . . 54.539999999999999 110.703 -177.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.05 50.44 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.491 -1.044 . . . . 75.329999999999998 110.491 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -97.59 169.59 9.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 74.519999999999996 108.24 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.2 m -82.98 155.35 24.02 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.183 -1.043 . . . . 74.239999999999995 108.183 -175.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 13.5 p -52.63 -41.38 37.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 123.488 0.715 . . . . 60.32 111.973 -177.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.19 -43.98 76.88 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.531 -0.468 . . . . 73.230000000000004 112.144 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.08 -34.96 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 119.848 -0.741 . . . . 74.450000000000003 111.684 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.22 84.57 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.033 -0.985 . . . . 63.219999999999999 111.205 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -63.73 -36.19 83.05 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.225 0.328 . . . . 74.230000000000004 110.502 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.446 ' O ' HG23 ' A' ' 514' ' ' VAL . 91.1 mttt -65.02 -49.91 68.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.934 -0.575 . . . . 74.219999999999999 111.794 177.737 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.01 -41.45 86.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.468 -0.493 . . . . 74.349999999999994 110.328 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.85 -44.27 94.2 Favored 'General case' 0 C--O 1.195 -1.765 0 CA-C-N 115.839 -0.618 . . . . 75.329999999999998 110.124 -179.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.07 -37.83 78.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.54 0.57 . . . . 70.129999999999995 112.54 -178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 510' ' ' LYS . 66.8 t -59.09 -36.78 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.442 0.464 . . . . 71.430000000000007 111.195 -178.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.05 -34.75 8.33 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.809 -0.756 . . . . 75.239999999999995 110.495 -177.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -94.99 -122.84 3.87 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.707 -1.133 . . . . 70.420000000000002 115.869 -170.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 19.0 m-85 -122.58 178.13 5.13 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.92 0.391 . . . . 71.230000000000004 110.07 -168.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.8 m -116.44 8.9 14.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.217 1.008 . . . . 73.310000000000002 109.301 178.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.86 115.27 29.77 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.99 -1.115 . . . . 75.400000000000006 107.99 178.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -125.96 151.72 46.63 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.215 0.531 . . . . 64.0 110.956 -175.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.0 m -141.55 153.39 44.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.537 -1.653 . . . . 72.099999999999994 106.537 170.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.46 135.78 52.69 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 118.268 0.485 . . . . 63.219999999999999 110.412 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.56 ' HB2' ' OE1' ' A' ' 554' ' ' GLN . . . -130.08 145.08 51.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.239 -0.652 . . . . 63.109999999999999 109.239 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 21.2 m -87.83 124.97 34.18 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.833 0.349 . . . . 73.239999999999995 111.394 -175.445 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.3 163.16 30.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.579 -0.897 . . . . 73.340000000000003 108.579 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.42 137.32 37.93 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.682 0.993 . . . . 62.219999999999999 113.682 -172.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.3 t -162.01 115.1 1.2 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.598 1.559 . . . . 75.450000000000003 106.852 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.03 -89.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.378 2.719 . . . . 70.209999999999994 115.793 -172.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 530' ' ' PRO . 57.3 mtt180 -86.33 -42.56 0.58 Allowed Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 113.547 0.943 . . . . 73.129999999999995 113.547 178.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 11.1 Cg_endo -57.17 133.91 60.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 120.502 1.215 . . . . 61.310000000000002 109.524 173.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.96 140.74 21.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.041 0.448 . . . . 74.409999999999997 110.704 -172.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.06 77.22 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.629 -0.714 . . . . 61.409999999999997 111.368 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.47 148.78 24.79 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.317 0.579 . . . . 72.120000000000005 110.94 177.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 76.9 t -75.2 122.18 28.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.33 -1.359 . . . . 75.129999999999995 107.33 176.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.4 m -98.33 -1.35 41.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.242 -0.89 . . . . 62.130000000000003 110.148 -174.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.69 -169.24 32.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.659 -0.576 . . . . 70.219999999999999 111.659 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.7 p -137.27 160.65 38.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.407 -0.96 . . . . 75.219999999999999 108.407 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.3 t30 -58.48 -56.87 31.0 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.429 -0.32 . . . . 70.430000000000007 111.45 177.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.7 Cg_endo -84.19 151.3 12.26 Favored 'Trans proline' 0 C--N 1.365 1.433 0 N-CA-C 108.954 -1.21 . . . . 71.329999999999998 108.954 174.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.63 148.76 53.94 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.644 1.563 . . . . 73.319999999999993 111.658 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.08 129.48 41.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.262 -0.426 . . . . 71.340000000000003 110.061 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -15.12 37.33 Favored Glycine 0 C--N 1.301 -1.375 0 C-N-CA 120.884 -0.674 . . . . 72.129999999999995 112.05 -177.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.5 m -81.08 134.82 35.72 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 110.036 -0.357 . . . . 73.519999999999996 110.036 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 85.3 m -90.65 123.32 34.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.879 -0.6 . . . . 74.299999999999997 109.799 177.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.69 158.7 67.1 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.793 -0.817 . . . . 74.430000000000007 108.793 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.33 146.63 86.32 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.514 2.143 . . . . 75.120000000000005 112.118 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 19.1 m -67.7 -19.89 25.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.379 1.085 . . . . 72.299999999999997 110.027 177.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.32 -17.26 60.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.918 -1.492 . . . . 72.239999999999995 109.481 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.5 t -86.61 142.11 28.5 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.412 -0.813 . . . . 54.420000000000002 108.93 -176.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.36 126.28 44.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.506 -1.294 . . . . 73.540000000000006 107.506 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.87 137.95 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.266 0.555 . . . . 73.530000000000001 111.121 -176.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.74 119.93 39.55 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 108.91 -0.774 . . . . 73.340000000000003 108.91 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -99.32 124.1 44.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.985 -1.461 . . . . 72.140000000000001 107.936 -177.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.56 ' OE1' ' HB2' ' A' ' 523' ' ' ALA . 4.1 mm-40 -90.13 108.51 19.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.505 0.669 . . . . 74.530000000000001 110.128 -175.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.99 140.56 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.737 -1.12 . . . . 75.150000000000006 111.856 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 40.1 m -56.24 127.89 33.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.666 0.746 . . . . 72.120000000000005 112.521 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 77.6 tttt . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.959 -1.126 . . . . 74.420000000000002 107.959 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.4 0 N-CA-C 110.82 -0.912 . . . . 43.049999999999997 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.45 168.46 24.24 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.96 2.44 . . . . 71.109999999999999 112.008 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.41 -7.75 59.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.69 1.233 . . . . 73.400000000000006 108.637 176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 54.3 mt-30 -94.48 140.11 30.26 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.33 -1.759 . . . . 72.420000000000002 108.949 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpp180 -120.87 152.35 38.55 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.827 -1.175 . . . . 73.120000000000005 107.827 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.36 140.88 32.16 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 124.091 0.87 . . . . 64.129999999999995 109.775 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -89.98 122.76 67.46 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 109.33 -0.619 . . . . 73.019999999999996 109.33 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.45 141.14 94.94 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.597 2.198 . . . . 72.030000000000001 112.581 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.41 24.13 4.12 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.35 -0.841 . . . . 73.099999999999994 110.891 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.5 -7.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.047 0.927 . . . . 74.430000000000007 109.024 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 13.2 m -62.74 -36.32 82.66 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.472 -1.24 . . . . 73.120000000000005 110.097 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.42 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 18.1 p -62.11 -26.6 68.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.25 -1.341 . . . . 70.109999999999999 110.839 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.472 ' C ' ' HG1' ' A' ' 436' ' ' THR . 59.9 mt -83.71 -44.62 14.29 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.041 -0.527 . . . . 65.219999999999999 110.586 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.472 ' HG1' ' C ' ' A' ' 435' ' ' LEU . 22.3 m -160.87 145.61 14.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.671 -0.492 . . . . 75.219999999999999 109.671 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -54.92 -42.37 72.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.478 0.711 . . . . 72.310000000000002 110.92 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 436' ' ' THR . . . -57.55 -44.39 85.16 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.888 -0.596 . . . . 74.349999999999994 110.579 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.66 -43.61 98.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.369 -0.832 . . . . 73.120000000000005 111.256 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -59.76 -51.73 68.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.443 -0.799 . . . . 62.119999999999997 110.978 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.1 -47.55 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.869 -0.605 . . . . 73.340000000000003 112.333 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -64.78 -47.15 79.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.7 -0.4 . . . . 75.239999999999995 111.65 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.89 -40.33 83.51 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.633 -0.427 . . . . 71.140000000000001 111.984 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.487 HD22 ' CE2' ' A' ' 452' ' ' PHE . 19.4 tp -68.89 -33.64 74.11 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.363 0.601 . . . . 73.299999999999997 110.261 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.6 m -64.06 -41.63 97.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.62 -0.718 . . . . 73.040000000000006 109.59 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.57 62.79 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.798 -0.637 . . . . 74.099999999999994 110.82 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.4 -13.47 52.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.063 0.459 . . . . 74.129999999999995 110.077 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.77 -2.36 27.43 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.567 -0.825 . . . . 75.129999999999995 113.844 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 95.6 m-85 -83.56 136.49 34.23 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 117.303 0.552 . . . . 75.439999999999998 111.671 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.21 4.82 4.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.549 -0.751 . . . . 73.120000000000005 112.451 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.426 ' NE ' ' HB ' ' A' ' 483' ' ' VAL . 77.2 ttt180 -111.29 115.56 29.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.702 -0.851 . . . . 75.340000000000003 108.702 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.487 ' CE2' HD22 ' A' ' 444' ' ' LEU . 65.2 m-85 -130.82 156.9 44.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.024 -0.534 . . . . 74.430000000000007 111.12 -173.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -139.41 121.82 16.09 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 104.615 -2.365 . . . . 74.230000000000004 104.615 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -110.65 135.19 51.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.744 0.307 . . . . 71.409999999999997 111.397 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.3 156.56 46.4 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.987 -1.116 . . . . 65.230000000000004 107.987 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -136.09 143.06 44.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.219999999999999 107.732 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.8 m -130.99 139.19 34.83 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 109.501 -0.555 . . . . 63.520000000000003 109.501 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -64.41 123.07 11.21 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.292 1.995 . . . . 74.439999999999998 110.326 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 68.0 m -151.81 -179.51 7.52 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.087 -1.079 . . . . 61.039999999999999 108.087 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 2.8 t -33.97 108.53 0.32 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 125.787 1.635 . . . . 61.240000000000002 112.625 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.33 -29.75 78.06 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 124.139 3.226 . . . . 73.409999999999997 115.274 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -71.98 -6.91 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.583 0.586 . . . . 75.030000000000001 112.583 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 78.8 mt -111.3 13.81 21.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.006 0.432 . . . . 74.219999999999999 110.936 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.82 133.62 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.826 -0.625 . . . . 72.319999999999993 112.008 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.86 79.55 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 121.037 -0.602 . . . . 70.329999999999998 113.793 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 434' ' ' THR . 11.1 pttp -101.67 162.26 13.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.761 -1.2 . . . . 73.409999999999997 107.761 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 486' ' ' ILE . 53.3 t -81.46 133.21 29.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.851 -1.166 . . . . 74.319999999999993 107.851 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.6 pt -102.11 -6.73 9.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.593 -0.443 . . . . 73.239999999999995 110.819 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.5 143.69 4.05 Favored Glycine 0 N--CA 1.423 -2.224 0 C-N-CA 120.237 -0.983 . . . . 74.409999999999997 112.864 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.4 p -119.35 147.46 44.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.837 -1.171 . . . . 73.329999999999998 107.837 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.49 -51.38 42.2 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 119.394 -0.336 . . . . 73.219999999999999 111.595 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.12 127.81 13.99 Favored 'Trans proline' 0 C--N 1.361 1.223 0 N-CA-C 108.012 -1.572 . . . . 71.430000000000007 108.012 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.27 158.22 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.893 1.729 . . . . 63.009999999999998 113.102 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.429 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.08 -17.0 51.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.842 0.829 . . . . 74.109999999999999 109.981 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -96.87 -25.92 15.27 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.389 -0.823 . . . . 64.530000000000001 111.537 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.11 156.68 17.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.889 -0.411 . . . . 73.349999999999994 109.889 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.5 p -90.57 140.83 29.38 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.183 -0.673 . . . . 70.019999999999996 109.183 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.1 m -126.7 142.6 51.49 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.752 -0.832 . . . . 60.439999999999998 108.752 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.43 140.17 57.35 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.226 -0.657 . . . . 53.030000000000001 109.226 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.21 -9.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.98 0.895 . . . . 70.030000000000001 111.616 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -81.94 -3.29 53.96 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.613 -0.721 . . . . 73.140000000000001 109.185 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.43 147.38 28.78 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 121.983 -0.448 . . . . 73.040000000000006 110.644 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.426 ' HB ' ' NE ' ' A' ' 451' ' ' ARG . 5.1 p -85.66 124.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.837 -1.171 . . . . 74.099999999999994 107.837 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.94 118.12 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.285 -0.966 . . . . 75.140000000000001 108.588 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.65 115.11 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.785 -1.561 . . . . 75.310000000000002 106.785 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.06 124.18 69.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.24 -0.891 . . . . 74.319999999999993 109.377 -176.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.59 123.17 61.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.303 -0.628 . . . . 73.329999999999998 109.303 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.21 141.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.314 -0.624 . . . . 74.450000000000003 109.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -76.92 113.51 3.8 Favored Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.526 -1.429 . . . . 75.010000000000005 109.526 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -102.19 130.04 48.73 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.618 -0.512 . . . . 71.030000000000001 109.618 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -114.59 99.73 0.96 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 109.024 -1.63 . . . . 73.349999999999994 109.024 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.41 156.87 32.83 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.488 2.125 . . . . 65.209999999999994 112.427 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.03 109.95 21.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.171 -1.418 . . . . 73.430000000000007 107.171 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 8.8 p -119.89 151.26 39.16 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.167 -0.924 . . . . 71.439999999999998 109.738 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -146.65 149.47 33.56 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.114 0.483 . . . . 72.25 111.432 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 543' ' ' THR . 9.1 p-10 -82.6 134.48 35.18 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.381 -1.281 . . . . 74.340000000000003 107.602 173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 540' ' ' PRO . 0.2 OUTLIER -75.62 122.73 87.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 119.622 -0.831 . . . . 65.329999999999998 109.091 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.9 170.53 9.87 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.403 2.069 . . . . 74.510000000000005 112.712 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.02 116.62 29.08 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.817 -0.629 . . . . 71.150000000000006 109.948 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.84 17.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 122.621 1.2 . . . . 72.030000000000001 107.942 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 147.55 48.57 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.325 -1.307 . . . . 74.209999999999994 109.45 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.13 -6.48 53.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 111.363 -0.695 . . . . 55.340000000000003 111.363 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.47 177.28 4.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.3 m -77.47 156.35 31.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.248 -0.649 . . . . 72.219999999999999 109.248 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.62 -44.03 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 123.448 0.468 . . . . 73.099999999999994 111.598 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.3 -42.68 79.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.031 0.382 . . . . 72.439999999999998 112.031 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.07 -35.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.651 -0.819 . . . . 70.430000000000007 111.121 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.45 81.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.698 -0.683 . . . . 61.100000000000001 111.094 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.66 -38.22 84.15 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.395 0.434 . . . . 74.409999999999997 110.538 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.1 tttm -63.7 -52.01 62.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.654 -0.703 . . . . 71.129999999999995 110.27 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -65.02 -41.61 95.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.969 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.25 -39.39 89.47 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.616 -0.72 . . . . 64.310000000000002 109.762 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -59.02 -41.57 88.07 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.186 0.594 . . . . 71.230000000000004 112.427 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.1 t -59.02 -35.35 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 111.088 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -112.28 4.31 17.64 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.024 -0.67 . . . . 75.5 111.398 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.93 -100.25 0.29 Allowed Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 118.036 -2.031 . . . . 61.219999999999999 117.625 -168.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 60.9 m-85 -120.08 161.47 20.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.404 -0.398 . . . . 74.120000000000005 111.295 -164.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 m -119.01 -13.96 9.39 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.527 0.68 . . . . 64.319999999999993 110.782 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -107.97 115.49 30.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.422 -0.955 . . . . 71.409999999999997 108.422 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -120.97 156.64 31.67 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.542 0.687 . . . . 72.140000000000001 111.318 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.7 m -139.99 155.75 46.96 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.518 -1.66 . . . . 75.219999999999999 106.518 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -121.28 138.46 54.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.038 0.447 . . . . 74.120000000000005 110.007 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.94 131.75 56.05 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.545 -0.909 . . . . 73.530000000000001 108.545 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 36.1 m -88.61 123.17 32.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.572 0.545 . . . . 73.519999999999996 109.677 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 35.3 m -121.61 162.64 20.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.768 -1.197 . . . . 73.230000000000004 107.768 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 11.1 m-20 -78.06 133.3 37.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.095 0.474 . . . . 75.150000000000006 110.79 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.509 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 11.0 m -95.95 105.42 21.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.732 -1.122 . . . . 54.049999999999997 111.563 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 2.4 Cg_endo -81.16 -77.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 121.701 1.6 . . . . 64.209999999999994 109.506 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -95.24 -58.47 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 120.325 -0.55 . . . . 75.439999999999998 109.892 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 527' ' ' SER . 36.6 Cg_endo -65.34 144.62 80.97 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.945 1.763 . . . . 72.340000000000003 112.309 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -151.37 132.73 14.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.837 -0.801 . . . . 63.240000000000002 108.837 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.86 -24.66 5.79 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-O 121.922 0.735 . . . . 65.519999999999996 112.075 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.15 150.38 24.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 C-N-CA 124.372 1.069 . . . . 73.340000000000003 111.492 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.18 128.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.081 -0.963 . . . . 74.230000000000004 110.018 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -92.25 -22.23 19.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.255 -1.339 . . . . 72.540000000000006 109.733 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.96 33.67 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.156 -0.777 . . . . 61.020000000000003 111.156 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.9 p -117.94 160.33 21.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.643 -0.873 . . . . 75.219999999999999 108.643 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -64.13 -58.5 14.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.338 -0.363 . . . . 73.129999999999995 111.035 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.49 148.81 43.32 Favored 'Trans proline' 0 C--N 1.373 1.862 0 N-CA-C 109.17 -1.127 . . . . 62.229999999999997 109.17 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . 0.437 ' O ' HD13 ' A' ' 497' ' ' ILE . 32.1 Cg_exo -60.46 140.06 89.58 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.069 1.846 . . . . 54.200000000000003 110.661 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.39 131.94 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.618 0.367 . . . . 73.109999999999999 110.847 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.22 40.7 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.363 -0.922 . . . . 74.25 112.274 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 60.3 m -67.44 126.47 29.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.144 -0.687 . . . . 75.010000000000005 109.144 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 13.2 m -94.33 122.86 37.32 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.942 -0.762 . . . . 63.539999999999999 108.942 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.03 161.0 66.37 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.282 -0.636 . . . . 75.219999999999999 109.282 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.83 134.93 63.59 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.468 2.112 . . . . 62.399999999999999 111.355 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.513 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 20.0 m -65.94 -19.85 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.244 0.545 . . . . 72.340000000000003 111.263 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -77.67 -10.27 59.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.647 -0.706 . . . . 70.430000000000007 111.516 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.0 t -85.39 161.13 19.58 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 74.349999999999994 108.922 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.32 130.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.012 0.434 . . . . 74.049999999999997 111.278 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.9 tt -101.6 132.84 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.071 0.462 . . . . 74.310000000000002 110.011 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.59 127.45 51.01 Favored 'General case' 0 N--CA 1.399 -2.999 0 N-CA-C 108.73 -0.841 . . . . 75.310000000000002 108.73 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.5 tp -104.19 133.58 48.88 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.944 -1.025 . . . . 74.510000000000005 108.854 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -94.46 109.23 21.12 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.708 -1.219 . . . . 74.230000000000004 107.708 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.71 138.51 44.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 121.177 0.513 . . . . 74.200000000000003 112.187 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -68.09 114.95 7.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.722 -0.844 . . . . 62.130000000000003 108.722 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 61.9 pttt . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 115.802 -0.636 . . . . 74.25 110.702 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 110.338 -1.105 . . . . 62.409999999999997 110.338 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -71.12 152.19 61.99 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.455 2.103 . . . . 74.040000000000006 111.222 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 480' ' ' ILE . 12.4 pt-20 -87.93 14.46 8.85 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.77 0.319 . . . . 73.319999999999993 111.491 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 478' ' ' SER . 68.6 mt-30 -90.84 119.14 30.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.291 -0.564 . . . . 72.219999999999999 110.018 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -120.18 160.24 23.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.462 -1.31 . . . . 71.540000000000006 107.462 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.09 141.39 29.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.385 0.428 . . . . 63.130000000000003 111.4 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.1 130.72 68.63 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.597 -0.89 . . . . 73.310000000000002 108.597 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.34 142.93 78.54 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.319 2.68 . . . . 74.319999999999993 114.426 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.46 -7.5 50.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.314 -0.857 . . . . 75.549999999999997 111.091 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 32.4 m -80.38 1.05 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.6 0.714 . . . . 70.230000000000004 110.801 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.3 m -63.77 -28.05 69.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.091 -0.959 . . . . 44.039999999999999 109.476 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -62.07 -28.4 69.58 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.587 -1.188 . . . . 72.519999999999996 111.186 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.414 ' C ' ' HG1' ' A' ' 436' ' ' THR . 63.9 mt -83.37 -45.27 13.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.089 -0.505 . . . . 74.319999999999993 110.572 -172.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.465 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.5 m -165.69 149.06 7.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.655 -0.869 . . . . 73.5 108.655 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.08 -45.41 75.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.407 0.683 . . . . 75.219999999999999 110.655 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.41 -44.7 76.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.038 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.465 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 31.2 mm-40 -64.32 -37.89 89.1 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.014 -0.539 . . . . 74.420000000000002 110.935 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.79 -51.33 68.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 74.329999999999998 110.477 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.41 -46.03 97.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.221 -0.9 . . . . 75.310000000000002 112.309 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -63.03 -44.55 95.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.561 0.22 . . . . 74.25 111.319 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.34 -38.44 84.85 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.04 0.385 . . . . 72.209999999999994 112.04 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.1 tp -68.53 -34.26 75.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.516 0.674 . . . . 74.040000000000006 109.938 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.2 m -65.66 -40.74 92.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.418 -0.81 . . . . 73.040000000000006 109.305 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -16.57 62.71 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.315 0.578 . . . . 72.010000000000005 110.419 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.78 -14.14 49.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.222 0.534 . . . . 71.120000000000005 109.589 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.39 50.16 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.884 -0.674 . . . . 64.25 113.616 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.438 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.0 m-85 -92.29 121.36 33.72 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.177 0.489 . . . . 62.210000000000001 110.123 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.21 5.02 21.87 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 111.197 -0.761 . . . . 73.099999999999994 111.197 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -102.86 116.46 32.6 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.326 -0.62 . . . . 74.530000000000001 109.326 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.434 ' CE2' HD21 ' A' ' 444' ' ' LEU . 73.8 m-85 -130.4 144.79 51.61 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.281 0.563 . . . . 73.120000000000005 111.075 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 485' ' ' ILE . 22.3 tptm -131.02 121.84 25.75 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.897 -2.26 . . . . 73.519999999999996 104.897 167.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -105.32 134.99 47.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.695 -0.483 . . . . 75.099999999999994 109.695 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -139.93 150.32 44.4 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.695 -0.854 . . . . 71.120000000000005 108.695 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -125.73 148.74 48.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.762 -1.199 . . . . 75.230000000000004 107.762 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.2 m -143.17 144.79 30.0 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 109.115 -0.698 . . . . 74.239999999999995 109.115 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.44 123.05 10.91 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.608 2.206 . . . . 72.109999999999999 112.571 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.8 t -137.17 -179.13 5.54 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.699 -1.963 . . . . 74.129999999999995 105.699 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.435 ' CG2' HD23 ' A' ' 463' ' ' LEU . 6.9 t -61.88 141.64 95.3 Favored Pre-proline 0 N--CA 1.423 -1.791 0 N-CA-C 109.944 -0.391 . . . . 73.340000000000003 109.944 178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.76 -29.66 34.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.108 3.205 . . . . 74.140000000000001 112.32 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.05 -20.65 65.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.999 0.74 . . . . 73.299999999999997 112.999 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 460' ' ' THR . 4.5 mm? -106.33 11.47 30.97 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.107 -0.371 . . . . 75.120000000000005 111.964 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.92 128.99 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.156 0.503 . . . . 75.329999999999998 111.419 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.29 -9.58 77.01 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.655 -0.783 . . . . 73.430000000000007 112.49 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -100.55 155.35 17.9 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.175 -1.046 . . . . 74.310000000000002 108.175 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.96 129.75 36.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.901 -1.148 . . . . 73.200000000000003 107.901 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.2 pt -98.55 -16.04 7.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.42 -0.512 . . . . 74.519999999999996 110.799 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 176.32 149.1 7.36 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.675 -0.693 . . . . 73.310000000000002 111.738 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.3 p -116.82 152.85 33.56 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.606 -1.257 . . . . 74.409999999999997 107.606 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.477 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.1 t-20 -68.03 -51.94 25.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 C-N-CA 120.502 -0.479 . . . . 75.219999999999999 110.714 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.9 Cg_exo -79.13 130.59 9.38 Favored 'Trans proline' 0 C--N 1.371 1.751 0 N-CA-C 107.952 -1.595 . . . . 74.439999999999998 107.952 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.88 157.15 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.791 1.661 . . . . 72.450000000000003 112.845 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.19 -6.75 57.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.358 1.075 . . . . 72.150000000000006 109.109 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 -40.32 14.29 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.14 -1.391 . . . . 75.239999999999995 111.048 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.77 167.13 10.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 74.340000000000003 110.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 p -101.57 133.56 46.06 Favored 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 108.708 -0.849 . . . . 74.230000000000004 108.708 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.2 m -118.9 148.6 42.75 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.379 -0.6 . . . . 65.329999999999998 109.379 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.25 51.78 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.282 0.364 . . . . 71.439999999999998 111.403 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.8 mm -57.7 -28.51 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.708 1.203 . . . . 74.409999999999997 111.147 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.1 t -76.56 -7.36 55.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.73 -0.668 . . . . 73.540000000000006 110.876 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.99 142.22 28.1 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 122.074 -0.391 . . . . 60.140000000000001 110.435 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.96 126.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.786 -0.82 . . . . 74.219999999999999 108.786 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.19 119.37 36.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.137 -0.69 . . . . 74.5 109.137 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.453 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.9 mp -92.94 119.65 40.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.182 -1.414 . . . . 74.329999999999998 107.182 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.06 125.91 74.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 109.53 -0.545 . . . . 74.099999999999994 109.53 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.3 mp -104.43 119.18 52.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.538 -0.542 . . . . 75.040000000000006 109.538 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.21 144.12 10.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.98 -0.748 . . . . 64.120000000000005 108.98 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -77.71 122.21 6.0 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 111.823 -0.511 . . . . 73.25 111.823 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.9 t -118.45 131.93 56.25 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.16 -1.793 . . . . 63.219999999999999 106.16 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -115.08 136.08 12.84 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.672 -1.251 . . . . 72.349999999999994 111.12 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.9 122.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.318 2.012 . . . . 74.409999999999997 111.247 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.86 102.4 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.864 -1.532 . . . . 71.430000000000007 106.864 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.434 ' HB ' HG21 ' A' ' 544' ' ' THR . 40.6 p -125.21 152.79 44.07 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.88 -0.6 . . . . 75.239999999999995 110.119 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.466 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -133.67 135.6 44.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.31 -0.405 . . . . 72.019999999999996 109.939 -177.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.7 p-10 -83.28 130.54 35.08 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.454 -0.943 . . . . 74.439999999999998 108.454 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.8 pt -81.52 131.99 56.62 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 115.991 -0.55 . . . . 73.230000000000004 110.423 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -84.36 152.62 12.16 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.518 2.145 . . . . 74.340000000000003 112.111 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.56 101.22 2.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.533 0.683 . . . . 73.340000000000003 109.95 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.06 1.81 8.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.278 -0.874 . . . . 71.329999999999998 109.484 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.85 122.95 19.25 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.999 -1.0 . . . . 64.349999999999994 110.679 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.94 -29.73 3.87 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.607 -0.597 . . . . 60.450000000000003 111.607 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -88.87 -175.48 4.88 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.109 -0.701 . . . . 74.049999999999997 109.109 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 70.0 p -80.49 157.38 26.17 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.637 -0.825 . . . . 70.349999999999994 110.644 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.01 -41.6 80.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.452 0.644 . . . . 73.140000000000001 109.333 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.71 -43.28 89.57 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.259 -0.882 . . . . 65.549999999999997 112.504 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.58 -34.68 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 119.945 -0.702 . . . . 60.210000000000001 110.585 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.12 77.94 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.803 -0.635 . . . . 75.140000000000001 110.834 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.24 -41.74 97.41 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.638 0.586 . . . . 74.120000000000005 110.203 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 514' ' ' VAL . 56.0 mtmt -65.16 -51.73 59.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 113.203 0.816 . . . . 73.299999999999997 113.203 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -63.48 -40.93 98.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.912 0.386 . . . . 73.040000000000006 110.725 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.53 -39.51 88.64 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 115.626 -0.716 . . . . 71.230000000000004 110.796 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.77 -37.66 87.51 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.891 0.377 . . . . 73.239999999999995 110.654 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 510' ' ' LYS . 47.7 t -69.16 -30.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.965 -0.561 . . . . 60.009999999999998 111.476 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.92 18.83 7.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 120.201 -0.6 . . . . 71.319999999999993 111.748 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -150.06 -110.75 0.53 Allowed Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 118.869 -1.634 . . . . 72.319999999999993 115.135 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.27 164.25 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.373 -0.414 . . . . 72.409999999999997 110.214 -168.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -105.57 -7.98 18.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.426 -0.806 . . . . 75.230000000000004 109.916 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.417 ' HZ1' ' HB3' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -118.71 119.27 33.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 75.25 111.544 -174.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.79 155.95 42.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.149 -0.932 . . . . 73.040000000000006 109.711 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 72.7 m -135.03 148.18 49.86 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.135 -1.432 . . . . 65.099999999999994 107.135 170.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -122.23 128.2 50.87 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.264 -0.643 . . . . 65.319999999999993 109.264 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.411 ' HB2' ' OE1' ' A' ' 554' ' ' GLN . . . -119.75 131.48 55.37 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.319 -0.993 . . . . 72.519999999999996 108.319 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -88.69 126.69 35.43 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.447 0.641 . . . . 55.43 111.425 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.02 162.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.228 -1.397 . . . . 72.329999999999998 107.228 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.423 ' HA ' ' HE2' ' A' ' 557' ' ' LYS . 5.9 p-10 -79.36 129.26 34.29 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.795 0.807 . . . . 71.299999999999997 112.426 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 556' ' ' SER . 10.9 p -92.94 122.25 64.11 Favored Pre-proline 0 N--CA 1.416 -2.152 0 CA-C-N 114.272 -1.331 . . . . 75.150000000000006 108.712 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.82 -67.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.472 2.114 . . . . 70.140000000000001 111.882 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.1 -52.08 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 123.704 0.802 . . . . 74.420000000000002 109.473 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.6 150.14 89.21 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.215 1.276 . . . . 75.140000000000001 110.196 168.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.62 139.89 16.63 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.469 -0.567 . . . . 61.200000000000003 109.469 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.64 10.92 Favored Glycine 0 C--O 1.242 0.607 0 C-N-CA 120.905 -0.665 . . . . 52.25 111.775 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.4 OUTLIER -87.14 147.02 25.81 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.933 0.397 . . . . 71.25 110.626 177.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.62 122.71 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 108.219 -1.03 . . . . 74.409999999999997 108.219 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.41 -25.59 59.56 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.296 -0.865 . . . . 73.430000000000007 109.571 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.79 -156.3 26.8 Favored Glycine 0 N--CA 1.424 -2.115 0 N-CA-C 110.299 -1.12 . . . . 73.129999999999995 110.299 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.0 p -130.0 160.54 33.32 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.379 -0.971 . . . . 72.439999999999998 108.379 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.58 -56.35 36.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 123.461 0.476 . . . . 74.209999999999994 110.751 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.26 146.92 28.82 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.009 1.139 . . . . 72.319999999999993 109.96 170.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -73.3 156.07 50.98 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.363 2.042 . . . . 72.120000000000005 112.465 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.8 136.99 58.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.075 0.55 . . . . 74.209999999999994 111.351 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -17.45 56.52 Favored Glycine 0 C--N 1.312 -0.765 0 C-N-CA 120.85 -0.69 . . . . 53.520000000000003 112.004 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.5 m -71.54 132.48 44.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.397 -0.594 . . . . 73.239999999999995 109.397 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -99.25 122.77 42.88 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.023 -1.103 . . . . 74.310000000000002 108.023 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.85 154.95 73.53 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.486 -0.931 . . . . 74.109999999999999 108.486 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' HG21 ' A' ' 494' ' ' THR . 31.8 Cg_exo -59.91 141.99 97.65 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.229 1.952 . . . . 73.099999999999994 111.621 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.8 -19.28 25.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 121.797 0.808 . . . . 74.140000000000001 111.575 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -87.31 2.73 49.34 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.982 -1.008 . . . . 75.549999999999997 109.541 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -103.45 149.06 25.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.351 -0.84 . . . . 62.130000000000003 108.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.36 130.13 42.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.008 0.433 . . . . 74.120000000000005 110.721 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.1 tt -95.38 130.84 43.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 75.209999999999994 110.6 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.99 121.7 43.1 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.209 0.528 . . . . 70.239999999999995 110.581 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.04 133.76 39.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.824 -1.08 . . . . 75.120000000000005 110.087 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.411 ' OE1' ' HB2' ' A' ' 523' ' ' ALA . 12.4 mm-40 -90.18 109.57 20.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.523 -1.658 . . . . 75.439999999999998 106.523 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.47 133.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.119 0.414 . . . . 74.150000000000006 112.119 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 527' ' ' SER . 14.5 m -70.47 114.48 8.62 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.247 -1.39 . . . . 71.540000000000006 107.247 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 526' ' ' ASP 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 117.903 -1.519 . . . . 74.510000000000005 111.77 -176.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.255 0 N-CA-C 110.232 -1.147 . . . . 44.520000000000003 110.232 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.88 148.94 25.63 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.722 1.615 . . . . 75.219999999999999 111.693 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.97 11.1 14.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 73.129999999999995 110.379 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -83.37 126.92 33.23 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.463 -1.31 . . . . 71.030000000000001 107.463 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -130.05 162.32 29.02 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.845 -1.169 . . . . 74.239999999999995 107.845 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.32 141.53 29.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.257 0.465 . . . . 62.020000000000003 112.257 -173.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -82.39 129.2 64.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 107.285 -1.376 . . . . 72.409999999999997 107.285 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.34 141.19 96.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.056 1.837 . . . . 75.129999999999995 112.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -94.24 4.17 54.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.862 -0.608 . . . . 73.120000000000005 109.809 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.96 -2.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.201 -0.909 . . . . 70.5 109.955 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 15.1 m -60.52 -33.64 72.93 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.441 -1.254 . . . . 73.540000000000006 110.181 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.3 t -64.91 -25.61 67.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.051 -0.977 . . . . 73.540000000000006 110.607 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.8 mt -81.4 -45.74 15.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.691 -0.404 . . . . 75.409999999999997 110.279 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.9 m -163.37 142.33 8.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.707 -0.849 . . . . 72.439999999999998 108.707 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -54.75 -45.11 74.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.045 0.538 . . . . 73.400000000000006 110.898 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.91 -42.95 76.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.067 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.35 -42.91 99.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 116.031 -0.532 . . . . 75.519999999999996 111.782 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.63 -51.73 68.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.516 -0.765 . . . . 73.430000000000007 111.324 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.35 -47.58 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.368 -0.833 . . . . 65.319999999999993 111.956 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.34 -46.21 81.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.975 0.417 . . . . 74.340000000000003 110.948 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.251 59.5 mttp -67.28 -37.9 84.17 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 113.08 0.77 . . . . 72.349999999999994 113.08 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.405 HD23 ' CE2' ' A' ' 452' ' ' PHE . 41.5 tp -67.77 -36.78 81.11 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.143 0.497 . . . . 74.349999999999994 109.728 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.3 m -60.65 -42.69 97.5 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 51.439999999999998 109.294 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.7 -19.65 62.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.414 -0.812 . . . . 74.329999999999998 111.336 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.21 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.275 0.56 . . . . 60.219999999999999 110.218 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.32 29.36 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.767 -0.73 . . . . 72.129999999999995 113.437 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.93 130.96 35.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.883 0.341 . . . . 74.209999999999994 110.597 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 30.4 4.27 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.11 -0.796 . . . . 72.340000000000003 111.11 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -132.58 115.9 16.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.551 -0.907 . . . . 74.340000000000003 108.551 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.405 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.9 m-85 -133.39 148.09 51.8 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.177 -0.919 . . . . 63.399999999999999 110.306 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.476 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.2 tppp? -138.97 122.64 17.49 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.202 -1.777 . . . . 73.439999999999998 106.202 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -103.1 135.22 45.17 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.874 0.369 . . . . 74.099999999999994 111.321 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.91 152.34 43.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.696 -1.594 . . . . 70.129999999999995 106.696 172.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.67 150.74 48.82 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.879 -0.786 . . . . 73.019999999999996 108.879 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.4 m -140.22 150.25 60.86 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 109.11 -0.7 . . . . 75.109999999999999 109.11 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.2 Cg_exo -65.39 132.44 31.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.325 2.017 . . . . 71.129999999999995 111.218 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.2 m -146.8 177.12 9.35 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.229 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.0 t -62.54 144.49 95.69 Favored Pre-proline 0 N--CA 1.432 -1.347 0 C-N-CA 123.852 0.861 . . . . 61.200000000000003 110.015 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.15 -31.72 37.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.966 3.111 . . . . 73.239999999999995 113.067 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.99 -12.04 60.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 120.027 -0.669 . . . . 75.019999999999996 111.754 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.5 mt -109.61 -4.45 16.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.7 -0.227 . . . . 73.099999999999994 111.528 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.8 t -61.2 127.5 20.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.567 -0.531 . . . . 74.409999999999997 109.567 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.42 75.33 Favored Glycine 0 C--O 1.25 1.101 0 C-N-CA 121.082 -0.58 . . . . 53.439999999999998 111.738 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 95.5 mttt -125.27 159.22 32.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.405 -0.961 . . . . 75.310000000000002 108.405 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 486' ' ' ILE . 39.1 t -82.75 133.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 109.329 -0.619 . . . . 75.219999999999999 109.329 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.72 -7.59 9.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 120.462 -0.495 . . . . 74.219999999999999 110.342 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.16 165.08 18.48 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.995 -0.842 . . . . 63.420000000000002 110.995 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.1 p -120.0 145.45 46.79 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.25 -0.648 . . . . 42.43 109.25 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.471 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.1 t-20 -57.4 -50.58 87.37 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 118.981 -0.533 . . . . 64.450000000000003 111.886 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.3 Cg_exo -76.7 131.82 12.69 Favored 'Trans proline' 0 C--N 1.37 1.709 0 N-CA-C 108.377 -1.432 . . . . 75.549999999999997 108.377 171.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.65 138.56 70.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.429 2.086 . . . . 73.209999999999994 112.037 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.49 1.77 50.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.133 0.968 . . . . 54.32 110.484 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.03 -27.78 15.45 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.798 -1.092 . . . . 73.340000000000003 109.639 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -109.89 164.85 12.19 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.848 -0.614 . . . . 71.319999999999993 109.455 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 15.5 p -90.61 136.86 32.79 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 120.736 0.303 . . . . 70.109999999999999 111.247 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.7 m -120.1 142.03 49.26 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.69 -0.856 . . . . 71.319999999999993 108.69 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.97 39.35 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.932 0.345 . . . . 74.329999999999998 111.932 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.81 -23.54 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.044 0.937 . . . . 74.219999999999999 111.282 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -80.67 -8.94 59.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.549 -0.75 . . . . 75.219999999999999 110.9 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 140.63 43.3 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.921 0.391 . . . . 71.030000000000001 112.04 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.3 122.89 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.942 -1.133 . . . . 74.0 107.942 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.95 118.84 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.223 -1.029 . . . . 74.409999999999997 108.223 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.476 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.6 mp -92.74 117.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.064 -1.828 . . . . 75.430000000000007 106.064 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.56 120.57 62.36 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 CA-C-N 115.566 -0.743 . . . . 73.409999999999997 109.429 -174.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.66 121.45 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.645 0.736 . . . . 75.439999999999998 111.242 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 142.72 13.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.778 -1.101 . . . . 74.409999999999997 109.386 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.38 118.99 4.9 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 109.024 -1.63 . . . . 63.420000000000002 109.024 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.6 t -122.79 155.6 36.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.557 -0.905 . . . . 65.010000000000005 108.557 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -114.21 123.2 5.97 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 109.602 -1.399 . . . . 62.32 109.602 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.2 112.43 2.07 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.978 1.785 . . . . 75.519999999999996 110.316 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -71.21 95.52 1.28 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.123 0.963 . . . . 73.209999999999994 110.448 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 546' ' ' PRO . 8.9 p -140.41 153.86 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.735 -1.12 . . . . 73.120000000000005 109.053 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.96 146.96 36.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.328 -0.249 . . . . 74.239999999999995 110.328 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.41 135.53 41.71 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.613 -0.884 . . . . 75.140000000000001 108.613 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.99 137.7 28.01 Favored Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 115.919 -0.582 . . . . 72.319999999999993 111.526 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.19 -172.09 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.224 1.949 . . . . 74.540000000000006 110.25 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.1 128.58 35.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.169 0.509 . . . . 72.25 110.487 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.39 4.16 2.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.845 0.831 . . . . 64.340000000000003 109.435 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.67 144.06 26.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.489 -0.778 . . . . 62.039999999999999 110.279 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 95.3 13.09 53.25 Favored Glycine 0 CA--C 1.498 -1.007 0 N-CA-C 111.081 -0.808 . . . . 61.240000000000002 111.081 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -118.88 176.18 5.4 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.056 -1.09 . . . . 75.349999999999994 108.056 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 m -86.58 155.41 20.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.715 -1.217 . . . . 62.219999999999999 107.715 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 10.3 p -54.87 -41.51 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 123.383 0.427 . . . . 73.450000000000003 111.968 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.25 -42.53 83.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.138 0.422 . . . . 72.150000000000006 112.138 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.52 -34.38 24.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 119.884 -0.726 . . . . 70.200000000000003 110.646 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.431 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -61.14 -47.66 85.2 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.078 -0.964 . . . . 74.209999999999994 111.017 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.2 mt-30 -62.75 -38.3 89.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.631 0.582 . . . . 73.549999999999997 110.002 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 514' ' ' VAL . 44.7 mmtm -63.03 -52.82 61.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.529 0.518 . . . . 74.439999999999998 111.911 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.57 -42.78 99.76 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 110.939 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.09 -43.33 95.72 Favored 'General case' 0 C--O 1.197 -1.698 0 CA-C-N 115.641 -0.709 . . . . 75.519999999999996 109.939 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.99 -38.61 79.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.41 0.684 . . . . 70.340000000000003 111.383 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.8 t -62.03 -40.52 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.291 -0.413 . . . . 71.519999999999996 111.63 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -101.29 -36.4 8.91 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.505 -0.878 . . . . 72.200000000000003 110.863 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -89.6 -115.77 1.55 Allowed Glycine 0 N--CA 1.415 -2.739 0 CA-C-N 114.435 -1.257 . . . . 74.209999999999994 115.783 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 17.3 m-85 -125.15 -175.29 3.26 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.194 -0.503 . . . . 73.409999999999997 110.235 -167.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.3 p -113.2 -7.71 13.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.305 0.483 . . . . 74.219999999999999 112.305 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.65 120.86 43.69 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 120.617 -0.433 . . . . 63.5 110.147 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -125.67 155.97 40.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.42 -0.809 . . . . 72.120000000000005 109.284 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 154.82 45.61 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.842 -1.54 . . . . 75.450000000000003 106.842 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -120.97 128.42 52.71 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.229 -0.588 . . . . 72.239999999999995 110.193 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.07 131.19 57.01 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.086 -1.079 . . . . 61.409999999999997 108.086 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.3 p -88.78 131.41 35.07 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.745 -0.661 . . . . 74.430000000000007 111.184 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.4 m -121.96 162.0 21.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.803 -1.184 . . . . 75.439999999999998 107.803 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -79.8 123.75 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.254 0.549 . . . . 75.140000000000001 111.733 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 7.2 m -85.15 149.75 53.44 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.203 -0.908 . . . . 63.200000000000003 108.567 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.599 1.532 . . . . 75.450000000000003 109.285 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -122.97 -58.46 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.802 -0.618 . . . . 74.400000000000006 111.003 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.34 148.4 54.96 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.823 1.33 . . . . 65.230000000000004 111.522 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.71 175.68 9.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.045 -0.724 . . . . 54.420000000000002 109.045 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 86.51 -15.85 48.51 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 121.256 -0.497 . . . . 54.229999999999997 111.927 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.92 147.83 25.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.657 0.741 . . . . 73.400000000000006 111.598 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.431 HG23 ' CB ' ' A' ' 508' ' ' ALA . 69.7 t -81.46 123.7 38.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 114.991 -1.004 . . . . 71.219999999999999 109.614 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.9 m -86.13 -26.45 25.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.733 -1.122 . . . . 72.120000000000005 109.242 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.13 -153.27 23.72 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 111.019 -0.832 . . . . 74.310000000000002 111.019 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -134.81 161.29 35.63 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.954 -0.758 . . . . 74.340000000000003 108.954 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -54.69 -54.44 49.08 Favored Pre-proline 0 CA--C 1.561 1.374 0 O-C-N 123.291 0.369 . . . . 70.319999999999993 110.615 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.35 149.4 14.96 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.103 1.202 . . . . 75.420000000000002 110.191 171.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -67.64 154.13 74.26 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.317 2.011 . . . . 62.119999999999997 113.024 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.78 129.56 40.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.18 -0.674 . . . . 43.350000000000001 109.18 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.59 46.46 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 111.862 -0.495 . . . . 54.109999999999999 111.862 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 93.2 m -78.06 137.36 38.2 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.986 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 25.6 m -94.56 123.89 38.26 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.727 -0.669 . . . . 74.540000000000006 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.9 155.0 78.27 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 110.092 -0.336 . . . . 75.200000000000003 110.092 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.419 ' HA ' HG23 ' A' ' 494' ' ' THR . 26.4 Cg_exo -64.03 139.72 68.75 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.242 2.628 . . . . 74.25 112.482 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.542 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 16.3 m -67.75 -21.19 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.785 0.803 . . . . 72.239999999999995 111.114 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.12 -10.92 59.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.646 -1.161 . . . . 75.400000000000006 110.349 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.8 t -93.24 155.1 17.64 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.927 -0.768 . . . . 72.209999999999994 108.927 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.68 130.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.937 -0.764 . . . . 71.150000000000006 108.937 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 18.7 tt -93.64 135.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.539 0.685 . . . . 75.319999999999993 111.377 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -102.74 124.49 48.37 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.65 -0.705 . . . . 75.120000000000005 109.485 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 28.4 tp -96.72 132.78 42.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.893 -1.048 . . . . 74.310000000000002 109.204 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -96.33 106.66 18.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.414 -1.328 . . . . 71.219999999999999 107.414 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.62 137.0 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 111.125 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.464 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 50.2 m -65.83 115.65 6.17 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.025 -1.102 . . . . 72.510000000000005 108.025 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 C--N 1.314 -0.955 0 O-C-N 123.643 0.589 . . . . 73.540000000000006 109.773 -176.345 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.495 0 N-CA-C 110.343 -1.103 . . . . 75.129999999999995 110.343 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.88 150.2 88.46 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.484 2.123 . . . . 71.329999999999998 112.147 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.88 23.27 8.68 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.516 -0.55 . . . . 74.340000000000003 109.516 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 66.2 mt-30 -83.83 138.74 33.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.842 -0.617 . . . . 62.539999999999999 112.435 -171.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -130.18 154.73 47.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.852 -1.907 . . . . 75.420000000000002 105.852 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.15 28.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 117.737 0.244 . . . . 74.329999999999998 110.727 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.2 mp -79.69 129.98 69.25 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 108.493 -0.928 . . . . 74.030000000000001 108.493 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.61 141.14 54.05 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.938 1.759 . . . . 75.510000000000005 111.062 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.39 67.23 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.267 1.032 . . . . 74.209999999999994 109.844 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.39 -2.55 9.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.556 -1.646 . . . . 74.040000000000006 106.556 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 8.2 m -60.96 -41.22 95.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.394 -1.73 . . . . 74.200000000000003 111.373 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 13.9 t -58.15 -26.29 62.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.6 -0.727 . . . . 74.400000000000006 111.623 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.93 -44.53 18.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.318 -0.553 . . . . 73.430000000000007 110.916 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.474 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.5 m -164.64 145.2 7.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.695 -0.854 . . . . 74.519999999999996 108.695 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.38 -43.65 79.45 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.787 0.835 . . . . 72.310000000000002 110.77 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.17 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.695 0.76 . . . . 74.209999999999994 110.704 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.9 mm-40 -70.42 -38.78 74.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.663 -0.699 . . . . 72.439999999999998 110.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -59.84 -50.95 71.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.472 -0.786 . . . . 73.5 111.036 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.4 t -59.37 -46.32 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 111.571 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -65.13 -44.79 87.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.744 -0.383 . . . . 75.200000000000003 111.139 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -63.4 -44.69 93.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.259 -0.428 . . . . 75.209999999999994 111.821 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.591 HD21 ' CE2' ' A' ' 452' ' ' PHE . 29.4 tp -67.26 -40.11 86.17 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.329 -0.396 . . . . 75.140000000000001 110.295 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.2 m -60.44 -44.15 96.12 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 110.468 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.08 -18.05 62.56 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.784 -0.644 . . . . 74.310000000000002 111.431 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.62 57.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.092 0.472 . . . . 70.450000000000003 110.825 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.9 -6.03 37.17 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.368 -0.92 . . . . 72.430000000000007 112.675 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.7 130.84 35.2 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.098 -0.704 . . . . 74.510000000000005 109.098 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.62 2.03 6.47 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.47 -0.872 . . . . 71.439999999999998 113.129 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -104.37 115.35 30.22 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.126 -1.065 . . . . 73.109999999999999 108.126 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.591 ' CE2' HD21 ' A' ' 444' ' ' LEU . 27.0 m-85 -123.28 144.89 49.12 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.318 0.58 . . . . 75.439999999999998 110.8 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -135.26 122.62 21.79 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.77 -1.567 . . . . 72.329999999999998 106.77 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -93.89 121.75 35.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.045 0.45 . . . . 64.349999999999994 109.881 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.02 151.68 45.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.929 -1.138 . . . . 75.030000000000001 107.929 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -132.03 134.35 45.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.331 -0.618 . . . . 74.329999999999998 109.331 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.4 m -119.04 137.53 25.2 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 107.979 -1.119 . . . . 74.120000000000005 107.979 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.07 121.63 9.17 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.458 1.438 . . . . 74.310000000000002 109.606 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.575 ' O ' ' HD3' ' A' ' 492' ' ' PRO . 15.3 m -138.93 179.22 6.62 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.121 -1.437 . . . . 73.530000000000001 107.121 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.3 t -56.43 126.24 68.65 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-O 121.659 0.742 . . . . 72.409999999999997 110.164 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.51 -28.91 29.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 125.25 3.966 . . . . 63.020000000000003 115.739 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.69 -15.96 62.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.66 0.615 . . . . 73.510000000000005 112.66 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 73.3 mt -87.69 4.74 42.89 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 72.140000000000001 112.149 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.5 p -60.25 130.08 23.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 121.023 0.439 . . . . 61.25 110.172 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.51 68.54 Favored Glycine 0 C--N 1.307 -1.04 0 C-N-CA 120.631 -0.795 . . . . 61.200000000000003 111.656 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.88 144.33 42.62 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.138 0.494 . . . . 73.450000000000003 109.914 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.441 HG22 HD11 ' A' ' 486' ' ' ILE . 46.0 t -82.13 135.82 24.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.376 -0.972 . . . . 73.219999999999999 108.376 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.3 pt -97.96 -29.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 119.84 -0.744 . . . . 71.140000000000001 110.417 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -174.28 161.17 31.11 Favored Glycine 0 N--CA 1.424 -2.162 0 C-N-CA 120.395 -0.907 . . . . 74.209999999999994 111.639 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.0 p -118.7 152.81 35.44 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.194 -0.669 . . . . 73.140000000000001 109.194 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.473 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 16.7 t-20 -62.76 -54.56 46.34 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-O 119.156 -0.45 . . . . 73.219999999999999 111.416 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -75.81 134.16 16.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 N-CA-C 108.529 -1.374 . . . . 63.43 108.529 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.89 143.65 73.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.854 2.37 . . . . 72.439999999999998 113.206 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -88.89 -7.57 55.86 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.442 1.115 . . . . 60.32 109.437 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.91 -33.01 17.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.449 -1.25 . . . . 75.230000000000004 110.06 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -114.91 175.67 5.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.597 -0.729 . . . . 75.150000000000006 110.681 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 18.0 p -92.42 139.98 30.04 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 116.338 -0.392 . . . . 72.0 109.99 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 53.4 m -130.1 147.07 51.8 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.883 -0.784 . . . . 74.420000000000002 108.883 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.468 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.98 150.37 48.76 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.521 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.38 -24.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.626 -0.715 . . . . 72.319999999999993 110.025 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -81.14 2.27 28.24 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.807 -0.633 . . . . 70.209999999999994 111.085 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.37 145.66 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.924 -0.398 . . . . 71.5 109.924 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.4 p -86.35 120.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.265 -1.013 . . . . 71.420000000000002 108.265 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.44 117.23 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 C-N-CA 118.233 -1.387 . . . . 73.120000000000005 107.456 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.473 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.4 mt -97.97 112.21 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 105.438 -2.06 . . . . 74.109999999999999 105.438 175.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.85 120.4 51.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 N-CA-C 108.346 -0.983 . . . . 73.430000000000007 108.346 -175.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 120.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.328 0.585 . . . . 74.049999999999997 110.124 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.72 138.83 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.887 -1.153 . . . . 73.019999999999996 107.887 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.9 104.66 2.23 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 108.753 -1.739 . . . . 71.439999999999998 108.753 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.5 t -105.63 139.73 39.78 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.815 -1.18 . . . . 72.150000000000006 107.815 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -72.2 139.31 27.92 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 108.902 -1.679 . . . . 74.230000000000004 108.902 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 459' ' ' SER . 12.1 Cg_exo -66.89 105.76 1.01 Allowed 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.796 1.664 . . . . 72.109999999999999 111.404 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -79.3 104.51 9.97 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.483 -1.235 . . . . 73.230000000000004 108.965 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 546' ' ' PRO . 46.1 p -121.68 158.96 27.56 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.813 -1.085 . . . . 74.310000000000002 108.379 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -150.0 148.53 29.17 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.087 -0.338 . . . . 74.340000000000003 110.087 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.5 p-10 -80.36 131.6 35.65 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.45 0.643 . . . . 60.0 110.322 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.3 pt -75.4 131.29 77.98 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.177 -0.919 . . . . 75.450000000000003 111.461 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -92.14 119.64 0.5 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 122.639 2.226 . . . . 74.409999999999997 111.753 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.75 122.28 28.89 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.675 -1.232 . . . . 75.010000000000005 107.675 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.44 43.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.829 1.299 . . . . 72.129999999999995 110.631 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.72 145.97 43.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.358 -1.292 . . . . 72.340000000000003 112.242 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.0 -12.64 31.83 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.134 -0.555 . . . . 73.109999999999999 113.012 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.518 ' O ' HG11 ' A' ' 534' ' ' VAL . 25.5 mt-30 -108.17 -170.9 1.76 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 121.048 -0.261 . . . . 75.319999999999993 111.311 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.1 m -85.07 156.36 21.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.498 -1.297 . . . . 73.109999999999999 107.498 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.99 -41.19 90.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.576 0.626 . . . . 72.239999999999995 111.232 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.82 -42.06 97.73 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 116.492 -0.322 . . . . 65.319999999999993 111.424 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.8 -34.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 119.194 -1.003 . . . . 74.430000000000007 111.018 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.78 86.66 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.873 -0.603 . . . . 74.430000000000007 110.247 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -61.91 -42.27 98.89 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 123.255 0.347 . . . . 72.030000000000001 110.097 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.25 -48.36 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.342 -0.614 . . . . 73.310000000000002 109.342 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 -38.9 92.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.540000000000006 110.771 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.29 -43.68 73.34 Favored 'General case' 0 C--O 1.186 -2.263 0 CA-C-N 115.352 -0.84 . . . . 73.310000000000002 110.185 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.36 -46.55 86.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.433 0.635 . . . . 74.329999999999998 111.435 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.04 -18.65 21.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 74.310000000000002 111.316 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -129.87 18.41 5.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.932 -0.766 . . . . 75.0 108.932 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -162.61 -110.74 0.25 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.111 -1.042 . . . . 44.539999999999999 114.691 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -123.31 167.74 13.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.856 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 9.3 p -104.68 7.03 34.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.829 0.678 . . . . 73.310000000000002 112.829 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.0 OUTLIER -131.04 123.01 27.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.775 0.321 . . . . 73.230000000000004 110.781 -178.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.76 152.15 48.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 74.099999999999994 110.528 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 47.8 t -127.51 147.83 50.32 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.818 -1.919 . . . . 70.0 105.818 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -121.53 127.51 51.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 110.258 -0.275 . . . . 74.439999999999998 110.258 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 135.29 48.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.8 -0.637 . . . . 73.409999999999997 109.741 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 2.7 p -88.47 130.1 35.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.71 -0.677 . . . . 74.140000000000001 109.551 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.605 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.44 159.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.639 -0.504 . . . . 73.239999999999995 109.639 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.32 115.95 17.53 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.962 0.887 . . . . 73.400000000000006 109.795 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.9 m -95.26 157.3 36.61 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.883 -1.508 . . . . 71.230000000000004 110.68 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.72 -142.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.641 2.227 . . . . 73.439999999999998 108.817 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.578 ' HA ' ' NE ' ' A' ' 529' ' ' ARG . 4.3 mmp_? -58.35 -49.78 91.69 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 113.481 0.919 . . . . 73.510000000000005 113.481 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.82 149.0 47.17 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.269 1.313 . . . . 73.109999999999999 111.455 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.86 145.97 26.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.254 -1.017 . . . . 74.109999999999999 108.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.48 -53.07 0.74 Allowed Glycine 0 N--CA 1.437 -1.274 0 C-N-CA 120.683 -0.77 . . . . 74.299999999999997 112.431 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.06 149.56 48.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.127 0.571 . . . . 52.109999999999999 111.965 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -73.49 127.65 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 121.486 0.66 . . . . 73.230000000000004 109.584 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -24.65 44.55 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.717 -1.128 . . . . 74.329999999999998 109.642 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.09 -146.38 16.63 Favored Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 111.311 -0.716 . . . . 64.420000000000002 111.311 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -116.19 160.07 20.91 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.487 -0.931 . . . . 72.439999999999998 108.487 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -53.74 -54.24 48.56 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 111.813 0.301 . . . . 71.319999999999993 111.813 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.4 Cg_endo -92.56 167.67 2.73 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.253 1.969 . . . . 65.109999999999999 110.179 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.95 155.6 57.35 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.466 2.11 . . . . 71.450000000000003 111.538 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 137.88 58.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.757 -0.46 . . . . 75.25 109.757 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.43 -19.11 34.62 Favored Glycine 0 C--N 1.294 -1.751 0 C-N-CA 120.023 -1.084 . . . . 75.310000000000002 111.717 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -65.64 123.14 18.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.484 -0.932 . . . . 74.510000000000005 108.484 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 16.8 m -94.87 122.48 37.55 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.703 -0.48 . . . . 75.420000000000002 109.703 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.74 159.19 69.48 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.662 -0.866 . . . . 72.129999999999995 108.662 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.404 ' HA ' HG21 ' A' ' 494' ' ' THR . 32.2 Cg_exo -61.39 139.25 81.47 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.074 1.849 . . . . 72.519999999999996 111.339 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.63 -18.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.302 -0.863 . . . . 75.340000000000003 112.481 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.58 -9.55 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.16 -0.927 . . . . 74.519999999999996 109.78 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 45.1 m -92.34 152.1 19.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.217 -0.901 . . . . 54.200000000000003 110.795 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.5 t -88.38 133.53 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.869 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.2 tt -98.49 139.27 20.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.513 -0.551 . . . . 74.239999999999995 109.513 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.82 125.83 49.71 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 109.902 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.82 133.7 42.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.453 -0.943 . . . . 71.25 108.453 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -97.51 111.19 23.56 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.035 -1.098 . . . . 72.439999999999998 108.035 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.21 137.71 41.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 C-N-CA 120.532 -0.467 . . . . 75.430000000000007 111.996 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.2 m -68.02 117.67 10.18 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.353 -1.351 . . . . 73.200000000000003 107.353 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 8.1 ptmm? . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 118.516 -0.754 . . . . 75.530000000000001 112.341 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.756 0 N-CA-C 109.965 -1.254 . . . . 73.340000000000003 109.965 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.71 132.72 38.8 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.796 2.331 . . . . 74.439999999999998 111.866 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.15 31.06 6.32 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.164 0.507 . . . . 74.420000000000002 110.112 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -83.9 147.21 27.64 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 119.683 -0.807 . . . . 74.430000000000007 109.384 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 7.9 tpp85 -143.26 161.16 39.03 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.137 -1.06 . . . . 75.120000000000005 108.137 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.23 140.29 33.76 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 123.582 0.753 . . . . 64.010000000000005 112.018 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -96.67 126.89 41.47 Favored Pre-proline 0 N--CA 1.424 -1.735 0 N-CA-C 104.607 -2.368 . . . . 74.439999999999998 104.607 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.62 141.34 90.82 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.35 2.034 . . . . 73.209999999999994 114.381 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -100.76 -5.22 26.67 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.845 -1.07 . . . . 52.420000000000002 108.492 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.43 -4.68 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 122.542 1.163 . . . . 73.439999999999998 108.524 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 10.0 m -58.51 -31.98 68.4 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.922 -1.49 . . . . 75.340000000000003 109.283 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -57.14 -27.51 61.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.538 -1.21 . . . . 70.099999999999994 110.642 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.1 mt -89.99 -44.47 9.84 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.008 -0.677 . . . . 74.439999999999998 111.724 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 24.5 m -158.34 143.55 16.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.326 -0.859 . . . . 74.519999999999996 109.947 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.27 -45.92 79.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.848 0.459 . . . . 63.420000000000002 110.006 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.73 -35.27 65.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.901 -0.591 . . . . 75.349999999999994 111.782 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.468 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.0 mm-40 -70.79 -43.59 68.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.412 -0.358 . . . . 72.329999999999998 111.154 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.07 -51.22 70.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.363 -0.835 . . . . 73.099999999999994 110.554 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.87 -47.62 88.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 115.493 -0.776 . . . . 73.030000000000001 112.125 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -64.81 -42.91 94.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.677 -0.409 . . . . 74.25 111.629 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -66.44 -45.49 79.65 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.096 0.474 . . . . 74.299999999999997 110.176 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 34.6 tp -68.58 -37.35 79.78 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.767 -0.651 . . . . 73.349999999999994 111.065 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.9 m -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 109.846 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.9 -15.45 62.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.967 -0.56 . . . . 74.409999999999997 110.921 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -81.14 -14.83 57.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.211 0.529 . . . . 73.230000000000004 110.098 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.31 58.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.298 -0.954 . . . . 73.400000000000006 113.652 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 90.6 m-85 -72.58 146.02 46.98 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.911 -0.774 . . . . 74.5 108.911 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.25 -7.01 2.31 Favored Glycine 0 C--N 1.303 -1.275 0 C-N-CA 120.006 -1.092 . . . . 74.439999999999998 112.656 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 0.0 OUTLIER -102.5 115.42 30.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.859 -1.534 . . . . 75.150000000000006 106.859 -178.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.08 149.37 50.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.175 0.512 . . . . 75.150000000000006 110.722 -173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 485' ' ' ILE . 17.6 tppt? -138.64 123.02 18.3 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.537 -1.283 . . . . 74.349999999999994 107.537 169.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -102.74 134.85 45.45 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.331 0.586 . . . . 75.129999999999995 111.114 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.14 158.42 44.49 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.183 -1.043 . . . . 75.129999999999995 108.183 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -135.2 146.91 49.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.231 -1.026 . . . . 74.019999999999996 108.231 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.1 t -133.6 131.3 21.23 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.352 -0.981 . . . . 63.539999999999999 108.352 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -65.87 120.89 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.775 1.65 . . . . 73.519999999999996 109.989 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.0 m -140.79 179.48 6.68 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 106.735 -1.58 . . . . 74.319999999999993 106.735 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -52.49 133.82 44.18 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.341 0.401 . . . . 70.420000000000002 111.581 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG11 ' A' ' 464' ' ' VAL . 86.9 Cg_exo -50.45 -26.51 16.45 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 125.071 3.847 . . . . 72.319999999999993 113.05 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -57.27 -33.22 67.39 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.304 0.642 . . . . 53.520000000000003 110.568 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 93.9 mt -103.83 11.07 36.17 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.567 0.58 . . . . 74.120000000000005 112.567 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 461' ' ' PRO . 12.3 p -61.21 128.15 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 119.927 -0.709 . . . . 75.400000000000006 110.595 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.13 77.69 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 120.887 -0.673 . . . . 64.209999999999994 112.163 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.7 mptp? -100.31 148.69 24.4 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.685 -0.857 . . . . 74.120000000000005 108.685 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.93 125.35 39.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.758 -1.201 . . . . 70.129999999999995 107.758 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.92 -10.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 120.852 0.358 . . . . 74.200000000000003 111.386 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.22 149.04 8.06 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.176 -1.012 . . . . 71.239999999999995 112.193 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -119.03 140.48 49.97 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.494 -1.299 . . . . 74.120000000000005 107.494 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.6 t-20 -62.59 -53.83 53.56 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-O 118.963 -0.541 . . . . 75.420000000000002 111.765 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.1 Cg_exo -74.34 146.0 34.99 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 108.583 -1.353 . . . . 74.519999999999996 108.583 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.7 134.28 46.45 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.415 2.077 . . . . 72.200000000000003 112.918 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.63 6.44 47.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.481 1.134 . . . . 74.409999999999997 109.529 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.37 -21.87 13.75 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.279 -1.328 . . . . 63.130000000000003 109.278 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.7 155.54 39.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 111.413 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.7 p -83.99 123.91 30.49 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.653 -0.703 . . . . 74.140000000000001 109.516 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.8 m -115.59 150.74 36.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.716 -0.846 . . . . 62.310000000000002 108.716 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.99 151.21 46.51 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.24 0.216 . . . . 71.409999999999997 111.338 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.96 -17.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.83 0.852 . . . . 75.010000000000005 112.215 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.4 t -72.04 -6.05 39.55 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 116.44 -0.345 . . . . 72.519999999999996 110.851 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.95 131.1 35.75 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 122.633 0.373 . . . . 73.239999999999995 111.996 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.79 123.57 38.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.867 -1.16 . . . . 72.200000000000003 107.867 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.34 118.18 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 C-N-CA 119.067 -1.053 . . . . 74.510000000000005 109.322 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -97.21 112.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.685 -1.969 . . . . 73.129999999999995 105.685 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.42 121.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 115.908 -0.587 . . . . 73.310000000000002 109.559 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.97 120.45 52.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.183 0.516 . . . . 75.400000000000006 109.894 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.0 t -96.05 140.32 17.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-N 115.694 -0.684 . . . . 74.209999999999994 109.19 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.31 114.03 3.85 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.368 -1.093 . . . . 72.049999999999997 110.368 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 40.6 t -98.84 133.56 42.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.013 -1.106 . . . . 63.119999999999997 108.013 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -105.48 118.61 5.86 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.915 -0.874 . . . . 75.400000000000006 110.915 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.67 142.52 29.06 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.383 2.055 . . . . 70.400000000000006 110.505 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -97.67 100.25 11.63 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.259 -1.015 . . . . 75.409999999999997 108.259 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.7 p -131.55 143.9 50.71 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.429 -0.35 . . . . 74.239999999999995 110.534 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.84 164.59 27.23 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.07 -0.715 . . . . 72.349999999999994 109.07 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.17 134.02 35.77 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.06 -1.459 . . . . 74.200000000000003 107.06 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -76.65 132.49 71.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.67 -0.412 . . . . 74.109999999999999 110.251 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -91.42 178.46 1.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.763 2.309 . . . . 75.329999999999998 113.217 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.68 135.95 36.71 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.928 -1.138 . . . . 74.5 107.928 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.85 16.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.991 0.9 . . . . 61.020000000000003 109.407 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' A' ' 534' ' ' VAL . . . -68.06 132.43 47.24 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.899 -1.046 . . . . 62.420000000000002 111.801 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 117.91 -24.65 8.8 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.429 -0.891 . . . . 72.400000000000006 112.023 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.57 173.75 7.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.945 -0.761 . . . . 74.049999999999997 108.945 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 9.8 p -80.01 156.94 26.92 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.486 -0.486 . . . . 75.140000000000001 111.504 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.76 -42.26 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 O-C-N 123.838 0.712 . . . . 71.209999999999994 112.181 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.64 -39.44 80.71 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 121.017 -0.273 . . . . 73.439999999999998 111.592 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 83.8 t -71.1 -44.04 75.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.442 0.639 . . . . 73.319999999999993 110.827 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.08 -47.83 81.23 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 74.209999999999994 111.628 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.81 -35.62 81.68 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 121.042 -0.263 . . . . 71.310000000000002 110.579 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 514' ' ' VAL . 0.7 OUTLIER -65.14 -51.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.206 -0.664 . . . . 72.349999999999994 109.206 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.7 -37.8 87.92 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.96 -0.564 . . . . 74.420000000000002 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.67 -45.47 71.64 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.818 -0.628 . . . . 74.420000000000002 109.451 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.29 -41.27 88.53 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.033 0.753 . . . . 75.209999999999994 113.033 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 510' ' ' LYS . 90.3 t -64.23 -31.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 111.655 -177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.81 15.91 11.8 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.993 -0.283 . . . . 74.340000000000003 110.72 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.8 -98.08 0.2 Allowed Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 117.281 -2.39 . . . . 52.130000000000003 117.426 -169.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.646 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 78.1 m-85 -121.89 152.83 39.19 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.145 0.497 . . . . 74.549999999999997 111.791 -164.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.9 m -96.19 -27.48 15.01 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.02 -0.991 . . . . 73.430000000000007 111.871 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.75 134.66 51.16 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.156 -0.34 . . . . 75.129999999999995 110.09 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.77 145.53 51.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.347 0.594 . . . . 75.329999999999998 111.009 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.3 m -141.11 144.6 34.98 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.873 -1.529 . . . . 71.450000000000003 106.873 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.603 ' OE1' ' HB2' ' A' ' 553' ' ' LEU . 13.2 mm-40 -121.26 127.41 51.36 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.119 -1.067 . . . . 75.030000000000001 108.119 -172.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.427 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -114.28 133.45 55.64 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.991 -1.114 . . . . 73.030000000000001 107.991 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.7 m -88.55 130.81 35.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.165 0.507 . . . . 43.539999999999999 110.718 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.25 162.82 21.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 105.033 -2.21 . . . . 72.409999999999997 105.033 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.75 131.9 36.04 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 118.872 0.76 . . . . 61.149999999999999 111.991 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 66.4 p -77.04 150.38 80.88 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.946 -1.025 . . . . 75.400000000000006 109.215 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.52 -47.4 7.52 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.021 1.814 . . . . 71.5 110.512 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -163.2 -58.83 0.01 OUTLIER Pre-proline 0 C--O 1.222 -0.348 0 C-N-CA 127.316 2.246 . . . . 74.209999999999994 109.411 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 527' ' ' SER . 30.5 Cg_endo -66.85 135.96 39.99 Favored 'Trans proline' 0 C--N 1.36 1.137 0 N-CA-C 109.091 -1.157 . . . . 62.409999999999997 109.091 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.34 157.85 38.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.297 0.373 . . . . 73.109999999999999 110.145 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 115.13 -18.67 15.89 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 121.131 -0.557 . . . . 72.519999999999996 112.192 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.3 OUTLIER -87.36 148.46 25.02 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.253 0.549 . . . . 74.329999999999998 111.336 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 501' ' ' ALA . 11.4 p -81.26 128.87 38.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.822 -0.807 . . . . 73.430000000000007 108.822 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -78.44 -31.2 47.95 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.775 -0.824 . . . . 65.239999999999995 108.775 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.09 -157.29 28.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.16 -1.176 . . . . 52.329999999999998 110.16 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.4 p -117.56 160.77 20.7 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.154 -1.054 . . . . 72.030000000000001 108.154 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 64.4 t30 -58.67 -51.26 83.09 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 119.979 -0.688 . . . . 71.109999999999999 111.167 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.3 Cg_exo -81.53 155.73 18.68 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 121.33 1.353 . . . . 70.230000000000004 109.835 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.64 149.98 56.05 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.373 2.049 . . . . 71.230000000000004 112.025 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.18 129.89 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.353 0.661 . . . . 72.340000000000003 110.045 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -7.06 36.33 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.573 -0.822 . . . . 72.409999999999997 111.834 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.1 m -77.13 133.92 38.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.451 -0.574 . . . . 71.420000000000002 109.451 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.9 t -100.81 127.33 47.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.251 0.548 . . . . 73.430000000000007 110.312 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 517' ' ' PHE . 11.2 m -138.76 162.08 54.84 Favored Pre-proline 0 C--O 1.248 1.018 0 N-CA-C 109.331 -0.618 . . . . 72.140000000000001 109.331 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.84 135.03 46.23 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.483 2.122 . . . . 72.239999999999995 112.373 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.646 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 11.3 m -67.29 -21.12 27.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.699 0.762 . . . . 73.310000000000002 112.381 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.27 -7.96 55.95 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.602 -1.181 . . . . 64.010000000000005 109.324 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -92.14 179.0 5.69 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.432 -0.804 . . . . 72.439999999999998 110.764 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.31 124.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.84 -0.618 . . . . 64.340000000000003 112.365 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.3 tp -94.1 123.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 106.476 -1.676 . . . . 72.310000000000002 106.476 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.64 116.74 32.91 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-O 120.894 0.378 . . . . 74.109999999999999 110.082 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.603 ' HB2' ' OE1' ' A' ' 522' ' ' GLN . 6.1 mp -98.72 134.37 41.73 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.169 -0.923 . . . . 73.450000000000003 110.621 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.427 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 9.0 mm-40 -92.06 109.84 21.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.66 -1.978 . . . . 73.450000000000003 105.66 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.3 m -105.73 137.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 112.515 0.561 . . . . 74.519999999999996 112.515 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 49.5 m -72.72 114.53 10.96 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.577 0.703 . . . . 74.400000000000006 110.312 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 557' ' ' LYS . 7.3 tmtm? . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.046 -1.464 . . . . 75.519999999999996 107.046 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.3 0 N-CA-C 110.108 -1.197 . . . . 70.540000000000006 110.108 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 156.24 65.62 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.649 2.233 . . . . 62.200000000000003 111.959 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -107.55 20.7 18.52 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.992 0.901 . . . . 72.200000000000003 108.724 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.3 mt-30 -87.53 120.97 29.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.111 -0.95 . . . . 74.439999999999998 110.862 -174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -120.66 166.38 13.76 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.698 0.761 . . . . 73.209999999999994 110.536 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -84.38 140.3 31.66 Favored 'General case' 0 C--N 1.266 -3.053 0 CA-C-N 113.628 -1.623 . . . . 75.319999999999993 109.421 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.22 126.81 78.38 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 106.791 -1.559 . . . . 63.399999999999999 106.791 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.13 141.74 70.97 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.493 2.129 . . . . 71.219999999999999 112.399 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -112.41 70.64 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.532 1.158 . . . . 71.549999999999997 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.51 6.74 4.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 123.886 1.803 . . . . 65.5 106.226 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 0.7 OUTLIER -62.71 -30.97 71.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.32 -2.218 . . . . 73.109999999999999 109.308 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.0 m -58.37 -28.24 64.96 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 125.821 1.649 . . . . 64.25 110.642 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.5 -45.3 9.04 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.449 -0.501 . . . . 71.219999999999999 112.107 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.7 m -163.65 150.66 12.23 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.754 -0.832 . . . . 73.209999999999994 108.754 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.415 ' CZ ' HG22 ' A' ' 441' ' ' VAL . 32.7 t80 -53.08 -54.89 28.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.539 0.524 . . . . 75.549999999999997 110.704 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.7 -36.57 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 112.117 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -61.48 -45.77 92.83 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 112.313 0.486 . . . . 72.150000000000006 112.313 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -65.3 -44.58 87.49 Favored 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 123.68 0.613 . . . . 73.329999999999998 109.727 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.415 HG22 ' CZ ' ' A' ' 437' ' ' TYR . 90.8 t -59.02 -46.82 91.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.436 0 CA-C-N 115.368 -0.833 . . . . 74.019999999999996 111.629 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 442' ' ' LYS . 10.9 mmpt? -60.28 -47.03 87.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.824 0.284 . . . . 75.019999999999996 110.966 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.72 -38.95 87.71 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.937 -0.305 . . . . 63.549999999999997 111.244 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.8 tp -67.04 -41.27 86.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.16 0.505 . . . . 75.519999999999996 110.092 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.9 m -61.07 -45.27 95.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.998 -1.001 . . . . 73.219999999999999 109.022 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.96 62.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.68 -0.691 . . . . 74.129999999999995 111.718 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.28 -13.12 57.49 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.193 0.521 . . . . 74.530000000000001 110.724 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.93 20.35 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 120.665 -0.779 . . . . 65.230000000000004 112.3 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -69.23 118.08 11.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.53 -0.545 . . . . 74.239999999999995 109.53 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -106.72 -15.71 16.09 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.63 -0.714 . . . . 74.230000000000004 111.483 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -109.45 114.01 27.29 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.954 0.883 . . . . 74.25 110.344 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.7 154.46 40.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.665 -1.152 . . . . 75.209999999999994 111.208 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -131.33 125.45 32.76 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.16 -0.681 . . . . 73.349999999999994 109.16 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -88.69 121.02 30.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.981 0.419 . . . . 75.400000000000006 110.744 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.39 153.5 32.95 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 71.549999999999997 107.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.48 147.62 49.8 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.775 -0.824 . . . . 75.219999999999999 108.775 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.4 t -137.21 138.24 24.79 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 108.816 -0.809 . . . . 74.519999999999996 108.816 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.81 122.16 9.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 74.439999999999998 110.182 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -137.52 179.75 6.22 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.929 -1.137 . . . . 63.32 107.929 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.6 t -65.27 144.03 98.92 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.047 -0.723 . . . . 75.409999999999997 109.047 174.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.36 -28.03 25.82 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.571 3.514 . . . . 75.450000000000003 112.464 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -59.01 -34.44 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 123.393 0.677 . . . . 73.420000000000002 111.442 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.98 4.75 49.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.066 1.135 . . . . 75.430000000000007 114.066 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 79.5 t -60.5 130.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.152 0.501 . . . . 75.430000000000007 112.325 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.94 84.72 Favored Glycine 0 CA--C 1.504 -0.644 0 CA-C-N 115.252 -0.886 . . . . 72.129999999999995 112.646 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.07 151.62 38.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.838 -0.43 . . . . 75.420000000000002 109.838 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 486' ' ' ILE . 46.7 t -81.93 134.25 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.687 -0.857 . . . . 71.230000000000004 108.687 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.46 -24.36 4.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.59 -0.444 . . . . 70.140000000000001 111.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.85 168.05 38.17 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.684 -0.77 . . . . 74.209999999999994 111.952 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.3 p -121.03 153.13 37.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.668 -0.493 . . . . 72.209999999999994 109.668 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.467 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 23.2 t-20 -68.49 -52.74 19.17 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 119.299 -0.381 . . . . 73.019999999999996 111.272 174.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.76 129.64 10.08 Favored 'Trans proline' 0 C--N 1.365 1.418 0 CA-C-N 120.202 1.108 . . . . 75.439999999999998 109.605 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.41 ' HB2' ' NE2' ' A' ' 476' ' ' GLN . 28.9 Cg_endo -64.67 129.89 24.83 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.323 2.015 . . . . 75.230000000000004 112.25 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 0.71 30.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 111.605 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.99 -1.004 . . . . 55.329999999999998 109.165 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.584 HE21 ' N ' ' A' ' 476' ' ' GLN . 0.0 OUTLIER -129.79 157.84 41.08 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.109 -1.071 . . . . 71.430000000000007 108.109 177.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 37.4 p -86.72 123.67 32.13 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.997 -0.371 . . . . 74.230000000000004 109.997 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 50.4 m -108.58 145.18 35.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.395 -0.594 . . . . 71.439999999999998 109.395 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.26 153.2 43.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.152 -0.477 . . . . 71.219999999999999 110.781 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.87 -21.83 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.729 0.811 . . . . 74.540000000000006 110.7 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -76.66 9.09 3.0 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 116.037 -0.529 . . . . 74.209999999999994 111.944 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -98.6 145.83 26.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.378 0.271 . . . . 65.120000000000005 111.151 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.52 119.52 35.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.876 -1.157 . . . . 71.25 107.876 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 71.0 t -87.62 118.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 118.992 -1.083 . . . . 71.200000000000003 108.617 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.467 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 66.0 mt -94.86 114.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.795 -1.557 . . . . 74.239999999999995 106.795 176.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.27 128.36 59.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 115.656 -0.702 . . . . 75.310000000000002 109.488 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 38.1 mt -106.53 118.97 55.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 116.08 -0.509 . . . . 65.439999999999998 110.549 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.63 145.87 8.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.752 -0.658 . . . . 73.010000000000005 109.548 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -87.76 123.49 6.68 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.069 -0.812 . . . . 72.0 111.069 176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.8 m -123.6 137.61 54.71 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.414 -0.958 . . . . 62.509999999999998 108.414 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -100.78 144.49 16.7 Favored Glycine 0 C--N 1.314 -0.681 0 C-N-CA 120.541 -0.838 . . . . 70.209999999999994 112.827 -175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.84 116.2 4.46 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.01 2.473 . . . . 73.140000000000001 111.744 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -72.25 95.49 1.7 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.851 0.834 . . . . 72.040000000000006 111.483 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -134.67 154.39 51.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.206 -0.906 . . . . 74.409999999999997 110.85 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.49 149.6 30.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.869 -0.419 . . . . 75.409999999999997 109.869 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -90.58 139.14 30.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.654 -0.499 . . . . 74.450000000000003 109.654 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -96.19 138.44 21.59 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.777 -0.647 . . . . 73.310000000000002 112.019 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.25 171.26 11.46 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.522 2.148 . . . . 55.009999999999998 111.037 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -85.53 132.99 34.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.202 0.525 . . . . 74.010000000000005 110.174 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.73 11.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.962 0.887 . . . . 75.230000000000004 109.182 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.37 155.24 22.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.786 -0.643 . . . . 71.310000000000002 110.192 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 97.71 -13.26 64.08 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.539 -1.425 . . . . 63.140000000000001 109.539 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -94.53 179.65 5.2 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.438 -1.319 . . . . 75.109999999999999 107.438 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.0 m -83.67 155.28 23.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.718 -1.216 . . . . 73.019999999999996 107.718 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.8 -42.95 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.38 0.511 . . . . 73.230000000000004 112.38 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.24 -42.55 75.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.058 0.392 . . . . 70.129999999999995 112.058 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -75.08 -35.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.551 -0.86 . . . . 74.530000000000001 111.036 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.18 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.273 -0.876 . . . . 75.140000000000001 111.354 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.44 -34.74 78.89 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 121.249 -0.18 . . . . 75.0 110.969 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -64.67 -49.1 72.31 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.111 -0.329 . . . . 74.319999999999993 110.111 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.77 -46.52 81.79 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.242 0.544 . . . . 65.409999999999997 110.377 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.8 -36.58 81.53 Favored 'General case' 0 C--O 1.181 -2.551 0 CA-C-N 115.113 -0.949 . . . . 72.5 110.855 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.98 -39.28 81.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.246 0.546 . . . . 73.219999999999999 110.4 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.33 -34.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.496 -0.775 . . . . 73.420000000000002 111.336 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -111.27 11.3 21.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.566 0.698 . . . . 74.439999999999998 111.802 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.87 -111.97 1.33 Allowed Glycine 0 N--CA 1.417 -2.593 0 CA-C-N 115.412 -0.813 . . . . 75.519999999999996 111.893 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 37.1 m-85 -133.16 -177.15 4.39 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.542 -0.54 . . . . 72.439999999999998 109.542 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -106.98 -7.95 16.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.647 0.737 . . . . 72.530000000000001 109.729 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -108.11 115.99 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.863 -0.608 . . . . 63.329999999999998 110.061 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -126.25 151.49 47.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.785 0.802 . . . . 75.239999999999995 112.366 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.8 m -136.87 151.67 49.36 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.202 -1.407 . . . . 75.219999999999999 107.202 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.528 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.7 mm-40 -121.33 131.14 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.38 -0.6 . . . . 74.010000000000005 109.38 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.5 130.96 56.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.374 -0.602 . . . . 75.140000000000001 109.374 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 15.3 m -93.55 120.82 34.29 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.99 -0.745 . . . . 60.530000000000001 108.99 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.5 m -122.01 162.29 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 74.129999999999995 108.157 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . 0.262 13.8 m-20 -82.39 141.85 32.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.943 1.46 . . . . 74.439999999999998 114.943 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 2.7 m -97.55 144.03 27.24 Favored Pre-proline 0 C--N 1.28 -2.45 0 CA-C-N 113.425 -1.716 . . . . 73.430000000000007 109.016 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.94 -69.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 107.939 -1.6 . . . . 73.219999999999999 107.939 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -118.39 -59.4 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 118.494 -0.765 . . . . 75.329999999999998 112.291 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 527' ' ' SER . 54.7 Cg_endo -69.15 136.79 35.56 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 121.454 1.436 . . . . 71.439999999999998 111.811 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.08 123.03 16.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.861 -0.792 . . . . 65.319999999999993 108.861 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.08 -18.45 6.58 Favored Glycine 0 C--N 1.296 -1.662 0 N-CA-C 109.388 -1.485 . . . . 55.140000000000001 109.388 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -79.09 147.42 32.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.245 -0.977 . . . . 72.329999999999998 109.542 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.16 115.54 17.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 107.971 -1.122 . . . . 74.200000000000003 107.971 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 16.9 m -78.26 -24.83 46.68 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.65 -0.704 . . . . 75.409999999999997 109.544 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.54 -175.39 43.16 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.84 -0.904 . . . . 72.319999999999993 110.84 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.3 p -119.69 158.55 26.24 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.013 -1.477 . . . . 73.439999999999998 107.013 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.451 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -59.43 -53.14 68.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.292 -0.563 . . . . 73.450000000000003 111.609 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.6 Cg_endo -86.81 147.71 8.25 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.21 1.273 . . . . 64.219999999999999 109.172 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.63 153.01 65.2 Favored 'Trans proline' 0 C--O 1.245 0.825 0 C-N-CA 122.022 1.815 . . . . 73.129999999999995 112.279 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 129.49 40.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.87 -0.605 . . . . 72.319999999999993 109.488 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.34 -19.08 37.73 Favored Glycine 0 C--N 1.304 -1.225 0 C-N-CA 121.122 -0.561 . . . . 75.420000000000002 111.744 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 87.5 m -75.03 132.42 41.31 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.915 0.388 . . . . 71.030000000000001 110.386 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 29.1 m -91.05 123.72 34.73 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.79 -0.819 . . . . 75.519999999999996 108.79 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.67 160.98 63.76 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.159 -0.682 . . . . 74.530000000000001 109.159 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.39 134.69 49.64 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.275 1.983 . . . . 74.340000000000003 112.356 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 15.7 m -67.56 -19.87 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 122.434 1.111 . . . . 74.120000000000005 110.56 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.76 -13.71 58.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.599 -1.637 . . . . 64.430000000000007 109.307 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 64.1 m -93.25 169.43 10.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.074 -0.966 . . . . 75.409999999999997 111.865 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.35 133.48 44.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.964 -0.562 . . . . 71.439999999999998 110.188 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.8 tt -102.87 137.25 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.208 0.528 . . . . 74.400000000000006 110.015 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.79 129.71 51.24 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 116.076 -0.511 . . . . 72.140000000000001 110.355 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.528 ' HB3' ' OE1' ' A' ' 522' ' ' GLN . 6.4 tt -102.41 127.09 49.58 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.255 -1.387 . . . . 75.420000000000002 107.255 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -104.07 106.98 17.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.778 0.799 . . . . 71.299999999999997 109.28 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.62 138.02 37.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 114.831 -1.077 . . . . 75.430000000000007 111.793 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.485 ' HB2' ' OG ' ' A' ' 527' ' ' SER . 13.5 p -65.03 122.56 17.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 72.439999999999998 109.997 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 524' ' ' SER . 22.6 pttp . . . . . 0 C--O 1.259 1.564 0 CA-C-N 116.466 -0.334 . . . . 75.430000000000007 111.779 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.98 0 N-CA-C 109.7 -1.36 . . . . 52.409999999999997 109.7 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.54 132.98 30.59 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.159 1.906 . . . . 72.140000000000001 111.325 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 10.6 pt-20 -93.9 -4.92 49.05 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 75.219999999999999 109.935 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -114.28 133.04 55.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.552 -1.204 . . . . 74.549999999999997 109.022 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.562 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -120.51 161.51 21.17 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 108.109 -1.071 . . . . 74.010000000000005 108.109 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.84 141.6 32.15 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.369 0.668 . . . . 73.540000000000006 110.301 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.68 130.9 66.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 106.825 -1.546 . . . . 71.200000000000003 106.825 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.47 140.95 63.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.097 2.531 . . . . 71.340000000000003 113.931 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.53 -2.78 57.91 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.021 -0.99 . . . . 73.230000000000004 110.258 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.84 8.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.766 0.793 . . . . 72.209999999999994 110.832 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 4.3 p -61.39 -42.23 98.39 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.536 1.534 . . . . 75.140000000000001 110.832 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 7.1 p -66.34 -25.59 66.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.742 -1.117 . . . . 74.239999999999995 111.867 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.37 -46.31 17.86 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.26 -0.576 . . . . 73.530000000000001 110.297 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.9 m -169.59 147.15 3.47 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.058 -1.09 . . . . 74.140000000000001 108.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 441' ' ' VAL . 25.5 t80 -50.75 -49.13 58.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.657 0.783 . . . . 74.230000000000004 110.296 171.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -57.53 -35.86 70.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.652 -0.704 . . . . 53.509999999999998 111.871 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.495 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.6 mm-40 -70.66 -40.38 73.04 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.095 0.474 . . . . 75.420000000000002 110.857 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -46.38 90.09 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.169 -0.923 . . . . 70.230000000000004 110.364 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 437' ' ' TYR . 90.1 t -58.64 -47.41 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.45 -0.796 . . . . 74.340000000000003 111.961 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 61.7 mttp -62.91 -48.84 77.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.822 0.344 . . . . 74.409999999999997 110.439 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -68.27 -38.44 81.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.579 -0.737 . . . . 75.040000000000006 111.259 -176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 35.4 tp -68.47 -40.33 81.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.15 0.5 . . . . 74.329999999999998 109.983 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 38.6 m -60.93 -45.81 93.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.442 -0.799 . . . . 72.099999999999994 109.884 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.97 62.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.712 -0.676 . . . . 72.129999999999995 111.226 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.75 59.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.648 0.261 . . . . 64.120000000000005 110.358 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.25 -5.29 49.03 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.347 -0.93 . . . . 65.329999999999998 114.203 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 76.7 m-85 -62.96 139.12 58.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.866 0.333 . . . . 74.140000000000001 111.226 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.45 -2.93 9.66 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.39 -0.91 . . . . 73.530000000000001 113.37 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -119.31 115.63 24.54 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.527 -0.916 . . . . 75.319999999999993 108.527 -177.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -132.45 151.12 52.01 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.943 0.401 . . . . 74.400000000000006 110.161 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.46 ' HB3' HG13 ' A' ' 485' ' ' ILE . 61.8 tttp -139.6 122.62 16.75 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.251 -1.759 . . . . 74.209999999999994 106.251 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.84 135.08 42.85 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.88 -0.328 . . . . 73.519999999999996 110.244 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.95 155.17 50.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.494 -0.928 . . . . 61.420000000000002 108.494 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.42 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.5 p30 -133.9 138.53 45.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.679 -1.23 . . . . 73.219999999999999 107.679 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 t -134.98 143.54 46.56 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 108.849 -0.797 . . . . 73.030000000000001 108.849 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.68 122.19 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.142 1.895 . . . . 71.409999999999997 109.114 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -133.3 179.64 6.07 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.309 -0.86 . . . . 61.119999999999997 109.491 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -61.07 135.16 93.21 Favored Pre-proline 0 N--CA 1.417 -2.117 0 C-N-CA 123.755 0.822 . . . . 73.099999999999994 108.935 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 89.3 Cg_exo -50.64 -29.98 27.11 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.097 3.198 . . . . 65.209999999999994 115.123 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -75.76 -22.8 56.13 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.728 -0.789 . . . . 73.340000000000003 112.501 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.14 4.89 51.04 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.598 0.592 . . . . 75.319999999999993 112.598 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 15.0 p -61.2 127.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 C-N-CA 120.097 -0.641 . . . . 73.319999999999993 109.874 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.52 -6.05 77.53 Favored Glycine 0 C--N 1.308 -0.989 0 CA-C-N 115.595 -0.729 . . . . 73.319999999999993 113.169 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -110.0 157.14 19.61 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.61 -0.885 . . . . 75.209999999999994 108.61 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 48.9 t -82.26 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.844 -1.169 . . . . 75.349999999999994 107.844 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 34.9 pt -97.74 -20.41 5.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.21 -0.596 . . . . 71.430000000000007 109.688 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.54 155.24 14.64 Favored Glycine 0 N--CA 1.409 -3.132 0 C-N-CA 120.015 -1.088 . . . . 74.0 112.425 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.9 p -119.56 154.28 34.13 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.263 -1.754 . . . . 71.430000000000007 106.263 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.456 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 41.7 t-20 -65.12 -55.0 29.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 C-N-CA 119.975 -0.69 . . . . 62.140000000000001 110.625 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.73 126.94 9.21 Favored 'Trans proline' 0 C--N 1.365 1.428 0 N-CA-C 108.947 -1.213 . . . . 61.329999999999998 108.947 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.46 143.46 76.05 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.464 2.109 . . . . 65.310000000000002 112.264 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.533 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.27 4.58 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.183 0.992 . . . . 74.239999999999995 110.692 -176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -101.4 -9.28 21.27 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.456 -1.247 . . . . 74.030000000000001 109.471 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -122.27 167.48 13.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.517 -0.92 . . . . 74.409999999999997 108.517 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 30.6 p -98.03 143.43 28.59 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 109.619 -0.511 . . . . 72.019999999999996 109.619 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.6 m -128.98 147.41 50.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.016 -0.735 . . . . 73.349999999999994 109.016 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -54.52 153.39 5.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.586 0.958 . . . . 71.109999999999999 113.586 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.59 -32.29 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 110.241 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 36.39 4.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.779 1.276 . . . . 73.430000000000007 110.222 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.33 145.63 25.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 105.028 -2.212 . . . . 74.400000000000006 105.028 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.88 111.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.55 -1.26 . . . . 73.510000000000005 111.074 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.45 118.51 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.993 -1.114 . . . . 73.0 107.993 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.5 mp -95.23 112.69 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 74.239999999999995 106.286 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.79 118.39 50.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 109.481 -0.562 . . . . 74.120000000000005 109.481 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -100.07 121.68 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.393 -0.595 . . . . 72.0 109.393 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 134.02 35.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 109.087 -0.709 . . . . 75.340000000000003 109.087 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.36 115.73 5.21 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 109.82 -1.312 . . . . 71.099999999999994 109.82 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 456' ' ' ASN . 12.1 m -113.07 130.2 56.24 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.208 -0.664 . . . . 75.319999999999993 109.208 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -89.36 131.5 10.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 119.198 -0.779 . . . . 70.140000000000001 111.398 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.34 122.87 10.69 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.835 2.356 . . . . 75.519999999999996 112.394 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -75.43 95.82 3.33 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.254 1.026 . . . . 73.439999999999998 108.696 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.5 p -132.58 157.33 45.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.815 -1.084 . . . . 71.420000000000002 109.901 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 140.1 22.86 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.336 -0.987 . . . . 73.230000000000004 108.336 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.3 p-10 -89.78 136.08 33.25 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.305 -1.368 . . . . 72.099999999999994 107.305 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 541' ' ' ALA . 29.2 pt -81.97 134.99 48.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 116.071 -0.513 . . . . 73.219999999999999 112.367 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.54 -175.39 1.26 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.965 2.443 . . . . 74.420000000000002 112.08 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -91.22 95.39 10.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.289 0.566 . . . . 70.510000000000005 109.895 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.26 -3.86 10.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.828 0.823 . . . . 62.100000000000001 108.996 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.56 55.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.162 -1.381 . . . . 71.319999999999993 110.036 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.22 -16.72 38.29 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 111.001 -0.84 . . . . 64.430000000000007 111.001 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -97.92 -175.35 3.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.557 -0.905 . . . . 75.319999999999993 108.557 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.9 m -79.17 155.01 28.84 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.724 -0.843 . . . . 64.439999999999998 108.724 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.527 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 6.9 p -53.71 -45.65 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 123.608 0.568 . . . . 71.329999999999998 112.116 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.9 -41.96 77.54 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.76 0.652 . . . . 73.219999999999999 112.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.7 -37.41 35.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 119.946 -0.702 . . . . 73.219999999999999 111.788 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.05 91.25 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.082 -0.508 . . . . 71.299999999999997 111.202 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -65.26 -35.51 81.25 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.795 -0.362 . . . . 73.409999999999997 110.68 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 514' ' ' VAL . 19.5 mmtp -59.83 -50.49 73.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.165 0.432 . . . . 73.120000000000005 112.165 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -62.37 -38.66 90.42 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.915 0.388 . . . . 64.540000000000006 110.91 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.09 -46.28 71.42 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.632 -0.713 . . . . 74.310000000000002 109.906 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.3 t-20 -59.15 -48.03 83.1 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 124.025 0.93 . . . . 71.340000000000003 112.066 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 510' ' ' LYS . 98.3 t -60.89 -28.67 43.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.822 -0.626 . . . . 75.340000000000003 112.031 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.72 13.15 9.96 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.477 -0.889 . . . . 74.299999999999997 111.366 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -154.01 -88.78 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.44 0 C-N-CA 117.581 -2.247 . . . . 72.120000000000005 117.276 -170.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 55.7 m-85 -117.96 151.27 37.77 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.494 -0.353 . . . . 74.540000000000006 111.008 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 8.6 m -107.52 -25.72 11.25 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.081 -0.509 . . . . 74.230000000000004 110.673 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.3 126.29 52.66 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.32 -0.622 . . . . 75.349999999999994 109.32 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -128.4 144.11 51.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 110.853 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.4 m -121.79 153.59 38.1 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.005 -1.48 . . . . 74.450000000000003 107.005 172.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -127.2 129.36 47.67 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.116 -0.634 . . . . 63.020000000000003 110.833 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -117.57 144.03 45.52 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.225 -1.398 . . . . 74.230000000000004 107.225 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -101.86 135.36 43.54 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.971 0.415 . . . . 72.0 111.379 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 18.5 m -121.94 149.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.71 -1.219 . . . . 75.439999999999998 107.71 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.25 118.5 20.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.42 -0.585 . . . . 74.319999999999993 109.42 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 82.7 p -90.98 162.85 31.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 113.58 0.956 . . . . 74.209999999999994 113.58 -170.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -71.8 -138.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.548 2.832 . . . . 74.409999999999997 109.468 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -68.87 -53.45 14.85 Favored Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 113.082 0.771 . . . . 75.129999999999995 113.082 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.6 150.88 36.22 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 121.451 1.434 . . . . 73.530000000000001 112.062 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -149.9 145.69 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.682 -0.858 . . . . 50.409999999999997 108.682 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.11 -20.77 5.89 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 111.28 -0.728 . . . . 75.439999999999998 111.28 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 148.75 25.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.069 -0.345 . . . . 72.439999999999998 110.069 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.7 t -74.57 115.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.596 -1.631 . . . . 74.129999999999995 106.596 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.2 m -72.0 -33.27 67.96 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 109.824 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.93 -165.04 36.62 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 110.59 -1.004 . . . . 74.010000000000005 110.59 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.9 p -125.0 160.83 28.08 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 107.777 -1.194 . . . . 70.099999999999994 107.777 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.414 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 63.8 t30 -59.82 -51.13 82.96 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 119.757 -0.777 . . . . 74.129999999999995 111.27 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.1 Cg_exo -77.52 145.2 23.27 Favored 'Trans proline' 0 C--N 1.367 1.512 0 N-CA-C 108.832 -1.257 . . . . 73.030000000000001 108.832 171.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -70.54 152.09 65.05 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.188 1.925 . . . . 74.120000000000005 111.9 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.45 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -55.38 137.07 48.78 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.028 0.531 . . . . 71.329999999999998 110.765 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.68 -20.34 46.63 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 121.102 -0.57 . . . . 44.420000000000002 112.023 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 29.6 m -73.44 135.4 44.14 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.841 -0.211 . . . . 74.239999999999995 110.566 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 35.5 m -96.98 123.36 40.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.581 -0.525 . . . . 64.129999999999995 109.581 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.4 164.17 43.01 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 109.209 -0.663 . . . . 74.209999999999994 109.209 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -71.92 133.55 21.89 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 73.310000000000002 111.27 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.53 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.6 m -68.8 -20.88 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 74.340000000000003 111.141 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.8 -16.72 60.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.408 -1.269 . . . . 64.200000000000003 110.501 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.2 t -97.08 161.17 13.94 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.005 -0.739 . . . . 72.109999999999999 109.005 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.47 134.89 26.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.259 -0.645 . . . . 63.409999999999997 109.259 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -105.19 141.01 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.011 0.434 . . . . 53.350000000000001 110.577 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -103.08 121.56 42.86 Favored 'General case' 0 N--CA 1.406 -2.63 0 C-N-CA 123.525 0.73 . . . . 72.120000000000005 110.433 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.01 134.27 42.09 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 124.211 1.004 . . . . 62.409999999999997 110.015 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -92.27 108.25 19.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.859 -1.163 . . . . 71.209999999999994 107.859 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.82 138.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.798 -0.637 . . . . 72.120000000000005 110.33 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 6.2 p -65.91 119.55 11.5 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.129 0.966 . . . . 74.049999999999997 113.585 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 29.1 tttm . . . . . 0 C--O 1.262 1.763 0 C-N-CA 125.691 1.596 . . . . 74.209999999999994 108.431 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.655 0 N-CA-C 110.281 -1.128 . . . . 72.219999999999999 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.15 155.93 66.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.502 2.135 . . . . 61.549999999999997 111.502 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.0 OUTLIER -101.63 4.0 40.4 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.271 1.034 . . . . 70.239999999999995 108.443 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -107.69 137.92 44.84 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.986 -1.461 . . . . 73.219999999999999 109.662 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.15 156.12 40.62 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.947 -1.131 . . . . 73.209999999999994 107.947 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.08 141.89 31.68 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 123.524 0.73 . . . . 63.32 111.393 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -85.2 121.17 73.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.431 -0.951 . . . . 64.299999999999997 108.431 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.22 143.36 39.51 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.033 1.822 . . . . 74.340000000000003 112.253 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.66 32.24 0.59 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.778 0.799 . . . . 74.239999999999995 111.851 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.06 -12.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.863 -1.162 . . . . 74.120000000000005 107.863 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 11.6 m -60.49 -36.66 78.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.168 -1.378 . . . . 62.420000000000002 109.265 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -57.03 -27.74 61.9 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.217 -1.356 . . . . 75.209999999999994 110.465 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.59 -46.64 12.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.626 -0.43 . . . . 75.510000000000005 110.688 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 438' ' ' ALA . 40.5 m -166.47 149.05 6.81 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.201 -0.666 . . . . 74.439999999999998 109.201 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.54 -46.88 63.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.217 1.007 . . . . 73.25 110.374 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 73.340000000000003 111.365 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.49 -36.92 74.09 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.99 -0.55 . . . . 75.150000000000006 111.764 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -61.45 -52.37 64.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 124.342 1.026 . . . . 72.510000000000005 110.435 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 67.3 t -66.8 -50.64 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 115.129 -0.942 . . . . 73.329999999999998 111.808 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.405 ' HZ3' ' HB2' ' A' ' 442' ' ' LYS . 10.1 mtmp? -62.49 -45.37 93.34 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.767 0.654 . . . . 72.200000000000003 112.767 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -68.5 -40.81 80.74 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.873 -0.731 . . . . 74.329999999999998 110.933 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.51 -33.87 74.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.055 0.455 . . . . 73.329999999999998 109.813 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 37.1 m -59.68 -45.04 93.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.465 -0.789 . . . . 75.420000000000002 109.215 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -16.81 62.61 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.159 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.16 -13.78 54.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 110.452 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -18.18 9.1 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 120.308 -0.949 . . . . 61.149999999999999 113.178 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.95 130.59 42.61 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.889 -0.411 . . . . 75.540000000000006 109.889 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -118.92 -1.31 14.68 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.285 -0.959 . . . . 55.420000000000002 112.879 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.42 115.34 20.78 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.367 0.603 . . . . 74.140000000000001 109.961 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -125.62 154.87 41.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.895 -1.15 . . . . 75.120000000000005 107.895 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.438 ' HB3' HG12 ' A' ' 485' ' ' ILE . 28.0 tptp -133.98 122.97 23.83 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.569 -1.271 . . . . 73.25 107.569 174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -91.18 120.84 32.45 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.472 0.654 . . . . 60.140000000000001 110.662 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.08 155.62 28.96 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.212 -1.773 . . . . 74.099999999999994 106.212 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -138.15 144.3 40.71 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.288 -0.634 . . . . 75.409999999999997 109.288 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 t -134.59 140.32 35.19 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 107.616 -1.253 . . . . 72.310000000000002 107.616 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_exo -65.13 122.63 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.045 1.83 . . . . 71.420000000000002 110.634 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.6 t -144.05 179.91 6.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.587 -1.635 . . . . 52.219999999999999 106.587 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -63.55 145.32 97.41 Favored Pre-proline 0 N--CA 1.414 -2.262 0 O-C-N 123.316 0.385 . . . . 73.430000000000007 110.026 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -50.61 -28.07 21.17 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.734 3.623 . . . . 70.349999999999994 112.236 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.75 -24.1 65.46 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.923 0.889 . . . . 74.109999999999999 112.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.9 5.7 33.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.852 0.686 . . . . 64.109999999999999 112.852 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 98.8 t -61.06 128.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.975 0.416 . . . . 75.400000000000006 111.269 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.47 84.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.499 -0.773 . . . . 75.099999999999994 111.91 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -111.19 146.79 36.28 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.234 -1.025 . . . . 74.340000000000003 108.234 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.8 t -81.39 129.37 37.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.101 -1.074 . . . . 73.230000000000004 108.101 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.7 pt -98.75 -9.8 8.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 72.239999999999995 111.418 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.33 163.02 24.62 Favored Glycine 0 CA--C 1.482 -2.005 0 C-N-CA 119.547 -1.311 . . . . 73.299999999999997 110.863 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.8 p -116.73 146.13 43.0 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.779 -0.822 . . . . 63.509999999999998 108.779 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.5 t30 -57.72 -50.04 90.34 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 123.315 0.384 . . . . 73.319999999999993 110.531 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_endo -85.01 137.91 6.54 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 N-CA-C 107.838 -1.639 . . . . 75.239999999999995 107.838 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 475' ' ' ASN . 6.3 Cg_exo -61.27 141.01 91.62 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.343 1.362 . . . . 73.239999999999995 111.029 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.66 10.72 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.377 1.084 . . . . 72.340000000000003 109.905 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 473' ' ' PRO . 65.1 t30 -95.12 -29.91 14.32 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 113.84 -1.527 . . . . 65.450000000000003 108.398 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 473' ' ' PRO . 3.4 pt20 -98.86 170.78 8.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.779 -0.646 . . . . 64.230000000000004 109.93 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.7 p -98.49 134.02 42.05 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 116.036 -0.529 . . . . 71.129999999999995 109.886 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.0 m -114.0 145.53 41.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.462 -0.57 . . . . 72.219999999999999 109.462 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -59.39 148.11 33.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.974 0.416 . . . . 72.319999999999993 111.992 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.51 -30.74 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 123.537 0.735 . . . . 74.340000000000003 111.514 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -101.39 17.24 23.17 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.284 0.564 . . . . 65.510000000000005 110.549 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -88.56 139.3 30.62 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.785 -1.191 . . . . 72.319999999999993 107.785 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.95 111.08 16.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.642 0.734 . . . . 64.109999999999999 109.363 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.89 118.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.515 -0.92 . . . . 74.310000000000002 108.515 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 46.8 mt -99.25 111.55 29.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.501 -1.296 . . . . 74.239999999999995 107.501 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.466 ' O ' HD13 ' A' ' 486' ' ' ILE . 0.0 OUTLIER -103.7 129.97 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-O 121.075 0.464 . . . . 74.420000000000002 110.16 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.71 116.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.233 -1.025 . . . . 64.439999999999998 108.233 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.42 140.07 18.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.966 -0.561 . . . . 73.25 109.568 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.71 118.15 6.93 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.454 -1.058 . . . . 74.349999999999994 110.454 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.3 m -119.96 132.72 55.6 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.846 -0.798 . . . . 73.209999999999994 108.846 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -136.27 103.18 0.43 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.991 -1.243 . . . . 72.150000000000006 109.991 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.18 118.97 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.039 1.826 . . . . 72.409999999999997 111.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -74.79 99.84 3.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.12 -1.067 . . . . 75.120000000000005 108.12 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 35.6 p -124.66 156.92 36.75 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.077 -0.965 . . . . 70.239999999999995 108.956 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.05 150.29 31.53 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 75.510000000000005 107.779 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 544' ' ' THR . 6.7 p-10 -99.46 138.22 36.86 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 120.948 0.404 . . . . 74.530000000000001 110.282 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.419 HG13 ' HA ' ' A' ' 541' ' ' ALA . 31.5 pt -88.15 133.91 36.02 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.556 -0.747 . . . . 74.299999999999997 111.985 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.3 177.0 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.603 2.202 . . . . 72.349999999999994 110.877 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.07 115.45 27.34 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.635 -0.426 . . . . 74.209999999999994 110.295 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.2 14.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.514 1.15 . . . . 74.140000000000001 108.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.49 143.23 46.68 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.09 -0.959 . . . . 75.340000000000003 110.48 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.7 -24.71 10.09 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.056 -0.592 . . . . 70.030000000000001 111.631 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -91.89 177.62 6.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.183 -0.673 . . . . 74.340000000000003 109.183 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.6 m -75.85 155.47 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.628 -0.508 . . . . 74.219999999999999 109.628 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.51 -49.1 14.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 123.719 0.637 . . . . 73.140000000000001 112.614 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.42 -42.51 74.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.259 0.466 . . . . 64.319999999999993 112.259 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -39.48 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 119.786 -0.766 . . . . 75.129999999999995 111.861 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.56 83.66 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.785 -0.643 . . . . 65.319999999999993 111.365 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.75 -35.52 80.96 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 120.219 -0.592 . . . . 74.109999999999999 110.5 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 513' ' ' ASN . 59.9 tttp -63.11 -48.9 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.462 0.648 . . . . 73.099999999999994 110.139 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -68.84 -38.24 79.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.264 -0.88 . . . . 70.129999999999995 111.453 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.03 -35.94 81.01 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 108.969 -0.752 . . . . 70.420000000000002 108.969 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 510' ' ' LYS . 2.5 t-20 -57.28 -38.8 74.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 75.430000000000007 110.115 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.06 -44.28 97.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 110.632 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -103.23 16.46 26.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 65.209999999999994 111.235 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.1 -117.9 1.28 Allowed Glycine 0 N--CA 1.414 -2.792 0 C-N-CA 120.766 -0.731 . . . . 71.430000000000007 112.421 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 16.7 m-85 -122.01 173.4 7.56 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 110.263 -0.273 . . . . 72.0 110.263 -171.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 19.5 p -96.23 -14.26 22.83 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.752 -0.658 . . . . 75.209999999999994 111.409 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.18 115.69 29.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.559 -0.291 . . . . 75.340000000000003 111.448 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -120.98 151.34 39.85 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.278 0.561 . . . . 74.319999999999993 111.095 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.2 m -135.64 152.21 51.0 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.892 -1.892 . . . . 75.209999999999994 105.892 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -119.39 123.55 44.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.634 -0.876 . . . . 74.439999999999998 108.634 -170.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.84 121.24 42.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.451 -0.574 . . . . 72.5 109.451 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.4 p -87.88 116.27 25.92 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.115 0.484 . . . . 73.420000000000002 110.099 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.53 162.14 21.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 115.533 -0.758 . . . . 75.439999999999998 110.16 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.69 121.44 24.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.152 0.977 . . . . 72.430000000000007 109.967 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 556' ' ' SER . 2.6 p -144.9 101.77 4.52 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 114.189 -1.369 . . . . 72.450000000000003 109.967 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.61 -57.35 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.559 2.839 . . . . 71.25 114.481 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.434 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 57.1 mtt180 -80.04 -49.43 1.27 Allowed Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 113.06 0.763 . . . . 75.150000000000006 113.06 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 39.6 Cg_exo -62.03 134.94 52.2 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.739 1.626 . . . . 72.25 112.306 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.07 74.36 0.97 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.646 -0.872 . . . . 65.230000000000004 108.646 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.89 3.68 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 110.747 -0.941 . . . . 73.5 110.747 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -86.19 149.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.256 0.55 . . . . 75.030000000000001 111.147 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 87.7 t -73.71 124.7 31.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.345 -0.843 . . . . 64.25 109.079 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.6 m -76.23 -28.95 57.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.592 -1.185 . . . . 73.349999999999994 110.252 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.77 -159.66 31.2 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.03 -1.228 . . . . 73.219999999999999 110.03 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.5 p -127.18 157.38 39.92 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.261 -1.015 . . . . 65.219999999999999 108.261 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.5 t30 -66.81 -54.65 20.56 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.086 -0.645 . . . . 75.310000000000002 110.613 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.5 Cg_exo -71.7 131.59 18.82 Favored 'Trans proline' 0 C--N 1.377 2.033 0 N-CA-C 108.113 -1.534 . . . . 64.129999999999995 108.113 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.4 147.46 90.69 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.463 2.108 . . . . 71.120000000000005 113.075 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.419 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -63.26 142.82 58.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.988 -0.551 . . . . 53.299999999999997 110.56 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.99 64.0 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.519 -0.632 . . . . 61.210000000000001 111.519 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.1 m -79.65 132.39 36.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.582 -0.525 . . . . 71.510000000000005 109.582 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 496' ' ' ASP . 41.2 m -97.91 122.23 40.77 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.308 -0.997 . . . . 73.329999999999998 108.308 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.52 165.25 37.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.472 -0.936 . . . . 74.030000000000001 108.472 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 137.58 78.7 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.493 2.129 . . . . 72.519999999999996 113.69 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.653 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -67.3 -19.69 25.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.157 -0.929 . . . . 75.540000000000006 112.259 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.76 -3.67 58.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.674 -1.148 . . . . 65.439999999999998 109.667 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.7 m -95.7 152.24 18.64 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 115.371 -0.831 . . . . 65.209999999999994 110.559 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.9 t -88.71 134.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.688 -0.687 . . . . 75.209999999999994 110.433 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.53 141.96 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 109.551 -0.537 . . . . 75.409999999999997 109.551 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -103.02 122.37 44.49 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.814 -0.809 . . . . 72.420000000000002 108.814 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.22 128.85 44.9 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.031 -0.986 . . . . 74.129999999999995 108.751 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -88.2 106.31 18.11 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.82 -0.807 . . . . 71.230000000000004 108.82 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 524' ' ' SER . 29.7 m -105.56 139.11 27.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 115.662 -0.699 . . . . 74.120000000000005 110.429 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.429 ' HA ' ' OG ' ' A' ' 527' ' ' SER . 22.3 p -57.16 120.76 8.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.537 -0.756 . . . . 73.109999999999999 112.139 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 524' ' ' SER . 57.4 tttm . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 109.31 -0.626 . . . . 74.310000000000002 109.31 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.631 0 N-CA-C 110.408 -1.077 . . . . 62.109999999999999 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.8 141.28 96.51 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.699 2.266 . . . . 74.120000000000005 111.045 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER -92.7 -1.01 57.19 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.504 0.668 . . . . 74.510000000000005 109.552 -179.174 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 60.0 mt-30 -109.69 125.54 52.74 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.561 -1.2 . . . . 74.230000000000004 108.926 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -123.12 160.44 26.44 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.169 -1.048 . . . . 73.430000000000007 108.169 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.97 141.64 28.46 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.635 -0.505 . . . . 73.099999999999994 109.635 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.59 119.41 76.76 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.73 -0.841 . . . . 74.209999999999994 108.73 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.94 144.51 43.19 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.275 1.983 . . . . 65.209999999999994 111.99 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.97 59.44 5.63 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.164 1.459 . . . . 74.409999999999997 109.17 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.14 -5.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 106.333 -1.728 . . . . 73.409999999999997 106.333 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.472 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 1.3 p -63.25 -32.37 73.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.864 -1.971 . . . . 71.209999999999994 109.704 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.6 t -63.02 -26.79 69.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.332 -1.304 . . . . 63.109999999999999 111.103 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.54 -46.7 10.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.02 -1.072 . . . . 75.299999999999997 111.488 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.442 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 1.8 m -171.88 150.6 2.63 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.172 -1.047 . . . . 75.319999999999993 108.172 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -52.63 -48.27 66.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.224 0.61 . . . . 74.420000000000002 110.631 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.78 66.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.731 -0.668 . . . . 54.210000000000001 111.968 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.4 mm-40 -70.98 -42.85 69.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.285 -0.416 . . . . 75.439999999999998 111.126 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.6 -47.06 87.89 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.199 -0.909 . . . . 73.450000000000003 110.75 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.54 -48.78 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.663 -0.699 . . . . 71.450000000000003 111.227 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -62.29 -44.65 96.02 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.024 0.379 . . . . 72.430000000000007 112.024 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 443' ' ' LYS . 6.5 mmpt? -66.56 -42.68 86.72 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.76 -0.376 . . . . 73.409999999999997 111.673 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.3 tp -69.41 -32.97 72.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.274 0.559 . . . . 71.219999999999999 110.106 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.6 m -64.45 -41.55 96.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.847 -0.615 . . . . 74.019999999999996 109.405 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.23 -16.22 63.02 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.168 0.508 . . . . 73.120000000000005 110.942 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.65 -13.06 46.66 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.099 -0.5 . . . . 73.349999999999994 110.086 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.54 -9.31 24.08 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.002 -0.618 . . . . 72.319999999999993 113.95 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -71.85 143.72 49.32 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.889 0.344 . . . . 73.299999999999997 111.194 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -149.0 16.54 1.19 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.69 -0.767 . . . . 64.310000000000002 112.319 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -120.97 115.77 23.82 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.987 -1.486 . . . . 72.519999999999996 106.987 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.36 160.64 39.7 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 113.514 0.931 . . . . 74.200000000000003 113.514 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -142.33 134.08 26.93 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.197 1.799 . . . . 75.239999999999995 107.012 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -103.65 132.03 50.27 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.62 -0.511 . . . . 73.420000000000002 109.62 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.53 139.24 53.37 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.767 -0.827 . . . . 75.409999999999997 108.767 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -114.17 130.19 56.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.607 -0.886 . . . . 62.350000000000001 108.607 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.1 m -120.63 138.17 27.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.517 -0.311 . . . . 74.349999999999994 110.433 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.85 122.61 9.26 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.357 2.038 . . . . 74.319999999999993 111.007 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -144.75 179.07 7.55 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.039 -1.467 . . . . 74.510000000000005 107.039 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.557 ' OG1' ' HD2' ' A' ' 461' ' ' PRO . 6.6 t -70.76 144.2 90.56 Favored Pre-proline 0 N--CA 1.433 -1.322 0 N-CA-C 109.039 -0.726 . . . . 74.299999999999997 109.039 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.557 ' HD2' ' OG1' ' A' ' 460' ' ' THR . 2.0 Cg_endo -48.8 -27.88 12.0 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 125.165 3.91 . . . . 72.209999999999994 115.476 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.72 -13.22 61.98 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.29 -1.364 . . . . 54.420000000000002 112.343 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.23 -0.14 44.64 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.831 -0.543 . . . . 71.129999999999995 111.364 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 84.9 t -61.51 128.14 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.799 -0.445 . . . . 75.430000000000007 109.799 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.79 -16.73 60.15 Favored Glycine 0 C--O 1.244 0.773 0 C-N-CA 121.099 -0.572 . . . . 73.109999999999999 111.996 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -92.77 142.66 27.1 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.894 -0.78 . . . . 74.150000000000006 108.894 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 60.2 t -82.85 124.85 39.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.628 -1.619 . . . . 75.150000000000006 106.628 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.16 -5.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 118.667 -1.213 . . . . 75.010000000000005 111.803 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.14 160.14 27.84 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 119.775 -1.202 . . . . 55.119999999999997 112.666 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.4 p -134.42 145.33 48.79 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.196 -1.409 . . . . 71.510000000000005 107.196 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.441 ' OD1' ' HB ' ' A' ' 485' ' ' ILE . 12.5 m120 -64.4 -51.08 63.11 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 120.364 -0.534 . . . . 75.129999999999995 112.202 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.55 123.38 11.35 Favored 'Trans proline' 0 C--O 1.253 1.252 0 N-CA-C 108.716 -1.302 . . . . 70.420000000000002 108.716 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.38 139.19 37.52 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.217 1.945 . . . . 71.299999999999997 112.185 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.24 2.14 37.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.724 0.773 . . . . 73.5 110.608 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.24 -32.92 24.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.877 -1.056 . . . . 55.140000000000001 110.094 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.67 178.37 4.42 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.155 -1.054 . . . . 74.109999999999999 108.155 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 32.5 p -97.04 126.54 42.26 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-O 121.277 0.561 . . . . 70.409999999999997 110.547 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -106.77 147.05 30.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.479 -0.934 . . . . 60.310000000000002 108.479 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.5 147.58 41.75 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 120.9 0.381 . . . . 72.310000000000002 111.584 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.85 -21.9 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.31 1.044 . . . . 75.5 111.26 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -94.85 1.78 55.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.417 -0.811 . . . . 71.329999999999998 110.103 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -78.83 144.6 34.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.971 -0.751 . . . . 74.030000000000001 108.971 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 38.7 t -82.13 112.49 20.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.558 -1.275 . . . . 75.0 107.558 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.69 119.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 N-CA-C 109.176 -0.676 . . . . 71.519999999999996 109.176 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.441 ' HB ' ' OD1' ' A' ' 471' ' ' ASN . 3.3 mp -97.68 119.48 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.463 -2.051 . . . . 74.219999999999999 105.463 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.19 128.43 65.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.95 -0.568 . . . . 72.439999999999998 109.981 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 58.5 mt -103.65 112.51 37.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-N 115.299 -0.864 . . . . 74.430000000000007 110.52 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.16 140.57 17.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 115.517 -0.765 . . . . 73.530000000000001 109.585 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.68 129.3 9.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.237 -1.145 . . . . 33.119999999999997 110.237 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.5 p -135.58 152.03 50.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.842 -0.429 . . . . 62.520000000000003 109.842 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -108.38 156.3 15.8 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.986 -1.245 . . . . 54.140000000000001 109.986 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.53 120.18 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.1 1.867 . . . . 72.209999999999994 110.399 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -73.42 90.35 1.69 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.743 0.783 . . . . 62.420000000000002 109.512 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -138.72 162.81 33.76 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.197 -0.911 . . . . 72.200000000000003 110.476 -172.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.484 ' HB3' ' CE1' ' A' ' 517' ' ' PHE . 48.0 tptt -146.61 139.85 25.63 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.267 -0.424 . . . . 73.439999999999998 110.318 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -80.61 137.73 36.39 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.214 1.005 . . . . 72.450000000000003 109.023 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.6 pt -97.34 133.29 24.04 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 120.041 -0.663 . . . . 75.299999999999997 110.674 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.22 178.22 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.512 2.141 . . . . 74.200000000000003 110.296 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.0 122.53 38.92 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.153 -0.619 . . . . 73.239999999999995 110.045 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.36 6.02 5.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.652 -0.704 . . . . 72.230000000000004 110.102 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.446 ' HA ' HG11 ' A' ' 534' ' ' VAL . . . -74.01 147.2 43.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.553 -0.749 . . . . 73.019999999999996 110.712 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.46 -14.23 56.63 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.051 -0.82 . . . . 72.439999999999998 111.051 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -99.58 -170.04 1.84 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.583 -0.525 . . . . 61.130000000000003 109.583 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.1 m -82.08 155.77 24.91 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.667 -1.234 . . . . 74.430000000000007 107.667 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.76 -42.09 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.712 0.292 . . . . 74.409999999999997 111.537 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 31.9 t70 -68.19 -43.46 78.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.197 0.443 . . . . 61.0 112.197 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.26 -34.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.77 -0.772 . . . . 73.120000000000005 110.839 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.73 -49.18 78.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.728 . . . . 74.319999999999993 110.752 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.61 -34.66 78.76 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 120.669 -0.412 . . . . 73.129999999999995 111.009 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 12.7 mmmm -57.36 -53.16 61.29 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.166 0.291 . . . . 73.310000000000002 111.148 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -62.84 -40.63 98.04 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.38 0.61 . . . . 75.239999999999995 110.285 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.91 -38.51 91.21 Favored 'General case' 0 C--O 1.191 -2.02 0 CA-C-N 115.081 -0.963 . . . . 74.420000000000002 110.928 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.13 -37.96 84.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.163 0.585 . . . . 75.230000000000004 111.54 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.24 -29.8 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 73.299999999999997 110.697 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.66 31.21 6.36 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.166 -0.334 . . . . 74.430000000000007 110.363 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -160.39 -108.7 0.24 Allowed Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 119.009 -1.567 . . . . 51.420000000000002 113.759 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 495' ' ' LYS . 18.3 m-85 -137.69 177.26 8.01 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.876 -0.787 . . . . 75.129999999999995 108.876 -172.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 m -112.13 6.5 19.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 122.296 1.046 . . . . 71.340000000000003 108.725 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -108.52 115.75 30.69 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.647 -0.872 . . . . 72.219999999999999 108.647 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -128.16 150.87 49.81 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.293 0.371 . . . . 72.420000000000002 110.222 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.8 m -130.8 155.7 46.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.572 -1.27 . . . . 73.129999999999995 107.572 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -121.91 122.25 38.96 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.998 0.428 . . . . 75.329999999999998 110.001 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.47 56.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.777 -0.823 . . . . 62.399999999999999 108.777 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -90.07 118.9 29.96 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.575 -0.898 . . . . 75.319999999999993 108.575 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.6 152.23 25.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.584 -0.895 . . . . 74.409999999999997 108.584 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.64 123.04 25.53 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.606 1.193 . . . . 54.329999999999998 111.098 -169.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.5 m -128.49 101.04 21.63 Favored Pre-proline 0 N--CA 1.416 -2.138 0 CA-C-N 113.795 -1.548 . . . . 65.420000000000002 109.102 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.26 -57.15 1.19 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.032 2.488 . . . . 74.040000000000006 112.538 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -88.33 -49.41 0.43 Allowed Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 113.349 0.87 . . . . 74.239999999999995 113.349 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.59 146.52 95.38 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 121.883 1.722 . . . . 71.329999999999998 112.701 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.11 85.04 0.32 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.395 1.078 . . . . 75.310000000000002 108.381 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.0 -35.05 2.44 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 110.543 -1.023 . . . . 72.319999999999993 110.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -85.31 147.21 26.65 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.155 0.502 . . . . 71.420000000000002 109.91 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 501' ' ' ALA . 4.4 p -75.07 126.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.499 -0.926 . . . . 74.030000000000001 108.499 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.2 m -72.11 -36.57 69.48 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.331 -0.85 . . . . 63.32 109.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 172.46 -167.44 40.35 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.258 -0.972 . . . . 60.039999999999999 111.728 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.1 p -118.71 160.62 21.53 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.525 -0.917 . . . . 71.099999999999994 108.525 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.6 t-20 -61.58 -53.39 61.91 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.93 -0.308 . . . . 74.030000000000001 111.33 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -87.81 144.93 6.5 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 108.912 -1.226 . . . . 73.239999999999995 108.912 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.13 150.83 72.52 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 121.816 1.677 . . . . 73.340000000000003 111.447 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.09 135.83 36.72 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.674 0.79 . . . . 74.420000000000002 111.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.98 -26.51 20.52 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.228 -0.749 . . . . 61.439999999999998 111.228 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 88.2 m -65.68 133.69 51.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.501 . . . . 72.439999999999998 111.184 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.3 m -101.99 122.87 44.88 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.271 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.44 155.55 71.65 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.639 -0.504 . . . . 73.010000000000005 109.639 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.86 138.98 88.82 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.664 2.243 . . . . 70.450000000000003 112.944 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.464 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 21.4 m -67.04 -19.7 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 122.344 1.069 . . . . 71.549999999999997 110.344 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.31 -2.67 39.14 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.956 -1.475 . . . . 73.219999999999999 110.453 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -108.43 172.38 6.87 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.751 -0.833 . . . . 74.25 108.751 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.58 136.34 50.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.872 -0.788 . . . . 74.519999999999996 108.872 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.51 138.88 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 120.063 -0.655 . . . . 74.409999999999997 110.531 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -102.17 124.01 47.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-O 121.241 0.543 . . . . 74.310000000000002 110.032 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.98 131.2 46.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.233 -1.765 . . . . 73.099999999999994 106.233 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -107.12 105.95 16.2 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.717 0.77 . . . . 75.040000000000006 110.234 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.03 139.83 16.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.134 -1.394 . . . . 75.420000000000002 111.487 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.1 p -56.33 114.71 2.1 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 63.200000000000003 112.903 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.358 -1.719 . . . . 73.120000000000005 106.358 174.129 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 110.428 -1.069 . . . . 54.030000000000001 110.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.49 163.15 27.26 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.922 1.748 . . . . 72.109999999999999 113.073 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.45 33.53 2.68 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.829 1.252 . . . . 75.299999999999997 107.79 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HB3' ' C ' ' A' ' 477' ' ' THR . 96.0 mt-30 -110.1 135.67 50.54 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.004 -1.453 . . . . 74.129999999999995 109.962 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -126.29 158.53 35.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.036 0.446 . . . . 74.549999999999997 111.436 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.92 141.99 30.0 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.789 -1.096 . . . . 75.430000000000007 110.532 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.27 129.93 70.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.721 -0.844 . . . . 73.219999999999999 108.721 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.89 141.8 65.6 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.671 2.914 . . . . 72.319999999999993 114.792 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.26 -3.05 48.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.918 -1.037 . . . . 74.150000000000006 111.271 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.8 m -85.68 3.39 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.603 0.716 . . . . 71.400000000000006 110.812 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.453 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 14.8 m -61.48 -29.57 70.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.823 -1.08 . . . . 71.319999999999993 110.196 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.494 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 18.2 p -62.44 -27.87 69.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.102 -0.953 . . . . 75.409999999999997 111.524 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.409 ' C ' ' HG1' ' A' ' 436' ' ' THR . 65.4 mt -78.6 -45.44 21.63 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.925 -0.398 . . . . 74.549999999999997 109.925 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.486 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 16.1 m -166.79 148.27 6.13 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.717 -0.846 . . . . 71.540000000000006 108.717 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.401 ' O ' HG22 ' A' ' 441' ' ' VAL . 53.1 t80 -53.27 -43.01 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.925 0.89 . . . . 74.239999999999995 111.301 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.75 -41.16 85.88 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.483 -0.326 . . . . 63.32 111.24 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.486 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.5 mm-40 -63.69 -40.61 97.23 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.248 0.547 . . . . 74.519999999999996 110.099 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -50.96 71.54 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.982 -1.008 . . . . 73.010000000000005 110.595 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 437' ' ' TYR . 92.7 t -59.42 -45.84 93.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.37 -0.832 . . . . 71.230000000000004 111.819 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 67.7 mttm -63.05 -47.28 83.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.695 0.283 . . . . 74.109999999999999 111.591 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -67.78 -38.81 83.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.312 -0.404 . . . . 74.25 111.399 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.55 -37.98 83.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.235 0.54 . . . . 74.230000000000004 109.88 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.2 m -59.47 -47.87 83.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.425 -0.807 . . . . 73.109999999999999 109.784 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.45 -15.83 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.011 -0.541 . . . . 62.530000000000001 111.933 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.0 -13.73 59.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.242 0.544 . . . . 75.530000000000001 110.433 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.88 -17.62 24.88 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.421 -0.895 . . . . 62.130000000000003 113.11 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -64.05 126.95 29.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.109 0.481 . . . . 74.450000000000003 111.082 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.485 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -110.12 -1.89 29.91 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.385 -0.825 . . . . 73.109999999999999 111.277 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 3.0 mpt_? -123.73 114.87 20.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.227 0.536 . . . . 71.519999999999996 110.187 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -147.68 146.81 29.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.429 -0.805 . . . . 74.25 110.361 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -131.13 126.51 35.9 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.363 -0.606 . . . . 74.319999999999993 109.363 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -84.0 122.35 28.64 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 111.191 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.36 149.86 41.12 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.069 -1.456 . . . . 61.219999999999999 107.069 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -127.92 146.82 50.51 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.785 -0.45 . . . . 74.420000000000002 109.785 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 44.5 m -124.57 131.45 24.16 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.791 -0.818 . . . . 75.120000000000005 108.791 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.51 123.81 11.61 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.461 2.107 . . . . 71.510000000000005 111.056 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.472 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 49.7 m -147.02 -179.72 7.01 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.444 -0.947 . . . . 65.450000000000003 108.444 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -49.75 136.35 19.24 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.896 0.878 . . . . 73.310000000000002 110.66 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.491 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 9.1 Cg_endo -50.66 -36.5 50.83 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.666 3.578 . . . . 75.349999999999994 114.786 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -77.58 -8.75 58.32 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.261 0.837 . . . . 73.230000000000004 113.261 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 18.0 tp -84.39 -11.82 55.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.003 0.43 . . . . 73.140000000000001 110.433 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.3 p -56.72 135.91 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.443 -0.799 . . . . 72.329999999999998 112.028 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.04 55.21 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 121.06 -0.59 . . . . 74.420000000000002 114.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 434' ' ' THR . 14.3 ptmm? -107.85 148.18 29.92 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.919 -1.112 . . . . 74.450000000000003 110.396 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.46 ' CG2' HD11 ' A' ' 486' ' ' ILE . 61.0 t -81.39 131.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.719 -0.474 . . . . 75.439999999999998 109.719 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 33.8 pt -101.04 -10.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.992 -0.549 . . . . 73.120000000000005 111.529 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.98 172.42 33.31 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.213 -0.755 . . . . 74.340000000000003 111.213 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 159.07 37.63 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.099 -0.704 . . . . 75.299999999999997 109.099 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.3 t-20 -60.6 -56.17 37.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 119.16 -0.448 . . . . 72.310000000000002 111.58 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.7 Cg_endo -85.88 146.15 9.05 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 121.192 1.261 . . . . 73.319999999999993 109.486 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.534 ' HG2' ' HG2' ' A' ' 476' ' ' GLN . 14.2 Cg_exo -62.88 149.8 90.33 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.693 1.595 . . . . 73.319999999999993 111.637 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.7 -11.66 60.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.654 0.74 . . . . 72.319999999999993 109.798 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -96.2 -12.19 25.0 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.222 -0.899 . . . . 71.129999999999995 112.012 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.534 ' HG2' ' HG2' ' A' ' 473' ' ' PRO . 0.0 OUTLIER -96.11 155.07 16.91 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 119.435 -0.906 . . . . 65.239999999999995 108.845 176.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.404 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 34.7 p -101.2 120.68 40.6 Favored 'General case' 0 N--CA 1.395 -3.185 0 N-CA-C 108.372 -0.974 . . . . 74.540000000000006 108.372 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 24.6 m -105.1 140.05 38.86 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.203 -0.666 . . . . 71.329999999999998 109.203 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -61.63 146.78 47.94 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.953 -0.388 . . . . 73.319999999999993 109.953 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.39 -23.0 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 123.597 0.759 . . . . 75.439999999999998 111.965 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.6 t -77.84 -8.02 57.47 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.355 -0.384 . . . . 62.43 111.299 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -74.87 136.2 41.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 120.909 0.385 . . . . 72.450000000000003 110.833 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.66 113.85 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 0 N-CA-C 106.588 -1.634 . . . . 74.209999999999994 106.588 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 63.0 t -86.63 119.93 35.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.136 -0.69 . . . . 71.430000000000007 109.136 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.84 111.86 24.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.885 -1.524 . . . . 75.319999999999993 106.885 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.68 128.11 55.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.68 -1.146 . . . . 74.439999999999998 108.719 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 54.8 mt -104.52 114.04 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.614 0.721 . . . . 75.140000000000001 110.988 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.55 130.33 45.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.471 -0.786 . . . . 71.010000000000005 109.421 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.31 114.51 4.98 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 107.81 -2.116 . . . . 62.310000000000002 107.81 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.1 m -120.54 129.37 53.77 Favored 'General case' 0 N--CA 1.412 -2.347 0 C-N-CA 120.163 -0.615 . . . . 74.409999999999997 109.525 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -101.22 115.22 5.22 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 110.218 -1.153 . . . . 60.340000000000003 110.218 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.5 129.97 33.49 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.285 1.99 . . . . 75.019999999999996 111.195 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -70.69 97.17 1.31 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.9 p -133.5 152.26 51.88 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.678 -1.147 . . . . 74.239999999999995 109.467 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.82 143.75 27.69 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.717 -0.475 . . . . 75.25 109.717 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 543' ' ' THR . 7.3 p-10 -93.0 138.32 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.681 -0.859 . . . . 70.299999999999997 108.681 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.406 ' CG2' ' HE1' ' A' ' 517' ' ' PHE . 0.2 OUTLIER -93.82 121.04 65.29 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 114.849 1.426 . . . . 71.420000000000002 114.849 -176.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.75 136.27 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 106.294 -2.233 . . . . 73.120000000000005 106.294 164.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.37 139.86 56.64 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.796 0.807 . . . . 74.439999999999998 111.866 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.27 27.88 3.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.854 -1.535 . . . . 72.439999999999998 106.854 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.87 137.63 33.59 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.963 -1.471 . . . . 61.439999999999998 110.583 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.07 -48.23 0.93 Allowed Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.572 -0.823 . . . . 53.020000000000003 112.612 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.6 -168.69 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 111.877 0.325 . . . . 75.120000000000005 111.877 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.9 p -82.58 162.24 22.01 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 112.898 0.703 . . . . 75.530000000000001 112.898 -170.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.8 t -48.11 -52.5 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 O-C-N 124.839 1.337 . . . . 74.420000000000002 110.16 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 1.8 m-20 -68.04 -42.18 80.98 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.855 -1.066 . . . . 73.409999999999997 112.753 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.28 -35.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 119.214 -0.994 . . . . 73.329999999999998 111.497 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.58 96.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.754 -0.657 . . . . 72.439999999999998 111.021 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 79.4 mt-30 -61.4 -43.36 98.99 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.989 -0.375 . . . . 75.010000000000005 109.989 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.8 mptp? -61.74 -49.31 76.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.79 -0.641 . . . . 75.219999999999999 111.883 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -62.58 -47.78 82.3 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 123.205 0.315 . . . . 75.329999999999998 110.66 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.11 -43.29 99.1 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.938 -0.574 . . . . 73.150000000000006 110.719 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.38 -37.22 74.82 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.717 0.807 . . . . 71.140000000000001 111.75 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 510' ' ' LYS . 77.1 t -63.44 -42.48 96.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 116.282 -0.417 . . . . 74.120000000000005 111.869 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -108.21 -18.45 13.77 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.944 -1.102 . . . . 74.209999999999994 111.856 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -102.98 -100.47 2.57 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 115.079 0.792 . . . . 65.450000000000003 115.079 -171.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 49.0 m-85 -127.56 172.69 10.51 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.916 0.389 . . . . 74.420000000000002 111.183 -168.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.8 p -106.27 -25.73 11.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.485 -0.78 . . . . 71.430000000000007 111.047 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.73 121.65 45.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.871 -0.604 . . . . 74.120000000000005 109.72 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -128.46 143.4 50.98 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.591 . . . . 73.239999999999995 112.204 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.8 m -115.15 152.48 32.51 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.732 -1.951 . . . . 60.439999999999998 105.732 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -123.39 134.06 54.02 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.175 -0.61 . . . . 73.120000000000005 111.586 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.71 121.89 39.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.81 -0.811 . . . . 64.439999999999998 108.81 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.5 m -88.24 118.05 27.57 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.626 -1.62 . . . . 74.200000000000003 106.626 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.659 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.0 m -119.97 149.5 22.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.263 -1.384 . . . . 75.109999999999999 107.263 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.33 133.75 37.57 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.39 1.091 . . . . 73.219999999999999 112.579 -167.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 5.8 m -94.61 129.08 37.52 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 112.962 -1.926 . . . . 71.409999999999997 109.165 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.13 -71.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 121.073 1.182 . . . . 71.409999999999997 109.072 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.405 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 24.5 mmm180 -111.57 -55.05 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.036 -0.507 . . . . 74.310000000000002 112.165 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 527' ' ' SER . 10.7 Cg_exo -73.18 134.48 21.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.306 1.338 . . . . 74.319999999999993 111.339 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.51 159.46 43.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.436 -0.95 . . . . 65.299999999999997 108.436 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.91 -21.81 25.28 Favored Glycine 0 C--N 1.319 -0.402 0 CA-C-O 121.611 0.562 . . . . 65.019999999999996 111.862 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.52 147.77 25.2 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.245 0.545 . . . . 70.049999999999997 110.728 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.88 124.88 34.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.975 -0.75 . . . . 74.239999999999995 108.975 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -33.21 52.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.315 -0.857 . . . . 71.200000000000003 109.44 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.78 -147.18 15.19 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.333 -0.707 . . . . 72.340000000000003 111.333 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.0 p -121.79 160.41 24.68 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.955 -0.757 . . . . 71.329999999999998 108.955 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -62.55 -52.61 64.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 121.007 -0.277 . . . . 74.040000000000006 110.368 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.41 146.2 34.96 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 120.919 1.079 . . . . 75.340000000000003 109.791 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.67 154.25 70.35 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.197 1.931 . . . . 73.439999999999998 111.9 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.45 132.88 53.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.024 -0.535 . . . . 74.25 109.964 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.49 -10.84 56.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.113 -0.565 . . . . 63.299999999999997 111.824 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 71.5 m -77.46 129.3 35.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.616 -0.513 . . . . 73.030000000000001 109.616 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 7.0 t -93.85 122.6 36.5 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.476 0.655 . . . . 63.210000000000001 110.148 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.27 158.81 70.13 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.685 -0.857 . . . . 71.049999999999997 108.685 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.86 134.29 42.8 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.032 1.821 . . . . 75.230000000000004 112.081 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 17.2 m -67.61 -22.61 28.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.886 0.851 . . . . 73.540000000000006 110.849 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.15 0.73 52.89 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.353 -1.294 . . . . 75.319999999999993 111.685 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.8 t -98.02 -177.55 3.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.971 -0.751 . . . . 74.439999999999998 108.971 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.8 t -109.41 134.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.857 -1.164 . . . . 74.430000000000007 107.857 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -115.08 146.0 20.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.498 -0.556 . . . . 75.409999999999997 109.498 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.43 130.96 49.36 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-O 121.46 0.647 . . . . 72.209999999999994 110.454 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.75 130.96 48.27 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.68 -1.145 . . . . 73.450000000000003 108.624 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -94.8 115.33 27.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.959 -1.497 . . . . 75.310000000000002 106.959 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.74 135.2 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-N 116.525 -0.307 . . . . 72.310000000000002 111.089 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.5 m -74.23 114.39 12.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 109.04 -0.726 . . . . 72.549999999999997 109.04 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 11.5 ptmm? . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 114.795 -1.093 . . . . 72.439999999999998 110.919 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.82 0 N-CA-C 109.681 -1.367 . . . . 43.049999999999997 109.681 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.02 133.18 19.33 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 122.306 2.004 . . . . 64.040000000000006 109.22 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.4 pt-20 -85.91 57.79 4.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.411 1.1 . . . . 74.439999999999998 111.041 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 95.7 mt-30 -111.02 130.18 55.67 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.315 -1.311 . . . . 74.439999999999998 108.774 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -125.06 150.44 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.322 -0.854 . . . . 73.25 110.354 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 140.7 32.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 111.575 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -84.26 126.63 69.13 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 108.244 -1.021 . . . . 75.510000000000005 108.244 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.8 140.85 36.18 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.311 1.34 . . . . 73.439999999999998 110.517 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -105.81 69.37 0.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.457 1.122 . . . . 63.229999999999997 109.973 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.11 6.32 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 105.937 -1.875 . . . . 75.329999999999998 105.937 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.522 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.2 m -57.92 -30.05 65.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.031 -2.35 . . . . 73.430000000000007 110.399 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 3.2 m -61.76 -27.83 69.01 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.852 1.261 . . . . 72.400000000000006 110.856 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.0 -46.34 9.92 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 118.763 -1.175 . . . . 74.040000000000006 111.323 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.486 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.8 m -167.88 151.97 6.34 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -52.14 -49.29 64.02 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.266 1.026 . . . . 75.25 109.507 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.97 76.7 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.256 -0.883 . . . . 74.519999999999996 111.412 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.486 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 26.3 mm-40 -61.85 -46.06 91.07 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.239 0.337 . . . . 74.120000000000005 110.95 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -63.15 -47.25 83.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.629 -0.714 . . . . 63.229999999999997 110.463 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.25 -45.37 98.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.658 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -60.8 -47.58 85.67 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 122.197 0.199 . . . . 72.209999999999994 111.453 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -67.79 -39.14 84.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.381 -0.527 . . . . 72.430000000000007 112.34 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.4 tp -68.05 -37.06 80.88 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.319 0.58 . . . . 72.450000000000003 109.898 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -65.13 -41.81 94.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.509 -0.769 . . . . 75.319999999999993 109.4 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.75 -21.44 63.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.845 -0.616 . . . . 70.319999999999993 110.768 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.86 -13.33 59.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.335 0.588 . . . . 64.450000000000003 109.767 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.98 16.07 61.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.693 -0.685 . . . . 72.129999999999995 113.61 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.24 133.39 52.7 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.123 0.487 . . . . 72.209999999999994 111.141 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -90.39 -48.93 3.37 Favored Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.505 -0.771 . . . . 74.299999999999997 113.059 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -110.38 116.0 30.66 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.306 -0.958 . . . . 75.049999999999997 111.905 -172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.66 146.36 30.35 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.891 -0.595 . . . . 73.019999999999996 110.448 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -131.75 131.83 43.32 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.281 -0.637 . . . . 74.439999999999998 109.281 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -89.25 129.82 35.75 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.752 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.99 144.68 48.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.432 -1.321 . . . . 72.109999999999999 107.432 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -123.09 144.56 49.23 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.906 -0.718 . . . . 73.430000000000007 110.258 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.9 m -137.75 131.28 16.98 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.114 -0.494 . . . . 63.509999999999998 110.211 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.47 123.41 11.1 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.6 2.2 . . . . 72.239999999999995 111.218 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.5 p -142.78 179.25 7.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.991 -0.55 . . . . 71.420000000000002 110.476 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.2 t -56.38 143.38 66.0 Favored Pre-proline 0 N--CA 1.429 -1.485 0 C-N-CA 124.116 0.967 . . . . 70.549999999999997 109.987 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.58 -29.23 24.33 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.047 3.164 . . . . 75.409999999999997 113.01 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.06 -35.7 81.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.568 0.581 . . . . 74.049999999999997 112.568 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.87 -9.38 46.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 111.584 0.216 . . . . 74.549999999999997 111.584 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 61.4 t -61.5 127.02 20.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 109.88 -0.415 . . . . 75.420000000000002 109.88 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.3 71.4 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.562 -0.745 . . . . 75.209999999999994 111.798 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 434' ' ' THR . 4.3 mptp? -98.88 145.49 26.95 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.344 0.658 . . . . 75.409999999999997 109.475 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 94.9 t -82.12 126.61 39.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.378 -1.712 . . . . 74.340000000000003 106.378 173.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.24 -5.39 9.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.815 -0.754 . . . . 73.040000000000006 111.641 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.04 13.33 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.103 -1.046 . . . . 54.240000000000002 112.997 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 31.7 p -116.91 141.46 48.2 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.607 -1.257 . . . . 70.349999999999994 107.607 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 28.1 t-20 -57.16 -53.52 64.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-O 119.105 -0.474 . . . . 73.540000000000006 111.914 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.67 144.54 17.6 Favored 'Trans proline' 0 C--N 1.36 1.143 0 CA-C-N 120.459 1.2 . . . . 74.230000000000004 109.087 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.26 147.85 93.49 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.536 2.158 . . . . 75.129999999999995 111.536 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.85 -21.56 26.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.026 0.441 . . . . 45.520000000000003 111.625 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.85 -30.72 59.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.7 0.762 . . . . 52.530000000000001 109.717 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.25 152.93 17.94 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.539 -0.755 . . . . 74.420000000000002 110.036 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.2 p -85.19 117.68 24.28 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 115.945 -0.571 . . . . 71.329999999999998 110.593 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.2 m -100.79 146.63 27.03 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.573 -1.269 . . . . 73.150000000000006 107.573 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -71.31 150.79 44.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 118.078 0.399 . . . . 74.549999999999997 110.502 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.56 -25.06 23.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 124.316 1.046 . . . . 75.030000000000001 110.83 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -100.55 0.17 38.92 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.514 -0.766 . . . . 72.310000000000002 111.278 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -77.35 151.81 34.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.205 -1.406 . . . . 73.230000000000004 107.205 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.34 111.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 119.211 -0.995 . . . . 74.430000000000007 110.495 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 75.0 t -90.31 118.72 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.235 -1.024 . . . . 75.400000000000006 108.235 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 69.2 mt -95.18 119.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.345 -1.354 . . . . 74.329999999999998 107.345 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.99 119.67 55.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 109.361 -0.607 . . . . 75.549999999999997 109.361 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 487' ' ' ILE . 3.2 mp -99.03 119.67 47.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 109.68 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.65 136.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.299 -0.864 . . . . 75.030000000000001 109.995 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.97 112.47 3.81 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 107.595 -2.202 . . . . 72.319999999999993 107.595 172.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.5 m -114.27 158.41 21.44 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.705 -0.48 . . . . 74.230000000000004 109.705 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -91.24 136.58 13.41 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.673 -0.775 . . . . 74.099999999999994 111.345 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.08 121.31 7.16 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.865 1.71 . . . . 74.140000000000001 108.365 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -82.75 80.9 8.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.12 0.962 . . . . 74.439999999999998 110.131 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -137.31 156.31 48.4 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.756 -1.201 . . . . 72.099999999999994 107.756 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -149.85 157.04 42.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.632 0.604 . . . . 73.420000000000002 112.632 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.42 130.6 34.61 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 125.344 1.458 . . . . 75.519999999999996 110.219 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -87.27 129.23 52.33 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.397 -0.521 . . . . 75.430000000000007 111.402 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.04 162.34 23.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.66 2.24 . . . . 71.040000000000006 111.552 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.27 114.55 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.047 -0.524 . . . . 74.329999999999998 110.041 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.84 -0.02 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 112.305 0.483 . . . . 73.209999999999994 112.305 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.87 143.21 54.58 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.407 0.442 . . . . 74.329999999999998 110.398 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 90.38 11.61 62.4 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.406 -0.902 . . . . 75.150000000000006 111.027 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -122.43 -170.16 2.03 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.841 -0.8 . . . . 75.019999999999996 108.841 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.8 m -91.21 155.44 18.58 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.366 -1.346 . . . . 74.329999999999998 107.366 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.22 -41.35 80.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.266 0.354 . . . . 73.010000000000005 111.606 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.5 m-20 -66.08 -42.98 88.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 111.463 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.5 -36.38 28.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 119.757 -0.777 . . . . 73.5 110.988 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -63.53 -46.4 86.21 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.477 -0.783 . . . . 75.329999999999998 111.382 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.8 -35.72 82.02 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 120.447 -0.501 . . . . 52.210000000000001 110.084 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG22 ' A' ' 514' ' ' VAL . 33.6 mmtp -65.52 -50.69 64.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.552 -0.295 . . . . 73.349999999999994 111.516 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.24 -40.51 96.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.289 -0.414 . . . . 71.540000000000006 110.936 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.3 -42.61 75.21 Favored 'General case' 0 C--O 1.183 -2.441 0 N-CA-C 109.225 -0.658 . . . . 74.540000000000006 109.225 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.18 -40.01 84.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.943 0.497 . . . . 63.009999999999998 111.607 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 510' ' ' LYS . 84.6 t -67.01 -29.66 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 112.455 0.539 . . . . 74.530000000000001 112.455 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -118.55 -5.11 10.76 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.406 -0.918 . . . . 70.219999999999999 111.699 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -108.71 1.94 Allowed Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 115.402 -0.817 . . . . 61.119999999999997 113.497 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 31.3 m-85 -130.3 174.41 9.87 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.461 -0.495 . . . . 70.019999999999996 111.279 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -103.82 -5.13 22.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.403 -0.817 . . . . 73.019999999999996 111.096 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.439 ' HG3' ' HA ' ' A' ' 550' ' ' VAL . 14.8 ptpt -113.82 121.04 42.82 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.029 -0.532 . . . . 72.140000000000001 110.782 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -126.27 148.54 49.49 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.681 0.753 . . . . 74.239999999999995 111.766 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.9 m -127.81 154.94 44.85 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.851 -1.907 . . . . 64.340000000000003 105.851 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -121.81 143.21 49.54 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.722 -0.791 . . . . 75.5 109.848 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.73 123.0 48.83 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.933 -1.506 . . . . 74.510000000000005 106.933 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.3 m -88.76 116.45 27.03 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.437 -0.801 . . . . 71.209999999999994 109.779 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 29.9 m -121.14 156.92 24.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.179 -1.415 . . . . 62.409999999999997 107.179 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.39 124.04 27.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.252 0.549 . . . . 74.439999999999998 110.438 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 18.3 m -72.15 151.69 92.48 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.631 -1.168 . . . . 75.329999999999998 112.626 -173.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.62 -144.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.848 2.366 . . . . 73.040000000000006 107.441 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.83 -49.57 68.15 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 121.554 -0.716 . . . . 73.549999999999997 111.926 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.95 152.25 36.25 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 121.168 1.245 . . . . 60.020000000000003 111.111 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.13 149.66 43.3 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 101.03 -10.45 58.49 Favored Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.97 -0.633 . . . . 62.539999999999999 111.907 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.32 148.81 24.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.315 0.579 . . . . 74.200000000000003 111.701 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.521 HG23 ' CB ' ' A' ' 508' ' ' ALA . 95.5 t -75.75 120.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.271 -0.877 . . . . 72.420000000000002 109.133 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -82.1 -31.39 30.74 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.121 -0.945 . . . . 74.5 108.751 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 170.62 -169.64 42.5 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.284 -0.726 . . . . 72.030000000000001 111.284 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 32.7 p -123.69 149.46 45.46 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.221 -1.77 . . . . 64.439999999999998 106.221 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.6 t-20 -56.21 -58.32 17.25 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.978 -0.534 . . . . 74.310000000000002 112.069 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.8 Cg_exo -80.5 145.16 16.4 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.343 1.362 . . . . 74.230000000000004 108.784 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.1 147.56 73.56 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.898 1.732 . . . . 72.349999999999994 112.226 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.51 129.57 32.88 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.728 0.811 . . . . 73.129999999999995 110.267 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.68 -7.79 36.58 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.624 -0.798 . . . . 63.350000000000001 111.51 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.8 m -82.73 126.87 32.86 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.791 -0.448 . . . . 70.409999999999997 109.791 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 87.9 m -93.3 123.18 36.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.037 -1.098 . . . . 75.120000000000005 108.037 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.97 158.55 68.38 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 109.113 -0.699 . . . . 61.439999999999998 109.113 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 494' ' ' THR . 34.6 Cg_exo -61.09 145.66 98.63 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 122.664 2.242 . . . . 71.510000000000005 112.129 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 18.5 m -67.4 -19.24 25.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 122.144 0.974 . . . . 72.329999999999998 109.221 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.13 3.78 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 71.200000000000003 109.998 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 36.3 t -112.71 141.83 46.04 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.783 -1.192 . . . . 70.040000000000006 107.783 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.439 ' HA ' ' HG3' ' A' ' 519' ' ' LYS . 21.9 t -91.34 136.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.306 -0.627 . . . . 73.439999999999998 109.306 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.1 tp -91.32 135.02 28.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 110.078 -0.341 . . . . 74.409999999999997 110.078 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.86 117.64 35.08 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-O 121.573 0.701 . . . . 74.120000000000005 110.7 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.51 118.88 33.95 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.897 -1.52 . . . . 74.129999999999995 106.897 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -94.56 106.67 18.66 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.616 -1.253 . . . . 64.340000000000003 107.616 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.23 138.56 46.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-N 114.957 -1.02 . . . . 75.329999999999998 112.029 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.451 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 31.8 m -61.02 121.1 11.59 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.037 -0.983 . . . . 63.329999999999998 109.392 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 22.5 pttp . . . . . 0 C--O 1.254 1.305 0 CA-C-N 115.754 -0.657 . . . . 73.140000000000001 110.588 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.163 0 N-CA-C 109.001 -1.64 . . . . 73.099999999999994 109.001 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.3 132.16 25.14 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 CA-C-N 119.399 1.6 . . . . 74.400000000000006 109.419 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.1 pt-20 -96.34 17.57 15.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.808 0.813 . . . . 74.219999999999999 109.588 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -83.61 123.57 29.91 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.319 -0.855 . . . . 71.319999999999993 109.571 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -120.26 164.45 16.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.788 -1.189 . . . . 74.319999999999993 107.788 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.42 141.61 32.62 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 123.247 0.619 . . . . 64.230000000000004 112.323 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -85.06 131.46 48.6 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 105.33 -2.1 . . . . 64.200000000000003 105.33 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.34 141.5 97.78 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.994 1.796 . . . . 75.430000000000007 113.041 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -102.34 -13.03 17.49 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.411 -0.813 . . . . 64.239999999999995 108.913 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.61 8.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.046 -0.979 . . . . 73.450000000000003 110.331 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 7.1 m -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.798 -1.092 . . . . 74.430000000000007 108.865 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 p -59.29 -27.62 66.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.133 -1.394 . . . . 75.049999999999997 111.115 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.42 -45.08 23.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.609 -0.515 . . . . 71.25 109.609 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.7 m -163.69 144.49 8.85 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.148 -1.056 . . . . 74.129999999999995 108.148 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 441' ' ' VAL . 30.1 t80 -59.29 -41.38 88.8 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.75 0.42 . . . . 73.140000000000001 110.465 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.69 74.27 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.19 0.306 . . . . 73.519999999999996 111.176 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 40.7 mm-40 -61.87 -44.43 96.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 116.237 -0.438 . . . . 72.540000000000006 110.31 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.23 -47.71 84.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.351 -0.84 . . . . 54.329999999999998 110.708 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 437' ' ' TYR . 88.7 t -58.7 -50.55 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 O-C-N 123.704 0.628 . . . . 74.049999999999997 110.79 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -38.0 84.7 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.789 0.662 . . . . 75.439999999999998 112.789 -177.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -66.47 -43.29 85.89 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 120.739 0.305 . . . . 72.409999999999997 110.719 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.79 -36.88 78.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 74.430000000000007 110.313 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.4 m -63.63 -41.28 98.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.995 -0.743 . . . . 74.109999999999999 108.995 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.16 -18.67 62.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.987 -0.551 . . . . 63.32 111.239 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.47 -14.65 51.99 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.677 -0.49 . . . . 74.349999999999994 109.677 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 480' ' ' ILE . . . 85.98 8.73 78.62 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.953 -0.567 . . . . 63.149999999999999 114.33 172.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.49 124.54 20.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.213 0.506 . . . . 74.420000000000002 111.834 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -63.4 -55.41 25.79 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.054 -0.975 . . . . 52.229999999999997 114.285 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.544 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 0.4 OUTLIER -121.81 130.95 53.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.282 -0.567 . . . . 74.209999999999994 110.761 -174.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.77 144.59 31.25 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.805 -0.634 . . . . 75.140000000000001 109.304 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -131.34 141.5 49.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.456 -0.572 . . . . 74.409999999999997 109.456 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.63 136.4 34.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.878 0.736 . . . . 74.129999999999995 110.813 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.63 52.44 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.55 -2.018 . . . . 72.120000000000005 105.55 171.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -138.59 150.47 46.34 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 119.012 0.823 . . . . 72.310000000000002 110.138 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 25.6 m -131.94 145.7 58.56 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 108.627 -0.879 . . . . 55.409999999999997 108.627 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.63 134.8 26.93 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.505 2.137 . . . . 71.120000000000005 112.04 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.3 p -152.15 179.74 8.24 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.866 0.866 . . . . 64.099999999999994 109.207 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -59.68 142.3 87.98 Favored Pre-proline 0 N--CA 1.432 -1.339 0 C-N-CA 123.741 0.817 . . . . 44.450000000000003 111.411 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.486 ' O ' HG12 ' A' ' 464' ' ' VAL . 54.0 Cg_exo -52.57 -28.13 35.43 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.421 3.414 . . . . 74.140000000000001 113.428 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.98 -10.34 59.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.344 0.498 . . . . 74.530000000000001 112.344 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 9.5 mp -107.29 0.73 23.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.446 0.535 . . . . 75.5 112.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.1 p -61.29 128.81 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.286 0.565 . . . . 70.120000000000005 112.191 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.82 69.7 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 120.896 -0.669 . . . . 74.030000000000001 112.427 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 23.5 mtpp -109.91 146.17 35.62 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.318 -0.993 . . . . 72.510000000000005 108.318 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 486' ' ' ILE . 63.1 t -81.86 124.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.29 -0.633 . . . . 73.340000000000003 109.29 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.1 pt -101.68 -2.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.923 -0.58 . . . . 73.409999999999997 111.639 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.99 156.67 11.79 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.119 -0.562 . . . . 50.43 112.324 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 35.0 p -128.5 148.73 50.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.415 -0.957 . . . . 74.319999999999993 108.415 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.52 -56.18 20.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.273 -0.394 . . . . 75.109999999999999 110.477 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -82.2 131.37 6.72 Favored 'Trans proline' 0 C--N 1.364 1.369 0 CA-C-N 120.152 1.09 . . . . 75.200000000000003 109.473 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -72.69 152.61 53.49 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.976 1.784 . . . . 63.240000000000002 113.119 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.47 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 6.35 11.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.395 1.078 . . . . 73.140000000000001 111.232 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.23 -28.64 13.99 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.796 -0.638 . . . . 75.239999999999995 111.108 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -115.45 161.47 18.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.211 -0.663 . . . . 73.239999999999995 109.211 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 33.3 p -95.35 140.8 29.72 Favored 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 120.483 -0.487 . . . . 72.239999999999995 109.875 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.459 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . 23.4 m -120.88 147.94 44.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.452 -0.573 . . . . 62.219999999999999 109.452 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 482' ' ' ASN . . . -57.12 151.32 15.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.352 0.871 . . . . 64.239999999999995 113.352 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.1 mm -58.07 -32.98 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.049 0.939 . . . . 74.140000000000001 110.368 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.2 t -81.4 3.25 25.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.251 -0.886 . . . . 64.510000000000005 111.979 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 479' ' ' ALA . 0.8 OUTLIER -74.33 158.42 34.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.275 0.559 . . . . 70.010000000000005 112.349 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 451' ' ' ARG . 60.4 t -106.97 114.31 45.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.027 -1.101 . . . . 73.519999999999996 108.027 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 88.6 t -94.61 119.91 43.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.237 0.541 . . . . 74.510000000000005 110.439 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 71.9 mt -96.31 112.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.484 -1.673 . . . . 74.040000000000006 106.484 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.461 HD12 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.19 128.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 116.167 -0.47 . . . . 71.120000000000005 110.533 -176.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.93 115.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.599 0.714 . . . . 75.239999999999995 111.069 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.53 142.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.547 -0.752 . . . . 74.349999999999994 109.55 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.27 113.71 3.77 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.091 -1.204 . . . . 62.25 110.091 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 35.1 t -95.8 129.81 42.92 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 106.748 -1.575 . . . . 72.120000000000005 106.748 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -116.61 99.71 0.87 Allowed Glycine 0 C--N 1.297 -1.593 0 C-N-CA 119.754 -1.212 . . . . 73.420000000000002 112.029 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.8 114.52 3.98 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.147 1.898 . . . . 74.150000000000006 109.911 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.34 106.69 17.57 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.027 -0.731 . . . . 60.100000000000001 109.027 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 546' ' ' PRO . 66.6 p -124.92 164.93 19.02 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.25 -0.887 . . . . 74.319999999999993 109.123 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 517' ' ' PHE . 6.4 mmpt? -139.62 144.18 37.57 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.686 -0.857 . . . . 74.340000000000003 108.686 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 27.6 t70 -90.59 130.34 36.63 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.788 -0.819 . . . . 54.420000000000002 108.788 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 20.4 pt -96.12 121.39 60.77 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.268 -0.573 . . . . 73.109999999999999 112.525 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.23 169.96 4.93 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.915 1.743 . . . . 74.140000000000001 109.316 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.88 129.71 34.84 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.491 -0.884 . . . . 75.439999999999998 109.574 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.35 14.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 123.278 1.513 . . . . 73.420000000000002 107.093 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.436 ' HA ' HG11 ' A' ' 534' ' ' VAL . . . -71.61 138.57 48.82 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.546 -1.661 . . . . 60.409999999999997 110.293 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.09 -4.57 41.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.648 -0.787 . . . . 72.510000000000005 111.822 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -106.09 176.63 5.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.844 -1.539 . . . . 73.450000000000003 106.844 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 71.1 p -80.41 157.87 26.13 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.448 -0.901 . . . . 72.349999999999994 108.963 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.46 -43.14 86.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.495 0.664 . . . . 65.0 110.19 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.86 -42.8 85.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.77 -1.105 . . . . 73.310000000000002 111.812 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.18 -36.84 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 119.431 -0.908 . . . . 73.430000000000007 111.243 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.49 73.4 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.908 -0.587 . . . . 71.439999999999998 111.282 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.3 -35.97 82.62 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 120.318 -0.553 . . . . 71.349999999999994 110.614 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -61.37 -53.69 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.505 0.503 . . . . 75.239999999999995 110.775 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.11 -41.85 94.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.788 -0.642 . . . . 73.439999999999998 110.673 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.4 HD13 HD11 ' A' ' 551' ' ' ILE . 4.9 tt -66.36 -40.66 89.91 Favored 'General case' 0 C--O 1.186 -2.257 0 CA-C-N 115.404 -0.816 . . . . 75.510000000000005 109.246 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.1 t-20 -58.54 -38.29 77.46 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.387 0.675 . . . . 65.109999999999999 111.621 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.57 -40.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.726 -0.67 . . . . 72.129999999999995 112.032 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -107.4 -23.28 12.26 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.037 -0.665 . . . . 74.239999999999995 112.197 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -103.59 -100.16 2.58 Favored Glycine 0 N--CA 1.413 -2.861 0 CA-C-N 115.262 -0.881 . . . . 41.43 113.683 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 46.0 m-85 -131.23 166.86 20.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.331 0.586 . . . . 72.150000000000006 111.185 -171.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.452 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 4.7 p -102.8 -4.12 25.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.943 -1.026 . . . . 74.400000000000006 110.295 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -109.95 116.29 31.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.705 . . . . 73.209999999999994 109.763 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -128.94 145.84 51.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.332 0.587 . . . . 75.109999999999999 110.911 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 59.2 m -135.64 145.63 47.02 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.988 -1.486 . . . . 73.510000000000005 106.988 172.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -125.55 143.25 51.09 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.393 -0.523 . . . . 73.450000000000003 111.95 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.45 129.23 52.85 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.596 -1.261 . . . . 65.439999999999998 107.596 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -88.35 127.74 35.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.207 0.527 . . . . 73.209999999999994 110.422 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.1 m -121.54 162.53 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.287 -1.005 . . . . 75.420000000000002 108.287 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.78 140.51 38.23 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.937 -0.705 . . . . 73.409999999999997 110.065 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 8.3 m -90.08 114.17 59.9 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.377 -1.283 . . . . 74.219999999999999 110.825 -174.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.85 -83.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.729 1.619 . . . . 75.230000000000004 109.661 173.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -90.9 -54.8 0.27 Allowed Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-O 118.805 -0.616 . . . . 72.329999999999998 111.14 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 527' ' ' SER . 21.9 Cg_endo -61.61 153.26 68.2 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.99 1.794 . . . . 64.409999999999997 111.359 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.46 82.43 0.27 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.853 0.861 . . . . 71.310000000000002 108.993 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.31 -31.12 2.64 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.482 -1.047 . . . . 75.5 110.482 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -86.12 149.55 25.05 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.259 -0.471 . . . . 72.209999999999994 110.17 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' A' ' 501' ' ' ALA . 5.3 p -73.85 123.11 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.318 -0.993 . . . . 64.530000000000001 108.318 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -71.87 -41.58 67.86 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.872 -1.058 . . . . 75.400000000000006 110.874 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -174.26 -160.35 22.3 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.407 -0.902 . . . . 71.120000000000005 111.189 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.0 p -131.74 159.98 36.86 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.66 -0.867 . . . . 74.140000000000001 108.66 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 48.8 t30 -69.02 -55.36 10.53 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-O 118.937 -0.554 . . . . 72.530000000000001 110.512 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.0 Cg_endo -81.48 146.94 15.59 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.05 1.167 . . . . 74.329999999999998 109.533 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.04 147.73 43.66 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.943 1.762 . . . . 74.340000000000003 112.444 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.11 138.23 58.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.824 -0.626 . . . . 75.340000000000003 110.017 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.74 -5.75 60.16 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 111.173 -0.771 . . . . 65.430000000000007 111.173 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -88.78 126.04 35.16 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.593 -0.521 . . . . 73.519999999999996 109.593 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.1 m -90.51 123.13 33.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.802 -1.184 . . . . 63.530000000000001 107.802 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.74 154.74 75.8 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.82 -0.437 . . . . 75.510000000000005 109.82 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.473 ' HA ' HG21 ' A' ' 494' ' ' THR . 27.0 Cg_exo -64.72 147.71 89.91 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.945 2.43 . . . . 73.510000000000005 113.55 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.522 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.6 m -67.05 -19.42 25.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.163 0.982 . . . . 73.299999999999997 111.995 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.62 -8.03 59.03 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.688 -1.142 . . . . 55.299999999999997 109.365 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 41.4 m -97.44 149.91 21.62 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 115.165 -0.925 . . . . 71.120000000000005 109.204 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.87 136.57 26.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.94 -0.573 . . . . 74.040000000000006 110.309 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 512' ' ' LEU . 15.5 tt -98.93 129.01 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.665 0.745 . . . . 74.430000000000007 109.963 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 521' ' ' SER . 31.8 tt0 -103.74 129.67 51.15 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 115.696 -0.684 . . . . 72.349999999999994 110.379 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.72 134.5 48.74 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.419 1.088 . . . . 74.319999999999993 110.672 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.06 108.53 19.79 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.276 -1.75 . . . . 72.209999999999994 106.276 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.09 137.62 38.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 112.089 0.403 . . . . 75.200000000000003 112.089 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.7 m -60.42 122.02 13.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.668 -1.604 . . . . 73.010000000000005 106.668 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.836 -0.602 . . . . 70.140000000000001 111.863 -172.789 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.903 0 N-CA-C 109.993 -1.243 . . . . 71.319999999999993 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.58 152.29 70.22 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.298 1.999 . . . . 64.310000000000002 110.858 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.3 OUTLIER -82.59 49.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.041 0.924 . . . . 74.409999999999997 111.319 -177.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 96.2 mt-30 -102.93 130.22 49.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.81 -1.086 . . . . 72.329999999999998 108.758 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -128.23 158.85 36.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.206 -1.035 . . . . 73.329999999999998 108.206 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -82.66 141.5 32.43 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 123.254 0.622 . . . . 75.030000000000001 110.365 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 474' ' ' ALA . 2.8 mp -85.09 130.01 53.79 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.052 -0.721 . . . . 74.450000000000003 109.052 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.01 145.19 99.42 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.979 2.453 . . . . 75.129999999999995 112.333 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.24 11.72 35.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.433 1.111 . . . . 74.439999999999998 110.14 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.91 -9.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.581 1.182 . . . . 74.5 108.562 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.8 m -59.26 -33.75 71.41 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.916 -1.493 . . . . 65.299999999999997 110.292 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 4.2 m -60.68 -27.34 67.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.505 -1.225 . . . . 73.400000000000006 110.375 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.79 -44.25 17.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 119.991 -0.683 . . . . 74.510000000000005 110.959 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 91.5 m -162.0 144.61 11.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 109.394 -0.595 . . . . 71.319999999999993 109.394 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -52.68 -49.42 65.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.016 0.926 . . . . 73.510000000000005 111.227 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.69 -40.77 80.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 71.519999999999996 111.22 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.499 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 19.9 mm-40 -61.42 -41.42 97.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.827 -0.624 . . . . 73.450000000000003 111.101 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.05 -51.82 67.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 123.915 0.759 . . . . 71.439999999999998 110.718 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.77 -46.68 95.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 CA-C-N 115.114 -0.948 . . . . 75.019999999999996 111.994 -174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 75.6 mmtt -60.84 -47.89 84.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 110.028 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -68.26 -45.29 73.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.351 -0.84 . . . . 74.510000000000005 111.431 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.507 HD22 ' CE2' ' A' ' 452' ' ' PHE . 21.8 tp -69.07 -38.53 79.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.063 0.459 . . . . 72.140000000000001 110.845 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.6 m -64.16 -39.66 94.48 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.838 -0.619 . . . . 73.239999999999995 109.459 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -18.98 62.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.932 -0.577 . . . . 64.319999999999993 110.442 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.16 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.087 0.47 . . . . 70.439999999999998 110.124 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.84 -23.71 9.93 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.617 -0.802 . . . . 75.109999999999999 113.175 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.69 134.29 56.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.741 0.305 . . . . 74.439999999999998 110.783 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -130.13 -8.17 3.41 Favored Glycine 0 N--CA 1.428 -1.886 0 C-N-CA 119.811 -1.185 . . . . 70.019999999999996 112.898 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -102.69 115.4 30.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.548 -0.908 . . . . 74.239999999999995 108.548 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.507 ' CE2' HD22 ' A' ' 444' ' ' LEU . 42.3 m-85 -129.19 154.88 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.294 -0.866 . . . . 74.230000000000004 110.394 -175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.406 ' HB3' HG12 ' A' ' 485' ' ' ILE . 0.7 OUTLIER -138.86 122.92 17.93 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.37 -2.455 . . . . 75.420000000000002 104.37 169.239 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -105.17 134.61 47.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 110.904 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.13 153.3 47.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.497 -0.927 . . . . 73.340000000000003 108.497 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.35 146.49 50.02 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 70.430000000000007 109.396 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 53.4 m -139.89 135.21 16.37 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 116.555 -0.293 . . . . 74.209999999999994 110.373 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.72 122.39 10.23 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.386 2.057 . . . . 72.209999999999994 111.374 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.7 m -140.54 -179.91 6.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.81 -1.181 . . . . 71.409999999999997 107.81 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.8 t -50.2 142.99 13.46 Favored Pre-proline 0 C--O 1.25 1.131 0 C-N-CA 123.168 0.587 . . . . 73.349999999999994 110.795 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.12 -29.32 28.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.088 3.192 . . . . 73.109999999999999 112.986 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.52 -18.86 63.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.467 0.543 . . . . 71.040000000000006 112.467 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -100.97 6.8 43.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.978 0.732 . . . . 75.230000000000004 112.978 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.6 p -61.01 127.69 21.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.406 -0.518 . . . . 70.530000000000001 110.546 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.48 12.73 84.26 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.801 -0.714 . . . . 60.539999999999999 112.439 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 94.6 mttt -121.18 154.87 35.68 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.693 -0.854 . . . . 75.239999999999995 108.693 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 486' ' ' ILE . 40.5 t -82.06 126.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.174 -0.676 . . . . 75.329999999999998 109.174 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.4 pt -98.17 -13.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.462 -0.495 . . . . 63.299999999999997 110.358 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.45 160.82 19.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.595 -0.812 . . . . 73.319999999999993 111.684 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.5 p -120.86 146.72 46.28 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.546 -0.909 . . . . 71.329999999999998 108.546 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.549 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.3 t-20 -58.49 -57.93 22.81 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-O 119.128 -0.463 . . . . 73.310000000000002 111.042 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.34 129.55 14.04 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 108.737 -1.294 . . . . 73.450000000000003 108.737 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.7 133.08 37.72 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 74.209999999999994 112.254 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.436 ' CB ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.6 -5.7 46.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.939 0.876 . . . . 72.340000000000003 110.673 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.81 -28.44 28.08 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.224 -1.353 . . . . 74.319999999999993 109.4 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.91 165.21 11.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.041 -0.726 . . . . 74.109999999999999 109.041 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.5 p -87.84 120.83 29.56 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 109.094 -0.706 . . . . 75.150000000000006 109.094 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 19.8 m -104.39 147.98 26.93 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.359 -0.978 . . . . 74.409999999999997 108.359 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.81 148.58 44.38 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.752 0.31 . . . . 71.430000000000007 110.94 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.36 -21.9 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.869 0.842 . . . . 75.109999999999999 110.549 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 t -94.32 -0.56 54.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.228 -0.896 . . . . 71.219999999999999 110.566 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.9 142.13 38.63 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.345 -0.983 . . . . 71.430000000000007 108.345 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.63 112.0 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.702 -0.851 . . . . 70.519999999999996 108.702 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.77 118.41 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 108.389 -0.967 . . . . 71.040000000000006 108.389 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.4 mt -92.44 112.01 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 106.018 -1.845 . . . . 75.450000000000003 106.018 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.55 121.56 56.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.121 -0.945 . . . . 74.409999999999997 108.633 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.93 118.85 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.748 -0.66 . . . . 73.209999999999994 109.608 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.25 139.16 19.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.011 -1.107 . . . . 72.129999999999995 108.011 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.02 127.08 7.79 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 109.975 -1.25 . . . . 62.439999999999998 109.975 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 24.6 p -108.38 131.72 54.47 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.749 -0.834 . . . . 70.230000000000004 108.749 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -90.88 163.75 29.64 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.939 -1.264 . . . . 74.209999999999994 109.939 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.68 121.78 10.06 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.153 1.902 . . . . 73.409999999999997 112.016 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -112.57 70.12 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.353 -1.351 . . . . 74.319999999999993 107.353 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 41.5 p -135.51 166.36 23.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.854 -1.066 . . . . 74.400000000000006 109.583 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 27.6 mmtm -140.13 137.63 34.61 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.052 0.453 . . . . 73.430000000000007 111.802 173.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.78 126.46 31.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.626 -1.17 . . . . 72.519999999999996 108.058 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.9 pt -96.34 131.01 29.39 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.73 -0.788 . . . . 75.439999999999998 110.619 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.76 -177.95 1.03 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.356 2.037 . . . . 74.319999999999993 110.472 174.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.91 93.8 3.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.07 0.462 . . . . 74.349999999999994 110.232 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.19 -0.6 10.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.84 -1.541 . . . . 72.319999999999993 106.84 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.46 143.69 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.459 -1.7 . . . . 75.230000000000004 109.565 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.22 -15.45 25.36 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.477 -0.868 . . . . 62.130000000000003 111.52 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.64 -170.15 1.95 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.28 -0.568 . . . . 74.450000000000003 110.249 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.5 157.52 21.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.894 -1.15 . . . . 74.239999999999995 107.894 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 42.4 t -56.62 -49.62 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.416 0.627 . . . . 74.209999999999994 111.14 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.27 -41.96 80.3 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.282 -0.872 . . . . 75.200000000000003 111.129 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.32 -44.67 94.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.828 -1.078 . . . . 74.150000000000006 110.632 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.05 96.47 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.003 -0.544 . . . . 74.109999999999999 110.957 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.21 -40.17 95.19 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.89 -0.411 . . . . 73.450000000000003 109.89 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -44.03 89.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.832 -0.622 . . . . 75.140000000000001 110.6 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.65 -44.51 73.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.039 0.447 . . . . 73.140000000000001 110.519 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.15 -36.8 85.37 Favored 'General case' 0 C--O 1.191 -2.004 0 CA-C-N 115.565 -0.743 . . . . 71.409999999999997 109.54 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 26.2 t-20 -57.85 -37.96 74.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.263 0.625 . . . . 72.5 111.597 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.46 -43.16 91.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.585 -0.734 . . . . 74.409999999999997 111.675 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -110.85 13.29 22.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.521 -0.472 . . . . 71.450000000000003 110.549 -171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.9 -103.01 0.31 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.408 -1.377 . . . . 60.229999999999997 115.108 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 46.9 m-85 -127.04 177.56 6.56 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.005 0.431 . . . . 74.109999999999999 112.143 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 m -120.74 -14.52 8.54 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.739 -0.664 . . . . 65.439999999999998 110.949 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -108.23 119.68 40.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.431 -0.581 . . . . 75.239999999999995 109.431 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.72 147.57 44.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.714 -0.675 . . . . 73.010000000000005 111.001 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 44.3 m -137.5 151.64 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.756 -1.572 . . . . 73.099999999999994 106.756 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -121.53 137.83 54.56 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 118.339 0.518 . . . . 74.319999999999993 111.381 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -126.17 122.62 36.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.353 -1.351 . . . . 70.299999999999997 107.353 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 5.2 p -89.33 132.7 34.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.777 0.322 . . . . 71.099999999999994 111.5 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.76 149.31 24.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.183 -1.414 . . . . 72.109999999999999 107.183 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.88 136.3 37.25 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.133 -0.627 . . . . 74.010000000000005 110.972 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.1 m -133.64 160.5 68.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.065 -0.97 . . . . 73.549999999999997 109.982 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -70.19 -142.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.38 2.72 . . . . 75.420000000000002 111.964 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -51.39 81.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 113.888 1.07 . . . . 73.120000000000005 113.888 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.24 133.02 31.38 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 121.043 1.408 . . . . 72.109999999999999 109.799 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -168.78 125.49 0.98 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.303 0.641 . . . . 74.109999999999999 109.518 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.9 -23.53 1.45 Allowed Glycine 0 C--N 1.301 -1.413 0 N-CA-C 109.841 -1.304 . . . . 63.130000000000003 109.841 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.55 29.92 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.447 -0.946 . . . . 74.430000000000007 108.447 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 75.0 t -74.05 119.39 21.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.6 -0.889 . . . . 72.129999999999995 108.6 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.0 m -68.5 -40.36 80.89 Favored 'General case' 0 N--CA 1.427 -1.595 0 O-C-N 124.529 1.143 . . . . 74.140000000000001 109.642 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.61 -152.87 20.63 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.506 -0.854 . . . . 54.200000000000003 111.541 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -134.04 161.76 33.96 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.744 -1.206 . . . . 62.200000000000003 107.744 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -56.32 -65.3 1.67 Allowed Pre-proline 0 N--CA 1.474 0.76 0 CA-C-O 118.891 -0.576 . . . . 65.230000000000004 110.65 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.88 147.92 27.66 Favored 'Trans proline' 0 C--N 1.367 1.509 0 CA-C-N 120.633 1.262 . . . . 74.25 109.248 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.86 163.05 40.08 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.927 1.751 . . . . 71.109999999999999 111.528 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.76 58.66 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.187 -0.46 . . . . 73.420000000000002 110.21 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.49 -12.76 61.51 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.936 -0.865 . . . . 72.219999999999999 110.936 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.7 m -86.04 124.22 32.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 109.07 -0.715 . . . . 73.25 109.07 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.1 t -90.6 123.38 34.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.96 -1.126 . . . . 74.540000000000006 107.96 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.443 HG21 ' CZ ' ' A' ' 517' ' ' PHE . 19.4 m -123.64 156.27 64.93 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 109.671 -0.492 . . . . 74.230000000000004 109.671 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 135.08 65.29 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.213 2.609 . . . . 71.329999999999998 114.23 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.518 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.5 m -67.28 -20.78 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.274 -0.876 . . . . 64.120000000000005 111.518 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.11 -0.23 55.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 111.12 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 17.4 t -100.42 151.04 22.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.236 -1.024 . . . . 75.310000000000002 108.236 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.58 136.41 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 N-CA-C 108.022 -1.103 . . . . 73.409999999999997 108.022 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.6 tt -97.52 143.28 12.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 120.036 -0.665 . . . . 75.430000000000007 110.858 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -102.45 118.37 36.72 Favored 'General case' 0 N--CA 1.408 -2.547 0 C-N-CA 123.471 0.709 . . . . 64.239999999999995 109.404 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.0 tp -97.05 129.25 44.51 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.729 -1.123 . . . . 70.5 108.689 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -90.05 112.95 24.56 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.364 -0.976 . . . . 71.329999999999998 108.364 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.8 137.88 33.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.006 -0.543 . . . . 73.099999999999994 111.955 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.5 m -68.76 126.08 28.61 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 115.64 -0.709 . . . . 73.349999999999994 111.65 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 115.308 -0.86 . . . . 72.409999999999997 108.803 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.033 0 N-CA-C 110.443 -1.063 . . . . 70.219999999999999 110.443 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.06 144.05 23.39 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.224 1.95 . . . . 61.450000000000003 112.338 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.3 OUTLIER -86.25 64.15 8.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.559 1.171 . . . . 65.209999999999994 110.191 178.203 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.427 ' C ' ' HB ' ' A' ' 477' ' ' THR . 26.7 mt-30 -101.64 125.7 48.35 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.006 -1.452 . . . . 55.43 108.755 175.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -121.04 153.44 37.38 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.407 -0.36 . . . . 74.439999999999998 110.341 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.02 141.39 28.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 110.889 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.4 mp -85.09 128.33 60.53 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 107.47 -1.307 . . . . 75.319999999999993 107.47 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.8 147.05 61.78 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.561 2.174 . . . . 74.340000000000003 112.55 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -83.54 29.31 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.956 -0.565 . . . . 72.439999999999998 110.762 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.9 m -85.84 7.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.001 0.905 . . . . 72.019999999999996 109.784 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.559 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 2.3 p -58.0 -35.02 70.62 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 125.999 1.719 . . . . 72.230000000000004 109.982 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.52 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.6 t -60.47 -26.04 66.48 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.718 -1.583 . . . . 74.129999999999995 111.496 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.81 -47.81 10.01 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 118.953 -1.099 . . . . 73.420000000000002 111.05 -174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.4 m -174.41 153.99 2.03 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.736 -1.209 . . . . 73.420000000000002 107.736 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.468 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 29.2 t80 -50.37 -54.72 19.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.293 1.037 . . . . 71.219999999999999 110.656 171.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.18 -41.23 75.18 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.912 -0.586 . . . . 75.040000000000006 111.936 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 443' ' ' LYS . 66.2 mm-40 -61.51 -46.56 89.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.156 0.428 . . . . 74.129999999999995 112.156 -178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.83 58.64 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.603 0.594 . . . . 74.140000000000001 112.603 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.74 -47.6 88.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 70.430000000000007 110.958 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.62 -35.21 79.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.304 0.242 . . . . 71.019999999999996 110.973 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 439' ' ' GLU . 2.6 tmtm? -66.26 -47.61 73.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.155 -1.054 . . . . 75.340000000000003 108.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.1 tp -68.86 -32.66 72.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.723 -0.671 . . . . 72.209999999999994 110.519 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 96.9 m -60.89 -43.99 97.72 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.51 -0.768 . . . . 64.239999999999995 109.308 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -20.02 62.45 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.077 -0.51 . . . . 71.340000000000003 111.148 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.54 -10.9 59.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.997 -0.547 . . . . 71.310000000000002 110.414 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.51 -8.43 8.33 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 119.927 -1.13 . . . . 74.120000000000005 113.956 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 445' ' ' THR . 92.5 m-85 -86.17 133.37 33.86 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 117.306 0.553 . . . . 73.319999999999993 110.773 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.41 -13.96 3.04 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.886 -0.673 . . . . 53.229999999999997 112.692 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -103.06 116.29 32.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.41 0.605 . . . . 71.040000000000006 110.87 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.04 158.03 40.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.826 -0.625 . . . . 75.010000000000005 111.231 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.4 tppp? -134.61 135.7 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.042 -2.207 . . . . 63.149999999999999 105.042 172.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -115.95 135.09 54.3 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.535 0.607 . . . . 74.120000000000005 111.236 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.24 140.86 45.58 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.348 -0.982 . . . . 64.299999999999997 108.348 175.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.86 142.12 46.5 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.862 -0.792 . . . . 74.140000000000001 108.862 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.5 t -140.58 146.74 46.19 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 108.605 -0.887 . . . . 74.329999999999998 108.605 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.2 Cg_exo -65.08 140.17 64.31 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.846 1.698 . . . . 74.0 109.926 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 71.1 m -150.72 179.77 7.93 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.747 -0.835 . . . . 64.510000000000005 108.747 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -56.09 133.67 74.5 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.94 -0.763 . . . . 75.450000000000003 108.94 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 79.3 Cg_exo -50.1 -29.59 22.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.142 3.228 . . . . 74.409999999999997 115.117 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.81 -10.31 59.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.234 0.828 . . . . 75.109999999999999 113.234 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.8 mt -102.53 11.61 37.61 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.784 -0.366 . . . . 73.099999999999994 111.731 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -61.14 128.05 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.999 0.428 . . . . 73.540000000000006 110.737 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.8 3.99 90.39 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.996 -0.547 . . . . 73.329999999999998 112.292 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 434' ' ' THR . 93.5 mttt -112.23 159.69 18.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.371 -0.974 . . . . 72.319999999999993 108.371 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.559 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 46.0 t -82.67 129.07 38.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.557 -0.905 . . . . 63.5 108.557 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.33 -20.52 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.361 0.601 . . . . 65.230000000000004 109.764 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.75 170.2 33.09 Favored Glycine 0 N--CA 1.416 -2.688 0 N-CA-C 110.471 -1.052 . . . . 74.420000000000002 110.471 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.2 p -120.02 157.62 28.49 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.452 -0.573 . . . . 72.349999999999994 109.452 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.567 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 25.6 t-20 -60.21 -49.28 91.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 119.238 -0.41 . . . . 73.420000000000002 111.49 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.0 Cg_exo -83.14 155.88 14.82 Favored 'Trans proline' 0 C--N 1.365 1.402 0 N-CA-C 107.821 -1.646 . . . . 73.319999999999993 107.821 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.36 146.65 81.26 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 121.697 1.598 . . . . 64.439999999999998 109.887 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.94 -37.4 29.56 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 121.059 0.457 . . . . 73.329999999999998 111.166 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . 0.271 18.8 m-80 -85.41 -8.33 58.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.719 1.377 . . . . 73.400000000000006 114.719 -172.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.39 152.28 18.54 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.773 -1.195 . . . . 74.120000000000005 107.773 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.427 ' HB ' ' C ' ' A' ' 426' ' ' GLN . 33.1 p -79.51 121.63 25.46 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.272 0.558 . . . . 73.239999999999995 110.738 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.6 m -104.59 140.83 37.43 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.357 -0.979 . . . . 65.25 108.357 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 145.67 52.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.733 0.302 . . . . 72.319999999999993 111.635 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.0 mm -59.59 -21.89 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.472 0.709 . . . . 73.439999999999998 111.27 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.8 t -83.49 0.08 47.94 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.924 -0.485 . . . . 72.25 111.473 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.08 154.77 20.49 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.967 0.413 . . . . 75.219999999999999 110.605 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.25 124.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.17 -1.418 . . . . 74.150000000000006 107.17 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.41 118.7 37.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 C-N-CA 119.19 -1.004 . . . . 75.040000000000006 109.405 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.567 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.96 113.15 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.029 -1.841 . . . . 75.200000000000003 106.029 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.34 128.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 115.923 -0.58 . . . . 75.530000000000001 109.595 -175.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 31.5 mt -104.5 119.96 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.277 -0.874 . . . . 72.030000000000001 109.286 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.59 137.76 23.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.279 -0.873 . . . . 73.0 108.885 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -85.05 123.49 6.32 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 110.943 -0.863 . . . . 62.350000000000001 110.943 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 27.4 t -111.07 129.46 55.91 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.67 -1.604 . . . . 72.109999999999999 106.67 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -80.15 146.8 28.19 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 109.291 -1.523 . . . . 63.229999999999997 109.291 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.08 110.99 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.85 1.7 . . . . 75.040000000000006 111.819 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -98.73 61.27 1.32 Allowed 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.69 -1.226 . . . . 73.299999999999997 107.69 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 23.8 p -134.76 160.71 37.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.348 -0.842 . . . . 74.319999999999993 110.66 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -150.45 142.24 23.74 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.714 0.806 . . . . 73.329999999999998 109.052 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.6 p-10 -88.75 134.01 34.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.479 . . . . 75.120000000000005 107.008 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.95 124.92 88.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 CA-C-N 115.489 -0.778 . . . . 72.019999999999996 111.867 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.06 150.15 1.65 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.533 2.155 . . . . 72.230000000000004 111.212 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -87.64 107.55 18.66 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.345 1.069 . . . . 63.539999999999999 110.053 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.53 42.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 106.925 -1.509 . . . . 73.209999999999994 106.925 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.42 159.89 25.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.406 -1.27 . . . . 73.230000000000004 112.629 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.15 -16.09 46.37 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.216 -0.753 . . . . 72.319999999999993 111.216 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -89.93 -173.08 3.75 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.195 0.522 . . . . 74.510000000000005 111.696 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.6 m -90.85 156.56 17.93 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.403 -1.332 . . . . 74.109999999999999 107.403 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 19.2 t -55.05 -48.97 75.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 123.721 0.638 . . . . 73.239999999999995 111.08 -172.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.34 -41.62 80.46 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.619 0.6 . . . . 75.120000000000005 112.619 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.88 -34.86 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.507 -0.877 . . . . 75.540000000000006 111.234 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.78 89.22 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.727 -0.67 . . . . 75.310000000000002 110.216 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.1 mt-30 -62.73 -42.74 99.81 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 123.448 0.467 . . . . 73.109999999999999 110.481 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -42.67 99.44 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 112.897 0.703 . . . . 73.299999999999997 112.897 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -66.99 -48.11 69.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.53 -0.468 . . . . 65.400000000000006 110.094 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.427 HD23 HD12 ' A' ' 551' ' ' ILE . 41.8 tp -60.2 -41.17 92.44 Favored 'General case' 0 C--O 1.198 -1.614 0 CA-C-N 115.512 -0.767 . . . . 75.340000000000003 110.144 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.8 t-20 -59.21 -48.05 83.05 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.856 0.862 . . . . 74.200000000000003 111.29 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.88 -18.89 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.318 0.488 . . . . 75.150000000000006 112.318 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -118.96 8.66 11.7 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.778 -0.769 . . . . 74.150000000000006 110.229 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -149.84 -95.83 0.14 Allowed Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.02 -1.562 . . . . 65.530000000000001 115.836 -170.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 59.6 m-85 -123.11 170.18 10.47 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.221 0.534 . . . . 74.430000000000007 111.736 -165.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 20.4 p -97.11 -35.9 10.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.276 -0.874 . . . . 73.409999999999997 112.352 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -117.77 142.61 47.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.127 0.489 . . . . 71.530000000000001 112.075 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -127.6 156.99 41.4 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.735 -1.12 . . . . 75.099999999999994 110.404 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.4 t -129.73 141.99 50.79 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.845 -2.28 . . . . 74.530000000000001 104.845 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -121.28 129.78 53.31 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.944 -0.761 . . . . 75.209999999999994 108.944 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.03 136.96 51.0 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 123.601 0.563 . . . . 75.439999999999998 109.736 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 51.9 m -88.56 131.61 34.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.31 -0.859 . . . . 63.130000000000003 109.491 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 557' ' ' LYS . 34.4 m -122.24 149.53 25.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.734 -0.469 . . . . 72.109999999999999 109.734 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.93 111.45 16.27 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.74 0.781 . . . . 73.239999999999995 110.195 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 7.2 p -107.58 119.81 49.37 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.615 -1.175 . . . . 70.519999999999996 109.818 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -51.49 1.54 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.449 2.099 . . . . 74.120000000000005 111.527 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -102.78 -50.93 0.15 Allowed Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 114.186 1.18 . . . . 75.239999999999995 114.186 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.75 153.45 36.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.904 1.736 . . . . 74.420000000000002 112.373 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.89 108.01 0.86 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 122.918 0.487 . . . . 70.329999999999998 110.968 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.75 -24.08 33.19 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 120.935 -0.65 . . . . 74.420000000000002 114.336 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.24 23.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 2.7 p -73.68 120.16 22.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.945 -0.761 . . . . 73.439999999999998 108.945 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -71.73 -40.39 69.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.991 -1.004 . . . . 74.230000000000004 110.174 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.84 -149.81 13.81 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.488 -0.645 . . . . 73.5 111.488 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.5 p -117.9 160.03 22.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.277 -1.008 . . . . 73.230000000000004 108.277 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -74.3 -56.05 2.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.018 -1.073 . . . . 71.329999999999998 110.181 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.87 149.33 89.71 Favored 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 120.741 0.961 . . . . 72.450000000000003 109.614 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.8 152.36 80.66 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.525 2.15 . . . . 72.0 112.549 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.38 132.64 52.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.795 -0.817 . . . . 74.530000000000001 108.795 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.63 40.83 Favored Glycine 0 C--N 1.298 -1.574 0 C-N-CA 120.272 -0.966 . . . . 71.120000000000005 111.958 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.8 m -67.44 120.96 14.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.871 -0.789 . . . . 64.120000000000005 108.871 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.4 m -90.18 122.75 33.41 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.556 -0.905 . . . . 74.109999999999999 108.556 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.01 157.63 77.7 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 108.095 -1.076 . . . . 70.25 108.095 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.81 144.3 98.53 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.182 1.922 . . . . 75.319999999999993 111.577 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -65.03 -18.55 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.18 0.991 . . . . 72.420000000000002 110.786 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.32 -17.73 53.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.883 -1.508 . . . . 74.329999999999998 109.83 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 172.4 13.79 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.985 -1.007 . . . . 72.409999999999997 113.644 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.03 124.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.358 -1.292 . . . . 75.150000000000006 109.42 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.427 HD12 HD23 ' A' ' 512' ' ' LEU . 13.1 tt -100.46 136.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.558 -0.534 . . . . 72.099999999999994 109.558 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.29 122.6 45.13 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-O 121.435 0.636 . . . . 72.120000000000005 111.126 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 12.7 tp -101.39 133.83 45.4 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.203 1.401 . . . . 73.319999999999993 109.356 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -104.01 114.56 28.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.157 -0.682 . . . . 73.129999999999995 109.157 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 137.84 34.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 111.496 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 10.4 m -64.11 115.06 4.6 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 106.94 -1.504 . . . . 65.549999999999997 106.94 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.543 ' OXT' ' HD2' ' A' ' 557' ' ' LYS 0.306 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 N-CA-C 114.828 1.418 . . . . 64.450000000000003 114.828 -172.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.749 0 N-CA-C 110.487 -1.045 . . . . 70.420000000000002 110.487 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.37 132.48 31.53 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.613 2.209 . . . . 74.219999999999999 110.72 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.554 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -89.14 50.48 1.95 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.894 0.854 . . . . 65.219999999999999 110.445 -176.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -83.43 137.69 33.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.355 -0.839 . . . . 64.230000000000004 111.87 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.439 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 21.6 tpp180 -129.51 157.38 42.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.351 -0.981 . . . . 73.099999999999994 108.351 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.43 141.92 28.79 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 123.332 0.653 . . . . 72.120000000000005 111.279 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -85.15 130.49 51.79 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 108.109 -1.071 . . . . 73.310000000000002 108.109 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.97 158.38 34.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.546 2.83 . . . . 71.0 115.393 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -113.3 16.32 19.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.917 -1.038 . . . . 65.549999999999997 110.309 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.98 -2.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.244 1.021 . . . . 64.299999999999997 109.224 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 4.1 m -61.22 -38.87 88.17 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.977 -1.465 . . . . 75.25 110.828 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 9.4 t -59.03 -26.82 64.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.607 -0.724 . . . . 74.540000000000006 111.672 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.414 ' C ' ' HG1' ' A' ' 436' ' ' THR . 89.4 mt -76.9 -45.54 27.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 120.063 -0.655 . . . . 74.340000000000003 110.097 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.463 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 14.3 m -168.82 147.49 4.06 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.301 -1.0 . . . . 72.239999999999995 108.301 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -51.64 -44.47 62.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.607 0.763 . . . . 74.219999999999999 111.112 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.75 -35.41 66.16 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.984 0.514 . . . . 74.010000000000005 111.6 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.463 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 10.7 mm-40 -70.52 -42.29 71.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.796 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -60.34 -50.77 72.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.358 -0.837 . . . . 65.340000000000003 110.113 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.0 t -58.55 -49.19 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.214 -0.903 . . . . 75.439999999999998 112.015 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.66 -46.83 83.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.839 -0.344 . . . . 73.019999999999996 111.622 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.78 -41.62 87.35 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 75.420000000000002 110.122 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.3 tp -68.48 -43.21 77.43 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.916 -0.584 . . . . 72.420000000000002 110.155 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 39.5 m -59.51 -44.68 93.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.676 -0.693 . . . . 75.420000000000002 109.804 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.69 62.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.906 -0.588 . . . . 64.510000000000005 111.395 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -80.93 -13.72 58.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.132 0.492 . . . . 72.530000000000001 110.152 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.65 -5.78 26.15 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.126 -1.035 . . . . 70.230000000000004 112.794 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 97.3 m-85 -82.65 111.54 18.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.576 -0.527 . . . . 73.129999999999995 109.576 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.25 41.32 Favored Glycine 0 N--CA 1.427 -1.918 0 CA-C-N 115.476 -0.784 . . . . 75.019999999999996 111.836 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.51 114.63 26.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.264 0.554 . . . . 71.109999999999999 111.239 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.82 156.83 43.14 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.322 -0.854 . . . . 72.530000000000001 112.366 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 123.06 29.31 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.176 -1.416 . . . . 75.099999999999994 107.176 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -94.0 125.71 38.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.858 -0.61 . . . . 73.450000000000003 109.873 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.04 147.15 50.5 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.327 -1.36 . . . . 72.420000000000002 107.327 176.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -122.57 139.88 53.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.344 -0.543 . . . . 73.010000000000005 109.652 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.4 m -126.44 140.85 38.35 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 109.259 -0.645 . . . . 74.420000000000002 109.259 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -64.77 121.91 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.597 1.531 . . . . 75.310000000000002 109.842 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 492' ' ' PRO . 13.5 m -133.67 179.99 5.88 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.761 -1.57 . . . . 70.549999999999997 106.761 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.0 t -60.56 136.98 92.56 Favored Pre-proline 0 N--CA 1.419 -2.003 0 N-CA-C 109.136 -0.69 . . . . 71.120000000000005 109.136 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 85.2 Cg_exo -49.86 -28.96 19.38 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.464 3.443 . . . . 73.150000000000006 114.829 -173.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.18 -18.43 61.86 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.07 0.767 . . . . 74.129999999999995 113.07 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.28 7.96 44.59 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.934 -0.479 . . . . 74.540000000000006 111.983 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -60.96 128.36 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 120.968 0.414 . . . . 73.209999999999994 110.505 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.13 89.31 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.77 -0.728 . . . . 73.510000000000005 111.97 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -113.65 148.22 36.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.646 -1.242 . . . . 74.140000000000001 107.646 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 44.8 t -82.36 140.43 16.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.534 -0.913 . . . . 74.239999999999995 108.534 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.8 pt -96.96 -23.37 4.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.448 0.642 . . . . 73.409999999999997 109.402 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.39 175.48 38.62 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 109.062 -1.615 . . . . 75.030000000000001 109.062 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.6 p -116.49 154.36 30.51 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.879 -0.785 . . . . 74.010000000000005 108.879 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.7 t30 -61.09 -46.65 96.23 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 123.56 0.537 . . . . 74.230000000000004 110.165 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.4 Cg_exo -83.36 137.07 7.97 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.036 1.158 . . . . 74.329999999999998 109.391 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.442 ' HG2' ' CG ' ' A' ' 476' ' ' GLN . 9.8 Cg_endo -62.56 140.19 80.08 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.266 1.977 . . . . 73.230000000000004 112.051 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.53 -8.08 55.17 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 122.134 0.969 . . . . 75.109999999999999 111.153 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -94.65 -3.98 48.47 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.603 -1.18 . . . . 70.409999999999997 110.399 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.442 ' CG ' ' HG2' ' A' ' 473' ' ' PRO . 31.3 mm-40 -109.94 159.98 16.8 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 109.081 -0.711 . . . . 73.109999999999999 109.081 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.1 p -101.8 115.21 30.03 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.34 -1.356 . . . . 74.109999999999999 107.34 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 48.8 m -100.59 140.97 34.1 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.795 -0.446 . . . . 75.049999999999997 109.795 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.58 145.66 54.65 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.036 -0.529 . . . . 74.230000000000004 110.61 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.1 mm -67.24 -9.16 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 122.085 0.945 . . . . 73.109999999999999 110.752 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -77.51 -5.91 51.7 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.613 -0.679 . . . . 74.030000000000001 109.894 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.05 158.09 16.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.706 -0.621 . . . . 73.200000000000003 111.742 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.98 125.77 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.013 -1.847 . . . . 74.400000000000006 106.013 169.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.71 120.53 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.813 -0.755 . . . . 75.540000000000006 110.609 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.81 114.84 29.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.098 -1.445 . . . . 74.219999999999999 107.098 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.63 121.52 61.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 109.016 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.11 120.26 51.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.9 0.857 . . . . 73.230000000000004 112.446 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.0 t -96.56 146.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.588 -1.187 . . . . 73.319999999999993 108.955 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -82.83 123.41 6.09 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.026 -1.23 . . . . 50.420000000000002 110.026 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 28.8 t -110.95 143.83 40.99 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.167 -1.42 . . . . 75.400000000000006 107.167 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -96.66 137.5 13.38 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.33 -0.938 . . . . 72.209999999999994 111.308 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 459' ' ' SER . 12.9 Cg_exo -70.39 115.44 4.18 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.955 1.77 . . . . 72.409999999999997 109.156 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -83.75 87.02 7.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.915 0.864 . . . . 74.239999999999995 109.813 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 32.6 p -137.32 160.06 40.15 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.75 -1.114 . . . . 74.150000000000006 108.957 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -141.47 143.06 33.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.33 0.394 . . . . 74.340000000000003 110.371 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.1 t70 -89.96 119.2 30.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.231 -1.396 . . . . 61.420000000000002 107.231 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.4 pt -81.9 123.42 80.1 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 112.473 0.546 . . . . 75.010000000000005 112.473 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.96 177.44 2.07 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.381 2.054 . . . . 72.519999999999996 109.287 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -85.57 138.12 32.4 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.026 -1.07 . . . . 73.409999999999997 109.526 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.67 19.01 4.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.561 -1.644 . . . . 74.140000000000001 106.561 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.01 153.37 34.56 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.167 -1.833 . . . . 75.129999999999995 111.657 -174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.08 58.71 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.91 -0.662 . . . . 71.540000000000006 111.79 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG13 ' A' ' 534' ' ' VAL . 21.0 mt-30 -121.47 -176.26 3.26 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 74.409999999999997 108.877 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.3 m -81.18 155.7 26.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 119.386 -0.925 . . . . 73.219999999999999 108.576 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.16 -41.45 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 111.619 0.229 . . . . 73.219999999999999 111.619 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.93 -42.25 85.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.378 -0.374 . . . . 75.239999999999995 111.46 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.7 p -76.04 -35.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.646 -0.822 . . . . 74.109999999999999 111.501 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.02 76.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.582 -0.736 . . . . 52.43 111.106 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.09 -38.52 91.02 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.959 -0.564 . . . . 74.329999999999998 110.355 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 514' ' ' VAL . 39.5 ttmt -63.53 -52.37 61.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 123.509 0.506 . . . . 75.239999999999995 110.866 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -62.9 -44.92 94.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 123.209 0.318 . . . . 65.420000000000002 110.302 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 31.0 tp -64.89 -36.88 85.79 Favored 'General case' 0 C--O 1.188 -2.149 0 CA-C-N 116.08 -0.509 . . . . 74.230000000000004 110.542 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.9 t-20 -59.61 -42.92 93.73 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.198 0.599 . . . . 74.409999999999997 110.492 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.9 t -67.7 -30.31 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.799 . . . . 72.140000000000001 111.443 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.18 15.09 14.05 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 121.679 -0.638 . . . . 74.140000000000001 110.785 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -155.12 -99.9 0.17 Allowed Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 118.248 -1.93 . . . . 64.310000000000002 116.637 -169.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 51.2 m-85 -115.31 161.84 17.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.264 . . . . 74.040000000000006 110.633 -168.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.2 p -102.51 -27.88 12.52 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.482 0.549 . . . . 70.109999999999999 112.482 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 9.3 mmpt? -108.79 128.46 54.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 120.589 0.233 . . . . 72.329999999999998 110.722 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 93.9 m-85 -125.18 145.21 50.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.512 -0.767 . . . . 74.400000000000006 110.375 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.1 t -115.71 159.57 21.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.137 -1.431 . . . . 60.399999999999999 107.137 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -121.18 129.09 53.07 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.744 -0.465 . . . . 74.329999999999998 109.744 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.55 129.75 44.85 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.221 -1.029 . . . . 61.130000000000003 108.221 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 9.2 m -89.21 130.68 35.58 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.041 -0.726 . . . . 70.530000000000001 109.041 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.37 157.57 26.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.339 -0.986 . . . . 74.040000000000006 108.339 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -79.69 142.21 35.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.229 0.537 . . . . 75.420000000000002 110.984 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 22.2 p -102.35 110.22 62.27 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.992 -1.004 . . . . 72.409999999999997 112.649 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -76.95 -51.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 121.644 1.562 . . . . 73.519999999999996 110.155 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.6 -64.25 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 112.38 0.511 . . . . 74.530000000000001 112.38 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.47 149.06 34.33 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.671 1.58 . . . . 63.229999999999997 112.969 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.93 138.81 25.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.575 -0.528 . . . . 62.420000000000002 109.575 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 87.79 -26.69 7.19 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 122.004 0.78 . . . . 50.130000000000003 111.816 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.57 150.0 23.98 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.614 -0.793 . . . . 73.129999999999995 111.826 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 503' ' ' GLN . 2.8 p -74.41 125.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.433 -0.803 . . . . 63.450000000000003 110.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 14.3 p -88.97 -22.0 23.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.799 -0.637 . . . . 63.100000000000001 109.899 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.44 -159.13 30.95 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.205 -0.758 . . . . 74.519999999999996 111.205 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -118.39 161.04 20.62 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.27 -1.011 . . . . 75.140000000000001 108.27 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.431 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 15.1 t-20 -54.94 -55.3 40.27 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 119.216 -0.421 . . . . 72.409999999999997 111.877 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.8 Cg_exo -80.47 143.58 15.42 Favored 'Trans proline' 0 C--N 1.366 1.499 0 N-CA-C 108.374 -1.433 . . . . 65.329999999999998 108.374 170.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.71 157.36 52.24 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.306 2.004 . . . . 73.019999999999996 113.405 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.41 131.33 50.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.329 -0.85 . . . . 73.299999999999997 109.541 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.52 -6.95 36.32 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 110.765 -0.934 . . . . 53.409999999999997 110.765 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 36.0 m -88.45 129.33 35.46 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.543 -0.54 . . . . 73.239999999999995 109.543 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.0 m -96.75 123.22 40.38 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.195 -1.039 . . . . 54.219999999999999 108.195 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.62 158.37 72.17 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 110.179 -0.304 . . . . 75.200000000000003 110.179 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.7 137.2 53.06 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.823 2.349 . . . . 74.120000000000005 111.654 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.495 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.5 m -67.48 -20.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.469 0.652 . . . . 54.43 111.808 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.69 2.1 46.69 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 74.040000000000006 111.319 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -93.09 167.78 11.55 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.292 -1.003 . . . . 75.329999999999998 108.292 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.43 116.61 44.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.133 -0.692 . . . . 74.450000000000003 109.133 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 15.4 tt -88.71 132.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.191 0.52 . . . . 72.450000000000003 109.99 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -102.91 131.07 50.1 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-O 121.489 0.661 . . . . 72.420000000000002 111.747 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 554' ' ' GLN . 1.8 tm? -99.78 135.3 41.41 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.951 1.3 . . . . 72.540000000000006 109.304 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.408 ' N ' HD13 ' A' ' 553' ' ' LEU . 25.9 mm-40 -94.69 106.44 18.42 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.489 -0.778 . . . . 74.400000000000006 108.91 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.07 122.33 47.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 109.427 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 25.6 p -76.52 115.35 16.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 108.779 -0.822 . . . . 74.140000000000001 108.779 -176.468 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.763 0 N-CA-C 110.319 -1.112 . . . . 63.140000000000001 110.319 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.91 154.7 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.206 1.938 . . . . 72.319999999999993 111.125 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.82 25.68 10.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.56 -0.533 . . . . 75.010000000000005 109.56 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.1 mt-30 -90.15 119.51 30.53 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.321 -0.4 . . . . 74.010000000000005 109.933 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.6 mmp_? -121.27 156.21 33.0 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 110.932 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.17 141.79 28.39 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.387 -0.824 . . . . 73.319999999999993 109.917 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -84.9 119.36 72.56 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.856 -1.164 . . . . 71.150000000000006 107.856 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 25.8 Cg_exo -68.47 142.28 53.6 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.265 1.977 . . . . 73.219999999999999 112.197 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 434' ' ' THR . 10.6 m-20 -84.95 37.57 0.67 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.696 0.76 . . . . 73.109999999999999 111.458 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.9 p -87.26 -6.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.609 1.195 . . . . 75.5 108.086 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 3.3 p -59.02 -36.47 75.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.664 1.586 . . . . 73.430000000000007 110.47 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 431' ' ' ASP . 14.7 t -61.69 -26.71 68.21 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.0 -1.0 . . . . 65.099999999999994 110.789 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.47 -46.5 13.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.31 -0.956 . . . . 75.239999999999995 111.407 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 85.7 m -169.73 149.72 3.86 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.788 -0.819 . . . . 63.32 108.788 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.405 ' O ' HG21 ' A' ' 441' ' ' VAL . 54.4 t80 -52.75 -49.4 65.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.928 0.491 . . . . 75.299999999999997 111.309 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.19 -39.87 73.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 64.239999999999995 111.589 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.472 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.7 mm-40 -62.97 -43.78 97.85 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.935 -0.575 . . . . 73.319999999999993 111.01 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.11 -44.06 95.13 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.269 -0.878 . . . . 72.420000000000002 109.932 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 437' ' ' TYR . 88.5 t -60.01 -49.53 83.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 115.999 -0.546 . . . . 75.230000000000004 111.142 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.0 mmtp -60.62 -47.67 85.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.045 0.45 . . . . 74.400000000000006 110.485 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 30.6 mmmt -67.93 -41.39 82.66 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.798 0.666 . . . . 74.450000000000003 112.798 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.48 -38.8 81.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 64.420000000000002 109.736 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.2 m -59.28 -46.04 89.62 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.266 -0.879 . . . . 70.209999999999994 109.278 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.28 -20.17 63.91 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.522 -0.763 . . . . 64.120000000000005 111.692 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.4 -13.61 59.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.306 0.574 . . . . 61.25 109.986 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.23 -9.13 42.21 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.983 -0.627 . . . . 74.030000000000001 113.232 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.38 115.59 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.941 0.371 . . . . 75.519999999999996 110.011 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.09 2.06 40.81 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.467 -0.873 . . . . 64.120000000000005 111.619 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -126.75 113.19 16.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.3 0.572 . . . . 75.129999999999995 109.553 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -148.73 165.15 32.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.539 -0.755 . . . . 74.0 112.188 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -140.4 131.7 26.68 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.828 -0.804 . . . . 73.140000000000001 108.828 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -93.21 135.31 34.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 123.425 0.453 . . . . 75.549999999999997 110.053 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -142.7 162.47 35.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.336 -1.357 . . . . 72.319999999999993 107.336 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.84 150.68 51.89 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 118.146 0.43 . . . . 74.030000000000001 110.636 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.0 m -138.03 146.75 53.49 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 107.963 -1.125 . . . . 71.310000000000002 107.963 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.98 130.01 22.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.733 1.622 . . . . 74.510000000000005 111.143 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -143.66 -179.72 6.62 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.579 -1.637 . . . . 61.039999999999999 106.579 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.06 142.61 85.37 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 123.004 0.522 . . . . 71.409999999999997 111.32 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 464' ' ' VAL . 75.9 Cg_exo -51.68 -29.13 32.12 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.259 3.306 . . . . 75.129999999999995 111.66 174.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.1 -29.36 67.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.512 -0.767 . . . . 72.299999999999997 111.054 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.46 13.42 24.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.409 0.522 . . . . 71.120000000000005 112.409 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 461' ' ' PRO . 15.0 p -60.47 128.02 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.075 -0.65 . . . . 74.239999999999995 110.468 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.18 11.46 83.53 Favored Glycine 0 C--O 1.249 1.069 0 C-N-CA 120.941 -0.647 . . . . 60.119999999999997 111.789 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -122.97 154.44 38.41 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.083 -1.08 . . . . 73.25 108.083 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 46.2 t -82.43 141.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.275 -0.639 . . . . 74.200000000000003 109.275 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.2 pt -97.49 -29.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.456 -0.498 . . . . 73.510000000000005 110.339 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.62 -179.01 47.05 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.531 -1.028 . . . . 62.509999999999998 110.531 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -124.23 152.17 43.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.512 -0.551 . . . . 61.210000000000001 109.512 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.0 t-20 -60.91 -49.95 86.99 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 112.285 0.476 . . . . 74.010000000000005 112.285 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.1 Cg_exo -78.16 142.69 19.48 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.154 1.236 . . . . 72.0 109.361 171.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.49 132.98 40.53 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.697 2.265 . . . . 63.140000000000001 111.897 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.72 -12.73 59.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.025 0.917 . . . . 65.140000000000001 110.706 -175.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.93 11.55 37.06 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.902 -1.045 . . . . 64.109999999999999 109.713 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -125.57 169.96 11.94 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 106.527 -1.657 . . . . 74.439999999999998 106.527 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.2 p -107.11 115.3 29.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 N-CA-C 108.031 -1.099 . . . . 74.310000000000002 108.031 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 30.3 m -102.03 138.81 38.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.407 -0.59 . . . . 74.150000000000006 109.407 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.415 ' HB1' ' ND2' ' A' ' 482' ' ' ASN . . . -66.67 137.16 56.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.614 -0.513 . . . . 71.25 109.614 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.23 -25.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 124.543 1.137 . . . . 61.210000000000001 113.074 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.3 t -71.44 -7.01 44.59 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 120.996 0.427 . . . . 71.140000000000001 111.76 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.415 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 32.7 m-80 -90.11 145.5 25.01 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 116.519 -0.309 . . . . 65.329999999999998 110.966 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.08 117.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.347 0.594 . . . . 70.109999999999999 109.759 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.79 118.86 34.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.707 -0.849 . . . . 75.530000000000001 108.707 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -92.63 113.23 27.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.247 -1.39 . . . . 65.409999999999997 107.247 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.51 119.82 53.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.337 -0.847 . . . . 75.049999999999997 109.397 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -104.11 123.79 58.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.718 0.77 . . . . 75.319999999999993 112.252 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.18 144.29 10.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 114.802 -1.09 . . . . 74.140000000000001 108.724 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.74 120.72 5.54 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 111.345 -0.702 . . . . 70.030000000000001 111.345 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.8 t -101.46 129.49 47.51 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.909 -1.885 . . . . 73.340000000000003 105.909 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -112.16 121.28 5.61 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.271 -0.966 . . . . 74.219999999999999 113.089 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.98 112.37 3.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.735 2.29 . . . . 73.420000000000002 111.786 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.18 87.76 2.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.503 -0.925 . . . . 73.439999999999998 108.503 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.402 HG21 ' HA ' ' A' ' 546' ' ' PRO . 16.6 p -136.99 154.67 50.35 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.821 -1.081 . . . . 74.519999999999996 109.232 -176.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.01 142.49 36.27 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.368 0.418 . . . . 72.349999999999994 109.982 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -80.82 132.2 35.46 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.262 -1.385 . . . . 72.409999999999997 107.262 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.69 129.88 80.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.998 -0.546 . . . . 75.420000000000002 110.059 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -87.07 160.79 8.67 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.565 2.177 . . . . 72.329999999999998 110.948 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.69 135.69 33.55 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.588 -0.845 . . . . 71.340000000000003 109.434 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.6 16.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 122.507 1.146 . . . . 63.219999999999999 108.416 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.63 40.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.726 -1.125 . . . . 64.439999999999998 109.719 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.68 -26.9 11.06 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.973 -1.251 . . . . 70.409999999999997 109.973 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -91.01 176.36 6.62 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.668 -1.234 . . . . 72.310000000000002 107.668 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.3 p -81.57 157.24 24.84 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.167 -0.613 . . . . 74.310000000000002 110.15 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.61 -41.73 38.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.601 0.563 . . . . 72.230000000000004 112.28 -177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.25 -43.08 78.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.574 0.583 . . . . 73.540000000000006 112.574 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.29 -36.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 118.837 -1.145 . . . . 75.150000000000006 111.519 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.36 77.48 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.136 -0.938 . . . . 71.209999999999994 111.39 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.94 -35.01 79.8 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 123.238 0.336 . . . . 75.129999999999995 110.513 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.424 ' O ' HG21 ' A' ' 514' ' ' VAL . 53.4 tttp -60.98 -51.61 68.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 123.244 0.34 . . . . 73.430000000000007 110.13 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.66 -44.77 95.42 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.726 -0.67 . . . . 73.409999999999997 110.376 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.08 -43.21 95.67 Favored 'General case' 0 C--O 1.179 -2.606 0 CA-C-N 115.404 -0.816 . . . . 75.340000000000003 109.999 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 24.6 t-20 -59.05 -39.54 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.508 0.723 . . . . 73.420000000000002 112.146 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.94 -0.573 . . . . 73.140000000000001 111.626 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.75 -39.28 7.91 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.311 -0.956 . . . . 74.349999999999994 110.165 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -95.09 -101.19 1.79 Allowed Glycine 0 N--CA 1.412 -2.945 0 CA-C-N 113.954 -1.475 . . . . 52.229999999999997 115.3 -170.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 16.9 m-85 -133.53 172.17 13.09 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.911 -167.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 18.7 m -109.84 -1.95 17.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.593 -0.73 . . . . 72.120000000000005 110.073 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.36 116.39 31.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.125 -0.488 . . . . 74.349999999999994 109.899 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.35 151.27 49.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.005 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -140.98 158.53 43.8 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.142 -1.429 . . . . 75.109999999999999 107.142 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -121.77 152.11 39.83 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.416 0.627 . . . . 72.140000000000001 111.818 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 554' ' ' GLN . . . -134.29 125.74 28.31 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.747 -1.205 . . . . 72.219999999999999 107.747 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.9 m -88.68 131.36 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.33 -1.359 . . . . 73.349999999999994 107.33 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.3 150.52 24.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.236 -0.586 . . . . 72.430000000000007 109.921 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.07 133.6 36.78 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.014 -0.735 . . . . 70.450000000000003 109.014 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.6 m -143.59 138.85 15.71 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.049 -0.722 . . . . 73.540000000000006 109.049 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.12 -58.51 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.2 . . . . 74.340000000000003 113.178 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 -41.26 0.07 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 118.586 -0.721 . . . . 74.420000000000002 112.943 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -55.83 149.73 49.38 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 121.688 1.592 . . . . 73.239999999999995 112.972 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.95 113.16 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.813 -1.18 . . . . 74.030000000000001 107.813 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.04 -34.05 4.63 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.385 -0.912 . . . . 61.109999999999999 112.192 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -85.17 147.96 26.35 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-O 121.579 0.704 . . . . 74.319999999999993 111.813 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.23 125.51 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.877 -1.157 . . . . 71.129999999999995 107.877 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.2 m -86.18 -33.95 20.65 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.677 -0.692 . . . . 73.420000000000002 109.596 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -179.94 -176.63 47.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.78 -0.928 . . . . 63.109999999999999 110.78 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.7 p -117.88 160.12 21.95 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 107.585 -1.265 . . . . 64.239999999999995 107.585 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.2 t-20 -60.23 -53.84 61.01 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.532 -0.467 . . . . 72.129999999999995 111.348 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 75.2 Cg_endo -88.41 146.73 6.2 Favored 'Trans proline' 0 C--N 1.369 1.613 0 CA-C-N 120.103 1.072 . . . . 73.530000000000001 110.116 171.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.39 159.53 52.63 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.174 1.916 . . . . 72.519999999999996 111.335 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 135.02 57.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.625 0.37 . . . . 74.439999999999998 110.729 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.88 48.62 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.678 -0.772 . . . . 63.5 111.933 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.7 m -71.39 121.7 19.03 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.442 -0.577 . . . . 75.540000000000006 109.442 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.4 t -83.61 126.7 33.11 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.5 0.5 . . . . 74.25 109.825 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.91 156.57 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.801 -0.814 . . . . 74.310000000000002 108.801 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' HG21 ' A' ' 494' ' ' THR . 32.4 Cg_exo -59.47 144.71 99.34 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.436 2.09 . . . . 74.409999999999997 111.741 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.9 m -66.15 -20.54 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.327 0.492 . . . . 71.099999999999994 112.327 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.81 3.51 54.23 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.067 -0.515 . . . . 74.019999999999996 111.196 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -84.68 146.14 27.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.57 -0.529 . . . . 70.409999999999997 109.57 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.83 118.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.057 -1.09 . . . . 74.120000000000005 108.057 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.1 tt -94.32 145.91 7.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 120.962 0.411 . . . . 73.140000000000001 110.398 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -102.62 127.91 49.52 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-O 121.203 0.525 . . . . 75.200000000000003 109.932 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.05 115.19 29.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.49 -1.232 . . . . 62.350000000000001 107.867 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 523' ' ' ALA . 77.3 mt-30 -92.48 108.01 19.65 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.456 0.646 . . . . 74.319999999999993 109.468 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.0 p -113.78 139.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.056 -0.974 . . . . 75.239999999999995 111.368 -174.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 m -57.81 128.66 38.2 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.928 -1.138 . . . . 51.439999999999998 107.928 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 65.8 pttt . . . . . 0 C--O 1.264 1.868 0 N-CA-C 113.619 0.97 . . . . 74.430000000000007 113.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.726 0 N-CA-C 111.635 -0.586 . . . . 70.420000000000002 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.4 132.85 26.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.946 2.431 . . . . 75.510000000000005 112.149 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -92.33 63.59 4.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 123.143 1.449 . . . . 73.400000000000006 109.059 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.4 mt-30 -111.09 153.88 25.05 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.48 -1.691 . . . . 72.230000000000004 111.886 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.05 149.74 52.16 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.365 -0.834 . . . . 74.0 110.364 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -95.14 140.57 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 74.420000000000002 108.129 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.47 122.0 82.06 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 122.912 0.133 . . . . 75.209999999999994 110.69 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 142.49 33.43 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.014 2.476 . . . . 73.099999999999994 111.908 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -99.46 78.03 2.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.425 1.107 . . . . 75.400000000000006 110.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.1 m -112.44 5.34 8.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 N-CA-C 106.061 -1.829 . . . . 74.140000000000001 106.061 171.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.447 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -59.62 -38.69 82.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.684 -2.053 . . . . 72.310000000000002 110.611 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -26.34 68.46 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.283 -1.326 . . . . 72.420000000000002 112.166 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.22 -46.01 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.847 -0.427 . . . . 65.340000000000003 109.847 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 175.49 158.3 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.671 1.188 . . . . 65.430000000000007 111.335 175.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.424 ' O ' HG22 ' A' ' 441' ' ' VAL . 58.1 t80 -51.54 -43.69 62.43 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.91 1.284 . . . . 74.109999999999999 110.78 172.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.88 83.03 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.743 0.652 . . . . 44.530000000000001 111.036 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 19.4 mm-40 -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.692 -0.686 . . . . 70.230000000000004 109.903 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.53 85.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.197 -0.91 . . . . 73.019999999999996 111.352 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 437' ' ' TYR . 98.8 t -59.37 -48.47 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 123.433 0.458 . . . . 72.409999999999997 111.371 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 442' ' ' LYS . 10.5 mmpt? -63.86 -47.11 82.01 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.09 0.244 . . . . 73.430000000000007 111.283 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.7 mptp? -67.29 -38.52 85.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.488 0.551 . . . . 74.049999999999997 112.488 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 tp -68.02 -39.62 83.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.459 0.647 . . . . 72.219999999999999 109.44 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.24 -41.16 99.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.522 -0.763 . . . . 75.25 109.376 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.42 62.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.475 -0.784 . . . . 64.200000000000003 111.216 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.46 -13.81 53.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 74.239999999999995 109.431 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.92 56.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-N 115.702 -0.681 . . . . 75.430000000000007 113.862 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.93 133.04 46.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.157 0.503 . . . . 74.030000000000001 111.893 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.98 18.34 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.409 -0.814 . . . . 74.129999999999995 112.109 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -123.92 116.36 22.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.74 0.781 . . . . 73.200000000000003 112.044 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -143.06 147.19 34.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.225 -0.898 . . . . 75.120000000000005 110.181 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -131.02 133.9 46.17 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.688 -1.227 . . . . 75.420000000000002 107.688 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -95.47 121.43 37.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.204 0.526 . . . . 74.329999999999998 110.779 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.23 141.45 48.28 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.386 -0.968 . . . . 74.329999999999998 108.386 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -126.72 144.15 51.02 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.535 -0.543 . . . . 75.150000000000006 109.535 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.8 p -144.52 149.9 45.6 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.988 -0.551 . . . . 72.319999999999993 109.997 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.3 Cg_exo -65.54 140.55 63.32 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.258 1.972 . . . . 72.510000000000005 111.114 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.2 t -152.27 179.39 8.57 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.765 -1.198 . . . . 73.109999999999999 107.765 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.4 t -66.65 144.55 98.67 Favored Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 123.705 0.802 . . . . 63.409999999999997 110.589 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.42 -29.34 30.7 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.41 3.407 . . . . 73.340000000000003 112.623 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -68.51 -32.13 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.804 -0.634 . . . . 75.140000000000001 111.823 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.91 9.01 39.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.551 0.575 . . . . 74.409999999999997 112.551 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.76 127.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.822 -0.436 . . . . 74.319999999999993 109.822 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.45 -12.28 64.91 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.627 -0.797 . . . . 64.349999999999994 111.946 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.2 146.73 23.48 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.313 -0.625 . . . . 75.319999999999993 109.313 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 64.9 t -82.67 124.79 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 N-CA-C 106.649 -1.611 . . . . 75.340000000000003 106.649 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 25.5 pt -97.85 -2.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 120.9 0.381 . . . . 65.329999999999998 111.579 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.96 164.93 20.26 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 120.236 -0.983 . . . . 63.140000000000001 111.788 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.4 p -120.77 142.71 49.32 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.725 -1.583 . . . . 73.239999999999995 106.725 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.465 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 6.1 t30 -63.97 -45.01 80.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 123.544 0.527 . . . . 75.230000000000004 110.494 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.99 139.8 12.23 Favored 'Trans proline' 0 C--N 1.375 1.938 0 CA-C-N 120.347 1.16 . . . . 74.120000000000005 109.912 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.9 144.08 63.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.697 2.264 . . . . 62.229999999999997 112.338 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.94 15.9 4.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.069 0.938 . . . . 73.299999999999997 110.483 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.02 -28.74 12.56 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.863 -1.062 . . . . 74.409999999999997 111.576 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.02 154.09 31.53 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.118 -0.697 . . . . 73.439999999999998 109.118 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.3 p -81.59 135.27 35.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.973 -0.558 . . . . 73.439999999999998 110.566 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.3 m -111.9 138.24 48.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.832 -0.803 . . . . 72.310000000000002 108.832 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -61.02 150.41 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.272 0.358 . . . . 63.509999999999998 110.824 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.58 -28.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.449 0.7 . . . . 72.209999999999994 111.041 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -88.07 0.87 55.46 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.686 -0.688 . . . . 70.230000000000004 111.439 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.08 148.99 27.18 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.002 -0.74 . . . . 75.120000000000005 109.002 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 30.9 t -92.14 111.49 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.746 -0.835 . . . . 74.540000000000006 108.746 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 86.0 t -91.0 118.82 37.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.131 -0.692 . . . . 64.230000000000004 109.131 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.8 mt -93.8 114.25 30.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.745 -0.835 . . . . 74.040000000000006 108.745 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.6 124.97 54.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.271 -0.64 . . . . 75.120000000000005 109.271 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.48 116.25 49.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.354 0.597 . . . . 73.129999999999995 111.073 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.98 140.72 16.91 Favored 'Isoleucine or valine' 0 C--O 1.252 1.225 0 CA-C-N 115.824 -0.626 . . . . 74.340000000000003 110.288 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.69 117.23 4.6 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.546 -1.422 . . . . 61.539999999999999 109.546 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.8 m -125.03 135.68 52.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.684 -0.488 . . . . 64.540000000000006 109.684 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -133.07 123.92 3.6 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 110.006 -1.238 . . . . 75.109999999999999 110.006 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.03 125.28 11.33 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.001 1.801 . . . . 73.540000000000006 111.47 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -69.33 96.01 0.83 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.279 -1.008 . . . . 74.430000000000007 108.279 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 544' ' ' THR . 13.2 p -128.29 155.29 44.84 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.79 -1.095 . . . . 64.120000000000005 109.842 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -142.65 149.98 39.63 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 71.510000000000005 109.35 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -85.35 138.07 32.53 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.47 -1.307 . . . . 73.140000000000001 107.47 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -83.1 120.39 75.87 Favored Pre-proline 0 C--N 1.291 -1.937 0 C-N-CA 119.808 -0.757 . . . . 75.420000000000002 110.028 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.76 158.48 21.49 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.737 1.625 . . . . 73.209999999999994 109.431 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.42 101.91 2.07 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.064 0.935 . . . . 75.319999999999993 110.977 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.36 -1.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.72 119.91 15.56 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 113.822 -1.536 . . . . 63.520000000000003 107.962 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.37 -27.65 5.74 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.439 -1.464 . . . . 72.140000000000001 109.439 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -83.94 178.41 7.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.021 -0.733 . . . . 75.400000000000006 109.021 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.3 m -91.12 155.87 18.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.978 . . . . 72.219999999999999 108.361 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 -47.85 56.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 112.55 0.574 . . . . 72.319999999999993 112.55 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.403 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 20.6 m-20 -69.46 -41.38 76.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.538 0.57 . . . . 72.420000000000002 112.538 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.26 -35.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.445 -0.902 . . . . 63.509999999999998 111.55 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.67 -48.95 77.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.44 -0.8 . . . . 63.149999999999999 111.322 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.42 -37.02 85.7 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 120.194 -0.602 . . . . 62.119999999999997 110.608 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 2.1 mptm? -65.94 -52.13 52.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.136 0.791 . . . . 73.219999999999999 113.136 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . 0.253 33.3 p30 -69.08 -37.59 78.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.761 0.652 . . . . 74.450000000000003 112.761 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.28 -36.8 83.89 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-O 120.516 0.198 . . . . 74.310000000000002 110.742 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.5 t-20 -58.28 -37.53 75.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.59 0.756 . . . . 75.010000000000005 111.724 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.88 -38.72 83.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.717 -0.674 . . . . 73.200000000000003 111.53 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -105.51 -13.86 15.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.764 -0.774 . . . . 64.519999999999996 110.695 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -125.12 -97.74 1.15 Allowed Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 117.067 1.587 . . . . 74.530000000000001 117.067 -166.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 2.7 m-85 -127.59 153.69 46.1 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.04 0.448 . . . . 72.450000000000003 110.161 -163.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.4 m -106.31 -6.43 18.37 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.196 -0.911 . . . . 73.319999999999993 109.436 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -108.23 115.02 29.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.838 -0.619 . . . . 74.340000000000003 109.973 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.42 156.25 37.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.212 -0.904 . . . . 73.420000000000002 111.482 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 65.7 m -138.09 152.94 49.25 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.036 -1.839 . . . . 43.329999999999998 106.036 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -119.77 131.19 55.27 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.829 -0.804 . . . . 75.239999999999995 108.829 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.48 140.43 49.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.442 -0.947 . . . . 70.329999999999998 108.442 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.1 m -104.36 119.47 39.03 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.165 -0.68 . . . . 73.209999999999994 109.165 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.4 153.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.968 -0.753 . . . . 74.319999999999993 108.968 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.7 135.4 36.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.039 -0.664 . . . . 74.400000000000006 110.041 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 m -146.26 136.31 11.94 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 107.242 -1.392 . . . . 73.109999999999999 107.242 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.12 150.97 66.76 Favored 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.365 2.043 . . . . 73.129999999999995 112.156 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HB2' ' HD3' ' A' ' 530' ' ' PRO 0.406 75.8 mtm180 37.64 -89.49 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 118.166 2.654 . . . . 73.340000000000003 118.166 179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 50.7 Cg_exo -57.56 148.53 72.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.15 1.9 . . . . 61.219999999999999 113.743 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.05 160.09 40.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.906 -0.776 . . . . 71.120000000000005 108.906 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 105.3 -21.28 35.66 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 120.523 -0.846 . . . . 63.030000000000001 112.695 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.65 148.29 25.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.282 0.563 . . . . 73.340000000000003 111.215 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.53 119.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 74.340000000000003 108.676 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.0 m -88.21 -25.52 22.86 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.58 0.705 . . . . 65.420000000000002 109.836 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.24 178.66 47.09 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.212 -0.755 . . . . 61.329999999999998 111.212 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.2 p -118.57 160.4 21.85 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.123 -1.065 . . . . 74.120000000000005 108.123 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.4 t-20 -60.49 -54.67 52.62 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-O 119.146 -0.454 . . . . 72.510000000000005 112.057 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.2 Cg_endo -86.17 153.0 9.53 Favored 'Trans proline' 0 C--N 1.365 1.413 0 CA-C-N 120.461 1.2 . . . . 75.129999999999995 109.549 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.68 150.87 85.9 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.032 1.822 . . . . 73.219999999999999 111.577 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.64 58.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.604 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.99 54.1 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 121.095 -0.574 . . . . 51.439999999999998 112.0 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.8 m -69.55 129.17 38.93 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.776 -0.25 . . . . 74.150000000000006 110.332 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -93.86 122.95 36.87 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.5 161.42 60.82 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.449 -0.796 . . . . 73.239999999999995 109.07 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.61 136.25 65.85 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.569 2.18 . . . . 74.409999999999997 111.381 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 29.2 m -67.07 -21.36 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 74.099999999999994 111.494 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -86.34 -1.81 57.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.762 -0.654 . . . . 72.310000000000002 110.863 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.1 t -85.85 168.38 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.322 0.582 . . . . 74.340000000000003 110.419 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.9 t -97.61 136.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.34 -0.846 . . . . 75.109999999999999 108.804 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.0 tt -112.84 144.26 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.723 -0.473 . . . . 75.109999999999999 109.723 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 26.6 tt0 -103.53 122.71 45.5 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 108.815 -0.809 . . . . 75.129999999999995 108.815 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.4 tp -100.68 117.82 35.56 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.045 -1.094 . . . . 75.030000000000001 108.045 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.3 mt-30 -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.987 0.899 . . . . 74.409999999999997 110.325 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.33 141.21 23.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.085 -1.416 . . . . 74.239999999999995 111.872 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -55.78 122.84 12.37 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.618 -0.719 . . . . 73.0 110.208 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.147 -1.057 . . . . 72.140000000000001 108.147 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.457 0 N-CA-C 111.285 -0.726 . . . . 75.030000000000001 111.285 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.34 151.73 84.28 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.9 2.4 . . . . 72.510000000000005 112.113 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.12 1.11 56.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.142 0.496 . . . . 74.450000000000003 110.808 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.85 156.33 26.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.057 . . . . 75.510000000000005 108.145 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -150.95 155.41 39.04 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.404 -1.332 . . . . 74.510000000000005 107.404 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.36 141.1 28.89 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 110.061 -0.348 . . . . 73.439999999999998 110.061 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 474' ' ' ALA . 2.9 mp -78.39 130.21 72.35 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.005 -1.109 . . . . 73.340000000000003 108.005 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.64 144.19 93.75 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.572 2.182 . . . . 74.239999999999995 112.839 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.16 20.4 11.43 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.238 0.542 . . . . 65.120000000000005 111.342 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 8.7 p -83.29 -1.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.408 1.099 . . . . 73.019999999999996 108.435 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 2.8 p -60.09 -34.23 73.19 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.178 1.391 . . . . 54.310000000000002 110.097 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -59.33 -27.84 66.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.253 -1.339 . . . . 73.019999999999996 111.27 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 70.5 mt -90.77 -47.19 7.78 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 119.204 -0.998 . . . . 64.319999999999993 112.041 -175.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 6.4 m -159.9 148.28 17.21 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.386 -0.598 . . . . 73.200000000000003 109.386 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.414 ' O ' HG22 ' A' ' 441' ' ' VAL . 26.7 t80 -56.42 -47.85 78.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.022 0.529 . . . . 71.010000000000005 110.396 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -56.81 -44.28 81.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.944 -0.571 . . . . 65.430000000000007 111.165 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.6 mm-40 -63.82 -41.6 97.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.929 -0.578 . . . . 74.010000000000005 110.945 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -59.92 -46.33 89.7 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.361 -0.836 . . . . 65.519999999999996 110.673 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 437' ' ' TYR . 87.4 t -60.95 -46.31 96.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 O-C-N 123.792 0.683 . . . . 72.109999999999999 111.361 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 66.7 mttm -60.62 -48.53 81.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.06 0.457 . . . . 74.200000000000003 110.38 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -67.65 -38.94 84.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.676 -0.693 . . . . 75.329999999999998 112.85 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.5 tp -68.54 -38.48 80.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.284 0.564 . . . . 72.430000000000007 109.574 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -61.82 -43.38 98.97 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.354 -0.839 . . . . 73.040000000000006 109.226 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.3 -16.0 62.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.73 -0.668 . . . . 71.540000000000006 111.736 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.84 -14.16 51.93 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 121.328 0.585 . . . . 75.420000000000002 109.539 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.93 55.88 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.616 -0.72 . . . . 71.25 113.891 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -59.62 131.1 49.9 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.391 0.595 . . . . 75.049999999999997 112.419 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -80.28 -43.77 9.3 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.214 -0.903 . . . . 73.200000000000003 114.183 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -129.62 132.77 46.84 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.793 0.806 . . . . 74.230000000000004 112.531 -175.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -140.73 150.38 43.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.814 -1.084 . . . . 65.349999999999994 109.991 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -130.31 130.69 44.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.059 -0.719 . . . . 74.140000000000001 109.059 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.92 132.42 37.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.274 0.559 . . . . 71.409999999999997 111.321 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.48 148.94 50.31 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.946 -1.501 . . . . 62.100000000000001 106.946 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.6 148.07 48.09 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.174 -0.611 . . . . 71.420000000000002 110.091 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.6 m -142.75 142.55 22.95 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.988 -0.745 . . . . 74.450000000000003 108.988 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.5 Cg_exo -67.06 128.57 18.87 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.436 2.091 . . . . 73.109999999999999 111.57 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.9 m -140.28 179.22 6.77 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.757 -0.46 . . . . 74.450000000000003 109.757 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.8 t -54.88 139.87 61.61 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 123.885 0.874 . . . . 73.030000000000001 111.439 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.01 -31.28 43.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.112 3.208 . . . . 70.310000000000002 113.387 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.34 -12.7 60.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.039 0.447 . . . . 73.319999999999993 111.847 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 30.8 tp -113.17 1.27 15.2 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.227 0.537 . . . . 74.010000000000005 110.29 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.35 127.23 20.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.102 0.477 . . . . 73.019999999999996 110.722 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.18 -6.86 66.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 116.011 -0.54 . . . . 65.430000000000007 112.281 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.5 mptp? -99.87 157.3 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.786 -0.82 . . . . 73.030000000000001 108.786 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.426 HG22 HD12 ' A' ' 486' ' ' ILE . 59.0 t -81.94 131.5 33.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 73.340000000000003 107.944 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.4 pt -98.57 -4.53 9.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.43 -0.508 . . . . 75.099999999999994 111.425 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.92 154.18 7.29 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.461 -0.791 . . . . 55.409999999999997 111.493 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 18.4 p -116.76 146.37 42.87 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.135 -0.691 . . . . 74.540000000000006 109.135 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -59.1 -49.66 91.92 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.086 -0.483 . . . . 75.519999999999996 111.654 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.9 Cg_exo -82.86 144.07 12.03 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.443 1.429 . . . . 75.140000000000001 110.305 172.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -75.65 135.92 18.49 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.325 2.016 . . . . 75.319999999999993 111.871 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 429' ' ' ILE . . . -77.96 -0.29 27.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.837 0.827 . . . . 74.329999999999998 111.058 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.61 -27.01 34.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.64 -1.164 . . . . 65.340000000000003 110.418 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -113.88 175.03 5.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.291 -0.413 . . . . 74.530000000000001 110.578 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -98.68 115.37 28.54 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 108.534 -0.913 . . . . 73.349999999999994 108.534 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.2 m -100.44 144.19 29.72 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.906 -0.775 . . . . 63.32 108.906 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.496 ' HB2' ' ND2' ' A' ' 482' ' ' ASN . . . -62.11 135.08 57.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 74.099999999999994 111.388 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.4 mm -57.11 -27.09 26.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.062 1.745 . . . . 75.439999999999998 112.524 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -75.27 -11.01 59.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.969 -0.56 . . . . 75.010000000000005 111.046 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 43.9 m-80 -78.08 150.24 33.77 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 112.797 0.666 . . . . 72.540000000000006 112.797 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.4 t -86.36 114.93 26.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.632 -1.247 . . . . 74.25 107.632 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.0 119.4 35.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.879 -0.785 . . . . 72.349999999999994 108.879 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -92.86 118.75 39.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.413 -1.328 . . . . 75.209999999999994 107.413 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.29 123.27 68.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.725 -0.67 . . . . 71.329999999999998 109.544 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 487' ' ' ILE . 3.1 mp -104.87 124.53 59.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.137 0.494 . . . . 73.230000000000004 110.005 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.21 140.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.728 -0.669 . . . . 72.310000000000002 110.064 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 120.51 5.17 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.521 -1.432 . . . . 74.319999999999993 109.521 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.0 t -118.33 160.45 21.63 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.411 -0.959 . . . . 73.319999999999993 108.411 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -87.6 137.36 14.52 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.418 -0.896 . . . . 61.43 111.796 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.33 132.08 26.58 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.126 1.884 . . . . 64.299999999999997 109.141 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.66 74.88 8.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.066 0.936 . . . . 72.030000000000001 110.382 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 546' ' ' PRO . 10.4 p -135.26 159.21 42.28 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.872 -1.058 . . . . 74.340000000000003 109.498 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -146.28 141.79 27.69 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.352 -0.61 . . . . 75.310000000000002 109.352 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.8 p-10 -89.14 138.13 31.7 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.961 -0.755 . . . . 74.099999999999994 108.961 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.3 pt -93.86 137.54 23.07 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 116.197 -0.456 . . . . 72.519999999999996 111.93 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.53 171.83 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.935 2.423 . . . . 74.219999999999999 112.112 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -82.84 110.57 17.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.588 0.709 . . . . 73.230000000000004 111.115 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.55 8.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.389 -0.823 . . . . 73.420000000000002 110.053 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.02 140.27 32.81 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.044 -0.525 . . . . 74.010000000000005 109.744 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.09 -13.44 58.8 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.126 -1.19 . . . . 71.010000000000005 110.126 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.446 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 17.2 mt-30 -93.96 178.3 5.7 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.264 -1.013 . . . . 73.430000000000007 108.264 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.2 p -85.54 157.5 20.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.145 -0.687 . . . . 74.540000000000006 109.145 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.41 -42.21 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.481 0.488 . . . . 74.019999999999996 112.092 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.01 -41.99 81.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.128 -0.629 . . . . 74.209999999999994 111.354 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 7.1 p -76.9 -36.42 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 118.577 -1.249 . . . . 73.0 111.125 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.84 -48.77 75.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.874 -0.603 . . . . 74.109999999999999 111.315 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.51 -35.15 80.02 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 123.293 0.37 . . . . 64.25 110.072 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.414 ' O ' HG22 ' A' ' 514' ' ' VAL . 50.4 tptt -63.49 -51.72 64.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.342 0.401 . . . . 71.120000000000005 110.248 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -61.89 -41.53 98.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.164 0.506 . . . . 75.430000000000007 110.126 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.35 -47.77 78.07 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 110.171 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.87 -41.21 91.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.811 0.444 . . . . 74.329999999999998 111.919 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 510' ' ' LYS . 91.3 t -63.87 -34.09 66.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.326 0.491 . . . . 64.420000000000002 112.326 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.27 -19.23 11.37 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.003 -1.079 . . . . 75.519999999999996 112.274 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -99.93 -103.5 2.52 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.71 -0.677 . . . . 71.549999999999997 114.541 -173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 11.5 m-85 -135.77 -178.59 5.2 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 110.265 -0.272 . . . . 65.319999999999993 110.265 -169.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -115.56 3.95 14.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.135 0.493 . . . . 55.200000000000003 111.106 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -108.12 115.54 30.31 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.658 -0.867 . . . . 74.510000000000005 108.658 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.63 151.5 50.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.757 0.789 . . . . 74.409999999999997 111.518 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.0 m -134.69 151.08 50.74 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.623 -1.621 . . . . 74.329999999999998 106.623 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -120.77 122.6 40.71 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.582 -1.266 . . . . 73.049999999999997 107.582 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.97 117.15 30.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.748 -1.204 . . . . 73.329999999999998 107.748 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.9 p -88.75 124.52 34.21 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 108.304 -0.999 . . . . 71.329999999999998 108.304 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.98 153.53 26.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.857 -0.794 . . . . 73.010000000000005 108.857 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.8 115.63 17.7 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.631 -1.248 . . . . 73.540000000000006 107.631 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.2 m -119.89 168.77 9.59 Favored Pre-proline 0 C--N 1.282 -2.356 0 CA-C-N 114.515 -1.22 . . . . 70.430000000000007 110.663 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.9 -166.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 123.031 2.487 . . . . 75.340000000000003 112.165 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -50.67 -51.86 61.64 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 115.272 1.582 . . . . 73.5 115.272 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.24 133.71 36.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 CA-C-N 120.706 1.288 . . . . 75.120000000000005 111.495 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.418 ' HA ' ' OG ' ' A' ' 556' ' ' SER . . . -142.61 157.79 44.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.32 -0.622 . . . . 74.430000000000007 109.32 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 99.86 -24.89 30.39 Favored Glycine 0 C--N 1.313 -0.696 0 N-CA-C 110.389 -1.084 . . . . 63.240000000000002 110.389 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.95 148.04 25.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.346 -0.927 . . . . 75.140000000000001 110.154 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.83 119.12 23.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.109 -0.496 . . . . 72.129999999999995 111.038 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 24.0 m -73.16 -35.1 66.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.942 -1.026 . . . . 73.209999999999994 109.046 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.46 -161.58 35.31 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 111.084 -0.807 . . . . 74.319999999999993 111.084 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -130.34 160.8 32.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.524 -0.917 . . . . 74.329999999999998 108.524 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.5 t-20 -53.22 -57.87 14.88 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.493 0.496 . . . . 73.310000000000002 111.398 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.3 Cg_endo -89.2 147.42 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 CA-C-N 120.797 1.32 . . . . 74.349999999999994 109.11 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.75 155.64 69.61 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.692 1.595 . . . . 72.239999999999995 111.811 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.6 137.46 58.17 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 122.62 0.368 . . . . 65.140000000000001 110.118 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.26 -6.0 61.28 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.988 -0.625 . . . . 53.32 111.834 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.9 m -86.79 134.56 33.55 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.67 -0.312 . . . . 73.530000000000001 110.863 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.7 m -92.49 123.78 36.05 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.5 -0.926 . . . . 75.420000000000002 108.5 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.03 158.2 75.86 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.452 -0.573 . . . . 75.019999999999996 109.452 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.422 ' HA ' HG23 ' A' ' 494' ' ' THR . 47.2 Cg_exo -58.74 144.33 98.19 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.825 2.35 . . . . 70.310000000000002 112.162 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.577 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 34.4 m -67.48 -20.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.664 0.616 . . . . 75.299999999999997 112.664 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.23 4.41 54.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.209 -0.451 . . . . 73.209999999999994 110.683 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -77.33 140.97 40.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.08 -1.081 . . . . 63.549999999999997 108.08 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.5 t -88.31 112.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.488 -1.301 . . . . 74.150000000000006 107.488 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 19.8 tt -86.57 133.73 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.743 0.782 . . . . 72.450000000000003 111.399 -176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 21.0 tt0 -102.81 125.67 49.65 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.145 -0.934 . . . . 75.409999999999997 109.437 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.59 131.82 44.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.901 -1.148 . . . . 74.310000000000002 107.901 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -92.67 105.02 17.25 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 107.74 -1.207 . . . . 74.019999999999996 107.74 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.8 p -100.29 132.81 45.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.31 0.576 . . . . 75.439999999999998 110.145 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 531' ' ' ALA . 26.7 p -66.87 128.02 34.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.441 -0.8 . . . . 52.340000000000003 111.895 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 108.036 -1.098 . . . . 74.409999999999997 108.036 176.836 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 109.546 -1.421 . . . . 61.149999999999999 109.546 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.07 132.41 34.22 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 121.974 1.782 . . . . 74.549999999999997 111.28 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER -105.39 12.35 31.68 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.633 0.73 . . . . 72.109999999999999 109.658 -179.394 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 77.0 mt-30 -101.22 130.98 47.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.076 -0.965 . . . . 74.439999999999998 110.298 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.63 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.3 mmp_? -123.92 155.59 37.85 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.678 0.791 . . . . 74.340000000000003 110.955 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -84.77 141.55 30.44 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.782 -0.645 . . . . 75.510000000000005 111.596 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -79.25 131.18 66.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.626 -0.716 . . . . 74.319999999999993 109.551 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.43 152.32 65.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.962 2.441 . . . . 75.120000000000005 112.774 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.85 8.38 43.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.427 0.632 . . . . 65.219999999999999 110.142 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.7 -12.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 122.542 1.163 . . . . 74.120000000000005 108.293 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.5 m -58.79 -38.39 78.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.855 -1.52 . . . . 73.230000000000004 110.804 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.2 m -60.21 -26.5 66.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.696 -1.138 . . . . 73.430000000000007 111.167 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.35 -45.45 12.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.812 -0.355 . . . . 72.109999999999999 111.108 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 28.3 m -161.86 143.78 11.34 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.031 -0.729 . . . . 72.450000000000003 109.031 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -52.51 -44.72 65.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.792 0.837 . . . . 74.400000000000006 111.455 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.37 90.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.159 -0.473 . . . . 72.349999999999994 111.19 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 8.4 mm-40 -69.2 -37.34 78.06 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.731 -0.668 . . . . 73.420000000000002 110.202 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.91 -51.92 67.62 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.092 -0.958 . . . . 72.329999999999998 111.349 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.84 -40.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.425 -0.807 . . . . 75.349999999999994 111.777 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -66.08 -44.86 83.21 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.768 -0.373 . . . . 71.340000000000003 111.08 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.52 -40.57 89.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.643 0.259 . . . . 73.420000000000002 111.624 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 30.3 tp -68.94 -34.75 75.87 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.25 0.548 . . . . 60.420000000000002 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.1 m -64.48 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.381 -0.6 . . . . 74.430000000000007 109.381 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.07 62.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.72 -0.673 . . . . 71.409999999999997 110.398 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.8 -13.63 53.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.724 -0.472 . . . . 71.219999999999999 109.724 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.32 -13.11 18.91 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.785 -0.643 . . . . 74.099999999999994 113.831 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.401 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 66.6 m-85 -71.09 138.94 50.16 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 111.143 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -138.38 10.63 3.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.156 -1.021 . . . . 73.099999999999994 113.149 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -120.74 115.01 22.47 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.278 -1.008 . . . . 73.439999999999998 108.278 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.17 153.83 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.847 0.356 . . . . 73.420000000000002 110.559 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -131.42 122.35 26.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.002 -1.481 . . . . 75.200000000000003 107.002 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -94.36 115.78 28.05 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.177 0.513 . . . . 64.219999999999999 110.193 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -118.53 154.61 32.28 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.997 -1.112 . . . . 72.400000000000006 107.997 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.21 148.22 52.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.365 -0.606 . . . . 73.129999999999995 109.365 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.6 m -135.63 147.21 60.57 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 109.06 -0.718 . . . . 63.0 109.06 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.9 Cg_exo -65.07 122.72 10.58 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.428 2.086 . . . . 74.219999999999999 110.933 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.9 t -148.88 179.4 7.89 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.017 -1.105 . . . . 75.239999999999995 108.017 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.84 139.83 90.1 Favored Pre-proline 0 N--CA 1.427 -1.593 0 C-N-CA 124.333 1.053 . . . . 64.329999999999998 110.662 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -50.87 -29.87 28.19 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.311 3.341 . . . . 74.329999999999998 113.141 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.78 -29.73 69.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.097 -0.502 . . . . 74.25 111.818 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.31 -2.13 49.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.033 -0.531 . . . . 71.409999999999997 111.68 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.7 t -61.28 127.04 20.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.23 -0.656 . . . . 75.329999999999998 109.23 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.93 -3.54 82.87 Favored Glycine 0 C--N 1.307 -1.065 0 C-N-CA 121.067 -0.587 . . . . 71.120000000000005 112.121 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.7 154.29 26.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.545 -0.909 . . . . 74.400000000000006 108.545 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.468 HG23 HD12 ' A' ' 486' ' ' ILE . 43.3 t -82.12 125.36 39.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.844 -0.798 . . . . 75.219999999999999 108.844 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.8 pt -98.45 -7.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.141 0.496 . . . . 72.219999999999999 110.415 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.46 150.2 5.92 Favored Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.631 -0.713 . . . . 75.030000000000001 111.487 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 10.4 p -116.47 158.32 23.77 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.481 -1.303 . . . . 74.030000000000001 107.481 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.94 -55.11 14.22 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 119.059 -1.056 . . . . 73.040000000000006 110.609 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.26 116.33 4.46 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 108.574 -1.356 . . . . 64.129999999999995 108.574 170.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 158.79 41.56 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.566 2.177 . . . . 73.230000000000004 113.413 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.413 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.33 7.25 9.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.307 -0.86 . . . . 75.340000000000003 110.401 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.16 -40.8 11.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.356 -0.838 . . . . 73.549999999999997 110.802 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -118.73 165.27 14.21 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.589 -0.523 . . . . 73.239999999999995 109.589 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 23.9 p -84.06 142.79 30.17 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.459 -0.337 . . . . 74.549999999999997 110.682 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.3 m -124.3 150.77 45.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.883 -1.154 . . . . 65.340000000000003 107.883 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.63 146.22 42.61 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.534 0.606 . . . . 74.510000000000005 111.328 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.71 -23.09 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.44 1.096 . . . . 75.239999999999995 111.014 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -95.5 1.18 53.86 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.784 -1.098 . . . . 70.219999999999999 110.428 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -80.67 155.45 26.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.13 121.23 38.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.889 -0.782 . . . . 73.329999999999998 108.889 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.85 118.89 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.926 -0.768 . . . . 75.219999999999999 108.926 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.44 117.43 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 106.157 -1.794 . . . . 75.340000000000003 106.157 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.468 HD12 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.92 124.24 65.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.701 -0.851 . . . . 62.140000000000001 108.701 -176.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.14 118.53 49.12 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 CA-C-O 121.396 0.617 . . . . 74.310000000000002 109.608 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.54 141.49 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.294 -0.866 . . . . 75.540000000000006 108.915 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.98 128.48 11.95 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 108.516 -1.833 . . . . 64.420000000000002 108.516 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.8 m -140.91 150.72 43.53 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.141 -0.623 . . . . 72.019999999999996 109.513 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -135.38 130.75 5.52 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.689 -1.364 . . . . 73.310000000000002 109.689 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.17 123.23 12.46 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.472 2.115 . . . . 75.25 111.618 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -83.81 92.45 7.76 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.788 0.804 . . . . 75.239999999999995 109.084 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 546' ' ' PRO . 47.0 p -131.87 160.58 35.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.356 -0.979 . . . . 72.129999999999995 108.356 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 544' ' ' THR . 67.8 mttm -135.59 147.22 48.61 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.215 -0.291 . . . . 75.219999999999999 110.215 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.28 126.51 36.39 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.593 -0.892 . . . . 74.150000000000006 108.593 175.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 541' ' ' ALA . 38.1 pt -81.95 137.41 46.76 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.524 -0.762 . . . . 63.539999999999999 112.358 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.43 175.47 6.25 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.563 2.175 . . . . 75.140000000000001 111.224 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.45 121.61 31.85 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 75.030000000000001 110.27 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.66 9.8 6.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.35 -0.841 . . . . 64.209999999999994 109.378 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.17 147.6 40.29 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.342 -0.844 . . . . 73.519999999999996 112.191 -172.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.64 69.46 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.178 -0.769 . . . . 64.239999999999995 111.178 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -117.32 -167.82 1.38 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.984 -0.747 . . . . 75.549999999999997 108.984 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.4 m -90.67 155.66 18.68 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.299 -0.961 . . . . 72.319999999999993 109.608 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.76 -43.93 57.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.196 0.598 . . . . 74.349999999999994 112.141 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.15 -42.2 80.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 111.906 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.59 -34.23 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.894 -0.722 . . . . 74.109999999999999 111.09 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.47 -47.28 86.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.534 -0.757 . . . . 72.409999999999997 110.736 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.89 -37.37 87.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 123.257 0.348 . . . . 73.049999999999997 110.632 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 514' ' ' VAL . 60.4 tttp -62.39 -53.67 51.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.64 -0.709 . . . . 75.409999999999997 110.062 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.07 -42.76 96.87 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.344 -0.844 . . . . 74.219999999999999 110.676 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.6 -41.12 96.98 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 115.592 -0.731 . . . . 74.150000000000006 109.715 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.18 -40.08 84.59 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.82 0.448 . . . . 74.430000000000007 110.708 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.2 t -67.18 -36.88 78.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.848 -0.615 . . . . 72.299999999999997 111.71 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -113.84 9.17 17.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.135 -0.626 . . . . 71.400000000000006 111.025 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -140.38 -107.5 0.7 Allowed Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.156 -1.497 . . . . 73.439999999999998 115.198 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.7 m-85 -127.6 -176.59 3.8 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.06 0.392 . . . . 74.239999999999995 112.06 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.87 -14.34 10.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.623 0.725 . . . . 74.120000000000005 110.559 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -108.14 115.72 30.65 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.246 -0.65 . . . . 75.120000000000005 109.246 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -124.29 155.59 38.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.298 -0.41 . . . . 75.25 110.347 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.3 m -140.86 158.29 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.447 -1.686 . . . . 75.439999999999998 106.447 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -121.95 144.12 49.06 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.735 -0.468 . . . . 73.129999999999995 109.735 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.31 134.91 54.65 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.208 -0.664 . . . . 73.329999999999998 109.208 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.4 m -90.26 119.9 30.96 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.606 -0.887 . . . . 70.019999999999996 108.606 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.51 163.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.626 -1.25 . . . . 73.129999999999995 107.626 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.43 129.18 35.42 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.642 0.734 . . . . 71.430000000000007 109.488 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 11.2 p -77.27 132.48 69.92 Favored Pre-proline 0 N--CA 1.419 -2.015 0 CA-C-N 114.682 -1.144 . . . . 72.349999999999994 110.576 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . 0.446 ' O ' ' HD2' ' A' ' 529' ' ' ARG . 11.9 Cg_endo -63.69 -75.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.524 1.482 . . . . 73.129999999999995 109.579 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.486 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 10.9 mmm180 -121.17 -57.7 0.03 OUTLIER Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.663 -0.495 . . . . 65.200000000000003 109.663 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 2.7 Cg_exo -77.36 153.15 31.01 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.305 2.004 . . . . 73.310000000000002 111.609 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.98 149.28 52.47 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.785 -0.82 . . . . 73.239999999999995 108.785 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 103.82 -22.08 36.49 Favored Glycine 0 C--O 1.249 1.035 0 N-CA-C 111.156 -0.778 . . . . 61.399999999999999 111.156 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.09 148.09 25.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.579 0.704 . . . . 64.099999999999994 111.674 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 3.8 p -75.8 125.16 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.977 -1.011 . . . . 74.239999999999995 110.15 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 8.4 m -77.45 -37.08 52.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.262 -1.014 . . . . 74.299999999999997 108.262 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.43 35.2 Favored Glycine 0 N--CA 1.417 -2.603 0 N-CA-C 109.665 -1.374 . . . . 73.140000000000001 109.665 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.3 p -117.74 159.88 22.27 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.209 -1.404 . . . . 62.32 107.209 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -56.75 -57.15 25.81 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 123.489 0.493 . . . . 73.129999999999995 110.716 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.26 142.84 21.77 Favored 'Trans proline' 0 C--N 1.368 1.588 0 N-CA-C 109.125 -1.144 . . . . 74.239999999999995 109.125 171.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.22 151.02 86.78 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.282 1.988 . . . . 74.409999999999997 111.804 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.421 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -58.92 138.45 57.38 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.747 0.308 . . . . 62.340000000000003 110.196 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.78 -21.13 43.36 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 111.309 -0.716 . . . . 74.239999999999995 111.309 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 46.2 m -70.75 132.35 45.22 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.105 0.478 . . . . 75.450000000000003 110.394 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 m -96.67 122.66 39.86 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.397 -0.819 . . . . 74.400000000000006 108.82 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.16 159.63 71.35 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.398 -0.593 . . . . 74.540000000000006 109.398 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.452 ' HA ' HG21 ' A' ' 494' ' ' THR . 39.2 Cg_exo -61.03 142.26 96.84 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.217 2.611 . . . . 73.420000000000002 114.584 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.488 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 30.9 m -67.43 -19.32 25.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.95 0.881 . . . . 73.510000000000005 111.146 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.9 -10.12 55.79 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.22 -1.354 . . . . 74.409999999999997 109.747 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 59.9 p -92.3 171.76 8.85 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.866 -0.606 . . . . 71.329999999999998 112.03 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.25 136.39 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.261 -1.014 . . . . 74.310000000000002 108.261 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.0 tt -113.76 142.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 120.895 0.379 . . . . 74.420000000000002 110.538 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -102.99 128.3 49.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 122.968 0.507 . . . . 75.200000000000003 111.606 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.3 122.01 42.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.135 -1.431 . . . . 75.510000000000005 107.135 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -104.32 110.13 22.25 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.606 -0.887 . . . . 72.129999999999995 108.606 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.36 139.13 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.461 -0.791 . . . . 73.519999999999996 112.944 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 69.6 m -64.76 115.05 4.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.484 -0.78 . . . . 71.340000000000003 109.581 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 106.46 -1.682 . . . . 73.219999999999999 106.46 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.772 0 N-CA-C 110.376 -1.09 . . . . 54.509999999999998 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.69 145.06 86.01 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.172 1.914 . . . . 72.439999999999998 110.635 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 56.89 1.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.296 1.046 . . . . 73.209999999999994 111.617 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -121.75 131.03 53.85 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.222 -1.354 . . . . 72.219999999999999 108.122 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -122.72 151.56 41.44 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.154 -0.684 . . . . 75.450000000000003 109.154 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -93.74 142.16 27.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.266 -0.879 . . . . 74.239999999999995 110.082 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 474' ' ' ALA . 2.9 mp -79.13 125.11 84.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.858 -0.793 . . . . 75.540000000000006 108.858 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.43 141.79 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.727 1.618 . . . . 74.219999999999999 111.332 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.65 52.19 1.85 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.728 0.775 . . . . 73.140000000000001 110.652 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 440' ' ' ALA . 14.8 p -102.39 -2.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.018 -1.475 . . . . 74.109999999999999 107.018 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.492 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 1.7 p -59.11 -41.44 88.16 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.998 -1.91 . . . . 72.030000000000001 110.703 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.3 p -61.71 -26.37 68.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.9 -1.045 . . . . 72.140000000000001 112.807 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.3 -46.48 13.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 119.077 -1.049 . . . . 73.439999999999998 111.575 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.6 m -170.39 147.36 3.0 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.942 -0.762 . . . . 75.319999999999993 108.942 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -50.82 -48.91 59.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.507 1.123 . . . . 71.200000000000003 110.581 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.76 75.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.204 -0.453 . . . . 75.450000000000003 111.579 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 25.0 mm-40 -69.59 -44.68 70.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.088 0.47 . . . . 70.349999999999994 110.363 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.44 -51.18 70.55 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.045 -0.979 . . . . 63.100000000000001 111.704 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.01 -45.95 89.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 CA-C-N 115.737 -0.665 . . . . 75.549999999999997 111.511 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.19 -47.91 80.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -67.79 -39.52 84.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.31 -0.556 . . . . 74.200000000000003 110.668 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 452' ' ' PHE . 20.9 tp -69.7 -34.78 74.37 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.252 0.548 . . . . 75.409999999999997 110.716 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 27.1 m -62.06 -43.31 99.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.651 -0.704 . . . . 71.329999999999998 109.64 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.87 62.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.626 -0.715 . . . . 75.310000000000002 110.836 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.65 59.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.049 0.452 . . . . 72.200000000000003 110.454 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.92 6.95 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.329 -0.938 . . . . 75.340000000000003 113.171 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 445' ' ' THR . 97.1 m-85 -80.85 130.93 35.31 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.69 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -136.22 14.74 4.0 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.184 -1.166 . . . . 60.109999999999999 110.184 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -116.95 115.3 25.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.978 -1.49 . . . . 75.239999999999995 106.978 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 87.7 m-85 -139.04 156.43 47.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.301 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.432 ' HB2' HG13 ' A' ' 485' ' ' ILE . 68.8 mttm -133.55 122.97 24.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.114 -1.809 . . . . 74.120000000000005 106.114 167.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -93.79 120.02 33.51 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.763 -0.775 . . . . 75.040000000000006 112.027 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.31 43.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.232 -1.025 . . . . 74.530000000000001 108.232 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.89 150.75 33.19 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.915 -1.143 . . . . 63.409999999999997 107.915 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.1 p -134.6 138.21 29.4 Favored Pre-proline 0 C--N 1.277 -2.575 0 N-CA-C 108.964 -0.754 . . . . 61.43 108.964 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.57 123.6 11.64 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.086 1.857 . . . . 74.409999999999997 110.042 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 179.31 7.55 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 108.43 -0.952 . . . . 60.100000000000001 108.43 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -67.92 137.89 92.54 Favored Pre-proline 0 N--CA 1.418 -2.065 0 C-N-CA 123.467 0.707 . . . . 72.150000000000006 110.461 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.78 -29.21 25.45 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 124.669 3.579 . . . . 64.519999999999996 113.596 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.65 -21.53 61.81 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 111.401 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.422 HD11 ' HD2' ' A' ' 466' ' ' LYS . 23.0 tp -105.15 2.92 29.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 74.140000000000001 110.683 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.46 128.03 20.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 111.013 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.31 -2.55 56.37 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.717 -0.674 . . . . 64.129999999999995 111.676 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.422 ' HD2' HD11 ' A' ' 463' ' ' LEU . 96.6 mttt -112.21 145.05 40.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.38 -0.6 . . . . 75.109999999999999 109.38 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.75 134.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.193 -0.669 . . . . 74.310000000000002 109.193 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.7 pt -98.28 -20.09 5.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.484 -0.886 . . . . 72.219999999999999 110.08 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.927 -0.654 . . . . 54.210000000000001 111.565 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.2 p -116.77 161.0 19.95 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.518 -0.919 . . . . 65.349999999999994 108.518 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.522 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.4 t-20 -65.69 -52.43 43.06 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-O 119.012 -0.518 . . . . 75.319999999999993 111.568 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.5 Cg_exo -75.02 135.81 19.52 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 120.359 1.164 . . . . 62.009999999999998 109.116 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.57 136.26 53.42 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.614 2.209 . . . . 75.030000000000001 111.351 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 429' ' ' ILE . . . -77.0 -17.68 58.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.822 -0.626 . . . . 72.239999999999995 111.964 -172.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -76.49 -31.87 58.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.386 0.612 . . . . 72.049999999999997 109.71 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -95.34 164.87 12.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.456 -0.793 . . . . 64.540000000000006 110.836 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -97.63 127.1 43.33 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.525 -0.761 . . . . 62.439999999999998 110.449 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.4 m -110.06 139.68 44.92 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.283 -1.006 . . . . 64.129999999999995 108.283 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.452 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -57.89 150.39 20.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.075 0.398 . . . . 74.239999999999995 112.075 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.1 -25.71 38.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.847 -0.615 . . . . 75.120000000000005 110.82 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -86.71 5.29 36.95 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 116.146 -0.479 . . . . 75.239999999999995 111.363 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.13 157.52 24.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 120.909 0.385 . . . . 64.450000000000003 111.031 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.05 123.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.034 -1.099 . . . . 73.530000000000001 108.034 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 62.1 t -94.18 119.01 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 C-N-CA 119.069 -1.053 . . . . 73.5 108.844 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.522 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.1 mp -92.65 118.35 38.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 105.308 -2.108 . . . . 71.420000000000002 105.308 174.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 tt -102.13 124.35 55.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 116.347 -0.388 . . . . 74.409999999999997 109.967 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.95 108.46 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.395 -0.965 . . . . 75.439999999999998 108.395 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.67 139.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.005 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.07 123.89 6.53 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.484 -1.446 . . . . 55.509999999999998 109.484 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.3 m -135.85 149.74 49.15 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 41.439999999999998 108.286 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -153.62 168.93 32.27 Favored Glycine 0 N--CA 1.424 -2.164 0 C-N-CA 119.746 -1.216 . . . . 73.099999999999994 110.768 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.58 124.29 6.91 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.251 1.967 . . . . 73.310000000000002 112.334 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.67 80.6 8.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.471 -1.678 . . . . 65.129999999999995 106.471 173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 546' ' ' PRO . 37.2 p -127.96 161.29 29.47 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 114.519 -1.218 . . . . 74.420000000000002 109.858 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 544' ' ' THR . 96.0 mttt -143.31 156.33 44.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.835 -0.431 . . . . 74.319999999999993 109.835 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -92.78 135.87 33.74 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.952 -0.758 . . . . 74.120000000000005 108.952 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 541' ' ' ALA . 23.2 pt -78.14 136.67 61.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.998 -0.546 . . . . 75.239999999999995 110.926 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.83 -172.49 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.577 2.184 . . . . 74.219999999999999 110.339 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -99.41 136.35 39.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.454 -0.943 . . . . 71.040000000000006 108.454 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 m -128.66 16.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 120.887 0.375 . . . . 72.519999999999996 110.835 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -72.0 116.45 12.42 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.915 -0.584 . . . . 65.109999999999999 111.367 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 116.69 -19.33 12.57 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.811 -0.709 . . . . 64.439999999999998 112.103 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -81.76 177.7 8.74 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.845 -0.342 . . . . 72.319999999999993 110.153 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.3 m -91.4 156.29 17.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.553 -1.277 . . . . 74.329999999999998 107.553 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.96 -43.47 75.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.921 0.391 . . . . 73.109999999999999 112.054 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.59 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 5.9 p-10 -68.51 -42.08 79.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 111.897 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.94 -34.63 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.142 -1.023 . . . . 73.319999999999993 111.141 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -62.0 -48.89 78.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.448 -0.796 . . . . 70.319999999999993 111.364 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.4 -36.77 84.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.404 0.44 . . . . 71.030000000000001 110.746 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.59 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.6 mptp? -64.01 -47.58 79.72 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.123 0.264 . . . . 74.5 111.56 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -65.13 -42.91 93.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.975 0.417 . . . . 75.349999999999994 110.318 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.74 -37.26 85.88 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 115.762 -0.653 . . . . 73.219999999999999 109.655 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -62.25 -37.9 87.21 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 122.762 0.425 . . . . 70.239999999999995 110.714 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 510' ' ' LYS . 61.0 t -72.44 -27.21 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.089 0.471 . . . . 74.329999999999998 110.637 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.77 36.54 4.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.552 -0.295 . . . . 65.239999999999995 110.23 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -169.33 -100.92 0.14 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 117.106 -2.473 . . . . 75.25 116.613 -173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 545' ' ' VAL . 61.3 m-85 -127.63 162.36 26.69 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 115.212 -0.494 . . . . 62.130000000000003 111.312 -162.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.2 m -104.37 -17.37 14.82 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.225 -0.898 . . . . 65.319999999999993 110.869 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -109.98 123.93 50.52 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.92 -0.488 . . . . 71.049999999999997 109.804 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.97 151.28 45.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.473 0.654 . . . . 75.109999999999999 111.666 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -141.6 152.03 43.67 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.121 -1.437 . . . . 74.409999999999997 107.121 169.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.23 128.12 50.77 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 120.741 0.305 . . . . 75.140000000000001 110.233 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.58 127.34 52.04 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.878 -0.786 . . . . 73.519999999999996 108.878 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -91.29 143.07 27.03 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.117 -0.697 . . . . 62.43 109.117 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.87 159.45 26.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.375 -0.972 . . . . 73.299999999999997 108.375 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.32 134.43 36.61 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.362 0.601 . . . . 73.120000000000005 109.432 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 8.1 t -129.81 162.3 54.28 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 108.021 -1.103 . . . . 63.509999999999998 108.021 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 122.519 2.146 . . . . 72.450000000000003 110.079 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.17 -46.52 62.19 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 118.986 -1.086 . . . . 71.040000000000006 113.315 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.67 134.65 38.75 Favored 'Trans proline' 0 C--N 1.365 1.401 0 CA-C-N 120.383 1.172 . . . . 71.140000000000001 109.897 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -153.71 176.33 12.23 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.682 -0.859 . . . . 73.230000000000004 108.682 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.93 7.15 62.88 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 111.049 -0.82 . . . . 74.409999999999997 111.049 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.9 141.1 28.99 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 107.633 -1.247 . . . . 74.299999999999997 107.633 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 95.8 t -77.12 115.76 19.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 104.781 -2.303 . . . . 70.109999999999999 104.781 165.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.8 m -76.1 -26.73 56.72 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.739 -0.837 . . . . 73.140000000000001 108.739 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.43 -149.43 21.2 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.291 -0.868 . . . . 61.329999999999998 111.023 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -118.09 161.67 19.46 Favored 'General case' 0 C--N 1.279 -2.498 0 C-N-CA 123.522 0.729 . . . . 71.0 109.108 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.6 t-20 -52.33 -51.96 67.42 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 123.427 0.454 . . . . 65.420000000000002 111.636 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.3 Cg_endo -91.6 161.16 3.53 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.473 1.449 . . . . 73.430000000000007 109.845 171.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.95 150.58 61.19 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.154 1.902 . . . . 72.120000000000005 112.194 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -50.94 131.02 26.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.102 0.961 . . . . 74.420000000000002 111.422 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -17.29 36.69 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.773 -0.648 . . . . 72.010000000000005 112.099 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 48.6 m -67.86 128.01 34.93 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.567 -0.372 . . . . 70.439999999999998 110.301 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 27.8 m -97.59 123.36 41.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.761 -0.459 . . . . 74.519999999999996 109.761 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 517' ' ' PHE . 9.5 m -134.14 162.26 58.76 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.264 -0.643 . . . . 71.209999999999994 109.264 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.431 ' HA ' HG23 ' A' ' 494' ' ' THR . 31.2 Cg_exo -61.93 136.21 60.06 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.104 2.536 . . . . 75.420000000000002 113.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.57 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 33.2 m -66.73 -22.82 30.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.663 -0.699 . . . . 73.150000000000006 112.343 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.97 -2.13 57.74 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.134 -0.939 . . . . 73.120000000000005 110.011 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -93.97 173.19 7.79 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.087 -0.709 . . . . 72.319999999999993 109.087 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.99 127.65 44.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 111.827 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.15 130.13 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.825 -1.176 . . . . 73.310000000000002 107.825 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.04 127.19 50.38 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-O 121.268 0.556 . . . . 75.430000000000007 110.111 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.6 tp -95.28 132.58 40.13 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.979 -1.009 . . . . 63.439999999999998 109.06 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -100.18 113.34 25.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.425 -0.954 . . . . 74.329999999999998 108.425 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.81 137.67 44.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-O 120.627 0.251 . . . . 75.329999999999998 111.24 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 58.6 p -83.39 124.49 30.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 109.785 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 108.829 -0.804 . . . . 74.109999999999999 108.829 -177.368 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 N-CA-C 110.987 -0.845 . . . . 44.439999999999998 110.987 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.05 133.06 12.05 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 121.713 1.609 . . . . 74.310000000000002 111.746 -178.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.2 OUTLIER -87.0 -0.27 56.34 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.908 0.861 . . . . 75.530000000000001 109.916 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 153.5 34.13 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.222 -1.399 . . . . 63.329999999999998 107.222 174.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -145.85 152.62 39.79 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.292 -1.744 . . . . 73.319999999999993 106.292 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.41 140.94 30.34 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.503 0.668 . . . . 73.430000000000007 112.503 -177.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.49 131.04 69.44 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 107.51 -1.293 . . . . 73.409999999999997 107.51 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.0 140.6 94.54 Favored 'Trans proline' 0 C--O 1.243 0.734 0 C-N-CA 122.664 2.242 . . . . 73.439999999999998 113.346 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -96.47 -5.25 40.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.025 -0.989 . . . . 65.319999999999993 109.84 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.18 5.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.947 0.879 . . . . 64.319999999999993 110.703 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -62.63 -30.45 71.37 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.869 1.268 . . . . 71.519999999999996 109.918 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.5 t -57.65 -26.76 62.1 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.42 -1.263 . . . . 75.25 111.077 176.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.57 -44.96 15.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 120.788 -0.365 . . . . 75.319999999999993 110.422 -175.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.502 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 3.7 m -164.1 149.44 10.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.702 -0.851 . . . . 72.099999999999994 108.702 175.381 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -54.71 -44.02 73.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.783 0.833 . . . . 72.239999999999995 110.768 174.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.63 -43.56 76.26 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.305 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.0 mm-40 -61.67 -42.43 98.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 123.514 0.509 . . . . 74.409999999999997 110.44 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.47 77.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.157 -0.929 . . . . 71.5 110.097 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.96 -47.61 92.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 CA-C-N 115.788 -0.642 . . . . 74.549999999999997 112.101 -177.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.5 mmtp -60.96 -48.6 81.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.035 0.445 . . . . 74.510000000000005 110.452 -176.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 443' ' ' LYS . 10.3 mmpt? -68.2 -39.19 82.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.899 -0.591 . . . . 75.409999999999997 111.843 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 452' ' ' PHE . 23.4 tp -68.54 -40.25 80.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.195 0.521 . . . . 75.329999999999998 110.044 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 42.8 m -59.41 -45.85 90.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.249 -0.887 . . . . 73.409999999999997 109.461 176.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -17.28 62.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.63 -0.714 . . . . 75.219999999999999 111.473 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.59 -13.92 57.4 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 110.861 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.9 -11.81 22.67 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.15 -1.024 . . . . 74.340000000000003 113.519 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.5 138.55 47.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.976 0.417 . . . . 70.150000000000006 110.857 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 -12.74 3.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.591 -0.814 . . . . 75.340000000000003 113.599 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -103.38 114.99 29.7 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.095 -0.706 . . . . 74.219999999999999 109.095 -178.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.53 ' CE2' HD22 ' A' ' 444' ' ' LEU . 37.1 m-85 -120.03 153.27 36.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.369 -0.832 . . . . 72.340000000000003 109.696 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 485' ' ' ILE . 16.3 tppt? -143.73 122.33 12.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 105.566 -2.013 . . . . 72.230000000000004 105.566 170.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -104.2 125.4 50.46 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 120.862 0.363 . . . . 71.439999999999998 110.732 -176.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.93 49.04 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.231 -1.026 . . . . 74.409999999999997 108.231 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -124.02 149.35 46.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.543 -0.91 . . . . 63.009999999999998 108.543 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.2 m -140.42 140.65 23.4 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 108.97 -0.752 . . . . 70.109999999999999 108.97 176.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.7 Cg_exo -65.76 122.0 9.51 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.965 1.777 . . . . 75.129999999999995 109.946 177.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.4 m -151.99 -179.54 7.57 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.756 -1.201 . . . . 71.319999999999993 107.756 -178.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -24.98 100.24 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.51 0 C-N-CA 126.563 1.945 . . . . 73.239999999999995 112.83 177.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.437 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 73.8 Cg_exo -51.53 -38.09 63.89 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 124.499 3.466 . . . . 64.099999999999994 115.973 -170.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.45 -11.33 59.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.191 0.811 . . . . 74.209999999999994 113.191 -176.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.65 14.15 31.71 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.692 0.282 . . . . 71.219999999999999 111.186 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.1 p -52.86 128.73 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.335 176.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.49 -3.06 56.27 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.826 -0.702 . . . . 72.209999999999994 111.506 -179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -103.48 146.01 29.15 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.316 -0.624 . . . . 73.519999999999996 109.316 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.443 HG22 HD12 ' A' ' 486' ' ' ILE . 46.9 t -81.78 132.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.477 -0.564 . . . . 72.219999999999999 109.477 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.5 -21.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.624 -0.43 . . . . 72.150000000000006 110.625 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.96 159.92 23.54 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 111.106 -0.798 . . . . 73.510000000000005 111.106 177.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -122.63 152.32 40.6 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.326 -0.99 . . . . 74.140000000000001 108.326 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 66.0 t30 -64.44 -50.59 65.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.499 -0.481 . . . . 75.540000000000006 111.058 177.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.3 Cg_exo -79.59 147.83 20.06 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 120.371 1.168 . . . . 75.129999999999995 109.104 172.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -71.37 140.89 37.71 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.142 1.894 . . . . 75.310000000000002 113.463 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.11 6.67 28.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.115 0.96 . . . . 73.420000000000002 109.183 176.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.1 -26.83 13.55 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.667 -1.151 . . . . 73.420000000000002 111.988 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -137.85 174.96 10.01 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.279 -0.569 . . . . 75.150000000000006 110.263 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.7 p -86.94 147.71 25.64 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.238 0.542 . . . . 71.519999999999996 112.368 -176.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.4 m -133.83 150.1 51.39 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.393 -1.336 . . . . 70.400000000000006 107.393 174.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 482' ' ' ASN . . . -55.48 142.24 33.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.617 0.599 . . . . 65.230000000000004 112.617 -176.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.02 -29.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.563 1.145 . . . . 63.299999999999997 111.532 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -94.08 12.26 27.02 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.527 -0.469 . . . . 74.120000000000005 111.577 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.95 146.32 35.55 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 122.14 -0.35 . . . . 73.010000000000005 110.365 176.652 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.2 122.98 36.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.632 -0.877 . . . . 71.200000000000003 108.632 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.82 118.51 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 108.039 -1.097 . . . . 75.200000000000003 108.039 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.0 mp -96.99 114.47 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 106.194 -1.78 . . . . 75.150000000000006 106.194 175.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.443 HD12 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.88 125.68 59.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 108.901 -0.777 . . . . 74.109999999999999 108.901 -177.713 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.46 116.47 49.31 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 CA-C-O 121.693 0.758 . . . . 70.230000000000004 109.988 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.41 136.83 25.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.22 -0.9 . . . . 72.420000000000002 109.461 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.91 112.1 3.53 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.783 -2.127 . . . . 62.420000000000002 107.783 174.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.4 t -115.3 145.37 42.54 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 119.873 -0.731 . . . . 74.430000000000007 109.787 -176.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -111.98 113.07 3.22 Favored Glycine 0 N--CA 1.406 -3.301 0 N-CA-C 107.965 -2.054 . . . . 71.430000000000007 107.965 176.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 115.68 2.73 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.115 1.876 . . . . 74.219999999999999 111.106 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -65.57 96.83 0.28 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.081 -0.963 . . . . 75.299999999999997 108.503 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.6 p -136.27 157.56 46.51 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.543 -1.208 . . . . 62.43 108.268 -175.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 28.9 mtpp -143.94 157.36 44.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.666 -0.864 . . . . 75.129999999999995 108.666 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.0 t70 -91.36 130.92 37.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.677 -1.231 . . . . 75.120000000000005 107.677 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 23.8 pt -77.15 126.11 85.73 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 112.366 0.506 . . . . 64.400000000000006 112.366 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 55.2 Cg_endo -94.07 114.46 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.32 2.013 . . . . 75.219999999999999 112.886 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.67 124.36 29.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.422 -0.955 . . . . 64.319999999999993 108.422 175.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.4 t -114.53 45.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.154 -1.054 . . . . 75.109999999999999 108.154 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.29 130.73 45.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.848 -1.069 . . . . 65.150000000000006 111.381 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 129.99 -32.04 3.22 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.316 -0.945 . . . . 72.540000000000006 113.29 176.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.481 ' O ' HG12 ' A' ' 534' ' ' VAL . 23.7 mt-30 -94.7 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.691 -0.485 . . . . 71.340000000000003 109.691 -177.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 157.38 19.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.178 -1.009 . . . . 74.150000000000006 109.564 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.5 t -55.92 -44.14 77.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.593 0.558 . . . . 72.310000000000002 111.151 -176.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.442 ' CG ' ' HZ3' ' A' ' 510' ' ' LYS . 19.8 t70 -67.61 -41.75 83.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.693 -0.685 . . . . 74.219999999999999 111.921 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -36.26 27.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 118.884 -1.126 . . . . 74.450000000000003 110.654 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.58 87.25 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.53 -0.759 . . . . 73.219999999999999 110.959 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -64.82 -35.17 80.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 123.307 0.38 . . . . 75.010000000000005 110.041 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.442 ' HZ3' ' CG ' ' A' ' 506' ' ' ASP . 52.5 mttp -61.42 -47.48 85.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 123.127 0.267 . . . . 73.329999999999998 111.517 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -68.84 -43.12 76.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.376 -0.375 . . . . 73.200000000000003 111.006 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 520' ' ' PHE . 5.8 tt -64.27 -37.54 87.86 Favored 'General case' 0 C--O 1.173 -2.947 0 CA-C-N 115.928 -0.578 . . . . 63.549999999999997 109.537 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.33 -37.44 75.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.929 0.491 . . . . 71.420000000000002 110.362 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.88 -39.86 75.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.73 -0.668 . . . . 74.340000000000003 111.122 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -94.99 -10.83 29.76 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.431 0.634 . . . . 74.239999999999995 110.384 -174.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -117.25 -117.54 2.9 Favored Glycine 0 N--CA 1.411 -2.978 0 CA-C-N 115.243 -0.889 . . . . 73.319999999999993 113.139 -172.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.674 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 35.9 m-85 -136.46 -175.41 4.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.459 -0.571 . . . . 74.319999999999993 109.459 -169.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 m -99.37 -18.5 17.48 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.719 -0.673 . . . . 74.120000000000005 111.811 -178.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -107.29 115.87 30.93 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.876 -0.729 . . . . 71.109999999999999 111.54 -175.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . 0.435 ' CE2' HD23 ' A' ' 512' ' ' LEU . 19.7 m-85 -120.84 142.57 49.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.578 -1.192 . . . . 74.140000000000001 108.543 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.5 p -115.62 145.28 42.84 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 104.936 -2.246 . . . . 72.200000000000003 104.936 171.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -121.82 138.3 54.43 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.829 -1.148 . . . . 73.040000000000006 111.09 -174.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.6 139.91 52.92 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.782 -0.822 . . . . 54.039999999999999 108.782 178.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.0 m -101.75 125.18 48.37 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.998 -1.112 . . . . 75.140000000000001 107.998 177.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.15 160.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.972 -0.751 . . . . 73.310000000000002 108.972 -176.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 8.4 p-10 -78.55 132.68 37.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.445 0.641 . . . . 71.510000000000005 109.901 -175.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 p -95.51 106.12 24.72 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 114.568 -1.197 . . . . 72.129999999999995 111.963 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 4.3 Cg_exo -76.55 -66.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.34 2.027 . . . . 73.219999999999999 110.986 177.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -108.72 -52.19 0.07 OUTLIER Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 118.977 -0.535 . . . . 75.450000000000003 111.879 178.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.96 134.19 17.57 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 120.4 1.178 . . . . 74.510000000000005 110.635 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.76 128.54 14.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.259 -0.274 . . . . 74.230000000000004 110.259 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.42 23.38 Favored Glycine 0 CA--C 1.502 -0.726 0 N-CA-C 110.185 -1.166 . . . . 65.030000000000001 110.185 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.59 149.19 23.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.276 -0.962 . . . . 65.430000000000007 109.529 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.7 p -73.18 127.07 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.175 -1.046 . . . . 74.549999999999997 108.175 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.6 m -73.5 -25.75 60.58 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.208 -1.36 . . . . 74.530000000000001 109.841 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.18 20.36 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 110.767 -0.933 . . . . 54.109999999999999 110.767 175.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -120.27 159.4 25.05 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.147 -1.427 . . . . 72.329999999999998 107.147 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -63.05 -54.54 45.28 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 119.942 -0.703 . . . . 75.239999999999995 110.56 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.4 Cg_endo -93.07 134.05 1.06 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.225 1.283 . . . . 72.340000000000003 109.665 171.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -72.91 164.0 36.8 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.717 2.278 . . . . 74.329999999999998 113.429 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -54.1 145.07 17.88 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-N 115.486 -0.779 . . . . 61.310000000000002 109.372 173.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.62 34.01 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.832 -1.707 . . . . 73.450000000000003 108.832 -172.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.0 m -88.62 119.85 29.47 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.816 -0.809 . . . . 65.430000000000007 108.816 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 86.5 m -101.77 127.43 48.56 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.147 -0.686 . . . . 74.430000000000007 109.147 176.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.84 160.21 64.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.647 -0.871 . . . . 75.319999999999993 108.647 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 494' ' ' THR . 42.9 Cg_exo -58.46 152.74 52.5 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.394 2.062 . . . . 62.149999999999999 111.773 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.674 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.9 m -65.98 -20.78 27.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.239 0.543 . . . . 73.030000000000001 112.39 -177.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.14 3.73 54.87 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.645 -0.707 . . . . 75.230000000000004 110.83 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.7 t -79.67 167.95 20.0 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.939 -0.393 . . . . 74.420000000000002 109.939 -177.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.19 120.64 62.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 109.757 -0.46 . . . . 75.120000000000005 109.757 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.4 tt -92.52 138.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.962 -0.385 . . . . 75.329999999999998 109.962 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -101.82 121.76 42.71 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 121.479 0.656 . . . . 74.150000000000006 110.654 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.94 134.91 41.12 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.98 1.312 . . . . 75.099999999999994 109.24 -177.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.27 108.68 20.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.625 -0.716 . . . . 74.349999999999994 110.017 -176.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.9 131.76 42.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 124.066 0.946 . . . . 74.219999999999999 110.008 -179.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 45.6 p -69.05 125.01 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.289 0.566 . . . . 74.140000000000001 110.769 175.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 105.875 -1.898 . . . . 75.340000000000003 105.875 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.833 0 N-CA-C 110.093 -1.203 . . . . 52.219999999999999 110.093 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.46 142.18 44.22 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.622 2.214 . . . . 72.310000000000002 111.272 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.1 5.01 23.65 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.961 -0.755 . . . . 62.009999999999998 108.961 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 478' ' ' SER . 21.0 mp0 -82.67 125.21 30.96 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.266 -0.879 . . . . 63.450000000000003 109.979 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.527 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 18.9 tpp180 -120.7 155.87 32.96 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.68 -0.859 . . . . 73.409999999999997 108.68 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 142.02 28.83 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.207 1.003 . . . . 74.400000000000006 111.691 -174.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -86.0 128.7 57.0 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 109.524 -0.547 . . . . 75.409999999999997 109.524 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.72 160.1 47.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.161 2.574 . . . . 73.310000000000002 112.332 176.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.52 24.68 9.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.945 0.498 . . . . 71.510000000000005 111.257 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.7 t -76.4 -2.98 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.8 1.286 . . . . 73.129999999999995 109.281 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.472 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 3.1 m -52.37 -34.27 46.96 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.444 2.298 . . . . 75.109999999999999 111.323 177.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.9 t -60.97 -28.01 68.69 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.851 -0.613 . . . . 75.219999999999999 112.014 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.4 -47.51 8.72 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 118.874 -1.13 . . . . 64.349999999999994 111.836 -172.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 18.9 m -172.1 154.11 3.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.071 -1.085 . . . . 72.400000000000006 108.071 -178.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -51.91 -54.82 24.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 75.450000000000003 110.463 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.04 73.05 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 123.467 0.479 . . . . 70.25 111.91 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.04 -45.84 93.12 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.722 0.639 . . . . 50.109999999999999 111.327 -178.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -71.27 -43.75 66.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.016 -0.538 . . . . 71.230000000000004 110.774 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.23 -48.36 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.965 -0.561 . . . . 72.420000000000002 111.985 -178.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.94 -40.1 96.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 71.530000000000001 110.344 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -66.57 -43.06 86.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.075 -0.512 . . . . 73.420000000000002 111.005 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 452' ' ' PHE . 22.8 tp -68.69 -33.41 73.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.396 0.617 . . . . 74.439999999999998 109.611 179.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.3 m -62.42 -41.29 98.58 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.485 -0.78 . . . . 73.209999999999994 109.212 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.02 63.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.75 -0.659 . . . . 71.530000000000001 110.991 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.18 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.193 0.521 . . . . 75.510000000000005 110.02 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.98 -6.88 17.31 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.78 -0.724 . . . . 43.310000000000002 113.423 175.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.527 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 85.7 m-85 -75.28 136.8 40.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.084 0.772 . . . . 73.540000000000006 113.084 -176.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.57 25.93 3.73 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.169 -1.172 . . . . 71.510000000000005 110.169 175.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.61 115.19 15.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.821 -1.178 . . . . 75.340000000000003 107.821 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CE2' HD22 ' A' ' 444' ' ' LEU . 67.8 m-85 -140.18 150.06 43.73 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.894 -0.41 . . . . 74.230000000000004 109.894 -175.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.401 ' HB3' HG13 ' A' ' 485' ' ' ILE . 15.1 tppt? -133.67 122.91 24.11 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 106.42 -1.696 . . . . 74.439999999999998 106.42 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -95.31 123.6 38.91 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 110.278 -0.267 . . . . 74.329999999999998 110.278 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.26 151.67 51.71 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.542 -1.281 . . . . 73.400000000000006 107.542 176.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.14 143.64 40.42 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.085 -0.646 . . . . 73.329999999999998 110.232 178.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.3 m -124.04 149.32 59.87 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 109.242 -0.651 . . . . 64.349999999999994 109.242 -178.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.03 122.88 10.52 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.171 1.914 . . . . 74.439999999999998 110.238 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 t -134.2 179.81 6.03 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.601 -0.889 . . . . 75.409999999999997 108.601 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.1 t -65.56 141.43 97.91 Favored Pre-proline 0 N--CA 1.423 -1.825 0 C-N-CA 123.74 0.816 . . . . 74.310000000000002 110.793 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.72 -29.23 32.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.389 3.393 . . . . 74.430000000000007 112.62 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.48 -23.92 61.9 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.626 -0.716 . . . . 74.299999999999997 112.049 -177.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.551 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 11.2 mp -108.49 8.7 27.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.449 0.537 . . . . 72.420000000000002 112.449 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.7 133.4 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.967 0.413 . . . . 74.409999999999997 110.963 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.57 -16.21 57.94 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 120.9 -0.666 . . . . 75.019999999999996 113.438 175.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 463' ' ' LEU . 0.2 OUTLIER -103.82 166.22 10.55 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.538 -0.865 . . . . 74.319999999999993 109.588 178.671 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 59.3 t -82.13 130.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.429 -1.322 . . . . 74.329999999999998 107.429 176.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.1 pt -98.43 -0.87 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.17 -0.612 . . . . 74.230000000000004 110.937 -178.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.0 162.84 11.83 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 115.621 -0.718 . . . . 74.019999999999996 112.069 174.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.5 p -116.47 149.77 38.95 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.679 -1.23 . . . . 70.200000000000003 107.679 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.47 -52.02 55.91 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 120.298 -0.561 . . . . 72.409999999999997 110.874 177.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.88 136.46 22.94 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 119.912 1.004 . . . . 72.400000000000006 109.854 172.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.505 2.136 . . . . 73.200000000000003 112.165 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -85.92 0.15 53.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.398 1.095 . . . . 74.329999999999998 109.053 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -91.07 -32.07 16.02 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.67 -1.605 . . . . 73.239999999999995 110.358 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.06 168.52 9.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.446 -0.501 . . . . 74.349999999999994 110.575 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 25.0 p -98.69 137.15 37.73 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.345 -0.389 . . . . 54.32 111.047 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.5 m -116.36 148.82 40.23 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.406 -0.59 . . . . 72.019999999999996 109.406 179.141 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.539 ' HB1' ' ND2' ' A' ' 482' ' ' ASN . . . -69.64 157.63 36.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.742 0.246 . . . . 74.140000000000001 111.32 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.7 mm -70.35 -25.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.896 0.855 . . . . 75.230000000000004 110.199 -175.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.9 t -95.62 2.21 54.03 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.347 -0.842 . . . . 74.040000000000006 110.337 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.539 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -80.82 139.59 35.91 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 108.267 -1.012 . . . . 73.340000000000003 108.267 176.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.34 111.99 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.006 -0.739 . . . . 64.430000000000007 109.006 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.57 118.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.865 -1.161 . . . . 70.209999999999994 107.865 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -93.87 122.05 45.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.777 -1.194 . . . . 75.430000000000007 107.777 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.19 126.0 68.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.232 -1.025 . . . . 74.209999999999994 108.232 -179.11 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.4 mp -104.09 120.93 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.392 0.615 . . . . 64.450000000000003 110.125 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.09 145.34 8.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.646 -0.706 . . . . 73.310000000000002 109.281 -177.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.6 106.73 3.29 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.83 -0.908 . . . . 73.430000000000007 110.83 176.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.0 m -108.2 138.56 44.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.149 -1.056 . . . . 73.030000000000001 108.149 177.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -107.8 170.97 15.75 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.875 -1.155 . . . . 71.219999999999999 111.705 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.08 120.47 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.129 1.886 . . . . 74.140000000000001 110.633 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -82.11 79.18 8.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.67 -1.233 . . . . 54.409999999999997 107.67 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 43.4 p -134.89 162.78 31.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.012 -0.995 . . . . 71.439999999999998 110.766 -173.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.432 ' HG2' ' HA2' ' A' ' 516' ' ' GLY . 0.3 OUTLIER -142.83 132.0 23.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.21 -1.033 . . . . 74.239999999999995 108.21 178.007 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.9 p-10 -80.73 138.33 36.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.436 -0.949 . . . . 61.100000000000001 108.436 173.144 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.415 HG13 ' HA ' ' A' ' 541' ' ' ALA . 42.8 pt -98.61 137.58 20.65 Favored Pre-proline 0 C--N 1.292 -1.902 0 C-N-CA 120.433 -0.507 . . . . 75.099999999999994 111.742 -177.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.69 -176.97 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.472 2.115 . . . . 73.239999999999995 110.11 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -77.02 125.95 30.17 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.402 -0.962 . . . . 74.209999999999994 108.402 176.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 7.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.139 0.971 . . . . 74.040000000000006 110.264 -177.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -93.05 160.44 14.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.628 -0.714 . . . . 71.030000000000001 110.844 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 94.96 -7.98 70.18 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 109.691 -1.364 . . . . 63.32 109.691 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -102.04 -180.0 4.16 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.32 -0.94 . . . . 75.439999999999998 108.665 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 38.4 m -88.2 155.64 19.65 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.909 -1.145 . . . . 61.399999999999999 107.909 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.79 -42.78 53.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 122.879 0.472 . . . . 75.040000000000006 112.15 -177.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.09 -42.04 85.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.857 -0.611 . . . . 73.319999999999993 111.287 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.0 p -76.6 -35.65 26.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.401 -0.92 . . . . 73.439999999999998 110.798 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.31 -48.51 77.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.184 -0.916 . . . . 71.219999999999999 111.186 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.12 -35.69 81.59 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 123.039 0.212 . . . . 75.340000000000003 110.973 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -64.65 -53.24 50.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.592 0.558 . . . . 71.329999999999998 109.882 179.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.92 -42.94 99.96 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.007 -0.542 . . . . 64.400000000000006 110.525 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.33 -37.99 89.47 Favored 'General case' 0 C--O 1.184 -2.362 0 CA-C-N 116.061 -0.518 . . . . 71.319999999999993 110.638 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.96 -46.57 89.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.842 0.353 . . . . 73.099999999999994 110.791 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -27.63 37.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 73.25 111.422 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -120.16 24.4 10.46 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.078 -0.649 . . . . 75.310000000000002 109.956 -175.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 495' ' ' LYS . . . -164.51 -110.26 0.23 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 118.507 -1.806 . . . . 54.240000000000002 116.244 -173.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.4 m-85 -116.15 176.73 4.97 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.039 0.447 . . . . 73.230000000000004 111.243 -164.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.7 m -118.63 -17.42 9.27 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.562 -0.745 . . . . 64.310000000000002 110.495 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.84 115.64 30.51 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.758 -0.777 . . . . 73.530000000000001 110.968 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -120.77 135.28 55.19 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.436 -1.257 . . . . 75.219999999999999 108.676 -177.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.0 t -115.86 152.39 33.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.9 -2.259 . . . . 72.549999999999997 104.9 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -121.46 128.72 52.42 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.996 -0.682 . . . . 73.049999999999997 110.809 -175.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.172 -1.418 . . . . 71.099999999999994 107.172 177.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 41.0 m -88.75 125.91 35.09 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.821 -0.627 . . . . 74.109999999999999 109.784 -177.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.88 156.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 176.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -79.55 118.35 21.32 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 113.588 0.959 . . . . 65.519999999999996 113.588 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 12.7 m -60.75 136.56 92.96 Favored Pre-proline 0 N--CA 1.427 -1.606 0 CA-C-N 113.288 -1.778 . . . . 75.209999999999994 110.631 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -78.08 -88.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 108.505 -1.383 . . . . 71.120000000000005 108.505 172.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.434 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 92.7 mtt180 -102.54 -55.99 0.11 Allowed Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 118.788 -0.625 . . . . 74.329999999999998 111.548 171.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 4.3 Cg_exo -75.81 149.96 34.16 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.376 1.384 . . . . 70.400000000000006 110.967 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.61 128.24 38.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.139 -1.06 . . . . 62.25 108.139 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.95 -7.31 17.11 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 110.705 -0.958 . . . . 73.400000000000006 110.705 -178.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.68 147.1 27.11 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.067 -0.716 . . . . 75.120000000000005 109.067 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.26 115.63 20.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.567 -1.642 . . . . 73.420000000000002 106.567 173.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 31.4 m -89.65 -27.45 20.14 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 115.634 -0.712 . . . . 73.409999999999997 109.775 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -177.2 -173.99 43.21 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.959 -1.115 . . . . 72.430000000000007 111.766 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.3 p -134.81 160.32 38.57 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.657 -1.238 . . . . 74.510000000000005 107.657 176.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.53 -54.55 42.34 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.22 0.325 . . . . 74.040000000000006 110.608 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.64 138.45 8.37 Favored 'Trans proline' 0 C--N 1.365 1.403 0 N-CA-C 109.314 -1.071 . . . . 75.219999999999999 109.314 169.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 159.48 46.6 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 121.766 1.644 . . . . 62.539999999999999 111.82 178.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.415 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -60.76 135.1 57.67 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.436 -0.347 . . . . 71.239999999999995 110.27 177.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.65 -29.05 10.91 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 111.038 -0.825 . . . . 65.439999999999998 111.038 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.6 m -73.28 136.84 44.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.048 0.451 . . . . 71.319999999999993 110.863 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -100.78 122.36 43.26 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.478 -0.783 . . . . 74.019999999999996 109.265 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.06 157.59 69.05 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.585 -0.28 . . . . 70.129999999999995 110.474 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.92 134.21 42.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.936 2.424 . . . . 70.340000000000003 113.488 -178.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.7 m -68.06 -21.29 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 111.434 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.22 0.57 51.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.393 -0.821 . . . . 75.420000000000002 110.738 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.4 t -103.52 161.84 13.54 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.45 130.54 44.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.062 -1.088 . . . . 73.209999999999994 108.062 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -95.04 145.95 7.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 110.023 -0.362 . . . . 75.319999999999993 110.023 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -102.64 116.54 32.79 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.57 -0.53 . . . . 75.219999999999999 109.57 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 25.4 tp -95.74 125.04 40.04 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.74 -1.578 . . . . 71.540000000000006 106.74 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -103.94 102.53 12.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.076 0.941 . . . . 74.140000000000001 108.507 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.0 138.19 30.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 114.418 -1.264 . . . . 74.010000000000005 110.368 -173.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 30.2 p -61.88 118.33 7.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.625 -0.88 . . . . 75.540000000000006 108.625 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 107.809 -1.182 . . . . 75.129999999999995 107.809 -176.409 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.219 0 N-CA-C 110.862 -0.895 . . . . 51.420000000000002 110.862 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.8 131.81 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.077 1.851 . . . . 74.120000000000005 112.716 -176.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.13 8.74 4.76 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.54 -0.755 . . . . 74.329999999999998 109.675 175.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -82.8 145.45 29.51 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 114.901 -1.045 . . . . 75.549999999999997 109.577 -172.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -131.23 153.24 49.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.38 -0.97 . . . . 74.450000000000003 108.38 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.28 141.27 28.77 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 123.079 0.552 . . . . 63.520000000000003 111.153 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.8 mp -81.12 130.39 63.16 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.728 -0.841 . . . . 74.530000000000001 108.728 175.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.45 160.43 48.59 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.644 2.229 . . . . 74.030000000000001 113.89 -177.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -102.02 0.22 34.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.013 -0.994 . . . . 73.510000000000005 109.971 -179.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.05 1.51 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.775 0.797 . . . . 73.310000000000002 110.665 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.8 m -63.93 -30.31 71.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.793 -1.094 . . . . 62.020000000000003 109.455 177.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.9 t -62.21 -26.57 68.44 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.064 -0.971 . . . . 72.349999999999994 110.316 176.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.18 -46.29 20.92 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.926 -0.71 . . . . 71.049999999999997 109.998 -175.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.429 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 22.7 m -165.59 147.37 7.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.855 -0.794 . . . . 71.209999999999994 108.855 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -50.62 -49.06 57.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.17 0.988 . . . . 74.209999999999994 111.44 174.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.43 -43.9 75.78 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 123.407 0.442 . . . . 74.25 111.363 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.429 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 16.2 mm-40 -61.57 -41.38 97.31 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.143 -0.48 . . . . 74.129999999999995 111.766 -178.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.66 -51.58 68.79 Favored 'General case' 0 CA--C 1.508 -0.662 0 O-C-N 123.898 0.749 . . . . 74.519999999999996 110.216 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.75 -48.36 86.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 114.65 -1.159 . . . . 74.310000000000002 112.087 -175.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.6 mmtp -60.42 -45.43 93.63 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 117.874 0.306 . . . . 74.299999999999997 110.726 -176.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -66.51 -46.23 76.91 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.695 -0.684 . . . . 74.140000000000001 110.502 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.2 tp -69.21 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.22 0.533 . . . . 71.310000000000002 111.476 -177.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.61 -42.89 98.19 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.131 -0.692 . . . . 73.439999999999998 109.131 176.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -18.25 62.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 61.140000000000001 110.801 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.24 59.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.222 0.534 . . . . 74.450000000000003 110.145 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.48 -9.16 15.03 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 120.142 -1.028 . . . . 65.549999999999997 113.702 174.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -77.56 131.78 38.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.898 0.38 . . . . 75.519999999999996 111.169 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.87 12.6 5.34 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.713 -0.955 . . . . 53.240000000000002 110.713 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -118.65 115.97 25.62 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.709 -1.219 . . . . 74.340000000000003 107.709 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -134.91 154.3 51.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.494 0.664 . . . . 75.329999999999998 111.557 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.437 ' HB3' HG13 ' A' ' 485' ' ' ILE . 63.5 tttp -143.04 123.03 13.55 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 106.447 -1.686 . . . . 74.310000000000002 106.447 170.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -91.62 132.79 36.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.545 -0.462 . . . . 71.120000000000005 110.319 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.33 143.84 50.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.674 -0.862 . . . . 71.530000000000001 108.674 176.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -119.79 144.18 47.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.264 -0.643 . . . . 71.120000000000005 109.264 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -141.34 134.97 14.65 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 107.133 -1.432 . . . . 73.030000000000001 107.133 177.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_endo -65.53 122.19 9.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.758 1.639 . . . . 73.540000000000006 109.715 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.4 m -124.72 174.63 7.76 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 116.064 -0.516 . . . . 61.109999999999999 110.269 -176.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -62.81 142.85 97.17 Favored Pre-proline 0 N--CA 1.416 -2.171 0 N-CA-C 107.801 -1.185 . . . . 75.109999999999999 107.801 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.42 -30.93 28.71 Favored 'Trans proline' 0 N--CA 1.473 0.295 0 C-N-CA 123.85 3.033 . . . . 72.120000000000005 113.377 -176.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.8 -27.01 65.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.586 -0.279 . . . . 71.200000000000003 111.429 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.78 -0.53 29.18 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.613 0.598 . . . . 74.329999999999998 112.613 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -61.37 127.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 109.96 -0.385 . . . . 74.430000000000007 109.96 176.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.85 -4.36 71.81 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 112.019 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -114.46 154.21 28.59 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.57 -0.9 . . . . 73.329999999999998 108.57 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.11 134.3 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.122 -0.696 . . . . 74.040000000000006 109.122 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.3 pt -98.08 -20.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.55 -0.46 . . . . 73.439999999999998 110.538 -178.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 166.17 28.76 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.666 -0.778 . . . . 74.329999999999998 111.676 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 37.6 p -120.94 156.23 32.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.716 -0.475 . . . . 75.450000000000003 109.716 178.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -71.59 -48.35 12.12 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.303 -0.408 . . . . 60.119999999999997 111.326 175.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.3 Cg_exo -71.59 140.26 35.72 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 109.04 -1.177 . . . . 72.420000000000002 109.04 170.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.81 142.92 90.68 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.02 2.48 . . . . 73.319999999999993 114.294 -174.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.4 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -91.16 -6.97 52.75 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 74.340000000000003 109.386 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -99.52 -27.98 13.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.578 -0.737 . . . . 73.450000000000003 111.41 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.48 151.33 38.75 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.744 0.306 . . . . 71.409999999999997 110.358 -179.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 55.3 p -74.83 131.48 40.8 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.683 -0.69 . . . . 63.310000000000002 110.538 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.2 m -106.87 151.31 25.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.139 -0.689 . . . . 72.109999999999999 109.139 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.84 152.58 40.2 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.0 -0.741 . . . . 72.219999999999999 109.0 -175.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.52 -17.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.888 0.851 . . . . 62.149999999999999 110.563 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -93.11 7.03 45.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.553 -0.749 . . . . 75.099999999999994 110.008 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.45 140.21 32.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.681 -0.859 . . . . 63.200000000000003 108.681 176.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.03 121.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.895 -1.52 . . . . 61.450000000000003 106.895 176.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.46 117.92 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 C-N-CA 118.976 -1.09 . . . . 72.019999999999996 109.37 -179.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.7 mp -96.49 111.81 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 106.091 -1.818 . . . . 75.030000000000001 106.091 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 123.56 59.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 109.041 -0.725 . . . . 74.239999999999995 109.041 -177.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.19 115.98 46.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.582 -0.736 . . . . 71.310000000000002 109.946 -173.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 30.0 t -96.86 137.98 23.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.659 -0.701 . . . . 73.530000000000001 109.547 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.23 107.6 2.22 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 107.685 -2.166 . . . . 64.319999999999993 107.685 172.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -111.39 150.97 29.03 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.219 0.533 . . . . 63.130000000000003 110.797 -172.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -147.77 124.44 1.91 Allowed Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.146 -1.182 . . . . 75.510000000000005 110.146 177.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.28 156.71 58.54 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.228 1.952 . . . . 75.319999999999993 110.528 177.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.88 86.77 6.44 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.255 0.55 . . . . 75.239999999999995 109.992 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.1 p -124.89 155.99 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.813 -0.631 . . . . 75.349999999999994 109.808 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -140.89 148.95 41.27 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.09 0.556 . . . . 72.450000000000003 109.805 176.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.62 125.01 29.47 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.944 -1.502 . . . . 53.43 106.944 178.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.0 pt -79.46 132.37 62.36 Favored Pre-proline 0 C--N 1.301 -1.501 0 C-N-CA 120.182 -0.607 . . . . 62.439999999999998 110.738 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -87.22 -171.27 0.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 122.13 1.887 . . . . 71.430000000000007 111.448 177.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.92 99.39 11.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.519 -0.919 . . . . 71.329999999999998 108.519 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.4 t -99.51 -5.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.906 0.86 . . . . 64.540000000000006 108.752 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.84 146.51 49.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.83 -1.077 . . . . 73.510000000000005 110.779 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.5 -20.07 23.35 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 119.888 -1.149 . . . . 74.209999999999994 112.08 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -92.09 -171.44 2.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.456 -0.942 . . . . 74.219999999999999 108.456 177.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 m -84.95 155.22 21.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.124 -1.806 . . . . 73.430000000000007 106.124 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.4 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 10.1 p -64.11 -40.77 90.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 118.514 0.597 . . . . 65.230000000000004 110.984 -177.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 9.4 t70 -64.08 -43.19 96.15 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.403 -0.817 . . . . 65.430000000000007 111.611 178.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.94 -34.98 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.634 -0.826 . . . . 65.319999999999993 111.03 -178.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.62 76.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 73.239999999999995 111.256 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -65.41 -36.77 84.94 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 116.096 -0.502 . . . . 72.129999999999995 110.638 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.5 mptp? -62.7 -49.24 75.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.264 0.352 . . . . 74.109999999999999 111.946 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -63.67 -47.96 79.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.718 -0.393 . . . . 74.120000000000005 110.413 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.8 tp -62.27 -37.05 83.99 Favored 'General case' 0 C--O 1.192 -1.96 0 CA-C-N 115.759 -0.655 . . . . 64.319999999999993 111.313 -176.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.3 t-20 -59.01 -41.26 87.28 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.516 0.726 . . . . 61.409999999999997 110.294 177.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.1 -32.09 31.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.802 -0.635 . . . . 74.219999999999999 111.347 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.08 12.11 25.32 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.006 -0.678 . . . . 71.540000000000006 109.949 -174.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.33 -98.52 0.13 Allowed Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 117.735 -2.174 . . . . 71.239999999999995 117.29 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.657 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 67.2 m-85 -103.13 155.32 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 112.716 0.636 . . . . 74.030000000000001 112.716 -161.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 15.3 p -99.65 -36.19 9.58 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.991 -1.004 . . . . 72.25 112.151 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -108.22 131.93 54.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.269 0.557 . . . . 75.040000000000006 110.365 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.7 147.88 51.53 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.596 -0.729 . . . . 65.040000000000006 110.405 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.86 158.79 43.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.886 -1.153 . . . . 62.240000000000002 107.886 171.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.02 150.23 42.39 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.295 0.569 . . . . 72.200000000000003 111.48 -174.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.59 135.91 53.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.441 -1.689 . . . . 73.540000000000006 106.441 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 1.6 p -88.39 126.8 35.39 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 120.927 0.394 . . . . 73.409999999999997 111.369 -175.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.62 160.92 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 109.934 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.86 113.52 19.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.921 0.867 . . . . 63.530000000000001 112.892 -175.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.8 m -114.54 117.39 42.75 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.386 -1.338 . . . . 75.409999999999997 107.386 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.93 -39.05 15.03 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.96 2.44 . . . . 73.430000000000007 115.331 -171.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.417 ' HG3' ' HD3' ' A' ' 530' ' ' PRO 0.446 7.4 ptm180 -122.19 -88.22 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 115.095 1.516 . . . . 75.349999999999994 115.095 -175.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.417 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 10.9 Cg_exo -75.22 153.51 40.78 Favored 'Trans proline' 0 C--N 1.372 1.768 0 CA-C-N 123.123 2.151 . . . . 65.140000000000001 111.072 173.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -134.94 159.41 41.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 73.349999999999994 108.073 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.33 -17.46 7.01 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.962 -0.855 . . . . 74.109999999999999 110.962 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.495 ' OE2' ' HB3' ' A' ' 556' ' ' SER . 4.3 pm0 -81.95 147.44 29.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 110.1 -0.333 . . . . 71.340000000000003 110.1 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 4.2 p -77.07 115.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 106.839 -1.541 . . . . 75.530000000000001 106.839 173.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.1 m -79.71 -21.21 44.88 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.243 -0.89 . . . . 74.230000000000004 110.529 -174.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.83 -168.69 34.48 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.856 -0.687 . . . . 72.319999999999993 112.101 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.1 p -117.85 160.31 21.62 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.372 -0.974 . . . . 73.129999999999995 108.372 176.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -61.82 -52.91 65.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 121.058 -0.257 . . . . 71.230000000000004 111.404 177.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.5 Cg_exo -83.95 152.75 12.85 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.077 1.185 . . . . 74.510000000000005 109.023 173.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.8 158.55 46.55 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.115 1.877 . . . . 73.349999999999994 112.417 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.41 130.52 46.62 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.131 0.491 . . . . 73.549999999999997 110.243 176.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -14.68 37.55 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 115.92 -0.582 . . . . 72.25 112.063 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 89.8 m -80.6 131.26 35.48 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.606 -0.349 . . . . 72.109999999999999 110.434 177.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.1 t -98.33 127.87 44.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.386 -0.598 . . . . 62.140000000000001 109.386 178.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 517' ' ' PHE . 7.9 m -135.2 158.45 74.66 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.759 -0.83 . . . . 73.209999999999994 108.759 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.1 133.15 34.41 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.819 1.679 . . . . 75.439999999999998 112.41 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.657 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 21.6 m -68.57 -25.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.783 -1.099 . . . . 72.439999999999998 112.306 -176.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.06 -6.35 59.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.926 -1.034 . . . . 74.510000000000005 109.882 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.8 t -92.95 -172.84 3.11 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.673 -0.694 . . . . 73.439999999999998 110.267 -175.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.02 113.23 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.668 -0.696 . . . . 75.319999999999993 110.513 -174.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.7 tt -96.2 142.61 13.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.748 -0.834 . . . . 74.150000000000006 108.748 176.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.01 124.17 48.54 Favored 'General case' 0 N--CA 1.399 -2.986 0 CA-C-O 121.125 0.488 . . . . 74.299999999999997 110.929 -175.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.66 136.03 38.61 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.054 -0.975 . . . . 74.430000000000007 111.719 176.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -91.62 109.41 20.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.599 -1.63 . . . . 73.150000000000006 106.599 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.89 135.6 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.399 0.619 . . . . 74.040000000000006 111.295 -174.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.495 ' HB3' ' OE2' ' A' ' 533' ' ' GLU . 1.8 p -62.58 117.97 6.96 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 124.792 1.237 . . . . 62.420000000000002 112.388 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.427 -1.622 0 N-CA-C 108.746 -0.835 . . . . 75.430000000000007 108.746 178.473 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.758 0 N-CA-C 110.532 -1.027 . . . . 71.329999999999998 110.532 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.15 154.05 65.36 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.02 2.48 . . . . 75.120000000000005 112.162 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 480' ' ' ILE . 9.7 pt-20 -83.0 37.26 0.53 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.24 0.616 . . . . 75.439999999999998 111.829 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -96.91 122.94 40.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.97 0.414 . . . . 65.400000000000006 110.813 -176.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -120.89 146.85 46.17 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.87 -0.605 . . . . 74.439999999999998 111.97 -179.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.1 141.76 28.31 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.86 -1.064 . . . . 74.010000000000005 109.791 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.35 119.64 77.71 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.414 -0.587 . . . . 75.400000000000006 109.414 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.69 142.48 35.94 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.917 2.412 . . . . 75.129999999999995 111.522 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -88.81 78.47 7.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.811 1.291 . . . . 52.240000000000002 113.494 -176.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.55 4.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.469 -2.048 . . . . 70.299999999999997 105.469 167.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.461 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.0 m -62.16 -41.3 98.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 112.355 -2.202 . . . . 71.150000000000006 109.057 178.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 42.4 m -58.07 -27.01 63.25 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.407 -1.27 . . . . 74.230000000000004 111.243 176.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.09 -46.31 11.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.233 -0.587 . . . . 74.319999999999993 111.035 -174.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.7 m -170.16 154.17 4.87 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.926 -0.768 . . . . 63.439999999999998 108.926 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -51.82 -49.84 62.01 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.255 1.022 . . . . 73.099999999999994 110.05 169.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.97 84.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.288 -0.869 . . . . 64.450000000000003 111.772 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 17.5 mm-40 -61.28 -46.09 91.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.993 -177.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -68.0 -49.47 61.4 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.765 -0.652 . . . . 75.310000000000002 111.34 -178.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.15 -48.2 90.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 123.537 0.523 . . . . 72.040000000000006 111.779 -176.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.14 -45.88 89.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.747 0.308 . . . . 73.109999999999999 111.023 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -67.22 -40.55 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.388 -0.369 . . . . 72.329999999999998 111.364 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.81 -33.03 73.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.189 0.519 . . . . 64.420000000000002 109.876 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 41.1 m -60.12 -44.17 95.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.56 -0.746 . . . . 73.0 109.232 173.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.11 64.4 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.602 -0.726 . . . . 75.439999999999998 111.298 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.15 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.241 0.543 . . . . 74.140000000000001 110.219 178.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.78 -18.66 5.94 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.748 -0.739 . . . . 62.030000000000001 113.308 176.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 445' ' ' THR . 96.3 m-85 -74.35 136.11 42.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 110.584 -177.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.19 -12.61 1.24 Allowed Glycine 0 C--N 1.296 -1.68 0 CA-C-N 115.754 -0.657 . . . . 74.219999999999999 112.356 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -102.51 115.38 30.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.351 -0.611 . . . . 75.329999999999998 109.351 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -128.0 165.18 20.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.703 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 1.9 tmtp? -146.68 124.99 12.24 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.884 -2.265 . . . . 74.540000000000006 104.884 172.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -94.54 128.75 41.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.433 0.635 . . . . 75.420000000000002 111.173 -177.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.78 154.29 45.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.225 -1.028 . . . . 74.439999999999998 108.225 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.31 151.29 47.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.968 -0.382 . . . . 70.319999999999993 109.968 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 54.5 m -140.56 148.41 53.2 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.62 -0.882 . . . . 75.5 108.62 174.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.74 129.32 21.92 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.209 1.94 . . . . 75.519999999999996 111.346 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.8 t -141.46 173.48 11.45 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.74 -0.837 . . . . 74.140000000000001 108.74 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.4 t -66.34 146.64 99.05 Favored Pre-proline 0 N--CA 1.412 -2.332 0 C-N-CA 123.757 0.823 . . . . 74.420000000000002 109.141 177.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.23 -28.88 21.32 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.497 3.465 . . . . 73.120000000000005 113.061 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.854 -0.612 . . . . 74.319999999999993 111.176 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.35 -3.17 29.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.255 0.465 . . . . 74.319999999999993 112.255 -176.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 93.9 t -61.11 127.68 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 177.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.93 -12.0 68.99 Favored Glycine 0 C--N 1.314 -0.681 0 N-CA-C 111.49 -0.644 . . . . 73.019999999999996 111.49 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -101.74 159.5 15.27 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.644 -0.873 . . . . 74.109999999999999 108.644 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 54.6 t -82.32 132.11 32.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 74.409999999999997 108.812 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.9 pt -102.95 -23.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.966 -0.693 . . . . 75.049999999999997 111.69 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.89 157.54 22.74 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 111.564 -0.614 . . . . 61.439999999999998 111.564 178.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.2 p -124.62 147.82 48.27 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.646 -0.501 . . . . 62.539999999999999 109.646 177.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.488 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.6 t-20 -64.48 -50.15 67.52 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.054 -0.498 . . . . 73.230000000000004 110.56 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.0 Cg_exo -72.63 124.99 10.2 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.198 -1.501 . . . . 75.239999999999995 108.198 170.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.21 139.32 65.61 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.646 2.231 . . . . 64.140000000000001 112.874 -175.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.06 -16.26 41.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.857 0.837 . . . . 64.310000000000002 109.508 177.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -78.74 -31.97 46.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.325 -1.307 . . . . 74.129999999999995 109.358 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -108.98 172.44 6.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.536 -0.913 . . . . 74.510000000000005 108.536 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.6 p -98.54 133.72 42.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.549999999999997 108.85 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.2 m -116.16 140.87 48.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.38 -0.6 . . . . 74.120000000000005 109.38 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.07 145.39 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 74.230000000000004 111.659 -178.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -58.52 -31.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 110.643 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.5 t -77.44 8.85 3.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 111.705 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.54 144.64 25.42 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 122.058 -0.401 . . . . 65.040000000000006 110.16 178.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.55 122.32 35.55 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 N-CA-C 108.367 -0.975 . . . . 71.329999999999998 108.367 175.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.4 t -87.87 117.52 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 C-N-CA 119.277 -0.969 . . . . 75.129999999999995 108.722 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.488 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 54.4 mt -99.38 111.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.595 -2.002 . . . . 74.409999999999997 105.595 175.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 125.34 58.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 109.099 -0.704 . . . . 73.140000000000001 109.099 -175.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.5 mp -99.86 116.91 44.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 N-CA-C 109.187 -0.672 . . . . 75.430000000000007 109.187 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.18 143.15 12.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 64.319999999999993 109.061 -177.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.8 114.01 3.96 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.163 -1.975 . . . . 63.439999999999998 108.163 172.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -116.11 153.49 31.66 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.69 -0.855 . . . . 75.310000000000002 108.69 -176.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -130.69 110.73 1.03 Allowed Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.485 -0.864 . . . . 65.019999999999996 111.215 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.31 120.84 8.27 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.318 2.012 . . . . 74.299999999999997 110.524 176.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.48 91.37 7.82 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.002 0.905 . . . . 74.400000000000006 110.691 -176.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 546' ' ' PRO . 25.3 p -131.79 159.81 37.42 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.602 -1.258 . . . . 72.099999999999994 107.602 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -147.61 145.04 28.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.834 -0.747 . . . . 75.340000000000003 110.837 177.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.64 113.11 19.42 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.035 -1.468 . . . . 74.400000000000006 107.035 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 30.7 pt -75.83 127.91 84.55 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 113.112 0.782 . . . . 74.540000000000006 113.112 -173.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -101.21 112.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 122.982 2.455 . . . . 73.530000000000001 111.324 171.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.69 132.11 34.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.219 -0.659 . . . . 74.140000000000001 109.219 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.04 59.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 107.582 -1.266 . . . . 72.349999999999994 107.582 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -57.51 140.6 50.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.156 -1.838 . . . . 72.030000000000001 110.616 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.48 -11.29 30.68 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.673 -0.775 . . . . 41.32 111.264 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.512 ' O ' HG12 ' A' ' 534' ' ' VAL . 26.6 mt-30 -97.5 -171.15 2.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.103 -0.332 . . . . 65.349999999999994 110.103 177.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 12.1 m -84.86 156.75 21.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.842 -1.169 . . . . 75.340000000000003 107.842 -177.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -41.97 93.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.78 0.324 . . . . 74.219999999999999 110.608 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.49 -42.04 95.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.707 -0.679 . . . . 73.019999999999996 110.821 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.88 -34.98 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 119.638 -0.825 . . . . 63.530000000000001 110.721 -177.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.76 85.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.367 -0.833 . . . . 65.430000000000007 111.029 178.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -62.76 -45.95 90.29 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.487 0.492 . . . . 75.129999999999995 109.916 178.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -61.9 -54.03 47.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.603 -0.726 . . . . 72.120000000000005 112.053 -173.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.88 -38.33 88.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.544 -0.463 . . . . 73.010000000000005 110.919 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.71 -43.22 72.86 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 109.422 -0.584 . . . . 75.329999999999998 109.422 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.92 -45.8 89.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.351 0.661 . . . . 74.219999999999999 111.815 -178.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.72 -30.85 49.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 72.25 111.418 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.26 22.44 12.88 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 122.059 -0.401 . . . . 74.239999999999995 110.415 -174.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.74 -101.82 0.17 Allowed Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 117.165 -2.445 . . . . 72.030000000000001 116.514 -172.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 23.3 m-85 -109.6 156.37 20.26 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.513 -0.844 . . . . 72.430000000000007 110.601 -165.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.5 m -107.92 -24.27 11.7 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.762 -0.654 . . . . 71.400000000000006 111.426 -174.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -107.93 115.55 30.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.841 0.353 . . . . 71.400000000000006 110.143 -176.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -117.04 154.54 30.77 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.745 -0.661 . . . . 74.409999999999997 110.383 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.29 155.58 45.96 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.481 -1.674 . . . . 61.520000000000003 106.481 171.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.465 HE22 HD21 ' A' ' 553' ' ' LEU . 11.7 mm100 -119.96 148.3 43.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.294 -1.002 . . . . 74.340000000000003 108.294 -174.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.12 128.5 30.23 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.223 -0.658 . . . . 74.420000000000002 109.223 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -88.02 122.44 31.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.444 -1.317 . . . . 74.209999999999994 107.444 176.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.72 153.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 109.169 -175.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.34 114.59 18.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.436 1.112 . . . . 74.409999999999997 110.883 -175.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.9 p -117.17 120.52 33.51 Favored Pre-proline 0 N--CA 1.408 -2.535 0 CA-C-N 113.799 -1.546 . . . . 72.120000000000005 109.769 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.95 -55.12 3.18 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.766 2.311 . . . . 72.109999999999999 112.818 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.434 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 23.8 mtp180 -99.92 -54.4 0.17 Allowed Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 114.081 1.141 . . . . 75.239999999999995 114.081 177.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 32.1 Cg_exo -60.21 153.27 60.28 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.138 1.892 . . . . 74.329999999999998 113.798 -176.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.05 133.74 9.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.604 -1.258 . . . . 63.399999999999999 107.604 176.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 84.23 -45.16 3.44 Favored Glycine 0 C--N 1.312 -0.754 0 C-N-CA 121.258 -0.496 . . . . 75.450000000000003 113.516 177.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.22 149.68 48.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.248 1.019 . . . . 75.140000000000001 111.406 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 503' ' ' GLN . 9.3 p -75.17 127.35 36.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.193 0.52 . . . . 75.310000000000002 111.073 -174.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -82.19 -22.21 36.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.518 -0.765 . . . . 73.420000000000002 109.226 -178.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 140.67 -149.5 20.99 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.901 -1.28 . . . . 65.150000000000006 109.901 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.0 p -116.94 157.26 26.02 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.766 -1.198 . . . . 74.019999999999996 107.766 176.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.414 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 52.1 t30 -59.44 -53.48 65.48 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.39 -0.338 . . . . 75.200000000000003 111.734 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.9 Cg_exo -77.19 138.84 18.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 108.386 -1.428 . . . . 75.340000000000003 108.386 172.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.07 155.43 69.68 Favored 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 121.958 1.772 . . . . 64.319999999999993 111.948 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -59.09 143.42 48.67 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 110.695 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 94.02 -9.27 72.89 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 120.944 -0.646 . . . . 75.430000000000007 111.853 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 29.5 m -80.16 128.22 33.26 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.218 -0.66 . . . . 75.010000000000005 109.218 177.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 1.8 m -84.88 122.68 29.53 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.712 -1.218 . . . . 73.239999999999995 107.712 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.11 154.72 81.76 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.626 -0.509 . . . . 75.450000000000003 109.626 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.443 ' HA ' HG23 ' A' ' 494' ' ' THR . 21.4 Cg_exo -67.42 133.95 31.79 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.428 2.085 . . . . 75.209999999999994 111.813 -178.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.563 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 19.5 m -67.69 -20.48 26.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.166 0.507 . . . . 75.200000000000003 112.08 -177.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.67 -3.04 55.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.83 -0.623 . . . . 73.329999999999998 110.444 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.7 t -95.19 164.99 12.62 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.361 -0.607 . . . . 73.150000000000006 109.361 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.73 136.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.604 -0.517 . . . . 73.340000000000003 109.604 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.5 tt -110.65 138.47 38.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 120.936 0.398 . . . . 74.340000000000003 109.937 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -103.4 127.43 50.76 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 122.771 0.428 . . . . 65.219999999999999 109.85 -178.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.465 HD21 HE22 ' A' ' 522' ' ' GLN . 18.4 tp -100.63 132.96 45.75 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.485 -0.78 . . . . 63.310000000000002 108.899 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -88.88 113.66 24.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.115 -0.698 . . . . 74.319999999999993 109.115 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 47.8 t -103.96 124.16 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 108.542 -0.91 . . . . 64.430000000000007 108.542 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 16.0 m -61.58 121.84 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.302 -0.999 . . . . 55.549999999999997 108.302 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 60.2 tttm . . . . . 0 N--CA 1.42 -1.96 0 CA-C-O 118.462 -0.78 . . . . 74.129999999999995 110.745 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.928 0 N-CA-C 110.348 -1.101 . . . . 71.109999999999999 110.348 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.0 156.06 56.58 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.282 1.988 . . . . 75.140000000000001 111.479 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.5 pt-20 -125.08 40.12 3.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.116 0.96 . . . . 72.450000000000003 108.641 -178.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -83.53 121.88 27.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.802 -1.09 . . . . 74.109999999999999 109.946 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -121.07 156.92 31.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.096 -1.076 . . . . 71.230000000000004 108.096 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -83.43 140.84 32.13 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 109.844 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -84.71 127.88 63.36 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.318 -0.993 . . . . 70.510000000000005 108.318 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.3 141.59 63.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.887 1.724 . . . . 63.240000000000002 111.93 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -111.31 70.22 0.71 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 122.669 1.224 . . . . 73.230000000000004 108.781 -177.124 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.96 5.92 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 113.779 -1.555 . . . . 65.329999999999998 107.812 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 440' ' ' ALA . 2.3 m -57.34 -34.62 68.97 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.872 -1.967 . . . . 54.130000000000003 112.428 -177.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.0 t -60.3 -27.06 67.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.156 0.582 . . . . 70.319999999999993 111.557 178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.45 -45.97 18.39 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 120.127 -0.629 . . . . 71.099999999999994 110.21 -172.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.4 m -170.3 149.08 3.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.494 -1.298 . . . . 73.25 107.494 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -53.22 -45.86 68.84 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.555 0.535 . . . . 74.019999999999996 110.389 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.13 74.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.52 -0.764 . . . . 71.420000000000002 111.867 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -61.35 -44.87 96.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.269 -0.423 . . . . 72.420000000000002 111.048 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -62.79 -51.05 68.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.831 -0.622 . . . . 61.329999999999998 110.766 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -62.95 -48.86 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.662 -0.699 . . . . 75.200000000000003 111.97 -175.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.06 -41.49 90.7 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 121.107 -0.237 . . . . 75.420000000000002 111.353 -177.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.445 ' HZ1' ' HB2' ' A' ' 443' ' ' LYS . 0.0 OUTLIER -66.65 -39.12 88.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.244 0.545 . . . . 72.239999999999995 109.887 -179.434 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.51 -40.32 80.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.671 -0.695 . . . . 74.319999999999993 109.904 177.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.4 m -59.47 -46.5 88.62 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.637 -0.71 . . . . 71.430000000000007 109.107 176.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.34 65.9 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.443 -0.799 . . . . 72.239999999999995 111.437 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.61 -14.01 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 74.450000000000003 111.023 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.03 -14.92 21.3 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.108 -1.044 . . . . 64.430000000000007 113.046 175.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -69.81 130.15 41.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.608 -0.516 . . . . 74.420000000000002 109.608 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.19 -23.92 6.48 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.894 -0.669 . . . . 61.229999999999997 111.704 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -103.01 115.79 31.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.831 0.824 . . . . 73.349999999999994 112.458 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -146.83 141.74 26.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.405 -1.27 . . . . 74.329999999999998 110.112 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -131.39 123.22 27.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.548 -0.751 . . . . 71.519999999999996 109.089 -174.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -85.78 135.35 33.76 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.003 -0.544 . . . . 74.239999999999995 110.576 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.68 147.7 52.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.396 -1.705 . . . . 74.310000000000002 106.396 171.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -114.4 149.2 36.53 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.438 -0.505 . . . . 70.349999999999994 109.808 -178.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -140.63 133.49 14.63 Favored Pre-proline 0 N--CA 1.422 -1.862 0 N-CA-C 108.01 -1.107 . . . . 72.310000000000002 108.01 -178.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.0 125.09 14.06 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.656 2.237 . . . . 74.030000000000001 111.93 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 31.4 t -139.26 179.5 6.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 -178.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.4 t -57.64 140.37 80.59 Favored Pre-proline 0 N--CA 1.432 -1.336 0 C-N-CA 123.213 0.605 . . . . 65.540000000000006 110.327 177.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.58 -29.61 25.57 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 124.312 3.342 . . . . 74.310000000000002 113.573 -178.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.58 -10.59 59.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.58 0.585 . . . . 70.049999999999997 112.58 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.6 8.11 35.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.525 0.565 . . . . 74.319999999999993 112.525 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.4 p -60.68 128.1 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.796 0.331 . . . . 72.409999999999997 110.453 179.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.54 87.62 Favored Glycine 0 C--O 1.252 1.26 0 C-N-CA 120.847 -0.692 . . . . 73.409999999999997 112.214 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -113.61 146.06 40.31 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.19 -1.041 . . . . 74.219999999999999 108.19 177.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 45.8 t -81.94 144.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.943 -0.391 . . . . 64.120000000000005 109.943 -176.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.6 pt -98.21 -19.0 6.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.142 0.496 . . . . 74.239999999999995 110.503 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.24 178.36 37.67 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 111.191 -0.764 . . . . 72.219999999999999 111.191 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 27.8 p -119.59 145.99 45.91 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.415 -0.587 . . . . 73.409999999999997 109.415 178.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.88 -52.1 74.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 123.266 0.353 . . . . 70.519999999999996 111.103 178.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.68 143.41 23.9 Favored 'Trans proline' 0 C--N 1.366 1.493 0 N-CA-C 108.89 -1.235 . . . . 73.319999999999993 108.89 170.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.94 153.11 79.49 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 122.459 2.106 . . . . 71.040000000000006 112.355 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -87.15 -20.07 27.55 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.424 -0.807 . . . . 72.340000000000003 110.262 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 -32.12 15.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.089 -0.959 . . . . 74.519999999999996 112.117 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -94.57 145.57 24.72 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.234 -0.986 . . . . 72.200000000000003 108.613 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 28.6 p -83.87 128.71 34.74 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 116.327 -0.397 . . . . 71.209999999999994 110.513 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 m -114.03 145.11 42.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.073 -1.084 . . . . 63.340000000000003 108.073 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.412 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.46 142.0 58.31 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.663 0.268 . . . . 55.450000000000003 111.542 -176.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 425' ' ' GLU . 50.2 mm -57.75 -25.84 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.779 0.832 . . . . 74.109999999999999 110.578 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -79.56 3.61 18.33 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.971 -0.559 . . . . 74.439999999999998 111.226 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.412 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -95.52 157.77 15.75 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.975 -0.453 . . . . 74.409999999999997 110.241 179.272 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.39 122.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.962 -1.125 . . . . 71.540000000000006 107.962 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.25 119.38 36.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.616 -0.512 . . . . 71.549999999999997 109.616 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.31 121.81 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.588 -1.264 . . . . 74.209999999999994 107.588 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.95 121.29 66.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 115.626 -0.715 . . . . 75.450000000000003 109.277 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.73 118.36 49.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 121.808 0.813 . . . . 75.540000000000006 112.511 -178.283 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.77 145.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.883 -1.053 . . . . 73.530000000000001 109.1 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.77 117.31 4.63 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 110.477 -1.049 . . . . 71.129999999999995 110.477 176.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 7.3 p -99.57 128.66 45.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 107.486 -1.302 . . . . 64.299999999999997 107.486 174.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -108.76 119.43 5.61 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.213 -0.994 . . . . 71.519999999999996 112.057 -174.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.74 116.96 4.89 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.393 2.062 . . . . 74.109999999999999 111.15 177.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.58 109.1 20.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 73.0 107.44 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.9 p -122.61 158.77 29.23 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 115.538 -0.755 . . . . 75.540000000000006 109.847 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -135.65 141.63 45.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.323 -0.398 . . . . 75.349999999999994 110.76 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.07 127.1 32.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.723 -1.214 . . . . 75.209999999999994 107.723 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.97 129.79 80.0 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 115.87 -0.605 . . . . 74.239999999999995 111.863 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -94.26 124.28 0.43 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.769 2.313 . . . . 55.030000000000001 112.471 173.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.18 135.43 36.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 174.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 t -125.28 33.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.754 0.787 . . . . 75.510000000000005 108.928 -176.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -61.28 116.16 4.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 72.140000000000001 110.771 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.57 -23.92 5.01 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.651 -0.785 . . . . 72.299999999999997 112.244 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.31 -179.17 3.87 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.712 -0.847 . . . . 65.540000000000006 108.712 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 25.7 m -84.09 155.7 22.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 119.928 -0.709 . . . . 71.230000000000004 109.652 -172.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.06 -41.31 68.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.787 0.435 . . . . 74.109999999999999 111.199 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.64 -42.06 87.3 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.535 -0.757 . . . . 75.349999999999994 111.59 -178.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.06 -36.37 56.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 118.952 -1.099 . . . . 75.129999999999995 110.631 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.16 74.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.942 -1.026 . . . . 74.120000000000005 111.56 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.35 -35.24 79.74 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 123.116 0.26 . . . . 63.109999999999999 110.676 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -63.54 -49.15 74.61 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.332 0.395 . . . . 75.209999999999994 111.918 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -68.88 -38.27 79.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.897 0.379 . . . . 72.319999999999993 110.472 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.4 -44.67 95.89 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 115.84 -0.618 . . . . 74.0 110.065 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.0 t-20 -59.54 -47.69 84.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.413 0.685 . . . . 71.0 111.989 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.69 -20.0 17.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.169 -0.469 . . . . 63.310000000000002 112.04 -175.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -116.61 4.02 13.14 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 120.034 -0.666 . . . . 73.040000000000006 111.13 -178.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.73 -96.64 0.2 Allowed Glycine 0 N--CA 1.41 -3.089 0 C-N-CA 118.806 -1.664 . . . . 75.420000000000002 115.763 -169.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 9.6 m-85 -129.74 158.4 39.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.278 -0.461 . . . . 72.439999999999998 110.292 -165.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -104.95 -2.21 24.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.609 -0.885 . . . . 65.329999999999998 108.609 177.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.73 115.61 30.41 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 72.040000000000006 109.462 -175.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -126.24 152.42 46.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.603 0.716 . . . . 72.230000000000004 111.786 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -133.59 148.82 51.62 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.629 -1.619 . . . . 75.319999999999993 106.629 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.27 123.25 42.72 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.691 -1.226 . . . . 72.420000000000002 107.691 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.86 126.53 54.92 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.78 -1.192 . . . . 74.219999999999999 107.78 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -91.92 120.45 32.6 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.019 -0.734 . . . . 74.150000000000006 109.019 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.39 151.51 24.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.568 -1.271 . . . . 74.319999999999993 107.568 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.473 ' HA ' ' OXT' ' A' ' 557' ' ' LYS . 12.6 m-20 -79.05 128.22 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.024 0.916 . . . . 70.310000000000002 113.411 -170.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.4 m -143.4 111.7 5.47 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.84 -1.541 . . . . 74.230000000000004 106.84 177.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -56.17 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.048 2.498 . . . . 62.420000000000002 114.568 -174.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -82.34 -44.78 0.98 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 114.715 1.376 . . . . 73.140000000000001 114.715 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 533' ' ' GLU . 72.6 Cg_exo -57.07 133.76 59.94 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.352 1.368 . . . . 72.230000000000004 110.803 174.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -143.09 127.21 17.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.587 -0.279 . . . . 74.129999999999995 110.652 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.0 -11.28 55.2 Favored Glycine 0 N--CA 1.469 0.858 0 CA-C-O 121.372 0.429 . . . . 62.450000000000003 113.024 175.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 530' ' ' PRO . 11.4 pt-20 -86.78 150.89 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.505 0.722 . . . . 74.319999999999993 110.976 178.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 47.8 t -74.71 124.64 32.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.226 -1.028 . . . . 75.129999999999995 108.226 178.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 28.8 m -83.38 -33.64 25.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 71.519999999999996 108.44 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.05 -167.12 39.92 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.834 -0.621 . . . . 65.120000000000005 111.655 177.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.5 p -118.97 160.38 22.1 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.579 -0.897 . . . . 72.400000000000006 108.579 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.516 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.9 t-20 -57.8 -56.77 31.13 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 119.274 -0.394 . . . . 74.239999999999995 111.95 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.3 Cg_endo -89.38 166.05 5.37 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.833 1.688 . . . . 62.450000000000003 109.506 174.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.28 152.55 55.75 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.295 1.996 . . . . 70.5 111.974 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.14 135.94 57.73 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.862 0.465 . . . . 65.230000000000004 110.351 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.47 37.16 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.99 -0.624 . . . . 72.129999999999995 111.564 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.6 m -67.89 131.56 45.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.483 -0.562 . . . . 74.230000000000004 109.483 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.3 t -100.02 123.72 44.58 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.994 0.902 . . . . 75.140000000000001 110.971 -177.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.69 158.93 60.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 73.040000000000006 108.465 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.62 143.78 98.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.237 1.958 . . . . 74.439999999999998 110.894 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.32 -21.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.246 0.461 . . . . 73.329999999999998 112.246 -176.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.97 -2.77 58.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.325 -0.398 . . . . 75.329999999999998 111.034 178.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -81.21 152.58 27.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.18 -0.674 . . . . 52.219999999999999 109.18 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.06 125.5 42.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.312 -0.625 . . . . 73.150000000000006 109.312 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.2 tt -97.25 139.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.122 -0.325 . . . . 74.439999999999998 110.122 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -102.85 120.27 40.3 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 120.902 0.382 . . . . 65.239999999999995 110.119 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 tt -100.89 130.18 46.86 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.423 -1.325 . . . . 73.25 107.423 176.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.8 mt-30 -101.21 109.51 21.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.661 0.743 . . . . 75.340000000000003 110.186 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.18 139.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.448 -1.251 . . . . 75.120000000000005 111.598 -175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -57.14 121.05 9.13 Favored 'General case' 0 C--O 1.25 1.108 0 C-N-CA 123.825 0.85 . . . . 70.010000000000005 112.973 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.473 ' OXT' ' HA ' ' A' ' 526' ' ' ASP . 28.4 ttpp . . . . . 0 N--CA 1.432 -1.367 0 C-N-CA 124.951 1.301 . . . . 72.5 108.362 175.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.186 0 N-CA-C 109.753 -1.339 . . . . 43.049999999999997 109.753 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.51 147.39 70.68 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.022 1.815 . . . . 71.030000000000001 112.496 -177.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.48 4.3 53.39 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.866 -1.161 . . . . 63.229999999999997 107.866 177.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.422 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 96.6 mt-30 -83.47 149.09 26.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.649 -1.614 . . . . 74.409999999999997 108.396 178.472 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.464 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 17.6 tpp180 -120.92 155.33 34.44 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.528 -1.286 . . . . 74.329999999999998 107.528 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.39 141.48 31.7 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.49 -0.93 . . . . 72.239999999999995 108.49 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -80.07 127.4 77.03 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.018 -1.475 . . . . 65.430000000000007 107.018 177.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.27 139.93 32.99 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 109.431 -1.027 . . . . 74.140000000000001 109.431 175.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -115.28 72.04 0.78 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.889 1.328 . . . . 73.319999999999993 109.93 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.14 14.68 7.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 113.552 -1.658 . . . . 74.340000000000003 107.1 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.508 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.3 m -52.39 -41.29 63.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 127.637 2.375 . . . . 75.219999999999999 110.395 178.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.3 t -56.43 -26.71 54.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.003 1.321 . . . . 74.510000000000005 112.017 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.4 mt -85.85 -46.92 10.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.118 -1.033 . . . . 63.200000000000003 111.048 -174.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 20.1 m -174.23 153.7 2.05 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.535 -0.913 . . . . 75.420000000000002 108.535 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.487 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 40.3 t80 -50.55 -50.68 52.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.142 0.977 . . . . 74.340000000000003 111.009 171.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.48 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.757 0.661 . . . . 64.420000000000002 111.461 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -61.49 -45.98 91.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.317 -0.402 . . . . 73.430000000000007 111.463 -178.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 433' ' ' SER . . . -63.38 -48.36 78.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.87 -0.605 . . . . 65.439999999999998 110.967 -178.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.18 -46.59 90.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.894 -0.594 . . . . 72.430000000000007 112.238 -176.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -66.55 -41.55 88.49 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.488 0.181 . . . . 71.400000000000006 111.488 -178.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.08 -38.99 86.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.458 -0.497 . . . . 75.219999999999999 111.179 176.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.516 HD21 ' CE2' ' A' ' 452' ' ' PHE . 33.5 tp -67.11 -36.61 82.29 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.251 0.548 . . . . 75.120000000000005 110.041 178.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.2 m -59.49 -44.72 93.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.459 -0.791 . . . . 73.239999999999995 109.582 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.68 -18.65 62.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.44 -0.8 . . . . 73.329999999999998 111.181 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.16 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.228 0.537 . . . . 72.439999999999998 110.903 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.06 -25.77 9.74 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.813 -0.708 . . . . 60.009999999999998 113.454 174.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 96.2 m-85 -57.42 130.7 47.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.038 0.535 . . . . 72.319999999999993 112.0 -176.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.0 26.29 4.79 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.398 -0.906 . . . . 72.439999999999998 112.849 -178.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -132.91 115.59 15.43 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.235 -1.024 . . . . 75.010000000000005 108.235 178.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.516 ' CE2' HD21 ' A' ' 444' ' ' LEU . 27.6 m-85 -128.93 150.11 50.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.575 0.702 . . . . 71.420000000000002 111.731 -174.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.484 ' HB2' HG13 ' A' ' 485' ' ' ILE . 36.3 mmtm -136.24 130.62 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.646 -1.983 . . . . 75.540000000000006 105.646 169.374 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -108.26 124.72 50.74 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.703 -0.799 . . . . 74.519999999999996 110.83 -175.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.05 145.01 48.56 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.934 -0.575 . . . . 63.119999999999997 109.547 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -118.88 134.54 55.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.436 -1.32 . . . . 70.540000000000006 107.436 175.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.1 t -122.29 137.23 27.3 Favored Pre-proline 0 C--N 1.283 -2.284 0 N-CA-C 108.479 -0.934 . . . . 75.409999999999997 108.479 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.11 122.17 9.86 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.847 1.698 . . . . 72.040000000000006 110.801 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 40.5 m -134.07 178.7 6.76 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.353 -0.98 . . . . 74.400000000000006 108.353 -177.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.7 t -74.0 151.26 88.39 Favored Pre-proline 0 N--CA 1.403 -2.804 0 N-CA-C 107.651 -1.24 . . . . 74.329999999999998 107.651 176.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.493 ' O ' HG13 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -50.42 -28.91 22.44 Favored 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 124.121 3.214 . . . . 74.0 112.718 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.97 -26.25 68.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.121 -0.49 . . . . 74.049999999999997 111.344 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.34 -0.42 35.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.81 1.041 . . . . 75.530000000000001 113.81 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -60.81 128.13 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 119.962 -0.695 . . . . 74.140000000000001 110.696 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.24 -12.77 67.8 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 121.12 -0.562 . . . . 74.400000000000006 112.654 177.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.27 139.72 38.35 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.732 -0.47 . . . . 73.209999999999994 109.732 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 61.6 t -82.49 128.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.767 -0.651 . . . . 75.219999999999999 109.628 -178.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.47 -6.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.937 0.399 . . . . 74.450000000000003 112.019 -176.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.29 160.92 15.43 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.939 -1.125 . . . . 75.400000000000006 112.829 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.0 p -118.95 142.29 47.91 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.255 -1.017 . . . . 71.519999999999996 108.255 176.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.7 t-20 -54.74 -51.58 77.68 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 112.387 0.514 . . . . 72.129999999999995 112.387 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.5 Cg_exo -77.2 124.13 7.05 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 N-CA-C 108.158 -1.516 . . . . 75.140000000000001 108.158 169.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.32 142.17 65.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.326 2.017 . . . . 75.120000000000005 112.037 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.504 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.21 -14.65 61.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.144 0.973 . . . . 45.43 110.697 -177.152 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.27 -9.98 55.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.731 -1.577 . . . . 71.409999999999997 111.33 -176.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -120.84 151.06 40.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.945 -0.761 . . . . 64.230000000000004 108.945 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 10.7 p -84.44 132.7 34.54 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 108.807 -0.812 . . . . 73.109999999999999 108.807 176.513 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.6 m -122.2 145.71 47.94 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.358 -0.608 . . . . 73.409999999999997 109.358 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.402 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -59.55 154.64 16.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.439 . . . . 74.530000000000001 111.001 179.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.1 -25.42 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.796 0.807 . . . . 74.349999999999994 110.603 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.4 t -94.54 11.48 30.79 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.014 -0.994 . . . . 71.109999999999999 110.921 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.74 141.35 39.34 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 121.697 -0.627 . . . . 72.530000000000001 109.853 176.47 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.57 117.33 25.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.609 0.719 . . . . 74.540000000000006 110.075 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.44 118.61 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.734 -0.839 . . . . 74.140000000000001 108.734 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.495 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 2.5 mp -96.5 117.83 41.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 105.411 -2.07 . . . . 71.129999999999995 105.411 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.72 119.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 109.068 -0.715 . . . . 73.540000000000006 109.068 -176.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.53 114.26 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.942 -0.572 . . . . 75.540000000000006 110.528 -175.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 17.5 t -95.99 136.59 26.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.688 -0.856 . . . . 63.539999999999999 108.688 -178.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.44 125.08 6.8 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.815 -1.714 . . . . 73.150000000000006 108.815 175.072 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -128.63 129.84 46.44 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 109.12 -0.696 . . . . 73.409999999999997 109.12 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -88.99 131.7 10.84 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.104 -1.598 . . . . 74.0 109.104 178.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.59 118.27 5.13 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.375 2.05 . . . . 73.430000000000007 111.482 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -71.45 91.78 1.05 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.147 0.975 . . . . 70.129999999999995 109.591 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 546' ' ' PRO . 17.9 p -137.1 154.11 50.38 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.644 -1.243 . . . . 74.340000000000003 107.644 -176.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -138.64 150.0 45.78 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.562 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.36 113.73 26.7 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.02 -1.104 . . . . 74.109999999999999 108.02 -179.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.6 134.84 21.37 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 113.443 0.905 . . . . 71.239999999999995 113.443 -174.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.4 -178.15 1.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.767 2.311 . . . . 70.129999999999995 109.04 170.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.69 153.64 18.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.091 -0.707 . . . . 70.150000000000006 109.091 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.65 33.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 104.937 -2.246 . . . . 72.430000000000007 104.937 175.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.89 147.45 33.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.794 -1.548 . . . . 72.439999999999998 111.327 -173.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 103.65 -12.98 53.96 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.64 -0.984 . . . . 43.539999999999999 110.64 -177.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.12 179.92 4.08 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.72 156.15 26.4 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.647 -0.421 . . . . 64.239999999999995 109.941 -170.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.1 p -54.3 -43.7 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.383 0.512 . . . . 75.299999999999997 112.383 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.64 -41.91 78.74 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.332 0.493 . . . . 64.340000000000003 112.332 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.83 -38.9 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 119.47 -0.892 . . . . 75.25 111.524 -174.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.38 80.93 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.61 -0.723 . . . . 71.530000000000001 111.39 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -64.82 -34.68 78.93 Favored 'General case' 0 C--O 1.205 -1.282 0 O-C-N 123.214 0.321 . . . . 71.519999999999996 110.394 -177.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -59.5 -52.48 65.4 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.495 -0.557 . . . . 74.329999999999998 109.495 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -66.86 -44.72 80.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.457 -0.792 . . . . 72.099999999999994 110.704 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.47 -37.0 82.03 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 115.915 -0.584 . . . . 71.510000000000005 110.531 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.81 -38.15 77.98 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.552 0.741 . . . . 74.5 110.942 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -37.62 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.718 -0.674 . . . . 74.430000000000007 111.267 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -122.74 33.83 5.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.713 0.768 . . . . 72.430000000000007 111.455 -176.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -153.39 -128.52 1.29 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.98 -1.009 . . . . 62.240000000000002 111.553 -178.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 44.7 m-85 -105.66 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.053 0.454 . . . . 71.239999999999995 110.319 -173.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.6 p -110.03 -3.63 16.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.577 -0.738 . . . . 74.230000000000004 110.902 178.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 550' ' ' VAL . 28.2 mtpp -113.77 115.73 28.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.84 -0.8 . . . . 74.239999999999995 108.84 -177.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.83 156.46 43.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.152 0.501 . . . . 74.209999999999994 111.456 -175.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -140.99 156.62 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.017 -1.475 . . . . 75.219999999999999 107.017 171.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -121.75 124.87 45.24 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.385 -0.598 . . . . 74.409999999999997 109.385 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.82 140.63 48.78 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.529 -0.915 . . . . 75.230000000000004 108.529 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 20.0 m -88.18 124.81 34.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.974 -0.557 . . . . 60.549999999999997 110.704 -176.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.562 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 33.2 m -121.17 156.8 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.954 -1.128 . . . . 74.450000000000003 107.954 176.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.88 142.4 38.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.999 0.904 . . . . 72.209999999999994 112.048 -170.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 p -118.17 135.29 23.43 Favored Pre-proline 0 N--CA 1.413 -2.294 0 CA-C-N 114.264 -1.334 . . . . 72.439999999999998 110.187 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.55 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.275 0 N-CA-C 109.075 -1.163 . . . . 64.519999999999996 109.075 171.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.494 ' HG3' ' HD3' ' A' ' 530' ' ' PRO . 23.2 ptt180 -127.43 -47.07 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 114.72 1.378 . . . . 74.450000000000003 114.72 176.572 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.494 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 84.7 Cg_endo -76.54 135.89 16.8 Favored 'Trans proline' 0 C--N 1.385 2.45 0 CA-C-N 121.763 1.665 . . . . 73.120000000000005 112.107 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -137.32 145.44 43.41 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.955 -0.387 . . . . 73.519999999999996 109.955 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 100.21 -18.83 54.97 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.899 -0.48 . . . . 74.329999999999998 111.899 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.43 148.4 24.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.638 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.73 122.45 28.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.289 -0.869 . . . . 75.340000000000003 109.472 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.3 m -92.68 -10.01 38.78 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.788 -1.096 . . . . 75.140000000000001 109.348 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -159.12 27.98 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 110.774 -0.931 . . . . 75.430000000000007 110.774 177.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -134.36 157.75 45.59 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.698 -1.223 . . . . 71.5 107.698 177.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -52.68 -58.72 10.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.861 -0.59 . . . . 52.350000000000001 110.908 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.51 140.53 15.13 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 120.464 1.202 . . . . 63.100000000000001 109.063 170.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.47 155.8 65.9 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 121.935 1.757 . . . . 73.239999999999995 112.193 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.53 136.14 57.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.944 -0.571 . . . . 73.340000000000003 109.914 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -5.36 57.04 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.088 -1.053 . . . . 62.299999999999997 111.815 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 16.7 m -89.2 137.72 32.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.446 -0.575 . . . . 74.319999999999993 109.446 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 26.7 m -98.8 123.04 42.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.244 -1.021 . . . . 63.049999999999997 108.244 175.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.74 161.96 57.97 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 110.054 -0.351 . . . . 71.519999999999996 110.054 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.401 ' HA ' HG23 ' A' ' 494' ' ' THR . 20.7 Cg_exo -66.33 137.79 48.57 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.02 2.48 . . . . 61.009999999999998 113.995 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.538 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 15.0 m -67.86 -20.45 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.005 0.907 . . . . 72.040000000000006 111.248 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.45 -5.15 58.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.446 -1.252 . . . . 73.400000000000006 110.456 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -103.72 152.25 22.05 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.69 -1.226 . . . . 74.049999999999997 107.69 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 519' ' ' LYS . 38.8 t -88.71 136.2 23.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.859 -0.423 . . . . 73.510000000000005 109.859 -177.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.0 tt -95.88 135.49 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.352 0.596 . . . . 73.200000000000003 109.408 176.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.59 120.61 40.59 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.379 -0.971 . . . . 74.409999999999997 108.379 -177.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.0 tp -95.5 126.58 40.89 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.811 -1.086 . . . . 72.0 108.472 -177.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -89.53 105.64 17.93 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.632 -0.877 . . . . 75.310000000000002 108.632 -177.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.48 134.49 47.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 120.789 0.328 . . . . 72.310000000000002 110.667 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.7 p -66.35 121.46 15.3 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.044 -0.525 . . . . 75.310000000000002 109.743 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 20.6 pttp . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 115.557 -0.747 . . . . 75.510000000000005 110.626 -177.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.288 0 N-CA-C 110.537 -1.025 . . . . 51.43 110.537 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.91 132.61 45.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.798 2.332 . . . . 75.010000000000005 111.079 178.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.29 27.0 4.16 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.775 0.797 . . . . 64.239999999999995 109.521 -177.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -101.39 147.89 25.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.162 -1.051 . . . . 62.420000000000002 108.162 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 18.4 tpt180 -120.72 158.82 26.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.966 0.413 . . . . 75.400000000000006 110.166 -175.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.3 141.47 29.22 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.149 0.979 . . . . 75.340000000000003 110.41 -176.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.0 mp -87.85 121.49 70.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.617 -1.623 . . . . 74.200000000000003 106.617 173.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.74 141.83 55.86 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.091 1.861 . . . . 73.420000000000002 112.898 -175.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.58 11.64 23.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.74 -0.663 . . . . 74.430000000000007 110.767 -178.192 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.416 HG22 ' HG3' ' A' ' 443' ' ' LYS . 21.5 m -73.27 -9.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.701 -0.851 . . . . 74.209999999999994 108.701 176.177 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.518 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 18.0 m -57.23 -38.2 73.44 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.329 -1.305 . . . . 75.129999999999995 109.866 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.1 m -60.02 -27.56 67.0 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.779 -1.1 . . . . 70.239999999999995 110.647 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.8 mt -79.85 -47.63 14.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.382 -0.927 . . . . 74.430000000000007 109.975 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 49.8 m -166.01 145.77 6.27 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.682 -0.858 . . . . 74.5 108.682 177.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -55.29 -44.5 75.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.468 0.707 . . . . 72.439999999999998 111.914 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.19 -43.29 78.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.447 . . . . 74.120000000000005 110.881 177.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.9 mm-40 -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 71.439999999999998 110.534 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -59.54 -51.39 70.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.98 -1.009 . . . . 72.409999999999997 110.95 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.31 -48.52 88.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 114.851 -1.068 . . . . 73.129999999999995 111.784 -176.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.16 -46.11 90.43 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.154 0.428 . . . . 74.120000000000005 112.154 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.416 ' HG3' HG22 ' A' ' 432' ' ' VAL . 74.5 mmtt -66.98 -42.71 84.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.847 0.356 . . . . 75.129999999999995 111.267 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.81 80.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 75.109999999999999 111.026 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 49.2 m -62.35 -45.57 92.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.204 -0.665 . . . . 70.109999999999999 109.204 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.88 62.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.593 -0.73 . . . . 62.149999999999999 111.054 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -79.33 -13.8 59.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.010000000000005 110.2 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.91 -9.82 15.84 Favored Glycine 0 CA--C 1.494 -1.229 0 C-N-CA 120.072 -1.061 . . . . 75.049999999999997 113.209 173.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -80.35 136.6 36.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.58 -0.526 . . . . 73.340000000000003 109.58 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.04 -1.82 6.71 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 120.405 -0.903 . . . . 53.420000000000002 112.603 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -112.65 115.96 29.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.523 -0.918 . . . . 74.349999999999994 108.523 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -131.0 152.08 50.7 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.319 -0.4 . . . . 74.230000000000004 110.173 -174.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -135.8 122.59 21.11 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.457 -1.312 . . . . 71.310000000000002 107.457 170.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -97.68 133.37 42.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.151 0.501 . . . . 75.530000000000001 110.21 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.31 138.96 54.33 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.264 -1.384 . . . . 74.109999999999999 107.264 175.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.09 136.64 53.16 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.695 -0.854 . . . . 72.200000000000003 108.695 177.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.1 p -128.2 144.49 51.93 Favored Pre-proline 0 C--N 1.289 -2.048 0 N-CA-C 109.779 -0.452 . . . . 61.219999999999999 109.779 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -64.93 123.46 11.65 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.12 1.88 . . . . 75.239999999999995 109.85 175.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.7 m -142.06 178.16 7.72 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.5 -0.926 . . . . 74.519999999999996 108.5 -177.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -58.76 141.71 84.74 Favored Pre-proline 0 C--O 1.253 1.272 0 C-N-CA 123.295 0.638 . . . . 75.519999999999996 111.431 178.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.46 -28.58 28.4 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.982 3.788 . . . . 73.129999999999995 113.382 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -75.39 -11.26 60.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.785 0.661 . . . . 73.25 112.785 -178.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 83.4 mt -111.0 6.36 20.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.978 0.362 . . . . 71.329999999999998 111.978 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 49.1 t -61.21 127.34 20.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 121.125 -0.23 . . . . 74.099999999999994 110.804 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.24 87.75 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 116.11 -0.496 . . . . 73.030000000000001 112.467 176.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 28.4 mtpp -106.75 142.13 36.89 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.113 -1.069 . . . . 73.219999999999999 108.113 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.428 HG23 HD12 ' A' ' 486' ' ' ILE . 60.8 t -81.76 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.408 -0.59 . . . . 72.230000000000004 109.408 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 20.2 pt -98.25 -10.08 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.085 -0.507 . . . . 75.040000000000006 111.652 -176.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 162.15 21.34 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.64 -0.79 . . . . 75.049999999999997 112.153 177.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 25.4 p -130.09 150.31 51.41 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.021 -1.103 . . . . 75.239999999999995 108.021 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.61 -52.9 61.6 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 119.325 -0.369 . . . . 74.310000000000002 111.855 176.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.99 140.81 38.85 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 120.836 1.024 . . . . 63.439999999999998 110.073 173.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.02 145.69 85.81 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.253 2.636 . . . . 71.0 113.248 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -90.95 -17.39 26.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.331 1.062 . . . . 71.450000000000003 109.122 178.15 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -92.92 -19.14 21.94 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.616 -1.175 . . . . 74.439999999999998 110.114 -176.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -118.97 150.94 39.07 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.14 -0.482 . . . . 64.340000000000003 110.378 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.7 p -85.99 127.2 34.59 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.513 -0.312 . . . . 74.420000000000002 111.226 -178.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.0 m -111.27 151.24 28.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.475 0.71 . . . . 75.540000000000006 109.777 -176.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.489 ' HB1' ' ND2' ' A' ' 482' ' ' ASN . . . -60.43 142.92 54.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 72.129999999999995 111.811 -178.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.89 -30.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.765 1.226 . . . . 73.049999999999997 111.275 -176.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -83.95 0.75 46.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.073 -0.512 . . . . 74.329999999999998 111.604 -175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.489 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -73.44 145.08 46.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 112.465 0.543 . . . . 74.510000000000005 112.465 -177.843 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.7 p -84.46 125.78 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.627 -0.879 . . . . 73.120000000000005 108.627 172.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.0 118.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 109.032 -0.729 . . . . 74.510000000000005 109.032 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.72 115.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 105.804 -1.924 . . . . 75.230000000000004 105.804 174.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.428 HD12 HG23 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.39 125.46 70.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.408 -0.815 . . . . 64.439999999999998 109.932 -174.234 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.33 120.75 55.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.083 0.468 . . . . 75.140000000000001 110.107 -177.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.8 t -102.84 140.39 21.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 CA-C-N 115.642 -0.708 . . . . 74.040000000000006 109.67 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.0 122.73 5.84 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 109.238 -1.545 . . . . 75.219999999999999 109.238 173.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.4 p -122.29 137.27 54.91 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.109 -0.7 . . . . 53.439999999999998 109.109 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.412 ' N ' HG21 ' A' ' 464' ' ' VAL . . . -103.56 130.67 10.33 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 120.141 -1.028 . . . . 74.140000000000001 111.464 -176.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.14 122.56 10.59 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.181 1.921 . . . . 72.209999999999994 109.625 175.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.5 104.24 14.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.939 -1.134 . . . . 71.530000000000001 107.939 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.5 p -125.33 166.05 17.26 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.335 -0.848 . . . . 74.519999999999996 111.242 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -149.57 147.13 27.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.741 0.817 . . . . 75.5 110.191 176.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 30.4 t70 -96.08 127.05 41.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.137 -1.06 . . . . 72.310000000000002 108.137 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.49 121.81 83.14 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 112.231 0.456 . . . . 74.340000000000003 112.231 -175.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.19 146.29 14.1 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.995 1.797 . . . . 65.439999999999998 110.437 175.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.81 121.01 17.25 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.362 -0.607 . . . . 75.299999999999997 109.362 179.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.01 19.09 3.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.68 1.228 . . . . 74.129999999999995 108.249 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.21 112.25 19.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.421 -1.263 . . . . 74.140000000000001 109.525 -176.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.98 -28.39 1.71 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.66 -0.976 . . . . 73.5 110.66 -178.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -86.46 178.57 7.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.425 -0.954 . . . . 71.450000000000003 108.425 177.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 155.95 28.55 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.154 -1.054 . . . . 55.119999999999997 108.154 -174.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.8 p -51.76 -45.9 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.608 0.595 . . . . 61.329999999999998 112.608 -176.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 510' ' ' LYS . 25.4 t70 -67.57 -42.76 82.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.22 0.325 . . . . 65.140000000000001 111.545 -178.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.92 -39.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 119.537 -0.865 . . . . 74.019999999999996 111.678 -175.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.3 71.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.465 -0.789 . . . . 63.25 112.284 179.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.02 -35.6 81.71 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 120.138 -0.625 . . . . 74.510000000000005 110.333 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 510' ' ' LYS . 33.1 ttmt -60.67 -48.15 83.07 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.951 0.782 . . . . 75.409999999999997 109.331 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -62.62 -43.7 98.14 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.438 -0.801 . . . . 72.530000000000001 110.689 178.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.25 -43.06 92.54 Favored 'General case' 0 C--O 1.188 -2.16 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 109.45 -178.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -58.74 -37.71 76.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.037 0.935 . . . . 72.510000000000005 111.76 -178.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 510' ' ' LYS . 98.0 t -66.05 -37.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 112.512 0.56 . . . . 73.349999999999994 112.512 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -112.19 -15.4 13.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.24 -0.584 . . . . 75.230000000000004 111.896 -173.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -106.14 -110.31 3.48 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 115.541 -0.754 . . . . 74.040000000000006 113.324 -175.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.535 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 21.0 m-85 -123.94 175.43 6.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.092 0.472 . . . . 73.120000000000005 110.992 -172.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.9 p -109.42 -3.45 17.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.362 -0.835 . . . . 74.219999999999999 110.477 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.42 115.72 30.64 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.008 -0.738 . . . . 74.25 109.008 -176.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.78 149.28 50.79 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 123.576 0.547 . . . . 63.409999999999997 110.846 -176.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.6 m -136.36 143.54 44.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.21 -1.774 . . . . 73.310000000000002 106.21 171.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -121.78 136.78 54.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 118.019 0.372 . . . . 73.319999999999993 110.157 -177.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.409 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -126.48 131.02 51.73 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.445 -0.946 . . . . 64.510000000000005 108.445 177.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.3 p -88.88 133.6 34.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.094 0.473 . . . . 72.030000000000001 112.167 -176.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.16 163.1 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.95 -1.5 . . . . 75.200000000000003 106.95 175.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.499 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 10.9 p-10 -78.29 137.32 38.02 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.047 0.451 . . . . 75.430000000000007 109.829 -175.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 8.2 m -97.94 108.23 45.14 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.157 -172.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 30.0 Cg_endo -90.92 -90.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 122.449 2.099 . . . . 73.219999999999999 110.332 172.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -84.18 -48.63 0.68 Allowed Pre-proline 0 N--CA 1.439 -1.008 0 C-N-CA 120.177 -0.609 . . . . 74.030000000000001 111.518 171.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.536 ' HA ' ' OE2' ' A' ' 533' ' ' GLU . 78.4 Cg_exo -58.74 134.1 58.36 Favored 'Trans proline' 0 C--N 1.374 1.918 0 CA-C-N 120.19 1.104 . . . . 75.019999999999996 110.488 169.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.46 116.26 3.87 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 123.192 0.308 . . . . 72.340000000000003 110.796 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.17 -15.16 35.03 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 121.997 0.776 . . . . 73.219999999999999 111.64 178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.536 ' OE2' ' HA ' ' A' ' 530' ' ' PRO . 13.9 pt-20 -87.55 150.04 23.96 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 125.315 1.446 . . . . 74.430000000000007 110.939 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.2 t -73.15 122.4 25.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 107.68 -1.23 . . . . 70.230000000000004 107.68 178.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.8 m -87.8 -24.68 23.67 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.007 -0.997 . . . . 74.439999999999998 110.593 -174.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.01 -163.28 37.02 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.906 -0.878 . . . . 64.420000000000002 110.906 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.9 p -140.7 160.22 40.51 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 72.519999999999996 107.964 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.45 -60.27 11.11 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 119.243 -0.408 . . . . 75.510000000000005 110.786 178.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.13 139.86 19.39 Favored 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 120.189 1.103 . . . . 72.540000000000006 109.265 172.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.12 153.94 52.0 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.976 1.784 . . . . 75.049999999999997 112.229 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.71 131.77 51.28 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.475 -0.565 . . . . 74.200000000000003 109.475 176.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.25 -5.77 36.12 Favored Glycine 0 C--N 1.299 -1.49 0 N-CA-C 110.464 -1.054 . . . . 71.299999999999997 110.464 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -88.41 125.33 34.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.517 -0.549 . . . . 71.420000000000002 109.517 174.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.1 m -101.6 123.49 45.69 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.426 -0.953 . . . . 74.219999999999999 108.426 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.31 164.49 42.95 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.636 -0.505 . . . . 73.510000000000005 109.636 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.65 147.84 85.31 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.605 2.203 . . . . 75.299999999999997 111.436 176.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.535 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.2 m -66.86 -19.19 25.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.624 0.601 . . . . 74.319999999999993 112.624 -178.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.67 3.51 44.4 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.899 -0.591 . . . . 73.120000000000005 110.968 176.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.0 t -80.89 139.65 35.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.965 -0.754 . . . . 73.019999999999996 108.965 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.77 115.93 29.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.138 -0.689 . . . . 74.409999999999997 109.138 -179.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.4 tt -88.0 134.53 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.61 0.719 . . . . 75.219999999999999 111.039 -177.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.72 122.12 43.32 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 107.43 -1.322 . . . . 64.040000000000006 107.43 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.18 127.42 55.58 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.636 -1.165 . . . . 75.25 108.648 -175.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 5.7 mm-40 -92.41 109.53 20.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.963 -0.754 . . . . 74.209999999999994 108.963 -174.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.95 138.38 26.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 74.040000000000006 111.572 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 p -71.53 125.25 26.57 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.935 -1.505 . . . . 73.540000000000006 106.935 171.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.264 1.867 0 CA-C-N 115.646 -0.706 . . . . 74.109999999999999 111.246 -172.845 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.349 0 N-CA-C 110.493 -1.043 . . . . 73.25 110.493 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 132.03 14.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.45 1.625 . . . . 74.439999999999998 110.985 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 480' ' ' ILE . 11.1 pt-20 -110.45 16.13 21.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.014 0.912 . . . . 73.310000000000002 109.657 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -121.12 134.73 55.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.548 -1.279 . . . . 74.209999999999994 107.548 175.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -125.15 158.93 32.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.353 -0.61 . . . . 72.299999999999997 109.353 -176.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.64 142.49 30.76 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 123.715 0.806 . . . . 74.400000000000006 109.581 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -79.59 130.06 69.28 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 107.876 -1.157 . . . . 73.329999999999998 107.876 178.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 149.52 49.87 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.912 1.742 . . . . 73.030000000000001 111.967 178.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -114.9 72.96 0.81 Allowed 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 122.054 0.93 . . . . 74.549999999999997 110.355 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.6 4.67 5.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.119 -1.808 . . . . 73.409999999999997 106.119 175.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.01 -32.89 74.35 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 112.754 -2.021 . . . . 70.450000000000003 110.93 -176.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 t -61.44 -27.23 68.41 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.415 -0.812 . . . . 51.210000000000001 111.122 176.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.13 -46.32 15.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.159 -1.416 . . . . 72.420000000000002 110.416 -174.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 9.5 m -166.01 147.36 6.83 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.662 -0.866 . . . . 74.239999999999995 108.662 177.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.25 -45.54 65.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.954 0.902 . . . . 74.310000000000002 111.154 172.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.0 74.6 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.909 0.484 . . . . 73.209999999999994 110.869 178.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.555 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 12.2 mm-40 -66.29 -41.19 90.15 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.511 -0.768 . . . . 72.120000000000005 110.611 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.61 -50.12 75.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.913 -0.585 . . . . 64.310000000000002 110.407 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.56 -48.21 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.541 -0.754 . . . . 74.319999999999993 111.554 -176.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -60.95 -46.67 89.76 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.473 0.546 . . . . 74.230000000000004 112.473 -177.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.6 mptp? -67.38 -38.92 85.48 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 121.029 -0.269 . . . . 72.209999999999994 111.489 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -39.74 86.59 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.244 0.545 . . . . 74.150000000000006 109.889 178.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -59.4 -45.76 90.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.286 -0.87 . . . . 73.25 109.41 176.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.28 62.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.76 -0.654 . . . . 72.109999999999999 111.689 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -13.08 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 71.420000000000002 110.265 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.14 -16.1 25.22 Favored Glycine 0 CA--C 1.494 -1.253 0 C-N-CA 120.842 -0.694 . . . . 52.009999999999998 113.039 173.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.97 121.18 14.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.156 0.503 . . . . 74.340000000000003 111.035 -177.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.6 -2.73 40.48 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.411 -0.813 . . . . 75.109999999999999 111.6 178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -120.85 114.93 22.31 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.202 0.525 . . . . 75.109999999999999 110.176 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -148.26 148.36 30.38 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.321 -0.854 . . . . 73.319999999999993 111.083 178.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.503 ' HZ2' ' HB2' ' A' ' 453' ' ' LYS . 5.1 ttmp? -131.09 129.18 41.57 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.326 -0.99 . . . . 75.530000000000001 108.326 -178.022 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -93.33 124.82 37.58 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.417 0.448 . . . . 72.340000000000003 110.656 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 150.56 42.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.465 -1.309 . . . . 61.140000000000001 107.465 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.87 141.17 49.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.508 -0.923 . . . . 75.349999999999994 108.508 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 13.4 t -127.96 137.67 31.3 Favored Pre-proline 0 N--CA 1.416 -2.158 0 N-CA-C 109.007 -0.738 . . . . 55.399999999999999 109.007 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.97 123.66 11.93 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.488 2.125 . . . . 72.519999999999996 111.045 179.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 m -138.94 179.47 6.47 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.846 -1.539 . . . . 75.230000000000004 106.846 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 15.4 t -60.53 141.81 91.57 Favored Pre-proline 0 N--CA 1.422 -1.85 0 N-CA-C 108.385 -0.969 . . . . 61.229999999999997 108.385 175.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.85 -29.29 26.12 Favored 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 124.176 3.251 . . . . 74.400000000000006 113.721 -176.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -75.5 -13.97 60.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.708 0.632 . . . . 75.540000000000006 112.708 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.42 2.38 55.69 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 122.157 -0.34 . . . . 64.409999999999997 111.845 179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -60.75 128.43 21.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.258 0.551 . . . . 72.239999999999995 110.436 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.26 -12.94 67.61 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 120.834 -0.698 . . . . 75.329999999999998 111.774 178.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -98.76 139.97 33.65 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 60.7 t -82.27 138.89 18.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.119 -1.067 . . . . 75.129999999999995 108.119 176.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 32.3 pt -98.38 -29.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 120.033 -0.667 . . . . 74.439999999999998 111.227 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.82 168.76 40.89 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.345 -1.407 . . . . 63.200000000000003 112.502 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 34.2 p -117.64 143.32 46.26 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.27 -0.641 . . . . 73.010000000000005 109.27 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.472 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.3 t-20 -60.16 -49.77 89.28 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.578 0.584 . . . . 71.25 112.578 177.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.4 Cg_exo -81.97 144.59 13.61 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.03 1.153 . . . . 73.340000000000003 109.203 172.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.55 145.01 41.32 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.34 2.026 . . . . 74.219999999999999 111.237 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.422 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -79.86 -18.25 51.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.522 -0.763 . . . . 75.109999999999999 110.09 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -77.4 -27.44 52.42 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.931 -1.031 . . . . 75.150000000000006 113.019 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -100.76 160.89 13.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.222 -1.029 . . . . 72.219999999999999 108.222 175.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.2 p -97.94 126.04 43.15 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 109.414 -0.587 . . . . 65.329999999999998 109.414 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 142.82 34.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.491 -0.929 . . . . 62.109999999999999 108.491 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -56.49 153.22 10.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.568 0.581 . . . . 75.409999999999997 112.568 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.2 mm -61.51 -30.02 47.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.434 0.635 . . . . 74.450000000000003 110.149 178.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 8.31 39.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 65.409999999999997 111.128 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.09 149.4 26.93 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.148 -1.056 . . . . 71.450000000000003 108.148 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.38 117.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.845 0.831 . . . . 73.439999999999998 111.382 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.1 t -92.44 119.92 40.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.359 -0.837 . . . . 62.420000000000002 109.545 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.472 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.61 116.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.766 -1.568 . . . . 74.129999999999995 106.766 175.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.13 126.16 58.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.715 -0.675 . . . . 72.120000000000005 109.327 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 26.7 mt -104.49 115.61 46.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.776 -0.647 . . . . 74.420000000000002 110.224 -173.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.14 136.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.231 -0.655 . . . . 73.310000000000002 109.231 -177.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.43 124.67 6.56 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 109.096 -1.602 . . . . 72.439999999999998 109.096 175.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.5 m -135.31 140.78 45.39 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.138 -0.69 . . . . 71.099999999999994 109.138 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -93.1 160.34 24.88 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.162 -1.018 . . . . 35.140000000000001 110.651 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.07 126.37 17.08 Favored 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 122.759 2.306 . . . . 74.239999999999995 111.334 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -80.67 81.62 6.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.081 0.944 . . . . 71.219999999999999 109.493 177.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.407 HG23 ' HA ' ' A' ' 546' ' ' PRO . 46.6 p -136.02 152.93 51.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.705 -1.134 . . . . 74.239999999999995 108.165 -177.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -141.22 153.4 45.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.085 -0.339 . . . . 74.25 110.085 177.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -93.91 138.54 31.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.123 -0.489 . . . . 72.120000000000005 110.128 179.083 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.0 pt -94.79 129.19 36.82 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 116.123 -0.49 . . . . 74.299999999999997 111.049 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.1 174.12 13.33 Favored 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.355 2.037 . . . . 73.540000000000006 110.779 172.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.97 128.86 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 71.200000000000003 111.123 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.45 -9.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.502 0.668 . . . . 71.200000000000003 110.275 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.56 136.23 47.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.514 -0.766 . . . . 73.510000000000005 112.142 -174.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.5 -16.1 29.33 Favored Glycine 0 CA--C 1.492 -1.363 0 C-N-CA 120.784 -0.722 . . . . 73.540000000000006 111.578 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.16 177.99 7.02 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 110.149 -0.315 . . . . 75.230000000000004 110.149 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.1 155.84 18.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.709 -1.219 . . . . 75.540000000000006 107.709 -177.068 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.69 -46.69 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.086 0.773 . . . . 72.109999999999999 113.086 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.85 -41.82 74.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.28 0.474 . . . . 74.299999999999997 112.28 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.52 -34.4 29.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.608 -0.837 . . . . 74.329999999999998 110.737 -175.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.62 85.06 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.928 -1.033 . . . . 51.020000000000003 110.134 177.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.37 -35.99 82.68 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.084 -0.507 . . . . 74.329999999999998 111.456 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.76 -51.54 61.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.834 -0.346 . . . . 75.340000000000003 110.776 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 514' ' ' VAL . 62.2 m-20 -68.3 -39.7 81.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 109.978 -177.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.59 -37.31 87.13 Favored 'General case' 0 C--O 1.181 -2.527 0 CA-C-N 116.277 -0.42 . . . . 75.109999999999999 110.142 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -58.94 -39.85 82.85 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.039 0.536 . . . . 62.520000000000003 111.535 -178.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 511' ' ' ASN . 7.7 p -74.18 -31.28 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 120.149 -0.62 . . . . 62.229999999999997 112.197 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.73 -33.76 9.72 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.982 0.896 . . . . 74.409999999999997 110.897 -175.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -92.74 -112.74 2.07 Favored Glycine 0 N--CA 1.416 -2.645 0 CA-C-N 114.301 -1.318 . . . . 65.230000000000004 113.933 -172.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 57.5 m-85 -130.61 175.97 8.57 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.759 -0.46 . . . . 74.099999999999994 109.759 -170.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 m -98.03 -25.71 14.86 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.233 -0.439 . . . . 72.209999999999994 112.076 -173.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.66 123.16 48.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.871 -0.732 . . . . 72.310000000000002 110.839 -177.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.74 146.09 34.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.153 -0.931 . . . . 70.519999999999996 109.867 -176.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.5 m -126.88 149.5 49.73 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.323 -1.732 . . . . 65.209999999999994 106.323 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.51 131.37 54.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.623 -0.51 . . . . 74.209999999999994 109.623 -174.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.3 52.27 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.969 -1.123 . . . . 71.329999999999998 107.969 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.7 m -103.45 129.35 50.56 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.854 0.359 . . . . 71.329999999999998 110.708 -176.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.0 m -122.47 156.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 110.145 178.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.95 142.48 27.76 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.755 . . . . 63.399999999999999 109.422 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 37.9 t -137.13 140.34 30.91 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 106.556 -1.646 . . . . 74.340000000000003 106.556 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.12 -72.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.815 2.343 . . . . 75.310000000000002 113.167 -176.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 529' ' ' ARG 0.285 30.9 mmt180 -116.47 -54.97 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.653 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 178.19 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.59 133.84 56.97 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.174 1.249 . . . . 65.030000000000001 110.855 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.93 4.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.698 -0.482 . . . . 71.439999999999998 109.698 -178.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.48 -25.52 2.98 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.439 -1.064 . . . . 74.510000000000005 110.439 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.63 150.27 23.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.633 0.773 . . . . 73.409999999999997 110.454 177.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.13 120.0 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 106.879 -1.526 . . . . 75.540000000000006 106.879 175.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 21.2 m -70.04 -27.59 64.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.976 -1.011 . . . . 75.019999999999996 109.851 -175.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.68 24.88 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 110.297 -1.121 . . . . 73.310000000000002 110.297 177.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.2 p -129.87 161.33 31.05 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 107.753 -1.203 . . . . 74.219999999999999 107.753 178.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.1 t-20 -61.64 -52.58 68.34 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 120.654 -0.418 . . . . 75.120000000000005 110.131 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_exo -79.85 127.35 6.99 Favored 'Trans proline' 0 C--N 1.364 1.351 0 N-CA-C 108.459 -1.4 . . . . 72.0 108.459 170.041 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.06 154.45 73.99 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.151 1.901 . . . . 65.120000000000005 112.229 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -52.03 132.6 32.85 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.078 0.551 . . . . 75.209999999999994 111.282 179.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.85 -25.29 21.24 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 111.05 -0.82 . . . . 74.310000000000002 111.05 -176.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.1 m -65.7 135.59 55.17 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.21 0.528 . . . . 72.219999999999999 110.73 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.7 m -94.97 123.61 38.54 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.239 -1.393 . . . . 73.430000000000007 107.239 177.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 517' ' ' PHE . 20.5 t -123.22 152.21 63.49 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 107.012 -1.477 . . . . 72.129999999999995 107.012 -176.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 494' ' ' THR . 51.9 Cg_exo -59.87 140.03 91.11 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 73.430000000000007 112.077 174.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.493 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 23.8 m -67.62 -21.34 27.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.397 0.617 . . . . 51.350000000000001 111.685 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -88.89 3.59 50.81 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.027 -0.988 . . . . 73.109999999999999 110.756 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -97.25 154.23 17.53 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.267 -0.642 . . . . 75.430000000000007 109.267 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.77 137.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.838 -0.801 . . . . 74.010000000000005 108.838 177.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.7 tp -93.16 129.89 43.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.48 -0.563 . . . . 75.239999999999995 109.48 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -103.0 116.57 32.8 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 122.798 0.439 . . . . 74.420000000000002 110.712 -176.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.31 134.28 39.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.323 -0.853 . . . . 65.349999999999994 111.111 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -96.97 108.51 21.25 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 73.25 107.529 178.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.67 138.37 29.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 120.428 0.156 . . . . 74.319999999999993 111.223 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.7 p -72.64 119.8 17.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.338 -0.615 . . . . 65.439999999999998 109.338 179.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 C--N 1.294 -1.836 0 CA-C-N 115.87 -0.605 . . . . 75.140000000000001 109.539 -177.033 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.964 0 N-CA-C 110.411 -1.076 . . . . 70.420000000000002 110.411 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.58 142.26 76.86 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.92 2.413 . . . . 73.129999999999995 112.379 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.85 3.89 53.29 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.032 0.92 . . . . 75.019999999999996 109.042 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.416 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 92.5 mt-30 -83.11 152.08 25.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.546 -1.206 . . . . 75.400000000000006 110.734 -176.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -127.56 157.62 39.66 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.458 -1.312 . . . . 75.530000000000001 107.458 177.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.45 141.55 31.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 123.588 0.555 . . . . 74.430000000000007 110.13 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.9 mp -79.66 130.83 66.3 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.097 -1.075 . . . . 75.450000000000003 108.097 177.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -64.61 141.0 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.833 1.688 . . . . 74.349999999999994 112.314 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.59 9.01 43.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.583 -0.735 . . . . 75.349999999999994 110.362 -177.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.41 7.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.016 0.913 . . . . 74.25 110.656 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.492 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 3.2 p -60.72 -38.7 85.96 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 125.324 1.45 . . . . 64.319999999999993 110.514 177.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.1 t -60.7 -26.66 67.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.124 -0.943 . . . . 75.310000000000002 111.278 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 51.8 mt -81.88 -46.42 14.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.11 -0.636 . . . . 73.299999999999997 110.224 -174.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 21.0 m -167.94 150.21 5.56 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.819 -1.178 . . . . 74.129999999999995 107.819 177.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.37 -48.71 68.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.139 173.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.61 71.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.626 0.77 . . . . 75.120000000000005 112.094 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -61.68 -45.72 92.79 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.297 -0.411 . . . . 74.230000000000004 111.584 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -66.62 -45.74 78.13 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.92 -47.53 89.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.832 0 O-C-N 123.822 0.701 . . . . 64.299999999999997 112.388 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.09 -47.42 86.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.617 0.246 . . . . 73.209999999999994 111.661 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.62 -42.31 86.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.408 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.65 -38.38 80.42 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 75.010000000000005 110.562 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 46.8 m -63.26 -42.5 99.17 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.865 -0.607 . . . . 72.540000000000006 109.578 175.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.11 -18.48 64.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.044 -0.526 . . . . 74.049999999999997 110.561 177.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.92 -13.96 58.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.1 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.99 -14.05 26.46 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.851 -0.69 . . . . 71.120000000000005 112.991 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.59 130.08 41.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.71 0.291 . . . . 72.200000000000003 110.525 -178.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.38 11.11 6.81 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.236 -0.746 . . . . 73.140000000000001 111.236 178.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.04 115.43 29.44 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.052 -1.462 . . . . 75.0 107.052 -178.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -136.76 147.49 46.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.662 -0.415 . . . . 73.340000000000003 111.043 -174.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -132.14 122.75 25.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.254 -1.387 . . . . 75.329999999999998 107.254 169.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -103.72 128.94 51.03 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.866 -0.42 . . . . 63.439999999999998 109.866 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -129.86 144.04 51.11 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.187 -1.412 . . . . 74.519999999999996 107.187 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.03 135.79 53.63 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.447 -0.946 . . . . 73.109999999999999 108.447 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.3 m -116.44 138.57 24.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.669 -0.863 . . . . 64.310000000000002 108.669 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.9 122.31 10.09 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.063 1.842 . . . . 63.43 110.416 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.454 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 25.1 t -143.66 -179.18 6.29 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 105.914 -1.884 . . . . 71.099999999999994 105.914 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.1 t -66.07 132.99 94.66 Favored Pre-proline 0 N--CA 1.416 -2.175 0 CA-C-O 121.071 0.462 . . . . 71.129999999999995 109.886 176.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.73 -28.51 30.29 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.917 3.078 . . . . 71.340000000000003 112.039 176.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.87 -17.33 63.06 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.738 -0.665 . . . . 74.010000000000005 112.103 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.65 13.39 19.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.177 -0.327 . . . . 73.510000000000005 111.698 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.9 p -57.47 128.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 73.209999999999994 111.572 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.47 -12.92 59.92 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.626 -0.797 . . . . 61.140000000000001 112.131 177.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -92.84 139.78 30.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.179 -0.675 . . . . 62.329999999999998 109.179 176.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 61.5 t -82.47 134.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.992 -0.744 . . . . 72.019999999999996 108.992 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.0 pt -97.31 -7.41 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.251 -0.58 . . . . 73.510000000000005 110.73 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 167.81 25.86 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.656 -0.783 . . . . 53.32 111.651 175.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.5 p -120.43 149.47 42.33 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.893 -1.151 . . . . 74.109999999999999 107.893 176.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.425 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -65.05 -52.94 45.3 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-O 119.248 -0.406 . . . . 73.230000000000004 111.079 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.6 Cg_exo -73.93 139.58 27.52 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 108.8 -1.269 . . . . 71.099999999999994 108.8 172.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.47 141.31 66.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.578 2.185 . . . . 65.0 112.63 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.32 -11.86 55.63 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.204 -0.907 . . . . 54.140000000000001 110.164 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -94.56 -24.77 17.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 111.458 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.86 174.16 5.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.08 -0.648 . . . . 73.230000000000004 109.538 177.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.416 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 19.1 p -101.18 144.33 30.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.967 -0.561 . . . . 75.209999999999994 109.776 178.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.3 m -127.85 148.8 50.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.708 -0.849 . . . . 73.049999999999997 108.708 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 152.29 42.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 110.061 -0.348 . . . . 74.340000000000003 110.061 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.03 -12.74 16.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.859 0.838 . . . . 74.219999999999999 111.213 -173.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -90.18 1.12 56.79 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.844 -0.616 . . . . 74.349999999999994 110.923 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.52 141.76 41.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.01 0.433 . . . . 71.019999999999996 111.977 -177.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.76 115.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.79 -1.189 . . . . 72.120000000000005 107.79 176.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.48 119.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.587 -0.845 . . . . 75.420000000000002 108.931 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.5 mp -99.4 123.23 51.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.239 -1.763 . . . . 74.430000000000007 106.239 175.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.38 123.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 109.327 -0.62 . . . . 74.450000000000003 109.327 -177.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -103.52 117.54 49.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 CA-C-O 121.76 0.79 . . . . 71.519999999999996 111.802 178.749 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 20.1 t -96.61 140.47 17.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.872 -1.058 . . . . 74.219999999999999 109.335 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.42 116.8 4.38 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.29 -1.524 . . . . 70.420000000000002 109.29 174.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -126.64 129.95 49.5 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 107.36 -1.348 . . . . 73.129999999999995 107.36 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 459' ' ' SER . . . -96.15 144.08 17.07 Favored Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 119.464 -1.35 . . . . 65.400000000000006 111.373 -178.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.88 119.76 6.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.374 2.05 . . . . 75.519999999999996 110.088 176.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.12 79.68 9.05 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.874 0.845 . . . . 75.439999999999998 109.545 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 546' ' ' PRO . 14.5 p -137.94 157.55 46.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.693 -1.14 . . . . 64.400000000000006 108.735 -177.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.25 147.48 32.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.949 0.404 . . . . 72.040000000000006 110.652 178.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.6 p-10 -84.71 131.82 34.53 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.161 -0.927 . . . . 74.439999999999998 108.54 175.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.9 pt -76.47 134.7 69.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.712 -0.676 . . . . 73.140000000000001 110.843 -177.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.13 167.43 9.38 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.565 2.177 . . . . 74.420000000000002 109.778 173.088 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.02 141.88 28.34 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.631 -1.248 . . . . 74.340000000000003 107.631 176.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.62 13.84 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-O 121.986 0.898 . . . . 73.299999999999997 110.492 -174.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.58 147.52 29.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.398 -0.819 . . . . 71.209999999999994 111.649 -175.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 91.48 11.81 60.41 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 111.099 -0.8 . . . . 71.030000000000001 111.099 177.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.469 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 22.5 mt-30 -119.89 178.42 4.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.8 0.334 . . . . 75.209999999999994 111.831 -176.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.679 -1.23 . . . . 75.209999999999994 107.679 -176.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.05 -41.65 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 117.833 0.288 . . . . 73.040000000000006 111.381 -177.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.04 -42.51 80.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.549 0.574 . . . . 65.400000000000006 112.549 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 11.2 p -73.67 -34.94 42.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 118.98 -1.088 . . . . 75.530000000000001 110.16 -176.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 534' ' ' VAL . . . -63.36 -49.9 72.06 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.941 -1.027 . . . . 61.219999999999999 111.157 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -65.13 -37.5 87.63 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 116.264 -0.426 . . . . 75.299999999999997 110.642 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -65.59 -53.6 39.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.107 0.41 . . . . 74.450000000000003 112.107 178.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -62.42 -39.0 91.86 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.078 0.466 . . . . 71.340000000000003 110.596 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.59 -47.66 62.77 Favored 'General case' 0 C--O 1.187 -2.192 0 CA-C-N 115.884 -0.598 . . . . 71.349999999999994 110.575 178.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.38 -41.19 98.79 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.448 0.536 . . . . 74.040000000000006 112.448 -176.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.05 -29.11 43.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.335 0.495 . . . . 74.109999999999999 112.335 -177.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.88 -26.37 6.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.204 -0.998 . . . . 73.230000000000004 111.798 -174.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.65 -98.92 2.38 Favored Glycine 0 N--CA 1.41 -3.065 0 CA-C-N 115.26 -0.882 . . . . 73.049999999999997 114.533 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 50.1 m-85 -133.68 160.11 38.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.761 0.315 . . . . 61.32 110.487 -167.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 p -103.63 -7.9 20.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.586 -0.734 . . . . 73.129999999999995 112.004 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.48 119.92 40.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.725 -0.472 . . . . 75.329999999999998 109.725 -176.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -126.3 153.47 44.77 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.595 0.712 . . . . 71.209999999999994 111.533 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.5 m -141.16 153.71 45.49 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.928 -1.508 . . . . 64.239999999999995 106.928 169.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -121.65 132.31 54.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 118.28 0.491 . . . . 74.409999999999997 110.956 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.14 136.14 53.44 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.068 -1.456 . . . . 72.409999999999997 107.068 174.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 25.9 m -98.53 133.49 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.948 0.404 . . . . 62.219999999999999 110.491 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.13 163.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.42 -0.955 . . . . 53.119999999999997 108.42 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.17 140.08 38.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.262 0.553 . . . . 70.239999999999995 110.213 -174.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.0 p -103.17 118.23 58.43 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.402 -0.817 . . . . 73.150000000000006 113.015 -172.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -80.62 -75.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.829 1.686 . . . . 74.540000000000006 109.226 172.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -107.79 -52.73 0.07 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.751 -0.642 . . . . 74.439999999999998 112.472 171.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.81 134.21 45.74 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 120.644 1.266 . . . . 73.430000000000007 111.355 175.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.62 126.53 7.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.066 -1.087 . . . . 74.510000000000005 108.066 178.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.21 -29.33 7.72 Favored Glycine 0 C--N 1.308 -0.979 0 N-CA-C 111.372 -0.691 . . . . 73.439999999999998 111.372 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.93 149.78 26.84 Favored 'General case' 0 C--O 1.255 1.361 0 C-N-CA 123.232 0.613 . . . . 74.310000000000002 110.044 176.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 508' ' ' ALA . 80.4 t -74.31 126.92 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.891 0 CA-C-O 121.527 0.68 . . . . 73.010000000000005 109.554 -173.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.6 m -92.15 -12.65 32.28 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 110.136 -175.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.73 -150.77 19.99 Favored Glycine 0 N--CA 1.425 -2.069 0 C-N-CA 120.1 -1.048 . . . . 65.150000000000006 112.815 174.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 17.9 p -118.16 161.5 19.77 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 124.591 1.156 . . . . 75.319999999999993 109.254 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.9 t-20 -61.33 -57.12 27.69 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 119.298 -0.382 . . . . 72.510000000000005 111.094 176.217 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.2 Cg_exo -83.41 156.29 14.38 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.224 1.282 . . . . 74.209999999999994 109.852 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.14 158.83 48.61 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.042 1.828 . . . . 74.109999999999999 112.196 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.89 133.81 54.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.204 0.601 . . . . 75.230000000000004 111.045 178.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.98 -19.64 32.4 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.805 -0.712 . . . . 51.119999999999997 111.676 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.0 m -65.56 123.84 20.76 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.676 -0.49 . . . . 53.409999999999997 109.676 177.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 41.6 m -94.03 123.81 37.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 109.944 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.8 157.01 72.84 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 70.129999999999995 108.978 177.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 494' ' ' THR . 51.4 Cg_exo -58.7 146.01 93.71 Favored 'Trans proline' 0 CA--C 1.519 -0.24 0 C-N-CA 122.929 2.419 . . . . 64.239999999999995 111.619 177.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 32.4 m -66.75 -20.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.434 0.635 . . . . 75.209999999999994 111.767 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -91.11 3.85 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.345 -0.843 . . . . 61.340000000000003 111.38 176.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -83.06 152.06 25.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.939 -0.763 . . . . 74.109999999999999 108.939 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.58 119.2 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.02 -1.104 . . . . 72.140000000000001 108.02 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -89.83 141.64 14.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.189 0.518 . . . . 74.329999999999998 110.139 -177.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.0 121.78 43.25 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 121.618 0.723 . . . . 75.319999999999993 110.228 -176.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.7 134.54 39.83 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.207 1.403 . . . . 74.409999999999997 108.954 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -103.83 115.91 31.32 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.246 -0.888 . . . . 62.009999999999998 109.244 -177.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.18 129.83 75.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 116.107 -0.497 . . . . 74.200000000000003 111.061 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 68.2 m -74.52 116.67 15.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.347 -0.983 . . . . 72.430000000000007 108.347 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.446 -0.797 . . . . 73.510000000000005 108.955 -175.988 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 N-CA-C 110.479 -1.049 . . . . 75.040000000000006 110.479 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.19 132.98 17.25 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.635 2.224 . . . . 75.0 110.633 179.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -90.26 6.76 41.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.599 0.714 . . . . 74.439999999999998 110.023 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 78.2 mt-30 -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 114.95 -1.023 . . . . 74.209999999999994 110.577 -177.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -129.88 156.76 43.87 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.078 -1.082 . . . . 74.430000000000007 108.078 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.43 143.16 27.37 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.167 0.432 . . . . 73.040000000000006 112.167 -178.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.53 130.67 73.38 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.875 -0.602 . . . . 65.319999999999993 111.413 -174.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.1 148.95 37.57 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.887 3.724 . . . . 74.129999999999995 115.524 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -94.64 -5.24 46.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.437 -0.801 . . . . 63.530000000000001 110.125 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.5 p -74.95 -5.99 7.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.256 1.027 . . . . 73.420000000000002 109.679 -176.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.428 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 5.5 m -63.61 -26.69 68.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.409 -1.268 . . . . 71.439999999999998 109.119 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.1 p -58.51 -27.67 64.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.816 -1.083 . . . . 73.310000000000002 111.341 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.6 mt -86.75 -47.35 9.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.709 -0.796 . . . . 74.230000000000004 110.978 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 25.6 m -167.01 150.17 6.5 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 109.533 -0.543 . . . . 74.140000000000001 109.533 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -51.63 -46.56 63.7 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.116 1.366 . . . . 75.129999999999995 111.199 174.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.21 85.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.998 -0.546 . . . . 72.319999999999993 111.277 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.69 -44.11 97.58 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.668 -0.696 . . . . 73.299999999999997 110.827 178.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -50.79 72.35 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.093 -0.958 . . . . 71.209999999999994 110.399 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -46.58 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.799 -0.637 . . . . 74.219999999999999 112.129 -176.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -63.31 -48.01 79.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.476 0.179 . . . . 72.439999999999998 110.984 -177.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -68.25 -39.47 82.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.071 -0.513 . . . . 74.329999999999998 111.63 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.514 HD22 ' CE2' ' A' ' 452' ' ' PHE . 28.9 tp -67.44 -37.49 83.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 109.686 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 -44.13 95.94 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.326 -0.852 . . . . 71.340000000000003 109.722 175.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.76 62.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.606 -0.725 . . . . 74.450000000000003 111.442 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.91 -12.96 54.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 72.510000000000005 111.047 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.61 -18.74 10.74 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.536 -0.84 . . . . 73.200000000000003 112.693 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.456 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 81.5 m-85 -75.69 136.51 40.37 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.663 0.268 . . . . 75.409999999999997 110.301 -176.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -137.99 26.0 2.89 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.721 -0.951 . . . . 74.420000000000002 110.721 177.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -124.52 116.03 21.82 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.374 -1.343 . . . . 73.319999999999993 107.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 444' ' ' LEU . 64.0 m-85 -130.18 146.5 51.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.301 0.572 . . . . 75.430000000000007 110.903 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -140.86 123.29 15.92 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.807 -1.553 . . . . 75.230000000000004 106.807 169.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.93 130.07 37.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.16 0.505 . . . . 74.409999999999997 111.306 -177.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -130.03 141.94 50.68 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.37 -1.344 . . . . 73.319999999999993 107.37 175.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.15 149.09 45.01 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.199 -0.601 . . . . 53.329999999999998 110.791 -177.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 457' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 56.0 m -132.49 134.27 24.62 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-N 115.475 -0.784 . . . . 70.439999999999998 108.889 177.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 27.3 Cg_exo -65.58 127.51 18.18 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.627 2.218 . . . . 74.430000000000007 112.243 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 38.6 m -146.94 -179.94 7.16 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 125.498 1.519 . . . . 72.230000000000004 107.077 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.4 t -50.51 114.56 4.67 Favored Pre-proline 0 CA--C 1.584 2.269 0 C-N-CA 124.135 0.974 . . . . 74.400000000000006 110.14 177.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.11 -28.91 34.8 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.736 3.624 . . . . 63.509999999999998 116.425 -171.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.97 -20.83 64.2 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.956 -0.698 . . . . 73.340000000000003 112.077 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.37 14.37 22.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.485 0.55 . . . . 73.109999999999999 112.485 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.09 128.09 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.386 0.613 . . . . 75.0 110.697 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.3 1.77 55.72 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.677 -0.692 . . . . 54.32 112.783 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -91.79 138.49 31.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.623 -1.251 . . . . 74.030000000000001 107.623 176.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 486' ' ' ILE . 50.7 t -82.96 124.82 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.212 -0.995 . . . . 73.400000000000006 108.39 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -99.51 -14.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 120.221 -0.592 . . . . 72.400000000000006 111.272 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.04 39.17 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.602 -0.809 . . . . 63.240000000000002 111.203 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.6 p -132.19 147.78 52.43 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.683 -0.858 . . . . 74.310000000000002 108.683 177.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.7 t-20 -64.02 -51.93 59.71 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 119.167 -0.444 . . . . 72.420000000000002 111.272 176.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.2 Cg_exo -74.12 145.18 34.76 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.334 1.356 . . . . 73.120000000000005 109.74 173.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.78 146.01 58.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.696 2.264 . . . . 73.400000000000006 112.995 -177.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -101.77 -9.7 20.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.544 -0.753 . . . . 73.109999999999999 110.196 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.475 -0.935 . . . . 70.420000000000002 108.475 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -117.77 175.56 5.6 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.164 -0.926 . . . . 71.439999999999998 108.531 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 27.4 p -88.3 148.74 24.15 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 116.648 -0.251 . . . . 62.25 111.592 -177.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.6 m -126.05 148.61 49.28 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.781 -1.192 . . . . 73.230000000000004 107.781 175.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 147.13 53.52 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-O 120.611 0.243 . . . . 75.040000000000006 111.331 -177.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.01 -28.14 41.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 75.5 111.311 179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.0 t -85.48 7.48 22.66 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.717 -0.674 . . . . 75.420000000000002 110.399 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.97 144.68 27.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.346 -0.613 . . . . 64.340000000000003 109.346 -177.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.68 111.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.346 -0.983 . . . . 75.310000000000002 108.346 179.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.22 118.23 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 C-N-CA 118.925 -1.11 . . . . 75.420000000000002 108.424 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 58.5 mt -100.43 113.94 37.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.345 -1.724 . . . . 75.329999999999998 106.345 176.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.46 128.12 52.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 CA-C-N 115.652 -0.703 . . . . 61.340000000000003 109.458 -174.706 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 30.9 mm -97.59 109.9 24.34 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-O 121.361 0.6 . . . . 74.209999999999994 109.484 -176.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.69 133.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.543 -0.753 . . . . 74.299999999999997 110.143 -177.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.71 115.91 4.91 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.146 -1.982 . . . . 65.540000000000006 108.146 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.0 m -127.44 160.39 31.61 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.084 -1.08 . . . . 63.329999999999998 108.084 -176.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -135.5 145.26 17.3 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.207 -1.473 . . . . 70.299999999999997 111.064 -178.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.32 114.53 2.25 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.579 2.186 . . . . 74.219999999999999 110.802 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -70.43 96.09 1.12 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.938 0.875 . . . . 74.129999999999995 109.042 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 17.2 p -136.45 166.35 23.7 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.909 -1.041 . . . . 65.129999999999995 110.009 -174.064 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -150.6 151.05 31.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.142 0.977 . . . . 72.030000000000001 108.908 175.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -95.65 133.11 40.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.399 -1.334 . . . . 73.430000000000007 107.399 173.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 43.6 pt -84.32 134.84 42.27 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 120.534 -0.466 . . . . 75.129999999999995 111.638 -175.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.04 170.37 7.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.621 2.214 . . . . 75.409999999999997 111.509 175.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -85.61 133.13 34.06 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.933 -0.576 . . . . 75.310000000000002 110.638 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.71 13.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.63 -0.714 . . . . 73.140000000000001 110.526 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.76 137.47 40.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.099 -0.5 . . . . 54.539999999999999 110.703 -177.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.05 50.44 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.491 -1.044 . . . . 75.329999999999998 110.491 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -97.59 169.59 9.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 74.519999999999996 108.24 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.2 m -82.98 155.35 24.02 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.183 -1.043 . . . . 74.239999999999995 108.183 -175.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 13.5 p -52.63 -41.38 37.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 123.488 0.715 . . . . 60.32 111.973 -177.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.19 -43.98 76.88 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.531 -0.468 . . . . 73.230000000000004 112.144 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.08 -34.96 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 119.848 -0.741 . . . . 74.450000000000003 111.684 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.22 84.57 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.033 -0.985 . . . . 63.219999999999999 111.205 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -63.73 -36.19 83.05 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.225 0.328 . . . . 74.230000000000004 110.502 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.446 ' O ' HG23 ' A' ' 514' ' ' VAL . 91.1 mttt -65.02 -49.91 68.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.934 -0.575 . . . . 74.219999999999999 111.794 177.737 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.01 -41.45 86.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.468 -0.493 . . . . 74.349999999999994 110.328 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.85 -44.27 94.2 Favored 'General case' 0 C--O 1.195 -1.765 0 CA-C-N 115.839 -0.618 . . . . 75.329999999999998 110.124 -179.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.07 -37.83 78.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.54 0.57 . . . . 70.129999999999995 112.54 -178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 510' ' ' LYS . 66.8 t -59.09 -36.78 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.442 0.464 . . . . 71.430000000000007 111.195 -178.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.05 -34.75 8.33 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.809 -0.756 . . . . 75.239999999999995 110.495 -177.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -94.99 -122.84 3.87 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.707 -1.133 . . . . 70.420000000000002 115.869 -170.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 19.0 m-85 -122.58 178.13 5.13 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.92 0.391 . . . . 71.230000000000004 110.07 -168.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.8 m -116.44 8.9 14.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.217 1.008 . . . . 73.310000000000002 109.301 178.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.86 115.27 29.77 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.99 -1.115 . . . . 75.400000000000006 107.99 178.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -125.96 151.72 46.63 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.215 0.531 . . . . 64.0 110.956 -175.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.0 m -141.55 153.39 44.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.537 -1.653 . . . . 72.099999999999994 106.537 170.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.46 135.78 52.69 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 118.268 0.485 . . . . 63.219999999999999 110.412 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.56 ' HB2' ' OE1' ' A' ' 554' ' ' GLN . . . -130.08 145.08 51.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.239 -0.652 . . . . 63.109999999999999 109.239 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 21.2 m -87.83 124.97 34.18 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.833 0.349 . . . . 73.239999999999995 111.394 -175.445 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.3 163.16 30.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.579 -0.897 . . . . 73.340000000000003 108.579 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.42 137.32 37.93 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.682 0.993 . . . . 62.219999999999999 113.682 -172.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.3 t -162.01 115.1 1.2 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.598 1.559 . . . . 75.450000000000003 106.852 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.03 -89.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.378 2.719 . . . . 70.209999999999994 115.793 -172.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 530' ' ' PRO . 57.3 mtt180 -86.33 -42.56 0.58 Allowed Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 113.547 0.943 . . . . 73.129999999999995 113.547 178.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 11.1 Cg_endo -57.17 133.91 60.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 120.502 1.215 . . . . 61.310000000000002 109.524 173.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.96 140.74 21.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.041 0.448 . . . . 74.409999999999997 110.704 -172.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.06 77.22 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.629 -0.714 . . . . 61.409999999999997 111.368 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.47 148.78 24.79 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.317 0.579 . . . . 72.120000000000005 110.94 177.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 76.9 t -75.2 122.18 28.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.33 -1.359 . . . . 75.129999999999995 107.33 176.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.4 m -98.33 -1.35 41.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.242 -0.89 . . . . 62.130000000000003 110.148 -174.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.69 -169.24 32.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.659 -0.576 . . . . 70.219999999999999 111.659 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.7 p -137.27 160.65 38.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.407 -0.96 . . . . 75.219999999999999 108.407 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.3 t30 -58.48 -56.87 31.0 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.429 -0.32 . . . . 70.430000000000007 111.45 177.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.7 Cg_endo -84.19 151.3 12.26 Favored 'Trans proline' 0 C--N 1.365 1.433 0 N-CA-C 108.954 -1.21 . . . . 71.329999999999998 108.954 174.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.63 148.76 53.94 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.644 1.563 . . . . 73.319999999999993 111.658 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.08 129.48 41.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.262 -0.426 . . . . 71.340000000000003 110.061 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -15.12 37.33 Favored Glycine 0 C--N 1.301 -1.375 0 C-N-CA 120.884 -0.674 . . . . 72.129999999999995 112.05 -177.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.5 m -81.08 134.82 35.72 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 110.036 -0.357 . . . . 73.519999999999996 110.036 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 85.3 m -90.65 123.32 34.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.879 -0.6 . . . . 74.299999999999997 109.799 177.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.69 158.7 67.1 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.793 -0.817 . . . . 74.430000000000007 108.793 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.33 146.63 86.32 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.514 2.143 . . . . 75.120000000000005 112.118 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 19.1 m -67.7 -19.89 25.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.379 1.085 . . . . 72.299999999999997 110.027 177.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.32 -17.26 60.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.918 -1.492 . . . . 72.239999999999995 109.481 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.5 t -86.61 142.11 28.5 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.412 -0.813 . . . . 54.420000000000002 108.93 -176.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.36 126.28 44.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.506 -1.294 . . . . 73.540000000000006 107.506 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.87 137.95 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.266 0.555 . . . . 73.530000000000001 111.121 -176.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.74 119.93 39.55 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 108.91 -0.774 . . . . 73.340000000000003 108.91 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -99.32 124.1 44.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.985 -1.461 . . . . 72.140000000000001 107.936 -177.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.56 ' OE1' ' HB2' ' A' ' 523' ' ' ALA . 4.1 mm-40 -90.13 108.51 19.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.505 0.669 . . . . 74.530000000000001 110.128 -175.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.99 140.56 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.737 -1.12 . . . . 75.150000000000006 111.856 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 40.1 m -56.24 127.89 33.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.666 0.746 . . . . 72.120000000000005 112.521 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 77.6 tttt . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.959 -1.126 . . . . 74.420000000000002 107.959 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 122.69 1.233 . . . . 73.4 108.637 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 54.3 mt-30 -94.48 140.11 30.26 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.33 -1.759 . . . . 72.42 108.949 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpp180 -120.87 152.35 38.55 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.827 -1.175 . . . . 73.12 107.827 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.36 140.88 32.16 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 124.091 0.87 . . . . 64.13 109.775 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -89.98 122.76 67.46 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 109.33 -0.619 . . . . 54.01 109.33 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.45 141.14 94.94 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.597 2.198 . . . . 70.12 112.581 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.41 24.13 4.12 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.35 -0.841 . . . . 73.1 110.891 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.5 -7.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.047 0.927 . . . . 74.33 109.024 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 13.2 m -62.74 -36.32 82.66 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.472 -1.24 . . . . 73.12 110.097 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 18.1 p -62.11 -26.6 68.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.25 -1.341 . . . . 70.11 110.839 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.9 mt -83.71 -44.62 14.29 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.041 -0.527 . . . . 63.21 110.586 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 438' ' ' ALA . 22.3 m -160.87 145.61 14.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.671 -0.492 . . . . 74.41 109.671 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -54.92 -42.37 72.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.478 0.711 . . . . 71.41 110.92 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 436' ' ' THR . . . -57.55 -44.39 85.16 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.888 -0.596 . . . . 63.21 110.579 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.66 -43.61 98.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.369 -0.832 . . . . 55.4 111.256 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.76 -51.73 68.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.443 -0.799 . . . . 62.12 110.978 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.1 -47.55 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.869 -0.605 . . . . 60.04 112.333 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -64.78 -47.15 79.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.7 -0.4 . . . . 61.43 111.65 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.89 -40.33 83.51 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.633 -0.427 . . . . 71.14 111.984 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.508 HD23 ' CE2' ' A' ' 452' ' ' PHE . 19.4 tp -68.89 -33.64 74.11 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.363 0.601 . . . . 73.3 110.261 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.6 m -64.06 -41.63 97.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.62 -0.718 . . . . 72.33 109.59 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.57 62.79 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.798 -0.637 . . . . 74.1 110.82 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.4 -13.47 52.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.063 0.459 . . . . 74.13 110.077 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.77 -2.36 27.43 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.567 -0.825 . . . . 75.13 113.844 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 95.6 m-85 -83.56 136.49 34.23 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 117.303 0.552 . . . . 62.42 111.671 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.21 4.82 4.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.549 -0.751 . . . . 73.12 112.451 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.436 ' NE ' ' HB ' ' A' ' 483' ' ' VAL . 77.2 ttt180 -111.29 115.56 29.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.702 -0.851 . . . . 75.34 108.702 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.508 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.2 m-85 -130.82 156.9 44.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.024 -0.534 . . . . 74.43 111.12 -173.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 485' ' ' ILE . 27.5 tptp -139.41 121.82 16.09 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 104.615 -2.365 . . . . 74.01 104.615 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -110.65 135.19 51.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.744 0.307 . . . . 71.41 111.397 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.3 156.56 46.4 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.987 -1.116 . . . . 65.23 107.987 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -136.09 143.06 44.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.22 107.732 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 27.8 m -130.99 139.19 34.83 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 109.501 -0.555 . . . . 63.52 109.501 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 35.8 Cg_exo -64.41 123.07 11.21 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.292 1.995 . . . . 74.44 110.326 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 68.0 m -151.81 -179.51 7.52 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.087 -1.079 . . . . 53.54 108.087 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.475 ' HA ' ' HD2' ' A' ' 461' ' ' PRO . 2.8 t -33.97 108.53 0.32 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 125.787 1.635 . . . . 61.03 112.625 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 460' ' ' THR . 16.3 Cg_endo -56.33 -29.75 78.06 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 124.139 3.226 . . . . 52.14 115.274 -173.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -71.98 -6.91 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.583 0.586 . . . . 75.03 112.583 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 78.8 mt -111.3 13.81 21.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.006 0.432 . . . . 60.41 110.936 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.82 133.62 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.826 -0.625 . . . . 55.21 112.008 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.86 79.55 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 121.037 -0.602 . . . . 70.33 113.793 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 434' ' ' THR . 11.1 pttp -101.67 162.26 13.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.761 -1.2 . . . . 73.41 107.761 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 53.3 t -81.46 133.21 29.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.851 -1.166 . . . . 71.14 107.851 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.6 pt -102.11 -6.73 9.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.593 -0.443 . . . . 65.13 110.819 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.5 143.69 4.05 Favored Glycine 0 N--CA 1.423 -2.224 0 C-N-CA 120.237 -0.983 . . . . 74.41 112.864 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.4 p -119.35 147.46 44.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.837 -1.171 . . . . 73.33 107.837 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 4.7 m-20 -66.49 -51.38 42.2 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 119.394 -0.336 . . . . 73.22 111.595 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 24.4 Cg_exo -71.12 127.81 13.99 Favored 'Trans proline' 0 C--N 1.361 1.223 0 N-CA-C 108.012 -1.572 . . . . 64.34 108.012 169.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 6.1 Cg_exo -75.27 158.22 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.893 1.729 . . . . 55.44 113.102 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.08 -17.0 51.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.842 0.829 . . . . 43.22 109.981 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -96.87 -25.92 15.27 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.389 -0.823 . . . . 64.53 111.537 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.11 156.68 17.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.889 -0.411 . . . . 73.35 109.889 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.5 p -90.57 140.83 29.38 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.183 -0.673 . . . . 70.02 109.183 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.1 m -126.7 142.6 51.49 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.752 -0.832 . . . . 60.44 108.752 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.43 140.17 57.35 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.226 -0.657 . . . . 53.03 109.226 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 427' ' ' ARG . 59.6 mt -72.21 -9.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.98 0.895 . . . . 70.03 111.616 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -81.94 -3.29 53.96 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.613 -0.721 . . . . 73.14 109.185 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.43 147.38 28.78 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 121.983 -0.448 . . . . 73.04 110.644 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.436 ' HB ' ' NE ' ' A' ' 451' ' ' ARG . 5.1 p -85.66 124.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.837 -1.171 . . . . 73.32 107.837 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 444' ' ' LEU . 60.1 t -87.94 118.12 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.285 -0.966 . . . . 75.14 108.588 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -94.65 115.11 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.785 -1.561 . . . . 75.31 106.785 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.06 124.18 69.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.24 -0.891 . . . . 52.51 109.377 -176.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.59 123.17 61.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.303 -0.628 . . . . 73.33 109.303 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.21 141.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.314 -0.624 . . . . 42.35 109.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -76.92 113.51 3.8 Favored Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.526 -1.429 . . . . 75.01 109.526 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -102.19 130.04 48.73 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.618 -0.512 . . . . 71.03 109.618 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.981 0 N-CA-C 109.024 -1.63 . . . . 50.24 109.024 177.711 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.179 0 N-CA-C 107.171 -1.418 . . . . 65.42 107.171 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.8 p -119.89 151.26 39.16 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.167 -0.924 . . . . 71.44 109.738 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 495' ' ' LYS . 21.8 mmmt -146.65 149.47 33.56 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.114 0.483 . . . . 64.33 111.432 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 543' ' ' THR . 9.1 p-10 -82.6 134.48 35.18 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.381 -1.281 . . . . 74.34 107.602 173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 540' ' ' PRO . 0.2 OUTLIER -75.62 122.73 87.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 119.622 -0.831 . . . . 62.3 109.091 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.9 170.53 9.87 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.403 2.069 . . . . 53.24 112.712 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.02 116.62 29.08 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.817 -0.629 . . . . 65.11 109.948 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.84 17.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 122.621 1.2 . . . . 60.42 107.942 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 147.55 48.57 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.325 -1.307 . . . . 63.3 109.45 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.13 -6.48 53.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 111.363 -0.695 . . . . 34.01 111.363 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -114.47 177.28 4.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.011 -0.737 . . . . 72.53 109.011 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.3 m -77.47 156.35 31.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.248 -0.649 . . . . 72.22 109.248 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.62 -44.03 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 123.448 0.468 . . . . 72.54 111.598 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.3 -42.68 79.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.031 0.382 . . . . 72.44 112.031 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.07 -35.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.651 -0.819 . . . . 40.52 111.121 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.45 81.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.698 -0.683 . . . . 61.1 111.094 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.66 -38.22 84.15 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.395 0.434 . . . . 74.41 110.538 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.1 tttm -63.7 -52.01 62.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.654 -0.703 . . . . 61.43 110.27 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -65.02 -41.61 95.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.899 0.38 . . . . 62.43 110.969 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.25 -39.39 89.47 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.616 -0.72 . . . . 64.31 109.762 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.02 -41.57 88.07 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.186 0.594 . . . . 71.23 112.427 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.1 t -59.02 -35.35 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 55.25 111.088 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -112.28 4.31 17.64 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.024 -0.67 . . . . 74.34 111.398 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.93 -100.25 0.29 Allowed Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 118.036 -2.031 . . . . 61.22 117.625 -168.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 60.9 m-85 -120.08 161.47 20.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.404 -0.398 . . . . 72.12 111.295 -164.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 m -119.01 -13.96 9.39 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.527 0.68 . . . . 64.32 110.782 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -107.97 115.49 30.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.422 -0.955 . . . . 54.25 108.422 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -120.97 156.64 31.67 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.542 0.687 . . . . 71.24 111.318 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.7 m -139.99 155.75 46.96 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.518 -1.66 . . . . 75.22 106.518 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -121.28 138.46 54.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.038 0.447 . . . . 74.12 110.007 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.94 131.75 56.05 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.545 -0.909 . . . . 43.45 108.545 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 36.1 m -88.61 123.17 32.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.572 0.545 . . . . 73.23 109.677 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 35.3 m -121.61 162.64 20.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.768 -1.197 . . . . 73.23 107.768 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 11.1 m-20 -78.06 133.3 37.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.095 0.474 . . . . 75.15 110.79 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 11.0 m -95.95 105.42 21.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.732 -1.122 . . . . 54.05 111.563 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 2.4 Cg_endo -81.16 -77.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 121.701 1.6 . . . . 61.42 109.506 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.447 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 48.8 mmm-85 -95.24 -58.47 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 120.325 -0.55 . . . . 75.44 109.892 173.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 527' ' ' SER . 36.6 Cg_endo -65.34 144.62 80.97 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.945 1.763 . . . . 72.34 112.309 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -151.37 132.73 14.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.837 -0.801 . . . . 63.24 108.837 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.86 -24.66 5.79 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-O 121.922 0.735 . . . . 65.52 112.075 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.15 150.38 24.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 C-N-CA 124.372 1.069 . . . . 73.34 111.492 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.18 128.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.081 -0.963 . . . . 74.23 110.018 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -92.25 -22.23 19.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.255 -1.339 . . . . 61.04 109.733 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.96 33.67 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.156 -0.777 . . . . 61.02 111.156 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.9 p -117.94 160.33 21.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.643 -0.873 . . . . 61.14 108.643 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -64.13 -58.5 14.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.338 -0.363 . . . . 41.03 111.035 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.49 148.81 43.32 Favored 'Trans proline' 0 C--N 1.373 1.862 0 N-CA-C 109.17 -1.127 . . . . 62.23 109.17 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.471 ' O ' HD11 ' A' ' 497' ' ' ILE . 32.1 Cg_exo -60.46 140.06 89.58 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.069 1.846 . . . . 54.2 110.661 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.39 131.94 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.618 0.367 . . . . 73.11 110.847 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.22 40.7 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.363 -0.922 . . . . 74.25 112.274 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 60.3 m -67.44 126.47 29.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.144 -0.687 . . . . 74.31 109.144 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.2 m -94.33 122.86 37.32 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.942 -0.762 . . . . 63.54 108.942 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.03 161.0 66.37 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.282 -0.636 . . . . 75.22 109.282 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 494' ' ' THR . 49.7 Cg_exo -58.83 134.93 63.59 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.468 2.112 . . . . 62.4 111.355 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.517 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 20.0 m -65.94 -19.85 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.244 0.545 . . . . 62.14 111.263 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -77.67 -10.27 59.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.647 -0.706 . . . . 62.22 111.516 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.0 t -85.39 161.13 19.58 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 64.41 108.922 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.32 130.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.012 0.434 . . . . 74.05 111.278 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.9 tt -101.6 132.84 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.071 0.462 . . . . 45.4 110.011 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.59 127.45 51.01 Favored 'General case' 0 N--CA 1.399 -2.999 0 N-CA-C 108.73 -0.841 . . . . 51.1 108.73 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.5 tp -104.19 133.58 48.88 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.944 -1.025 . . . . 74.51 108.854 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -94.46 109.23 21.12 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.708 -1.219 . . . . 72.01 107.708 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.71 138.51 44.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 121.177 0.513 . . . . 54.22 112.187 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -68.09 114.95 7.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.722 -0.844 . . . . 43.54 108.722 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 61.9 pttt . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 115.802 -0.636 . . . . 62.23 110.702 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 480' ' ' ILE . 12.4 pt-20 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.77 0.319 . . . . 73.3 111.491 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 478' ' ' SER . 68.6 mt-30 -90.84 119.14 30.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.291 -0.564 . . . . 65.53 110.018 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -120.18 160.24 23.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.462 -1.31 . . . . 71.54 107.462 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -86.09 141.39 29.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.385 0.428 . . . . 61.21 111.4 -177.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.1 130.72 68.63 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.597 -0.89 . . . . 72.31 108.597 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.34 142.93 78.54 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.319 2.68 . . . . 74.32 114.426 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.46 -7.5 50.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.314 -0.857 . . . . 75.55 111.091 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 32.4 m -80.38 1.05 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.6 0.714 . . . . 60.12 110.801 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.3 m -63.77 -28.05 69.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.091 -0.959 . . . . 42.24 109.476 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -62.07 -28.4 69.58 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.587 -1.188 . . . . 72.52 111.186 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 63.9 mt -83.37 -45.27 13.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.089 -0.505 . . . . 53.33 110.572 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.521 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.5 m -165.69 149.06 7.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.655 -0.869 . . . . 65.13 108.655 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.08 -45.41 75.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.407 0.683 . . . . 71.21 110.655 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 442' ' ' LYS . . . -55.41 -44.7 76.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.038 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.521 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 31.2 mm-40 -64.32 -37.89 89.1 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.014 -0.539 . . . . 74.42 110.935 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.79 -51.33 68.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 73.31 110.477 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.41 -46.03 97.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.221 -0.9 . . . . 73.31 112.309 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 438' ' ' ALA . 15.8 ptpt -63.03 -44.55 95.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.561 0.22 . . . . 74.25 111.319 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.34 -38.44 84.85 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.04 0.385 . . . . 72.01 112.04 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.1 tp -68.53 -34.26 75.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.516 0.674 . . . . 74.04 109.938 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.2 m -65.66 -40.74 92.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.418 -0.81 . . . . 73.04 109.305 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -16.57 62.71 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.315 0.578 . . . . 72.01 110.419 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.78 -14.14 49.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.222 0.534 . . . . 61.33 109.589 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.39 50.16 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.884 -0.674 . . . . 64.25 113.616 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.0 m-85 -92.29 121.36 33.72 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.177 0.489 . . . . 62.21 110.123 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.21 5.02 21.87 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 111.197 -0.761 . . . . 73.1 111.197 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -102.86 116.46 32.6 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.326 -0.62 . . . . 74.51 109.326 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.439 ' CE2' HD23 ' A' ' 444' ' ' LEU . 73.8 m-85 -130.4 144.79 51.61 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.281 0.563 . . . . 73.12 111.075 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.489 ' HB3' HG13 ' A' ' 485' ' ' ILE . 22.3 tptm -131.02 121.84 25.75 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.897 -2.26 . . . . 73.32 104.897 167.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -105.32 134.99 47.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.695 -0.483 . . . . 63.34 109.695 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.93 150.32 44.4 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.695 -0.854 . . . . 71.12 108.695 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -125.73 148.74 48.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.762 -1.199 . . . . 73.11 107.762 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.2 m -143.17 144.79 30.0 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 109.115 -0.698 . . . . 74.24 109.115 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.4 Cg_exo -65.44 123.05 10.91 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.608 2.206 . . . . 51.04 112.571 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.8 t -137.17 -179.13 5.54 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.699 -1.963 . . . . 74.13 105.699 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.46 ' CG2' HD23 ' A' ' 463' ' ' LEU . 6.9 t -61.88 141.64 95.3 Favored Pre-proline 0 N--CA 1.423 -1.791 0 N-CA-C 109.944 -0.391 . . . . 53.3 109.944 178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.76 -29.66 34.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.108 3.205 . . . . 74.14 112.32 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.05 -20.65 65.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.999 0.74 . . . . 73.3 112.999 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.46 HD23 ' CG2' ' A' ' 460' ' ' THR . 4.5 mm? -106.33 11.47 30.97 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.107 -0.371 . . . . 75.12 111.964 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.92 128.99 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.156 0.503 . . . . 74.33 111.419 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.29 -9.58 77.01 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.655 -0.783 . . . . 73.43 112.49 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.423 ' HD2' HD13 ' A' ' 463' ' ' LEU . 68.1 mttm -100.55 155.35 17.9 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.175 -1.046 . . . . 74.31 108.175 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.577 HG22 HD11 ' A' ' 486' ' ' ILE . 53.7 t -81.96 129.75 36.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.901 -1.148 . . . . 70.23 107.901 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.2 pt -98.55 -16.04 7.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.42 -0.512 . . . . 74.52 110.799 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 176.32 149.1 7.36 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.675 -0.693 . . . . 73.31 111.738 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.3 p -116.82 152.85 33.56 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.606 -1.257 . . . . 73.35 107.606 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.1 t-20 -68.03 -51.94 25.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 C-N-CA 120.502 -0.479 . . . . 74.01 110.714 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.9 Cg_exo -79.13 130.59 9.38 Favored 'Trans proline' 0 C--N 1.371 1.751 0 N-CA-C 107.952 -1.595 . . . . 52.3 107.952 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 7.2 Cg_exo -69.88 157.15 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.791 1.661 . . . . 62.42 112.845 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.19 -6.75 57.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.358 1.075 . . . . 72.15 109.109 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 -40.32 14.29 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.14 -1.391 . . . . 75.24 111.048 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.77 167.13 10.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 71.0 110.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 p -101.57 133.56 46.06 Favored 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 108.708 -0.849 . . . . 74.23 108.708 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.2 m -118.9 148.6 42.75 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.379 -0.6 . . . . 65.33 109.379 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.25 51.78 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.282 0.364 . . . . 63.33 111.403 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.8 mm -57.7 -28.51 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.708 1.203 . . . . 74.41 111.147 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.1 t -76.56 -7.36 55.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.73 -0.668 . . . . 62.24 110.876 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -86.99 142.22 28.1 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 122.074 -0.391 . . . . 54.24 110.435 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.96 126.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.786 -0.82 . . . . 74.22 108.786 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.19 119.37 36.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.137 -0.69 . . . . 43.24 109.137 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.9 mp -92.94 119.65 40.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.182 -1.414 . . . . 72.14 107.182 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.577 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -117.06 125.91 74.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 109.53 -0.545 . . . . 74.1 109.53 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.43 119.18 52.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.538 -0.542 . . . . 71.24 109.538 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.21 144.12 10.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.98 -0.748 . . . . 60.33 108.98 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -77.71 122.21 6.0 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 111.823 -0.511 . . . . 55.34 111.823 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.9 t -118.45 131.93 56.25 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.16 -1.793 . . . . 63.22 106.16 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.673 0 C-N-CA 119.672 -1.251 . . . . 72.35 111.12 -177.567 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.61 0 N-CA-C 106.864 -1.532 . . . . 71.43 106.864 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.6 p -125.21 152.79 44.07 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.88 -0.6 . . . . 75.24 110.119 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -133.67 135.6 44.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.31 -0.405 . . . . 44.32 109.939 -177.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.7 p-10 -83.28 130.54 35.08 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.454 -0.943 . . . . 34.55 108.454 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.8 pt -81.52 131.99 56.62 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 115.991 -0.55 . . . . 62.31 110.423 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -84.36 152.62 12.16 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.518 2.145 . . . . 72.53 112.111 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.56 101.22 2.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.533 0.683 . . . . 73.34 109.95 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.06 1.81 8.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.278 -0.874 . . . . 71.33 109.484 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -67.85 122.95 19.25 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.999 -1.0 . . . . 64.35 110.679 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.94 -29.73 3.87 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.607 -0.597 . . . . 60.45 111.607 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -88.87 -175.48 4.88 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.109 -0.701 . . . . 73.45 109.109 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 70.0 p -80.49 157.38 26.17 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.637 -0.825 . . . . 43.32 110.644 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.01 -41.6 80.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.452 0.644 . . . . 53.21 109.333 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.71 -43.28 89.57 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.259 -0.882 . . . . 64.05 112.504 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.58 -34.68 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 119.945 -0.702 . . . . 45.21 110.585 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.12 77.94 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.803 -0.635 . . . . 75.14 110.834 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.24 -41.74 97.41 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.638 0.586 . . . . 63.45 110.203 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 514' ' ' VAL . 56.0 mtmt -65.16 -51.73 59.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 113.203 0.816 . . . . 62.02 113.203 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -63.48 -40.93 98.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.912 0.386 . . . . 73.04 110.725 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 551' ' ' ILE . 59.0 tp -66.53 -39.51 88.64 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 115.626 -0.716 . . . . 64.21 110.796 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.77 -37.66 87.51 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.891 0.377 . . . . 73.24 110.654 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 510' ' ' LYS . 47.7 t -69.16 -30.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.965 -0.561 . . . . 51.34 111.476 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.92 18.83 7.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 120.201 -0.6 . . . . 71.32 111.748 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -150.06 -110.75 0.53 Allowed Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 118.869 -1.634 . . . . 72.32 115.135 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.27 164.25 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.373 -0.414 . . . . 71.03 110.214 -168.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -105.57 -7.98 18.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.426 -0.806 . . . . 75.23 109.916 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.71 119.27 33.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 74.21 111.544 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.79 155.95 42.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.149 -0.932 . . . . 71.11 109.711 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 72.7 m -135.03 148.18 49.86 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.135 -1.432 . . . . 65.1 107.135 170.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -122.23 128.2 50.87 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.264 -0.643 . . . . 53.12 109.264 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -119.75 131.48 55.37 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.319 -0.993 . . . . 54.21 108.319 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -88.69 126.69 35.43 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.447 0.641 . . . . 52.12 111.425 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.02 162.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.228 -1.397 . . . . 72.33 107.228 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 557' ' ' LYS . 5.9 p-10 -79.36 129.26 34.29 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.795 0.807 . . . . 71.3 112.426 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 556' ' ' SER . 10.9 p -92.94 122.25 64.11 Favored Pre-proline 0 N--CA 1.416 -2.152 0 CA-C-N 114.272 -1.331 . . . . 75.15 108.712 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.82 -67.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.472 2.114 . . . . 64.1 111.882 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -136.1 -52.08 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 123.704 0.802 . . . . 74.42 109.473 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 20.4 Cg_endo -63.6 150.14 89.21 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.215 1.276 . . . . 75.14 110.196 168.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.62 139.89 16.63 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.469 -0.567 . . . . 61.2 109.469 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.64 10.92 Favored Glycine 0 C--O 1.242 0.607 0 C-N-CA 120.905 -0.665 . . . . 52.25 111.775 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 533' ' ' GLU . 0.4 OUTLIER -87.14 147.02 25.81 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.933 0.397 . . . . 63.01 110.626 177.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 501' ' ' ALA . 7.9 p -77.62 122.71 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 108.219 -1.03 . . . . 74.41 108.219 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.41 -25.59 59.56 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.296 -0.865 . . . . 54.14 109.571 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.79 -156.3 26.8 Favored Glycine 0 N--CA 1.424 -2.115 0 N-CA-C 110.299 -1.12 . . . . 73.13 110.299 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.0 p -130.0 160.54 33.32 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.379 -0.971 . . . . 72.44 108.379 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.58 -56.35 36.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 123.461 0.476 . . . . 74.21 110.751 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.26 146.92 28.82 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.009 1.139 . . . . 71.32 109.96 170.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -73.3 156.07 50.98 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.363 2.042 . . . . 44.31 112.465 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.8 136.99 58.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.075 0.55 . . . . 74.21 111.351 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -17.45 56.52 Favored Glycine 0 C--N 1.312 -0.765 0 C-N-CA 120.85 -0.69 . . . . 32.04 112.004 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.5 m -71.54 132.48 44.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -99.25 122.77 42.88 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.023 -1.103 . . . . 71.53 108.023 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.85 154.95 73.53 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.486 -0.931 . . . . 74.11 108.486 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.492 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.8 Cg_exo -59.91 141.99 97.65 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.229 1.952 . . . . 73.1 111.621 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.8 -19.28 25.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 121.797 0.808 . . . . 60.42 111.575 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -87.31 2.73 49.34 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.982 -1.008 . . . . 74.12 109.541 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -103.45 149.06 25.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.351 -0.84 . . . . 33.32 108.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.36 130.13 42.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.008 0.433 . . . . 72.14 110.721 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.444 HD13 HD21 ' A' ' 512' ' ' LEU . 12.1 tt -95.38 130.84 43.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 74.12 110.6 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.99 121.7 43.1 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.209 0.528 . . . . 70.24 110.581 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.04 133.76 39.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.824 -1.08 . . . . 53.54 110.087 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.407 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 12.4 mm-40 -90.18 109.57 20.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.523 -1.658 . . . . 75.33 106.523 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.47 133.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.119 0.414 . . . . 74.15 112.119 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 527' ' ' SER . 14.5 m -70.47 114.48 8.62 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.247 -1.39 . . . . 71.54 107.247 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 526' ' ' ASP 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 117.903 -1.519 . . . . 71.22 111.77 -176.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.295 0.569 . . . . 73.13 110.379 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 91.9 mt-30 -83.37 126.92 33.23 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.463 -1.31 . . . . 64.44 107.463 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -130.05 162.32 29.02 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.845 -1.169 . . . . 64.35 107.845 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.32 141.53 29.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.257 0.465 . . . . 62.02 112.257 -173.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -82.39 129.2 64.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 107.285 -1.376 . . . . 65.12 107.285 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.34 141.19 96.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.056 1.837 . . . . 75.13 112.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -94.24 4.17 54.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.862 -0.608 . . . . 73.12 109.809 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.529 HG21 ' HD2' ' A' ' 443' ' ' LYS . 35.2 m -75.96 -2.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.201 -0.909 . . . . 70.5 109.955 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 15.1 m -60.52 -33.64 72.93 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.441 -1.254 . . . . 73.54 110.181 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.407 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.3 t -64.91 -25.61 67.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.051 -0.977 . . . . 72.42 110.607 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.8 mt -81.4 -45.74 15.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.691 -0.404 . . . . 75.41 110.279 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 438' ' ' ALA . 58.9 m -163.37 142.33 8.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.707 -0.849 . . . . 72.44 108.707 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.417 ' HA ' HG23 ' A' ' 467' ' ' VAL . 25.9 t80 -54.75 -45.11 74.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.045 0.538 . . . . 73.4 110.898 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.448 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.91 -42.95 76.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.096 -0.502 . . . . 75.34 111.067 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.35 -42.91 99.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 116.031 -0.532 . . . . 75.52 111.782 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.63 -51.73 68.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.516 -0.765 . . . . 73.43 111.324 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.35 -47.58 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.368 -0.833 . . . . 65.32 111.956 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.34 -46.21 81.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.975 0.417 . . . . 74.34 110.948 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.529 ' HD2' HG21 ' A' ' 432' ' ' VAL 0.251 59.5 mttp -67.28 -37.9 84.17 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 113.08 0.77 . . . . 72.35 113.08 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 41.5 tp -67.77 -36.78 81.11 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.143 0.497 . . . . 74.35 109.728 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.3 m -60.65 -42.69 97.5 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 51.44 109.294 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.7 -19.65 62.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.414 -0.812 . . . . 74.0 111.336 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.21 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.275 0.56 . . . . 60.21 110.218 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.32 29.36 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.767 -0.73 . . . . 72.13 113.437 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.93 130.96 35.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.883 0.341 . . . . 74.21 110.597 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 30.4 4.27 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.11 -0.796 . . . . 33.21 111.11 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.408 ' HB3' HG22 ' A' ' 483' ' ' VAL . 3.0 mmp_? -132.58 115.9 16.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.551 -0.907 . . . . 54.13 108.551 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.9 m-85 -133.39 148.09 51.8 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.177 -0.919 . . . . 63.4 110.306 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.527 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.2 tppp? -138.97 122.64 17.49 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.202 -1.777 . . . . 73.44 106.202 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -103.1 135.22 45.17 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.874 0.369 . . . . 74.1 111.321 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.91 152.34 43.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.696 -1.594 . . . . 70.13 106.696 172.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.67 150.74 48.82 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.879 -0.786 . . . . 60.14 108.879 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.4 m -140.22 150.25 60.86 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 109.11 -0.7 . . . . 74.51 109.11 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.2 Cg_exo -65.39 132.44 31.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.325 2.017 . . . . 71.13 111.218 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.2 m -146.8 177.12 9.35 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.181 -0.463 . . . . 62.54 110.229 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.0 t -62.54 144.49 95.69 Favored Pre-proline 0 N--CA 1.432 -1.347 0 C-N-CA 123.852 0.861 . . . . 61.2 110.015 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.9 Cg_exo -51.15 -31.72 37.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.966 3.111 . . . . 73.24 113.067 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.99 -12.04 60.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 120.027 -0.669 . . . . 75.02 111.754 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.5 mt -109.61 -4.45 16.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.7 -0.227 . . . . 62.1 111.528 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.8 t -61.2 127.5 20.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.567 -0.531 . . . . 72.31 109.567 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.42 75.33 Favored Glycine 0 C--O 1.25 1.101 0 C-N-CA 121.082 -0.58 . . . . 53.44 111.738 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 95.5 mttt -125.27 159.22 32.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.405 -0.961 . . . . 61.25 108.405 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.642 HG22 HD11 ' A' ' 486' ' ' ILE . 39.1 t -82.75 133.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 109.329 -0.619 . . . . 75.22 109.329 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.72 -7.59 9.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 120.462 -0.495 . . . . 74.22 110.342 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.495 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 162.16 165.08 18.48 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.995 -0.842 . . . . 63.42 110.995 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.1 p -120.0 145.45 46.79 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.25 -0.648 . . . . 42.43 109.25 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.49 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.1 t-20 -57.4 -50.58 87.37 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 118.981 -0.533 . . . . 64.45 111.886 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.3 Cg_exo -76.7 131.82 12.69 Favored 'Trans proline' 0 C--N 1.37 1.709 0 N-CA-C 108.377 -1.432 . . . . 75.55 108.377 171.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.65 138.56 70.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.429 2.086 . . . . 72.24 112.037 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.49 1.77 50.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.133 0.968 . . . . 54.32 110.484 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.03 -27.78 15.45 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.798 -1.092 . . . . 73.34 109.639 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -109.89 164.85 12.19 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.848 -0.614 . . . . 71.32 109.455 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 15.5 p -90.61 136.86 32.79 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 120.736 0.303 . . . . 64.34 111.247 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.7 m -120.1 142.03 49.26 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.69 -0.856 . . . . 71.32 108.69 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.97 39.35 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.932 0.345 . . . . 74.33 111.932 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.81 -23.54 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.044 0.937 . . . . 74.22 111.282 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -80.67 -8.94 59.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.549 -0.75 . . . . 74.43 110.9 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.27 140.63 43.3 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.921 0.391 . . . . 52.44 112.04 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 451' ' ' ARG . 99.4 t -85.3 122.89 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.942 -1.133 . . . . 74.0 107.942 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.95 118.84 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.223 -1.029 . . . . 74.41 108.223 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.527 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.6 mp -92.74 117.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.064 -1.828 . . . . 74.22 106.064 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.642 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.56 120.57 62.36 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 CA-C-N 115.566 -0.743 . . . . 73.41 109.429 -174.217 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.66 121.45 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.645 0.736 . . . . 60.33 111.242 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 142.72 13.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.778 -1.101 . . . . 72.04 109.386 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.38 118.99 4.9 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 109.024 -1.63 . . . . 63.42 109.024 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.6 t -122.79 155.6 36.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.947 0 N-CA-C 109.602 -1.399 . . . . 62.32 109.602 178.514 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 CA-C-O 122.123 0.963 . . . . 61.3 110.448 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.9 p -140.41 153.86 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.735 -1.12 . . . . 65.41 109.053 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.96 146.96 36.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.328 -0.249 . . . . 74.24 110.328 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.0 p-10 -100.41 135.53 41.71 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.613 -0.884 . . . . 75.14 108.613 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 32.7 pt -89.99 137.7 28.01 Favored Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 115.919 -0.582 . . . . 72.32 111.526 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.6 Cg_endo -83.19 -172.09 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.224 1.949 . . . . 73.25 110.25 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.1 128.58 35.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.169 0.509 . . . . 72.25 110.487 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.39 4.16 2.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.845 0.831 . . . . 62.01 109.435 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.67 144.06 26.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.489 -0.778 . . . . 62.04 110.279 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 95.3 13.09 53.25 Favored Glycine 0 CA--C 1.498 -1.007 0 N-CA-C 111.081 -0.808 . . . . 61.24 111.081 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 507' ' ' VAL . 92.6 mt-30 -118.88 176.18 5.4 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.056 -1.09 . . . . 75.23 108.056 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 m -86.58 155.41 20.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.715 -1.217 . . . . 52.52 107.715 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 10.3 p -54.87 -41.51 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 123.383 0.427 . . . . 71.25 111.968 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.25 -42.53 83.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.138 0.422 . . . . 52.4 112.138 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.3 p -76.52 -34.38 24.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 119.884 -0.726 . . . . 55.51 110.646 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.446 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -61.14 -47.66 85.2 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.078 -0.964 . . . . 74.21 111.017 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.2 mt-30 -62.75 -38.3 89.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.631 0.582 . . . . 73.55 110.002 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 514' ' ' VAL . 44.7 mmtm -63.03 -52.82 61.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.529 0.518 . . . . 64.24 111.911 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.57 -42.78 99.76 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.94 0.4 . . . . 75.01 110.939 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.09 -43.33 95.72 Favored 'General case' 0 C--O 1.197 -1.698 0 CA-C-N 115.641 -0.709 . . . . 72.4 109.939 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.99 -38.61 79.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.41 0.684 . . . . 70.34 111.383 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.8 t -62.03 -40.52 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.291 -0.413 . . . . 41.54 111.63 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -101.29 -36.4 8.91 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.505 -0.878 . . . . 72.2 110.863 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -89.6 -115.77 1.55 Allowed Glycine 0 N--CA 1.415 -2.739 0 CA-C-N 114.435 -1.257 . . . . 74.21 115.783 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 17.3 m-85 -125.15 -175.29 3.26 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.194 -0.503 . . . . 73.41 110.235 -167.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.3 p -113.2 -7.71 13.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.305 0.483 . . . . 74.22 112.305 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.65 120.86 43.69 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 120.617 -0.433 . . . . 63.5 110.147 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -125.67 155.97 40.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.42 -0.809 . . . . 71.1 109.284 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 154.82 45.61 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.842 -1.54 . . . . 75.45 106.842 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -120.97 128.42 52.71 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.229 -0.588 . . . . 72.24 110.193 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.07 131.19 57.01 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.086 -1.079 . . . . 61.41 108.086 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.3 p -88.78 131.41 35.07 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.745 -0.661 . . . . 70.42 111.184 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.4 m -121.96 162.0 21.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.803 -1.184 . . . . 75.44 107.803 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -79.8 123.75 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.254 0.549 . . . . 75.14 111.733 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 7.2 m -85.15 149.75 53.44 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.203 -0.908 . . . . 63.2 108.567 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.599 1.532 . . . . 75.45 109.285 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.487 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.4 mtt180 -122.97 -58.46 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.802 -0.618 . . . . 74.4 111.003 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 57.2 Cg_endo -71.34 148.4 54.96 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.823 1.33 . . . . 32.04 111.522 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.71 175.68 9.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.045 -0.724 . . . . 51.03 109.045 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 86.51 -15.85 48.51 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 121.256 -0.497 . . . . 54.23 111.927 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.92 147.83 25.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.657 0.741 . . . . 65.24 111.598 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 508' ' ' ALA . 69.7 t -81.46 123.7 38.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 114.991 -1.004 . . . . 71.14 109.614 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.9 m -86.13 -26.45 25.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.733 -1.122 . . . . 70.11 109.242 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.13 -153.27 23.72 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 111.019 -0.832 . . . . 74.31 111.019 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -134.81 161.29 35.63 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.954 -0.758 . . . . 74.34 108.954 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.6 t-20 -54.69 -54.44 49.08 Favored Pre-proline 0 CA--C 1.561 1.374 0 O-C-N 123.291 0.369 . . . . 70.32 110.615 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 79.4 Cg_endo -82.35 149.4 14.96 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.103 1.202 . . . . 63.43 110.191 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 21.6 Cg_exo -67.64 154.13 74.26 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.317 2.011 . . . . 62.12 113.024 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.78 129.56 40.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.18 -0.674 . . . . 43.35 109.18 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.59 46.46 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 111.862 -0.495 . . . . 34.3 111.862 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 93.2 m -78.06 137.36 38.2 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.781 0.324 . . . . 73.44 110.986 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -94.56 123.89 38.26 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.727 -0.669 . . . . 74.44 109.77 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.9 155.0 78.27 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 110.092 -0.336 . . . . 75.2 110.092 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.4 Cg_exo -64.03 139.72 68.75 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.242 2.628 . . . . 71.4 112.482 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.556 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 16.3 m -67.75 -21.19 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.785 0.803 . . . . 64.14 111.114 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.12 -10.92 59.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.646 -1.161 . . . . 75.23 110.349 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.8 t -93.24 155.1 17.64 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.927 -0.768 . . . . 71.03 108.927 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.68 130.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.937 -0.764 . . . . 60.11 108.937 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 18.7 tt -93.64 135.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.539 0.685 . . . . 64.5 111.377 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -102.74 124.49 48.37 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.65 -0.705 . . . . 74.31 109.485 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 28.4 tp -96.72 132.78 42.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.893 -1.048 . . . . 72.14 109.204 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -96.33 106.66 18.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.414 -1.328 . . . . 71.22 107.414 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.62 137.0 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 120.819 0.342 . . . . 72.22 111.125 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.471 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 50.2 m -65.83 115.65 6.17 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.025 -1.102 . . . . 51.12 108.025 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 C--N 1.314 -0.955 0 O-C-N 123.643 0.589 . . . . 71.21 109.773 -176.345 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.238 0.479 0 N-CA-C 109.516 -0.55 . . . . 74.34 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.524 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 66.2 mt-30 -83.83 138.74 33.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.842 -0.617 . . . . 62.54 112.435 -171.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -130.18 154.73 47.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.852 -1.907 . . . . 75.24 105.852 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.15 28.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 117.737 0.244 . . . . 74.33 110.727 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.2 mp -79.69 129.98 69.25 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 108.493 -0.928 . . . . 74.03 108.493 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.61 141.14 54.05 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.938 1.759 . . . . 75.51 111.062 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.39 67.23 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.267 1.032 . . . . 74.21 109.844 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.422 HG13 HD12 ' A' ' 435' ' ' LEU . 43.6 t -117.39 -2.55 9.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.556 -1.646 . . . . 72.51 106.556 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.674 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.2 m -60.96 -41.22 95.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.394 -1.73 . . . . 74.2 111.373 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 13.9 t -58.15 -26.29 62.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.6 -0.727 . . . . 74.24 111.623 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 432' ' ' VAL . 78.4 mt -80.93 -44.53 18.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.318 -0.553 . . . . 72.33 110.916 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.5 m -164.64 145.2 7.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.695 -0.854 . . . . 74.52 108.695 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.38 -43.65 79.45 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.787 0.835 . . . . 72.31 110.77 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.17 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.695 0.76 . . . . 74.21 110.704 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.535 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.9 mm-40 -70.42 -38.78 74.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.663 -0.699 . . . . 72.43 110.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.674 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.84 -50.95 71.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.472 -0.786 . . . . 44.32 111.036 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.4 t -59.37 -46.32 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 73.34 111.571 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -65.13 -44.79 87.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.744 -0.383 . . . . 75.2 111.139 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -63.4 -44.69 93.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.259 -0.428 . . . . 75.21 111.821 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.601 HD23 ' CE2' ' A' ' 452' ' ' PHE . 29.4 tp -67.26 -40.11 86.17 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.329 -0.396 . . . . 73.22 110.295 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.2 m -60.44 -44.15 96.12 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.468 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.08 -18.05 62.56 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.784 -0.644 . . . . 71.25 111.431 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.62 57.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.092 0.472 . . . . 41.21 110.825 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.9 -6.03 37.17 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.368 -0.92 . . . . 72.43 112.675 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.6 m-85 -81.7 130.84 35.2 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.098 -0.704 . . . . 71.41 109.098 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.62 2.03 6.47 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.47 -0.872 . . . . 71.44 113.129 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HG3' HG23 ' A' ' 483' ' ' VAL . 9.1 tpp180 -104.37 115.35 30.22 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.126 -1.065 . . . . 71.14 108.126 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.601 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.0 m-85 -123.28 144.89 49.12 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.318 0.58 . . . . 75.44 110.8 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -135.26 122.62 21.79 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.77 -1.567 . . . . 63.44 106.77 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -93.89 121.75 35.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.045 0.45 . . . . 53.12 109.881 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.02 151.68 45.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.929 -1.138 . . . . 75.03 107.929 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -132.03 134.35 45.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.331 -0.618 . . . . 74.33 109.331 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.4 m -119.04 137.53 25.2 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 107.979 -1.119 . . . . 72.14 107.979 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.07 121.63 9.17 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.458 1.438 . . . . 53.34 109.606 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -138.93 179.22 6.62 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.121 -1.437 . . . . 72.12 107.121 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.3 t -56.43 126.24 68.65 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-O 121.659 0.742 . . . . 72.41 110.164 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.51 -28.91 29.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 125.25 3.966 . . . . 62.3 115.739 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.69 -15.96 62.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.66 0.615 . . . . 73.51 112.66 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 73.3 mt -87.69 4.74 42.89 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 64.23 112.149 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.5 p -60.25 130.08 23.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 121.023 0.439 . . . . 55.54 110.172 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.51 68.54 Favored Glycine 0 C--N 1.307 -1.04 0 C-N-CA 120.631 -0.795 . . . . 52.14 111.656 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.88 144.33 42.62 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.138 0.494 . . . . 53.2 109.914 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.629 HG22 HD11 ' A' ' 486' ' ' ILE . 46.0 t -82.13 135.82 24.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.376 -0.972 . . . . 73.22 108.376 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.3 pt -97.96 -29.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 119.84 -0.744 . . . . 64.13 110.417 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -174.28 161.17 31.11 Favored Glycine 0 N--CA 1.424 -2.162 0 C-N-CA 120.395 -0.907 . . . . 61.31 111.639 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.0 p -118.7 152.81 35.44 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.194 -0.669 . . . . 54.54 109.194 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 16.7 t-20 -62.76 -54.56 46.34 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-O 119.156 -0.45 . . . . 72.33 111.416 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -75.81 134.16 16.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 N-CA-C 108.529 -1.374 . . . . 63.43 108.529 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.89 143.65 73.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.854 2.37 . . . . 72.44 113.206 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -88.89 -7.57 55.86 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.442 1.115 . . . . 60.32 109.437 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.91 -33.01 17.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.449 -1.25 . . . . 73.33 110.06 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -114.91 175.67 5.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.597 -0.729 . . . . 75.15 110.681 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 18.0 p -92.42 139.98 30.04 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 116.338 -0.392 . . . . 72.0 109.99 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 53.4 m -130.1 147.07 51.8 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.883 -0.784 . . . . 74.42 108.883 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.98 150.37 48.76 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.012 0.434 . . . . 73.42 111.521 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.38 -24.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.626 -0.715 . . . . 72.32 110.025 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -81.14 2.27 28.24 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.807 -0.633 . . . . 64.52 111.085 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -82.37 145.66 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.924 -0.398 . . . . 71.5 109.924 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 451' ' ' ARG . 3.4 p -86.35 120.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.265 -1.013 . . . . 64.42 108.265 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.44 117.23 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 C-N-CA 118.233 -1.387 . . . . 71.54 107.456 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 64.4 mt -97.97 112.21 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 105.438 -2.06 . . . . 74.11 105.438 175.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.629 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.85 120.4 51.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 N-CA-C 108.346 -0.983 . . . . 65.41 108.346 -175.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 120.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.328 0.585 . . . . 74.05 110.124 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.72 138.83 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.887 -1.153 . . . . 70.41 107.887 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.9 104.66 2.23 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 108.753 -1.739 . . . . 71.44 108.753 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.5 t -105.63 139.73 39.78 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.815 -1.18 . . . . 72.15 107.815 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.953 0 N-CA-C 108.902 -1.679 . . . . 74.23 108.902 177.168 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.888 0 N-CA-C 108.965 -0.754 . . . . 70.43 108.965 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.1 p -121.68 158.96 27.56 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.813 -1.085 . . . . 74.31 108.379 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -150.0 148.53 29.17 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.087 -0.338 . . . . 70.34 110.087 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.5 p-10 -80.36 131.6 35.65 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.45 0.643 . . . . 60.0 110.322 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.3 pt -75.4 131.29 77.98 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.177 -0.919 . . . . 75.23 111.461 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -92.14 119.64 0.5 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 122.639 2.226 . . . . 74.41 111.753 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.75 122.28 28.89 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.675 -1.232 . . . . 75.01 107.675 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.44 43.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.829 1.299 . . . . 63.23 110.631 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -59.72 145.97 43.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.358 -1.292 . . . . 72.34 112.242 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.0 -12.64 31.83 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.134 -0.555 . . . . 73.11 113.012 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.528 ' O ' HG12 ' A' ' 534' ' ' VAL . 25.5 mt-30 -108.17 -170.9 1.76 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 121.048 -0.261 . . . . 75.32 111.311 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.1 m -85.07 156.36 21.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.498 -1.297 . . . . 73.11 107.498 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.99 -41.19 90.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.576 0.626 . . . . 70.11 111.232 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.82 -42.06 97.73 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 116.492 -0.322 . . . . 65.32 111.424 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.8 -34.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 119.194 -1.003 . . . . 63.34 111.018 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.78 86.66 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.873 -0.603 . . . . 72.51 110.247 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -61.91 -42.27 98.89 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 123.255 0.347 . . . . 62.01 110.097 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.25 -48.36 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.342 -0.614 . . . . 72.03 109.342 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 -38.9 92.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.54 110.771 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.29 -43.68 73.34 Favored 'General case' 0 C--O 1.186 -2.263 0 CA-C-N 115.352 -0.84 . . . . 64.44 110.185 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.36 -46.55 86.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.433 0.635 . . . . 74.33 111.435 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.04 -18.65 21.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 62.32 111.316 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -129.87 18.41 5.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.932 -0.766 . . . . 73.15 108.932 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -162.61 -110.74 0.25 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.111 -1.042 . . . . 44.54 114.691 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -123.31 167.74 13.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.878 0.37 . . . . 72.43 111.856 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 9.3 p -104.68 7.03 34.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.829 0.678 . . . . 73.31 112.829 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 550' ' ' VAL . 0.0 OUTLIER -131.04 123.01 27.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.775 0.321 . . . . 73.23 110.781 -178.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.76 152.15 48.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 74.1 110.528 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 47.8 t -127.51 147.83 50.32 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.818 -1.919 . . . . 70.0 105.818 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -121.53 127.51 51.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 110.258 -0.275 . . . . 74.44 110.258 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 135.29 48.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.8 -0.637 . . . . 73.41 109.741 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 2.7 p -88.47 130.1 35.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.71 -0.677 . . . . 74.14 109.551 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.44 159.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.639 -0.504 . . . . 71.01 109.639 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.32 115.95 17.53 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.962 0.887 . . . . 73.4 109.795 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 2.9 m -95.26 157.3 36.61 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.883 -1.508 . . . . 71.23 110.68 -171.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 6.1 Cg_exo -80.72 -142.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.641 2.227 . . . . 73.44 108.817 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 529' ' ' ARG . 4.3 mmp_? -58.35 -49.78 91.69 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 113.481 0.919 . . . . 73.51 113.481 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.82 149.0 47.17 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.269 1.313 . . . . 73.11 111.455 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.86 145.97 26.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.254 -1.017 . . . . 62.11 108.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.48 -53.07 0.74 Allowed Glycine 0 N--CA 1.437 -1.274 0 C-N-CA 120.683 -0.77 . . . . 74.3 112.431 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.06 149.56 48.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.127 0.571 . . . . 52.11 111.965 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -73.49 127.65 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 121.486 0.66 . . . . 72.43 109.584 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -24.65 44.55 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.717 -1.128 . . . . 64.51 109.642 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.09 -146.38 16.63 Favored Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 111.311 -0.716 . . . . 61.44 111.311 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -116.19 160.07 20.91 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.487 -0.931 . . . . 72.44 108.487 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -53.74 -54.24 48.56 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 111.813 0.301 . . . . 71.32 111.813 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.4 Cg_endo -92.56 167.67 2.73 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.253 1.969 . . . . 64.23 110.179 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.95 155.6 57.35 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.466 2.11 . . . . 71.45 111.538 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 137.88 58.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.757 -0.46 . . . . 45.21 109.757 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.43 -19.11 34.62 Favored Glycine 0 C--N 1.294 -1.751 0 C-N-CA 120.023 -1.084 . . . . 72.25 111.717 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -65.64 123.14 18.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.484 -0.932 . . . . 61.11 108.484 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 16.8 m -94.87 122.48 37.55 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.703 -0.48 . . . . 73.45 109.703 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.74 159.19 69.48 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.662 -0.866 . . . . 63.42 108.662 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.2 Cg_exo -61.39 139.25 81.47 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.074 1.849 . . . . 52.43 111.339 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.63 -18.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.302 -0.863 . . . . 72.3 112.481 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.58 -9.55 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.16 -0.927 . . . . 63.4 109.78 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 45.1 m -92.34 152.1 19.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.217 -0.901 . . . . 51.34 110.795 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.463 ' HA ' ' HG2' ' A' ' 519' ' ' LYS . 39.5 t -88.38 133.53 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.869 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.2 tt -98.49 139.27 20.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.513 -0.551 . . . . 61.42 109.513 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.82 125.83 49.71 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.108 0.48 . . . . 74.04 109.902 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.82 133.7 42.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.453 -0.943 . . . . 71.25 108.453 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -97.51 111.19 23.56 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.035 -1.098 . . . . 72.44 108.035 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.21 137.71 41.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 C-N-CA 120.532 -0.467 . . . . 75.43 111.996 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.2 m -68.02 117.67 10.18 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.353 -1.351 . . . . 54.2 107.353 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 8.1 ptmm? . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 118.516 -0.754 . . . . 72.21 112.341 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 121.164 0.507 . . . . 72.05 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 18.7 mp0 -83.9 147.21 27.64 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 119.683 -0.807 . . . . 74.43 109.384 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 7.9 tpp85 -143.26 161.16 39.03 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.137 -1.06 . . . . 63.31 108.137 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 9.5 pt-20 -82.23 140.29 33.76 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 123.582 0.753 . . . . 62.04 112.018 -172.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -96.67 126.89 41.47 Favored Pre-proline 0 N--CA 1.424 -1.735 0 N-CA-C 104.607 -2.368 . . . . 64.32 104.607 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.62 141.34 90.82 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.35 2.034 . . . . 73.21 114.381 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -100.76 -5.22 26.67 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.845 -1.07 . . . . 51.52 108.492 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.43 -4.68 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 122.542 1.163 . . . . 63.31 108.524 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.0 m -58.51 -31.98 68.4 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.922 -1.49 . . . . 72.11 109.283 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -57.14 -27.51 61.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.538 -1.21 . . . . 70.1 110.642 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.1 mt -89.99 -44.47 9.84 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.008 -0.677 . . . . 71.43 111.724 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.552 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 24.5 m -158.34 143.55 16.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.326 -0.859 . . . . 74.52 109.947 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.27 -45.92 79.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.848 0.459 . . . . 63.42 110.006 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.45 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.73 -35.27 65.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.901 -0.591 . . . . 75.35 111.782 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.552 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.0 mm-40 -70.79 -43.59 68.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.412 -0.358 . . . . 72.33 111.154 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.07 -51.22 70.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.363 -0.835 . . . . 71.45 110.554 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.87 -47.62 88.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 115.493 -0.776 . . . . 64.21 112.125 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -64.81 -42.91 94.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.677 -0.409 . . . . 73.42 111.629 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -66.44 -45.49 79.65 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.096 0.474 . . . . 74.3 110.176 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 34.6 tp -68.58 -37.35 79.78 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.767 -0.651 . . . . 73.33 111.065 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.9 m -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.056 -0.52 . . . . 73.14 109.846 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.9 -15.45 62.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.967 -0.56 . . . . 52.13 110.921 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.574 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -81.14 -14.83 57.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.211 0.529 . . . . 64.21 110.098 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.31 58.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.298 -0.954 . . . . 73.4 113.652 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 90.6 m-85 -72.58 146.02 46.98 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.911 -0.774 . . . . 74.31 108.911 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.25 -7.01 2.31 Favored Glycine 0 C--N 1.303 -1.275 0 C-N-CA 120.006 -1.092 . . . . 73.12 112.656 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 483' ' ' VAL . 0.0 OUTLIER -102.5 115.42 30.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.859 -1.534 . . . . 61.31 106.859 -178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.08 149.37 50.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.175 0.512 . . . . 75.15 110.722 -173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.459 ' HB3' HG13 ' A' ' 485' ' ' ILE . 17.6 tppt? -138.64 123.02 18.3 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.537 -1.283 . . . . 73.25 107.537 169.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -102.74 134.85 45.45 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.331 0.586 . . . . 75.13 111.114 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.14 158.42 44.49 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.183 -1.043 . . . . 64.43 108.183 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -135.2 146.91 49.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.231 -1.026 . . . . 74.02 108.231 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 35.1 t -133.6 131.3 21.23 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.352 -0.981 . . . . 55.34 108.352 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.8 Cg_exo -65.87 120.89 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.775 1.65 . . . . 72.32 109.989 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.0 m -140.79 179.48 6.68 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 106.735 -1.58 . . . . 74.32 106.735 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -52.49 133.82 44.18 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.341 0.401 . . . . 65.22 111.581 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.481 ' O ' HG12 ' A' ' 464' ' ' VAL . 86.9 Cg_exo -50.45 -26.51 16.45 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 125.071 3.847 . . . . 72.32 113.05 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -57.27 -33.22 67.39 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.304 0.642 . . . . 53.52 110.568 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 93.9 mt -103.83 11.07 36.17 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.567 0.58 . . . . 74.12 112.567 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.3 p -61.21 128.15 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 119.927 -0.709 . . . . 74.14 110.595 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.13 77.69 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 120.887 -0.673 . . . . 52.04 112.163 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.7 mptp? -100.31 148.69 24.4 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.685 -0.857 . . . . 74.12 108.685 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 486' ' ' ILE . 58.5 t -81.93 125.35 39.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.758 -1.201 . . . . 70.13 107.758 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.92 -10.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 120.852 0.358 . . . . 74.2 111.386 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.22 149.04 8.06 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.176 -1.012 . . . . 71.24 112.193 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -119.03 140.48 49.97 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.494 -1.299 . . . . 73.43 107.494 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.514 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.6 t-20 -62.59 -53.83 53.56 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-O 118.963 -0.541 . . . . 75.42 111.765 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.1 Cg_exo -74.34 146.0 34.99 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 108.583 -1.353 . . . . 74.52 108.583 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.7 134.28 46.45 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.415 2.077 . . . . 72.2 112.918 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.63 6.44 47.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.481 1.134 . . . . 74.41 109.529 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.37 -21.87 13.75 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.279 -1.328 . . . . 63.02 109.278 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -124.7 155.54 39.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.225 -0.443 . . . . 64.44 111.413 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.7 p -83.99 123.91 30.49 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.653 -0.703 . . . . 74.14 109.516 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.8 m -115.59 150.74 36.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.716 -0.846 . . . . 60.52 108.716 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.99 151.21 46.51 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.24 0.216 . . . . 62.11 111.338 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.96 -17.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.83 0.852 . . . . 72.21 112.215 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.4 t -72.04 -6.05 39.55 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 116.44 -0.345 . . . . 72.52 110.851 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.95 131.1 35.75 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 122.633 0.373 . . . . 63.13 111.996 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 451' ' ' ARG . 6.6 p -83.79 123.57 38.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.867 -1.16 . . . . 61.24 107.867 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.34 118.18 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 C-N-CA 119.067 -1.053 . . . . 74.51 109.322 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.514 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -97.21 112.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.685 -1.969 . . . . 73.13 105.685 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.42 121.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 115.908 -0.587 . . . . 65.14 109.559 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.97 120.45 52.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.183 0.516 . . . . 75.4 109.894 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.0 t -96.05 140.32 17.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-N 115.694 -0.684 . . . . 72.25 109.19 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.31 114.03 3.85 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.368 -1.093 . . . . 72.05 110.368 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 40.6 t -98.84 133.56 42.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.013 -1.106 . . . . 43.3 108.013 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.528 0 N-CA-C 110.915 -0.874 . . . . 75.4 110.915 -178.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 108.259 -1.015 . . . . 64.51 108.259 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 546' ' ' PRO . 33.7 p -131.55 143.9 50.71 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.429 -0.35 . . . . 71.31 110.534 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.84 164.59 27.23 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.07 -0.715 . . . . 63.03 109.07 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.17 134.02 35.77 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 517' ' ' PHE . 32.5 pt -76.65 132.49 71.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.67 -0.412 . . . . 74.11 110.251 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -91.42 178.46 1.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.763 2.309 . . . . 75.33 113.217 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.68 135.95 36.71 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.928 -1.138 . . . . 71.15 107.928 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.85 16.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.991 0.9 . . . . 42.44 109.407 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.48 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -68.06 132.43 47.24 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.899 -1.046 . . . . 41.14 111.801 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 117.91 -24.65 8.8 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.429 -0.891 . . . . 72.4 112.023 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.57 173.75 7.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.945 -0.761 . . . . 74.05 108.945 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 9.8 p -80.01 156.94 26.92 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.486 -0.486 . . . . 55.01 111.504 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.76 -42.26 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 O-C-N 123.838 0.712 . . . . 71.21 112.181 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.64 -39.44 80.71 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 121.017 -0.273 . . . . 64.1 111.592 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 83.8 t -71.1 -44.04 75.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.442 0.639 . . . . 63.52 110.827 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.08 -47.83 81.23 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 74.21 111.628 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.81 -35.62 81.68 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 121.042 -0.263 . . . . 71.31 110.579 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.7 OUTLIER -65.14 -51.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.206 -0.664 . . . . 52.15 109.206 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.7 -37.8 87.92 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.96 -0.564 . . . . 65.24 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.67 -45.47 71.64 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.818 -0.628 . . . . 74.42 109.451 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.29 -41.27 88.53 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.033 0.753 . . . . 72.53 113.033 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.3 t -64.23 -31.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.197 -0.456 . . . . 74.35 111.655 -177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.81 15.91 11.8 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.993 -0.283 . . . . 74.23 110.72 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.8 -98.08 0.2 Allowed Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 117.281 -2.39 . . . . 42.12 117.426 -169.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.667 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 78.1 m-85 -121.89 152.83 39.19 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.145 0.497 . . . . 74.55 111.791 -164.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.9 m -96.19 -27.48 15.01 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.02 -0.991 . . . . 62.42 111.871 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.75 134.66 51.16 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.156 -0.34 . . . . 64.2 110.09 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.77 145.53 51.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.347 0.594 . . . . 75.33 111.009 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.3 m -141.11 144.6 34.98 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.873 -1.529 . . . . 71.45 106.873 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 553' ' ' LEU . 13.2 mm-40 -121.26 127.41 51.36 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.119 -1.067 . . . . 72.4 108.119 -172.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.436 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -114.28 133.45 55.64 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.991 -1.114 . . . . 64.21 107.991 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.7 m -88.55 130.81 35.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.165 0.507 . . . . 22.21 110.718 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.25 162.82 21.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 105.033 -2.21 . . . . 72.41 105.033 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.75 131.9 36.04 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 118.872 0.76 . . . . 61.15 111.991 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 66.4 p -77.04 150.38 80.88 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.946 -1.025 . . . . 75.4 109.215 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.52 -47.4 7.52 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.021 1.814 . . . . 71.5 110.512 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 20.4 mmt180 -163.2 -58.83 0.01 OUTLIER Pre-proline 0 C--O 1.222 -0.348 0 C-N-CA 127.316 2.246 . . . . 74.21 109.411 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 527' ' ' SER . 30.5 Cg_endo -66.85 135.96 39.99 Favored 'Trans proline' 0 C--N 1.36 1.137 0 N-CA-C 109.091 -1.157 . . . . 62.41 109.091 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.34 157.85 38.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.297 0.373 . . . . 54.22 110.145 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 115.13 -18.67 15.89 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 121.131 -0.557 . . . . 61.12 112.192 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.3 OUTLIER -87.36 148.46 25.02 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.253 0.549 . . . . 74.33 111.336 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 501' ' ' ALA . 11.4 p -81.26 128.87 38.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.822 -0.807 . . . . 73.43 108.822 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -78.44 -31.2 47.95 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.775 -0.824 . . . . 65.24 108.775 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.09 -157.29 28.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.16 -1.176 . . . . 52.33 110.16 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.4 p -117.56 160.77 20.7 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.154 -1.054 . . . . 70.42 108.154 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 64.4 t30 -58.67 -51.26 83.09 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 119.979 -0.688 . . . . 71.11 111.167 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.3 Cg_exo -81.53 155.73 18.68 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 121.33 1.353 . . . . 53.34 109.835 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.64 149.98 56.05 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.373 2.049 . . . . 65.14 112.025 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.18 129.89 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.353 0.661 . . . . 72.25 110.045 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -7.06 36.33 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.573 -0.822 . . . . 63.3 111.834 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.1 m -77.13 133.92 38.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.451 -0.574 . . . . 71.42 109.451 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.9 t -100.81 127.33 47.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.251 0.548 . . . . 73.43 110.312 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 517' ' ' PHE . 11.2 m -138.76 162.08 54.84 Favored Pre-proline 0 C--O 1.248 1.018 0 N-CA-C 109.331 -0.618 . . . . 72.14 109.331 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.4 Cg_exo -63.84 135.03 46.23 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.483 2.122 . . . . 72.24 112.373 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.667 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 11.3 m -67.29 -21.12 27.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.699 0.762 . . . . 64.1 112.381 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.27 -7.96 55.95 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.602 -1.181 . . . . 64.01 109.324 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -92.14 179.0 5.69 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.432 -0.804 . . . . 70.21 110.764 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.31 124.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.84 -0.618 . . . . 64.34 112.365 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.3 tp -94.1 123.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 106.476 -1.676 . . . . 72.31 106.476 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.64 116.74 32.91 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-O 120.894 0.378 . . . . 72.43 110.082 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.614 ' HB2' ' OE1' ' A' ' 522' ' ' GLN . 6.1 mp -98.72 134.37 41.73 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.169 -0.923 . . . . 70.24 110.621 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 9.0 mm-40 -92.06 109.84 21.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.66 -1.978 . . . . 73.45 105.66 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.3 m -105.73 137.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 112.515 0.561 . . . . 71.31 112.515 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 49.5 m -72.72 114.53 10.96 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.577 0.703 . . . . 61.31 110.312 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.448 ' C ' ' HD3' ' A' ' 557' ' ' LYS . 7.3 tmtm? . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.046 -1.464 . . . . 71.42 107.046 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.992 0.901 . . . . 64.34 108.724 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.3 mt-30 -87.53 120.97 29.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.111 -0.95 . . . . 64.14 110.862 -174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -120.66 166.38 13.76 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.698 0.761 . . . . 65.53 110.536 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -84.38 140.3 31.66 Favored 'General case' 0 C--N 1.266 -3.053 0 CA-C-N 113.628 -1.623 . . . . 74.33 109.421 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.22 126.81 78.38 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 106.791 -1.559 . . . . 54.53 106.791 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.13 141.74 70.97 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.493 2.129 . . . . 71.22 112.399 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -112.41 70.64 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.532 1.158 . . . . 63.44 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.51 6.74 4.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 123.886 1.803 . . . . 65.5 106.226 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 0.7 OUTLIER -62.71 -30.97 71.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.32 -2.218 . . . . 73.11 109.308 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.0 m -58.37 -28.24 64.96 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 125.821 1.649 . . . . 64.25 110.642 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.5 -45.3 9.04 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.449 -0.501 . . . . 71.22 112.107 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.7 m -163.65 150.66 12.23 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.754 -0.832 . . . . 72.0 108.754 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 441' ' ' VAL . 32.7 t80 -53.08 -54.89 28.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.539 0.524 . . . . 74.23 110.704 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.7 -36.57 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.613 -0.721 . . . . 72.44 112.117 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -61.48 -45.77 92.83 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 112.313 0.486 . . . . 64.4 112.313 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -65.3 -44.58 87.49 Favored 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 123.68 0.613 . . . . 71.32 109.727 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.422 HG21 ' CZ ' ' A' ' 437' ' ' TYR . 90.8 t -59.02 -46.82 91.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.436 0 CA-C-N 115.368 -0.833 . . . . 53.22 111.629 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.9 mmpt? -60.28 -47.03 87.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.824 0.284 . . . . 74.03 110.966 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.72 -38.95 87.71 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.937 -0.305 . . . . 63.55 111.244 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.8 tp -67.04 -41.27 86.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.16 0.505 . . . . 75.52 110.092 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.9 m -61.07 -45.27 95.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.998 -1.001 . . . . 64.11 109.022 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.96 62.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.68 -0.691 . . . . 74.13 111.718 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.28 -13.12 57.49 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.193 0.521 . . . . 74.53 110.724 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.93 20.35 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 120.665 -0.779 . . . . 64.24 112.3 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.4 m-85 -69.23 118.08 11.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.53 -0.545 . . . . 74.24 109.53 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -106.72 -15.71 16.09 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.63 -0.714 . . . . 74.23 111.483 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -109.45 114.01 27.29 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.954 0.883 . . . . 73.05 110.344 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.7 154.46 40.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.665 -1.152 . . . . 54.15 111.208 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -131.33 125.45 32.76 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.16 -0.681 . . . . 72.21 109.16 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -88.69 121.02 30.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.981 0.419 . . . . 72.23 110.744 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.39 153.5 32.95 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 71.55 107.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.48 147.62 49.8 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.775 -0.824 . . . . 75.22 108.775 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.4 t -137.21 138.24 24.79 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 108.816 -0.809 . . . . 74.52 108.816 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 490' ' ' SER . 25.9 Cg_exo -64.81 122.16 9.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 72.12 110.182 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -137.52 179.75 6.22 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.929 -1.137 . . . . 63.15 107.929 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.6 t -65.27 144.03 98.92 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.047 -0.723 . . . . 75.41 109.047 174.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.36 -28.03 25.82 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.571 3.514 . . . . 75.45 112.464 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -59.01 -34.44 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 123.393 0.677 . . . . 73.42 111.442 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.98 4.75 49.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.066 1.135 . . . . 63.33 114.066 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 79.5 t -60.5 130.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.152 0.501 . . . . 54.42 112.325 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.94 84.72 Favored Glycine 0 CA--C 1.504 -0.644 0 CA-C-N 115.252 -0.886 . . . . 72.13 112.646 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.07 151.62 38.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.838 -0.43 . . . . 62.34 109.838 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 486' ' ' ILE . 46.7 t -81.93 134.25 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.687 -0.857 . . . . 71.23 108.687 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.46 -24.36 4.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.59 -0.444 . . . . 62.04 111.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.85 168.05 38.17 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.684 -0.77 . . . . 51.45 111.952 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.3 p -121.03 153.13 37.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.668 -0.493 . . . . 72.21 109.668 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 23.2 t-20 -68.49 -52.74 19.17 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 119.299 -0.381 . . . . 72.34 111.272 174.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.76 129.64 10.08 Favored 'Trans proline' 0 C--N 1.365 1.418 0 CA-C-N 120.202 1.108 . . . . 54.32 109.605 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.67 129.89 24.83 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.323 2.015 . . . . 75.23 112.25 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 0.71 30.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.755 0.788 . . . . 51.14 111.605 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.99 -1.004 . . . . 52.22 109.165 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -129.79 157.84 41.08 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.109 -1.071 . . . . 71.43 108.109 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 37.4 p -86.72 123.67 32.13 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.997 -0.371 . . . . 73.52 109.997 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 50.4 m -108.58 145.18 35.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.395 -0.594 . . . . 71.44 109.395 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.26 153.2 43.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.152 -0.477 . . . . 70.4 110.781 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.87 -21.83 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.729 0.811 . . . . 73.45 110.7 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -76.66 9.09 3.0 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 116.037 -0.529 . . . . 74.21 111.944 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -98.6 145.83 26.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.378 0.271 . . . . 61.12 111.151 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.52 119.52 35.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.876 -1.157 . . . . 71.25 107.876 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 71.0 t -87.62 118.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 118.992 -1.083 . . . . 62.43 108.617 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 66.0 mt -94.86 114.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.795 -1.557 . . . . 72.21 106.795 176.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.27 128.36 59.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 115.656 -0.702 . . . . 72.23 109.488 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 38.1 mt -106.53 118.97 55.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 116.08 -0.509 . . . . 65.44 110.549 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.63 145.87 8.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.752 -0.658 . . . . 73.01 109.548 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -87.76 123.49 6.68 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.069 -0.812 . . . . 72.0 111.069 176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.8 m -123.6 137.61 54.71 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.414 -0.958 . . . . 55.3 108.414 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.681 0 C-N-CA 120.541 -0.838 . . . . 70.21 112.827 -175.593 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.193 0 CA-C-O 121.851 0.834 . . . . 63.24 111.483 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -134.67 154.39 51.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.206 -0.906 . . . . 74.41 110.85 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.49 149.6 30.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.869 -0.419 . . . . 71.24 109.869 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -90.58 139.14 30.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.654 -0.499 . . . . 74.33 109.654 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -96.19 138.44 21.59 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.777 -0.647 . . . . 65.24 112.019 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.25 171.26 11.46 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.522 2.148 . . . . 55.01 111.037 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -85.53 132.99 34.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.202 0.525 . . . . 73.13 110.174 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.73 11.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.962 0.887 . . . . 74.23 109.182 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.37 155.24 22.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.786 -0.643 . . . . 64.24 110.192 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 97.71 -13.26 64.08 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.539 -1.425 . . . . 63.14 109.539 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -94.53 179.65 5.2 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.438 -1.319 . . . . 74.43 107.438 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.0 m -83.67 155.28 23.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.718 -1.216 . . . . 61.23 107.718 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.8 -42.95 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.24 -42.55 75.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.058 0.392 . . . . 70.13 112.058 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -75.08 -35.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.551 -0.86 . . . . 72.4 111.036 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.437 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.85 -48.18 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.273 -0.876 . . . . 73.34 111.354 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.44 -34.74 78.89 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 121.249 -0.18 . . . . 75.0 110.969 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -64.67 -49.1 72.31 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.111 -0.329 . . . . 74.32 110.111 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.77 -46.52 81.79 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.242 0.544 . . . . 62.22 110.377 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.8 -36.58 81.53 Favored 'General case' 0 C--O 1.181 -2.551 0 CA-C-N 115.113 -0.949 . . . . 72.5 110.855 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.98 -39.28 81.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.246 0.546 . . . . 73.22 110.4 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.33 -34.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.496 -0.775 . . . . 65.42 111.336 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -111.27 11.3 21.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.566 0.698 . . . . 73.32 111.802 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.87 -111.97 1.33 Allowed Glycine 0 N--CA 1.417 -2.593 0 CA-C-N 115.412 -0.813 . . . . 41.13 111.893 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 37.1 m-85 -133.16 -177.15 4.39 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.542 -0.54 . . . . 72.44 109.542 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -106.98 -7.95 16.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.647 0.737 . . . . 62.43 109.729 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -108.11 115.99 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.863 -0.608 . . . . 63.33 110.061 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -126.25 151.49 47.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.785 0.802 . . . . 75.24 112.366 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.8 m -136.87 151.67 49.36 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.202 -1.407 . . . . 51.3 107.202 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.538 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.7 mm-40 -121.33 131.14 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.38 -0.6 . . . . 74.01 109.38 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.5 130.96 56.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.374 -0.602 . . . . 72.43 109.374 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 15.3 m -93.55 120.82 34.29 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.99 -0.745 . . . . 60.53 108.99 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.5 m -122.01 162.29 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 74.13 108.157 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . 0.262 13.8 m-20 -82.39 141.85 32.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.943 1.46 . . . . 74.44 114.943 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 2.7 m -97.55 144.03 27.24 Favored Pre-proline 0 C--N 1.28 -2.45 0 CA-C-N 113.425 -1.716 . . . . 63.22 109.016 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.94 -69.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 107.939 -1.6 . . . . 65.2 107.939 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.475 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 36.5 mmt180 -118.39 -59.4 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 118.494 -0.765 . . . . 75.33 112.291 170.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 527' ' ' SER . 54.7 Cg_endo -69.15 136.79 35.56 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 121.454 1.436 . . . . 71.44 111.811 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.08 123.03 16.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.861 -0.792 . . . . 65.32 108.861 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.08 -18.45 6.58 Favored Glycine 0 C--N 1.296 -1.662 0 N-CA-C 109.388 -1.485 . . . . 55.14 109.388 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -79.09 147.42 32.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.245 -0.977 . . . . 72.33 109.542 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 553' ' ' LEU . 58.7 t -76.16 115.54 17.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 107.971 -1.122 . . . . 72.2 107.971 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 16.9 m -78.26 -24.83 46.68 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.65 -0.704 . . . . 75.41 109.544 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.54 -175.39 43.16 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.84 -0.904 . . . . 51.23 110.84 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.3 p -119.69 158.55 26.24 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.013 -1.477 . . . . 73.44 107.013 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -59.43 -53.14 68.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.292 -0.563 . . . . 73.45 111.609 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.6 Cg_endo -86.81 147.71 8.25 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.21 1.273 . . . . 61.0 109.172 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.63 153.01 65.2 Favored 'Trans proline' 0 C--O 1.245 0.825 0 C-N-CA 122.022 1.815 . . . . 73.13 112.279 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 129.49 40.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.87 -0.605 . . . . 72.32 109.488 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.34 -19.08 37.73 Favored Glycine 0 C--N 1.304 -1.225 0 C-N-CA 121.122 -0.561 . . . . 75.42 111.744 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 87.5 m -75.03 132.42 41.31 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.915 0.388 . . . . 54.14 110.386 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 29.1 m -91.05 123.72 34.73 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.79 -0.819 . . . . 64.35 108.79 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.67 160.98 63.76 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.159 -0.682 . . . . 74.53 109.159 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.39 134.69 49.64 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.275 1.983 . . . . 63.41 112.356 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.6 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 15.7 m -67.56 -19.87 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 122.434 1.111 . . . . 53.2 110.56 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.76 -13.71 58.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.599 -1.637 . . . . 54.34 109.307 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 64.1 m -93.25 169.43 10.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.074 -0.966 . . . . 73.32 111.865 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.35 133.48 44.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.964 -0.562 . . . . 62.13 110.188 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.8 tt -102.87 137.25 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.208 0.528 . . . . 64.41 110.015 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 24.9 tt0 -103.79 129.71 51.24 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.355 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.538 ' HB3' ' OE1' ' A' ' 522' ' ' GLN . 6.4 tt -102.41 127.09 49.58 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.255 -1.387 . . . . 75.42 107.255 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -104.07 106.98 17.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.778 0.799 . . . . 71.3 109.28 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.62 138.02 37.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 114.831 -1.077 . . . . 64.43 111.793 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.497 ' HB2' ' OG ' ' A' ' 527' ' ' SER . 13.5 p -65.03 122.56 17.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 62.34 109.997 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 524' ' ' SER . 22.6 pttp . . . . . 0 C--O 1.259 1.564 0 CA-C-N 116.466 -0.334 . . . . 72.31 111.779 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 10.6 pt-20 . . . . . 0 CA--C 1.499 -1.007 0 CA-C-O 121.7 0.762 . . . . 60.04 109.935 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -114.28 133.04 55.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.552 -1.204 . . . . 74.11 109.022 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.597 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -120.51 161.51 21.17 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 108.109 -1.071 . . . . 73.32 108.109 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.84 141.6 32.15 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.369 0.668 . . . . 73.54 110.301 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.586 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.68 130.9 66.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 106.825 -1.546 . . . . 71.2 106.825 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.408 ' HB3' ' HD3' ' A' ' 443' ' ' LYS . 85.5 Cg_exo -53.47 140.95 63.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.097 2.531 . . . . 61.43 113.931 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.53 -2.78 57.91 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.021 -0.99 . . . . 73.23 110.258 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.84 8.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.766 0.793 . . . . 72.21 110.832 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.3 p -61.39 -42.23 98.39 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.536 1.534 . . . . 75.14 110.832 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 7.1 p -66.34 -25.59 66.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.742 -1.117 . . . . 54.22 111.867 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.37 -46.31 17.86 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.26 -0.576 . . . . 64.42 110.297 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.9 m -169.59 147.15 3.47 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.058 -1.09 . . . . 74.14 108.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 441' ' ' VAL . 25.5 t80 -50.75 -49.13 58.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.657 0.783 . . . . 74.23 110.296 171.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -57.53 -35.86 70.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.652 -0.704 . . . . 41.4 111.871 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.544 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.6 mm-40 -70.66 -40.38 73.04 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.095 0.474 . . . . 75.42 110.857 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -46.38 90.09 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.169 -0.923 . . . . 70.23 110.364 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 437' ' ' TYR . 90.1 t -58.64 -47.41 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.45 -0.796 . . . . 63.1 111.961 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 61.7 mttp -62.91 -48.84 77.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.822 0.344 . . . . 70.51 110.439 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 430' ' ' PRO . 49.2 tttp -68.27 -38.44 81.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.579 -0.737 . . . . 53.13 111.259 -176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 35.4 tp -68.47 -40.33 81.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.15 0.5 . . . . 74.33 109.983 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 38.6 m -60.93 -45.81 93.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.442 -0.799 . . . . 71.32 109.884 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.97 62.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.712 -0.676 . . . . 72.13 111.226 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -80.18 -13.75 59.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.648 0.261 . . . . 64.12 110.358 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.25 -5.29 49.03 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.347 -0.93 . . . . 65.33 114.203 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 76.7 m-85 -62.96 139.12 58.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.866 0.333 . . . . 72.3 111.226 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.45 -2.93 9.66 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.39 -0.91 . . . . 72.11 113.37 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -119.31 115.63 24.54 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.527 -0.916 . . . . 74.35 108.527 -177.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -132.45 151.12 52.01 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.943 0.401 . . . . 74.13 110.161 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 485' ' ' ILE . 61.8 tttp -139.6 122.62 16.75 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.251 -1.759 . . . . 74.21 106.251 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.84 135.08 42.85 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.88 -0.328 . . . . 64.33 110.244 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.95 155.17 50.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.494 -0.928 . . . . 54.04 108.494 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.431 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.5 p30 -133.9 138.53 45.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.679 -1.23 . . . . 73.22 107.679 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 t -134.98 143.54 46.56 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 108.849 -0.797 . . . . 73.03 108.849 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.68 122.19 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.142 1.895 . . . . 71.41 109.114 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -133.3 179.64 6.07 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.309 -0.86 . . . . 53.2 109.491 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -61.07 135.16 93.21 Favored Pre-proline 0 N--CA 1.417 -2.117 0 C-N-CA 123.755 0.822 . . . . 73.1 108.935 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 89.3 Cg_exo -50.64 -29.98 27.11 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.097 3.198 . . . . 65.21 115.123 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -75.76 -22.8 56.13 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.728 -0.789 . . . . 73.34 112.501 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.14 4.89 51.04 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.598 0.592 . . . . 65.31 112.598 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 15.0 p -61.2 127.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 C-N-CA 120.097 -0.641 . . . . 43.43 109.874 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.52 -6.05 77.53 Favored Glycine 0 C--N 1.308 -0.989 0 CA-C-N 115.595 -0.729 . . . . 51.11 113.169 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -110.0 157.14 19.61 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.61 -0.885 . . . . 75.21 108.61 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 486' ' ' ILE . 48.9 t -82.26 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.844 -1.169 . . . . 52.02 107.844 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 34.9 pt -97.74 -20.41 5.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.21 -0.596 . . . . 63.44 109.688 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.54 155.24 14.64 Favored Glycine 0 N--CA 1.409 -3.132 0 C-N-CA 120.015 -1.088 . . . . 74.0 112.425 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.9 p -119.56 154.28 34.13 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.263 -1.754 . . . . 71.43 106.263 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 41.7 t-20 -65.12 -55.0 29.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 C-N-CA 119.975 -0.69 . . . . 62.14 110.625 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.73 126.94 9.21 Favored 'Trans proline' 0 C--N 1.365 1.428 0 N-CA-C 108.947 -1.213 . . . . 51.43 108.947 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.46 143.46 76.05 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.464 2.109 . . . . 62.23 112.264 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.27 4.58 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.183 0.992 . . . . 73.25 110.692 -176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -101.4 -9.28 21.27 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.456 -1.247 . . . . 72.13 109.471 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -122.27 167.48 13.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.517 -0.92 . . . . 74.41 108.517 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 30.6 p -98.03 143.43 28.59 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 109.619 -0.511 . . . . 71.41 109.619 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.6 m -128.98 147.41 50.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.016 -0.735 . . . . 73.35 109.016 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -54.52 153.39 5.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.586 0.958 . . . . 71.11 113.586 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.59 -32.29 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.116 0.966 . . . . 74.33 110.241 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 36.39 4.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.779 1.276 . . . . 72.43 110.222 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 19.2 t-20 -88.33 145.63 25.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 105.028 -2.212 . . . . 71.14 105.028 173.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.88 111.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.55 -1.26 . . . . 73.51 111.074 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.45 118.51 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.993 -1.114 . . . . 73.0 107.993 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.5 mp -95.23 112.69 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 72.14 106.286 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.79 118.39 50.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 109.481 -0.562 . . . . 73.55 109.481 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -100.07 121.68 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.393 -0.595 . . . . 62.03 109.393 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 134.02 35.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.36 115.73 5.21 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 109.82 -1.312 . . . . 71.1 109.82 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 456' ' ' ASN . 12.1 m -113.07 130.2 56.24 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.208 -0.664 . . . . 75.32 109.208 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.0 0 CA-C-O 119.198 -0.779 . . . . 23.33 111.398 -177.983 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 547' ' ' VAL . . . . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 122.254 1.026 . . . . 63.05 108.696 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 546' ' ' PRO . 7.5 p -132.58 157.33 45.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.815 -1.084 . . . . 71.42 109.901 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 140.1 22.86 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.336 -0.987 . . . . 73.23 108.336 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.3 p-10 -89.78 136.08 33.25 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.305 -1.368 . . . . 72.1 107.305 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 541' ' ' ALA . 29.2 pt -81.97 134.99 48.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 116.071 -0.513 . . . . 73.22 112.367 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.54 -175.39 1.26 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.965 2.443 . . . . 74.42 112.08 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -91.22 95.39 10.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.289 0.566 . . . . 70.51 109.895 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.26 -3.86 10.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.828 0.823 . . . . 62.1 108.996 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.56 55.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.162 -1.381 . . . . 71.32 110.036 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.22 -16.72 38.29 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 111.001 -0.84 . . . . 53.14 111.001 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -97.92 -175.35 3.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.557 -0.905 . . . . 75.25 108.557 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.9 m -79.17 155.01 28.84 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.724 -0.843 . . . . 63.24 108.724 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.534 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 6.9 p -53.71 -45.65 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 123.608 0.568 . . . . 71.33 112.116 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.9 -41.96 77.54 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.76 0.652 . . . . 73.22 112.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.7 -37.41 35.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 119.946 -0.702 . . . . 61.31 111.788 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.05 91.25 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.082 -0.508 . . . . 71.3 111.202 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -65.26 -35.51 81.25 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.795 -0.362 . . . . 71.34 110.68 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 514' ' ' VAL . 19.5 mmtp -59.83 -50.49 73.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.165 0.432 . . . . 73.12 112.165 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -62.37 -38.66 90.42 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.915 0.388 . . . . 63.21 110.91 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.09 -46.28 71.42 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.632 -0.713 . . . . 74.31 109.906 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 7.2 t30 -59.15 -48.03 83.1 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 124.025 0.93 . . . . 70.21 112.066 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.3 t -60.89 -28.67 43.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.822 -0.626 . . . . 73.53 112.031 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.72 13.15 9.96 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.477 -0.889 . . . . 73.24 111.366 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -154.01 -88.78 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.44 0 C-N-CA 117.581 -2.247 . . . . 72.12 117.276 -170.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 55.7 m-85 -117.96 151.27 37.77 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.494 -0.353 . . . . 74.54 111.008 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 8.6 m -107.52 -25.72 11.25 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.081 -0.509 . . . . 74.23 110.673 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.3 126.29 52.66 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.32 -0.622 . . . . 75.35 109.32 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -128.4 144.11 51.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.153 -0.476 . . . . 75.14 110.853 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.4 m -121.79 153.59 38.1 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.005 -1.48 . . . . 74.45 107.005 172.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -127.2 129.36 47.67 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.116 -0.634 . . . . 63.02 110.833 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -117.57 144.03 45.52 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.225 -1.398 . . . . 74.23 107.225 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -101.86 135.36 43.54 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.971 0.415 . . . . 72.0 111.379 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 18.5 m -121.94 149.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.71 -1.219 . . . . 75.44 107.71 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.25 118.5 20.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.42 -0.585 . . . . 73.24 109.42 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 556' ' ' SER . 82.7 p -90.98 162.85 31.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 113.58 0.956 . . . . 51.12 113.58 -170.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -71.8 -138.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.548 2.832 . . . . 71.32 109.468 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -68.87 -53.45 14.85 Favored Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 113.082 0.771 . . . . 75.13 113.082 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.6 150.88 36.22 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 121.451 1.434 . . . . 73.53 112.062 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -149.9 145.69 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.682 -0.858 . . . . 50.41 108.682 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.11 -20.77 5.89 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 111.28 -0.728 . . . . 74.34 111.28 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 148.75 25.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.069 -0.345 . . . . 52.45 110.069 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.7 t -74.57 115.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.596 -1.631 . . . . 74.13 106.596 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.2 m -72.0 -33.27 67.96 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.72 -0.673 . . . . 72.43 109.824 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.93 -165.04 36.62 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 110.59 -1.004 . . . . 74.01 110.59 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.9 p -125.0 160.83 28.08 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 107.777 -1.194 . . . . 60.42 107.777 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 63.8 t30 -59.82 -51.13 82.96 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 119.757 -0.777 . . . . 74.13 111.27 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.1 Cg_exo -77.52 145.2 23.27 Favored 'Trans proline' 0 C--N 1.367 1.512 0 N-CA-C 108.832 -1.257 . . . . 71.21 108.832 171.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.2 Cg_exo -70.54 152.09 65.05 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.188 1.925 . . . . 63.52 111.9 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -55.38 137.07 48.78 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.028 0.531 . . . . 71.33 110.765 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.68 -20.34 46.63 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 121.102 -0.57 . . . . 32.35 112.023 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 29.6 m -73.44 135.4 44.14 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.841 -0.211 . . . . 52.1 110.566 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 35.5 m -96.98 123.36 40.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.581 -0.525 . . . . 63.25 109.581 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.4 164.17 43.01 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 109.209 -0.663 . . . . 74.21 109.209 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.495 ' HA ' HG22 ' A' ' 494' ' ' THR . 7.4 Cg_exo -71.92 133.55 21.89 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 73.31 111.27 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.6 m -68.8 -20.88 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 70.52 111.141 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.8 -16.72 60.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.408 -1.269 . . . . 64.2 110.501 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.2 t -97.08 161.17 13.94 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.005 -0.739 . . . . 72.11 109.005 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.47 134.89 26.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.259 -0.645 . . . . 50.0 109.259 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -105.19 141.01 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.011 0.434 . . . . 51.22 110.577 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -103.08 121.56 42.86 Favored 'General case' 0 N--CA 1.406 -2.63 0 C-N-CA 123.525 0.73 . . . . 72.12 110.433 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.01 134.27 42.09 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 124.211 1.004 . . . . 52.34 110.015 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -92.27 108.25 19.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.859 -1.163 . . . . 71.21 107.859 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.82 138.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.798 -0.637 . . . . 71.34 110.33 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 527' ' ' SER . 6.2 p -65.91 119.55 11.5 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.129 0.966 . . . . 74.05 113.585 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 29.1 tttm . . . . . 0 C--O 1.262 1.763 0 C-N-CA 125.691 1.596 . . . . 74.21 108.431 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.281 0 CA-C-O 122.271 1.034 . . . . 63.03 108.443 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -107.69 137.92 44.84 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.986 -1.461 . . . . 73.22 109.662 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.15 156.12 40.62 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.947 -1.131 . . . . 63.04 107.947 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.6 OUTLIER -83.08 141.89 31.68 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 123.524 0.73 . . . . 55.12 111.393 -176.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -85.2 121.17 73.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.431 -0.951 . . . . 64.3 108.431 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.22 143.36 39.51 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.033 1.822 . . . . 72.02 112.253 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.66 32.24 0.59 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.778 0.799 . . . . 63.55 111.851 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.06 -12.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.863 -1.162 . . . . 74.12 107.863 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.6 m -60.49 -36.66 78.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.168 -1.378 . . . . 62.42 109.265 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -57.03 -27.74 61.9 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.217 -1.356 . . . . 75.21 110.465 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.59 -46.64 12.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.626 -0.43 . . . . 73.15 110.688 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 438' ' ' ALA . 40.5 m -166.47 149.05 6.81 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.201 -0.666 . . . . 63.54 109.201 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.54 -46.88 63.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.217 1.007 . . . . 73.22 110.374 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.513 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 73.34 111.365 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.49 -36.92 74.09 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.99 -0.55 . . . . 75.15 111.764 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.45 -52.37 64.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 124.342 1.026 . . . . 72.51 110.435 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 67.3 t -66.8 -50.64 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 115.129 -0.942 . . . . 65.03 111.808 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -62.49 -45.37 93.34 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.767 0.654 . . . . 71.34 112.767 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -68.5 -40.81 80.74 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.873 -0.731 . . . . 64.34 110.933 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.51 -33.87 74.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.055 0.455 . . . . 44.01 109.813 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 37.1 m -59.68 -45.04 93.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.465 -0.789 . . . . 75.42 109.215 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -16.81 62.61 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.726 -0.67 . . . . 63.22 111.159 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.16 -13.78 54.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.825 0.345 . . . . 71.43 110.452 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -18.18 9.1 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 120.308 -0.949 . . . . 61.15 113.178 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.95 130.59 42.61 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.889 -0.411 . . . . 75.54 109.889 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -118.92 -1.31 14.68 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.285 -0.959 . . . . 55.42 112.879 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.42 115.34 20.78 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.367 0.603 . . . . 74.14 109.961 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -125.62 154.87 41.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.895 -1.15 . . . . 74.13 107.895 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 485' ' ' ILE . 28.0 tptp -133.98 122.97 23.83 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.569 -1.271 . . . . 73.25 107.569 174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -91.18 120.84 32.45 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.472 0.654 . . . . 50.2 110.662 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.08 155.62 28.96 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.212 -1.773 . . . . 63.13 106.212 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.8 p30 -138.15 144.3 40.71 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.288 -0.634 . . . . 75.41 109.288 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 t -134.59 140.32 35.19 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 107.616 -1.253 . . . . 64.22 107.616 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_exo -65.13 122.63 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.045 1.83 . . . . 64.23 110.634 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.6 t -144.05 179.91 6.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.587 -1.635 . . . . 52.22 106.587 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -63.55 145.32 97.41 Favored Pre-proline 0 N--CA 1.414 -2.262 0 O-C-N 123.316 0.385 . . . . 73.43 110.026 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 464' ' ' VAL . 4.7 Cg_endo -50.61 -28.07 21.17 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.734 3.623 . . . . 55.31 112.236 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.75 -24.1 65.46 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.923 0.889 . . . . 74.11 112.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.9 5.7 33.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.852 0.686 . . . . 64.11 112.852 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.8 t -61.06 128.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.975 0.416 . . . . 75.4 111.269 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.47 84.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.499 -0.773 . . . . 75.1 111.91 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -111.19 146.79 36.28 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.234 -1.025 . . . . 74.34 108.234 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.8 t -81.39 129.37 37.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.101 -1.074 . . . . 64.4 108.101 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.7 pt -98.75 -9.8 8.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.35 111.418 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.33 163.02 24.62 Favored Glycine 0 CA--C 1.482 -2.005 0 C-N-CA 119.547 -1.311 . . . . 73.3 110.863 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.8 p -116.73 146.13 43.0 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.779 -0.822 . . . . 63.05 108.779 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.5 t30 -57.72 -50.04 90.34 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 123.315 0.384 . . . . 73.32 110.531 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_endo -85.01 137.91 6.54 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 N-CA-C 107.838 -1.639 . . . . 71.31 107.838 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 476' ' ' GLN . 6.3 Cg_exo -61.27 141.01 91.62 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.343 1.362 . . . . 73.24 111.029 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.66 10.72 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.377 1.084 . . . . 72.34 109.905 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -95.12 -29.91 14.32 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 113.84 -1.527 . . . . 65.45 108.398 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 473' ' ' PRO . 14.2 pt20 -98.86 170.78 8.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.779 -0.646 . . . . 62.31 109.93 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.7 p -98.49 134.02 42.05 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 116.036 -0.529 . . . . 50.15 109.886 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.0 m -114.0 145.53 41.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.462 -0.57 . . . . 72.22 109.462 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -59.39 148.11 33.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.974 0.416 . . . . 72.32 111.992 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.51 -30.74 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 123.537 0.735 . . . . 74.34 111.514 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -101.39 17.24 23.17 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.284 0.564 . . . . 65.51 110.549 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -88.56 139.3 30.62 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.785 -1.191 . . . . 65.15 107.785 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.95 111.08 16.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.642 0.734 . . . . 55.21 109.363 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.89 118.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.515 -0.92 . . . . 73.43 108.515 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 453' ' ' LYS . 46.8 mt -99.25 111.55 29.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.501 -1.296 . . . . 74.24 107.501 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 486' ' ' ILE . 0.0 OUTLIER -103.7 129.97 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-O 121.075 0.464 . . . . 61.11 110.16 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.71 116.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.233 -1.025 . . . . 64.41 108.233 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.42 140.07 18.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.966 -0.561 . . . . 73.25 109.568 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.71 118.15 6.93 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.454 -1.058 . . . . 74.35 110.454 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.3 m -119.96 132.72 55.6 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.846 -0.798 . . . . 73.21 108.846 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.329 0 N-CA-C 109.991 -1.243 . . . . 72.15 109.991 -177.083 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.643 0 N-CA-C 108.12 -1.067 . . . . 75.12 108.12 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 546' ' ' PRO . 35.6 p -124.66 156.92 36.75 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.077 -0.965 . . . . 63.43 108.956 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.05 150.29 31.53 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 70.05 107.779 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 544' ' ' THR . 6.7 p-10 -99.46 138.22 36.86 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 120.948 0.404 . . . . 74.53 110.282 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 541' ' ' ALA . 31.5 pt -88.15 133.91 36.02 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.556 -0.747 . . . . 74.12 111.985 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.3 177.0 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.603 2.202 . . . . 63.32 110.877 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.07 115.45 27.34 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.635 -0.426 . . . . 74.21 110.295 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.2 14.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.514 1.15 . . . . 63.11 108.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.49 143.23 46.68 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.09 -0.959 . . . . 61.21 110.48 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.7 -24.71 10.09 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.056 -0.592 . . . . 64.22 111.631 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.89 177.62 6.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.6 m -75.85 155.47 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.628 -0.508 . . . . 74.22 109.628 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.51 -49.1 14.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 123.719 0.637 . . . . 73.14 112.614 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.42 -42.51 74.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.259 0.466 . . . . 64.32 112.259 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -39.48 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 119.786 -0.766 . . . . 74.45 111.861 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.56 83.66 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.785 -0.643 . . . . 65.32 111.365 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.75 -35.52 80.96 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 120.219 -0.592 . . . . 70.24 110.5 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 513' ' ' ASN . 59.9 tttp -63.11 -48.9 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.462 0.648 . . . . 73.1 110.139 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -68.84 -38.24 79.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.264 -0.88 . . . . 63.24 111.453 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.03 -35.94 81.01 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 108.969 -0.752 . . . . 70.13 108.969 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 510' ' ' LYS . 2.5 t-20 -57.28 -38.8 74.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 75.43 110.115 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.06 -44.28 97.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.223 0.535 . . . . 54.01 110.632 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -103.23 16.46 26.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 65.21 111.235 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.1 -117.9 1.28 Allowed Glycine 0 N--CA 1.414 -2.792 0 C-N-CA 120.766 -0.731 . . . . 44.41 112.421 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 16.7 m-85 -122.01 173.4 7.56 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 110.263 -0.273 . . . . 72.0 110.263 -171.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 19.5 p -96.23 -14.26 22.83 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.752 -0.658 . . . . 75.21 111.409 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.18 115.69 29.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.559 -0.291 . . . . 64.33 111.448 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -120.98 151.34 39.85 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.278 0.561 . . . . 74.32 111.095 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.2 m -135.64 152.21 51.0 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.892 -1.892 . . . . 75.21 105.892 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -119.39 123.55 44.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.634 -0.876 . . . . 54.3 108.634 -170.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.84 121.24 42.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.451 -0.574 . . . . 72.21 109.451 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 557' ' ' LYS . 19.4 p -87.88 116.27 25.92 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.115 0.484 . . . . 51.42 110.099 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.53 162.14 21.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 115.533 -0.758 . . . . 73.01 110.16 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.69 121.44 24.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.152 0.977 . . . . 72.43 109.967 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 556' ' ' SER . 2.6 p -144.9 101.77 4.52 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 114.189 -1.369 . . . . 72.45 109.967 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.61 -57.35 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.559 2.839 . . . . 54.34 114.481 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 57.1 mtt180 -80.04 -49.43 1.27 Allowed Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 113.06 0.763 . . . . 72.31 113.06 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 39.6 Cg_exo -62.03 134.94 52.2 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.739 1.626 . . . . 72.25 112.306 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.07 74.36 0.97 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.89 3.68 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 110.747 -0.941 . . . . 73.5 110.747 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -86.19 149.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.256 0.55 . . . . 75.03 111.147 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 553' ' ' LEU . 87.7 t -73.71 124.7 31.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.345 -0.843 . . . . 64.25 109.079 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.6 m -76.23 -28.95 57.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.592 -1.185 . . . . 52.31 110.252 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.77 -159.66 31.2 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.03 -1.228 . . . . 73.22 110.03 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.5 p -127.18 157.38 39.92 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.261 -1.015 . . . . 62.23 108.261 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.5 t30 -66.81 -54.65 20.56 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.086 -0.645 . . . . 74.31 110.613 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.5 Cg_exo -71.7 131.59 18.82 Favored 'Trans proline' 0 C--N 1.377 2.033 0 N-CA-C 108.113 -1.534 . . . . 64.13 108.113 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.4 147.46 90.69 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.463 2.108 . . . . 64.43 113.075 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -63.26 142.82 58.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.988 -0.551 . . . . 53.3 110.56 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.99 64.0 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.519 -0.632 . . . . 61.21 111.519 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.1 m -79.65 132.39 36.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.582 -0.525 . . . . 71.51 109.582 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 496' ' ' ASP . 41.2 m -97.91 122.23 40.77 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.308 -0.997 . . . . 73.33 108.308 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.52 165.25 37.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.472 -0.936 . . . . 74.03 108.472 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.486 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.3 Cg_exo -59.5 137.58 78.7 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.493 2.129 . . . . 63.33 113.69 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.665 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -67.3 -19.69 25.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.157 -0.929 . . . . 71.54 112.259 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.76 -3.67 58.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.674 -1.148 . . . . 64.55 109.667 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.7 m -95.7 152.24 18.64 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 115.371 -0.831 . . . . 53.11 110.559 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.9 t -88.71 134.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.688 -0.687 . . . . 73.25 110.433 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 497' ' ' ILE . 9.3 tt -102.53 141.96 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 109.551 -0.537 . . . . 75.41 109.551 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -103.02 122.37 44.49 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.814 -0.809 . . . . 72.42 108.814 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 534' ' ' VAL . 20.0 tp -98.22 128.85 44.9 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.031 -0.986 . . . . 74.13 108.751 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -88.2 106.31 18.11 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.82 -0.807 . . . . 71.23 108.82 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 524' ' ' SER . 29.7 m -105.56 139.11 27.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 115.662 -0.699 . . . . 33.42 110.429 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.411 ' HA ' ' OG ' ' A' ' 527' ' ' SER . 22.3 p -57.16 120.76 8.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.537 -0.756 . . . . 73.11 112.139 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 524' ' ' SER . 57.4 tttm . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 109.31 -0.626 . . . . 74.31 109.31 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.858 0 CA-C-O 121.504 0.668 . . . . 71.42 109.552 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 60.0 mt-30 -109.69 125.54 52.74 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.561 -1.2 . . . . 74.23 108.926 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -123.12 160.44 26.44 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.169 -1.048 . . . . 73.43 108.169 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.97 141.64 28.46 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.635 -0.505 . . . . 73.1 109.635 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.59 119.41 76.76 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.73 -0.841 . . . . 74.21 108.73 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.94 144.51 43.19 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.275 1.983 . . . . 65.21 111.99 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.97 59.44 5.63 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.164 1.459 . . . . 72.52 109.17 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 439' ' ' GLU . 11.3 p -108.14 -5.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 106.333 -1.728 . . . . 64.21 106.333 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 1.3 p -63.25 -32.37 73.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.864 -1.971 . . . . 71.21 109.704 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.416 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 12.6 t -63.02 -26.79 69.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.332 -1.304 . . . . 63.11 111.103 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 432' ' ' VAL . 80.4 mt -85.54 -46.7 10.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.02 -1.072 . . . . 52.43 111.488 -173.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 1.8 m -171.88 150.6 2.63 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.172 -1.047 . . . . 72.0 108.172 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -52.63 -48.27 66.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.224 0.61 . . . . 74.42 110.631 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.78 66.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.731 -0.668 . . . . 54.21 111.968 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.503 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.4 mm-40 -70.98 -42.85 69.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.285 -0.416 . . . . 75.44 111.126 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.457 ' HA ' HG13 ' A' ' 432' ' ' VAL . . . -60.6 -47.06 87.89 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.199 -0.909 . . . . 73.41 110.75 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.54 -48.78 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.663 -0.699 . . . . 51.52 111.227 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -62.29 -44.65 96.02 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.024 0.379 . . . . 54.35 112.024 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 443' ' ' LYS . 6.5 mmpt? -66.56 -42.68 86.72 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.76 -0.376 . . . . 43.44 111.673 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.431 HD23 ' CE1' ' A' ' 452' ' ' PHE . 10.3 tp -69.41 -32.97 72.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.274 0.559 . . . . 71.22 110.106 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.6 m -64.45 -41.55 96.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.847 -0.615 . . . . 64.54 109.405 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.23 -16.22 63.02 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.168 0.508 . . . . 64.12 110.942 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.65 -13.06 46.66 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.099 -0.5 . . . . 63.04 110.086 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.54 -9.31 24.08 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.002 -0.618 . . . . 72.32 113.95 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -71.85 143.72 49.32 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.889 0.344 . . . . 73.3 111.194 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -149.0 16.54 1.19 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.69 -0.767 . . . . 64.31 112.319 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -120.97 115.77 23.82 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.987 -1.486 . . . . 71.32 106.987 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.431 ' CE1' HD23 ' A' ' 444' ' ' LEU . 96.5 m-85 -141.36 160.64 39.7 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 113.514 0.931 . . . . 72.41 113.514 -171.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -142.33 134.08 26.93 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.197 1.799 . . . . 74.14 107.012 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -103.65 132.03 50.27 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.62 -0.511 . . . . 73.42 109.62 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.53 139.24 53.37 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.767 -0.827 . . . . 75.41 108.767 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -114.17 130.19 56.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.607 -0.886 . . . . 62.35 108.607 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.1 m -120.63 138.17 27.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.517 -0.311 . . . . 74.35 110.433 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 14.9 Cg_exo -69.85 122.61 9.26 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.357 2.038 . . . . 74.32 111.007 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -144.75 179.07 7.55 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.039 -1.467 . . . . 41.31 107.039 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.532 ' OG1' ' HD2' ' A' ' 461' ' ' PRO . 6.6 t -70.76 144.2 90.56 Favored Pre-proline 0 N--CA 1.433 -1.322 0 N-CA-C 109.039 -0.726 . . . . 74.3 109.039 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 464' ' ' VAL . 2.0 Cg_endo -48.8 -27.88 12.0 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 125.165 3.91 . . . . 61.15 115.476 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.72 -13.22 61.98 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.29 -1.364 . . . . 54.42 112.343 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' A' ' 466' ' ' LYS . 2.8 mm? -98.23 -0.14 44.64 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.831 -0.543 . . . . 71.13 111.364 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 461' ' ' PRO . 84.9 t -61.51 128.14 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.799 -0.445 . . . . 71.42 109.799 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.79 -16.73 60.15 Favored Glycine 0 C--O 1.244 0.773 0 C-N-CA 121.099 -0.572 . . . . 73.11 111.996 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 463' ' ' LEU . 78.5 tttt -92.77 142.66 27.1 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.894 -0.78 . . . . 74.15 108.894 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.595 HG22 HD11 ' A' ' 486' ' ' ILE . 60.2 t -82.85 124.85 39.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.628 -1.619 . . . . 75.15 106.628 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -105.16 -5.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 118.667 -1.213 . . . . 74.0 111.803 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.14 160.14 27.84 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 119.775 -1.202 . . . . 55.12 112.666 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.4 p -134.42 145.33 48.79 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.196 -1.409 . . . . 71.51 107.196 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.41 ' OD1' ' HB ' ' A' ' 485' ' ' ILE . 12.5 m120 -64.4 -51.08 63.11 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 120.364 -0.534 . . . . 75.13 112.202 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.55 123.38 11.35 Favored 'Trans proline' 0 C--O 1.253 1.252 0 N-CA-C 108.716 -1.302 . . . . 70.42 108.716 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.38 139.19 37.52 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.217 1.945 . . . . 55.11 112.185 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.24 2.14 37.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.724 0.773 . . . . 54.13 110.608 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.24 -32.92 24.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.877 -1.056 . . . . 55.14 110.094 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.67 178.37 4.42 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.155 -1.054 . . . . 44.41 108.155 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 32.5 p -97.04 126.54 42.26 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-O 121.277 0.561 . . . . 61.51 110.547 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -106.77 147.05 30.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.479 -0.934 . . . . 52.45 108.479 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.5 147.58 41.75 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 120.9 0.381 . . . . 60.33 111.584 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.85 -21.9 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.31 1.044 . . . . 75.5 111.26 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -94.85 1.78 55.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.417 -0.811 . . . . 71.33 110.103 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -78.83 144.6 34.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.971 -0.751 . . . . 74.03 108.971 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 38.7 t -82.13 112.49 20.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.558 -1.275 . . . . 62.31 107.558 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.69 119.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 N-CA-C 109.176 -0.676 . . . . 63.12 109.176 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.41 ' HB ' ' OD1' ' A' ' 471' ' ' ASN . 3.3 mp -97.68 119.48 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.463 -2.051 . . . . 44.35 105.463 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.595 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -109.19 128.43 65.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.95 -0.568 . . . . 72.44 109.981 -175.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 58.5 mt -103.65 112.51 37.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-N 115.299 -0.864 . . . . 73.25 110.52 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.16 140.57 17.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 115.517 -0.765 . . . . 73.53 109.585 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.68 129.3 9.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.237 -1.145 . . . . 30.11 110.237 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.5 p -135.58 152.03 50.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.842 -0.429 . . . . 62.52 109.842 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 109.986 -1.245 . . . . 54.12 109.986 178.271 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 121.743 0.783 . . . . 54.01 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.7 p -138.72 162.81 33.76 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.197 -0.911 . . . . 70.23 110.476 -172.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 517' ' ' PHE . 48.0 tptt -146.61 139.85 25.63 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.318 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -80.61 137.73 36.39 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.214 1.005 . . . . 63.33 109.023 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.6 pt -97.34 133.29 24.04 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 120.041 -0.663 . . . . 74.15 110.674 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.22 178.22 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.512 2.141 . . . . 72.14 110.296 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.0 122.53 38.92 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.153 -0.619 . . . . 73.24 110.045 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.36 6.02 5.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.652 -0.704 . . . . 72.23 110.102 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.561 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -74.01 147.2 43.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.553 -0.749 . . . . 73.02 110.712 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.46 -14.23 56.63 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.051 -0.82 . . . . 63.42 111.051 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -99.58 -170.04 1.84 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.583 -0.525 . . . . 61.13 109.583 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.1 m -82.08 155.77 24.91 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.667 -1.234 . . . . 74.43 107.667 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.76 -42.09 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.712 0.292 . . . . 74.41 111.537 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 31.9 t70 -68.19 -43.46 78.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.197 0.443 . . . . 55.22 112.197 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.26 -34.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.77 -0.772 . . . . 70.22 110.839 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.73 -49.18 78.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.728 . . . . 74.32 110.752 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.61 -34.66 78.76 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 120.669 -0.412 . . . . 73.13 111.009 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 12.7 mmmm -57.36 -53.16 61.29 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.166 0.291 . . . . 71.01 111.148 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -62.84 -40.63 98.04 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.38 0.61 . . . . 65.41 110.285 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 551' ' ' ILE . 46.7 tp -64.91 -38.51 91.21 Favored 'General case' 0 C--O 1.191 -2.02 0 CA-C-N 115.081 -0.963 . . . . 71.01 110.928 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -61.13 -37.96 84.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.163 0.585 . . . . 70.35 111.54 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.24 -29.8 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 64.23 110.697 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.66 31.21 6.36 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.166 -0.334 . . . . 72.12 110.363 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -160.39 -108.7 0.24 Allowed Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 119.009 -1.567 . . . . 51.42 113.759 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 495' ' ' LYS . 18.3 m-85 -137.69 177.26 8.01 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.876 -0.787 . . . . 75.13 108.876 -172.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 m -112.13 6.5 19.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 122.296 1.046 . . . . 61.52 108.725 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -108.52 115.75 30.69 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.647 -0.872 . . . . 72.22 108.647 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -128.16 150.87 49.81 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.293 0.371 . . . . 72.42 110.222 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.8 m -130.8 155.7 46.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.572 -1.27 . . . . 63.21 107.572 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -121.91 122.25 38.96 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.998 0.428 . . . . 74.13 110.001 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.47 56.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -90.07 118.9 29.96 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.575 -0.898 . . . . 74.53 108.575 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.6 152.23 25.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.584 -0.895 . . . . 70.23 108.584 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.64 123.04 25.53 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.606 1.193 . . . . 54.33 111.098 -169.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.5 m -128.49 101.04 21.63 Favored Pre-proline 0 N--CA 1.416 -2.138 0 CA-C-N 113.795 -1.548 . . . . 65.01 109.102 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.26 -57.15 1.19 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.032 2.488 . . . . 74.04 112.538 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -88.33 -49.41 0.43 Allowed Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 113.349 0.87 . . . . 73.33 113.349 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.59 146.52 95.38 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 121.883 1.722 . . . . 44.31 112.701 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.11 85.04 0.32 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.395 1.078 . . . . 72.33 108.381 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.0 -35.05 2.44 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 110.543 -1.023 . . . . 72.32 110.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -85.31 147.21 26.65 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.155 0.502 . . . . 65.12 109.91 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.4 p -75.07 126.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.499 -0.926 . . . . 74.03 108.499 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.2 m -72.11 -36.57 69.48 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.331 -0.85 . . . . 61.11 109.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 172.46 -167.44 40.35 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.258 -0.972 . . . . 60.04 111.728 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.1 p -118.71 160.62 21.53 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.525 -0.917 . . . . 71.1 108.525 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.6 t-20 -61.58 -53.39 61.91 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.93 -0.308 . . . . 74.03 111.33 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -87.81 144.93 6.5 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 108.912 -1.226 . . . . 73.24 108.912 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.3 Cg_exo -69.13 150.83 72.52 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 121.816 1.677 . . . . 64.53 111.447 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.09 135.83 36.72 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.674 0.79 . . . . 61.43 111.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.98 -26.51 20.52 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.228 -0.749 . . . . 61.44 111.228 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 88.2 m -65.68 133.69 51.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.501 . . . . 72.44 111.184 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.3 m -101.99 122.87 44.88 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.271 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.44 155.55 71.65 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.639 -0.504 . . . . 73.01 109.639 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 494' ' ' THR . 11.6 Cg_endo -58.86 138.98 88.82 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.664 2.243 . . . . 70.45 112.944 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.492 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 21.4 m -67.04 -19.7 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 122.344 1.069 . . . . 71.42 110.344 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.31 -2.67 39.14 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.956 -1.475 . . . . 72.53 110.453 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -108.43 172.38 6.87 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.751 -0.833 . . . . 74.25 108.751 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.58 136.34 50.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.872 -0.788 . . . . 74.52 108.872 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 512' ' ' LEU . 16.7 tt -94.51 138.88 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 120.063 -0.655 . . . . 72.53 110.531 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -102.17 124.01 47.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-O 121.241 0.543 . . . . 74.31 110.032 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.98 131.2 46.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.233 -1.765 . . . . 73.1 106.233 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -107.12 105.95 16.2 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.717 0.77 . . . . 63.21 110.234 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.03 139.83 16.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.134 -1.394 . . . . 75.42 111.487 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.1 p -56.33 114.71 2.1 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 63.2 112.903 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.358 -1.719 . . . . 52.31 106.358 174.129 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 122.67 1.224 . . . . 75.3 107.79 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 478' ' ' SER . 96.0 mt-30 -110.1 135.67 50.54 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.004 -1.453 . . . . 73.22 109.962 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -126.29 158.53 35.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.036 0.446 . . . . 64.45 111.436 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.92 141.99 30.0 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.789 -1.096 . . . . 75.43 110.532 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.27 129.93 70.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.721 -0.844 . . . . 63.43 108.721 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.89 141.8 65.6 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.671 2.914 . . . . 72.32 114.792 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.26 -3.05 48.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.918 -1.037 . . . . 74.15 111.271 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.8 m -85.68 3.39 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.603 0.716 . . . . 61.32 110.812 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 14.8 m -61.48 -29.57 70.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.823 -1.08 . . . . 71.32 110.196 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.494 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 18.2 p -62.44 -27.87 69.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.102 -0.953 . . . . 75.41 111.524 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.6 -45.44 21.63 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.925 -0.398 . . . . 74.55 109.925 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 16.1 m -166.79 148.27 6.13 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.717 -0.846 . . . . 71.54 108.717 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 441' ' ' VAL . 53.1 t80 -53.27 -43.01 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.925 0.89 . . . . 74.24 111.301 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.75 -41.16 85.88 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.483 -0.326 . . . . 53.12 111.24 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.5 mm-40 -63.69 -40.61 97.23 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.248 0.547 . . . . 74.52 110.099 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -50.96 71.54 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.982 -1.008 . . . . 73.01 110.595 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 437' ' ' TYR . 92.7 t -59.42 -45.84 93.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.37 -0.832 . . . . 71.23 111.819 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 67.7 mttm -63.05 -47.28 83.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.695 0.283 . . . . 72.23 111.591 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -67.78 -38.81 83.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.312 -0.404 . . . . 74.25 111.399 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.55 -37.98 83.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.235 0.54 . . . . 74.23 109.88 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.2 m -59.47 -47.87 83.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.425 -0.807 . . . . 73.11 109.784 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.45 -15.83 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.011 -0.541 . . . . 62.53 111.933 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.0 -13.73 59.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.242 0.544 . . . . 74.41 110.433 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.88 -17.62 24.88 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.421 -0.895 . . . . 53.32 113.11 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -64.05 126.95 29.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.109 0.481 . . . . 55.43 111.082 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -110.12 -1.89 29.91 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.385 -0.825 . . . . 73.11 111.277 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 3.0 mpt_? -123.73 114.87 20.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.227 0.536 . . . . 71.52 110.187 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -147.68 146.81 29.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.429 -0.805 . . . . 61.14 110.361 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -131.13 126.51 35.9 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.363 -0.606 . . . . 72.44 109.363 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -84.0 122.35 28.64 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.613 -0.721 . . . . 72.44 111.191 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.36 149.86 41.12 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.069 -1.456 . . . . 40.21 107.069 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -127.92 146.82 50.51 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.785 -0.45 . . . . 50.22 109.785 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 44.5 m -124.57 131.45 24.16 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.791 -0.818 . . . . 75.12 108.791 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.51 123.81 11.61 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.461 2.107 . . . . 71.51 111.056 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 49.7 m -147.02 -179.72 7.01 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.444 -0.947 . . . . 65.45 108.444 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -49.75 136.35 19.24 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.896 0.878 . . . . 73.31 110.66 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.599 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 9.1 Cg_endo -50.66 -36.5 50.83 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.666 3.578 . . . . 75.35 114.786 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -77.58 -8.75 58.32 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.261 0.837 . . . . 73.23 113.261 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 18.0 tp -84.39 -11.82 55.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.003 0.43 . . . . 71.25 110.433 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.3 p -56.72 135.91 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.443 -0.799 . . . . 72.33 112.028 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.04 55.21 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 121.06 -0.59 . . . . 74.42 114.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 434' ' ' THR . 14.3 ptmm? -107.85 148.18 29.92 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.919 -1.112 . . . . 74.45 110.396 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 61.0 t -81.39 131.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.719 -0.474 . . . . 50.25 109.719 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 33.8 pt -101.04 -10.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.992 -0.549 . . . . 73.12 111.529 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.98 172.42 33.31 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.213 -0.755 . . . . 74.34 111.213 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 159.07 37.63 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.099 -0.704 . . . . 44.34 109.099 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.3 t-20 -60.6 -56.17 37.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 119.16 -0.448 . . . . 72.31 111.58 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.7 Cg_endo -85.88 146.15 9.05 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 121.192 1.261 . . . . 73.32 109.486 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.618 ' HG2' ' HG2' ' A' ' 476' ' ' GLN . 14.2 Cg_exo -62.88 149.8 90.33 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.693 1.595 . . . . 73.32 111.637 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.7 -11.66 60.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.654 0.74 . . . . 72.32 109.798 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -96.2 -12.19 25.0 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.222 -0.899 . . . . 71.13 112.012 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.618 ' HG2' ' HG2' ' A' ' 473' ' ' PRO . 4.1 mm-40 -96.11 155.07 16.91 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 119.435 -0.906 . . . . 63.34 108.845 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.416 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 34.7 p -101.2 120.68 40.6 Favored 'General case' 0 N--CA 1.395 -3.185 0 N-CA-C 108.372 -0.974 . . . . 74.54 108.372 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 24.6 m -105.1 140.05 38.86 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.203 -0.666 . . . . 33.01 109.203 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -61.63 146.78 47.94 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.953 -0.388 . . . . 73.32 109.953 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.39 -23.0 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 123.597 0.759 . . . . 70.34 111.965 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.6 t -77.84 -8.02 57.47 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.355 -0.384 . . . . 62.43 111.299 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -74.87 136.2 41.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 120.909 0.385 . . . . 72.01 110.833 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.66 113.85 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 0 N-CA-C 106.588 -1.634 . . . . 74.21 106.588 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 63.0 t -86.63 119.93 35.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.136 -0.69 . . . . 71.43 109.136 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.84 111.86 24.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.885 -1.524 . . . . 75.32 106.885 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.68 128.11 55.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.68 -1.146 . . . . 74.44 108.719 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 54.8 mt -104.52 114.04 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.614 0.721 . . . . 75.14 110.988 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.55 130.33 45.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.471 -0.786 . . . . 62.42 109.421 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.31 114.51 4.98 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 107.81 -2.116 . . . . 30.3 107.81 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.1 m -120.54 129.37 53.77 Favored 'General case' 0 N--CA 1.412 -2.347 0 C-N-CA 120.163 -0.615 . . . . 74.41 109.525 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.409 -3.155 0 N-CA-C 110.218 -1.153 . . . . 60.34 110.218 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.702 -0.851 . . . . 73.24 108.702 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 546' ' ' PRO . 6.9 p -133.5 152.26 51.88 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.678 -1.147 . . . . 73.32 109.467 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.82 143.75 27.69 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.717 -0.475 . . . . 75.03 109.717 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 543' ' ' THR . 7.3 p-10 -93.0 138.32 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.681 -0.859 . . . . 65.52 108.681 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 497' ' ' ILE . 0.2 OUTLIER -93.82 121.04 65.29 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 114.849 1.426 . . . . 62.11 114.849 -176.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.75 136.27 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 106.294 -2.233 . . . . 73.11 106.294 164.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.37 139.86 56.64 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.796 0.807 . . . . 74.44 111.866 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.27 27.88 3.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.854 -1.535 . . . . 72.44 106.854 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.87 137.63 33.59 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.963 -1.471 . . . . 61.44 110.583 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.07 -48.23 0.93 Allowed Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.572 -0.823 . . . . 53.02 112.612 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -91.6 -168.69 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 111.877 0.325 . . . . 74.51 111.877 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.9 p -82.58 162.24 22.01 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 112.898 0.703 . . . . 73.34 112.898 -170.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.8 t -48.11 -52.5 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 O-C-N 124.839 1.337 . . . . 74.42 110.16 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 1.8 m-20 -68.04 -42.18 80.98 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.855 -1.066 . . . . 70.21 112.753 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.28 -35.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 119.214 -0.994 . . . . 73.33 111.497 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.444 ' HB3' HG21 ' A' ' 534' ' ' VAL . . . -64.06 -42.58 96.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.754 -0.657 . . . . 71.21 111.021 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 28.4 mt-30 -61.4 -43.36 98.99 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.989 -0.375 . . . . 75.01 109.989 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.8 mptp? -61.74 -49.31 76.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.79 -0.641 . . . . 62.15 111.883 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -62.58 -47.78 82.3 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 123.205 0.315 . . . . 75.33 110.66 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.11 -43.29 99.1 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.938 -0.574 . . . . 73.15 110.719 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.38 -37.22 74.82 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.717 0.807 . . . . 71.14 111.75 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.1 t -63.44 -42.48 96.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 116.282 -0.417 . . . . 73.11 111.869 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -108.21 -18.45 13.77 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.944 -1.102 . . . . 73.43 111.856 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -102.98 -100.47 2.57 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 115.079 0.792 . . . . 43.12 115.079 -171.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.568 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 49.0 m-85 -127.56 172.69 10.51 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.916 0.389 . . . . 73.32 111.183 -168.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.8 p -106.27 -25.73 11.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.485 -0.78 . . . . 65.32 111.047 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.73 121.65 45.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.871 -0.604 . . . . 64.11 109.72 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -128.46 143.4 50.98 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.591 . . . . 72.33 112.204 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.8 m -115.15 152.48 32.51 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.732 -1.951 . . . . 54.33 105.732 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -123.39 134.06 54.02 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.175 -0.61 . . . . 73.12 111.586 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.71 121.89 39.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.81 -0.811 . . . . 54.44 108.81 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.5 m -88.24 118.05 27.57 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.626 -1.62 . . . . 74.2 106.626 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.0 m -119.97 149.5 22.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.263 -1.384 . . . . 74.13 107.263 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.33 133.75 37.57 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.39 1.091 . . . . 73.22 112.579 -167.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 5.8 m -94.61 129.08 37.52 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 112.962 -1.926 . . . . 71.41 109.165 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.13 -71.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 121.073 1.182 . . . . 71.41 109.072 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.429 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 24.5 mmm180 -111.57 -55.05 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.036 -0.507 . . . . 74.31 112.165 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 527' ' ' SER . 10.7 Cg_exo -73.18 134.48 21.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.306 1.338 . . . . 74.32 111.339 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.51 159.46 43.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.436 -0.95 . . . . 65.3 108.436 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.91 -21.81 25.28 Favored Glycine 0 C--N 1.319 -0.402 0 CA-C-O 121.611 0.562 . . . . 65.02 111.862 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.52 147.77 25.2 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.245 0.545 . . . . 51.35 110.728 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 508' ' ' ALA . 64.5 t -75.88 124.88 34.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -33.21 52.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.315 -0.857 . . . . 70.12 109.44 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.78 -147.18 15.19 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.333 -0.707 . . . . 72.34 111.333 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.0 p -121.79 160.41 24.68 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.955 -0.757 . . . . 62.3 108.955 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -62.55 -52.61 64.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 121.007 -0.277 . . . . 74.04 110.368 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 57.8 Cg_endo -74.41 146.2 34.96 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 120.919 1.079 . . . . 75.34 109.791 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.2 Cg_exo -63.67 154.25 70.35 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.197 1.931 . . . . 73.44 111.9 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.45 132.88 53.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.024 -0.535 . . . . 74.25 109.964 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.49 -10.84 56.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.113 -0.565 . . . . 63.3 111.824 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 71.5 m -77.46 129.3 35.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.616 -0.513 . . . . 65.22 109.616 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.0 t -93.85 122.6 36.5 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.476 0.655 . . . . 63.21 110.148 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.27 158.81 70.13 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.685 -0.857 . . . . 54.44 108.685 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.418 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.7 Cg_exo -63.86 134.29 42.8 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.032 1.821 . . . . 75.23 112.081 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.568 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 17.2 m -67.61 -22.61 28.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.886 0.851 . . . . 73.54 110.849 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.15 0.73 52.89 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.353 -1.294 . . . . 75.32 111.685 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.8 t -98.02 -177.55 3.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.971 -0.751 . . . . 74.44 108.971 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.8 t -109.41 134.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.857 -1.164 . . . . 73.11 107.857 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -115.08 146.0 20.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.498 -0.556 . . . . 75.31 109.498 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.43 130.96 49.36 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-O 121.46 0.647 . . . . 72.21 110.454 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.75 130.96 48.27 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.68 -1.145 . . . . 71.35 108.624 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -94.8 115.33 27.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.959 -1.497 . . . . 73.25 106.959 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.74 135.2 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-N 116.525 -0.307 . . . . 72.31 111.089 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.5 m -74.23 114.39 12.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 109.04 -0.726 . . . . 72.55 109.04 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 11.5 ptmm? . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 114.795 -1.093 . . . . 72.44 110.919 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.4 pt-20 . . . . . 0 N--CA 1.438 -1.074 0 CA-C-O 122.411 1.1 . . . . 74.44 111.041 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 95.7 mt-30 -111.02 130.18 55.67 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.315 -1.311 . . . . 62.04 108.774 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -125.06 150.44 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.322 -0.854 . . . . 70.45 110.354 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 140.7 32.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.107 -0.497 . . . . 74.45 111.575 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -84.26 126.63 69.13 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 108.244 -1.021 . . . . 74.25 108.244 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.8 140.85 36.18 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.311 1.34 . . . . 63.35 110.517 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -105.81 69.37 0.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.457 1.122 . . . . 63.23 109.973 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.483 HG11 ' HD2' ' A' ' 443' ' ' LYS . 14.5 p -113.11 6.32 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 105.937 -1.875 . . . . 75.33 105.937 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.645 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.2 m -57.92 -30.05 65.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.031 -2.35 . . . . 60.5 110.399 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 3.2 m -61.76 -27.83 69.01 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.852 1.261 . . . . 72.15 110.856 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.0 -46.34 9.92 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 118.763 -1.175 . . . . 54.55 111.323 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.569 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.8 m -167.88 151.97 6.34 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.336 -0.616 . . . . 73.45 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -52.14 -49.29 64.02 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.266 1.026 . . . . 74.14 109.507 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.97 76.7 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.256 -0.883 . . . . 71.24 111.412 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.569 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 26.3 mm-40 -61.85 -46.06 91.07 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.239 0.337 . . . . 71.31 110.95 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -63.15 -47.25 83.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.629 -0.714 . . . . 62.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.25 -45.37 98.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-N 116.059 -0.519 . . . . 72.34 111.658 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -60.8 -47.58 85.67 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 122.197 0.199 . . . . 72.21 111.453 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 432' ' ' VAL . 65.0 mttm -67.79 -39.14 84.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.381 -0.527 . . . . 71.12 112.34 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.4 tp -68.05 -37.06 80.88 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.319 0.58 . . . . 72.45 109.898 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -65.13 -41.81 94.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.509 -0.769 . . . . 75.32 109.4 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.75 -21.44 63.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.845 -0.616 . . . . 70.32 110.768 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.86 -13.33 59.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.335 0.588 . . . . 64.45 109.767 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.98 16.07 61.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.693 -0.685 . . . . 72.13 113.61 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.24 133.39 52.7 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.123 0.487 . . . . 72.21 111.141 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -90.39 -48.93 3.37 Favored Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.505 -0.771 . . . . 74.3 113.059 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -110.38 116.0 30.66 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.306 -0.958 . . . . 73.13 111.905 -172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 39.7 p90 -146.66 146.36 30.35 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.891 -0.595 . . . . 73.02 110.448 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -131.75 131.83 43.32 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.281 -0.637 . . . . 71.31 109.281 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -89.25 129.82 35.75 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.806 0.336 . . . . 74.24 110.752 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.99 144.68 48.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.432 -1.321 . . . . 72.11 107.432 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -123.09 144.56 49.23 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.906 -0.718 . . . . 63.03 110.258 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.9 m -137.75 131.28 16.98 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.114 -0.494 . . . . 63.51 110.211 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.47 123.41 11.1 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.6 2.2 . . . . 72.24 111.218 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.5 p -142.78 179.25 7.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.991 -0.55 . . . . 52.24 110.476 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.2 t -56.38 143.38 66.0 Favored Pre-proline 0 N--CA 1.429 -1.485 0 C-N-CA 124.116 0.967 . . . . 63.14 109.987 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 464' ' ' VAL . 85.5 Cg_exo -50.58 -29.23 24.33 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.047 3.164 . . . . 75.41 113.01 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.06 -35.7 81.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.568 0.581 . . . . 74.05 112.568 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.87 -9.38 46.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 111.584 0.216 . . . . 42.02 111.584 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 61.4 t -61.5 127.02 20.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 109.88 -0.415 . . . . 75.42 109.88 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.3 71.4 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.562 -0.745 . . . . 33.05 111.798 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 434' ' ' THR . 4.3 mptp? -98.88 145.49 26.95 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.344 0.658 . . . . 75.41 109.475 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 94.9 t -82.12 126.61 39.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.378 -1.712 . . . . 74.34 106.378 173.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.24 -5.39 9.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.815 -0.754 . . . . 72.12 111.641 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.04 13.33 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.103 -1.046 . . . . 54.24 112.997 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 31.7 p -116.91 141.46 48.2 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.607 -1.257 . . . . 70.35 107.607 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.461 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 28.1 t-20 -57.16 -53.52 64.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-O 119.105 -0.474 . . . . 73.54 111.914 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.67 144.54 17.6 Favored 'Trans proline' 0 C--N 1.36 1.143 0 CA-C-N 120.459 1.2 . . . . 74.23 109.087 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.26 147.85 93.49 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.536 2.158 . . . . 75.13 111.536 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.85 -21.56 26.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.026 0.441 . . . . 42.54 111.625 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.85 -30.72 59.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.7 0.762 . . . . 35.3 109.717 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.25 152.93 17.94 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.539 -0.755 . . . . 74.42 110.036 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.2 p -85.19 117.68 24.28 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 115.945 -0.571 . . . . 71.33 110.593 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.2 m -100.79 146.63 27.03 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.573 -1.269 . . . . 73.15 107.573 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -71.31 150.79 44.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 118.078 0.399 . . . . 62.54 110.502 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.56 -25.06 23.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 124.316 1.046 . . . . 75.03 110.83 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -100.55 0.17 38.92 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.514 -0.766 . . . . 72.31 111.278 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -77.35 151.81 34.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.205 -1.406 . . . . 73.23 107.205 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.34 111.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 119.211 -0.995 . . . . 70.55 110.495 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 75.0 t -90.31 118.72 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.235 -1.024 . . . . 75.4 108.235 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 69.2 mt -95.18 119.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.345 -1.354 . . . . 72.32 107.345 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.99 119.67 55.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 109.361 -0.607 . . . . 64.3 109.361 -177.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 487' ' ' ILE . 3.2 mp -99.03 119.67 47.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 121.352 0.596 . . . . 73.31 109.68 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.65 136.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.299 -0.864 . . . . 54.12 109.995 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.97 112.47 3.81 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 107.595 -2.202 . . . . 63.54 107.595 172.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.5 m -114.27 158.41 21.44 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.705 -0.48 . . . . 74.01 109.705 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.408 0 C-N-CA 120.673 -0.775 . . . . 64.02 111.345 -178.323 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.7 0 CA-C-O 122.12 0.962 . . . . 74.44 110.131 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -137.31 156.31 48.4 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.756 -1.201 . . . . 64.23 107.756 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -149.85 157.04 42.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.632 0.604 . . . . 73.42 112.632 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.42 130.6 34.61 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 125.344 1.458 . . . . 75.52 110.219 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -87.27 129.23 52.33 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.397 -0.521 . . . . 54.1 111.402 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.04 162.34 23.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.66 2.24 . . . . 64.34 111.552 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.27 114.55 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.047 -0.524 . . . . 74.33 110.041 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.84 -0.02 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 112.305 0.483 . . . . 72.13 112.305 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -68.87 143.21 54.58 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.407 0.442 . . . . 74.21 110.398 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 90.38 11.61 62.4 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.406 -0.902 . . . . 75.15 111.027 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -122.43 -170.16 2.03 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.841 -0.8 . . . . 75.02 108.841 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.8 m -91.21 155.44 18.58 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.366 -1.346 . . . . 74.33 107.366 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.22 -41.35 80.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.266 0.354 . . . . 73.01 111.606 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.5 m-20 -66.08 -42.98 88.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.23 -0.441 . . . . 74.01 111.463 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.5 -36.38 28.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 119.757 -0.777 . . . . 64.33 110.988 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.53 -46.4 86.21 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.477 -0.783 . . . . 75.33 111.382 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.8 -35.72 82.02 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 120.447 -0.501 . . . . 52.21 110.084 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 mmtp -65.52 -50.69 64.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.552 -0.295 . . . . 73.24 111.516 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.24 -40.51 96.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.289 -0.414 . . . . 71.54 110.936 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.3 -42.61 75.21 Favored 'General case' 0 C--O 1.183 -2.441 0 N-CA-C 109.225 -0.658 . . . . 72.42 109.225 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.18 -40.01 84.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.943 0.497 . . . . 63.01 111.607 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.6 t -67.01 -29.66 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 112.455 0.539 . . . . 73.11 112.455 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -118.55 -5.11 10.76 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.406 -0.918 . . . . 70.22 111.699 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -108.71 1.94 Allowed Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 115.402 -0.817 . . . . 61.12 113.497 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 31.3 m-85 -130.3 174.41 9.87 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.461 -0.495 . . . . 61.33 111.279 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -103.82 -5.13 22.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.403 -0.817 . . . . 54.21 111.096 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 550' ' ' VAL . 14.8 ptpt -113.82 121.04 42.82 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.029 -0.532 . . . . 72.14 110.782 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -126.27 148.54 49.49 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.681 0.753 . . . . 74.24 111.766 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.9 m -127.81 154.94 44.85 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.851 -1.907 . . . . 64.34 105.851 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -121.81 143.21 49.54 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.722 -0.791 . . . . 74.3 109.848 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 554' ' ' GLN . . . -113.73 123.0 48.83 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.933 -1.506 . . . . 70.33 106.933 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.3 m -88.76 116.45 27.03 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.437 -0.801 . . . . 62.21 109.779 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 29.9 m -121.14 156.92 24.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.179 -1.415 . . . . 62.41 107.179 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.39 124.04 27.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.252 0.549 . . . . 74.44 110.438 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 18.3 m -72.15 151.69 92.48 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.631 -1.168 . . . . 75.33 112.626 -173.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 4.5 Cg_exo -80.62 -144.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.848 2.366 . . . . 65.34 107.441 168.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.83 -49.57 68.15 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 121.554 -0.716 . . . . 72.11 111.926 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.95 152.25 36.25 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 121.168 1.245 . . . . 54.4 111.111 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.13 149.66 43.3 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.369 -0.604 . . . . 73.13 109.369 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 101.03 -10.45 58.49 Favored Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.97 -0.633 . . . . 62.54 111.907 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.32 148.81 24.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.315 0.579 . . . . 74.2 111.701 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.536 HG21 ' CB ' ' A' ' 508' ' ' ALA . 95.5 t -75.75 120.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.271 -0.877 . . . . 72.42 109.133 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -82.1 -31.39 30.74 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.121 -0.945 . . . . 74.5 108.751 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 170.62 -169.64 42.5 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.284 -0.726 . . . . 71.35 111.284 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 32.7 p -123.69 149.46 45.46 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.221 -1.77 . . . . 64.1 106.221 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.6 t-20 -56.21 -58.32 17.25 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.978 -0.534 . . . . 61.45 112.069 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.8 Cg_exo -80.5 145.16 16.4 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.343 1.362 . . . . 74.23 108.784 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.1 147.56 73.56 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.898 1.732 . . . . 63.23 112.226 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.51 129.57 32.88 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.728 0.811 . . . . 44.33 110.267 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.68 -7.79 36.58 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.624 -0.798 . . . . 54.51 111.51 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.8 m -82.73 126.87 32.86 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.791 -0.448 . . . . 70.41 109.791 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 87.9 m -93.3 123.18 36.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.037 -1.098 . . . . 63.31 108.037 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.97 158.55 68.38 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 109.113 -0.699 . . . . 52.5 109.113 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 34.6 Cg_exo -61.09 145.66 98.63 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 122.664 2.242 . . . . 71.51 112.129 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.439 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 18.5 m -67.4 -19.24 25.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 122.144 0.974 . . . . 72.33 109.221 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.13 3.78 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 63.0 109.998 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 36.3 t -112.71 141.83 46.04 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.783 -1.192 . . . . 70.04 107.783 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.471 ' HA ' ' HG3' ' A' ' 519' ' ' LYS . 21.9 t -91.34 136.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.306 -0.627 . . . . 72.43 109.306 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.1 tp -91.32 135.02 28.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 110.078 -0.341 . . . . 62.33 110.078 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.86 117.64 35.08 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-O 121.573 0.701 . . . . 72.3 110.7 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.51 118.88 33.95 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.897 -1.52 . . . . 74.13 106.897 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 523' ' ' ALA . 8.9 mt-30 -94.56 106.67 18.66 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.616 -1.253 . . . . 63.34 107.616 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.23 138.56 46.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-N 114.957 -1.02 . . . . 75.33 112.029 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.463 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 31.8 m -61.02 121.1 11.59 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.037 -0.983 . . . . 54.54 109.392 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 22.5 pttp . . . . . 0 C--O 1.254 1.305 0 CA-C-N 115.754 -0.657 . . . . 62.31 110.588 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.1 pt-20 . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.808 0.813 . . . . 73.24 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -83.61 123.57 29.91 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.319 -0.855 . . . . 54.15 109.571 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -120.26 164.45 16.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.788 -1.189 . . . . 71.52 107.788 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.42 141.61 32.62 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 123.247 0.619 . . . . 64.23 112.323 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -85.06 131.46 48.6 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 105.33 -2.1 . . . . 55.23 105.33 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.34 141.5 97.78 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.994 1.796 . . . . 71.41 113.041 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -102.34 -13.03 17.49 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.411 -0.813 . . . . 64.24 108.913 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.61 8.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.046 -0.979 . . . . 62.13 110.331 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.1 m -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.798 -1.092 . . . . 74.43 108.865 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 p -59.29 -27.62 66.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.133 -1.394 . . . . 75.05 111.115 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.42 -45.08 23.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.609 -0.515 . . . . 71.25 109.609 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.7 m -163.69 144.49 8.85 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.148 -1.056 . . . . 51.33 108.148 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 441' ' ' VAL . 30.1 t80 -59.29 -41.38 88.8 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.75 0.42 . . . . 73.14 110.465 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.42 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.16 -40.69 74.27 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.19 0.306 . . . . 64.33 111.176 175.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.456 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 40.7 mm-40 -61.87 -44.43 96.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 116.237 -0.438 . . . . 70.44 110.31 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.23 -47.71 84.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.351 -0.84 . . . . 51.41 110.708 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.7 t -58.7 -50.55 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 O-C-N 123.704 0.628 . . . . 74.05 110.79 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -38.0 84.7 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.789 0.662 . . . . 75.44 112.789 -177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -66.47 -43.29 85.89 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 120.739 0.305 . . . . 72.41 110.719 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.79 -36.88 78.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 74.43 110.313 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.4 m -63.63 -41.28 98.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.995 -0.743 . . . . 74.11 108.995 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.16 -18.67 62.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.987 -0.551 . . . . 63.32 111.239 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.47 -14.65 51.99 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.677 -0.49 . . . . 74.35 109.677 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 85.98 8.73 78.62 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.953 -0.567 . . . . 63.15 114.33 172.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.49 124.54 20.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.213 0.506 . . . . 74.42 111.834 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -63.4 -55.41 25.79 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.054 -0.975 . . . . 21.1 114.285 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 0.4 OUTLIER -121.81 130.95 53.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.282 -0.567 . . . . 74.21 110.761 -174.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.77 144.59 31.25 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.805 -0.634 . . . . 75.14 109.304 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -131.34 141.5 49.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.456 -0.572 . . . . 63.1 109.456 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.63 136.4 34.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.878 0.736 . . . . 64.13 110.813 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.63 52.44 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.55 -2.018 . . . . 72.12 105.55 171.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -138.59 150.47 46.34 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 119.012 0.823 . . . . 72.31 110.138 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 25.6 m -131.94 145.7 58.56 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 108.627 -0.879 . . . . 55.41 108.627 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.63 134.8 26.93 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.505 2.137 . . . . 71.12 112.04 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.3 p -152.15 179.74 8.24 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.866 0.866 . . . . 64.1 109.207 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -59.68 142.3 87.98 Favored Pre-proline 0 N--CA 1.432 -1.339 0 C-N-CA 123.741 0.817 . . . . 44.45 111.411 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 464' ' ' VAL . 54.0 Cg_exo -52.57 -28.13 35.43 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.421 3.414 . . . . 73.13 113.428 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.98 -10.34 59.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.344 0.498 . . . . 64.01 112.344 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 9.5 mp -107.29 0.73 23.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.446 0.535 . . . . 75.5 112.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.1 p -61.29 128.81 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.286 0.565 . . . . 55.31 112.191 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.82 69.7 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 120.896 -0.669 . . . . 74.03 112.427 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 23.5 mtpp -109.91 146.17 35.62 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.318 -0.993 . . . . 72.51 108.318 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 486' ' ' ILE . 63.1 t -81.86 124.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.29 -0.633 . . . . 73.23 109.29 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.1 pt -101.68 -2.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.923 -0.58 . . . . 62.14 111.639 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.99 156.67 11.79 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.119 -0.562 . . . . 50.43 112.324 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 35.0 p -128.5 148.73 50.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.415 -0.957 . . . . 64.12 108.415 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -65.52 -56.18 20.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.273 -0.394 . . . . 61.23 110.477 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 57.3 Cg_endo -82.2 131.37 6.72 Favored 'Trans proline' 0 C--N 1.364 1.369 0 CA-C-N 120.152 1.09 . . . . 74.05 109.473 170.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -72.69 152.61 53.49 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.976 1.784 . . . . 42.53 113.119 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 6.35 11.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.395 1.078 . . . . 72.41 111.232 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.23 -28.64 13.99 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.796 -0.638 . . . . 73.32 111.108 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -115.45 161.47 18.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.211 -0.663 . . . . 73.24 109.211 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 33.3 p -95.35 140.8 29.72 Favored 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 120.483 -0.487 . . . . 71.22 109.875 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . 23.4 m -120.88 147.94 44.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.452 -0.573 . . . . 62.22 109.452 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 482' ' ' ASN . . . -57.12 151.32 15.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.352 0.871 . . . . 64.13 113.352 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 448' ' ' GLY . 45.1 mm -58.07 -32.98 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.049 0.939 . . . . 74.14 110.368 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.2 t -81.4 3.25 25.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.251 -0.886 . . . . 64.51 111.979 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 478' ' ' SER . 0.8 OUTLIER -74.33 158.42 34.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.275 0.559 . . . . 70.01 112.349 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 451' ' ' ARG . 60.4 t -106.97 114.31 45.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.027 -1.101 . . . . 73.52 108.027 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 88.6 t -94.61 119.91 43.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.237 0.541 . . . . 73.25 110.439 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 71.9 mt -96.31 112.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.484 -1.673 . . . . 74.04 106.484 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.19 128.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 116.167 -0.47 . . . . 71.1 110.533 -176.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.93 115.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.599 0.714 . . . . 75.24 111.069 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.53 142.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.547 -0.752 . . . . 72.14 109.55 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.27 113.71 3.77 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.091 -1.204 . . . . 62.25 110.091 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 35.1 t -95.8 129.81 42.92 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 106.748 -1.575 . . . . 61.42 106.748 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.593 0 C-N-CA 119.754 -1.212 . . . . 73.42 112.029 -177.695 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 109.027 -0.731 . . . . 60.1 109.027 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 546' ' ' PRO . 66.6 p -124.92 164.93 19.02 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.25 -0.887 . . . . 74.32 109.123 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 6.4 mmpt? -139.62 144.18 37.57 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.686 -0.857 . . . . 72.11 108.686 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 27.6 t70 -90.59 130.34 36.63 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.788 -0.819 . . . . 54.42 108.788 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 20.4 pt -96.12 121.39 60.77 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.268 -0.573 . . . . 71.34 112.525 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.23 169.96 4.93 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.915 1.743 . . . . 65.31 109.316 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.88 129.71 34.84 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.491 -0.884 . . . . 75.44 109.574 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.35 14.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 123.278 1.513 . . . . 62.11 107.093 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -71.61 138.57 48.82 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.546 -1.661 . . . . 60.41 110.293 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.09 -4.57 41.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.648 -0.787 . . . . 72.51 111.822 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -106.09 176.63 5.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 71.1 p -80.41 157.87 26.13 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.448 -0.901 . . . . 72.35 108.963 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.46 -43.14 86.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.495 0.664 . . . . 62.24 110.19 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.86 -42.8 85.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.77 -1.105 . . . . 73.31 111.812 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.18 -36.84 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 119.431 -0.908 . . . . 73.43 111.243 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.49 73.4 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.908 -0.587 . . . . 71.44 111.282 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.3 -35.97 82.62 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 120.318 -0.553 . . . . 65.25 110.614 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -61.37 -53.69 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.505 0.503 . . . . 75.24 110.775 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.11 -41.85 94.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.788 -0.642 . . . . 73.42 110.673 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 551' ' ' ILE . 4.9 tt -66.36 -40.66 89.91 Favored 'General case' 0 C--O 1.186 -2.257 0 CA-C-N 115.404 -0.816 . . . . 75.51 109.246 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 61.4 t30 -58.54 -38.29 77.46 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.387 0.675 . . . . 60.23 111.621 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.57 -40.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.726 -0.67 . . . . 72.13 112.032 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -107.4 -23.28 12.26 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.037 -0.665 . . . . 70.23 112.197 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -103.59 -100.16 2.58 Favored Glycine 0 N--CA 1.413 -2.861 0 CA-C-N 115.262 -0.881 . . . . 34.42 113.683 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 46.0 m-85 -131.23 166.86 20.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.331 0.586 . . . . 64.45 111.185 -171.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -102.8 -4.12 25.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.943 -1.026 . . . . 74.4 110.295 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -109.95 116.29 31.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.705 . . . . 72.24 109.763 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -128.94 145.84 51.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.332 0.587 . . . . 73.13 110.911 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 59.2 m -135.64 145.63 47.02 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.988 -1.486 . . . . 73.51 106.988 172.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -125.55 143.25 51.09 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.393 -0.523 . . . . 72.44 111.95 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.45 129.23 52.85 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.596 -1.261 . . . . 65.44 107.596 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -88.35 127.74 35.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.207 0.527 . . . . 73.21 110.422 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.1 m -121.54 162.53 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.287 -1.005 . . . . 75.42 108.287 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.78 140.51 38.23 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.937 -0.705 . . . . 73.41 110.065 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 8.3 m -90.08 114.17 59.9 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.377 -1.283 . . . . 62.24 110.825 -174.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.85 -83.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.729 1.619 . . . . 52.52 109.661 173.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.3 mtt180 -90.9 -54.8 0.27 Allowed Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-O 118.805 -0.616 . . . . 64.53 111.14 172.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.66 ' O ' ' HB3' ' A' ' 527' ' ' SER . 21.9 Cg_endo -61.61 153.26 68.2 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.99 1.794 . . . . 64.41 111.359 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.46 82.43 0.27 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.853 0.861 . . . . 71.31 108.993 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.31 -31.12 2.64 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.482 -1.047 . . . . 75.5 110.482 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -86.12 149.55 25.05 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.259 -0.471 . . . . 72.21 110.17 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 501' ' ' ALA . 5.3 p -73.85 123.11 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.318 -0.993 . . . . 64.53 108.318 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -71.87 -41.58 67.86 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.872 -1.058 . . . . 60.11 110.874 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -174.26 -160.35 22.3 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.407 -0.902 . . . . 71.12 111.189 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.0 p -131.74 159.98 36.86 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.66 -0.867 . . . . 73.42 108.66 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.473 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 48.8 t30 -69.02 -55.36 10.53 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-O 118.937 -0.554 . . . . 72.53 110.512 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.0 Cg_endo -81.48 146.94 15.59 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.05 1.167 . . . . 74.33 109.533 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.04 147.73 43.66 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.943 1.762 . . . . 74.34 112.444 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.11 138.23 58.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.824 -0.626 . . . . 53.23 110.017 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.74 -5.75 60.16 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 111.173 -0.771 . . . . 65.43 111.173 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -88.78 126.04 35.16 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.593 -0.521 . . . . 62.32 109.593 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.1 m -90.51 123.13 33.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.802 -1.184 . . . . 63.53 107.802 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.74 154.74 75.8 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.82 -0.437 . . . . 52.44 109.82 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.533 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.0 Cg_exo -64.72 147.71 89.91 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.945 2.43 . . . . 73.51 113.55 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.534 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.6 m -67.05 -19.42 25.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.163 0.982 . . . . 70.04 111.995 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.62 -8.03 59.03 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.688 -1.142 . . . . 34.05 109.365 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 41.4 m -97.44 149.91 21.62 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 115.165 -0.925 . . . . 62.4 109.204 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.87 136.57 26.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.94 -0.573 . . . . 73.3 110.309 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 512' ' ' LEU . 15.5 tt -98.93 129.01 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.665 0.745 . . . . 74.43 109.963 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 521' ' ' SER . 31.8 tt0 -103.74 129.67 51.15 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 115.696 -0.684 . . . . 50.11 110.379 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.72 134.5 48.74 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.419 1.088 . . . . 71.42 110.672 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.06 108.53 19.79 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.276 -1.75 . . . . 61.33 106.276 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.09 137.62 38.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 112.089 0.403 . . . . 75.2 112.089 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.7 m -60.42 122.02 13.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.668 -1.604 . . . . 73.01 106.668 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.836 -0.602 . . . . 70.14 111.863 -172.789 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.041 0.924 . . . . 74.41 111.319 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 96.2 mt-30 -102.93 130.22 49.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.81 -1.086 . . . . 72.33 108.758 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -128.23 158.85 36.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.206 -1.035 . . . . 73.33 108.206 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -82.66 141.5 32.43 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 123.254 0.622 . . . . 72.51 110.365 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -85.09 130.01 53.79 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.052 -0.721 . . . . 70.21 109.052 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.01 145.19 99.42 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.979 2.453 . . . . 71.32 112.333 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.24 11.72 35.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.433 1.111 . . . . 74.44 110.14 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.91 -9.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.581 1.182 . . . . 73.31 108.562 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.8 m -59.26 -33.75 71.41 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.916 -1.493 . . . . 65.3 110.292 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 4.2 m -60.68 -27.34 67.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.505 -1.225 . . . . 65.53 110.375 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.79 -44.25 17.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 119.991 -0.683 . . . . 74.51 110.959 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.614 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 91.5 m -162.0 144.61 11.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 109.394 -0.595 . . . . 61.25 109.394 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -52.68 -49.42 65.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.016 0.926 . . . . 73.51 111.227 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.69 -40.77 80.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 43.33 111.22 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 19.9 mm-40 -61.42 -41.42 97.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.827 -0.624 . . . . 73.45 111.101 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.05 -51.82 67.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 123.915 0.759 . . . . 53.11 110.718 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.77 -46.68 95.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 CA-C-N 115.114 -0.948 . . . . 75.02 111.994 -174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 75.6 mmtt -60.84 -47.89 84.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 74.24 110.028 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -68.26 -45.29 73.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.351 -0.84 . . . . 74.51 111.431 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 452' ' ' PHE . 21.8 tp -69.07 -38.53 79.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.063 0.459 . . . . 63.41 110.845 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.6 m -64.16 -39.66 94.48 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.838 -0.619 . . . . 73.24 109.459 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -18.98 62.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.932 -0.577 . . . . 64.32 110.442 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.16 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.087 0.47 . . . . 61.02 110.124 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.84 -23.71 9.93 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.617 -0.802 . . . . 43.25 113.175 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.69 134.29 56.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.741 0.305 . . . . 74.44 110.783 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -130.13 -8.17 3.41 Favored Glycine 0 N--CA 1.428 -1.886 0 C-N-CA 119.811 -1.185 . . . . 61.04 112.898 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -102.69 115.4 30.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.548 -0.908 . . . . 71.21 108.548 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 444' ' ' LEU . 42.3 m-85 -129.19 154.88 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.294 -0.866 . . . . 74.23 110.394 -175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.468 ' HB3' HG12 ' A' ' 485' ' ' ILE . 0.7 OUTLIER -138.86 122.92 17.93 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.37 -2.455 . . . . 75.42 104.37 169.239 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -105.17 134.61 47.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.012 0.434 . . . . 72.11 110.904 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.13 153.3 47.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.497 -0.927 . . . . 52.24 108.497 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.35 146.49 50.02 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 62.11 109.396 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 53.4 m -139.89 135.21 16.37 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 116.555 -0.293 . . . . 65.34 110.373 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 26.6 Cg_exo -64.72 122.39 10.23 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.386 2.057 . . . . 62.22 111.374 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.7 m -140.54 -179.91 6.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.81 -1.181 . . . . 71.41 107.81 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.406 ' CG2' HD23 ' A' ' 463' ' ' LEU . 10.8 t -50.2 142.99 13.46 Favored Pre-proline 0 C--O 1.25 1.131 0 C-N-CA 123.168 0.587 . . . . 73.35 110.795 176.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.12 -29.32 28.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.088 3.192 . . . . 72.13 112.986 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.52 -18.86 63.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.467 0.543 . . . . 54.24 112.467 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -100.97 6.8 43.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.978 0.732 . . . . 75.23 112.978 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.6 p -61.01 127.69 21.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.406 -0.518 . . . . 55.12 110.546 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.48 12.73 84.26 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.801 -0.714 . . . . 60.54 112.439 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 94.6 mttt -121.18 154.87 35.68 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.693 -0.854 . . . . 71.14 108.693 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.645 HG22 HD11 ' A' ' 486' ' ' ILE . 40.5 t -82.06 126.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.174 -0.676 . . . . 64.23 109.174 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.4 pt -98.17 -13.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.462 -0.495 . . . . 60.24 110.358 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.45 160.82 19.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.595 -0.812 . . . . 73.32 111.684 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.5 p -120.86 146.72 46.28 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.546 -0.909 . . . . 71.33 108.546 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.561 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.3 t-20 -58.49 -57.93 22.81 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-O 119.128 -0.463 . . . . 73.31 111.042 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.34 129.55 14.04 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 108.737 -1.294 . . . . 73.45 108.737 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.7 133.08 37.72 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 74.21 112.254 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.6 -5.7 46.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.939 0.876 . . . . 63.32 110.673 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.81 -28.44 28.08 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.224 -1.353 . . . . 73.11 109.4 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.91 165.21 11.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.041 -0.726 . . . . 74.11 109.041 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.5 p -87.84 120.83 29.56 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 109.094 -0.706 . . . . 75.15 109.094 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 19.8 m -104.39 147.98 26.93 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.359 -0.978 . . . . 73.42 108.359 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.81 148.58 44.38 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.752 0.31 . . . . 71.43 110.94 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.36 -21.9 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.869 0.842 . . . . 64.31 110.549 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 t -94.32 -0.56 54.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.228 -0.896 . . . . 71.22 110.566 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.9 142.13 38.63 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.345 -0.983 . . . . 71.43 108.345 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.63 112.0 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.702 -0.851 . . . . 63.52 108.702 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.77 118.41 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 108.389 -0.967 . . . . 52.14 108.389 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.4 mt -92.44 112.01 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 106.018 -1.845 . . . . 75.45 106.018 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.55 121.56 56.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.121 -0.945 . . . . 73.31 108.633 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.93 118.85 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.748 -0.66 . . . . 71.2 109.608 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.25 139.16 19.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.011 -1.107 . . . . 62.12 108.011 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.02 127.08 7.79 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 109.975 -1.25 . . . . 54.44 109.975 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 24.6 p -108.38 131.72 54.47 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.749 -0.834 . . . . 70.23 108.749 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.089 0 N-CA-C 109.939 -1.264 . . . . 74.21 109.939 179.524 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.338 0 N-CA-C 107.353 -1.351 . . . . 74.32 107.353 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 41.5 p -135.51 166.36 23.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.854 -1.066 . . . . 62.42 109.583 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 27.6 mmtm -140.13 137.63 34.61 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.052 0.453 . . . . 65.11 111.802 173.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.78 126.46 31.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.626 -1.17 . . . . 72.52 108.058 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.9 pt -96.34 131.01 29.39 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.73 -0.788 . . . . 75.44 110.619 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.76 -177.95 1.03 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.356 2.037 . . . . 71.22 110.472 174.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.91 93.8 3.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.07 0.462 . . . . 74.35 110.232 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.19 -0.6 10.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.84 -1.541 . . . . 60.22 106.84 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -70.46 143.69 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.459 -1.7 . . . . 73.41 109.565 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.22 -15.45 25.36 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.477 -0.868 . . . . 45.1 111.52 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -97.64 -170.15 1.95 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.28 -0.568 . . . . 74.43 110.249 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.5 157.52 21.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.894 -1.15 . . . . 74.24 107.894 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 42.4 t -56.62 -49.62 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.416 0.627 . . . . 43.5 111.14 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.27 -41.96 80.3 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.282 -0.872 . . . . 74.3 111.129 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.32 -44.67 94.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.828 -1.078 . . . . 45.43 110.632 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.05 96.47 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.003 -0.544 . . . . 61.33 110.957 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.21 -40.17 95.19 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.89 -0.411 . . . . 73.45 109.89 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -44.03 89.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.832 -0.622 . . . . 75.14 110.6 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -68.65 -44.51 73.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.039 0.447 . . . . 73.14 110.519 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.15 -36.8 85.37 Favored 'General case' 0 C--O 1.191 -2.004 0 CA-C-N 115.565 -0.743 . . . . 71.41 109.54 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 7.7 t30 -57.85 -37.96 74.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.263 0.625 . . . . 61.04 111.597 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.46 -43.16 91.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.585 -0.734 . . . . 55.3 111.675 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -110.85 13.29 22.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.521 -0.472 . . . . 71.45 110.549 -171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.9 -103.01 0.31 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.408 -1.377 . . . . 44.5 115.108 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 46.9 m-85 -127.04 177.56 6.56 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.005 0.431 . . . . 74.11 112.143 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 m -120.74 -14.52 8.54 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.739 -0.664 . . . . 64.54 110.949 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.438 ' HB3' HG12 ' A' ' 550' ' ' VAL . 31.5 mmmt -108.23 119.68 40.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.431 -0.581 . . . . 75.24 109.431 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.72 147.57 44.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.714 -0.675 . . . . 73.01 111.001 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 44.3 m -137.5 151.64 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.756 -1.572 . . . . 65.02 106.756 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -121.53 137.83 54.56 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 118.339 0.518 . . . . 71.23 111.381 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -126.17 122.62 36.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.353 -1.351 . . . . 70.3 107.353 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 5.2 p -89.33 132.7 34.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.777 0.322 . . . . 52.13 111.5 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.76 149.31 24.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.183 -1.414 . . . . 72.11 107.183 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.88 136.3 37.25 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.133 -0.627 . . . . 64.32 110.972 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.1 m -133.64 160.5 68.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.065 -0.97 . . . . 73.55 109.982 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -70.19 -142.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.38 2.72 . . . . 63.44 111.964 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -51.39 81.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 113.888 1.07 . . . . 73.04 113.888 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.24 133.02 31.38 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 121.043 1.408 . . . . 72.11 109.799 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -168.78 125.49 0.98 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.303 0.641 . . . . 74.11 109.518 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.9 -23.53 1.45 Allowed Glycine 0 C--N 1.301 -1.413 0 N-CA-C 109.841 -1.304 . . . . 63.13 109.841 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.55 29.92 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.447 -0.946 . . . . 74.02 108.447 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 75.0 t -74.05 119.39 21.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.6 -0.889 . . . . 61.0 108.6 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.0 m -68.5 -40.36 80.89 Favored 'General case' 0 N--CA 1.427 -1.595 0 O-C-N 124.529 1.143 . . . . 71.32 109.642 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 169.61 -152.87 20.63 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.506 -0.854 . . . . 42.23 111.541 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -134.04 161.76 33.96 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.744 -1.206 . . . . 61.33 107.744 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -56.32 -65.3 1.67 Allowed Pre-proline 0 N--CA 1.474 0.76 0 CA-C-O 118.891 -0.576 . . . . 63.41 110.65 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 60.2 Cg_endo -76.88 147.92 27.66 Favored 'Trans proline' 0 C--N 1.367 1.509 0 CA-C-N 120.633 1.262 . . . . 74.25 109.248 173.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.86 163.05 40.08 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.927 1.751 . . . . 71.11 111.528 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.76 58.66 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.187 -0.46 . . . . 61.2 110.21 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.49 -12.76 61.51 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.936 -0.865 . . . . 65.42 110.936 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.7 m -86.04 124.22 32.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 109.07 -0.715 . . . . 73.25 109.07 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.1 t -90.6 123.38 34.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.96 -1.126 . . . . 74.21 107.96 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 517' ' ' PHE . 19.4 m -123.64 156.27 64.93 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 109.671 -0.492 . . . . 55.03 109.671 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 135.08 65.29 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.213 2.609 . . . . 71.33 114.23 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.5 m -67.28 -20.78 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.274 -0.876 . . . . 63.55 111.518 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.11 -0.23 55.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.457 -0.792 . . . . 71.15 111.12 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 17.4 t -100.42 151.04 22.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.236 -1.024 . . . . 63.15 108.236 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 519' ' ' LYS . 5.7 m -88.58 136.41 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 N-CA-C 108.022 -1.103 . . . . 73.41 108.022 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.6 tt -97.52 143.28 12.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 120.036 -0.665 . . . . 74.1 110.858 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -102.45 118.37 36.72 Favored 'General case' 0 N--CA 1.408 -2.547 0 C-N-CA 123.471 0.709 . . . . 64.24 109.404 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.0 tp -97.05 129.25 44.51 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.729 -1.123 . . . . 50.2 108.689 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -90.05 112.95 24.56 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.364 -0.976 . . . . 71.33 108.364 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.8 137.88 33.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.006 -0.543 . . . . 65.31 111.955 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.5 m -68.76 126.08 28.61 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 115.64 -0.709 . . . . 73.35 111.65 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 115.308 -0.86 . . . . 52.24 108.803 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 122.559 1.171 . . . . 64.22 110.191 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.435 ' C ' ' HB ' ' A' ' 477' ' ' THR . 26.7 mt-30 -101.64 125.7 48.35 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.006 -1.452 . . . . 55.14 108.755 175.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -121.04 153.44 37.38 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.407 -0.36 . . . . 62.33 110.341 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.02 141.39 28.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.581 -0.736 . . . . 73.14 110.889 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.4 mp -85.09 128.33 60.53 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 107.47 -1.307 . . . . 73.14 107.47 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.414 ' HG3' ' HD2' ' A' ' 443' ' ' LYS . 61.9 Cg_endo -69.8 147.05 61.78 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.561 2.174 . . . . 65.44 112.55 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -83.54 29.31 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.956 -0.565 . . . . 72.44 110.762 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 440' ' ' ALA . 35.9 m -85.84 7.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.001 0.905 . . . . 72.02 109.784 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 2.3 p -58.0 -35.02 70.62 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 125.999 1.719 . . . . 72.21 109.982 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.6 t -60.47 -26.04 66.48 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.718 -1.583 . . . . 74.13 111.496 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.81 -47.81 10.01 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 118.953 -1.099 . . . . 73.1 111.05 -174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.4 m -174.41 153.99 2.03 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.736 -1.209 . . . . 73.21 107.736 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 467' ' ' VAL . 29.2 t80 -50.37 -54.72 19.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.293 1.037 . . . . 64.11 110.656 171.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.18 -41.23 75.18 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.912 -0.586 . . . . 63.34 111.936 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 443' ' ' LYS . 66.2 mm-40 -61.51 -46.56 89.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.156 0.428 . . . . 74.13 112.156 -178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.433 ' HA ' HG23 ' A' ' 432' ' ' VAL . . . -72.22 -45.83 58.64 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.603 0.594 . . . . 63.41 112.603 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.74 -47.6 88.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 53.35 110.958 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.62 -35.21 79.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.304 0.242 . . . . 50.15 110.973 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 439' ' ' GLU . 2.6 tmtm? -66.26 -47.61 73.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.155 -1.054 . . . . 62.42 108.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.1 tp -68.86 -32.66 72.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.723 -0.671 . . . . 72.21 110.519 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 96.9 m -60.89 -43.99 97.72 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.51 -0.768 . . . . 64.24 109.308 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -20.02 62.45 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.077 -0.51 . . . . 71.34 111.148 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.54 -10.9 59.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.997 -0.547 . . . . 71.31 110.414 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.51 -8.43 8.33 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 119.927 -1.13 . . . . 74.12 113.956 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 445' ' ' THR . 92.5 m-85 -86.17 133.37 33.86 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 117.306 0.553 . . . . 73.32 110.773 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.41 -13.96 3.04 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.886 -0.673 . . . . 53.23 112.692 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 483' ' ' VAL . 14.3 ttm180 -103.06 116.29 32.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.41 0.605 . . . . 71.04 110.87 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.04 158.03 40.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.826 -0.625 . . . . 75.01 111.231 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.4 tppp? -134.61 135.7 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.042 -2.207 . . . . 61.44 105.042 172.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -115.95 135.09 54.3 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.535 0.607 . . . . 73.32 111.236 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.24 140.86 45.58 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.348 -0.982 . . . . 64.3 108.348 175.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.86 142.12 46.5 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.862 -0.792 . . . . 74.14 108.862 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.5 t -140.58 146.74 46.19 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 108.605 -0.887 . . . . 54.15 108.605 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.2 Cg_exo -65.08 140.17 64.31 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.846 1.698 . . . . 70.3 109.926 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 71.1 m -150.72 179.77 7.93 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.747 -0.835 . . . . 60.2 108.747 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -56.09 133.67 74.5 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.94 -0.763 . . . . 75.45 108.94 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 79.3 Cg_exo -50.1 -29.59 22.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.142 3.228 . . . . 62.41 115.117 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.81 -10.31 59.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.234 0.828 . . . . 54.23 113.234 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.8 mt -102.53 11.61 37.61 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.784 -0.366 . . . . 64.24 111.731 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -61.14 128.05 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.999 0.428 . . . . 73.54 110.737 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.8 3.99 90.39 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.996 -0.547 . . . . 73.33 112.292 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 434' ' ' THR . 93.5 mttt -112.23 159.69 18.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.371 -0.974 . . . . 71.3 108.371 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 46.0 t -82.67 129.07 38.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.557 -0.905 . . . . 52.41 108.557 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.33 -20.52 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.361 0.601 . . . . 63.3 109.764 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.75 170.2 33.09 Favored Glycine 0 N--CA 1.416 -2.688 0 N-CA-C 110.471 -1.052 . . . . 53.53 110.471 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.2 p -120.02 157.62 28.49 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.452 -0.573 . . . . 72.35 109.452 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.577 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 25.6 t-20 -60.21 -49.28 91.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 119.238 -0.41 . . . . 51.34 111.49 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.0 Cg_exo -83.14 155.88 14.82 Favored 'Trans proline' 0 C--N 1.365 1.402 0 N-CA-C 107.821 -1.646 . . . . 73.25 107.821 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 68.4 Cg_endo -66.36 146.65 81.26 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 121.697 1.598 . . . . 60.51 109.887 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.94 -37.4 29.56 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 121.059 0.457 . . . . 73.22 111.166 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . 0.271 18.8 m-80 -85.41 -8.33 58.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.719 1.377 . . . . 41.04 114.719 -172.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.8 mp0 -95.39 152.28 18.54 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.773 -1.195 . . . . 74.12 107.773 174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.435 ' HB ' ' C ' ' A' ' 426' ' ' GLN . 33.1 p -79.51 121.63 25.46 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.272 0.558 . . . . 62.14 110.738 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.6 m -104.59 140.83 37.43 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.357 -0.979 . . . . 65.25 108.357 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.73 145.67 52.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.733 0.302 . . . . 64.13 111.635 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.0 mm -59.59 -21.89 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.472 0.709 . . . . 71.11 111.27 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.8 t -83.49 0.08 47.94 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.924 -0.485 . . . . 72.25 111.473 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.08 154.77 20.49 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.967 0.413 . . . . 74.13 110.605 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 451' ' ' ARG . 2.6 p -98.25 124.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.17 -1.418 . . . . 42.24 107.17 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.41 118.7 37.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 C-N-CA 119.19 -1.004 . . . . 75.04 109.405 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.577 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.96 113.15 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.029 -1.841 . . . . 74.11 106.029 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.34 128.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 115.923 -0.58 . . . . 75.53 109.595 -175.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 31.5 mt -104.5 119.96 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.277 -0.874 . . . . 64.01 109.286 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.59 137.76 23.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.279 -0.873 . . . . 73.0 108.885 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -85.05 123.49 6.32 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 110.943 -0.863 . . . . 62.35 110.943 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 27.4 t -111.07 129.46 55.91 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.67 -1.604 . . . . 62.2 106.67 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.612 0 N-CA-C 109.291 -1.523 . . . . 63.23 109.291 179.163 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.36 0 N-CA-C 107.69 -1.226 . . . . 64.43 107.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 23.8 p -134.76 160.71 37.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.348 -0.842 . . . . 74.32 110.66 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -150.45 142.24 23.74 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.714 0.806 . . . . 63.44 109.052 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.6 p-10 -88.75 134.01 34.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.479 . . . . 72.35 107.008 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.95 124.92 88.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 CA-C-N 115.489 -0.778 . . . . 63.41 111.867 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.06 150.15 1.65 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.533 2.155 . . . . 60.25 111.212 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -87.64 107.55 18.66 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.345 1.069 . . . . 63.54 110.053 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.53 42.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 106.925 -1.509 . . . . 64.01 106.925 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -80.42 159.89 25.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.406 -1.27 . . . . 64.51 112.629 -173.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.15 -16.09 46.37 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.216 -0.753 . . . . 72.32 111.216 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.443 ' HB3' HG13 ' A' ' 507' ' ' VAL . 46.4 mt-30 -89.93 -173.08 3.75 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.195 0.522 . . . . 74.24 111.696 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.6 m -90.85 156.56 17.93 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.403 -1.332 . . . . 63.32 107.403 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 19.2 t -55.05 -48.97 75.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 123.721 0.638 . . . . 64.44 111.08 -172.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.34 -41.62 80.46 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.619 0.6 . . . . 75.12 112.619 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.9 p -73.88 -34.86 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.507 -0.877 . . . . 75.54 111.234 -174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.78 89.22 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.727 -0.67 . . . . 73.15 110.216 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.1 mt-30 -62.73 -42.74 99.81 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 123.448 0.467 . . . . 73.11 110.481 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 510' ' ' LYS . 0.0 OUTLIER -62.08 -42.67 99.44 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 112.897 0.703 . . . . 73.3 112.897 178.548 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -66.99 -48.11 69.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.53 -0.468 . . . . 65.4 110.094 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 551' ' ' ILE . 41.8 tp -60.2 -41.17 92.44 Favored 'General case' 0 C--O 1.198 -1.614 0 CA-C-N 115.512 -0.767 . . . . 63.03 110.144 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.8 t-20 -59.21 -48.05 83.05 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.856 0.862 . . . . 74.2 111.29 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.88 -18.89 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.318 0.488 . . . . 75.15 112.318 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -118.96 8.66 11.7 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.778 -0.769 . . . . 64.0 110.229 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -149.84 -95.83 0.14 Allowed Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.02 -1.562 . . . . 65.53 115.836 -170.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 59.6 m-85 -123.11 170.18 10.47 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.221 0.534 . . . . 74.43 111.736 -165.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 20.4 p -97.11 -35.9 10.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.276 -0.874 . . . . 54.22 112.352 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -117.77 142.61 47.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.127 0.489 . . . . 71.53 112.075 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -127.6 156.99 41.4 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.735 -1.12 . . . . 74.12 110.404 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.4 t -129.73 141.99 50.79 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.845 -2.28 . . . . 71.13 104.845 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -121.28 129.78 53.31 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.944 -0.761 . . . . 72.34 108.944 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.03 136.96 51.0 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 123.601 0.563 . . . . 61.33 109.736 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 51.9 m -88.56 131.61 34.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.31 -0.859 . . . . 63.13 109.491 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.434 ' O ' ' HG3' ' A' ' 557' ' ' LYS . 34.4 m -122.24 149.53 25.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.734 -0.469 . . . . 70.12 109.734 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.93 111.45 16.27 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.74 0.781 . . . . 73.04 110.195 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 7.2 p -107.58 119.81 49.37 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.615 -1.175 . . . . 52.04 109.818 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 26.9 Cg_exo -65.13 -51.49 1.54 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.449 2.099 . . . . 65.55 111.527 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 529' ' ' ARG . 14.9 mmm180 -102.78 -50.93 0.15 Allowed Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 114.186 1.18 . . . . 74.32 114.186 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.75 153.45 36.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.904 1.736 . . . . 74.42 112.373 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.89 108.01 0.86 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 122.918 0.487 . . . . 70.33 110.968 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.75 -24.08 33.19 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 120.935 -0.65 . . . . 74.42 114.336 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.24 23.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.7 p -73.68 120.16 22.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.945 -0.761 . . . . 64.01 108.945 176.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -71.73 -40.39 69.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.991 -1.004 . . . . 74.23 110.174 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.84 -149.81 13.81 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.488 -0.645 . . . . 71.3 111.488 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.5 p -117.9 160.03 22.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.277 -1.008 . . . . 72.12 108.277 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -74.3 -56.05 2.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.018 -1.073 . . . . 71.33 110.181 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.4 Cg_endo -64.87 149.33 89.71 Favored 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 120.741 0.961 . . . . 63.04 109.614 170.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 18.9 Cg_exo -66.8 152.36 80.66 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.525 2.15 . . . . 71.25 112.549 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.38 132.64 52.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.795 -0.817 . . . . 74.53 108.795 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.63 40.83 Favored Glycine 0 C--N 1.298 -1.574 0 C-N-CA 120.272 -0.966 . . . . 42.24 111.958 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.8 m -67.44 120.96 14.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.871 -0.789 . . . . 42.1 108.871 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.4 m -90.18 122.75 33.41 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.556 -0.905 . . . . 74.11 108.556 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.01 157.63 77.7 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 108.095 -1.076 . . . . 63.2 108.095 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.81 144.3 98.53 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.182 1.922 . . . . 73.44 111.577 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -65.03 -18.55 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.18 0.991 . . . . 71.45 110.786 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.32 -17.73 53.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.883 -1.508 . . . . 74.03 109.83 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 172.4 13.79 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.985 -1.007 . . . . 61.42 113.644 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.03 124.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.358 -1.292 . . . . 75.15 109.42 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.538 HD13 HD21 ' A' ' 512' ' ' LEU . 13.1 tt -100.46 136.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.558 -0.534 . . . . 62.24 109.558 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.29 122.6 45.13 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-O 121.435 0.636 . . . . 72.12 111.126 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 12.7 tp -101.39 133.83 45.4 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.203 1.401 . . . . 70.43 109.356 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -104.01 114.56 28.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.157 -0.682 . . . . 73.13 109.157 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 137.84 34.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 116.164 -0.471 . . . . 73.31 111.496 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 10.4 m -64.11 115.06 4.6 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 106.94 -1.504 . . . . 65.55 106.94 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 524' ' ' SER 0.306 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 N-CA-C 114.828 1.418 . . . . 62.43 114.828 -172.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.894 0.854 . . . . 65.22 110.445 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.8 mt-30 -83.43 137.69 33.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.355 -0.839 . . . . 64.23 111.87 -174.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 21.6 tpp180 -129.51 157.38 42.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.351 -0.981 . . . . 65.44 108.351 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.43 141.92 28.79 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 123.332 0.653 . . . . 72.12 111.279 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -85.15 130.49 51.79 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 108.109 -1.071 . . . . 73.31 108.109 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HB3' ' HG2' ' A' ' 443' ' ' LYS . 22.3 Cg_endo -60.97 158.38 34.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.546 2.83 . . . . 65.04 115.393 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -113.3 16.32 19.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.917 -1.038 . . . . 65.55 110.309 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.98 -2.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.244 1.021 . . . . 64.3 109.224 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.1 m -61.22 -38.87 88.17 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.977 -1.465 . . . . 54.13 110.828 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 9.4 t -59.03 -26.82 64.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.607 -0.724 . . . . 74.54 111.672 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.4 mt -76.9 -45.54 27.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 120.063 -0.655 . . . . 74.34 110.097 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 14.3 m -168.82 147.49 4.06 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.301 -1.0 . . . . 53.11 108.301 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -51.64 -44.47 62.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.607 0.763 . . . . 73.11 111.112 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.75 -35.41 66.16 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.984 0.514 . . . . 74.01 111.6 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 10.7 mm-40 -70.52 -42.29 71.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.796 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.34 -50.77 72.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.358 -0.837 . . . . 63.12 110.113 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.0 t -58.55 -49.19 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.214 -0.903 . . . . 75.44 112.015 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.66 -46.83 83.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.839 -0.344 . . . . 71.52 111.622 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 430' ' ' PRO . 26.6 tptp -66.78 -41.62 87.35 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 75.42 110.122 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 28.3 tp -68.48 -43.21 77.43 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.916 -0.584 . . . . 55.32 110.155 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 39.5 m -59.51 -44.68 93.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.676 -0.693 . . . . 75.42 109.804 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.69 62.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.906 -0.588 . . . . 62.25 111.395 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -80.93 -13.72 58.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.132 0.492 . . . . 51.25 110.152 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.65 -5.78 26.15 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.126 -1.035 . . . . 32.43 112.794 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.439 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.3 m-85 -82.65 111.54 18.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.576 -0.527 . . . . 73.13 109.576 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.25 41.32 Favored Glycine 0 N--CA 1.427 -1.918 0 CA-C-N 115.476 -0.784 . . . . 75.02 111.836 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.51 114.63 26.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.264 0.554 . . . . 71.11 111.239 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.82 156.83 43.14 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.322 -0.854 . . . . 72.53 112.366 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 123.06 29.31 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.176 -1.416 . . . . 65.14 107.176 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -94.0 125.71 38.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.858 -0.61 . . . . 73.45 109.873 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.04 147.15 50.5 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.327 -1.36 . . . . 40.44 107.327 176.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -122.57 139.88 53.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.344 -0.543 . . . . 73.01 109.652 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.4 m -126.44 140.85 38.35 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 109.259 -0.645 . . . . 74.42 109.259 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -64.77 121.91 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.597 1.531 . . . . 72.4 109.842 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.5 m -133.67 179.99 5.88 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.761 -1.57 . . . . 70.55 106.761 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.0 t -60.56 136.98 92.56 Favored Pre-proline 0 N--CA 1.419 -2.003 0 N-CA-C 109.136 -0.69 . . . . 65.42 109.136 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 85.2 Cg_exo -49.86 -28.96 19.38 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.464 3.443 . . . . 73.15 114.829 -173.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.18 -18.43 61.86 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.28 7.96 44.59 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.934 -0.479 . . . . 61.3 111.983 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -60.96 128.36 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 120.968 0.414 . . . . 73.21 110.505 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.13 89.31 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.77 -0.728 . . . . 73.51 111.97 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -113.65 148.22 36.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.646 -1.242 . . . . 42.3 107.646 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.484 HG22 HD11 ' A' ' 486' ' ' ILE . 44.8 t -82.36 140.43 16.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.8 pt -96.96 -23.37 4.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.448 0.642 . . . . 54.03 109.402 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.39 175.48 38.62 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 109.062 -1.615 . . . . 75.03 109.062 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 472' ' ' PRO . 2.6 p -116.49 154.36 30.51 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.879 -0.785 . . . . 74.01 108.879 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.7 t30 -61.09 -46.65 96.23 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 123.56 0.537 . . . . 73.5 110.165 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.4 Cg_exo -83.36 137.07 7.97 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.036 1.158 . . . . 55.12 109.391 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 476' ' ' GLN . 9.8 Cg_endo -62.56 140.19 80.08 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.266 1.977 . . . . 73.14 112.051 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.567 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.53 -8.08 55.17 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 122.134 0.969 . . . . 75.11 111.153 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -94.65 -3.98 48.47 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.603 -1.18 . . . . 70.14 110.399 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.449 ' CG ' ' HG2' ' A' ' 473' ' ' PRO . 31.3 mm-40 -109.94 159.98 16.8 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 109.081 -0.711 . . . . 73.11 109.081 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.4 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 24.1 p -101.8 115.21 30.03 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.34 -1.356 . . . . 53.24 107.34 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 48.8 m -100.59 140.97 34.1 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.795 -0.446 . . . . 53.22 109.795 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.58 145.66 54.65 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.036 -0.529 . . . . 62.2 110.61 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.1 mm -67.24 -9.16 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 122.085 0.945 . . . . 72.01 110.752 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -77.51 -5.91 51.7 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.613 -0.679 . . . . 70.21 109.894 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.05 158.09 16.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.706 -0.621 . . . . 72.21 111.742 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.98 125.77 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.013 -1.847 . . . . 71.21 106.013 169.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.71 120.53 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.813 -0.755 . . . . 75.54 110.609 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.81 114.84 29.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.098 -1.445 . . . . 74.22 107.098 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.63 121.52 61.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.033 -0.985 . . . . 74.24 109.016 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.11 120.26 51.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.9 0.857 . . . . 73.23 112.446 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.0 t -96.56 146.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.588 -1.187 . . . . 73.32 108.955 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -82.83 123.41 6.09 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.026 -1.23 . . . . 50.42 110.026 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 28.8 t -110.95 143.83 40.99 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.167 -1.42 . . . . 75.4 107.167 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.874 0 C-N-CA 120.33 -0.938 . . . . 41.42 111.308 -177.505 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.915 0.864 . . . . 62.31 109.813 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 546' ' ' PRO . 32.6 p -137.32 160.06 40.15 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.75 -1.114 . . . . 74.15 108.957 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.402 ' CD ' ' HA2' ' A' ' 516' ' ' GLY . 50.7 mttm -141.47 143.06 33.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.33 0.394 . . . . 73.25 110.371 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.1 t70 -89.96 119.2 30.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.231 -1.396 . . . . 61.42 107.231 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.4 pt -81.9 123.42 80.1 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 112.473 0.546 . . . . 75.01 112.473 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.96 177.44 2.07 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.381 2.054 . . . . 72.52 109.287 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -85.57 138.12 32.4 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.026 -1.07 . . . . 73.41 109.526 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.67 19.01 4.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.561 -1.644 . . . . 53.11 106.561 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.592 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -77.01 153.37 34.56 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.167 -1.833 . . . . 75.13 111.657 -174.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.08 58.71 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.91 -0.662 . . . . 71.54 111.79 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.526 ' O ' HG12 ' A' ' 534' ' ' VAL . 95.8 mt-30 -121.47 -176.26 3.26 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 72.0 108.877 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.3 m -81.18 155.7 26.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 119.386 -0.925 . . . . 73.22 108.576 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.16 -41.45 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 111.619 0.229 . . . . 71.52 111.619 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.93 -42.25 85.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.378 -0.374 . . . . 64.2 111.46 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.7 p -76.04 -35.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.646 -0.822 . . . . 72.04 111.501 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.02 76.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.582 -0.736 . . . . 52.43 111.106 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.09 -38.52 91.02 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.959 -0.564 . . . . 74.33 110.355 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 514' ' ' VAL . 39.5 ttmt -63.53 -52.37 61.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 123.509 0.506 . . . . 64.44 110.866 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -62.9 -44.92 94.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 123.209 0.318 . . . . 65.24 110.302 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 31.0 tp -64.89 -36.88 85.79 Favored 'General case' 0 C--O 1.188 -2.149 0 CA-C-N 116.08 -0.509 . . . . 72.32 110.542 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.9 t-20 -59.61 -42.92 93.73 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.198 0.599 . . . . 74.41 110.492 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.9 t -67.7 -30.31 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.799 . . . . 70.33 111.443 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.18 15.09 14.05 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 121.679 -0.638 . . . . 74.14 110.785 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.402 ' HA2' ' CD ' ' A' ' 495' ' ' LYS . . . -155.12 -99.9 0.17 Allowed Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 118.248 -1.93 . . . . 64.31 116.637 -169.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 51.2 m-85 -115.31 161.84 17.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.264 . . . . 70.43 110.633 -168.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.2 p -102.51 -27.88 12.52 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.482 0.549 . . . . 62.44 112.482 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 9.3 mmpt? -108.79 128.46 54.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 120.589 0.233 . . . . 70.35 110.722 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 93.9 m-85 -125.18 145.21 50.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.512 -0.767 . . . . 74.4 110.375 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.1 t -115.71 159.57 21.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.137 -1.431 . . . . 60.4 107.137 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -121.18 129.09 53.07 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.744 -0.465 . . . . 72.02 109.744 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.55 129.75 44.85 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.221 -1.029 . . . . 23.35 108.221 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 9.2 m -89.21 130.68 35.58 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.041 -0.726 . . . . 70.53 109.041 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.37 157.57 26.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.339 -0.986 . . . . 74.04 108.339 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -79.69 142.21 35.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.229 0.537 . . . . 75.42 110.984 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 22.2 p -102.35 110.22 62.27 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.992 -1.004 . . . . 72.41 112.649 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -76.95 -51.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 121.644 1.562 . . . . 71.21 110.155 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.6 -64.25 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 112.38 0.511 . . . . 73.41 112.38 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.47 149.06 34.33 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.671 1.58 . . . . 63.23 112.969 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.93 138.81 25.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.575 -0.528 . . . . 62.42 109.575 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 87.79 -26.69 7.19 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 122.004 0.78 . . . . 50.13 111.816 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.57 150.0 23.98 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.614 -0.793 . . . . 72.0 111.826 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.8 p -74.41 125.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.433 -0.803 . . . . 41.1 110.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 14.3 p -88.97 -22.0 23.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.799 -0.637 . . . . 55.21 109.899 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.44 -159.13 30.95 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.205 -0.758 . . . . 74.44 111.205 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -118.39 161.04 20.62 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.27 -1.011 . . . . 75.14 108.27 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 15.1 t-20 -54.94 -55.3 40.27 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 119.216 -0.421 . . . . 72.41 111.877 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.8 Cg_exo -80.47 143.58 15.42 Favored 'Trans proline' 0 C--N 1.366 1.499 0 N-CA-C 108.374 -1.433 . . . . 65.33 108.374 170.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.71 157.36 52.24 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.306 2.004 . . . . 73.02 113.405 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.41 131.33 50.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.329 -0.85 . . . . 73.3 109.541 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.52 -6.95 36.32 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 110.765 -0.934 . . . . 53.41 110.765 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 36.0 m -88.45 129.33 35.46 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.543 -0.54 . . . . 73.24 109.543 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.0 m -96.75 123.22 40.38 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.195 -1.039 . . . . 54.22 108.195 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.62 158.37 72.17 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 110.179 -0.304 . . . . 74.32 110.179 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.421 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.6 Cg_exo -64.7 137.2 53.06 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.823 2.349 . . . . 74.12 111.654 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.508 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.5 m -67.48 -20.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.469 0.652 . . . . 52.51 111.808 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.69 2.1 46.69 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 74.04 111.319 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -93.09 167.78 11.55 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.292 -1.003 . . . . 42.34 108.292 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.43 116.61 44.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.133 -0.692 . . . . 74.45 109.133 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 15.4 tt -88.71 132.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.191 0.52 . . . . 64.14 109.99 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -102.91 131.07 50.1 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-O 121.489 0.661 . . . . 71.01 111.747 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.426 HD13 ' N ' ' A' ' 554' ' ' GLN . 1.8 tm? -99.78 135.3 41.41 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.951 1.3 . . . . 72.54 109.304 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.426 ' N ' HD13 ' A' ' 553' ' ' LEU . 13.2 mm100 -94.69 106.44 18.42 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.489 -0.778 . . . . 64.03 108.91 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.07 122.33 47.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.697 -0.683 . . . . 74.33 109.427 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 25.6 p -76.52 115.35 16.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.652 -0.499 . . . . 64.41 109.652 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 108.779 -0.822 . . . . 74.14 108.779 -176.468 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 109.56 -0.533 . . . . 75.01 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.1 mt-30 -90.15 119.51 30.53 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.321 -0.4 . . . . 74.01 109.933 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.6 mmp_? -121.27 156.21 33.0 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.189 -0.46 . . . . 65.03 110.932 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.17 141.79 28.39 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.387 -0.824 . . . . 73.05 109.917 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -84.9 119.36 72.56 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.856 -1.164 . . . . 71.15 107.856 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.445 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 25.8 Cg_exo -68.47 142.28 53.6 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.265 1.977 . . . . 41.55 112.197 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 434' ' ' THR . 10.6 m-20 -84.95 37.57 0.67 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.696 0.76 . . . . 73.11 111.458 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 439' ' ' GLU . 10.9 p -87.26 -6.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.609 1.195 . . . . 52.11 108.086 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 3.3 p -59.02 -36.47 75.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.664 1.586 . . . . 73.43 110.47 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 431' ' ' ASP . 14.7 t -61.69 -26.71 68.21 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.0 -1.0 . . . . 65.1 110.789 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.47 -46.5 13.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.31 -0.956 . . . . 74.12 111.407 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.554 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 85.7 m -169.73 149.72 3.86 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.788 -0.819 . . . . 52.23 108.788 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 441' ' ' VAL . 54.4 t80 -52.75 -49.4 65.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.928 0.491 . . . . 72.35 111.309 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.19 -39.87 73.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 61.2 111.589 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.554 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.7 mm-40 -62.97 -43.78 97.85 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.935 -0.575 . . . . 65.31 111.01 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.11 -44.06 95.13 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.269 -0.878 . . . . 72.42 109.932 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.5 t -60.01 -49.53 83.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 115.999 -0.546 . . . . 64.21 111.142 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.0 mmtp -60.62 -47.67 85.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.045 0.45 . . . . 74.4 110.485 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.445 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 30.6 mmmt -67.93 -41.39 82.66 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.798 0.666 . . . . 62.33 112.798 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 22.4 tp -68.48 -38.8 81.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 60.01 109.736 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.2 m -59.28 -46.04 89.62 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.266 -0.879 . . . . 70.21 109.278 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.28 -20.17 63.91 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.522 -0.763 . . . . 54.22 111.692 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.4 -13.61 59.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.306 0.574 . . . . 51.33 109.986 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.23 -9.13 42.21 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.983 -0.627 . . . . 64.34 113.232 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 95.8 m-85 -67.38 115.59 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.941 0.371 . . . . 73.41 110.011 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.09 2.06 40.81 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.467 -0.873 . . . . 44.02 111.619 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -126.75 113.19 16.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.3 0.572 . . . . 75.13 109.553 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -148.73 165.15 32.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.539 -0.755 . . . . 72.32 112.188 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -140.4 131.7 26.68 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.828 -0.804 . . . . 73.14 108.828 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -93.21 135.31 34.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 123.425 0.453 . . . . 75.55 110.053 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -142.7 162.47 35.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.336 -1.357 . . . . 50.53 107.336 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.84 150.68 51.89 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 118.146 0.43 . . . . 74.03 110.636 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.0 m -138.03 146.75 53.49 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 107.963 -1.125 . . . . 71.31 107.963 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.98 130.01 22.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.733 1.622 . . . . 54.21 111.143 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -143.66 -179.72 6.62 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.579 -1.637 . . . . 61.04 106.579 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.06 142.61 85.37 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 123.004 0.522 . . . . 42.44 111.32 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 75.9 Cg_exo -51.68 -29.13 32.12 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.259 3.306 . . . . 75.13 111.66 174.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.1 -29.36 67.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.512 -0.767 . . . . 71.53 111.054 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.46 13.42 24.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.409 0.522 . . . . 71.12 112.409 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 15.0 p -60.47 128.02 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.075 -0.65 . . . . 73.31 110.468 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.18 11.46 83.53 Favored Glycine 0 C--O 1.249 1.069 0 C-N-CA 120.941 -0.647 . . . . 52.12 111.789 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -122.97 154.44 38.41 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.083 -1.08 . . . . 73.25 108.083 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 486' ' ' ILE . 46.2 t -82.43 141.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.275 -0.639 . . . . 74.2 109.275 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.2 pt -97.49 -29.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.456 -0.498 . . . . 73.51 110.339 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.62 -179.01 47.05 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.531 -1.028 . . . . 62.51 110.531 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -124.23 152.17 43.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.512 -0.551 . . . . 34.42 109.512 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.0 t-20 -60.91 -49.95 86.99 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 112.285 0.476 . . . . 74.01 112.285 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.1 Cg_exo -78.16 142.69 19.48 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.154 1.236 . . . . 72.0 109.361 171.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.49 132.98 40.53 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.697 2.265 . . . . 63.14 111.897 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.72 -12.73 59.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.025 0.917 . . . . 65.14 110.706 -175.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.93 11.55 37.06 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.902 -1.045 . . . . 64.11 109.713 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -125.57 169.96 11.94 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 106.527 -1.657 . . . . 74.44 106.527 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.2 p -107.11 115.3 29.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 N-CA-C 108.031 -1.099 . . . . 74.31 108.031 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 30.3 m -102.03 138.81 38.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.407 -0.59 . . . . 74.15 109.407 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.67 137.16 56.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.614 -0.513 . . . . 64.35 109.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.23 -25.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 124.543 1.137 . . . . 44.24 113.074 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.3 t -71.44 -7.01 44.59 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 120.996 0.427 . . . . 71.14 111.76 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -90.11 145.5 25.01 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 116.519 -0.309 . . . . 65.33 110.966 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.08 117.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.347 0.594 . . . . 70.11 109.759 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.79 118.86 34.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.707 -0.849 . . . . 75.53 108.707 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -92.63 113.23 27.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.247 -1.39 . . . . 53.22 107.247 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.51 119.82 53.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.337 -0.847 . . . . 73.25 109.397 -178.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -104.11 123.79 58.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.718 0.77 . . . . 72.3 112.252 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.18 144.29 10.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 114.802 -1.09 . . . . 72.01 108.724 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.74 120.72 5.54 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 111.345 -0.702 . . . . 70.03 111.345 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.8 t -101.46 129.49 47.51 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.909 -1.885 . . . . 73.34 105.909 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.431 0 C-N-CA 120.271 -0.966 . . . . 63.21 113.089 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 108.503 -0.925 . . . . 73.44 108.503 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 546' ' ' PRO . 16.6 p -136.99 154.67 50.35 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.821 -1.081 . . . . 71.3 109.232 -176.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.01 142.49 36.27 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.368 0.418 . . . . 72.34 109.982 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -80.82 132.2 35.46 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.262 -1.385 . . . . 72.41 107.262 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.69 129.88 80.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.998 -0.546 . . . . 75.42 110.059 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -87.07 160.79 8.67 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.565 2.177 . . . . 62.42 110.948 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.69 135.69 33.55 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.588 -0.845 . . . . 52.33 109.434 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.6 16.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 122.507 1.146 . . . . 63.22 108.416 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.63 40.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.726 -1.125 . . . . 54.11 109.719 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.68 -26.9 11.06 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.973 -1.251 . . . . 70.41 109.973 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.01 176.36 6.62 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 36.3 p -81.57 157.24 24.84 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.167 -0.613 . . . . 74.31 110.15 -175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 555' ' ' VAL . 9.9 p -52.61 -41.73 38.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.601 0.563 . . . . 72.23 112.28 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.25 -43.08 78.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.574 0.583 . . . . 73.54 112.574 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.29 -36.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 118.837 -1.145 . . . . 75.15 111.519 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.36 77.48 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.136 -0.938 . . . . 71.21 111.39 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.94 -35.01 79.8 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 123.238 0.336 . . . . 71.33 110.513 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.4 tttp -60.98 -51.61 68.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 123.244 0.34 . . . . 61.31 110.13 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.66 -44.77 95.42 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.726 -0.67 . . . . 54.43 110.376 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.08 -43.21 95.67 Favored 'General case' 0 C--O 1.179 -2.606 0 CA-C-N 115.404 -0.816 . . . . 70.15 109.999 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 7.9 t30 -59.05 -39.54 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.508 0.723 . . . . 73.42 112.146 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.94 -0.573 . . . . 52.42 111.626 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.75 -39.28 7.91 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.311 -0.956 . . . . 74.35 110.165 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -95.09 -101.19 1.79 Allowed Glycine 0 N--CA 1.412 -2.945 0 CA-C-N 113.954 -1.475 . . . . 52.23 115.3 -170.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 16.9 m-85 -133.53 172.17 13.09 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 120.957 0.408 . . . . 74.52 109.911 -167.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 18.7 m -109.84 -1.95 17.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.593 -0.73 . . . . 72.12 110.073 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.36 116.39 31.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.125 -0.488 . . . . 72.25 109.899 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.35 151.27 49.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.554 0.692 . . . . 75.54 112.005 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -140.98 158.53 43.8 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.142 -1.429 . . . . 34.44 107.142 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -121.77 152.11 39.83 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.416 0.627 . . . . 71.04 111.818 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.487 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -134.29 125.74 28.31 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.747 -1.205 . . . . 40.53 107.747 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.9 m -88.68 131.36 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.33 -1.359 . . . . 62.44 107.33 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.3 150.52 24.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.236 -0.586 . . . . 72.43 109.921 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.07 133.6 36.78 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.014 -0.735 . . . . 70.45 109.014 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.6 m -143.59 138.85 15.71 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.049 -0.722 . . . . 73.54 109.049 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.12 -58.51 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.2 . . . . 74.34 113.178 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.417 ' H ' ' CD ' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -115.26 -41.26 0.07 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 118.586 -0.721 . . . . 74.42 112.943 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.417 ' CD ' ' H ' ' A' ' 529' ' ' ARG . 80.8 Cg_exo -55.83 149.73 49.38 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 121.688 1.592 . . . . 73.24 112.972 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.95 113.16 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.813 -1.18 . . . . 55.44 107.813 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.04 -34.05 4.63 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.385 -0.912 . . . . 54.52 112.192 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 2.5 pm0 -85.17 147.96 26.35 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-O 121.579 0.704 . . . . 74.32 111.813 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.23 125.51 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.877 -1.157 . . . . 71.13 107.877 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.2 m -86.18 -33.95 20.65 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.677 -0.692 . . . . 72.01 109.596 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -179.94 -176.63 47.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.78 -0.928 . . . . 63.11 110.78 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.7 p -117.88 160.12 21.95 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 107.585 -1.265 . . . . 64.24 107.585 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.477 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.2 t-20 -60.23 -53.84 61.01 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.532 -0.467 . . . . 51.12 111.348 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 75.2 Cg_endo -88.41 146.73 6.2 Favored 'Trans proline' 0 C--N 1.369 1.613 0 CA-C-N 120.103 1.072 . . . . 71.44 110.116 171.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.39 159.53 52.63 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.174 1.916 . . . . 72.52 111.335 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 135.02 57.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.625 0.37 . . . . 73.42 110.729 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.88 48.62 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.678 -0.772 . . . . 63.5 111.933 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.7 m -71.39 121.7 19.03 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.442 -0.577 . . . . 72.43 109.442 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.4 t -83.61 126.7 33.11 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.5 0.5 . . . . 71.2 109.825 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.91 156.57 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.801 -0.814 . . . . 63.23 108.801 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.4 Cg_exo -59.47 144.71 99.34 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.436 2.09 . . . . 71.41 111.741 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.9 m -66.15 -20.54 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.327 0.492 . . . . 71.1 112.327 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.81 3.51 54.23 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.067 -0.515 . . . . 74.02 111.196 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -84.68 146.14 27.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.57 -0.529 . . . . 65.33 109.57 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.83 118.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.057 -1.09 . . . . 74.12 108.057 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.1 tt -94.32 145.91 7.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 120.962 0.411 . . . . 54.12 110.398 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 27.1 tt0 -102.62 127.91 49.52 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-O 121.203 0.525 . . . . 75.2 109.932 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.05 115.19 29.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.49 -1.232 . . . . 62.35 107.867 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.487 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 77.3 mt-30 -92.48 108.01 19.65 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.456 0.646 . . . . 74.32 109.468 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.483 HG21 ' HB ' ' A' ' 505' ' ' VAL . 8.0 p -113.78 139.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.056 -0.974 . . . . 75.24 111.368 -174.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 m -57.81 128.66 38.2 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.928 -1.138 . . . . 50.22 107.928 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 65.8 pttt . . . . . 0 C--O 1.264 1.868 0 N-CA-C 113.619 0.97 . . . . 74.34 113.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 123.143 1.449 . . . . 73.4 109.059 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.4 mt-30 -111.09 153.88 25.05 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.48 -1.691 . . . . 72.23 111.886 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.05 149.74 52.16 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.365 -0.834 . . . . 73.23 110.364 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -95.14 140.57 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 72.23 108.129 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.47 122.0 82.06 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 122.912 0.133 . . . . 53.31 110.69 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 142.49 33.43 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.014 2.476 . . . . 73.1 111.908 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -99.46 78.03 2.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.425 1.107 . . . . 70.02 110.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.1 m -112.44 5.34 8.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 N-CA-C 106.061 -1.829 . . . . 74.14 106.061 171.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.466 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -59.62 -38.69 82.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.684 -2.053 . . . . 64.24 110.611 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -26.34 68.46 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.283 -1.326 . . . . 61.25 112.166 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.22 -46.01 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.847 -0.427 . . . . 65.21 109.847 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 175.49 158.3 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.671 1.188 . . . . 63.43 111.335 175.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 441' ' ' VAL . 58.1 t80 -51.54 -43.69 62.43 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.91 1.284 . . . . 74.11 110.78 172.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.88 83.03 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.743 0.652 . . . . 33.44 111.036 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 19.4 mm-40 -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.692 -0.686 . . . . 64.45 109.903 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.55 -47.53 85.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.197 -0.91 . . . . 72.45 111.352 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 437' ' ' TYR . 98.8 t -59.37 -48.47 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 123.433 0.458 . . . . 72.41 111.371 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.5 mmpt? -63.86 -47.11 82.01 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.09 0.244 . . . . 54.43 111.283 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.7 mptp? -67.29 -38.52 85.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.488 0.551 . . . . 74.05 112.488 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 tp -68.02 -39.62 83.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.459 0.647 . . . . 51.51 109.44 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.24 -41.16 99.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.522 -0.763 . . . . 75.25 109.376 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.42 62.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.475 -0.784 . . . . 63.11 111.216 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.46 -13.81 53.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 74.24 109.431 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.92 56.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-N 115.702 -0.681 . . . . 75.43 113.862 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.93 133.04 46.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.157 0.503 . . . . 74.03 111.893 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.98 18.34 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.409 -0.814 . . . . 74.13 112.109 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -123.92 116.36 22.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.74 0.781 . . . . 73.2 112.044 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -143.06 147.19 34.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.225 -0.898 . . . . 74.52 110.181 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -131.02 133.9 46.17 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.688 -1.227 . . . . 73.1 107.688 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -95.47 121.43 37.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.204 0.526 . . . . 71.24 110.779 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.23 141.45 48.28 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.386 -0.968 . . . . 74.33 108.386 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -126.72 144.15 51.02 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.535 -0.543 . . . . 72.04 109.535 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.8 p -144.52 149.9 45.6 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.988 -0.551 . . . . 43.05 109.997 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.3 Cg_exo -65.54 140.55 63.32 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.258 1.972 . . . . 72.51 111.114 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.2 t -152.27 179.39 8.57 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.765 -1.198 . . . . 73.11 107.765 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.4 t -66.65 144.55 98.67 Favored Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 123.705 0.802 . . . . 63.41 110.589 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.464 ' HA ' HG23 ' A' ' 464' ' ' VAL . 88.9 Cg_exo -51.42 -29.34 30.7 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.41 3.407 . . . . 73.34 112.623 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -68.51 -32.13 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.804 -0.634 . . . . 75.14 111.823 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.91 9.01 39.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.551 0.575 . . . . 73.42 112.551 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 461' ' ' PRO . 92.6 t -60.76 127.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.822 -0.436 . . . . 70.42 109.822 177.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.45 -12.28 64.91 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.627 -0.797 . . . . 64.35 111.946 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.2 146.73 23.48 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.313 -0.625 . . . . 74.23 109.313 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 64.9 t -82.67 124.79 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 N-CA-C 106.649 -1.611 . . . . 75.34 106.649 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 25.5 pt -97.85 -2.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 120.9 0.381 . . . . 64.32 111.579 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.96 164.93 20.26 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 120.236 -0.983 . . . . 63.14 111.788 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.4 p -120.77 142.71 49.32 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.725 -1.583 . . . . 73.24 106.725 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 6.1 t30 -63.97 -45.01 80.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 123.544 0.527 . . . . 73.44 110.494 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.99 139.8 12.23 Favored 'Trans proline' 0 C--N 1.375 1.938 0 CA-C-N 120.347 1.16 . . . . 71.21 109.912 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.9 144.08 63.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.697 2.264 . . . . 62.23 112.338 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.94 15.9 4.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.069 0.938 . . . . 52.42 110.483 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.02 -28.74 12.56 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.863 -1.062 . . . . 74.41 111.576 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -117.02 154.09 31.53 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 16.3 p -81.59 135.27 35.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.973 -0.558 . . . . 73.44 110.566 -177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.3 m -111.9 138.24 48.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.832 -0.803 . . . . 72.31 108.832 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -61.02 150.41 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.272 0.358 . . . . 60.44 110.824 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.58 -28.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.449 0.7 . . . . 72.21 111.041 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -88.07 0.87 55.46 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.686 -0.688 . . . . 70.23 111.439 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.08 148.99 27.18 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.002 -0.74 . . . . 75.12 109.002 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 30.9 t -92.14 111.49 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.746 -0.835 . . . . 74.54 108.746 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 86.0 t -91.0 118.82 37.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.131 -0.692 . . . . 61.12 109.131 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.475 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.8 mt -93.8 114.25 30.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.745 -0.835 . . . . 61.41 108.745 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.6 124.97 54.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.271 -0.64 . . . . 63.25 109.271 -178.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.48 116.25 49.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.354 0.597 . . . . 73.13 111.073 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.98 140.72 16.91 Favored 'Isoleucine or valine' 0 C--O 1.252 1.225 0 CA-C-N 115.824 -0.626 . . . . 74.34 110.288 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.69 117.23 4.6 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.546 -1.422 . . . . 61.44 109.546 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.8 m -125.03 135.68 52.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.684 -0.488 . . . . 64.54 109.684 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.739 0 N-CA-C 110.006 -1.238 . . . . 75.11 110.006 -179.468 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.279 -1.008 . . . . 74.43 108.279 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.2 p -128.29 155.29 44.84 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.79 -1.095 . . . . 64.12 109.842 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -142.65 149.98 39.63 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 71.15 109.35 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -85.35 138.07 32.53 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.47 -1.307 . . . . 72.12 107.47 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -83.1 120.39 75.87 Favored Pre-proline 0 C--N 1.291 -1.937 0 C-N-CA 119.808 -0.757 . . . . 73.12 110.028 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.76 158.48 21.49 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.737 1.625 . . . . 73.21 109.431 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.42 101.91 2.07 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.064 0.935 . . . . 75.32 110.977 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.36 -1.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.666 -1.235 . . . . 70.23 107.666 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.72 119.91 15.56 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 113.822 -1.536 . . . . 63.13 107.962 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.37 -27.65 5.74 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.439 -1.464 . . . . 61.41 109.439 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -83.94 178.41 7.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.021 -0.733 . . . . 75.4 109.021 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.3 m -91.12 155.87 18.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.978 . . . . 72.22 108.361 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 -47.85 56.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 112.55 0.574 . . . . 72.32 112.55 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 20.6 m-20 -69.46 -41.38 76.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.538 0.57 . . . . 63.14 112.538 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.26 -35.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.445 -0.902 . . . . 63.51 111.55 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.67 -48.95 77.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.44 -0.8 . . . . 63.15 111.322 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.42 -37.02 85.7 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 120.194 -0.602 . . . . 62.12 110.608 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 2.1 mptm? -65.94 -52.13 52.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . 0.253 33.3 p30 -69.08 -37.59 78.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.761 0.652 . . . . 72.52 112.761 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.28 -36.8 83.89 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-O 120.516 0.198 . . . . 74.22 110.742 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 8.0 t30 -58.28 -37.53 75.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.59 0.756 . . . . 75.01 111.724 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.88 -38.72 83.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.717 -0.674 . . . . 65.33 111.53 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -105.51 -13.86 15.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.764 -0.774 . . . . 64.14 110.695 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -125.12 -97.74 1.15 Allowed Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 117.067 1.587 . . . . 51.14 117.067 -166.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 2.7 m-85 -127.59 153.69 46.1 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.04 0.448 . . . . 72.45 110.161 -163.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.4 m -106.31 -6.43 18.37 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.196 -0.911 . . . . 71.21 109.436 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -108.23 115.02 29.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.838 -0.619 . . . . 53.0 109.973 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.42 156.25 37.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.212 -0.904 . . . . 73.42 111.482 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 65.7 m -138.09 152.94 49.25 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.036 -1.839 . . . . 43.33 106.036 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -119.77 131.19 55.27 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.829 -0.804 . . . . 75.04 108.829 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -115.48 140.43 49.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.442 -0.947 . . . . 70.33 108.442 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.1 m -104.36 119.47 39.03 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.165 -0.68 . . . . 70.22 109.165 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.4 153.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.968 -0.753 . . . . 74.32 108.968 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.7 135.4 36.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.039 -0.664 . . . . 74.4 110.041 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 m -146.26 136.31 11.94 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 107.242 -1.392 . . . . 51.15 107.242 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.12 150.97 66.76 Favored 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.365 2.043 . . . . 73.13 112.156 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 530' ' ' PRO 0.406 75.8 mtm180 37.64 -89.49 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 118.166 2.654 . . . . 71.14 118.166 179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 50.7 Cg_exo -57.56 148.53 72.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.15 1.9 . . . . 54.54 113.743 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.05 160.09 40.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.906 -0.776 . . . . 71.12 108.906 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 105.3 -21.28 35.66 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 120.523 -0.846 . . . . 33.31 112.695 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.65 148.29 25.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.282 0.563 . . . . 73.34 111.215 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.53 119.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 63.22 108.676 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.0 m -88.21 -25.52 22.86 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.58 0.705 . . . . 65.42 109.836 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.24 178.66 47.09 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.212 -0.755 . . . . 61.33 111.212 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.2 p -118.57 160.4 21.85 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.123 -1.065 . . . . 73.23 108.123 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.4 t-20 -60.49 -54.67 52.62 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-O 119.146 -0.454 . . . . 72.51 112.057 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.2 Cg_endo -86.17 153.0 9.53 Favored 'Trans proline' 0 C--N 1.365 1.413 0 CA-C-N 120.461 1.2 . . . . 70.44 109.549 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.68 150.87 85.9 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.032 1.822 . . . . 73.22 111.577 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.64 58.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.071 -0.513 . . . . 72.41 110.604 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.99 54.1 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 121.095 -0.574 . . . . 51.44 112.0 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.8 m -69.55 129.17 38.93 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.776 -0.25 . . . . 74.15 110.332 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -93.86 122.95 36.87 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.652 -0.499 . . . . 64.41 109.652 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.5 161.42 60.82 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.449 -0.796 . . . . 51.04 109.07 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.518 ' HA ' HG22 ' A' ' 494' ' ' THR . 33.4 Cg_exo -60.61 136.25 65.85 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.569 2.18 . . . . 73.11 111.381 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 29.2 m -67.07 -21.36 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 70.4 111.494 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -86.34 -1.81 57.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.762 -0.654 . . . . 72.31 110.863 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.1 t -85.85 168.38 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.322 0.582 . . . . 51.13 110.419 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.9 t -97.61 136.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.34 -0.846 . . . . 74.32 108.804 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.0 tt -112.84 144.26 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.723 -0.473 . . . . 75.11 109.723 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 26.6 tt0 -103.53 122.71 45.5 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 108.815 -0.809 . . . . 72.12 108.815 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.4 tp -100.68 117.82 35.56 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.045 -1.094 . . . . 72.43 108.045 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.501 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 78.3 mt-30 -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.987 0.899 . . . . 74.41 110.325 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.33 141.21 23.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.085 -1.416 . . . . 64.41 111.872 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -55.78 122.84 12.37 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.618 -0.719 . . . . 73.0 110.208 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.147 -1.057 . . . . 61.43 108.147 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.142 0.496 . . . . 74.45 110.808 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 58.9 mt-30 -115.85 156.33 26.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.057 . . . . 75.51 108.145 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -150.95 155.41 39.04 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.404 -1.332 . . . . 74.51 107.404 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.36 141.1 28.89 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 110.061 -0.348 . . . . 73.44 110.061 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -78.39 130.21 72.35 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.005 -1.109 . . . . 73.34 108.005 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.64 144.19 93.75 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.572 2.182 . . . . 74.24 112.839 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.16 20.4 11.43 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.238 0.542 . . . . 65.12 111.342 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.405 HG11 ' HG3' ' A' ' 443' ' ' LYS . 8.7 p -83.29 -1.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.408 1.099 . . . . 71.31 108.435 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.8 p -60.09 -34.23 73.19 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.178 1.391 . . . . 41.4 110.097 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -59.33 -27.84 66.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.253 -1.339 . . . . 65.23 111.27 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 70.5 mt -90.77 -47.19 7.78 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 119.204 -0.998 . . . . 43.35 112.041 -175.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 6.4 m -159.9 148.28 17.21 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.386 -0.598 . . . . 73.2 109.386 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 441' ' ' VAL . 26.7 t80 -56.42 -47.85 78.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.022 0.529 . . . . 71.01 110.396 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -56.81 -44.28 81.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.944 -0.571 . . . . 65.43 111.165 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.524 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.6 mm-40 -63.82 -41.6 97.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.929 -0.578 . . . . 71.43 110.945 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.92 -46.33 89.7 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.361 -0.836 . . . . 65.52 110.673 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 437' ' ' TYR . 87.4 t -60.95 -46.31 96.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 O-C-N 123.792 0.683 . . . . 71.44 111.361 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 66.7 mttm -60.62 -48.53 81.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.06 0.457 . . . . 74.14 110.38 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.405 ' HG3' HG11 ' A' ' 432' ' ' VAL . 46.7 mmtm -67.65 -38.94 84.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.676 -0.693 . . . . 61.51 112.85 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.5 tp -68.54 -38.48 80.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.284 0.564 . . . . 72.22 109.574 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -61.82 -43.38 98.97 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.354 -0.839 . . . . 63.34 109.226 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.3 -16.0 62.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.73 -0.668 . . . . 71.54 111.736 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.84 -14.16 51.93 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 121.328 0.585 . . . . 71.11 109.539 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.93 55.88 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.616 -0.72 . . . . 71.25 113.891 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -59.62 131.1 49.9 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.391 0.595 . . . . 65.31 112.419 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -80.28 -43.77 9.3 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.214 -0.903 . . . . 72.51 114.183 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.406 ' HG3' HG13 ' A' ' 483' ' ' VAL . 30.7 tpt180 -129.62 132.77 46.84 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.793 0.806 . . . . 73.22 112.531 -175.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -140.73 150.38 43.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.814 -1.084 . . . . 61.0 109.991 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -130.31 130.69 44.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.059 -0.719 . . . . 60.21 109.059 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -92.92 132.42 37.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.274 0.559 . . . . 71.41 111.321 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.48 148.94 50.31 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.946 -1.501 . . . . 62.1 106.946 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.6 148.07 48.09 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.174 -0.611 . . . . 71.42 110.091 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 28.6 m -142.75 142.55 22.95 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.988 -0.745 . . . . 74.45 108.988 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.5 Cg_exo -67.06 128.57 18.87 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.436 2.091 . . . . 72.02 111.57 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.9 m -140.28 179.22 6.77 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.757 -0.46 . . . . 70.03 109.757 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.8 t -54.88 139.87 61.61 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 123.885 0.874 . . . . 73.03 111.439 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.412 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.6 Cg_endo -52.01 -31.28 43.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.112 3.208 . . . . 63.02 113.387 -178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.34 -12.7 60.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.039 0.447 . . . . 73.32 111.847 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 30.8 tp -113.17 1.27 15.2 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.227 0.537 . . . . 71.12 110.29 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.1 t -61.35 127.23 20.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.102 0.477 . . . . 34.53 110.722 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.18 -6.86 66.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 116.011 -0.54 . . . . 65.43 112.281 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.5 mptp? -99.87 157.3 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.786 -0.82 . . . . 73.03 108.786 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.578 HG22 HD11 ' A' ' 486' ' ' ILE . 59.0 t -81.94 131.5 33.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 73.31 107.944 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.4 pt -98.57 -4.53 9.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.43 -0.508 . . . . 64.44 111.425 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.92 154.18 7.29 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.461 -0.791 . . . . 55.41 111.493 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 18.4 p -116.76 146.37 42.87 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.135 -0.691 . . . . 64.2 109.135 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -59.1 -49.66 91.92 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.086 -0.483 . . . . 75.52 111.654 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.9 Cg_exo -82.86 144.07 12.03 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.443 1.429 . . . . 75.14 110.305 172.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 9.5 Cg_endo -75.65 135.92 18.49 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.325 2.016 . . . . 75.32 111.871 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.96 -0.29 27.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.837 0.827 . . . . 65.32 111.058 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.61 -27.01 34.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.64 -1.164 . . . . 65.34 110.418 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -113.88 175.03 5.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.291 -0.413 . . . . 74.53 110.578 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 17.2 p -98.68 115.37 28.54 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 108.534 -0.913 . . . . 73.35 108.534 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.2 m -100.44 144.19 29.72 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.906 -0.775 . . . . 61.54 108.906 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -62.11 135.08 57.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 61.35 111.388 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.4 mm -57.11 -27.09 26.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.062 1.745 . . . . 74.02 112.524 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -75.27 -11.01 59.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.969 -0.56 . . . . 60.13 111.046 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.08 150.24 33.77 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 112.797 0.666 . . . . 64.52 112.797 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 451' ' ' ARG . 77.4 t -86.36 114.93 26.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.632 -1.247 . . . . 72.51 107.632 175.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.0 119.4 35.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.879 -0.785 . . . . 62.51 108.879 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -92.86 118.75 39.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.413 -1.328 . . . . 53.03 107.413 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.29 123.27 68.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.725 -0.67 . . . . 54.05 109.544 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 487' ' ' ILE . 3.1 mp -104.87 124.53 59.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.137 0.494 . . . . 73.23 110.005 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.21 140.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.728 -0.669 . . . . 71.23 110.064 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 120.51 5.17 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.521 -1.432 . . . . 74.32 109.521 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.0 t -118.33 160.45 21.63 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.411 -0.959 . . . . 73.32 108.411 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.378 0 C-N-CA 120.418 -0.896 . . . . 61.43 111.796 -178.27 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 122.066 0.936 . . . . 72.03 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 546' ' ' PRO . 10.4 p -135.26 159.21 42.28 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.872 -1.058 . . . . 74.34 109.498 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -146.28 141.79 27.69 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.352 -0.61 . . . . 75.31 109.352 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.8 p-10 -89.14 138.13 31.7 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.961 -0.755 . . . . 74.1 108.961 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.3 pt -93.86 137.54 23.07 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 116.197 -0.456 . . . . 72.52 111.93 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.53 171.83 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.935 2.423 . . . . 74.22 112.112 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -82.84 110.57 17.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.588 0.709 . . . . 71.54 111.115 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.55 8.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.389 -0.823 . . . . 64.4 110.053 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.02 140.27 32.81 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.044 -0.525 . . . . 74.01 109.744 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.09 -13.44 58.8 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.126 -1.19 . . . . 71.01 110.126 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.477 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 79.3 mt-30 -93.96 178.3 5.7 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.264 -1.013 . . . . 73.43 108.264 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.2 p -85.54 157.5 20.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.145 -0.687 . . . . 74.54 109.145 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.41 -42.21 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.481 0.488 . . . . 65.42 112.092 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.01 -41.99 81.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.128 -0.629 . . . . 74.21 111.354 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 7.1 p -76.9 -36.42 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 118.577 -1.249 . . . . 52.03 111.125 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.84 -48.77 75.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.874 -0.603 . . . . 74.11 111.315 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -64.51 -35.15 80.02 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 123.293 0.37 . . . . 64.25 110.072 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 514' ' ' VAL . 50.4 tptt -63.49 -51.72 64.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.342 0.401 . . . . 54.22 110.248 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -61.89 -41.53 98.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.164 0.506 . . . . 75.43 110.126 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.408 HD21 HD13 ' A' ' 551' ' ' ILE . 37.2 tp -64.35 -47.77 78.07 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 115.192 -0.913 . . . . 75.1 110.171 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.87 -41.21 91.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.811 0.444 . . . . 53.33 111.919 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.3 t -63.87 -34.09 66.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.326 0.491 . . . . 63.2 112.326 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.27 -19.23 11.37 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.003 -1.079 . . . . 75.52 112.274 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -99.93 -103.5 2.52 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.71 -0.677 . . . . 61.41 114.541 -173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 11.5 m-85 -135.77 -178.59 5.2 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 110.265 -0.272 . . . . 64.25 110.265 -169.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -115.56 3.95 14.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.135 0.493 . . . . 55.2 111.106 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -108.12 115.54 30.31 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.658 -0.867 . . . . 74.51 108.658 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.63 151.5 50.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.757 0.789 . . . . 74.41 111.518 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.0 m -134.69 151.08 50.74 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.623 -1.621 . . . . 61.24 106.623 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -120.77 122.6 40.71 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.582 -1.266 . . . . 62.54 107.582 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.97 117.15 30.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.748 -1.204 . . . . 73.33 107.748 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.9 p -88.75 124.52 34.21 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 108.304 -0.999 . . . . 71.33 108.304 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.98 153.53 26.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.857 -0.794 . . . . 73.01 108.857 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.8 115.63 17.7 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.631 -1.248 . . . . 64.42 107.631 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 19.2 m -119.89 168.77 9.59 Favored Pre-proline 0 C--N 1.282 -2.356 0 CA-C-N 114.515 -1.22 . . . . 70.43 110.663 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 25.4 Cg_endo -61.9 -166.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 123.031 2.487 . . . . 75.34 112.165 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -50.67 -51.86 61.64 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 115.272 1.582 . . . . 73.44 115.272 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.24 133.71 36.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 CA-C-N 120.706 1.288 . . . . 64.21 111.495 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.424 ' HA ' ' OG ' ' A' ' 556' ' ' SER . . . -142.61 157.79 44.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.32 -0.622 . . . . 32.2 109.32 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 99.86 -24.89 30.39 Favored Glycine 0 C--N 1.313 -0.696 0 N-CA-C 110.389 -1.084 . . . . 51.33 110.389 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.95 148.04 25.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.346 -0.927 . . . . 75.14 110.154 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.83 119.12 23.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.109 -0.496 . . . . 72.13 111.038 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 24.0 m -73.16 -35.1 66.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.942 -1.026 . . . . 73.02 109.046 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.46 -161.58 35.31 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 111.084 -0.807 . . . . 74.32 111.084 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -130.34 160.8 32.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.524 -0.917 . . . . 61.14 108.524 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.5 t-20 -53.22 -57.87 14.88 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.493 0.496 . . . . 73.31 111.398 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.3 Cg_endo -89.2 147.42 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 CA-C-N 120.797 1.32 . . . . 73.5 109.11 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.75 155.64 69.61 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.692 1.595 . . . . 54.15 111.811 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.6 137.46 58.17 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 122.62 0.368 . . . . 65.14 110.118 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.26 -6.0 61.28 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.988 -0.625 . . . . 53.11 111.834 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.9 m -86.79 134.56 33.55 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.67 -0.312 . . . . 43.43 110.863 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.7 m -92.49 123.78 36.05 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.5 -0.926 . . . . 75.42 108.5 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.03 158.2 75.86 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.452 -0.573 . . . . 75.02 109.452 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 494' ' ' THR . 47.2 Cg_exo -58.74 144.33 98.19 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.825 2.35 . . . . 41.24 112.162 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 34.4 m -67.48 -20.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.664 0.616 . . . . 62.11 112.664 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.23 4.41 54.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.683 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -77.33 140.97 40.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.08 -1.081 . . . . 60.34 108.08 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.5 t -88.31 112.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.488 -1.301 . . . . 62.5 107.488 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 512' ' ' LEU . 19.8 tt -86.57 133.73 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.743 0.782 . . . . 72.45 111.399 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 21.0 tt0 -102.81 125.67 49.65 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.145 -0.934 . . . . 71.13 109.437 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.59 131.82 44.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.901 -1.148 . . . . 74.31 107.901 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -92.67 105.02 17.25 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 107.74 -1.207 . . . . 62.24 107.74 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.8 p -100.29 132.81 45.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.31 0.576 . . . . 70.44 110.145 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 531' ' ' ALA . 26.7 p -66.87 128.02 34.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.441 -0.8 . . . . 52.34 111.895 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 108.036 -1.098 . . . . 73.14 108.036 176.836 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.633 0.73 . . . . 71.52 109.658 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 77.0 mt-30 -101.22 130.98 47.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.076 -0.965 . . . . 74.44 110.298 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.3 mmp_? -123.92 155.59 37.85 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.678 0.791 . . . . 64.03 110.955 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -84.77 141.55 30.44 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.782 -0.645 . . . . 62.32 111.596 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -79.25 131.18 66.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.626 -0.716 . . . . 74.32 109.551 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.43 152.32 65.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.962 2.441 . . . . 75.12 112.774 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.85 8.38 43.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.427 0.632 . . . . 65.13 110.142 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 439' ' ' GLU . 21.4 t -74.7 -12.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 122.542 1.163 . . . . 74.12 108.293 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.5 m -58.79 -38.39 78.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.855 -1.52 . . . . 25.13 110.804 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.2 m -60.21 -26.5 66.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.696 -1.138 . . . . 71.55 111.167 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.35 -45.45 12.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.812 -0.355 . . . . 70.14 111.108 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 28.3 m -161.86 143.78 11.34 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.031 -0.729 . . . . 72.45 109.031 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -52.51 -44.72 65.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.792 0.837 . . . . 73.12 111.455 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 436' ' ' THR . . . -62.77 -38.37 90.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.159 -0.473 . . . . 44.13 111.19 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 8.4 mm-40 -69.2 -37.34 78.06 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.731 -0.668 . . . . 73.42 110.202 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.91 -51.92 67.62 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.092 -0.958 . . . . 64.53 111.349 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.84 -40.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.425 -0.807 . . . . 74.13 111.777 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -66.08 -44.86 83.21 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.768 -0.373 . . . . 70.43 111.08 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.52 -40.57 89.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.643 0.259 . . . . 60.35 111.624 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 30.3 tp -68.94 -34.75 75.87 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.25 0.548 . . . . 44.23 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.1 m -64.48 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.381 -0.6 . . . . 74.43 109.381 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.07 62.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.72 -0.673 . . . . 71.41 110.398 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.8 -13.63 53.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.724 -0.472 . . . . 63.31 109.724 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.32 -13.11 18.91 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.785 -0.643 . . . . 73.53 113.831 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 66.6 m-85 -71.09 138.94 50.16 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.613 0.244 . . . . 75.43 111.143 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -138.38 10.63 3.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.156 -1.021 . . . . 64.04 113.149 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 483' ' ' VAL . 32.6 tpt180 -120.74 115.01 22.47 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.17 153.83 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.847 0.356 . . . . 73.42 110.559 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -131.42 122.35 26.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.002 -1.481 . . . . 75.2 107.002 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -94.36 115.78 28.05 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.177 0.513 . . . . 64.22 110.193 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -118.53 154.61 32.28 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.997 -1.112 . . . . 70.24 107.997 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.21 148.22 52.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.365 -0.606 . . . . 54.11 109.365 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.6 m -135.63 147.21 60.57 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 109.06 -0.718 . . . . 54.32 109.06 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.9 Cg_exo -65.07 122.72 10.58 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.428 2.086 . . . . 74.22 110.933 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.9 t -148.88 179.4 7.89 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.017 -1.105 . . . . 74.54 108.017 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.84 139.83 90.1 Favored Pre-proline 0 N--CA 1.427 -1.593 0 C-N-CA 124.333 1.053 . . . . 64.33 110.662 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 82.4 Cg_exo -50.87 -29.87 28.19 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.311 3.341 . . . . 61.11 113.141 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.78 -29.73 69.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.097 -0.502 . . . . 74.25 111.818 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.31 -2.13 49.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.033 -0.531 . . . . 71.41 111.68 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.7 t -61.28 127.04 20.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.23 -0.656 . . . . 75.33 109.23 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.93 -3.54 82.87 Favored Glycine 0 C--N 1.307 -1.065 0 C-N-CA 121.067 -0.587 . . . . 71.12 112.121 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.7 154.29 26.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.545 -0.909 . . . . 74.4 108.545 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.661 HG22 HD11 ' A' ' 486' ' ' ILE . 43.3 t -82.12 125.36 39.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.844 -0.798 . . . . 75.22 108.844 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.8 pt -98.45 -7.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.141 0.496 . . . . 44.21 110.415 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.46 150.2 5.92 Favored Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.631 -0.713 . . . . 74.34 111.487 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 10.4 p -116.47 158.32 23.77 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.481 -1.303 . . . . 74.03 107.481 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.9 m120 -67.94 -55.11 14.22 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 119.059 -1.056 . . . . 63.32 110.609 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -69.26 116.33 4.46 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 108.574 -1.356 . . . . 64.13 108.574 170.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 158.79 41.56 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.566 2.177 . . . . 73.23 113.413 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.33 7.25 9.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.307 -0.86 . . . . 62.54 110.401 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.16 -40.8 11.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.356 -0.838 . . . . 73.55 110.802 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -118.73 165.27 14.21 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.589 -0.523 . . . . 73.24 109.589 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 23.9 p -84.06 142.79 30.17 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.459 -0.337 . . . . 72.31 110.682 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.3 m -124.3 150.77 45.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.883 -1.154 . . . . 52.35 107.883 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -74.63 146.22 42.61 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.534 0.606 . . . . 74.41 111.328 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.71 -23.09 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.44 1.096 . . . . 60.25 111.014 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -95.5 1.18 53.86 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.784 -1.098 . . . . 60.41 110.428 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -80.67 155.45 26.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.098 -0.704 . . . . 74.13 109.098 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 451' ' ' ARG . 7.7 p -88.13 121.23 38.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.889 -0.782 . . . . 64.23 108.889 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.85 118.89 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.926 -0.768 . . . . 75.22 108.926 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.44 117.43 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 106.157 -1.794 . . . . 63.53 106.157 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.92 124.24 65.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.701 -0.851 . . . . 61.01 108.701 -176.496 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.14 118.53 49.12 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 CA-C-O 121.396 0.617 . . . . 44.43 109.608 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.54 141.49 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.294 -0.866 . . . . 73.35 108.915 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.98 128.48 11.95 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 108.516 -1.833 . . . . 64.42 108.516 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.8 m -140.91 150.72 43.53 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.141 -0.623 . . . . 63.34 109.513 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.166 0 N-CA-C 109.689 -1.364 . . . . 73.31 109.689 179.197 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 121.788 0.804 . . . . 72.32 109.084 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 546' ' ' PRO . 47.0 p -131.87 160.58 35.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.356 -0.979 . . . . 72.13 108.356 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 544' ' ' THR . 67.8 mttm -135.59 147.22 48.61 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.215 -0.291 . . . . 63.42 110.215 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.28 126.51 36.39 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.593 -0.892 . . . . 74.15 108.593 175.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 541' ' ' ALA . 38.1 pt -81.95 137.41 46.76 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.524 -0.762 . . . . 63.54 112.358 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.43 175.47 6.25 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.563 2.175 . . . . 75.14 111.224 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.45 121.61 31.85 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 75.03 110.27 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.66 9.8 6.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.35 -0.841 . . . . 64.21 109.378 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.474 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -75.17 147.6 40.29 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.342 -0.844 . . . . 62.23 112.191 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.64 69.46 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.178 -0.769 . . . . 64.24 111.178 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.413 ' O ' HG12 ' A' ' 534' ' ' VAL . 43.6 mt-30 -117.32 -167.82 1.38 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.984 -0.747 . . . . 74.53 108.984 177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.4 m -90.67 155.66 18.68 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.299 -0.961 . . . . 72.32 109.608 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.76 -43.93 57.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.196 0.598 . . . . 72.44 112.141 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.15 -42.2 80.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 63.34 111.906 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.59 -34.23 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.894 -0.722 . . . . 65.32 111.09 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.47 -47.28 86.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.534 -0.757 . . . . 70.02 110.736 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.89 -37.37 87.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 123.257 0.348 . . . . 64.22 110.632 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 60.4 tttp -62.39 -53.67 51.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.64 -0.709 . . . . 71.04 110.062 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.07 -42.76 96.87 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.344 -0.844 . . . . 74.02 110.676 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.6 -41.12 96.98 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 115.592 -0.731 . . . . 74.15 109.715 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.18 -40.08 84.59 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.82 0.448 . . . . 74.43 110.708 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.2 t -67.18 -36.88 78.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.848 -0.615 . . . . 72.3 111.71 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -113.84 9.17 17.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.135 -0.626 . . . . 71.4 111.025 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -140.38 -107.5 0.7 Allowed Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.156 -1.497 . . . . 73.44 115.198 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.7 m-85 -127.6 -176.59 3.8 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.06 0.392 . . . . 74.24 112.06 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.87 -14.34 10.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.623 0.725 . . . . 74.12 110.559 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -108.14 115.72 30.65 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.246 -0.65 . . . . 73.41 109.246 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -124.29 155.59 38.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.298 -0.41 . . . . 75.25 110.347 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.3 m -140.86 158.29 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.447 -1.686 . . . . 71.02 106.447 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -121.95 144.12 49.06 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.735 -0.468 . . . . 73.13 109.735 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.31 134.91 54.65 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.208 -0.664 . . . . 73.33 109.208 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.4 m -90.26 119.9 30.96 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.606 -0.887 . . . . 63.24 108.606 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.51 163.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.626 -1.25 . . . . 71.44 107.626 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.43 129.18 35.42 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.642 0.734 . . . . 71.43 109.488 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 11.2 p -77.27 132.48 69.92 Favored Pre-proline 0 N--CA 1.419 -2.015 0 CA-C-N 114.682 -1.144 . . . . 72.35 110.576 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.453 ' O ' ' HD2' ' A' ' 529' ' ' ARG . 11.9 Cg_endo -63.69 -75.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.524 1.482 . . . . 72.33 109.579 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.548 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 10.9 mmm180 -121.17 -57.7 0.03 OUTLIER Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.663 -0.495 . . . . 65.2 109.663 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 2.7 Cg_exo -77.36 153.15 31.01 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.305 2.004 . . . . 65.42 111.609 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.98 149.28 52.47 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.785 -0.82 . . . . 54.33 108.785 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 103.82 -22.08 36.49 Favored Glycine 0 C--O 1.249 1.035 0 N-CA-C 111.156 -0.778 . . . . 55.34 111.156 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.09 148.09 25.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.579 0.704 . . . . 55.14 111.674 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 501' ' ' ALA . 3.8 p -75.8 125.16 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.977 -1.011 . . . . 74.24 110.15 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 8.4 m -77.45 -37.08 52.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.262 -1.014 . . . . 62.43 108.262 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.43 35.2 Favored Glycine 0 N--CA 1.417 -2.603 0 N-CA-C 109.665 -1.374 . . . . 73.14 109.665 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.3 p -117.74 159.88 22.27 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.209 -1.404 . . . . 62.32 107.209 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -56.75 -57.15 25.81 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 123.489 0.493 . . . . 73.13 110.716 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 59.8 Cg_endo -77.26 142.84 21.77 Favored 'Trans proline' 0 C--N 1.368 1.588 0 N-CA-C 109.125 -1.144 . . . . 74.24 109.125 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -65.22 151.02 86.78 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.282 1.988 . . . . 74.41 111.804 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -58.92 138.45 57.38 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.747 0.308 . . . . 34.52 110.196 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.78 -21.13 43.36 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 111.309 -0.716 . . . . 74.24 111.309 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 46.2 m -70.75 132.35 45.22 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.105 0.478 . . . . 72.23 110.394 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 m -96.67 122.66 39.86 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.397 -0.819 . . . . 74.4 108.82 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.16 159.63 71.35 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.398 -0.593 . . . . 62.3 109.398 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.583 ' HA ' HG22 ' A' ' 494' ' ' THR . 39.2 Cg_exo -61.03 142.26 96.84 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.217 2.611 . . . . 73.23 114.584 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.499 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 30.9 m -67.43 -19.32 25.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.95 0.881 . . . . 73.51 111.146 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.9 -10.12 55.79 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.22 -1.354 . . . . 63.23 109.747 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 59.9 p -92.3 171.76 8.85 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.866 -0.606 . . . . 62.42 112.03 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.25 136.39 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.261 -1.014 . . . . 74.31 108.261 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.0 tt -113.76 142.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 120.895 0.379 . . . . 74.42 110.538 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -102.99 128.3 49.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 122.968 0.507 . . . . 75.2 111.606 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.3 122.01 42.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.135 -1.431 . . . . 75.51 107.135 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -104.32 110.13 22.25 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.606 -0.887 . . . . 70.14 108.606 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.36 139.13 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.461 -0.791 . . . . 73.52 112.944 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 69.6 m -64.76 115.05 4.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.484 -0.78 . . . . 71.34 109.581 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 106.46 -1.682 . . . . 73.22 106.46 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 122.296 1.046 . . . . 72.22 111.617 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 91.7 mt-30 -121.75 131.03 53.85 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.222 -1.354 . . . . 72.22 108.122 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -122.72 151.56 41.44 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.154 -0.684 . . . . 75.45 109.154 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -93.74 142.16 27.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.266 -0.879 . . . . 74.24 110.082 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.497 ' O ' ' HB1' ' A' ' 474' ' ' ALA . 2.9 mp -79.13 125.11 84.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.858 -0.793 . . . . 73.34 108.858 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.43 141.79 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.727 1.618 . . . . 74.22 111.332 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.65 52.19 1.85 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.728 0.775 . . . . 65.35 110.652 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 440' ' ' ALA . 14.8 p -102.39 -2.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.018 -1.475 . . . . 72.12 107.018 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 1.7 p -59.11 -41.44 88.16 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.998 -1.91 . . . . 72.03 110.703 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.3 p -61.71 -26.37 68.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.9 -1.045 . . . . 72.14 112.807 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.3 -46.48 13.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 119.077 -1.049 . . . . 64.42 111.575 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.6 m -170.39 147.36 3.0 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.942 -0.762 . . . . 75.32 108.942 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -50.82 -48.91 59.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.507 1.123 . . . . 71.2 110.581 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 436' ' ' THR . . . -58.31 -37.76 75.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.204 -0.453 . . . . 74.44 111.579 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.511 ' HB3' HG22 ' A' ' 432' ' ' VAL . 25.0 mm-40 -69.59 -44.68 70.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.088 0.47 . . . . 65.44 110.363 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.44 -51.18 70.55 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.045 -0.979 . . . . 54.55 111.704 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.01 -45.95 89.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 CA-C-N 115.737 -0.665 . . . . 75.55 111.511 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.19 -47.91 80.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.018 0.377 . . . . 71.54 112.018 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -67.79 -39.52 84.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.31 -0.556 . . . . 63.12 110.668 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 20.9 tp -69.7 -34.78 74.37 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.252 0.548 . . . . 75.41 110.716 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 27.1 m -62.06 -43.31 99.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.651 -0.704 . . . . 71.33 109.64 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.87 62.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.626 -0.715 . . . . 72.33 110.836 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.65 59.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.049 0.452 . . . . 72.2 110.454 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.92 6.95 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.329 -0.938 . . . . 75.34 113.171 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 445' ' ' THR . 97.1 m-85 -80.85 130.93 35.31 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.927 0.394 . . . . 74.31 111.69 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -136.22 14.74 4.0 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.184 -1.166 . . . . 60.11 110.184 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -116.95 115.3 25.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.978 -1.49 . . . . 74.21 106.978 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 87.7 m-85 -139.04 156.43 47.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 73.53 112.301 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.466 ' HB2' HG13 ' A' ' 485' ' ' ILE . 68.8 mttm -133.55 122.97 24.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.114 -1.809 . . . . 61.12 106.114 167.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -93.79 120.02 33.51 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.763 -0.775 . . . . 75.04 112.027 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.31 43.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.232 -1.025 . . . . 74.13 108.232 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.89 150.75 33.19 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.915 -1.143 . . . . 63.41 107.915 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 37.1 p -134.6 138.21 29.4 Favored Pre-proline 0 C--N 1.277 -2.575 0 N-CA-C 108.964 -0.754 . . . . 61.43 108.964 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 22.8 Cg_exo -65.57 123.6 11.64 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.086 1.857 . . . . 74.41 110.042 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 179.31 7.55 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 108.43 -0.952 . . . . 54.22 108.43 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -67.92 137.89 92.54 Favored Pre-proline 0 N--CA 1.418 -2.065 0 C-N-CA 123.467 0.707 . . . . 71.14 110.461 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 464' ' ' VAL . 98.2 Cg_exo -50.78 -29.21 25.45 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 124.669 3.579 . . . . 61.42 113.596 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.65 -21.53 61.81 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.227 -0.442 . . . . 71.53 111.401 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 466' ' ' LYS . 23.0 tp -105.15 2.92 29.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 64.31 110.683 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 461' ' ' PRO . 65.2 t -60.46 128.03 20.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.013 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.31 -2.55 56.37 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.717 -0.674 . . . . 64.13 111.676 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.489 ' HD2' HD12 ' A' ' 463' ' ' LEU . 96.6 mttt -112.21 145.05 40.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.38 -0.6 . . . . 64.11 109.38 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 47.1 t -82.75 134.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.193 -0.669 . . . . 74.31 109.193 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.7 pt -98.28 -20.09 5.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.484 -0.886 . . . . 71.22 110.08 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.927 -0.654 . . . . 54.21 111.565 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.2 p -116.77 161.0 19.95 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.518 -0.919 . . . . 65.35 108.518 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.543 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.4 t-20 -65.69 -52.43 43.06 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-O 119.012 -0.518 . . . . 73.14 111.568 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.5 Cg_exo -75.02 135.81 19.52 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 120.359 1.164 . . . . 52.42 109.116 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.57 136.26 53.42 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.614 2.209 . . . . 75.03 111.351 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 429' ' ' ILE . . . -77.0 -17.68 58.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.822 -0.626 . . . . 72.24 111.964 -172.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -76.49 -31.87 58.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.386 0.612 . . . . 72.05 109.71 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -95.34 164.87 12.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.456 -0.793 . . . . 64.54 110.836 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -97.63 127.1 43.33 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.525 -0.761 . . . . 62.44 110.449 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.4 m -110.06 139.68 44.92 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.283 -1.006 . . . . 61.34 108.283 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -57.89 150.39 20.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.075 0.398 . . . . 74.12 112.075 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.1 -25.71 38.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.847 -0.615 . . . . 62.42 110.82 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -86.71 5.29 36.95 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 116.146 -0.479 . . . . 75.24 111.363 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.13 157.52 24.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 120.909 0.385 . . . . 64.45 111.031 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 453' ' ' LYS . 22.3 t -100.05 123.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.034 -1.099 . . . . 53.24 108.034 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.18 119.01 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 C-N-CA 119.069 -1.053 . . . . 63.31 108.844 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.543 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.1 mp -92.65 118.35 38.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 105.308 -2.108 . . . . 71.31 105.308 174.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 tt -102.13 124.35 55.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 116.347 -0.388 . . . . 74.41 109.967 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.95 108.46 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.395 -0.965 . . . . 75.44 108.395 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.67 139.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.071 -0.968 . . . . 74.13 110.005 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.07 123.89 6.53 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.484 -1.446 . . . . 53.11 109.484 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.3 m -135.85 149.74 49.15 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 31.32 108.286 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.164 0 C-N-CA 119.746 -1.216 . . . . 73.1 110.768 -176.852 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 106.471 -1.678 . . . . 51.12 106.471 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 546' ' ' PRO . 37.2 p -127.96 161.29 29.47 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 114.519 -1.218 . . . . 74.42 109.858 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 544' ' ' THR . 96.0 mttt -143.31 156.33 44.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.835 -0.431 . . . . 74.32 109.835 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.8 p-10 -92.78 135.87 33.74 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.952 -0.758 . . . . 74.12 108.952 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 23.2 pt -78.14 136.67 61.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.998 -0.546 . . . . 73.53 110.926 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.83 -172.49 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.577 2.184 . . . . 74.22 110.339 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -99.41 136.35 39.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.454 -0.943 . . . . 52.23 108.454 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 m -128.66 16.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 120.887 0.375 . . . . 62.23 110.835 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -72.0 116.45 12.42 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.915 -0.584 . . . . 65.11 111.367 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 116.69 -19.33 12.57 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.811 -0.709 . . . . 62.42 112.103 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 507' ' ' VAL . 97.8 mt-30 -81.76 177.7 8.74 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.845 -0.342 . . . . 52.31 110.153 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.3 m -91.4 156.29 17.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.553 -1.277 . . . . 74.33 107.553 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.96 -43.47 75.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.921 0.391 . . . . 73.11 112.054 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 5.9 p-10 -68.51 -42.08 79.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.899 -0.591 . . . . 75.22 111.897 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 503' ' ' GLN . 8.9 p -75.94 -34.63 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.142 -1.023 . . . . 55.11 111.141 -175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.417 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -62.0 -48.89 78.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.448 -0.796 . . . . 34.34 111.364 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.4 -36.77 84.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.404 0.44 . . . . 71.03 110.746 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.6 mptp? -64.01 -47.58 79.72 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.123 0.264 . . . . 61.13 111.56 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -65.13 -42.91 93.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.975 0.417 . . . . 73.55 110.318 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.74 -37.26 85.88 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 115.762 -0.653 . . . . 73.22 109.655 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -62.25 -37.9 87.21 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 122.762 0.425 . . . . 70.24 110.714 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 510' ' ' LYS . 61.0 t -72.44 -27.21 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.089 0.471 . . . . 74.33 110.637 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.77 36.54 4.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.552 -0.295 . . . . 62.23 110.23 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -169.33 -100.92 0.14 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 117.106 -2.473 . . . . 75.25 116.613 -173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.588 ' CE2' HG23 ' A' ' 545' ' ' VAL . 61.3 m-85 -127.63 162.36 26.69 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 115.212 -0.494 . . . . 62.13 111.312 -162.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.2 m -104.37 -17.37 14.82 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.225 -0.898 . . . . 65.32 110.869 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 550' ' ' VAL . 35.3 mmtp -109.98 123.93 50.52 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.92 -0.488 . . . . 70.44 109.804 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.97 151.28 45.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.473 0.654 . . . . 73.33 111.666 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -141.6 152.03 43.67 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.121 -1.437 . . . . 74.41 107.121 169.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.23 128.12 50.77 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 120.741 0.305 . . . . 72.34 110.233 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.58 127.34 52.04 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.878 -0.786 . . . . 65.21 108.878 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.438 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 20.1 m -91.29 143.07 27.03 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.117 -0.697 . . . . 62.43 109.117 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.87 159.45 26.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.375 -0.972 . . . . 73.3 108.375 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.32 134.43 36.61 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.362 0.601 . . . . 65.15 109.432 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 8.1 t -129.81 162.3 54.28 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 108.021 -1.103 . . . . 63.51 108.021 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 122.519 2.146 . . . . 65.35 110.079 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.17 -46.52 62.19 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 118.986 -1.086 . . . . 64.14 113.315 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.67 134.65 38.75 Favored 'Trans proline' 0 C--N 1.365 1.401 0 CA-C-N 120.383 1.172 . . . . 52.21 109.897 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -153.71 176.33 12.23 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.682 -0.859 . . . . 73.23 108.682 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.93 7.15 62.88 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 111.049 -0.82 . . . . 55.21 111.049 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.9 141.1 28.99 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 107.633 -1.247 . . . . 74.3 107.633 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 95.8 t -77.12 115.76 19.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 104.781 -2.303 . . . . 70.11 104.781 165.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.8 m -76.1 -26.73 56.72 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.739 -0.837 . . . . 73.14 108.739 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.43 -149.43 21.2 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.291 -0.868 . . . . 61.33 111.023 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -118.09 161.67 19.46 Favored 'General case' 0 C--N 1.279 -2.498 0 C-N-CA 123.522 0.729 . . . . 63.2 109.108 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.6 t-20 -52.33 -51.96 67.42 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 123.427 0.454 . . . . 63.35 111.636 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.3 Cg_endo -91.6 161.16 3.53 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.473 1.449 . . . . 73.43 109.845 171.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.95 150.58 61.19 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.154 1.902 . . . . 72.12 112.194 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -50.94 131.02 26.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.102 0.961 . . . . 33.2 111.422 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -17.29 36.69 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.773 -0.648 . . . . 51.31 112.099 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 48.6 m -67.86 128.01 34.93 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.567 -0.372 . . . . 70.44 110.301 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 27.8 m -97.59 123.36 41.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.761 -0.459 . . . . 51.04 109.761 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' A' ' 517' ' ' PHE . 9.5 m -134.14 162.26 58.76 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.264 -0.643 . . . . 71.21 109.264 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.593 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.2 Cg_exo -61.93 136.21 60.06 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.104 2.536 . . . . 75.42 113.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 33.2 m -66.73 -22.82 30.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.663 -0.699 . . . . 62.12 112.343 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.97 -2.13 57.74 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.134 -0.939 . . . . 73.12 110.011 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -93.97 173.19 7.79 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.087 -0.709 . . . . 65.53 109.087 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 519' ' ' LYS . 60.2 t -91.99 127.65 44.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.993 -0.549 . . . . 74.34 111.827 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.15 130.13 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.825 -1.176 . . . . 53.42 107.825 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 32.7 tt0 -103.04 127.19 50.38 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-O 121.268 0.556 . . . . 63.1 110.111 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.6 tp -95.28 132.58 40.13 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.979 -1.009 . . . . 61.13 109.06 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -100.18 113.34 25.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.425 -0.954 . . . . 74.23 108.425 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.81 137.67 44.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-O 120.627 0.251 . . . . 75.33 111.24 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 58.6 p -83.39 124.49 30.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.115 0.483 . . . . 72.44 109.785 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 524' ' ' SER . 14.9 ttpp . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.512 -0.509 0 CA-C-O 121.908 0.861 . . . . 73.13 109.916 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 77.1 mt-30 -118.57 153.5 34.13 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.222 -1.399 . . . . 63.33 107.222 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -145.85 152.62 39.79 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.292 -1.744 . . . . 72.21 106.292 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.41 140.94 30.34 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.503 0.668 . . . . 73.43 112.503 -177.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.49 131.04 69.44 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 107.51 -1.293 . . . . 73.41 107.51 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.0 140.6 94.54 Favored 'Trans proline' 0 C--O 1.243 0.734 0 C-N-CA 122.664 2.242 . . . . 73.44 113.346 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -96.47 -5.25 40.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.025 -0.989 . . . . 43.11 109.84 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.18 5.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.947 0.879 . . . . 53.22 110.703 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.5 p -62.63 -30.45 71.37 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.869 1.268 . . . . 60.24 109.918 177.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.5 t -57.65 -26.76 62.1 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.42 -1.263 . . . . 75.25 111.077 176.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.57 -44.96 15.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 120.788 -0.365 . . . . 62.5 110.422 -175.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.575 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 3.7 m -164.1 149.44 10.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.702 -0.851 . . . . 42.33 108.702 175.381 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -54.71 -44.02 73.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.783 0.833 . . . . 71.34 110.768 174.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.63 -43.56 76.26 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.305 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.575 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.0 mm-40 -61.67 -42.43 98.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 123.514 0.509 . . . . 74.41 110.44 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.1 -49.47 77.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.157 -0.929 . . . . 71.5 110.097 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.96 -47.61 92.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 CA-C-N 115.788 -0.642 . . . . 73.12 112.101 -177.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.5 mmtp -60.96 -48.6 81.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.035 0.445 . . . . 61.52 110.452 -176.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 443' ' ' LYS . 10.3 mmpt? -68.2 -39.19 82.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.899 -0.591 . . . . 75.41 111.843 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 23.4 tp -68.54 -40.25 80.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.195 0.521 . . . . 64.44 110.044 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 42.8 m -59.41 -45.85 90.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.249 -0.887 . . . . 64.15 109.461 176.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -17.28 62.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.63 -0.714 . . . . 60.32 111.473 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.59 -13.92 57.4 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.919 0.39 . . . . 74.35 110.861 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.9 -11.81 22.67 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.15 -1.024 . . . . 64.41 113.519 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.8 m-85 -72.5 138.55 47.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.976 0.417 . . . . 70.15 110.857 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 -12.74 3.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.591 -0.814 . . . . 75.34 113.599 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 451' ' ' ARG . 2.1 tpm_? -103.38 114.99 29.7 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.095 -0.706 . . . . 74.22 109.095 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 37.1 m-85 -120.03 153.27 36.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.369 -0.832 . . . . 72.34 109.696 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.521 ' HB3' HG13 ' A' ' 485' ' ' ILE . 16.3 tppt? -143.73 122.33 12.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 105.566 -2.013 . . . . 72.23 105.566 170.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -104.2 125.4 50.46 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 120.862 0.363 . . . . 71.24 110.732 -176.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.93 49.04 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.231 -1.026 . . . . 74.41 108.231 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -124.02 149.35 46.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.543 -0.91 . . . . 63.01 108.543 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.2 m -140.42 140.65 23.4 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 108.97 -0.752 . . . . 55.3 108.97 176.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.7 Cg_exo -65.76 122.0 9.51 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.965 1.777 . . . . 75.13 109.946 177.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.4 m -151.99 -179.54 7.57 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.756 -1.201 . . . . 71.04 107.756 -178.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 463' ' ' LEU . 6.9 t -24.98 100.24 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.51 0 C-N-CA 126.563 1.945 . . . . 73.24 112.83 177.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 73.8 Cg_exo -51.53 -38.09 63.89 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 124.499 3.466 . . . . 62.32 115.973 -170.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.45 -11.33 59.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.191 0.811 . . . . 74.21 113.191 -176.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.494 ' HB2' HG23 ' A' ' 460' ' ' THR . 3.9 mm? -103.65 14.15 31.71 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.692 0.282 . . . . 71.22 111.186 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.1 p -52.86 128.73 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 116.159 -0.473 . . . . 72.5 110.335 176.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.49 -3.06 56.27 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.826 -0.702 . . . . 63.25 111.506 -179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -103.48 146.01 29.15 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.316 -0.624 . . . . 73.52 109.316 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.644 HG22 HD11 ' A' ' 486' ' ' ILE . 46.9 t -81.78 132.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.477 -0.564 . . . . 72.22 109.477 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.5 -21.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.624 -0.43 . . . . 72.15 110.625 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.96 159.92 23.54 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 111.106 -0.798 . . . . 73.51 111.106 177.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -122.63 152.32 40.6 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.326 -0.99 . . . . 65.31 108.326 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.6 t-20 -64.44 -50.59 65.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.499 -0.481 . . . . 75.54 111.058 177.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.3 Cg_exo -79.59 147.83 20.06 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 120.371 1.168 . . . . 64.53 109.104 172.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 3.7 Cg_exo -71.37 140.89 37.71 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.142 1.894 . . . . 43.14 113.463 -175.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.11 6.67 28.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.115 0.96 . . . . 73.42 109.183 176.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.1 -26.83 13.55 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.667 -1.151 . . . . 73.42 111.988 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -137.85 174.96 10.01 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.279 -0.569 . . . . 75.15 110.263 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 41.7 p -86.94 147.71 25.64 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.238 0.542 . . . . 64.44 112.368 -176.112 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.4 m -133.83 150.1 51.39 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.393 -1.336 . . . . 62.05 107.393 174.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -55.48 142.24 33.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.617 0.599 . . . . 65.23 112.617 -176.121 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.02 -29.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.563 1.145 . . . . 63.3 111.532 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -94.08 12.26 27.02 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.527 -0.469 . . . . 74.12 111.577 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -77.95 146.32 35.55 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 122.14 -0.35 . . . . 70.14 110.365 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.2 122.98 36.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.632 -0.877 . . . . 71.2 108.632 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.82 118.51 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 108.039 -1.097 . . . . 75.2 108.039 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.0 mp -96.99 114.47 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 106.194 -1.78 . . . . 54.3 106.194 175.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.644 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.88 125.68 59.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 108.901 -0.777 . . . . 64.3 108.901 -177.713 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.46 116.47 49.31 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 CA-C-O 121.693 0.758 . . . . 53.12 109.988 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.41 136.83 25.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.22 -0.9 . . . . 71.3 109.461 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.91 112.1 3.53 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.783 -2.127 . . . . 54.22 107.783 174.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.4 t -115.3 145.37 42.54 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 119.873 -0.731 . . . . 74.43 109.787 -176.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.406 -3.301 0 N-CA-C 107.965 -2.054 . . . . 71.43 107.965 176.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 108.503 -0.925 . . . . 75.3 108.503 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.6 p -136.27 157.56 46.51 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.543 -1.208 . . . . 62.43 108.268 -175.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 28.9 mtpp -143.94 157.36 44.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.666 -0.864 . . . . 75.13 108.666 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.0 t70 -91.36 130.92 37.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.677 -1.231 . . . . 75.12 107.677 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 23.8 pt -77.15 126.11 85.73 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 112.366 0.506 . . . . 64.4 112.366 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 55.2 Cg_endo -94.07 114.46 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.32 2.013 . . . . 71.52 112.886 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.67 124.36 29.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.422 -0.955 . . . . 64.32 108.422 175.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.4 t -114.53 45.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.154 -1.054 . . . . 75.11 108.154 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -63.29 130.73 45.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.848 -1.069 . . . . 65.15 111.381 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 129.99 -32.04 3.22 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.316 -0.945 . . . . 72.54 113.29 176.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 534' ' ' VAL . 93.6 mt-30 -94.7 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.691 -0.485 . . . . 64.14 109.691 -177.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 157.38 19.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.178 -1.009 . . . . 74.15 109.564 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.454 HG21 HG13 ' A' ' 555' ' ' VAL . 89.5 t -55.92 -44.14 77.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.593 0.558 . . . . 63.33 111.151 -176.215 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.61 -41.75 83.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.693 -0.685 . . . . 74.22 111.921 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -36.26 27.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 118.884 -1.126 . . . . 64.41 110.654 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.58 87.25 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.53 -0.759 . . . . 61.41 110.959 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.82 -35.17 80.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 123.307 0.38 . . . . 70.43 110.041 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -61.42 -47.48 85.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 123.127 0.267 . . . . 73.33 111.517 176.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -68.84 -43.12 76.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.376 -0.375 . . . . 71.51 111.006 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 520' ' ' PHE . 5.8 tt -64.27 -37.54 87.86 Favored 'General case' 0 C--O 1.173 -2.947 0 CA-C-N 115.928 -0.578 . . . . 62.35 109.537 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.33 -37.44 75.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.929 0.491 . . . . 71.42 110.362 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.88 -39.86 75.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.73 -0.668 . . . . 74.34 111.122 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -94.99 -10.83 29.76 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.431 0.634 . . . . 71.2 110.384 -174.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -117.25 -117.54 2.9 Favored Glycine 0 N--CA 1.411 -2.978 0 CA-C-N 115.243 -0.889 . . . . 73.32 113.139 -172.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.684 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 35.9 m-85 -136.46 -175.41 4.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.459 -0.571 . . . . 74.32 109.459 -169.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 m -99.37 -18.5 17.48 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.719 -0.673 . . . . 40.24 111.811 -178.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -107.29 115.87 30.93 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.876 -0.729 . . . . 71.11 111.54 -175.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.471 ' CE2' HD22 ' A' ' 512' ' ' LEU . 19.7 m-85 -120.84 142.57 49.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.578 -1.192 . . . . 74.14 108.543 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.5 p -115.62 145.28 42.84 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 104.936 -2.246 . . . . 64.43 104.936 171.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -121.82 138.3 54.43 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.829 -1.148 . . . . 73.04 111.09 -174.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.6 139.91 52.92 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.782 -0.822 . . . . 54.04 108.782 178.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 40.0 m -101.75 125.18 48.37 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.998 -1.112 . . . . 75.14 107.998 177.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.15 160.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.972 -0.751 . . . . 73.31 108.972 -176.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 8.4 p-10 -78.55 132.68 37.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.445 0.641 . . . . 65.43 109.901 -175.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 p -95.51 106.12 24.72 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 114.568 -1.197 . . . . 72.13 111.963 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 4.3 Cg_exo -76.55 -66.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.34 2.027 . . . . 73.22 110.986 177.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -108.72 -52.19 0.07 OUTLIER Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 118.977 -0.535 . . . . 75.45 111.879 178.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.96 134.19 17.57 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 120.4 1.178 . . . . 70.44 110.635 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.76 128.54 14.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.259 -0.274 . . . . 61.01 110.259 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.42 23.38 Favored Glycine 0 CA--C 1.502 -0.726 0 N-CA-C 110.185 -1.166 . . . . 65.03 110.185 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.59 149.19 23.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.276 -0.962 . . . . 65.43 109.529 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.7 p -73.18 127.07 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.175 -1.046 . . . . 74.55 108.175 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.6 m -73.5 -25.75 60.58 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.208 -1.36 . . . . 74.53 109.841 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.18 20.36 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 110.767 -0.933 . . . . 50.52 110.767 175.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -120.27 159.4 25.05 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.147 -1.427 . . . . 44.45 107.147 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.558 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -63.05 -54.54 45.28 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 119.942 -0.703 . . . . 70.04 110.56 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.4 Cg_endo -93.07 134.05 1.06 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.225 1.283 . . . . 72.34 109.665 171.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.7 Cg_exo -72.91 164.0 36.8 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.717 2.278 . . . . 64.24 113.429 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -54.1 145.07 17.88 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-N 115.486 -0.779 . . . . 61.31 109.372 173.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.62 34.01 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.832 -1.707 . . . . 64.32 108.832 -172.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 497' ' ' ILE . 23.0 m -88.62 119.85 29.47 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.816 -0.809 . . . . 65.43 108.816 173.303 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 86.5 m -101.77 127.43 48.56 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.147 -0.686 . . . . 74.43 109.147 176.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.84 160.21 64.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.647 -0.871 . . . . 72.0 108.647 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 494' ' ' THR . 42.9 Cg_exo -58.46 152.74 52.5 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.394 2.062 . . . . 55.12 111.773 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.684 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.9 m -65.98 -20.78 27.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.239 0.543 . . . . 73.03 112.39 -177.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.14 3.73 54.87 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.645 -0.707 . . . . 40.24 110.83 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.7 t -79.67 167.95 20.0 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.939 -0.393 . . . . 74.42 109.939 -177.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.19 120.64 62.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 109.757 -0.46 . . . . 62.43 109.757 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.4 tt -92.52 138.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.962 -0.385 . . . . 75.33 109.962 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -101.82 121.76 42.71 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 121.479 0.656 . . . . 74.15 110.654 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.94 134.91 41.12 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.98 1.312 . . . . 75.1 109.24 -177.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -101.27 108.68 20.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.625 -0.716 . . . . 73.41 110.017 -176.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 505' ' ' VAL . 64.1 t -96.9 131.76 42.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 124.066 0.946 . . . . 64.35 110.008 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 45.6 p -69.05 125.01 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.289 0.566 . . . . 74.14 110.769 175.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 1.0 OUTLIER . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 105.875 -1.898 . . . . 74.52 105.875 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 108.961 -0.755 . . . . 62.01 108.961 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 478' ' ' SER . 21.0 mp0 -82.67 125.21 30.96 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.266 -0.879 . . . . 63.45 109.979 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.531 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 18.9 tpp180 -120.7 155.87 32.96 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.68 -0.859 . . . . 73.41 108.68 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 142.02 28.83 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.207 1.003 . . . . 74.4 111.691 -174.085 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -86.0 128.7 57.0 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 109.524 -0.547 . . . . 73.31 109.524 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.72 160.1 47.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.161 2.574 . . . . 73.31 112.332 176.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.52 24.68 9.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.945 0.498 . . . . 71.51 111.257 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 439' ' ' GLU . 14.7 t -76.4 -2.98 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.8 1.286 . . . . 54.22 109.281 -176.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.573 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 3.1 m -52.37 -34.27 46.96 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.444 2.298 . . . . 65.13 111.323 177.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.9 t -60.97 -28.01 68.69 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.851 -0.613 . . . . 73.22 112.014 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.4 -47.51 8.72 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 118.874 -1.13 . . . . 60.45 111.836 -172.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 18.9 m -172.1 154.11 3.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.071 -1.085 . . . . 71.11 108.071 -178.204 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -51.91 -54.82 24.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 75.45 110.463 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.04 73.05 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 123.467 0.479 . . . . 70.25 111.91 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' A' ' 432' ' ' VAL . 10.2 mm-40 -61.04 -45.84 93.12 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.722 0.639 . . . . 50.11 111.327 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -71.27 -43.75 66.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.016 -0.538 . . . . 52.3 110.774 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.23 -48.36 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.965 -0.561 . . . . 51.14 111.985 -178.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.94 -40.1 96.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 70.24 110.344 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -66.57 -43.06 86.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.075 -0.512 . . . . 52.35 111.005 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 22.8 tp -68.69 -33.41 73.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.396 0.617 . . . . 74.44 109.611 179.202 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.3 m -62.42 -41.29 98.58 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.485 -0.78 . . . . 70.54 109.212 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.02 63.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.75 -0.659 . . . . 54.13 110.991 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.18 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.193 0.521 . . . . 45.14 110.02 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.98 -6.88 17.31 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.78 -0.724 . . . . 43.31 113.423 175.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 85.7 m-85 -75.28 136.8 40.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.084 0.772 . . . . 64.04 113.084 -176.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.57 25.93 3.73 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.169 -1.172 . . . . 71.51 110.169 175.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -132.61 115.19 15.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.821 -1.178 . . . . 75.34 107.821 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 67.8 m-85 -140.18 150.06 43.73 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.894 -0.41 . . . . 72.31 109.894 -175.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.471 ' HB3' HG13 ' A' ' 485' ' ' ILE . 15.1 tppt? -133.67 122.91 24.11 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 106.42 -1.696 . . . . 70.31 106.42 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -95.31 123.6 38.91 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 110.278 -0.267 . . . . 74.33 110.278 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.26 151.67 51.71 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.542 -1.281 . . . . 73.4 107.542 176.061 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.14 143.64 40.42 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.085 -0.646 . . . . 73.33 110.232 178.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.3 m -124.04 149.32 59.87 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 109.242 -0.651 . . . . 64.35 109.242 -178.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 490' ' ' SER . 20.9 Cg_exo -66.03 122.88 10.52 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.171 1.914 . . . . 74.44 110.238 176.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 t -134.2 179.81 6.03 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.601 -0.889 . . . . 74.11 108.601 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.1 t -65.56 141.43 97.91 Favored Pre-proline 0 N--CA 1.423 -1.825 0 C-N-CA 123.74 0.816 . . . . 74.31 110.793 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.5 Cg_exo -51.72 -29.23 32.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.389 3.393 . . . . 72.31 112.62 177.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.48 -23.92 61.9 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.626 -0.716 . . . . 74.3 112.049 -177.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 11.2 mp -108.49 8.7 27.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.449 0.537 . . . . 72.42 112.449 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 461' ' ' PRO . 93.2 t -60.7 133.4 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.967 0.413 . . . . 74.41 110.963 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.57 -16.21 57.94 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 120.9 -0.666 . . . . 44.41 113.438 175.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 463' ' ' LEU . 0.2 OUTLIER -103.82 166.22 10.55 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.538 -0.865 . . . . 73.55 109.588 178.671 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 59.3 t -82.13 130.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.429 -1.322 . . . . 72.41 107.429 176.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.1 pt -98.43 -0.87 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.17 -0.612 . . . . 63.41 110.937 -178.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 157.0 162.84 11.83 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 115.621 -0.718 . . . . 52.01 112.069 174.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.5 p -116.47 149.77 38.95 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.679 -1.23 . . . . 63.32 107.679 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.47 -52.02 55.91 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 120.298 -0.561 . . . . 72.41 110.874 177.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 57.7 Cg_endo -73.88 136.46 22.94 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 119.912 1.004 . . . . 71.21 109.854 172.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 22.9 Cg_exo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.505 2.136 . . . . 64.13 112.165 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -85.92 0.15 53.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.398 1.095 . . . . 43.44 109.053 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -91.07 -32.07 16.02 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.67 -1.605 . . . . 73.24 110.358 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -111.06 168.52 9.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.446 -0.501 . . . . 73.15 110.575 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 25.0 p -98.69 137.15 37.73 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.345 -0.389 . . . . 51.1 111.047 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.5 m -116.36 148.82 40.23 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.406 -0.59 . . . . 72.02 109.406 179.141 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.411 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . . . -69.64 157.63 36.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.742 0.246 . . . . 54.15 111.32 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.7 mm -70.35 -25.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.896 0.855 . . . . 75.23 110.199 -175.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.9 t -95.62 2.21 54.03 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.347 -0.842 . . . . 74.04 110.337 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 479' ' ' ALA . 7.1 m-20 -80.82 139.59 35.91 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 108.267 -1.012 . . . . 73.34 108.267 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.34 111.99 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.006 -0.739 . . . . 64.4 109.006 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.57 118.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.865 -1.161 . . . . 63.41 107.865 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -93.87 122.05 45.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.777 -1.194 . . . . 71.55 107.777 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.19 126.0 68.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.232 -1.025 . . . . 74.21 108.232 -179.11 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.4 mp -104.09 120.93 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.392 0.615 . . . . 32.41 110.125 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.09 145.34 8.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.646 -0.706 . . . . 73.31 109.281 -177.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.6 106.73 3.29 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.83 -0.908 . . . . 72.45 110.83 176.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 64.0 m -108.2 138.56 44.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.149 -1.056 . . . . 61.44 108.149 177.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.124 0 C-N-CA 119.875 -1.155 . . . . 51.12 111.705 -177.587 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.273 0 N-CA-C 107.67 -1.233 . . . . 42.43 107.67 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 546' ' ' PRO . 43.4 p -134.89 162.78 31.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.012 -0.995 . . . . 71.44 110.766 -173.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 0.3 OUTLIER -142.83 132.0 23.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.21 -1.033 . . . . 71.22 108.21 178.007 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.9 p-10 -80.73 138.33 36.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.436 -0.949 . . . . 61.1 108.436 173.144 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 42.8 pt -98.61 137.58 20.65 Favored Pre-proline 0 C--N 1.292 -1.902 0 C-N-CA 120.433 -0.507 . . . . 73.03 111.742 -177.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.69 -176.97 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.472 2.115 . . . . 73.24 110.11 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -77.02 125.95 30.17 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.402 -0.962 . . . . 73.45 108.402 176.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 7.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.139 0.971 . . . . 74.04 110.264 -177.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -93.05 160.44 14.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.628 -0.714 . . . . 71.03 110.844 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 94.96 -7.98 70.18 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 109.691 -1.364 . . . . 63.32 109.691 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -102.04 -180.0 4.16 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.32 -0.94 . . . . 75.44 108.665 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 38.4 m -88.2 155.64 19.65 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.909 -1.145 . . . . 52.41 107.909 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.79 -42.78 53.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 122.879 0.472 . . . . 62.44 112.15 -177.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.09 -42.04 85.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.857 -0.611 . . . . 73.32 111.287 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.0 p -76.6 -35.65 26.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.401 -0.92 . . . . 70.31 110.798 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.31 -48.51 77.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.184 -0.916 . . . . 71.22 111.186 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.12 -35.69 81.59 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 123.039 0.212 . . . . 75.34 110.973 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -64.65 -53.24 50.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.592 0.558 . . . . 65.13 109.882 179.036 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.92 -42.94 99.96 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.007 -0.542 . . . . 52.4 110.525 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.33 -37.99 89.47 Favored 'General case' 0 C--O 1.184 -2.362 0 CA-C-N 116.061 -0.518 . . . . 45.44 110.638 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.96 -46.57 89.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.842 0.353 . . . . 73.1 110.791 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -27.63 37.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 73.25 111.422 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -120.16 24.4 10.46 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.078 -0.649 . . . . 75.31 109.956 -175.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 495' ' ' LYS . . . -164.51 -110.26 0.23 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 118.507 -1.806 . . . . 54.24 116.244 -173.195 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.4 m-85 -116.15 176.73 4.97 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.039 0.447 . . . . 62.34 111.243 -164.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.7 m -118.63 -17.42 9.27 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.562 -0.745 . . . . 64.31 110.495 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.84 115.64 30.51 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.758 -0.777 . . . . 70.03 110.968 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -120.77 135.28 55.19 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.436 -1.257 . . . . 74.34 108.676 -177.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.0 t -115.86 152.39 33.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.9 -2.259 . . . . 72.55 104.9 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -121.46 128.72 52.42 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.996 -0.682 . . . . 73.05 110.809 -175.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.172 -1.418 . . . . 55.53 107.172 177.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 41.0 m -88.75 125.91 35.09 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.821 -0.627 . . . . 61.14 109.784 -177.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.88 156.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 176.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -79.55 118.35 21.32 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 113.588 0.959 . . . . 65.52 113.588 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 12.7 m -60.75 136.56 92.96 Favored Pre-proline 0 N--CA 1.427 -1.606 0 CA-C-N 113.288 -1.778 . . . . 62.34 110.631 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -78.08 -88.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 108.505 -1.383 . . . . 50.54 108.505 172.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 92.7 mtt180 -102.54 -55.99 0.11 Allowed Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 118.788 -0.625 . . . . 62.44 111.548 171.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 4.3 Cg_exo -75.81 149.96 34.16 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.376 1.384 . . . . 70.4 110.967 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.61 128.24 38.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.139 -1.06 . . . . 61.52 108.139 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.95 -7.31 17.11 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 110.705 -0.958 . . . . 73.4 110.705 -178.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.68 147.1 27.11 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.067 -0.716 . . . . 75.12 109.067 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.26 115.63 20.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.567 -1.642 . . . . 73.42 106.567 173.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 31.4 m -89.65 -27.45 20.14 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 115.634 -0.712 . . . . 73.41 109.775 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -177.2 -173.99 43.21 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.959 -1.115 . . . . 72.43 111.766 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.3 p -134.81 160.32 38.57 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.657 -1.238 . . . . 74.51 107.657 176.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -63.53 -54.55 42.34 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.22 0.325 . . . . 74.04 110.608 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 72.9 Cg_endo -83.64 138.45 8.37 Favored 'Trans proline' 0 C--N 1.365 1.403 0 N-CA-C 109.314 -1.071 . . . . 75.22 109.314 169.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 159.48 46.6 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 121.766 1.644 . . . . 55.14 111.82 178.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -60.76 135.1 57.67 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.436 -0.347 . . . . 71.24 110.27 177.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.65 -29.05 10.91 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 111.038 -0.825 . . . . 65.44 111.038 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.6 m -73.28 136.84 44.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.048 0.451 . . . . 70.42 110.863 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -100.78 122.36 43.26 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.478 -0.783 . . . . 72.25 109.265 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.06 157.59 69.05 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.585 -0.28 . . . . 65.35 110.474 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.514 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.9 Cg_exo -63.92 134.21 42.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.936 2.424 . . . . 70.34 113.488 -178.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.418 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.7 m -68.06 -21.29 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.554 -0.748 . . . . 73.24 111.434 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.22 0.57 51.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.393 -0.821 . . . . 75.42 110.738 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.4 t -103.52 161.84 13.54 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.81 -0.811 . . . . 73.42 108.81 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.45 130.54 44.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.062 -1.088 . . . . 73.21 108.062 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -95.04 145.95 7.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 110.023 -0.362 . . . . 74.34 110.023 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -102.64 116.54 32.79 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.57 -0.53 . . . . 75.22 109.57 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 25.4 tp -95.74 125.04 40.04 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.74 -1.578 . . . . 62.03 106.74 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -103.94 102.53 12.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.076 0.941 . . . . 74.14 108.507 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.0 138.19 30.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 114.418 -1.264 . . . . 74.01 110.368 -173.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 30.2 p -61.88 118.33 7.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.625 -0.88 . . . . 75.54 108.625 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 107.809 -1.182 . . . . 44.11 107.809 -176.409 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 121.628 0.728 . . . . 73.43 109.675 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -82.8 145.45 29.51 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 114.901 -1.045 . . . . 75.55 109.577 -172.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.426 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 2.7 tpt180 -131.23 153.24 49.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.38 -0.97 . . . . 74.45 108.38 -177.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.28 141.27 28.77 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 123.079 0.552 . . . . 63.52 111.153 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.8 mp -81.12 130.39 63.16 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.728 -0.841 . . . . 71.34 108.728 175.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.46 ' HB2' HG22 ' A' ' 432' ' ' VAL . 66.3 Cg_endo -71.45 160.43 48.59 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.644 2.229 . . . . 74.03 113.89 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -102.02 0.22 34.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.013 -0.994 . . . . 73.51 109.971 -179.353 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 430' ' ' PRO . 35.7 m -80.05 1.51 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.775 0.797 . . . . 34.54 110.665 -179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.8 m -63.93 -30.31 71.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.793 -1.094 . . . . 62.02 109.455 177.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.9 t -62.21 -26.57 68.44 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.064 -0.971 . . . . 45.32 110.316 176.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.18 -46.29 20.92 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.926 -0.71 . . . . 71.05 109.998 -175.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 22.7 m -165.59 147.37 7.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.855 -0.794 . . . . 71.21 108.855 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -50.62 -49.06 57.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.17 0.988 . . . . 74.21 111.44 174.084 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.43 -43.9 75.78 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 123.407 0.442 . . . . 74.25 111.363 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 16.2 mm-40 -61.57 -41.38 97.31 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.143 -0.48 . . . . 74.13 111.766 -178.088 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.66 -51.58 68.79 Favored 'General case' 0 CA--C 1.508 -0.662 0 O-C-N 123.898 0.749 . . . . 55.15 110.216 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.75 -48.36 86.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 114.65 -1.159 . . . . 74.31 112.087 -175.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.6 mmtp -60.42 -45.43 93.63 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 117.874 0.306 . . . . 72.44 110.726 -176.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -66.51 -46.23 76.91 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.695 -0.684 . . . . 72.31 110.502 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.2 tp -69.21 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.22 0.533 . . . . 65.0 111.476 -177.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.61 -42.89 98.19 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.131 -0.692 . . . . 64.43 109.131 176.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -18.25 62.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 40.31 110.801 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.43 -13.24 59.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.222 0.534 . . . . 55.13 110.145 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.48 -9.16 15.03 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 120.142 -1.028 . . . . 51.03 113.702 174.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -77.56 131.78 38.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.898 0.38 . . . . 75.52 111.169 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.87 12.6 5.34 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.713 -0.955 . . . . 53.24 110.713 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -118.65 115.97 25.62 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.709 -1.219 . . . . 74.24 107.709 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -134.91 154.3 51.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.494 0.664 . . . . 75.14 111.557 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 485' ' ' ILE . 63.5 tttp -143.04 123.03 13.55 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 106.447 -1.686 . . . . 63.24 106.447 170.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -91.62 132.79 36.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.545 -0.462 . . . . 71.12 110.319 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.33 143.84 50.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.674 -0.862 . . . . 62.53 108.674 176.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -119.79 144.18 47.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.264 -0.643 . . . . 71.12 109.264 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -141.34 134.97 14.65 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 107.133 -1.432 . . . . 73.03 107.133 177.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_endo -65.53 122.19 9.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.758 1.639 . . . . 72.44 109.715 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.4 m -124.72 174.63 7.76 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 116.064 -0.516 . . . . 61.11 110.269 -176.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -62.81 142.85 97.17 Favored Pre-proline 0 N--CA 1.416 -2.171 0 N-CA-C 107.801 -1.185 . . . . 64.43 107.801 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.42 -30.93 28.71 Favored 'Trans proline' 0 N--CA 1.473 0.295 0 C-N-CA 123.85 3.033 . . . . 64.21 113.377 -176.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.8 -27.01 65.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.586 -0.279 . . . . 71.2 111.429 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.78 -0.53 29.18 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.613 0.598 . . . . 74.33 112.613 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -61.37 127.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 109.96 -0.385 . . . . 74.43 109.96 176.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.85 -4.36 71.81 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 116.061 -0.518 . . . . 75.41 112.019 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -114.46 154.21 28.59 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.57 -0.9 . . . . 72.42 108.57 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 486' ' ' ILE . 53.2 t -82.11 134.3 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.122 -0.696 . . . . 55.23 109.122 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.3 pt -98.08 -20.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.55 -0.46 . . . . 73.44 110.538 -178.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 166.17 28.76 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.666 -0.778 . . . . 74.33 111.676 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 37.6 p -120.94 156.23 32.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.716 -0.475 . . . . 74.23 109.716 178.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -71.59 -48.35 12.12 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.303 -0.408 . . . . 33.41 111.326 175.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.3 Cg_exo -71.59 140.26 35.72 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 109.04 -1.177 . . . . 72.42 109.04 170.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.81 142.92 90.68 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.02 2.48 . . . . 61.03 114.294 -174.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.43 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -91.16 -6.97 52.75 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 74.34 109.386 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -99.52 -27.98 13.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.578 -0.737 . . . . 61.32 111.41 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.4 mp0 -119.48 151.33 38.75 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.744 0.306 . . . . 71.41 110.358 -179.012 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 55.3 p -74.83 131.48 40.8 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.683 -0.69 . . . . 62.42 110.538 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.2 m -106.87 151.31 25.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.139 -0.689 . . . . 62.12 109.139 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.84 152.58 40.2 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.0 -0.741 . . . . 62.11 109.0 -175.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.52 -17.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.888 0.851 . . . . 55.34 110.563 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -93.11 7.03 45.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.553 -0.749 . . . . 75.1 110.008 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.45 140.21 32.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.681 -0.859 . . . . 63.2 108.681 176.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.03 121.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.895 -1.52 . . . . 40.33 106.895 176.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.46 117.92 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 C-N-CA 118.976 -1.09 . . . . 63.53 109.37 -179.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.478 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.7 mp -96.49 111.81 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 106.091 -1.818 . . . . 75.03 106.091 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.34 123.56 59.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 109.041 -0.725 . . . . 74.12 109.041 -177.41 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.19 115.98 46.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.582 -0.736 . . . . 55.21 109.946 -173.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 30.0 t -96.86 137.98 23.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.659 -0.701 . . . . 72.01 109.547 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.23 107.6 2.22 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 107.685 -2.166 . . . . 61.25 107.685 172.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -111.39 150.97 29.03 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.219 0.533 . . . . 63.13 110.797 -172.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.263 0 N-CA-C 110.146 -1.182 . . . . 75.51 110.146 177.673 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 121.255 0.55 . . . . 75.24 109.992 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.1 p -124.89 155.99 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.813 -0.631 . . . . 74.31 109.808 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -140.89 148.95 41.27 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.09 0.556 . . . . 72.45 109.805 176.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.62 125.01 29.47 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.944 -1.502 . . . . 53.21 106.944 178.107 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.0 pt -79.46 132.37 62.36 Favored Pre-proline 0 C--N 1.301 -1.501 0 C-N-CA 120.182 -0.607 . . . . 62.44 110.738 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -87.22 -171.27 0.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 122.13 1.887 . . . . 71.43 111.448 177.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.92 99.39 11.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.519 -0.919 . . . . 71.33 108.519 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.4 t -99.51 -5.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.906 0.86 . . . . 44.24 108.752 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -70.84 146.51 49.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.83 -1.077 . . . . 73.51 110.779 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.5 -20.07 23.35 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 119.888 -1.149 . . . . 72.41 112.08 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.436 ' O ' HG12 ' A' ' 534' ' ' VAL . 96.8 mt-30 -92.09 -171.44 2.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.456 -0.942 . . . . 74.22 108.456 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 m -84.95 155.22 21.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.124 -1.806 . . . . 73.43 106.124 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 10.1 p -64.11 -40.77 90.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 118.514 0.597 . . . . 64.0 110.984 -177.565 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 9.4 t70 -64.08 -43.19 96.15 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.403 -0.817 . . . . 65.43 111.611 178.073 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.94 -34.98 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.634 -0.826 . . . . 61.2 111.03 -178.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.62 76.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 64.24 111.256 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -65.41 -36.77 84.94 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 116.096 -0.502 . . . . 72.13 110.638 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.5 mptp? -62.7 -49.24 75.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.264 0.352 . . . . 65.2 111.946 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -63.67 -47.96 79.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.718 -0.393 . . . . 73.55 110.413 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.447 HD21 HD13 ' A' ' 551' ' ' ILE . 34.8 tp -62.27 -37.05 83.99 Favored 'General case' 0 C--O 1.192 -1.96 0 CA-C-N 115.759 -0.655 . . . . 64.01 111.313 -176.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.3 t-20 -59.01 -41.26 87.28 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.516 0.726 . . . . 61.41 110.294 177.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.1 -32.09 31.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.802 -0.635 . . . . 74.22 111.347 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.08 12.11 25.32 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.006 -0.678 . . . . 71.54 109.949 -174.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.33 -98.52 0.13 Allowed Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 117.735 -2.174 . . . . 71.24 117.29 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 67.2 m-85 -103.13 155.32 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 112.716 0.636 . . . . 74.03 112.716 -161.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 15.3 p -99.65 -36.19 9.58 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.991 -1.004 . . . . 72.12 112.151 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -108.22 131.93 54.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.269 0.557 . . . . 75.04 110.365 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.7 147.88 51.53 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.596 -0.729 . . . . 61.51 110.405 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.86 158.79 43.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.886 -1.153 . . . . 62.24 107.886 171.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.02 150.23 42.39 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.295 0.569 . . . . 72.2 111.48 -174.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.59 135.91 53.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.441 -1.689 . . . . 62.44 106.441 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 1.6 p -88.39 126.8 35.39 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 120.927 0.394 . . . . 72.55 111.369 -175.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.62 160.92 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.058 0.456 . . . . 73.41 109.934 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.86 113.52 19.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.921 0.867 . . . . 63.53 112.892 -175.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.8 m -114.54 117.39 42.75 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.386 -1.338 . . . . 74.33 107.386 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.93 -39.05 15.03 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.96 2.44 . . . . 73.43 115.331 -171.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.525 ' HG3' ' HD3' ' A' ' 530' ' ' PRO 0.446 7.4 ptm180 -122.19 -88.22 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 115.095 1.516 . . . . 75.35 115.095 -175.997 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.525 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 10.9 Cg_exo -75.22 153.51 40.78 Favored 'Trans proline' 0 C--N 1.372 1.768 0 CA-C-N 123.123 2.151 . . . . 63.4 111.072 173.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -134.94 159.41 41.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 61.15 108.073 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.33 -17.46 7.01 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.962 -0.855 . . . . 74.11 110.962 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.51 ' OE2' ' HB3' ' A' ' 556' ' ' SER . 4.3 pm0 -81.95 147.44 29.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 110.1 -0.333 . . . . 71.34 110.1 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.2 p -77.07 115.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 106.839 -1.541 . . . . 75.53 106.839 173.047 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.1 m -79.71 -21.21 44.88 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.243 -0.89 . . . . 74.11 110.529 -174.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.83 -168.69 34.48 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.856 -0.687 . . . . 72.32 112.101 177.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.442 HG22 HD13 ' A' ' 553' ' ' LEU . 12.1 p -117.85 160.31 21.62 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.372 -0.974 . . . . 71.04 108.372 176.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -61.82 -52.91 65.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 121.058 -0.257 . . . . 60.45 111.404 177.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.5 Cg_exo -83.95 152.75 12.85 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.077 1.185 . . . . 74.51 109.023 173.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.8 158.55 46.55 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.115 1.877 . . . . 73.35 112.417 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.41 130.52 46.62 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.131 0.491 . . . . 50.14 110.243 176.081 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -14.68 37.55 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 115.92 -0.582 . . . . 72.25 112.063 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 89.8 m -80.6 131.26 35.48 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.606 -0.349 . . . . 65.2 110.434 177.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.1 t -98.33 127.87 44.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.386 -0.598 . . . . 62.14 109.386 178.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' A' ' 517' ' ' PHE . 7.9 m -135.2 158.45 74.66 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.759 -0.83 . . . . 73.21 108.759 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 494' ' ' THR . 22.6 Cg_exo -65.1 133.15 34.41 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.819 1.679 . . . . 75.44 112.41 -177.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 21.6 m -68.57 -25.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.783 -1.099 . . . . 72.44 112.306 -176.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.06 -6.35 59.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.926 -1.034 . . . . 74.51 109.882 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.8 t -92.95 -172.84 3.11 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.673 -0.694 . . . . 73.44 110.267 -175.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.02 113.23 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.668 -0.696 . . . . 75.32 110.513 -174.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 512' ' ' LEU . 13.7 tt -96.2 142.61 13.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.097 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 34.7 tt0 -104.01 124.17 48.54 Favored 'General case' 0 N--CA 1.399 -2.986 0 CA-C-O 121.125 0.488 . . . . 74.3 110.929 -175.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -97.66 136.03 38.61 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.054 -0.975 . . . . 74.43 111.719 176.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -91.62 109.41 20.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.599 -1.63 . . . . 73.15 106.599 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.89 135.6 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.399 0.619 . . . . 74.04 111.295 -174.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.51 ' HB3' ' OE2' ' A' ' 533' ' ' GLU . 1.8 p -62.58 117.97 6.96 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 124.792 1.237 . . . . 62.42 112.388 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.427 -1.622 0 N-CA-C 108.746 -0.835 . . . . 74.22 108.746 178.473 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 480' ' ' ILE . 9.7 pt-20 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.998 0.428 . . . . 50.35 111.829 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -96.91 122.94 40.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.97 0.414 . . . . 65.4 110.813 -176.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -120.89 146.85 46.17 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.87 -0.605 . . . . 74.44 111.97 -179.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.1 141.76 28.31 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.86 -1.064 . . . . 74.01 109.791 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.35 119.64 77.71 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.414 -0.587 . . . . 74.25 109.414 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.69 142.48 35.94 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.917 2.412 . . . . 71.43 111.522 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -88.81 78.47 7.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.811 1.291 . . . . 52.24 113.494 -176.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 440' ' ' ALA . 16.5 m -115.55 4.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.469 -2.048 . . . . 50.53 105.469 167.361 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.0 m -62.16 -41.3 98.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 112.355 -2.202 . . . . 71.15 109.057 178.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 42.4 m -58.07 -27.01 63.25 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.407 -1.27 . . . . 74.23 111.243 176.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.09 -46.31 11.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.233 -0.587 . . . . 74.32 111.035 -174.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.7 m -170.16 154.17 4.87 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.926 -0.768 . . . . 63.44 108.926 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -51.82 -49.84 62.01 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.255 1.022 . . . . 73.1 110.05 169.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.97 84.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.288 -0.869 . . . . 44.54 111.772 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 17.5 mm-40 -61.28 -46.09 91.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.993 -177.334 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -68.0 -49.47 61.4 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.765 -0.652 . . . . 75.31 111.34 -178.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.15 -48.2 90.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 123.537 0.523 . . . . 63.41 111.779 -176.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.14 -45.88 89.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.747 0.308 . . . . 73.11 111.023 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -67.22 -40.55 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.388 -0.369 . . . . 72.33 111.364 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.81 -33.03 73.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.189 0.519 . . . . 64.42 109.876 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 41.1 m -60.12 -44.17 95.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.56 -0.746 . . . . 73.0 109.232 173.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.11 64.4 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.602 -0.726 . . . . 75.44 111.298 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.15 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.241 0.543 . . . . 74.14 110.219 178.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.78 -18.66 5.94 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.748 -0.739 . . . . 51.0 113.308 176.073 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 445' ' ' THR . 96.3 m-85 -74.35 136.11 42.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.041 0.448 . . . . 73.14 110.584 -177.284 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.19 -12.61 1.24 Allowed Glycine 0 C--N 1.296 -1.68 0 CA-C-N 115.754 -0.657 . . . . 74.22 112.356 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -102.51 115.38 30.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.351 -0.611 . . . . 75.33 109.351 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -128.0 165.18 20.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.471 -0.786 . . . . 72.34 111.703 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 1.9 tmtp? -146.68 124.99 12.24 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.884 -2.265 . . . . 74.54 104.884 172.017 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -94.54 128.75 41.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.433 0.635 . . . . 70.32 111.173 -177.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.78 154.29 45.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.225 -1.028 . . . . 74.44 108.225 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.31 151.29 47.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.968 -0.382 . . . . 70.32 109.968 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 54.5 m -140.56 148.41 53.2 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.62 -0.882 . . . . 61.14 108.62 174.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.8 Cg_endo -65.74 129.32 21.92 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.209 1.94 . . . . 62.0 111.346 178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.8 t -141.46 173.48 11.45 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.74 -0.837 . . . . 64.33 108.74 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.4 t -66.34 146.64 99.05 Favored Pre-proline 0 N--CA 1.412 -2.332 0 C-N-CA 123.757 0.823 . . . . 74.42 109.141 177.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.23 -28.88 21.32 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.497 3.465 . . . . 72.34 113.061 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.854 -0.612 . . . . 74.32 111.176 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.35 -3.17 29.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.255 0.465 . . . . 74.32 112.255 -176.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 93.9 t -61.11 127.68 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.964 -0.384 . . . . 74.31 109.964 177.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.93 -12.0 68.99 Favored Glycine 0 C--N 1.314 -0.681 0 N-CA-C 111.49 -0.644 . . . . 73.02 111.49 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -101.74 159.5 15.27 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.644 -0.873 . . . . 64.44 108.644 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 54.6 t -82.32 132.11 32.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 64.22 108.812 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.9 pt -102.95 -23.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.966 -0.693 . . . . 73.45 111.69 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.89 157.54 22.74 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 111.564 -0.614 . . . . 61.44 111.564 178.357 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.2 p -124.62 147.82 48.27 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.646 -0.501 . . . . 62.43 109.646 177.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 24.6 t-20 -64.48 -50.15 67.52 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.054 -0.498 . . . . 61.3 110.56 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.0 Cg_exo -72.63 124.99 10.2 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.198 -1.501 . . . . 75.24 108.198 170.183 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.423 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 40.9 Cg_endo -64.21 139.32 65.61 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.646 2.231 . . . . 64.14 112.874 -175.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.06 -16.26 41.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.857 0.837 . . . . 50.01 109.508 177.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -78.74 -31.97 46.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.325 -1.307 . . . . 72.43 109.358 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.423 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.9 mp0 -108.98 172.44 6.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.536 -0.913 . . . . 64.34 108.536 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.6 p -98.54 133.72 42.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.85 -0.796 . . . . 71.42 108.85 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.2 m -116.16 140.87 48.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.38 -0.6 . . . . 64.12 109.38 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.07 145.39 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 74.23 111.659 -178.098 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -58.52 -31.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 124.18 0.992 . . . . 63.44 110.643 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.5 t -77.44 8.85 3.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.81 -0.632 . . . . 73.34 111.705 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -94.54 144.64 25.42 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 122.058 -0.401 . . . . 65.04 110.16 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.55 122.32 35.55 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 N-CA-C 108.367 -0.975 . . . . 71.33 108.367 175.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.4 t -87.87 117.52 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 C-N-CA 119.277 -0.969 . . . . 75.13 108.722 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 54.4 mt -99.38 111.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.595 -2.002 . . . . 64.14 105.595 175.209 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 125.34 58.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 109.099 -0.704 . . . . 60.53 109.099 -175.954 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.5 mp -99.86 116.91 44.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 N-CA-C 109.187 -0.672 . . . . 71.15 109.187 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.18 143.15 12.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 64.32 109.061 -177.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.8 114.01 3.96 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.163 -1.975 . . . . 42.42 108.163 172.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t -116.11 153.49 31.66 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.69 -0.855 . . . . 75.31 108.69 -176.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.218 0 C-N-CA 120.485 -0.864 . . . . 65.02 111.215 -179.08 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.129 0 CA-C-O 122.002 0.905 . . . . 74.4 110.691 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.3 p -131.79 159.81 37.42 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.602 -1.258 . . . . 51.13 107.602 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -147.61 145.04 28.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.834 -0.747 . . . . 75.34 110.837 177.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.64 113.11 19.42 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.035 -1.468 . . . . 74.4 107.035 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 30.7 pt -75.83 127.91 84.55 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 113.112 0.782 . . . . 74.54 113.112 -173.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 25.5 Cg_endo -101.21 112.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 122.982 2.455 . . . . 60.54 111.324 171.043 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.69 132.11 34.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.219 -0.659 . . . . 64.04 109.219 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.04 59.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 107.582 -1.266 . . . . 72.35 107.582 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -57.51 140.6 50.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.156 -1.838 . . . . 72.03 110.616 176.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.48 -11.29 30.68 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.673 -0.775 . . . . 24.25 111.264 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 534' ' ' VAL . 88.5 mt-30 -97.5 -171.15 2.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.103 -0.332 . . . . 65.35 110.103 177.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 12.1 m -84.86 156.75 21.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.842 -1.169 . . . . 71.54 107.842 -177.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -41.97 93.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.78 0.324 . . . . 64.43 110.608 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.49 -42.04 95.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.707 -0.679 . . . . 71.4 110.821 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.88 -34.98 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 119.638 -0.825 . . . . 63.53 110.721 -177.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.76 85.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.367 -0.833 . . . . 64.44 111.029 178.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.76 -45.95 90.29 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.487 0.492 . . . . 62.12 109.916 178.657 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -61.9 -54.03 47.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.603 -0.726 . . . . 65.25 112.053 -173.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.88 -38.33 88.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.544 -0.463 . . . . 52.54 110.919 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.71 -43.22 72.86 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 109.422 -0.584 . . . . 63.22 109.422 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.92 -45.8 89.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.351 0.661 . . . . 74.22 111.815 -178.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.72 -30.85 49.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 71.14 111.418 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.26 22.44 12.88 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 122.059 -0.401 . . . . 74.24 110.415 -174.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.74 -101.82 0.17 Allowed Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 117.165 -2.445 . . . . 72.03 116.514 -172.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 23.3 m-85 -109.6 156.37 20.26 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.513 -0.844 . . . . 71.54 110.601 -165.263 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.5 m -107.92 -24.27 11.7 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.762 -0.654 . . . . 71.4 111.426 -174.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -107.93 115.55 30.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.841 0.353 . . . . 71.4 110.143 -176.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -117.04 154.54 30.77 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.745 -0.661 . . . . 74.41 110.383 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.29 155.58 45.96 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.481 -1.674 . . . . 61.13 106.481 171.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -119.96 148.3 43.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.294 -1.002 . . . . 74.21 108.294 -174.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.12 128.5 30.23 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.223 -0.658 . . . . 74.42 109.223 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -88.02 122.44 31.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.444 -1.317 . . . . 74.21 107.444 176.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.72 153.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.707 -0.679 . . . . 74.15 109.169 -175.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.34 114.59 18.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.436 1.112 . . . . 74.41 110.883 -175.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.9 p -117.17 120.52 33.51 Favored Pre-proline 0 N--CA 1.408 -2.535 0 CA-C-N 113.799 -1.546 . . . . 63.23 109.769 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.95 -55.12 3.18 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.766 2.311 . . . . 61.33 112.818 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.46 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 23.8 mtp180 -99.92 -54.4 0.17 Allowed Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 114.081 1.141 . . . . 73.01 114.081 177.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 32.1 Cg_exo -60.21 153.27 60.28 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.138 1.892 . . . . 74.33 113.798 -176.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.05 133.74 9.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.604 -1.258 . . . . 62.23 107.604 176.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 84.23 -45.16 3.44 Favored Glycine 0 C--N 1.312 -0.754 0 C-N-CA 121.258 -0.496 . . . . 75.45 113.516 177.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.22 149.68 48.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.248 1.019 . . . . 75.14 111.406 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 503' ' ' GLN . 9.3 p -75.17 127.35 36.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.193 0.52 . . . . 62.13 111.073 -174.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -82.19 -22.21 36.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.518 -0.765 . . . . 73.42 109.226 -178.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 140.67 -149.5 20.99 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.901 -1.28 . . . . 63.12 109.901 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.0 p -116.94 157.26 26.02 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.766 -1.198 . . . . 62.14 107.766 176.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 52.1 t30 -59.44 -53.48 65.48 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.39 -0.338 . . . . 75.14 111.734 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.9 Cg_exo -77.19 138.84 18.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 108.386 -1.428 . . . . 75.34 108.386 172.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.07 155.43 69.68 Favored 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 121.958 1.772 . . . . 53.21 111.948 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -59.09 143.42 48.67 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.511 -0.768 . . . . 74.35 110.695 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 94.02 -9.27 72.89 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 120.944 -0.646 . . . . 75.43 111.853 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 29.5 m -80.16 128.22 33.26 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.218 -0.66 . . . . 75.01 109.218 177.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 1.8 m -84.88 122.68 29.53 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.712 -1.218 . . . . 61.22 107.712 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.11 154.72 81.76 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.626 -0.509 . . . . 42.41 109.626 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 494' ' ' THR . 21.4 Cg_exo -67.42 133.95 31.79 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.428 2.085 . . . . 75.21 111.813 -178.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.578 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 19.5 m -67.69 -20.48 26.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.166 0.507 . . . . 72.32 112.08 -177.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.67 -3.04 55.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.83 -0.623 . . . . 73.33 110.444 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.7 t -95.19 164.99 12.62 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.361 -0.607 . . . . 73.15 109.361 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.73 136.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.604 -0.517 . . . . 72.1 109.604 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.5 tt -110.65 138.47 38.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 120.936 0.398 . . . . 64.51 109.937 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -103.4 127.43 50.76 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 122.771 0.428 . . . . 65.22 109.85 -178.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.4 tp -100.63 132.96 45.75 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.485 -0.78 . . . . 63.15 108.899 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -88.88 113.66 24.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.115 -0.698 . . . . 74.32 109.115 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 47.8 t -103.96 124.16 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 108.542 -0.91 . . . . 52.05 108.542 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 16.0 m -61.58 121.84 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.302 -0.999 . . . . 54.53 108.302 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 60.2 tttm . . . . . 0 N--CA 1.42 -1.96 0 CA-C-O 118.462 -0.78 . . . . 72.21 110.745 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.5 pt-20 . . . . . 0 N--CA 1.442 -0.838 0 CA-C-O 122.116 0.96 . . . . 72.45 108.641 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -83.53 121.88 27.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.802 -1.09 . . . . 74.11 109.946 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -121.07 156.92 31.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.096 -1.076 . . . . 71.23 108.096 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -83.43 140.84 32.13 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.142 -0.481 . . . . 74.34 109.844 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -84.71 127.88 63.36 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.318 -0.993 . . . . 70.51 108.318 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.3 141.59 63.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.887 1.724 . . . . 63.24 111.93 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -111.31 70.22 0.71 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 122.669 1.224 . . . . 73.23 108.781 -177.124 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.96 5.92 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 113.779 -1.555 . . . . 65.33 107.812 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.56 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.3 m -57.34 -34.62 68.97 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.872 -1.967 . . . . 53.51 112.428 -177.063 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.0 t -60.3 -27.06 67.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.156 0.582 . . . . 64.23 111.557 178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.45 -45.97 18.39 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 120.127 -0.629 . . . . 71.1 110.21 -172.004 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.4 m -170.3 149.08 3.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.494 -1.298 . . . . 73.25 107.494 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 42.2 t80 -53.22 -45.86 68.84 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.555 0.535 . . . . 74.02 110.389 171.187 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.13 74.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.52 -0.764 . . . . 71.04 111.867 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 30.2 mm-40 -61.35 -44.87 96.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.269 -0.423 . . . . 72.42 111.048 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -62.79 -51.05 68.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.831 -0.622 . . . . 54.1 110.766 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -62.95 -48.86 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.662 -0.699 . . . . 61.54 111.97 -175.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.06 -41.49 90.7 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 121.107 -0.237 . . . . 75.42 111.353 -177.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.12 88.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.244 0.545 . . . . 72.24 109.887 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.51 -40.32 80.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.671 -0.695 . . . . 74.32 109.904 177.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.4 m -59.47 -46.5 88.62 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.637 -0.71 . . . . 55.44 109.107 176.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.34 65.9 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.443 -0.799 . . . . 64.4 111.437 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.61 -14.01 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 74.44 111.023 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.03 -14.92 21.3 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.108 -1.044 . . . . 64.43 113.046 175.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -69.81 130.15 41.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.608 -0.516 . . . . 74.42 109.608 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.19 -23.92 6.48 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.894 -0.669 . . . . 51.22 111.704 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -103.01 115.79 31.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.831 0.824 . . . . 72.3 112.458 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 3.4 p90 -146.83 141.74 26.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.405 -1.27 . . . . 64.34 110.112 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -131.39 123.22 27.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.548 -0.751 . . . . 55.44 109.089 -174.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -85.78 135.35 33.76 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.003 -0.544 . . . . 74.24 110.576 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.68 147.7 52.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.396 -1.705 . . . . 64.04 106.396 171.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -114.4 149.2 36.53 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.438 -0.505 . . . . 70.35 109.808 -178.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 10.2 t -140.63 133.49 14.63 Favored Pre-proline 0 N--CA 1.422 -1.862 0 N-CA-C 108.01 -1.107 . . . . 72.31 108.01 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.2 Cg_exo -65.0 125.09 14.06 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.656 2.237 . . . . 63.05 111.93 -179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 31.4 t -139.26 179.5 6.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 -178.015 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.4 t -57.64 140.37 80.59 Favored Pre-proline 0 N--CA 1.432 -1.336 0 C-N-CA 123.213 0.605 . . . . 52.52 110.327 177.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 76.7 Cg_exo -50.58 -29.61 25.57 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 124.312 3.342 . . . . 74.31 113.573 -178.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.58 -10.59 59.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.58 0.585 . . . . 70.05 112.58 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.6 8.11 35.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.525 0.565 . . . . 74.32 112.525 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.4 p -60.68 128.1 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.796 0.331 . . . . 70.41 110.453 179.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.54 87.62 Favored Glycine 0 C--O 1.252 1.26 0 C-N-CA 120.847 -0.692 . . . . 73.41 112.214 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -113.61 146.06 40.31 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.19 -1.041 . . . . 65.42 108.19 177.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 45.8 t -81.94 144.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.943 -0.391 . . . . 64.12 109.943 -176.22 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.6 pt -98.21 -19.0 6.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.142 0.496 . . . . 60.34 110.503 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.24 178.36 37.67 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 111.191 -0.764 . . . . 72.22 111.191 177.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 27.8 p -119.59 145.99 45.91 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.415 -0.587 . . . . 73.41 109.415 178.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.88 -52.1 74.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 123.266 0.353 . . . . 70.52 111.103 178.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.68 143.41 23.9 Favored 'Trans proline' 0 C--N 1.366 1.493 0 N-CA-C 108.89 -1.235 . . . . 73.32 108.89 170.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 56.4 Cg_endo -65.94 153.11 79.49 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 122.459 2.106 . . . . 61.45 112.355 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -87.15 -20.07 27.55 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.424 -0.807 . . . . 72.34 110.262 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 -32.12 15.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.089 -0.959 . . . . 74.52 112.117 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 1.3 mp0 -94.57 145.57 24.72 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.234 -0.986 . . . . 70.34 108.613 178.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 28.6 p -83.87 128.71 34.74 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 116.327 -0.397 . . . . 71.21 110.513 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 m -114.03 145.11 42.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.073 -1.084 . . . . 63.34 108.073 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.46 142.0 58.31 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.663 0.268 . . . . 55.45 111.542 -176.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 425' ' ' GLU . 50.2 mm -57.75 -25.84 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.779 0.832 . . . . 73.04 110.578 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -79.56 3.61 18.33 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.971 -0.559 . . . . 74.44 111.226 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.52 157.77 15.75 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.975 -0.453 . . . . 74.41 110.241 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.39 122.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.962 -1.125 . . . . 71.54 107.962 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 93.3 t -89.25 119.38 36.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.616 -0.512 . . . . 71.35 109.616 179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.31 121.81 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.588 -1.264 . . . . 72.24 107.588 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.95 121.29 66.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 115.626 -0.715 . . . . 75.45 109.277 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.73 118.36 49.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 121.808 0.813 . . . . 72.44 112.511 -178.283 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 15.4 t -96.77 145.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.883 -1.053 . . . . 72.13 109.1 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.77 117.31 4.63 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 110.477 -1.049 . . . . 71.13 110.477 176.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 7.3 p -99.57 128.66 45.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 107.486 -1.302 . . . . 63.42 107.486 174.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.43 -1.729 0 C-N-CA 120.213 -0.994 . . . . 71.52 112.057 -174.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.827 0 N-CA-C 107.44 -1.318 . . . . 64.21 107.44 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 546' ' ' PRO . 21.9 p -122.61 158.77 29.23 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 115.538 -0.755 . . . . 55.33 109.847 -178.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -135.65 141.63 45.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.323 -0.398 . . . . 75.35 110.76 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.07 127.1 32.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.723 -1.214 . . . . 75.21 107.723 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.97 129.79 80.0 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 115.87 -0.605 . . . . 54.15 111.863 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -94.26 124.28 0.43 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.769 2.313 . . . . 42.11 112.471 173.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.18 135.43 36.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.278 -1.378 . . . . 74.32 107.278 174.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 t -125.28 33.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.754 0.787 . . . . 75.51 108.928 -176.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -61.28 116.16 4.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 70.11 110.771 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.57 -23.92 5.01 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.651 -0.785 . . . . 60.21 112.244 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.31 -179.17 3.87 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.712 -0.847 . . . . 65.54 108.712 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 25.7 m -84.09 155.7 22.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 119.928 -0.709 . . . . 71.23 109.652 -172.482 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.06 -41.31 68.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.787 0.435 . . . . 72.55 111.199 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.64 -42.06 87.3 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.535 -0.757 . . . . 75.35 111.59 -178.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.06 -36.37 56.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 118.952 -1.099 . . . . 74.33 110.631 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.16 74.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.942 -1.026 . . . . 74.12 111.56 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -63.35 -35.24 79.74 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 123.116 0.26 . . . . 63.11 110.676 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -63.54 -49.15 74.61 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.332 0.395 . . . . 61.41 111.918 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -68.88 -38.27 79.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.897 0.379 . . . . 72.14 110.472 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 551' ' ' ILE . 48.1 tp -62.4 -44.67 95.89 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 115.84 -0.618 . . . . 53.42 110.065 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.0 t-20 -59.54 -47.69 84.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.413 0.685 . . . . 62.42 111.989 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.69 -20.0 17.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.169 -0.469 . . . . 31.23 112.04 -175.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -116.61 4.02 13.14 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 120.034 -0.666 . . . . 70.44 111.13 -178.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.73 -96.64 0.2 Allowed Glycine 0 N--CA 1.41 -3.089 0 C-N-CA 118.806 -1.664 . . . . 64.31 115.763 -169.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 9.6 m-85 -129.74 158.4 39.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.278 -0.461 . . . . 65.45 110.292 -165.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -104.95 -2.21 24.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.609 -0.885 . . . . 64.54 108.609 177.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 550' ' ' VAL . 75.5 mmtt -108.73 115.61 30.41 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 72.04 109.462 -175.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -126.24 152.42 46.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.603 0.716 . . . . 72.23 111.786 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -133.59 148.82 51.62 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.629 -1.619 . . . . 75.32 106.629 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.6 mm-40 -120.27 123.25 42.72 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.691 -1.226 . . . . 72.42 107.691 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -114.86 126.53 54.92 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.78 -1.192 . . . . 74.22 107.78 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 19.4 m -91.92 120.45 32.6 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.019 -0.734 . . . . 74.15 109.019 -178.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.39 151.51 24.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.568 -1.271 . . . . 74.32 107.568 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.476 ' HA ' ' OXT' ' A' ' 557' ' ' LYS . 12.6 m-20 -79.05 128.22 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.024 0.916 . . . . 70.31 113.411 -170.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.4 m -143.4 111.7 5.47 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.84 -1.541 . . . . 42.35 106.84 177.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -56.17 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.048 2.498 . . . . 54.22 114.568 -174.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -82.34 -44.78 0.98 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 114.715 1.376 . . . . 73.14 114.715 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 533' ' ' GLU . 72.6 Cg_exo -57.07 133.76 59.94 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.352 1.368 . . . . 71.2 110.803 174.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -143.09 127.21 17.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.587 -0.279 . . . . 74.13 110.652 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.0 -11.28 55.2 Favored Glycine 0 N--CA 1.469 0.858 0 CA-C-O 121.372 0.429 . . . . 62.45 113.024 175.141 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 530' ' ' PRO . 11.4 pt-20 -86.78 150.89 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.505 0.722 . . . . 74.32 110.976 178.447 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 47.8 t -74.71 124.64 32.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.226 -1.028 . . . . 60.13 108.226 178.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 28.8 m -83.38 -33.64 25.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 71.52 108.44 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.05 -167.12 39.92 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.834 -0.621 . . . . 65.12 111.655 177.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.5 p -118.97 160.38 22.1 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.579 -0.897 . . . . 72.22 108.579 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.9 t-20 -57.8 -56.77 31.13 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 119.274 -0.394 . . . . 73.13 111.95 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.3 Cg_endo -89.38 166.05 5.37 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.833 1.688 . . . . 52.25 109.506 174.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.28 152.55 55.75 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.295 1.996 . . . . 64.23 111.974 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.14 135.94 57.73 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.862 0.465 . . . . 65.23 110.351 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.47 37.16 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.99 -0.624 . . . . 63.44 111.564 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.6 m -67.89 131.56 45.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.483 -0.562 . . . . 74.23 109.483 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.3 t -100.02 123.72 44.58 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.994 0.902 . . . . 72.22 110.971 -177.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.69 158.93 60.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 71.32 108.465 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 494' ' ' THR . 44.1 Cg_exo -58.62 143.78 98.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.237 1.958 . . . . 74.44 110.894 179.177 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.32 -21.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.246 0.461 . . . . 65.33 112.246 -176.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.97 -2.77 58.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.325 -0.398 . . . . 75.33 111.034 178.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -81.21 152.58 27.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.18 -0.674 . . . . 51.03 109.18 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.9 t -90.06 125.5 42.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.312 -0.625 . . . . 61.11 109.312 -179.039 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.435 HD13 HD21 ' A' ' 512' ' ' LEU . 14.2 tt -97.25 139.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.122 -0.325 . . . . 61.02 110.122 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -102.85 120.27 40.3 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 120.902 0.382 . . . . 61.12 110.119 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 534' ' ' VAL . 6.3 tt -100.89 130.18 46.86 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.423 -1.325 . . . . 72.44 107.423 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.8 mt-30 -101.21 109.51 21.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.661 0.743 . . . . 71.05 110.186 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.18 139.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.448 -1.251 . . . . 75.12 111.598 -175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -57.14 121.05 9.13 Favored 'General case' 0 C--O 1.25 1.108 0 C-N-CA 123.825 0.85 . . . . 64.43 112.973 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.476 ' OXT' ' HA ' ' A' ' 526' ' ' ASP . 28.4 ttpp . . . . . 0 N--CA 1.432 -1.367 0 C-N-CA 124.951 1.301 . . . . 72.5 108.362 175.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 107.866 -1.161 . . . . 63.23 107.866 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 96.6 mt-30 -83.47 149.09 26.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.649 -1.614 . . . . 74.41 108.396 178.472 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 17.6 tpp180 -120.92 155.33 34.44 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.528 -1.286 . . . . 62.11 107.528 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.39 141.48 31.7 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.49 -0.93 . . . . 72.24 108.49 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -80.07 127.4 77.03 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.018 -1.475 . . . . 64.14 107.018 177.545 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.27 139.93 32.99 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 109.431 -1.027 . . . . 53.45 109.431 175.053 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -115.28 72.04 0.78 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.889 1.328 . . . . 73.32 109.93 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.14 14.68 7.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 113.552 -1.658 . . . . 61.45 107.1 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.624 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.3 m -52.39 -41.29 63.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 127.637 2.375 . . . . 63.51 110.395 178.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.3 t -56.43 -26.71 54.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.003 1.321 . . . . 64.2 112.017 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.4 mt -85.85 -46.92 10.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.118 -1.033 . . . . 63.2 111.048 -174.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 20.1 m -174.23 153.7 2.05 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.535 -0.913 . . . . 72.34 108.535 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.497 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 40.3 t80 -50.55 -50.68 52.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.142 0.977 . . . . 74.34 111.009 171.186 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.48 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.757 0.661 . . . . 64.42 111.461 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.413 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 50.0 mm-40 -61.49 -45.98 91.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.317 -0.402 . . . . 62.35 111.463 -178.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -63.38 -48.36 78.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.87 -0.605 . . . . 61.14 110.967 -178.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.18 -46.59 90.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.894 -0.594 . . . . 64.52 112.238 -176.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -66.55 -41.55 88.49 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.488 0.181 . . . . 71.4 111.488 -178.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.08 -38.99 86.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.458 -0.497 . . . . 70.43 111.179 176.442 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 452' ' ' PHE . 33.5 tp -67.11 -36.61 82.29 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.251 0.548 . . . . 52.33 110.041 178.212 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.2 m -59.49 -44.72 93.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.459 -0.791 . . . . 45.02 109.582 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.68 -18.65 62.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.44 -0.8 . . . . 73.33 111.181 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.16 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.228 0.537 . . . . 72.44 110.903 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.06 -25.77 9.74 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.813 -0.708 . . . . 60.01 113.454 174.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 96.2 m-85 -57.42 130.7 47.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.038 0.535 . . . . 61.34 112.0 -176.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.0 26.29 4.79 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.398 -0.906 . . . . 53.13 112.849 -178.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -132.91 115.59 15.43 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.235 -1.024 . . . . 75.01 108.235 178.715 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.6 m-85 -128.93 150.11 50.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.575 0.702 . . . . 71.42 111.731 -174.332 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.573 ' HB2' HG13 ' A' ' 485' ' ' ILE . 36.3 mmtm -136.24 130.62 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.646 -1.983 . . . . 75.54 105.646 169.374 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -108.26 124.72 50.74 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.703 -0.799 . . . . 74.52 110.83 -175.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.05 145.01 48.56 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.934 -0.575 . . . . 63.12 109.547 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -118.88 134.54 55.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.436 -1.32 . . . . 70.54 107.436 175.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.1 t -122.29 137.23 27.3 Favored Pre-proline 0 C--N 1.283 -2.284 0 N-CA-C 108.479 -0.934 . . . . 75.41 108.479 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.11 122.17 9.86 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.847 1.698 . . . . 54.05 110.801 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 40.5 m -134.07 178.7 6.76 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.353 -0.98 . . . . 54.33 108.353 -177.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.7 t -74.0 151.26 88.39 Favored Pre-proline 0 N--CA 1.403 -2.804 0 N-CA-C 107.651 -1.24 . . . . 74.33 107.651 176.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.498 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -50.42 -28.91 22.44 Favored 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 124.121 3.214 . . . . 63.03 112.718 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.97 -26.25 68.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.121 -0.49 . . . . 74.05 111.344 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.34 -0.42 35.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.81 1.041 . . . . 63.42 113.81 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -60.81 128.13 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 119.962 -0.695 . . . . 74.14 110.696 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.24 -12.77 67.8 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 121.12 -0.562 . . . . 74.4 112.654 177.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.27 139.72 38.35 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.732 -0.47 . . . . 72.45 109.732 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 61.6 t -82.49 128.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.767 -0.651 . . . . 75.22 109.628 -178.102 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.47 -6.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.937 0.399 . . . . 74.45 112.019 -176.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.29 160.92 15.43 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.939 -1.125 . . . . 75.4 112.829 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.0 p -118.95 142.29 47.91 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.255 -1.017 . . . . 71.52 108.255 176.007 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.527 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.7 t-20 -54.74 -51.58 77.68 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 112.387 0.514 . . . . 72.13 112.387 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.5 Cg_exo -77.2 124.13 7.05 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 N-CA-C 108.158 -1.516 . . . . 75.14 108.158 169.378 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.32 142.17 65.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.326 2.017 . . . . 75.12 112.037 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.55 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.21 -14.65 61.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.144 0.973 . . . . 40.43 110.697 -177.152 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.27 -9.98 55.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.731 -1.577 . . . . 64.45 111.33 -176.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -120.84 151.06 40.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.945 -0.761 . . . . 64.23 108.945 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 10.7 p -84.44 132.7 34.54 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 108.807 -0.812 . . . . 73.11 108.807 176.513 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.6 m -122.2 145.71 47.94 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.358 -0.608 . . . . 53.34 109.358 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -59.55 154.64 16.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.439 . . . . 54.52 111.001 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.1 -25.42 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.796 0.807 . . . . 63.43 110.603 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.4 t -94.54 11.48 30.79 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.014 -0.994 . . . . 62.5 110.921 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -77.74 141.35 39.34 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 121.697 -0.627 . . . . 72.53 109.853 176.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.57 117.33 25.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.609 0.719 . . . . 73.0 110.075 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.44 118.61 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.734 -0.839 . . . . 72.34 108.734 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.573 HG13 ' HB2' ' A' ' 453' ' ' LYS . 2.5 mp -96.5 117.83 41.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 105.411 -2.07 . . . . 71.13 105.411 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.72 119.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 109.068 -0.715 . . . . 73.54 109.068 -176.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.53 114.26 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.528 -175.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 17.5 t -95.99 136.59 26.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.688 -0.856 . . . . 63.54 108.688 -178.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.44 125.08 6.8 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.815 -1.714 . . . . 73.15 108.815 175.072 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -128.63 129.84 46.44 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 109.12 -0.696 . . . . 71.43 109.12 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.85 0 N-CA-C 109.104 -1.598 . . . . 44.24 109.104 178.361 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.165 0 CA-C-O 122.147 0.975 . . . . 70.13 109.591 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.9 p -137.1 154.11 50.38 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.644 -1.243 . . . . 74.34 107.644 -176.344 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -138.64 150.0 45.78 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.807 0.337 . . . . 71.14 110.562 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.0 t70 -100.36 113.73 26.7 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.02 -1.104 . . . . 74.11 108.02 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 497' ' ' ILE . 0.2 OUTLIER -98.6 134.84 21.37 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 113.443 0.905 . . . . 71.24 113.443 -174.153 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.4 -178.15 1.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.767 2.311 . . . . 55.12 109.04 170.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.69 153.64 18.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.091 -0.707 . . . . 70.15 109.091 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.65 33.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 104.937 -2.246 . . . . 54.4 104.937 175.086 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.89 147.45 33.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.794 -1.548 . . . . 63.4 111.327 -173.421 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 103.65 -12.98 53.96 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.64 -0.984 . . . . 43.54 110.64 -177.23 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.12 179.92 4.08 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.098 -0.704 . . . . 74.13 109.098 177.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.72 156.15 26.4 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.647 -0.421 . . . . 64.22 109.941 -170.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.1 p -54.3 -43.7 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.383 0.512 . . . . 72.31 112.383 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.64 -41.91 78.74 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.332 0.493 . . . . 63.12 112.332 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.83 -38.9 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 119.47 -0.892 . . . . 72.35 111.524 -174.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.38 80.93 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.61 -0.723 . . . . 71.53 111.39 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -64.82 -34.68 78.93 Favored 'General case' 0 C--O 1.205 -1.282 0 O-C-N 123.214 0.321 . . . . 64.12 110.394 -177.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -59.5 -52.48 65.4 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.495 -0.557 . . . . 74.3 109.495 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -66.86 -44.72 80.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.457 -0.792 . . . . 72.1 110.704 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.47 -37.0 82.03 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 115.915 -0.584 . . . . 62.35 110.531 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -58.81 -38.15 77.98 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.552 0.741 . . . . 74.5 110.942 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -37.62 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.718 -0.674 . . . . 74.43 111.267 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -122.74 33.83 5.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.713 0.768 . . . . 72.43 111.455 -176.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -153.39 -128.52 1.29 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.98 -1.009 . . . . 62.24 111.553 -178.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 44.7 m-85 -105.66 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.053 0.454 . . . . 65.45 110.319 -173.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.6 p -110.03 -3.63 16.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.577 -0.738 . . . . 71.44 110.902 178.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 550' ' ' VAL . 28.2 mtpp -113.77 115.73 28.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.84 -0.8 . . . . 74.24 108.84 -177.741 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.83 156.46 43.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.152 0.501 . . . . 74.21 111.456 -175.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -140.99 156.62 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.017 -1.475 . . . . 75.22 107.017 171.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -121.75 124.87 45.24 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.385 -0.598 . . . . 74.41 109.385 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.82 140.63 48.78 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.529 -0.915 . . . . 75.23 108.529 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 20.0 m -88.18 124.81 34.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.974 -0.557 . . . . 52.53 110.704 -176.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 33.2 m -121.17 156.8 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.954 -1.128 . . . . 73.43 107.954 176.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.88 142.4 38.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.999 0.904 . . . . 72.21 112.048 -170.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 p -118.17 135.29 23.43 Favored Pre-proline 0 N--CA 1.413 -2.294 0 CA-C-N 114.264 -1.334 . . . . 51.11 110.187 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.55 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.275 0 N-CA-C 109.075 -1.163 . . . . 43.14 109.075 171.768 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.559 ' HG3' ' HD3' ' A' ' 530' ' ' PRO . 23.2 ptt180 -127.43 -47.07 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 114.72 1.378 . . . . 74.35 114.72 176.572 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.559 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 84.7 Cg_endo -76.54 135.89 16.8 Favored 'Trans proline' 0 C--N 1.385 2.45 0 CA-C-N 121.763 1.665 . . . . 71.41 112.107 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -137.32 145.44 43.41 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.955 -0.387 . . . . 73.52 109.955 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 100.21 -18.83 54.97 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.899 -0.48 . . . . 62.45 111.899 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.43 148.4 24.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.286 0.565 . . . . 75.32 111.638 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.73 122.45 28.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.289 -0.869 . . . . 75.34 109.472 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.3 m -92.68 -10.01 38.78 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.788 -1.096 . . . . 62.5 109.348 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -159.12 27.98 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 110.774 -0.931 . . . . 75.43 110.774 177.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -134.36 157.75 45.59 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.698 -1.223 . . . . 71.5 107.698 177.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 552' ' ' GLU . 25.2 t-20 -52.68 -58.72 10.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.861 -0.59 . . . . 51.0 110.908 -179.616 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.51 140.53 15.13 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 120.464 1.202 . . . . 63.1 109.063 170.421 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.47 155.8 65.9 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 121.935 1.757 . . . . 71.41 112.193 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.53 136.14 57.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.944 -0.571 . . . . 73.34 109.914 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -5.36 57.04 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.088 -1.053 . . . . 62.3 111.815 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 16.7 m -89.2 137.72 32.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.446 -0.575 . . . . 73.12 109.446 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.7 m -98.8 123.04 42.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.244 -1.021 . . . . 42.42 108.244 175.084 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.74 161.96 57.97 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 110.054 -0.351 . . . . 71.52 110.054 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 494' ' ' THR . 20.7 Cg_exo -66.33 137.79 48.57 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.02 2.48 . . . . 60.23 113.995 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.553 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 15.0 m -67.86 -20.45 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.005 0.907 . . . . 72.04 111.248 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.45 -5.15 58.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.446 -1.252 . . . . 63.23 110.456 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -103.72 152.25 22.05 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.69 -1.226 . . . . 74.05 107.69 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 519' ' ' LYS . 38.8 t -88.71 136.2 23.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.859 -0.423 . . . . 64.32 109.859 -177.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.0 tt -95.88 135.49 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.352 0.596 . . . . 70.11 109.408 176.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -101.59 120.61 40.59 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.379 -0.971 . . . . 72.43 108.379 -177.093 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.0 tp -95.5 126.58 40.89 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.811 -1.086 . . . . 71.44 108.472 -177.374 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -89.53 105.64 17.93 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.632 -0.877 . . . . 75.31 108.632 -177.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.48 134.49 47.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 120.789 0.328 . . . . 64.31 110.667 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.7 p -66.35 121.46 15.3 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.044 -0.525 . . . . 75.31 109.743 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 20.6 pttp . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 115.557 -0.747 . . . . 75.51 110.626 -177.426 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.775 0.797 . . . . 61.34 109.521 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -101.39 147.89 25.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.162 -1.051 . . . . 54.23 108.162 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 18.4 tpt180 -120.72 158.82 26.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.966 0.413 . . . . 73.43 110.166 -175.847 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.3 141.47 29.22 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.149 0.979 . . . . 74.52 110.41 -176.076 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.0 mp -87.85 121.49 70.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.617 -1.623 . . . . 60.01 106.617 173.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.74 141.83 55.86 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.091 1.861 . . . . 34.22 112.898 -175.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.58 11.64 23.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.74 -0.663 . . . . 73.12 110.767 -178.192 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 443' ' ' LYS . 21.5 m -73.27 -9.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.701 -0.851 . . . . 64.45 108.701 176.177 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.0 m -57.23 -38.2 73.44 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.329 -1.305 . . . . 71.14 109.866 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.1 m -60.02 -27.56 67.0 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.779 -1.1 . . . . 70.24 110.647 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.8 mt -79.85 -47.63 14.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.382 -0.927 . . . . 73.01 109.975 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.529 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 49.8 m -166.01 145.77 6.27 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.682 -0.858 . . . . 73.14 108.682 177.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -55.29 -44.5 75.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.468 0.707 . . . . 72.44 111.914 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.19 -43.29 78.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.447 . . . . 70.51 110.881 177.513 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.9 mm-40 -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 71.44 110.534 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.54 -51.39 70.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.98 -1.009 . . . . 54.15 110.95 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.31 -48.52 88.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 114.851 -1.068 . . . . 70.42 111.784 -176.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.16 -46.11 90.43 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.154 0.428 . . . . 43.42 112.154 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.528 ' HG3' HG21 ' A' ' 432' ' ' VAL . 74.5 mmtt -66.98 -42.71 84.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.847 0.356 . . . . 75.13 111.267 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.81 80.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 72.53 111.026 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 49.2 m -62.35 -45.57 92.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.204 -0.665 . . . . 64.01 109.204 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.88 62.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.593 -0.73 . . . . 14.11 111.054 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -79.33 -13.8 59.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 120.796 0.331 . . . . 51.45 110.2 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.91 -9.82 15.84 Favored Glycine 0 CA--C 1.494 -1.229 0 C-N-CA 120.072 -1.061 . . . . 75.05 113.209 173.491 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -80.35 136.6 36.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.58 -0.526 . . . . 73.34 109.58 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.04 -1.82 6.71 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 120.405 -0.903 . . . . 51.35 112.603 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -112.65 115.96 29.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.523 -0.918 . . . . 64.54 108.523 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -131.0 152.08 50.7 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.319 -0.4 . . . . 74.23 110.173 -174.333 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -135.8 122.59 21.11 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.457 -1.312 . . . . 71.31 107.457 170.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -97.68 133.37 42.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.151 0.501 . . . . 70.43 110.21 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.31 138.96 54.33 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.264 -1.384 . . . . 44.03 107.264 175.064 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.09 136.64 53.16 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.695 -0.854 . . . . 63.43 108.695 177.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.1 p -128.2 144.49 51.93 Favored Pre-proline 0 C--N 1.289 -2.048 0 N-CA-C 109.779 -0.452 . . . . 60.21 109.779 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -64.93 123.46 11.65 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.12 1.88 . . . . 75.24 109.85 175.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.7 m -142.06 178.16 7.72 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.5 -0.926 . . . . 54.23 108.5 -177.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -58.76 141.71 84.74 Favored Pre-proline 0 C--O 1.253 1.272 0 C-N-CA 123.295 0.638 . . . . 75.52 111.431 178.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.46 -28.58 28.4 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.982 3.788 . . . . 73.13 113.382 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -75.39 -11.26 60.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.785 0.661 . . . . 73.25 112.785 -178.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 83.4 mt -111.0 6.36 20.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.978 0.362 . . . . 71.33 111.978 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 49.1 t -61.21 127.34 20.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 121.125 -0.23 . . . . 74.1 110.804 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.24 87.75 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 116.11 -0.496 . . . . 73.03 112.467 176.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 28.4 mtpp -106.75 142.13 36.89 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.113 -1.069 . . . . 72.1 108.113 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -81.76 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.408 -0.59 . . . . 62.41 109.408 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 20.2 pt -98.25 -10.08 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.085 -0.507 . . . . 75.04 111.652 -176.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 162.15 21.34 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.64 -0.79 . . . . 75.05 112.153 177.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 25.4 p -130.09 150.31 51.41 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.021 -1.103 . . . . 65.05 108.021 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.61 -52.9 61.6 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 119.325 -0.369 . . . . 74.31 111.855 176.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.99 140.81 38.85 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 120.836 1.024 . . . . 61.54 110.073 173.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.02 145.69 85.81 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.253 2.636 . . . . 51.33 113.248 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -90.95 -17.39 26.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.331 1.062 . . . . 44.15 109.122 178.15 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -92.92 -19.14 21.94 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.616 -1.175 . . . . 55.01 110.114 -176.218 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -118.97 150.94 39.07 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.14 -0.482 . . . . 64.34 110.378 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.7 p -85.99 127.2 34.59 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.513 -0.312 . . . . 74.42 111.226 -178.355 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.0 m -111.27 151.24 28.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.475 0.71 . . . . 72.43 109.777 -176.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -60.43 142.92 54.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 61.3 111.811 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.89 -30.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.765 1.226 . . . . 73.05 111.275 -176.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -83.95 0.75 46.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.073 -0.512 . . . . 74.33 111.604 -175.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.44 145.08 46.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 112.465 0.543 . . . . 74.43 112.465 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.7 p -84.46 125.78 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.627 -0.879 . . . . 61.04 108.627 172.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.0 118.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 109.032 -0.729 . . . . 74.51 109.032 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.72 115.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 105.804 -1.924 . . . . 75.23 105.804 174.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.39 125.46 70.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.408 -0.815 . . . . 55.12 109.932 -174.234 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.33 120.75 55.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.083 0.468 . . . . 54.42 110.107 -177.05 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.8 t -102.84 140.39 21.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 CA-C-N 115.642 -0.708 . . . . 70.02 109.67 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.0 122.73 5.84 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 109.238 -1.545 . . . . 51.33 109.238 173.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.4 p -122.29 137.27 54.91 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.109 -0.7 . . . . 44.24 109.109 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 464' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.803 0 C-N-CA 120.141 -1.028 . . . . 45.1 111.464 -176.545 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.695 0 N-CA-C 107.939 -1.134 . . . . 71.53 107.939 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 546' ' ' PRO . 22.5 p -125.33 166.05 17.26 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.335 -0.848 . . . . 61.33 111.242 -175.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -149.57 147.13 27.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.741 0.817 . . . . 72.11 110.191 176.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 30.4 t70 -96.08 127.05 41.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.49 121.81 83.14 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -175.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.19 146.29 14.1 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.995 1.797 . . . . 54.22 110.437 175.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.81 121.01 17.25 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.362 -0.607 . . . . 72.31 109.362 179.154 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.01 19.09 3.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.68 1.228 . . . . 72.14 108.249 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.21 112.25 19.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.421 -1.263 . . . . 63.41 109.525 -176.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.98 -28.39 1.71 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.66 -0.976 . . . . 54.43 110.66 -178.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 507' ' ' VAL . 83.2 mt-30 -86.46 178.57 7.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.425 -0.954 . . . . 71.45 108.425 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 155.95 28.55 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.154 -1.054 . . . . 55.12 108.154 -174.681 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.8 p -51.76 -45.9 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.608 0.595 . . . . 60.35 112.608 -176.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.57 -42.76 82.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.22 0.325 . . . . 65.14 111.545 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 503' ' ' GLN . 13.2 p -76.92 -39.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 119.537 -0.865 . . . . 74.02 111.678 -175.574 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.3 71.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.465 -0.789 . . . . 41.23 112.284 179.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.02 -35.6 81.71 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 120.138 -0.625 . . . . 73.12 110.333 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 510' ' ' LYS . 33.1 ttmt -60.67 -48.15 83.07 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.951 0.782 . . . . 75.35 109.331 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -62.62 -43.7 98.14 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.438 -0.801 . . . . 72.53 110.689 178.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.25 -43.06 92.54 Favored 'General case' 0 C--O 1.188 -2.16 0 CA-C-N 115.63 -0.714 . . . . 74.11 109.45 -178.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -58.74 -37.71 76.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.037 0.935 . . . . 72.51 111.76 -178.32 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.0 t -66.05 -37.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 112.512 0.56 . . . . 53.11 112.512 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -112.19 -15.4 13.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.24 -0.584 . . . . 74.25 111.896 -173.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -106.14 -110.31 3.48 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 115.541 -0.754 . . . . 74.04 113.324 -175.062 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.544 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 21.0 m-85 -123.94 175.43 6.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.092 0.472 . . . . 71.44 110.992 -172.024 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.9 p -109.42 -3.45 17.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.362 -0.835 . . . . 62.2 110.477 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.42 115.72 30.64 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.008 -0.738 . . . . 72.33 109.008 -176.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.78 149.28 50.79 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 123.576 0.547 . . . . 62.22 110.846 -176.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.6 m -136.36 143.54 44.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.21 -1.774 . . . . 73.31 106.21 171.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -121.78 136.78 54.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 118.019 0.372 . . . . 65.51 110.157 -177.049 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.419 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -126.48 131.02 51.73 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.445 -0.946 . . . . 64.51 108.445 177.465 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 6.3 p -88.88 133.6 34.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.094 0.473 . . . . 72.03 112.167 -176.185 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.16 163.1 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.95 -1.5 . . . . 72.01 106.95 175.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 10.9 p-10 -78.29 137.32 38.02 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.047 0.451 . . . . 70.44 109.829 -175.146 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 8.2 m -97.94 108.23 45.14 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 115.544 -0.753 . . . . 65.24 112.157 -172.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 30.0 Cg_endo -90.92 -90.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 122.449 2.099 . . . . 72.41 110.332 172.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -84.18 -48.63 0.68 Allowed Pre-proline 0 N--CA 1.439 -1.008 0 C-N-CA 120.177 -0.609 . . . . 74.03 111.518 171.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.542 ' HA ' ' OE2' ' A' ' 533' ' ' GLU . 78.4 Cg_exo -58.74 134.1 58.36 Favored 'Trans proline' 0 C--N 1.374 1.918 0 CA-C-N 120.19 1.104 . . . . 63.41 110.488 169.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.46 116.26 3.87 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 123.192 0.308 . . . . 72.34 110.796 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.17 -15.16 35.03 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 121.997 0.776 . . . . 73.22 111.64 178.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.542 ' OE2' ' HA ' ' A' ' 530' ' ' PRO . 13.9 pt-20 -87.55 150.04 23.96 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 125.315 1.446 . . . . 74.43 110.939 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 553' ' ' LEU . 79.2 t -73.15 122.4 25.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 107.68 -1.23 . . . . 62.1 107.68 178.298 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.8 m -87.8 -24.68 23.67 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.007 -0.997 . . . . 74.44 110.593 -174.125 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.01 -163.28 37.02 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.906 -0.878 . . . . 64.42 110.906 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.9 p -140.7 160.22 40.51 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 72.52 107.964 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.45 -60.27 11.11 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 119.243 -0.408 . . . . 75.51 110.786 178.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.13 139.86 19.39 Favored 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 120.189 1.103 . . . . 72.54 109.265 172.323 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.12 153.94 52.0 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.976 1.784 . . . . 74.12 112.229 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.71 131.77 51.28 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.475 -0.565 . . . . 74.2 109.475 176.179 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.25 -5.77 36.12 Favored Glycine 0 C--N 1.299 -1.49 0 N-CA-C 110.464 -1.054 . . . . 45.14 110.464 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -88.41 125.33 34.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.517 -0.549 . . . . 54.4 109.517 174.37 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.1 m -101.6 123.49 45.69 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.426 -0.953 . . . . 74.22 108.426 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.31 164.49 42.95 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.636 -0.505 . . . . 62.03 109.636 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.5 Cg_exo -58.65 147.84 85.31 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.605 2.203 . . . . 75.3 111.436 176.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.544 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.2 m -66.86 -19.19 25.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.624 0.601 . . . . 61.53 112.624 -178.262 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.67 3.51 44.4 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.899 -0.591 . . . . 73.12 110.968 176.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.0 t -80.89 139.65 35.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.965 -0.754 . . . . 71.22 108.965 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.77 115.93 29.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.138 -0.689 . . . . 73.14 109.138 -179.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.4 tt -88.0 134.53 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.61 0.719 . . . . 64.13 111.039 -177.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.72 122.12 43.32 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 107.43 -1.322 . . . . 64.04 107.43 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 534' ' ' VAL . 7.6 tt -111.18 127.42 55.58 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.636 -1.165 . . . . 75.25 108.648 -175.138 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 5.7 mm-40 -92.41 109.53 20.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.963 -0.754 . . . . 73.33 108.963 -174.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.95 138.38 26.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 64.4 111.572 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 p -71.53 125.25 26.57 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.935 -1.505 . . . . 73.54 106.935 171.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 524' ' ' SER . 62.3 pttt . . . . . 0 C--O 1.264 1.867 0 CA-C-N 115.646 -0.706 . . . . 73.3 111.246 -172.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 480' ' ' ILE . 11.1 pt-20 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 122.014 0.912 . . . . 73.31 109.657 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -121.12 134.73 55.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.548 -1.279 . . . . 73.24 107.548 175.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -125.15 158.93 32.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.353 -0.61 . . . . 63.43 109.353 -176.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.64 142.49 30.76 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 123.715 0.806 . . . . 72.25 109.581 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -79.59 130.06 69.28 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 107.876 -1.157 . . . . 70.21 107.876 178.491 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 149.52 49.87 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.912 1.742 . . . . 73.03 111.967 178.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -114.9 72.96 0.81 Allowed 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 122.054 0.93 . . . . 74.55 110.355 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.6 4.67 5.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.119 -1.808 . . . . 73.41 106.119 175.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.01 -32.89 74.35 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 112.754 -2.021 . . . . 53.12 110.93 -176.403 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 t -61.44 -27.23 68.41 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.415 -0.812 . . . . 14.4 111.122 176.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.13 -46.32 15.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.159 -1.416 . . . . 72.42 110.416 -174.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 9.5 m -166.01 147.36 6.83 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.662 -0.866 . . . . 74.24 108.662 177.733 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.25 -45.54 65.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.954 0.902 . . . . 74.31 111.154 172.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.0 74.6 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.909 0.484 . . . . 73.21 110.869 178.069 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.568 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 12.2 mm-40 -66.29 -41.19 90.15 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.511 -0.768 . . . . 54.34 110.611 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.561 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.61 -50.12 75.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.913 -0.585 . . . . 64.31 110.407 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.56 -48.21 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.541 -0.754 . . . . 62.52 111.554 -176.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -60.95 -46.67 89.76 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.473 0.546 . . . . 74.23 112.473 -177.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.6 mptp? -67.38 -38.92 85.48 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 121.029 -0.269 . . . . 61.22 111.489 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -39.74 86.59 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.244 0.545 . . . . 74.15 109.889 178.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -59.4 -45.76 90.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.286 -0.87 . . . . 73.25 109.41 176.562 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.28 62.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.76 -0.654 . . . . 64.11 111.689 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -13.08 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 71.42 110.265 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.14 -16.1 25.22 Favored Glycine 0 CA--C 1.494 -1.253 0 C-N-CA 120.842 -0.694 . . . . 52.01 113.039 173.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.97 121.18 14.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.156 0.503 . . . . 74.34 111.035 -177.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.401 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -105.6 -2.73 40.48 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.411 -0.813 . . . . 44.33 111.6 178.331 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 9.4 mpt_? -120.85 114.93 22.31 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.202 0.525 . . . . 75.11 110.176 178.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -148.26 148.36 30.38 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.321 -0.854 . . . . 34.13 111.083 178.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -131.09 129.18 41.57 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.326 -0.99 . . . . 63.41 108.326 -178.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -93.33 124.82 37.58 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.417 0.448 . . . . 72.31 110.656 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 150.56 42.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.465 -1.309 . . . . 53.41 107.465 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.87 141.17 49.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.508 -0.923 . . . . 75.35 108.508 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 13.4 t -127.96 137.67 31.3 Favored Pre-proline 0 N--CA 1.416 -2.158 0 N-CA-C 109.007 -0.738 . . . . 32.34 109.007 -179.253 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 33.2 Cg_exo -64.97 123.66 11.93 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.488 2.125 . . . . 72.52 111.045 179.078 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 m -138.94 179.47 6.47 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.846 -1.539 . . . . 75.23 106.846 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 15.4 t -60.53 141.81 91.57 Favored Pre-proline 0 N--CA 1.422 -1.85 0 N-CA-C 108.385 -0.969 . . . . 51.51 108.385 175.331 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.85 -29.29 26.12 Favored 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 124.176 3.251 . . . . 72.21 113.721 -176.22 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -75.5 -13.97 60.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.708 0.632 . . . . 74.33 112.708 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.42 2.38 55.69 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 122.157 -0.34 . . . . 64.41 111.845 179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -60.75 128.43 21.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.258 0.551 . . . . 72.24 110.436 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.26 -12.94 67.61 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 120.834 -0.698 . . . . 75.33 111.774 178.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -98.76 139.97 33.65 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.369 -0.974 . . . . 65.31 108.369 177.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 60.7 t -82.27 138.89 18.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.119 -1.067 . . . . 64.14 108.119 176.406 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 32.3 pt -98.38 -29.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 120.033 -0.667 . . . . 74.34 111.227 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.82 168.76 40.89 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.345 -1.407 . . . . 62.02 112.502 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 34.2 p -117.64 143.32 46.26 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.27 -0.641 . . . . 63.4 109.27 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.3 t-20 -60.16 -49.77 89.28 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.578 0.584 . . . . 71.24 112.578 177.463 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.4 Cg_exo -81.97 144.59 13.61 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.03 1.153 . . . . 73.1 109.203 172.536 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 89.0 Cg_endo -72.55 145.01 41.32 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.34 2.026 . . . . 74.22 111.237 -179.446 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -79.86 -18.25 51.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.522 -0.763 . . . . 75.11 110.09 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -77.4 -27.44 52.42 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.931 -1.031 . . . . 75.15 113.019 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.0 mp0 -100.76 160.89 13.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.222 -1.029 . . . . 72.22 108.222 175.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.2 p -97.94 126.04 43.15 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 109.414 -0.587 . . . . 65.33 109.414 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 142.82 34.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.491 -0.929 . . . . 62.11 108.491 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -56.49 153.22 10.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.568 0.581 . . . . 65.03 112.568 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.2 mm -61.51 -30.02 47.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.434 0.635 . . . . 33.43 110.149 178.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 8.31 39.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 45.44 111.128 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.09 149.4 26.93 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.148 -1.056 . . . . 71.45 108.148 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.38 117.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.845 0.831 . . . . 71.21 111.382 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.1 t -92.44 119.92 40.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.359 -0.837 . . . . 52.03 109.545 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.61 116.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.766 -1.568 . . . . 74.13 106.766 175.724 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 126.16 58.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.715 -0.675 . . . . 63.45 109.327 -176.549 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 26.7 mt -104.49 115.61 46.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.776 -0.647 . . . . 74.42 110.224 -173.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.14 136.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.231 -0.655 . . . . 73.31 109.231 -177.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.43 124.67 6.56 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 109.096 -1.602 . . . . 72.44 109.096 175.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.5 m -135.31 140.78 45.39 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.138 -0.69 . . . . 62.54 109.138 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.866 0 C-N-CA 120.162 -1.018 . . . . 35.14 110.651 179.261 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.252 0 CA-C-O 122.081 0.944 . . . . 71.12 109.493 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.6 p -136.02 152.93 51.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.705 -1.134 . . . . 74.12 108.165 -177.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -141.22 153.4 45.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.085 -0.339 . . . . 74.25 110.085 177.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -93.91 138.54 31.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.123 -0.489 . . . . 63.3 110.128 179.083 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 31.0 pt -94.79 129.19 36.82 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 116.123 -0.49 . . . . 64.23 111.049 -179.066 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 5.3 Cg_exo -77.1 174.12 13.33 Favored 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.355 2.037 . . . . 73.54 110.779 172.396 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.97 128.86 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 70.43 111.123 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.45 -9.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.502 0.668 . . . . 71.2 110.275 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.56 136.23 47.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.514 -0.766 . . . . 72.25 112.142 -174.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.5 -16.1 29.33 Favored Glycine 0 CA--C 1.492 -1.363 0 C-N-CA 120.784 -0.722 . . . . 53.11 111.578 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.459 ' HB3' HG13 ' A' ' 507' ' ' VAL . 96.7 mt-30 -87.16 177.99 7.02 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 110.149 -0.315 . . . . 65.5 110.149 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.1 155.84 18.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.709 -1.219 . . . . 74.21 107.709 -177.068 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.69 -46.69 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.086 0.773 . . . . 64.12 113.086 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.85 -41.82 74.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.28 0.474 . . . . 74.3 112.28 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 503' ' ' GLN . 10.1 p -75.52 -34.4 29.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.608 -0.837 . . . . 74.33 110.737 -175.053 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.62 85.06 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.928 -1.033 . . . . 51.02 110.134 177.305 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.37 -35.99 82.68 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.084 -0.507 . . . . 71.4 111.456 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.76 -51.54 61.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.834 -0.346 . . . . 75.34 110.776 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.428 ' O ' HG12 ' A' ' 514' ' ' VAL . 9.3 m120 -68.3 -39.7 81.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.898 -0.592 . . . . 74.4 109.978 -177.689 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.59 -37.31 87.13 Favored 'General case' 0 C--O 1.181 -2.527 0 CA-C-N 116.277 -0.42 . . . . 75.11 110.142 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -58.94 -39.85 82.85 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.039 0.536 . . . . 62.52 111.535 -178.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 511' ' ' ASN . 7.7 p -74.18 -31.28 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 120.149 -0.62 . . . . 50.42 112.197 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.73 -33.76 9.72 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.982 0.896 . . . . 74.41 110.897 -175.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -92.74 -112.74 2.07 Favored Glycine 0 N--CA 1.416 -2.645 0 CA-C-N 114.301 -1.318 . . . . 61.4 113.933 -172.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 57.5 m-85 -130.61 175.97 8.57 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.759 -0.46 . . . . 74.1 109.759 -170.329 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 m -98.03 -25.71 14.86 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.233 -0.439 . . . . 72.21 112.076 -173.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.66 123.16 48.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.871 -0.732 . . . . 72.31 110.839 -177.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.74 146.09 34.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.153 -0.931 . . . . 63.42 109.867 -176.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.5 m -126.88 149.5 49.73 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.323 -1.732 . . . . 52.34 106.323 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.51 131.37 54.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.623 -0.51 . . . . 73.42 109.623 -174.117 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.3 52.27 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.969 -1.123 . . . . 71.33 107.969 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.7 m -103.45 129.35 50.56 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.854 0.359 . . . . 63.51 110.708 -176.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.0 m -122.47 156.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 116.109 -0.496 . . . . 74.43 110.145 178.115 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.95 142.48 27.76 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.755 . . . . 55.41 109.422 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 37.9 t -137.13 140.34 30.91 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 106.556 -1.646 . . . . 74.34 106.556 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.12 -72.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.815 2.343 . . . . 75.31 113.167 -176.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 529' ' ' ARG 0.285 30.9 mmt180 -116.47 -54.97 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.653 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 178.19 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.59 133.84 56.97 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.174 1.249 . . . . 61.45 110.855 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.93 4.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.698 -0.482 . . . . 71.44 109.698 -178.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.48 -25.52 2.98 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.439 -1.064 . . . . 74.1 110.439 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.63 150.27 23.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.633 0.773 . . . . 73.41 110.454 177.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.13 120.0 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 106.879 -1.526 . . . . 51.2 106.879 175.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 21.2 m -70.04 -27.59 64.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.976 -1.011 . . . . 75.02 109.851 -175.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.68 24.88 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 110.297 -1.121 . . . . 73.31 110.297 177.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.2 p -129.87 161.33 31.05 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 107.753 -1.203 . . . . 74.22 107.753 178.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.1 t-20 -61.64 -52.58 68.34 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 120.654 -0.418 . . . . 75.12 110.131 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_exo -79.85 127.35 6.99 Favored 'Trans proline' 0 C--N 1.364 1.351 0 N-CA-C 108.459 -1.4 . . . . 72.0 108.459 170.041 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.06 154.45 73.99 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.151 1.901 . . . . 65.12 112.229 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -52.03 132.6 32.85 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.078 0.551 . . . . 73.03 111.282 179.083 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.85 -25.29 21.24 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 111.05 -0.82 . . . . 74.3 111.05 -176.587 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.1 m -65.7 135.59 55.17 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.21 0.528 . . . . 72.22 110.73 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.7 m -94.97 123.61 38.54 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.239 -1.393 . . . . 65.12 107.239 177.485 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 517' ' ' PHE . 20.5 t -123.22 152.21 63.49 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 107.012 -1.477 . . . . 72.13 107.012 -176.743 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.9 Cg_exo -59.87 140.03 91.11 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 73.43 112.077 174.511 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 23.8 m -67.62 -21.34 27.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.397 0.617 . . . . 51.35 111.685 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -88.89 3.59 50.81 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.027 -0.988 . . . . 73.11 110.756 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -97.25 154.23 17.53 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.267 -0.642 . . . . 75.43 109.267 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.77 137.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.838 -0.801 . . . . 63.43 108.838 177.113 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.7 tp -93.16 129.89 43.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.48 -0.563 . . . . 73.05 109.48 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -103.0 116.57 32.8 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 122.798 0.439 . . . . 74.42 110.712 -176.408 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.31 134.28 39.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.323 -0.853 . . . . 65.35 111.111 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -96.97 108.51 21.25 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 63.14 107.529 178.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.67 138.37 29.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 120.428 0.156 . . . . 74.32 111.223 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.7 p -72.64 119.8 17.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.338 -0.615 . . . . 65.44 109.338 179.034 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 C--N 1.294 -1.836 0 CA-C-N 115.87 -0.605 . . . . 64.55 109.539 -177.033 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 122.032 0.92 . . . . 75.02 109.042 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.417 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 92.5 mt-30 -83.11 152.08 25.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.546 -1.206 . . . . 75.4 110.734 -176.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.496 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 13.7 tpp180 -127.56 157.62 39.66 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.458 -1.312 . . . . 54.11 107.458 177.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.45 141.55 31.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 123.588 0.555 . . . . 64.23 110.13 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.9 mp -79.66 130.83 66.3 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.097 -1.075 . . . . 75.45 108.097 177.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 30.5 Cg_exo -64.61 141.0 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.833 1.688 . . . . 74.35 112.314 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.59 9.01 43.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.583 -0.735 . . . . 75.35 110.362 -177.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.41 7.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.016 0.913 . . . . 74.25 110.656 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 3.2 p -60.72 -38.7 85.96 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 125.324 1.45 . . . . 64.32 110.514 177.449 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.1 t -60.7 -26.66 67.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.124 -0.943 . . . . 72.31 111.278 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 51.8 mt -81.88 -46.42 14.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.11 -0.636 . . . . 72.2 110.224 -174.562 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 21.0 m -167.94 150.21 5.56 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.819 -1.178 . . . . 74.13 107.819 177.514 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.37 -48.71 68.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 64.0 110.139 173.011 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.61 71.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.626 0.77 . . . . 75.12 112.094 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.4 mm-40 -61.68 -45.72 92.79 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.297 -0.411 . . . . 63.33 111.584 -178.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -66.62 -45.74 78.13 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.158 -0.474 . . . . 74.14 110.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.92 -47.53 89.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.832 0 O-C-N 123.822 0.701 . . . . 55.43 112.388 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.09 -47.42 86.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.617 0.246 . . . . 73.21 111.661 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.62 -42.31 86.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.218 -0.446 . . . . 73.21 111.408 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.65 -38.38 80.42 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 72.44 110.562 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 46.8 m -63.26 -42.5 99.17 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.865 -0.607 . . . . 72.54 109.578 175.848 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.11 -18.48 64.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.044 -0.526 . . . . 63.44 110.561 177.062 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.92 -13.96 58.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.04 0.448 . . . . 70.11 110.1 178.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.99 -14.05 26.46 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.851 -0.69 . . . . 64.11 112.991 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.59 130.08 41.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.71 0.291 . . . . 53.44 110.525 -178.321 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.38 11.11 6.81 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.236 -0.746 . . . . 42.12 111.236 178.035 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 451' ' ' ARG . 0.6 OUTLIER -111.04 115.43 29.44 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.052 -1.462 . . . . 52.45 107.052 -178.512 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -136.76 147.49 46.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.662 -0.415 . . . . 62.2 111.043 -174.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.401 ' HB2' HG13 ' A' ' 485' ' ' ILE . 14.6 mmmm -132.14 122.75 25.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.254 -1.387 . . . . 75.33 107.254 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -103.72 128.94 51.03 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.866 -0.42 . . . . 63.1 109.866 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -129.86 144.04 51.11 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.187 -1.412 . . . . 54.52 107.187 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.03 135.79 53.63 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.447 -0.946 . . . . 73.11 108.447 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.3 m -116.44 138.57 24.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.669 -0.863 . . . . 53.54 108.669 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.9 122.31 10.09 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.063 1.842 . . . . 61.52 110.416 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.473 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 25.1 t -143.66 -179.18 6.29 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 105.914 -1.884 . . . . 71.1 105.914 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.1 t -66.07 132.99 94.66 Favored Pre-proline 0 N--CA 1.416 -2.175 0 CA-C-O 121.071 0.462 . . . . 64.13 109.886 176.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.73 -28.51 30.29 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.917 3.078 . . . . 71.34 112.039 176.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.87 -17.33 63.06 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.738 -0.665 . . . . 71.13 112.103 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.65 13.39 19.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.177 -0.327 . . . . 73.51 111.698 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.9 p -57.47 128.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 42.44 111.572 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.47 -12.92 59.92 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.626 -0.797 . . . . 44.43 112.131 177.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -92.84 139.78 30.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.179 -0.675 . . . . 61.02 109.179 176.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 486' ' ' ILE . 61.5 t -82.47 134.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.992 -0.744 . . . . 72.02 108.992 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.0 pt -97.31 -7.41 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.251 -0.58 . . . . 73.51 110.73 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.72 167.81 25.86 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.656 -0.783 . . . . 53.32 111.651 175.686 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.5 p -120.43 149.47 42.33 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.893 -1.151 . . . . 74.11 107.893 176.402 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.8 t-20 -65.05 -52.94 45.3 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-O 119.248 -0.406 . . . . 73.23 111.079 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.6 Cg_exo -73.93 139.58 27.52 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 108.8 -1.269 . . . . 71.1 108.8 172.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.47 141.31 66.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.578 2.185 . . . . 65.0 112.63 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.32 -11.86 55.63 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.204 -0.907 . . . . 54.14 110.164 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -94.56 -24.77 17.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.934 -0.575 . . . . 63.34 111.458 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.86 174.16 5.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.08 -0.648 . . . . 73.23 109.538 177.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.417 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 19.1 p -101.18 144.33 30.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.967 -0.561 . . . . 55.15 109.776 178.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.3 m -127.85 148.8 50.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.708 -0.849 . . . . 73.05 108.708 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 152.29 42.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 110.061 -0.348 . . . . 70.43 110.061 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.03 -12.74 16.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.859 0.838 . . . . 74.22 111.213 -173.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -90.18 1.12 56.79 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.844 -0.616 . . . . 72.42 110.923 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.52 141.76 41.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.01 0.433 . . . . 71.02 111.977 -177.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.76 115.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.79 -1.189 . . . . 61.12 107.79 176.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.48 119.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.587 -0.845 . . . . 75.42 108.931 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.5 mp -99.4 123.23 51.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.239 -1.763 . . . . 71.03 106.239 175.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -115.38 123.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 109.327 -0.62 . . . . 74.45 109.327 -177.709 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -103.52 117.54 49.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 CA-C-O 121.76 0.79 . . . . 70.12 111.802 178.749 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 20.1 t -96.61 140.47 17.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.872 -1.058 . . . . 72.14 109.335 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.42 116.8 4.38 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.29 -1.524 . . . . 70.42 109.29 174.411 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -126.64 129.95 49.5 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 107.36 -1.348 . . . . 73.13 107.36 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.418 -2.526 0 C-N-CA 119.464 -1.35 . . . . 65.4 111.373 -178.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.874 0.845 . . . . 52.22 109.545 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 546' ' ' PRO . 14.5 p -137.94 157.55 46.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.693 -1.14 . . . . 64.4 108.735 -177.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.25 147.48 32.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.949 0.404 . . . . 71.2 110.652 178.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.6 p-10 -84.71 131.82 34.53 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.161 -0.927 . . . . 74.44 108.54 175.184 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.9 pt -76.47 134.7 69.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.712 -0.676 . . . . 73.14 110.843 -177.363 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.13 167.43 9.38 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.565 2.177 . . . . 74.42 109.778 173.088 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.02 141.88 28.34 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.631 -1.248 . . . . 74.34 107.631 176.65 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.62 13.84 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-O 121.986 0.898 . . . . 65.44 110.492 -174.073 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.58 147.52 29.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.398 -0.819 . . . . 71.21 111.649 -175.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 91.48 11.81 60.41 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 111.099 -0.8 . . . . 25.22 111.099 177.363 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.49 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 97.0 mt-30 -119.89 178.42 4.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.8 0.334 . . . . 75.21 111.831 -176.529 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.679 -1.23 . . . . 72.14 107.679 -176.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.05 -41.65 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 117.833 0.288 . . . . 54.23 111.381 -177.469 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.04 -42.51 80.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.549 0.574 . . . . 65.4 112.549 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 11.2 p -73.67 -34.94 42.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 118.98 -1.088 . . . . 72.44 110.16 -176.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.36 -49.9 72.06 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.941 -1.027 . . . . 51.4 111.157 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -65.13 -37.5 87.63 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.642 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -65.59 -53.6 39.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.107 0.41 . . . . 74.45 112.107 178.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -62.42 -39.0 91.86 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.078 0.466 . . . . 62.43 110.596 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.59 -47.66 62.77 Favored 'General case' 0 C--O 1.187 -2.192 0 CA-C-N 115.884 -0.598 . . . . 63.33 110.575 178.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.38 -41.19 98.79 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.448 0.536 . . . . 74.04 112.448 -176.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.05 -29.11 43.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.335 0.495 . . . . 52.22 112.335 -177.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.88 -26.37 6.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.204 -0.998 . . . . 73.02 111.798 -174.304 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.65 -98.92 2.38 Favored Glycine 0 N--CA 1.41 -3.065 0 CA-C-N 115.26 -0.882 . . . . 70.21 114.533 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 50.1 m-85 -133.68 160.11 38.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.761 0.315 . . . . 61.12 110.487 -167.728 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 p -103.63 -7.9 20.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.586 -0.734 . . . . 73.13 112.004 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.48 119.92 40.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.725 -0.472 . . . . 75.33 109.725 -176.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -126.3 153.47 44.77 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.595 0.712 . . . . 60.03 111.533 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.5 m -141.16 153.71 45.49 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.928 -1.508 . . . . 53.43 106.928 169.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -121.65 132.31 54.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 118.28 0.491 . . . . 74.41 110.956 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.14 136.14 53.44 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.068 -1.456 . . . . 63.51 107.068 174.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 25.9 m -98.53 133.49 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.948 0.404 . . . . 62.22 110.491 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.13 163.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.42 -0.955 . . . . 52.43 108.42 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.17 140.08 38.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.262 0.553 . . . . 70.24 110.213 -174.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.0 p -103.17 118.23 58.43 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.402 -0.817 . . . . 50.44 113.015 -172.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -80.62 -75.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.829 1.686 . . . . 74.54 109.226 172.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.549 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 28.7 mmm180 -107.79 -52.73 0.07 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.751 -0.642 . . . . 73.05 112.472 171.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.549 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 19.4 Cg_endo -62.81 134.21 45.74 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 120.644 1.266 . . . . 73.43 111.355 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.62 126.53 7.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.066 -1.087 . . . . 71.21 108.066 178.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.21 -29.33 7.72 Favored Glycine 0 C--N 1.308 -0.979 0 N-CA-C 111.372 -0.691 . . . . 55.14 111.372 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.93 149.78 26.84 Favored 'General case' 0 C--O 1.255 1.361 0 C-N-CA 123.232 0.613 . . . . 74.31 110.044 176.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.434 HG21 ' CB ' ' A' ' 508' ' ' ALA . 80.4 t -74.31 126.92 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.891 0 CA-C-O 121.527 0.68 . . . . 73.01 109.554 -173.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.6 m -92.15 -12.65 32.28 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.41 -1.268 . . . . 65.12 110.136 -175.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.73 -150.77 19.99 Favored Glycine 0 N--CA 1.425 -2.069 0 C-N-CA 120.1 -1.048 . . . . 65.15 112.815 174.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 17.9 p -118.16 161.5 19.77 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 124.591 1.156 . . . . 43.45 109.254 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.9 t-20 -61.33 -57.12 27.69 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 119.298 -0.382 . . . . 72.51 111.094 176.217 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.2 Cg_exo -83.41 156.29 14.38 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.224 1.282 . . . . 74.21 109.852 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.14 158.83 48.61 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.042 1.828 . . . . 71.11 112.196 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.89 133.81 54.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.204 0.601 . . . . 75.23 111.045 178.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.98 -19.64 32.4 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.805 -0.712 . . . . 51.12 111.676 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.0 m -65.56 123.84 20.76 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.676 -0.49 . . . . 53.41 109.676 177.343 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 41.6 m -94.03 123.81 37.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 120.954 0.407 . . . . 72.34 109.944 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.8 157.01 72.84 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 70.13 108.978 177.021 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.535 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.4 Cg_exo -58.7 146.01 93.71 Favored 'Trans proline' 0 CA--C 1.519 -0.24 0 C-N-CA 122.929 2.419 . . . . 64.05 111.619 177.408 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 32.4 m -66.75 -20.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.434 0.635 . . . . 75.21 111.767 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -91.11 3.85 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.345 -0.843 . . . . 61.2 111.38 176.396 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -83.06 152.06 25.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.939 -0.763 . . . . 74.11 108.939 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.58 119.2 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.02 -1.104 . . . . 71.32 108.02 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -89.83 141.64 14.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.189 0.518 . . . . 74.33 110.139 -177.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.0 121.78 43.25 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 121.618 0.723 . . . . 75.32 110.228 -176.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.7 134.54 39.83 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.207 1.403 . . . . 65.24 108.954 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -103.83 115.91 31.32 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.246 -0.888 . . . . 62.01 109.244 -177.352 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.18 129.83 75.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 116.107 -0.497 . . . . 72.4 111.061 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 68.2 m -74.52 116.67 15.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.347 -0.983 . . . . 62.04 108.347 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.446 -0.797 . . . . 64.23 108.955 -175.988 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.599 0.714 . . . . 74.44 110.023 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 78.2 mt-30 -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 114.95 -1.023 . . . . 74.21 110.577 -177.668 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -129.88 156.76 43.87 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.078 -1.082 . . . . 74.43 108.078 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.43 143.16 27.37 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.167 0.432 . . . . 72.31 112.167 -178.695 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 1.8 mp -77.53 130.67 73.38 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.875 -0.602 . . . . 65.32 111.413 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 75.0 Cg_exo -54.1 148.95 37.57 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.887 3.724 . . . . 73.21 115.524 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -94.64 -5.24 46.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.437 -0.801 . . . . 63.53 110.125 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.5 p -74.95 -5.99 7.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.256 1.027 . . . . 73.21 109.679 -176.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.61 -26.69 68.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.409 -1.268 . . . . 71.44 109.119 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.1 p -58.51 -27.67 64.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.816 -1.083 . . . . 64.35 111.341 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.6 mt -86.75 -47.35 9.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.709 -0.796 . . . . 74.23 110.978 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 25.6 m -167.01 150.17 6.5 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 109.533 -0.543 . . . . 74.14 109.533 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -51.63 -46.56 63.7 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.116 1.366 . . . . 73.03 111.199 174.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.21 85.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.998 -0.546 . . . . 64.04 111.277 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.69 -44.11 97.58 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.668 -0.696 . . . . 73.3 110.827 178.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -50.79 72.35 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.093 -0.958 . . . . 63.55 110.399 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -46.58 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.799 -0.637 . . . . 74.1 112.129 -176.727 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -63.31 -48.01 79.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.476 0.179 . . . . 60.12 110.984 -177.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -68.25 -39.47 82.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.071 -0.513 . . . . 74.33 111.63 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.524 HD23 ' CE2' ' A' ' 452' ' ' PHE . 28.9 tp -67.44 -37.49 83.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.223 0.535 . . . . 74.03 109.686 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 -44.13 95.94 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.326 -0.852 . . . . 71.34 109.722 175.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.76 62.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.606 -0.725 . . . . 72.24 111.442 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.91 -12.96 54.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 22.44 111.047 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.61 -18.74 10.74 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.536 -0.84 . . . . 73.2 112.693 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.506 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 81.5 m-85 -75.69 136.51 40.37 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.663 0.268 . . . . 75.41 110.301 -176.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -137.99 26.0 2.89 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.721 -0.951 . . . . 70.45 110.721 177.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -124.52 116.03 21.82 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.374 -1.343 . . . . 72.41 107.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.524 ' CE2' HD23 ' A' ' 444' ' ' LEU . 64.0 m-85 -130.18 146.5 51.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.301 0.572 . . . . 53.31 110.903 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.405 ' HB3' HG12 ' A' ' 485' ' ' ILE . 63.6 tttp -140.86 123.29 15.92 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.807 -1.553 . . . . 75.23 106.807 169.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.93 130.07 37.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.16 0.505 . . . . 74.41 111.306 -177.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -130.03 141.94 50.68 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.37 -1.344 . . . . 51.33 107.37 175.344 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.15 149.09 45.01 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.199 -0.601 . . . . 53.33 110.791 -177.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 56.0 m -132.49 134.27 24.62 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-N 115.475 -0.784 . . . . 62.23 108.889 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_exo -65.58 127.51 18.18 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.627 2.218 . . . . 73.31 112.243 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 38.6 m -146.94 -179.94 7.16 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 125.498 1.519 . . . . 72.23 107.077 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.4 t -50.51 114.56 4.67 Favored Pre-proline 0 CA--C 1.584 2.269 0 C-N-CA 124.135 0.974 . . . . 64.11 110.14 177.741 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.11 -28.91 34.8 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.736 3.624 . . . . 63.51 116.425 -171.511 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.97 -20.83 64.2 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.956 -0.698 . . . . 72.11 112.077 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -95.37 14.37 22.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.485 0.55 . . . . 73.11 112.485 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.09 128.09 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.386 0.613 . . . . 75.0 110.697 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.3 1.77 55.72 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.677 -0.692 . . . . 54.32 112.783 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.483 ' HD2' HD12 ' A' ' 463' ' ' LEU . 57.8 tttp -91.79 138.49 31.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.623 -1.251 . . . . 72.14 107.623 176.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 486' ' ' ILE . 50.7 t -82.96 124.82 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.212 -0.995 . . . . 73.22 108.39 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -99.51 -14.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 120.221 -0.592 . . . . 72.4 111.272 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.04 39.17 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.602 -0.809 . . . . 63.24 111.203 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.6 p -132.19 147.78 52.43 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.683 -0.858 . . . . 74.31 108.683 177.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.7 t-20 -64.02 -51.93 59.71 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 119.167 -0.444 . . . . 72.42 111.272 176.002 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.2 Cg_exo -74.12 145.18 34.76 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.334 1.356 . . . . 61.43 109.74 173.592 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.78 146.01 58.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.696 2.264 . . . . 65.44 112.995 -177.354 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -101.77 -9.7 20.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.544 -0.753 . . . . 72.51 110.196 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.475 -0.935 . . . . 70.42 108.475 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -117.77 175.56 5.6 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.164 -0.926 . . . . 71.44 108.531 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 27.4 p -88.3 148.74 24.15 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 116.648 -0.251 . . . . 62.25 111.592 -177.153 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.6 m -126.05 148.61 49.28 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.781 -1.192 . . . . 65.23 107.781 175.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 147.13 53.52 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-O 120.611 0.243 . . . . 34.32 111.331 -177.237 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.01 -28.14 41.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 75.5 111.311 179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.0 t -85.48 7.48 22.66 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.717 -0.674 . . . . 75.42 110.399 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.97 144.68 27.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.346 -0.613 . . . . 64.21 109.346 -177.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.68 111.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.346 -0.983 . . . . 74.44 108.346 179.171 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.22 118.23 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 C-N-CA 118.925 -1.11 . . . . 34.31 108.424 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.443 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 58.5 mt -100.43 113.94 37.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.345 -1.724 . . . . 70.41 106.345 176.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.46 128.12 52.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 CA-C-N 115.652 -0.703 . . . . 52.54 109.458 -174.706 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 30.9 mm -97.59 109.9 24.34 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-O 121.361 0.6 . . . . 71.42 109.484 -176.338 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.69 133.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.543 -0.753 . . . . 61.43 110.143 -177.215 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.71 115.91 4.91 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.146 -1.982 . . . . 65.54 108.146 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.0 m -127.44 160.39 31.61 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.084 -1.08 . . . . 63.33 108.084 -176.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.783 0 C-N-CA 119.207 -1.473 . . . . 70.3 111.064 -178.073 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.259 0 CA-C-O 121.938 0.875 . . . . 74.13 109.042 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -136.45 166.35 23.7 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.909 -1.041 . . . . 65.13 110.009 -174.064 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -150.6 151.05 31.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.142 0.977 . . . . 63.33 108.908 175.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -95.65 133.11 40.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.399 -1.334 . . . . 71.22 107.399 173.545 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 43.6 pt -84.32 134.84 42.27 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 120.534 -0.466 . . . . 73.4 111.638 -175.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.04 170.37 7.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.621 2.214 . . . . 75.41 111.509 175.765 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -85.61 133.13 34.06 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.933 -0.576 . . . . 75.31 110.638 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.71 13.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.63 -0.714 . . . . 61.31 110.526 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.76 137.47 40.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.099 -0.5 . . . . 43.33 110.703 -177.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.05 50.44 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.491 -1.044 . . . . 75.33 110.491 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.496 ' HB3' HG13 ' A' ' 507' ' ' VAL . 88.3 mt-30 -97.59 169.59 9.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 72.13 108.24 178.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 28.2 m -82.98 155.35 24.02 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.183 -1.043 . . . . 74.24 108.183 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 13.5 p -52.63 -41.38 37.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 123.488 0.715 . . . . 60.32 111.973 -177.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.19 -43.98 76.88 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.531 -0.468 . . . . 73.23 112.144 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 503' ' ' GLN . 12.6 p -77.08 -34.96 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 119.848 -0.741 . . . . 74.45 111.684 -176.378 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.22 84.57 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.033 -0.985 . . . . 52.3 111.205 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -63.73 -36.19 83.05 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.225 0.328 . . . . 70.22 110.502 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 91.1 mttt -65.02 -49.91 68.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.934 -0.575 . . . . 70.11 111.794 177.737 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.01 -41.45 86.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.468 -0.493 . . . . 70.53 110.328 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.85 -44.27 94.2 Favored 'General case' 0 C--O 1.195 -1.765 0 CA-C-N 115.839 -0.618 . . . . 74.1 110.124 -179.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.07 -37.83 78.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.54 0.57 . . . . 70.13 112.54 -178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 66.8 t -59.09 -36.78 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.442 0.464 . . . . 52.32 111.195 -178.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.05 -34.75 8.33 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.809 -0.756 . . . . 75.24 110.495 -177.14 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -94.99 -122.84 3.87 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.707 -1.133 . . . . 70.42 115.869 -170.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 19.0 m-85 -122.58 178.13 5.13 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.92 0.391 . . . . 65.33 110.07 -168.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.8 m -116.44 8.9 14.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.217 1.008 . . . . 71.31 109.301 178.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.86 115.27 29.77 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.99 -1.115 . . . . 75.4 107.99 178.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -125.96 151.72 46.63 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.215 0.531 . . . . 64.0 110.956 -175.373 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.0 m -141.55 153.39 44.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.537 -1.653 . . . . 52.41 106.537 170.181 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.46 135.78 52.69 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 118.268 0.485 . . . . 52.32 110.412 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.574 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -130.08 145.08 51.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.239 -0.652 . . . . 61.02 109.239 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 21.2 m -87.83 124.97 34.18 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.833 0.349 . . . . 73.24 111.394 -175.445 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.3 163.16 30.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.579 -0.897 . . . . 62.33 108.579 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.42 137.32 37.93 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.682 0.993 . . . . 61.44 113.682 -172.227 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.3 t -162.01 115.1 1.2 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.598 1.559 . . . . 75.45 106.852 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.03 -89.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.378 2.719 . . . . 44.32 115.793 -172.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 530' ' ' PRO . 57.3 mtt180 -86.33 -42.56 0.58 Allowed Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 113.547 0.943 . . . . 73.13 113.547 178.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 11.1 Cg_endo -57.17 133.91 60.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 120.502 1.215 . . . . 61.31 109.524 173.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.96 140.74 21.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.041 0.448 . . . . 74.41 110.704 -172.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.06 77.22 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.629 -0.714 . . . . 61.41 111.368 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 11.2 pt-20 -87.47 148.78 24.79 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.317 0.579 . . . . 64.12 110.94 177.418 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 76.9 t -75.2 122.18 28.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.33 -1.359 . . . . 75.13 107.33 176.416 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.4 m -98.33 -1.35 41.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.242 -0.89 . . . . 62.13 110.148 -174.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.69 -169.24 32.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.659 -0.576 . . . . 70.22 111.659 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.7 p -137.27 160.65 38.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.407 -0.96 . . . . 75.22 108.407 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.3 t30 -58.48 -56.87 31.0 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.429 -0.32 . . . . 70.21 111.45 177.439 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.7 Cg_endo -84.19 151.3 12.26 Favored 'Trans proline' 0 C--N 1.365 1.433 0 N-CA-C 108.954 -1.21 . . . . 71.33 108.954 174.143 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.63 148.76 53.94 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.644 1.563 . . . . 73.32 111.658 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.08 129.48 41.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.262 -0.426 . . . . 71.34 110.061 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -15.12 37.33 Favored Glycine 0 C--N 1.301 -1.375 0 C-N-CA 120.884 -0.674 . . . . 45.53 112.05 -177.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.5 m -81.08 134.82 35.72 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 110.036 -0.357 . . . . 43.23 110.036 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 85.3 m -90.65 123.32 34.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.879 -0.6 . . . . 74.3 109.799 177.659 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.69 158.7 67.1 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.49 ' HA ' HG22 ' A' ' 494' ' ' THR . 24.5 Cg_exo -65.33 146.63 86.32 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.514 2.143 . . . . 75.12 112.118 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 19.1 m -67.7 -19.89 25.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.379 1.085 . . . . 72.3 110.027 177.235 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.32 -17.26 60.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.918 -1.492 . . . . 72.24 109.481 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.5 t -86.61 142.11 28.5 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.412 -0.813 . . . . 50.22 108.93 -176.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.36 126.28 44.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.506 -1.294 . . . . 73.54 107.506 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.87 137.95 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.266 0.555 . . . . 72.2 111.121 -176.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.74 119.93 39.55 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 108.91 -0.774 . . . . 72.12 108.91 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -99.32 124.1 44.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.985 -1.461 . . . . 72.14 107.936 -177.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.574 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 4.1 mm-40 -90.13 108.51 19.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.505 0.669 . . . . 73.12 110.128 -175.63 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.99 140.56 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.737 -1.12 . . . . 72.33 111.856 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 40.1 m -56.24 127.89 33.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.666 0.746 . . . . 72.12 112.521 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 77.6 tttt . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.959 -1.126 . . . . 74.42 107.959 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.4 0 N-CA-C 110.82 -0.912 . . . . 43.05 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.45 168.46 24.24 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.96 2.44 . . . . 55.23 112.008 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 425' ' ' GLU . 0.1 OUTLIER -83.41 -7.75 59.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.69 1.233 . . . . 73.4 108.637 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 54.3 mt-30 -94.48 140.11 30.26 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.33 -1.759 . . . . 72.42 108.949 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpp180 -120.87 152.35 38.55 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.827 -1.175 . . . . 73.12 107.827 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.36 140.88 32.16 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 124.091 0.87 . . . . 64.13 109.775 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -89.98 122.76 67.46 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 109.33 -0.619 . . . . 54.01 109.33 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.45 141.14 94.94 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.597 2.198 . . . . 70.12 112.581 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.41 24.13 4.12 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.35 -0.841 . . . . 73.1 110.891 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.5 -7.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.047 0.927 . . . . 74.33 109.024 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 13.2 m -62.74 -36.32 82.66 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.472 -1.24 . . . . 73.12 110.097 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 18.1 p -62.11 -26.6 68.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.25 -1.341 . . . . 70.11 110.839 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.9 mt -83.71 -44.62 14.29 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.041 -0.527 . . . . 63.21 110.586 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 438' ' ' ALA . 22.3 m -160.87 145.61 14.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.671 -0.492 . . . . 74.41 109.671 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -54.92 -42.37 72.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.478 0.711 . . . . 71.41 110.92 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 436' ' ' THR . . . -57.55 -44.39 85.16 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.888 -0.596 . . . . 63.21 110.579 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.66 -43.61 98.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.369 -0.832 . . . . 55.4 111.256 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.76 -51.73 68.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.443 -0.799 . . . . 62.12 110.978 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.1 -47.55 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.869 -0.605 . . . . 60.04 112.333 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -64.78 -47.15 79.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.7 -0.4 . . . . 61.43 111.65 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.89 -40.33 83.51 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.633 -0.427 . . . . 71.14 111.984 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.508 HD23 ' CE2' ' A' ' 452' ' ' PHE . 19.4 tp -68.89 -33.64 74.11 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.363 0.601 . . . . 73.3 110.261 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.6 m -64.06 -41.63 97.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.62 -0.718 . . . . 72.33 109.59 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.57 62.79 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.798 -0.637 . . . . 74.1 110.82 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.4 -13.47 52.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.063 0.459 . . . . 74.13 110.077 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.77 -2.36 27.43 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.567 -0.825 . . . . 75.13 113.844 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 95.6 m-85 -83.56 136.49 34.23 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 117.303 0.552 . . . . 62.42 111.671 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.21 4.82 4.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.549 -0.751 . . . . 73.12 112.451 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.436 ' NE ' ' HB ' ' A' ' 483' ' ' VAL . 77.2 ttt180 -111.29 115.56 29.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.702 -0.851 . . . . 75.34 108.702 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.508 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.2 m-85 -130.82 156.9 44.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.024 -0.534 . . . . 74.43 111.12 -173.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 485' ' ' ILE . 27.5 tptp -139.41 121.82 16.09 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 104.615 -2.365 . . . . 74.01 104.615 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -110.65 135.19 51.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.744 0.307 . . . . 71.41 111.397 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.3 156.56 46.4 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.987 -1.116 . . . . 65.23 107.987 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -136.09 143.06 44.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.22 107.732 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 27.8 m -130.99 139.19 34.83 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 109.501 -0.555 . . . . 63.52 109.501 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 35.8 Cg_exo -64.41 123.07 11.21 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.292 1.995 . . . . 74.44 110.326 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 68.0 m -151.81 -179.51 7.52 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.087 -1.079 . . . . 53.54 108.087 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.475 ' HA ' ' HD2' ' A' ' 461' ' ' PRO . 2.8 t -33.97 108.53 0.32 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 125.787 1.635 . . . . 61.03 112.625 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 460' ' ' THR . 16.3 Cg_endo -56.33 -29.75 78.06 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 124.139 3.226 . . . . 52.14 115.274 -173.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -71.98 -6.91 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.583 0.586 . . . . 75.03 112.583 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 78.8 mt -111.3 13.81 21.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.006 0.432 . . . . 60.41 110.936 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.82 133.62 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.826 -0.625 . . . . 55.21 112.008 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.86 79.55 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 121.037 -0.602 . . . . 70.33 113.793 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 434' ' ' THR . 11.1 pttp -101.67 162.26 13.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.761 -1.2 . . . . 73.41 107.761 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 53.3 t -81.46 133.21 29.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.851 -1.166 . . . . 71.14 107.851 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.6 pt -102.11 -6.73 9.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.593 -0.443 . . . . 65.13 110.819 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.5 143.69 4.05 Favored Glycine 0 N--CA 1.423 -2.224 0 C-N-CA 120.237 -0.983 . . . . 74.41 112.864 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.4 p -119.35 147.46 44.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.837 -1.171 . . . . 73.33 107.837 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 4.7 m-20 -66.49 -51.38 42.2 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 119.394 -0.336 . . . . 73.22 111.595 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 24.4 Cg_exo -71.12 127.81 13.99 Favored 'Trans proline' 0 C--N 1.361 1.223 0 N-CA-C 108.012 -1.572 . . . . 64.34 108.012 169.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 6.1 Cg_exo -75.27 158.22 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.893 1.729 . . . . 55.44 113.102 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.08 -17.0 51.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.842 0.829 . . . . 43.22 109.981 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -96.87 -25.92 15.27 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.389 -0.823 . . . . 64.53 111.537 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.11 156.68 17.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.889 -0.411 . . . . 73.35 109.889 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.5 p -90.57 140.83 29.38 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.183 -0.673 . . . . 70.02 109.183 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.1 m -126.7 142.6 51.49 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.752 -0.832 . . . . 60.44 108.752 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.43 140.17 57.35 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.226 -0.657 . . . . 53.03 109.226 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 427' ' ' ARG . 59.6 mt -72.21 -9.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.98 0.895 . . . . 70.03 111.616 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -81.94 -3.29 53.96 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.613 -0.721 . . . . 73.14 109.185 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.43 147.38 28.78 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 121.983 -0.448 . . . . 73.04 110.644 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.436 ' HB ' ' NE ' ' A' ' 451' ' ' ARG . 5.1 p -85.66 124.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.837 -1.171 . . . . 73.32 107.837 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 444' ' ' LEU . 60.1 t -87.94 118.12 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.285 -0.966 . . . . 75.14 108.588 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -94.65 115.11 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.785 -1.561 . . . . 75.31 106.785 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.06 124.18 69.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.24 -0.891 . . . . 52.51 109.377 -176.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.59 123.17 61.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.303 -0.628 . . . . 73.33 109.303 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.21 141.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.314 -0.624 . . . . 42.35 109.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -76.92 113.51 3.8 Favored Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.526 -1.429 . . . . 75.01 109.526 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -102.19 130.04 48.73 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.618 -0.512 . . . . 71.03 109.618 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -114.59 99.73 0.96 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 109.024 -1.63 . . . . 50.24 109.024 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.41 156.87 32.83 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.488 2.125 . . . . 45.23 112.427 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.03 109.95 21.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.171 -1.418 . . . . 65.42 107.171 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.8 p -119.89 151.26 39.16 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.167 -0.924 . . . . 71.44 109.738 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 495' ' ' LYS . 21.8 mmmt -146.65 149.47 33.56 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.114 0.483 . . . . 64.33 111.432 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 543' ' ' THR . 9.1 p-10 -82.6 134.48 35.18 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.381 -1.281 . . . . 74.34 107.602 173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 540' ' ' PRO . 0.2 OUTLIER -75.62 122.73 87.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 119.622 -0.831 . . . . 62.3 109.091 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.9 170.53 9.87 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.403 2.069 . . . . 53.24 112.712 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.02 116.62 29.08 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.817 -0.629 . . . . 65.11 109.948 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.84 17.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 122.621 1.2 . . . . 60.42 107.942 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 147.55 48.57 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.325 -1.307 . . . . 63.3 109.45 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.13 -6.48 53.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 111.363 -0.695 . . . . 34.01 111.363 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -114.47 177.28 4.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.011 -0.737 . . . . 72.53 109.011 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.3 m -77.47 156.35 31.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.248 -0.649 . . . . 72.22 109.248 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.62 -44.03 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 123.448 0.468 . . . . 72.54 111.598 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.3 -42.68 79.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.031 0.382 . . . . 72.44 112.031 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.07 -35.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.651 -0.819 . . . . 40.52 111.121 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.45 81.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.698 -0.683 . . . . 61.1 111.094 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.66 -38.22 84.15 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.395 0.434 . . . . 74.41 110.538 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.1 tttm -63.7 -52.01 62.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.654 -0.703 . . . . 61.43 110.27 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -65.02 -41.61 95.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.899 0.38 . . . . 62.43 110.969 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.25 -39.39 89.47 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.616 -0.72 . . . . 64.31 109.762 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.02 -41.57 88.07 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.186 0.594 . . . . 71.23 112.427 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.1 t -59.02 -35.35 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 55.25 111.088 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -112.28 4.31 17.64 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.024 -0.67 . . . . 74.34 111.398 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.93 -100.25 0.29 Allowed Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 118.036 -2.031 . . . . 61.22 117.625 -168.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 60.9 m-85 -120.08 161.47 20.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.404 -0.398 . . . . 72.12 111.295 -164.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 m -119.01 -13.96 9.39 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.527 0.68 . . . . 64.32 110.782 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -107.97 115.49 30.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.422 -0.955 . . . . 54.25 108.422 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -120.97 156.64 31.67 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.542 0.687 . . . . 71.24 111.318 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.7 m -139.99 155.75 46.96 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.518 -1.66 . . . . 75.22 106.518 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -121.28 138.46 54.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.038 0.447 . . . . 74.12 110.007 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.94 131.75 56.05 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.545 -0.909 . . . . 43.45 108.545 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 36.1 m -88.61 123.17 32.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.572 0.545 . . . . 73.23 109.677 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 35.3 m -121.61 162.64 20.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.768 -1.197 . . . . 73.23 107.768 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 11.1 m-20 -78.06 133.3 37.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.095 0.474 . . . . 75.15 110.79 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 11.0 m -95.95 105.42 21.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.732 -1.122 . . . . 54.05 111.563 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 2.4 Cg_endo -81.16 -77.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 121.701 1.6 . . . . 61.42 109.506 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.447 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 48.8 mmm-85 -95.24 -58.47 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 120.325 -0.55 . . . . 75.44 109.892 173.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 527' ' ' SER . 36.6 Cg_endo -65.34 144.62 80.97 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.945 1.763 . . . . 72.34 112.309 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -151.37 132.73 14.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.837 -0.801 . . . . 63.24 108.837 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.86 -24.66 5.79 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-O 121.922 0.735 . . . . 65.52 112.075 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.15 150.38 24.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 C-N-CA 124.372 1.069 . . . . 73.34 111.492 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.18 128.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.081 -0.963 . . . . 74.23 110.018 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -92.25 -22.23 19.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.255 -1.339 . . . . 61.04 109.733 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.96 33.67 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.156 -0.777 . . . . 61.02 111.156 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.9 p -117.94 160.33 21.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.643 -0.873 . . . . 61.14 108.643 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -64.13 -58.5 14.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.338 -0.363 . . . . 41.03 111.035 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.49 148.81 43.32 Favored 'Trans proline' 0 C--N 1.373 1.862 0 N-CA-C 109.17 -1.127 . . . . 62.23 109.17 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.471 ' O ' HD11 ' A' ' 497' ' ' ILE . 32.1 Cg_exo -60.46 140.06 89.58 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.069 1.846 . . . . 54.2 110.661 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.39 131.94 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.618 0.367 . . . . 73.11 110.847 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.22 40.7 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.363 -0.922 . . . . 74.25 112.274 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 60.3 m -67.44 126.47 29.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.144 -0.687 . . . . 74.31 109.144 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.2 m -94.33 122.86 37.32 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.942 -0.762 . . . . 63.54 108.942 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.03 161.0 66.37 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.282 -0.636 . . . . 75.22 109.282 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 494' ' ' THR . 49.7 Cg_exo -58.83 134.93 63.59 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.468 2.112 . . . . 62.4 111.355 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.517 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 20.0 m -65.94 -19.85 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.244 0.545 . . . . 62.14 111.263 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -77.67 -10.27 59.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.647 -0.706 . . . . 62.22 111.516 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.0 t -85.39 161.13 19.58 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 64.41 108.922 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.32 130.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.012 0.434 . . . . 74.05 111.278 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.9 tt -101.6 132.84 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.071 0.462 . . . . 45.4 110.011 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.59 127.45 51.01 Favored 'General case' 0 N--CA 1.399 -2.999 0 N-CA-C 108.73 -0.841 . . . . 51.1 108.73 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.5 tp -104.19 133.58 48.88 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.944 -1.025 . . . . 74.51 108.854 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -94.46 109.23 21.12 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.708 -1.219 . . . . 72.01 107.708 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.71 138.51 44.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 121.177 0.513 . . . . 54.22 112.187 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -68.09 114.95 7.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.722 -0.844 . . . . 43.54 108.722 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 61.9 pttt . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 115.802 -0.636 . . . . 62.23 110.702 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 110.338 -1.105 . . . . 43.05 110.338 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -71.12 152.19 61.99 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.455 2.103 . . . . 70.24 111.222 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 480' ' ' ILE . 12.4 pt-20 -87.93 14.46 8.85 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.77 0.319 . . . . 73.3 111.491 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 478' ' ' SER . 68.6 mt-30 -90.84 119.14 30.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.291 -0.564 . . . . 65.53 110.018 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -120.18 160.24 23.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.462 -1.31 . . . . 71.54 107.462 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -86.09 141.39 29.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.385 0.428 . . . . 61.21 111.4 -177.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.1 130.72 68.63 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.597 -0.89 . . . . 72.31 108.597 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.34 142.93 78.54 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.319 2.68 . . . . 74.32 114.426 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.46 -7.5 50.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.314 -0.857 . . . . 75.55 111.091 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 32.4 m -80.38 1.05 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.6 0.714 . . . . 60.12 110.801 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.3 m -63.77 -28.05 69.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.091 -0.959 . . . . 42.24 109.476 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -62.07 -28.4 69.58 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.587 -1.188 . . . . 72.52 111.186 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 63.9 mt -83.37 -45.27 13.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.089 -0.505 . . . . 53.33 110.572 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.521 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.5 m -165.69 149.06 7.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.655 -0.869 . . . . 65.13 108.655 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.08 -45.41 75.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.407 0.683 . . . . 71.21 110.655 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 442' ' ' LYS . . . -55.41 -44.7 76.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.038 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.521 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 31.2 mm-40 -64.32 -37.89 89.1 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.014 -0.539 . . . . 74.42 110.935 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.79 -51.33 68.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 73.31 110.477 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.41 -46.03 97.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.221 -0.9 . . . . 73.31 112.309 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 438' ' ' ALA . 15.8 ptpt -63.03 -44.55 95.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.561 0.22 . . . . 74.25 111.319 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.34 -38.44 84.85 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.04 0.385 . . . . 72.01 112.04 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.1 tp -68.53 -34.26 75.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.516 0.674 . . . . 74.04 109.938 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.2 m -65.66 -40.74 92.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.418 -0.81 . . . . 73.04 109.305 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -16.57 62.71 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.315 0.578 . . . . 72.01 110.419 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.78 -14.14 49.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.222 0.534 . . . . 61.33 109.589 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.39 50.16 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.884 -0.674 . . . . 64.25 113.616 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.0 m-85 -92.29 121.36 33.72 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.177 0.489 . . . . 62.21 110.123 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.21 5.02 21.87 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 111.197 -0.761 . . . . 73.1 111.197 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -102.86 116.46 32.6 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.326 -0.62 . . . . 74.51 109.326 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.439 ' CE2' HD23 ' A' ' 444' ' ' LEU . 73.8 m-85 -130.4 144.79 51.61 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.281 0.563 . . . . 73.12 111.075 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.489 ' HB3' HG13 ' A' ' 485' ' ' ILE . 22.3 tptm -131.02 121.84 25.75 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.897 -2.26 . . . . 73.32 104.897 167.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -105.32 134.99 47.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.695 -0.483 . . . . 63.34 109.695 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.93 150.32 44.4 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.695 -0.854 . . . . 71.12 108.695 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -125.73 148.74 48.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.762 -1.199 . . . . 73.11 107.762 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.2 m -143.17 144.79 30.0 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 109.115 -0.698 . . . . 74.24 109.115 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.4 Cg_exo -65.44 123.05 10.91 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.608 2.206 . . . . 51.04 112.571 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.8 t -137.17 -179.13 5.54 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.699 -1.963 . . . . 74.13 105.699 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.46 ' CG2' HD23 ' A' ' 463' ' ' LEU . 6.9 t -61.88 141.64 95.3 Favored Pre-proline 0 N--CA 1.423 -1.791 0 N-CA-C 109.944 -0.391 . . . . 53.3 109.944 178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.76 -29.66 34.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.108 3.205 . . . . 74.14 112.32 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.05 -20.65 65.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.999 0.74 . . . . 73.3 112.999 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.46 HD23 ' CG2' ' A' ' 460' ' ' THR . 4.5 mm? -106.33 11.47 30.97 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.107 -0.371 . . . . 75.12 111.964 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.92 128.99 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.156 0.503 . . . . 74.33 111.419 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.29 -9.58 77.01 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.655 -0.783 . . . . 73.43 112.49 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.423 ' HD2' HD13 ' A' ' 463' ' ' LEU . 68.1 mttm -100.55 155.35 17.9 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.175 -1.046 . . . . 74.31 108.175 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.577 HG22 HD11 ' A' ' 486' ' ' ILE . 53.7 t -81.96 129.75 36.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.901 -1.148 . . . . 70.23 107.901 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.2 pt -98.55 -16.04 7.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.42 -0.512 . . . . 74.52 110.799 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 176.32 149.1 7.36 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.675 -0.693 . . . . 73.31 111.738 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.3 p -116.82 152.85 33.56 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.606 -1.257 . . . . 73.35 107.606 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.1 t-20 -68.03 -51.94 25.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 C-N-CA 120.502 -0.479 . . . . 74.01 110.714 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.9 Cg_exo -79.13 130.59 9.38 Favored 'Trans proline' 0 C--N 1.371 1.751 0 N-CA-C 107.952 -1.595 . . . . 52.3 107.952 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 7.2 Cg_exo -69.88 157.15 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.791 1.661 . . . . 62.42 112.845 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.19 -6.75 57.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.358 1.075 . . . . 72.15 109.109 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 -40.32 14.29 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.14 -1.391 . . . . 75.24 111.048 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.77 167.13 10.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 71.0 110.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 p -101.57 133.56 46.06 Favored 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 108.708 -0.849 . . . . 74.23 108.708 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.2 m -118.9 148.6 42.75 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.379 -0.6 . . . . 65.33 109.379 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.25 51.78 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.282 0.364 . . . . 63.33 111.403 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.8 mm -57.7 -28.51 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.708 1.203 . . . . 74.41 111.147 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.1 t -76.56 -7.36 55.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.73 -0.668 . . . . 62.24 110.876 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -86.99 142.22 28.1 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 122.074 -0.391 . . . . 54.24 110.435 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.96 126.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.786 -0.82 . . . . 74.22 108.786 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.19 119.37 36.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.137 -0.69 . . . . 43.24 109.137 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.9 mp -92.94 119.65 40.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.182 -1.414 . . . . 72.14 107.182 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.577 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -117.06 125.91 74.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 109.53 -0.545 . . . . 74.1 109.53 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.43 119.18 52.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.538 -0.542 . . . . 71.24 109.538 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.21 144.12 10.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.98 -0.748 . . . . 60.33 108.98 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -77.71 122.21 6.0 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 111.823 -0.511 . . . . 55.34 111.823 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.9 t -118.45 131.93 56.25 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.16 -1.793 . . . . 63.22 106.16 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -115.08 136.08 12.84 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.672 -1.251 . . . . 72.35 111.12 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.9 122.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.318 2.012 . . . . 55.23 111.247 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.86 102.4 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.864 -1.532 . . . . 71.43 106.864 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.6 p -125.21 152.79 44.07 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.88 -0.6 . . . . 75.24 110.119 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -133.67 135.6 44.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.31 -0.405 . . . . 44.32 109.939 -177.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.7 p-10 -83.28 130.54 35.08 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.454 -0.943 . . . . 34.55 108.454 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.8 pt -81.52 131.99 56.62 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 115.991 -0.55 . . . . 62.31 110.423 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -84.36 152.62 12.16 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.518 2.145 . . . . 72.53 112.111 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.56 101.22 2.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.533 0.683 . . . . 73.34 109.95 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.06 1.81 8.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.278 -0.874 . . . . 71.33 109.484 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -67.85 122.95 19.25 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.999 -1.0 . . . . 64.35 110.679 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.94 -29.73 3.87 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.607 -0.597 . . . . 60.45 111.607 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -88.87 -175.48 4.88 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.109 -0.701 . . . . 73.45 109.109 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 70.0 p -80.49 157.38 26.17 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.637 -0.825 . . . . 43.32 110.644 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.01 -41.6 80.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.452 0.644 . . . . 53.21 109.333 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.71 -43.28 89.57 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.259 -0.882 . . . . 64.05 112.504 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.58 -34.68 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 119.945 -0.702 . . . . 45.21 110.585 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.12 77.94 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.803 -0.635 . . . . 75.14 110.834 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.24 -41.74 97.41 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.638 0.586 . . . . 63.45 110.203 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 514' ' ' VAL . 56.0 mtmt -65.16 -51.73 59.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 113.203 0.816 . . . . 62.02 113.203 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -63.48 -40.93 98.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.912 0.386 . . . . 73.04 110.725 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 551' ' ' ILE . 59.0 tp -66.53 -39.51 88.64 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 115.626 -0.716 . . . . 64.21 110.796 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.77 -37.66 87.51 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.891 0.377 . . . . 73.24 110.654 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 510' ' ' LYS . 47.7 t -69.16 -30.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.965 -0.561 . . . . 51.34 111.476 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.92 18.83 7.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 120.201 -0.6 . . . . 71.32 111.748 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -150.06 -110.75 0.53 Allowed Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 118.869 -1.634 . . . . 72.32 115.135 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.27 164.25 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.373 -0.414 . . . . 71.03 110.214 -168.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -105.57 -7.98 18.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.426 -0.806 . . . . 75.23 109.916 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.71 119.27 33.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 74.21 111.544 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.79 155.95 42.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.149 -0.932 . . . . 71.11 109.711 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 72.7 m -135.03 148.18 49.86 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.135 -1.432 . . . . 65.1 107.135 170.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -122.23 128.2 50.87 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.264 -0.643 . . . . 53.12 109.264 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -119.75 131.48 55.37 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.319 -0.993 . . . . 54.21 108.319 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -88.69 126.69 35.43 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.447 0.641 . . . . 52.12 111.425 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.02 162.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.228 -1.397 . . . . 72.33 107.228 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 557' ' ' LYS . 5.9 p-10 -79.36 129.26 34.29 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.795 0.807 . . . . 71.3 112.426 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 556' ' ' SER . 10.9 p -92.94 122.25 64.11 Favored Pre-proline 0 N--CA 1.416 -2.152 0 CA-C-N 114.272 -1.331 . . . . 75.15 108.712 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.82 -67.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.472 2.114 . . . . 64.1 111.882 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -136.1 -52.08 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 123.704 0.802 . . . . 74.42 109.473 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 20.4 Cg_endo -63.6 150.14 89.21 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.215 1.276 . . . . 75.14 110.196 168.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.62 139.89 16.63 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.469 -0.567 . . . . 61.2 109.469 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.64 10.92 Favored Glycine 0 C--O 1.242 0.607 0 C-N-CA 120.905 -0.665 . . . . 52.25 111.775 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 533' ' ' GLU . 0.4 OUTLIER -87.14 147.02 25.81 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.933 0.397 . . . . 63.01 110.626 177.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 501' ' ' ALA . 7.9 p -77.62 122.71 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 108.219 -1.03 . . . . 74.41 108.219 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.41 -25.59 59.56 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.296 -0.865 . . . . 54.14 109.571 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.79 -156.3 26.8 Favored Glycine 0 N--CA 1.424 -2.115 0 N-CA-C 110.299 -1.12 . . . . 73.13 110.299 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.0 p -130.0 160.54 33.32 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.379 -0.971 . . . . 72.44 108.379 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.58 -56.35 36.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 123.461 0.476 . . . . 74.21 110.751 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.26 146.92 28.82 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.009 1.139 . . . . 71.32 109.96 170.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -73.3 156.07 50.98 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.363 2.042 . . . . 44.31 112.465 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.8 136.99 58.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.075 0.55 . . . . 74.21 111.351 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -17.45 56.52 Favored Glycine 0 C--N 1.312 -0.765 0 C-N-CA 120.85 -0.69 . . . . 32.04 112.004 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.5 m -71.54 132.48 44.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -99.25 122.77 42.88 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.023 -1.103 . . . . 71.53 108.023 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.85 154.95 73.53 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.486 -0.931 . . . . 74.11 108.486 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.492 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.8 Cg_exo -59.91 141.99 97.65 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.229 1.952 . . . . 73.1 111.621 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.8 -19.28 25.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 121.797 0.808 . . . . 60.42 111.575 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -87.31 2.73 49.34 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.982 -1.008 . . . . 74.12 109.541 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -103.45 149.06 25.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.351 -0.84 . . . . 33.32 108.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.36 130.13 42.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.008 0.433 . . . . 72.14 110.721 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.444 HD13 HD21 ' A' ' 512' ' ' LEU . 12.1 tt -95.38 130.84 43.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 74.12 110.6 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.99 121.7 43.1 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.209 0.528 . . . . 70.24 110.581 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.04 133.76 39.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.824 -1.08 . . . . 53.54 110.087 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.407 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 12.4 mm-40 -90.18 109.57 20.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.523 -1.658 . . . . 75.33 106.523 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.47 133.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.119 0.414 . . . . 74.15 112.119 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 527' ' ' SER . 14.5 m -70.47 114.48 8.62 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.247 -1.39 . . . . 71.54 107.247 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 526' ' ' ASP 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 117.903 -1.519 . . . . 71.22 111.77 -176.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.255 0 N-CA-C 110.232 -1.147 . . . . 44.52 110.232 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.88 148.94 25.63 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.722 1.615 . . . . 64.34 111.693 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.97 11.1 14.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 73.13 110.379 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 91.9 mt-30 -83.37 126.92 33.23 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.463 -1.31 . . . . 64.44 107.463 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -130.05 162.32 29.02 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.845 -1.169 . . . . 64.35 107.845 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.32 141.53 29.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.257 0.465 . . . . 62.02 112.257 -173.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -82.39 129.2 64.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 107.285 -1.376 . . . . 65.12 107.285 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.34 141.19 96.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.056 1.837 . . . . 75.13 112.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -94.24 4.17 54.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.862 -0.608 . . . . 73.12 109.809 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.529 HG21 ' HD2' ' A' ' 443' ' ' LYS . 35.2 m -75.96 -2.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.201 -0.909 . . . . 70.5 109.955 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 15.1 m -60.52 -33.64 72.93 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.441 -1.254 . . . . 73.54 110.181 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.407 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.3 t -64.91 -25.61 67.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.051 -0.977 . . . . 72.42 110.607 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.8 mt -81.4 -45.74 15.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.691 -0.404 . . . . 75.41 110.279 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 438' ' ' ALA . 58.9 m -163.37 142.33 8.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.707 -0.849 . . . . 72.44 108.707 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.417 ' HA ' HG23 ' A' ' 467' ' ' VAL . 25.9 t80 -54.75 -45.11 74.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.045 0.538 . . . . 73.4 110.898 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.448 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.91 -42.95 76.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.096 -0.502 . . . . 75.34 111.067 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.35 -42.91 99.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 116.031 -0.532 . . . . 75.52 111.782 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.63 -51.73 68.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.516 -0.765 . . . . 73.43 111.324 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.35 -47.58 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.368 -0.833 . . . . 65.32 111.956 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.34 -46.21 81.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.975 0.417 . . . . 74.34 110.948 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.529 ' HD2' HG21 ' A' ' 432' ' ' VAL 0.251 59.5 mttp -67.28 -37.9 84.17 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 113.08 0.77 . . . . 72.35 113.08 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 41.5 tp -67.77 -36.78 81.11 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.143 0.497 . . . . 74.35 109.728 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.3 m -60.65 -42.69 97.5 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 51.44 109.294 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.7 -19.65 62.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.414 -0.812 . . . . 74.0 111.336 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.21 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.275 0.56 . . . . 60.21 110.218 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.32 29.36 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.767 -0.73 . . . . 72.13 113.437 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.93 130.96 35.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.883 0.341 . . . . 74.21 110.597 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 30.4 4.27 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.11 -0.796 . . . . 33.21 111.11 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.408 ' HB3' HG22 ' A' ' 483' ' ' VAL . 3.0 mmp_? -132.58 115.9 16.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.551 -0.907 . . . . 54.13 108.551 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.9 m-85 -133.39 148.09 51.8 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.177 -0.919 . . . . 63.4 110.306 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.527 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.2 tppp? -138.97 122.64 17.49 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.202 -1.777 . . . . 73.44 106.202 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -103.1 135.22 45.17 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.874 0.369 . . . . 74.1 111.321 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.91 152.34 43.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.696 -1.594 . . . . 70.13 106.696 172.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.67 150.74 48.82 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.879 -0.786 . . . . 60.14 108.879 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.4 m -140.22 150.25 60.86 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 109.11 -0.7 . . . . 74.51 109.11 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.2 Cg_exo -65.39 132.44 31.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.325 2.017 . . . . 71.13 111.218 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.2 m -146.8 177.12 9.35 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.181 -0.463 . . . . 62.54 110.229 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.0 t -62.54 144.49 95.69 Favored Pre-proline 0 N--CA 1.432 -1.347 0 C-N-CA 123.852 0.861 . . . . 61.2 110.015 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.9 Cg_exo -51.15 -31.72 37.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.966 3.111 . . . . 73.24 113.067 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.99 -12.04 60.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 120.027 -0.669 . . . . 75.02 111.754 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.5 mt -109.61 -4.45 16.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.7 -0.227 . . . . 62.1 111.528 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.8 t -61.2 127.5 20.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.567 -0.531 . . . . 72.31 109.567 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.42 75.33 Favored Glycine 0 C--O 1.25 1.101 0 C-N-CA 121.082 -0.58 . . . . 53.44 111.738 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 95.5 mttt -125.27 159.22 32.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.405 -0.961 . . . . 61.25 108.405 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.642 HG22 HD11 ' A' ' 486' ' ' ILE . 39.1 t -82.75 133.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 109.329 -0.619 . . . . 75.22 109.329 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.72 -7.59 9.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 120.462 -0.495 . . . . 74.22 110.342 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.495 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 162.16 165.08 18.48 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.995 -0.842 . . . . 63.42 110.995 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.1 p -120.0 145.45 46.79 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.25 -0.648 . . . . 42.43 109.25 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.49 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.1 t-20 -57.4 -50.58 87.37 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 118.981 -0.533 . . . . 64.45 111.886 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.3 Cg_exo -76.7 131.82 12.69 Favored 'Trans proline' 0 C--N 1.37 1.709 0 N-CA-C 108.377 -1.432 . . . . 75.55 108.377 171.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.65 138.56 70.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.429 2.086 . . . . 72.24 112.037 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.49 1.77 50.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.133 0.968 . . . . 54.32 110.484 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.03 -27.78 15.45 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.798 -1.092 . . . . 73.34 109.639 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -109.89 164.85 12.19 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.848 -0.614 . . . . 71.32 109.455 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 15.5 p -90.61 136.86 32.79 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 120.736 0.303 . . . . 64.34 111.247 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.7 m -120.1 142.03 49.26 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.69 -0.856 . . . . 71.32 108.69 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.97 39.35 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.932 0.345 . . . . 74.33 111.932 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.81 -23.54 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.044 0.937 . . . . 74.22 111.282 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -80.67 -8.94 59.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.549 -0.75 . . . . 74.43 110.9 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.27 140.63 43.3 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.921 0.391 . . . . 52.44 112.04 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 451' ' ' ARG . 99.4 t -85.3 122.89 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.942 -1.133 . . . . 74.0 107.942 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.95 118.84 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.223 -1.029 . . . . 74.41 108.223 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.527 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.6 mp -92.74 117.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.064 -1.828 . . . . 74.22 106.064 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.642 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.56 120.57 62.36 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 CA-C-N 115.566 -0.743 . . . . 73.41 109.429 -174.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.66 121.45 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.645 0.736 . . . . 60.33 111.242 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 142.72 13.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.778 -1.101 . . . . 72.04 109.386 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.38 118.99 4.9 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 109.024 -1.63 . . . . 63.42 109.024 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.6 t -122.79 155.6 36.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -114.21 123.2 5.97 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 109.602 -1.399 . . . . 62.32 109.602 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.2 112.43 2.07 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.978 1.785 . . . . 73.55 110.316 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -71.21 95.52 1.28 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.123 0.963 . . . . 61.3 110.448 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.9 p -140.41 153.86 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.735 -1.12 . . . . 65.41 109.053 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.96 146.96 36.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.328 -0.249 . . . . 74.24 110.328 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.0 p-10 -100.41 135.53 41.71 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.613 -0.884 . . . . 75.14 108.613 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 32.7 pt -89.99 137.7 28.01 Favored Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 115.919 -0.582 . . . . 72.32 111.526 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.6 Cg_endo -83.19 -172.09 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.224 1.949 . . . . 73.25 110.25 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.1 128.58 35.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.169 0.509 . . . . 72.25 110.487 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.39 4.16 2.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.845 0.831 . . . . 62.01 109.435 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.67 144.06 26.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.489 -0.778 . . . . 62.04 110.279 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 95.3 13.09 53.25 Favored Glycine 0 CA--C 1.498 -1.007 0 N-CA-C 111.081 -0.808 . . . . 61.24 111.081 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 507' ' ' VAL . 92.6 mt-30 -118.88 176.18 5.4 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.056 -1.09 . . . . 75.23 108.056 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 m -86.58 155.41 20.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.715 -1.217 . . . . 52.52 107.715 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 10.3 p -54.87 -41.51 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 123.383 0.427 . . . . 71.25 111.968 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.25 -42.53 83.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.138 0.422 . . . . 52.4 112.138 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.3 p -76.52 -34.38 24.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 119.884 -0.726 . . . . 55.51 110.646 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.446 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -61.14 -47.66 85.2 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.078 -0.964 . . . . 74.21 111.017 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.2 mt-30 -62.75 -38.3 89.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.631 0.582 . . . . 73.55 110.002 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 514' ' ' VAL . 44.7 mmtm -63.03 -52.82 61.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.529 0.518 . . . . 64.24 111.911 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.57 -42.78 99.76 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.94 0.4 . . . . 75.01 110.939 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.09 -43.33 95.72 Favored 'General case' 0 C--O 1.197 -1.698 0 CA-C-N 115.641 -0.709 . . . . 72.4 109.939 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.99 -38.61 79.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.41 0.684 . . . . 70.34 111.383 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.8 t -62.03 -40.52 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.291 -0.413 . . . . 41.54 111.63 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -101.29 -36.4 8.91 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.505 -0.878 . . . . 72.2 110.863 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -89.6 -115.77 1.55 Allowed Glycine 0 N--CA 1.415 -2.739 0 CA-C-N 114.435 -1.257 . . . . 74.21 115.783 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 17.3 m-85 -125.15 -175.29 3.26 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.194 -0.503 . . . . 73.41 110.235 -167.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.3 p -113.2 -7.71 13.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.305 0.483 . . . . 74.22 112.305 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.65 120.86 43.69 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 120.617 -0.433 . . . . 63.5 110.147 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -125.67 155.97 40.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.42 -0.809 . . . . 71.1 109.284 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 154.82 45.61 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.842 -1.54 . . . . 75.45 106.842 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -120.97 128.42 52.71 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.229 -0.588 . . . . 72.24 110.193 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.07 131.19 57.01 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.086 -1.079 . . . . 61.41 108.086 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.3 p -88.78 131.41 35.07 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.745 -0.661 . . . . 70.42 111.184 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.4 m -121.96 162.0 21.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.803 -1.184 . . . . 75.44 107.803 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -79.8 123.75 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.254 0.549 . . . . 75.14 111.733 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 7.2 m -85.15 149.75 53.44 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.203 -0.908 . . . . 63.2 108.567 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.599 1.532 . . . . 75.45 109.285 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.487 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.4 mtt180 -122.97 -58.46 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.802 -0.618 . . . . 74.4 111.003 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 57.2 Cg_endo -71.34 148.4 54.96 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.823 1.33 . . . . 32.04 111.522 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.71 175.68 9.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.045 -0.724 . . . . 51.03 109.045 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 86.51 -15.85 48.51 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 121.256 -0.497 . . . . 54.23 111.927 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.92 147.83 25.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.657 0.741 . . . . 65.24 111.598 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 508' ' ' ALA . 69.7 t -81.46 123.7 38.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 114.991 -1.004 . . . . 71.14 109.614 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.9 m -86.13 -26.45 25.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.733 -1.122 . . . . 70.11 109.242 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.13 -153.27 23.72 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 111.019 -0.832 . . . . 74.31 111.019 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -134.81 161.29 35.63 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.954 -0.758 . . . . 74.34 108.954 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.6 t-20 -54.69 -54.44 49.08 Favored Pre-proline 0 CA--C 1.561 1.374 0 O-C-N 123.291 0.369 . . . . 70.32 110.615 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 79.4 Cg_endo -82.35 149.4 14.96 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.103 1.202 . . . . 63.43 110.191 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 21.6 Cg_exo -67.64 154.13 74.26 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.317 2.011 . . . . 62.12 113.024 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.78 129.56 40.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.18 -0.674 . . . . 43.35 109.18 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.59 46.46 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 111.862 -0.495 . . . . 34.3 111.862 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 93.2 m -78.06 137.36 38.2 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.781 0.324 . . . . 73.44 110.986 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -94.56 123.89 38.26 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.727 -0.669 . . . . 74.44 109.77 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.9 155.0 78.27 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 110.092 -0.336 . . . . 75.2 110.092 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.4 Cg_exo -64.03 139.72 68.75 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.242 2.628 . . . . 71.4 112.482 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.556 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 16.3 m -67.75 -21.19 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.785 0.803 . . . . 64.14 111.114 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.12 -10.92 59.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.646 -1.161 . . . . 75.23 110.349 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.8 t -93.24 155.1 17.64 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.927 -0.768 . . . . 71.03 108.927 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.68 130.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.937 -0.764 . . . . 60.11 108.937 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 18.7 tt -93.64 135.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.539 0.685 . . . . 64.5 111.377 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -102.74 124.49 48.37 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.65 -0.705 . . . . 74.31 109.485 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 28.4 tp -96.72 132.78 42.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.893 -1.048 . . . . 72.14 109.204 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -96.33 106.66 18.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.414 -1.328 . . . . 71.22 107.414 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.62 137.0 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 120.819 0.342 . . . . 72.22 111.125 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.471 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 50.2 m -65.83 115.65 6.17 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.025 -1.102 . . . . 51.12 108.025 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 C--N 1.314 -0.955 0 O-C-N 123.643 0.589 . . . . 71.21 109.773 -176.345 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.495 0 N-CA-C 110.343 -1.103 . . . . 75.13 110.343 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.88 150.2 88.46 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.484 2.123 . . . . 71.23 112.147 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.88 23.27 8.68 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.516 -0.55 . . . . 74.34 109.516 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.524 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 66.2 mt-30 -83.83 138.74 33.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.842 -0.617 . . . . 62.54 112.435 -171.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -130.18 154.73 47.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.852 -1.907 . . . . 75.24 105.852 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.15 28.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 117.737 0.244 . . . . 74.33 110.727 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.2 mp -79.69 129.98 69.25 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 108.493 -0.928 . . . . 74.03 108.493 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.61 141.14 54.05 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.938 1.759 . . . . 75.51 111.062 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.39 67.23 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.267 1.032 . . . . 74.21 109.844 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.422 HG13 HD12 ' A' ' 435' ' ' LEU . 43.6 t -117.39 -2.55 9.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.556 -1.646 . . . . 72.51 106.556 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.674 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.2 m -60.96 -41.22 95.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.394 -1.73 . . . . 74.2 111.373 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 13.9 t -58.15 -26.29 62.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.6 -0.727 . . . . 74.24 111.623 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 432' ' ' VAL . 78.4 mt -80.93 -44.53 18.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.318 -0.553 . . . . 72.33 110.916 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.5 m -164.64 145.2 7.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.695 -0.854 . . . . 74.52 108.695 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.38 -43.65 79.45 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.787 0.835 . . . . 72.31 110.77 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.17 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.695 0.76 . . . . 74.21 110.704 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.535 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.9 mm-40 -70.42 -38.78 74.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.663 -0.699 . . . . 72.43 110.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.674 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.84 -50.95 71.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.472 -0.786 . . . . 44.32 111.036 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.4 t -59.37 -46.32 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 73.34 111.571 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -65.13 -44.79 87.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.744 -0.383 . . . . 75.2 111.139 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -63.4 -44.69 93.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.259 -0.428 . . . . 75.21 111.821 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.601 HD23 ' CE2' ' A' ' 452' ' ' PHE . 29.4 tp -67.26 -40.11 86.17 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.329 -0.396 . . . . 73.22 110.295 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.2 m -60.44 -44.15 96.12 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.468 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.08 -18.05 62.56 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.784 -0.644 . . . . 71.25 111.431 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.62 57.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.092 0.472 . . . . 41.21 110.825 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.9 -6.03 37.17 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.368 -0.92 . . . . 72.43 112.675 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.6 m-85 -81.7 130.84 35.2 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.098 -0.704 . . . . 71.41 109.098 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.62 2.03 6.47 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.47 -0.872 . . . . 71.44 113.129 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HG3' HG23 ' A' ' 483' ' ' VAL . 9.1 tpp180 -104.37 115.35 30.22 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.126 -1.065 . . . . 71.14 108.126 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.601 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.0 m-85 -123.28 144.89 49.12 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.318 0.58 . . . . 75.44 110.8 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -135.26 122.62 21.79 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.77 -1.567 . . . . 63.44 106.77 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -93.89 121.75 35.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.045 0.45 . . . . 53.12 109.881 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.02 151.68 45.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.929 -1.138 . . . . 75.03 107.929 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -132.03 134.35 45.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.331 -0.618 . . . . 74.33 109.331 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.4 m -119.04 137.53 25.2 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 107.979 -1.119 . . . . 72.14 107.979 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.07 121.63 9.17 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.458 1.438 . . . . 53.34 109.606 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 492' ' ' PRO . 15.3 m -138.93 179.22 6.62 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.121 -1.437 . . . . 72.12 107.121 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.3 t -56.43 126.24 68.65 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-O 121.659 0.742 . . . . 72.41 110.164 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.51 -28.91 29.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 125.25 3.966 . . . . 62.3 115.739 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.69 -15.96 62.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.66 0.615 . . . . 73.51 112.66 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 73.3 mt -87.69 4.74 42.89 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 64.23 112.149 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.5 p -60.25 130.08 23.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 121.023 0.439 . . . . 55.54 110.172 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.51 68.54 Favored Glycine 0 C--N 1.307 -1.04 0 C-N-CA 120.631 -0.795 . . . . 52.14 111.656 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.88 144.33 42.62 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.138 0.494 . . . . 53.2 109.914 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.629 HG22 HD11 ' A' ' 486' ' ' ILE . 46.0 t -82.13 135.82 24.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.376 -0.972 . . . . 73.22 108.376 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.3 pt -97.96 -29.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 119.84 -0.744 . . . . 64.13 110.417 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -174.28 161.17 31.11 Favored Glycine 0 N--CA 1.424 -2.162 0 C-N-CA 120.395 -0.907 . . . . 61.31 111.639 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.0 p -118.7 152.81 35.44 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.194 -0.669 . . . . 54.54 109.194 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 16.7 t-20 -62.76 -54.56 46.34 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-O 119.156 -0.45 . . . . 72.33 111.416 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -75.81 134.16 16.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 N-CA-C 108.529 -1.374 . . . . 63.43 108.529 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.89 143.65 73.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.854 2.37 . . . . 72.44 113.206 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -88.89 -7.57 55.86 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.442 1.115 . . . . 60.32 109.437 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.91 -33.01 17.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.449 -1.25 . . . . 73.33 110.06 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -114.91 175.67 5.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.597 -0.729 . . . . 75.15 110.681 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 18.0 p -92.42 139.98 30.04 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 116.338 -0.392 . . . . 72.0 109.99 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 53.4 m -130.1 147.07 51.8 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.883 -0.784 . . . . 74.42 108.883 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.98 150.37 48.76 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.012 0.434 . . . . 73.42 111.521 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.38 -24.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.626 -0.715 . . . . 72.32 110.025 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -81.14 2.27 28.24 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.807 -0.633 . . . . 64.52 111.085 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -82.37 145.66 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.924 -0.398 . . . . 71.5 109.924 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 451' ' ' ARG . 3.4 p -86.35 120.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.265 -1.013 . . . . 64.42 108.265 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.44 117.23 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 C-N-CA 118.233 -1.387 . . . . 71.54 107.456 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 64.4 mt -97.97 112.21 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 105.438 -2.06 . . . . 74.11 105.438 175.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.629 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.85 120.4 51.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 N-CA-C 108.346 -0.983 . . . . 65.41 108.346 -175.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 120.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.328 0.585 . . . . 74.05 110.124 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.72 138.83 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.887 -1.153 . . . . 70.41 107.887 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.9 104.66 2.23 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 108.753 -1.739 . . . . 71.44 108.753 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.5 t -105.63 139.73 39.78 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.815 -1.18 . . . . 72.15 107.815 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -72.2 139.31 27.92 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 108.902 -1.679 . . . . 74.23 108.902 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 459' ' ' SER . 12.1 Cg_exo -66.89 105.76 1.01 Allowed 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.796 1.664 . . . . 72.11 111.404 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -79.3 104.51 9.97 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.483 -1.235 . . . . 70.43 108.965 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.1 p -121.68 158.96 27.56 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.813 -1.085 . . . . 74.31 108.379 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -150.0 148.53 29.17 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.087 -0.338 . . . . 70.34 110.087 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.5 p-10 -80.36 131.6 35.65 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.45 0.643 . . . . 60.0 110.322 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.3 pt -75.4 131.29 77.98 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.177 -0.919 . . . . 75.23 111.461 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -92.14 119.64 0.5 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 122.639 2.226 . . . . 74.41 111.753 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.75 122.28 28.89 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.675 -1.232 . . . . 75.01 107.675 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.44 43.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.829 1.299 . . . . 63.23 110.631 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -59.72 145.97 43.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.358 -1.292 . . . . 72.34 112.242 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.0 -12.64 31.83 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.134 -0.555 . . . . 73.11 113.012 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.528 ' O ' HG12 ' A' ' 534' ' ' VAL . 25.5 mt-30 -108.17 -170.9 1.76 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 121.048 -0.261 . . . . 75.32 111.311 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.1 m -85.07 156.36 21.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.498 -1.297 . . . . 73.11 107.498 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.99 -41.19 90.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.576 0.626 . . . . 70.11 111.232 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.82 -42.06 97.73 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 116.492 -0.322 . . . . 65.32 111.424 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.8 -34.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 119.194 -1.003 . . . . 63.34 111.018 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.78 86.66 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.873 -0.603 . . . . 72.51 110.247 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -61.91 -42.27 98.89 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 123.255 0.347 . . . . 62.01 110.097 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.25 -48.36 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.342 -0.614 . . . . 72.03 109.342 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 -38.9 92.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.54 110.771 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.29 -43.68 73.34 Favored 'General case' 0 C--O 1.186 -2.263 0 CA-C-N 115.352 -0.84 . . . . 64.44 110.185 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.36 -46.55 86.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.433 0.635 . . . . 74.33 111.435 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.04 -18.65 21.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 62.32 111.316 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -129.87 18.41 5.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.932 -0.766 . . . . 73.15 108.932 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -162.61 -110.74 0.25 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.111 -1.042 . . . . 44.54 114.691 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -123.31 167.74 13.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.878 0.37 . . . . 72.43 111.856 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 9.3 p -104.68 7.03 34.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.829 0.678 . . . . 73.31 112.829 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 550' ' ' VAL . 0.0 OUTLIER -131.04 123.01 27.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.775 0.321 . . . . 73.23 110.781 -178.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.76 152.15 48.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 74.1 110.528 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 47.8 t -127.51 147.83 50.32 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.818 -1.919 . . . . 70.0 105.818 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -121.53 127.51 51.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 110.258 -0.275 . . . . 74.44 110.258 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 135.29 48.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.8 -0.637 . . . . 73.41 109.741 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 2.7 p -88.47 130.1 35.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.71 -0.677 . . . . 74.14 109.551 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.44 159.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.639 -0.504 . . . . 71.01 109.639 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.32 115.95 17.53 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.962 0.887 . . . . 73.4 109.795 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 2.9 m -95.26 157.3 36.61 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.883 -1.508 . . . . 71.23 110.68 -171.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 6.1 Cg_exo -80.72 -142.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.641 2.227 . . . . 73.44 108.817 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 529' ' ' ARG . 4.3 mmp_? -58.35 -49.78 91.69 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 113.481 0.919 . . . . 73.51 113.481 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.82 149.0 47.17 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.269 1.313 . . . . 73.11 111.455 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.86 145.97 26.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.254 -1.017 . . . . 62.11 108.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.48 -53.07 0.74 Allowed Glycine 0 N--CA 1.437 -1.274 0 C-N-CA 120.683 -0.77 . . . . 74.3 112.431 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.06 149.56 48.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.127 0.571 . . . . 52.11 111.965 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -73.49 127.65 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 121.486 0.66 . . . . 72.43 109.584 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -24.65 44.55 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.717 -1.128 . . . . 64.51 109.642 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.09 -146.38 16.63 Favored Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 111.311 -0.716 . . . . 61.44 111.311 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -116.19 160.07 20.91 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.487 -0.931 . . . . 72.44 108.487 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -53.74 -54.24 48.56 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 111.813 0.301 . . . . 71.32 111.813 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.4 Cg_endo -92.56 167.67 2.73 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.253 1.969 . . . . 64.23 110.179 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.95 155.6 57.35 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.466 2.11 . . . . 71.45 111.538 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 137.88 58.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.757 -0.46 . . . . 45.21 109.757 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.43 -19.11 34.62 Favored Glycine 0 C--N 1.294 -1.751 0 C-N-CA 120.023 -1.084 . . . . 72.25 111.717 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -65.64 123.14 18.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.484 -0.932 . . . . 61.11 108.484 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 16.8 m -94.87 122.48 37.55 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.703 -0.48 . . . . 73.45 109.703 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.74 159.19 69.48 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.662 -0.866 . . . . 63.42 108.662 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.2 Cg_exo -61.39 139.25 81.47 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.074 1.849 . . . . 52.43 111.339 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.63 -18.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.302 -0.863 . . . . 72.3 112.481 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.58 -9.55 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.16 -0.927 . . . . 63.4 109.78 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 45.1 m -92.34 152.1 19.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.217 -0.901 . . . . 51.34 110.795 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.463 ' HA ' ' HG2' ' A' ' 519' ' ' LYS . 39.5 t -88.38 133.53 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.869 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.2 tt -98.49 139.27 20.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.513 -0.551 . . . . 61.42 109.513 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.82 125.83 49.71 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.108 0.48 . . . . 74.04 109.902 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.82 133.7 42.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.453 -0.943 . . . . 71.25 108.453 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -97.51 111.19 23.56 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.035 -1.098 . . . . 72.44 108.035 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.21 137.71 41.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 C-N-CA 120.532 -0.467 . . . . 75.43 111.996 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.2 m -68.02 117.67 10.18 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.353 -1.351 . . . . 54.2 107.353 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 8.1 ptmm? . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 118.516 -0.754 . . . . 72.21 112.341 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.756 0 N-CA-C 109.965 -1.254 . . . . 54.35 109.965 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.71 132.72 38.8 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.796 2.331 . . . . 74.44 111.866 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.15 31.06 6.32 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.164 0.507 . . . . 72.05 110.112 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 18.7 mp0 -83.9 147.21 27.64 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 119.683 -0.807 . . . . 74.43 109.384 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 7.9 tpp85 -143.26 161.16 39.03 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.137 -1.06 . . . . 63.31 108.137 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 9.5 pt-20 -82.23 140.29 33.76 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 123.582 0.753 . . . . 62.04 112.018 -172.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -96.67 126.89 41.47 Favored Pre-proline 0 N--CA 1.424 -1.735 0 N-CA-C 104.607 -2.368 . . . . 64.32 104.607 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.62 141.34 90.82 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.35 2.034 . . . . 73.21 114.381 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -100.76 -5.22 26.67 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.845 -1.07 . . . . 51.52 108.492 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.43 -4.68 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 122.542 1.163 . . . . 63.31 108.524 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.0 m -58.51 -31.98 68.4 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.922 -1.49 . . . . 72.11 109.283 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -57.14 -27.51 61.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.538 -1.21 . . . . 70.1 110.642 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.1 mt -89.99 -44.47 9.84 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.008 -0.677 . . . . 71.43 111.724 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.552 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 24.5 m -158.34 143.55 16.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.326 -0.859 . . . . 74.52 109.947 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.27 -45.92 79.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.848 0.459 . . . . 63.42 110.006 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.45 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.73 -35.27 65.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.901 -0.591 . . . . 75.35 111.782 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.552 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.0 mm-40 -70.79 -43.59 68.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.412 -0.358 . . . . 72.33 111.154 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.07 -51.22 70.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.363 -0.835 . . . . 71.45 110.554 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.87 -47.62 88.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 115.493 -0.776 . . . . 64.21 112.125 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -64.81 -42.91 94.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.677 -0.409 . . . . 73.42 111.629 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -66.44 -45.49 79.65 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.096 0.474 . . . . 74.3 110.176 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 34.6 tp -68.58 -37.35 79.78 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.767 -0.651 . . . . 73.33 111.065 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.9 m -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.056 -0.52 . . . . 73.14 109.846 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.9 -15.45 62.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.967 -0.56 . . . . 52.13 110.921 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.574 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -81.14 -14.83 57.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.211 0.529 . . . . 64.21 110.098 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.31 58.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.298 -0.954 . . . . 73.4 113.652 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 90.6 m-85 -72.58 146.02 46.98 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.911 -0.774 . . . . 74.31 108.911 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.25 -7.01 2.31 Favored Glycine 0 C--N 1.303 -1.275 0 C-N-CA 120.006 -1.092 . . . . 73.12 112.656 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 483' ' ' VAL . 0.0 OUTLIER -102.5 115.42 30.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.859 -1.534 . . . . 61.31 106.859 -178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.08 149.37 50.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.175 0.512 . . . . 75.15 110.722 -173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.459 ' HB3' HG13 ' A' ' 485' ' ' ILE . 17.6 tppt? -138.64 123.02 18.3 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.537 -1.283 . . . . 73.25 107.537 169.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -102.74 134.85 45.45 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.331 0.586 . . . . 75.13 111.114 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.14 158.42 44.49 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.183 -1.043 . . . . 64.43 108.183 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -135.2 146.91 49.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.231 -1.026 . . . . 74.02 108.231 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 35.1 t -133.6 131.3 21.23 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.352 -0.981 . . . . 55.34 108.352 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.8 Cg_exo -65.87 120.89 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.775 1.65 . . . . 72.32 109.989 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.0 m -140.79 179.48 6.68 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 106.735 -1.58 . . . . 74.32 106.735 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -52.49 133.82 44.18 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.341 0.401 . . . . 65.22 111.581 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.481 ' O ' HG12 ' A' ' 464' ' ' VAL . 86.9 Cg_exo -50.45 -26.51 16.45 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 125.071 3.847 . . . . 72.32 113.05 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -57.27 -33.22 67.39 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.304 0.642 . . . . 53.52 110.568 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 93.9 mt -103.83 11.07 36.17 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.567 0.58 . . . . 74.12 112.567 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.3 p -61.21 128.15 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 119.927 -0.709 . . . . 74.14 110.595 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.13 77.69 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 120.887 -0.673 . . . . 52.04 112.163 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.7 mptp? -100.31 148.69 24.4 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.685 -0.857 . . . . 74.12 108.685 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 486' ' ' ILE . 58.5 t -81.93 125.35 39.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.758 -1.201 . . . . 70.13 107.758 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.92 -10.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 120.852 0.358 . . . . 74.2 111.386 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.22 149.04 8.06 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.176 -1.012 . . . . 71.24 112.193 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -119.03 140.48 49.97 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.494 -1.299 . . . . 73.43 107.494 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.514 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.6 t-20 -62.59 -53.83 53.56 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-O 118.963 -0.541 . . . . 75.42 111.765 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.1 Cg_exo -74.34 146.0 34.99 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 108.583 -1.353 . . . . 74.52 108.583 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.7 134.28 46.45 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.415 2.077 . . . . 72.2 112.918 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.63 6.44 47.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.481 1.134 . . . . 74.41 109.529 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.37 -21.87 13.75 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.279 -1.328 . . . . 63.02 109.278 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -124.7 155.54 39.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.225 -0.443 . . . . 64.44 111.413 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.7 p -83.99 123.91 30.49 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.653 -0.703 . . . . 74.14 109.516 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.8 m -115.59 150.74 36.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.716 -0.846 . . . . 60.52 108.716 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.99 151.21 46.51 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.24 0.216 . . . . 62.11 111.338 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.96 -17.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.83 0.852 . . . . 72.21 112.215 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.4 t -72.04 -6.05 39.55 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 116.44 -0.345 . . . . 72.52 110.851 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.95 131.1 35.75 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 122.633 0.373 . . . . 63.13 111.996 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 451' ' ' ARG . 6.6 p -83.79 123.57 38.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.867 -1.16 . . . . 61.24 107.867 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.34 118.18 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 C-N-CA 119.067 -1.053 . . . . 74.51 109.322 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.514 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -97.21 112.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.685 -1.969 . . . . 73.13 105.685 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.42 121.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 115.908 -0.587 . . . . 65.14 109.559 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.97 120.45 52.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.183 0.516 . . . . 75.4 109.894 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.0 t -96.05 140.32 17.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-N 115.694 -0.684 . . . . 72.25 109.19 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.31 114.03 3.85 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.368 -1.093 . . . . 72.05 110.368 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 40.6 t -98.84 133.56 42.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.013 -1.106 . . . . 43.3 108.013 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -105.48 118.61 5.86 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.915 -0.874 . . . . 75.4 110.915 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.67 142.52 29.06 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.383 2.055 . . . . 70.4 110.505 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -97.67 100.25 11.63 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.259 -1.015 . . . . 64.51 108.259 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 546' ' ' PRO . 33.7 p -131.55 143.9 50.71 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.429 -0.35 . . . . 71.31 110.534 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.84 164.59 27.23 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.07 -0.715 . . . . 63.03 109.07 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.17 134.02 35.77 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 517' ' ' PHE . 32.5 pt -76.65 132.49 71.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.67 -0.412 . . . . 74.11 110.251 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -91.42 178.46 1.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.763 2.309 . . . . 75.33 113.217 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.68 135.95 36.71 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.928 -1.138 . . . . 71.15 107.928 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.85 16.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.991 0.9 . . . . 42.44 109.407 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.48 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -68.06 132.43 47.24 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.899 -1.046 . . . . 41.14 111.801 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 117.91 -24.65 8.8 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.429 -0.891 . . . . 72.4 112.023 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.57 173.75 7.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.945 -0.761 . . . . 74.05 108.945 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 9.8 p -80.01 156.94 26.92 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.486 -0.486 . . . . 55.01 111.504 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.76 -42.26 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 O-C-N 123.838 0.712 . . . . 71.21 112.181 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.64 -39.44 80.71 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 121.017 -0.273 . . . . 64.1 111.592 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 83.8 t -71.1 -44.04 75.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.442 0.639 . . . . 63.52 110.827 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.08 -47.83 81.23 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 74.21 111.628 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.81 -35.62 81.68 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 121.042 -0.263 . . . . 71.31 110.579 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.7 OUTLIER -65.14 -51.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.206 -0.664 . . . . 52.15 109.206 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.7 -37.8 87.92 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.96 -0.564 . . . . 65.24 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.67 -45.47 71.64 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.818 -0.628 . . . . 74.42 109.451 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.29 -41.27 88.53 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.033 0.753 . . . . 72.53 113.033 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.3 t -64.23 -31.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.197 -0.456 . . . . 74.35 111.655 -177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.81 15.91 11.8 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.993 -0.283 . . . . 74.23 110.72 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.8 -98.08 0.2 Allowed Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 117.281 -2.39 . . . . 42.12 117.426 -169.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.667 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 78.1 m-85 -121.89 152.83 39.19 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.145 0.497 . . . . 74.55 111.791 -164.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.9 m -96.19 -27.48 15.01 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.02 -0.991 . . . . 62.42 111.871 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.75 134.66 51.16 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.156 -0.34 . . . . 64.2 110.09 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.77 145.53 51.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.347 0.594 . . . . 75.33 111.009 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.3 m -141.11 144.6 34.98 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.873 -1.529 . . . . 71.45 106.873 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 553' ' ' LEU . 13.2 mm-40 -121.26 127.41 51.36 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.119 -1.067 . . . . 72.4 108.119 -172.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.436 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -114.28 133.45 55.64 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.991 -1.114 . . . . 64.21 107.991 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.7 m -88.55 130.81 35.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.165 0.507 . . . . 22.21 110.718 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.25 162.82 21.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 105.033 -2.21 . . . . 72.41 105.033 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.75 131.9 36.04 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 118.872 0.76 . . . . 61.15 111.991 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 66.4 p -77.04 150.38 80.88 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.946 -1.025 . . . . 75.4 109.215 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.52 -47.4 7.52 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.021 1.814 . . . . 71.5 110.512 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 20.4 mmt180 -163.2 -58.83 0.01 OUTLIER Pre-proline 0 C--O 1.222 -0.348 0 C-N-CA 127.316 2.246 . . . . 74.21 109.411 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 527' ' ' SER . 30.5 Cg_endo -66.85 135.96 39.99 Favored 'Trans proline' 0 C--N 1.36 1.137 0 N-CA-C 109.091 -1.157 . . . . 62.41 109.091 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.34 157.85 38.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.297 0.373 . . . . 54.22 110.145 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 115.13 -18.67 15.89 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 121.131 -0.557 . . . . 61.12 112.192 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.3 OUTLIER -87.36 148.46 25.02 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.253 0.549 . . . . 74.33 111.336 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 501' ' ' ALA . 11.4 p -81.26 128.87 38.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.822 -0.807 . . . . 73.43 108.822 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -78.44 -31.2 47.95 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.775 -0.824 . . . . 65.24 108.775 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.09 -157.29 28.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.16 -1.176 . . . . 52.33 110.16 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.4 p -117.56 160.77 20.7 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.154 -1.054 . . . . 70.42 108.154 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 64.4 t30 -58.67 -51.26 83.09 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 119.979 -0.688 . . . . 71.11 111.167 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.3 Cg_exo -81.53 155.73 18.68 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 121.33 1.353 . . . . 53.34 109.835 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.64 149.98 56.05 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.373 2.049 . . . . 65.14 112.025 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.18 129.89 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.353 0.661 . . . . 72.25 110.045 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -7.06 36.33 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.573 -0.822 . . . . 63.3 111.834 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.1 m -77.13 133.92 38.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.451 -0.574 . . . . 71.42 109.451 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.9 t -100.81 127.33 47.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.251 0.548 . . . . 73.43 110.312 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 517' ' ' PHE . 11.2 m -138.76 162.08 54.84 Favored Pre-proline 0 C--O 1.248 1.018 0 N-CA-C 109.331 -0.618 . . . . 72.14 109.331 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.4 Cg_exo -63.84 135.03 46.23 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.483 2.122 . . . . 72.24 112.373 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.667 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 11.3 m -67.29 -21.12 27.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.699 0.762 . . . . 64.1 112.381 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.27 -7.96 55.95 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.602 -1.181 . . . . 64.01 109.324 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -92.14 179.0 5.69 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.432 -0.804 . . . . 70.21 110.764 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.31 124.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.84 -0.618 . . . . 64.34 112.365 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.3 tp -94.1 123.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 106.476 -1.676 . . . . 72.31 106.476 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.64 116.74 32.91 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-O 120.894 0.378 . . . . 72.43 110.082 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.614 ' HB2' ' OE1' ' A' ' 522' ' ' GLN . 6.1 mp -98.72 134.37 41.73 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.169 -0.923 . . . . 70.24 110.621 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 9.0 mm-40 -92.06 109.84 21.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.66 -1.978 . . . . 73.45 105.66 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.3 m -105.73 137.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 112.515 0.561 . . . . 71.31 112.515 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 49.5 m -72.72 114.53 10.96 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.577 0.703 . . . . 61.31 110.312 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.448 ' C ' ' HD3' ' A' ' 557' ' ' LYS . 7.3 tmtm? . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.046 -1.464 . . . . 71.42 107.046 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.3 0 N-CA-C 110.108 -1.197 . . . . 63.52 110.108 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 156.24 65.62 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.649 2.233 . . . . 62.2 111.959 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -107.55 20.7 18.52 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.992 0.901 . . . . 64.34 108.724 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.3 mt-30 -87.53 120.97 29.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.111 -0.95 . . . . 64.14 110.862 -174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -120.66 166.38 13.76 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.698 0.761 . . . . 65.53 110.536 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -84.38 140.3 31.66 Favored 'General case' 0 C--N 1.266 -3.053 0 CA-C-N 113.628 -1.623 . . . . 74.33 109.421 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.22 126.81 78.38 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 106.791 -1.559 . . . . 54.53 106.791 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.13 141.74 70.97 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.493 2.129 . . . . 71.22 112.399 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -112.41 70.64 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.532 1.158 . . . . 63.44 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.51 6.74 4.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 123.886 1.803 . . . . 65.5 106.226 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 0.7 OUTLIER -62.71 -30.97 71.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.32 -2.218 . . . . 73.11 109.308 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.0 m -58.37 -28.24 64.96 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 125.821 1.649 . . . . 64.25 110.642 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.5 -45.3 9.04 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.449 -0.501 . . . . 71.22 112.107 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.7 m -163.65 150.66 12.23 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.754 -0.832 . . . . 72.0 108.754 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 441' ' ' VAL . 32.7 t80 -53.08 -54.89 28.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.539 0.524 . . . . 74.23 110.704 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.7 -36.57 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.613 -0.721 . . . . 72.44 112.117 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -61.48 -45.77 92.83 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 112.313 0.486 . . . . 64.4 112.313 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -65.3 -44.58 87.49 Favored 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 123.68 0.613 . . . . 71.32 109.727 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.422 HG21 ' CZ ' ' A' ' 437' ' ' TYR . 90.8 t -59.02 -46.82 91.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.436 0 CA-C-N 115.368 -0.833 . . . . 53.22 111.629 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.9 mmpt? -60.28 -47.03 87.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.824 0.284 . . . . 74.03 110.966 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.72 -38.95 87.71 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.937 -0.305 . . . . 63.55 111.244 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.8 tp -67.04 -41.27 86.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.16 0.505 . . . . 75.52 110.092 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.9 m -61.07 -45.27 95.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.998 -1.001 . . . . 64.11 109.022 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.96 62.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.68 -0.691 . . . . 74.13 111.718 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.28 -13.12 57.49 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.193 0.521 . . . . 74.53 110.724 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.93 20.35 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 120.665 -0.779 . . . . 64.24 112.3 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.4 m-85 -69.23 118.08 11.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.53 -0.545 . . . . 74.24 109.53 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -106.72 -15.71 16.09 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.63 -0.714 . . . . 74.23 111.483 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -109.45 114.01 27.29 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.954 0.883 . . . . 73.05 110.344 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.7 154.46 40.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.665 -1.152 . . . . 54.15 111.208 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -131.33 125.45 32.76 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.16 -0.681 . . . . 72.21 109.16 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -88.69 121.02 30.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.981 0.419 . . . . 72.23 110.744 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.39 153.5 32.95 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 71.55 107.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.48 147.62 49.8 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.775 -0.824 . . . . 75.22 108.775 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.4 t -137.21 138.24 24.79 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 108.816 -0.809 . . . . 74.52 108.816 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 490' ' ' SER . 25.9 Cg_exo -64.81 122.16 9.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 72.12 110.182 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -137.52 179.75 6.22 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.929 -1.137 . . . . 63.15 107.929 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.6 t -65.27 144.03 98.92 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.047 -0.723 . . . . 75.41 109.047 174.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.36 -28.03 25.82 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.571 3.514 . . . . 75.45 112.464 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -59.01 -34.44 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 123.393 0.677 . . . . 73.42 111.442 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.98 4.75 49.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.066 1.135 . . . . 63.33 114.066 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 79.5 t -60.5 130.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.152 0.501 . . . . 54.42 112.325 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.94 84.72 Favored Glycine 0 CA--C 1.504 -0.644 0 CA-C-N 115.252 -0.886 . . . . 72.13 112.646 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.07 151.62 38.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.838 -0.43 . . . . 62.34 109.838 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 486' ' ' ILE . 46.7 t -81.93 134.25 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.687 -0.857 . . . . 71.23 108.687 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.46 -24.36 4.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.59 -0.444 . . . . 62.04 111.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.85 168.05 38.17 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.684 -0.77 . . . . 51.45 111.952 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.3 p -121.03 153.13 37.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.668 -0.493 . . . . 72.21 109.668 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 23.2 t-20 -68.49 -52.74 19.17 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 119.299 -0.381 . . . . 72.34 111.272 174.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.76 129.64 10.08 Favored 'Trans proline' 0 C--N 1.365 1.418 0 CA-C-N 120.202 1.108 . . . . 54.32 109.605 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.67 129.89 24.83 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.323 2.015 . . . . 75.23 112.25 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 0.71 30.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.755 0.788 . . . . 51.14 111.605 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.99 -1.004 . . . . 52.22 109.165 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -129.79 157.84 41.08 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.109 -1.071 . . . . 71.43 108.109 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 37.4 p -86.72 123.67 32.13 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.997 -0.371 . . . . 73.52 109.997 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 50.4 m -108.58 145.18 35.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.395 -0.594 . . . . 71.44 109.395 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.26 153.2 43.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.152 -0.477 . . . . 70.4 110.781 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.87 -21.83 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.729 0.811 . . . . 73.45 110.7 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -76.66 9.09 3.0 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 116.037 -0.529 . . . . 74.21 111.944 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -98.6 145.83 26.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.378 0.271 . . . . 61.12 111.151 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.52 119.52 35.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.876 -1.157 . . . . 71.25 107.876 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 71.0 t -87.62 118.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 118.992 -1.083 . . . . 62.43 108.617 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 66.0 mt -94.86 114.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.795 -1.557 . . . . 72.21 106.795 176.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.27 128.36 59.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 115.656 -0.702 . . . . 72.23 109.488 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 38.1 mt -106.53 118.97 55.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 116.08 -0.509 . . . . 65.44 110.549 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.63 145.87 8.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.752 -0.658 . . . . 73.01 109.548 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -87.76 123.49 6.68 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.069 -0.812 . . . . 72.0 111.069 176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.8 m -123.6 137.61 54.71 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.414 -0.958 . . . . 55.3 108.414 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -100.78 144.49 16.7 Favored Glycine 0 C--N 1.314 -0.681 0 C-N-CA 120.541 -0.838 . . . . 70.21 112.827 -175.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.84 116.2 4.46 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.01 2.473 . . . . 72.34 111.744 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -72.25 95.49 1.7 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.851 0.834 . . . . 63.24 111.483 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -134.67 154.39 51.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.206 -0.906 . . . . 74.41 110.85 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.49 149.6 30.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.869 -0.419 . . . . 71.24 109.869 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -90.58 139.14 30.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.654 -0.499 . . . . 74.33 109.654 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -96.19 138.44 21.59 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.777 -0.647 . . . . 65.24 112.019 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.25 171.26 11.46 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.522 2.148 . . . . 55.01 111.037 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -85.53 132.99 34.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.202 0.525 . . . . 73.13 110.174 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.73 11.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.962 0.887 . . . . 74.23 109.182 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.37 155.24 22.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.786 -0.643 . . . . 64.24 110.192 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 97.71 -13.26 64.08 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.539 -1.425 . . . . 63.14 109.539 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -94.53 179.65 5.2 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.438 -1.319 . . . . 74.43 107.438 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.0 m -83.67 155.28 23.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.718 -1.216 . . . . 61.23 107.718 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.8 -42.95 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.24 -42.55 75.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.058 0.392 . . . . 70.13 112.058 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -75.08 -35.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.551 -0.86 . . . . 72.4 111.036 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.437 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.85 -48.18 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.273 -0.876 . . . . 73.34 111.354 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.44 -34.74 78.89 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 121.249 -0.18 . . . . 75.0 110.969 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -64.67 -49.1 72.31 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.111 -0.329 . . . . 74.32 110.111 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.77 -46.52 81.79 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.242 0.544 . . . . 62.22 110.377 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.8 -36.58 81.53 Favored 'General case' 0 C--O 1.181 -2.551 0 CA-C-N 115.113 -0.949 . . . . 72.5 110.855 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.98 -39.28 81.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.246 0.546 . . . . 73.22 110.4 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.33 -34.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.496 -0.775 . . . . 65.42 111.336 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -111.27 11.3 21.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.566 0.698 . . . . 73.32 111.802 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.87 -111.97 1.33 Allowed Glycine 0 N--CA 1.417 -2.593 0 CA-C-N 115.412 -0.813 . . . . 41.13 111.893 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 37.1 m-85 -133.16 -177.15 4.39 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.542 -0.54 . . . . 72.44 109.542 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -106.98 -7.95 16.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.647 0.737 . . . . 62.43 109.729 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -108.11 115.99 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.863 -0.608 . . . . 63.33 110.061 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -126.25 151.49 47.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.785 0.802 . . . . 75.24 112.366 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.8 m -136.87 151.67 49.36 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.202 -1.407 . . . . 51.3 107.202 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.538 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.7 mm-40 -121.33 131.14 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.38 -0.6 . . . . 74.01 109.38 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.5 130.96 56.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.374 -0.602 . . . . 72.43 109.374 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 15.3 m -93.55 120.82 34.29 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.99 -0.745 . . . . 60.53 108.99 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.5 m -122.01 162.29 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 74.13 108.157 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . 0.262 13.8 m-20 -82.39 141.85 32.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.943 1.46 . . . . 74.44 114.943 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 2.7 m -97.55 144.03 27.24 Favored Pre-proline 0 C--N 1.28 -2.45 0 CA-C-N 113.425 -1.716 . . . . 63.22 109.016 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.94 -69.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 107.939 -1.6 . . . . 65.2 107.939 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.475 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 36.5 mmt180 -118.39 -59.4 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 118.494 -0.765 . . . . 75.33 112.291 170.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 527' ' ' SER . 54.7 Cg_endo -69.15 136.79 35.56 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 121.454 1.436 . . . . 71.44 111.811 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.08 123.03 16.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.861 -0.792 . . . . 65.32 108.861 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.08 -18.45 6.58 Favored Glycine 0 C--N 1.296 -1.662 0 N-CA-C 109.388 -1.485 . . . . 55.14 109.388 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -79.09 147.42 32.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.245 -0.977 . . . . 72.33 109.542 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 553' ' ' LEU . 58.7 t -76.16 115.54 17.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 107.971 -1.122 . . . . 72.2 107.971 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 16.9 m -78.26 -24.83 46.68 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.65 -0.704 . . . . 75.41 109.544 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.54 -175.39 43.16 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.84 -0.904 . . . . 51.23 110.84 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.3 p -119.69 158.55 26.24 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.013 -1.477 . . . . 73.44 107.013 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -59.43 -53.14 68.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.292 -0.563 . . . . 73.45 111.609 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.6 Cg_endo -86.81 147.71 8.25 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.21 1.273 . . . . 61.0 109.172 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.63 153.01 65.2 Favored 'Trans proline' 0 C--O 1.245 0.825 0 C-N-CA 122.022 1.815 . . . . 73.13 112.279 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 129.49 40.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.87 -0.605 . . . . 72.32 109.488 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.34 -19.08 37.73 Favored Glycine 0 C--N 1.304 -1.225 0 C-N-CA 121.122 -0.561 . . . . 75.42 111.744 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 87.5 m -75.03 132.42 41.31 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.915 0.388 . . . . 54.14 110.386 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 29.1 m -91.05 123.72 34.73 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.79 -0.819 . . . . 64.35 108.79 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.67 160.98 63.76 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.159 -0.682 . . . . 74.53 109.159 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.39 134.69 49.64 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.275 1.983 . . . . 63.41 112.356 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.6 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 15.7 m -67.56 -19.87 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 122.434 1.111 . . . . 53.2 110.56 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.76 -13.71 58.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.599 -1.637 . . . . 54.34 109.307 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 64.1 m -93.25 169.43 10.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.074 -0.966 . . . . 73.32 111.865 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.35 133.48 44.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.964 -0.562 . . . . 62.13 110.188 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.8 tt -102.87 137.25 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.208 0.528 . . . . 64.41 110.015 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 24.9 tt0 -103.79 129.71 51.24 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.355 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.538 ' HB3' ' OE1' ' A' ' 522' ' ' GLN . 6.4 tt -102.41 127.09 49.58 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.255 -1.387 . . . . 75.42 107.255 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -104.07 106.98 17.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.778 0.799 . . . . 71.3 109.28 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.62 138.02 37.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 114.831 -1.077 . . . . 64.43 111.793 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.497 ' HB2' ' OG ' ' A' ' 527' ' ' SER . 13.5 p -65.03 122.56 17.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 62.34 109.997 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 524' ' ' SER . 22.6 pttp . . . . . 0 C--O 1.259 1.564 0 CA-C-N 116.466 -0.334 . . . . 72.31 111.779 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.98 0 N-CA-C 109.7 -1.36 . . . . 44.51 109.7 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.54 132.98 30.59 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.159 1.906 . . . . 51.14 111.325 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 10.6 pt-20 -93.9 -4.92 49.05 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 60.04 109.935 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -114.28 133.04 55.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.552 -1.204 . . . . 74.11 109.022 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.597 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -120.51 161.51 21.17 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 108.109 -1.071 . . . . 73.32 108.109 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.84 141.6 32.15 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.369 0.668 . . . . 73.54 110.301 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.586 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.68 130.9 66.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 106.825 -1.546 . . . . 71.2 106.825 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.408 ' HB3' ' HD3' ' A' ' 443' ' ' LYS . 85.5 Cg_exo -53.47 140.95 63.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.097 2.531 . . . . 61.43 113.931 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.53 -2.78 57.91 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.021 -0.99 . . . . 73.23 110.258 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.84 8.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.766 0.793 . . . . 72.21 110.832 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.3 p -61.39 -42.23 98.39 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.536 1.534 . . . . 75.14 110.832 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 7.1 p -66.34 -25.59 66.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.742 -1.117 . . . . 54.22 111.867 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.37 -46.31 17.86 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.26 -0.576 . . . . 64.42 110.297 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.9 m -169.59 147.15 3.47 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.058 -1.09 . . . . 74.14 108.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 441' ' ' VAL . 25.5 t80 -50.75 -49.13 58.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.657 0.783 . . . . 74.23 110.296 171.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -57.53 -35.86 70.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.652 -0.704 . . . . 41.4 111.871 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.544 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.6 mm-40 -70.66 -40.38 73.04 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.095 0.474 . . . . 75.42 110.857 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -46.38 90.09 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.169 -0.923 . . . . 70.23 110.364 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 437' ' ' TYR . 90.1 t -58.64 -47.41 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.45 -0.796 . . . . 63.1 111.961 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 61.7 mttp -62.91 -48.84 77.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.822 0.344 . . . . 70.51 110.439 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 430' ' ' PRO . 49.2 tttp -68.27 -38.44 81.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.579 -0.737 . . . . 53.13 111.259 -176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 35.4 tp -68.47 -40.33 81.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.15 0.5 . . . . 74.33 109.983 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 38.6 m -60.93 -45.81 93.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.442 -0.799 . . . . 71.32 109.884 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.97 62.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.712 -0.676 . . . . 72.13 111.226 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -80.18 -13.75 59.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.648 0.261 . . . . 64.12 110.358 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.25 -5.29 49.03 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.347 -0.93 . . . . 65.33 114.203 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 76.7 m-85 -62.96 139.12 58.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.866 0.333 . . . . 72.3 111.226 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.45 -2.93 9.66 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.39 -0.91 . . . . 72.11 113.37 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -119.31 115.63 24.54 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.527 -0.916 . . . . 74.35 108.527 -177.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -132.45 151.12 52.01 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.943 0.401 . . . . 74.13 110.161 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 485' ' ' ILE . 61.8 tttp -139.6 122.62 16.75 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.251 -1.759 . . . . 74.21 106.251 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.84 135.08 42.85 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.88 -0.328 . . . . 64.33 110.244 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.95 155.17 50.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.494 -0.928 . . . . 54.04 108.494 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.431 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.5 p30 -133.9 138.53 45.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.679 -1.23 . . . . 73.22 107.679 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 t -134.98 143.54 46.56 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 108.849 -0.797 . . . . 73.03 108.849 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.68 122.19 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.142 1.895 . . . . 71.41 109.114 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -133.3 179.64 6.07 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.309 -0.86 . . . . 53.2 109.491 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -61.07 135.16 93.21 Favored Pre-proline 0 N--CA 1.417 -2.117 0 C-N-CA 123.755 0.822 . . . . 73.1 108.935 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 89.3 Cg_exo -50.64 -29.98 27.11 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.097 3.198 . . . . 65.21 115.123 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -75.76 -22.8 56.13 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.728 -0.789 . . . . 73.34 112.501 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.14 4.89 51.04 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.598 0.592 . . . . 65.31 112.598 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 15.0 p -61.2 127.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 C-N-CA 120.097 -0.641 . . . . 43.43 109.874 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.52 -6.05 77.53 Favored Glycine 0 C--N 1.308 -0.989 0 CA-C-N 115.595 -0.729 . . . . 51.11 113.169 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -110.0 157.14 19.61 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.61 -0.885 . . . . 75.21 108.61 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 486' ' ' ILE . 48.9 t -82.26 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.844 -1.169 . . . . 52.02 107.844 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 34.9 pt -97.74 -20.41 5.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.21 -0.596 . . . . 63.44 109.688 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.54 155.24 14.64 Favored Glycine 0 N--CA 1.409 -3.132 0 C-N-CA 120.015 -1.088 . . . . 74.0 112.425 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.9 p -119.56 154.28 34.13 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.263 -1.754 . . . . 71.43 106.263 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 41.7 t-20 -65.12 -55.0 29.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 C-N-CA 119.975 -0.69 . . . . 62.14 110.625 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.73 126.94 9.21 Favored 'Trans proline' 0 C--N 1.365 1.428 0 N-CA-C 108.947 -1.213 . . . . 51.43 108.947 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.46 143.46 76.05 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.464 2.109 . . . . 62.23 112.264 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.27 4.58 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.183 0.992 . . . . 73.25 110.692 -176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -101.4 -9.28 21.27 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.456 -1.247 . . . . 72.13 109.471 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -122.27 167.48 13.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.517 -0.92 . . . . 74.41 108.517 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 30.6 p -98.03 143.43 28.59 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 109.619 -0.511 . . . . 71.41 109.619 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.6 m -128.98 147.41 50.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.016 -0.735 . . . . 73.35 109.016 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -54.52 153.39 5.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.586 0.958 . . . . 71.11 113.586 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.59 -32.29 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.116 0.966 . . . . 74.33 110.241 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 36.39 4.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.779 1.276 . . . . 72.43 110.222 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 19.2 t-20 -88.33 145.63 25.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 105.028 -2.212 . . . . 71.14 105.028 173.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.88 111.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.55 -1.26 . . . . 73.51 111.074 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.45 118.51 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.993 -1.114 . . . . 73.0 107.993 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.5 mp -95.23 112.69 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 72.14 106.286 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.79 118.39 50.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 109.481 -0.562 . . . . 73.55 109.481 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -100.07 121.68 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.393 -0.595 . . . . 62.03 109.393 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 134.02 35.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.36 115.73 5.21 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 109.82 -1.312 . . . . 71.1 109.82 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 456' ' ' ASN . 12.1 m -113.07 130.2 56.24 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.208 -0.664 . . . . 75.32 109.208 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 492' ' ' PRO . . . -89.36 131.5 10.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 119.198 -0.779 . . . . 23.33 111.398 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 25.5 Cg_exo -65.34 122.87 10.69 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.835 2.356 . . . . 75.52 112.394 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 547' ' ' VAL . . . -75.43 95.82 3.33 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.254 1.026 . . . . 63.05 108.696 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 546' ' ' PRO . 7.5 p -132.58 157.33 45.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.815 -1.084 . . . . 71.42 109.901 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 140.1 22.86 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.336 -0.987 . . . . 73.23 108.336 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.3 p-10 -89.78 136.08 33.25 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.305 -1.368 . . . . 72.1 107.305 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 541' ' ' ALA . 29.2 pt -81.97 134.99 48.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 116.071 -0.513 . . . . 73.22 112.367 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.54 -175.39 1.26 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.965 2.443 . . . . 74.42 112.08 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -91.22 95.39 10.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.289 0.566 . . . . 70.51 109.895 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.26 -3.86 10.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.828 0.823 . . . . 62.1 108.996 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.56 55.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.162 -1.381 . . . . 71.32 110.036 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.22 -16.72 38.29 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 111.001 -0.84 . . . . 53.14 111.001 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -97.92 -175.35 3.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.557 -0.905 . . . . 75.25 108.557 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.9 m -79.17 155.01 28.84 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.724 -0.843 . . . . 63.24 108.724 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.534 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 6.9 p -53.71 -45.65 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 123.608 0.568 . . . . 71.33 112.116 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.9 -41.96 77.54 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.76 0.652 . . . . 73.22 112.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.7 -37.41 35.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 119.946 -0.702 . . . . 61.31 111.788 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.05 91.25 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.082 -0.508 . . . . 71.3 111.202 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -65.26 -35.51 81.25 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.795 -0.362 . . . . 71.34 110.68 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 514' ' ' VAL . 19.5 mmtp -59.83 -50.49 73.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.165 0.432 . . . . 73.12 112.165 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -62.37 -38.66 90.42 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.915 0.388 . . . . 63.21 110.91 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.09 -46.28 71.42 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.632 -0.713 . . . . 74.31 109.906 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 7.2 t30 -59.15 -48.03 83.1 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 124.025 0.93 . . . . 70.21 112.066 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.3 t -60.89 -28.67 43.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.822 -0.626 . . . . 73.53 112.031 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.72 13.15 9.96 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.477 -0.889 . . . . 73.24 111.366 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -154.01 -88.78 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.44 0 C-N-CA 117.581 -2.247 . . . . 72.12 117.276 -170.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 55.7 m-85 -117.96 151.27 37.77 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.494 -0.353 . . . . 74.54 111.008 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 8.6 m -107.52 -25.72 11.25 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.081 -0.509 . . . . 74.23 110.673 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.3 126.29 52.66 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.32 -0.622 . . . . 75.35 109.32 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -128.4 144.11 51.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.153 -0.476 . . . . 75.14 110.853 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.4 m -121.79 153.59 38.1 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.005 -1.48 . . . . 74.45 107.005 172.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -127.2 129.36 47.67 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.116 -0.634 . . . . 63.02 110.833 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -117.57 144.03 45.52 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.225 -1.398 . . . . 74.23 107.225 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -101.86 135.36 43.54 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.971 0.415 . . . . 72.0 111.379 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 18.5 m -121.94 149.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.71 -1.219 . . . . 75.44 107.71 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.25 118.5 20.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.42 -0.585 . . . . 73.24 109.42 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 556' ' ' SER . 82.7 p -90.98 162.85 31.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 113.58 0.956 . . . . 51.12 113.58 -170.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -71.8 -138.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.548 2.832 . . . . 71.32 109.468 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -68.87 -53.45 14.85 Favored Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 113.082 0.771 . . . . 75.13 113.082 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.6 150.88 36.22 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 121.451 1.434 . . . . 73.53 112.062 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -149.9 145.69 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.682 -0.858 . . . . 50.41 108.682 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.11 -20.77 5.89 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 111.28 -0.728 . . . . 74.34 111.28 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 148.75 25.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.069 -0.345 . . . . 52.45 110.069 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.7 t -74.57 115.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.596 -1.631 . . . . 74.13 106.596 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.2 m -72.0 -33.27 67.96 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.72 -0.673 . . . . 72.43 109.824 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.93 -165.04 36.62 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 110.59 -1.004 . . . . 74.01 110.59 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.9 p -125.0 160.83 28.08 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 107.777 -1.194 . . . . 60.42 107.777 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 63.8 t30 -59.82 -51.13 82.96 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 119.757 -0.777 . . . . 74.13 111.27 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.1 Cg_exo -77.52 145.2 23.27 Favored 'Trans proline' 0 C--N 1.367 1.512 0 N-CA-C 108.832 -1.257 . . . . 71.21 108.832 171.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.2 Cg_exo -70.54 152.09 65.05 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.188 1.925 . . . . 63.52 111.9 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -55.38 137.07 48.78 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.028 0.531 . . . . 71.33 110.765 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.68 -20.34 46.63 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 121.102 -0.57 . . . . 32.35 112.023 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 29.6 m -73.44 135.4 44.14 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.841 -0.211 . . . . 52.1 110.566 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 35.5 m -96.98 123.36 40.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.581 -0.525 . . . . 63.25 109.581 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.4 164.17 43.01 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 109.209 -0.663 . . . . 74.21 109.209 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.495 ' HA ' HG22 ' A' ' 494' ' ' THR . 7.4 Cg_exo -71.92 133.55 21.89 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 73.31 111.27 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.6 m -68.8 -20.88 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 70.52 111.141 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.8 -16.72 60.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.408 -1.269 . . . . 64.2 110.501 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.2 t -97.08 161.17 13.94 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.005 -0.739 . . . . 72.11 109.005 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.47 134.89 26.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.259 -0.645 . . . . 50.0 109.259 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -105.19 141.01 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.011 0.434 . . . . 51.22 110.577 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -103.08 121.56 42.86 Favored 'General case' 0 N--CA 1.406 -2.63 0 C-N-CA 123.525 0.73 . . . . 72.12 110.433 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.01 134.27 42.09 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 124.211 1.004 . . . . 52.34 110.015 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -92.27 108.25 19.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.859 -1.163 . . . . 71.21 107.859 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.82 138.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.798 -0.637 . . . . 71.34 110.33 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 527' ' ' SER . 6.2 p -65.91 119.55 11.5 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.129 0.966 . . . . 74.05 113.585 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 29.1 tttm . . . . . 0 C--O 1.262 1.763 0 C-N-CA 125.691 1.596 . . . . 74.21 108.431 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.655 0 N-CA-C 110.281 -1.128 . . . . 72.22 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.15 155.93 66.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.502 2.135 . . . . 34.23 111.502 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.0 OUTLIER -101.63 4.0 40.4 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.271 1.034 . . . . 63.03 108.443 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -107.69 137.92 44.84 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.986 -1.461 . . . . 73.22 109.662 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.15 156.12 40.62 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.947 -1.131 . . . . 63.04 107.947 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.6 OUTLIER -83.08 141.89 31.68 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 123.524 0.73 . . . . 55.12 111.393 -176.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -85.2 121.17 73.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.431 -0.951 . . . . 64.3 108.431 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.22 143.36 39.51 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.033 1.822 . . . . 72.02 112.253 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.66 32.24 0.59 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.778 0.799 . . . . 63.55 111.851 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.06 -12.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.863 -1.162 . . . . 74.12 107.863 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.6 m -60.49 -36.66 78.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.168 -1.378 . . . . 62.42 109.265 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -57.03 -27.74 61.9 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.217 -1.356 . . . . 75.21 110.465 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.59 -46.64 12.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.626 -0.43 . . . . 73.15 110.688 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 438' ' ' ALA . 40.5 m -166.47 149.05 6.81 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.201 -0.666 . . . . 63.54 109.201 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.54 -46.88 63.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.217 1.007 . . . . 73.22 110.374 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.513 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 73.34 111.365 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.49 -36.92 74.09 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.99 -0.55 . . . . 75.15 111.764 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.45 -52.37 64.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 124.342 1.026 . . . . 72.51 110.435 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 67.3 t -66.8 -50.64 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 115.129 -0.942 . . . . 65.03 111.808 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -62.49 -45.37 93.34 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.767 0.654 . . . . 71.34 112.767 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -68.5 -40.81 80.74 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.873 -0.731 . . . . 64.34 110.933 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.51 -33.87 74.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.055 0.455 . . . . 44.01 109.813 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 37.1 m -59.68 -45.04 93.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.465 -0.789 . . . . 75.42 109.215 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -16.81 62.61 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.726 -0.67 . . . . 63.22 111.159 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.16 -13.78 54.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.825 0.345 . . . . 71.43 110.452 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -18.18 9.1 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 120.308 -0.949 . . . . 61.15 113.178 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.95 130.59 42.61 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.889 -0.411 . . . . 75.54 109.889 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -118.92 -1.31 14.68 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.285 -0.959 . . . . 55.42 112.879 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.42 115.34 20.78 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.367 0.603 . . . . 74.14 109.961 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -125.62 154.87 41.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.895 -1.15 . . . . 74.13 107.895 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 485' ' ' ILE . 28.0 tptp -133.98 122.97 23.83 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.569 -1.271 . . . . 73.25 107.569 174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -91.18 120.84 32.45 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.472 0.654 . . . . 50.2 110.662 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.08 155.62 28.96 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.212 -1.773 . . . . 63.13 106.212 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.8 p30 -138.15 144.3 40.71 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.288 -0.634 . . . . 75.41 109.288 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 t -134.59 140.32 35.19 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 107.616 -1.253 . . . . 64.22 107.616 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_exo -65.13 122.63 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.045 1.83 . . . . 64.23 110.634 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.6 t -144.05 179.91 6.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.587 -1.635 . . . . 52.22 106.587 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -63.55 145.32 97.41 Favored Pre-proline 0 N--CA 1.414 -2.262 0 O-C-N 123.316 0.385 . . . . 73.43 110.026 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 464' ' ' VAL . 4.7 Cg_endo -50.61 -28.07 21.17 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.734 3.623 . . . . 55.31 112.236 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.75 -24.1 65.46 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.923 0.889 . . . . 74.11 112.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.9 5.7 33.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.852 0.686 . . . . 64.11 112.852 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.8 t -61.06 128.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.975 0.416 . . . . 75.4 111.269 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.47 84.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.499 -0.773 . . . . 75.1 111.91 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -111.19 146.79 36.28 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.234 -1.025 . . . . 74.34 108.234 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.8 t -81.39 129.37 37.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.101 -1.074 . . . . 64.4 108.101 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.7 pt -98.75 -9.8 8.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.35 111.418 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.33 163.02 24.62 Favored Glycine 0 CA--C 1.482 -2.005 0 C-N-CA 119.547 -1.311 . . . . 73.3 110.863 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.8 p -116.73 146.13 43.0 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.779 -0.822 . . . . 63.05 108.779 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.5 t30 -57.72 -50.04 90.34 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 123.315 0.384 . . . . 73.32 110.531 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_endo -85.01 137.91 6.54 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 N-CA-C 107.838 -1.639 . . . . 71.31 107.838 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 476' ' ' GLN . 6.3 Cg_exo -61.27 141.01 91.62 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.343 1.362 . . . . 73.24 111.029 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.66 10.72 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.377 1.084 . . . . 72.34 109.905 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -95.12 -29.91 14.32 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 113.84 -1.527 . . . . 65.45 108.398 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 473' ' ' PRO . 14.2 pt20 -98.86 170.78 8.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.779 -0.646 . . . . 62.31 109.93 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.7 p -98.49 134.02 42.05 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 116.036 -0.529 . . . . 50.15 109.886 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.0 m -114.0 145.53 41.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.462 -0.57 . . . . 72.22 109.462 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -59.39 148.11 33.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.974 0.416 . . . . 72.32 111.992 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.51 -30.74 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 123.537 0.735 . . . . 74.34 111.514 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -101.39 17.24 23.17 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.284 0.564 . . . . 65.51 110.549 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -88.56 139.3 30.62 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.785 -1.191 . . . . 65.15 107.785 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.95 111.08 16.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.642 0.734 . . . . 55.21 109.363 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.89 118.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.515 -0.92 . . . . 73.43 108.515 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 453' ' ' LYS . 46.8 mt -99.25 111.55 29.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.501 -1.296 . . . . 74.24 107.501 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 486' ' ' ILE . 0.0 OUTLIER -103.7 129.97 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-O 121.075 0.464 . . . . 61.11 110.16 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.71 116.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.233 -1.025 . . . . 64.41 108.233 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.42 140.07 18.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.966 -0.561 . . . . 73.25 109.568 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.71 118.15 6.93 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.454 -1.058 . . . . 74.35 110.454 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.3 m -119.96 132.72 55.6 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.846 -0.798 . . . . 73.21 108.846 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -136.27 103.18 0.43 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.991 -1.243 . . . . 72.15 109.991 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.18 118.97 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.039 1.826 . . . . 72.41 111.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -74.79 99.84 3.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.12 -1.067 . . . . 75.12 108.12 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 546' ' ' PRO . 35.6 p -124.66 156.92 36.75 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.077 -0.965 . . . . 63.43 108.956 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.05 150.29 31.53 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 70.05 107.779 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 544' ' ' THR . 6.7 p-10 -99.46 138.22 36.86 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 120.948 0.404 . . . . 74.53 110.282 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 541' ' ' ALA . 31.5 pt -88.15 133.91 36.02 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.556 -0.747 . . . . 74.12 111.985 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.3 177.0 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.603 2.202 . . . . 63.32 110.877 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.07 115.45 27.34 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.635 -0.426 . . . . 74.21 110.295 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.2 14.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.514 1.15 . . . . 63.11 108.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.49 143.23 46.68 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.09 -0.959 . . . . 61.21 110.48 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.7 -24.71 10.09 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.056 -0.592 . . . . 64.22 111.631 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.89 177.62 6.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.6 m -75.85 155.47 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.628 -0.508 . . . . 74.22 109.628 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.51 -49.1 14.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 123.719 0.637 . . . . 73.14 112.614 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.42 -42.51 74.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.259 0.466 . . . . 64.32 112.259 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -39.48 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 119.786 -0.766 . . . . 74.45 111.861 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.56 83.66 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.785 -0.643 . . . . 65.32 111.365 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.75 -35.52 80.96 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 120.219 -0.592 . . . . 70.24 110.5 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 513' ' ' ASN . 59.9 tttp -63.11 -48.9 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.462 0.648 . . . . 73.1 110.139 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -68.84 -38.24 79.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.264 -0.88 . . . . 63.24 111.453 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.03 -35.94 81.01 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 108.969 -0.752 . . . . 70.13 108.969 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 510' ' ' LYS . 2.5 t-20 -57.28 -38.8 74.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 75.43 110.115 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.06 -44.28 97.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.223 0.535 . . . . 54.01 110.632 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -103.23 16.46 26.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 65.21 111.235 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.1 -117.9 1.28 Allowed Glycine 0 N--CA 1.414 -2.792 0 C-N-CA 120.766 -0.731 . . . . 44.41 112.421 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 16.7 m-85 -122.01 173.4 7.56 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 110.263 -0.273 . . . . 72.0 110.263 -171.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 19.5 p -96.23 -14.26 22.83 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.752 -0.658 . . . . 75.21 111.409 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.18 115.69 29.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.559 -0.291 . . . . 64.33 111.448 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -120.98 151.34 39.85 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.278 0.561 . . . . 74.32 111.095 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.2 m -135.64 152.21 51.0 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.892 -1.892 . . . . 75.21 105.892 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -119.39 123.55 44.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.634 -0.876 . . . . 54.3 108.634 -170.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.84 121.24 42.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.451 -0.574 . . . . 72.21 109.451 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 557' ' ' LYS . 19.4 p -87.88 116.27 25.92 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.115 0.484 . . . . 51.42 110.099 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.53 162.14 21.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 115.533 -0.758 . . . . 73.01 110.16 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.69 121.44 24.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.152 0.977 . . . . 72.43 109.967 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 556' ' ' SER . 2.6 p -144.9 101.77 4.52 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 114.189 -1.369 . . . . 72.45 109.967 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.61 -57.35 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.559 2.839 . . . . 54.34 114.481 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 57.1 mtt180 -80.04 -49.43 1.27 Allowed Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 113.06 0.763 . . . . 72.31 113.06 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 39.6 Cg_exo -62.03 134.94 52.2 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.739 1.626 . . . . 72.25 112.306 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.07 74.36 0.97 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.89 3.68 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 110.747 -0.941 . . . . 73.5 110.747 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -86.19 149.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.256 0.55 . . . . 75.03 111.147 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 553' ' ' LEU . 87.7 t -73.71 124.7 31.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.345 -0.843 . . . . 64.25 109.079 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.6 m -76.23 -28.95 57.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.592 -1.185 . . . . 52.31 110.252 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.77 -159.66 31.2 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.03 -1.228 . . . . 73.22 110.03 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.5 p -127.18 157.38 39.92 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.261 -1.015 . . . . 62.23 108.261 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.5 t30 -66.81 -54.65 20.56 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.086 -0.645 . . . . 74.31 110.613 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.5 Cg_exo -71.7 131.59 18.82 Favored 'Trans proline' 0 C--N 1.377 2.033 0 N-CA-C 108.113 -1.534 . . . . 64.13 108.113 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.4 147.46 90.69 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.463 2.108 . . . . 64.43 113.075 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -63.26 142.82 58.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.988 -0.551 . . . . 53.3 110.56 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.99 64.0 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.519 -0.632 . . . . 61.21 111.519 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.1 m -79.65 132.39 36.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.582 -0.525 . . . . 71.51 109.582 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 496' ' ' ASP . 41.2 m -97.91 122.23 40.77 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.308 -0.997 . . . . 73.33 108.308 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.52 165.25 37.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.472 -0.936 . . . . 74.03 108.472 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.486 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.3 Cg_exo -59.5 137.58 78.7 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.493 2.129 . . . . 63.33 113.69 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.665 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -67.3 -19.69 25.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.157 -0.929 . . . . 71.54 112.259 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.76 -3.67 58.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.674 -1.148 . . . . 64.55 109.667 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.7 m -95.7 152.24 18.64 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 115.371 -0.831 . . . . 53.11 110.559 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.9 t -88.71 134.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.688 -0.687 . . . . 73.25 110.433 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 497' ' ' ILE . 9.3 tt -102.53 141.96 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 109.551 -0.537 . . . . 75.41 109.551 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -103.02 122.37 44.49 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.814 -0.809 . . . . 72.42 108.814 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 534' ' ' VAL . 20.0 tp -98.22 128.85 44.9 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.031 -0.986 . . . . 74.13 108.751 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -88.2 106.31 18.11 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.82 -0.807 . . . . 71.23 108.82 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 524' ' ' SER . 29.7 m -105.56 139.11 27.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 115.662 -0.699 . . . . 33.42 110.429 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.411 ' HA ' ' OG ' ' A' ' 527' ' ' SER . 22.3 p -57.16 120.76 8.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.537 -0.756 . . . . 73.11 112.139 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 524' ' ' SER . 57.4 tttm . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 109.31 -0.626 . . . . 74.31 109.31 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.631 0 N-CA-C 110.408 -1.077 . . . . 62.11 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.8 141.28 96.51 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.699 2.266 . . . . 62.21 111.045 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER -92.7 -1.01 57.19 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.504 0.668 . . . . 71.42 109.552 -179.174 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 60.0 mt-30 -109.69 125.54 52.74 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.561 -1.2 . . . . 74.23 108.926 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -123.12 160.44 26.44 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.169 -1.048 . . . . 73.43 108.169 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.97 141.64 28.46 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.635 -0.505 . . . . 73.1 109.635 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.59 119.41 76.76 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.73 -0.841 . . . . 74.21 108.73 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.94 144.51 43.19 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.275 1.983 . . . . 65.21 111.99 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.97 59.44 5.63 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.164 1.459 . . . . 72.52 109.17 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 439' ' ' GLU . 11.3 p -108.14 -5.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 106.333 -1.728 . . . . 64.21 106.333 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 1.3 p -63.25 -32.37 73.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.864 -1.971 . . . . 71.21 109.704 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.416 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 12.6 t -63.02 -26.79 69.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.332 -1.304 . . . . 63.11 111.103 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 432' ' ' VAL . 80.4 mt -85.54 -46.7 10.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.02 -1.072 . . . . 52.43 111.488 -173.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 1.8 m -171.88 150.6 2.63 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.172 -1.047 . . . . 72.0 108.172 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -52.63 -48.27 66.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.224 0.61 . . . . 74.42 110.631 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.78 66.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.731 -0.668 . . . . 54.21 111.968 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.503 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.4 mm-40 -70.98 -42.85 69.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.285 -0.416 . . . . 75.44 111.126 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.457 ' HA ' HG13 ' A' ' 432' ' ' VAL . . . -60.6 -47.06 87.89 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.199 -0.909 . . . . 73.41 110.75 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.54 -48.78 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.663 -0.699 . . . . 51.52 111.227 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -62.29 -44.65 96.02 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.024 0.379 . . . . 54.35 112.024 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 443' ' ' LYS . 6.5 mmpt? -66.56 -42.68 86.72 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.76 -0.376 . . . . 43.44 111.673 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.431 HD23 ' CE1' ' A' ' 452' ' ' PHE . 10.3 tp -69.41 -32.97 72.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.274 0.559 . . . . 71.22 110.106 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.6 m -64.45 -41.55 96.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.847 -0.615 . . . . 64.54 109.405 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.23 -16.22 63.02 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.168 0.508 . . . . 64.12 110.942 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.65 -13.06 46.66 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.099 -0.5 . . . . 63.04 110.086 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.54 -9.31 24.08 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.002 -0.618 . . . . 72.32 113.95 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -71.85 143.72 49.32 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.889 0.344 . . . . 73.3 111.194 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -149.0 16.54 1.19 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.69 -0.767 . . . . 64.31 112.319 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -120.97 115.77 23.82 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.987 -1.486 . . . . 71.32 106.987 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.431 ' CE1' HD23 ' A' ' 444' ' ' LEU . 96.5 m-85 -141.36 160.64 39.7 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 113.514 0.931 . . . . 72.41 113.514 -171.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -142.33 134.08 26.93 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.197 1.799 . . . . 74.14 107.012 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -103.65 132.03 50.27 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.62 -0.511 . . . . 73.42 109.62 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.53 139.24 53.37 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.767 -0.827 . . . . 75.41 108.767 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -114.17 130.19 56.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.607 -0.886 . . . . 62.35 108.607 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.1 m -120.63 138.17 27.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.517 -0.311 . . . . 74.35 110.433 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 14.9 Cg_exo -69.85 122.61 9.26 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.357 2.038 . . . . 74.32 111.007 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -144.75 179.07 7.55 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.039 -1.467 . . . . 41.31 107.039 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.532 ' OG1' ' HD2' ' A' ' 461' ' ' PRO . 6.6 t -70.76 144.2 90.56 Favored Pre-proline 0 N--CA 1.433 -1.322 0 N-CA-C 109.039 -0.726 . . . . 74.3 109.039 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 464' ' ' VAL . 2.0 Cg_endo -48.8 -27.88 12.0 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 125.165 3.91 . . . . 61.15 115.476 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.72 -13.22 61.98 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.29 -1.364 . . . . 54.42 112.343 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' A' ' 466' ' ' LYS . 2.8 mm? -98.23 -0.14 44.64 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.831 -0.543 . . . . 71.13 111.364 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 461' ' ' PRO . 84.9 t -61.51 128.14 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.799 -0.445 . . . . 71.42 109.799 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.79 -16.73 60.15 Favored Glycine 0 C--O 1.244 0.773 0 C-N-CA 121.099 -0.572 . . . . 73.11 111.996 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 463' ' ' LEU . 78.5 tttt -92.77 142.66 27.1 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.894 -0.78 . . . . 74.15 108.894 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.595 HG22 HD11 ' A' ' 486' ' ' ILE . 60.2 t -82.85 124.85 39.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.628 -1.619 . . . . 75.15 106.628 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -105.16 -5.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 118.667 -1.213 . . . . 74.0 111.803 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.14 160.14 27.84 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 119.775 -1.202 . . . . 55.12 112.666 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.4 p -134.42 145.33 48.79 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.196 -1.409 . . . . 71.51 107.196 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.41 ' OD1' ' HB ' ' A' ' 485' ' ' ILE . 12.5 m120 -64.4 -51.08 63.11 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 120.364 -0.534 . . . . 75.13 112.202 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.55 123.38 11.35 Favored 'Trans proline' 0 C--O 1.253 1.252 0 N-CA-C 108.716 -1.302 . . . . 70.42 108.716 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.38 139.19 37.52 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.217 1.945 . . . . 55.11 112.185 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.24 2.14 37.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.724 0.773 . . . . 54.13 110.608 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.24 -32.92 24.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.877 -1.056 . . . . 55.14 110.094 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.67 178.37 4.42 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.155 -1.054 . . . . 44.41 108.155 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 32.5 p -97.04 126.54 42.26 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-O 121.277 0.561 . . . . 61.51 110.547 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -106.77 147.05 30.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.479 -0.934 . . . . 52.45 108.479 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.5 147.58 41.75 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 120.9 0.381 . . . . 60.33 111.584 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.85 -21.9 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.31 1.044 . . . . 75.5 111.26 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -94.85 1.78 55.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.417 -0.811 . . . . 71.33 110.103 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -78.83 144.6 34.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.971 -0.751 . . . . 74.03 108.971 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 38.7 t -82.13 112.49 20.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.558 -1.275 . . . . 62.31 107.558 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.69 119.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 N-CA-C 109.176 -0.676 . . . . 63.12 109.176 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.41 ' HB ' ' OD1' ' A' ' 471' ' ' ASN . 3.3 mp -97.68 119.48 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.463 -2.051 . . . . 44.35 105.463 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.595 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -109.19 128.43 65.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.95 -0.568 . . . . 72.44 109.981 -175.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 58.5 mt -103.65 112.51 37.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-N 115.299 -0.864 . . . . 73.25 110.52 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.16 140.57 17.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 115.517 -0.765 . . . . 73.53 109.585 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.68 129.3 9.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.237 -1.145 . . . . 30.11 110.237 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.5 p -135.58 152.03 50.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.842 -0.429 . . . . 62.52 109.842 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -108.38 156.3 15.8 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.986 -1.245 . . . . 54.12 109.986 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.53 120.18 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.1 1.867 . . . . 72.21 110.399 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -73.42 90.35 1.69 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.743 0.783 . . . . 54.01 109.512 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.7 p -138.72 162.81 33.76 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.197 -0.911 . . . . 70.23 110.476 -172.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 517' ' ' PHE . 48.0 tptt -146.61 139.85 25.63 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.318 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -80.61 137.73 36.39 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.214 1.005 . . . . 63.33 109.023 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.6 pt -97.34 133.29 24.04 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 120.041 -0.663 . . . . 74.15 110.674 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.22 178.22 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.512 2.141 . . . . 72.14 110.296 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.0 122.53 38.92 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.153 -0.619 . . . . 73.24 110.045 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.36 6.02 5.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.652 -0.704 . . . . 72.23 110.102 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.561 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -74.01 147.2 43.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.553 -0.749 . . . . 73.02 110.712 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.46 -14.23 56.63 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.051 -0.82 . . . . 63.42 111.051 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -99.58 -170.04 1.84 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.583 -0.525 . . . . 61.13 109.583 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.1 m -82.08 155.77 24.91 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.667 -1.234 . . . . 74.43 107.667 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.76 -42.09 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.712 0.292 . . . . 74.41 111.537 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 31.9 t70 -68.19 -43.46 78.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.197 0.443 . . . . 55.22 112.197 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.26 -34.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.77 -0.772 . . . . 70.22 110.839 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.73 -49.18 78.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.728 . . . . 74.32 110.752 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.61 -34.66 78.76 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 120.669 -0.412 . . . . 73.13 111.009 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 12.7 mmmm -57.36 -53.16 61.29 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.166 0.291 . . . . 71.01 111.148 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -62.84 -40.63 98.04 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.38 0.61 . . . . 65.41 110.285 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 551' ' ' ILE . 46.7 tp -64.91 -38.51 91.21 Favored 'General case' 0 C--O 1.191 -2.02 0 CA-C-N 115.081 -0.963 . . . . 71.01 110.928 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -61.13 -37.96 84.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.163 0.585 . . . . 70.35 111.54 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.24 -29.8 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 64.23 110.697 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.66 31.21 6.36 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.166 -0.334 . . . . 72.12 110.363 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -160.39 -108.7 0.24 Allowed Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 119.009 -1.567 . . . . 51.42 113.759 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 495' ' ' LYS . 18.3 m-85 -137.69 177.26 8.01 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.876 -0.787 . . . . 75.13 108.876 -172.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 m -112.13 6.5 19.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 122.296 1.046 . . . . 61.52 108.725 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -108.52 115.75 30.69 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.647 -0.872 . . . . 72.22 108.647 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -128.16 150.87 49.81 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.293 0.371 . . . . 72.42 110.222 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.8 m -130.8 155.7 46.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.572 -1.27 . . . . 63.21 107.572 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -121.91 122.25 38.96 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.998 0.428 . . . . 74.13 110.001 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.47 56.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -90.07 118.9 29.96 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.575 -0.898 . . . . 74.53 108.575 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.6 152.23 25.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.584 -0.895 . . . . 70.23 108.584 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.64 123.04 25.53 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.606 1.193 . . . . 54.33 111.098 -169.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.5 m -128.49 101.04 21.63 Favored Pre-proline 0 N--CA 1.416 -2.138 0 CA-C-N 113.795 -1.548 . . . . 65.01 109.102 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.26 -57.15 1.19 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.032 2.488 . . . . 74.04 112.538 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -88.33 -49.41 0.43 Allowed Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 113.349 0.87 . . . . 73.33 113.349 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.59 146.52 95.38 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 121.883 1.722 . . . . 44.31 112.701 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.11 85.04 0.32 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.395 1.078 . . . . 72.33 108.381 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.0 -35.05 2.44 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 110.543 -1.023 . . . . 72.32 110.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -85.31 147.21 26.65 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.155 0.502 . . . . 65.12 109.91 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.4 p -75.07 126.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.499 -0.926 . . . . 74.03 108.499 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.2 m -72.11 -36.57 69.48 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.331 -0.85 . . . . 61.11 109.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 172.46 -167.44 40.35 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.258 -0.972 . . . . 60.04 111.728 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.1 p -118.71 160.62 21.53 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.525 -0.917 . . . . 71.1 108.525 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.6 t-20 -61.58 -53.39 61.91 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.93 -0.308 . . . . 74.03 111.33 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -87.81 144.93 6.5 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 108.912 -1.226 . . . . 73.24 108.912 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.3 Cg_exo -69.13 150.83 72.52 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 121.816 1.677 . . . . 64.53 111.447 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.09 135.83 36.72 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.674 0.79 . . . . 61.43 111.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.98 -26.51 20.52 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.228 -0.749 . . . . 61.44 111.228 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 88.2 m -65.68 133.69 51.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.501 . . . . 72.44 111.184 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.3 m -101.99 122.87 44.88 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.271 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.44 155.55 71.65 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.639 -0.504 . . . . 73.01 109.639 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 494' ' ' THR . 11.6 Cg_endo -58.86 138.98 88.82 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.664 2.243 . . . . 70.45 112.944 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.492 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 21.4 m -67.04 -19.7 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 122.344 1.069 . . . . 71.42 110.344 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.31 -2.67 39.14 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.956 -1.475 . . . . 72.53 110.453 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -108.43 172.38 6.87 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.751 -0.833 . . . . 74.25 108.751 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.58 136.34 50.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.872 -0.788 . . . . 74.52 108.872 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 512' ' ' LEU . 16.7 tt -94.51 138.88 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 120.063 -0.655 . . . . 72.53 110.531 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -102.17 124.01 47.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-O 121.241 0.543 . . . . 74.31 110.032 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.98 131.2 46.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.233 -1.765 . . . . 73.1 106.233 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -107.12 105.95 16.2 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.717 0.77 . . . . 63.21 110.234 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.03 139.83 16.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.134 -1.394 . . . . 75.42 111.487 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.1 p -56.33 114.71 2.1 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 63.2 112.903 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.358 -1.719 . . . . 52.31 106.358 174.129 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 110.428 -1.069 . . . . 53.42 110.428 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.49 163.15 27.26 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.922 1.748 . . . . 53.31 113.073 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.2 OUTLIER -100.45 33.53 2.68 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.829 1.252 . . . . 75.3 107.79 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 478' ' ' SER . 96.0 mt-30 -110.1 135.67 50.54 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.004 -1.453 . . . . 73.22 109.962 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -126.29 158.53 35.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.036 0.446 . . . . 64.45 111.436 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.92 141.99 30.0 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.789 -1.096 . . . . 75.43 110.532 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.27 129.93 70.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.721 -0.844 . . . . 63.43 108.721 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.89 141.8 65.6 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.671 2.914 . . . . 72.32 114.792 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.26 -3.05 48.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.918 -1.037 . . . . 74.15 111.271 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.8 m -85.68 3.39 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.603 0.716 . . . . 61.32 110.812 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 14.8 m -61.48 -29.57 70.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.823 -1.08 . . . . 71.32 110.196 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.494 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 18.2 p -62.44 -27.87 69.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.102 -0.953 . . . . 75.41 111.524 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.6 -45.44 21.63 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.925 -0.398 . . . . 74.55 109.925 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 16.1 m -166.79 148.27 6.13 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.717 -0.846 . . . . 71.54 108.717 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 441' ' ' VAL . 53.1 t80 -53.27 -43.01 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.925 0.89 . . . . 74.24 111.301 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.75 -41.16 85.88 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.483 -0.326 . . . . 53.12 111.24 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.5 mm-40 -63.69 -40.61 97.23 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.248 0.547 . . . . 74.52 110.099 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -50.96 71.54 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.982 -1.008 . . . . 73.01 110.595 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 437' ' ' TYR . 92.7 t -59.42 -45.84 93.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.37 -0.832 . . . . 71.23 111.819 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 67.7 mttm -63.05 -47.28 83.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.695 0.283 . . . . 72.23 111.591 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -67.78 -38.81 83.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.312 -0.404 . . . . 74.25 111.399 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.55 -37.98 83.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.235 0.54 . . . . 74.23 109.88 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.2 m -59.47 -47.87 83.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.425 -0.807 . . . . 73.11 109.784 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.45 -15.83 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.011 -0.541 . . . . 62.53 111.933 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.0 -13.73 59.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.242 0.544 . . . . 74.41 110.433 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.88 -17.62 24.88 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.421 -0.895 . . . . 53.32 113.11 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -64.05 126.95 29.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.109 0.481 . . . . 55.43 111.082 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -110.12 -1.89 29.91 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.385 -0.825 . . . . 73.11 111.277 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 3.0 mpt_? -123.73 114.87 20.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.227 0.536 . . . . 71.52 110.187 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -147.68 146.81 29.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.429 -0.805 . . . . 61.14 110.361 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -131.13 126.51 35.9 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.363 -0.606 . . . . 72.44 109.363 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -84.0 122.35 28.64 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.613 -0.721 . . . . 72.44 111.191 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.36 149.86 41.12 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.069 -1.456 . . . . 40.21 107.069 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -127.92 146.82 50.51 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.785 -0.45 . . . . 50.22 109.785 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 44.5 m -124.57 131.45 24.16 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.791 -0.818 . . . . 75.12 108.791 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.51 123.81 11.61 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.461 2.107 . . . . 71.51 111.056 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 49.7 m -147.02 -179.72 7.01 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.444 -0.947 . . . . 65.45 108.444 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -49.75 136.35 19.24 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.896 0.878 . . . . 73.31 110.66 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.599 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 9.1 Cg_endo -50.66 -36.5 50.83 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.666 3.578 . . . . 75.35 114.786 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -77.58 -8.75 58.32 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.261 0.837 . . . . 73.23 113.261 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 18.0 tp -84.39 -11.82 55.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.003 0.43 . . . . 71.25 110.433 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.3 p -56.72 135.91 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.443 -0.799 . . . . 72.33 112.028 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.04 55.21 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 121.06 -0.59 . . . . 74.42 114.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 434' ' ' THR . 14.3 ptmm? -107.85 148.18 29.92 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.919 -1.112 . . . . 74.45 110.396 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 61.0 t -81.39 131.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.719 -0.474 . . . . 50.25 109.719 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 33.8 pt -101.04 -10.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.992 -0.549 . . . . 73.12 111.529 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.98 172.42 33.31 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.213 -0.755 . . . . 74.34 111.213 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 159.07 37.63 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.099 -0.704 . . . . 44.34 109.099 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.3 t-20 -60.6 -56.17 37.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 119.16 -0.448 . . . . 72.31 111.58 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.7 Cg_endo -85.88 146.15 9.05 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 121.192 1.261 . . . . 73.32 109.486 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.618 ' HG2' ' HG2' ' A' ' 476' ' ' GLN . 14.2 Cg_exo -62.88 149.8 90.33 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.693 1.595 . . . . 73.32 111.637 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.7 -11.66 60.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.654 0.74 . . . . 72.32 109.798 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -96.2 -12.19 25.0 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.222 -0.899 . . . . 71.13 112.012 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.618 ' HG2' ' HG2' ' A' ' 473' ' ' PRO . 4.1 mm-40 -96.11 155.07 16.91 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 119.435 -0.906 . . . . 63.34 108.845 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.416 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 34.7 p -101.2 120.68 40.6 Favored 'General case' 0 N--CA 1.395 -3.185 0 N-CA-C 108.372 -0.974 . . . . 74.54 108.372 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 24.6 m -105.1 140.05 38.86 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.203 -0.666 . . . . 33.01 109.203 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -61.63 146.78 47.94 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.953 -0.388 . . . . 73.32 109.953 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.39 -23.0 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 123.597 0.759 . . . . 70.34 111.965 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.6 t -77.84 -8.02 57.47 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.355 -0.384 . . . . 62.43 111.299 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -74.87 136.2 41.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 120.909 0.385 . . . . 72.01 110.833 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.66 113.85 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 0 N-CA-C 106.588 -1.634 . . . . 74.21 106.588 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 63.0 t -86.63 119.93 35.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.136 -0.69 . . . . 71.43 109.136 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.84 111.86 24.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.885 -1.524 . . . . 75.32 106.885 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.68 128.11 55.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.68 -1.146 . . . . 74.44 108.719 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 54.8 mt -104.52 114.04 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.614 0.721 . . . . 75.14 110.988 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.55 130.33 45.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.471 -0.786 . . . . 62.42 109.421 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.31 114.51 4.98 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 107.81 -2.116 . . . . 30.3 107.81 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.1 m -120.54 129.37 53.77 Favored 'General case' 0 N--CA 1.412 -2.347 0 C-N-CA 120.163 -0.615 . . . . 74.41 109.525 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -101.22 115.22 5.22 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 110.218 -1.153 . . . . 60.34 110.218 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.5 129.97 33.49 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.285 1.99 . . . . 72.23 111.195 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -70.69 97.17 1.31 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.702 -0.851 . . . . 73.24 108.702 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 546' ' ' PRO . 6.9 p -133.5 152.26 51.88 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.678 -1.147 . . . . 73.32 109.467 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.82 143.75 27.69 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.717 -0.475 . . . . 75.03 109.717 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 543' ' ' THR . 7.3 p-10 -93.0 138.32 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.681 -0.859 . . . . 65.52 108.681 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 497' ' ' ILE . 0.2 OUTLIER -93.82 121.04 65.29 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 114.849 1.426 . . . . 62.11 114.849 -176.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.75 136.27 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 106.294 -2.233 . . . . 73.11 106.294 164.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.37 139.86 56.64 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.796 0.807 . . . . 74.44 111.866 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.27 27.88 3.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.854 -1.535 . . . . 72.44 106.854 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.87 137.63 33.59 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.963 -1.471 . . . . 61.44 110.583 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.07 -48.23 0.93 Allowed Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.572 -0.823 . . . . 53.02 112.612 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -91.6 -168.69 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 111.877 0.325 . . . . 74.51 111.877 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.9 p -82.58 162.24 22.01 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 112.898 0.703 . . . . 73.34 112.898 -170.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.8 t -48.11 -52.5 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 O-C-N 124.839 1.337 . . . . 74.42 110.16 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 1.8 m-20 -68.04 -42.18 80.98 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.855 -1.066 . . . . 70.21 112.753 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.28 -35.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 119.214 -0.994 . . . . 73.33 111.497 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.444 ' HB3' HG21 ' A' ' 534' ' ' VAL . . . -64.06 -42.58 96.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.754 -0.657 . . . . 71.21 111.021 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 28.4 mt-30 -61.4 -43.36 98.99 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.989 -0.375 . . . . 75.01 109.989 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.8 mptp? -61.74 -49.31 76.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.79 -0.641 . . . . 62.15 111.883 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -62.58 -47.78 82.3 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 123.205 0.315 . . . . 75.33 110.66 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.11 -43.29 99.1 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.938 -0.574 . . . . 73.15 110.719 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.38 -37.22 74.82 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.717 0.807 . . . . 71.14 111.75 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.1 t -63.44 -42.48 96.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 116.282 -0.417 . . . . 73.11 111.869 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -108.21 -18.45 13.77 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.944 -1.102 . . . . 73.43 111.856 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -102.98 -100.47 2.57 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 115.079 0.792 . . . . 43.12 115.079 -171.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.568 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 49.0 m-85 -127.56 172.69 10.51 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.916 0.389 . . . . 73.32 111.183 -168.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.8 p -106.27 -25.73 11.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.485 -0.78 . . . . 65.32 111.047 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.73 121.65 45.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.871 -0.604 . . . . 64.11 109.72 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -128.46 143.4 50.98 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.591 . . . . 72.33 112.204 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.8 m -115.15 152.48 32.51 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.732 -1.951 . . . . 54.33 105.732 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -123.39 134.06 54.02 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.175 -0.61 . . . . 73.12 111.586 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.71 121.89 39.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.81 -0.811 . . . . 54.44 108.81 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.5 m -88.24 118.05 27.57 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.626 -1.62 . . . . 74.2 106.626 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.0 m -119.97 149.5 22.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.263 -1.384 . . . . 74.13 107.263 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.33 133.75 37.57 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.39 1.091 . . . . 73.22 112.579 -167.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 5.8 m -94.61 129.08 37.52 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 112.962 -1.926 . . . . 71.41 109.165 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.13 -71.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 121.073 1.182 . . . . 71.41 109.072 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.429 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 24.5 mmm180 -111.57 -55.05 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.036 -0.507 . . . . 74.31 112.165 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 527' ' ' SER . 10.7 Cg_exo -73.18 134.48 21.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.306 1.338 . . . . 74.32 111.339 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.51 159.46 43.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.436 -0.95 . . . . 65.3 108.436 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.91 -21.81 25.28 Favored Glycine 0 C--N 1.319 -0.402 0 CA-C-O 121.611 0.562 . . . . 65.02 111.862 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.52 147.77 25.2 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.245 0.545 . . . . 51.35 110.728 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 508' ' ' ALA . 64.5 t -75.88 124.88 34.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -33.21 52.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.315 -0.857 . . . . 70.12 109.44 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.78 -147.18 15.19 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.333 -0.707 . . . . 72.34 111.333 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.0 p -121.79 160.41 24.68 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.955 -0.757 . . . . 62.3 108.955 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -62.55 -52.61 64.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 121.007 -0.277 . . . . 74.04 110.368 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 57.8 Cg_endo -74.41 146.2 34.96 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 120.919 1.079 . . . . 75.34 109.791 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.2 Cg_exo -63.67 154.25 70.35 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.197 1.931 . . . . 73.44 111.9 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.45 132.88 53.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.024 -0.535 . . . . 74.25 109.964 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.49 -10.84 56.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.113 -0.565 . . . . 63.3 111.824 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 71.5 m -77.46 129.3 35.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.616 -0.513 . . . . 65.22 109.616 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.0 t -93.85 122.6 36.5 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.476 0.655 . . . . 63.21 110.148 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.27 158.81 70.13 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.685 -0.857 . . . . 54.44 108.685 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.418 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.7 Cg_exo -63.86 134.29 42.8 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.032 1.821 . . . . 75.23 112.081 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.568 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 17.2 m -67.61 -22.61 28.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.886 0.851 . . . . 73.54 110.849 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.15 0.73 52.89 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.353 -1.294 . . . . 75.32 111.685 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.8 t -98.02 -177.55 3.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.971 -0.751 . . . . 74.44 108.971 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.8 t -109.41 134.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.857 -1.164 . . . . 73.11 107.857 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -115.08 146.0 20.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.498 -0.556 . . . . 75.31 109.498 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.43 130.96 49.36 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-O 121.46 0.647 . . . . 72.21 110.454 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.75 130.96 48.27 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.68 -1.145 . . . . 71.35 108.624 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -94.8 115.33 27.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.959 -1.497 . . . . 73.25 106.959 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.74 135.2 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-N 116.525 -0.307 . . . . 72.31 111.089 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.5 m -74.23 114.39 12.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 109.04 -0.726 . . . . 72.55 109.04 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 11.5 ptmm? . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 114.795 -1.093 . . . . 72.44 110.919 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.82 0 N-CA-C 109.681 -1.367 . . . . 43.05 109.681 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.02 133.18 19.33 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 122.306 2.004 . . . . 63.25 109.22 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.4 pt-20 -85.91 57.79 4.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.411 1.1 . . . . 74.44 111.041 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 95.7 mt-30 -111.02 130.18 55.67 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.315 -1.311 . . . . 62.04 108.774 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -125.06 150.44 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.322 -0.854 . . . . 70.45 110.354 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 140.7 32.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.107 -0.497 . . . . 74.45 111.575 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -84.26 126.63 69.13 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 108.244 -1.021 . . . . 74.25 108.244 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.8 140.85 36.18 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.311 1.34 . . . . 63.35 110.517 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -105.81 69.37 0.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.457 1.122 . . . . 63.23 109.973 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.483 HG11 ' HD2' ' A' ' 443' ' ' LYS . 14.5 p -113.11 6.32 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 105.937 -1.875 . . . . 75.33 105.937 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.645 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.2 m -57.92 -30.05 65.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.031 -2.35 . . . . 60.5 110.399 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 3.2 m -61.76 -27.83 69.01 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.852 1.261 . . . . 72.15 110.856 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.0 -46.34 9.92 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 118.763 -1.175 . . . . 54.55 111.323 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.569 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.8 m -167.88 151.97 6.34 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.336 -0.616 . . . . 73.45 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -52.14 -49.29 64.02 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.266 1.026 . . . . 74.14 109.507 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.97 76.7 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.256 -0.883 . . . . 71.24 111.412 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.569 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 26.3 mm-40 -61.85 -46.06 91.07 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.239 0.337 . . . . 71.31 110.95 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -63.15 -47.25 83.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.629 -0.714 . . . . 62.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.25 -45.37 98.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-N 116.059 -0.519 . . . . 72.34 111.658 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -60.8 -47.58 85.67 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 122.197 0.199 . . . . 72.21 111.453 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 432' ' ' VAL . 65.0 mttm -67.79 -39.14 84.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.381 -0.527 . . . . 71.12 112.34 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.4 tp -68.05 -37.06 80.88 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.319 0.58 . . . . 72.45 109.898 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -65.13 -41.81 94.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.509 -0.769 . . . . 75.32 109.4 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.75 -21.44 63.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.845 -0.616 . . . . 70.32 110.768 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.86 -13.33 59.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.335 0.588 . . . . 64.45 109.767 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.98 16.07 61.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.693 -0.685 . . . . 72.13 113.61 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.24 133.39 52.7 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.123 0.487 . . . . 72.21 111.141 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -90.39 -48.93 3.37 Favored Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.505 -0.771 . . . . 74.3 113.059 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -110.38 116.0 30.66 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.306 -0.958 . . . . 73.13 111.905 -172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 39.7 p90 -146.66 146.36 30.35 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.891 -0.595 . . . . 73.02 110.448 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -131.75 131.83 43.32 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.281 -0.637 . . . . 71.31 109.281 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -89.25 129.82 35.75 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.806 0.336 . . . . 74.24 110.752 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.99 144.68 48.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.432 -1.321 . . . . 72.11 107.432 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -123.09 144.56 49.23 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.906 -0.718 . . . . 63.03 110.258 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.9 m -137.75 131.28 16.98 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.114 -0.494 . . . . 63.51 110.211 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.47 123.41 11.1 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.6 2.2 . . . . 72.24 111.218 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.5 p -142.78 179.25 7.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.991 -0.55 . . . . 52.24 110.476 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.2 t -56.38 143.38 66.0 Favored Pre-proline 0 N--CA 1.429 -1.485 0 C-N-CA 124.116 0.967 . . . . 63.14 109.987 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 464' ' ' VAL . 85.5 Cg_exo -50.58 -29.23 24.33 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.047 3.164 . . . . 75.41 113.01 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.06 -35.7 81.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.568 0.581 . . . . 74.05 112.568 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.87 -9.38 46.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 111.584 0.216 . . . . 42.02 111.584 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 61.4 t -61.5 127.02 20.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 109.88 -0.415 . . . . 75.42 109.88 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.3 71.4 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.562 -0.745 . . . . 33.05 111.798 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 434' ' ' THR . 4.3 mptp? -98.88 145.49 26.95 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.344 0.658 . . . . 75.41 109.475 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 94.9 t -82.12 126.61 39.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.378 -1.712 . . . . 74.34 106.378 173.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.24 -5.39 9.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.815 -0.754 . . . . 72.12 111.641 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.04 13.33 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.103 -1.046 . . . . 54.24 112.997 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 31.7 p -116.91 141.46 48.2 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.607 -1.257 . . . . 70.35 107.607 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.461 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 28.1 t-20 -57.16 -53.52 64.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-O 119.105 -0.474 . . . . 73.54 111.914 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.67 144.54 17.6 Favored 'Trans proline' 0 C--N 1.36 1.143 0 CA-C-N 120.459 1.2 . . . . 74.23 109.087 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.26 147.85 93.49 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.536 2.158 . . . . 75.13 111.536 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.85 -21.56 26.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.026 0.441 . . . . 42.54 111.625 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.85 -30.72 59.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.7 0.762 . . . . 35.3 109.717 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.25 152.93 17.94 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.539 -0.755 . . . . 74.42 110.036 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.2 p -85.19 117.68 24.28 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 115.945 -0.571 . . . . 71.33 110.593 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.2 m -100.79 146.63 27.03 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.573 -1.269 . . . . 73.15 107.573 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -71.31 150.79 44.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 118.078 0.399 . . . . 62.54 110.502 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.56 -25.06 23.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 124.316 1.046 . . . . 75.03 110.83 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -100.55 0.17 38.92 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.514 -0.766 . . . . 72.31 111.278 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -77.35 151.81 34.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.205 -1.406 . . . . 73.23 107.205 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.34 111.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 119.211 -0.995 . . . . 70.55 110.495 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 75.0 t -90.31 118.72 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.235 -1.024 . . . . 75.4 108.235 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 69.2 mt -95.18 119.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.345 -1.354 . . . . 72.32 107.345 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.99 119.67 55.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 109.361 -0.607 . . . . 64.3 109.361 -177.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 487' ' ' ILE . 3.2 mp -99.03 119.67 47.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 121.352 0.596 . . . . 73.31 109.68 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.65 136.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.299 -0.864 . . . . 54.12 109.995 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.97 112.47 3.81 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 107.595 -2.202 . . . . 63.54 107.595 172.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.5 m -114.27 158.41 21.44 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.705 -0.48 . . . . 74.01 109.705 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -91.24 136.58 13.41 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.673 -0.775 . . . . 64.02 111.345 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.08 121.31 7.16 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.865 1.71 . . . . 54.14 108.365 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -82.75 80.9 8.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.12 0.962 . . . . 74.44 110.131 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -137.31 156.31 48.4 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.756 -1.201 . . . . 64.23 107.756 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -149.85 157.04 42.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.632 0.604 . . . . 73.42 112.632 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.42 130.6 34.61 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 125.344 1.458 . . . . 75.52 110.219 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -87.27 129.23 52.33 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.397 -0.521 . . . . 54.1 111.402 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.04 162.34 23.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.66 2.24 . . . . 64.34 111.552 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.27 114.55 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.047 -0.524 . . . . 74.33 110.041 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.84 -0.02 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 112.305 0.483 . . . . 72.13 112.305 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -68.87 143.21 54.58 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.407 0.442 . . . . 74.21 110.398 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 90.38 11.61 62.4 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.406 -0.902 . . . . 75.15 111.027 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -122.43 -170.16 2.03 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.841 -0.8 . . . . 75.02 108.841 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.8 m -91.21 155.44 18.58 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.366 -1.346 . . . . 74.33 107.366 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.22 -41.35 80.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.266 0.354 . . . . 73.01 111.606 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.5 m-20 -66.08 -42.98 88.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.23 -0.441 . . . . 74.01 111.463 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.5 -36.38 28.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 119.757 -0.777 . . . . 64.33 110.988 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.53 -46.4 86.21 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.477 -0.783 . . . . 75.33 111.382 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.8 -35.72 82.02 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 120.447 -0.501 . . . . 52.21 110.084 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 mmtp -65.52 -50.69 64.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.552 -0.295 . . . . 73.24 111.516 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.24 -40.51 96.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.289 -0.414 . . . . 71.54 110.936 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.3 -42.61 75.21 Favored 'General case' 0 C--O 1.183 -2.441 0 N-CA-C 109.225 -0.658 . . . . 72.42 109.225 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.18 -40.01 84.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.943 0.497 . . . . 63.01 111.607 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.6 t -67.01 -29.66 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 112.455 0.539 . . . . 73.11 112.455 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -118.55 -5.11 10.76 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.406 -0.918 . . . . 70.22 111.699 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -108.71 1.94 Allowed Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 115.402 -0.817 . . . . 61.12 113.497 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 31.3 m-85 -130.3 174.41 9.87 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.461 -0.495 . . . . 61.33 111.279 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -103.82 -5.13 22.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.403 -0.817 . . . . 54.21 111.096 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 550' ' ' VAL . 14.8 ptpt -113.82 121.04 42.82 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.029 -0.532 . . . . 72.14 110.782 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -126.27 148.54 49.49 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.681 0.753 . . . . 74.24 111.766 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.9 m -127.81 154.94 44.85 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.851 -1.907 . . . . 64.34 105.851 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -121.81 143.21 49.54 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.722 -0.791 . . . . 74.3 109.848 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 554' ' ' GLN . . . -113.73 123.0 48.83 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.933 -1.506 . . . . 70.33 106.933 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.3 m -88.76 116.45 27.03 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.437 -0.801 . . . . 62.21 109.779 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 29.9 m -121.14 156.92 24.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.179 -1.415 . . . . 62.41 107.179 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.39 124.04 27.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.252 0.549 . . . . 74.44 110.438 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 18.3 m -72.15 151.69 92.48 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.631 -1.168 . . . . 75.33 112.626 -173.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 4.5 Cg_exo -80.62 -144.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.848 2.366 . . . . 65.34 107.441 168.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.83 -49.57 68.15 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 121.554 -0.716 . . . . 72.11 111.926 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.95 152.25 36.25 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 121.168 1.245 . . . . 54.4 111.111 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.13 149.66 43.3 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.369 -0.604 . . . . 73.13 109.369 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 101.03 -10.45 58.49 Favored Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.97 -0.633 . . . . 62.54 111.907 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.32 148.81 24.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.315 0.579 . . . . 74.2 111.701 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.536 HG21 ' CB ' ' A' ' 508' ' ' ALA . 95.5 t -75.75 120.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.271 -0.877 . . . . 72.42 109.133 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -82.1 -31.39 30.74 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.121 -0.945 . . . . 74.5 108.751 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 170.62 -169.64 42.5 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.284 -0.726 . . . . 71.35 111.284 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 32.7 p -123.69 149.46 45.46 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.221 -1.77 . . . . 64.1 106.221 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.6 t-20 -56.21 -58.32 17.25 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.978 -0.534 . . . . 61.45 112.069 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.8 Cg_exo -80.5 145.16 16.4 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.343 1.362 . . . . 74.23 108.784 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.1 147.56 73.56 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.898 1.732 . . . . 63.23 112.226 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.51 129.57 32.88 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.728 0.811 . . . . 44.33 110.267 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.68 -7.79 36.58 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.624 -0.798 . . . . 54.51 111.51 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.8 m -82.73 126.87 32.86 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.791 -0.448 . . . . 70.41 109.791 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 87.9 m -93.3 123.18 36.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.037 -1.098 . . . . 63.31 108.037 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.97 158.55 68.38 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 109.113 -0.699 . . . . 52.5 109.113 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 34.6 Cg_exo -61.09 145.66 98.63 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 122.664 2.242 . . . . 71.51 112.129 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.439 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 18.5 m -67.4 -19.24 25.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 122.144 0.974 . . . . 72.33 109.221 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.13 3.78 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 63.0 109.998 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 36.3 t -112.71 141.83 46.04 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.783 -1.192 . . . . 70.04 107.783 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.471 ' HA ' ' HG3' ' A' ' 519' ' ' LYS . 21.9 t -91.34 136.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.306 -0.627 . . . . 72.43 109.306 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.1 tp -91.32 135.02 28.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 110.078 -0.341 . . . . 62.33 110.078 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.86 117.64 35.08 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-O 121.573 0.701 . . . . 72.3 110.7 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.51 118.88 33.95 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.897 -1.52 . . . . 74.13 106.897 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 523' ' ' ALA . 8.9 mt-30 -94.56 106.67 18.66 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.616 -1.253 . . . . 63.34 107.616 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.23 138.56 46.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-N 114.957 -1.02 . . . . 75.33 112.029 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.463 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 31.8 m -61.02 121.1 11.59 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.037 -0.983 . . . . 54.54 109.392 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 22.5 pttp . . . . . 0 C--O 1.254 1.305 0 CA-C-N 115.754 -0.657 . . . . 62.31 110.588 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.163 0 N-CA-C 109.001 -1.64 . . . . 53.45 109.001 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.3 132.16 25.14 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 CA-C-N 119.399 1.6 . . . . 52.25 109.419 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.1 pt-20 -96.34 17.57 15.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.808 0.813 . . . . 73.24 109.588 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -83.61 123.57 29.91 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.319 -0.855 . . . . 54.15 109.571 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -120.26 164.45 16.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.788 -1.189 . . . . 71.52 107.788 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.42 141.61 32.62 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 123.247 0.619 . . . . 64.23 112.323 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -85.06 131.46 48.6 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 105.33 -2.1 . . . . 55.23 105.33 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.34 141.5 97.78 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.994 1.796 . . . . 71.41 113.041 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -102.34 -13.03 17.49 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.411 -0.813 . . . . 64.24 108.913 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.61 8.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.046 -0.979 . . . . 62.13 110.331 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.1 m -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.798 -1.092 . . . . 74.43 108.865 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 p -59.29 -27.62 66.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.133 -1.394 . . . . 75.05 111.115 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.42 -45.08 23.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.609 -0.515 . . . . 71.25 109.609 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.7 m -163.69 144.49 8.85 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.148 -1.056 . . . . 51.33 108.148 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 441' ' ' VAL . 30.1 t80 -59.29 -41.38 88.8 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.75 0.42 . . . . 73.14 110.465 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.42 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.16 -40.69 74.27 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.19 0.306 . . . . 64.33 111.176 175.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.456 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 40.7 mm-40 -61.87 -44.43 96.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 116.237 -0.438 . . . . 70.44 110.31 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.23 -47.71 84.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.351 -0.84 . . . . 51.41 110.708 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.7 t -58.7 -50.55 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 O-C-N 123.704 0.628 . . . . 74.05 110.79 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -38.0 84.7 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.789 0.662 . . . . 75.44 112.789 -177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -66.47 -43.29 85.89 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 120.739 0.305 . . . . 72.41 110.719 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.79 -36.88 78.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 74.43 110.313 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.4 m -63.63 -41.28 98.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.995 -0.743 . . . . 74.11 108.995 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.16 -18.67 62.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.987 -0.551 . . . . 63.32 111.239 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.47 -14.65 51.99 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.677 -0.49 . . . . 74.35 109.677 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 85.98 8.73 78.62 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.953 -0.567 . . . . 63.15 114.33 172.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.49 124.54 20.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.213 0.506 . . . . 74.42 111.834 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -63.4 -55.41 25.79 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.054 -0.975 . . . . 21.1 114.285 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 0.4 OUTLIER -121.81 130.95 53.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.282 -0.567 . . . . 74.21 110.761 -174.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.77 144.59 31.25 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.805 -0.634 . . . . 75.14 109.304 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -131.34 141.5 49.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.456 -0.572 . . . . 63.1 109.456 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.63 136.4 34.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.878 0.736 . . . . 64.13 110.813 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.63 52.44 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.55 -2.018 . . . . 72.12 105.55 171.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -138.59 150.47 46.34 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 119.012 0.823 . . . . 72.31 110.138 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 25.6 m -131.94 145.7 58.56 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 108.627 -0.879 . . . . 55.41 108.627 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.63 134.8 26.93 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.505 2.137 . . . . 71.12 112.04 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.3 p -152.15 179.74 8.24 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.866 0.866 . . . . 64.1 109.207 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -59.68 142.3 87.98 Favored Pre-proline 0 N--CA 1.432 -1.339 0 C-N-CA 123.741 0.817 . . . . 44.45 111.411 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 464' ' ' VAL . 54.0 Cg_exo -52.57 -28.13 35.43 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.421 3.414 . . . . 73.13 113.428 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.98 -10.34 59.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.344 0.498 . . . . 64.01 112.344 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 9.5 mp -107.29 0.73 23.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.446 0.535 . . . . 75.5 112.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.1 p -61.29 128.81 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.286 0.565 . . . . 55.31 112.191 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.82 69.7 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 120.896 -0.669 . . . . 74.03 112.427 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 23.5 mtpp -109.91 146.17 35.62 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.318 -0.993 . . . . 72.51 108.318 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 486' ' ' ILE . 63.1 t -81.86 124.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.29 -0.633 . . . . 73.23 109.29 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.1 pt -101.68 -2.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.923 -0.58 . . . . 62.14 111.639 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.99 156.67 11.79 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.119 -0.562 . . . . 50.43 112.324 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 35.0 p -128.5 148.73 50.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.415 -0.957 . . . . 64.12 108.415 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -65.52 -56.18 20.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.273 -0.394 . . . . 61.23 110.477 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 57.3 Cg_endo -82.2 131.37 6.72 Favored 'Trans proline' 0 C--N 1.364 1.369 0 CA-C-N 120.152 1.09 . . . . 74.05 109.473 170.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -72.69 152.61 53.49 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.976 1.784 . . . . 42.53 113.119 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 6.35 11.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.395 1.078 . . . . 72.41 111.232 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.23 -28.64 13.99 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.796 -0.638 . . . . 73.32 111.108 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -115.45 161.47 18.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.211 -0.663 . . . . 73.24 109.211 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 33.3 p -95.35 140.8 29.72 Favored 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 120.483 -0.487 . . . . 71.22 109.875 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . 23.4 m -120.88 147.94 44.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.452 -0.573 . . . . 62.22 109.452 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 482' ' ' ASN . . . -57.12 151.32 15.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.352 0.871 . . . . 64.13 113.352 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 448' ' ' GLY . 45.1 mm -58.07 -32.98 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.049 0.939 . . . . 74.14 110.368 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.2 t -81.4 3.25 25.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.251 -0.886 . . . . 64.51 111.979 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 478' ' ' SER . 0.8 OUTLIER -74.33 158.42 34.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.275 0.559 . . . . 70.01 112.349 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 451' ' ' ARG . 60.4 t -106.97 114.31 45.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.027 -1.101 . . . . 73.52 108.027 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 88.6 t -94.61 119.91 43.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.237 0.541 . . . . 73.25 110.439 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 71.9 mt -96.31 112.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.484 -1.673 . . . . 74.04 106.484 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.19 128.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 116.167 -0.47 . . . . 71.1 110.533 -176.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.93 115.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.599 0.714 . . . . 75.24 111.069 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.53 142.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.547 -0.752 . . . . 72.14 109.55 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.27 113.71 3.77 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.091 -1.204 . . . . 62.25 110.091 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 35.1 t -95.8 129.81 42.92 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 106.748 -1.575 . . . . 61.42 106.748 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -116.61 99.71 0.87 Allowed Glycine 0 C--N 1.297 -1.593 0 C-N-CA 119.754 -1.212 . . . . 73.42 112.029 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.8 114.52 3.98 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.147 1.898 . . . . 73.41 109.911 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.34 106.69 17.57 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.027 -0.731 . . . . 60.1 109.027 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 546' ' ' PRO . 66.6 p -124.92 164.93 19.02 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.25 -0.887 . . . . 74.32 109.123 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 6.4 mmpt? -139.62 144.18 37.57 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.686 -0.857 . . . . 72.11 108.686 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 27.6 t70 -90.59 130.34 36.63 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.788 -0.819 . . . . 54.42 108.788 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 20.4 pt -96.12 121.39 60.77 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.268 -0.573 . . . . 71.34 112.525 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.23 169.96 4.93 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.915 1.743 . . . . 65.31 109.316 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.88 129.71 34.84 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.491 -0.884 . . . . 75.44 109.574 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.35 14.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 123.278 1.513 . . . . 62.11 107.093 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -71.61 138.57 48.82 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.546 -1.661 . . . . 60.41 110.293 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.09 -4.57 41.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.648 -0.787 . . . . 72.51 111.822 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -106.09 176.63 5.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 71.1 p -80.41 157.87 26.13 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.448 -0.901 . . . . 72.35 108.963 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.46 -43.14 86.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.495 0.664 . . . . 62.24 110.19 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.86 -42.8 85.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.77 -1.105 . . . . 73.31 111.812 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.18 -36.84 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 119.431 -0.908 . . . . 73.43 111.243 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.49 73.4 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.908 -0.587 . . . . 71.44 111.282 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.3 -35.97 82.62 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 120.318 -0.553 . . . . 65.25 110.614 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -61.37 -53.69 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.505 0.503 . . . . 75.24 110.775 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.11 -41.85 94.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.788 -0.642 . . . . 73.42 110.673 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 551' ' ' ILE . 4.9 tt -66.36 -40.66 89.91 Favored 'General case' 0 C--O 1.186 -2.257 0 CA-C-N 115.404 -0.816 . . . . 75.51 109.246 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 61.4 t30 -58.54 -38.29 77.46 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.387 0.675 . . . . 60.23 111.621 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.57 -40.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.726 -0.67 . . . . 72.13 112.032 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -107.4 -23.28 12.26 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.037 -0.665 . . . . 70.23 112.197 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -103.59 -100.16 2.58 Favored Glycine 0 N--CA 1.413 -2.861 0 CA-C-N 115.262 -0.881 . . . . 34.42 113.683 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 46.0 m-85 -131.23 166.86 20.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.331 0.586 . . . . 64.45 111.185 -171.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -102.8 -4.12 25.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.943 -1.026 . . . . 74.4 110.295 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -109.95 116.29 31.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.705 . . . . 72.24 109.763 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -128.94 145.84 51.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.332 0.587 . . . . 73.13 110.911 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 59.2 m -135.64 145.63 47.02 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.988 -1.486 . . . . 73.51 106.988 172.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -125.55 143.25 51.09 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.393 -0.523 . . . . 72.44 111.95 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.45 129.23 52.85 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.596 -1.261 . . . . 65.44 107.596 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -88.35 127.74 35.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.207 0.527 . . . . 73.21 110.422 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.1 m -121.54 162.53 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.287 -1.005 . . . . 75.42 108.287 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.78 140.51 38.23 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.937 -0.705 . . . . 73.41 110.065 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 8.3 m -90.08 114.17 59.9 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.377 -1.283 . . . . 62.24 110.825 -174.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.85 -83.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.729 1.619 . . . . 52.52 109.661 173.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.3 mtt180 -90.9 -54.8 0.27 Allowed Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-O 118.805 -0.616 . . . . 64.53 111.14 172.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.66 ' O ' ' HB3' ' A' ' 527' ' ' SER . 21.9 Cg_endo -61.61 153.26 68.2 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.99 1.794 . . . . 64.41 111.359 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.46 82.43 0.27 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.853 0.861 . . . . 71.31 108.993 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.31 -31.12 2.64 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.482 -1.047 . . . . 75.5 110.482 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -86.12 149.55 25.05 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.259 -0.471 . . . . 72.21 110.17 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 501' ' ' ALA . 5.3 p -73.85 123.11 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.318 -0.993 . . . . 64.53 108.318 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -71.87 -41.58 67.86 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.872 -1.058 . . . . 60.11 110.874 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -174.26 -160.35 22.3 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.407 -0.902 . . . . 71.12 111.189 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.0 p -131.74 159.98 36.86 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.66 -0.867 . . . . 73.42 108.66 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.473 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 48.8 t30 -69.02 -55.36 10.53 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-O 118.937 -0.554 . . . . 72.53 110.512 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.0 Cg_endo -81.48 146.94 15.59 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.05 1.167 . . . . 74.33 109.533 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.04 147.73 43.66 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.943 1.762 . . . . 74.34 112.444 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.11 138.23 58.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.824 -0.626 . . . . 53.23 110.017 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.74 -5.75 60.16 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 111.173 -0.771 . . . . 65.43 111.173 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -88.78 126.04 35.16 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.593 -0.521 . . . . 62.32 109.593 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.1 m -90.51 123.13 33.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.802 -1.184 . . . . 63.53 107.802 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.74 154.74 75.8 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.82 -0.437 . . . . 52.44 109.82 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.533 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.0 Cg_exo -64.72 147.71 89.91 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.945 2.43 . . . . 73.51 113.55 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.534 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.6 m -67.05 -19.42 25.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.163 0.982 . . . . 70.04 111.995 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.62 -8.03 59.03 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.688 -1.142 . . . . 34.05 109.365 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 41.4 m -97.44 149.91 21.62 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 115.165 -0.925 . . . . 62.4 109.204 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.87 136.57 26.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.94 -0.573 . . . . 73.3 110.309 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 512' ' ' LEU . 15.5 tt -98.93 129.01 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.665 0.745 . . . . 74.43 109.963 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 521' ' ' SER . 31.8 tt0 -103.74 129.67 51.15 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 115.696 -0.684 . . . . 50.11 110.379 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.72 134.5 48.74 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.419 1.088 . . . . 71.42 110.672 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.06 108.53 19.79 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.276 -1.75 . . . . 61.33 106.276 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.09 137.62 38.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 112.089 0.403 . . . . 75.2 112.089 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.7 m -60.42 122.02 13.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.668 -1.604 . . . . 73.01 106.668 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.836 -0.602 . . . . 70.14 111.863 -172.789 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.903 0 N-CA-C 109.993 -1.243 . . . . 43.32 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.58 152.29 70.22 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.298 1.999 . . . . 62.21 110.858 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 425' ' ' GLU . 0.3 OUTLIER -82.59 49.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.041 0.924 . . . . 74.41 111.319 -177.436 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 96.2 mt-30 -102.93 130.22 49.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.81 -1.086 . . . . 72.33 108.758 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -128.23 158.85 36.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.206 -1.035 . . . . 73.33 108.206 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -82.66 141.5 32.43 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 123.254 0.622 . . . . 72.51 110.365 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -85.09 130.01 53.79 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.052 -0.721 . . . . 70.21 109.052 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.01 145.19 99.42 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.979 2.453 . . . . 71.32 112.333 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.24 11.72 35.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.433 1.111 . . . . 74.44 110.14 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.91 -9.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.581 1.182 . . . . 73.31 108.562 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.8 m -59.26 -33.75 71.41 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.916 -1.493 . . . . 65.3 110.292 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 4.2 m -60.68 -27.34 67.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.505 -1.225 . . . . 65.53 110.375 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.79 -44.25 17.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 119.991 -0.683 . . . . 74.51 110.959 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.614 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 91.5 m -162.0 144.61 11.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 109.394 -0.595 . . . . 61.25 109.394 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -52.68 -49.42 65.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.016 0.926 . . . . 73.51 111.227 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.69 -40.77 80.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 43.33 111.22 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 19.9 mm-40 -61.42 -41.42 97.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.827 -0.624 . . . . 73.45 111.101 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.05 -51.82 67.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 123.915 0.759 . . . . 53.11 110.718 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.77 -46.68 95.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 CA-C-N 115.114 -0.948 . . . . 75.02 111.994 -174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 75.6 mmtt -60.84 -47.89 84.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 74.24 110.028 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -68.26 -45.29 73.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.351 -0.84 . . . . 74.51 111.431 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 452' ' ' PHE . 21.8 tp -69.07 -38.53 79.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.063 0.459 . . . . 63.41 110.845 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.6 m -64.16 -39.66 94.48 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.838 -0.619 . . . . 73.24 109.459 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -18.98 62.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.932 -0.577 . . . . 64.32 110.442 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.16 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.087 0.47 . . . . 61.02 110.124 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.84 -23.71 9.93 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.617 -0.802 . . . . 43.25 113.175 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.69 134.29 56.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.741 0.305 . . . . 74.44 110.783 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -130.13 -8.17 3.41 Favored Glycine 0 N--CA 1.428 -1.886 0 C-N-CA 119.811 -1.185 . . . . 61.04 112.898 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -102.69 115.4 30.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.548 -0.908 . . . . 71.21 108.548 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 444' ' ' LEU . 42.3 m-85 -129.19 154.88 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.294 -0.866 . . . . 74.23 110.394 -175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.468 ' HB3' HG12 ' A' ' 485' ' ' ILE . 0.7 OUTLIER -138.86 122.92 17.93 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.37 -2.455 . . . . 75.42 104.37 169.239 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -105.17 134.61 47.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.012 0.434 . . . . 72.11 110.904 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.13 153.3 47.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.497 -0.927 . . . . 52.24 108.497 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.35 146.49 50.02 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 62.11 109.396 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 53.4 m -139.89 135.21 16.37 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 116.555 -0.293 . . . . 65.34 110.373 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 26.6 Cg_exo -64.72 122.39 10.23 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.386 2.057 . . . . 62.22 111.374 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.7 m -140.54 -179.91 6.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.81 -1.181 . . . . 71.41 107.81 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.406 ' CG2' HD23 ' A' ' 463' ' ' LEU . 10.8 t -50.2 142.99 13.46 Favored Pre-proline 0 C--O 1.25 1.131 0 C-N-CA 123.168 0.587 . . . . 73.35 110.795 176.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.12 -29.32 28.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.088 3.192 . . . . 72.13 112.986 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.52 -18.86 63.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.467 0.543 . . . . 54.24 112.467 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -100.97 6.8 43.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.978 0.732 . . . . 75.23 112.978 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.6 p -61.01 127.69 21.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.406 -0.518 . . . . 55.12 110.546 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.48 12.73 84.26 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.801 -0.714 . . . . 60.54 112.439 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 94.6 mttt -121.18 154.87 35.68 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.693 -0.854 . . . . 71.14 108.693 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.645 HG22 HD11 ' A' ' 486' ' ' ILE . 40.5 t -82.06 126.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.174 -0.676 . . . . 64.23 109.174 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.4 pt -98.17 -13.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.462 -0.495 . . . . 60.24 110.358 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.45 160.82 19.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.595 -0.812 . . . . 73.32 111.684 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.5 p -120.86 146.72 46.28 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.546 -0.909 . . . . 71.33 108.546 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.561 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.3 t-20 -58.49 -57.93 22.81 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-O 119.128 -0.463 . . . . 73.31 111.042 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.34 129.55 14.04 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 108.737 -1.294 . . . . 73.45 108.737 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.7 133.08 37.72 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 74.21 112.254 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.6 -5.7 46.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.939 0.876 . . . . 63.32 110.673 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.81 -28.44 28.08 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.224 -1.353 . . . . 73.11 109.4 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.91 165.21 11.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.041 -0.726 . . . . 74.11 109.041 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.5 p -87.84 120.83 29.56 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 109.094 -0.706 . . . . 75.15 109.094 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 19.8 m -104.39 147.98 26.93 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.359 -0.978 . . . . 73.42 108.359 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.81 148.58 44.38 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.752 0.31 . . . . 71.43 110.94 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.36 -21.9 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.869 0.842 . . . . 64.31 110.549 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 t -94.32 -0.56 54.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.228 -0.896 . . . . 71.22 110.566 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.9 142.13 38.63 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.345 -0.983 . . . . 71.43 108.345 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.63 112.0 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.702 -0.851 . . . . 63.52 108.702 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.77 118.41 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 108.389 -0.967 . . . . 52.14 108.389 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.4 mt -92.44 112.01 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 106.018 -1.845 . . . . 75.45 106.018 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.55 121.56 56.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.121 -0.945 . . . . 73.31 108.633 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.93 118.85 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.748 -0.66 . . . . 71.2 109.608 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.25 139.16 19.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.011 -1.107 . . . . 62.12 108.011 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.02 127.08 7.79 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 109.975 -1.25 . . . . 54.44 109.975 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 24.6 p -108.38 131.72 54.47 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.749 -0.834 . . . . 70.23 108.749 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -90.88 163.75 29.64 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.939 -1.264 . . . . 74.21 109.939 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.68 121.78 10.06 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.153 1.902 . . . . 73.41 112.016 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -112.57 70.12 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.353 -1.351 . . . . 74.32 107.353 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 41.5 p -135.51 166.36 23.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.854 -1.066 . . . . 62.42 109.583 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 27.6 mmtm -140.13 137.63 34.61 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.052 0.453 . . . . 65.11 111.802 173.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.78 126.46 31.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.626 -1.17 . . . . 72.52 108.058 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.9 pt -96.34 131.01 29.39 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.73 -0.788 . . . . 75.44 110.619 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.76 -177.95 1.03 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.356 2.037 . . . . 71.22 110.472 174.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.91 93.8 3.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.07 0.462 . . . . 74.35 110.232 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.19 -0.6 10.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.84 -1.541 . . . . 60.22 106.84 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -70.46 143.69 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.459 -1.7 . . . . 73.41 109.565 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.22 -15.45 25.36 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.477 -0.868 . . . . 45.1 111.52 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -97.64 -170.15 1.95 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.28 -0.568 . . . . 74.43 110.249 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.5 157.52 21.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.894 -1.15 . . . . 74.24 107.894 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 42.4 t -56.62 -49.62 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.416 0.627 . . . . 43.5 111.14 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.27 -41.96 80.3 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.282 -0.872 . . . . 74.3 111.129 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.32 -44.67 94.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.828 -1.078 . . . . 45.43 110.632 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.05 96.47 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.003 -0.544 . . . . 61.33 110.957 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.21 -40.17 95.19 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.89 -0.411 . . . . 73.45 109.89 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -44.03 89.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.832 -0.622 . . . . 75.14 110.6 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -68.65 -44.51 73.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.039 0.447 . . . . 73.14 110.519 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.15 -36.8 85.37 Favored 'General case' 0 C--O 1.191 -2.004 0 CA-C-N 115.565 -0.743 . . . . 71.41 109.54 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 7.7 t30 -57.85 -37.96 74.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.263 0.625 . . . . 61.04 111.597 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.46 -43.16 91.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.585 -0.734 . . . . 55.3 111.675 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -110.85 13.29 22.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.521 -0.472 . . . . 71.45 110.549 -171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.9 -103.01 0.31 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.408 -1.377 . . . . 44.5 115.108 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 46.9 m-85 -127.04 177.56 6.56 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.005 0.431 . . . . 74.11 112.143 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 m -120.74 -14.52 8.54 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.739 -0.664 . . . . 64.54 110.949 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.438 ' HB3' HG12 ' A' ' 550' ' ' VAL . 31.5 mmmt -108.23 119.68 40.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.431 -0.581 . . . . 75.24 109.431 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.72 147.57 44.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.714 -0.675 . . . . 73.01 111.001 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 44.3 m -137.5 151.64 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.756 -1.572 . . . . 65.02 106.756 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -121.53 137.83 54.56 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 118.339 0.518 . . . . 71.23 111.381 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -126.17 122.62 36.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.353 -1.351 . . . . 70.3 107.353 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 5.2 p -89.33 132.7 34.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.777 0.322 . . . . 52.13 111.5 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.76 149.31 24.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.183 -1.414 . . . . 72.11 107.183 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.88 136.3 37.25 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.133 -0.627 . . . . 64.32 110.972 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.1 m -133.64 160.5 68.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.065 -0.97 . . . . 73.55 109.982 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -70.19 -142.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.38 2.72 . . . . 63.44 111.964 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -51.39 81.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 113.888 1.07 . . . . 73.04 113.888 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.24 133.02 31.38 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 121.043 1.408 . . . . 72.11 109.799 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -168.78 125.49 0.98 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.303 0.641 . . . . 74.11 109.518 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.9 -23.53 1.45 Allowed Glycine 0 C--N 1.301 -1.413 0 N-CA-C 109.841 -1.304 . . . . 63.13 109.841 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.55 29.92 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.447 -0.946 . . . . 74.02 108.447 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 75.0 t -74.05 119.39 21.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.6 -0.889 . . . . 61.0 108.6 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.0 m -68.5 -40.36 80.89 Favored 'General case' 0 N--CA 1.427 -1.595 0 O-C-N 124.529 1.143 . . . . 71.32 109.642 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 169.61 -152.87 20.63 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.506 -0.854 . . . . 42.23 111.541 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -134.04 161.76 33.96 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.744 -1.206 . . . . 61.33 107.744 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -56.32 -65.3 1.67 Allowed Pre-proline 0 N--CA 1.474 0.76 0 CA-C-O 118.891 -0.576 . . . . 63.41 110.65 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 60.2 Cg_endo -76.88 147.92 27.66 Favored 'Trans proline' 0 C--N 1.367 1.509 0 CA-C-N 120.633 1.262 . . . . 74.25 109.248 173.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.86 163.05 40.08 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.927 1.751 . . . . 71.11 111.528 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.76 58.66 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.187 -0.46 . . . . 61.2 110.21 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.49 -12.76 61.51 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.936 -0.865 . . . . 65.42 110.936 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.7 m -86.04 124.22 32.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 109.07 -0.715 . . . . 73.25 109.07 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.1 t -90.6 123.38 34.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.96 -1.126 . . . . 74.21 107.96 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 517' ' ' PHE . 19.4 m -123.64 156.27 64.93 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 109.671 -0.492 . . . . 55.03 109.671 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 135.08 65.29 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.213 2.609 . . . . 71.33 114.23 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.5 m -67.28 -20.78 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.274 -0.876 . . . . 63.55 111.518 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.11 -0.23 55.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.457 -0.792 . . . . 71.15 111.12 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 17.4 t -100.42 151.04 22.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.236 -1.024 . . . . 63.15 108.236 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 519' ' ' LYS . 5.7 m -88.58 136.41 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 N-CA-C 108.022 -1.103 . . . . 73.41 108.022 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.6 tt -97.52 143.28 12.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 120.036 -0.665 . . . . 74.1 110.858 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -102.45 118.37 36.72 Favored 'General case' 0 N--CA 1.408 -2.547 0 C-N-CA 123.471 0.709 . . . . 64.24 109.404 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.0 tp -97.05 129.25 44.51 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.729 -1.123 . . . . 50.2 108.689 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -90.05 112.95 24.56 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.364 -0.976 . . . . 71.33 108.364 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.8 137.88 33.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.006 -0.543 . . . . 65.31 111.955 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.5 m -68.76 126.08 28.61 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 115.64 -0.709 . . . . 73.35 111.65 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 115.308 -0.86 . . . . 52.24 108.803 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.033 0 N-CA-C 110.443 -1.063 . . . . 51.22 110.443 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.06 144.05 23.39 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.224 1.95 . . . . 54.41 112.338 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.3 OUTLIER -86.25 64.15 8.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.559 1.171 . . . . 64.22 110.191 178.203 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.435 ' C ' ' HB ' ' A' ' 477' ' ' THR . 26.7 mt-30 -101.64 125.7 48.35 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.006 -1.452 . . . . 55.14 108.755 175.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -121.04 153.44 37.38 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.407 -0.36 . . . . 62.33 110.341 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.02 141.39 28.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.581 -0.736 . . . . 73.14 110.889 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.4 mp -85.09 128.33 60.53 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 107.47 -1.307 . . . . 73.14 107.47 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.414 ' HG3' ' HD2' ' A' ' 443' ' ' LYS . 61.9 Cg_endo -69.8 147.05 61.78 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.561 2.174 . . . . 65.44 112.55 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -83.54 29.31 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.956 -0.565 . . . . 72.44 110.762 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 440' ' ' ALA . 35.9 m -85.84 7.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.001 0.905 . . . . 72.02 109.784 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 2.3 p -58.0 -35.02 70.62 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 125.999 1.719 . . . . 72.21 109.982 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.6 t -60.47 -26.04 66.48 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.718 -1.583 . . . . 74.13 111.496 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.81 -47.81 10.01 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 118.953 -1.099 . . . . 73.1 111.05 -174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.4 m -174.41 153.99 2.03 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.736 -1.209 . . . . 73.21 107.736 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 467' ' ' VAL . 29.2 t80 -50.37 -54.72 19.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.293 1.037 . . . . 64.11 110.656 171.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.18 -41.23 75.18 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.912 -0.586 . . . . 63.34 111.936 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 443' ' ' LYS . 66.2 mm-40 -61.51 -46.56 89.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.156 0.428 . . . . 74.13 112.156 -178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.433 ' HA ' HG23 ' A' ' 432' ' ' VAL . . . -72.22 -45.83 58.64 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.603 0.594 . . . . 63.41 112.603 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.74 -47.6 88.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 53.35 110.958 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.62 -35.21 79.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.304 0.242 . . . . 50.15 110.973 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 439' ' ' GLU . 2.6 tmtm? -66.26 -47.61 73.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.155 -1.054 . . . . 62.42 108.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.1 tp -68.86 -32.66 72.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.723 -0.671 . . . . 72.21 110.519 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 96.9 m -60.89 -43.99 97.72 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.51 -0.768 . . . . 64.24 109.308 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -20.02 62.45 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.077 -0.51 . . . . 71.34 111.148 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.54 -10.9 59.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.997 -0.547 . . . . 71.31 110.414 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.51 -8.43 8.33 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 119.927 -1.13 . . . . 74.12 113.956 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 445' ' ' THR . 92.5 m-85 -86.17 133.37 33.86 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 117.306 0.553 . . . . 73.32 110.773 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.41 -13.96 3.04 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.886 -0.673 . . . . 53.23 112.692 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 483' ' ' VAL . 14.3 ttm180 -103.06 116.29 32.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.41 0.605 . . . . 71.04 110.87 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.04 158.03 40.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.826 -0.625 . . . . 75.01 111.231 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.4 tppp? -134.61 135.7 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.042 -2.207 . . . . 61.44 105.042 172.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -115.95 135.09 54.3 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.535 0.607 . . . . 73.32 111.236 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.24 140.86 45.58 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.348 -0.982 . . . . 64.3 108.348 175.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.86 142.12 46.5 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.862 -0.792 . . . . 74.14 108.862 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.5 t -140.58 146.74 46.19 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 108.605 -0.887 . . . . 54.15 108.605 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.2 Cg_exo -65.08 140.17 64.31 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.846 1.698 . . . . 70.3 109.926 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 71.1 m -150.72 179.77 7.93 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.747 -0.835 . . . . 60.2 108.747 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -56.09 133.67 74.5 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.94 -0.763 . . . . 75.45 108.94 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 79.3 Cg_exo -50.1 -29.59 22.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.142 3.228 . . . . 62.41 115.117 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.81 -10.31 59.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.234 0.828 . . . . 54.23 113.234 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.8 mt -102.53 11.61 37.61 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.784 -0.366 . . . . 64.24 111.731 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -61.14 128.05 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.999 0.428 . . . . 73.54 110.737 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.8 3.99 90.39 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.996 -0.547 . . . . 73.33 112.292 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 434' ' ' THR . 93.5 mttt -112.23 159.69 18.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.371 -0.974 . . . . 71.3 108.371 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 46.0 t -82.67 129.07 38.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.557 -0.905 . . . . 52.41 108.557 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.33 -20.52 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.361 0.601 . . . . 63.3 109.764 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.75 170.2 33.09 Favored Glycine 0 N--CA 1.416 -2.688 0 N-CA-C 110.471 -1.052 . . . . 53.53 110.471 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.2 p -120.02 157.62 28.49 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.452 -0.573 . . . . 72.35 109.452 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.577 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 25.6 t-20 -60.21 -49.28 91.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 119.238 -0.41 . . . . 51.34 111.49 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.0 Cg_exo -83.14 155.88 14.82 Favored 'Trans proline' 0 C--N 1.365 1.402 0 N-CA-C 107.821 -1.646 . . . . 73.25 107.821 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 68.4 Cg_endo -66.36 146.65 81.26 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 121.697 1.598 . . . . 60.51 109.887 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.94 -37.4 29.56 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 121.059 0.457 . . . . 73.22 111.166 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . 0.271 18.8 m-80 -85.41 -8.33 58.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.719 1.377 . . . . 41.04 114.719 -172.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.8 mp0 -95.39 152.28 18.54 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.773 -1.195 . . . . 74.12 107.773 174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.435 ' HB ' ' C ' ' A' ' 426' ' ' GLN . 33.1 p -79.51 121.63 25.46 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.272 0.558 . . . . 62.14 110.738 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.6 m -104.59 140.83 37.43 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.357 -0.979 . . . . 65.25 108.357 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.73 145.67 52.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.733 0.302 . . . . 64.13 111.635 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.0 mm -59.59 -21.89 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.472 0.709 . . . . 71.11 111.27 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.8 t -83.49 0.08 47.94 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.924 -0.485 . . . . 72.25 111.473 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.08 154.77 20.49 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.967 0.413 . . . . 74.13 110.605 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 451' ' ' ARG . 2.6 p -98.25 124.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.17 -1.418 . . . . 42.24 107.17 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.41 118.7 37.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 C-N-CA 119.19 -1.004 . . . . 75.04 109.405 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.577 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.96 113.15 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.029 -1.841 . . . . 74.11 106.029 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.34 128.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 115.923 -0.58 . . . . 75.53 109.595 -175.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 31.5 mt -104.5 119.96 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.277 -0.874 . . . . 64.01 109.286 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.59 137.76 23.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.279 -0.873 . . . . 73.0 108.885 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -85.05 123.49 6.32 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 110.943 -0.863 . . . . 62.35 110.943 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 27.4 t -111.07 129.46 55.91 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.67 -1.604 . . . . 62.2 106.67 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -80.15 146.8 28.19 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 109.291 -1.523 . . . . 63.23 109.291 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.08 110.99 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.85 1.7 . . . . 75.04 111.819 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -98.73 61.27 1.32 Allowed 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.69 -1.226 . . . . 64.43 107.69 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 23.8 p -134.76 160.71 37.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.348 -0.842 . . . . 74.32 110.66 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -150.45 142.24 23.74 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.714 0.806 . . . . 63.44 109.052 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.6 p-10 -88.75 134.01 34.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.479 . . . . 72.35 107.008 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.95 124.92 88.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 CA-C-N 115.489 -0.778 . . . . 63.41 111.867 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.06 150.15 1.65 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.533 2.155 . . . . 60.25 111.212 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -87.64 107.55 18.66 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.345 1.069 . . . . 63.54 110.053 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.53 42.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 106.925 -1.509 . . . . 64.01 106.925 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -80.42 159.89 25.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.406 -1.27 . . . . 64.51 112.629 -173.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.15 -16.09 46.37 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.216 -0.753 . . . . 72.32 111.216 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.443 ' HB3' HG13 ' A' ' 507' ' ' VAL . 46.4 mt-30 -89.93 -173.08 3.75 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.195 0.522 . . . . 74.24 111.696 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.6 m -90.85 156.56 17.93 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.403 -1.332 . . . . 63.32 107.403 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 19.2 t -55.05 -48.97 75.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 123.721 0.638 . . . . 64.44 111.08 -172.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.34 -41.62 80.46 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.619 0.6 . . . . 75.12 112.619 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.9 p -73.88 -34.86 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.507 -0.877 . . . . 75.54 111.234 -174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.78 89.22 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.727 -0.67 . . . . 73.15 110.216 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.1 mt-30 -62.73 -42.74 99.81 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 123.448 0.467 . . . . 73.11 110.481 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 510' ' ' LYS . 0.0 OUTLIER -62.08 -42.67 99.44 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 112.897 0.703 . . . . 73.3 112.897 178.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -66.99 -48.11 69.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.53 -0.468 . . . . 65.4 110.094 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 551' ' ' ILE . 41.8 tp -60.2 -41.17 92.44 Favored 'General case' 0 C--O 1.198 -1.614 0 CA-C-N 115.512 -0.767 . . . . 63.03 110.144 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.8 t-20 -59.21 -48.05 83.05 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.856 0.862 . . . . 74.2 111.29 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.88 -18.89 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.318 0.488 . . . . 75.15 112.318 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -118.96 8.66 11.7 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.778 -0.769 . . . . 64.0 110.229 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -149.84 -95.83 0.14 Allowed Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.02 -1.562 . . . . 65.53 115.836 -170.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 59.6 m-85 -123.11 170.18 10.47 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.221 0.534 . . . . 74.43 111.736 -165.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 20.4 p -97.11 -35.9 10.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.276 -0.874 . . . . 54.22 112.352 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -117.77 142.61 47.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.127 0.489 . . . . 71.53 112.075 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -127.6 156.99 41.4 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.735 -1.12 . . . . 74.12 110.404 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.4 t -129.73 141.99 50.79 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.845 -2.28 . . . . 71.13 104.845 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -121.28 129.78 53.31 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.944 -0.761 . . . . 72.34 108.944 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.03 136.96 51.0 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 123.601 0.563 . . . . 61.33 109.736 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 51.9 m -88.56 131.61 34.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.31 -0.859 . . . . 63.13 109.491 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.434 ' O ' ' HG3' ' A' ' 557' ' ' LYS . 34.4 m -122.24 149.53 25.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.734 -0.469 . . . . 70.12 109.734 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.93 111.45 16.27 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.74 0.781 . . . . 73.04 110.195 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 7.2 p -107.58 119.81 49.37 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.615 -1.175 . . . . 52.04 109.818 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 26.9 Cg_exo -65.13 -51.49 1.54 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.449 2.099 . . . . 65.55 111.527 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 529' ' ' ARG . 14.9 mmm180 -102.78 -50.93 0.15 Allowed Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 114.186 1.18 . . . . 74.32 114.186 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.75 153.45 36.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.904 1.736 . . . . 74.42 112.373 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.89 108.01 0.86 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 122.918 0.487 . . . . 70.33 110.968 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.75 -24.08 33.19 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 120.935 -0.65 . . . . 74.42 114.336 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.24 23.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.7 p -73.68 120.16 22.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.945 -0.761 . . . . 64.01 108.945 176.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -71.73 -40.39 69.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.991 -1.004 . . . . 74.23 110.174 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.84 -149.81 13.81 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.488 -0.645 . . . . 71.3 111.488 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.5 p -117.9 160.03 22.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.277 -1.008 . . . . 72.12 108.277 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -74.3 -56.05 2.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.018 -1.073 . . . . 71.33 110.181 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.4 Cg_endo -64.87 149.33 89.71 Favored 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 120.741 0.961 . . . . 63.04 109.614 170.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 18.9 Cg_exo -66.8 152.36 80.66 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.525 2.15 . . . . 71.25 112.549 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.38 132.64 52.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.795 -0.817 . . . . 74.53 108.795 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.63 40.83 Favored Glycine 0 C--N 1.298 -1.574 0 C-N-CA 120.272 -0.966 . . . . 42.24 111.958 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.8 m -67.44 120.96 14.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.871 -0.789 . . . . 42.1 108.871 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.4 m -90.18 122.75 33.41 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.556 -0.905 . . . . 74.11 108.556 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.01 157.63 77.7 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 108.095 -1.076 . . . . 63.2 108.095 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.81 144.3 98.53 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.182 1.922 . . . . 73.44 111.577 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -65.03 -18.55 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.18 0.991 . . . . 71.45 110.786 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.32 -17.73 53.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.883 -1.508 . . . . 74.03 109.83 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 172.4 13.79 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.985 -1.007 . . . . 61.42 113.644 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.03 124.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.358 -1.292 . . . . 75.15 109.42 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.538 HD13 HD21 ' A' ' 512' ' ' LEU . 13.1 tt -100.46 136.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.558 -0.534 . . . . 62.24 109.558 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.29 122.6 45.13 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-O 121.435 0.636 . . . . 72.12 111.126 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 12.7 tp -101.39 133.83 45.4 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.203 1.401 . . . . 70.43 109.356 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -104.01 114.56 28.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.157 -0.682 . . . . 73.13 109.157 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 137.84 34.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 116.164 -0.471 . . . . 73.31 111.496 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 10.4 m -64.11 115.06 4.6 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 106.94 -1.504 . . . . 65.55 106.94 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 524' ' ' SER 0.306 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 N-CA-C 114.828 1.418 . . . . 62.43 114.828 -172.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.749 0 N-CA-C 110.487 -1.045 . . . . 63.14 110.487 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.37 132.48 31.53 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.613 2.209 . . . . 71.55 110.72 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -89.14 50.48 1.95 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.894 0.854 . . . . 65.22 110.445 -176.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.8 mt-30 -83.43 137.69 33.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.355 -0.839 . . . . 64.23 111.87 -174.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 21.6 tpp180 -129.51 157.38 42.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.351 -0.981 . . . . 65.44 108.351 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.43 141.92 28.79 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 123.332 0.653 . . . . 72.12 111.279 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -85.15 130.49 51.79 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 108.109 -1.071 . . . . 73.31 108.109 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HB3' ' HG2' ' A' ' 443' ' ' LYS . 22.3 Cg_endo -60.97 158.38 34.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.546 2.83 . . . . 65.04 115.393 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -113.3 16.32 19.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.917 -1.038 . . . . 65.55 110.309 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.98 -2.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.244 1.021 . . . . 64.3 109.224 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.1 m -61.22 -38.87 88.17 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.977 -1.465 . . . . 54.13 110.828 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 9.4 t -59.03 -26.82 64.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.607 -0.724 . . . . 74.54 111.672 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.4 mt -76.9 -45.54 27.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 120.063 -0.655 . . . . 74.34 110.097 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 14.3 m -168.82 147.49 4.06 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.301 -1.0 . . . . 53.11 108.301 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -51.64 -44.47 62.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.607 0.763 . . . . 73.11 111.112 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.75 -35.41 66.16 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.984 0.514 . . . . 74.01 111.6 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 10.7 mm-40 -70.52 -42.29 71.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.796 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.34 -50.77 72.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.358 -0.837 . . . . 63.12 110.113 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.0 t -58.55 -49.19 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.214 -0.903 . . . . 75.44 112.015 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.66 -46.83 83.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.839 -0.344 . . . . 71.52 111.622 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 430' ' ' PRO . 26.6 tptp -66.78 -41.62 87.35 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 75.42 110.122 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 28.3 tp -68.48 -43.21 77.43 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.916 -0.584 . . . . 55.32 110.155 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 39.5 m -59.51 -44.68 93.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.676 -0.693 . . . . 75.42 109.804 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.69 62.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.906 -0.588 . . . . 62.25 111.395 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -80.93 -13.72 58.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.132 0.492 . . . . 51.25 110.152 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.65 -5.78 26.15 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.126 -1.035 . . . . 32.43 112.794 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.439 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.3 m-85 -82.65 111.54 18.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.576 -0.527 . . . . 73.13 109.576 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.25 41.32 Favored Glycine 0 N--CA 1.427 -1.918 0 CA-C-N 115.476 -0.784 . . . . 75.02 111.836 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.51 114.63 26.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.264 0.554 . . . . 71.11 111.239 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.82 156.83 43.14 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.322 -0.854 . . . . 72.53 112.366 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 123.06 29.31 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.176 -1.416 . . . . 65.14 107.176 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -94.0 125.71 38.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.858 -0.61 . . . . 73.45 109.873 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.04 147.15 50.5 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.327 -1.36 . . . . 40.44 107.327 176.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -122.57 139.88 53.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.344 -0.543 . . . . 73.01 109.652 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.4 m -126.44 140.85 38.35 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 109.259 -0.645 . . . . 74.42 109.259 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -64.77 121.91 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.597 1.531 . . . . 72.4 109.842 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 492' ' ' PRO . 13.5 m -133.67 179.99 5.88 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.761 -1.57 . . . . 70.55 106.761 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.0 t -60.56 136.98 92.56 Favored Pre-proline 0 N--CA 1.419 -2.003 0 N-CA-C 109.136 -0.69 . . . . 65.42 109.136 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 85.2 Cg_exo -49.86 -28.96 19.38 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.464 3.443 . . . . 73.15 114.829 -173.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.18 -18.43 61.86 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.28 7.96 44.59 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.934 -0.479 . . . . 61.3 111.983 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -60.96 128.36 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 120.968 0.414 . . . . 73.21 110.505 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.13 89.31 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.77 -0.728 . . . . 73.51 111.97 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -113.65 148.22 36.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.646 -1.242 . . . . 42.3 107.646 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.484 HG22 HD11 ' A' ' 486' ' ' ILE . 44.8 t -82.36 140.43 16.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.8 pt -96.96 -23.37 4.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.448 0.642 . . . . 54.03 109.402 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.39 175.48 38.62 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 109.062 -1.615 . . . . 75.03 109.062 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 472' ' ' PRO . 2.6 p -116.49 154.36 30.51 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.879 -0.785 . . . . 74.01 108.879 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.7 t30 -61.09 -46.65 96.23 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 123.56 0.537 . . . . 73.5 110.165 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.4 Cg_exo -83.36 137.07 7.97 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.036 1.158 . . . . 55.12 109.391 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 476' ' ' GLN . 9.8 Cg_endo -62.56 140.19 80.08 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.266 1.977 . . . . 73.14 112.051 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.567 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.53 -8.08 55.17 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 122.134 0.969 . . . . 75.11 111.153 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -94.65 -3.98 48.47 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.603 -1.18 . . . . 70.14 110.399 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.449 ' CG ' ' HG2' ' A' ' 473' ' ' PRO . 31.3 mm-40 -109.94 159.98 16.8 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 109.081 -0.711 . . . . 73.11 109.081 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.4 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 24.1 p -101.8 115.21 30.03 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.34 -1.356 . . . . 53.24 107.34 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 48.8 m -100.59 140.97 34.1 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.795 -0.446 . . . . 53.22 109.795 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.58 145.66 54.65 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.036 -0.529 . . . . 62.2 110.61 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.1 mm -67.24 -9.16 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 122.085 0.945 . . . . 72.01 110.752 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -77.51 -5.91 51.7 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.613 -0.679 . . . . 70.21 109.894 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.05 158.09 16.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.706 -0.621 . . . . 72.21 111.742 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.98 125.77 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.013 -1.847 . . . . 71.21 106.013 169.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.71 120.53 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.813 -0.755 . . . . 75.54 110.609 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.81 114.84 29.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.098 -1.445 . . . . 74.22 107.098 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.63 121.52 61.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.033 -0.985 . . . . 74.24 109.016 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.11 120.26 51.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.9 0.857 . . . . 73.23 112.446 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.0 t -96.56 146.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.588 -1.187 . . . . 73.32 108.955 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -82.83 123.41 6.09 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.026 -1.23 . . . . 50.42 110.026 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 28.8 t -110.95 143.83 40.99 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.167 -1.42 . . . . 75.4 107.167 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -96.66 137.5 13.38 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.33 -0.938 . . . . 41.42 111.308 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 459' ' ' SER . 12.9 Cg_exo -70.39 115.44 4.18 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.955 1.77 . . . . 72.41 109.156 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -83.75 87.02 7.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.915 0.864 . . . . 62.31 109.813 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 546' ' ' PRO . 32.6 p -137.32 160.06 40.15 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.75 -1.114 . . . . 74.15 108.957 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.402 ' CD ' ' HA2' ' A' ' 516' ' ' GLY . 50.7 mttm -141.47 143.06 33.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.33 0.394 . . . . 73.25 110.371 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.1 t70 -89.96 119.2 30.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.231 -1.396 . . . . 61.42 107.231 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.4 pt -81.9 123.42 80.1 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 112.473 0.546 . . . . 75.01 112.473 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.96 177.44 2.07 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.381 2.054 . . . . 72.52 109.287 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -85.57 138.12 32.4 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.026 -1.07 . . . . 73.41 109.526 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.67 19.01 4.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.561 -1.644 . . . . 53.11 106.561 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.592 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -77.01 153.37 34.56 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.167 -1.833 . . . . 75.13 111.657 -174.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.08 58.71 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.91 -0.662 . . . . 71.54 111.79 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.526 ' O ' HG12 ' A' ' 534' ' ' VAL . 95.8 mt-30 -121.47 -176.26 3.26 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 72.0 108.877 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.3 m -81.18 155.7 26.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 119.386 -0.925 . . . . 73.22 108.576 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.16 -41.45 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 111.619 0.229 . . . . 71.52 111.619 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.93 -42.25 85.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.378 -0.374 . . . . 64.2 111.46 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.7 p -76.04 -35.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.646 -0.822 . . . . 72.04 111.501 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.02 76.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.582 -0.736 . . . . 52.43 111.106 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.09 -38.52 91.02 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.959 -0.564 . . . . 74.33 110.355 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 514' ' ' VAL . 39.5 ttmt -63.53 -52.37 61.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 123.509 0.506 . . . . 64.44 110.866 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -62.9 -44.92 94.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 123.209 0.318 . . . . 65.24 110.302 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 31.0 tp -64.89 -36.88 85.79 Favored 'General case' 0 C--O 1.188 -2.149 0 CA-C-N 116.08 -0.509 . . . . 72.32 110.542 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.9 t-20 -59.61 -42.92 93.73 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.198 0.599 . . . . 74.41 110.492 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.9 t -67.7 -30.31 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.799 . . . . 70.33 111.443 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.18 15.09 14.05 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 121.679 -0.638 . . . . 74.14 110.785 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.402 ' HA2' ' CD ' ' A' ' 495' ' ' LYS . . . -155.12 -99.9 0.17 Allowed Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 118.248 -1.93 . . . . 64.31 116.637 -169.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 51.2 m-85 -115.31 161.84 17.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.264 . . . . 70.43 110.633 -168.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.2 p -102.51 -27.88 12.52 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.482 0.549 . . . . 62.44 112.482 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 9.3 mmpt? -108.79 128.46 54.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 120.589 0.233 . . . . 70.35 110.722 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 93.9 m-85 -125.18 145.21 50.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.512 -0.767 . . . . 74.4 110.375 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.1 t -115.71 159.57 21.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.137 -1.431 . . . . 60.4 107.137 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -121.18 129.09 53.07 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.744 -0.465 . . . . 72.02 109.744 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.55 129.75 44.85 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.221 -1.029 . . . . 23.35 108.221 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 9.2 m -89.21 130.68 35.58 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.041 -0.726 . . . . 70.53 109.041 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.37 157.57 26.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.339 -0.986 . . . . 74.04 108.339 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -79.69 142.21 35.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.229 0.537 . . . . 75.42 110.984 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 22.2 p -102.35 110.22 62.27 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.992 -1.004 . . . . 72.41 112.649 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -76.95 -51.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 121.644 1.562 . . . . 71.21 110.155 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.6 -64.25 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 112.38 0.511 . . . . 73.41 112.38 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.47 149.06 34.33 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.671 1.58 . . . . 63.23 112.969 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.93 138.81 25.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.575 -0.528 . . . . 62.42 109.575 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 87.79 -26.69 7.19 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 122.004 0.78 . . . . 50.13 111.816 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.57 150.0 23.98 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.614 -0.793 . . . . 72.0 111.826 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.8 p -74.41 125.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.433 -0.803 . . . . 41.1 110.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 14.3 p -88.97 -22.0 23.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.799 -0.637 . . . . 55.21 109.899 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.44 -159.13 30.95 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.205 -0.758 . . . . 74.44 111.205 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -118.39 161.04 20.62 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.27 -1.011 . . . . 75.14 108.27 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 15.1 t-20 -54.94 -55.3 40.27 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 119.216 -0.421 . . . . 72.41 111.877 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.8 Cg_exo -80.47 143.58 15.42 Favored 'Trans proline' 0 C--N 1.366 1.499 0 N-CA-C 108.374 -1.433 . . . . 65.33 108.374 170.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.71 157.36 52.24 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.306 2.004 . . . . 73.02 113.405 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.41 131.33 50.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.329 -0.85 . . . . 73.3 109.541 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.52 -6.95 36.32 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 110.765 -0.934 . . . . 53.41 110.765 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 36.0 m -88.45 129.33 35.46 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.543 -0.54 . . . . 73.24 109.543 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.0 m -96.75 123.22 40.38 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.195 -1.039 . . . . 54.22 108.195 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.62 158.37 72.17 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 110.179 -0.304 . . . . 74.32 110.179 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.421 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.6 Cg_exo -64.7 137.2 53.06 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.823 2.349 . . . . 74.12 111.654 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.508 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.5 m -67.48 -20.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.469 0.652 . . . . 52.51 111.808 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.69 2.1 46.69 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 74.04 111.319 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -93.09 167.78 11.55 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.292 -1.003 . . . . 42.34 108.292 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.43 116.61 44.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.133 -0.692 . . . . 74.45 109.133 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 15.4 tt -88.71 132.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.191 0.52 . . . . 64.14 109.99 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -102.91 131.07 50.1 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-O 121.489 0.661 . . . . 71.01 111.747 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.426 HD13 ' N ' ' A' ' 554' ' ' GLN . 1.8 tm? -99.78 135.3 41.41 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.951 1.3 . . . . 72.54 109.304 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.426 ' N ' HD13 ' A' ' 553' ' ' LEU . 13.2 mm100 -94.69 106.44 18.42 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.489 -0.778 . . . . 64.03 108.91 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.07 122.33 47.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.697 -0.683 . . . . 74.33 109.427 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 25.6 p -76.52 115.35 16.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.652 -0.499 . . . . 64.41 109.652 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 108.779 -0.822 . . . . 74.14 108.779 -176.468 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.763 0 N-CA-C 110.319 -1.112 . . . . 63.14 110.319 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.91 154.7 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.206 1.938 . . . . 72.25 111.125 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.82 25.68 10.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.56 -0.533 . . . . 75.01 109.56 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.1 mt-30 -90.15 119.51 30.53 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.321 -0.4 . . . . 74.01 109.933 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.6 mmp_? -121.27 156.21 33.0 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.189 -0.46 . . . . 65.03 110.932 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.17 141.79 28.39 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.387 -0.824 . . . . 73.05 109.917 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -84.9 119.36 72.56 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.856 -1.164 . . . . 71.15 107.856 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.445 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 25.8 Cg_exo -68.47 142.28 53.6 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.265 1.977 . . . . 41.55 112.197 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 434' ' ' THR . 10.6 m-20 -84.95 37.57 0.67 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.696 0.76 . . . . 73.11 111.458 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 439' ' ' GLU . 10.9 p -87.26 -6.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.609 1.195 . . . . 52.11 108.086 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 3.3 p -59.02 -36.47 75.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.664 1.586 . . . . 73.43 110.47 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 431' ' ' ASP . 14.7 t -61.69 -26.71 68.21 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.0 -1.0 . . . . 65.1 110.789 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.47 -46.5 13.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.31 -0.956 . . . . 74.12 111.407 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.554 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 85.7 m -169.73 149.72 3.86 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.788 -0.819 . . . . 52.23 108.788 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 441' ' ' VAL . 54.4 t80 -52.75 -49.4 65.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.928 0.491 . . . . 72.35 111.309 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.19 -39.87 73.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 61.2 111.589 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.554 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.7 mm-40 -62.97 -43.78 97.85 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.935 -0.575 . . . . 65.31 111.01 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.11 -44.06 95.13 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.269 -0.878 . . . . 72.42 109.932 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.5 t -60.01 -49.53 83.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 115.999 -0.546 . . . . 64.21 111.142 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.0 mmtp -60.62 -47.67 85.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.045 0.45 . . . . 74.4 110.485 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.445 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 30.6 mmmt -67.93 -41.39 82.66 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.798 0.666 . . . . 62.33 112.798 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 22.4 tp -68.48 -38.8 81.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 60.01 109.736 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.2 m -59.28 -46.04 89.62 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.266 -0.879 . . . . 70.21 109.278 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.28 -20.17 63.91 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.522 -0.763 . . . . 54.22 111.692 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.4 -13.61 59.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.306 0.574 . . . . 51.33 109.986 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.23 -9.13 42.21 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.983 -0.627 . . . . 64.34 113.232 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 95.8 m-85 -67.38 115.59 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.941 0.371 . . . . 73.41 110.011 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.09 2.06 40.81 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.467 -0.873 . . . . 44.02 111.619 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -126.75 113.19 16.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.3 0.572 . . . . 75.13 109.553 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -148.73 165.15 32.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.539 -0.755 . . . . 72.32 112.188 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -140.4 131.7 26.68 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.828 -0.804 . . . . 73.14 108.828 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -93.21 135.31 34.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 123.425 0.453 . . . . 75.55 110.053 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -142.7 162.47 35.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.336 -1.357 . . . . 50.53 107.336 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.84 150.68 51.89 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 118.146 0.43 . . . . 74.03 110.636 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.0 m -138.03 146.75 53.49 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 107.963 -1.125 . . . . 71.31 107.963 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.98 130.01 22.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.733 1.622 . . . . 54.21 111.143 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -143.66 -179.72 6.62 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.579 -1.637 . . . . 61.04 106.579 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.06 142.61 85.37 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 123.004 0.522 . . . . 42.44 111.32 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 75.9 Cg_exo -51.68 -29.13 32.12 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.259 3.306 . . . . 75.13 111.66 174.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.1 -29.36 67.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.512 -0.767 . . . . 71.53 111.054 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.46 13.42 24.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.409 0.522 . . . . 71.12 112.409 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 15.0 p -60.47 128.02 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.075 -0.65 . . . . 73.31 110.468 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.18 11.46 83.53 Favored Glycine 0 C--O 1.249 1.069 0 C-N-CA 120.941 -0.647 . . . . 52.12 111.789 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -122.97 154.44 38.41 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.083 -1.08 . . . . 73.25 108.083 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 486' ' ' ILE . 46.2 t -82.43 141.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.275 -0.639 . . . . 74.2 109.275 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.2 pt -97.49 -29.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.456 -0.498 . . . . 73.51 110.339 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.62 -179.01 47.05 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.531 -1.028 . . . . 62.51 110.531 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -124.23 152.17 43.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.512 -0.551 . . . . 34.42 109.512 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.0 t-20 -60.91 -49.95 86.99 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 112.285 0.476 . . . . 74.01 112.285 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.1 Cg_exo -78.16 142.69 19.48 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.154 1.236 . . . . 72.0 109.361 171.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.49 132.98 40.53 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.697 2.265 . . . . 63.14 111.897 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.72 -12.73 59.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.025 0.917 . . . . 65.14 110.706 -175.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.93 11.55 37.06 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.902 -1.045 . . . . 64.11 109.713 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -125.57 169.96 11.94 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 106.527 -1.657 . . . . 74.44 106.527 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.2 p -107.11 115.3 29.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 N-CA-C 108.031 -1.099 . . . . 74.31 108.031 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 30.3 m -102.03 138.81 38.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.407 -0.59 . . . . 74.15 109.407 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.67 137.16 56.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.614 -0.513 . . . . 64.35 109.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.23 -25.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 124.543 1.137 . . . . 44.24 113.074 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.3 t -71.44 -7.01 44.59 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 120.996 0.427 . . . . 71.14 111.76 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -90.11 145.5 25.01 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 116.519 -0.309 . . . . 65.33 110.966 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.08 117.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.347 0.594 . . . . 70.11 109.759 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.79 118.86 34.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.707 -0.849 . . . . 75.53 108.707 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -92.63 113.23 27.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.247 -1.39 . . . . 53.22 107.247 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.51 119.82 53.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.337 -0.847 . . . . 73.25 109.397 -178.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -104.11 123.79 58.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.718 0.77 . . . . 72.3 112.252 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.18 144.29 10.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 114.802 -1.09 . . . . 72.01 108.724 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.74 120.72 5.54 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 111.345 -0.702 . . . . 70.03 111.345 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.8 t -101.46 129.49 47.51 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.909 -1.885 . . . . 73.34 105.909 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -112.16 121.28 5.61 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.271 -0.966 . . . . 63.21 113.089 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 3.2 Cg_exo -77.98 112.37 3.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.735 2.29 . . . . 64.52 111.786 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.18 87.76 2.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.503 -0.925 . . . . 73.44 108.503 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 546' ' ' PRO . 16.6 p -136.99 154.67 50.35 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.821 -1.081 . . . . 71.3 109.232 -176.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.01 142.49 36.27 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.368 0.418 . . . . 72.34 109.982 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -80.82 132.2 35.46 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.262 -1.385 . . . . 72.41 107.262 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.69 129.88 80.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.998 -0.546 . . . . 75.42 110.059 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -87.07 160.79 8.67 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.565 2.177 . . . . 62.42 110.948 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.69 135.69 33.55 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.588 -0.845 . . . . 52.33 109.434 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.6 16.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 122.507 1.146 . . . . 63.22 108.416 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.63 40.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.726 -1.125 . . . . 54.11 109.719 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.68 -26.9 11.06 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.973 -1.251 . . . . 70.41 109.973 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.01 176.36 6.62 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 36.3 p -81.57 157.24 24.84 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.167 -0.613 . . . . 74.31 110.15 -175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 555' ' ' VAL . 9.9 p -52.61 -41.73 38.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.601 0.563 . . . . 72.23 112.28 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.25 -43.08 78.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.574 0.583 . . . . 73.54 112.574 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.29 -36.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 118.837 -1.145 . . . . 75.15 111.519 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.36 77.48 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.136 -0.938 . . . . 71.21 111.39 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.94 -35.01 79.8 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 123.238 0.336 . . . . 71.33 110.513 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.4 tttp -60.98 -51.61 68.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 123.244 0.34 . . . . 61.31 110.13 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.66 -44.77 95.42 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.726 -0.67 . . . . 54.43 110.376 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.08 -43.21 95.67 Favored 'General case' 0 C--O 1.179 -2.606 0 CA-C-N 115.404 -0.816 . . . . 70.15 109.999 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 7.9 t30 -59.05 -39.54 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.508 0.723 . . . . 73.42 112.146 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.94 -0.573 . . . . 52.42 111.626 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.75 -39.28 7.91 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.311 -0.956 . . . . 74.35 110.165 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -95.09 -101.19 1.79 Allowed Glycine 0 N--CA 1.412 -2.945 0 CA-C-N 113.954 -1.475 . . . . 52.23 115.3 -170.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 16.9 m-85 -133.53 172.17 13.09 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 120.957 0.408 . . . . 74.52 109.911 -167.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 18.7 m -109.84 -1.95 17.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.593 -0.73 . . . . 72.12 110.073 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.36 116.39 31.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.125 -0.488 . . . . 72.25 109.899 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.35 151.27 49.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.554 0.692 . . . . 75.54 112.005 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -140.98 158.53 43.8 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.142 -1.429 . . . . 34.44 107.142 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -121.77 152.11 39.83 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.416 0.627 . . . . 71.04 111.818 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.487 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -134.29 125.74 28.31 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.747 -1.205 . . . . 40.53 107.747 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.9 m -88.68 131.36 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.33 -1.359 . . . . 62.44 107.33 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.3 150.52 24.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.236 -0.586 . . . . 72.43 109.921 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.07 133.6 36.78 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.014 -0.735 . . . . 70.45 109.014 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.6 m -143.59 138.85 15.71 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.049 -0.722 . . . . 73.54 109.049 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.12 -58.51 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.2 . . . . 74.34 113.178 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.417 ' H ' ' CD ' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -115.26 -41.26 0.07 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 118.586 -0.721 . . . . 74.42 112.943 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.417 ' CD ' ' H ' ' A' ' 529' ' ' ARG . 80.8 Cg_exo -55.83 149.73 49.38 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 121.688 1.592 . . . . 73.24 112.972 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.95 113.16 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.813 -1.18 . . . . 55.44 107.813 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.04 -34.05 4.63 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.385 -0.912 . . . . 54.52 112.192 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 2.5 pm0 -85.17 147.96 26.35 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-O 121.579 0.704 . . . . 74.32 111.813 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.23 125.51 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.877 -1.157 . . . . 71.13 107.877 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.2 m -86.18 -33.95 20.65 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.677 -0.692 . . . . 72.01 109.596 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -179.94 -176.63 47.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.78 -0.928 . . . . 63.11 110.78 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.7 p -117.88 160.12 21.95 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 107.585 -1.265 . . . . 64.24 107.585 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.477 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.2 t-20 -60.23 -53.84 61.01 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.532 -0.467 . . . . 51.12 111.348 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 75.2 Cg_endo -88.41 146.73 6.2 Favored 'Trans proline' 0 C--N 1.369 1.613 0 CA-C-N 120.103 1.072 . . . . 71.44 110.116 171.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.39 159.53 52.63 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.174 1.916 . . . . 72.52 111.335 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 135.02 57.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.625 0.37 . . . . 73.42 110.729 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.88 48.62 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.678 -0.772 . . . . 63.5 111.933 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.7 m -71.39 121.7 19.03 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.442 -0.577 . . . . 72.43 109.442 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.4 t -83.61 126.7 33.11 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.5 0.5 . . . . 71.2 109.825 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.91 156.57 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.801 -0.814 . . . . 63.23 108.801 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.4 Cg_exo -59.47 144.71 99.34 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.436 2.09 . . . . 71.41 111.741 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.9 m -66.15 -20.54 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.327 0.492 . . . . 71.1 112.327 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.81 3.51 54.23 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.067 -0.515 . . . . 74.02 111.196 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -84.68 146.14 27.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.57 -0.529 . . . . 65.33 109.57 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.83 118.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.057 -1.09 . . . . 74.12 108.057 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.1 tt -94.32 145.91 7.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 120.962 0.411 . . . . 54.12 110.398 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 27.1 tt0 -102.62 127.91 49.52 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-O 121.203 0.525 . . . . 75.2 109.932 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.05 115.19 29.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.49 -1.232 . . . . 62.35 107.867 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.487 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 77.3 mt-30 -92.48 108.01 19.65 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.456 0.646 . . . . 74.32 109.468 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.483 HG21 ' HB ' ' A' ' 505' ' ' VAL . 8.0 p -113.78 139.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.056 -0.974 . . . . 75.24 111.368 -174.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 m -57.81 128.66 38.2 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.928 -1.138 . . . . 50.22 107.928 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 65.8 pttt . . . . . 0 C--O 1.264 1.868 0 N-CA-C 113.619 0.97 . . . . 74.34 113.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.726 0 N-CA-C 111.635 -0.586 . . . . 43.05 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.4 132.85 26.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.946 2.431 . . . . 75.51 112.149 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -92.33 63.59 4.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 123.143 1.449 . . . . 73.4 109.059 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.4 mt-30 -111.09 153.88 25.05 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.48 -1.691 . . . . 72.23 111.886 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.05 149.74 52.16 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.365 -0.834 . . . . 73.23 110.364 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -95.14 140.57 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 72.23 108.129 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.47 122.0 82.06 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 122.912 0.133 . . . . 53.31 110.69 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 142.49 33.43 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.014 2.476 . . . . 73.1 111.908 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -99.46 78.03 2.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.425 1.107 . . . . 70.02 110.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.1 m -112.44 5.34 8.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 N-CA-C 106.061 -1.829 . . . . 74.14 106.061 171.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.466 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -59.62 -38.69 82.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.684 -2.053 . . . . 64.24 110.611 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -26.34 68.46 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.283 -1.326 . . . . 61.25 112.166 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.22 -46.01 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.847 -0.427 . . . . 65.21 109.847 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 175.49 158.3 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.671 1.188 . . . . 63.43 111.335 175.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 441' ' ' VAL . 58.1 t80 -51.54 -43.69 62.43 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.91 1.284 . . . . 74.11 110.78 172.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.88 83.03 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.743 0.652 . . . . 33.44 111.036 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 19.4 mm-40 -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.692 -0.686 . . . . 64.45 109.903 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.55 -47.53 85.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.197 -0.91 . . . . 72.45 111.352 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 437' ' ' TYR . 98.8 t -59.37 -48.47 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 123.433 0.458 . . . . 72.41 111.371 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.5 mmpt? -63.86 -47.11 82.01 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.09 0.244 . . . . 54.43 111.283 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.7 mptp? -67.29 -38.52 85.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.488 0.551 . . . . 74.05 112.488 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 tp -68.02 -39.62 83.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.459 0.647 . . . . 51.51 109.44 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.24 -41.16 99.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.522 -0.763 . . . . 75.25 109.376 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.42 62.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.475 -0.784 . . . . 63.11 111.216 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.46 -13.81 53.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 74.24 109.431 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.92 56.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-N 115.702 -0.681 . . . . 75.43 113.862 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.93 133.04 46.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.157 0.503 . . . . 74.03 111.893 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.98 18.34 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.409 -0.814 . . . . 74.13 112.109 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -123.92 116.36 22.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.74 0.781 . . . . 73.2 112.044 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -143.06 147.19 34.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.225 -0.898 . . . . 74.52 110.181 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -131.02 133.9 46.17 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.688 -1.227 . . . . 73.1 107.688 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -95.47 121.43 37.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.204 0.526 . . . . 71.24 110.779 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.23 141.45 48.28 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.386 -0.968 . . . . 74.33 108.386 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -126.72 144.15 51.02 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.535 -0.543 . . . . 72.04 109.535 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.8 p -144.52 149.9 45.6 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.988 -0.551 . . . . 43.05 109.997 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.3 Cg_exo -65.54 140.55 63.32 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.258 1.972 . . . . 72.51 111.114 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.2 t -152.27 179.39 8.57 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.765 -1.198 . . . . 73.11 107.765 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.4 t -66.65 144.55 98.67 Favored Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 123.705 0.802 . . . . 63.41 110.589 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.464 ' HA ' HG23 ' A' ' 464' ' ' VAL . 88.9 Cg_exo -51.42 -29.34 30.7 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.41 3.407 . . . . 73.34 112.623 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -68.51 -32.13 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.804 -0.634 . . . . 75.14 111.823 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.91 9.01 39.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.551 0.575 . . . . 73.42 112.551 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 461' ' ' PRO . 92.6 t -60.76 127.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.822 -0.436 . . . . 70.42 109.822 177.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.45 -12.28 64.91 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.627 -0.797 . . . . 64.35 111.946 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.2 146.73 23.48 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.313 -0.625 . . . . 74.23 109.313 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 64.9 t -82.67 124.79 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 N-CA-C 106.649 -1.611 . . . . 75.34 106.649 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 25.5 pt -97.85 -2.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 120.9 0.381 . . . . 64.32 111.579 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.96 164.93 20.26 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 120.236 -0.983 . . . . 63.14 111.788 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.4 p -120.77 142.71 49.32 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.725 -1.583 . . . . 73.24 106.725 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 6.1 t30 -63.97 -45.01 80.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 123.544 0.527 . . . . 73.44 110.494 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.99 139.8 12.23 Favored 'Trans proline' 0 C--N 1.375 1.938 0 CA-C-N 120.347 1.16 . . . . 71.21 109.912 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.9 144.08 63.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.697 2.264 . . . . 62.23 112.338 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.94 15.9 4.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.069 0.938 . . . . 52.42 110.483 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.02 -28.74 12.56 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.863 -1.062 . . . . 74.41 111.576 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -117.02 154.09 31.53 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 16.3 p -81.59 135.27 35.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.973 -0.558 . . . . 73.44 110.566 -177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.3 m -111.9 138.24 48.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.832 -0.803 . . . . 72.31 108.832 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -61.02 150.41 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.272 0.358 . . . . 60.44 110.824 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.58 -28.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.449 0.7 . . . . 72.21 111.041 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -88.07 0.87 55.46 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.686 -0.688 . . . . 70.23 111.439 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.08 148.99 27.18 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.002 -0.74 . . . . 75.12 109.002 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 30.9 t -92.14 111.49 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.746 -0.835 . . . . 74.54 108.746 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 86.0 t -91.0 118.82 37.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.131 -0.692 . . . . 61.12 109.131 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.475 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.8 mt -93.8 114.25 30.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.745 -0.835 . . . . 61.41 108.745 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.6 124.97 54.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.271 -0.64 . . . . 63.25 109.271 -178.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.48 116.25 49.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.354 0.597 . . . . 73.13 111.073 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.98 140.72 16.91 Favored 'Isoleucine or valine' 0 C--O 1.252 1.225 0 CA-C-N 115.824 -0.626 . . . . 74.34 110.288 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.69 117.23 4.6 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.546 -1.422 . . . . 61.44 109.546 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.8 m -125.03 135.68 52.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.684 -0.488 . . . . 64.54 109.684 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -133.07 123.92 3.6 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 110.006 -1.238 . . . . 75.11 110.006 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.03 125.28 11.33 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.001 1.801 . . . . 63.22 111.47 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -69.33 96.01 0.83 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.279 -1.008 . . . . 74.43 108.279 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.2 p -128.29 155.29 44.84 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.79 -1.095 . . . . 64.12 109.842 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -142.65 149.98 39.63 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 71.15 109.35 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -85.35 138.07 32.53 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.47 -1.307 . . . . 72.12 107.47 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -83.1 120.39 75.87 Favored Pre-proline 0 C--N 1.291 -1.937 0 C-N-CA 119.808 -0.757 . . . . 73.12 110.028 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.76 158.48 21.49 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.737 1.625 . . . . 73.21 109.431 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.42 101.91 2.07 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.064 0.935 . . . . 75.32 110.977 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.36 -1.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.666 -1.235 . . . . 70.23 107.666 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.72 119.91 15.56 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 113.822 -1.536 . . . . 63.13 107.962 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.37 -27.65 5.74 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.439 -1.464 . . . . 61.41 109.439 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -83.94 178.41 7.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.021 -0.733 . . . . 75.4 109.021 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.3 m -91.12 155.87 18.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.978 . . . . 72.22 108.361 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 -47.85 56.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 112.55 0.574 . . . . 72.32 112.55 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 20.6 m-20 -69.46 -41.38 76.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.538 0.57 . . . . 63.14 112.538 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.26 -35.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.445 -0.902 . . . . 63.51 111.55 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.67 -48.95 77.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.44 -0.8 . . . . 63.15 111.322 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.42 -37.02 85.7 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 120.194 -0.602 . . . . 62.12 110.608 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 2.1 mptm? -65.94 -52.13 52.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . 0.253 33.3 p30 -69.08 -37.59 78.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.761 0.652 . . . . 72.52 112.761 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.28 -36.8 83.89 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-O 120.516 0.198 . . . . 74.22 110.742 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 8.0 t30 -58.28 -37.53 75.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.59 0.756 . . . . 75.01 111.724 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.88 -38.72 83.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.717 -0.674 . . . . 65.33 111.53 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -105.51 -13.86 15.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.764 -0.774 . . . . 64.14 110.695 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -125.12 -97.74 1.15 Allowed Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 117.067 1.587 . . . . 51.14 117.067 -166.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 2.7 m-85 -127.59 153.69 46.1 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.04 0.448 . . . . 72.45 110.161 -163.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.4 m -106.31 -6.43 18.37 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.196 -0.911 . . . . 71.21 109.436 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -108.23 115.02 29.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.838 -0.619 . . . . 53.0 109.973 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.42 156.25 37.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.212 -0.904 . . . . 73.42 111.482 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 65.7 m -138.09 152.94 49.25 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.036 -1.839 . . . . 43.33 106.036 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -119.77 131.19 55.27 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.829 -0.804 . . . . 75.04 108.829 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -115.48 140.43 49.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.442 -0.947 . . . . 70.33 108.442 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.1 m -104.36 119.47 39.03 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.165 -0.68 . . . . 70.22 109.165 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.4 153.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.968 -0.753 . . . . 74.32 108.968 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.7 135.4 36.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.039 -0.664 . . . . 74.4 110.041 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 m -146.26 136.31 11.94 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 107.242 -1.392 . . . . 51.15 107.242 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.12 150.97 66.76 Favored 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.365 2.043 . . . . 73.13 112.156 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 530' ' ' PRO 0.406 75.8 mtm180 37.64 -89.49 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 118.166 2.654 . . . . 71.14 118.166 179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 50.7 Cg_exo -57.56 148.53 72.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.15 1.9 . . . . 54.54 113.743 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.05 160.09 40.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.906 -0.776 . . . . 71.12 108.906 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 105.3 -21.28 35.66 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 120.523 -0.846 . . . . 33.31 112.695 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.65 148.29 25.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.282 0.563 . . . . 73.34 111.215 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.53 119.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 63.22 108.676 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.0 m -88.21 -25.52 22.86 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.58 0.705 . . . . 65.42 109.836 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.24 178.66 47.09 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.212 -0.755 . . . . 61.33 111.212 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.2 p -118.57 160.4 21.85 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.123 -1.065 . . . . 73.23 108.123 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.4 t-20 -60.49 -54.67 52.62 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-O 119.146 -0.454 . . . . 72.51 112.057 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.2 Cg_endo -86.17 153.0 9.53 Favored 'Trans proline' 0 C--N 1.365 1.413 0 CA-C-N 120.461 1.2 . . . . 70.44 109.549 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.68 150.87 85.9 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.032 1.822 . . . . 73.22 111.577 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.64 58.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.071 -0.513 . . . . 72.41 110.604 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.99 54.1 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 121.095 -0.574 . . . . 51.44 112.0 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.8 m -69.55 129.17 38.93 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.776 -0.25 . . . . 74.15 110.332 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -93.86 122.95 36.87 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.652 -0.499 . . . . 64.41 109.652 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.5 161.42 60.82 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.449 -0.796 . . . . 51.04 109.07 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.518 ' HA ' HG22 ' A' ' 494' ' ' THR . 33.4 Cg_exo -60.61 136.25 65.85 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.569 2.18 . . . . 73.11 111.381 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 29.2 m -67.07 -21.36 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 70.4 111.494 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -86.34 -1.81 57.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.762 -0.654 . . . . 72.31 110.863 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.1 t -85.85 168.38 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.322 0.582 . . . . 51.13 110.419 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.9 t -97.61 136.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.34 -0.846 . . . . 74.32 108.804 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.0 tt -112.84 144.26 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.723 -0.473 . . . . 75.11 109.723 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 26.6 tt0 -103.53 122.71 45.5 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 108.815 -0.809 . . . . 72.12 108.815 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.4 tp -100.68 117.82 35.56 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.045 -1.094 . . . . 72.43 108.045 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.501 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 78.3 mt-30 -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.987 0.899 . . . . 74.41 110.325 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.33 141.21 23.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.085 -1.416 . . . . 64.41 111.872 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -55.78 122.84 12.37 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.618 -0.719 . . . . 73.0 110.208 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.147 -1.057 . . . . 61.43 108.147 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.457 0 N-CA-C 111.285 -0.726 . . . . 75.03 111.285 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.34 151.73 84.28 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.9 2.4 . . . . 72.51 112.113 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.12 1.11 56.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.142 0.496 . . . . 74.45 110.808 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 58.9 mt-30 -115.85 156.33 26.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.057 . . . . 75.51 108.145 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -150.95 155.41 39.04 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.404 -1.332 . . . . 74.51 107.404 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.36 141.1 28.89 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 110.061 -0.348 . . . . 73.44 110.061 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -78.39 130.21 72.35 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.005 -1.109 . . . . 73.34 108.005 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.64 144.19 93.75 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.572 2.182 . . . . 74.24 112.839 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.16 20.4 11.43 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.238 0.542 . . . . 65.12 111.342 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.405 HG11 ' HG3' ' A' ' 443' ' ' LYS . 8.7 p -83.29 -1.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.408 1.099 . . . . 71.31 108.435 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.8 p -60.09 -34.23 73.19 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.178 1.391 . . . . 41.4 110.097 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -59.33 -27.84 66.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.253 -1.339 . . . . 65.23 111.27 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 70.5 mt -90.77 -47.19 7.78 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 119.204 -0.998 . . . . 43.35 112.041 -175.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 6.4 m -159.9 148.28 17.21 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.386 -0.598 . . . . 73.2 109.386 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 441' ' ' VAL . 26.7 t80 -56.42 -47.85 78.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.022 0.529 . . . . 71.01 110.396 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -56.81 -44.28 81.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.944 -0.571 . . . . 65.43 111.165 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.524 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.6 mm-40 -63.82 -41.6 97.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.929 -0.578 . . . . 71.43 110.945 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.92 -46.33 89.7 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.361 -0.836 . . . . 65.52 110.673 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 437' ' ' TYR . 87.4 t -60.95 -46.31 96.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 O-C-N 123.792 0.683 . . . . 71.44 111.361 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 66.7 mttm -60.62 -48.53 81.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.06 0.457 . . . . 74.14 110.38 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.405 ' HG3' HG11 ' A' ' 432' ' ' VAL . 46.7 mmtm -67.65 -38.94 84.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.676 -0.693 . . . . 61.51 112.85 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.5 tp -68.54 -38.48 80.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.284 0.564 . . . . 72.22 109.574 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -61.82 -43.38 98.97 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.354 -0.839 . . . . 63.34 109.226 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.3 -16.0 62.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.73 -0.668 . . . . 71.54 111.736 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.84 -14.16 51.93 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 121.328 0.585 . . . . 71.11 109.539 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.93 55.88 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.616 -0.72 . . . . 71.25 113.891 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -59.62 131.1 49.9 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.391 0.595 . . . . 65.31 112.419 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -80.28 -43.77 9.3 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.214 -0.903 . . . . 72.51 114.183 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.406 ' HG3' HG13 ' A' ' 483' ' ' VAL . 30.7 tpt180 -129.62 132.77 46.84 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.793 0.806 . . . . 73.22 112.531 -175.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -140.73 150.38 43.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.814 -1.084 . . . . 61.0 109.991 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -130.31 130.69 44.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.059 -0.719 . . . . 60.21 109.059 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -92.92 132.42 37.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.274 0.559 . . . . 71.41 111.321 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.48 148.94 50.31 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.946 -1.501 . . . . 62.1 106.946 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.6 148.07 48.09 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.174 -0.611 . . . . 71.42 110.091 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 28.6 m -142.75 142.55 22.95 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.988 -0.745 . . . . 74.45 108.988 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.5 Cg_exo -67.06 128.57 18.87 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.436 2.091 . . . . 72.02 111.57 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.9 m -140.28 179.22 6.77 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.757 -0.46 . . . . 70.03 109.757 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.8 t -54.88 139.87 61.61 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 123.885 0.874 . . . . 73.03 111.439 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.412 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.6 Cg_endo -52.01 -31.28 43.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.112 3.208 . . . . 63.02 113.387 -178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.34 -12.7 60.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.039 0.447 . . . . 73.32 111.847 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 30.8 tp -113.17 1.27 15.2 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.227 0.537 . . . . 71.12 110.29 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.1 t -61.35 127.23 20.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.102 0.477 . . . . 34.53 110.722 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.18 -6.86 66.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 116.011 -0.54 . . . . 65.43 112.281 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.5 mptp? -99.87 157.3 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.786 -0.82 . . . . 73.03 108.786 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.578 HG22 HD11 ' A' ' 486' ' ' ILE . 59.0 t -81.94 131.5 33.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 73.31 107.944 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.4 pt -98.57 -4.53 9.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.43 -0.508 . . . . 64.44 111.425 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.92 154.18 7.29 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.461 -0.791 . . . . 55.41 111.493 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 18.4 p -116.76 146.37 42.87 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.135 -0.691 . . . . 64.2 109.135 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -59.1 -49.66 91.92 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.086 -0.483 . . . . 75.52 111.654 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.9 Cg_exo -82.86 144.07 12.03 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.443 1.429 . . . . 75.14 110.305 172.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 9.5 Cg_endo -75.65 135.92 18.49 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.325 2.016 . . . . 75.32 111.871 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.96 -0.29 27.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.837 0.827 . . . . 65.32 111.058 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.61 -27.01 34.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.64 -1.164 . . . . 65.34 110.418 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -113.88 175.03 5.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.291 -0.413 . . . . 74.53 110.578 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 17.2 p -98.68 115.37 28.54 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 108.534 -0.913 . . . . 73.35 108.534 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.2 m -100.44 144.19 29.72 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.906 -0.775 . . . . 61.54 108.906 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -62.11 135.08 57.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 61.35 111.388 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.4 mm -57.11 -27.09 26.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.062 1.745 . . . . 74.02 112.524 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -75.27 -11.01 59.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.969 -0.56 . . . . 60.13 111.046 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.08 150.24 33.77 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 112.797 0.666 . . . . 64.52 112.797 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 451' ' ' ARG . 77.4 t -86.36 114.93 26.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.632 -1.247 . . . . 72.51 107.632 175.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.0 119.4 35.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.879 -0.785 . . . . 62.51 108.879 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -92.86 118.75 39.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.413 -1.328 . . . . 53.03 107.413 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.29 123.27 68.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.725 -0.67 . . . . 54.05 109.544 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 487' ' ' ILE . 3.1 mp -104.87 124.53 59.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.137 0.494 . . . . 73.23 110.005 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.21 140.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.728 -0.669 . . . . 71.23 110.064 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 120.51 5.17 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.521 -1.432 . . . . 74.32 109.521 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.0 t -118.33 160.45 21.63 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.411 -0.959 . . . . 73.32 108.411 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -87.6 137.36 14.52 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.418 -0.896 . . . . 61.43 111.796 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.33 132.08 26.58 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.126 1.884 . . . . 55.21 109.141 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.66 74.88 8.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.066 0.936 . . . . 72.03 110.382 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 546' ' ' PRO . 10.4 p -135.26 159.21 42.28 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.872 -1.058 . . . . 74.34 109.498 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -146.28 141.79 27.69 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.352 -0.61 . . . . 75.31 109.352 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.8 p-10 -89.14 138.13 31.7 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.961 -0.755 . . . . 74.1 108.961 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.3 pt -93.86 137.54 23.07 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 116.197 -0.456 . . . . 72.52 111.93 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.53 171.83 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.935 2.423 . . . . 74.22 112.112 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -82.84 110.57 17.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.588 0.709 . . . . 71.54 111.115 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.55 8.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.389 -0.823 . . . . 64.4 110.053 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.02 140.27 32.81 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.044 -0.525 . . . . 74.01 109.744 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.09 -13.44 58.8 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.126 -1.19 . . . . 71.01 110.126 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.477 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 79.3 mt-30 -93.96 178.3 5.7 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.264 -1.013 . . . . 73.43 108.264 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.2 p -85.54 157.5 20.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.145 -0.687 . . . . 74.54 109.145 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.41 -42.21 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.481 0.488 . . . . 65.42 112.092 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.01 -41.99 81.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.128 -0.629 . . . . 74.21 111.354 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 7.1 p -76.9 -36.42 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 118.577 -1.249 . . . . 52.03 111.125 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.84 -48.77 75.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.874 -0.603 . . . . 74.11 111.315 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -64.51 -35.15 80.02 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 123.293 0.37 . . . . 64.25 110.072 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 514' ' ' VAL . 50.4 tptt -63.49 -51.72 64.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.342 0.401 . . . . 54.22 110.248 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -61.89 -41.53 98.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.164 0.506 . . . . 75.43 110.126 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.408 HD21 HD13 ' A' ' 551' ' ' ILE . 37.2 tp -64.35 -47.77 78.07 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 115.192 -0.913 . . . . 75.1 110.171 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.87 -41.21 91.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.811 0.444 . . . . 53.33 111.919 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.3 t -63.87 -34.09 66.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.326 0.491 . . . . 63.2 112.326 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.27 -19.23 11.37 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.003 -1.079 . . . . 75.52 112.274 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -99.93 -103.5 2.52 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.71 -0.677 . . . . 61.41 114.541 -173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 11.5 m-85 -135.77 -178.59 5.2 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 110.265 -0.272 . . . . 64.25 110.265 -169.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -115.56 3.95 14.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.135 0.493 . . . . 55.2 111.106 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -108.12 115.54 30.31 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.658 -0.867 . . . . 74.51 108.658 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.63 151.5 50.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.757 0.789 . . . . 74.41 111.518 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.0 m -134.69 151.08 50.74 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.623 -1.621 . . . . 61.24 106.623 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -120.77 122.6 40.71 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.582 -1.266 . . . . 62.54 107.582 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.97 117.15 30.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.748 -1.204 . . . . 73.33 107.748 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.9 p -88.75 124.52 34.21 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 108.304 -0.999 . . . . 71.33 108.304 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.98 153.53 26.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.857 -0.794 . . . . 73.01 108.857 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.8 115.63 17.7 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.631 -1.248 . . . . 64.42 107.631 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 19.2 m -119.89 168.77 9.59 Favored Pre-proline 0 C--N 1.282 -2.356 0 CA-C-N 114.515 -1.22 . . . . 70.43 110.663 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 25.4 Cg_endo -61.9 -166.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 123.031 2.487 . . . . 75.34 112.165 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -50.67 -51.86 61.64 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 115.272 1.582 . . . . 73.44 115.272 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.24 133.71 36.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 CA-C-N 120.706 1.288 . . . . 64.21 111.495 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.424 ' HA ' ' OG ' ' A' ' 556' ' ' SER . . . -142.61 157.79 44.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.32 -0.622 . . . . 32.2 109.32 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 99.86 -24.89 30.39 Favored Glycine 0 C--N 1.313 -0.696 0 N-CA-C 110.389 -1.084 . . . . 51.33 110.389 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.95 148.04 25.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.346 -0.927 . . . . 75.14 110.154 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.83 119.12 23.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.109 -0.496 . . . . 72.13 111.038 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 24.0 m -73.16 -35.1 66.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.942 -1.026 . . . . 73.02 109.046 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.46 -161.58 35.31 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 111.084 -0.807 . . . . 74.32 111.084 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -130.34 160.8 32.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.524 -0.917 . . . . 61.14 108.524 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.5 t-20 -53.22 -57.87 14.88 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.493 0.496 . . . . 73.31 111.398 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.3 Cg_endo -89.2 147.42 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 CA-C-N 120.797 1.32 . . . . 73.5 109.11 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.75 155.64 69.61 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.692 1.595 . . . . 54.15 111.811 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.6 137.46 58.17 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 122.62 0.368 . . . . 65.14 110.118 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.26 -6.0 61.28 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.988 -0.625 . . . . 53.11 111.834 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.9 m -86.79 134.56 33.55 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.67 -0.312 . . . . 43.43 110.863 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.7 m -92.49 123.78 36.05 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.5 -0.926 . . . . 75.42 108.5 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.03 158.2 75.86 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.452 -0.573 . . . . 75.02 109.452 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 494' ' ' THR . 47.2 Cg_exo -58.74 144.33 98.19 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.825 2.35 . . . . 41.24 112.162 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 34.4 m -67.48 -20.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.664 0.616 . . . . 62.11 112.664 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.23 4.41 54.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.683 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -77.33 140.97 40.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.08 -1.081 . . . . 60.34 108.08 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.5 t -88.31 112.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.488 -1.301 . . . . 62.5 107.488 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 512' ' ' LEU . 19.8 tt -86.57 133.73 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.743 0.782 . . . . 72.45 111.399 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 21.0 tt0 -102.81 125.67 49.65 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.145 -0.934 . . . . 71.13 109.437 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.59 131.82 44.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.901 -1.148 . . . . 74.31 107.901 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -92.67 105.02 17.25 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 107.74 -1.207 . . . . 62.24 107.74 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.8 p -100.29 132.81 45.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.31 0.576 . . . . 70.44 110.145 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 531' ' ' ALA . 26.7 p -66.87 128.02 34.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.441 -0.8 . . . . 52.34 111.895 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 108.036 -1.098 . . . . 73.14 108.036 176.836 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 109.546 -1.421 . . . . 61.15 109.546 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.07 132.41 34.22 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 121.974 1.782 . . . . 72.44 111.28 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER -105.39 12.35 31.68 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.633 0.73 . . . . 71.52 109.658 -179.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 77.0 mt-30 -101.22 130.98 47.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.076 -0.965 . . . . 74.44 110.298 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.3 mmp_? -123.92 155.59 37.85 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.678 0.791 . . . . 64.03 110.955 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -84.77 141.55 30.44 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.782 -0.645 . . . . 62.32 111.596 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -79.25 131.18 66.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.626 -0.716 . . . . 74.32 109.551 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.43 152.32 65.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.962 2.441 . . . . 75.12 112.774 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.85 8.38 43.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.427 0.632 . . . . 65.13 110.142 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 439' ' ' GLU . 21.4 t -74.7 -12.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 122.542 1.163 . . . . 74.12 108.293 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.5 m -58.79 -38.39 78.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.855 -1.52 . . . . 25.13 110.804 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.2 m -60.21 -26.5 66.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.696 -1.138 . . . . 71.55 111.167 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.35 -45.45 12.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.812 -0.355 . . . . 70.14 111.108 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 28.3 m -161.86 143.78 11.34 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.031 -0.729 . . . . 72.45 109.031 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -52.51 -44.72 65.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.792 0.837 . . . . 73.12 111.455 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 436' ' ' THR . . . -62.77 -38.37 90.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.159 -0.473 . . . . 44.13 111.19 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 8.4 mm-40 -69.2 -37.34 78.06 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.731 -0.668 . . . . 73.42 110.202 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.91 -51.92 67.62 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.092 -0.958 . . . . 64.53 111.349 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.84 -40.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.425 -0.807 . . . . 74.13 111.777 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -66.08 -44.86 83.21 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.768 -0.373 . . . . 70.43 111.08 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.52 -40.57 89.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.643 0.259 . . . . 60.35 111.624 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 30.3 tp -68.94 -34.75 75.87 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.25 0.548 . . . . 44.23 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.1 m -64.48 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.381 -0.6 . . . . 74.43 109.381 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.07 62.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.72 -0.673 . . . . 71.41 110.398 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.8 -13.63 53.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.724 -0.472 . . . . 63.31 109.724 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.32 -13.11 18.91 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.785 -0.643 . . . . 73.53 113.831 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 66.6 m-85 -71.09 138.94 50.16 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.613 0.244 . . . . 75.43 111.143 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -138.38 10.63 3.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.156 -1.021 . . . . 64.04 113.149 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 483' ' ' VAL . 32.6 tpt180 -120.74 115.01 22.47 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.17 153.83 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.847 0.356 . . . . 73.42 110.559 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -131.42 122.35 26.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.002 -1.481 . . . . 75.2 107.002 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -94.36 115.78 28.05 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.177 0.513 . . . . 64.22 110.193 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -118.53 154.61 32.28 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.997 -1.112 . . . . 70.24 107.997 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.21 148.22 52.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.365 -0.606 . . . . 54.11 109.365 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.6 m -135.63 147.21 60.57 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 109.06 -0.718 . . . . 54.32 109.06 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.9 Cg_exo -65.07 122.72 10.58 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.428 2.086 . . . . 74.22 110.933 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.9 t -148.88 179.4 7.89 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.017 -1.105 . . . . 74.54 108.017 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.84 139.83 90.1 Favored Pre-proline 0 N--CA 1.427 -1.593 0 C-N-CA 124.333 1.053 . . . . 64.33 110.662 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 82.4 Cg_exo -50.87 -29.87 28.19 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.311 3.341 . . . . 61.11 113.141 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.78 -29.73 69.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.097 -0.502 . . . . 74.25 111.818 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.31 -2.13 49.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.033 -0.531 . . . . 71.41 111.68 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.7 t -61.28 127.04 20.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.23 -0.656 . . . . 75.33 109.23 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.93 -3.54 82.87 Favored Glycine 0 C--N 1.307 -1.065 0 C-N-CA 121.067 -0.587 . . . . 71.12 112.121 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.7 154.29 26.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.545 -0.909 . . . . 74.4 108.545 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.661 HG22 HD11 ' A' ' 486' ' ' ILE . 43.3 t -82.12 125.36 39.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.844 -0.798 . . . . 75.22 108.844 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.8 pt -98.45 -7.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.141 0.496 . . . . 44.21 110.415 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.46 150.2 5.92 Favored Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.631 -0.713 . . . . 74.34 111.487 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 10.4 p -116.47 158.32 23.77 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.481 -1.303 . . . . 74.03 107.481 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.9 m120 -67.94 -55.11 14.22 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 119.059 -1.056 . . . . 63.32 110.609 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -69.26 116.33 4.46 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 108.574 -1.356 . . . . 64.13 108.574 170.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 158.79 41.56 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.566 2.177 . . . . 73.23 113.413 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.33 7.25 9.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.307 -0.86 . . . . 62.54 110.401 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.16 -40.8 11.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.356 -0.838 . . . . 73.55 110.802 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -118.73 165.27 14.21 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.589 -0.523 . . . . 73.24 109.589 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 23.9 p -84.06 142.79 30.17 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.459 -0.337 . . . . 72.31 110.682 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.3 m -124.3 150.77 45.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.883 -1.154 . . . . 52.35 107.883 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -74.63 146.22 42.61 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.534 0.606 . . . . 74.41 111.328 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.71 -23.09 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.44 1.096 . . . . 60.25 111.014 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -95.5 1.18 53.86 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.784 -1.098 . . . . 60.41 110.428 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -80.67 155.45 26.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.098 -0.704 . . . . 74.13 109.098 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 451' ' ' ARG . 7.7 p -88.13 121.23 38.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.889 -0.782 . . . . 64.23 108.889 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.85 118.89 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.926 -0.768 . . . . 75.22 108.926 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.44 117.43 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 106.157 -1.794 . . . . 63.53 106.157 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.92 124.24 65.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.701 -0.851 . . . . 61.01 108.701 -176.496 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.14 118.53 49.12 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 CA-C-O 121.396 0.617 . . . . 44.43 109.608 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.54 141.49 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.294 -0.866 . . . . 73.35 108.915 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.98 128.48 11.95 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 108.516 -1.833 . . . . 64.42 108.516 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.8 m -140.91 150.72 43.53 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.141 -0.623 . . . . 63.34 109.513 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -135.38 130.75 5.52 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.689 -1.364 . . . . 73.31 109.689 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.17 123.23 12.46 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.472 2.115 . . . . 44.11 111.618 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -83.81 92.45 7.76 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.788 0.804 . . . . 72.32 109.084 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 546' ' ' PRO . 47.0 p -131.87 160.58 35.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.356 -0.979 . . . . 72.13 108.356 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 544' ' ' THR . 67.8 mttm -135.59 147.22 48.61 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.215 -0.291 . . . . 63.42 110.215 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.28 126.51 36.39 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.593 -0.892 . . . . 74.15 108.593 175.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 541' ' ' ALA . 38.1 pt -81.95 137.41 46.76 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.524 -0.762 . . . . 63.54 112.358 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.43 175.47 6.25 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.563 2.175 . . . . 75.14 111.224 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.45 121.61 31.85 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 75.03 110.27 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.66 9.8 6.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.35 -0.841 . . . . 64.21 109.378 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.474 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -75.17 147.6 40.29 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.342 -0.844 . . . . 62.23 112.191 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.64 69.46 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.178 -0.769 . . . . 64.24 111.178 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.413 ' O ' HG12 ' A' ' 534' ' ' VAL . 43.6 mt-30 -117.32 -167.82 1.38 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.984 -0.747 . . . . 74.53 108.984 177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.4 m -90.67 155.66 18.68 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.299 -0.961 . . . . 72.32 109.608 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.76 -43.93 57.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.196 0.598 . . . . 72.44 112.141 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.15 -42.2 80.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 63.34 111.906 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.59 -34.23 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.894 -0.722 . . . . 65.32 111.09 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.47 -47.28 86.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.534 -0.757 . . . . 70.02 110.736 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.89 -37.37 87.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 123.257 0.348 . . . . 64.22 110.632 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 60.4 tttp -62.39 -53.67 51.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.64 -0.709 . . . . 71.04 110.062 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.07 -42.76 96.87 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.344 -0.844 . . . . 74.02 110.676 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.6 -41.12 96.98 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 115.592 -0.731 . . . . 74.15 109.715 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.18 -40.08 84.59 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.82 0.448 . . . . 74.43 110.708 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.2 t -67.18 -36.88 78.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.848 -0.615 . . . . 72.3 111.71 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -113.84 9.17 17.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.135 -0.626 . . . . 71.4 111.025 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -140.38 -107.5 0.7 Allowed Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.156 -1.497 . . . . 73.44 115.198 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.7 m-85 -127.6 -176.59 3.8 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.06 0.392 . . . . 74.24 112.06 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.87 -14.34 10.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.623 0.725 . . . . 74.12 110.559 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -108.14 115.72 30.65 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.246 -0.65 . . . . 73.41 109.246 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -124.29 155.59 38.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.298 -0.41 . . . . 75.25 110.347 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.3 m -140.86 158.29 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.447 -1.686 . . . . 71.02 106.447 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -121.95 144.12 49.06 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.735 -0.468 . . . . 73.13 109.735 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.31 134.91 54.65 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.208 -0.664 . . . . 73.33 109.208 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.4 m -90.26 119.9 30.96 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.606 -0.887 . . . . 63.24 108.606 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.51 163.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.626 -1.25 . . . . 71.44 107.626 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.43 129.18 35.42 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.642 0.734 . . . . 71.43 109.488 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 11.2 p -77.27 132.48 69.92 Favored Pre-proline 0 N--CA 1.419 -2.015 0 CA-C-N 114.682 -1.144 . . . . 72.35 110.576 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.453 ' O ' ' HD2' ' A' ' 529' ' ' ARG . 11.9 Cg_endo -63.69 -75.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.524 1.482 . . . . 72.33 109.579 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.548 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 10.9 mmm180 -121.17 -57.7 0.03 OUTLIER Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.663 -0.495 . . . . 65.2 109.663 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 2.7 Cg_exo -77.36 153.15 31.01 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.305 2.004 . . . . 65.42 111.609 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.98 149.28 52.47 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.785 -0.82 . . . . 54.33 108.785 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 103.82 -22.08 36.49 Favored Glycine 0 C--O 1.249 1.035 0 N-CA-C 111.156 -0.778 . . . . 55.34 111.156 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.09 148.09 25.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.579 0.704 . . . . 55.14 111.674 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 501' ' ' ALA . 3.8 p -75.8 125.16 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.977 -1.011 . . . . 74.24 110.15 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 8.4 m -77.45 -37.08 52.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.262 -1.014 . . . . 62.43 108.262 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.43 35.2 Favored Glycine 0 N--CA 1.417 -2.603 0 N-CA-C 109.665 -1.374 . . . . 73.14 109.665 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.3 p -117.74 159.88 22.27 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.209 -1.404 . . . . 62.32 107.209 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -56.75 -57.15 25.81 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 123.489 0.493 . . . . 73.13 110.716 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 59.8 Cg_endo -77.26 142.84 21.77 Favored 'Trans proline' 0 C--N 1.368 1.588 0 N-CA-C 109.125 -1.144 . . . . 74.24 109.125 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -65.22 151.02 86.78 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.282 1.988 . . . . 74.41 111.804 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -58.92 138.45 57.38 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.747 0.308 . . . . 34.52 110.196 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.78 -21.13 43.36 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 111.309 -0.716 . . . . 74.24 111.309 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 46.2 m -70.75 132.35 45.22 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.105 0.478 . . . . 72.23 110.394 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 m -96.67 122.66 39.86 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.397 -0.819 . . . . 74.4 108.82 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.16 159.63 71.35 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.398 -0.593 . . . . 62.3 109.398 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.583 ' HA ' HG22 ' A' ' 494' ' ' THR . 39.2 Cg_exo -61.03 142.26 96.84 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.217 2.611 . . . . 73.23 114.584 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.499 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 30.9 m -67.43 -19.32 25.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.95 0.881 . . . . 73.51 111.146 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.9 -10.12 55.79 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.22 -1.354 . . . . 63.23 109.747 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 59.9 p -92.3 171.76 8.85 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.866 -0.606 . . . . 62.42 112.03 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.25 136.39 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.261 -1.014 . . . . 74.31 108.261 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.0 tt -113.76 142.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 120.895 0.379 . . . . 74.42 110.538 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -102.99 128.3 49.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 122.968 0.507 . . . . 75.2 111.606 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.3 122.01 42.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.135 -1.431 . . . . 75.51 107.135 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -104.32 110.13 22.25 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.606 -0.887 . . . . 70.14 108.606 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.36 139.13 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.461 -0.791 . . . . 73.52 112.944 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 69.6 m -64.76 115.05 4.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.484 -0.78 . . . . 71.34 109.581 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 106.46 -1.682 . . . . 73.22 106.46 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.772 0 N-CA-C 110.376 -1.09 . . . . 43.05 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.69 145.06 86.01 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.172 1.914 . . . . 72.03 110.635 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 56.89 1.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.296 1.046 . . . . 72.22 111.617 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 91.7 mt-30 -121.75 131.03 53.85 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.222 -1.354 . . . . 72.22 108.122 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -122.72 151.56 41.44 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.154 -0.684 . . . . 75.45 109.154 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -93.74 142.16 27.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.266 -0.879 . . . . 74.24 110.082 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.497 ' O ' ' HB1' ' A' ' 474' ' ' ALA . 2.9 mp -79.13 125.11 84.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.858 -0.793 . . . . 73.34 108.858 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.43 141.79 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.727 1.618 . . . . 74.22 111.332 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.65 52.19 1.85 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.728 0.775 . . . . 65.35 110.652 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 440' ' ' ALA . 14.8 p -102.39 -2.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.018 -1.475 . . . . 72.12 107.018 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 1.7 p -59.11 -41.44 88.16 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.998 -1.91 . . . . 72.03 110.703 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.3 p -61.71 -26.37 68.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.9 -1.045 . . . . 72.14 112.807 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.3 -46.48 13.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 119.077 -1.049 . . . . 64.42 111.575 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.6 m -170.39 147.36 3.0 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.942 -0.762 . . . . 75.32 108.942 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -50.82 -48.91 59.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.507 1.123 . . . . 71.2 110.581 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 436' ' ' THR . . . -58.31 -37.76 75.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.204 -0.453 . . . . 74.44 111.579 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.511 ' HB3' HG22 ' A' ' 432' ' ' VAL . 25.0 mm-40 -69.59 -44.68 70.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.088 0.47 . . . . 65.44 110.363 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.44 -51.18 70.55 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.045 -0.979 . . . . 54.55 111.704 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.01 -45.95 89.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 CA-C-N 115.737 -0.665 . . . . 75.55 111.511 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.19 -47.91 80.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.018 0.377 . . . . 71.54 112.018 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -67.79 -39.52 84.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.31 -0.556 . . . . 63.12 110.668 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 20.9 tp -69.7 -34.78 74.37 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.252 0.548 . . . . 75.41 110.716 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 27.1 m -62.06 -43.31 99.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.651 -0.704 . . . . 71.33 109.64 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.87 62.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.626 -0.715 . . . . 72.33 110.836 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.65 59.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.049 0.452 . . . . 72.2 110.454 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.92 6.95 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.329 -0.938 . . . . 75.34 113.171 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 445' ' ' THR . 97.1 m-85 -80.85 130.93 35.31 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.927 0.394 . . . . 74.31 111.69 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -136.22 14.74 4.0 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.184 -1.166 . . . . 60.11 110.184 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -116.95 115.3 25.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.978 -1.49 . . . . 74.21 106.978 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 87.7 m-85 -139.04 156.43 47.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 73.53 112.301 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.466 ' HB2' HG13 ' A' ' 485' ' ' ILE . 68.8 mttm -133.55 122.97 24.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.114 -1.809 . . . . 61.12 106.114 167.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -93.79 120.02 33.51 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.763 -0.775 . . . . 75.04 112.027 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.31 43.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.232 -1.025 . . . . 74.13 108.232 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.89 150.75 33.19 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.915 -1.143 . . . . 63.41 107.915 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 37.1 p -134.6 138.21 29.4 Favored Pre-proline 0 C--N 1.277 -2.575 0 N-CA-C 108.964 -0.754 . . . . 61.43 108.964 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 22.8 Cg_exo -65.57 123.6 11.64 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.086 1.857 . . . . 74.41 110.042 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 179.31 7.55 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 108.43 -0.952 . . . . 54.22 108.43 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -67.92 137.89 92.54 Favored Pre-proline 0 N--CA 1.418 -2.065 0 C-N-CA 123.467 0.707 . . . . 71.14 110.461 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 464' ' ' VAL . 98.2 Cg_exo -50.78 -29.21 25.45 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 124.669 3.579 . . . . 61.42 113.596 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.65 -21.53 61.81 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.227 -0.442 . . . . 71.53 111.401 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 466' ' ' LYS . 23.0 tp -105.15 2.92 29.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 64.31 110.683 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 461' ' ' PRO . 65.2 t -60.46 128.03 20.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.013 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.31 -2.55 56.37 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.717 -0.674 . . . . 64.13 111.676 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.489 ' HD2' HD12 ' A' ' 463' ' ' LEU . 96.6 mttt -112.21 145.05 40.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.38 -0.6 . . . . 64.11 109.38 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 47.1 t -82.75 134.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.193 -0.669 . . . . 74.31 109.193 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.7 pt -98.28 -20.09 5.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.484 -0.886 . . . . 71.22 110.08 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.927 -0.654 . . . . 54.21 111.565 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.2 p -116.77 161.0 19.95 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.518 -0.919 . . . . 65.35 108.518 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.543 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.4 t-20 -65.69 -52.43 43.06 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-O 119.012 -0.518 . . . . 73.14 111.568 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.5 Cg_exo -75.02 135.81 19.52 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 120.359 1.164 . . . . 52.42 109.116 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.57 136.26 53.42 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.614 2.209 . . . . 75.03 111.351 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 429' ' ' ILE . . . -77.0 -17.68 58.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.822 -0.626 . . . . 72.24 111.964 -172.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -76.49 -31.87 58.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.386 0.612 . . . . 72.05 109.71 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -95.34 164.87 12.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.456 -0.793 . . . . 64.54 110.836 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -97.63 127.1 43.33 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.525 -0.761 . . . . 62.44 110.449 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.4 m -110.06 139.68 44.92 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.283 -1.006 . . . . 61.34 108.283 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -57.89 150.39 20.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.075 0.398 . . . . 74.12 112.075 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.1 -25.71 38.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.847 -0.615 . . . . 62.42 110.82 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -86.71 5.29 36.95 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 116.146 -0.479 . . . . 75.24 111.363 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.13 157.52 24.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 120.909 0.385 . . . . 64.45 111.031 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 453' ' ' LYS . 22.3 t -100.05 123.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.034 -1.099 . . . . 53.24 108.034 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.18 119.01 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 C-N-CA 119.069 -1.053 . . . . 63.31 108.844 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.543 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.1 mp -92.65 118.35 38.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 105.308 -2.108 . . . . 71.31 105.308 174.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 tt -102.13 124.35 55.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 116.347 -0.388 . . . . 74.41 109.967 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.95 108.46 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.395 -0.965 . . . . 75.44 108.395 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.67 139.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.071 -0.968 . . . . 74.13 110.005 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.07 123.89 6.53 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.484 -1.446 . . . . 53.11 109.484 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.3 m -135.85 149.74 49.15 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 31.32 108.286 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -153.62 168.93 32.27 Favored Glycine 0 N--CA 1.424 -2.164 0 C-N-CA 119.746 -1.216 . . . . 73.1 110.768 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.58 124.29 6.91 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.251 1.967 . . . . 71.54 112.334 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.67 80.6 8.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.471 -1.678 . . . . 51.12 106.471 173.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 546' ' ' PRO . 37.2 p -127.96 161.29 29.47 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 114.519 -1.218 . . . . 74.42 109.858 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 544' ' ' THR . 96.0 mttt -143.31 156.33 44.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.835 -0.431 . . . . 74.32 109.835 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.8 p-10 -92.78 135.87 33.74 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.952 -0.758 . . . . 74.12 108.952 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 23.2 pt -78.14 136.67 61.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.998 -0.546 . . . . 73.53 110.926 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.83 -172.49 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.577 2.184 . . . . 74.22 110.339 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -99.41 136.35 39.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.454 -0.943 . . . . 52.23 108.454 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 m -128.66 16.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 120.887 0.375 . . . . 62.23 110.835 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -72.0 116.45 12.42 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.915 -0.584 . . . . 65.11 111.367 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 116.69 -19.33 12.57 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.811 -0.709 . . . . 62.42 112.103 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 507' ' ' VAL . 97.8 mt-30 -81.76 177.7 8.74 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.845 -0.342 . . . . 52.31 110.153 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.3 m -91.4 156.29 17.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.553 -1.277 . . . . 74.33 107.553 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.96 -43.47 75.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.921 0.391 . . . . 73.11 112.054 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 5.9 p-10 -68.51 -42.08 79.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.899 -0.591 . . . . 75.22 111.897 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 503' ' ' GLN . 8.9 p -75.94 -34.63 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.142 -1.023 . . . . 55.11 111.141 -175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.417 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -62.0 -48.89 78.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.448 -0.796 . . . . 34.34 111.364 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.4 -36.77 84.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.404 0.44 . . . . 71.03 110.746 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.6 mptp? -64.01 -47.58 79.72 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.123 0.264 . . . . 61.13 111.56 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -65.13 -42.91 93.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.975 0.417 . . . . 73.55 110.318 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.74 -37.26 85.88 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 115.762 -0.653 . . . . 73.22 109.655 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -62.25 -37.9 87.21 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 122.762 0.425 . . . . 70.24 110.714 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 510' ' ' LYS . 61.0 t -72.44 -27.21 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.089 0.471 . . . . 74.33 110.637 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.77 36.54 4.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.552 -0.295 . . . . 62.23 110.23 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -169.33 -100.92 0.14 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 117.106 -2.473 . . . . 75.25 116.613 -173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.588 ' CE2' HG23 ' A' ' 545' ' ' VAL . 61.3 m-85 -127.63 162.36 26.69 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 115.212 -0.494 . . . . 62.13 111.312 -162.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.2 m -104.37 -17.37 14.82 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.225 -0.898 . . . . 65.32 110.869 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 550' ' ' VAL . 35.3 mmtp -109.98 123.93 50.52 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.92 -0.488 . . . . 70.44 109.804 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.97 151.28 45.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.473 0.654 . . . . 73.33 111.666 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -141.6 152.03 43.67 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.121 -1.437 . . . . 74.41 107.121 169.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.23 128.12 50.77 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 120.741 0.305 . . . . 72.34 110.233 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.58 127.34 52.04 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.878 -0.786 . . . . 65.21 108.878 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.438 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 20.1 m -91.29 143.07 27.03 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.117 -0.697 . . . . 62.43 109.117 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.87 159.45 26.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.375 -0.972 . . . . 73.3 108.375 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.32 134.43 36.61 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.362 0.601 . . . . 65.15 109.432 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 8.1 t -129.81 162.3 54.28 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 108.021 -1.103 . . . . 63.51 108.021 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 122.519 2.146 . . . . 65.35 110.079 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.17 -46.52 62.19 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 118.986 -1.086 . . . . 64.14 113.315 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.67 134.65 38.75 Favored 'Trans proline' 0 C--N 1.365 1.401 0 CA-C-N 120.383 1.172 . . . . 52.21 109.897 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -153.71 176.33 12.23 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.682 -0.859 . . . . 73.23 108.682 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.93 7.15 62.88 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 111.049 -0.82 . . . . 55.21 111.049 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.9 141.1 28.99 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 107.633 -1.247 . . . . 74.3 107.633 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 95.8 t -77.12 115.76 19.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 104.781 -2.303 . . . . 70.11 104.781 165.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.8 m -76.1 -26.73 56.72 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.739 -0.837 . . . . 73.14 108.739 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.43 -149.43 21.2 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.291 -0.868 . . . . 61.33 111.023 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -118.09 161.67 19.46 Favored 'General case' 0 C--N 1.279 -2.498 0 C-N-CA 123.522 0.729 . . . . 63.2 109.108 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.6 t-20 -52.33 -51.96 67.42 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 123.427 0.454 . . . . 63.35 111.636 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.3 Cg_endo -91.6 161.16 3.53 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.473 1.449 . . . . 73.43 109.845 171.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.95 150.58 61.19 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.154 1.902 . . . . 72.12 112.194 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -50.94 131.02 26.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.102 0.961 . . . . 33.2 111.422 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -17.29 36.69 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.773 -0.648 . . . . 51.31 112.099 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 48.6 m -67.86 128.01 34.93 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.567 -0.372 . . . . 70.44 110.301 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 27.8 m -97.59 123.36 41.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.761 -0.459 . . . . 51.04 109.761 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' A' ' 517' ' ' PHE . 9.5 m -134.14 162.26 58.76 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.264 -0.643 . . . . 71.21 109.264 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.593 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.2 Cg_exo -61.93 136.21 60.06 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.104 2.536 . . . . 75.42 113.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 33.2 m -66.73 -22.82 30.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.663 -0.699 . . . . 62.12 112.343 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.97 -2.13 57.74 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.134 -0.939 . . . . 73.12 110.011 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -93.97 173.19 7.79 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.087 -0.709 . . . . 65.53 109.087 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 519' ' ' LYS . 60.2 t -91.99 127.65 44.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.993 -0.549 . . . . 74.34 111.827 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.15 130.13 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.825 -1.176 . . . . 53.42 107.825 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 32.7 tt0 -103.04 127.19 50.38 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-O 121.268 0.556 . . . . 63.1 110.111 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.6 tp -95.28 132.58 40.13 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.979 -1.009 . . . . 61.13 109.06 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -100.18 113.34 25.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.425 -0.954 . . . . 74.23 108.425 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.81 137.67 44.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-O 120.627 0.251 . . . . 75.33 111.24 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 58.6 p -83.39 124.49 30.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.115 0.483 . . . . 72.44 109.785 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 524' ' ' SER . 14.9 ttpp . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 N-CA-C 110.987 -0.845 . . . . 43.05 110.987 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.05 133.06 12.05 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 121.713 1.609 . . . . 74.31 111.746 -178.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 425' ' ' GLU . 0.2 OUTLIER -87.0 -0.27 56.34 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.908 0.861 . . . . 73.13 109.916 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 77.1 mt-30 -118.57 153.5 34.13 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.222 -1.399 . . . . 63.33 107.222 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -145.85 152.62 39.79 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.292 -1.744 . . . . 72.21 106.292 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.41 140.94 30.34 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.503 0.668 . . . . 73.43 112.503 -177.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.49 131.04 69.44 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 107.51 -1.293 . . . . 73.41 107.51 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.0 140.6 94.54 Favored 'Trans proline' 0 C--O 1.243 0.734 0 C-N-CA 122.664 2.242 . . . . 73.44 113.346 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -96.47 -5.25 40.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.025 -0.989 . . . . 43.11 109.84 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.18 5.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.947 0.879 . . . . 53.22 110.703 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.5 p -62.63 -30.45 71.37 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.869 1.268 . . . . 60.24 109.918 177.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.5 t -57.65 -26.76 62.1 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.42 -1.263 . . . . 75.25 111.077 176.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.57 -44.96 15.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 120.788 -0.365 . . . . 62.5 110.422 -175.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.575 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 3.7 m -164.1 149.44 10.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.702 -0.851 . . . . 42.33 108.702 175.381 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -54.71 -44.02 73.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.783 0.833 . . . . 71.34 110.768 174.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.63 -43.56 76.26 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.305 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.575 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.0 mm-40 -61.67 -42.43 98.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 123.514 0.509 . . . . 74.41 110.44 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.1 -49.47 77.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.157 -0.929 . . . . 71.5 110.097 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.96 -47.61 92.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 CA-C-N 115.788 -0.642 . . . . 73.12 112.101 -177.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.5 mmtp -60.96 -48.6 81.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.035 0.445 . . . . 61.52 110.452 -176.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 443' ' ' LYS . 10.3 mmpt? -68.2 -39.19 82.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.899 -0.591 . . . . 75.41 111.843 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 23.4 tp -68.54 -40.25 80.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.195 0.521 . . . . 64.44 110.044 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 42.8 m -59.41 -45.85 90.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.249 -0.887 . . . . 64.15 109.461 176.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -17.28 62.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.63 -0.714 . . . . 60.32 111.473 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.59 -13.92 57.4 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.919 0.39 . . . . 74.35 110.861 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.9 -11.81 22.67 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.15 -1.024 . . . . 64.41 113.519 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.8 m-85 -72.5 138.55 47.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.976 0.417 . . . . 70.15 110.857 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 -12.74 3.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.591 -0.814 . . . . 75.34 113.599 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 451' ' ' ARG . 2.1 tpm_? -103.38 114.99 29.7 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.095 -0.706 . . . . 74.22 109.095 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 37.1 m-85 -120.03 153.27 36.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.369 -0.832 . . . . 72.34 109.696 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.521 ' HB3' HG13 ' A' ' 485' ' ' ILE . 16.3 tppt? -143.73 122.33 12.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 105.566 -2.013 . . . . 72.23 105.566 170.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -104.2 125.4 50.46 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 120.862 0.363 . . . . 71.24 110.732 -176.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.93 49.04 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.231 -1.026 . . . . 74.41 108.231 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -124.02 149.35 46.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.543 -0.91 . . . . 63.01 108.543 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.2 m -140.42 140.65 23.4 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 108.97 -0.752 . . . . 55.3 108.97 176.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.7 Cg_exo -65.76 122.0 9.51 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.965 1.777 . . . . 75.13 109.946 177.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.4 m -151.99 -179.54 7.57 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.756 -1.201 . . . . 71.04 107.756 -178.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 463' ' ' LEU . 6.9 t -24.98 100.24 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.51 0 C-N-CA 126.563 1.945 . . . . 73.24 112.83 177.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 73.8 Cg_exo -51.53 -38.09 63.89 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 124.499 3.466 . . . . 62.32 115.973 -170.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.45 -11.33 59.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.191 0.811 . . . . 74.21 113.191 -176.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.494 ' HB2' HG23 ' A' ' 460' ' ' THR . 3.9 mm? -103.65 14.15 31.71 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.692 0.282 . . . . 71.22 111.186 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.1 p -52.86 128.73 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 116.159 -0.473 . . . . 72.5 110.335 176.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.49 -3.06 56.27 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.826 -0.702 . . . . 63.25 111.506 -179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -103.48 146.01 29.15 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.316 -0.624 . . . . 73.52 109.316 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.644 HG22 HD11 ' A' ' 486' ' ' ILE . 46.9 t -81.78 132.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.477 -0.564 . . . . 72.22 109.477 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.5 -21.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.624 -0.43 . . . . 72.15 110.625 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.96 159.92 23.54 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 111.106 -0.798 . . . . 73.51 111.106 177.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -122.63 152.32 40.6 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.326 -0.99 . . . . 65.31 108.326 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.6 t-20 -64.44 -50.59 65.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.499 -0.481 . . . . 75.54 111.058 177.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.3 Cg_exo -79.59 147.83 20.06 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 120.371 1.168 . . . . 64.53 109.104 172.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 3.7 Cg_exo -71.37 140.89 37.71 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.142 1.894 . . . . 43.14 113.463 -175.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.11 6.67 28.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.115 0.96 . . . . 73.42 109.183 176.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.1 -26.83 13.55 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.667 -1.151 . . . . 73.42 111.988 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -137.85 174.96 10.01 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.279 -0.569 . . . . 75.15 110.263 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 41.7 p -86.94 147.71 25.64 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.238 0.542 . . . . 64.44 112.368 -176.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.4 m -133.83 150.1 51.39 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.393 -1.336 . . . . 62.05 107.393 174.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -55.48 142.24 33.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.617 0.599 . . . . 65.23 112.617 -176.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.02 -29.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.563 1.145 . . . . 63.3 111.532 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -94.08 12.26 27.02 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.527 -0.469 . . . . 74.12 111.577 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -77.95 146.32 35.55 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 122.14 -0.35 . . . . 70.14 110.365 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.2 122.98 36.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.632 -0.877 . . . . 71.2 108.632 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.82 118.51 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 108.039 -1.097 . . . . 75.2 108.039 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.0 mp -96.99 114.47 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 106.194 -1.78 . . . . 54.3 106.194 175.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.644 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.88 125.68 59.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 108.901 -0.777 . . . . 64.3 108.901 -177.713 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.46 116.47 49.31 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 CA-C-O 121.693 0.758 . . . . 53.12 109.988 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.41 136.83 25.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.22 -0.9 . . . . 71.3 109.461 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.91 112.1 3.53 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.783 -2.127 . . . . 54.22 107.783 174.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.4 t -115.3 145.37 42.54 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 119.873 -0.731 . . . . 74.43 109.787 -176.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -111.98 113.07 3.22 Favored Glycine 0 N--CA 1.406 -3.301 0 N-CA-C 107.965 -2.054 . . . . 71.43 107.965 176.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 115.68 2.73 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.115 1.876 . . . . 53.32 111.106 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -65.57 96.83 0.28 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.081 -0.963 . . . . 75.3 108.503 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.6 p -136.27 157.56 46.51 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.543 -1.208 . . . . 62.43 108.268 -175.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 28.9 mtpp -143.94 157.36 44.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.666 -0.864 . . . . 75.13 108.666 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.0 t70 -91.36 130.92 37.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.677 -1.231 . . . . 75.12 107.677 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 23.8 pt -77.15 126.11 85.73 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 112.366 0.506 . . . . 64.4 112.366 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 55.2 Cg_endo -94.07 114.46 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.32 2.013 . . . . 71.52 112.886 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.67 124.36 29.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.422 -0.955 . . . . 64.32 108.422 175.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.4 t -114.53 45.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.154 -1.054 . . . . 75.11 108.154 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -63.29 130.73 45.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.848 -1.069 . . . . 65.15 111.381 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 129.99 -32.04 3.22 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.316 -0.945 . . . . 72.54 113.29 176.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 534' ' ' VAL . 93.6 mt-30 -94.7 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.691 -0.485 . . . . 64.14 109.691 -177.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 157.38 19.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.178 -1.009 . . . . 74.15 109.564 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.454 HG21 HG13 ' A' ' 555' ' ' VAL . 89.5 t -55.92 -44.14 77.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.593 0.558 . . . . 63.33 111.151 -176.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.61 -41.75 83.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.693 -0.685 . . . . 74.22 111.921 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -36.26 27.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 118.884 -1.126 . . . . 64.41 110.654 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.58 87.25 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.53 -0.759 . . . . 61.41 110.959 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.82 -35.17 80.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 123.307 0.38 . . . . 70.43 110.041 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -61.42 -47.48 85.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 123.127 0.267 . . . . 73.33 111.517 176.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -68.84 -43.12 76.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.376 -0.375 . . . . 71.51 111.006 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 520' ' ' PHE . 5.8 tt -64.27 -37.54 87.86 Favored 'General case' 0 C--O 1.173 -2.947 0 CA-C-N 115.928 -0.578 . . . . 62.35 109.537 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.33 -37.44 75.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.929 0.491 . . . . 71.42 110.362 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.88 -39.86 75.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.73 -0.668 . . . . 74.34 111.122 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -94.99 -10.83 29.76 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.431 0.634 . . . . 71.2 110.384 -174.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -117.25 -117.54 2.9 Favored Glycine 0 N--CA 1.411 -2.978 0 CA-C-N 115.243 -0.889 . . . . 73.32 113.139 -172.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.684 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 35.9 m-85 -136.46 -175.41 4.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.459 -0.571 . . . . 74.32 109.459 -169.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 m -99.37 -18.5 17.48 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.719 -0.673 . . . . 40.24 111.811 -178.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -107.29 115.87 30.93 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.876 -0.729 . . . . 71.11 111.54 -175.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.471 ' CE2' HD22 ' A' ' 512' ' ' LEU . 19.7 m-85 -120.84 142.57 49.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.578 -1.192 . . . . 74.14 108.543 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.5 p -115.62 145.28 42.84 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 104.936 -2.246 . . . . 64.43 104.936 171.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -121.82 138.3 54.43 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.829 -1.148 . . . . 73.04 111.09 -174.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.6 139.91 52.92 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.782 -0.822 . . . . 54.04 108.782 178.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 40.0 m -101.75 125.18 48.37 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.998 -1.112 . . . . 75.14 107.998 177.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.15 160.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.972 -0.751 . . . . 73.31 108.972 -176.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 8.4 p-10 -78.55 132.68 37.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.445 0.641 . . . . 65.43 109.901 -175.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 p -95.51 106.12 24.72 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 114.568 -1.197 . . . . 72.13 111.963 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 4.3 Cg_exo -76.55 -66.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.34 2.027 . . . . 73.22 110.986 177.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -108.72 -52.19 0.07 OUTLIER Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 118.977 -0.535 . . . . 75.45 111.879 178.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.96 134.19 17.57 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 120.4 1.178 . . . . 70.44 110.635 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.76 128.54 14.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.259 -0.274 . . . . 61.01 110.259 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.42 23.38 Favored Glycine 0 CA--C 1.502 -0.726 0 N-CA-C 110.185 -1.166 . . . . 65.03 110.185 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.59 149.19 23.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.276 -0.962 . . . . 65.43 109.529 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.7 p -73.18 127.07 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.175 -1.046 . . . . 74.55 108.175 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.6 m -73.5 -25.75 60.58 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.208 -1.36 . . . . 74.53 109.841 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.18 20.36 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 110.767 -0.933 . . . . 50.52 110.767 175.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -120.27 159.4 25.05 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.147 -1.427 . . . . 44.45 107.147 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.558 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -63.05 -54.54 45.28 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 119.942 -0.703 . . . . 70.04 110.56 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.4 Cg_endo -93.07 134.05 1.06 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.225 1.283 . . . . 72.34 109.665 171.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.7 Cg_exo -72.91 164.0 36.8 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.717 2.278 . . . . 64.24 113.429 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -54.1 145.07 17.88 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-N 115.486 -0.779 . . . . 61.31 109.372 173.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.62 34.01 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.832 -1.707 . . . . 64.32 108.832 -172.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 497' ' ' ILE . 23.0 m -88.62 119.85 29.47 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.816 -0.809 . . . . 65.43 108.816 173.303 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 86.5 m -101.77 127.43 48.56 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.147 -0.686 . . . . 74.43 109.147 176.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.84 160.21 64.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.647 -0.871 . . . . 72.0 108.647 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 494' ' ' THR . 42.9 Cg_exo -58.46 152.74 52.5 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.394 2.062 . . . . 55.12 111.773 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.684 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.9 m -65.98 -20.78 27.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.239 0.543 . . . . 73.03 112.39 -177.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.14 3.73 54.87 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.645 -0.707 . . . . 40.24 110.83 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.7 t -79.67 167.95 20.0 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.939 -0.393 . . . . 74.42 109.939 -177.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.19 120.64 62.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 109.757 -0.46 . . . . 62.43 109.757 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.4 tt -92.52 138.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.962 -0.385 . . . . 75.33 109.962 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -101.82 121.76 42.71 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 121.479 0.656 . . . . 74.15 110.654 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.94 134.91 41.12 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.98 1.312 . . . . 75.1 109.24 -177.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -101.27 108.68 20.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.625 -0.716 . . . . 73.41 110.017 -176.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 505' ' ' VAL . 64.1 t -96.9 131.76 42.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 124.066 0.946 . . . . 64.35 110.008 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 45.6 p -69.05 125.01 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.289 0.566 . . . . 74.14 110.769 175.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 1.0 OUTLIER . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 105.875 -1.898 . . . . 74.52 105.875 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.833 0 N-CA-C 110.093 -1.203 . . . . 52.22 110.093 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.46 142.18 44.22 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.622 2.214 . . . . 54.42 111.272 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.1 5.01 23.65 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.961 -0.755 . . . . 62.01 108.961 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 478' ' ' SER . 21.0 mp0 -82.67 125.21 30.96 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.266 -0.879 . . . . 63.45 109.979 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.531 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 18.9 tpp180 -120.7 155.87 32.96 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.68 -0.859 . . . . 73.41 108.68 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 142.02 28.83 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.207 1.003 . . . . 74.4 111.691 -174.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -86.0 128.7 57.0 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 109.524 -0.547 . . . . 73.31 109.524 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.72 160.1 47.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.161 2.574 . . . . 73.31 112.332 176.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.52 24.68 9.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.945 0.498 . . . . 71.51 111.257 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 439' ' ' GLU . 14.7 t -76.4 -2.98 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.8 1.286 . . . . 54.22 109.281 -176.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.573 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 3.1 m -52.37 -34.27 46.96 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.444 2.298 . . . . 65.13 111.323 177.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.9 t -60.97 -28.01 68.69 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.851 -0.613 . . . . 73.22 112.014 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.4 -47.51 8.72 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 118.874 -1.13 . . . . 60.45 111.836 -172.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 18.9 m -172.1 154.11 3.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.071 -1.085 . . . . 71.11 108.071 -178.204 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -51.91 -54.82 24.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 75.45 110.463 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.04 73.05 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 123.467 0.479 . . . . 70.25 111.91 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' A' ' 432' ' ' VAL . 10.2 mm-40 -61.04 -45.84 93.12 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.722 0.639 . . . . 50.11 111.327 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -71.27 -43.75 66.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.016 -0.538 . . . . 52.3 110.774 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.23 -48.36 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.965 -0.561 . . . . 51.14 111.985 -178.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.94 -40.1 96.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 70.24 110.344 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -66.57 -43.06 86.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.075 -0.512 . . . . 52.35 111.005 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 22.8 tp -68.69 -33.41 73.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.396 0.617 . . . . 74.44 109.611 179.202 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.3 m -62.42 -41.29 98.58 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.485 -0.78 . . . . 70.54 109.212 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.02 63.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.75 -0.659 . . . . 54.13 110.991 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.18 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.193 0.521 . . . . 45.14 110.02 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.98 -6.88 17.31 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.78 -0.724 . . . . 43.31 113.423 175.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 85.7 m-85 -75.28 136.8 40.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.084 0.772 . . . . 64.04 113.084 -176.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.57 25.93 3.73 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.169 -1.172 . . . . 71.51 110.169 175.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -132.61 115.19 15.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.821 -1.178 . . . . 75.34 107.821 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 67.8 m-85 -140.18 150.06 43.73 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.894 -0.41 . . . . 72.31 109.894 -175.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.471 ' HB3' HG13 ' A' ' 485' ' ' ILE . 15.1 tppt? -133.67 122.91 24.11 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 106.42 -1.696 . . . . 70.31 106.42 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -95.31 123.6 38.91 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 110.278 -0.267 . . . . 74.33 110.278 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.26 151.67 51.71 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.542 -1.281 . . . . 73.4 107.542 176.061 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.14 143.64 40.42 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.085 -0.646 . . . . 73.33 110.232 178.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.3 m -124.04 149.32 59.87 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 109.242 -0.651 . . . . 64.35 109.242 -178.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 490' ' ' SER . 20.9 Cg_exo -66.03 122.88 10.52 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.171 1.914 . . . . 74.44 110.238 176.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 t -134.2 179.81 6.03 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.601 -0.889 . . . . 74.11 108.601 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.1 t -65.56 141.43 97.91 Favored Pre-proline 0 N--CA 1.423 -1.825 0 C-N-CA 123.74 0.816 . . . . 74.31 110.793 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.5 Cg_exo -51.72 -29.23 32.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.389 3.393 . . . . 72.31 112.62 177.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.48 -23.92 61.9 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.626 -0.716 . . . . 74.3 112.049 -177.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 11.2 mp -108.49 8.7 27.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.449 0.537 . . . . 72.42 112.449 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 461' ' ' PRO . 93.2 t -60.7 133.4 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.967 0.413 . . . . 74.41 110.963 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.57 -16.21 57.94 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 120.9 -0.666 . . . . 44.41 113.438 175.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 463' ' ' LEU . 0.2 OUTLIER -103.82 166.22 10.55 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.538 -0.865 . . . . 73.55 109.588 178.671 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 59.3 t -82.13 130.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.429 -1.322 . . . . 72.41 107.429 176.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.1 pt -98.43 -0.87 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.17 -0.612 . . . . 63.41 110.937 -178.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 157.0 162.84 11.83 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 115.621 -0.718 . . . . 52.01 112.069 174.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.5 p -116.47 149.77 38.95 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.679 -1.23 . . . . 63.32 107.679 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.47 -52.02 55.91 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 120.298 -0.561 . . . . 72.41 110.874 177.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 57.7 Cg_endo -73.88 136.46 22.94 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 119.912 1.004 . . . . 71.21 109.854 172.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 22.9 Cg_exo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.505 2.136 . . . . 64.13 112.165 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -85.92 0.15 53.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.398 1.095 . . . . 43.44 109.053 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -91.07 -32.07 16.02 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.67 -1.605 . . . . 73.24 110.358 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -111.06 168.52 9.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.446 -0.501 . . . . 73.15 110.575 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 25.0 p -98.69 137.15 37.73 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.345 -0.389 . . . . 51.1 111.047 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.5 m -116.36 148.82 40.23 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.406 -0.59 . . . . 72.02 109.406 179.141 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.411 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . . . -69.64 157.63 36.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.742 0.246 . . . . 54.15 111.32 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.7 mm -70.35 -25.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.896 0.855 . . . . 75.23 110.199 -175.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.9 t -95.62 2.21 54.03 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.347 -0.842 . . . . 74.04 110.337 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 479' ' ' ALA . 7.1 m-20 -80.82 139.59 35.91 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 108.267 -1.012 . . . . 73.34 108.267 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.34 111.99 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.006 -0.739 . . . . 64.4 109.006 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.57 118.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.865 -1.161 . . . . 63.41 107.865 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -93.87 122.05 45.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.777 -1.194 . . . . 71.55 107.777 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.19 126.0 68.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.232 -1.025 . . . . 74.21 108.232 -179.11 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.4 mp -104.09 120.93 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.392 0.615 . . . . 32.41 110.125 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.09 145.34 8.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.646 -0.706 . . . . 73.31 109.281 -177.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.6 106.73 3.29 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.83 -0.908 . . . . 72.45 110.83 176.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 64.0 m -108.2 138.56 44.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.149 -1.056 . . . . 61.44 108.149 177.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -107.8 170.97 15.75 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.875 -1.155 . . . . 51.12 111.705 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.08 120.47 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.129 1.886 . . . . 41.23 110.633 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -82.11 79.18 8.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.67 -1.233 . . . . 42.43 107.67 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 546' ' ' PRO . 43.4 p -134.89 162.78 31.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.012 -0.995 . . . . 71.44 110.766 -173.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 0.3 OUTLIER -142.83 132.0 23.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.21 -1.033 . . . . 71.22 108.21 178.007 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.9 p-10 -80.73 138.33 36.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.436 -0.949 . . . . 61.1 108.436 173.144 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 42.8 pt -98.61 137.58 20.65 Favored Pre-proline 0 C--N 1.292 -1.902 0 C-N-CA 120.433 -0.507 . . . . 73.03 111.742 -177.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.69 -176.97 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.472 2.115 . . . . 73.24 110.11 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -77.02 125.95 30.17 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.402 -0.962 . . . . 73.45 108.402 176.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 7.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.139 0.971 . . . . 74.04 110.264 -177.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -93.05 160.44 14.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.628 -0.714 . . . . 71.03 110.844 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 94.96 -7.98 70.18 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 109.691 -1.364 . . . . 63.32 109.691 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -102.04 -180.0 4.16 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.32 -0.94 . . . . 75.44 108.665 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 38.4 m -88.2 155.64 19.65 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.909 -1.145 . . . . 52.41 107.909 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.79 -42.78 53.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 122.879 0.472 . . . . 62.44 112.15 -177.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.09 -42.04 85.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.857 -0.611 . . . . 73.32 111.287 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.0 p -76.6 -35.65 26.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.401 -0.92 . . . . 70.31 110.798 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.31 -48.51 77.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.184 -0.916 . . . . 71.22 111.186 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.12 -35.69 81.59 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 123.039 0.212 . . . . 75.34 110.973 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -64.65 -53.24 50.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.592 0.558 . . . . 65.13 109.882 179.036 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.92 -42.94 99.96 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.007 -0.542 . . . . 52.4 110.525 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.33 -37.99 89.47 Favored 'General case' 0 C--O 1.184 -2.362 0 CA-C-N 116.061 -0.518 . . . . 45.44 110.638 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.96 -46.57 89.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.842 0.353 . . . . 73.1 110.791 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -27.63 37.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 73.25 111.422 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -120.16 24.4 10.46 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.078 -0.649 . . . . 75.31 109.956 -175.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 495' ' ' LYS . . . -164.51 -110.26 0.23 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 118.507 -1.806 . . . . 54.24 116.244 -173.195 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.4 m-85 -116.15 176.73 4.97 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.039 0.447 . . . . 62.34 111.243 -164.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.7 m -118.63 -17.42 9.27 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.562 -0.745 . . . . 64.31 110.495 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.84 115.64 30.51 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.758 -0.777 . . . . 70.03 110.968 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -120.77 135.28 55.19 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.436 -1.257 . . . . 74.34 108.676 -177.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.0 t -115.86 152.39 33.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.9 -2.259 . . . . 72.55 104.9 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -121.46 128.72 52.42 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.996 -0.682 . . . . 73.05 110.809 -175.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.172 -1.418 . . . . 55.53 107.172 177.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 41.0 m -88.75 125.91 35.09 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.821 -0.627 . . . . 61.14 109.784 -177.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.88 156.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 176.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -79.55 118.35 21.32 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 113.588 0.959 . . . . 65.52 113.588 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 12.7 m -60.75 136.56 92.96 Favored Pre-proline 0 N--CA 1.427 -1.606 0 CA-C-N 113.288 -1.778 . . . . 62.34 110.631 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -78.08 -88.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 108.505 -1.383 . . . . 50.54 108.505 172.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 92.7 mtt180 -102.54 -55.99 0.11 Allowed Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 118.788 -0.625 . . . . 62.44 111.548 171.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 4.3 Cg_exo -75.81 149.96 34.16 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.376 1.384 . . . . 70.4 110.967 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.61 128.24 38.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.139 -1.06 . . . . 61.52 108.139 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.95 -7.31 17.11 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 110.705 -0.958 . . . . 73.4 110.705 -178.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.68 147.1 27.11 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.067 -0.716 . . . . 75.12 109.067 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.26 115.63 20.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.567 -1.642 . . . . 73.42 106.567 173.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 31.4 m -89.65 -27.45 20.14 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 115.634 -0.712 . . . . 73.41 109.775 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -177.2 -173.99 43.21 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.959 -1.115 . . . . 72.43 111.766 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.3 p -134.81 160.32 38.57 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.657 -1.238 . . . . 74.51 107.657 176.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -63.53 -54.55 42.34 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.22 0.325 . . . . 74.04 110.608 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 72.9 Cg_endo -83.64 138.45 8.37 Favored 'Trans proline' 0 C--N 1.365 1.403 0 N-CA-C 109.314 -1.071 . . . . 75.22 109.314 169.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 159.48 46.6 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 121.766 1.644 . . . . 55.14 111.82 178.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -60.76 135.1 57.67 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.436 -0.347 . . . . 71.24 110.27 177.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.65 -29.05 10.91 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 111.038 -0.825 . . . . 65.44 111.038 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.6 m -73.28 136.84 44.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.048 0.451 . . . . 70.42 110.863 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -100.78 122.36 43.26 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.478 -0.783 . . . . 72.25 109.265 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.06 157.59 69.05 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.585 -0.28 . . . . 65.35 110.474 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.514 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.9 Cg_exo -63.92 134.21 42.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.936 2.424 . . . . 70.34 113.488 -178.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.418 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.7 m -68.06 -21.29 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.554 -0.748 . . . . 73.24 111.434 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.22 0.57 51.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.393 -0.821 . . . . 75.42 110.738 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.4 t -103.52 161.84 13.54 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.81 -0.811 . . . . 73.42 108.81 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.45 130.54 44.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.062 -1.088 . . . . 73.21 108.062 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -95.04 145.95 7.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 110.023 -0.362 . . . . 74.34 110.023 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -102.64 116.54 32.79 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.57 -0.53 . . . . 75.22 109.57 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 25.4 tp -95.74 125.04 40.04 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.74 -1.578 . . . . 62.03 106.74 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -103.94 102.53 12.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.076 0.941 . . . . 74.14 108.507 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.0 138.19 30.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 114.418 -1.264 . . . . 74.01 110.368 -173.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 30.2 p -61.88 118.33 7.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.625 -0.88 . . . . 75.54 108.625 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 107.809 -1.182 . . . . 44.11 107.809 -176.409 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.219 0 N-CA-C 110.862 -0.895 . . . . 43.05 110.862 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.8 131.81 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.077 1.851 . . . . 74.12 112.716 -176.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.13 8.74 4.76 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.54 -0.755 . . . . 73.43 109.675 175.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -82.8 145.45 29.51 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 114.901 -1.045 . . . . 75.55 109.577 -172.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.426 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 2.7 tpt180 -131.23 153.24 49.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.38 -0.97 . . . . 74.45 108.38 -177.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.28 141.27 28.77 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 123.079 0.552 . . . . 63.52 111.153 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.8 mp -81.12 130.39 63.16 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.728 -0.841 . . . . 71.34 108.728 175.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.46 ' HB2' HG22 ' A' ' 432' ' ' VAL . 66.3 Cg_endo -71.45 160.43 48.59 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.644 2.229 . . . . 74.03 113.89 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -102.02 0.22 34.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.013 -0.994 . . . . 73.51 109.971 -179.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 430' ' ' PRO . 35.7 m -80.05 1.51 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.775 0.797 . . . . 34.54 110.665 -179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.8 m -63.93 -30.31 71.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.793 -1.094 . . . . 62.02 109.455 177.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.9 t -62.21 -26.57 68.44 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.064 -0.971 . . . . 45.32 110.316 176.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.18 -46.29 20.92 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.926 -0.71 . . . . 71.05 109.998 -175.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 22.7 m -165.59 147.37 7.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.855 -0.794 . . . . 71.21 108.855 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -50.62 -49.06 57.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.17 0.988 . . . . 74.21 111.44 174.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.43 -43.9 75.78 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 123.407 0.442 . . . . 74.25 111.363 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 16.2 mm-40 -61.57 -41.38 97.31 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.143 -0.48 . . . . 74.13 111.766 -178.088 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.66 -51.58 68.79 Favored 'General case' 0 CA--C 1.508 -0.662 0 O-C-N 123.898 0.749 . . . . 55.15 110.216 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.75 -48.36 86.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 114.65 -1.159 . . . . 74.31 112.087 -175.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.6 mmtp -60.42 -45.43 93.63 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 117.874 0.306 . . . . 72.44 110.726 -176.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -66.51 -46.23 76.91 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.695 -0.684 . . . . 72.31 110.502 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.2 tp -69.21 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.22 0.533 . . . . 65.0 111.476 -177.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.61 -42.89 98.19 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.131 -0.692 . . . . 64.43 109.131 176.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -18.25 62.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 40.31 110.801 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.43 -13.24 59.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.222 0.534 . . . . 55.13 110.145 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.48 -9.16 15.03 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 120.142 -1.028 . . . . 51.03 113.702 174.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -77.56 131.78 38.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.898 0.38 . . . . 75.52 111.169 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.87 12.6 5.34 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.713 -0.955 . . . . 53.24 110.713 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -118.65 115.97 25.62 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.709 -1.219 . . . . 74.24 107.709 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -134.91 154.3 51.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.494 0.664 . . . . 75.14 111.557 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 485' ' ' ILE . 63.5 tttp -143.04 123.03 13.55 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 106.447 -1.686 . . . . 63.24 106.447 170.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -91.62 132.79 36.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.545 -0.462 . . . . 71.12 110.319 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.33 143.84 50.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.674 -0.862 . . . . 62.53 108.674 176.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -119.79 144.18 47.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.264 -0.643 . . . . 71.12 109.264 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -141.34 134.97 14.65 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 107.133 -1.432 . . . . 73.03 107.133 177.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_endo -65.53 122.19 9.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.758 1.639 . . . . 72.44 109.715 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.4 m -124.72 174.63 7.76 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 116.064 -0.516 . . . . 61.11 110.269 -176.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -62.81 142.85 97.17 Favored Pre-proline 0 N--CA 1.416 -2.171 0 N-CA-C 107.801 -1.185 . . . . 64.43 107.801 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.42 -30.93 28.71 Favored 'Trans proline' 0 N--CA 1.473 0.295 0 C-N-CA 123.85 3.033 . . . . 64.21 113.377 -176.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.8 -27.01 65.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.586 -0.279 . . . . 71.2 111.429 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.78 -0.53 29.18 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.613 0.598 . . . . 74.33 112.613 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -61.37 127.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 109.96 -0.385 . . . . 74.43 109.96 176.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.85 -4.36 71.81 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 116.061 -0.518 . . . . 75.41 112.019 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -114.46 154.21 28.59 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.57 -0.9 . . . . 72.42 108.57 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 486' ' ' ILE . 53.2 t -82.11 134.3 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.122 -0.696 . . . . 55.23 109.122 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.3 pt -98.08 -20.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.55 -0.46 . . . . 73.44 110.538 -178.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 166.17 28.76 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.666 -0.778 . . . . 74.33 111.676 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 37.6 p -120.94 156.23 32.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.716 -0.475 . . . . 74.23 109.716 178.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -71.59 -48.35 12.12 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.303 -0.408 . . . . 33.41 111.326 175.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.3 Cg_exo -71.59 140.26 35.72 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 109.04 -1.177 . . . . 72.42 109.04 170.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.81 142.92 90.68 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.02 2.48 . . . . 61.03 114.294 -174.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.43 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -91.16 -6.97 52.75 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 74.34 109.386 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -99.52 -27.98 13.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.578 -0.737 . . . . 61.32 111.41 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.4 mp0 -119.48 151.33 38.75 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.744 0.306 . . . . 71.41 110.358 -179.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 55.3 p -74.83 131.48 40.8 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.683 -0.69 . . . . 62.42 110.538 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.2 m -106.87 151.31 25.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.139 -0.689 . . . . 62.12 109.139 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.84 152.58 40.2 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.0 -0.741 . . . . 62.11 109.0 -175.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.52 -17.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.888 0.851 . . . . 55.34 110.563 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -93.11 7.03 45.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.553 -0.749 . . . . 75.1 110.008 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.45 140.21 32.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.681 -0.859 . . . . 63.2 108.681 176.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.03 121.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.895 -1.52 . . . . 40.33 106.895 176.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.46 117.92 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 C-N-CA 118.976 -1.09 . . . . 63.53 109.37 -179.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.478 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.7 mp -96.49 111.81 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 106.091 -1.818 . . . . 75.03 106.091 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.34 123.56 59.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 109.041 -0.725 . . . . 74.12 109.041 -177.41 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.19 115.98 46.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.582 -0.736 . . . . 55.21 109.946 -173.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 30.0 t -96.86 137.98 23.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.659 -0.701 . . . . 72.01 109.547 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.23 107.6 2.22 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 107.685 -2.166 . . . . 61.25 107.685 172.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -111.39 150.97 29.03 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.219 0.533 . . . . 63.13 110.797 -172.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -147.77 124.44 1.91 Allowed Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.146 -1.182 . . . . 75.51 110.146 177.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.28 156.71 58.54 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.228 1.952 . . . . 72.1 110.528 177.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.88 86.77 6.44 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.255 0.55 . . . . 75.24 109.992 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.1 p -124.89 155.99 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.813 -0.631 . . . . 74.31 109.808 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -140.89 148.95 41.27 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.09 0.556 . . . . 72.45 109.805 176.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.62 125.01 29.47 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.944 -1.502 . . . . 53.21 106.944 178.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.0 pt -79.46 132.37 62.36 Favored Pre-proline 0 C--N 1.301 -1.501 0 C-N-CA 120.182 -0.607 . . . . 62.44 110.738 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -87.22 -171.27 0.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 122.13 1.887 . . . . 71.43 111.448 177.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.92 99.39 11.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.519 -0.919 . . . . 71.33 108.519 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.4 t -99.51 -5.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.906 0.86 . . . . 44.24 108.752 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -70.84 146.51 49.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.83 -1.077 . . . . 73.51 110.779 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.5 -20.07 23.35 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 119.888 -1.149 . . . . 72.41 112.08 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.436 ' O ' HG12 ' A' ' 534' ' ' VAL . 96.8 mt-30 -92.09 -171.44 2.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.456 -0.942 . . . . 74.22 108.456 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 m -84.95 155.22 21.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.124 -1.806 . . . . 73.43 106.124 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 10.1 p -64.11 -40.77 90.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 118.514 0.597 . . . . 64.0 110.984 -177.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 9.4 t70 -64.08 -43.19 96.15 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.403 -0.817 . . . . 65.43 111.611 178.073 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.94 -34.98 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.634 -0.826 . . . . 61.2 111.03 -178.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.62 76.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 64.24 111.256 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -65.41 -36.77 84.94 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 116.096 -0.502 . . . . 72.13 110.638 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.5 mptp? -62.7 -49.24 75.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.264 0.352 . . . . 65.2 111.946 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -63.67 -47.96 79.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.718 -0.393 . . . . 73.55 110.413 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.447 HD21 HD13 ' A' ' 551' ' ' ILE . 34.8 tp -62.27 -37.05 83.99 Favored 'General case' 0 C--O 1.192 -1.96 0 CA-C-N 115.759 -0.655 . . . . 64.01 111.313 -176.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.3 t-20 -59.01 -41.26 87.28 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.516 0.726 . . . . 61.41 110.294 177.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.1 -32.09 31.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.802 -0.635 . . . . 74.22 111.347 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.08 12.11 25.32 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.006 -0.678 . . . . 71.54 109.949 -174.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.33 -98.52 0.13 Allowed Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 117.735 -2.174 . . . . 71.24 117.29 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 67.2 m-85 -103.13 155.32 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 112.716 0.636 . . . . 74.03 112.716 -161.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 15.3 p -99.65 -36.19 9.58 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.991 -1.004 . . . . 72.12 112.151 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -108.22 131.93 54.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.269 0.557 . . . . 75.04 110.365 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.7 147.88 51.53 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.596 -0.729 . . . . 61.51 110.405 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.86 158.79 43.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.886 -1.153 . . . . 62.24 107.886 171.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.02 150.23 42.39 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.295 0.569 . . . . 72.2 111.48 -174.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.59 135.91 53.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.441 -1.689 . . . . 62.44 106.441 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 1.6 p -88.39 126.8 35.39 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 120.927 0.394 . . . . 72.55 111.369 -175.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.62 160.92 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.058 0.456 . . . . 73.41 109.934 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.86 113.52 19.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.921 0.867 . . . . 63.53 112.892 -175.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.8 m -114.54 117.39 42.75 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.386 -1.338 . . . . 74.33 107.386 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.93 -39.05 15.03 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.96 2.44 . . . . 73.43 115.331 -171.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.525 ' HG3' ' HD3' ' A' ' 530' ' ' PRO 0.446 7.4 ptm180 -122.19 -88.22 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 115.095 1.516 . . . . 75.35 115.095 -175.997 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.525 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 10.9 Cg_exo -75.22 153.51 40.78 Favored 'Trans proline' 0 C--N 1.372 1.768 0 CA-C-N 123.123 2.151 . . . . 63.4 111.072 173.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -134.94 159.41 41.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 61.15 108.073 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.33 -17.46 7.01 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.962 -0.855 . . . . 74.11 110.962 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.51 ' OE2' ' HB3' ' A' ' 556' ' ' SER . 4.3 pm0 -81.95 147.44 29.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 110.1 -0.333 . . . . 71.34 110.1 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.2 p -77.07 115.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 106.839 -1.541 . . . . 75.53 106.839 173.047 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.1 m -79.71 -21.21 44.88 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.243 -0.89 . . . . 74.11 110.529 -174.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.83 -168.69 34.48 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.856 -0.687 . . . . 72.32 112.101 177.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.442 HG22 HD13 ' A' ' 553' ' ' LEU . 12.1 p -117.85 160.31 21.62 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.372 -0.974 . . . . 71.04 108.372 176.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -61.82 -52.91 65.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 121.058 -0.257 . . . . 60.45 111.404 177.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.5 Cg_exo -83.95 152.75 12.85 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.077 1.185 . . . . 74.51 109.023 173.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.8 158.55 46.55 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.115 1.877 . . . . 73.35 112.417 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.41 130.52 46.62 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.131 0.491 . . . . 50.14 110.243 176.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -14.68 37.55 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 115.92 -0.582 . . . . 72.25 112.063 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 89.8 m -80.6 131.26 35.48 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.606 -0.349 . . . . 65.2 110.434 177.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.1 t -98.33 127.87 44.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.386 -0.598 . . . . 62.14 109.386 178.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' A' ' 517' ' ' PHE . 7.9 m -135.2 158.45 74.66 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.759 -0.83 . . . . 73.21 108.759 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 494' ' ' THR . 22.6 Cg_exo -65.1 133.15 34.41 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.819 1.679 . . . . 75.44 112.41 -177.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 21.6 m -68.57 -25.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.783 -1.099 . . . . 72.44 112.306 -176.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.06 -6.35 59.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.926 -1.034 . . . . 74.51 109.882 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.8 t -92.95 -172.84 3.11 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.673 -0.694 . . . . 73.44 110.267 -175.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.02 113.23 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.668 -0.696 . . . . 75.32 110.513 -174.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 512' ' ' LEU . 13.7 tt -96.2 142.61 13.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.097 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 34.7 tt0 -104.01 124.17 48.54 Favored 'General case' 0 N--CA 1.399 -2.986 0 CA-C-O 121.125 0.488 . . . . 74.3 110.929 -175.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -97.66 136.03 38.61 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.054 -0.975 . . . . 74.43 111.719 176.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -91.62 109.41 20.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.599 -1.63 . . . . 73.15 106.599 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.89 135.6 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.399 0.619 . . . . 74.04 111.295 -174.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.51 ' HB3' ' OE2' ' A' ' 533' ' ' GLU . 1.8 p -62.58 117.97 6.96 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 124.792 1.237 . . . . 62.42 112.388 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.427 -1.622 0 N-CA-C 108.746 -0.835 . . . . 74.22 108.746 178.473 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.758 0 N-CA-C 110.532 -1.027 . . . . 55.35 110.532 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.15 154.05 65.36 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.02 2.48 . . . . 65.13 112.162 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 480' ' ' ILE . 9.7 pt-20 -83.0 37.26 0.53 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.24 0.616 . . . . 50.35 111.829 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -96.91 122.94 40.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.97 0.414 . . . . 65.4 110.813 -176.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -120.89 146.85 46.17 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.87 -0.605 . . . . 74.44 111.97 -179.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.1 141.76 28.31 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.86 -1.064 . . . . 74.01 109.791 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.35 119.64 77.71 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.414 -0.587 . . . . 74.25 109.414 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.69 142.48 35.94 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.917 2.412 . . . . 71.43 111.522 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -88.81 78.47 7.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.811 1.291 . . . . 52.24 113.494 -176.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 440' ' ' ALA . 16.5 m -115.55 4.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.469 -2.048 . . . . 50.53 105.469 167.361 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.0 m -62.16 -41.3 98.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 112.355 -2.202 . . . . 71.15 109.057 178.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 42.4 m -58.07 -27.01 63.25 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.407 -1.27 . . . . 74.23 111.243 176.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.09 -46.31 11.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.233 -0.587 . . . . 74.32 111.035 -174.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.7 m -170.16 154.17 4.87 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.926 -0.768 . . . . 63.44 108.926 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -51.82 -49.84 62.01 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.255 1.022 . . . . 73.1 110.05 169.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.97 84.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.288 -0.869 . . . . 44.54 111.772 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 17.5 mm-40 -61.28 -46.09 91.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.993 -177.334 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -68.0 -49.47 61.4 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.765 -0.652 . . . . 75.31 111.34 -178.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.15 -48.2 90.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 123.537 0.523 . . . . 63.41 111.779 -176.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.14 -45.88 89.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.747 0.308 . . . . 73.11 111.023 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -67.22 -40.55 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.388 -0.369 . . . . 72.33 111.364 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.81 -33.03 73.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.189 0.519 . . . . 64.42 109.876 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 41.1 m -60.12 -44.17 95.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.56 -0.746 . . . . 73.0 109.232 173.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.11 64.4 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.602 -0.726 . . . . 75.44 111.298 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.15 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.241 0.543 . . . . 74.14 110.219 178.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.78 -18.66 5.94 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.748 -0.739 . . . . 51.0 113.308 176.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 445' ' ' THR . 96.3 m-85 -74.35 136.11 42.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.041 0.448 . . . . 73.14 110.584 -177.284 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.19 -12.61 1.24 Allowed Glycine 0 C--N 1.296 -1.68 0 CA-C-N 115.754 -0.657 . . . . 74.22 112.356 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -102.51 115.38 30.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.351 -0.611 . . . . 75.33 109.351 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -128.0 165.18 20.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.471 -0.786 . . . . 72.34 111.703 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 1.9 tmtp? -146.68 124.99 12.24 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.884 -2.265 . . . . 74.54 104.884 172.017 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -94.54 128.75 41.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.433 0.635 . . . . 70.32 111.173 -177.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.78 154.29 45.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.225 -1.028 . . . . 74.44 108.225 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.31 151.29 47.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.968 -0.382 . . . . 70.32 109.968 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 54.5 m -140.56 148.41 53.2 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.62 -0.882 . . . . 61.14 108.62 174.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.8 Cg_endo -65.74 129.32 21.92 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.209 1.94 . . . . 62.0 111.346 178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.8 t -141.46 173.48 11.45 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.74 -0.837 . . . . 64.33 108.74 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.4 t -66.34 146.64 99.05 Favored Pre-proline 0 N--CA 1.412 -2.332 0 C-N-CA 123.757 0.823 . . . . 74.42 109.141 177.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.23 -28.88 21.32 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.497 3.465 . . . . 72.34 113.061 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.854 -0.612 . . . . 74.32 111.176 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.35 -3.17 29.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.255 0.465 . . . . 74.32 112.255 -176.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 93.9 t -61.11 127.68 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.964 -0.384 . . . . 74.31 109.964 177.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.93 -12.0 68.99 Favored Glycine 0 C--N 1.314 -0.681 0 N-CA-C 111.49 -0.644 . . . . 73.02 111.49 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -101.74 159.5 15.27 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.644 -0.873 . . . . 64.44 108.644 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 54.6 t -82.32 132.11 32.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 64.22 108.812 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.9 pt -102.95 -23.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.966 -0.693 . . . . 73.45 111.69 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.89 157.54 22.74 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 111.564 -0.614 . . . . 61.44 111.564 178.357 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.2 p -124.62 147.82 48.27 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.646 -0.501 . . . . 62.43 109.646 177.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 24.6 t-20 -64.48 -50.15 67.52 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.054 -0.498 . . . . 61.3 110.56 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.0 Cg_exo -72.63 124.99 10.2 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.198 -1.501 . . . . 75.24 108.198 170.183 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.423 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 40.9 Cg_endo -64.21 139.32 65.61 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.646 2.231 . . . . 64.14 112.874 -175.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.06 -16.26 41.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.857 0.837 . . . . 50.01 109.508 177.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -78.74 -31.97 46.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.325 -1.307 . . . . 72.43 109.358 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.423 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.9 mp0 -108.98 172.44 6.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.536 -0.913 . . . . 64.34 108.536 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.6 p -98.54 133.72 42.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.85 -0.796 . . . . 71.42 108.85 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.2 m -116.16 140.87 48.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.38 -0.6 . . . . 64.12 109.38 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.07 145.39 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 74.23 111.659 -178.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -58.52 -31.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 124.18 0.992 . . . . 63.44 110.643 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.5 t -77.44 8.85 3.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.81 -0.632 . . . . 73.34 111.705 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -94.54 144.64 25.42 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 122.058 -0.401 . . . . 65.04 110.16 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.55 122.32 35.55 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 N-CA-C 108.367 -0.975 . . . . 71.33 108.367 175.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.4 t -87.87 117.52 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 C-N-CA 119.277 -0.969 . . . . 75.13 108.722 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 54.4 mt -99.38 111.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.595 -2.002 . . . . 64.14 105.595 175.209 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 125.34 58.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 109.099 -0.704 . . . . 60.53 109.099 -175.954 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.5 mp -99.86 116.91 44.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 N-CA-C 109.187 -0.672 . . . . 71.15 109.187 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.18 143.15 12.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 64.32 109.061 -177.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.8 114.01 3.96 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.163 -1.975 . . . . 42.42 108.163 172.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t -116.11 153.49 31.66 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.69 -0.855 . . . . 75.31 108.69 -176.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -130.69 110.73 1.03 Allowed Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.485 -0.864 . . . . 65.02 111.215 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.31 120.84 8.27 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.318 2.012 . . . . 74.3 110.524 176.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.48 91.37 7.82 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.002 0.905 . . . . 74.4 110.691 -176.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.3 p -131.79 159.81 37.42 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.602 -1.258 . . . . 51.13 107.602 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -147.61 145.04 28.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.834 -0.747 . . . . 75.34 110.837 177.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.64 113.11 19.42 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.035 -1.468 . . . . 74.4 107.035 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 30.7 pt -75.83 127.91 84.55 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 113.112 0.782 . . . . 74.54 113.112 -173.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 25.5 Cg_endo -101.21 112.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 122.982 2.455 . . . . 60.54 111.324 171.043 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.69 132.11 34.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.219 -0.659 . . . . 64.04 109.219 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.04 59.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 107.582 -1.266 . . . . 72.35 107.582 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -57.51 140.6 50.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.156 -1.838 . . . . 72.03 110.616 176.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.48 -11.29 30.68 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.673 -0.775 . . . . 24.25 111.264 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 534' ' ' VAL . 88.5 mt-30 -97.5 -171.15 2.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.103 -0.332 . . . . 65.35 110.103 177.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 12.1 m -84.86 156.75 21.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.842 -1.169 . . . . 71.54 107.842 -177.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -41.97 93.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.78 0.324 . . . . 64.43 110.608 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.49 -42.04 95.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.707 -0.679 . . . . 71.4 110.821 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.88 -34.98 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 119.638 -0.825 . . . . 63.53 110.721 -177.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.76 85.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.367 -0.833 . . . . 64.44 111.029 178.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.76 -45.95 90.29 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.487 0.492 . . . . 62.12 109.916 178.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -61.9 -54.03 47.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.603 -0.726 . . . . 65.25 112.053 -173.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.88 -38.33 88.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.544 -0.463 . . . . 52.54 110.919 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.71 -43.22 72.86 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 109.422 -0.584 . . . . 63.22 109.422 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.92 -45.8 89.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.351 0.661 . . . . 74.22 111.815 -178.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.72 -30.85 49.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 71.14 111.418 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.26 22.44 12.88 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 122.059 -0.401 . . . . 74.24 110.415 -174.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.74 -101.82 0.17 Allowed Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 117.165 -2.445 . . . . 72.03 116.514 -172.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 23.3 m-85 -109.6 156.37 20.26 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.513 -0.844 . . . . 71.54 110.601 -165.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.5 m -107.92 -24.27 11.7 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.762 -0.654 . . . . 71.4 111.426 -174.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -107.93 115.55 30.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.841 0.353 . . . . 71.4 110.143 -176.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -117.04 154.54 30.77 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.745 -0.661 . . . . 74.41 110.383 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.29 155.58 45.96 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.481 -1.674 . . . . 61.13 106.481 171.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -119.96 148.3 43.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.294 -1.002 . . . . 74.21 108.294 -174.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.12 128.5 30.23 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.223 -0.658 . . . . 74.42 109.223 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -88.02 122.44 31.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.444 -1.317 . . . . 74.21 107.444 176.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.72 153.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.707 -0.679 . . . . 74.15 109.169 -175.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.34 114.59 18.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.436 1.112 . . . . 74.41 110.883 -175.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.9 p -117.17 120.52 33.51 Favored Pre-proline 0 N--CA 1.408 -2.535 0 CA-C-N 113.799 -1.546 . . . . 63.23 109.769 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.95 -55.12 3.18 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.766 2.311 . . . . 61.33 112.818 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.46 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 23.8 mtp180 -99.92 -54.4 0.17 Allowed Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 114.081 1.141 . . . . 73.01 114.081 177.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 32.1 Cg_exo -60.21 153.27 60.28 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.138 1.892 . . . . 74.33 113.798 -176.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.05 133.74 9.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.604 -1.258 . . . . 62.23 107.604 176.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 84.23 -45.16 3.44 Favored Glycine 0 C--N 1.312 -0.754 0 C-N-CA 121.258 -0.496 . . . . 75.45 113.516 177.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.22 149.68 48.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.248 1.019 . . . . 75.14 111.406 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 503' ' ' GLN . 9.3 p -75.17 127.35 36.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.193 0.52 . . . . 62.13 111.073 -174.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -82.19 -22.21 36.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.518 -0.765 . . . . 73.42 109.226 -178.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 140.67 -149.5 20.99 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.901 -1.28 . . . . 63.12 109.901 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.0 p -116.94 157.26 26.02 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.766 -1.198 . . . . 62.14 107.766 176.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 52.1 t30 -59.44 -53.48 65.48 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.39 -0.338 . . . . 75.14 111.734 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.9 Cg_exo -77.19 138.84 18.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 108.386 -1.428 . . . . 75.34 108.386 172.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.07 155.43 69.68 Favored 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 121.958 1.772 . . . . 53.21 111.948 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -59.09 143.42 48.67 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.511 -0.768 . . . . 74.35 110.695 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 94.02 -9.27 72.89 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 120.944 -0.646 . . . . 75.43 111.853 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 29.5 m -80.16 128.22 33.26 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.218 -0.66 . . . . 75.01 109.218 177.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 1.8 m -84.88 122.68 29.53 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.712 -1.218 . . . . 61.22 107.712 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.11 154.72 81.76 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.626 -0.509 . . . . 42.41 109.626 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 494' ' ' THR . 21.4 Cg_exo -67.42 133.95 31.79 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.428 2.085 . . . . 75.21 111.813 -178.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.578 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 19.5 m -67.69 -20.48 26.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.166 0.507 . . . . 72.32 112.08 -177.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.67 -3.04 55.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.83 -0.623 . . . . 73.33 110.444 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.7 t -95.19 164.99 12.62 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.361 -0.607 . . . . 73.15 109.361 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.73 136.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.604 -0.517 . . . . 72.1 109.604 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.5 tt -110.65 138.47 38.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 120.936 0.398 . . . . 64.51 109.937 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -103.4 127.43 50.76 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 122.771 0.428 . . . . 65.22 109.85 -178.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.4 tp -100.63 132.96 45.75 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.485 -0.78 . . . . 63.15 108.899 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -88.88 113.66 24.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.115 -0.698 . . . . 74.32 109.115 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 47.8 t -103.96 124.16 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 108.542 -0.91 . . . . 52.05 108.542 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 16.0 m -61.58 121.84 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.302 -0.999 . . . . 54.53 108.302 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 60.2 tttm . . . . . 0 N--CA 1.42 -1.96 0 CA-C-O 118.462 -0.78 . . . . 72.21 110.745 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.928 0 N-CA-C 110.348 -1.101 . . . . 71.11 110.348 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.0 156.06 56.58 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.282 1.988 . . . . 64.4 111.479 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.5 pt-20 -125.08 40.12 3.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.116 0.96 . . . . 72.45 108.641 -178.287 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -83.53 121.88 27.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.802 -1.09 . . . . 74.11 109.946 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -121.07 156.92 31.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.096 -1.076 . . . . 71.23 108.096 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -83.43 140.84 32.13 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.142 -0.481 . . . . 74.34 109.844 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -84.71 127.88 63.36 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.318 -0.993 . . . . 70.51 108.318 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.3 141.59 63.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.887 1.724 . . . . 63.24 111.93 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -111.31 70.22 0.71 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 122.669 1.224 . . . . 73.23 108.781 -177.124 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.96 5.92 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 113.779 -1.555 . . . . 65.33 107.812 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.56 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.3 m -57.34 -34.62 68.97 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.872 -1.967 . . . . 53.51 112.428 -177.063 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.0 t -60.3 -27.06 67.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.156 0.582 . . . . 64.23 111.557 178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.45 -45.97 18.39 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 120.127 -0.629 . . . . 71.1 110.21 -172.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.4 m -170.3 149.08 3.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.494 -1.298 . . . . 73.25 107.494 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 42.2 t80 -53.22 -45.86 68.84 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.555 0.535 . . . . 74.02 110.389 171.187 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.13 74.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.52 -0.764 . . . . 71.04 111.867 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 30.2 mm-40 -61.35 -44.87 96.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.269 -0.423 . . . . 72.42 111.048 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -62.79 -51.05 68.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.831 -0.622 . . . . 54.1 110.766 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -62.95 -48.86 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.662 -0.699 . . . . 61.54 111.97 -175.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.06 -41.49 90.7 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 121.107 -0.237 . . . . 75.42 111.353 -177.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.12 88.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.244 0.545 . . . . 72.24 109.887 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.51 -40.32 80.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.671 -0.695 . . . . 74.32 109.904 177.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.4 m -59.47 -46.5 88.62 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.637 -0.71 . . . . 55.44 109.107 176.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.34 65.9 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.443 -0.799 . . . . 64.4 111.437 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.61 -14.01 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 74.44 111.023 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.03 -14.92 21.3 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.108 -1.044 . . . . 64.43 113.046 175.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -69.81 130.15 41.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.608 -0.516 . . . . 74.42 109.608 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.19 -23.92 6.48 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.894 -0.669 . . . . 51.22 111.704 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -103.01 115.79 31.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.831 0.824 . . . . 72.3 112.458 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 3.4 p90 -146.83 141.74 26.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.405 -1.27 . . . . 64.34 110.112 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -131.39 123.22 27.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.548 -0.751 . . . . 55.44 109.089 -174.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -85.78 135.35 33.76 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.003 -0.544 . . . . 74.24 110.576 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.68 147.7 52.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.396 -1.705 . . . . 64.04 106.396 171.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -114.4 149.2 36.53 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.438 -0.505 . . . . 70.35 109.808 -178.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 10.2 t -140.63 133.49 14.63 Favored Pre-proline 0 N--CA 1.422 -1.862 0 N-CA-C 108.01 -1.107 . . . . 72.31 108.01 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.2 Cg_exo -65.0 125.09 14.06 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.656 2.237 . . . . 63.05 111.93 -179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 31.4 t -139.26 179.5 6.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 -178.015 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.4 t -57.64 140.37 80.59 Favored Pre-proline 0 N--CA 1.432 -1.336 0 C-N-CA 123.213 0.605 . . . . 52.52 110.327 177.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 76.7 Cg_exo -50.58 -29.61 25.57 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 124.312 3.342 . . . . 74.31 113.573 -178.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.58 -10.59 59.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.58 0.585 . . . . 70.05 112.58 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.6 8.11 35.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.525 0.565 . . . . 74.32 112.525 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.4 p -60.68 128.1 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.796 0.331 . . . . 70.41 110.453 179.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.54 87.62 Favored Glycine 0 C--O 1.252 1.26 0 C-N-CA 120.847 -0.692 . . . . 73.41 112.214 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -113.61 146.06 40.31 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.19 -1.041 . . . . 65.42 108.19 177.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 45.8 t -81.94 144.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.943 -0.391 . . . . 64.12 109.943 -176.22 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.6 pt -98.21 -19.0 6.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.142 0.496 . . . . 60.34 110.503 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.24 178.36 37.67 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 111.191 -0.764 . . . . 72.22 111.191 177.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 27.8 p -119.59 145.99 45.91 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.415 -0.587 . . . . 73.41 109.415 178.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.88 -52.1 74.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 123.266 0.353 . . . . 70.52 111.103 178.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.68 143.41 23.9 Favored 'Trans proline' 0 C--N 1.366 1.493 0 N-CA-C 108.89 -1.235 . . . . 73.32 108.89 170.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 56.4 Cg_endo -65.94 153.11 79.49 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 122.459 2.106 . . . . 61.45 112.355 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -87.15 -20.07 27.55 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.424 -0.807 . . . . 72.34 110.262 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 -32.12 15.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.089 -0.959 . . . . 74.52 112.117 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 1.3 mp0 -94.57 145.57 24.72 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.234 -0.986 . . . . 70.34 108.613 178.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 28.6 p -83.87 128.71 34.74 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 116.327 -0.397 . . . . 71.21 110.513 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 m -114.03 145.11 42.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.073 -1.084 . . . . 63.34 108.073 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.46 142.0 58.31 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.663 0.268 . . . . 55.45 111.542 -176.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 425' ' ' GLU . 50.2 mm -57.75 -25.84 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.779 0.832 . . . . 73.04 110.578 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -79.56 3.61 18.33 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.971 -0.559 . . . . 74.44 111.226 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.52 157.77 15.75 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.975 -0.453 . . . . 74.41 110.241 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.39 122.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.962 -1.125 . . . . 71.54 107.962 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 93.3 t -89.25 119.38 36.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.616 -0.512 . . . . 71.35 109.616 179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.31 121.81 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.588 -1.264 . . . . 72.24 107.588 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.95 121.29 66.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 115.626 -0.715 . . . . 75.45 109.277 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.73 118.36 49.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 121.808 0.813 . . . . 72.44 112.511 -178.283 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 15.4 t -96.77 145.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.883 -1.053 . . . . 72.13 109.1 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.77 117.31 4.63 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 110.477 -1.049 . . . . 71.13 110.477 176.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 7.3 p -99.57 128.66 45.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 107.486 -1.302 . . . . 63.42 107.486 174.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -108.76 119.43 5.61 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.213 -0.994 . . . . 71.52 112.057 -174.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.74 116.96 4.89 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.393 2.062 . . . . 74.11 111.15 177.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.58 109.1 20.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 64.21 107.44 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 546' ' ' PRO . 21.9 p -122.61 158.77 29.23 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 115.538 -0.755 . . . . 55.33 109.847 -178.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -135.65 141.63 45.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.323 -0.398 . . . . 75.35 110.76 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.07 127.1 32.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.723 -1.214 . . . . 75.21 107.723 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.97 129.79 80.0 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 115.87 -0.605 . . . . 54.15 111.863 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -94.26 124.28 0.43 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.769 2.313 . . . . 42.11 112.471 173.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.18 135.43 36.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.278 -1.378 . . . . 74.32 107.278 174.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 t -125.28 33.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.754 0.787 . . . . 75.51 108.928 -176.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -61.28 116.16 4.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 70.11 110.771 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.57 -23.92 5.01 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.651 -0.785 . . . . 60.21 112.244 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.31 -179.17 3.87 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.712 -0.847 . . . . 65.54 108.712 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 25.7 m -84.09 155.7 22.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 119.928 -0.709 . . . . 71.23 109.652 -172.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.06 -41.31 68.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.787 0.435 . . . . 72.55 111.199 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.64 -42.06 87.3 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.535 -0.757 . . . . 75.35 111.59 -178.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.06 -36.37 56.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 118.952 -1.099 . . . . 74.33 110.631 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.16 74.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.942 -1.026 . . . . 74.12 111.56 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -63.35 -35.24 79.74 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 123.116 0.26 . . . . 63.11 110.676 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -63.54 -49.15 74.61 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.332 0.395 . . . . 61.41 111.918 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -68.88 -38.27 79.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.897 0.379 . . . . 72.14 110.472 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 551' ' ' ILE . 48.1 tp -62.4 -44.67 95.89 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 115.84 -0.618 . . . . 53.42 110.065 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.0 t-20 -59.54 -47.69 84.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.413 0.685 . . . . 62.42 111.989 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.69 -20.0 17.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.169 -0.469 . . . . 31.23 112.04 -175.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -116.61 4.02 13.14 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 120.034 -0.666 . . . . 70.44 111.13 -178.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.73 -96.64 0.2 Allowed Glycine 0 N--CA 1.41 -3.089 0 C-N-CA 118.806 -1.664 . . . . 64.31 115.763 -169.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 9.6 m-85 -129.74 158.4 39.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.278 -0.461 . . . . 65.45 110.292 -165.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -104.95 -2.21 24.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.609 -0.885 . . . . 64.54 108.609 177.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 550' ' ' VAL . 75.5 mmtt -108.73 115.61 30.41 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 72.04 109.462 -175.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -126.24 152.42 46.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.603 0.716 . . . . 72.23 111.786 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -133.59 148.82 51.62 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.629 -1.619 . . . . 75.32 106.629 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.6 mm-40 -120.27 123.25 42.72 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.691 -1.226 . . . . 72.42 107.691 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -114.86 126.53 54.92 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.78 -1.192 . . . . 74.22 107.78 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 19.4 m -91.92 120.45 32.6 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.019 -0.734 . . . . 74.15 109.019 -178.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.39 151.51 24.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.568 -1.271 . . . . 74.32 107.568 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.476 ' HA ' ' OXT' ' A' ' 557' ' ' LYS . 12.6 m-20 -79.05 128.22 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.024 0.916 . . . . 70.31 113.411 -170.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.4 m -143.4 111.7 5.47 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.84 -1.541 . . . . 42.35 106.84 177.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -56.17 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.048 2.498 . . . . 54.22 114.568 -174.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -82.34 -44.78 0.98 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 114.715 1.376 . . . . 73.14 114.715 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 533' ' ' GLU . 72.6 Cg_exo -57.07 133.76 59.94 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.352 1.368 . . . . 71.2 110.803 174.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -143.09 127.21 17.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.587 -0.279 . . . . 74.13 110.652 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.0 -11.28 55.2 Favored Glycine 0 N--CA 1.469 0.858 0 CA-C-O 121.372 0.429 . . . . 62.45 113.024 175.141 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 530' ' ' PRO . 11.4 pt-20 -86.78 150.89 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.505 0.722 . . . . 74.32 110.976 178.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 47.8 t -74.71 124.64 32.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.226 -1.028 . . . . 60.13 108.226 178.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 28.8 m -83.38 -33.64 25.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 71.52 108.44 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.05 -167.12 39.92 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.834 -0.621 . . . . 65.12 111.655 177.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.5 p -118.97 160.38 22.1 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.579 -0.897 . . . . 72.22 108.579 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.9 t-20 -57.8 -56.77 31.13 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 119.274 -0.394 . . . . 73.13 111.95 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.3 Cg_endo -89.38 166.05 5.37 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.833 1.688 . . . . 52.25 109.506 174.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.28 152.55 55.75 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.295 1.996 . . . . 64.23 111.974 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.14 135.94 57.73 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.862 0.465 . . . . 65.23 110.351 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.47 37.16 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.99 -0.624 . . . . 63.44 111.564 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.6 m -67.89 131.56 45.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.483 -0.562 . . . . 74.23 109.483 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.3 t -100.02 123.72 44.58 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.994 0.902 . . . . 72.22 110.971 -177.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.69 158.93 60.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 71.32 108.465 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 494' ' ' THR . 44.1 Cg_exo -58.62 143.78 98.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.237 1.958 . . . . 74.44 110.894 179.177 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.32 -21.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.246 0.461 . . . . 65.33 112.246 -176.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.97 -2.77 58.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.325 -0.398 . . . . 75.33 111.034 178.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -81.21 152.58 27.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.18 -0.674 . . . . 51.03 109.18 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.9 t -90.06 125.5 42.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.312 -0.625 . . . . 61.11 109.312 -179.039 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.435 HD13 HD21 ' A' ' 512' ' ' LEU . 14.2 tt -97.25 139.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.122 -0.325 . . . . 61.02 110.122 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -102.85 120.27 40.3 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 120.902 0.382 . . . . 61.12 110.119 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 534' ' ' VAL . 6.3 tt -100.89 130.18 46.86 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.423 -1.325 . . . . 72.44 107.423 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.8 mt-30 -101.21 109.51 21.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.661 0.743 . . . . 71.05 110.186 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.18 139.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.448 -1.251 . . . . 75.12 111.598 -175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -57.14 121.05 9.13 Favored 'General case' 0 C--O 1.25 1.108 0 C-N-CA 123.825 0.85 . . . . 64.43 112.973 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.476 ' OXT' ' HA ' ' A' ' 526' ' ' ASP . 28.4 ttpp . . . . . 0 N--CA 1.432 -1.367 0 C-N-CA 124.951 1.301 . . . . 72.5 108.362 175.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.186 0 N-CA-C 109.753 -1.339 . . . . 43.05 109.753 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.51 147.39 70.68 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.022 1.815 . . . . 71.03 112.496 -177.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 425' ' ' GLU . 0.1 OUTLIER -95.48 4.3 53.39 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.866 -1.161 . . . . 63.23 107.866 177.677 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 96.6 mt-30 -83.47 149.09 26.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.649 -1.614 . . . . 74.41 108.396 178.472 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 17.6 tpp180 -120.92 155.33 34.44 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.528 -1.286 . . . . 62.11 107.528 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.39 141.48 31.7 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.49 -0.93 . . . . 72.24 108.49 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -80.07 127.4 77.03 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.018 -1.475 . . . . 64.14 107.018 177.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.27 139.93 32.99 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 109.431 -1.027 . . . . 53.45 109.431 175.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -115.28 72.04 0.78 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.889 1.328 . . . . 73.32 109.93 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.14 14.68 7.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 113.552 -1.658 . . . . 61.45 107.1 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.624 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.3 m -52.39 -41.29 63.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 127.637 2.375 . . . . 63.51 110.395 178.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.3 t -56.43 -26.71 54.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.003 1.321 . . . . 64.2 112.017 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.4 mt -85.85 -46.92 10.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.118 -1.033 . . . . 63.2 111.048 -174.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 20.1 m -174.23 153.7 2.05 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.535 -0.913 . . . . 72.34 108.535 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.497 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 40.3 t80 -50.55 -50.68 52.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.142 0.977 . . . . 74.34 111.009 171.186 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.48 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.757 0.661 . . . . 64.42 111.461 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.413 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 50.0 mm-40 -61.49 -45.98 91.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.317 -0.402 . . . . 62.35 111.463 -178.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -63.38 -48.36 78.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.87 -0.605 . . . . 61.14 110.967 -178.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.18 -46.59 90.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.894 -0.594 . . . . 64.52 112.238 -176.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -66.55 -41.55 88.49 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.488 0.181 . . . . 71.4 111.488 -178.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.08 -38.99 86.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.458 -0.497 . . . . 70.43 111.179 176.442 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 452' ' ' PHE . 33.5 tp -67.11 -36.61 82.29 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.251 0.548 . . . . 52.33 110.041 178.212 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.2 m -59.49 -44.72 93.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.459 -0.791 . . . . 45.02 109.582 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.68 -18.65 62.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.44 -0.8 . . . . 73.33 111.181 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.16 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.228 0.537 . . . . 72.44 110.903 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.06 -25.77 9.74 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.813 -0.708 . . . . 60.01 113.454 174.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 96.2 m-85 -57.42 130.7 47.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.038 0.535 . . . . 61.34 112.0 -176.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.0 26.29 4.79 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.398 -0.906 . . . . 53.13 112.849 -178.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -132.91 115.59 15.43 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.235 -1.024 . . . . 75.01 108.235 178.715 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.6 m-85 -128.93 150.11 50.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.575 0.702 . . . . 71.42 111.731 -174.332 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.573 ' HB2' HG13 ' A' ' 485' ' ' ILE . 36.3 mmtm -136.24 130.62 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.646 -1.983 . . . . 75.54 105.646 169.374 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -108.26 124.72 50.74 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.703 -0.799 . . . . 74.52 110.83 -175.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.05 145.01 48.56 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.934 -0.575 . . . . 63.12 109.547 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -118.88 134.54 55.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.436 -1.32 . . . . 70.54 107.436 175.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.1 t -122.29 137.23 27.3 Favored Pre-proline 0 C--N 1.283 -2.284 0 N-CA-C 108.479 -0.934 . . . . 75.41 108.479 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.11 122.17 9.86 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.847 1.698 . . . . 54.05 110.801 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 40.5 m -134.07 178.7 6.76 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.353 -0.98 . . . . 54.33 108.353 -177.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.7 t -74.0 151.26 88.39 Favored Pre-proline 0 N--CA 1.403 -2.804 0 N-CA-C 107.651 -1.24 . . . . 74.33 107.651 176.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.498 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -50.42 -28.91 22.44 Favored 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 124.121 3.214 . . . . 63.03 112.718 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.97 -26.25 68.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.121 -0.49 . . . . 74.05 111.344 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.34 -0.42 35.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.81 1.041 . . . . 63.42 113.81 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -60.81 128.13 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 119.962 -0.695 . . . . 74.14 110.696 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.24 -12.77 67.8 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 121.12 -0.562 . . . . 74.4 112.654 177.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.27 139.72 38.35 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.732 -0.47 . . . . 72.45 109.732 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 61.6 t -82.49 128.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.767 -0.651 . . . . 75.22 109.628 -178.102 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.47 -6.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.937 0.399 . . . . 74.45 112.019 -176.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.29 160.92 15.43 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.939 -1.125 . . . . 75.4 112.829 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.0 p -118.95 142.29 47.91 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.255 -1.017 . . . . 71.52 108.255 176.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.527 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.7 t-20 -54.74 -51.58 77.68 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 112.387 0.514 . . . . 72.13 112.387 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.5 Cg_exo -77.2 124.13 7.05 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 N-CA-C 108.158 -1.516 . . . . 75.14 108.158 169.378 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.32 142.17 65.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.326 2.017 . . . . 75.12 112.037 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.55 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.21 -14.65 61.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.144 0.973 . . . . 40.43 110.697 -177.152 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.27 -9.98 55.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.731 -1.577 . . . . 64.45 111.33 -176.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -120.84 151.06 40.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.945 -0.761 . . . . 64.23 108.945 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 10.7 p -84.44 132.7 34.54 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 108.807 -0.812 . . . . 73.11 108.807 176.513 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.6 m -122.2 145.71 47.94 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.358 -0.608 . . . . 53.34 109.358 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -59.55 154.64 16.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.439 . . . . 54.52 111.001 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.1 -25.42 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.796 0.807 . . . . 63.43 110.603 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.4 t -94.54 11.48 30.79 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.014 -0.994 . . . . 62.5 110.921 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -77.74 141.35 39.34 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 121.697 -0.627 . . . . 72.53 109.853 176.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.57 117.33 25.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.609 0.719 . . . . 73.0 110.075 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.44 118.61 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.734 -0.839 . . . . 72.34 108.734 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.573 HG13 ' HB2' ' A' ' 453' ' ' LYS . 2.5 mp -96.5 117.83 41.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 105.411 -2.07 . . . . 71.13 105.411 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.72 119.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 109.068 -0.715 . . . . 73.54 109.068 -176.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.53 114.26 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.528 -175.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 17.5 t -95.99 136.59 26.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.688 -0.856 . . . . 63.54 108.688 -178.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.44 125.08 6.8 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.815 -1.714 . . . . 73.15 108.815 175.072 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -128.63 129.84 46.44 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 109.12 -0.696 . . . . 71.43 109.12 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 492' ' ' PRO . . . -88.99 131.7 10.84 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.104 -1.598 . . . . 44.24 109.104 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 32.5 Cg_exo -61.59 118.27 5.13 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.375 2.05 . . . . 54.11 111.482 -178.662 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -71.45 91.78 1.05 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.147 0.975 . . . . 70.13 109.591 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.9 p -137.1 154.11 50.38 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.644 -1.243 . . . . 74.34 107.644 -176.344 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -138.64 150.0 45.78 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.807 0.337 . . . . 71.14 110.562 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.0 t70 -100.36 113.73 26.7 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.02 -1.104 . . . . 74.11 108.02 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 497' ' ' ILE . 0.2 OUTLIER -98.6 134.84 21.37 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 113.443 0.905 . . . . 71.24 113.443 -174.153 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.4 -178.15 1.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.767 2.311 . . . . 55.12 109.04 170.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.69 153.64 18.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.091 -0.707 . . . . 70.15 109.091 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.65 33.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 104.937 -2.246 . . . . 54.4 104.937 175.086 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.89 147.45 33.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.794 -1.548 . . . . 63.4 111.327 -173.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 103.65 -12.98 53.96 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.64 -0.984 . . . . 43.54 110.64 -177.23 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.12 179.92 4.08 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.098 -0.704 . . . . 74.13 109.098 177.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.72 156.15 26.4 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.647 -0.421 . . . . 64.22 109.941 -170.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.1 p -54.3 -43.7 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.383 0.512 . . . . 72.31 112.383 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.64 -41.91 78.74 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.332 0.493 . . . . 63.12 112.332 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.83 -38.9 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 119.47 -0.892 . . . . 72.35 111.524 -174.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.38 80.93 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.61 -0.723 . . . . 71.53 111.39 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -64.82 -34.68 78.93 Favored 'General case' 0 C--O 1.205 -1.282 0 O-C-N 123.214 0.321 . . . . 64.12 110.394 -177.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -59.5 -52.48 65.4 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.495 -0.557 . . . . 74.3 109.495 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -66.86 -44.72 80.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.457 -0.792 . . . . 72.1 110.704 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.47 -37.0 82.03 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 115.915 -0.584 . . . . 62.35 110.531 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -58.81 -38.15 77.98 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.552 0.741 . . . . 74.5 110.942 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -37.62 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.718 -0.674 . . . . 74.43 111.267 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -122.74 33.83 5.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.713 0.768 . . . . 72.43 111.455 -176.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -153.39 -128.52 1.29 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.98 -1.009 . . . . 62.24 111.553 -178.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 44.7 m-85 -105.66 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.053 0.454 . . . . 65.45 110.319 -173.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.6 p -110.03 -3.63 16.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.577 -0.738 . . . . 71.44 110.902 178.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 550' ' ' VAL . 28.2 mtpp -113.77 115.73 28.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.84 -0.8 . . . . 74.24 108.84 -177.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.83 156.46 43.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.152 0.501 . . . . 74.21 111.456 -175.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -140.99 156.62 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.017 -1.475 . . . . 75.22 107.017 171.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -121.75 124.87 45.24 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.385 -0.598 . . . . 74.41 109.385 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.82 140.63 48.78 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.529 -0.915 . . . . 75.23 108.529 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 20.0 m -88.18 124.81 34.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.974 -0.557 . . . . 52.53 110.704 -176.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 33.2 m -121.17 156.8 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.954 -1.128 . . . . 73.43 107.954 176.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.88 142.4 38.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.999 0.904 . . . . 72.21 112.048 -170.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 p -118.17 135.29 23.43 Favored Pre-proline 0 N--CA 1.413 -2.294 0 CA-C-N 114.264 -1.334 . . . . 51.11 110.187 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.55 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.275 0 N-CA-C 109.075 -1.163 . . . . 43.14 109.075 171.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.559 ' HG3' ' HD3' ' A' ' 530' ' ' PRO . 23.2 ptt180 -127.43 -47.07 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 114.72 1.378 . . . . 74.35 114.72 176.572 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.559 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 84.7 Cg_endo -76.54 135.89 16.8 Favored 'Trans proline' 0 C--N 1.385 2.45 0 CA-C-N 121.763 1.665 . . . . 71.41 112.107 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -137.32 145.44 43.41 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.955 -0.387 . . . . 73.52 109.955 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 100.21 -18.83 54.97 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.899 -0.48 . . . . 62.45 111.899 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.43 148.4 24.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.286 0.565 . . . . 75.32 111.638 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.73 122.45 28.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.289 -0.869 . . . . 75.34 109.472 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.3 m -92.68 -10.01 38.78 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.788 -1.096 . . . . 62.5 109.348 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -159.12 27.98 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 110.774 -0.931 . . . . 75.43 110.774 177.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -134.36 157.75 45.59 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.698 -1.223 . . . . 71.5 107.698 177.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 552' ' ' GLU . 25.2 t-20 -52.68 -58.72 10.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.861 -0.59 . . . . 51.0 110.908 -179.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.51 140.53 15.13 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 120.464 1.202 . . . . 63.1 109.063 170.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.47 155.8 65.9 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 121.935 1.757 . . . . 71.41 112.193 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.53 136.14 57.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.944 -0.571 . . . . 73.34 109.914 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -5.36 57.04 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.088 -1.053 . . . . 62.3 111.815 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 16.7 m -89.2 137.72 32.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.446 -0.575 . . . . 73.12 109.446 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.7 m -98.8 123.04 42.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.244 -1.021 . . . . 42.42 108.244 175.084 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.74 161.96 57.97 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 110.054 -0.351 . . . . 71.52 110.054 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 494' ' ' THR . 20.7 Cg_exo -66.33 137.79 48.57 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.02 2.48 . . . . 60.23 113.995 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.553 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 15.0 m -67.86 -20.45 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.005 0.907 . . . . 72.04 111.248 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.45 -5.15 58.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.446 -1.252 . . . . 63.23 110.456 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -103.72 152.25 22.05 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.69 -1.226 . . . . 74.05 107.69 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 519' ' ' LYS . 38.8 t -88.71 136.2 23.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.859 -0.423 . . . . 64.32 109.859 -177.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.0 tt -95.88 135.49 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.352 0.596 . . . . 70.11 109.408 176.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -101.59 120.61 40.59 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.379 -0.971 . . . . 72.43 108.379 -177.093 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.0 tp -95.5 126.58 40.89 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.811 -1.086 . . . . 71.44 108.472 -177.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -89.53 105.64 17.93 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.632 -0.877 . . . . 75.31 108.632 -177.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.48 134.49 47.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 120.789 0.328 . . . . 64.31 110.667 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.7 p -66.35 121.46 15.3 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.044 -0.525 . . . . 75.31 109.743 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 20.6 pttp . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 115.557 -0.747 . . . . 75.51 110.626 -177.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.288 0 N-CA-C 110.537 -1.025 . . . . 43.05 110.537 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.91 132.61 45.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.798 2.332 . . . . 73.21 111.079 178.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.29 27.0 4.16 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.775 0.797 . . . . 61.34 109.521 -177.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -101.39 147.89 25.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.162 -1.051 . . . . 54.23 108.162 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 18.4 tpt180 -120.72 158.82 26.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.966 0.413 . . . . 73.43 110.166 -175.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.3 141.47 29.22 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.149 0.979 . . . . 74.52 110.41 -176.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.0 mp -87.85 121.49 70.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.617 -1.623 . . . . 60.01 106.617 173.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.74 141.83 55.86 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.091 1.861 . . . . 34.22 112.898 -175.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.58 11.64 23.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.74 -0.663 . . . . 73.12 110.767 -178.192 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 443' ' ' LYS . 21.5 m -73.27 -9.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.701 -0.851 . . . . 64.45 108.701 176.177 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.0 m -57.23 -38.2 73.44 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.329 -1.305 . . . . 71.14 109.866 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.1 m -60.02 -27.56 67.0 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.779 -1.1 . . . . 70.24 110.647 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.8 mt -79.85 -47.63 14.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.382 -0.927 . . . . 73.01 109.975 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.529 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 49.8 m -166.01 145.77 6.27 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.682 -0.858 . . . . 73.14 108.682 177.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -55.29 -44.5 75.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.468 0.707 . . . . 72.44 111.914 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.19 -43.29 78.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.447 . . . . 70.51 110.881 177.513 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.9 mm-40 -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 71.44 110.534 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.54 -51.39 70.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.98 -1.009 . . . . 54.15 110.95 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.31 -48.52 88.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 114.851 -1.068 . . . . 70.42 111.784 -176.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.16 -46.11 90.43 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.154 0.428 . . . . 43.42 112.154 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.528 ' HG3' HG21 ' A' ' 432' ' ' VAL . 74.5 mmtt -66.98 -42.71 84.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.847 0.356 . . . . 75.13 111.267 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.81 80.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 72.53 111.026 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 49.2 m -62.35 -45.57 92.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.204 -0.665 . . . . 64.01 109.204 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.88 62.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.593 -0.73 . . . . 14.11 111.054 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -79.33 -13.8 59.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 120.796 0.331 . . . . 51.45 110.2 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.91 -9.82 15.84 Favored Glycine 0 CA--C 1.494 -1.229 0 C-N-CA 120.072 -1.061 . . . . 75.05 113.209 173.491 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -80.35 136.6 36.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.58 -0.526 . . . . 73.34 109.58 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.04 -1.82 6.71 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 120.405 -0.903 . . . . 51.35 112.603 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -112.65 115.96 29.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.523 -0.918 . . . . 64.54 108.523 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -131.0 152.08 50.7 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.319 -0.4 . . . . 74.23 110.173 -174.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -135.8 122.59 21.11 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.457 -1.312 . . . . 71.31 107.457 170.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -97.68 133.37 42.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.151 0.501 . . . . 70.43 110.21 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.31 138.96 54.33 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.264 -1.384 . . . . 44.03 107.264 175.064 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.09 136.64 53.16 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.695 -0.854 . . . . 63.43 108.695 177.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.1 p -128.2 144.49 51.93 Favored Pre-proline 0 C--N 1.289 -2.048 0 N-CA-C 109.779 -0.452 . . . . 60.21 109.779 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -64.93 123.46 11.65 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.12 1.88 . . . . 75.24 109.85 175.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.7 m -142.06 178.16 7.72 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.5 -0.926 . . . . 54.23 108.5 -177.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -58.76 141.71 84.74 Favored Pre-proline 0 C--O 1.253 1.272 0 C-N-CA 123.295 0.638 . . . . 75.52 111.431 178.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.46 -28.58 28.4 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.982 3.788 . . . . 73.13 113.382 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -75.39 -11.26 60.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.785 0.661 . . . . 73.25 112.785 -178.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 83.4 mt -111.0 6.36 20.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.978 0.362 . . . . 71.33 111.978 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 49.1 t -61.21 127.34 20.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 121.125 -0.23 . . . . 74.1 110.804 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.24 87.75 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 116.11 -0.496 . . . . 73.03 112.467 176.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 28.4 mtpp -106.75 142.13 36.89 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.113 -1.069 . . . . 72.1 108.113 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -81.76 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.408 -0.59 . . . . 62.41 109.408 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 20.2 pt -98.25 -10.08 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.085 -0.507 . . . . 75.04 111.652 -176.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 162.15 21.34 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.64 -0.79 . . . . 75.05 112.153 177.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 25.4 p -130.09 150.31 51.41 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.021 -1.103 . . . . 65.05 108.021 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.61 -52.9 61.6 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 119.325 -0.369 . . . . 74.31 111.855 176.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.99 140.81 38.85 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 120.836 1.024 . . . . 61.54 110.073 173.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.02 145.69 85.81 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.253 2.636 . . . . 51.33 113.248 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -90.95 -17.39 26.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.331 1.062 . . . . 44.15 109.122 178.15 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -92.92 -19.14 21.94 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.616 -1.175 . . . . 55.01 110.114 -176.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -118.97 150.94 39.07 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.14 -0.482 . . . . 64.34 110.378 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.7 p -85.99 127.2 34.59 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.513 -0.312 . . . . 74.42 111.226 -178.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.0 m -111.27 151.24 28.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.475 0.71 . . . . 72.43 109.777 -176.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -60.43 142.92 54.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 61.3 111.811 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.89 -30.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.765 1.226 . . . . 73.05 111.275 -176.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -83.95 0.75 46.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.073 -0.512 . . . . 74.33 111.604 -175.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.44 145.08 46.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 112.465 0.543 . . . . 74.43 112.465 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.7 p -84.46 125.78 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.627 -0.879 . . . . 61.04 108.627 172.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.0 118.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 109.032 -0.729 . . . . 74.51 109.032 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.72 115.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 105.804 -1.924 . . . . 75.23 105.804 174.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.39 125.46 70.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.408 -0.815 . . . . 55.12 109.932 -174.234 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.33 120.75 55.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.083 0.468 . . . . 54.42 110.107 -177.05 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.8 t -102.84 140.39 21.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 CA-C-N 115.642 -0.708 . . . . 70.02 109.67 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.0 122.73 5.84 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 109.238 -1.545 . . . . 51.33 109.238 173.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.4 p -122.29 137.27 54.91 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.109 -0.7 . . . . 44.24 109.109 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 464' ' ' VAL . . . -103.56 130.67 10.33 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 120.141 -1.028 . . . . 45.1 111.464 -176.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.14 122.56 10.59 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.181 1.921 . . . . 55.33 109.625 175.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.5 104.24 14.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.939 -1.134 . . . . 71.53 107.939 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 546' ' ' PRO . 22.5 p -125.33 166.05 17.26 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.335 -0.848 . . . . 61.33 111.242 -175.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -149.57 147.13 27.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.741 0.817 . . . . 72.11 110.191 176.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 30.4 t70 -96.08 127.05 41.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.49 121.81 83.14 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -175.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.19 146.29 14.1 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.995 1.797 . . . . 54.22 110.437 175.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.81 121.01 17.25 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.362 -0.607 . . . . 72.31 109.362 179.154 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.01 19.09 3.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.68 1.228 . . . . 72.14 108.249 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.21 112.25 19.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.421 -1.263 . . . . 63.41 109.525 -176.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.98 -28.39 1.71 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.66 -0.976 . . . . 54.43 110.66 -178.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 507' ' ' VAL . 83.2 mt-30 -86.46 178.57 7.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.425 -0.954 . . . . 71.45 108.425 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 155.95 28.55 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.154 -1.054 . . . . 55.12 108.154 -174.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.8 p -51.76 -45.9 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.608 0.595 . . . . 60.35 112.608 -176.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.57 -42.76 82.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.22 0.325 . . . . 65.14 111.545 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 503' ' ' GLN . 13.2 p -76.92 -39.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 119.537 -0.865 . . . . 74.02 111.678 -175.574 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.3 71.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.465 -0.789 . . . . 41.23 112.284 179.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.02 -35.6 81.71 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 120.138 -0.625 . . . . 73.12 110.333 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 510' ' ' LYS . 33.1 ttmt -60.67 -48.15 83.07 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.951 0.782 . . . . 75.35 109.331 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -62.62 -43.7 98.14 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.438 -0.801 . . . . 72.53 110.689 178.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.25 -43.06 92.54 Favored 'General case' 0 C--O 1.188 -2.16 0 CA-C-N 115.63 -0.714 . . . . 74.11 109.45 -178.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -58.74 -37.71 76.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.037 0.935 . . . . 72.51 111.76 -178.32 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.0 t -66.05 -37.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 112.512 0.56 . . . . 53.11 112.512 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -112.19 -15.4 13.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.24 -0.584 . . . . 74.25 111.896 -173.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -106.14 -110.31 3.48 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 115.541 -0.754 . . . . 74.04 113.324 -175.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.544 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 21.0 m-85 -123.94 175.43 6.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.092 0.472 . . . . 71.44 110.992 -172.024 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.9 p -109.42 -3.45 17.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.362 -0.835 . . . . 62.2 110.477 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.42 115.72 30.64 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.008 -0.738 . . . . 72.33 109.008 -176.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.78 149.28 50.79 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 123.576 0.547 . . . . 62.22 110.846 -176.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.6 m -136.36 143.54 44.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.21 -1.774 . . . . 73.31 106.21 171.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -121.78 136.78 54.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 118.019 0.372 . . . . 65.51 110.157 -177.049 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.419 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -126.48 131.02 51.73 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.445 -0.946 . . . . 64.51 108.445 177.465 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 6.3 p -88.88 133.6 34.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.094 0.473 . . . . 72.03 112.167 -176.185 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.16 163.1 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.95 -1.5 . . . . 72.01 106.95 175.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 10.9 p-10 -78.29 137.32 38.02 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.047 0.451 . . . . 70.44 109.829 -175.146 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 8.2 m -97.94 108.23 45.14 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 115.544 -0.753 . . . . 65.24 112.157 -172.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 30.0 Cg_endo -90.92 -90.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 122.449 2.099 . . . . 72.41 110.332 172.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -84.18 -48.63 0.68 Allowed Pre-proline 0 N--CA 1.439 -1.008 0 C-N-CA 120.177 -0.609 . . . . 74.03 111.518 171.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.542 ' HA ' ' OE2' ' A' ' 533' ' ' GLU . 78.4 Cg_exo -58.74 134.1 58.36 Favored 'Trans proline' 0 C--N 1.374 1.918 0 CA-C-N 120.19 1.104 . . . . 63.41 110.488 169.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.46 116.26 3.87 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 123.192 0.308 . . . . 72.34 110.796 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.17 -15.16 35.03 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 121.997 0.776 . . . . 73.22 111.64 178.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.542 ' OE2' ' HA ' ' A' ' 530' ' ' PRO . 13.9 pt-20 -87.55 150.04 23.96 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 125.315 1.446 . . . . 74.43 110.939 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 553' ' ' LEU . 79.2 t -73.15 122.4 25.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 107.68 -1.23 . . . . 62.1 107.68 178.298 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.8 m -87.8 -24.68 23.67 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.007 -0.997 . . . . 74.44 110.593 -174.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.01 -163.28 37.02 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.906 -0.878 . . . . 64.42 110.906 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.9 p -140.7 160.22 40.51 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 72.52 107.964 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.45 -60.27 11.11 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 119.243 -0.408 . . . . 75.51 110.786 178.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.13 139.86 19.39 Favored 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 120.189 1.103 . . . . 72.54 109.265 172.323 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.12 153.94 52.0 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.976 1.784 . . . . 74.12 112.229 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.71 131.77 51.28 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.475 -0.565 . . . . 74.2 109.475 176.179 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.25 -5.77 36.12 Favored Glycine 0 C--N 1.299 -1.49 0 N-CA-C 110.464 -1.054 . . . . 45.14 110.464 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -88.41 125.33 34.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.517 -0.549 . . . . 54.4 109.517 174.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.1 m -101.6 123.49 45.69 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.426 -0.953 . . . . 74.22 108.426 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.31 164.49 42.95 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.636 -0.505 . . . . 62.03 109.636 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.5 Cg_exo -58.65 147.84 85.31 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.605 2.203 . . . . 75.3 111.436 176.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.544 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.2 m -66.86 -19.19 25.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.624 0.601 . . . . 61.53 112.624 -178.262 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.67 3.51 44.4 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.899 -0.591 . . . . 73.12 110.968 176.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.0 t -80.89 139.65 35.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.965 -0.754 . . . . 71.22 108.965 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.77 115.93 29.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.138 -0.689 . . . . 73.14 109.138 -179.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.4 tt -88.0 134.53 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.61 0.719 . . . . 64.13 111.039 -177.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.72 122.12 43.32 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 107.43 -1.322 . . . . 64.04 107.43 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 534' ' ' VAL . 7.6 tt -111.18 127.42 55.58 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.636 -1.165 . . . . 75.25 108.648 -175.138 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 5.7 mm-40 -92.41 109.53 20.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.963 -0.754 . . . . 73.33 108.963 -174.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.95 138.38 26.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 64.4 111.572 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 p -71.53 125.25 26.57 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.935 -1.505 . . . . 73.54 106.935 171.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 524' ' ' SER . 62.3 pttt . . . . . 0 C--O 1.264 1.867 0 CA-C-N 115.646 -0.706 . . . . 73.3 111.246 -172.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.349 0 N-CA-C 110.493 -1.043 . . . . 73.25 110.493 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 132.03 14.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.45 1.625 . . . . 74.44 110.985 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 480' ' ' ILE . 11.1 pt-20 -110.45 16.13 21.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.014 0.912 . . . . 73.31 109.657 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -121.12 134.73 55.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.548 -1.279 . . . . 73.24 107.548 175.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -125.15 158.93 32.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.353 -0.61 . . . . 63.43 109.353 -176.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.64 142.49 30.76 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 123.715 0.806 . . . . 72.25 109.581 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -79.59 130.06 69.28 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 107.876 -1.157 . . . . 70.21 107.876 178.491 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 149.52 49.87 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.912 1.742 . . . . 73.03 111.967 178.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -114.9 72.96 0.81 Allowed 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 122.054 0.93 . . . . 74.55 110.355 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.6 4.67 5.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.119 -1.808 . . . . 73.41 106.119 175.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.01 -32.89 74.35 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 112.754 -2.021 . . . . 53.12 110.93 -176.403 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 t -61.44 -27.23 68.41 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.415 -0.812 . . . . 14.4 111.122 176.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.13 -46.32 15.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.159 -1.416 . . . . 72.42 110.416 -174.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 9.5 m -166.01 147.36 6.83 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.662 -0.866 . . . . 74.24 108.662 177.733 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.25 -45.54 65.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.954 0.902 . . . . 74.31 111.154 172.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.0 74.6 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.909 0.484 . . . . 73.21 110.869 178.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.568 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 12.2 mm-40 -66.29 -41.19 90.15 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.511 -0.768 . . . . 54.34 110.611 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.561 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.61 -50.12 75.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.913 -0.585 . . . . 64.31 110.407 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.56 -48.21 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.541 -0.754 . . . . 62.52 111.554 -176.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -60.95 -46.67 89.76 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.473 0.546 . . . . 74.23 112.473 -177.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.6 mptp? -67.38 -38.92 85.48 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 121.029 -0.269 . . . . 61.22 111.489 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -39.74 86.59 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.244 0.545 . . . . 74.15 109.889 178.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -59.4 -45.76 90.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.286 -0.87 . . . . 73.25 109.41 176.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.28 62.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.76 -0.654 . . . . 64.11 111.689 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -13.08 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 71.42 110.265 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.14 -16.1 25.22 Favored Glycine 0 CA--C 1.494 -1.253 0 C-N-CA 120.842 -0.694 . . . . 52.01 113.039 173.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.97 121.18 14.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.156 0.503 . . . . 74.34 111.035 -177.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.401 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -105.6 -2.73 40.48 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.411 -0.813 . . . . 44.33 111.6 178.331 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 9.4 mpt_? -120.85 114.93 22.31 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.202 0.525 . . . . 75.11 110.176 178.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -148.26 148.36 30.38 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.321 -0.854 . . . . 34.13 111.083 178.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -131.09 129.18 41.57 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.326 -0.99 . . . . 63.41 108.326 -178.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -93.33 124.82 37.58 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.417 0.448 . . . . 72.31 110.656 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 150.56 42.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.465 -1.309 . . . . 53.41 107.465 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.87 141.17 49.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.508 -0.923 . . . . 75.35 108.508 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 13.4 t -127.96 137.67 31.3 Favored Pre-proline 0 N--CA 1.416 -2.158 0 N-CA-C 109.007 -0.738 . . . . 32.34 109.007 -179.253 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 33.2 Cg_exo -64.97 123.66 11.93 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.488 2.125 . . . . 72.52 111.045 179.078 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 m -138.94 179.47 6.47 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.846 -1.539 . . . . 75.23 106.846 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 15.4 t -60.53 141.81 91.57 Favored Pre-proline 0 N--CA 1.422 -1.85 0 N-CA-C 108.385 -0.969 . . . . 51.51 108.385 175.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.85 -29.29 26.12 Favored 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 124.176 3.251 . . . . 72.21 113.721 -176.22 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -75.5 -13.97 60.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.708 0.632 . . . . 74.33 112.708 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.42 2.38 55.69 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 122.157 -0.34 . . . . 64.41 111.845 179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -60.75 128.43 21.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.258 0.551 . . . . 72.24 110.436 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.26 -12.94 67.61 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 120.834 -0.698 . . . . 75.33 111.774 178.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -98.76 139.97 33.65 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.369 -0.974 . . . . 65.31 108.369 177.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 60.7 t -82.27 138.89 18.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.119 -1.067 . . . . 64.14 108.119 176.406 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 32.3 pt -98.38 -29.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 120.033 -0.667 . . . . 74.34 111.227 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.82 168.76 40.89 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.345 -1.407 . . . . 62.02 112.502 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 34.2 p -117.64 143.32 46.26 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.27 -0.641 . . . . 63.4 109.27 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.3 t-20 -60.16 -49.77 89.28 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.578 0.584 . . . . 71.24 112.578 177.463 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.4 Cg_exo -81.97 144.59 13.61 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.03 1.153 . . . . 73.1 109.203 172.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 89.0 Cg_endo -72.55 145.01 41.32 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.34 2.026 . . . . 74.22 111.237 -179.446 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -79.86 -18.25 51.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.522 -0.763 . . . . 75.11 110.09 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -77.4 -27.44 52.42 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.931 -1.031 . . . . 75.15 113.019 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.0 mp0 -100.76 160.89 13.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.222 -1.029 . . . . 72.22 108.222 175.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.2 p -97.94 126.04 43.15 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 109.414 -0.587 . . . . 65.33 109.414 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 142.82 34.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.491 -0.929 . . . . 62.11 108.491 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -56.49 153.22 10.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.568 0.581 . . . . 65.03 112.568 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.2 mm -61.51 -30.02 47.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.434 0.635 . . . . 33.43 110.149 178.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 8.31 39.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 45.44 111.128 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.09 149.4 26.93 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.148 -1.056 . . . . 71.45 108.148 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.38 117.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.845 0.831 . . . . 71.21 111.382 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.1 t -92.44 119.92 40.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.359 -0.837 . . . . 52.03 109.545 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.61 116.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.766 -1.568 . . . . 74.13 106.766 175.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 126.16 58.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.715 -0.675 . . . . 63.45 109.327 -176.549 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 26.7 mt -104.49 115.61 46.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.776 -0.647 . . . . 74.42 110.224 -173.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.14 136.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.231 -0.655 . . . . 73.31 109.231 -177.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.43 124.67 6.56 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 109.096 -1.602 . . . . 72.44 109.096 175.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.5 m -135.31 140.78 45.39 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.138 -0.69 . . . . 62.54 109.138 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -93.1 160.34 24.88 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.162 -1.018 . . . . 35.14 110.651 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.07 126.37 17.08 Favored 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 122.759 2.306 . . . . 71.43 111.334 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -80.67 81.62 6.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.081 0.944 . . . . 71.12 109.493 177.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.6 p -136.02 152.93 51.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.705 -1.134 . . . . 74.12 108.165 -177.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -141.22 153.4 45.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.085 -0.339 . . . . 74.25 110.085 177.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -93.91 138.54 31.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.123 -0.489 . . . . 63.3 110.128 179.083 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 31.0 pt -94.79 129.19 36.82 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 116.123 -0.49 . . . . 64.23 111.049 -179.066 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 5.3 Cg_exo -77.1 174.12 13.33 Favored 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.355 2.037 . . . . 73.54 110.779 172.396 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.97 128.86 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 70.43 111.123 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.45 -9.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.502 0.668 . . . . 71.2 110.275 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.56 136.23 47.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.514 -0.766 . . . . 72.25 112.142 -174.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.5 -16.1 29.33 Favored Glycine 0 CA--C 1.492 -1.363 0 C-N-CA 120.784 -0.722 . . . . 53.11 111.578 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.459 ' HB3' HG13 ' A' ' 507' ' ' VAL . 96.7 mt-30 -87.16 177.99 7.02 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 110.149 -0.315 . . . . 65.5 110.149 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.1 155.84 18.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.709 -1.219 . . . . 74.21 107.709 -177.068 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.69 -46.69 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.086 0.773 . . . . 64.12 113.086 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.85 -41.82 74.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.28 0.474 . . . . 74.3 112.28 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 503' ' ' GLN . 10.1 p -75.52 -34.4 29.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.608 -0.837 . . . . 74.33 110.737 -175.053 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.62 85.06 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.928 -1.033 . . . . 51.02 110.134 177.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.37 -35.99 82.68 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.084 -0.507 . . . . 71.4 111.456 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.76 -51.54 61.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.834 -0.346 . . . . 75.34 110.776 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.428 ' O ' HG12 ' A' ' 514' ' ' VAL . 9.3 m120 -68.3 -39.7 81.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.898 -0.592 . . . . 74.4 109.978 -177.689 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.59 -37.31 87.13 Favored 'General case' 0 C--O 1.181 -2.527 0 CA-C-N 116.277 -0.42 . . . . 75.11 110.142 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -58.94 -39.85 82.85 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.039 0.536 . . . . 62.52 111.535 -178.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 511' ' ' ASN . 7.7 p -74.18 -31.28 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 120.149 -0.62 . . . . 50.42 112.197 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.73 -33.76 9.72 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.982 0.896 . . . . 74.41 110.897 -175.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -92.74 -112.74 2.07 Favored Glycine 0 N--CA 1.416 -2.645 0 CA-C-N 114.301 -1.318 . . . . 61.4 113.933 -172.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 57.5 m-85 -130.61 175.97 8.57 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.759 -0.46 . . . . 74.1 109.759 -170.329 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 m -98.03 -25.71 14.86 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.233 -0.439 . . . . 72.21 112.076 -173.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.66 123.16 48.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.871 -0.732 . . . . 72.31 110.839 -177.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.74 146.09 34.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.153 -0.931 . . . . 63.42 109.867 -176.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.5 m -126.88 149.5 49.73 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.323 -1.732 . . . . 52.34 106.323 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.51 131.37 54.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.623 -0.51 . . . . 73.42 109.623 -174.117 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.3 52.27 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.969 -1.123 . . . . 71.33 107.969 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.7 m -103.45 129.35 50.56 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.854 0.359 . . . . 63.51 110.708 -176.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.0 m -122.47 156.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 116.109 -0.496 . . . . 74.43 110.145 178.115 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.95 142.48 27.76 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.755 . . . . 55.41 109.422 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 37.9 t -137.13 140.34 30.91 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 106.556 -1.646 . . . . 74.34 106.556 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.12 -72.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.815 2.343 . . . . 75.31 113.167 -176.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 529' ' ' ARG 0.285 30.9 mmt180 -116.47 -54.97 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.653 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 178.19 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.59 133.84 56.97 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.174 1.249 . . . . 61.45 110.855 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.93 4.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.698 -0.482 . . . . 71.44 109.698 -178.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.48 -25.52 2.98 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.439 -1.064 . . . . 74.1 110.439 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.63 150.27 23.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.633 0.773 . . . . 73.41 110.454 177.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.13 120.0 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 106.879 -1.526 . . . . 51.2 106.879 175.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 21.2 m -70.04 -27.59 64.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.976 -1.011 . . . . 75.02 109.851 -175.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.68 24.88 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 110.297 -1.121 . . . . 73.31 110.297 177.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.2 p -129.87 161.33 31.05 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 107.753 -1.203 . . . . 74.22 107.753 178.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.1 t-20 -61.64 -52.58 68.34 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 120.654 -0.418 . . . . 75.12 110.131 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_exo -79.85 127.35 6.99 Favored 'Trans proline' 0 C--N 1.364 1.351 0 N-CA-C 108.459 -1.4 . . . . 72.0 108.459 170.041 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.06 154.45 73.99 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.151 1.901 . . . . 65.12 112.229 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -52.03 132.6 32.85 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.078 0.551 . . . . 73.03 111.282 179.083 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.85 -25.29 21.24 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 111.05 -0.82 . . . . 74.3 111.05 -176.587 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.1 m -65.7 135.59 55.17 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.21 0.528 . . . . 72.22 110.73 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.7 m -94.97 123.61 38.54 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.239 -1.393 . . . . 65.12 107.239 177.485 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 517' ' ' PHE . 20.5 t -123.22 152.21 63.49 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 107.012 -1.477 . . . . 72.13 107.012 -176.743 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.9 Cg_exo -59.87 140.03 91.11 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 73.43 112.077 174.511 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 23.8 m -67.62 -21.34 27.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.397 0.617 . . . . 51.35 111.685 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -88.89 3.59 50.81 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.027 -0.988 . . . . 73.11 110.756 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -97.25 154.23 17.53 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.267 -0.642 . . . . 75.43 109.267 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.77 137.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.838 -0.801 . . . . 63.43 108.838 177.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.7 tp -93.16 129.89 43.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.48 -0.563 . . . . 73.05 109.48 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -103.0 116.57 32.8 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 122.798 0.439 . . . . 74.42 110.712 -176.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.31 134.28 39.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.323 -0.853 . . . . 65.35 111.111 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -96.97 108.51 21.25 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 63.14 107.529 178.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.67 138.37 29.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 120.428 0.156 . . . . 74.32 111.223 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.7 p -72.64 119.8 17.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.338 -0.615 . . . . 65.44 109.338 179.034 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 C--N 1.294 -1.836 0 CA-C-N 115.87 -0.605 . . . . 64.55 109.539 -177.033 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.964 0 N-CA-C 110.411 -1.076 . . . . 43.11 110.411 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.58 142.26 76.86 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.92 2.413 . . . . 62.54 112.379 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.85 3.89 53.29 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.032 0.92 . . . . 75.02 109.042 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.417 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 92.5 mt-30 -83.11 152.08 25.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.546 -1.206 . . . . 75.4 110.734 -176.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.496 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 13.7 tpp180 -127.56 157.62 39.66 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.458 -1.312 . . . . 54.11 107.458 177.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.45 141.55 31.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 123.588 0.555 . . . . 64.23 110.13 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.9 mp -79.66 130.83 66.3 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.097 -1.075 . . . . 75.45 108.097 177.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 30.5 Cg_exo -64.61 141.0 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.833 1.688 . . . . 74.35 112.314 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.59 9.01 43.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.583 -0.735 . . . . 75.35 110.362 -177.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.41 7.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.016 0.913 . . . . 74.25 110.656 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 3.2 p -60.72 -38.7 85.96 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 125.324 1.45 . . . . 64.32 110.514 177.449 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.1 t -60.7 -26.66 67.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.124 -0.943 . . . . 72.31 111.278 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 51.8 mt -81.88 -46.42 14.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.11 -0.636 . . . . 72.2 110.224 -174.562 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 21.0 m -167.94 150.21 5.56 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.819 -1.178 . . . . 74.13 107.819 177.514 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.37 -48.71 68.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 64.0 110.139 173.011 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.61 71.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.626 0.77 . . . . 75.12 112.094 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.4 mm-40 -61.68 -45.72 92.79 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.297 -0.411 . . . . 63.33 111.584 -178.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -66.62 -45.74 78.13 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.158 -0.474 . . . . 74.14 110.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.92 -47.53 89.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.832 0 O-C-N 123.822 0.701 . . . . 55.43 112.388 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.09 -47.42 86.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.617 0.246 . . . . 73.21 111.661 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.62 -42.31 86.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.218 -0.446 . . . . 73.21 111.408 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.65 -38.38 80.42 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 72.44 110.562 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 46.8 m -63.26 -42.5 99.17 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.865 -0.607 . . . . 72.54 109.578 175.848 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.11 -18.48 64.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.044 -0.526 . . . . 63.44 110.561 177.062 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.92 -13.96 58.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.04 0.448 . . . . 70.11 110.1 178.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.99 -14.05 26.46 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.851 -0.69 . . . . 64.11 112.991 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.59 130.08 41.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.71 0.291 . . . . 53.44 110.525 -178.321 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.38 11.11 6.81 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.236 -0.746 . . . . 42.12 111.236 178.035 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 451' ' ' ARG . 0.6 OUTLIER -111.04 115.43 29.44 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.052 -1.462 . . . . 52.45 107.052 -178.512 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -136.76 147.49 46.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.662 -0.415 . . . . 62.2 111.043 -174.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.401 ' HB2' HG13 ' A' ' 485' ' ' ILE . 14.6 mmmm -132.14 122.75 25.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.254 -1.387 . . . . 75.33 107.254 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -103.72 128.94 51.03 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.866 -0.42 . . . . 63.1 109.866 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -129.86 144.04 51.11 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.187 -1.412 . . . . 54.52 107.187 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.03 135.79 53.63 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.447 -0.946 . . . . 73.11 108.447 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.3 m -116.44 138.57 24.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.669 -0.863 . . . . 53.54 108.669 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.9 122.31 10.09 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.063 1.842 . . . . 61.52 110.416 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.473 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 25.1 t -143.66 -179.18 6.29 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 105.914 -1.884 . . . . 71.1 105.914 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.1 t -66.07 132.99 94.66 Favored Pre-proline 0 N--CA 1.416 -2.175 0 CA-C-O 121.071 0.462 . . . . 64.13 109.886 176.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.73 -28.51 30.29 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.917 3.078 . . . . 71.34 112.039 176.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.87 -17.33 63.06 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.738 -0.665 . . . . 71.13 112.103 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.65 13.39 19.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.177 -0.327 . . . . 73.51 111.698 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.9 p -57.47 128.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 42.44 111.572 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.47 -12.92 59.92 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.626 -0.797 . . . . 44.43 112.131 177.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -92.84 139.78 30.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.179 -0.675 . . . . 61.02 109.179 176.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 486' ' ' ILE . 61.5 t -82.47 134.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.992 -0.744 . . . . 72.02 108.992 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.0 pt -97.31 -7.41 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.251 -0.58 . . . . 73.51 110.73 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.72 167.81 25.86 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.656 -0.783 . . . . 53.32 111.651 175.686 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.5 p -120.43 149.47 42.33 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.893 -1.151 . . . . 74.11 107.893 176.402 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.8 t-20 -65.05 -52.94 45.3 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-O 119.248 -0.406 . . . . 73.23 111.079 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.6 Cg_exo -73.93 139.58 27.52 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 108.8 -1.269 . . . . 71.1 108.8 172.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.47 141.31 66.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.578 2.185 . . . . 65.0 112.63 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.32 -11.86 55.63 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.204 -0.907 . . . . 54.14 110.164 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -94.56 -24.77 17.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.934 -0.575 . . . . 63.34 111.458 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.86 174.16 5.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.08 -0.648 . . . . 73.23 109.538 177.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.417 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 19.1 p -101.18 144.33 30.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.967 -0.561 . . . . 55.15 109.776 178.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.3 m -127.85 148.8 50.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.708 -0.849 . . . . 73.05 108.708 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 152.29 42.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 110.061 -0.348 . . . . 70.43 110.061 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.03 -12.74 16.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.859 0.838 . . . . 74.22 111.213 -173.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -90.18 1.12 56.79 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.844 -0.616 . . . . 72.42 110.923 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.52 141.76 41.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.01 0.433 . . . . 71.02 111.977 -177.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.76 115.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.79 -1.189 . . . . 61.12 107.79 176.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.48 119.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.587 -0.845 . . . . 75.42 108.931 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.5 mp -99.4 123.23 51.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.239 -1.763 . . . . 71.03 106.239 175.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -115.38 123.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 109.327 -0.62 . . . . 74.45 109.327 -177.709 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -103.52 117.54 49.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 CA-C-O 121.76 0.79 . . . . 70.12 111.802 178.749 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 20.1 t -96.61 140.47 17.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.872 -1.058 . . . . 72.14 109.335 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.42 116.8 4.38 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.29 -1.524 . . . . 70.42 109.29 174.411 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -126.64 129.95 49.5 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 107.36 -1.348 . . . . 73.13 107.36 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 459' ' ' SER . . . -96.15 144.08 17.07 Favored Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 119.464 -1.35 . . . . 65.4 111.373 -178.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.88 119.76 6.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.374 2.05 . . . . 75.52 110.088 176.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.12 79.68 9.05 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.874 0.845 . . . . 52.22 109.545 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 546' ' ' PRO . 14.5 p -137.94 157.55 46.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.693 -1.14 . . . . 64.4 108.735 -177.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.25 147.48 32.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.949 0.404 . . . . 71.2 110.652 178.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.6 p-10 -84.71 131.82 34.53 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.161 -0.927 . . . . 74.44 108.54 175.184 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.9 pt -76.47 134.7 69.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.712 -0.676 . . . . 73.14 110.843 -177.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.13 167.43 9.38 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.565 2.177 . . . . 74.42 109.778 173.088 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.02 141.88 28.34 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.631 -1.248 . . . . 74.34 107.631 176.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.62 13.84 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-O 121.986 0.898 . . . . 65.44 110.492 -174.073 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.58 147.52 29.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.398 -0.819 . . . . 71.21 111.649 -175.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 91.48 11.81 60.41 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 111.099 -0.8 . . . . 25.22 111.099 177.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.49 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 97.0 mt-30 -119.89 178.42 4.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.8 0.334 . . . . 75.21 111.831 -176.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.679 -1.23 . . . . 72.14 107.679 -176.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.05 -41.65 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 117.833 0.288 . . . . 54.23 111.381 -177.469 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.04 -42.51 80.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.549 0.574 . . . . 65.4 112.549 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 11.2 p -73.67 -34.94 42.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 118.98 -1.088 . . . . 72.44 110.16 -176.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.36 -49.9 72.06 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.941 -1.027 . . . . 51.4 111.157 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -65.13 -37.5 87.63 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.642 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -65.59 -53.6 39.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.107 0.41 . . . . 74.45 112.107 178.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -62.42 -39.0 91.86 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.078 0.466 . . . . 62.43 110.596 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.59 -47.66 62.77 Favored 'General case' 0 C--O 1.187 -2.192 0 CA-C-N 115.884 -0.598 . . . . 63.33 110.575 178.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.38 -41.19 98.79 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.448 0.536 . . . . 74.04 112.448 -176.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.05 -29.11 43.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.335 0.495 . . . . 52.22 112.335 -177.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.88 -26.37 6.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.204 -0.998 . . . . 73.02 111.798 -174.304 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.65 -98.92 2.38 Favored Glycine 0 N--CA 1.41 -3.065 0 CA-C-N 115.26 -0.882 . . . . 70.21 114.533 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 50.1 m-85 -133.68 160.11 38.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.761 0.315 . . . . 61.12 110.487 -167.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 p -103.63 -7.9 20.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.586 -0.734 . . . . 73.13 112.004 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.48 119.92 40.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.725 -0.472 . . . . 75.33 109.725 -176.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -126.3 153.47 44.77 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.595 0.712 . . . . 60.03 111.533 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.5 m -141.16 153.71 45.49 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.928 -1.508 . . . . 53.43 106.928 169.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -121.65 132.31 54.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 118.28 0.491 . . . . 74.41 110.956 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.14 136.14 53.44 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.068 -1.456 . . . . 63.51 107.068 174.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 25.9 m -98.53 133.49 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.948 0.404 . . . . 62.22 110.491 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.13 163.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.42 -0.955 . . . . 52.43 108.42 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.17 140.08 38.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.262 0.553 . . . . 70.24 110.213 -174.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.0 p -103.17 118.23 58.43 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.402 -0.817 . . . . 50.44 113.015 -172.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -80.62 -75.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.829 1.686 . . . . 74.54 109.226 172.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.549 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 28.7 mmm180 -107.79 -52.73 0.07 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.751 -0.642 . . . . 73.05 112.472 171.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.549 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 19.4 Cg_endo -62.81 134.21 45.74 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 120.644 1.266 . . . . 73.43 111.355 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.62 126.53 7.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.066 -1.087 . . . . 71.21 108.066 178.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.21 -29.33 7.72 Favored Glycine 0 C--N 1.308 -0.979 0 N-CA-C 111.372 -0.691 . . . . 55.14 111.372 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.93 149.78 26.84 Favored 'General case' 0 C--O 1.255 1.361 0 C-N-CA 123.232 0.613 . . . . 74.31 110.044 176.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.434 HG21 ' CB ' ' A' ' 508' ' ' ALA . 80.4 t -74.31 126.92 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.891 0 CA-C-O 121.527 0.68 . . . . 73.01 109.554 -173.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.6 m -92.15 -12.65 32.28 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.41 -1.268 . . . . 65.12 110.136 -175.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.73 -150.77 19.99 Favored Glycine 0 N--CA 1.425 -2.069 0 C-N-CA 120.1 -1.048 . . . . 65.15 112.815 174.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 17.9 p -118.16 161.5 19.77 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 124.591 1.156 . . . . 43.45 109.254 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.9 t-20 -61.33 -57.12 27.69 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 119.298 -0.382 . . . . 72.51 111.094 176.217 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.2 Cg_exo -83.41 156.29 14.38 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.224 1.282 . . . . 74.21 109.852 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.14 158.83 48.61 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.042 1.828 . . . . 71.11 112.196 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.89 133.81 54.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.204 0.601 . . . . 75.23 111.045 178.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.98 -19.64 32.4 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.805 -0.712 . . . . 51.12 111.676 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.0 m -65.56 123.84 20.76 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.676 -0.49 . . . . 53.41 109.676 177.343 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 41.6 m -94.03 123.81 37.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 120.954 0.407 . . . . 72.34 109.944 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.8 157.01 72.84 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 70.13 108.978 177.021 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.535 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.4 Cg_exo -58.7 146.01 93.71 Favored 'Trans proline' 0 CA--C 1.519 -0.24 0 C-N-CA 122.929 2.419 . . . . 64.05 111.619 177.408 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 32.4 m -66.75 -20.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.434 0.635 . . . . 75.21 111.767 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -91.11 3.85 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.345 -0.843 . . . . 61.2 111.38 176.396 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -83.06 152.06 25.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.939 -0.763 . . . . 74.11 108.939 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.58 119.2 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.02 -1.104 . . . . 71.32 108.02 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -89.83 141.64 14.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.189 0.518 . . . . 74.33 110.139 -177.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.0 121.78 43.25 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 121.618 0.723 . . . . 75.32 110.228 -176.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.7 134.54 39.83 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.207 1.403 . . . . 65.24 108.954 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -103.83 115.91 31.32 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.246 -0.888 . . . . 62.01 109.244 -177.352 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.18 129.83 75.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 116.107 -0.497 . . . . 72.4 111.061 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 68.2 m -74.52 116.67 15.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.347 -0.983 . . . . 62.04 108.347 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.446 -0.797 . . . . 64.23 108.955 -175.988 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 N-CA-C 110.479 -1.049 . . . . 45.44 110.479 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.19 132.98 17.25 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.635 2.224 . . . . 73.01 110.633 179.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -90.26 6.76 41.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.599 0.714 . . . . 74.44 110.023 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 78.2 mt-30 -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 114.95 -1.023 . . . . 74.21 110.577 -177.668 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -129.88 156.76 43.87 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.078 -1.082 . . . . 74.43 108.078 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.43 143.16 27.37 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.167 0.432 . . . . 72.31 112.167 -178.695 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 1.8 mp -77.53 130.67 73.38 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.875 -0.602 . . . . 65.32 111.413 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 75.0 Cg_exo -54.1 148.95 37.57 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.887 3.724 . . . . 73.21 115.524 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -94.64 -5.24 46.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.437 -0.801 . . . . 63.53 110.125 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.5 p -74.95 -5.99 7.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.256 1.027 . . . . 73.21 109.679 -176.201 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.61 -26.69 68.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.409 -1.268 . . . . 71.44 109.119 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.1 p -58.51 -27.67 64.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.816 -1.083 . . . . 64.35 111.341 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.6 mt -86.75 -47.35 9.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.709 -0.796 . . . . 74.23 110.978 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 25.6 m -167.01 150.17 6.5 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 109.533 -0.543 . . . . 74.14 109.533 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -51.63 -46.56 63.7 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.116 1.366 . . . . 73.03 111.199 174.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.21 85.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.998 -0.546 . . . . 64.04 111.277 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.69 -44.11 97.58 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.668 -0.696 . . . . 73.3 110.827 178.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -50.79 72.35 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.093 -0.958 . . . . 63.55 110.399 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -46.58 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.799 -0.637 . . . . 74.1 112.129 -176.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -63.31 -48.01 79.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.476 0.179 . . . . 60.12 110.984 -177.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -68.25 -39.47 82.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.071 -0.513 . . . . 74.33 111.63 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.524 HD23 ' CE2' ' A' ' 452' ' ' PHE . 28.9 tp -67.44 -37.49 83.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.223 0.535 . . . . 74.03 109.686 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 -44.13 95.94 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.326 -0.852 . . . . 71.34 109.722 175.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.76 62.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.606 -0.725 . . . . 72.24 111.442 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.91 -12.96 54.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 22.44 111.047 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.61 -18.74 10.74 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.536 -0.84 . . . . 73.2 112.693 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.506 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 81.5 m-85 -75.69 136.51 40.37 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.663 0.268 . . . . 75.41 110.301 -176.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -137.99 26.0 2.89 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.721 -0.951 . . . . 70.45 110.721 177.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -124.52 116.03 21.82 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.374 -1.343 . . . . 72.41 107.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.524 ' CE2' HD23 ' A' ' 444' ' ' LEU . 64.0 m-85 -130.18 146.5 51.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.301 0.572 . . . . 53.31 110.903 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.405 ' HB3' HG12 ' A' ' 485' ' ' ILE . 63.6 tttp -140.86 123.29 15.92 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.807 -1.553 . . . . 75.23 106.807 169.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.93 130.07 37.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.16 0.505 . . . . 74.41 111.306 -177.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -130.03 141.94 50.68 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.37 -1.344 . . . . 51.33 107.37 175.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.15 149.09 45.01 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.199 -0.601 . . . . 53.33 110.791 -177.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 56.0 m -132.49 134.27 24.62 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-N 115.475 -0.784 . . . . 62.23 108.889 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_exo -65.58 127.51 18.18 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.627 2.218 . . . . 73.31 112.243 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 38.6 m -146.94 -179.94 7.16 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 125.498 1.519 . . . . 72.23 107.077 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.4 t -50.51 114.56 4.67 Favored Pre-proline 0 CA--C 1.584 2.269 0 C-N-CA 124.135 0.974 . . . . 64.11 110.14 177.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.11 -28.91 34.8 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.736 3.624 . . . . 63.51 116.425 -171.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.97 -20.83 64.2 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.956 -0.698 . . . . 72.11 112.077 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -95.37 14.37 22.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.485 0.55 . . . . 73.11 112.485 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.09 128.09 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.386 0.613 . . . . 75.0 110.697 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.3 1.77 55.72 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.677 -0.692 . . . . 54.32 112.783 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.483 ' HD2' HD12 ' A' ' 463' ' ' LEU . 57.8 tttp -91.79 138.49 31.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.623 -1.251 . . . . 72.14 107.623 176.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 486' ' ' ILE . 50.7 t -82.96 124.82 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.212 -0.995 . . . . 73.22 108.39 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -99.51 -14.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 120.221 -0.592 . . . . 72.4 111.272 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.04 39.17 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.602 -0.809 . . . . 63.24 111.203 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.6 p -132.19 147.78 52.43 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.683 -0.858 . . . . 74.31 108.683 177.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.7 t-20 -64.02 -51.93 59.71 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 119.167 -0.444 . . . . 72.42 111.272 176.002 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.2 Cg_exo -74.12 145.18 34.76 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.334 1.356 . . . . 61.43 109.74 173.592 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.78 146.01 58.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.696 2.264 . . . . 65.44 112.995 -177.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -101.77 -9.7 20.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.544 -0.753 . . . . 72.51 110.196 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.475 -0.935 . . . . 70.42 108.475 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -117.77 175.56 5.6 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.164 -0.926 . . . . 71.44 108.531 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 27.4 p -88.3 148.74 24.15 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 116.648 -0.251 . . . . 62.25 111.592 -177.153 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.6 m -126.05 148.61 49.28 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.781 -1.192 . . . . 65.23 107.781 175.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 147.13 53.52 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-O 120.611 0.243 . . . . 34.32 111.331 -177.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.01 -28.14 41.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 75.5 111.311 179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.0 t -85.48 7.48 22.66 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.717 -0.674 . . . . 75.42 110.399 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.97 144.68 27.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.346 -0.613 . . . . 64.21 109.346 -177.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.68 111.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.346 -0.983 . . . . 74.44 108.346 179.171 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.22 118.23 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 C-N-CA 118.925 -1.11 . . . . 34.31 108.424 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.443 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 58.5 mt -100.43 113.94 37.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.345 -1.724 . . . . 70.41 106.345 176.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.46 128.12 52.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 CA-C-N 115.652 -0.703 . . . . 52.54 109.458 -174.706 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 30.9 mm -97.59 109.9 24.34 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-O 121.361 0.6 . . . . 71.42 109.484 -176.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.69 133.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.543 -0.753 . . . . 61.43 110.143 -177.215 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.71 115.91 4.91 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.146 -1.982 . . . . 65.54 108.146 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.0 m -127.44 160.39 31.61 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.084 -1.08 . . . . 63.33 108.084 -176.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -135.5 145.26 17.3 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.207 -1.473 . . . . 70.3 111.064 -178.073 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.32 114.53 2.25 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.579 2.186 . . . . 71.14 110.802 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -70.43 96.09 1.12 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.938 0.875 . . . . 74.13 109.042 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -136.45 166.35 23.7 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.909 -1.041 . . . . 65.13 110.009 -174.064 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -150.6 151.05 31.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.142 0.977 . . . . 63.33 108.908 175.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -95.65 133.11 40.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.399 -1.334 . . . . 71.22 107.399 173.545 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 43.6 pt -84.32 134.84 42.27 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 120.534 -0.466 . . . . 73.4 111.638 -175.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.04 170.37 7.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.621 2.214 . . . . 75.41 111.509 175.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -85.61 133.13 34.06 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.933 -0.576 . . . . 75.31 110.638 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.71 13.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.63 -0.714 . . . . 61.31 110.526 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.76 137.47 40.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.099 -0.5 . . . . 43.33 110.703 -177.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.05 50.44 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.491 -1.044 . . . . 75.33 110.491 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.496 ' HB3' HG13 ' A' ' 507' ' ' VAL . 88.3 mt-30 -97.59 169.59 9.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 72.13 108.24 178.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 28.2 m -82.98 155.35 24.02 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.183 -1.043 . . . . 74.24 108.183 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 13.5 p -52.63 -41.38 37.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 123.488 0.715 . . . . 60.32 111.973 -177.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.19 -43.98 76.88 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.531 -0.468 . . . . 73.23 112.144 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 503' ' ' GLN . 12.6 p -77.08 -34.96 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 119.848 -0.741 . . . . 74.45 111.684 -176.378 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.22 84.57 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.033 -0.985 . . . . 52.3 111.205 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -63.73 -36.19 83.05 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.225 0.328 . . . . 70.22 110.502 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 91.1 mttt -65.02 -49.91 68.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.934 -0.575 . . . . 70.11 111.794 177.737 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.01 -41.45 86.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.468 -0.493 . . . . 70.53 110.328 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.85 -44.27 94.2 Favored 'General case' 0 C--O 1.195 -1.765 0 CA-C-N 115.839 -0.618 . . . . 74.1 110.124 -179.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.07 -37.83 78.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.54 0.57 . . . . 70.13 112.54 -178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 66.8 t -59.09 -36.78 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.442 0.464 . . . . 52.32 111.195 -178.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.05 -34.75 8.33 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.809 -0.756 . . . . 75.24 110.495 -177.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -94.99 -122.84 3.87 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.707 -1.133 . . . . 70.42 115.869 -170.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 19.0 m-85 -122.58 178.13 5.13 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.92 0.391 . . . . 65.33 110.07 -168.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.8 m -116.44 8.9 14.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.217 1.008 . . . . 71.31 109.301 178.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.86 115.27 29.77 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.99 -1.115 . . . . 75.4 107.99 178.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -125.96 151.72 46.63 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.215 0.531 . . . . 64.0 110.956 -175.373 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.0 m -141.55 153.39 44.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.537 -1.653 . . . . 52.41 106.537 170.181 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.46 135.78 52.69 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 118.268 0.485 . . . . 52.32 110.412 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.574 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -130.08 145.08 51.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.239 -0.652 . . . . 61.02 109.239 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 21.2 m -87.83 124.97 34.18 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.833 0.349 . . . . 73.24 111.394 -175.445 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.3 163.16 30.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.579 -0.897 . . . . 62.33 108.579 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.42 137.32 37.93 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.682 0.993 . . . . 61.44 113.682 -172.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.3 t -162.01 115.1 1.2 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.598 1.559 . . . . 75.45 106.852 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.03 -89.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.378 2.719 . . . . 44.32 115.793 -172.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 530' ' ' PRO . 57.3 mtt180 -86.33 -42.56 0.58 Allowed Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 113.547 0.943 . . . . 73.13 113.547 178.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 11.1 Cg_endo -57.17 133.91 60.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 120.502 1.215 . . . . 61.31 109.524 173.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.96 140.74 21.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.041 0.448 . . . . 74.41 110.704 -172.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.06 77.22 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.629 -0.714 . . . . 61.41 111.368 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 11.2 pt-20 -87.47 148.78 24.79 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.317 0.579 . . . . 64.12 110.94 177.418 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 76.9 t -75.2 122.18 28.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.33 -1.359 . . . . 75.13 107.33 176.416 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.4 m -98.33 -1.35 41.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.242 -0.89 . . . . 62.13 110.148 -174.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.69 -169.24 32.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.659 -0.576 . . . . 70.22 111.659 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.7 p -137.27 160.65 38.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.407 -0.96 . . . . 75.22 108.407 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.3 t30 -58.48 -56.87 31.0 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.429 -0.32 . . . . 70.21 111.45 177.439 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.7 Cg_endo -84.19 151.3 12.26 Favored 'Trans proline' 0 C--N 1.365 1.433 0 N-CA-C 108.954 -1.21 . . . . 71.33 108.954 174.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.63 148.76 53.94 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.644 1.563 . . . . 73.32 111.658 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.08 129.48 41.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.262 -0.426 . . . . 71.34 110.061 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -15.12 37.33 Favored Glycine 0 C--N 1.301 -1.375 0 C-N-CA 120.884 -0.674 . . . . 45.53 112.05 -177.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.5 m -81.08 134.82 35.72 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 110.036 -0.357 . . . . 43.23 110.036 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 85.3 m -90.65 123.32 34.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.879 -0.6 . . . . 74.3 109.799 177.659 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.69 158.7 67.1 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.49 ' HA ' HG22 ' A' ' 494' ' ' THR . 24.5 Cg_exo -65.33 146.63 86.32 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.514 2.143 . . . . 75.12 112.118 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 19.1 m -67.7 -19.89 25.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.379 1.085 . . . . 72.3 110.027 177.235 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.32 -17.26 60.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.918 -1.492 . . . . 72.24 109.481 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.5 t -86.61 142.11 28.5 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.412 -0.813 . . . . 50.22 108.93 -176.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.36 126.28 44.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.506 -1.294 . . . . 73.54 107.506 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.87 137.95 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.266 0.555 . . . . 72.2 111.121 -176.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.74 119.93 39.55 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 108.91 -0.774 . . . . 72.12 108.91 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -99.32 124.1 44.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.985 -1.461 . . . . 72.14 107.936 -177.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.574 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 4.1 mm-40 -90.13 108.51 19.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.505 0.669 . . . . 73.12 110.128 -175.63 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.99 140.56 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.737 -1.12 . . . . 72.33 111.856 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 40.1 m -56.24 127.89 33.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.666 0.746 . . . . 72.12 112.521 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 77.6 tttt . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.959 -1.126 . . . . 74.42 107.959 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 122.69 1.233 . . . . 73.400000000000006 108.637 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 54.3 mt-30 -94.48 140.11 30.26 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.33 -1.759 . . . . 72.420000000000002 108.949 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpp180 -120.87 152.35 38.55 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.827 -1.175 . . . . 73.120000000000005 107.827 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.36 140.88 32.16 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 124.091 0.87 . . . . 64.129999999999995 109.775 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -89.98 122.76 67.46 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 109.33 -0.619 . . . . 54.009999999999998 109.33 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.45 141.14 94.94 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.597 2.198 . . . . 70.120000000000005 112.581 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.41 24.13 4.12 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.35 -0.841 . . . . 73.099999999999994 110.891 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.5 -7.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.047 0.927 . . . . 74.329999999999998 109.024 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 13.2 m -62.74 -36.32 82.66 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.472 -1.24 . . . . 73.120000000000005 110.097 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 18.1 p -62.11 -26.6 68.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.25 -1.341 . . . . 70.109999999999999 110.839 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.9 mt -83.71 -44.62 14.29 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.041 -0.527 . . . . 63.210000000000001 110.586 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 438' ' ' ALA . 22.3 m -160.87 145.61 14.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.671 -0.492 . . . . 74.409999999999997 109.671 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -54.92 -42.37 72.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.478 0.711 . . . . 71.409999999999997 110.92 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 436' ' ' THR . . . -57.55 -44.39 85.16 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.888 -0.596 . . . . 63.210000000000001 110.579 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.66 -43.61 98.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.369 -0.832 . . . . 55.399999999999999 111.256 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.76 -51.73 68.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.443 -0.799 . . . . 62.119999999999997 110.978 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.1 -47.55 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.869 -0.605 . . . . 60.039999999999999 112.333 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -64.78 -47.15 79.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.7 -0.4 . . . . 61.43 111.65 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.89 -40.33 83.51 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.633 -0.427 . . . . 71.140000000000001 111.984 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.508 HD23 ' CE2' ' A' ' 452' ' ' PHE . 19.4 tp -68.89 -33.64 74.11 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.363 0.601 . . . . 73.299999999999997 110.261 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.6 m -64.06 -41.63 97.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.62 -0.718 . . . . 72.329999999999998 109.59 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.57 62.79 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.798 -0.637 . . . . 74.099999999999994 110.82 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.4 -13.47 52.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.063 0.459 . . . . 74.129999999999995 110.077 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.77 -2.36 27.43 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.567 -0.825 . . . . 75.129999999999995 113.844 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 95.6 m-85 -83.56 136.49 34.23 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 117.303 0.552 . . . . 62.420000000000002 111.671 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.21 4.82 4.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.549 -0.751 . . . . 73.120000000000005 112.451 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.436 ' NE ' ' HB ' ' A' ' 483' ' ' VAL . 77.2 ttt180 -111.29 115.56 29.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.702 -0.851 . . . . 75.340000000000003 108.702 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.508 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.2 m-85 -130.82 156.9 44.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.024 -0.534 . . . . 74.430000000000007 111.12 -173.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 485' ' ' ILE . 27.5 tptp -139.41 121.82 16.09 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 104.615 -2.365 . . . . 74.010000000000005 104.615 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -110.65 135.19 51.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.744 0.307 . . . . 71.409999999999997 111.397 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.3 156.56 46.4 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.987 -1.116 . . . . 65.230000000000004 107.987 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -136.09 143.06 44.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.219999999999999 107.732 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 27.8 m -130.99 139.19 34.83 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 109.501 -0.555 . . . . 63.520000000000003 109.501 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 35.8 Cg_exo -64.41 123.07 11.21 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.292 1.995 . . . . 74.439999999999998 110.326 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 68.0 m -151.81 -179.51 7.52 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.087 -1.079 . . . . 53.539999999999999 108.087 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.475 ' HA ' ' HD2' ' A' ' 461' ' ' PRO . 2.8 t -33.97 108.53 0.32 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 125.787 1.635 . . . . 61.030000000000001 112.625 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 460' ' ' THR . 16.3 Cg_endo -56.33 -29.75 78.06 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 124.139 3.226 . . . . 52.140000000000001 115.274 -173.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -71.98 -6.91 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.583 0.586 . . . . 75.030000000000001 112.583 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 78.8 mt -111.3 13.81 21.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.006 0.432 . . . . 60.409999999999997 110.936 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.82 133.62 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.826 -0.625 . . . . 55.210000000000001 112.008 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.86 79.55 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 121.037 -0.602 . . . . 70.329999999999998 113.793 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 434' ' ' THR . 11.1 pttp -101.67 162.26 13.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.761 -1.2 . . . . 73.409999999999997 107.761 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 53.3 t -81.46 133.21 29.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.851 -1.166 . . . . 71.140000000000001 107.851 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.6 pt -102.11 -6.73 9.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.593 -0.443 . . . . 65.129999999999995 110.819 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.5 143.69 4.05 Favored Glycine 0 N--CA 1.423 -2.224 0 C-N-CA 120.237 -0.983 . . . . 74.409999999999997 112.864 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.4 p -119.35 147.46 44.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.837 -1.171 . . . . 73.329999999999998 107.837 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 4.7 m-20 -66.49 -51.38 42.2 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 119.394 -0.336 . . . . 73.219999999999999 111.595 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 24.4 Cg_exo -71.12 127.81 13.99 Favored 'Trans proline' 0 C--N 1.361 1.223 0 N-CA-C 108.012 -1.572 . . . . 64.340000000000003 108.012 169.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 6.1 Cg_exo -75.27 158.22 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.893 1.729 . . . . 55.439999999999998 113.102 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.08 -17.0 51.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.842 0.829 . . . . 43.219999999999999 109.981 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -96.87 -25.92 15.27 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.389 -0.823 . . . . 64.530000000000001 111.537 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.11 156.68 17.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.889 -0.411 . . . . 73.349999999999994 109.889 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.5 p -90.57 140.83 29.38 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.183 -0.673 . . . . 70.019999999999996 109.183 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.1 m -126.7 142.6 51.49 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.752 -0.832 . . . . 60.439999999999998 108.752 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.427 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -60.43 140.17 57.35 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.226 -0.657 . . . . 53.030000000000001 109.226 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 427' ' ' ARG . 59.6 mt -72.21 -9.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.98 0.895 . . . . 70.030000000000001 111.616 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -81.94 -3.29 53.96 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.613 -0.721 . . . . 73.140000000000001 109.185 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.43 147.38 28.78 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 121.983 -0.448 . . . . 73.040000000000006 110.644 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.436 ' HB ' ' NE ' ' A' ' 451' ' ' ARG . 5.1 p -85.66 124.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.837 -1.171 . . . . 73.319999999999993 107.837 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 444' ' ' LEU . 60.1 t -87.94 118.12 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.285 -0.966 . . . . 75.140000000000001 108.588 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -94.65 115.11 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.785 -1.561 . . . . 75.310000000000002 106.785 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.06 124.18 69.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.24 -0.891 . . . . 52.509999999999998 109.377 -176.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.59 123.17 61.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.303 -0.628 . . . . 73.329999999999998 109.303 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.21 141.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.314 -0.624 . . . . 42.350000000000001 109.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -76.92 113.51 3.8 Favored Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.526 -1.429 . . . . 75.010000000000005 109.526 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -102.19 130.04 48.73 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.618 -0.512 . . . . 71.030000000000001 109.618 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.981 0 N-CA-C 109.024 -1.63 . . . . 50.240000000000002 109.024 177.711 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.179 0 N-CA-C 107.171 -1.418 . . . . 65.420000000000002 107.171 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.8 p -119.89 151.26 39.16 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.167 -0.924 . . . . 71.439999999999998 109.738 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 495' ' ' LYS . 21.8 mmmt -146.65 149.47 33.56 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.114 0.483 . . . . 64.329999999999998 111.432 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 543' ' ' THR . 9.1 p-10 -82.6 134.48 35.18 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.381 -1.281 . . . . 74.340000000000003 107.602 173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 540' ' ' PRO . 0.2 OUTLIER -75.62 122.73 87.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 119.622 -0.831 . . . . 62.299999999999997 109.091 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.9 170.53 9.87 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.403 2.069 . . . . 53.240000000000002 112.712 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.02 116.62 29.08 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.817 -0.629 . . . . 65.109999999999999 109.948 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.84 17.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 122.621 1.2 . . . . 60.420000000000002 107.942 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 147.55 48.57 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.325 -1.307 . . . . 63.299999999999997 109.45 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.13 -6.48 53.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 111.363 -0.695 . . . . 34.009999999999998 111.363 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.47 177.28 4.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.3 m -77.47 156.35 31.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.248 -0.649 . . . . 72.219999999999999 109.248 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.62 -44.03 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 123.448 0.468 . . . . 72.540000000000006 111.598 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.3 -42.68 79.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.031 0.382 . . . . 72.439999999999998 112.031 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.07 -35.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.651 -0.819 . . . . 40.520000000000003 111.121 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.45 81.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.698 -0.683 . . . . 61.100000000000001 111.094 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.66 -38.22 84.15 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.395 0.434 . . . . 74.409999999999997 110.538 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.1 tttm -63.7 -52.01 62.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.654 -0.703 . . . . 61.43 110.27 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -65.02 -41.61 95.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.899 0.38 . . . . 62.43 110.969 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.25 -39.39 89.47 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.616 -0.72 . . . . 64.310000000000002 109.762 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -59.02 -41.57 88.07 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.186 0.594 . . . . 71.230000000000004 112.427 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.1 t -59.02 -35.35 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 55.25 111.088 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -112.28 4.31 17.64 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.024 -0.67 . . . . 74.340000000000003 111.398 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.93 -100.25 0.29 Allowed Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 118.036 -2.031 . . . . 61.219999999999999 117.625 -168.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 60.9 m-85 -120.08 161.47 20.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.404 -0.398 . . . . 72.120000000000005 111.295 -164.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 m -119.01 -13.96 9.39 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.527 0.68 . . . . 64.319999999999993 110.782 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -107.97 115.49 30.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.422 -0.955 . . . . 54.25 108.422 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -120.97 156.64 31.67 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.542 0.687 . . . . 71.239999999999995 111.318 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.7 m -139.99 155.75 46.96 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.518 -1.66 . . . . 75.219999999999999 106.518 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -121.28 138.46 54.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.038 0.447 . . . . 74.120000000000005 110.007 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.94 131.75 56.05 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.545 -0.909 . . . . 43.450000000000003 108.545 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 36.1 m -88.61 123.17 32.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.572 0.545 . . . . 73.230000000000004 109.677 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 35.3 m -121.61 162.64 20.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.768 -1.197 . . . . 73.230000000000004 107.768 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 11.1 m-20 -78.06 133.3 37.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.095 0.474 . . . . 75.150000000000006 110.79 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 11.0 m -95.95 105.42 21.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.732 -1.122 . . . . 54.049999999999997 111.563 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 2.4 Cg_endo -81.16 -77.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 121.701 1.6 . . . . 61.420000000000002 109.506 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.447 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 48.8 mmm-85 -95.24 -58.47 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 120.325 -0.55 . . . . 75.439999999999998 109.892 173.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 527' ' ' SER . 36.6 Cg_endo -65.34 144.62 80.97 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.945 1.763 . . . . 72.340000000000003 112.309 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -151.37 132.73 14.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.837 -0.801 . . . . 63.240000000000002 108.837 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.86 -24.66 5.79 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-O 121.922 0.735 . . . . 65.519999999999996 112.075 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.15 150.38 24.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 C-N-CA 124.372 1.069 . . . . 73.340000000000003 111.492 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.18 128.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.081 -0.963 . . . . 74.230000000000004 110.018 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -92.25 -22.23 19.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.255 -1.339 . . . . 61.039999999999999 109.733 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.96 33.67 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.156 -0.777 . . . . 61.020000000000003 111.156 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.9 p -117.94 160.33 21.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.643 -0.873 . . . . 61.140000000000001 108.643 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -64.13 -58.5 14.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.338 -0.363 . . . . 41.030000000000001 111.035 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.49 148.81 43.32 Favored 'Trans proline' 0 C--N 1.373 1.862 0 N-CA-C 109.17 -1.127 . . . . 62.229999999999997 109.17 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.471 ' O ' HD11 ' A' ' 497' ' ' ILE . 32.1 Cg_exo -60.46 140.06 89.58 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.069 1.846 . . . . 54.200000000000003 110.661 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.39 131.94 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.618 0.367 . . . . 73.109999999999999 110.847 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.22 40.7 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.363 -0.922 . . . . 74.25 112.274 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 60.3 m -67.44 126.47 29.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.144 -0.687 . . . . 74.310000000000002 109.144 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.2 m -94.33 122.86 37.32 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.942 -0.762 . . . . 63.539999999999999 108.942 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.03 161.0 66.37 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.282 -0.636 . . . . 75.219999999999999 109.282 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 494' ' ' THR . 49.7 Cg_exo -58.83 134.93 63.59 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.468 2.112 . . . . 62.399999999999999 111.355 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.517 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 20.0 m -65.94 -19.85 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.244 0.545 . . . . 62.140000000000001 111.263 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -77.67 -10.27 59.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.647 -0.706 . . . . 62.219999999999999 111.516 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.0 t -85.39 161.13 19.58 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 64.409999999999997 108.922 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.32 130.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.012 0.434 . . . . 74.049999999999997 111.278 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.9 tt -101.6 132.84 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.071 0.462 . . . . 45.399999999999999 110.011 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.59 127.45 51.01 Favored 'General case' 0 N--CA 1.399 -2.999 0 N-CA-C 108.73 -0.841 . . . . 51.100000000000001 108.73 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.5 tp -104.19 133.58 48.88 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.944 -1.025 . . . . 74.510000000000005 108.854 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -94.46 109.23 21.12 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.708 -1.219 . . . . 72.010000000000005 107.708 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.71 138.51 44.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 121.177 0.513 . . . . 54.219999999999999 112.187 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -68.09 114.95 7.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.722 -0.844 . . . . 43.539999999999999 108.722 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 61.9 pttt . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 115.802 -0.636 . . . . 62.229999999999997 110.702 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 480' ' ' ILE . 12.4 pt-20 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.77 0.319 . . . . 73.299999999999997 111.491 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 478' ' ' SER . 68.6 mt-30 -90.84 119.14 30.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.291 -0.564 . . . . 65.530000000000001 110.018 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -120.18 160.24 23.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.462 -1.31 . . . . 71.540000000000006 107.462 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -86.09 141.39 29.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.385 0.428 . . . . 61.210000000000001 111.4 -177.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.1 130.72 68.63 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.597 -0.89 . . . . 72.310000000000002 108.597 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.34 142.93 78.54 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.319 2.68 . . . . 74.319999999999993 114.426 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.46 -7.5 50.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.314 -0.857 . . . . 75.549999999999997 111.091 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 32.4 m -80.38 1.05 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.6 0.714 . . . . 60.119999999999997 110.801 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.3 m -63.77 -28.05 69.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.091 -0.959 . . . . 42.240000000000002 109.476 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -62.07 -28.4 69.58 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.587 -1.188 . . . . 72.519999999999996 111.186 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 63.9 mt -83.37 -45.27 13.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.089 -0.505 . . . . 53.329999999999998 110.572 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.521 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.5 m -165.69 149.06 7.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.655 -0.869 . . . . 65.129999999999995 108.655 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.08 -45.41 75.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.407 0.683 . . . . 71.209999999999994 110.655 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 442' ' ' LYS . . . -55.41 -44.7 76.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.038 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.521 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 31.2 mm-40 -64.32 -37.89 89.1 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.014 -0.539 . . . . 74.420000000000002 110.935 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.79 -51.33 68.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 73.310000000000002 110.477 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.41 -46.03 97.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.221 -0.9 . . . . 73.310000000000002 112.309 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 438' ' ' ALA . 15.8 ptpt -63.03 -44.55 95.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.561 0.22 . . . . 74.25 111.319 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.34 -38.44 84.85 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.04 0.385 . . . . 72.010000000000005 112.04 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.1 tp -68.53 -34.26 75.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.516 0.674 . . . . 74.040000000000006 109.938 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.2 m -65.66 -40.74 92.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.418 -0.81 . . . . 73.040000000000006 109.305 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -16.57 62.71 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.315 0.578 . . . . 72.010000000000005 110.419 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.78 -14.14 49.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.222 0.534 . . . . 61.329999999999998 109.589 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.39 50.16 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.884 -0.674 . . . . 64.25 113.616 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.0 m-85 -92.29 121.36 33.72 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.177 0.489 . . . . 62.210000000000001 110.123 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.21 5.02 21.87 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 111.197 -0.761 . . . . 73.099999999999994 111.197 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -102.86 116.46 32.6 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.326 -0.62 . . . . 74.510000000000005 109.326 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.439 ' CE2' HD23 ' A' ' 444' ' ' LEU . 73.8 m-85 -130.4 144.79 51.61 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.281 0.563 . . . . 73.120000000000005 111.075 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.489 ' HB3' HG13 ' A' ' 485' ' ' ILE . 22.3 tptm -131.02 121.84 25.75 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.897 -2.26 . . . . 73.319999999999993 104.897 167.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -105.32 134.99 47.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.695 -0.483 . . . . 63.340000000000003 109.695 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.93 150.32 44.4 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.695 -0.854 . . . . 71.120000000000005 108.695 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -125.73 148.74 48.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.762 -1.199 . . . . 73.109999999999999 107.762 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.2 m -143.17 144.79 30.0 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 109.115 -0.698 . . . . 74.239999999999995 109.115 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.4 Cg_exo -65.44 123.05 10.91 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.608 2.206 . . . . 51.039999999999999 112.571 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.8 t -137.17 -179.13 5.54 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.699 -1.963 . . . . 74.129999999999995 105.699 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.46 ' CG2' HD23 ' A' ' 463' ' ' LEU . 6.9 t -61.88 141.64 95.3 Favored Pre-proline 0 N--CA 1.423 -1.791 0 N-CA-C 109.944 -0.391 . . . . 53.299999999999997 109.944 178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.76 -29.66 34.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.108 3.205 . . . . 74.140000000000001 112.32 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.05 -20.65 65.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.999 0.74 . . . . 73.299999999999997 112.999 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.46 HD23 ' CG2' ' A' ' 460' ' ' THR . 4.5 mm? -106.33 11.47 30.97 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.107 -0.371 . . . . 75.120000000000005 111.964 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.92 128.99 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.156 0.503 . . . . 74.329999999999998 111.419 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.29 -9.58 77.01 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.655 -0.783 . . . . 73.430000000000007 112.49 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.423 ' HD2' HD13 ' A' ' 463' ' ' LEU . 68.1 mttm -100.55 155.35 17.9 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.175 -1.046 . . . . 74.310000000000002 108.175 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.577 HG22 HD11 ' A' ' 486' ' ' ILE . 53.7 t -81.96 129.75 36.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.901 -1.148 . . . . 70.230000000000004 107.901 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.2 pt -98.55 -16.04 7.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.42 -0.512 . . . . 74.519999999999996 110.799 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 176.32 149.1 7.36 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.675 -0.693 . . . . 73.310000000000002 111.738 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.3 p -116.82 152.85 33.56 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.606 -1.257 . . . . 73.349999999999994 107.606 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.1 t-20 -68.03 -51.94 25.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 C-N-CA 120.502 -0.479 . . . . 74.010000000000005 110.714 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.9 Cg_exo -79.13 130.59 9.38 Favored 'Trans proline' 0 C--N 1.371 1.751 0 N-CA-C 107.952 -1.595 . . . . 52.299999999999997 107.952 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 7.2 Cg_exo -69.88 157.15 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.791 1.661 . . . . 62.420000000000002 112.845 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.19 -6.75 57.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.358 1.075 . . . . 72.150000000000006 109.109 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 -40.32 14.29 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.14 -1.391 . . . . 75.239999999999995 111.048 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.77 167.13 10.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 71.0 110.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 p -101.57 133.56 46.06 Favored 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 108.708 -0.849 . . . . 74.230000000000004 108.708 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.2 m -118.9 148.6 42.75 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.379 -0.6 . . . . 65.329999999999998 109.379 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.25 51.78 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.282 0.364 . . . . 63.329999999999998 111.403 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.8 mm -57.7 -28.51 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.708 1.203 . . . . 74.409999999999997 111.147 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.1 t -76.56 -7.36 55.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.73 -0.668 . . . . 62.240000000000002 110.876 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.99 142.22 28.1 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 122.074 -0.391 . . . . 54.240000000000002 110.435 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.96 126.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.786 -0.82 . . . . 74.219999999999999 108.786 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.19 119.37 36.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.137 -0.69 . . . . 43.240000000000002 109.137 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.9 mp -92.94 119.65 40.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.182 -1.414 . . . . 72.140000000000001 107.182 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.577 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -117.06 125.91 74.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 109.53 -0.545 . . . . 74.099999999999994 109.53 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.43 119.18 52.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.538 -0.542 . . . . 71.239999999999995 109.538 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.21 144.12 10.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.98 -0.748 . . . . 60.329999999999998 108.98 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -77.71 122.21 6.0 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 111.823 -0.511 . . . . 55.340000000000003 111.823 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.9 t -118.45 131.93 56.25 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.16 -1.793 . . . . 63.219999999999999 106.16 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.673 0 C-N-CA 119.672 -1.251 . . . . 72.349999999999994 111.12 -177.567 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.61 0 N-CA-C 106.864 -1.532 . . . . 71.430000000000007 106.864 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.6 p -125.21 152.79 44.07 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.88 -0.6 . . . . 75.239999999999995 110.119 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -133.67 135.6 44.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.31 -0.405 . . . . 44.32 109.939 -177.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.7 p-10 -83.28 130.54 35.08 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.454 -0.943 . . . . 34.549999999999997 108.454 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.8 pt -81.52 131.99 56.62 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 115.991 -0.55 . . . . 62.310000000000002 110.423 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -84.36 152.62 12.16 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.518 2.145 . . . . 72.530000000000001 112.111 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.56 101.22 2.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.533 0.683 . . . . 73.340000000000003 109.95 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.06 1.81 8.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.278 -0.874 . . . . 71.329999999999998 109.484 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -67.85 122.95 19.25 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.999 -1.0 . . . . 64.349999999999994 110.679 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.94 -29.73 3.87 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.607 -0.597 . . . . 60.450000000000003 111.607 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -88.87 -175.48 4.88 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.109 -0.701 . . . . 73.450000000000003 109.109 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 70.0 p -80.49 157.38 26.17 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.637 -0.825 . . . . 43.32 110.644 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.01 -41.6 80.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.452 0.644 . . . . 53.210000000000001 109.333 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.71 -43.28 89.57 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.259 -0.882 . . . . 64.049999999999997 112.504 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.58 -34.68 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 119.945 -0.702 . . . . 45.210000000000001 110.585 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.12 77.94 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.803 -0.635 . . . . 75.140000000000001 110.834 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.24 -41.74 97.41 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.638 0.586 . . . . 63.450000000000003 110.203 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 514' ' ' VAL . 56.0 mtmt -65.16 -51.73 59.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 113.203 0.816 . . . . 62.020000000000003 113.203 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -63.48 -40.93 98.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.912 0.386 . . . . 73.040000000000006 110.725 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 551' ' ' ILE . 59.0 tp -66.53 -39.51 88.64 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 115.626 -0.716 . . . . 64.209999999999994 110.796 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.77 -37.66 87.51 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.891 0.377 . . . . 73.239999999999995 110.654 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 510' ' ' LYS . 47.7 t -69.16 -30.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.965 -0.561 . . . . 51.340000000000003 111.476 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.92 18.83 7.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 120.201 -0.6 . . . . 71.319999999999993 111.748 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -150.06 -110.75 0.53 Allowed Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 118.869 -1.634 . . . . 72.319999999999993 115.135 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.27 164.25 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.373 -0.414 . . . . 71.030000000000001 110.214 -168.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -105.57 -7.98 18.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.426 -0.806 . . . . 75.230000000000004 109.916 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.71 119.27 33.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 74.209999999999994 111.544 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.79 155.95 42.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.149 -0.932 . . . . 71.109999999999999 109.711 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 72.7 m -135.03 148.18 49.86 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.135 -1.432 . . . . 65.099999999999994 107.135 170.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -122.23 128.2 50.87 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.264 -0.643 . . . . 53.119999999999997 109.264 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -119.75 131.48 55.37 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.319 -0.993 . . . . 54.210000000000001 108.319 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -88.69 126.69 35.43 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.447 0.641 . . . . 52.119999999999997 111.425 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.02 162.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.228 -1.397 . . . . 72.329999999999998 107.228 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 557' ' ' LYS . 5.9 p-10 -79.36 129.26 34.29 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.795 0.807 . . . . 71.299999999999997 112.426 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 556' ' ' SER . 10.9 p -92.94 122.25 64.11 Favored Pre-proline 0 N--CA 1.416 -2.152 0 CA-C-N 114.272 -1.331 . . . . 75.150000000000006 108.712 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.82 -67.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.472 2.114 . . . . 64.099999999999994 111.882 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -136.1 -52.08 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 123.704 0.802 . . . . 74.420000000000002 109.473 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 20.4 Cg_endo -63.6 150.14 89.21 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.215 1.276 . . . . 75.140000000000001 110.196 168.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.62 139.89 16.63 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.469 -0.567 . . . . 61.200000000000003 109.469 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.64 10.92 Favored Glycine 0 C--O 1.242 0.607 0 C-N-CA 120.905 -0.665 . . . . 52.25 111.775 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 533' ' ' GLU . 0.4 OUTLIER -87.14 147.02 25.81 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.933 0.397 . . . . 63.009999999999998 110.626 177.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 501' ' ' ALA . 7.9 p -77.62 122.71 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 108.219 -1.03 . . . . 74.409999999999997 108.219 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.41 -25.59 59.56 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.296 -0.865 . . . . 54.140000000000001 109.571 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.79 -156.3 26.8 Favored Glycine 0 N--CA 1.424 -2.115 0 N-CA-C 110.299 -1.12 . . . . 73.129999999999995 110.299 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.0 p -130.0 160.54 33.32 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.379 -0.971 . . . . 72.439999999999998 108.379 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.58 -56.35 36.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 123.461 0.476 . . . . 74.209999999999994 110.751 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.26 146.92 28.82 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.009 1.139 . . . . 71.319999999999993 109.96 170.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -73.3 156.07 50.98 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.363 2.042 . . . . 44.310000000000002 112.465 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.8 136.99 58.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.075 0.55 . . . . 74.209999999999994 111.351 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -17.45 56.52 Favored Glycine 0 C--N 1.312 -0.765 0 C-N-CA 120.85 -0.69 . . . . 32.039999999999999 112.004 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.5 m -71.54 132.48 44.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.397 -0.594 . . . . 71.140000000000001 109.397 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -99.25 122.77 42.88 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.023 -1.103 . . . . 71.530000000000001 108.023 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.85 154.95 73.53 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.486 -0.931 . . . . 74.109999999999999 108.486 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.492 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.8 Cg_exo -59.91 141.99 97.65 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.229 1.952 . . . . 73.099999999999994 111.621 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.8 -19.28 25.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 121.797 0.808 . . . . 60.420000000000002 111.575 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -87.31 2.73 49.34 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.982 -1.008 . . . . 74.120000000000005 109.541 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -103.45 149.06 25.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.351 -0.84 . . . . 33.32 108.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.36 130.13 42.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.008 0.433 . . . . 72.140000000000001 110.721 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.444 HD13 HD21 ' A' ' 512' ' ' LEU . 12.1 tt -95.38 130.84 43.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 74.120000000000005 110.6 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.99 121.7 43.1 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.209 0.528 . . . . 70.239999999999995 110.581 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.04 133.76 39.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.824 -1.08 . . . . 53.539999999999999 110.087 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.407 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 12.4 mm-40 -90.18 109.57 20.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.523 -1.658 . . . . 75.329999999999998 106.523 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.47 133.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.119 0.414 . . . . 74.150000000000006 112.119 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 527' ' ' SER . 14.5 m -70.47 114.48 8.62 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.247 -1.39 . . . . 71.540000000000006 107.247 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 526' ' ' ASP 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 117.903 -1.519 . . . . 71.219999999999999 111.77 -176.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.295 0.569 . . . . 73.129999999999995 110.379 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 91.9 mt-30 -83.37 126.92 33.23 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.463 -1.31 . . . . 64.439999999999998 107.463 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -130.05 162.32 29.02 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.845 -1.169 . . . . 64.349999999999994 107.845 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.32 141.53 29.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.257 0.465 . . . . 62.020000000000003 112.257 -173.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -82.39 129.2 64.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 107.285 -1.376 . . . . 65.120000000000005 107.285 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.34 141.19 96.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.056 1.837 . . . . 75.129999999999995 112.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -94.24 4.17 54.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.862 -0.608 . . . . 73.120000000000005 109.809 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.529 HG21 ' HD2' ' A' ' 443' ' ' LYS . 35.2 m -75.96 -2.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.201 -0.909 . . . . 70.5 109.955 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 15.1 m -60.52 -33.64 72.93 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.441 -1.254 . . . . 73.540000000000006 110.181 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.407 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.3 t -64.91 -25.61 67.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.051 -0.977 . . . . 72.420000000000002 110.607 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.8 mt -81.4 -45.74 15.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.691 -0.404 . . . . 75.409999999999997 110.279 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 438' ' ' ALA . 58.9 m -163.37 142.33 8.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.707 -0.849 . . . . 72.439999999999998 108.707 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.417 ' HA ' HG23 ' A' ' 467' ' ' VAL . 25.9 t80 -54.75 -45.11 74.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.045 0.538 . . . . 73.400000000000006 110.898 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.448 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.91 -42.95 76.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.067 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.35 -42.91 99.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 116.031 -0.532 . . . . 75.519999999999996 111.782 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.63 -51.73 68.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.516 -0.765 . . . . 73.430000000000007 111.324 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.35 -47.58 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.368 -0.833 . . . . 65.319999999999993 111.956 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.34 -46.21 81.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.975 0.417 . . . . 74.340000000000003 110.948 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.529 ' HD2' HG21 ' A' ' 432' ' ' VAL 0.251 59.5 mttp -67.28 -37.9 84.17 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 113.08 0.77 . . . . 72.349999999999994 113.08 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 41.5 tp -67.77 -36.78 81.11 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.143 0.497 . . . . 74.349999999999994 109.728 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.3 m -60.65 -42.69 97.5 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 51.439999999999998 109.294 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.7 -19.65 62.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.414 -0.812 . . . . 74.0 111.336 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.21 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.275 0.56 . . . . 60.210000000000001 110.218 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.32 29.36 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.767 -0.73 . . . . 72.129999999999995 113.437 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.93 130.96 35.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.883 0.341 . . . . 74.209999999999994 110.597 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 30.4 4.27 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.11 -0.796 . . . . 33.210000000000001 111.11 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.408 ' HB3' HG22 ' A' ' 483' ' ' VAL . 3.0 mmp_? -132.58 115.9 16.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.551 -0.907 . . . . 54.130000000000003 108.551 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.9 m-85 -133.39 148.09 51.8 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.177 -0.919 . . . . 63.399999999999999 110.306 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.527 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.2 tppp? -138.97 122.64 17.49 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.202 -1.777 . . . . 73.439999999999998 106.202 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -103.1 135.22 45.17 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.874 0.369 . . . . 74.099999999999994 111.321 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.91 152.34 43.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.696 -1.594 . . . . 70.129999999999995 106.696 172.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.67 150.74 48.82 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.879 -0.786 . . . . 60.140000000000001 108.879 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.4 m -140.22 150.25 60.86 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 109.11 -0.7 . . . . 74.510000000000005 109.11 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.2 Cg_exo -65.39 132.44 31.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.325 2.017 . . . . 71.129999999999995 111.218 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.2 m -146.8 177.12 9.35 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.181 -0.463 . . . . 62.539999999999999 110.229 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.0 t -62.54 144.49 95.69 Favored Pre-proline 0 N--CA 1.432 -1.347 0 C-N-CA 123.852 0.861 . . . . 61.200000000000003 110.015 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.9 Cg_exo -51.15 -31.72 37.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.966 3.111 . . . . 73.239999999999995 113.067 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.99 -12.04 60.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 120.027 -0.669 . . . . 75.019999999999996 111.754 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.5 mt -109.61 -4.45 16.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.7 -0.227 . . . . 62.100000000000001 111.528 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.8 t -61.2 127.5 20.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.567 -0.531 . . . . 72.310000000000002 109.567 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.42 75.33 Favored Glycine 0 C--O 1.25 1.101 0 C-N-CA 121.082 -0.58 . . . . 53.439999999999998 111.738 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 95.5 mttt -125.27 159.22 32.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.405 -0.961 . . . . 61.25 108.405 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.642 HG22 HD11 ' A' ' 486' ' ' ILE . 39.1 t -82.75 133.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 109.329 -0.619 . . . . 75.219999999999999 109.329 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.72 -7.59 9.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 120.462 -0.495 . . . . 74.219999999999999 110.342 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.495 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 162.16 165.08 18.48 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.995 -0.842 . . . . 63.420000000000002 110.995 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.1 p -120.0 145.45 46.79 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.25 -0.648 . . . . 42.43 109.25 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.49 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.1 t-20 -57.4 -50.58 87.37 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 118.981 -0.533 . . . . 64.450000000000003 111.886 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.3 Cg_exo -76.7 131.82 12.69 Favored 'Trans proline' 0 C--N 1.37 1.709 0 N-CA-C 108.377 -1.432 . . . . 75.549999999999997 108.377 171.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.65 138.56 70.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.429 2.086 . . . . 72.239999999999995 112.037 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.49 1.77 50.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.133 0.968 . . . . 54.32 110.484 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.03 -27.78 15.45 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.798 -1.092 . . . . 73.340000000000003 109.639 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -109.89 164.85 12.19 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.848 -0.614 . . . . 71.319999999999993 109.455 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 15.5 p -90.61 136.86 32.79 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 120.736 0.303 . . . . 64.340000000000003 111.247 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.7 m -120.1 142.03 49.26 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.69 -0.856 . . . . 71.319999999999993 108.69 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.97 39.35 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.932 0.345 . . . . 74.329999999999998 111.932 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.81 -23.54 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.044 0.937 . . . . 74.219999999999999 111.282 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -80.67 -8.94 59.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.549 -0.75 . . . . 74.430000000000007 110.9 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 140.63 43.3 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.921 0.391 . . . . 52.439999999999998 112.04 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 451' ' ' ARG . 99.4 t -85.3 122.89 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.942 -1.133 . . . . 74.0 107.942 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.95 118.84 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.223 -1.029 . . . . 74.409999999999997 108.223 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.527 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.6 mp -92.74 117.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.064 -1.828 . . . . 74.219999999999999 106.064 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.642 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.56 120.57 62.36 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 CA-C-N 115.566 -0.743 . . . . 73.409999999999997 109.429 -174.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.66 121.45 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.645 0.736 . . . . 60.329999999999998 111.242 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 142.72 13.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.778 -1.101 . . . . 72.040000000000006 109.386 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.38 118.99 4.9 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 109.024 -1.63 . . . . 63.420000000000002 109.024 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.6 t -122.79 155.6 36.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.557 -0.905 . . . . 65.010000000000005 108.557 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.947 0 N-CA-C 109.602 -1.399 . . . . 62.32 109.602 178.514 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 CA-C-O 122.123 0.963 . . . . 61.299999999999997 110.448 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.9 p -140.41 153.86 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.735 -1.12 . . . . 65.409999999999997 109.053 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.96 146.96 36.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.328 -0.249 . . . . 74.239999999999995 110.328 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.0 p-10 -100.41 135.53 41.71 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.613 -0.884 . . . . 75.140000000000001 108.613 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 32.7 pt -89.99 137.7 28.01 Favored Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 115.919 -0.582 . . . . 72.319999999999993 111.526 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.6 Cg_endo -83.19 -172.09 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.224 1.949 . . . . 73.25 110.25 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.1 128.58 35.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.169 0.509 . . . . 72.25 110.487 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.39 4.16 2.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.845 0.831 . . . . 62.009999999999998 109.435 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.67 144.06 26.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.489 -0.778 . . . . 62.039999999999999 110.279 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 95.3 13.09 53.25 Favored Glycine 0 CA--C 1.498 -1.007 0 N-CA-C 111.081 -0.808 . . . . 61.240000000000002 111.081 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 507' ' ' VAL . 19.8 mt-30 -118.88 176.18 5.4 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.056 -1.09 . . . . 75.230000000000004 108.056 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 m -86.58 155.41 20.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.715 -1.217 . . . . 52.520000000000003 107.715 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 10.3 p -54.87 -41.51 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 123.383 0.427 . . . . 71.25 111.968 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.25 -42.53 83.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.138 0.422 . . . . 52.399999999999999 112.138 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.3 p -76.52 -34.38 24.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 119.884 -0.726 . . . . 55.509999999999998 110.646 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.446 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -61.14 -47.66 85.2 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.078 -0.964 . . . . 74.209999999999994 111.017 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.2 mt-30 -62.75 -38.3 89.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.631 0.582 . . . . 73.549999999999997 110.002 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 514' ' ' VAL . 44.7 mmtm -63.03 -52.82 61.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.529 0.518 . . . . 64.239999999999995 111.911 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.57 -42.78 99.76 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 110.939 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.09 -43.33 95.72 Favored 'General case' 0 C--O 1.197 -1.698 0 CA-C-N 115.641 -0.709 . . . . 72.400000000000006 109.939 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.99 -38.61 79.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.41 0.684 . . . . 70.340000000000003 111.383 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.8 t -62.03 -40.52 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.291 -0.413 . . . . 41.539999999999999 111.63 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -101.29 -36.4 8.91 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.505 -0.878 . . . . 72.200000000000003 110.863 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -89.6 -115.77 1.55 Allowed Glycine 0 N--CA 1.415 -2.739 0 CA-C-N 114.435 -1.257 . . . . 74.209999999999994 115.783 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 17.3 m-85 -125.15 -175.29 3.26 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.194 -0.503 . . . . 73.409999999999997 110.235 -167.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.3 p -113.2 -7.71 13.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.305 0.483 . . . . 74.219999999999999 112.305 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.65 120.86 43.69 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 120.617 -0.433 . . . . 63.5 110.147 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -125.67 155.97 40.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.42 -0.809 . . . . 71.099999999999994 109.284 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 154.82 45.61 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.842 -1.54 . . . . 75.450000000000003 106.842 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -120.97 128.42 52.71 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.229 -0.588 . . . . 72.239999999999995 110.193 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.07 131.19 57.01 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.086 -1.079 . . . . 61.409999999999997 108.086 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.3 p -88.78 131.41 35.07 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.745 -0.661 . . . . 70.420000000000002 111.184 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.4 m -121.96 162.0 21.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.803 -1.184 . . . . 75.439999999999998 107.803 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -79.8 123.75 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.254 0.549 . . . . 75.140000000000001 111.733 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 7.2 m -85.15 149.75 53.44 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.203 -0.908 . . . . 63.200000000000003 108.567 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.599 1.532 . . . . 75.450000000000003 109.285 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.487 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.4 mtt180 -122.97 -58.46 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.802 -0.618 . . . . 74.400000000000006 111.003 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 57.2 Cg_endo -71.34 148.4 54.96 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.823 1.33 . . . . 32.039999999999999 111.522 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.71 175.68 9.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.045 -0.724 . . . . 51.030000000000001 109.045 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 86.51 -15.85 48.51 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 121.256 -0.497 . . . . 54.229999999999997 111.927 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.92 147.83 25.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.657 0.741 . . . . 65.239999999999995 111.598 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 508' ' ' ALA . 69.7 t -81.46 123.7 38.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 114.991 -1.004 . . . . 71.140000000000001 109.614 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.9 m -86.13 -26.45 25.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.733 -1.122 . . . . 70.109999999999999 109.242 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.13 -153.27 23.72 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 111.019 -0.832 . . . . 74.310000000000002 111.019 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -134.81 161.29 35.63 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.954 -0.758 . . . . 74.340000000000003 108.954 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.6 t-20 -54.69 -54.44 49.08 Favored Pre-proline 0 CA--C 1.561 1.374 0 O-C-N 123.291 0.369 . . . . 70.319999999999993 110.615 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 79.4 Cg_endo -82.35 149.4 14.96 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.103 1.202 . . . . 63.43 110.191 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 21.6 Cg_exo -67.64 154.13 74.26 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.317 2.011 . . . . 62.119999999999997 113.024 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.78 129.56 40.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.18 -0.674 . . . . 43.350000000000001 109.18 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.59 46.46 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 111.862 -0.495 . . . . 34.299999999999997 111.862 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 93.2 m -78.06 137.36 38.2 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.986 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -94.56 123.89 38.26 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.727 -0.669 . . . . 74.439999999999998 109.77 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.9 155.0 78.27 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 110.092 -0.336 . . . . 75.200000000000003 110.092 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.4 Cg_exo -64.03 139.72 68.75 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.242 2.628 . . . . 71.400000000000006 112.482 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.556 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 16.3 m -67.75 -21.19 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.785 0.803 . . . . 64.140000000000001 111.114 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.12 -10.92 59.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.646 -1.161 . . . . 75.230000000000004 110.349 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.8 t -93.24 155.1 17.64 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.927 -0.768 . . . . 71.030000000000001 108.927 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.68 130.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.937 -0.764 . . . . 60.109999999999999 108.937 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 18.7 tt -93.64 135.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.539 0.685 . . . . 64.5 111.377 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -102.74 124.49 48.37 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 109.485 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 28.4 tp -96.72 132.78 42.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.893 -1.048 . . . . 72.140000000000001 109.204 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -96.33 106.66 18.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.414 -1.328 . . . . 71.219999999999999 107.414 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.62 137.0 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 111.125 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.471 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 50.2 m -65.83 115.65 6.17 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.025 -1.102 . . . . 51.119999999999997 108.025 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 C--N 1.314 -0.955 0 O-C-N 123.643 0.589 . . . . 71.209999999999994 109.773 -176.345 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.238 0.479 0 N-CA-C 109.516 -0.55 . . . . 74.340000000000003 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.524 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 66.2 mt-30 -83.83 138.74 33.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.842 -0.617 . . . . 62.539999999999999 112.435 -171.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -130.18 154.73 47.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.852 -1.907 . . . . 75.239999999999995 105.852 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.15 28.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 117.737 0.244 . . . . 74.329999999999998 110.727 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.2 mp -79.69 129.98 69.25 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 108.493 -0.928 . . . . 74.030000000000001 108.493 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.61 141.14 54.05 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.938 1.759 . . . . 75.510000000000005 111.062 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.39 67.23 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.267 1.032 . . . . 74.209999999999994 109.844 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.422 HG13 HD12 ' A' ' 435' ' ' LEU . 43.6 t -117.39 -2.55 9.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.556 -1.646 . . . . 72.510000000000005 106.556 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.674 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.2 m -60.96 -41.22 95.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.394 -1.73 . . . . 74.200000000000003 111.373 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 13.9 t -58.15 -26.29 62.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.6 -0.727 . . . . 74.239999999999995 111.623 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 432' ' ' VAL . 78.4 mt -80.93 -44.53 18.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.318 -0.553 . . . . 72.329999999999998 110.916 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.5 m -164.64 145.2 7.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.695 -0.854 . . . . 74.519999999999996 108.695 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.38 -43.65 79.45 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.787 0.835 . . . . 72.310000000000002 110.77 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.17 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.695 0.76 . . . . 74.209999999999994 110.704 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.535 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.9 mm-40 -70.42 -38.78 74.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.663 -0.699 . . . . 72.430000000000007 110.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.674 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.84 -50.95 71.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.472 -0.786 . . . . 44.32 111.036 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.4 t -59.37 -46.32 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 111.571 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -65.13 -44.79 87.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.744 -0.383 . . . . 75.200000000000003 111.139 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -63.4 -44.69 93.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.259 -0.428 . . . . 75.209999999999994 111.821 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.601 HD23 ' CE2' ' A' ' 452' ' ' PHE . 29.4 tp -67.26 -40.11 86.17 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.329 -0.396 . . . . 73.219999999999999 110.295 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.2 m -60.44 -44.15 96.12 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 110.468 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.08 -18.05 62.56 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.784 -0.644 . . . . 71.25 111.431 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.62 57.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.092 0.472 . . . . 41.210000000000001 110.825 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.9 -6.03 37.17 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.368 -0.92 . . . . 72.430000000000007 112.675 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.6 m-85 -81.7 130.84 35.2 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.098 -0.704 . . . . 71.409999999999997 109.098 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.62 2.03 6.47 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.47 -0.872 . . . . 71.439999999999998 113.129 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HG3' HG23 ' A' ' 483' ' ' VAL . 9.1 tpp180 -104.37 115.35 30.22 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.126 -1.065 . . . . 71.140000000000001 108.126 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.601 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.0 m-85 -123.28 144.89 49.12 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.318 0.58 . . . . 75.439999999999998 110.8 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -135.26 122.62 21.79 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.77 -1.567 . . . . 63.439999999999998 106.77 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -93.89 121.75 35.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.045 0.45 . . . . 53.119999999999997 109.881 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.02 151.68 45.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.929 -1.138 . . . . 75.030000000000001 107.929 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -132.03 134.35 45.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.331 -0.618 . . . . 74.329999999999998 109.331 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.4 m -119.04 137.53 25.2 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 107.979 -1.119 . . . . 72.140000000000001 107.979 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.07 121.63 9.17 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.458 1.438 . . . . 53.340000000000003 109.606 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -138.93 179.22 6.62 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.121 -1.437 . . . . 72.120000000000005 107.121 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.3 t -56.43 126.24 68.65 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-O 121.659 0.742 . . . . 72.409999999999997 110.164 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.51 -28.91 29.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 125.25 3.966 . . . . 62.299999999999997 115.739 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.69 -15.96 62.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.66 0.615 . . . . 73.510000000000005 112.66 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 73.3 mt -87.69 4.74 42.89 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 64.230000000000004 112.149 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.5 p -60.25 130.08 23.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 121.023 0.439 . . . . 55.539999999999999 110.172 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.51 68.54 Favored Glycine 0 C--N 1.307 -1.04 0 C-N-CA 120.631 -0.795 . . . . 52.140000000000001 111.656 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.88 144.33 42.62 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.138 0.494 . . . . 53.200000000000003 109.914 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.629 HG22 HD11 ' A' ' 486' ' ' ILE . 46.0 t -82.13 135.82 24.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.376 -0.972 . . . . 73.219999999999999 108.376 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.3 pt -97.96 -29.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 119.84 -0.744 . . . . 64.129999999999995 110.417 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -174.28 161.17 31.11 Favored Glycine 0 N--CA 1.424 -2.162 0 C-N-CA 120.395 -0.907 . . . . 61.310000000000002 111.639 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.0 p -118.7 152.81 35.44 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.194 -0.669 . . . . 54.539999999999999 109.194 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 16.7 t-20 -62.76 -54.56 46.34 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-O 119.156 -0.45 . . . . 72.329999999999998 111.416 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -75.81 134.16 16.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 N-CA-C 108.529 -1.374 . . . . 63.43 108.529 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.89 143.65 73.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.854 2.37 . . . . 72.439999999999998 113.206 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -88.89 -7.57 55.86 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.442 1.115 . . . . 60.32 109.437 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.91 -33.01 17.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.449 -1.25 . . . . 73.329999999999998 110.06 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -114.91 175.67 5.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.597 -0.729 . . . . 75.150000000000006 110.681 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 18.0 p -92.42 139.98 30.04 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 116.338 -0.392 . . . . 72.0 109.99 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 53.4 m -130.1 147.07 51.8 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.883 -0.784 . . . . 74.420000000000002 108.883 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.485 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.98 150.37 48.76 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.012 0.434 . . . . 73.420000000000002 111.521 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.38 -24.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.626 -0.715 . . . . 72.319999999999993 110.025 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -81.14 2.27 28.24 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.807 -0.633 . . . . 64.519999999999996 111.085 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.37 145.66 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.924 -0.398 . . . . 71.5 109.924 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 451' ' ' ARG . 3.4 p -86.35 120.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.265 -1.013 . . . . 64.420000000000002 108.265 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.44 117.23 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 C-N-CA 118.233 -1.387 . . . . 71.540000000000006 107.456 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 64.4 mt -97.97 112.21 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 105.438 -2.06 . . . . 74.109999999999999 105.438 175.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.629 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.85 120.4 51.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 N-CA-C 108.346 -0.983 . . . . 65.409999999999997 108.346 -175.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 120.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.328 0.585 . . . . 74.049999999999997 110.124 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.72 138.83 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.887 -1.153 . . . . 70.409999999999997 107.887 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.9 104.66 2.23 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 108.753 -1.739 . . . . 71.439999999999998 108.753 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.5 t -105.63 139.73 39.78 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.815 -1.18 . . . . 72.150000000000006 107.815 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.953 0 N-CA-C 108.902 -1.679 . . . . 74.230000000000004 108.902 177.168 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.888 0 N-CA-C 108.965 -0.754 . . . . 70.430000000000007 108.965 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.1 p -121.68 158.96 27.56 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.813 -1.085 . . . . 74.310000000000002 108.379 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -150.0 148.53 29.17 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.087 -0.338 . . . . 70.340000000000003 110.087 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.5 p-10 -80.36 131.6 35.65 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.45 0.643 . . . . 60.0 110.322 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.3 pt -75.4 131.29 77.98 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.177 -0.919 . . . . 75.230000000000004 111.461 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -92.14 119.64 0.5 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 122.639 2.226 . . . . 74.409999999999997 111.753 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.75 122.28 28.89 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.675 -1.232 . . . . 75.010000000000005 107.675 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.44 43.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.829 1.299 . . . . 63.229999999999997 110.631 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -59.72 145.97 43.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.358 -1.292 . . . . 72.340000000000003 112.242 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.0 -12.64 31.83 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.134 -0.555 . . . . 73.109999999999999 113.012 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.528 ' O ' HG12 ' A' ' 534' ' ' VAL . 25.5 mt-30 -108.17 -170.9 1.76 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 121.048 -0.261 . . . . 75.319999999999993 111.311 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.1 m -85.07 156.36 21.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.498 -1.297 . . . . 73.109999999999999 107.498 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.99 -41.19 90.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.576 0.626 . . . . 70.109999999999999 111.232 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.82 -42.06 97.73 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 116.492 -0.322 . . . . 65.319999999999993 111.424 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.8 -34.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 119.194 -1.003 . . . . 63.340000000000003 111.018 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.78 86.66 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.873 -0.603 . . . . 72.510000000000005 110.247 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -61.91 -42.27 98.89 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 123.255 0.347 . . . . 62.009999999999998 110.097 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.25 -48.36 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.342 -0.614 . . . . 72.030000000000001 109.342 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 -38.9 92.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.540000000000006 110.771 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.29 -43.68 73.34 Favored 'General case' 0 C--O 1.186 -2.263 0 CA-C-N 115.352 -0.84 . . . . 64.439999999999998 110.185 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.36 -46.55 86.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.433 0.635 . . . . 74.329999999999998 111.435 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.04 -18.65 21.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 62.32 111.316 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -129.87 18.41 5.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.932 -0.766 . . . . 73.150000000000006 108.932 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -162.61 -110.74 0.25 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.111 -1.042 . . . . 44.539999999999999 114.691 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -123.31 167.74 13.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.856 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 9.3 p -104.68 7.03 34.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.829 0.678 . . . . 73.310000000000002 112.829 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 550' ' ' VAL . 0.0 OUTLIER -131.04 123.01 27.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.775 0.321 . . . . 73.230000000000004 110.781 -178.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.76 152.15 48.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 74.099999999999994 110.528 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 47.8 t -127.51 147.83 50.32 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.818 -1.919 . . . . 70.0 105.818 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -121.53 127.51 51.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 110.258 -0.275 . . . . 74.439999999999998 110.258 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 135.29 48.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.8 -0.637 . . . . 73.409999999999997 109.741 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 2.7 p -88.47 130.1 35.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.71 -0.677 . . . . 74.140000000000001 109.551 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.44 159.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.639 -0.504 . . . . 71.010000000000005 109.639 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.32 115.95 17.53 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.962 0.887 . . . . 73.400000000000006 109.795 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 2.9 m -95.26 157.3 36.61 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.883 -1.508 . . . . 71.230000000000004 110.68 -171.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 6.1 Cg_exo -80.72 -142.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.641 2.227 . . . . 73.439999999999998 108.817 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.601 ' HA ' ' NE ' ' A' ' 529' ' ' ARG . 4.3 mmp_? -58.35 -49.78 91.69 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 113.481 0.919 . . . . 73.510000000000005 113.481 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.82 149.0 47.17 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.269 1.313 . . . . 73.109999999999999 111.455 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.86 145.97 26.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.254 -1.017 . . . . 62.109999999999999 108.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.48 -53.07 0.74 Allowed Glycine 0 N--CA 1.437 -1.274 0 C-N-CA 120.683 -0.77 . . . . 74.299999999999997 112.431 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.06 149.56 48.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.127 0.571 . . . . 52.109999999999999 111.965 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -73.49 127.65 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 121.486 0.66 . . . . 72.430000000000007 109.584 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -24.65 44.55 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.717 -1.128 . . . . 64.510000000000005 109.642 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.09 -146.38 16.63 Favored Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 111.311 -0.716 . . . . 61.439999999999998 111.311 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -116.19 160.07 20.91 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.487 -0.931 . . . . 72.439999999999998 108.487 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -53.74 -54.24 48.56 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 111.813 0.301 . . . . 71.319999999999993 111.813 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.4 Cg_endo -92.56 167.67 2.73 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.253 1.969 . . . . 64.230000000000004 110.179 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.95 155.6 57.35 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.466 2.11 . . . . 71.450000000000003 111.538 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 137.88 58.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.757 -0.46 . . . . 45.210000000000001 109.757 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.43 -19.11 34.62 Favored Glycine 0 C--N 1.294 -1.751 0 C-N-CA 120.023 -1.084 . . . . 72.25 111.717 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -65.64 123.14 18.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.484 -0.932 . . . . 61.109999999999999 108.484 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 16.8 m -94.87 122.48 37.55 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.703 -0.48 . . . . 73.450000000000003 109.703 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.74 159.19 69.48 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.662 -0.866 . . . . 63.420000000000002 108.662 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.2 Cg_exo -61.39 139.25 81.47 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.074 1.849 . . . . 52.43 111.339 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.63 -18.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.302 -0.863 . . . . 72.299999999999997 112.481 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.58 -9.55 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.16 -0.927 . . . . 63.399999999999999 109.78 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 45.1 m -92.34 152.1 19.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.217 -0.901 . . . . 51.340000000000003 110.795 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.463 ' HA ' ' HG2' ' A' ' 519' ' ' LYS . 39.5 t -88.38 133.53 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.261 -0.427 . . . . 70.109999999999999 110.869 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.2 tt -98.49 139.27 20.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.513 -0.551 . . . . 61.420000000000002 109.513 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.82 125.83 49.71 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 109.902 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.82 133.7 42.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.453 -0.943 . . . . 71.25 108.453 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -97.51 111.19 23.56 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.035 -1.098 . . . . 72.439999999999998 108.035 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.21 137.71 41.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 C-N-CA 120.532 -0.467 . . . . 75.430000000000007 111.996 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.2 m -68.02 117.67 10.18 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.353 -1.351 . . . . 54.200000000000003 107.353 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 8.1 ptmm? . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 118.516 -0.754 . . . . 72.209999999999994 112.341 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 121.164 0.507 . . . . 72.049999999999997 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 18.7 mp0 -83.9 147.21 27.64 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 119.683 -0.807 . . . . 74.430000000000007 109.384 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 7.9 tpp85 -143.26 161.16 39.03 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.137 -1.06 . . . . 63.310000000000002 108.137 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 9.5 pt-20 -82.23 140.29 33.76 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 123.582 0.753 . . . . 62.039999999999999 112.018 -172.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -96.67 126.89 41.47 Favored Pre-proline 0 N--CA 1.424 -1.735 0 N-CA-C 104.607 -2.368 . . . . 64.319999999999993 104.607 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.62 141.34 90.82 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.35 2.034 . . . . 73.209999999999994 114.381 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -100.76 -5.22 26.67 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.845 -1.07 . . . . 51.520000000000003 108.492 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.43 -4.68 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 122.542 1.163 . . . . 63.310000000000002 108.524 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.0 m -58.51 -31.98 68.4 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.922 -1.49 . . . . 72.109999999999999 109.283 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -57.14 -27.51 61.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.538 -1.21 . . . . 70.099999999999994 110.642 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.1 mt -89.99 -44.47 9.84 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.008 -0.677 . . . . 71.430000000000007 111.724 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.552 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 24.5 m -158.34 143.55 16.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.326 -0.859 . . . . 74.519999999999996 109.947 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.27 -45.92 79.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.848 0.459 . . . . 63.420000000000002 110.006 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.45 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.73 -35.27 65.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.901 -0.591 . . . . 75.349999999999994 111.782 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.552 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.0 mm-40 -70.79 -43.59 68.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.412 -0.358 . . . . 72.329999999999998 111.154 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.07 -51.22 70.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.363 -0.835 . . . . 71.450000000000003 110.554 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.87 -47.62 88.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 115.493 -0.776 . . . . 64.209999999999994 112.125 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -64.81 -42.91 94.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.677 -0.409 . . . . 73.420000000000002 111.629 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -66.44 -45.49 79.65 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.096 0.474 . . . . 74.299999999999997 110.176 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 34.6 tp -68.58 -37.35 79.78 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.767 -0.651 . . . . 73.329999999999998 111.065 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.9 m -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 109.846 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.9 -15.45 62.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.967 -0.56 . . . . 52.130000000000003 110.921 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.574 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -81.14 -14.83 57.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.211 0.529 . . . . 64.209999999999994 110.098 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.31 58.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.298 -0.954 . . . . 73.400000000000006 113.652 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 90.6 m-85 -72.58 146.02 46.98 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.911 -0.774 . . . . 74.310000000000002 108.911 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.25 -7.01 2.31 Favored Glycine 0 C--N 1.303 -1.275 0 C-N-CA 120.006 -1.092 . . . . 73.120000000000005 112.656 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 483' ' ' VAL . 0.0 OUTLIER -102.5 115.42 30.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.859 -1.534 . . . . 61.310000000000002 106.859 -178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.08 149.37 50.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.175 0.512 . . . . 75.150000000000006 110.722 -173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.459 ' HB3' HG13 ' A' ' 485' ' ' ILE . 17.6 tppt? -138.64 123.02 18.3 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.537 -1.283 . . . . 73.25 107.537 169.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -102.74 134.85 45.45 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.331 0.586 . . . . 75.129999999999995 111.114 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.14 158.42 44.49 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.183 -1.043 . . . . 64.430000000000007 108.183 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -135.2 146.91 49.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.231 -1.026 . . . . 74.019999999999996 108.231 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 35.1 t -133.6 131.3 21.23 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.352 -0.981 . . . . 55.340000000000003 108.352 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.8 Cg_exo -65.87 120.89 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.775 1.65 . . . . 72.319999999999993 109.989 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.0 m -140.79 179.48 6.68 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 106.735 -1.58 . . . . 74.319999999999993 106.735 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -52.49 133.82 44.18 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.341 0.401 . . . . 65.219999999999999 111.581 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.481 ' O ' HG12 ' A' ' 464' ' ' VAL . 86.9 Cg_exo -50.45 -26.51 16.45 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 125.071 3.847 . . . . 72.319999999999993 113.05 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -57.27 -33.22 67.39 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.304 0.642 . . . . 53.520000000000003 110.568 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 93.9 mt -103.83 11.07 36.17 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.567 0.58 . . . . 74.120000000000005 112.567 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.3 p -61.21 128.15 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 119.927 -0.709 . . . . 74.140000000000001 110.595 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.13 77.69 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 120.887 -0.673 . . . . 52.039999999999999 112.163 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.7 mptp? -100.31 148.69 24.4 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.685 -0.857 . . . . 74.120000000000005 108.685 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 486' ' ' ILE . 58.5 t -81.93 125.35 39.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.758 -1.201 . . . . 70.129999999999995 107.758 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.92 -10.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 120.852 0.358 . . . . 74.200000000000003 111.386 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.22 149.04 8.06 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.176 -1.012 . . . . 71.239999999999995 112.193 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -119.03 140.48 49.97 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.494 -1.299 . . . . 73.430000000000007 107.494 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.514 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.6 t-20 -62.59 -53.83 53.56 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-O 118.963 -0.541 . . . . 75.420000000000002 111.765 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.1 Cg_exo -74.34 146.0 34.99 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 108.583 -1.353 . . . . 74.519999999999996 108.583 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.7 134.28 46.45 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.415 2.077 . . . . 72.200000000000003 112.918 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.63 6.44 47.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.481 1.134 . . . . 74.409999999999997 109.529 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.37 -21.87 13.75 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.279 -1.328 . . . . 63.020000000000003 109.278 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.7 155.54 39.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.225 -0.443 . . . . 64.439999999999998 111.413 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.7 p -83.99 123.91 30.49 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.653 -0.703 . . . . 74.140000000000001 109.516 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.8 m -115.59 150.74 36.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.716 -0.846 . . . . 60.520000000000003 108.716 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.99 151.21 46.51 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.24 0.216 . . . . 62.109999999999999 111.338 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.96 -17.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.83 0.852 . . . . 72.209999999999994 112.215 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.4 t -72.04 -6.05 39.55 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 116.44 -0.345 . . . . 72.519999999999996 110.851 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.95 131.1 35.75 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 122.633 0.373 . . . . 63.130000000000003 111.996 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 451' ' ' ARG . 6.6 p -83.79 123.57 38.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.867 -1.16 . . . . 61.240000000000002 107.867 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.34 118.18 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 C-N-CA 119.067 -1.053 . . . . 74.510000000000005 109.322 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.514 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -97.21 112.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.685 -1.969 . . . . 73.129999999999995 105.685 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.42 121.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 115.908 -0.587 . . . . 65.140000000000001 109.559 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.97 120.45 52.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.183 0.516 . . . . 75.400000000000006 109.894 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.0 t -96.05 140.32 17.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-N 115.694 -0.684 . . . . 72.25 109.19 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.31 114.03 3.85 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.368 -1.093 . . . . 72.049999999999997 110.368 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 40.6 t -98.84 133.56 42.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.013 -1.106 . . . . 43.299999999999997 108.013 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.528 0 N-CA-C 110.915 -0.874 . . . . 75.400000000000006 110.915 -178.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 108.259 -1.015 . . . . 64.510000000000005 108.259 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 546' ' ' PRO . 33.7 p -131.55 143.9 50.71 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.429 -0.35 . . . . 71.310000000000002 110.534 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.84 164.59 27.23 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.07 -0.715 . . . . 63.030000000000001 109.07 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.17 134.02 35.77 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.06 -1.459 . . . . 73.340000000000003 107.06 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 517' ' ' PHE . 32.5 pt -76.65 132.49 71.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.67 -0.412 . . . . 74.109999999999999 110.251 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -91.42 178.46 1.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.763 2.309 . . . . 75.329999999999998 113.217 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.68 135.95 36.71 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.928 -1.138 . . . . 71.150000000000006 107.928 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.85 16.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.991 0.9 . . . . 42.439999999999998 109.407 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.48 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -68.06 132.43 47.24 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.899 -1.046 . . . . 41.140000000000001 111.801 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 117.91 -24.65 8.8 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.429 -0.891 . . . . 72.400000000000006 112.023 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.57 173.75 7.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.945 -0.761 . . . . 74.049999999999997 108.945 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 9.8 p -80.01 156.94 26.92 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.486 -0.486 . . . . 55.009999999999998 111.504 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.76 -42.26 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 O-C-N 123.838 0.712 . . . . 71.209999999999994 112.181 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.64 -39.44 80.71 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 121.017 -0.273 . . . . 64.099999999999994 111.592 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 83.8 t -71.1 -44.04 75.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.442 0.639 . . . . 63.520000000000003 110.827 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.08 -47.83 81.23 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 74.209999999999994 111.628 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.81 -35.62 81.68 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 121.042 -0.263 . . . . 71.310000000000002 110.579 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.7 OUTLIER -65.14 -51.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.206 -0.664 . . . . 52.149999999999999 109.206 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.7 -37.8 87.92 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.96 -0.564 . . . . 65.239999999999995 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.67 -45.47 71.64 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.818 -0.628 . . . . 74.420000000000002 109.451 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.29 -41.27 88.53 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.033 0.753 . . . . 72.530000000000001 113.033 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.3 t -64.23 -31.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 111.655 -177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.81 15.91 11.8 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.993 -0.283 . . . . 74.230000000000004 110.72 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.8 -98.08 0.2 Allowed Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 117.281 -2.39 . . . . 42.119999999999997 117.426 -169.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.667 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 78.1 m-85 -121.89 152.83 39.19 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.145 0.497 . . . . 74.549999999999997 111.791 -164.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.9 m -96.19 -27.48 15.01 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.02 -0.991 . . . . 62.420000000000002 111.871 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.75 134.66 51.16 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.156 -0.34 . . . . 64.200000000000003 110.09 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.77 145.53 51.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.347 0.594 . . . . 75.329999999999998 111.009 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.3 m -141.11 144.6 34.98 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.873 -1.529 . . . . 71.450000000000003 106.873 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 553' ' ' LEU . 13.2 mm-40 -121.26 127.41 51.36 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.119 -1.067 . . . . 72.400000000000006 108.119 -172.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.436 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -114.28 133.45 55.64 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.991 -1.114 . . . . 64.209999999999994 107.991 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.7 m -88.55 130.81 35.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.165 0.507 . . . . 22.210000000000001 110.718 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.25 162.82 21.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 105.033 -2.21 . . . . 72.409999999999997 105.033 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.75 131.9 36.04 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 118.872 0.76 . . . . 61.149999999999999 111.991 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 66.4 p -77.04 150.38 80.88 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.946 -1.025 . . . . 75.400000000000006 109.215 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.52 -47.4 7.52 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.021 1.814 . . . . 71.5 110.512 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 20.4 mmt180 -163.2 -58.83 0.01 OUTLIER Pre-proline 0 C--O 1.222 -0.348 0 C-N-CA 127.316 2.246 . . . . 74.209999999999994 109.411 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 527' ' ' SER . 30.5 Cg_endo -66.85 135.96 39.99 Favored 'Trans proline' 0 C--N 1.36 1.137 0 N-CA-C 109.091 -1.157 . . . . 62.409999999999997 109.091 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.34 157.85 38.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.297 0.373 . . . . 54.219999999999999 110.145 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 115.13 -18.67 15.89 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 121.131 -0.557 . . . . 61.119999999999997 112.192 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.3 OUTLIER -87.36 148.46 25.02 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.253 0.549 . . . . 74.329999999999998 111.336 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 501' ' ' ALA . 11.4 p -81.26 128.87 38.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.822 -0.807 . . . . 73.430000000000007 108.822 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -78.44 -31.2 47.95 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.775 -0.824 . . . . 65.239999999999995 108.775 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.09 -157.29 28.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.16 -1.176 . . . . 52.329999999999998 110.16 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.4 p -117.56 160.77 20.7 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.154 -1.054 . . . . 70.420000000000002 108.154 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 64.4 t30 -58.67 -51.26 83.09 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 119.979 -0.688 . . . . 71.109999999999999 111.167 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.3 Cg_exo -81.53 155.73 18.68 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 121.33 1.353 . . . . 53.340000000000003 109.835 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.64 149.98 56.05 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.373 2.049 . . . . 65.140000000000001 112.025 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.18 129.89 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.353 0.661 . . . . 72.25 110.045 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -7.06 36.33 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.573 -0.822 . . . . 63.299999999999997 111.834 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.1 m -77.13 133.92 38.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.451 -0.574 . . . . 71.420000000000002 109.451 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.9 t -100.81 127.33 47.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.251 0.548 . . . . 73.430000000000007 110.312 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 517' ' ' PHE . 11.2 m -138.76 162.08 54.84 Favored Pre-proline 0 C--O 1.248 1.018 0 N-CA-C 109.331 -0.618 . . . . 72.140000000000001 109.331 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.4 Cg_exo -63.84 135.03 46.23 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.483 2.122 . . . . 72.239999999999995 112.373 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.667 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 11.3 m -67.29 -21.12 27.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.699 0.762 . . . . 64.099999999999994 112.381 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.27 -7.96 55.95 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.602 -1.181 . . . . 64.010000000000005 109.324 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -92.14 179.0 5.69 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.432 -0.804 . . . . 70.209999999999994 110.764 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.31 124.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.84 -0.618 . . . . 64.340000000000003 112.365 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.3 tp -94.1 123.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 106.476 -1.676 . . . . 72.310000000000002 106.476 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.64 116.74 32.91 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-O 120.894 0.378 . . . . 72.430000000000007 110.082 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.614 ' HB2' ' OE1' ' A' ' 522' ' ' GLN . 6.1 mp -98.72 134.37 41.73 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.169 -0.923 . . . . 70.239999999999995 110.621 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 9.0 mm-40 -92.06 109.84 21.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.66 -1.978 . . . . 73.450000000000003 105.66 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.3 m -105.73 137.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 112.515 0.561 . . . . 71.310000000000002 112.515 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 49.5 m -72.72 114.53 10.96 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.577 0.703 . . . . 61.310000000000002 110.312 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 557' ' ' LYS . 7.3 tmtm? . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.046 -1.464 . . . . 71.420000000000002 107.046 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.992 0.901 . . . . 64.340000000000003 108.724 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.3 mt-30 -87.53 120.97 29.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.111 -0.95 . . . . 64.140000000000001 110.862 -174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -120.66 166.38 13.76 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.698 0.761 . . . . 65.530000000000001 110.536 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -84.38 140.3 31.66 Favored 'General case' 0 C--N 1.266 -3.053 0 CA-C-N 113.628 -1.623 . . . . 74.329999999999998 109.421 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.22 126.81 78.38 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 106.791 -1.559 . . . . 54.530000000000001 106.791 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.13 141.74 70.97 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.493 2.129 . . . . 71.219999999999999 112.399 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -112.41 70.64 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.532 1.158 . . . . 63.439999999999998 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.51 6.74 4.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 123.886 1.803 . . . . 65.5 106.226 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 0.7 OUTLIER -62.71 -30.97 71.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.32 -2.218 . . . . 73.109999999999999 109.308 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.0 m -58.37 -28.24 64.96 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 125.821 1.649 . . . . 64.25 110.642 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.5 -45.3 9.04 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.449 -0.501 . . . . 71.219999999999999 112.107 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.7 m -163.65 150.66 12.23 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.754 -0.832 . . . . 72.0 108.754 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 441' ' ' VAL . 32.7 t80 -53.08 -54.89 28.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.539 0.524 . . . . 74.230000000000004 110.704 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.7 -36.57 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 112.117 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -61.48 -45.77 92.83 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 112.313 0.486 . . . . 64.400000000000006 112.313 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -65.3 -44.58 87.49 Favored 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 123.68 0.613 . . . . 71.319999999999993 109.727 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.422 HG21 ' CZ ' ' A' ' 437' ' ' TYR . 90.8 t -59.02 -46.82 91.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.436 0 CA-C-N 115.368 -0.833 . . . . 53.219999999999999 111.629 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.9 mmpt? -60.28 -47.03 87.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.824 0.284 . . . . 74.030000000000001 110.966 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.72 -38.95 87.71 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.937 -0.305 . . . . 63.549999999999997 111.244 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.8 tp -67.04 -41.27 86.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.16 0.505 . . . . 75.519999999999996 110.092 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.9 m -61.07 -45.27 95.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.998 -1.001 . . . . 64.109999999999999 109.022 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.96 62.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.68 -0.691 . . . . 74.129999999999995 111.718 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.28 -13.12 57.49 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.193 0.521 . . . . 74.530000000000001 110.724 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.93 20.35 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 120.665 -0.779 . . . . 64.239999999999995 112.3 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.4 m-85 -69.23 118.08 11.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.53 -0.545 . . . . 74.239999999999995 109.53 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -106.72 -15.71 16.09 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.63 -0.714 . . . . 74.230000000000004 111.483 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -109.45 114.01 27.29 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.954 0.883 . . . . 73.049999999999997 110.344 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.7 154.46 40.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.665 -1.152 . . . . 54.149999999999999 111.208 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -131.33 125.45 32.76 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.16 -0.681 . . . . 72.209999999999994 109.16 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -88.69 121.02 30.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.981 0.419 . . . . 72.230000000000004 110.744 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.39 153.5 32.95 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 71.549999999999997 107.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.48 147.62 49.8 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.775 -0.824 . . . . 75.219999999999999 108.775 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.4 t -137.21 138.24 24.79 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 108.816 -0.809 . . . . 74.519999999999996 108.816 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 490' ' ' SER . 25.9 Cg_exo -64.81 122.16 9.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 72.120000000000005 110.182 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -137.52 179.75 6.22 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.929 -1.137 . . . . 63.149999999999999 107.929 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.6 t -65.27 144.03 98.92 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.047 -0.723 . . . . 75.409999999999997 109.047 174.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.36 -28.03 25.82 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.571 3.514 . . . . 75.450000000000003 112.464 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -59.01 -34.44 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 123.393 0.677 . . . . 73.420000000000002 111.442 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.98 4.75 49.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.066 1.135 . . . . 63.329999999999998 114.066 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 79.5 t -60.5 130.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.152 0.501 . . . . 54.420000000000002 112.325 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.94 84.72 Favored Glycine 0 CA--C 1.504 -0.644 0 CA-C-N 115.252 -0.886 . . . . 72.129999999999995 112.646 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.07 151.62 38.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.838 -0.43 . . . . 62.340000000000003 109.838 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 486' ' ' ILE . 46.7 t -81.93 134.25 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.687 -0.857 . . . . 71.230000000000004 108.687 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.46 -24.36 4.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.59 -0.444 . . . . 62.039999999999999 111.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.85 168.05 38.17 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.684 -0.77 . . . . 51.450000000000003 111.952 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.3 p -121.03 153.13 37.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.668 -0.493 . . . . 72.209999999999994 109.668 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 23.2 t-20 -68.49 -52.74 19.17 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 119.299 -0.381 . . . . 72.340000000000003 111.272 174.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.76 129.64 10.08 Favored 'Trans proline' 0 C--N 1.365 1.418 0 CA-C-N 120.202 1.108 . . . . 54.32 109.605 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.437 ' HB2' ' NE2' ' A' ' 476' ' ' GLN . 28.9 Cg_endo -64.67 129.89 24.83 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.323 2.015 . . . . 75.230000000000004 112.25 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 0.71 30.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.755 0.788 . . . . 51.140000000000001 111.605 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.99 -1.004 . . . . 52.219999999999999 109.165 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.607 ' N ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -129.79 157.84 41.08 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.109 -1.071 . . . . 71.430000000000007 108.109 177.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 37.4 p -86.72 123.67 32.13 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.997 -0.371 . . . . 73.519999999999996 109.997 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 50.4 m -108.58 145.18 35.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.395 -0.594 . . . . 71.439999999999998 109.395 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.26 153.2 43.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.152 -0.477 . . . . 70.400000000000006 110.781 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.87 -21.83 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.729 0.811 . . . . 73.450000000000003 110.7 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -76.66 9.09 3.0 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 116.037 -0.529 . . . . 74.209999999999994 111.944 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -98.6 145.83 26.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.378 0.271 . . . . 61.119999999999997 111.151 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.52 119.52 35.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.876 -1.157 . . . . 71.25 107.876 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 71.0 t -87.62 118.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 118.992 -1.083 . . . . 62.43 108.617 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 66.0 mt -94.86 114.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.795 -1.557 . . . . 72.209999999999994 106.795 176.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.27 128.36 59.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 115.656 -0.702 . . . . 72.230000000000004 109.488 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 38.1 mt -106.53 118.97 55.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 116.08 -0.509 . . . . 65.439999999999998 110.549 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.63 145.87 8.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.752 -0.658 . . . . 73.010000000000005 109.548 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -87.76 123.49 6.68 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.069 -0.812 . . . . 72.0 111.069 176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.8 m -123.6 137.61 54.71 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.414 -0.958 . . . . 55.299999999999997 108.414 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.681 0 C-N-CA 120.541 -0.838 . . . . 70.209999999999994 112.827 -175.593 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.193 0 CA-C-O 121.851 0.834 . . . . 63.240000000000002 111.483 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -134.67 154.39 51.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.206 -0.906 . . . . 74.409999999999997 110.85 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.49 149.6 30.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.869 -0.419 . . . . 71.239999999999995 109.869 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -90.58 139.14 30.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -96.19 138.44 21.59 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.777 -0.647 . . . . 65.239999999999995 112.019 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.25 171.26 11.46 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.522 2.148 . . . . 55.009999999999998 111.037 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -85.53 132.99 34.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.202 0.525 . . . . 73.129999999999995 110.174 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.73 11.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.962 0.887 . . . . 74.230000000000004 109.182 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.37 155.24 22.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.786 -0.643 . . . . 64.239999999999995 110.192 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 97.71 -13.26 64.08 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.539 -1.425 . . . . 63.140000000000001 109.539 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -94.53 179.65 5.2 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.438 -1.319 . . . . 74.430000000000007 107.438 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.0 m -83.67 155.28 23.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.718 -1.216 . . . . 61.229999999999997 107.718 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.8 -42.95 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.24 -42.55 75.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.058 0.392 . . . . 70.129999999999995 112.058 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -75.08 -35.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.551 -0.86 . . . . 72.400000000000006 111.036 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.437 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.85 -48.18 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.273 -0.876 . . . . 73.340000000000003 111.354 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.44 -34.74 78.89 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 121.249 -0.18 . . . . 75.0 110.969 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -64.67 -49.1 72.31 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.111 -0.329 . . . . 74.319999999999993 110.111 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.77 -46.52 81.79 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.242 0.544 . . . . 62.219999999999999 110.377 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.8 -36.58 81.53 Favored 'General case' 0 C--O 1.181 -2.551 0 CA-C-N 115.113 -0.949 . . . . 72.5 110.855 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.98 -39.28 81.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.246 0.546 . . . . 73.219999999999999 110.4 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.33 -34.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.496 -0.775 . . . . 65.420000000000002 111.336 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -111.27 11.3 21.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.566 0.698 . . . . 73.319999999999993 111.802 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.87 -111.97 1.33 Allowed Glycine 0 N--CA 1.417 -2.593 0 CA-C-N 115.412 -0.813 . . . . 41.130000000000003 111.893 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 37.1 m-85 -133.16 -177.15 4.39 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.542 -0.54 . . . . 72.439999999999998 109.542 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -106.98 -7.95 16.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.647 0.737 . . . . 62.43 109.729 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -108.11 115.99 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.863 -0.608 . . . . 63.329999999999998 110.061 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -126.25 151.49 47.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.785 0.802 . . . . 75.239999999999995 112.366 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.8 m -136.87 151.67 49.36 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.202 -1.407 . . . . 51.299999999999997 107.202 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.538 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.7 mm-40 -121.33 131.14 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.38 -0.6 . . . . 74.010000000000005 109.38 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.5 130.96 56.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.374 -0.602 . . . . 72.430000000000007 109.374 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 15.3 m -93.55 120.82 34.29 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.99 -0.745 . . . . 60.530000000000001 108.99 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.5 m -122.01 162.29 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 74.129999999999995 108.157 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . 0.262 13.8 m-20 -82.39 141.85 32.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.943 1.46 . . . . 74.439999999999998 114.943 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 2.7 m -97.55 144.03 27.24 Favored Pre-proline 0 C--N 1.28 -2.45 0 CA-C-N 113.425 -1.716 . . . . 63.219999999999999 109.016 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.94 -69.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 107.939 -1.6 . . . . 65.200000000000003 107.939 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.475 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 36.5 mmt180 -118.39 -59.4 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 118.494 -0.765 . . . . 75.329999999999998 112.291 170.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 527' ' ' SER . 54.7 Cg_endo -69.15 136.79 35.56 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 121.454 1.436 . . . . 71.439999999999998 111.811 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.08 123.03 16.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.861 -0.792 . . . . 65.319999999999993 108.861 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.08 -18.45 6.58 Favored Glycine 0 C--N 1.296 -1.662 0 N-CA-C 109.388 -1.485 . . . . 55.140000000000001 109.388 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -79.09 147.42 32.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.245 -0.977 . . . . 72.329999999999998 109.542 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 553' ' ' LEU . 58.7 t -76.16 115.54 17.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 107.971 -1.122 . . . . 72.200000000000003 107.971 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 16.9 m -78.26 -24.83 46.68 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.65 -0.704 . . . . 75.409999999999997 109.544 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.54 -175.39 43.16 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.84 -0.904 . . . . 51.229999999999997 110.84 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.3 p -119.69 158.55 26.24 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.013 -1.477 . . . . 73.439999999999998 107.013 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -59.43 -53.14 68.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.292 -0.563 . . . . 73.450000000000003 111.609 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.6 Cg_endo -86.81 147.71 8.25 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.21 1.273 . . . . 61.0 109.172 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.63 153.01 65.2 Favored 'Trans proline' 0 C--O 1.245 0.825 0 C-N-CA 122.022 1.815 . . . . 73.129999999999995 112.279 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 129.49 40.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.87 -0.605 . . . . 72.319999999999993 109.488 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.34 -19.08 37.73 Favored Glycine 0 C--N 1.304 -1.225 0 C-N-CA 121.122 -0.561 . . . . 75.420000000000002 111.744 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 87.5 m -75.03 132.42 41.31 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.915 0.388 . . . . 54.140000000000001 110.386 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 29.1 m -91.05 123.72 34.73 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.79 -0.819 . . . . 64.349999999999994 108.79 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.67 160.98 63.76 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.159 -0.682 . . . . 74.530000000000001 109.159 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.39 134.69 49.64 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.275 1.983 . . . . 63.409999999999997 112.356 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.6 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 15.7 m -67.56 -19.87 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 122.434 1.111 . . . . 53.200000000000003 110.56 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.76 -13.71 58.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.599 -1.637 . . . . 54.340000000000003 109.307 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 64.1 m -93.25 169.43 10.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.074 -0.966 . . . . 73.319999999999993 111.865 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.35 133.48 44.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.964 -0.562 . . . . 62.130000000000003 110.188 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.8 tt -102.87 137.25 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.208 0.528 . . . . 64.409999999999997 110.015 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 24.9 tt0 -103.79 129.71 51.24 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 116.076 -0.511 . . . . 72.129999999999995 110.355 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.538 ' HB3' ' OE1' ' A' ' 522' ' ' GLN . 6.4 tt -102.41 127.09 49.58 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.255 -1.387 . . . . 75.420000000000002 107.255 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -104.07 106.98 17.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.778 0.799 . . . . 71.299999999999997 109.28 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.62 138.02 37.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 114.831 -1.077 . . . . 64.430000000000007 111.793 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.497 ' HB2' ' OG ' ' A' ' 527' ' ' SER . 13.5 p -65.03 122.56 17.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 62.340000000000003 109.997 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 524' ' ' SER . 22.6 pttp . . . . . 0 C--O 1.259 1.564 0 CA-C-N 116.466 -0.334 . . . . 72.310000000000002 111.779 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 10.6 pt-20 . . . . . 0 CA--C 1.499 -1.007 0 CA-C-O 121.7 0.762 . . . . 60.039999999999999 109.935 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -114.28 133.04 55.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.552 -1.204 . . . . 74.109999999999999 109.022 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.597 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -120.51 161.51 21.17 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 108.109 -1.071 . . . . 73.319999999999993 108.109 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.84 141.6 32.15 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.369 0.668 . . . . 73.540000000000006 110.301 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.586 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.68 130.9 66.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 106.825 -1.546 . . . . 71.200000000000003 106.825 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.408 ' HB3' ' HD3' ' A' ' 443' ' ' LYS . 85.5 Cg_exo -53.47 140.95 63.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.097 2.531 . . . . 61.43 113.931 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.53 -2.78 57.91 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.021 -0.99 . . . . 73.230000000000004 110.258 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.84 8.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.766 0.793 . . . . 72.209999999999994 110.832 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.3 p -61.39 -42.23 98.39 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.536 1.534 . . . . 75.140000000000001 110.832 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 7.1 p -66.34 -25.59 66.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.742 -1.117 . . . . 54.219999999999999 111.867 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.37 -46.31 17.86 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.26 -0.576 . . . . 64.420000000000002 110.297 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.9 m -169.59 147.15 3.47 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.058 -1.09 . . . . 74.140000000000001 108.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 441' ' ' VAL . 25.5 t80 -50.75 -49.13 58.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.657 0.783 . . . . 74.230000000000004 110.296 171.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -57.53 -35.86 70.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.652 -0.704 . . . . 41.399999999999999 111.871 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.544 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.6 mm-40 -70.66 -40.38 73.04 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.095 0.474 . . . . 75.420000000000002 110.857 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -46.38 90.09 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.169 -0.923 . . . . 70.230000000000004 110.364 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 437' ' ' TYR . 90.1 t -58.64 -47.41 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.45 -0.796 . . . . 63.100000000000001 111.961 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 61.7 mttp -62.91 -48.84 77.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.822 0.344 . . . . 70.510000000000005 110.439 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 430' ' ' PRO . 49.2 tttp -68.27 -38.44 81.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.579 -0.737 . . . . 53.130000000000003 111.259 -176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 35.4 tp -68.47 -40.33 81.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.15 0.5 . . . . 74.329999999999998 109.983 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 38.6 m -60.93 -45.81 93.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.442 -0.799 . . . . 71.319999999999993 109.884 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.97 62.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.712 -0.676 . . . . 72.129999999999995 111.226 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -80.18 -13.75 59.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.648 0.261 . . . . 64.120000000000005 110.358 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.25 -5.29 49.03 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.347 -0.93 . . . . 65.329999999999998 114.203 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 76.7 m-85 -62.96 139.12 58.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.866 0.333 . . . . 72.299999999999997 111.226 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.45 -2.93 9.66 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.39 -0.91 . . . . 72.109999999999999 113.37 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -119.31 115.63 24.54 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.527 -0.916 . . . . 74.349999999999994 108.527 -177.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -132.45 151.12 52.01 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.943 0.401 . . . . 74.129999999999995 110.161 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 485' ' ' ILE . 61.8 tttp -139.6 122.62 16.75 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.251 -1.759 . . . . 74.209999999999994 106.251 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.84 135.08 42.85 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.88 -0.328 . . . . 64.329999999999998 110.244 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.95 155.17 50.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.494 -0.928 . . . . 54.039999999999999 108.494 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.431 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.5 p30 -133.9 138.53 45.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.679 -1.23 . . . . 73.219999999999999 107.679 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 t -134.98 143.54 46.56 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 108.849 -0.797 . . . . 73.030000000000001 108.849 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.68 122.19 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.142 1.895 . . . . 71.409999999999997 109.114 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -133.3 179.64 6.07 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.309 -0.86 . . . . 53.200000000000003 109.491 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -61.07 135.16 93.21 Favored Pre-proline 0 N--CA 1.417 -2.117 0 C-N-CA 123.755 0.822 . . . . 73.099999999999994 108.935 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 89.3 Cg_exo -50.64 -29.98 27.11 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.097 3.198 . . . . 65.209999999999994 115.123 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -75.76 -22.8 56.13 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.728 -0.789 . . . . 73.340000000000003 112.501 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.14 4.89 51.04 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.598 0.592 . . . . 65.310000000000002 112.598 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 15.0 p -61.2 127.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 C-N-CA 120.097 -0.641 . . . . 43.43 109.874 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.52 -6.05 77.53 Favored Glycine 0 C--N 1.308 -0.989 0 CA-C-N 115.595 -0.729 . . . . 51.109999999999999 113.169 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -110.0 157.14 19.61 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.61 -0.885 . . . . 75.209999999999994 108.61 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 486' ' ' ILE . 48.9 t -82.26 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.844 -1.169 . . . . 52.020000000000003 107.844 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 34.9 pt -97.74 -20.41 5.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.21 -0.596 . . . . 63.439999999999998 109.688 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.54 155.24 14.64 Favored Glycine 0 N--CA 1.409 -3.132 0 C-N-CA 120.015 -1.088 . . . . 74.0 112.425 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.9 p -119.56 154.28 34.13 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.263 -1.754 . . . . 71.430000000000007 106.263 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 41.7 t-20 -65.12 -55.0 29.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 C-N-CA 119.975 -0.69 . . . . 62.140000000000001 110.625 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.73 126.94 9.21 Favored 'Trans proline' 0 C--N 1.365 1.428 0 N-CA-C 108.947 -1.213 . . . . 51.43 108.947 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.46 143.46 76.05 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.464 2.109 . . . . 62.229999999999997 112.264 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.27 4.58 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.183 0.992 . . . . 73.25 110.692 -176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -101.4 -9.28 21.27 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.456 -1.247 . . . . 72.129999999999995 109.471 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -122.27 167.48 13.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.517 -0.92 . . . . 74.409999999999997 108.517 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 30.6 p -98.03 143.43 28.59 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 109.619 -0.511 . . . . 71.409999999999997 109.619 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.6 m -128.98 147.41 50.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.016 -0.735 . . . . 73.349999999999994 109.016 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -54.52 153.39 5.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.586 0.958 . . . . 71.109999999999999 113.586 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.59 -32.29 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 110.241 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 36.39 4.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.779 1.276 . . . . 72.430000000000007 110.222 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 19.2 t-20 -88.33 145.63 25.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 105.028 -2.212 . . . . 71.140000000000001 105.028 173.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.88 111.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.55 -1.26 . . . . 73.510000000000005 111.074 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.45 118.51 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.993 -1.114 . . . . 73.0 107.993 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.5 mp -95.23 112.69 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 72.140000000000001 106.286 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.79 118.39 50.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 109.481 -0.562 . . . . 73.549999999999997 109.481 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -100.07 121.68 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.393 -0.595 . . . . 62.030000000000001 109.393 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 134.02 35.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.36 115.73 5.21 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 109.82 -1.312 . . . . 71.099999999999994 109.82 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 456' ' ' ASN . 12.1 m -113.07 130.2 56.24 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.208 -0.664 . . . . 75.319999999999993 109.208 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.0 0 CA-C-O 119.198 -0.779 . . . . 23.329999999999998 111.398 -177.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 547' ' ' VAL . . . . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 122.254 1.026 . . . . 63.049999999999997 108.696 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 546' ' ' PRO . 7.5 p -132.58 157.33 45.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.815 -1.084 . . . . 71.420000000000002 109.901 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 140.1 22.86 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.336 -0.987 . . . . 73.230000000000004 108.336 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.3 p-10 -89.78 136.08 33.25 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.305 -1.368 . . . . 72.099999999999994 107.305 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 541' ' ' ALA . 29.2 pt -81.97 134.99 48.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 116.071 -0.513 . . . . 73.219999999999999 112.367 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.54 -175.39 1.26 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.965 2.443 . . . . 74.420000000000002 112.08 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -91.22 95.39 10.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.289 0.566 . . . . 70.510000000000005 109.895 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.26 -3.86 10.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.828 0.823 . . . . 62.100000000000001 108.996 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.56 55.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.162 -1.381 . . . . 71.319999999999993 110.036 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.22 -16.72 38.29 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 111.001 -0.84 . . . . 53.140000000000001 111.001 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -97.92 -175.35 3.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.557 -0.905 . . . . 75.25 108.557 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.9 m -79.17 155.01 28.84 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.724 -0.843 . . . . 63.240000000000002 108.724 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.534 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 6.9 p -53.71 -45.65 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 123.608 0.568 . . . . 71.329999999999998 112.116 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.9 -41.96 77.54 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.76 0.652 . . . . 73.219999999999999 112.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.7 -37.41 35.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 119.946 -0.702 . . . . 61.310000000000002 111.788 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.05 91.25 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.082 -0.508 . . . . 71.299999999999997 111.202 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -65.26 -35.51 81.25 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.795 -0.362 . . . . 71.340000000000003 110.68 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 514' ' ' VAL . 19.5 mmtp -59.83 -50.49 73.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.165 0.432 . . . . 73.120000000000005 112.165 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -62.37 -38.66 90.42 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.915 0.388 . . . . 63.210000000000001 110.91 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.09 -46.28 71.42 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.632 -0.713 . . . . 74.310000000000002 109.906 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.3 t-20 -59.15 -48.03 83.1 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 124.025 0.93 . . . . 70.209999999999994 112.066 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.3 t -60.89 -28.67 43.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.822 -0.626 . . . . 73.530000000000001 112.031 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.72 13.15 9.96 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.477 -0.889 . . . . 73.239999999999995 111.366 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -154.01 -88.78 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.44 0 C-N-CA 117.581 -2.247 . . . . 72.120000000000005 117.276 -170.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 55.7 m-85 -117.96 151.27 37.77 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.494 -0.353 . . . . 74.540000000000006 111.008 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 8.6 m -107.52 -25.72 11.25 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.081 -0.509 . . . . 74.230000000000004 110.673 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.3 126.29 52.66 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.32 -0.622 . . . . 75.349999999999994 109.32 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -128.4 144.11 51.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 110.853 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.4 m -121.79 153.59 38.1 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.005 -1.48 . . . . 74.450000000000003 107.005 172.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -127.2 129.36 47.67 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.116 -0.634 . . . . 63.020000000000003 110.833 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -117.57 144.03 45.52 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.225 -1.398 . . . . 74.230000000000004 107.225 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -101.86 135.36 43.54 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.971 0.415 . . . . 72.0 111.379 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 18.5 m -121.94 149.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.71 -1.219 . . . . 75.439999999999998 107.71 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.25 118.5 20.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.42 -0.585 . . . . 73.239999999999995 109.42 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 556' ' ' SER . 82.7 p -90.98 162.85 31.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 113.58 0.956 . . . . 51.119999999999997 113.58 -170.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -71.8 -138.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.548 2.832 . . . . 71.319999999999993 109.468 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -68.87 -53.45 14.85 Favored Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 113.082 0.771 . . . . 75.129999999999995 113.082 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.6 150.88 36.22 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 121.451 1.434 . . . . 73.530000000000001 112.062 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -149.9 145.69 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.682 -0.858 . . . . 50.409999999999997 108.682 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.11 -20.77 5.89 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 111.28 -0.728 . . . . 74.340000000000003 111.28 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 148.75 25.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.069 -0.345 . . . . 52.450000000000003 110.069 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.7 t -74.57 115.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.596 -1.631 . . . . 74.129999999999995 106.596 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.2 m -72.0 -33.27 67.96 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 109.824 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.93 -165.04 36.62 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 110.59 -1.004 . . . . 74.010000000000005 110.59 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.9 p -125.0 160.83 28.08 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 107.777 -1.194 . . . . 60.420000000000002 107.777 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 63.8 t30 -59.82 -51.13 82.96 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 119.757 -0.777 . . . . 74.129999999999995 111.27 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.1 Cg_exo -77.52 145.2 23.27 Favored 'Trans proline' 0 C--N 1.367 1.512 0 N-CA-C 108.832 -1.257 . . . . 71.209999999999994 108.832 171.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.2 Cg_exo -70.54 152.09 65.05 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.188 1.925 . . . . 63.520000000000003 111.9 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -55.38 137.07 48.78 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.028 0.531 . . . . 71.329999999999998 110.765 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.68 -20.34 46.63 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 121.102 -0.57 . . . . 32.350000000000001 112.023 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 29.6 m -73.44 135.4 44.14 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.841 -0.211 . . . . 52.100000000000001 110.566 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 35.5 m -96.98 123.36 40.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.581 -0.525 . . . . 63.25 109.581 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.4 164.17 43.01 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 109.209 -0.663 . . . . 74.209999999999994 109.209 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.495 ' HA ' HG22 ' A' ' 494' ' ' THR . 7.4 Cg_exo -71.92 133.55 21.89 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 73.310000000000002 111.27 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.6 m -68.8 -20.88 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 70.519999999999996 111.141 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.8 -16.72 60.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.408 -1.269 . . . . 64.200000000000003 110.501 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.2 t -97.08 161.17 13.94 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.005 -0.739 . . . . 72.109999999999999 109.005 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.47 134.89 26.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.259 -0.645 . . . . 50.0 109.259 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -105.19 141.01 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.011 0.434 . . . . 51.219999999999999 110.577 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -103.08 121.56 42.86 Favored 'General case' 0 N--CA 1.406 -2.63 0 C-N-CA 123.525 0.73 . . . . 72.120000000000005 110.433 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.01 134.27 42.09 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 124.211 1.004 . . . . 52.340000000000003 110.015 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -92.27 108.25 19.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.859 -1.163 . . . . 71.209999999999994 107.859 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.82 138.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.798 -0.637 . . . . 71.340000000000003 110.33 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 527' ' ' SER . 6.2 p -65.91 119.55 11.5 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.129 0.966 . . . . 74.049999999999997 113.585 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 29.1 tttm . . . . . 0 C--O 1.262 1.763 0 C-N-CA 125.691 1.596 . . . . 74.209999999999994 108.431 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.281 0 CA-C-O 122.271 1.034 . . . . 63.030000000000001 108.443 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -107.69 137.92 44.84 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.986 -1.461 . . . . 73.219999999999999 109.662 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.15 156.12 40.62 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.947 -1.131 . . . . 63.039999999999999 107.947 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.6 OUTLIER -83.08 141.89 31.68 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 123.524 0.73 . . . . 55.119999999999997 111.393 -176.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -85.2 121.17 73.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.431 -0.951 . . . . 64.299999999999997 108.431 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.22 143.36 39.51 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.033 1.822 . . . . 72.019999999999996 112.253 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.66 32.24 0.59 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.778 0.799 . . . . 63.549999999999997 111.851 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.06 -12.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.863 -1.162 . . . . 74.120000000000005 107.863 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.6 m -60.49 -36.66 78.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.168 -1.378 . . . . 62.420000000000002 109.265 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -57.03 -27.74 61.9 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.217 -1.356 . . . . 75.209999999999994 110.465 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.59 -46.64 12.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.626 -0.43 . . . . 73.150000000000006 110.688 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 438' ' ' ALA . 40.5 m -166.47 149.05 6.81 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.201 -0.666 . . . . 63.539999999999999 109.201 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.54 -46.88 63.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.217 1.007 . . . . 73.219999999999999 110.374 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.513 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 73.340000000000003 111.365 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.49 -36.92 74.09 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.99 -0.55 . . . . 75.150000000000006 111.764 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.45 -52.37 64.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 124.342 1.026 . . . . 72.510000000000005 110.435 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 67.3 t -66.8 -50.64 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 115.129 -0.942 . . . . 65.030000000000001 111.808 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -62.49 -45.37 93.34 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.767 0.654 . . . . 71.340000000000003 112.767 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -68.5 -40.81 80.74 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.873 -0.731 . . . . 64.340000000000003 110.933 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.51 -33.87 74.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.055 0.455 . . . . 44.009999999999998 109.813 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 37.1 m -59.68 -45.04 93.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.465 -0.789 . . . . 75.420000000000002 109.215 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -16.81 62.61 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.726 -0.67 . . . . 63.219999999999999 111.159 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.16 -13.78 54.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 110.452 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -18.18 9.1 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 120.308 -0.949 . . . . 61.149999999999999 113.178 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.95 130.59 42.61 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.889 -0.411 . . . . 75.540000000000006 109.889 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -118.92 -1.31 14.68 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.285 -0.959 . . . . 55.420000000000002 112.879 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.42 115.34 20.78 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.367 0.603 . . . . 74.140000000000001 109.961 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -125.62 154.87 41.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.895 -1.15 . . . . 74.129999999999995 107.895 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 485' ' ' ILE . 28.0 tptp -133.98 122.97 23.83 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.569 -1.271 . . . . 73.25 107.569 174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -91.18 120.84 32.45 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.472 0.654 . . . . 50.200000000000003 110.662 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.08 155.62 28.96 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.212 -1.773 . . . . 63.130000000000003 106.212 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.8 p30 -138.15 144.3 40.71 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.288 -0.634 . . . . 75.409999999999997 109.288 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 t -134.59 140.32 35.19 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 107.616 -1.253 . . . . 64.219999999999999 107.616 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_exo -65.13 122.63 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.045 1.83 . . . . 64.230000000000004 110.634 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.6 t -144.05 179.91 6.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.587 -1.635 . . . . 52.219999999999999 106.587 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -63.55 145.32 97.41 Favored Pre-proline 0 N--CA 1.414 -2.262 0 O-C-N 123.316 0.385 . . . . 73.430000000000007 110.026 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 464' ' ' VAL . 4.7 Cg_endo -50.61 -28.07 21.17 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.734 3.623 . . . . 55.310000000000002 112.236 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.75 -24.1 65.46 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.923 0.889 . . . . 74.109999999999999 112.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.9 5.7 33.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.852 0.686 . . . . 64.109999999999999 112.852 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.8 t -61.06 128.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.975 0.416 . . . . 75.400000000000006 111.269 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.47 84.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.499 -0.773 . . . . 75.099999999999994 111.91 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -111.19 146.79 36.28 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.234 -1.025 . . . . 74.340000000000003 108.234 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.8 t -81.39 129.37 37.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.101 -1.074 . . . . 64.400000000000006 108.101 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.7 pt -98.75 -9.8 8.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.349999999999994 111.418 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.33 163.02 24.62 Favored Glycine 0 CA--C 1.482 -2.005 0 C-N-CA 119.547 -1.311 . . . . 73.299999999999997 110.863 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.8 p -116.73 146.13 43.0 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.779 -0.822 . . . . 63.049999999999997 108.779 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.5 t30 -57.72 -50.04 90.34 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 123.315 0.384 . . . . 73.319999999999993 110.531 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_endo -85.01 137.91 6.54 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 N-CA-C 107.838 -1.639 . . . . 71.310000000000002 107.838 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 476' ' ' GLN . 6.3 Cg_exo -61.27 141.01 91.62 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.343 1.362 . . . . 73.239999999999995 111.029 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.66 10.72 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.377 1.084 . . . . 72.340000000000003 109.905 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -95.12 -29.91 14.32 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 113.84 -1.527 . . . . 65.450000000000003 108.398 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 473' ' ' PRO . 3.4 pt20 -98.86 170.78 8.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.779 -0.646 . . . . 62.310000000000002 109.93 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.7 p -98.49 134.02 42.05 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 116.036 -0.529 . . . . 50.149999999999999 109.886 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.0 m -114.0 145.53 41.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.462 -0.57 . . . . 72.219999999999999 109.462 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -59.39 148.11 33.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.974 0.416 . . . . 72.319999999999993 111.992 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.51 -30.74 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 123.537 0.735 . . . . 74.340000000000003 111.514 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -101.39 17.24 23.17 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.284 0.564 . . . . 65.510000000000005 110.549 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -88.56 139.3 30.62 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.785 -1.191 . . . . 65.150000000000006 107.785 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.95 111.08 16.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.642 0.734 . . . . 55.210000000000001 109.363 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.89 118.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.515 -0.92 . . . . 73.430000000000007 108.515 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 453' ' ' LYS . 46.8 mt -99.25 111.55 29.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.501 -1.296 . . . . 74.239999999999995 107.501 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 486' ' ' ILE . 0.0 OUTLIER -103.7 129.97 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-O 121.075 0.464 . . . . 61.109999999999999 110.16 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.71 116.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.233 -1.025 . . . . 64.409999999999997 108.233 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.42 140.07 18.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.966 -0.561 . . . . 73.25 109.568 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.71 118.15 6.93 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.454 -1.058 . . . . 74.349999999999994 110.454 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.3 m -119.96 132.72 55.6 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.846 -0.798 . . . . 73.209999999999994 108.846 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.329 0 N-CA-C 109.991 -1.243 . . . . 72.150000000000006 109.991 -177.083 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.643 0 N-CA-C 108.12 -1.067 . . . . 75.120000000000005 108.12 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 546' ' ' PRO . 35.6 p -124.66 156.92 36.75 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.077 -0.965 . . . . 63.43 108.956 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.05 150.29 31.53 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 70.049999999999997 107.779 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 544' ' ' THR . 6.7 p-10 -99.46 138.22 36.86 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 120.948 0.404 . . . . 74.530000000000001 110.282 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 541' ' ' ALA . 31.5 pt -88.15 133.91 36.02 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.556 -0.747 . . . . 74.120000000000005 111.985 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.3 177.0 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.603 2.202 . . . . 63.32 110.877 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.07 115.45 27.34 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.635 -0.426 . . . . 74.209999999999994 110.295 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.2 14.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.514 1.15 . . . . 63.109999999999999 108.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.49 143.23 46.68 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.09 -0.959 . . . . 61.210000000000001 110.48 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.7 -24.71 10.09 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.056 -0.592 . . . . 64.219999999999999 111.631 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -91.89 177.62 6.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.183 -0.673 . . . . 74.340000000000003 109.183 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.6 m -75.85 155.47 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.628 -0.508 . . . . 74.219999999999999 109.628 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.51 -49.1 14.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 123.719 0.637 . . . . 73.140000000000001 112.614 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.42 -42.51 74.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.259 0.466 . . . . 64.319999999999993 112.259 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -39.48 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 119.786 -0.766 . . . . 74.450000000000003 111.861 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.56 83.66 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.785 -0.643 . . . . 65.319999999999993 111.365 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.75 -35.52 80.96 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 120.219 -0.592 . . . . 70.239999999999995 110.5 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 513' ' ' ASN . 59.9 tttp -63.11 -48.9 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.462 0.648 . . . . 73.099999999999994 110.139 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -68.84 -38.24 79.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.264 -0.88 . . . . 63.240000000000002 111.453 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.03 -35.94 81.01 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 108.969 -0.752 . . . . 70.129999999999995 108.969 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 510' ' ' LYS . 2.5 t-20 -57.28 -38.8 74.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 75.430000000000007 110.115 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.06 -44.28 97.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.223 0.535 . . . . 54.009999999999998 110.632 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -103.23 16.46 26.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 65.209999999999994 111.235 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.1 -117.9 1.28 Allowed Glycine 0 N--CA 1.414 -2.792 0 C-N-CA 120.766 -0.731 . . . . 44.409999999999997 112.421 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 16.7 m-85 -122.01 173.4 7.56 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 110.263 -0.273 . . . . 72.0 110.263 -171.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 19.5 p -96.23 -14.26 22.83 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.752 -0.658 . . . . 75.209999999999994 111.409 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.18 115.69 29.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.559 -0.291 . . . . 64.329999999999998 111.448 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -120.98 151.34 39.85 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.278 0.561 . . . . 74.319999999999993 111.095 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.2 m -135.64 152.21 51.0 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.892 -1.892 . . . . 75.209999999999994 105.892 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -119.39 123.55 44.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.634 -0.876 . . . . 54.299999999999997 108.634 -170.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.84 121.24 42.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.451 -0.574 . . . . 72.209999999999994 109.451 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 557' ' ' LYS . 19.4 p -87.88 116.27 25.92 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.115 0.484 . . . . 51.420000000000002 110.099 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.53 162.14 21.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 115.533 -0.758 . . . . 73.010000000000005 110.16 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.69 121.44 24.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.152 0.977 . . . . 72.430000000000007 109.967 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 556' ' ' SER . 2.6 p -144.9 101.77 4.52 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 114.189 -1.369 . . . . 72.450000000000003 109.967 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.61 -57.35 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.559 2.839 . . . . 54.340000000000003 114.481 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 57.1 mtt180 -80.04 -49.43 1.27 Allowed Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 113.06 0.763 . . . . 72.310000000000002 113.06 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 39.6 Cg_exo -62.03 134.94 52.2 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.739 1.626 . . . . 72.25 112.306 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.07 74.36 0.97 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.89 3.68 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 110.747 -0.941 . . . . 73.5 110.747 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -86.19 149.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.256 0.55 . . . . 75.030000000000001 111.147 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 553' ' ' LEU . 87.7 t -73.71 124.7 31.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.345 -0.843 . . . . 64.25 109.079 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.6 m -76.23 -28.95 57.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.592 -1.185 . . . . 52.310000000000002 110.252 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.77 -159.66 31.2 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.03 -1.228 . . . . 73.219999999999999 110.03 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.5 p -127.18 157.38 39.92 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.261 -1.015 . . . . 62.229999999999997 108.261 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.5 t30 -66.81 -54.65 20.56 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.086 -0.645 . . . . 74.310000000000002 110.613 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.5 Cg_exo -71.7 131.59 18.82 Favored 'Trans proline' 0 C--N 1.377 2.033 0 N-CA-C 108.113 -1.534 . . . . 64.129999999999995 108.113 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.4 147.46 90.69 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.463 2.108 . . . . 64.430000000000007 113.075 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -63.26 142.82 58.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.988 -0.551 . . . . 53.299999999999997 110.56 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.99 64.0 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.519 -0.632 . . . . 61.210000000000001 111.519 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.1 m -79.65 132.39 36.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.582 -0.525 . . . . 71.510000000000005 109.582 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 496' ' ' ASP . 41.2 m -97.91 122.23 40.77 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.308 -0.997 . . . . 73.329999999999998 108.308 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.52 165.25 37.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.472 -0.936 . . . . 74.030000000000001 108.472 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.486 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.3 Cg_exo -59.5 137.58 78.7 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.493 2.129 . . . . 63.329999999999998 113.69 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.665 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -67.3 -19.69 25.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.157 -0.929 . . . . 71.540000000000006 112.259 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.76 -3.67 58.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.674 -1.148 . . . . 64.549999999999997 109.667 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.7 m -95.7 152.24 18.64 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 115.371 -0.831 . . . . 53.109999999999999 110.559 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.9 t -88.71 134.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.688 -0.687 . . . . 73.25 110.433 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 497' ' ' ILE . 9.3 tt -102.53 141.96 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 109.551 -0.537 . . . . 75.409999999999997 109.551 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -103.02 122.37 44.49 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.814 -0.809 . . . . 72.420000000000002 108.814 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 534' ' ' VAL . 20.0 tp -98.22 128.85 44.9 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.031 -0.986 . . . . 74.129999999999995 108.751 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -88.2 106.31 18.11 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.82 -0.807 . . . . 71.230000000000004 108.82 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 524' ' ' SER . 29.7 m -105.56 139.11 27.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 115.662 -0.699 . . . . 33.420000000000002 110.429 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.411 ' HA ' ' OG ' ' A' ' 527' ' ' SER . 22.3 p -57.16 120.76 8.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.537 -0.756 . . . . 73.109999999999999 112.139 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 524' ' ' SER . 57.4 tttm . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 109.31 -0.626 . . . . 74.310000000000002 109.31 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.858 0 CA-C-O 121.504 0.668 . . . . 71.420000000000002 109.552 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 60.0 mt-30 -109.69 125.54 52.74 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.561 -1.2 . . . . 74.230000000000004 108.926 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -123.12 160.44 26.44 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.169 -1.048 . . . . 73.430000000000007 108.169 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.97 141.64 28.46 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.635 -0.505 . . . . 73.099999999999994 109.635 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.59 119.41 76.76 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.73 -0.841 . . . . 74.209999999999994 108.73 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.94 144.51 43.19 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.275 1.983 . . . . 65.209999999999994 111.99 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.97 59.44 5.63 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.164 1.459 . . . . 72.519999999999996 109.17 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 439' ' ' GLU . 11.3 p -108.14 -5.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 106.333 -1.728 . . . . 64.209999999999994 106.333 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 1.3 p -63.25 -32.37 73.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.864 -1.971 . . . . 71.209999999999994 109.704 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.416 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 12.6 t -63.02 -26.79 69.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.332 -1.304 . . . . 63.109999999999999 111.103 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 432' ' ' VAL . 80.4 mt -85.54 -46.7 10.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.02 -1.072 . . . . 52.43 111.488 -173.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 1.8 m -171.88 150.6 2.63 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.172 -1.047 . . . . 72.0 108.172 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -52.63 -48.27 66.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.224 0.61 . . . . 74.420000000000002 110.631 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.78 66.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.731 -0.668 . . . . 54.210000000000001 111.968 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.503 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.4 mm-40 -70.98 -42.85 69.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.285 -0.416 . . . . 75.439999999999998 111.126 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.457 ' HA ' HG13 ' A' ' 432' ' ' VAL . . . -60.6 -47.06 87.89 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.199 -0.909 . . . . 73.409999999999997 110.75 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.54 -48.78 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.663 -0.699 . . . . 51.520000000000003 111.227 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -62.29 -44.65 96.02 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.024 0.379 . . . . 54.350000000000001 112.024 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 443' ' ' LYS . 6.5 mmpt? -66.56 -42.68 86.72 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.76 -0.376 . . . . 43.439999999999998 111.673 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.431 HD23 ' CE1' ' A' ' 452' ' ' PHE . 10.3 tp -69.41 -32.97 72.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.274 0.559 . . . . 71.219999999999999 110.106 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.6 m -64.45 -41.55 96.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.847 -0.615 . . . . 64.540000000000006 109.405 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.23 -16.22 63.02 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.168 0.508 . . . . 64.120000000000005 110.942 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.65 -13.06 46.66 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.099 -0.5 . . . . 63.039999999999999 110.086 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.54 -9.31 24.08 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.002 -0.618 . . . . 72.319999999999993 113.95 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -71.85 143.72 49.32 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.889 0.344 . . . . 73.299999999999997 111.194 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -149.0 16.54 1.19 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.69 -0.767 . . . . 64.310000000000002 112.319 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -120.97 115.77 23.82 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.987 -1.486 . . . . 71.319999999999993 106.987 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.431 ' CE1' HD23 ' A' ' 444' ' ' LEU . 96.5 m-85 -141.36 160.64 39.7 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 113.514 0.931 . . . . 72.409999999999997 113.514 -171.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -142.33 134.08 26.93 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.197 1.799 . . . . 74.140000000000001 107.012 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -103.65 132.03 50.27 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.62 -0.511 . . . . 73.420000000000002 109.62 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.53 139.24 53.37 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.767 -0.827 . . . . 75.409999999999997 108.767 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -114.17 130.19 56.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.607 -0.886 . . . . 62.350000000000001 108.607 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.1 m -120.63 138.17 27.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.517 -0.311 . . . . 74.349999999999994 110.433 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 14.9 Cg_exo -69.85 122.61 9.26 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.357 2.038 . . . . 74.319999999999993 111.007 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -144.75 179.07 7.55 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.039 -1.467 . . . . 41.310000000000002 107.039 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.532 ' OG1' ' HD2' ' A' ' 461' ' ' PRO . 6.6 t -70.76 144.2 90.56 Favored Pre-proline 0 N--CA 1.433 -1.322 0 N-CA-C 109.039 -0.726 . . . . 74.299999999999997 109.039 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 464' ' ' VAL . 2.0 Cg_endo -48.8 -27.88 12.0 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 125.165 3.91 . . . . 61.149999999999999 115.476 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.72 -13.22 61.98 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.29 -1.364 . . . . 54.420000000000002 112.343 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' A' ' 466' ' ' LYS . 2.8 mm? -98.23 -0.14 44.64 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.831 -0.543 . . . . 71.129999999999995 111.364 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 461' ' ' PRO . 84.9 t -61.51 128.14 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.799 -0.445 . . . . 71.420000000000002 109.799 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.79 -16.73 60.15 Favored Glycine 0 C--O 1.244 0.773 0 C-N-CA 121.099 -0.572 . . . . 73.109999999999999 111.996 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 463' ' ' LEU . 78.5 tttt -92.77 142.66 27.1 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.894 -0.78 . . . . 74.150000000000006 108.894 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.595 HG22 HD11 ' A' ' 486' ' ' ILE . 60.2 t -82.85 124.85 39.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.628 -1.619 . . . . 75.150000000000006 106.628 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.46 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -105.16 -5.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 118.667 -1.213 . . . . 74.0 111.803 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.14 160.14 27.84 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 119.775 -1.202 . . . . 55.119999999999997 112.666 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.4 p -134.42 145.33 48.79 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.196 -1.409 . . . . 71.510000000000005 107.196 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.41 ' OD1' ' HB ' ' A' ' 485' ' ' ILE . 12.5 m120 -64.4 -51.08 63.11 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 120.364 -0.534 . . . . 75.129999999999995 112.202 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.55 123.38 11.35 Favored 'Trans proline' 0 C--O 1.253 1.252 0 N-CA-C 108.716 -1.302 . . . . 70.420000000000002 108.716 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.38 139.19 37.52 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.217 1.945 . . . . 55.109999999999999 112.185 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.24 2.14 37.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.724 0.773 . . . . 54.130000000000003 110.608 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.24 -32.92 24.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.877 -1.056 . . . . 55.140000000000001 110.094 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.67 178.37 4.42 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.155 -1.054 . . . . 44.409999999999997 108.155 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 32.5 p -97.04 126.54 42.26 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-O 121.277 0.561 . . . . 61.509999999999998 110.547 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -106.77 147.05 30.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.479 -0.934 . . . . 52.450000000000003 108.479 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.5 147.58 41.75 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 120.9 0.381 . . . . 60.329999999999998 111.584 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.85 -21.9 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.31 1.044 . . . . 75.5 111.26 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -94.85 1.78 55.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.417 -0.811 . . . . 71.329999999999998 110.103 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -78.83 144.6 34.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.971 -0.751 . . . . 74.030000000000001 108.971 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 38.7 t -82.13 112.49 20.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.558 -1.275 . . . . 62.310000000000002 107.558 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.69 119.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 N-CA-C 109.176 -0.676 . . . . 63.119999999999997 109.176 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.41 ' HB ' ' OD1' ' A' ' 471' ' ' ASN . 3.3 mp -97.68 119.48 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.463 -2.051 . . . . 44.350000000000001 105.463 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.595 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -109.19 128.43 65.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.95 -0.568 . . . . 72.439999999999998 109.981 -175.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 58.5 mt -103.65 112.51 37.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-N 115.299 -0.864 . . . . 73.25 110.52 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.16 140.57 17.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 115.517 -0.765 . . . . 73.530000000000001 109.585 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.68 129.3 9.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.237 -1.145 . . . . 30.109999999999999 110.237 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.5 p -135.58 152.03 50.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.842 -0.429 . . . . 62.520000000000003 109.842 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 109.986 -1.245 . . . . 54.119999999999997 109.986 178.271 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 121.743 0.783 . . . . 54.009999999999998 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.7 p -138.72 162.81 33.76 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.197 -0.911 . . . . 70.230000000000004 110.476 -172.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 517' ' ' PHE . 48.0 tptt -146.61 139.85 25.63 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.267 -0.424 . . . . 73.439999999999998 110.318 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -80.61 137.73 36.39 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.214 1.005 . . . . 63.329999999999998 109.023 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.6 pt -97.34 133.29 24.04 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 120.041 -0.663 . . . . 74.150000000000006 110.674 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.22 178.22 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.512 2.141 . . . . 72.140000000000001 110.296 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.0 122.53 38.92 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.153 -0.619 . . . . 73.239999999999995 110.045 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.36 6.02 5.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.652 -0.704 . . . . 72.230000000000004 110.102 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.561 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -74.01 147.2 43.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.553 -0.749 . . . . 73.019999999999996 110.712 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.46 -14.23 56.63 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.051 -0.82 . . . . 63.420000000000002 111.051 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -99.58 -170.04 1.84 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.583 -0.525 . . . . 61.130000000000003 109.583 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.1 m -82.08 155.77 24.91 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.667 -1.234 . . . . 74.430000000000007 107.667 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.76 -42.09 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.712 0.292 . . . . 74.409999999999997 111.537 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 31.9 t70 -68.19 -43.46 78.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.197 0.443 . . . . 55.219999999999999 112.197 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.26 -34.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.77 -0.772 . . . . 70.219999999999999 110.839 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.73 -49.18 78.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.728 . . . . 74.319999999999993 110.752 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.61 -34.66 78.76 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 120.669 -0.412 . . . . 73.129999999999995 111.009 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 12.7 mmmm -57.36 -53.16 61.29 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.166 0.291 . . . . 71.010000000000005 111.148 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -62.84 -40.63 98.04 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.38 0.61 . . . . 65.409999999999997 110.285 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 551' ' ' ILE . 46.7 tp -64.91 -38.51 91.21 Favored 'General case' 0 C--O 1.191 -2.02 0 CA-C-N 115.081 -0.963 . . . . 71.010000000000005 110.928 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.13 -37.96 84.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.163 0.585 . . . . 70.349999999999994 111.54 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.24 -29.8 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 64.230000000000004 110.697 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.66 31.21 6.36 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.166 -0.334 . . . . 72.120000000000005 110.363 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -160.39 -108.7 0.24 Allowed Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 119.009 -1.567 . . . . 51.420000000000002 113.759 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 495' ' ' LYS . 18.3 m-85 -137.69 177.26 8.01 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.876 -0.787 . . . . 75.129999999999995 108.876 -172.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 m -112.13 6.5 19.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 122.296 1.046 . . . . 61.520000000000003 108.725 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -108.52 115.75 30.69 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.647 -0.872 . . . . 72.219999999999999 108.647 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -128.16 150.87 49.81 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.293 0.371 . . . . 72.420000000000002 110.222 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.8 m -130.8 155.7 46.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.572 -1.27 . . . . 63.210000000000001 107.572 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -121.91 122.25 38.96 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.998 0.428 . . . . 74.129999999999995 110.001 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.47 56.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.777 -0.823 . . . . 60.340000000000003 108.777 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -90.07 118.9 29.96 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.575 -0.898 . . . . 74.530000000000001 108.575 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.6 152.23 25.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.584 -0.895 . . . . 70.230000000000004 108.584 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.64 123.04 25.53 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.606 1.193 . . . . 54.329999999999998 111.098 -169.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.5 m -128.49 101.04 21.63 Favored Pre-proline 0 N--CA 1.416 -2.138 0 CA-C-N 113.795 -1.548 . . . . 65.010000000000005 109.102 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.26 -57.15 1.19 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.032 2.488 . . . . 74.040000000000006 112.538 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -88.33 -49.41 0.43 Allowed Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 113.349 0.87 . . . . 73.329999999999998 113.349 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.59 146.52 95.38 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 121.883 1.722 . . . . 44.310000000000002 112.701 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.11 85.04 0.32 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.395 1.078 . . . . 72.329999999999998 108.381 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.0 -35.05 2.44 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 110.543 -1.023 . . . . 72.319999999999993 110.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -85.31 147.21 26.65 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.155 0.502 . . . . 65.120000000000005 109.91 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.4 p -75.07 126.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.499 -0.926 . . . . 74.030000000000001 108.499 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.2 m -72.11 -36.57 69.48 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.331 -0.85 . . . . 61.109999999999999 109.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 172.46 -167.44 40.35 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.258 -0.972 . . . . 60.039999999999999 111.728 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.1 p -118.71 160.62 21.53 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.525 -0.917 . . . . 71.099999999999994 108.525 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.6 t-20 -61.58 -53.39 61.91 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.93 -0.308 . . . . 74.030000000000001 111.33 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -87.81 144.93 6.5 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 108.912 -1.226 . . . . 73.239999999999995 108.912 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.3 Cg_exo -69.13 150.83 72.52 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 121.816 1.677 . . . . 64.530000000000001 111.447 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.09 135.83 36.72 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.674 0.79 . . . . 61.43 111.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.98 -26.51 20.52 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.228 -0.749 . . . . 61.439999999999998 111.228 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 88.2 m -65.68 133.69 51.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.501 . . . . 72.439999999999998 111.184 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.3 m -101.99 122.87 44.88 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.271 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.44 155.55 71.65 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.639 -0.504 . . . . 73.010000000000005 109.639 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 494' ' ' THR . 11.6 Cg_endo -58.86 138.98 88.82 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.664 2.243 . . . . 70.450000000000003 112.944 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.492 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 21.4 m -67.04 -19.7 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 122.344 1.069 . . . . 71.420000000000002 110.344 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.31 -2.67 39.14 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.956 -1.475 . . . . 72.530000000000001 110.453 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -108.43 172.38 6.87 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.751 -0.833 . . . . 74.25 108.751 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.58 136.34 50.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.872 -0.788 . . . . 74.519999999999996 108.872 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 512' ' ' LEU . 16.7 tt -94.51 138.88 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 120.063 -0.655 . . . . 72.530000000000001 110.531 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -102.17 124.01 47.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-O 121.241 0.543 . . . . 74.310000000000002 110.032 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.98 131.2 46.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.233 -1.765 . . . . 73.099999999999994 106.233 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -107.12 105.95 16.2 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.717 0.77 . . . . 63.210000000000001 110.234 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.03 139.83 16.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.134 -1.394 . . . . 75.420000000000002 111.487 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.1 p -56.33 114.71 2.1 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 63.200000000000003 112.903 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.358 -1.719 . . . . 52.310000000000002 106.358 174.129 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 122.67 1.224 . . . . 75.299999999999997 107.79 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 478' ' ' SER . 96.0 mt-30 -110.1 135.67 50.54 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.004 -1.453 . . . . 73.219999999999999 109.962 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -126.29 158.53 35.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.036 0.446 . . . . 64.450000000000003 111.436 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.92 141.99 30.0 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.789 -1.096 . . . . 75.430000000000007 110.532 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.27 129.93 70.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.721 -0.844 . . . . 63.43 108.721 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.89 141.8 65.6 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.671 2.914 . . . . 72.319999999999993 114.792 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.26 -3.05 48.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.918 -1.037 . . . . 74.150000000000006 111.271 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.8 m -85.68 3.39 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.603 0.716 . . . . 61.32 110.812 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 14.8 m -61.48 -29.57 70.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.823 -1.08 . . . . 71.319999999999993 110.196 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.494 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 18.2 p -62.44 -27.87 69.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.102 -0.953 . . . . 75.409999999999997 111.524 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.6 -45.44 21.63 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.925 -0.398 . . . . 74.549999999999997 109.925 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 16.1 m -166.79 148.27 6.13 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.717 -0.846 . . . . 71.540000000000006 108.717 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 441' ' ' VAL . 53.1 t80 -53.27 -43.01 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.925 0.89 . . . . 74.239999999999995 111.301 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.75 -41.16 85.88 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.483 -0.326 . . . . 53.119999999999997 111.24 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.5 mm-40 -63.69 -40.61 97.23 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.248 0.547 . . . . 74.519999999999996 110.099 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -50.96 71.54 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.982 -1.008 . . . . 73.010000000000005 110.595 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 437' ' ' TYR . 92.7 t -59.42 -45.84 93.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.37 -0.832 . . . . 71.230000000000004 111.819 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 67.7 mttm -63.05 -47.28 83.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.695 0.283 . . . . 72.230000000000004 111.591 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -67.78 -38.81 83.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.312 -0.404 . . . . 74.25 111.399 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.55 -37.98 83.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.235 0.54 . . . . 74.230000000000004 109.88 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.2 m -59.47 -47.87 83.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.425 -0.807 . . . . 73.109999999999999 109.784 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.45 -15.83 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.011 -0.541 . . . . 62.530000000000001 111.933 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.0 -13.73 59.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.242 0.544 . . . . 74.409999999999997 110.433 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.88 -17.62 24.88 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.421 -0.895 . . . . 53.32 113.11 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -64.05 126.95 29.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.109 0.481 . . . . 55.43 111.082 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -110.12 -1.89 29.91 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.385 -0.825 . . . . 73.109999999999999 111.277 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 3.0 mpt_? -123.73 114.87 20.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.227 0.536 . . . . 71.519999999999996 110.187 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -147.68 146.81 29.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.429 -0.805 . . . . 61.140000000000001 110.361 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -131.13 126.51 35.9 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.363 -0.606 . . . . 72.439999999999998 109.363 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -84.0 122.35 28.64 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 111.191 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.36 149.86 41.12 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.069 -1.456 . . . . 40.210000000000001 107.069 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -127.92 146.82 50.51 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.785 -0.45 . . . . 50.219999999999999 109.785 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 44.5 m -124.57 131.45 24.16 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.791 -0.818 . . . . 75.120000000000005 108.791 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.51 123.81 11.61 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.461 2.107 . . . . 71.510000000000005 111.056 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 49.7 m -147.02 -179.72 7.01 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.444 -0.947 . . . . 65.450000000000003 108.444 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -49.75 136.35 19.24 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.896 0.878 . . . . 73.310000000000002 110.66 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.599 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 9.1 Cg_endo -50.66 -36.5 50.83 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.666 3.578 . . . . 75.349999999999994 114.786 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -77.58 -8.75 58.32 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.261 0.837 . . . . 73.230000000000004 113.261 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 18.0 tp -84.39 -11.82 55.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.003 0.43 . . . . 71.25 110.433 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.3 p -56.72 135.91 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.443 -0.799 . . . . 72.329999999999998 112.028 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.04 55.21 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 121.06 -0.59 . . . . 74.420000000000002 114.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 434' ' ' THR . 14.3 ptmm? -107.85 148.18 29.92 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.919 -1.112 . . . . 74.450000000000003 110.396 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 61.0 t -81.39 131.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.719 -0.474 . . . . 50.25 109.719 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 33.8 pt -101.04 -10.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.992 -0.549 . . . . 73.120000000000005 111.529 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.98 172.42 33.31 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.213 -0.755 . . . . 74.340000000000003 111.213 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 159.07 37.63 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.099 -0.704 . . . . 44.340000000000003 109.099 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.3 t-20 -60.6 -56.17 37.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 119.16 -0.448 . . . . 72.310000000000002 111.58 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.7 Cg_endo -85.88 146.15 9.05 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 121.192 1.261 . . . . 73.319999999999993 109.486 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.618 ' HG2' ' HG2' ' A' ' 476' ' ' GLN . 14.2 Cg_exo -62.88 149.8 90.33 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.693 1.595 . . . . 73.319999999999993 111.637 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.7 -11.66 60.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.654 0.74 . . . . 72.319999999999993 109.798 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -96.2 -12.19 25.0 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.222 -0.899 . . . . 71.129999999999995 112.012 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.618 ' HG2' ' HG2' ' A' ' 473' ' ' PRO . 0.0 OUTLIER -96.11 155.07 16.91 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 119.435 -0.906 . . . . 63.340000000000003 108.845 176.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.416 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 34.7 p -101.2 120.68 40.6 Favored 'General case' 0 N--CA 1.395 -3.185 0 N-CA-C 108.372 -0.974 . . . . 74.540000000000006 108.372 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 24.6 m -105.1 140.05 38.86 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.203 -0.666 . . . . 33.009999999999998 109.203 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -61.63 146.78 47.94 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.953 -0.388 . . . . 73.319999999999993 109.953 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.39 -23.0 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 123.597 0.759 . . . . 70.340000000000003 111.965 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.6 t -77.84 -8.02 57.47 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.355 -0.384 . . . . 62.43 111.299 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -74.87 136.2 41.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 120.909 0.385 . . . . 72.010000000000005 110.833 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.66 113.85 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 0 N-CA-C 106.588 -1.634 . . . . 74.209999999999994 106.588 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 63.0 t -86.63 119.93 35.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.136 -0.69 . . . . 71.430000000000007 109.136 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.84 111.86 24.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.885 -1.524 . . . . 75.319999999999993 106.885 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.68 128.11 55.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.68 -1.146 . . . . 74.439999999999998 108.719 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 54.8 mt -104.52 114.04 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.614 0.721 . . . . 75.140000000000001 110.988 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.55 130.33 45.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.471 -0.786 . . . . 62.420000000000002 109.421 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.31 114.51 4.98 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 107.81 -2.116 . . . . 30.300000000000001 107.81 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.1 m -120.54 129.37 53.77 Favored 'General case' 0 N--CA 1.412 -2.347 0 C-N-CA 120.163 -0.615 . . . . 74.409999999999997 109.525 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.409 -3.155 0 N-CA-C 110.218 -1.153 . . . . 60.340000000000003 110.218 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 546' ' ' PRO . 6.9 p -133.5 152.26 51.88 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.678 -1.147 . . . . 73.319999999999993 109.467 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.82 143.75 27.69 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.717 -0.475 . . . . 75.030000000000001 109.717 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 543' ' ' THR . 7.3 p-10 -93.0 138.32 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.681 -0.859 . . . . 65.519999999999996 108.681 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 497' ' ' ILE . 0.2 OUTLIER -93.82 121.04 65.29 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 114.849 1.426 . . . . 62.109999999999999 114.849 -176.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.75 136.27 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 106.294 -2.233 . . . . 73.109999999999999 106.294 164.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.37 139.86 56.64 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.796 0.807 . . . . 74.439999999999998 111.866 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.27 27.88 3.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.854 -1.535 . . . . 72.439999999999998 106.854 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.87 137.63 33.59 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.963 -1.471 . . . . 61.439999999999998 110.583 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.07 -48.23 0.93 Allowed Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.572 -0.823 . . . . 53.020000000000003 112.612 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.6 -168.69 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 111.877 0.325 . . . . 74.510000000000005 111.877 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.9 p -82.58 162.24 22.01 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 112.898 0.703 . . . . 73.340000000000003 112.898 -170.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.8 t -48.11 -52.5 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 O-C-N 124.839 1.337 . . . . 74.420000000000002 110.16 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 1.8 m-20 -68.04 -42.18 80.98 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.855 -1.066 . . . . 70.209999999999994 112.753 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.28 -35.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 119.214 -0.994 . . . . 73.329999999999998 111.497 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.444 ' HB3' HG21 ' A' ' 534' ' ' VAL . . . -64.06 -42.58 96.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.754 -0.657 . . . . 71.209999999999994 111.021 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 79.4 mt-30 -61.4 -43.36 98.99 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.989 -0.375 . . . . 75.010000000000005 109.989 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.8 mptp? -61.74 -49.31 76.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.79 -0.641 . . . . 62.149999999999999 111.883 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -62.58 -47.78 82.3 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 123.205 0.315 . . . . 75.329999999999998 110.66 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.11 -43.29 99.1 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.938 -0.574 . . . . 73.150000000000006 110.719 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.38 -37.22 74.82 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.717 0.807 . . . . 71.140000000000001 111.75 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.1 t -63.44 -42.48 96.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 116.282 -0.417 . . . . 73.109999999999999 111.869 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -108.21 -18.45 13.77 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.944 -1.102 . . . . 73.430000000000007 111.856 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -102.98 -100.47 2.57 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 115.079 0.792 . . . . 43.119999999999997 115.079 -171.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.568 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 49.0 m-85 -127.56 172.69 10.51 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.916 0.389 . . . . 73.319999999999993 111.183 -168.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.8 p -106.27 -25.73 11.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.485 -0.78 . . . . 65.319999999999993 111.047 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.73 121.65 45.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.871 -0.604 . . . . 64.109999999999999 109.72 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -128.46 143.4 50.98 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.591 . . . . 72.329999999999998 112.204 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.8 m -115.15 152.48 32.51 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.732 -1.951 . . . . 54.329999999999998 105.732 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -123.39 134.06 54.02 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.175 -0.61 . . . . 73.120000000000005 111.586 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.71 121.89 39.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.81 -0.811 . . . . 54.439999999999998 108.81 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.5 m -88.24 118.05 27.57 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.626 -1.62 . . . . 74.200000000000003 106.626 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.0 m -119.97 149.5 22.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.263 -1.384 . . . . 74.129999999999995 107.263 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.33 133.75 37.57 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.39 1.091 . . . . 73.219999999999999 112.579 -167.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 5.8 m -94.61 129.08 37.52 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 112.962 -1.926 . . . . 71.409999999999997 109.165 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.13 -71.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 121.073 1.182 . . . . 71.409999999999997 109.072 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.429 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 24.5 mmm180 -111.57 -55.05 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.036 -0.507 . . . . 74.310000000000002 112.165 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 527' ' ' SER . 10.7 Cg_exo -73.18 134.48 21.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.306 1.338 . . . . 74.319999999999993 111.339 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.51 159.46 43.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.436 -0.95 . . . . 65.299999999999997 108.436 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.91 -21.81 25.28 Favored Glycine 0 C--N 1.319 -0.402 0 CA-C-O 121.611 0.562 . . . . 65.019999999999996 111.862 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.52 147.77 25.2 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.245 0.545 . . . . 51.350000000000001 110.728 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 508' ' ' ALA . 64.5 t -75.88 124.88 34.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.975 -0.75 . . . . 74.239999999999995 108.975 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -33.21 52.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.315 -0.857 . . . . 70.120000000000005 109.44 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.78 -147.18 15.19 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.333 -0.707 . . . . 72.340000000000003 111.333 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.0 p -121.79 160.41 24.68 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.955 -0.757 . . . . 62.299999999999997 108.955 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -62.55 -52.61 64.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 121.007 -0.277 . . . . 74.040000000000006 110.368 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 57.8 Cg_endo -74.41 146.2 34.96 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 120.919 1.079 . . . . 75.340000000000003 109.791 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.2 Cg_exo -63.67 154.25 70.35 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.197 1.931 . . . . 73.439999999999998 111.9 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.45 132.88 53.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.024 -0.535 . . . . 74.25 109.964 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.49 -10.84 56.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.113 -0.565 . . . . 63.299999999999997 111.824 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 71.5 m -77.46 129.3 35.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.616 -0.513 . . . . 65.219999999999999 109.616 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.0 t -93.85 122.6 36.5 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.476 0.655 . . . . 63.210000000000001 110.148 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.27 158.81 70.13 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.685 -0.857 . . . . 54.439999999999998 108.685 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.418 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.7 Cg_exo -63.86 134.29 42.8 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.032 1.821 . . . . 75.230000000000004 112.081 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.568 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 17.2 m -67.61 -22.61 28.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.886 0.851 . . . . 73.540000000000006 110.849 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.15 0.73 52.89 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.353 -1.294 . . . . 75.319999999999993 111.685 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.8 t -98.02 -177.55 3.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.971 -0.751 . . . . 74.439999999999998 108.971 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.8 t -109.41 134.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.857 -1.164 . . . . 73.109999999999999 107.857 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -115.08 146.0 20.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.498 -0.556 . . . . 75.310000000000002 109.498 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.43 130.96 49.36 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-O 121.46 0.647 . . . . 72.209999999999994 110.454 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.75 130.96 48.27 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.68 -1.145 . . . . 71.349999999999994 108.624 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -94.8 115.33 27.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.959 -1.497 . . . . 73.25 106.959 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.74 135.2 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-N 116.525 -0.307 . . . . 72.310000000000002 111.089 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.5 m -74.23 114.39 12.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 109.04 -0.726 . . . . 72.549999999999997 109.04 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 11.5 ptmm? . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 114.795 -1.093 . . . . 72.439999999999998 110.919 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.4 pt-20 . . . . . 0 N--CA 1.438 -1.074 0 CA-C-O 122.411 1.1 . . . . 74.439999999999998 111.041 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 95.7 mt-30 -111.02 130.18 55.67 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.315 -1.311 . . . . 62.039999999999999 108.774 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -125.06 150.44 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.322 -0.854 . . . . 70.450000000000003 110.354 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 140.7 32.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 111.575 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -84.26 126.63 69.13 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 108.244 -1.021 . . . . 74.25 108.244 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.8 140.85 36.18 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.311 1.34 . . . . 63.350000000000001 110.517 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -105.81 69.37 0.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.457 1.122 . . . . 63.229999999999997 109.973 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.483 HG11 ' HD2' ' A' ' 443' ' ' LYS . 14.5 p -113.11 6.32 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 105.937 -1.875 . . . . 75.329999999999998 105.937 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.645 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.2 m -57.92 -30.05 65.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.031 -2.35 . . . . 60.5 110.399 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 3.2 m -61.76 -27.83 69.01 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.852 1.261 . . . . 72.150000000000006 110.856 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.0 -46.34 9.92 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 118.763 -1.175 . . . . 54.549999999999997 111.323 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.569 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.8 m -167.88 151.97 6.34 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -52.14 -49.29 64.02 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.266 1.026 . . . . 74.140000000000001 109.507 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.97 76.7 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.256 -0.883 . . . . 71.239999999999995 111.412 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.569 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 26.3 mm-40 -61.85 -46.06 91.07 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.239 0.337 . . . . 71.310000000000002 110.95 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -63.15 -47.25 83.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.629 -0.714 . . . . 62.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.25 -45.37 98.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.658 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -60.8 -47.58 85.67 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 122.197 0.199 . . . . 72.209999999999994 111.453 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 432' ' ' VAL . 65.0 mttm -67.79 -39.14 84.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.381 -0.527 . . . . 71.120000000000005 112.34 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.4 tp -68.05 -37.06 80.88 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.319 0.58 . . . . 72.450000000000003 109.898 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -65.13 -41.81 94.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.509 -0.769 . . . . 75.319999999999993 109.4 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.75 -21.44 63.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.845 -0.616 . . . . 70.319999999999993 110.768 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.86 -13.33 59.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.335 0.588 . . . . 64.450000000000003 109.767 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.98 16.07 61.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.693 -0.685 . . . . 72.129999999999995 113.61 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.24 133.39 52.7 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.123 0.487 . . . . 72.209999999999994 111.141 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -90.39 -48.93 3.37 Favored Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.505 -0.771 . . . . 74.299999999999997 113.059 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -110.38 116.0 30.66 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.306 -0.958 . . . . 73.129999999999995 111.905 -172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 39.7 p90 -146.66 146.36 30.35 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.891 -0.595 . . . . 73.019999999999996 110.448 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -131.75 131.83 43.32 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.281 -0.637 . . . . 71.310000000000002 109.281 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -89.25 129.82 35.75 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.752 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.99 144.68 48.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.432 -1.321 . . . . 72.109999999999999 107.432 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -123.09 144.56 49.23 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.906 -0.718 . . . . 63.030000000000001 110.258 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.9 m -137.75 131.28 16.98 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.114 -0.494 . . . . 63.509999999999998 110.211 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.47 123.41 11.1 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.6 2.2 . . . . 72.239999999999995 111.218 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.5 p -142.78 179.25 7.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.991 -0.55 . . . . 52.240000000000002 110.476 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.2 t -56.38 143.38 66.0 Favored Pre-proline 0 N--CA 1.429 -1.485 0 C-N-CA 124.116 0.967 . . . . 63.140000000000001 109.987 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 464' ' ' VAL . 85.5 Cg_exo -50.58 -29.23 24.33 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.047 3.164 . . . . 75.409999999999997 113.01 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.06 -35.7 81.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.568 0.581 . . . . 74.049999999999997 112.568 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.87 -9.38 46.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 111.584 0.216 . . . . 42.020000000000003 111.584 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 61.4 t -61.5 127.02 20.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 109.88 -0.415 . . . . 75.420000000000002 109.88 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.3 71.4 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.562 -0.745 . . . . 33.049999999999997 111.798 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 434' ' ' THR . 4.3 mptp? -98.88 145.49 26.95 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.344 0.658 . . . . 75.409999999999997 109.475 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 94.9 t -82.12 126.61 39.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.378 -1.712 . . . . 74.340000000000003 106.378 173.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.24 -5.39 9.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.815 -0.754 . . . . 72.120000000000005 111.641 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.04 13.33 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.103 -1.046 . . . . 54.240000000000002 112.997 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 31.7 p -116.91 141.46 48.2 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.607 -1.257 . . . . 70.349999999999994 107.607 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.461 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 28.1 t-20 -57.16 -53.52 64.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-O 119.105 -0.474 . . . . 73.540000000000006 111.914 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.67 144.54 17.6 Favored 'Trans proline' 0 C--N 1.36 1.143 0 CA-C-N 120.459 1.2 . . . . 74.230000000000004 109.087 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.26 147.85 93.49 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.536 2.158 . . . . 75.129999999999995 111.536 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.85 -21.56 26.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.026 0.441 . . . . 42.539999999999999 111.625 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.85 -30.72 59.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.7 0.762 . . . . 35.299999999999997 109.717 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.25 152.93 17.94 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.539 -0.755 . . . . 74.420000000000002 110.036 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.2 p -85.19 117.68 24.28 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 115.945 -0.571 . . . . 71.329999999999998 110.593 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.2 m -100.79 146.63 27.03 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.573 -1.269 . . . . 73.150000000000006 107.573 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -71.31 150.79 44.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 118.078 0.399 . . . . 62.539999999999999 110.502 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.56 -25.06 23.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 124.316 1.046 . . . . 75.030000000000001 110.83 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -100.55 0.17 38.92 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.514 -0.766 . . . . 72.310000000000002 111.278 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -77.35 151.81 34.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.205 -1.406 . . . . 73.230000000000004 107.205 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.34 111.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 119.211 -0.995 . . . . 70.549999999999997 110.495 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 75.0 t -90.31 118.72 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.235 -1.024 . . . . 75.400000000000006 108.235 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 69.2 mt -95.18 119.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.345 -1.354 . . . . 72.319999999999993 107.345 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.99 119.67 55.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 109.361 -0.607 . . . . 64.299999999999997 109.361 -177.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 487' ' ' ILE . 3.2 mp -99.03 119.67 47.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 109.68 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.65 136.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.299 -0.864 . . . . 54.119999999999997 109.995 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.97 112.47 3.81 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 107.595 -2.202 . . . . 63.539999999999999 107.595 172.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.5 m -114.27 158.41 21.44 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.705 -0.48 . . . . 74.010000000000005 109.705 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.408 0 C-N-CA 120.673 -0.775 . . . . 64.019999999999996 111.345 -178.323 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.7 0 CA-C-O 122.12 0.962 . . . . 74.439999999999998 110.131 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -137.31 156.31 48.4 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.756 -1.201 . . . . 64.230000000000004 107.756 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -149.85 157.04 42.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.632 0.604 . . . . 73.420000000000002 112.632 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.42 130.6 34.61 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 125.344 1.458 . . . . 75.519999999999996 110.219 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -87.27 129.23 52.33 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.397 -0.521 . . . . 54.100000000000001 111.402 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.04 162.34 23.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.66 2.24 . . . . 64.340000000000003 111.552 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.27 114.55 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.047 -0.524 . . . . 74.329999999999998 110.041 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.41 ' HA ' HE21 ' A' ' 503' ' ' GLN . 27.7 m -122.84 -0.02 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 112.305 0.483 . . . . 72.129999999999995 112.305 -177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -68.87 143.21 54.58 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.407 0.442 . . . . 74.209999999999994 110.398 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 90.38 11.61 62.4 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.406 -0.902 . . . . 75.150000000000006 111.027 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 500' ' ' VAL . 42.1 mt-30 -122.43 -170.16 2.03 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.841 -0.8 . . . . 75.019999999999996 108.841 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.8 m -91.21 155.44 18.58 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.366 -1.346 . . . . 74.329999999999998 107.366 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.22 -41.35 80.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.266 0.354 . . . . 73.010000000000005 111.606 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.5 m-20 -66.08 -42.98 88.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 111.463 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.5 -36.38 28.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 119.757 -0.777 . . . . 64.329999999999998 110.988 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.53 -46.4 86.21 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.477 -0.783 . . . . 75.329999999999998 111.382 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.8 -35.72 82.02 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 120.447 -0.501 . . . . 52.210000000000001 110.084 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 mmtp -65.52 -50.69 64.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.552 -0.295 . . . . 73.239999999999995 111.516 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.24 -40.51 96.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.289 -0.414 . . . . 71.540000000000006 110.936 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.3 -42.61 75.21 Favored 'General case' 0 C--O 1.183 -2.441 0 N-CA-C 109.225 -0.658 . . . . 72.420000000000002 109.225 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.18 -40.01 84.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.943 0.497 . . . . 63.009999999999998 111.607 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.6 t -67.01 -29.66 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 112.455 0.539 . . . . 73.109999999999999 112.455 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -118.55 -5.11 10.76 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.406 -0.918 . . . . 70.219999999999999 111.699 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -108.71 1.94 Allowed Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 115.402 -0.817 . . . . 61.119999999999997 113.497 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 31.3 m-85 -130.3 174.41 9.87 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.461 -0.495 . . . . 61.329999999999998 111.279 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -103.82 -5.13 22.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.403 -0.817 . . . . 54.210000000000001 111.096 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 550' ' ' VAL . 14.8 ptpt -113.82 121.04 42.82 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.029 -0.532 . . . . 72.140000000000001 110.782 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -126.27 148.54 49.49 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.681 0.753 . . . . 74.239999999999995 111.766 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.9 m -127.81 154.94 44.85 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.851 -1.907 . . . . 64.340000000000003 105.851 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -121.81 143.21 49.54 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.722 -0.791 . . . . 74.299999999999997 109.848 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 554' ' ' GLN . . . -113.73 123.0 48.83 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.933 -1.506 . . . . 70.329999999999998 106.933 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.3 m -88.76 116.45 27.03 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.437 -0.801 . . . . 62.210000000000001 109.779 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 29.9 m -121.14 156.92 24.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.179 -1.415 . . . . 62.409999999999997 107.179 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.39 124.04 27.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.252 0.549 . . . . 74.439999999999998 110.438 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 18.3 m -72.15 151.69 92.48 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.631 -1.168 . . . . 75.329999999999998 112.626 -173.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 4.5 Cg_exo -80.62 -144.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.848 2.366 . . . . 65.340000000000003 107.441 168.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.83 -49.57 68.15 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 121.554 -0.716 . . . . 72.109999999999999 111.926 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.95 152.25 36.25 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 121.168 1.245 . . . . 54.399999999999999 111.111 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.13 149.66 43.3 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 101.03 -10.45 58.49 Favored Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.97 -0.633 . . . . 62.539999999999999 111.907 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.32 148.81 24.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.315 0.579 . . . . 74.200000000000003 111.701 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.536 HG21 ' CB ' ' A' ' 508' ' ' ALA . 95.5 t -75.75 120.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.271 -0.877 . . . . 72.420000000000002 109.133 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -82.1 -31.39 30.74 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.121 -0.945 . . . . 74.5 108.751 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 170.62 -169.64 42.5 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.284 -0.726 . . . . 71.349999999999994 111.284 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 32.7 p -123.69 149.46 45.46 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.221 -1.77 . . . . 64.099999999999994 106.221 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.6 t-20 -56.21 -58.32 17.25 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.978 -0.534 . . . . 61.450000000000003 112.069 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.8 Cg_exo -80.5 145.16 16.4 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.343 1.362 . . . . 74.230000000000004 108.784 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.1 147.56 73.56 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.898 1.732 . . . . 63.229999999999997 112.226 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.51 129.57 32.88 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.728 0.811 . . . . 44.329999999999998 110.267 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.68 -7.79 36.58 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.624 -0.798 . . . . 54.509999999999998 111.51 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.8 m -82.73 126.87 32.86 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.791 -0.448 . . . . 70.409999999999997 109.791 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 87.9 m -93.3 123.18 36.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.037 -1.098 . . . . 63.310000000000002 108.037 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.97 158.55 68.38 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 109.113 -0.699 . . . . 52.5 109.113 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 34.6 Cg_exo -61.09 145.66 98.63 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 122.664 2.242 . . . . 71.510000000000005 112.129 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.439 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 18.5 m -67.4 -19.24 25.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 122.144 0.974 . . . . 72.329999999999998 109.221 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.13 3.78 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 63.0 109.998 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 36.3 t -112.71 141.83 46.04 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.783 -1.192 . . . . 70.040000000000006 107.783 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.471 ' HA ' ' HG3' ' A' ' 519' ' ' LYS . 21.9 t -91.34 136.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.306 -0.627 . . . . 72.430000000000007 109.306 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.1 tp -91.32 135.02 28.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 110.078 -0.341 . . . . 62.329999999999998 110.078 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.86 117.64 35.08 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-O 121.573 0.701 . . . . 72.299999999999997 110.7 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.51 118.88 33.95 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.897 -1.52 . . . . 74.129999999999995 106.897 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 523' ' ' ALA . 8.9 mt-30 -94.56 106.67 18.66 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.616 -1.253 . . . . 63.340000000000003 107.616 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.23 138.56 46.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-N 114.957 -1.02 . . . . 75.329999999999998 112.029 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.463 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 31.8 m -61.02 121.1 11.59 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.037 -0.983 . . . . 54.539999999999999 109.392 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 22.5 pttp . . . . . 0 C--O 1.254 1.305 0 CA-C-N 115.754 -0.657 . . . . 62.310000000000002 110.588 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.1 pt-20 . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.808 0.813 . . . . 73.239999999999995 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -83.61 123.57 29.91 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.319 -0.855 . . . . 54.149999999999999 109.571 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -120.26 164.45 16.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.788 -1.189 . . . . 71.519999999999996 107.788 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.42 141.61 32.62 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 123.247 0.619 . . . . 64.230000000000004 112.323 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -85.06 131.46 48.6 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 105.33 -2.1 . . . . 55.229999999999997 105.33 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.34 141.5 97.78 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.994 1.796 . . . . 71.409999999999997 113.041 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -102.34 -13.03 17.49 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.411 -0.813 . . . . 64.239999999999995 108.913 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.61 8.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.046 -0.979 . . . . 62.130000000000003 110.331 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.1 m -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.798 -1.092 . . . . 74.430000000000007 108.865 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 p -59.29 -27.62 66.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.133 -1.394 . . . . 75.049999999999997 111.115 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.42 -45.08 23.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.609 -0.515 . . . . 71.25 109.609 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.7 m -163.69 144.49 8.85 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.148 -1.056 . . . . 51.329999999999998 108.148 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 441' ' ' VAL . 30.1 t80 -59.29 -41.38 88.8 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.75 0.42 . . . . 73.140000000000001 110.465 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.42 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.16 -40.69 74.27 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.19 0.306 . . . . 64.329999999999998 111.176 175.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.456 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 40.7 mm-40 -61.87 -44.43 96.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 116.237 -0.438 . . . . 70.439999999999998 110.31 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.23 -47.71 84.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.351 -0.84 . . . . 51.409999999999997 110.708 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.7 t -58.7 -50.55 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 O-C-N 123.704 0.628 . . . . 74.049999999999997 110.79 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -38.0 84.7 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.789 0.662 . . . . 75.439999999999998 112.789 -177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -66.47 -43.29 85.89 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 120.739 0.305 . . . . 72.409999999999997 110.719 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.79 -36.88 78.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 74.430000000000007 110.313 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.4 m -63.63 -41.28 98.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.995 -0.743 . . . . 74.109999999999999 108.995 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.16 -18.67 62.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.987 -0.551 . . . . 63.32 111.239 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.47 -14.65 51.99 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.677 -0.49 . . . . 74.349999999999994 109.677 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 85.98 8.73 78.62 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.953 -0.567 . . . . 63.149999999999999 114.33 172.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.49 124.54 20.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.213 0.506 . . . . 74.420000000000002 111.834 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -63.4 -55.41 25.79 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.054 -0.975 . . . . 21.100000000000001 114.285 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 0.4 OUTLIER -121.81 130.95 53.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.282 -0.567 . . . . 74.209999999999994 110.761 -174.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.77 144.59 31.25 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.805 -0.634 . . . . 75.140000000000001 109.304 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -131.34 141.5 49.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.456 -0.572 . . . . 63.100000000000001 109.456 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.63 136.4 34.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.878 0.736 . . . . 64.129999999999995 110.813 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.63 52.44 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.55 -2.018 . . . . 72.120000000000005 105.55 171.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -138.59 150.47 46.34 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 119.012 0.823 . . . . 72.310000000000002 110.138 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 25.6 m -131.94 145.7 58.56 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 108.627 -0.879 . . . . 55.409999999999997 108.627 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.63 134.8 26.93 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.505 2.137 . . . . 71.120000000000005 112.04 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.3 p -152.15 179.74 8.24 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.866 0.866 . . . . 64.099999999999994 109.207 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -59.68 142.3 87.98 Favored Pre-proline 0 N--CA 1.432 -1.339 0 C-N-CA 123.741 0.817 . . . . 44.450000000000003 111.411 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 464' ' ' VAL . 54.0 Cg_exo -52.57 -28.13 35.43 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.421 3.414 . . . . 73.129999999999995 113.428 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.98 -10.34 59.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.344 0.498 . . . . 64.010000000000005 112.344 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 9.5 mp -107.29 0.73 23.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.446 0.535 . . . . 75.5 112.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.1 p -61.29 128.81 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.286 0.565 . . . . 55.310000000000002 112.191 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.82 69.7 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 120.896 -0.669 . . . . 74.030000000000001 112.427 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 23.5 mtpp -109.91 146.17 35.62 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.318 -0.993 . . . . 72.510000000000005 108.318 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 486' ' ' ILE . 63.1 t -81.86 124.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.29 -0.633 . . . . 73.230000000000004 109.29 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.1 pt -101.68 -2.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.923 -0.58 . . . . 62.140000000000001 111.639 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.99 156.67 11.79 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.119 -0.562 . . . . 50.43 112.324 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 35.0 p -128.5 148.73 50.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.415 -0.957 . . . . 64.120000000000005 108.415 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -65.52 -56.18 20.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.273 -0.394 . . . . 61.229999999999997 110.477 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 57.3 Cg_endo -82.2 131.37 6.72 Favored 'Trans proline' 0 C--N 1.364 1.369 0 CA-C-N 120.152 1.09 . . . . 74.049999999999997 109.473 170.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -72.69 152.61 53.49 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.976 1.784 . . . . 42.530000000000001 113.119 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 6.35 11.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.395 1.078 . . . . 72.409999999999997 111.232 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.23 -28.64 13.99 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.796 -0.638 . . . . 73.319999999999993 111.108 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -115.45 161.47 18.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.211 -0.663 . . . . 73.239999999999995 109.211 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 33.3 p -95.35 140.8 29.72 Favored 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 120.483 -0.487 . . . . 71.219999999999999 109.875 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . 23.4 m -120.88 147.94 44.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.452 -0.573 . . . . 62.219999999999999 109.452 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 482' ' ' ASN . . . -57.12 151.32 15.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.352 0.871 . . . . 64.129999999999995 113.352 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 448' ' ' GLY . 45.1 mm -58.07 -32.98 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.049 0.939 . . . . 74.140000000000001 110.368 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.2 t -81.4 3.25 25.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.251 -0.886 . . . . 64.510000000000005 111.979 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 478' ' ' SER . 0.8 OUTLIER -74.33 158.42 34.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.275 0.559 . . . . 70.010000000000005 112.349 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 451' ' ' ARG . 60.4 t -106.97 114.31 45.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.027 -1.101 . . . . 73.519999999999996 108.027 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 88.6 t -94.61 119.91 43.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.237 0.541 . . . . 73.25 110.439 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 71.9 mt -96.31 112.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.484 -1.673 . . . . 74.040000000000006 106.484 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.19 128.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 116.167 -0.47 . . . . 71.099999999999994 110.533 -176.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.93 115.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.599 0.714 . . . . 75.239999999999995 111.069 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.53 142.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.547 -0.752 . . . . 72.140000000000001 109.55 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.27 113.71 3.77 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.091 -1.204 . . . . 62.25 110.091 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 35.1 t -95.8 129.81 42.92 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 106.748 -1.575 . . . . 61.420000000000002 106.748 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.593 0 C-N-CA 119.754 -1.212 . . . . 73.420000000000002 112.029 -177.695 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 109.027 -0.731 . . . . 60.100000000000001 109.027 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 546' ' ' PRO . 66.6 p -124.92 164.93 19.02 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.25 -0.887 . . . . 74.319999999999993 109.123 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 495' ' ' LYS . 6.4 mmpt? -139.62 144.18 37.57 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.686 -0.857 . . . . 72.109999999999999 108.686 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 27.6 t70 -90.59 130.34 36.63 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.788 -0.819 . . . . 54.420000000000002 108.788 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 20.4 pt -96.12 121.39 60.77 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.268 -0.573 . . . . 71.340000000000003 112.525 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.23 169.96 4.93 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.915 1.743 . . . . 65.310000000000002 109.316 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.88 129.71 34.84 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.491 -0.884 . . . . 75.439999999999998 109.574 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.35 14.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 123.278 1.513 . . . . 62.109999999999999 107.093 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -71.61 138.57 48.82 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.546 -1.661 . . . . 60.409999999999997 110.293 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.09 -4.57 41.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.648 -0.787 . . . . 72.510000000000005 111.822 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -106.09 176.63 5.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.844 -1.539 . . . . 73.340000000000003 106.844 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 71.1 p -80.41 157.87 26.13 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.448 -0.901 . . . . 72.349999999999994 108.963 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.46 -43.14 86.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.495 0.664 . . . . 62.240000000000002 110.19 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.86 -42.8 85.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.77 -1.105 . . . . 73.310000000000002 111.812 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.18 -36.84 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 119.431 -0.908 . . . . 73.430000000000007 111.243 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.49 73.4 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.908 -0.587 . . . . 71.439999999999998 111.282 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.3 -35.97 82.62 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 120.318 -0.553 . . . . 65.25 110.614 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -61.37 -53.69 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.505 0.503 . . . . 75.239999999999995 110.775 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.11 -41.85 94.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.788 -0.642 . . . . 73.420000000000002 110.673 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 551' ' ' ILE . 4.9 tt -66.36 -40.66 89.91 Favored 'General case' 0 C--O 1.186 -2.257 0 CA-C-N 115.404 -0.816 . . . . 75.510000000000005 109.246 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.1 t-20 -58.54 -38.29 77.46 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.387 0.675 . . . . 60.229999999999997 111.621 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.57 -40.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.726 -0.67 . . . . 72.129999999999995 112.032 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -107.4 -23.28 12.26 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.037 -0.665 . . . . 70.230000000000004 112.197 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -103.59 -100.16 2.58 Favored Glycine 0 N--CA 1.413 -2.861 0 CA-C-N 115.262 -0.881 . . . . 34.420000000000002 113.683 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 46.0 m-85 -131.23 166.86 20.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.331 0.586 . . . . 64.450000000000003 111.185 -171.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.443 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 4.7 p -102.8 -4.12 25.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.943 -1.026 . . . . 74.400000000000006 110.295 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -109.95 116.29 31.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.705 . . . . 72.239999999999995 109.763 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -128.94 145.84 51.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 110.911 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 59.2 m -135.64 145.63 47.02 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.988 -1.486 . . . . 73.510000000000005 106.988 172.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -125.55 143.25 51.09 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.393 -0.523 . . . . 72.439999999999998 111.95 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.45 129.23 52.85 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.596 -1.261 . . . . 65.439999999999998 107.596 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -88.35 127.74 35.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.207 0.527 . . . . 73.209999999999994 110.422 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.1 m -121.54 162.53 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.287 -1.005 . . . . 75.420000000000002 108.287 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.78 140.51 38.23 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.937 -0.705 . . . . 73.409999999999997 110.065 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 8.3 m -90.08 114.17 59.9 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.377 -1.283 . . . . 62.240000000000002 110.825 -174.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.85 -83.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.729 1.619 . . . . 52.520000000000003 109.661 173.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.3 mtt180 -90.9 -54.8 0.27 Allowed Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-O 118.805 -0.616 . . . . 64.530000000000001 111.14 172.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.66 ' O ' ' HB3' ' A' ' 527' ' ' SER . 21.9 Cg_endo -61.61 153.26 68.2 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.99 1.794 . . . . 64.409999999999997 111.359 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.46 82.43 0.27 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.853 0.861 . . . . 71.310000000000002 108.993 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.31 -31.12 2.64 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.482 -1.047 . . . . 75.5 110.482 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -86.12 149.55 25.05 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.259 -0.471 . . . . 72.209999999999994 110.17 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 501' ' ' ALA . 5.3 p -73.85 123.11 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.318 -0.993 . . . . 64.530000000000001 108.318 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -71.87 -41.58 67.86 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.872 -1.058 . . . . 60.109999999999999 110.874 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -174.26 -160.35 22.3 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.407 -0.902 . . . . 71.120000000000005 111.189 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.0 p -131.74 159.98 36.86 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.66 -0.867 . . . . 73.420000000000002 108.66 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.473 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 48.8 t30 -69.02 -55.36 10.53 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-O 118.937 -0.554 . . . . 72.530000000000001 110.512 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.0 Cg_endo -81.48 146.94 15.59 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.05 1.167 . . . . 74.329999999999998 109.533 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.04 147.73 43.66 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.943 1.762 . . . . 74.340000000000003 112.444 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.11 138.23 58.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.824 -0.626 . . . . 53.229999999999997 110.017 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.74 -5.75 60.16 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 111.173 -0.771 . . . . 65.430000000000007 111.173 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -88.78 126.04 35.16 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.593 -0.521 . . . . 62.32 109.593 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.1 m -90.51 123.13 33.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.802 -1.184 . . . . 63.530000000000001 107.802 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.74 154.74 75.8 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.82 -0.437 . . . . 52.439999999999998 109.82 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.533 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.0 Cg_exo -64.72 147.71 89.91 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.945 2.43 . . . . 73.510000000000005 113.55 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.534 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.6 m -67.05 -19.42 25.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.163 0.982 . . . . 70.040000000000006 111.995 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.62 -8.03 59.03 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.688 -1.142 . . . . 34.049999999999997 109.365 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 41.4 m -97.44 149.91 21.62 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 115.165 -0.925 . . . . 62.399999999999999 109.204 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.87 136.57 26.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.94 -0.573 . . . . 73.299999999999997 110.309 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 512' ' ' LEU . 15.5 tt -98.93 129.01 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.665 0.745 . . . . 74.430000000000007 109.963 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 521' ' ' SER . 31.8 tt0 -103.74 129.67 51.15 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 115.696 -0.684 . . . . 50.109999999999999 110.379 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.72 134.5 48.74 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.419 1.088 . . . . 71.420000000000002 110.672 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.06 108.53 19.79 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.276 -1.75 . . . . 61.329999999999998 106.276 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.09 137.62 38.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 112.089 0.403 . . . . 75.200000000000003 112.089 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.7 m -60.42 122.02 13.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.668 -1.604 . . . . 73.010000000000005 106.668 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.836 -0.602 . . . . 70.140000000000001 111.863 -172.789 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.041 0.924 . . . . 74.409999999999997 111.319 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 96.2 mt-30 -102.93 130.22 49.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.81 -1.086 . . . . 72.329999999999998 108.758 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -128.23 158.85 36.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.206 -1.035 . . . . 73.329999999999998 108.206 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -82.66 141.5 32.43 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 123.254 0.622 . . . . 72.510000000000005 110.365 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -85.09 130.01 53.79 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.052 -0.721 . . . . 70.209999999999994 109.052 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.01 145.19 99.42 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.979 2.453 . . . . 71.319999999999993 112.333 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.24 11.72 35.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.433 1.111 . . . . 74.439999999999998 110.14 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.91 -9.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.581 1.182 . . . . 73.310000000000002 108.562 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.8 m -59.26 -33.75 71.41 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.916 -1.493 . . . . 65.299999999999997 110.292 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 4.2 m -60.68 -27.34 67.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.505 -1.225 . . . . 65.530000000000001 110.375 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.79 -44.25 17.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 119.991 -0.683 . . . . 74.510000000000005 110.959 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.614 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 91.5 m -162.0 144.61 11.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 109.394 -0.595 . . . . 61.25 109.394 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -52.68 -49.42 65.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.016 0.926 . . . . 73.510000000000005 111.227 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.69 -40.77 80.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 43.329999999999998 111.22 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 19.9 mm-40 -61.42 -41.42 97.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.827 -0.624 . . . . 73.450000000000003 111.101 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.05 -51.82 67.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 123.915 0.759 . . . . 53.109999999999999 110.718 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.77 -46.68 95.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 CA-C-N 115.114 -0.948 . . . . 75.019999999999996 111.994 -174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 75.6 mmtt -60.84 -47.89 84.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 110.028 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -68.26 -45.29 73.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.351 -0.84 . . . . 74.510000000000005 111.431 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 452' ' ' PHE . 21.8 tp -69.07 -38.53 79.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.063 0.459 . . . . 63.409999999999997 110.845 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.6 m -64.16 -39.66 94.48 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.838 -0.619 . . . . 73.239999999999995 109.459 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -18.98 62.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.932 -0.577 . . . . 64.319999999999993 110.442 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.16 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.087 0.47 . . . . 61.020000000000003 110.124 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.84 -23.71 9.93 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.617 -0.802 . . . . 43.25 113.175 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.69 134.29 56.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.741 0.305 . . . . 74.439999999999998 110.783 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -130.13 -8.17 3.41 Favored Glycine 0 N--CA 1.428 -1.886 0 C-N-CA 119.811 -1.185 . . . . 61.039999999999999 112.898 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -102.69 115.4 30.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.548 -0.908 . . . . 71.209999999999994 108.548 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 444' ' ' LEU . 42.3 m-85 -129.19 154.88 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.294 -0.866 . . . . 74.230000000000004 110.394 -175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.468 ' HB3' HG12 ' A' ' 485' ' ' ILE . 0.7 OUTLIER -138.86 122.92 17.93 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.37 -2.455 . . . . 75.420000000000002 104.37 169.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -105.17 134.61 47.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 110.904 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.13 153.3 47.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.497 -0.927 . . . . 52.240000000000002 108.497 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.35 146.49 50.02 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 62.109999999999999 109.396 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 53.4 m -139.89 135.21 16.37 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 116.555 -0.293 . . . . 65.340000000000003 110.373 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 26.6 Cg_exo -64.72 122.39 10.23 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.386 2.057 . . . . 62.219999999999999 111.374 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.7 m -140.54 -179.91 6.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.81 -1.181 . . . . 71.409999999999997 107.81 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.406 ' CG2' HD23 ' A' ' 463' ' ' LEU . 10.8 t -50.2 142.99 13.46 Favored Pre-proline 0 C--O 1.25 1.131 0 C-N-CA 123.168 0.587 . . . . 73.349999999999994 110.795 176.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.12 -29.32 28.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.088 3.192 . . . . 72.129999999999995 112.986 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.52 -18.86 63.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.467 0.543 . . . . 54.240000000000002 112.467 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -100.97 6.8 43.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.978 0.732 . . . . 75.230000000000004 112.978 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.6 p -61.01 127.69 21.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.406 -0.518 . . . . 55.119999999999997 110.546 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.48 12.73 84.26 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.801 -0.714 . . . . 60.539999999999999 112.439 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 94.6 mttt -121.18 154.87 35.68 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.693 -0.854 . . . . 71.140000000000001 108.693 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.645 HG22 HD11 ' A' ' 486' ' ' ILE . 40.5 t -82.06 126.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.174 -0.676 . . . . 64.230000000000004 109.174 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.4 pt -98.17 -13.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.462 -0.495 . . . . 60.240000000000002 110.358 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.45 160.82 19.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.595 -0.812 . . . . 73.319999999999993 111.684 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.5 p -120.86 146.72 46.28 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.546 -0.909 . . . . 71.329999999999998 108.546 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.561 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.3 t-20 -58.49 -57.93 22.81 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-O 119.128 -0.463 . . . . 73.310000000000002 111.042 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.34 129.55 14.04 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 108.737 -1.294 . . . . 73.450000000000003 108.737 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.7 133.08 37.72 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 74.209999999999994 112.254 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.6 -5.7 46.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.939 0.876 . . . . 63.32 110.673 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.81 -28.44 28.08 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.224 -1.353 . . . . 73.109999999999999 109.4 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.91 165.21 11.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.041 -0.726 . . . . 74.109999999999999 109.041 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.5 p -87.84 120.83 29.56 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 109.094 -0.706 . . . . 75.150000000000006 109.094 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 19.8 m -104.39 147.98 26.93 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.359 -0.978 . . . . 73.420000000000002 108.359 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.81 148.58 44.38 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.752 0.31 . . . . 71.430000000000007 110.94 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.36 -21.9 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.869 0.842 . . . . 64.310000000000002 110.549 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 t -94.32 -0.56 54.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.228 -0.896 . . . . 71.219999999999999 110.566 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.9 142.13 38.63 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.345 -0.983 . . . . 71.430000000000007 108.345 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.63 112.0 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.702 -0.851 . . . . 63.520000000000003 108.702 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.77 118.41 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 108.389 -0.967 . . . . 52.140000000000001 108.389 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.4 mt -92.44 112.01 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 106.018 -1.845 . . . . 75.450000000000003 106.018 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.55 121.56 56.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.121 -0.945 . . . . 73.310000000000002 108.633 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.93 118.85 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.748 -0.66 . . . . 71.200000000000003 109.608 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.25 139.16 19.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.011 -1.107 . . . . 62.119999999999997 108.011 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.02 127.08 7.79 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 109.975 -1.25 . . . . 54.439999999999998 109.975 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 24.6 p -108.38 131.72 54.47 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.749 -0.834 . . . . 70.230000000000004 108.749 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.089 0 N-CA-C 109.939 -1.264 . . . . 74.209999999999994 109.939 179.524 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.338 0 N-CA-C 107.353 -1.351 . . . . 74.319999999999993 107.353 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 41.5 p -135.51 166.36 23.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.854 -1.066 . . . . 62.420000000000002 109.583 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 27.6 mmtm -140.13 137.63 34.61 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.052 0.453 . . . . 65.109999999999999 111.802 173.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.78 126.46 31.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.626 -1.17 . . . . 72.519999999999996 108.058 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.9 pt -96.34 131.01 29.39 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.73 -0.788 . . . . 75.439999999999998 110.619 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.76 -177.95 1.03 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.356 2.037 . . . . 71.219999999999999 110.472 174.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.91 93.8 3.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.07 0.462 . . . . 74.349999999999994 110.232 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.19 -0.6 10.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.84 -1.541 . . . . 60.219999999999999 106.84 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -70.46 143.69 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.459 -1.7 . . . . 73.409999999999997 109.565 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.22 -15.45 25.36 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.477 -0.868 . . . . 45.100000000000001 111.52 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.64 -170.15 1.95 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.28 -0.568 . . . . 74.430000000000007 110.249 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.5 157.52 21.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.894 -1.15 . . . . 74.239999999999995 107.894 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 42.4 t -56.62 -49.62 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.416 0.627 . . . . 43.5 111.14 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.27 -41.96 80.3 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.282 -0.872 . . . . 74.299999999999997 111.129 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.32 -44.67 94.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.828 -1.078 . . . . 45.43 110.632 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.05 96.47 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.003 -0.544 . . . . 61.329999999999998 110.957 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.21 -40.17 95.19 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.89 -0.411 . . . . 73.450000000000003 109.89 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -44.03 89.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.832 -0.622 . . . . 75.140000000000001 110.6 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.65 -44.51 73.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.039 0.447 . . . . 73.140000000000001 110.519 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.15 -36.8 85.37 Favored 'General case' 0 C--O 1.191 -2.004 0 CA-C-N 115.565 -0.743 . . . . 71.409999999999997 109.54 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 26.2 t-20 -57.85 -37.96 74.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.263 0.625 . . . . 61.039999999999999 111.597 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.46 -43.16 91.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.585 -0.734 . . . . 55.299999999999997 111.675 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -110.85 13.29 22.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.521 -0.472 . . . . 71.450000000000003 110.549 -171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.9 -103.01 0.31 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.408 -1.377 . . . . 44.5 115.108 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 46.9 m-85 -127.04 177.56 6.56 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.005 0.431 . . . . 74.109999999999999 112.143 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 m -120.74 -14.52 8.54 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.739 -0.664 . . . . 64.540000000000006 110.949 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.438 ' HB3' HG12 ' A' ' 550' ' ' VAL . 31.5 mmmt -108.23 119.68 40.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.431 -0.581 . . . . 75.239999999999995 109.431 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.72 147.57 44.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.714 -0.675 . . . . 73.010000000000005 111.001 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 44.3 m -137.5 151.64 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.756 -1.572 . . . . 65.019999999999996 106.756 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -121.53 137.83 54.56 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 118.339 0.518 . . . . 71.230000000000004 111.381 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -126.17 122.62 36.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.353 -1.351 . . . . 70.299999999999997 107.353 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 5.2 p -89.33 132.7 34.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.777 0.322 . . . . 52.130000000000003 111.5 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.76 149.31 24.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.183 -1.414 . . . . 72.109999999999999 107.183 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.88 136.3 37.25 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.133 -0.627 . . . . 64.319999999999993 110.972 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.1 m -133.64 160.5 68.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.065 -0.97 . . . . 73.549999999999997 109.982 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -70.19 -142.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.38 2.72 . . . . 63.439999999999998 111.964 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -51.39 81.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 113.888 1.07 . . . . 73.040000000000006 113.888 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.24 133.02 31.38 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 121.043 1.408 . . . . 72.109999999999999 109.799 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -168.78 125.49 0.98 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.303 0.641 . . . . 74.109999999999999 109.518 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.9 -23.53 1.45 Allowed Glycine 0 C--N 1.301 -1.413 0 N-CA-C 109.841 -1.304 . . . . 63.130000000000003 109.841 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.55 29.92 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.447 -0.946 . . . . 74.019999999999996 108.447 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 75.0 t -74.05 119.39 21.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.6 -0.889 . . . . 61.0 108.6 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.0 m -68.5 -40.36 80.89 Favored 'General case' 0 N--CA 1.427 -1.595 0 O-C-N 124.529 1.143 . . . . 71.319999999999993 109.642 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 169.61 -152.87 20.63 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.506 -0.854 . . . . 42.229999999999997 111.541 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -134.04 161.76 33.96 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.744 -1.206 . . . . 61.329999999999998 107.744 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -56.32 -65.3 1.67 Allowed Pre-proline 0 N--CA 1.474 0.76 0 CA-C-O 118.891 -0.576 . . . . 63.409999999999997 110.65 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 60.2 Cg_endo -76.88 147.92 27.66 Favored 'Trans proline' 0 C--N 1.367 1.509 0 CA-C-N 120.633 1.262 . . . . 74.25 109.248 173.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.86 163.05 40.08 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.927 1.751 . . . . 71.109999999999999 111.528 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.76 58.66 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.187 -0.46 . . . . 61.200000000000003 110.21 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.49 -12.76 61.51 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.936 -0.865 . . . . 65.420000000000002 110.936 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.7 m -86.04 124.22 32.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 109.07 -0.715 . . . . 73.25 109.07 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.1 t -90.6 123.38 34.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.96 -1.126 . . . . 74.209999999999994 107.96 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 517' ' ' PHE . 19.4 m -123.64 156.27 64.93 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 109.671 -0.492 . . . . 55.030000000000001 109.671 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 135.08 65.29 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.213 2.609 . . . . 71.329999999999998 114.23 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.5 m -67.28 -20.78 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.274 -0.876 . . . . 63.549999999999997 111.518 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.11 -0.23 55.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 111.12 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 17.4 t -100.42 151.04 22.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.236 -1.024 . . . . 63.149999999999999 108.236 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 519' ' ' LYS . 5.7 m -88.58 136.41 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 N-CA-C 108.022 -1.103 . . . . 73.409999999999997 108.022 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.6 tt -97.52 143.28 12.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 120.036 -0.665 . . . . 74.099999999999994 110.858 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -102.45 118.37 36.72 Favored 'General case' 0 N--CA 1.408 -2.547 0 C-N-CA 123.471 0.709 . . . . 64.239999999999995 109.404 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.0 tp -97.05 129.25 44.51 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.729 -1.123 . . . . 50.200000000000003 108.689 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -90.05 112.95 24.56 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.364 -0.976 . . . . 71.329999999999998 108.364 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.8 137.88 33.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.006 -0.543 . . . . 65.310000000000002 111.955 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.5 m -68.76 126.08 28.61 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 115.64 -0.709 . . . . 73.349999999999994 111.65 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 115.308 -0.86 . . . . 52.240000000000002 108.803 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 122.559 1.171 . . . . 64.219999999999999 110.191 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.435 ' C ' ' HB ' ' A' ' 477' ' ' THR . 26.7 mt-30 -101.64 125.7 48.35 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.006 -1.452 . . . . 55.140000000000001 108.755 175.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -121.04 153.44 37.38 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.407 -0.36 . . . . 62.329999999999998 110.341 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.02 141.39 28.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 110.889 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.4 mp -85.09 128.33 60.53 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 107.47 -1.307 . . . . 73.140000000000001 107.47 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.414 ' HG3' ' HD2' ' A' ' 443' ' ' LYS . 61.9 Cg_endo -69.8 147.05 61.78 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.561 2.174 . . . . 65.439999999999998 112.55 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -83.54 29.31 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.956 -0.565 . . . . 72.439999999999998 110.762 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 440' ' ' ALA . 35.9 m -85.84 7.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.001 0.905 . . . . 72.019999999999996 109.784 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 2.3 p -58.0 -35.02 70.62 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 125.999 1.719 . . . . 72.209999999999994 109.982 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.6 t -60.47 -26.04 66.48 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.718 -1.583 . . . . 74.129999999999995 111.496 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.81 -47.81 10.01 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 118.953 -1.099 . . . . 73.099999999999994 111.05 -174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.4 m -174.41 153.99 2.03 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.736 -1.209 . . . . 73.209999999999994 107.736 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 467' ' ' VAL . 29.2 t80 -50.37 -54.72 19.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.293 1.037 . . . . 64.109999999999999 110.656 171.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.18 -41.23 75.18 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.912 -0.586 . . . . 63.340000000000003 111.936 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 443' ' ' LYS . 66.2 mm-40 -61.51 -46.56 89.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.156 0.428 . . . . 74.129999999999995 112.156 -178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.433 ' HA ' HG23 ' A' ' 432' ' ' VAL . . . -72.22 -45.83 58.64 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.603 0.594 . . . . 63.409999999999997 112.603 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.74 -47.6 88.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 53.350000000000001 110.958 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.62 -35.21 79.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.304 0.242 . . . . 50.149999999999999 110.973 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 439' ' ' GLU . 2.6 tmtm? -66.26 -47.61 73.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.155 -1.054 . . . . 62.420000000000002 108.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.1 tp -68.86 -32.66 72.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.723 -0.671 . . . . 72.209999999999994 110.519 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 96.9 m -60.89 -43.99 97.72 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.51 -0.768 . . . . 64.239999999999995 109.308 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -20.02 62.45 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.077 -0.51 . . . . 71.340000000000003 111.148 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.54 -10.9 59.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.997 -0.547 . . . . 71.310000000000002 110.414 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.51 -8.43 8.33 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 119.927 -1.13 . . . . 74.120000000000005 113.956 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 445' ' ' THR . 92.5 m-85 -86.17 133.37 33.86 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 117.306 0.553 . . . . 73.319999999999993 110.773 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.41 -13.96 3.04 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.886 -0.673 . . . . 53.229999999999997 112.692 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 483' ' ' VAL . 14.3 ttm180 -103.06 116.29 32.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.41 0.605 . . . . 71.040000000000006 110.87 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.04 158.03 40.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.826 -0.625 . . . . 75.010000000000005 111.231 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.4 tppp? -134.61 135.7 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.042 -2.207 . . . . 61.439999999999998 105.042 172.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -115.95 135.09 54.3 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.535 0.607 . . . . 73.319999999999993 111.236 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.24 140.86 45.58 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.348 -0.982 . . . . 64.299999999999997 108.348 175.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.86 142.12 46.5 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.862 -0.792 . . . . 74.140000000000001 108.862 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.5 t -140.58 146.74 46.19 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 108.605 -0.887 . . . . 54.149999999999999 108.605 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.2 Cg_exo -65.08 140.17 64.31 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.846 1.698 . . . . 70.299999999999997 109.926 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 71.1 m -150.72 179.77 7.93 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.747 -0.835 . . . . 60.200000000000003 108.747 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -56.09 133.67 74.5 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.94 -0.763 . . . . 75.450000000000003 108.94 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 79.3 Cg_exo -50.1 -29.59 22.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.142 3.228 . . . . 62.409999999999997 115.117 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.81 -10.31 59.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.234 0.828 . . . . 54.229999999999997 113.234 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.8 mt -102.53 11.61 37.61 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.784 -0.366 . . . . 64.239999999999995 111.731 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -61.14 128.05 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.999 0.428 . . . . 73.540000000000006 110.737 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.8 3.99 90.39 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.996 -0.547 . . . . 73.329999999999998 112.292 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 434' ' ' THR . 93.5 mttt -112.23 159.69 18.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.371 -0.974 . . . . 71.299999999999997 108.371 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 46.0 t -82.67 129.07 38.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.557 -0.905 . . . . 52.409999999999997 108.557 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.33 -20.52 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.361 0.601 . . . . 63.299999999999997 109.764 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.75 170.2 33.09 Favored Glycine 0 N--CA 1.416 -2.688 0 N-CA-C 110.471 -1.052 . . . . 53.530000000000001 110.471 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.2 p -120.02 157.62 28.49 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.452 -0.573 . . . . 72.349999999999994 109.452 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.577 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 25.6 t-20 -60.21 -49.28 91.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 119.238 -0.41 . . . . 51.340000000000003 111.49 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.0 Cg_exo -83.14 155.88 14.82 Favored 'Trans proline' 0 C--N 1.365 1.402 0 N-CA-C 107.821 -1.646 . . . . 73.25 107.821 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 68.4 Cg_endo -66.36 146.65 81.26 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 121.697 1.598 . . . . 60.509999999999998 109.887 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.94 -37.4 29.56 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 121.059 0.457 . . . . 73.219999999999999 111.166 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . 0.271 18.8 m-80 -85.41 -8.33 58.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.719 1.377 . . . . 41.039999999999999 114.719 -172.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.8 mp0 -95.39 152.28 18.54 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.773 -1.195 . . . . 74.120000000000005 107.773 174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.435 ' HB ' ' C ' ' A' ' 426' ' ' GLN . 33.1 p -79.51 121.63 25.46 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.272 0.558 . . . . 62.140000000000001 110.738 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.6 m -104.59 140.83 37.43 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.357 -0.979 . . . . 65.25 108.357 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.73 145.67 52.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.733 0.302 . . . . 64.129999999999995 111.635 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.0 mm -59.59 -21.89 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.472 0.709 . . . . 71.109999999999999 111.27 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.8 t -83.49 0.08 47.94 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.924 -0.485 . . . . 72.25 111.473 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.08 154.77 20.49 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.967 0.413 . . . . 74.129999999999995 110.605 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 451' ' ' ARG . 2.6 p -98.25 124.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.17 -1.418 . . . . 42.240000000000002 107.17 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.41 118.7 37.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 C-N-CA 119.19 -1.004 . . . . 75.040000000000006 109.405 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.577 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.96 113.15 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.029 -1.841 . . . . 74.109999999999999 106.029 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.34 128.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 115.923 -0.58 . . . . 75.530000000000001 109.595 -175.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 31.5 mt -104.5 119.96 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.277 -0.874 . . . . 64.010000000000005 109.286 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.59 137.76 23.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.279 -0.873 . . . . 73.0 108.885 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -85.05 123.49 6.32 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 110.943 -0.863 . . . . 62.350000000000001 110.943 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 27.4 t -111.07 129.46 55.91 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.67 -1.604 . . . . 62.200000000000003 106.67 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.612 0 N-CA-C 109.291 -1.523 . . . . 63.229999999999997 109.291 179.163 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.36 0 N-CA-C 107.69 -1.226 . . . . 64.430000000000007 107.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 23.8 p -134.76 160.71 37.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.348 -0.842 . . . . 74.319999999999993 110.66 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -150.45 142.24 23.74 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.714 0.806 . . . . 63.439999999999998 109.052 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.6 p-10 -88.75 134.01 34.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.479 . . . . 72.349999999999994 107.008 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.95 124.92 88.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 CA-C-N 115.489 -0.778 . . . . 63.409999999999997 111.867 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.06 150.15 1.65 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.533 2.155 . . . . 60.25 111.212 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -87.64 107.55 18.66 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.345 1.069 . . . . 63.539999999999999 110.053 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.489 HG12 HE21 ' A' ' 503' ' ' GLN . 5.1 t -105.53 42.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 106.925 -1.509 . . . . 64.010000000000005 106.925 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -80.42 159.89 25.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.406 -1.27 . . . . 64.510000000000005 112.629 -173.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.15 -16.09 46.37 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.216 -0.753 . . . . 72.319999999999993 111.216 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.489 HE21 HG12 ' A' ' 500' ' ' VAL . 39.0 mt-30 -89.93 -173.08 3.75 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.195 0.522 . . . . 74.239999999999995 111.696 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.6 m -90.85 156.56 17.93 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.403 -1.332 . . . . 63.32 107.403 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 19.2 t -55.05 -48.97 75.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 123.721 0.638 . . . . 64.439999999999998 111.08 -172.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.34 -41.62 80.46 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.619 0.6 . . . . 75.120000000000005 112.619 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.9 p -73.88 -34.86 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.507 -0.877 . . . . 75.540000000000006 111.234 -174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.78 89.22 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.727 -0.67 . . . . 73.150000000000006 110.216 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.1 mt-30 -62.73 -42.74 99.81 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 123.448 0.467 . . . . 73.109999999999999 110.481 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 0.0 OUTLIER -62.08 -42.67 99.44 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 112.897 0.703 . . . . 73.299999999999997 112.897 178.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -66.99 -48.11 69.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.53 -0.468 . . . . 65.400000000000006 110.094 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 551' ' ' ILE . 41.8 tp -60.2 -41.17 92.44 Favored 'General case' 0 C--O 1.198 -1.614 0 CA-C-N 115.512 -0.767 . . . . 63.030000000000001 110.144 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.8 t-20 -59.21 -48.05 83.05 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.856 0.862 . . . . 74.200000000000003 111.29 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.88 -18.89 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.318 0.488 . . . . 75.150000000000006 112.318 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -118.96 8.66 11.7 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.778 -0.769 . . . . 64.0 110.229 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -149.84 -95.83 0.14 Allowed Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.02 -1.562 . . . . 65.530000000000001 115.836 -170.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 59.6 m-85 -123.11 170.18 10.47 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.221 0.534 . . . . 74.430000000000007 111.736 -165.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 20.4 p -97.11 -35.9 10.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.276 -0.874 . . . . 54.219999999999999 112.352 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -117.77 142.61 47.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.127 0.489 . . . . 71.530000000000001 112.075 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -127.6 156.99 41.4 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.735 -1.12 . . . . 74.120000000000005 110.404 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.4 t -129.73 141.99 50.79 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.845 -2.28 . . . . 71.129999999999995 104.845 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -121.28 129.78 53.31 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.944 -0.761 . . . . 72.340000000000003 108.944 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.411 ' HB3' HE22 ' A' ' 554' ' ' GLN . . . -129.03 136.96 51.0 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 123.601 0.563 . . . . 61.329999999999998 109.736 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 51.9 m -88.56 131.61 34.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.31 -0.859 . . . . 63.130000000000003 109.491 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.434 ' O ' ' HG3' ' A' ' 557' ' ' LYS . 34.4 m -122.24 149.53 25.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.734 -0.469 . . . . 70.120000000000005 109.734 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.93 111.45 16.27 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.74 0.781 . . . . 73.040000000000006 110.195 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 7.2 p -107.58 119.81 49.37 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.615 -1.175 . . . . 52.039999999999999 109.818 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 26.9 Cg_exo -65.13 -51.49 1.54 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.449 2.099 . . . . 65.549999999999997 111.527 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 529' ' ' ARG . 14.9 mmm180 -102.78 -50.93 0.15 Allowed Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 114.186 1.18 . . . . 74.319999999999993 114.186 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.75 153.45 36.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.904 1.736 . . . . 74.420000000000002 112.373 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.89 108.01 0.86 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 122.918 0.487 . . . . 70.329999999999998 110.968 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.75 -24.08 33.19 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 120.935 -0.65 . . . . 74.420000000000002 114.336 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.24 23.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.7 p -73.68 120.16 22.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.945 -0.761 . . . . 64.010000000000005 108.945 176.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -71.73 -40.39 69.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.991 -1.004 . . . . 74.230000000000004 110.174 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.84 -149.81 13.81 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.488 -0.645 . . . . 71.299999999999997 111.488 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.5 p -117.9 160.03 22.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.277 -1.008 . . . . 72.120000000000005 108.277 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -74.3 -56.05 2.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.018 -1.073 . . . . 71.329999999999998 110.181 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.4 Cg_endo -64.87 149.33 89.71 Favored 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 120.741 0.961 . . . . 63.039999999999999 109.614 170.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 18.9 Cg_exo -66.8 152.36 80.66 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.525 2.15 . . . . 71.25 112.549 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.38 132.64 52.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.795 -0.817 . . . . 74.530000000000001 108.795 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.63 40.83 Favored Glycine 0 C--N 1.298 -1.574 0 C-N-CA 120.272 -0.966 . . . . 42.240000000000002 111.958 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.8 m -67.44 120.96 14.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.871 -0.789 . . . . 42.100000000000001 108.871 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.4 m -90.18 122.75 33.41 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.556 -0.905 . . . . 74.109999999999999 108.556 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.01 157.63 77.7 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 108.095 -1.076 . . . . 63.200000000000003 108.095 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.81 144.3 98.53 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.182 1.922 . . . . 73.439999999999998 111.577 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -65.03 -18.55 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.18 0.991 . . . . 71.450000000000003 110.786 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.32 -17.73 53.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.883 -1.508 . . . . 74.030000000000001 109.83 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 172.4 13.79 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.985 -1.007 . . . . 61.420000000000002 113.644 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.03 124.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.358 -1.292 . . . . 75.150000000000006 109.42 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.538 HD13 HD21 ' A' ' 512' ' ' LEU . 13.1 tt -100.46 136.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.558 -0.534 . . . . 62.240000000000002 109.558 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.29 122.6 45.13 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-O 121.435 0.636 . . . . 72.120000000000005 111.126 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 12.7 tp -101.39 133.83 45.4 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.203 1.401 . . . . 70.430000000000007 109.356 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.411 HE22 ' HB3' ' A' ' 523' ' ' ALA . 25.0 mm-40 -104.01 114.56 28.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.157 -0.682 . . . . 73.129999999999995 109.157 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 137.84 34.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 111.496 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 10.4 m -64.11 115.06 4.6 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 106.94 -1.504 . . . . 65.549999999999997 106.94 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 524' ' ' SER 0.306 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 N-CA-C 114.828 1.418 . . . . 62.43 114.828 -172.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.894 0.854 . . . . 65.219999999999999 110.445 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.8 mt-30 -83.43 137.69 33.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.355 -0.839 . . . . 64.230000000000004 111.87 -174.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 21.6 tpp180 -129.51 157.38 42.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.351 -0.981 . . . . 65.439999999999998 108.351 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.43 141.92 28.79 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 123.332 0.653 . . . . 72.120000000000005 111.279 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -85.15 130.49 51.79 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 108.109 -1.071 . . . . 73.310000000000002 108.109 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HB3' ' HG2' ' A' ' 443' ' ' LYS . 22.3 Cg_endo -60.97 158.38 34.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.546 2.83 . . . . 65.040000000000006 115.393 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -113.3 16.32 19.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.917 -1.038 . . . . 65.549999999999997 110.309 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.98 -2.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.244 1.021 . . . . 64.299999999999997 109.224 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.1 m -61.22 -38.87 88.17 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.977 -1.465 . . . . 54.130000000000003 110.828 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 9.4 t -59.03 -26.82 64.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.607 -0.724 . . . . 74.540000000000006 111.672 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.4 mt -76.9 -45.54 27.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 120.063 -0.655 . . . . 74.340000000000003 110.097 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 14.3 m -168.82 147.49 4.06 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.301 -1.0 . . . . 53.109999999999999 108.301 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -51.64 -44.47 62.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.607 0.763 . . . . 73.109999999999999 111.112 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.75 -35.41 66.16 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.984 0.514 . . . . 74.010000000000005 111.6 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 10.7 mm-40 -70.52 -42.29 71.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.796 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.34 -50.77 72.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.358 -0.837 . . . . 63.119999999999997 110.113 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.0 t -58.55 -49.19 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.214 -0.903 . . . . 75.439999999999998 112.015 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.66 -46.83 83.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.839 -0.344 . . . . 71.519999999999996 111.622 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 430' ' ' PRO . 26.6 tptp -66.78 -41.62 87.35 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 75.420000000000002 110.122 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 28.3 tp -68.48 -43.21 77.43 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.916 -0.584 . . . . 55.32 110.155 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 39.5 m -59.51 -44.68 93.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.676 -0.693 . . . . 75.420000000000002 109.804 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.69 62.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.906 -0.588 . . . . 62.25 111.395 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -80.93 -13.72 58.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.132 0.492 . . . . 51.25 110.152 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.65 -5.78 26.15 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.126 -1.035 . . . . 32.43 112.794 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.439 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.3 m-85 -82.65 111.54 18.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.576 -0.527 . . . . 73.129999999999995 109.576 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.25 41.32 Favored Glycine 0 N--CA 1.427 -1.918 0 CA-C-N 115.476 -0.784 . . . . 75.019999999999996 111.836 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.51 114.63 26.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.264 0.554 . . . . 71.109999999999999 111.239 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.82 156.83 43.14 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.322 -0.854 . . . . 72.530000000000001 112.366 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 123.06 29.31 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.176 -1.416 . . . . 65.140000000000001 107.176 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -94.0 125.71 38.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.858 -0.61 . . . . 73.450000000000003 109.873 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.04 147.15 50.5 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.327 -1.36 . . . . 40.439999999999998 107.327 176.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -122.57 139.88 53.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.344 -0.543 . . . . 73.010000000000005 109.652 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.4 m -126.44 140.85 38.35 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 109.259 -0.645 . . . . 74.420000000000002 109.259 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -64.77 121.91 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.597 1.531 . . . . 72.400000000000006 109.842 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.5 m -133.67 179.99 5.88 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.761 -1.57 . . . . 70.549999999999997 106.761 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.0 t -60.56 136.98 92.56 Favored Pre-proline 0 N--CA 1.419 -2.003 0 N-CA-C 109.136 -0.69 . . . . 65.420000000000002 109.136 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 85.2 Cg_exo -49.86 -28.96 19.38 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.464 3.443 . . . . 73.150000000000006 114.829 -173.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.18 -18.43 61.86 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.07 0.767 . . . . 74.129999999999995 113.07 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.28 7.96 44.59 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.934 -0.479 . . . . 61.299999999999997 111.983 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -60.96 128.36 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 120.968 0.414 . . . . 73.209999999999994 110.505 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.13 89.31 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.77 -0.728 . . . . 73.510000000000005 111.97 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -113.65 148.22 36.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.646 -1.242 . . . . 42.299999999999997 107.646 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.484 HG22 HD11 ' A' ' 486' ' ' ILE . 44.8 t -82.36 140.43 16.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.534 -0.913 . . . . 74.239999999999995 108.534 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.8 pt -96.96 -23.37 4.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.448 0.642 . . . . 54.030000000000001 109.402 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.39 175.48 38.62 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 109.062 -1.615 . . . . 75.030000000000001 109.062 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 472' ' ' PRO . 2.6 p -116.49 154.36 30.51 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.879 -0.785 . . . . 74.010000000000005 108.879 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.7 t30 -61.09 -46.65 96.23 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 123.56 0.537 . . . . 73.5 110.165 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.4 Cg_exo -83.36 137.07 7.97 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.036 1.158 . . . . 55.119999999999997 109.391 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 476' ' ' GLN . 9.8 Cg_endo -62.56 140.19 80.08 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.266 1.977 . . . . 73.140000000000001 112.051 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.567 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.53 -8.08 55.17 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 122.134 0.969 . . . . 75.109999999999999 111.153 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -94.65 -3.98 48.47 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.603 -1.18 . . . . 70.140000000000001 110.399 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.449 ' CG ' ' HG2' ' A' ' 473' ' ' PRO . 31.3 mm-40 -109.94 159.98 16.8 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 109.081 -0.711 . . . . 73.109999999999999 109.081 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.4 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 24.1 p -101.8 115.21 30.03 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.34 -1.356 . . . . 53.240000000000002 107.34 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 48.8 m -100.59 140.97 34.1 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.795 -0.446 . . . . 53.219999999999999 109.795 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.58 145.66 54.65 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.036 -0.529 . . . . 62.200000000000003 110.61 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.1 mm -67.24 -9.16 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 122.085 0.945 . . . . 72.010000000000005 110.752 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -77.51 -5.91 51.7 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.613 -0.679 . . . . 70.209999999999994 109.894 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.05 158.09 16.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.706 -0.621 . . . . 72.209999999999994 111.742 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.98 125.77 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.013 -1.847 . . . . 71.209999999999994 106.013 169.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.71 120.53 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.813 -0.755 . . . . 75.540000000000006 110.609 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.81 114.84 29.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.098 -1.445 . . . . 74.219999999999999 107.098 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.63 121.52 61.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 109.016 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.11 120.26 51.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.9 0.857 . . . . 73.230000000000004 112.446 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.0 t -96.56 146.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.588 -1.187 . . . . 73.319999999999993 108.955 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -82.83 123.41 6.09 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.026 -1.23 . . . . 50.420000000000002 110.026 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 28.8 t -110.95 143.83 40.99 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.167 -1.42 . . . . 75.400000000000006 107.167 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.874 0 C-N-CA 120.33 -0.938 . . . . 41.420000000000002 111.308 -177.505 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.915 0.864 . . . . 62.310000000000002 109.813 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 546' ' ' PRO . 32.6 p -137.32 160.06 40.15 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.75 -1.114 . . . . 74.150000000000006 108.957 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.402 ' CD ' ' HA2' ' A' ' 516' ' ' GLY . 50.7 mttm -141.47 143.06 33.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.33 0.394 . . . . 73.25 110.371 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.1 t70 -89.96 119.2 30.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.231 -1.396 . . . . 61.420000000000002 107.231 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.4 pt -81.9 123.42 80.1 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 112.473 0.546 . . . . 75.010000000000005 112.473 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.96 177.44 2.07 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.381 2.054 . . . . 72.519999999999996 109.287 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -85.57 138.12 32.4 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.026 -1.07 . . . . 73.409999999999997 109.526 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.67 19.01 4.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.561 -1.644 . . . . 53.109999999999999 106.561 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.592 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -77.01 153.37 34.56 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.167 -1.833 . . . . 75.129999999999995 111.657 -174.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.08 58.71 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.91 -0.662 . . . . 71.540000000000006 111.79 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.526 ' O ' HG12 ' A' ' 534' ' ' VAL . 21.0 mt-30 -121.47 -176.26 3.26 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 72.0 108.877 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.3 m -81.18 155.7 26.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 119.386 -0.925 . . . . 73.219999999999999 108.576 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.16 -41.45 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 111.619 0.229 . . . . 71.519999999999996 111.619 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.93 -42.25 85.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.378 -0.374 . . . . 64.200000000000003 111.46 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.7 p -76.04 -35.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.646 -0.822 . . . . 72.040000000000006 111.501 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.02 76.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.582 -0.736 . . . . 52.43 111.106 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.09 -38.52 91.02 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.959 -0.564 . . . . 74.329999999999998 110.355 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 514' ' ' VAL . 39.5 ttmt -63.53 -52.37 61.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 123.509 0.506 . . . . 64.439999999999998 110.866 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -62.9 -44.92 94.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 123.209 0.318 . . . . 65.239999999999995 110.302 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 31.0 tp -64.89 -36.88 85.79 Favored 'General case' 0 C--O 1.188 -2.149 0 CA-C-N 116.08 -0.509 . . . . 72.319999999999993 110.542 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.9 t-20 -59.61 -42.92 93.73 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.198 0.599 . . . . 74.409999999999997 110.492 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.9 t -67.7 -30.31 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.799 . . . . 70.329999999999998 111.443 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.18 15.09 14.05 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 121.679 -0.638 . . . . 74.140000000000001 110.785 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.402 ' HA2' ' CD ' ' A' ' 495' ' ' LYS . . . -155.12 -99.9 0.17 Allowed Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 118.248 -1.93 . . . . 64.310000000000002 116.637 -169.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 51.2 m-85 -115.31 161.84 17.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.264 . . . . 70.430000000000007 110.633 -168.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.2 p -102.51 -27.88 12.52 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.482 0.549 . . . . 62.439999999999998 112.482 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 9.3 mmpt? -108.79 128.46 54.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 120.589 0.233 . . . . 70.349999999999994 110.722 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 93.9 m-85 -125.18 145.21 50.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.512 -0.767 . . . . 74.400000000000006 110.375 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.1 t -115.71 159.57 21.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.137 -1.431 . . . . 60.399999999999999 107.137 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -121.18 129.09 53.07 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.744 -0.465 . . . . 72.019999999999996 109.744 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.55 129.75 44.85 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.221 -1.029 . . . . 23.350000000000001 108.221 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 9.2 m -89.21 130.68 35.58 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.041 -0.726 . . . . 70.530000000000001 109.041 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.37 157.57 26.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.339 -0.986 . . . . 74.040000000000006 108.339 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -79.69 142.21 35.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.229 0.537 . . . . 75.420000000000002 110.984 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 22.2 p -102.35 110.22 62.27 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.992 -1.004 . . . . 72.409999999999997 112.649 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -76.95 -51.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 121.644 1.562 . . . . 71.209999999999994 110.155 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.6 -64.25 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 112.38 0.511 . . . . 73.409999999999997 112.38 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.47 149.06 34.33 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.671 1.58 . . . . 63.229999999999997 112.969 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.93 138.81 25.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.575 -0.528 . . . . 62.420000000000002 109.575 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 87.79 -26.69 7.19 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 122.004 0.78 . . . . 50.130000000000003 111.816 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.57 150.0 23.98 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.614 -0.793 . . . . 72.0 111.826 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.8 p -74.41 125.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.433 -0.803 . . . . 41.100000000000001 110.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 14.3 p -88.97 -22.0 23.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.799 -0.637 . . . . 55.210000000000001 109.899 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.44 -159.13 30.95 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.205 -0.758 . . . . 74.439999999999998 111.205 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -118.39 161.04 20.62 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.27 -1.011 . . . . 75.140000000000001 108.27 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 15.1 t-20 -54.94 -55.3 40.27 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 119.216 -0.421 . . . . 72.409999999999997 111.877 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.8 Cg_exo -80.47 143.58 15.42 Favored 'Trans proline' 0 C--N 1.366 1.499 0 N-CA-C 108.374 -1.433 . . . . 65.329999999999998 108.374 170.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.71 157.36 52.24 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.306 2.004 . . . . 73.019999999999996 113.405 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.41 131.33 50.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.329 -0.85 . . . . 73.299999999999997 109.541 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.52 -6.95 36.32 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 110.765 -0.934 . . . . 53.409999999999997 110.765 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 36.0 m -88.45 129.33 35.46 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.543 -0.54 . . . . 73.239999999999995 109.543 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.0 m -96.75 123.22 40.38 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.195 -1.039 . . . . 54.219999999999999 108.195 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.62 158.37 72.17 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 110.179 -0.304 . . . . 74.319999999999993 110.179 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.421 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.6 Cg_exo -64.7 137.2 53.06 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.823 2.349 . . . . 74.120000000000005 111.654 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.508 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.5 m -67.48 -20.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.469 0.652 . . . . 52.509999999999998 111.808 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.69 2.1 46.69 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 74.040000000000006 111.319 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -93.09 167.78 11.55 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.292 -1.003 . . . . 42.340000000000003 108.292 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.43 116.61 44.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.133 -0.692 . . . . 74.450000000000003 109.133 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 15.4 tt -88.71 132.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.191 0.52 . . . . 64.140000000000001 109.99 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -102.91 131.07 50.1 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-O 121.489 0.661 . . . . 71.010000000000005 111.747 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.426 HD13 ' N ' ' A' ' 554' ' ' GLN . 1.8 tm? -99.78 135.3 41.41 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.951 1.3 . . . . 72.540000000000006 109.304 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.426 ' N ' HD13 ' A' ' 553' ' ' LEU . 25.9 mm-40 -94.69 106.44 18.42 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.489 -0.778 . . . . 64.030000000000001 108.91 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.07 122.33 47.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 109.427 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 25.6 p -76.52 115.35 16.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 108.779 -0.822 . . . . 74.140000000000001 108.779 -176.468 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 109.56 -0.533 . . . . 75.010000000000005 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.1 mt-30 -90.15 119.51 30.53 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.321 -0.4 . . . . 74.010000000000005 109.933 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.6 mmp_? -121.27 156.21 33.0 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.189 -0.46 . . . . 65.030000000000001 110.932 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.17 141.79 28.39 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.387 -0.824 . . . . 73.049999999999997 109.917 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -84.9 119.36 72.56 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.856 -1.164 . . . . 71.150000000000006 107.856 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.445 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 25.8 Cg_exo -68.47 142.28 53.6 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.265 1.977 . . . . 41.549999999999997 112.197 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 434' ' ' THR . 10.6 m-20 -84.95 37.57 0.67 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.696 0.76 . . . . 73.109999999999999 111.458 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 439' ' ' GLU . 10.9 p -87.26 -6.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.609 1.195 . . . . 52.109999999999999 108.086 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 3.3 p -59.02 -36.47 75.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.664 1.586 . . . . 73.430000000000007 110.47 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 431' ' ' ASP . 14.7 t -61.69 -26.71 68.21 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.0 -1.0 . . . . 65.099999999999994 110.789 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.47 -46.5 13.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.31 -0.956 . . . . 74.120000000000005 111.407 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.554 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 85.7 m -169.73 149.72 3.86 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.788 -0.819 . . . . 52.229999999999997 108.788 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 441' ' ' VAL . 54.4 t80 -52.75 -49.4 65.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.928 0.491 . . . . 72.349999999999994 111.309 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.19 -39.87 73.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 61.200000000000003 111.589 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.554 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.7 mm-40 -62.97 -43.78 97.85 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.935 -0.575 . . . . 65.310000000000002 111.01 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.11 -44.06 95.13 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.269 -0.878 . . . . 72.420000000000002 109.932 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.5 t -60.01 -49.53 83.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 115.999 -0.546 . . . . 64.209999999999994 111.142 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.0 mmtp -60.62 -47.67 85.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.045 0.45 . . . . 74.400000000000006 110.485 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.445 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 30.6 mmmt -67.93 -41.39 82.66 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.798 0.666 . . . . 62.329999999999998 112.798 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 22.4 tp -68.48 -38.8 81.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 60.009999999999998 109.736 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.2 m -59.28 -46.04 89.62 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.266 -0.879 . . . . 70.209999999999994 109.278 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.28 -20.17 63.91 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.522 -0.763 . . . . 54.219999999999999 111.692 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.4 -13.61 59.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.306 0.574 . . . . 51.329999999999998 109.986 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.23 -9.13 42.21 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.983 -0.627 . . . . 64.340000000000003 113.232 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 95.8 m-85 -67.38 115.59 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.941 0.371 . . . . 73.409999999999997 110.011 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.09 2.06 40.81 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.467 -0.873 . . . . 44.020000000000003 111.619 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -126.75 113.19 16.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.3 0.572 . . . . 75.129999999999995 109.553 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -148.73 165.15 32.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.539 -0.755 . . . . 72.319999999999993 112.188 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -140.4 131.7 26.68 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.828 -0.804 . . . . 73.140000000000001 108.828 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -93.21 135.31 34.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 123.425 0.453 . . . . 75.549999999999997 110.053 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -142.7 162.47 35.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.336 -1.357 . . . . 50.530000000000001 107.336 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.84 150.68 51.89 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 118.146 0.43 . . . . 74.030000000000001 110.636 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.0 m -138.03 146.75 53.49 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 107.963 -1.125 . . . . 71.310000000000002 107.963 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.98 130.01 22.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.733 1.622 . . . . 54.210000000000001 111.143 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -143.66 -179.72 6.62 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.579 -1.637 . . . . 61.039999999999999 106.579 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.06 142.61 85.37 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 123.004 0.522 . . . . 42.439999999999998 111.32 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 75.9 Cg_exo -51.68 -29.13 32.12 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.259 3.306 . . . . 75.129999999999995 111.66 174.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.1 -29.36 67.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.512 -0.767 . . . . 71.530000000000001 111.054 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.46 13.42 24.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.409 0.522 . . . . 71.120000000000005 112.409 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 15.0 p -60.47 128.02 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.075 -0.65 . . . . 73.310000000000002 110.468 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.18 11.46 83.53 Favored Glycine 0 C--O 1.249 1.069 0 C-N-CA 120.941 -0.647 . . . . 52.119999999999997 111.789 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -122.97 154.44 38.41 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.083 -1.08 . . . . 73.25 108.083 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 486' ' ' ILE . 46.2 t -82.43 141.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.275 -0.639 . . . . 74.200000000000003 109.275 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.2 pt -97.49 -29.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.456 -0.498 . . . . 73.510000000000005 110.339 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.62 -179.01 47.05 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.531 -1.028 . . . . 62.509999999999998 110.531 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -124.23 152.17 43.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.512 -0.551 . . . . 34.420000000000002 109.512 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.0 t-20 -60.91 -49.95 86.99 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 112.285 0.476 . . . . 74.010000000000005 112.285 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.1 Cg_exo -78.16 142.69 19.48 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.154 1.236 . . . . 72.0 109.361 171.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.49 132.98 40.53 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.697 2.265 . . . . 63.140000000000001 111.897 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.72 -12.73 59.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.025 0.917 . . . . 65.140000000000001 110.706 -175.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.93 11.55 37.06 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.902 -1.045 . . . . 64.109999999999999 109.713 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -125.57 169.96 11.94 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 106.527 -1.657 . . . . 74.439999999999998 106.527 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.2 p -107.11 115.3 29.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 N-CA-C 108.031 -1.099 . . . . 74.310000000000002 108.031 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 30.3 m -102.03 138.81 38.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.407 -0.59 . . . . 74.150000000000006 109.407 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -66.67 137.16 56.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.614 -0.513 . . . . 64.349999999999994 109.614 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.23 -25.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 124.543 1.137 . . . . 44.240000000000002 113.074 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.3 t -71.44 -7.01 44.59 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 120.996 0.427 . . . . 71.140000000000001 111.76 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 32.7 m-80 -90.11 145.5 25.01 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 116.519 -0.309 . . . . 65.329999999999998 110.966 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.08 117.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.347 0.594 . . . . 70.109999999999999 109.759 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.79 118.86 34.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.707 -0.849 . . . . 75.530000000000001 108.707 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -92.63 113.23 27.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.247 -1.39 . . . . 53.219999999999999 107.247 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.51 119.82 53.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.337 -0.847 . . . . 73.25 109.397 -178.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -104.11 123.79 58.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.718 0.77 . . . . 72.299999999999997 112.252 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.18 144.29 10.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 114.802 -1.09 . . . . 72.010000000000005 108.724 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.74 120.72 5.54 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 111.345 -0.702 . . . . 70.030000000000001 111.345 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.8 t -101.46 129.49 47.51 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.909 -1.885 . . . . 73.340000000000003 105.909 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.431 0 C-N-CA 120.271 -0.966 . . . . 63.210000000000001 113.089 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 108.503 -0.925 . . . . 73.439999999999998 108.503 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 546' ' ' PRO . 16.6 p -136.99 154.67 50.35 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.821 -1.081 . . . . 71.299999999999997 109.232 -176.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.01 142.49 36.27 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.368 0.418 . . . . 72.340000000000003 109.982 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -80.82 132.2 35.46 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.262 -1.385 . . . . 72.409999999999997 107.262 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.69 129.88 80.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.998 -0.546 . . . . 75.420000000000002 110.059 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -87.07 160.79 8.67 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.565 2.177 . . . . 62.420000000000002 110.948 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.69 135.69 33.55 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.588 -0.845 . . . . 52.329999999999998 109.434 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.6 16.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 122.507 1.146 . . . . 63.219999999999999 108.416 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.63 40.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.726 -1.125 . . . . 54.109999999999999 109.719 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.68 -26.9 11.06 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.973 -1.251 . . . . 70.409999999999997 109.973 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -91.01 176.36 6.62 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.668 -1.234 . . . . 72.310000000000002 107.668 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 36.3 p -81.57 157.24 24.84 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.167 -0.613 . . . . 74.310000000000002 110.15 -175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 555' ' ' VAL . 9.9 p -52.61 -41.73 38.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.601 0.563 . . . . 72.230000000000004 112.28 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.25 -43.08 78.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.574 0.583 . . . . 73.540000000000006 112.574 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.29 -36.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 118.837 -1.145 . . . . 75.150000000000006 111.519 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.36 77.48 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.136 -0.938 . . . . 71.209999999999994 111.39 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.94 -35.01 79.8 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 123.238 0.336 . . . . 71.329999999999998 110.513 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.4 tttp -60.98 -51.61 68.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 123.244 0.34 . . . . 61.310000000000002 110.13 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.66 -44.77 95.42 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.726 -0.67 . . . . 54.43 110.376 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.08 -43.21 95.67 Favored 'General case' 0 C--O 1.179 -2.606 0 CA-C-N 115.404 -0.816 . . . . 70.150000000000006 109.999 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 24.6 t-20 -59.05 -39.54 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.508 0.723 . . . . 73.420000000000002 112.146 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.94 -0.573 . . . . 52.420000000000002 111.626 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.75 -39.28 7.91 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.311 -0.956 . . . . 74.349999999999994 110.165 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -95.09 -101.19 1.79 Allowed Glycine 0 N--CA 1.412 -2.945 0 CA-C-N 113.954 -1.475 . . . . 52.229999999999997 115.3 -170.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 16.9 m-85 -133.53 172.17 13.09 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.911 -167.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 18.7 m -109.84 -1.95 17.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.593 -0.73 . . . . 72.120000000000005 110.073 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.36 116.39 31.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.125 -0.488 . . . . 72.25 109.899 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.35 151.27 49.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.005 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -140.98 158.53 43.8 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.142 -1.429 . . . . 34.439999999999998 107.142 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -121.77 152.11 39.83 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.416 0.627 . . . . 71.040000000000006 111.818 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.487 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -134.29 125.74 28.31 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.747 -1.205 . . . . 40.530000000000001 107.747 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.9 m -88.68 131.36 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.33 -1.359 . . . . 62.439999999999998 107.33 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.3 150.52 24.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.236 -0.586 . . . . 72.430000000000007 109.921 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.07 133.6 36.78 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.014 -0.735 . . . . 70.450000000000003 109.014 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.6 m -143.59 138.85 15.71 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.049 -0.722 . . . . 73.540000000000006 109.049 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.12 -58.51 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.2 . . . . 74.340000000000003 113.178 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.417 ' H ' ' CD ' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -115.26 -41.26 0.07 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 118.586 -0.721 . . . . 74.420000000000002 112.943 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.417 ' CD ' ' H ' ' A' ' 529' ' ' ARG . 80.8 Cg_exo -55.83 149.73 49.38 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 121.688 1.592 . . . . 73.239999999999995 112.972 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.95 113.16 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.813 -1.18 . . . . 55.439999999999998 107.813 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.04 -34.05 4.63 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.385 -0.912 . . . . 54.520000000000003 112.192 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 2.5 pm0 -85.17 147.96 26.35 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-O 121.579 0.704 . . . . 74.319999999999993 111.813 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.23 125.51 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.877 -1.157 . . . . 71.129999999999995 107.877 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.2 m -86.18 -33.95 20.65 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.677 -0.692 . . . . 72.010000000000005 109.596 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -179.94 -176.63 47.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.78 -0.928 . . . . 63.109999999999999 110.78 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.7 p -117.88 160.12 21.95 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 107.585 -1.265 . . . . 64.239999999999995 107.585 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.477 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.2 t-20 -60.23 -53.84 61.01 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.532 -0.467 . . . . 51.119999999999997 111.348 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 75.2 Cg_endo -88.41 146.73 6.2 Favored 'Trans proline' 0 C--N 1.369 1.613 0 CA-C-N 120.103 1.072 . . . . 71.439999999999998 110.116 171.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.39 159.53 52.63 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.174 1.916 . . . . 72.519999999999996 111.335 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 135.02 57.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.625 0.37 . . . . 73.420000000000002 110.729 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.88 48.62 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.678 -0.772 . . . . 63.5 111.933 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.7 m -71.39 121.7 19.03 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.442 -0.577 . . . . 72.430000000000007 109.442 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.4 t -83.61 126.7 33.11 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.5 0.5 . . . . 71.200000000000003 109.825 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.91 156.57 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.801 -0.814 . . . . 63.229999999999997 108.801 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.4 Cg_exo -59.47 144.71 99.34 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.436 2.09 . . . . 71.409999999999997 111.741 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.9 m -66.15 -20.54 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.327 0.492 . . . . 71.099999999999994 112.327 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.81 3.51 54.23 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.067 -0.515 . . . . 74.019999999999996 111.196 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -84.68 146.14 27.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.57 -0.529 . . . . 65.329999999999998 109.57 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.83 118.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.057 -1.09 . . . . 74.120000000000005 108.057 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.1 tt -94.32 145.91 7.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 120.962 0.411 . . . . 54.119999999999997 110.398 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 27.1 tt0 -102.62 127.91 49.52 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-O 121.203 0.525 . . . . 75.200000000000003 109.932 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.05 115.19 29.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.49 -1.232 . . . . 62.350000000000001 107.867 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.487 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 77.3 mt-30 -92.48 108.01 19.65 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.456 0.646 . . . . 74.319999999999993 109.468 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.483 HG21 ' HB ' ' A' ' 505' ' ' VAL . 8.0 p -113.78 139.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.056 -0.974 . . . . 75.239999999999995 111.368 -174.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 m -57.81 128.66 38.2 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.928 -1.138 . . . . 50.219999999999999 107.928 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 65.8 pttt . . . . . 0 C--O 1.264 1.868 0 N-CA-C 113.619 0.97 . . . . 74.340000000000003 113.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 123.143 1.449 . . . . 73.400000000000006 109.059 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.4 mt-30 -111.09 153.88 25.05 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.48 -1.691 . . . . 72.230000000000004 111.886 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.05 149.74 52.16 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.365 -0.834 . . . . 73.230000000000004 110.364 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -95.14 140.57 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 72.230000000000004 108.129 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.47 122.0 82.06 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 122.912 0.133 . . . . 53.310000000000002 110.69 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 142.49 33.43 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.014 2.476 . . . . 73.099999999999994 111.908 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -99.46 78.03 2.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.425 1.107 . . . . 70.019999999999996 110.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.1 m -112.44 5.34 8.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 N-CA-C 106.061 -1.829 . . . . 74.140000000000001 106.061 171.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.466 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -59.62 -38.69 82.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.684 -2.053 . . . . 64.239999999999995 110.611 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -26.34 68.46 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.283 -1.326 . . . . 61.25 112.166 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.22 -46.01 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.847 -0.427 . . . . 65.209999999999994 109.847 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 175.49 158.3 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.671 1.188 . . . . 63.43 111.335 175.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 441' ' ' VAL . 58.1 t80 -51.54 -43.69 62.43 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.91 1.284 . . . . 74.109999999999999 110.78 172.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.88 83.03 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.743 0.652 . . . . 33.439999999999998 111.036 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 19.4 mm-40 -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.692 -0.686 . . . . 64.450000000000003 109.903 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.55 -47.53 85.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.197 -0.91 . . . . 72.450000000000003 111.352 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 437' ' ' TYR . 98.8 t -59.37 -48.47 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 123.433 0.458 . . . . 72.409999999999997 111.371 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.5 mmpt? -63.86 -47.11 82.01 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.09 0.244 . . . . 54.43 111.283 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.7 mptp? -67.29 -38.52 85.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.488 0.551 . . . . 74.049999999999997 112.488 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 tp -68.02 -39.62 83.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.459 0.647 . . . . 51.509999999999998 109.44 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.24 -41.16 99.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.522 -0.763 . . . . 75.25 109.376 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.42 62.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.475 -0.784 . . . . 63.109999999999999 111.216 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.46 -13.81 53.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 74.239999999999995 109.431 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.92 56.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-N 115.702 -0.681 . . . . 75.430000000000007 113.862 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.93 133.04 46.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.157 0.503 . . . . 74.030000000000001 111.893 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.98 18.34 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.409 -0.814 . . . . 74.129999999999995 112.109 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -123.92 116.36 22.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.74 0.781 . . . . 73.200000000000003 112.044 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -143.06 147.19 34.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.225 -0.898 . . . . 74.519999999999996 110.181 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -131.02 133.9 46.17 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.688 -1.227 . . . . 73.099999999999994 107.688 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -95.47 121.43 37.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.204 0.526 . . . . 71.239999999999995 110.779 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.23 141.45 48.28 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.386 -0.968 . . . . 74.329999999999998 108.386 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -126.72 144.15 51.02 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.535 -0.543 . . . . 72.040000000000006 109.535 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.8 p -144.52 149.9 45.6 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.988 -0.551 . . . . 43.049999999999997 109.997 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.3 Cg_exo -65.54 140.55 63.32 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.258 1.972 . . . . 72.510000000000005 111.114 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.2 t -152.27 179.39 8.57 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.765 -1.198 . . . . 73.109999999999999 107.765 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.4 t -66.65 144.55 98.67 Favored Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 123.705 0.802 . . . . 63.409999999999997 110.589 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.464 ' HA ' HG23 ' A' ' 464' ' ' VAL . 88.9 Cg_exo -51.42 -29.34 30.7 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.41 3.407 . . . . 73.340000000000003 112.623 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -68.51 -32.13 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.804 -0.634 . . . . 75.140000000000001 111.823 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.91 9.01 39.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.551 0.575 . . . . 73.420000000000002 112.551 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 461' ' ' PRO . 92.6 t -60.76 127.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.822 -0.436 . . . . 70.420000000000002 109.822 177.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.45 -12.28 64.91 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.627 -0.797 . . . . 64.349999999999994 111.946 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.2 146.73 23.48 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.313 -0.625 . . . . 74.230000000000004 109.313 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 64.9 t -82.67 124.79 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 N-CA-C 106.649 -1.611 . . . . 75.340000000000003 106.649 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 25.5 pt -97.85 -2.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 120.9 0.381 . . . . 64.319999999999993 111.579 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.96 164.93 20.26 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 120.236 -0.983 . . . . 63.140000000000001 111.788 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.4 p -120.77 142.71 49.32 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.725 -1.583 . . . . 73.239999999999995 106.725 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 6.1 t30 -63.97 -45.01 80.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 123.544 0.527 . . . . 73.439999999999998 110.494 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.99 139.8 12.23 Favored 'Trans proline' 0 C--N 1.375 1.938 0 CA-C-N 120.347 1.16 . . . . 71.209999999999994 109.912 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.9 144.08 63.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.697 2.264 . . . . 62.229999999999997 112.338 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.94 15.9 4.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.069 0.938 . . . . 52.420000000000002 110.483 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.02 -28.74 12.56 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.863 -1.062 . . . . 74.409999999999997 111.576 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.02 154.09 31.53 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.118 -0.697 . . . . 73.439999999999998 109.118 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 16.3 p -81.59 135.27 35.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.973 -0.558 . . . . 73.439999999999998 110.566 -177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.3 m -111.9 138.24 48.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.832 -0.803 . . . . 72.310000000000002 108.832 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -61.02 150.41 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.272 0.358 . . . . 60.439999999999998 110.824 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.58 -28.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.449 0.7 . . . . 72.209999999999994 111.041 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -88.07 0.87 55.46 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.686 -0.688 . . . . 70.230000000000004 111.439 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.08 148.99 27.18 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.002 -0.74 . . . . 75.120000000000005 109.002 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 30.9 t -92.14 111.49 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.746 -0.835 . . . . 74.540000000000006 108.746 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 86.0 t -91.0 118.82 37.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.131 -0.692 . . . . 61.119999999999997 109.131 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.475 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.8 mt -93.8 114.25 30.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.745 -0.835 . . . . 61.409999999999997 108.745 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.6 124.97 54.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.271 -0.64 . . . . 63.25 109.271 -178.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.48 116.25 49.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.354 0.597 . . . . 73.129999999999995 111.073 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.98 140.72 16.91 Favored 'Isoleucine or valine' 0 C--O 1.252 1.225 0 CA-C-N 115.824 -0.626 . . . . 74.340000000000003 110.288 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.69 117.23 4.6 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.546 -1.422 . . . . 61.439999999999998 109.546 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.8 m -125.03 135.68 52.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.684 -0.488 . . . . 64.540000000000006 109.684 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.739 0 N-CA-C 110.006 -1.238 . . . . 75.109999999999999 110.006 -179.468 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.279 -1.008 . . . . 74.430000000000007 108.279 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.2 p -128.29 155.29 44.84 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.79 -1.095 . . . . 64.120000000000005 109.842 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -142.65 149.98 39.63 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 71.150000000000006 109.35 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -85.35 138.07 32.53 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.47 -1.307 . . . . 72.120000000000005 107.47 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -83.1 120.39 75.87 Favored Pre-proline 0 C--N 1.291 -1.937 0 C-N-CA 119.808 -0.757 . . . . 73.120000000000005 110.028 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.76 158.48 21.49 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.737 1.625 . . . . 73.209999999999994 109.431 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.42 101.91 2.07 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.064 0.935 . . . . 75.319999999999993 110.977 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.36 -1.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.666 -1.235 . . . . 70.230000000000004 107.666 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.72 119.91 15.56 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 113.822 -1.536 . . . . 63.130000000000003 107.962 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.37 -27.65 5.74 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.439 -1.464 . . . . 61.409999999999997 109.439 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -83.94 178.41 7.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.021 -0.733 . . . . 75.400000000000006 109.021 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.3 m -91.12 155.87 18.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.978 . . . . 72.219999999999999 108.361 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 -47.85 56.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 112.55 0.574 . . . . 72.319999999999993 112.55 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 20.6 m-20 -69.46 -41.38 76.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.538 0.57 . . . . 63.140000000000001 112.538 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.26 -35.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.445 -0.902 . . . . 63.509999999999998 111.55 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.67 -48.95 77.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.44 -0.8 . . . . 63.149999999999999 111.322 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.42 -37.02 85.7 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 120.194 -0.602 . . . . 62.119999999999997 110.608 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 2.1 mptm? -65.94 -52.13 52.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.136 0.791 . . . . 73.219999999999999 113.136 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . 0.253 33.3 p30 -69.08 -37.59 78.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.761 0.652 . . . . 72.519999999999996 112.761 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.28 -36.8 83.89 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-O 120.516 0.198 . . . . 74.219999999999999 110.742 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.5 t-20 -58.28 -37.53 75.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.59 0.756 . . . . 75.010000000000005 111.724 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.88 -38.72 83.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.717 -0.674 . . . . 65.329999999999998 111.53 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -105.51 -13.86 15.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.764 -0.774 . . . . 64.140000000000001 110.695 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -125.12 -97.74 1.15 Allowed Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 117.067 1.587 . . . . 51.140000000000001 117.067 -166.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 2.7 m-85 -127.59 153.69 46.1 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.04 0.448 . . . . 72.450000000000003 110.161 -163.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.4 m -106.31 -6.43 18.37 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.196 -0.911 . . . . 71.209999999999994 109.436 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -108.23 115.02 29.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.838 -0.619 . . . . 53.0 109.973 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.42 156.25 37.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.212 -0.904 . . . . 73.420000000000002 111.482 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 65.7 m -138.09 152.94 49.25 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.036 -1.839 . . . . 43.329999999999998 106.036 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -119.77 131.19 55.27 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.829 -0.804 . . . . 75.040000000000006 108.829 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -115.48 140.43 49.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.442 -0.947 . . . . 70.329999999999998 108.442 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.1 m -104.36 119.47 39.03 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.165 -0.68 . . . . 70.219999999999999 109.165 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.4 153.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.968 -0.753 . . . . 74.319999999999993 108.968 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.7 135.4 36.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.039 -0.664 . . . . 74.400000000000006 110.041 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 m -146.26 136.31 11.94 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 107.242 -1.392 . . . . 51.149999999999999 107.242 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.12 150.97 66.76 Favored 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.365 2.043 . . . . 73.129999999999995 112.156 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 530' ' ' PRO 0.406 75.8 mtm180 37.64 -89.49 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 118.166 2.654 . . . . 71.140000000000001 118.166 179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 50.7 Cg_exo -57.56 148.53 72.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.15 1.9 . . . . 54.539999999999999 113.743 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.05 160.09 40.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.906 -0.776 . . . . 71.120000000000005 108.906 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 105.3 -21.28 35.66 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 120.523 -0.846 . . . . 33.310000000000002 112.695 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.65 148.29 25.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.282 0.563 . . . . 73.340000000000003 111.215 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.53 119.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 63.219999999999999 108.676 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.0 m -88.21 -25.52 22.86 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.58 0.705 . . . . 65.420000000000002 109.836 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.24 178.66 47.09 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.212 -0.755 . . . . 61.329999999999998 111.212 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.2 p -118.57 160.4 21.85 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.123 -1.065 . . . . 73.230000000000004 108.123 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.4 t-20 -60.49 -54.67 52.62 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-O 119.146 -0.454 . . . . 72.510000000000005 112.057 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.2 Cg_endo -86.17 153.0 9.53 Favored 'Trans proline' 0 C--N 1.365 1.413 0 CA-C-N 120.461 1.2 . . . . 70.439999999999998 109.549 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.68 150.87 85.9 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.032 1.822 . . . . 73.219999999999999 111.577 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.64 58.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.604 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.99 54.1 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 121.095 -0.574 . . . . 51.439999999999998 112.0 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.8 m -69.55 129.17 38.93 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.776 -0.25 . . . . 74.150000000000006 110.332 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -93.86 122.95 36.87 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.5 161.42 60.82 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.449 -0.796 . . . . 51.039999999999999 109.07 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.518 ' HA ' HG22 ' A' ' 494' ' ' THR . 33.4 Cg_exo -60.61 136.25 65.85 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.569 2.18 . . . . 73.109999999999999 111.381 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 29.2 m -67.07 -21.36 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 70.400000000000006 111.494 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -86.34 -1.81 57.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.762 -0.654 . . . . 72.310000000000002 110.863 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.1 t -85.85 168.38 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.322 0.582 . . . . 51.130000000000003 110.419 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.9 t -97.61 136.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.34 -0.846 . . . . 74.319999999999993 108.804 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.0 tt -112.84 144.26 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.723 -0.473 . . . . 75.109999999999999 109.723 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 26.6 tt0 -103.53 122.71 45.5 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 108.815 -0.809 . . . . 72.120000000000005 108.815 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.4 tp -100.68 117.82 35.56 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.045 -1.094 . . . . 72.430000000000007 108.045 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.501 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 78.3 mt-30 -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.987 0.899 . . . . 74.409999999999997 110.325 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.33 141.21 23.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.085 -1.416 . . . . 64.409999999999997 111.872 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -55.78 122.84 12.37 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.618 -0.719 . . . . 73.0 110.208 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.147 -1.057 . . . . 61.43 108.147 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.142 0.496 . . . . 74.450000000000003 110.808 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 58.9 mt-30 -115.85 156.33 26.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.057 . . . . 75.510000000000005 108.145 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -150.95 155.41 39.04 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.404 -1.332 . . . . 74.510000000000005 107.404 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.36 141.1 28.89 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 110.061 -0.348 . . . . 73.439999999999998 110.061 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -78.39 130.21 72.35 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.005 -1.109 . . . . 73.340000000000003 108.005 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.64 144.19 93.75 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.572 2.182 . . . . 74.239999999999995 112.839 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.16 20.4 11.43 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.238 0.542 . . . . 65.120000000000005 111.342 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.405 HG11 ' HG3' ' A' ' 443' ' ' LYS . 8.7 p -83.29 -1.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.408 1.099 . . . . 71.310000000000002 108.435 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.8 p -60.09 -34.23 73.19 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.178 1.391 . . . . 41.399999999999999 110.097 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -59.33 -27.84 66.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.253 -1.339 . . . . 65.230000000000004 111.27 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 70.5 mt -90.77 -47.19 7.78 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 119.204 -0.998 . . . . 43.350000000000001 112.041 -175.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 6.4 m -159.9 148.28 17.21 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.386 -0.598 . . . . 73.200000000000003 109.386 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 441' ' ' VAL . 26.7 t80 -56.42 -47.85 78.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.022 0.529 . . . . 71.010000000000005 110.396 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -56.81 -44.28 81.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.944 -0.571 . . . . 65.430000000000007 111.165 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.524 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.6 mm-40 -63.82 -41.6 97.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.929 -0.578 . . . . 71.430000000000007 110.945 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.92 -46.33 89.7 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.361 -0.836 . . . . 65.519999999999996 110.673 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 437' ' ' TYR . 87.4 t -60.95 -46.31 96.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 O-C-N 123.792 0.683 . . . . 71.439999999999998 111.361 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 66.7 mttm -60.62 -48.53 81.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.06 0.457 . . . . 74.140000000000001 110.38 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.405 ' HG3' HG11 ' A' ' 432' ' ' VAL . 46.7 mmtm -67.65 -38.94 84.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.676 -0.693 . . . . 61.509999999999998 112.85 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.5 tp -68.54 -38.48 80.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.284 0.564 . . . . 72.219999999999999 109.574 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -61.82 -43.38 98.97 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.354 -0.839 . . . . 63.340000000000003 109.226 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.3 -16.0 62.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.73 -0.668 . . . . 71.540000000000006 111.736 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.84 -14.16 51.93 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 121.328 0.585 . . . . 71.109999999999999 109.539 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.93 55.88 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.616 -0.72 . . . . 71.25 113.891 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -59.62 131.1 49.9 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.391 0.595 . . . . 65.310000000000002 112.419 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -80.28 -43.77 9.3 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.214 -0.903 . . . . 72.510000000000005 114.183 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.406 ' HG3' HG13 ' A' ' 483' ' ' VAL . 30.7 tpt180 -129.62 132.77 46.84 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.793 0.806 . . . . 73.219999999999999 112.531 -175.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -140.73 150.38 43.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.814 -1.084 . . . . 61.0 109.991 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -130.31 130.69 44.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.059 -0.719 . . . . 60.210000000000001 109.059 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.418 HE21 HG21 ' A' ' 488' ' ' VAL . 57.7 tt0 -92.92 132.42 37.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.274 0.559 . . . . 71.409999999999997 111.321 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.48 148.94 50.31 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.946 -1.501 . . . . 62.100000000000001 106.946 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.6 148.07 48.09 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.174 -0.611 . . . . 71.420000000000002 110.091 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 28.6 m -142.75 142.55 22.95 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.988 -0.745 . . . . 74.450000000000003 108.988 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.5 Cg_exo -67.06 128.57 18.87 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.436 2.091 . . . . 72.019999999999996 111.57 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.9 m -140.28 179.22 6.77 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.757 -0.46 . . . . 70.030000000000001 109.757 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.8 t -54.88 139.87 61.61 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 123.885 0.874 . . . . 73.030000000000001 111.439 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.412 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.6 Cg_endo -52.01 -31.28 43.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.112 3.208 . . . . 63.020000000000003 113.387 -178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.34 -12.7 60.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.039 0.447 . . . . 73.319999999999993 111.847 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 30.8 tp -113.17 1.27 15.2 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.227 0.537 . . . . 71.120000000000005 110.29 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.1 t -61.35 127.23 20.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.102 0.477 . . . . 34.530000000000001 110.722 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.18 -6.86 66.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 116.011 -0.54 . . . . 65.430000000000007 112.281 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.5 mptp? -99.87 157.3 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.786 -0.82 . . . . 73.030000000000001 108.786 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.578 HG22 HD11 ' A' ' 486' ' ' ILE . 59.0 t -81.94 131.5 33.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 73.310000000000002 107.944 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.4 pt -98.57 -4.53 9.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.43 -0.508 . . . . 64.439999999999998 111.425 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.92 154.18 7.29 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.461 -0.791 . . . . 55.409999999999997 111.493 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 18.4 p -116.76 146.37 42.87 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.135 -0.691 . . . . 64.200000000000003 109.135 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -59.1 -49.66 91.92 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.086 -0.483 . . . . 75.519999999999996 111.654 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.9 Cg_exo -82.86 144.07 12.03 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.443 1.429 . . . . 75.140000000000001 110.305 172.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 9.5 Cg_endo -75.65 135.92 18.49 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.325 2.016 . . . . 75.319999999999993 111.871 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.96 -0.29 27.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.837 0.827 . . . . 65.319999999999993 111.058 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.61 -27.01 34.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.64 -1.164 . . . . 65.340000000000003 110.418 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -113.88 175.03 5.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.291 -0.413 . . . . 74.530000000000001 110.578 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 17.2 p -98.68 115.37 28.54 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 108.534 -0.913 . . . . 73.349999999999994 108.534 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.2 m -100.44 144.19 29.72 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.906 -0.775 . . . . 61.539999999999999 108.906 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -62.11 135.08 57.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 61.350000000000001 111.388 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.4 mm -57.11 -27.09 26.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.062 1.745 . . . . 74.019999999999996 112.524 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -75.27 -11.01 59.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.969 -0.56 . . . . 60.130000000000003 111.046 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 43.9 m-80 -78.08 150.24 33.77 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 112.797 0.666 . . . . 64.519999999999996 112.797 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 451' ' ' ARG . 77.4 t -86.36 114.93 26.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.632 -1.247 . . . . 72.510000000000005 107.632 175.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.0 119.4 35.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.879 -0.785 . . . . 62.509999999999998 108.879 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -92.86 118.75 39.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.413 -1.328 . . . . 53.030000000000001 107.413 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.29 123.27 68.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.725 -0.67 . . . . 54.049999999999997 109.544 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 487' ' ' ILE . 3.1 mp -104.87 124.53 59.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.137 0.494 . . . . 73.230000000000004 110.005 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.418 HG21 HE21 ' A' ' 454' ' ' GLN . 21.7 t -103.21 140.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.728 -0.669 . . . . 71.230000000000004 110.064 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 120.51 5.17 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.521 -1.432 . . . . 74.319999999999993 109.521 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.0 t -118.33 160.45 21.63 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.411 -0.959 . . . . 73.319999999999993 108.411 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.378 0 C-N-CA 120.418 -0.896 . . . . 61.43 111.796 -178.27 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 122.066 0.936 . . . . 72.030000000000001 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 546' ' ' PRO . 10.4 p -135.26 159.21 42.28 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.872 -1.058 . . . . 74.340000000000003 109.498 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -146.28 141.79 27.69 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.352 -0.61 . . . . 75.310000000000002 109.352 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.8 p-10 -89.14 138.13 31.7 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.961 -0.755 . . . . 74.099999999999994 108.961 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.3 pt -93.86 137.54 23.07 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 116.197 -0.456 . . . . 72.519999999999996 111.93 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.53 171.83 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.935 2.423 . . . . 74.219999999999999 112.112 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -82.84 110.57 17.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.588 0.709 . . . . 71.540000000000006 111.115 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.55 8.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.389 -0.823 . . . . 64.400000000000006 110.053 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.02 140.27 32.81 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.044 -0.525 . . . . 74.010000000000005 109.744 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.09 -13.44 58.8 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.126 -1.19 . . . . 71.010000000000005 110.126 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.477 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 17.2 mt-30 -93.96 178.3 5.7 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.264 -1.013 . . . . 73.430000000000007 108.264 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.2 p -85.54 157.5 20.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.145 -0.687 . . . . 74.540000000000006 109.145 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.41 -42.21 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.481 0.488 . . . . 65.420000000000002 112.092 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.01 -41.99 81.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.128 -0.629 . . . . 74.209999999999994 111.354 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 7.1 p -76.9 -36.42 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 118.577 -1.249 . . . . 52.030000000000001 111.125 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.84 -48.77 75.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.874 -0.603 . . . . 74.109999999999999 111.315 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.51 -35.15 80.02 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 123.293 0.37 . . . . 64.25 110.072 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 514' ' ' VAL . 50.4 tptt -63.49 -51.72 64.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.342 0.401 . . . . 54.219999999999999 110.248 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -61.89 -41.53 98.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.164 0.506 . . . . 75.430000000000007 110.126 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.408 HD21 HD13 ' A' ' 551' ' ' ILE . 37.2 tp -64.35 -47.77 78.07 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 110.171 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.87 -41.21 91.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.811 0.444 . . . . 53.329999999999998 111.919 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.3 t -63.87 -34.09 66.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.326 0.491 . . . . 63.200000000000003 112.326 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.27 -19.23 11.37 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.003 -1.079 . . . . 75.519999999999996 112.274 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -99.93 -103.5 2.52 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.71 -0.677 . . . . 61.409999999999997 114.541 -173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 11.5 m-85 -135.77 -178.59 5.2 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 110.265 -0.272 . . . . 64.25 110.265 -169.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -115.56 3.95 14.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.135 0.493 . . . . 55.200000000000003 111.106 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -108.12 115.54 30.31 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.658 -0.867 . . . . 74.510000000000005 108.658 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.63 151.5 50.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.757 0.789 . . . . 74.409999999999997 111.518 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.0 m -134.69 151.08 50.74 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.623 -1.621 . . . . 61.240000000000002 106.623 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -120.77 122.6 40.71 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.582 -1.266 . . . . 62.539999999999999 107.582 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.97 117.15 30.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.748 -1.204 . . . . 73.329999999999998 107.748 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.9 p -88.75 124.52 34.21 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 108.304 -0.999 . . . . 71.329999999999998 108.304 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.98 153.53 26.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.857 -0.794 . . . . 73.010000000000005 108.857 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.8 115.63 17.7 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.631 -1.248 . . . . 64.420000000000002 107.631 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 19.2 m -119.89 168.77 9.59 Favored Pre-proline 0 C--N 1.282 -2.356 0 CA-C-N 114.515 -1.22 . . . . 70.430000000000007 110.663 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 25.4 Cg_endo -61.9 -166.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 123.031 2.487 . . . . 75.340000000000003 112.165 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -50.67 -51.86 61.64 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 115.272 1.582 . . . . 73.439999999999998 115.272 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.24 133.71 36.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 CA-C-N 120.706 1.288 . . . . 64.209999999999994 111.495 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.424 ' HA ' ' OG ' ' A' ' 556' ' ' SER . . . -142.61 157.79 44.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.32 -0.622 . . . . 32.200000000000003 109.32 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 99.86 -24.89 30.39 Favored Glycine 0 C--N 1.313 -0.696 0 N-CA-C 110.389 -1.084 . . . . 51.329999999999998 110.389 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.95 148.04 25.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.346 -0.927 . . . . 75.140000000000001 110.154 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.83 119.12 23.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.109 -0.496 . . . . 72.129999999999995 111.038 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 24.0 m -73.16 -35.1 66.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.942 -1.026 . . . . 73.019999999999996 109.046 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.46 -161.58 35.31 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 111.084 -0.807 . . . . 74.319999999999993 111.084 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -130.34 160.8 32.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.524 -0.917 . . . . 61.140000000000001 108.524 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.5 t-20 -53.22 -57.87 14.88 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.493 0.496 . . . . 73.310000000000002 111.398 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.3 Cg_endo -89.2 147.42 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 CA-C-N 120.797 1.32 . . . . 73.5 109.11 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.75 155.64 69.61 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.692 1.595 . . . . 54.149999999999999 111.811 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.6 137.46 58.17 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 122.62 0.368 . . . . 65.140000000000001 110.118 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.26 -6.0 61.28 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.988 -0.625 . . . . 53.109999999999999 111.834 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.9 m -86.79 134.56 33.55 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.67 -0.312 . . . . 43.43 110.863 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.7 m -92.49 123.78 36.05 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.5 -0.926 . . . . 75.420000000000002 108.5 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.03 158.2 75.86 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.452 -0.573 . . . . 75.019999999999996 109.452 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 494' ' ' THR . 47.2 Cg_exo -58.74 144.33 98.19 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.825 2.35 . . . . 41.240000000000002 112.162 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 34.4 m -67.48 -20.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.664 0.616 . . . . 62.109999999999999 112.664 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.23 4.41 54.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.209 -0.451 . . . . 73.209999999999994 110.683 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -77.33 140.97 40.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.08 -1.081 . . . . 60.340000000000003 108.08 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.5 t -88.31 112.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.488 -1.301 . . . . 62.5 107.488 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 512' ' ' LEU . 19.8 tt -86.57 133.73 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.743 0.782 . . . . 72.450000000000003 111.399 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 21.0 tt0 -102.81 125.67 49.65 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.145 -0.934 . . . . 71.129999999999995 109.437 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.59 131.82 44.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.901 -1.148 . . . . 74.310000000000002 107.901 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -92.67 105.02 17.25 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 107.74 -1.207 . . . . 62.240000000000002 107.74 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.8 p -100.29 132.81 45.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.31 0.576 . . . . 70.439999999999998 110.145 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 531' ' ' ALA . 26.7 p -66.87 128.02 34.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.441 -0.8 . . . . 52.340000000000003 111.895 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 108.036 -1.098 . . . . 73.140000000000001 108.036 176.836 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.633 0.73 . . . . 71.519999999999996 109.658 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 77.0 mt-30 -101.22 130.98 47.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.076 -0.965 . . . . 74.439999999999998 110.298 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.3 mmp_? -123.92 155.59 37.85 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.678 0.791 . . . . 64.030000000000001 110.955 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -84.77 141.55 30.44 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.782 -0.645 . . . . 62.32 111.596 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -79.25 131.18 66.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.626 -0.716 . . . . 74.319999999999993 109.551 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.43 152.32 65.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.962 2.441 . . . . 75.120000000000005 112.774 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.85 8.38 43.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.427 0.632 . . . . 65.129999999999995 110.142 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 439' ' ' GLU . 21.4 t -74.7 -12.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 122.542 1.163 . . . . 74.120000000000005 108.293 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.5 m -58.79 -38.39 78.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.855 -1.52 . . . . 25.129999999999999 110.804 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.2 m -60.21 -26.5 66.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.696 -1.138 . . . . 71.549999999999997 111.167 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.35 -45.45 12.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.812 -0.355 . . . . 70.140000000000001 111.108 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 28.3 m -161.86 143.78 11.34 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.031 -0.729 . . . . 72.450000000000003 109.031 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -52.51 -44.72 65.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.792 0.837 . . . . 73.120000000000005 111.455 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 436' ' ' THR . . . -62.77 -38.37 90.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.159 -0.473 . . . . 44.130000000000003 111.19 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 8.4 mm-40 -69.2 -37.34 78.06 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.731 -0.668 . . . . 73.420000000000002 110.202 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.91 -51.92 67.62 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.092 -0.958 . . . . 64.530000000000001 111.349 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.84 -40.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.425 -0.807 . . . . 74.129999999999995 111.777 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -66.08 -44.86 83.21 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.768 -0.373 . . . . 70.430000000000007 111.08 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.52 -40.57 89.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.643 0.259 . . . . 60.350000000000001 111.624 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 30.3 tp -68.94 -34.75 75.87 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.25 0.548 . . . . 44.229999999999997 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.1 m -64.48 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.381 -0.6 . . . . 74.430000000000007 109.381 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.07 62.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.72 -0.673 . . . . 71.409999999999997 110.398 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.8 -13.63 53.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.724 -0.472 . . . . 63.310000000000002 109.724 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.32 -13.11 18.91 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.785 -0.643 . . . . 73.530000000000001 113.831 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 66.6 m-85 -71.09 138.94 50.16 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 111.143 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -138.38 10.63 3.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.156 -1.021 . . . . 64.040000000000006 113.149 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 483' ' ' VAL . 32.6 tpt180 -120.74 115.01 22.47 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.278 -1.008 . . . . 73.439999999999998 108.278 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.17 153.83 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.847 0.356 . . . . 73.420000000000002 110.559 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -131.42 122.35 26.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.002 -1.481 . . . . 75.200000000000003 107.002 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.41 HE21 HG21 ' A' ' 488' ' ' VAL . 59.0 tt0 -94.36 115.78 28.05 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.177 0.513 . . . . 64.219999999999999 110.193 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -118.53 154.61 32.28 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.997 -1.112 . . . . 70.239999999999995 107.997 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.21 148.22 52.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.365 -0.606 . . . . 54.109999999999999 109.365 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.6 m -135.63 147.21 60.57 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 109.06 -0.718 . . . . 54.32 109.06 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.9 Cg_exo -65.07 122.72 10.58 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.428 2.086 . . . . 74.219999999999999 110.933 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.9 t -148.88 179.4 7.89 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.017 -1.105 . . . . 74.540000000000006 108.017 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.84 139.83 90.1 Favored Pre-proline 0 N--CA 1.427 -1.593 0 C-N-CA 124.333 1.053 . . . . 64.329999999999998 110.662 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 82.4 Cg_exo -50.87 -29.87 28.19 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.311 3.341 . . . . 61.109999999999999 113.141 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.78 -29.73 69.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.097 -0.502 . . . . 74.25 111.818 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.31 -2.13 49.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.033 -0.531 . . . . 71.409999999999997 111.68 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.7 t -61.28 127.04 20.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.23 -0.656 . . . . 75.329999999999998 109.23 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.93 -3.54 82.87 Favored Glycine 0 C--N 1.307 -1.065 0 C-N-CA 121.067 -0.587 . . . . 71.120000000000005 112.121 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.7 154.29 26.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.545 -0.909 . . . . 74.400000000000006 108.545 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.661 HG22 HD11 ' A' ' 486' ' ' ILE . 43.3 t -82.12 125.36 39.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.844 -0.798 . . . . 75.219999999999999 108.844 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.8 pt -98.45 -7.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.141 0.496 . . . . 44.210000000000001 110.415 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.46 150.2 5.92 Favored Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.631 -0.713 . . . . 74.340000000000003 111.487 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 10.4 p -116.47 158.32 23.77 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.481 -1.303 . . . . 74.030000000000001 107.481 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.9 m120 -67.94 -55.11 14.22 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 119.059 -1.056 . . . . 63.32 110.609 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -69.26 116.33 4.46 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 108.574 -1.356 . . . . 64.129999999999995 108.574 170.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 158.79 41.56 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.566 2.177 . . . . 73.230000000000004 113.413 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.33 7.25 9.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.307 -0.86 . . . . 62.539999999999999 110.401 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.16 -40.8 11.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.356 -0.838 . . . . 73.549999999999997 110.802 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -118.73 165.27 14.21 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.589 -0.523 . . . . 73.239999999999995 109.589 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 23.9 p -84.06 142.79 30.17 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.459 -0.337 . . . . 72.310000000000002 110.682 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.3 m -124.3 150.77 45.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.883 -1.154 . . . . 52.350000000000001 107.883 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -74.63 146.22 42.61 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.534 0.606 . . . . 74.409999999999997 111.328 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.71 -23.09 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.44 1.096 . . . . 60.25 111.014 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -95.5 1.18 53.86 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.784 -1.098 . . . . 60.409999999999997 110.428 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -80.67 155.45 26.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 451' ' ' ARG . 7.7 p -88.13 121.23 38.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.889 -0.782 . . . . 64.230000000000004 108.889 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.85 118.89 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.926 -0.768 . . . . 75.219999999999999 108.926 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.44 117.43 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 106.157 -1.794 . . . . 63.530000000000001 106.157 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.92 124.24 65.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.701 -0.851 . . . . 61.009999999999998 108.701 -176.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.14 118.53 49.12 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 CA-C-O 121.396 0.617 . . . . 44.43 109.608 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.41 HG21 HE21 ' A' ' 454' ' ' GLN . 27.1 t -96.54 141.49 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.294 -0.866 . . . . 73.349999999999994 108.915 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.98 128.48 11.95 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 108.516 -1.833 . . . . 64.420000000000002 108.516 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.8 m -140.91 150.72 43.53 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.141 -0.623 . . . . 63.340000000000003 109.513 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.166 0 N-CA-C 109.689 -1.364 . . . . 73.310000000000002 109.689 179.197 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 121.788 0.804 . . . . 72.319999999999993 109.084 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 546' ' ' PRO . 47.0 p -131.87 160.58 35.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.356 -0.979 . . . . 72.129999999999995 108.356 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 544' ' ' THR . 67.8 mttm -135.59 147.22 48.61 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.215 -0.291 . . . . 63.420000000000002 110.215 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.28 126.51 36.39 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.593 -0.892 . . . . 74.150000000000006 108.593 175.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 541' ' ' ALA . 38.1 pt -81.95 137.41 46.76 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.524 -0.762 . . . . 63.539999999999999 112.358 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.43 175.47 6.25 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.563 2.175 . . . . 75.140000000000001 111.224 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.45 121.61 31.85 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 75.030000000000001 110.27 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.66 9.8 6.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.35 -0.841 . . . . 64.209999999999994 109.378 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.474 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -75.17 147.6 40.29 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.342 -0.844 . . . . 62.229999999999997 112.191 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.64 69.46 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.178 -0.769 . . . . 64.239999999999995 111.178 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.413 ' O ' HG12 ' A' ' 534' ' ' VAL . 43.6 mt-30 -117.32 -167.82 1.38 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.984 -0.747 . . . . 74.530000000000001 108.984 177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.4 m -90.67 155.66 18.68 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.299 -0.961 . . . . 72.319999999999993 109.608 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.76 -43.93 57.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.196 0.598 . . . . 72.439999999999998 112.141 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.15 -42.2 80.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 111.906 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.59 -34.23 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.894 -0.722 . . . . 65.319999999999993 111.09 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.47 -47.28 86.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.534 -0.757 . . . . 70.019999999999996 110.736 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.89 -37.37 87.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 123.257 0.348 . . . . 64.219999999999999 110.632 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 60.4 tttp -62.39 -53.67 51.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.64 -0.709 . . . . 71.040000000000006 110.062 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.07 -42.76 96.87 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.344 -0.844 . . . . 74.019999999999996 110.676 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.6 -41.12 96.98 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 115.592 -0.731 . . . . 74.150000000000006 109.715 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.18 -40.08 84.59 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.82 0.448 . . . . 74.430000000000007 110.708 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.2 t -67.18 -36.88 78.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.848 -0.615 . . . . 72.299999999999997 111.71 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -113.84 9.17 17.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.135 -0.626 . . . . 71.400000000000006 111.025 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -140.38 -107.5 0.7 Allowed Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.156 -1.497 . . . . 73.439999999999998 115.198 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.7 m-85 -127.6 -176.59 3.8 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.06 0.392 . . . . 74.239999999999995 112.06 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.87 -14.34 10.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.623 0.725 . . . . 74.120000000000005 110.559 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -108.14 115.72 30.65 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.246 -0.65 . . . . 73.409999999999997 109.246 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -124.29 155.59 38.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.298 -0.41 . . . . 75.25 110.347 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.3 m -140.86 158.29 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.447 -1.686 . . . . 71.019999999999996 106.447 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -121.95 144.12 49.06 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.735 -0.468 . . . . 73.129999999999995 109.735 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.31 134.91 54.65 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.208 -0.664 . . . . 73.329999999999998 109.208 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.4 m -90.26 119.9 30.96 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.606 -0.887 . . . . 63.240000000000002 108.606 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.51 163.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.626 -1.25 . . . . 71.439999999999998 107.626 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.43 129.18 35.42 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.642 0.734 . . . . 71.430000000000007 109.488 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 11.2 p -77.27 132.48 69.92 Favored Pre-proline 0 N--CA 1.419 -2.015 0 CA-C-N 114.682 -1.144 . . . . 72.349999999999994 110.576 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.453 ' O ' ' HD2' ' A' ' 529' ' ' ARG . 11.9 Cg_endo -63.69 -75.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.524 1.482 . . . . 72.329999999999998 109.579 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.548 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 10.9 mmm180 -121.17 -57.7 0.03 OUTLIER Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.663 -0.495 . . . . 65.200000000000003 109.663 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 2.7 Cg_exo -77.36 153.15 31.01 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.305 2.004 . . . . 65.420000000000002 111.609 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.98 149.28 52.47 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.785 -0.82 . . . . 54.329999999999998 108.785 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 103.82 -22.08 36.49 Favored Glycine 0 C--O 1.249 1.035 0 N-CA-C 111.156 -0.778 . . . . 55.340000000000003 111.156 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.09 148.09 25.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.579 0.704 . . . . 55.140000000000001 111.674 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 501' ' ' ALA . 3.8 p -75.8 125.16 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.977 -1.011 . . . . 74.239999999999995 110.15 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 8.4 m -77.45 -37.08 52.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.262 -1.014 . . . . 62.43 108.262 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.43 35.2 Favored Glycine 0 N--CA 1.417 -2.603 0 N-CA-C 109.665 -1.374 . . . . 73.140000000000001 109.665 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.3 p -117.74 159.88 22.27 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.209 -1.404 . . . . 62.32 107.209 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -56.75 -57.15 25.81 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 123.489 0.493 . . . . 73.129999999999995 110.716 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 59.8 Cg_endo -77.26 142.84 21.77 Favored 'Trans proline' 0 C--N 1.368 1.588 0 N-CA-C 109.125 -1.144 . . . . 74.239999999999995 109.125 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -65.22 151.02 86.78 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.282 1.988 . . . . 74.409999999999997 111.804 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -58.92 138.45 57.38 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.747 0.308 . . . . 34.520000000000003 110.196 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.78 -21.13 43.36 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 111.309 -0.716 . . . . 74.239999999999995 111.309 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 46.2 m -70.75 132.35 45.22 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.105 0.478 . . . . 72.230000000000004 110.394 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 m -96.67 122.66 39.86 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.397 -0.819 . . . . 74.400000000000006 108.82 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.16 159.63 71.35 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.398 -0.593 . . . . 62.299999999999997 109.398 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.583 ' HA ' HG22 ' A' ' 494' ' ' THR . 39.2 Cg_exo -61.03 142.26 96.84 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.217 2.611 . . . . 73.230000000000004 114.584 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.499 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 30.9 m -67.43 -19.32 25.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.95 0.881 . . . . 73.510000000000005 111.146 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.9 -10.12 55.79 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.22 -1.354 . . . . 63.229999999999997 109.747 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 59.9 p -92.3 171.76 8.85 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.866 -0.606 . . . . 62.420000000000002 112.03 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.25 136.39 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.261 -1.014 . . . . 74.310000000000002 108.261 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.0 tt -113.76 142.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 120.895 0.379 . . . . 74.420000000000002 110.538 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -102.99 128.3 49.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 122.968 0.507 . . . . 75.200000000000003 111.606 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.3 122.01 42.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.135 -1.431 . . . . 75.510000000000005 107.135 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -104.32 110.13 22.25 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.606 -0.887 . . . . 70.140000000000001 108.606 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.36 139.13 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.461 -0.791 . . . . 73.519999999999996 112.944 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 69.6 m -64.76 115.05 4.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.484 -0.78 . . . . 71.340000000000003 109.581 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 106.46 -1.682 . . . . 73.219999999999999 106.46 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 122.296 1.046 . . . . 72.219999999999999 111.617 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 91.7 mt-30 -121.75 131.03 53.85 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.222 -1.354 . . . . 72.219999999999999 108.122 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -122.72 151.56 41.44 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.154 -0.684 . . . . 75.450000000000003 109.154 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -93.74 142.16 27.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.266 -0.879 . . . . 74.239999999999995 110.082 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.497 ' O ' ' HB1' ' A' ' 474' ' ' ALA . 2.9 mp -79.13 125.11 84.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.858 -0.793 . . . . 73.340000000000003 108.858 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.43 141.79 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.727 1.618 . . . . 74.219999999999999 111.332 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.65 52.19 1.85 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.728 0.775 . . . . 65.349999999999994 110.652 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 440' ' ' ALA . 14.8 p -102.39 -2.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.018 -1.475 . . . . 72.120000000000005 107.018 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 1.7 p -59.11 -41.44 88.16 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.998 -1.91 . . . . 72.030000000000001 110.703 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.3 p -61.71 -26.37 68.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.9 -1.045 . . . . 72.140000000000001 112.807 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.3 -46.48 13.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 119.077 -1.049 . . . . 64.420000000000002 111.575 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.6 m -170.39 147.36 3.0 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.942 -0.762 . . . . 75.319999999999993 108.942 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -50.82 -48.91 59.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.507 1.123 . . . . 71.200000000000003 110.581 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 436' ' ' THR . . . -58.31 -37.76 75.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 111.579 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.511 ' HB3' HG22 ' A' ' 432' ' ' VAL . 25.0 mm-40 -69.59 -44.68 70.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.088 0.47 . . . . 65.439999999999998 110.363 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.44 -51.18 70.55 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.045 -0.979 . . . . 54.549999999999997 111.704 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.01 -45.95 89.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 CA-C-N 115.737 -0.665 . . . . 75.549999999999997 111.511 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.19 -47.91 80.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.018 0.377 . . . . 71.540000000000006 112.018 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -67.79 -39.52 84.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.31 -0.556 . . . . 63.119999999999997 110.668 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 20.9 tp -69.7 -34.78 74.37 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.252 0.548 . . . . 75.409999999999997 110.716 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 27.1 m -62.06 -43.31 99.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.651 -0.704 . . . . 71.329999999999998 109.64 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.87 62.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.626 -0.715 . . . . 72.329999999999998 110.836 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.65 59.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.049 0.452 . . . . 72.200000000000003 110.454 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.92 6.95 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.329 -0.938 . . . . 75.340000000000003 113.171 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 445' ' ' THR . 97.1 m-85 -80.85 130.93 35.31 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.69 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -136.22 14.74 4.0 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.184 -1.166 . . . . 60.109999999999999 110.184 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -116.95 115.3 25.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 87.7 m-85 -139.04 156.43 47.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.301 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.466 ' HB2' HG13 ' A' ' 485' ' ' ILE . 68.8 mttm -133.55 122.97 24.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.114 -1.809 . . . . 61.119999999999997 106.114 167.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -93.79 120.02 33.51 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.763 -0.775 . . . . 75.040000000000006 112.027 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.31 43.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.232 -1.025 . . . . 74.129999999999995 108.232 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.89 150.75 33.19 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.915 -1.143 . . . . 63.409999999999997 107.915 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 37.1 p -134.6 138.21 29.4 Favored Pre-proline 0 C--N 1.277 -2.575 0 N-CA-C 108.964 -0.754 . . . . 61.43 108.964 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 22.8 Cg_exo -65.57 123.6 11.64 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.086 1.857 . . . . 74.409999999999997 110.042 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 179.31 7.55 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 108.43 -0.952 . . . . 54.219999999999999 108.43 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -67.92 137.89 92.54 Favored Pre-proline 0 N--CA 1.418 -2.065 0 C-N-CA 123.467 0.707 . . . . 71.140000000000001 110.461 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 464' ' ' VAL . 98.2 Cg_exo -50.78 -29.21 25.45 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 124.669 3.579 . . . . 61.420000000000002 113.596 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.65 -21.53 61.81 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 111.401 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 466' ' ' LYS . 23.0 tp -105.15 2.92 29.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 64.310000000000002 110.683 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 461' ' ' PRO . 65.2 t -60.46 128.03 20.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-N 116.156 -0.475 . . . . 64.400000000000006 111.013 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.31 -2.55 56.37 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.717 -0.674 . . . . 64.129999999999995 111.676 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.489 ' HD2' HD12 ' A' ' 463' ' ' LEU . 96.6 mttt -112.21 145.05 40.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.38 -0.6 . . . . 64.109999999999999 109.38 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 47.1 t -82.75 134.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.193 -0.669 . . . . 74.310000000000002 109.193 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.7 pt -98.28 -20.09 5.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.484 -0.886 . . . . 71.219999999999999 110.08 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.927 -0.654 . . . . 54.210000000000001 111.565 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.2 p -116.77 161.0 19.95 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.518 -0.919 . . . . 65.349999999999994 108.518 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.543 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.4 t-20 -65.69 -52.43 43.06 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-O 119.012 -0.518 . . . . 73.140000000000001 111.568 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.5 Cg_exo -75.02 135.81 19.52 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 120.359 1.164 . . . . 52.420000000000002 109.116 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.57 136.26 53.42 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.614 2.209 . . . . 75.030000000000001 111.351 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 429' ' ' ILE . . . -77.0 -17.68 58.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.822 -0.626 . . . . 72.239999999999995 111.964 -172.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -76.49 -31.87 58.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.386 0.612 . . . . 72.049999999999997 109.71 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -95.34 164.87 12.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.456 -0.793 . . . . 64.540000000000006 110.836 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -97.63 127.1 43.33 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.525 -0.761 . . . . 62.439999999999998 110.449 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.4 m -110.06 139.68 44.92 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.283 -1.006 . . . . 61.340000000000003 108.283 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -57.89 150.39 20.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.075 0.398 . . . . 74.120000000000005 112.075 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.1 -25.71 38.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.847 -0.615 . . . . 62.420000000000002 110.82 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -86.71 5.29 36.95 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 116.146 -0.479 . . . . 75.239999999999995 111.363 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.13 157.52 24.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 120.909 0.385 . . . . 64.450000000000003 111.031 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 453' ' ' LYS . 22.3 t -100.05 123.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.034 -1.099 . . . . 53.240000000000002 108.034 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.18 119.01 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 C-N-CA 119.069 -1.053 . . . . 63.310000000000002 108.844 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.543 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.1 mp -92.65 118.35 38.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 105.308 -2.108 . . . . 71.310000000000002 105.308 174.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 tt -102.13 124.35 55.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 116.347 -0.388 . . . . 74.409999999999997 109.967 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.95 108.46 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.395 -0.965 . . . . 75.439999999999998 108.395 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.67 139.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.005 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.07 123.89 6.53 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.484 -1.446 . . . . 53.109999999999999 109.484 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.3 m -135.85 149.74 49.15 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 31.32 108.286 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.164 0 C-N-CA 119.746 -1.216 . . . . 73.099999999999994 110.768 -176.852 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 106.471 -1.678 . . . . 51.119999999999997 106.471 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 546' ' ' PRO . 37.2 p -127.96 161.29 29.47 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 114.519 -1.218 . . . . 74.420000000000002 109.858 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 544' ' ' THR . 96.0 mttt -143.31 156.33 44.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.835 -0.431 . . . . 74.319999999999993 109.835 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.8 p-10 -92.78 135.87 33.74 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.952 -0.758 . . . . 74.120000000000005 108.952 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 23.2 pt -78.14 136.67 61.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.998 -0.546 . . . . 73.530000000000001 110.926 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.83 -172.49 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.577 2.184 . . . . 74.219999999999999 110.339 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -99.41 136.35 39.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.454 -0.943 . . . . 52.229999999999997 108.454 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 m -128.66 16.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 120.887 0.375 . . . . 62.229999999999997 110.835 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -72.0 116.45 12.42 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.915 -0.584 . . . . 65.109999999999999 111.367 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 116.69 -19.33 12.57 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.811 -0.709 . . . . 62.420000000000002 112.103 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 507' ' ' VAL . 25.5 mt-30 -81.76 177.7 8.74 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.845 -0.342 . . . . 52.310000000000002 110.153 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.3 m -91.4 156.29 17.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.553 -1.277 . . . . 74.329999999999998 107.553 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.96 -43.47 75.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.921 0.391 . . . . 73.109999999999999 112.054 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 5.9 p-10 -68.51 -42.08 79.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 111.897 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 503' ' ' GLN . 8.9 p -75.94 -34.63 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.142 -1.023 . . . . 55.109999999999999 111.141 -175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.417 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -62.0 -48.89 78.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.448 -0.796 . . . . 34.340000000000003 111.364 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.4 -36.77 84.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.404 0.44 . . . . 71.030000000000001 110.746 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.6 mptp? -64.01 -47.58 79.72 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.123 0.264 . . . . 61.130000000000003 111.56 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -65.13 -42.91 93.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.975 0.417 . . . . 73.549999999999997 110.318 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.74 -37.26 85.88 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 115.762 -0.653 . . . . 73.219999999999999 109.655 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -62.25 -37.9 87.21 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 122.762 0.425 . . . . 70.239999999999995 110.714 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 510' ' ' LYS . 61.0 t -72.44 -27.21 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.089 0.471 . . . . 74.329999999999998 110.637 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.77 36.54 4.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.552 -0.295 . . . . 62.229999999999997 110.23 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -169.33 -100.92 0.14 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 117.106 -2.473 . . . . 75.25 116.613 -173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.588 ' CE2' HG23 ' A' ' 545' ' ' VAL . 61.3 m-85 -127.63 162.36 26.69 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 115.212 -0.494 . . . . 62.130000000000003 111.312 -162.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.2 m -104.37 -17.37 14.82 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.225 -0.898 . . . . 65.319999999999993 110.869 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 550' ' ' VAL . 35.3 mmtp -109.98 123.93 50.52 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.92 -0.488 . . . . 70.439999999999998 109.804 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.97 151.28 45.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.473 0.654 . . . . 73.329999999999998 111.666 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -141.6 152.03 43.67 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.121 -1.437 . . . . 74.409999999999997 107.121 169.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.23 128.12 50.77 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 110.233 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.58 127.34 52.04 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.878 -0.786 . . . . 65.209999999999994 108.878 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.438 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 20.1 m -91.29 143.07 27.03 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.117 -0.697 . . . . 62.43 109.117 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.87 159.45 26.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.375 -0.972 . . . . 73.299999999999997 108.375 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.32 134.43 36.61 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.362 0.601 . . . . 65.150000000000006 109.432 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 8.1 t -129.81 162.3 54.28 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 108.021 -1.103 . . . . 63.509999999999998 108.021 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 122.519 2.146 . . . . 65.349999999999994 110.079 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.17 -46.52 62.19 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 118.986 -1.086 . . . . 64.140000000000001 113.315 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.67 134.65 38.75 Favored 'Trans proline' 0 C--N 1.365 1.401 0 CA-C-N 120.383 1.172 . . . . 52.210000000000001 109.897 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -153.71 176.33 12.23 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.682 -0.859 . . . . 73.230000000000004 108.682 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.93 7.15 62.88 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 111.049 -0.82 . . . . 55.210000000000001 111.049 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.9 141.1 28.99 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 107.633 -1.247 . . . . 74.299999999999997 107.633 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 95.8 t -77.12 115.76 19.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 104.781 -2.303 . . . . 70.109999999999999 104.781 165.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.8 m -76.1 -26.73 56.72 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.739 -0.837 . . . . 73.140000000000001 108.739 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.43 -149.43 21.2 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.291 -0.868 . . . . 61.329999999999998 111.023 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -118.09 161.67 19.46 Favored 'General case' 0 C--N 1.279 -2.498 0 C-N-CA 123.522 0.729 . . . . 63.200000000000003 109.108 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.6 t-20 -52.33 -51.96 67.42 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 123.427 0.454 . . . . 63.350000000000001 111.636 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.3 Cg_endo -91.6 161.16 3.53 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.473 1.449 . . . . 73.430000000000007 109.845 171.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.95 150.58 61.19 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.154 1.902 . . . . 72.120000000000005 112.194 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -50.94 131.02 26.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.102 0.961 . . . . 33.200000000000003 111.422 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -17.29 36.69 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.773 -0.648 . . . . 51.310000000000002 112.099 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 48.6 m -67.86 128.01 34.93 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.567 -0.372 . . . . 70.439999999999998 110.301 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 27.8 m -97.59 123.36 41.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.761 -0.459 . . . . 51.039999999999999 109.761 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' A' ' 517' ' ' PHE . 9.5 m -134.14 162.26 58.76 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.264 -0.643 . . . . 71.209999999999994 109.264 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.593 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.2 Cg_exo -61.93 136.21 60.06 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.104 2.536 . . . . 75.420000000000002 113.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 33.2 m -66.73 -22.82 30.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.663 -0.699 . . . . 62.119999999999997 112.343 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.97 -2.13 57.74 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.134 -0.939 . . . . 73.120000000000005 110.011 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -93.97 173.19 7.79 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.087 -0.709 . . . . 65.530000000000001 109.087 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 519' ' ' LYS . 60.2 t -91.99 127.65 44.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 111.827 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.15 130.13 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.825 -1.176 . . . . 53.420000000000002 107.825 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 32.7 tt0 -103.04 127.19 50.38 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-O 121.268 0.556 . . . . 63.100000000000001 110.111 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.6 tp -95.28 132.58 40.13 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.979 -1.009 . . . . 61.130000000000003 109.06 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -100.18 113.34 25.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.425 -0.954 . . . . 74.230000000000004 108.425 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.81 137.67 44.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-O 120.627 0.251 . . . . 75.329999999999998 111.24 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 58.6 p -83.39 124.49 30.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 109.785 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 524' ' ' SER . 14.9 ttpp . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 108.829 -0.804 . . . . 74.109999999999999 108.829 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.512 -0.509 0 CA-C-O 121.908 0.861 . . . . 73.129999999999995 109.916 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 77.1 mt-30 -118.57 153.5 34.13 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.222 -1.399 . . . . 63.329999999999998 107.222 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -145.85 152.62 39.79 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.292 -1.744 . . . . 72.209999999999994 106.292 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.41 140.94 30.34 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.503 0.668 . . . . 73.430000000000007 112.503 -177.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.49 131.04 69.44 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 107.51 -1.293 . . . . 73.409999999999997 107.51 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.0 140.6 94.54 Favored 'Trans proline' 0 C--O 1.243 0.734 0 C-N-CA 122.664 2.242 . . . . 73.439999999999998 113.346 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -96.47 -5.25 40.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.025 -0.989 . . . . 43.109999999999999 109.84 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.18 5.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.947 0.879 . . . . 53.219999999999999 110.703 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.5 p -62.63 -30.45 71.37 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.869 1.268 . . . . 60.240000000000002 109.918 177.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.5 t -57.65 -26.76 62.1 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.42 -1.263 . . . . 75.25 111.077 176.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.57 -44.96 15.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 120.788 -0.365 . . . . 62.5 110.422 -175.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.575 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 3.7 m -164.1 149.44 10.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.702 -0.851 . . . . 42.329999999999998 108.702 175.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -54.71 -44.02 73.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.783 0.833 . . . . 71.340000000000003 110.768 174.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.63 -43.56 76.26 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.305 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.575 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.0 mm-40 -61.67 -42.43 98.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 123.514 0.509 . . . . 74.409999999999997 110.44 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.1 -49.47 77.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.157 -0.929 . . . . 71.5 110.097 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.96 -47.61 92.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 CA-C-N 115.788 -0.642 . . . . 73.120000000000005 112.101 -177.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.5 mmtp -60.96 -48.6 81.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.035 0.445 . . . . 61.520000000000003 110.452 -176.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 443' ' ' LYS . 10.3 mmpt? -68.2 -39.19 82.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.899 -0.591 . . . . 75.409999999999997 111.843 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 23.4 tp -68.54 -40.25 80.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.195 0.521 . . . . 64.439999999999998 110.044 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 42.8 m -59.41 -45.85 90.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.249 -0.887 . . . . 64.150000000000006 109.461 176.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -17.28 62.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.63 -0.714 . . . . 60.32 111.473 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.59 -13.92 57.4 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 110.861 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.9 -11.81 22.67 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.15 -1.024 . . . . 64.409999999999997 113.519 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.8 m-85 -72.5 138.55 47.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.976 0.417 . . . . 70.150000000000006 110.857 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 -12.74 3.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.591 -0.814 . . . . 75.340000000000003 113.599 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 451' ' ' ARG . 2.1 tpm_? -103.38 114.99 29.7 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.095 -0.706 . . . . 74.219999999999999 109.095 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 37.1 m-85 -120.03 153.27 36.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.369 -0.832 . . . . 72.340000000000003 109.696 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.521 ' HB3' HG13 ' A' ' 485' ' ' ILE . 16.3 tppt? -143.73 122.33 12.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 105.566 -2.013 . . . . 72.230000000000004 105.566 170.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -104.2 125.4 50.46 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 120.862 0.363 . . . . 71.239999999999995 110.732 -176.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.93 49.04 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.231 -1.026 . . . . 74.409999999999997 108.231 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -124.02 149.35 46.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.543 -0.91 . . . . 63.009999999999998 108.543 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.2 m -140.42 140.65 23.4 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 108.97 -0.752 . . . . 55.299999999999997 108.97 176.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.7 Cg_exo -65.76 122.0 9.51 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.965 1.777 . . . . 75.129999999999995 109.946 177.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.4 m -151.99 -179.54 7.57 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.756 -1.201 . . . . 71.040000000000006 107.756 -178.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 463' ' ' LEU . 6.9 t -24.98 100.24 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.51 0 C-N-CA 126.563 1.945 . . . . 73.239999999999995 112.83 177.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 73.8 Cg_exo -51.53 -38.09 63.89 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 124.499 3.466 . . . . 62.32 115.973 -170.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.45 -11.33 59.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.191 0.811 . . . . 74.209999999999994 113.191 -176.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.494 ' HB2' HG23 ' A' ' 460' ' ' THR . 3.9 mm? -103.65 14.15 31.71 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.692 0.282 . . . . 71.219999999999999 111.186 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.1 p -52.86 128.73 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 116.159 -0.473 . . . . 72.5 110.335 176.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.49 -3.06 56.27 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.826 -0.702 . . . . 63.25 111.506 -179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -103.48 146.01 29.15 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.316 -0.624 . . . . 73.519999999999996 109.316 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.644 HG22 HD11 ' A' ' 486' ' ' ILE . 46.9 t -81.78 132.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.477 -0.564 . . . . 72.219999999999999 109.477 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.5 -21.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.624 -0.43 . . . . 72.150000000000006 110.625 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.96 159.92 23.54 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 111.106 -0.798 . . . . 73.510000000000005 111.106 177.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -122.63 152.32 40.6 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.326 -0.99 . . . . 65.310000000000002 108.326 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.468 HD22 HD13 ' A' ' 485' ' ' ILE . 66.0 t30 -64.44 -50.59 65.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.499 -0.481 . . . . 75.540000000000006 111.058 177.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.3 Cg_exo -79.59 147.83 20.06 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 120.371 1.168 . . . . 64.530000000000001 109.104 172.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 3.7 Cg_exo -71.37 140.89 37.71 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.142 1.894 . . . . 43.140000000000001 113.463 -175.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.11 6.67 28.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.115 0.96 . . . . 73.420000000000002 109.183 176.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.1 -26.83 13.55 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.667 -1.151 . . . . 73.420000000000002 111.988 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -137.85 174.96 10.01 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.279 -0.569 . . . . 75.150000000000006 110.263 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 41.7 p -86.94 147.71 25.64 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.238 0.542 . . . . 64.439999999999998 112.368 -176.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.4 m -133.83 150.1 51.39 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.393 -1.336 . . . . 62.049999999999997 107.393 174.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.534 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -55.48 142.24 33.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.617 0.599 . . . . 65.230000000000004 112.617 -176.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.02 -29.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.563 1.145 . . . . 63.299999999999997 111.532 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -94.08 12.26 27.02 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.527 -0.469 . . . . 74.120000000000005 111.577 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.95 146.32 35.55 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 122.14 -0.35 . . . . 70.140000000000001 110.365 176.652 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.2 122.98 36.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.632 -0.877 . . . . 71.200000000000003 108.632 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.82 118.51 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 108.039 -1.097 . . . . 75.200000000000003 108.039 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.0 mp -96.99 114.47 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 106.194 -1.78 . . . . 54.299999999999997 106.194 175.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.644 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.88 125.68 59.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 108.901 -0.777 . . . . 64.299999999999997 108.901 -177.713 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.46 116.47 49.31 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 CA-C-O 121.693 0.758 . . . . 53.119999999999997 109.988 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.41 136.83 25.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.22 -0.9 . . . . 71.299999999999997 109.461 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.91 112.1 3.53 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.783 -2.127 . . . . 54.219999999999999 107.783 174.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.4 t -115.3 145.37 42.54 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 119.873 -0.731 . . . . 74.430000000000007 109.787 -176.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.406 -3.301 0 N-CA-C 107.965 -2.054 . . . . 71.430000000000007 107.965 176.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 108.503 -0.925 . . . . 75.299999999999997 108.503 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.6 p -136.27 157.56 46.51 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.543 -1.208 . . . . 62.43 108.268 -175.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 28.9 mtpp -143.94 157.36 44.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.666 -0.864 . . . . 75.129999999999995 108.666 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.0 t70 -91.36 130.92 37.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.677 -1.231 . . . . 75.120000000000005 107.677 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 23.8 pt -77.15 126.11 85.73 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 112.366 0.506 . . . . 64.400000000000006 112.366 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 55.2 Cg_endo -94.07 114.46 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.32 2.013 . . . . 71.519999999999996 112.886 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.67 124.36 29.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.422 -0.955 . . . . 64.319999999999993 108.422 175.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.4 t -114.53 45.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.154 -1.054 . . . . 75.109999999999999 108.154 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -63.29 130.73 45.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.848 -1.069 . . . . 65.150000000000006 111.381 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 129.99 -32.04 3.22 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.316 -0.945 . . . . 72.540000000000006 113.29 176.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 534' ' ' VAL . 23.7 mt-30 -94.7 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.691 -0.485 . . . . 64.140000000000001 109.691 -177.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 157.38 19.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.178 -1.009 . . . . 74.150000000000006 109.564 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.454 HG21 HG13 ' A' ' 555' ' ' VAL . 89.5 t -55.92 -44.14 77.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.593 0.558 . . . . 63.329999999999998 111.151 -176.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.61 -41.75 83.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.693 -0.685 . . . . 74.219999999999999 111.921 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -36.26 27.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 118.884 -1.126 . . . . 64.409999999999997 110.654 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.58 87.25 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.53 -0.759 . . . . 61.409999999999997 110.959 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -64.82 -35.17 80.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 123.307 0.38 . . . . 70.430000000000007 110.041 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -61.42 -47.48 85.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 123.127 0.267 . . . . 73.329999999999998 111.517 176.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -68.84 -43.12 76.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.376 -0.375 . . . . 71.510000000000005 111.006 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 520' ' ' PHE . 5.8 tt -64.27 -37.54 87.86 Favored 'General case' 0 C--O 1.173 -2.947 0 CA-C-N 115.928 -0.578 . . . . 62.350000000000001 109.537 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.33 -37.44 75.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.929 0.491 . . . . 71.420000000000002 110.362 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.88 -39.86 75.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.73 -0.668 . . . . 74.340000000000003 111.122 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -94.99 -10.83 29.76 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.431 0.634 . . . . 71.200000000000003 110.384 -174.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -117.25 -117.54 2.9 Favored Glycine 0 N--CA 1.411 -2.978 0 CA-C-N 115.243 -0.889 . . . . 73.319999999999993 113.139 -172.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.684 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 35.9 m-85 -136.46 -175.41 4.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.459 -0.571 . . . . 74.319999999999993 109.459 -169.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 m -99.37 -18.5 17.48 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.719 -0.673 . . . . 40.240000000000002 111.811 -178.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -107.29 115.87 30.93 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.876 -0.729 . . . . 71.109999999999999 111.54 -175.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.471 ' CE2' HD22 ' A' ' 512' ' ' LEU . 19.7 m-85 -120.84 142.57 49.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.578 -1.192 . . . . 74.140000000000001 108.543 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.5 p -115.62 145.28 42.84 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 104.936 -2.246 . . . . 64.430000000000007 104.936 171.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -121.82 138.3 54.43 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.829 -1.148 . . . . 73.040000000000006 111.09 -174.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.6 139.91 52.92 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.782 -0.822 . . . . 54.039999999999999 108.782 178.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 40.0 m -101.75 125.18 48.37 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.998 -1.112 . . . . 75.140000000000001 107.998 177.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.15 160.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.972 -0.751 . . . . 73.310000000000002 108.972 -176.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 8.4 p-10 -78.55 132.68 37.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.445 0.641 . . . . 65.430000000000007 109.901 -175.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 p -95.51 106.12 24.72 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 114.568 -1.197 . . . . 72.129999999999995 111.963 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 4.3 Cg_exo -76.55 -66.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.34 2.027 . . . . 73.219999999999999 110.986 177.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -108.72 -52.19 0.07 OUTLIER Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 118.977 -0.535 . . . . 75.450000000000003 111.879 178.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.96 134.19 17.57 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 120.4 1.178 . . . . 70.439999999999998 110.635 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.76 128.54 14.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.259 -0.274 . . . . 61.009999999999998 110.259 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.42 23.38 Favored Glycine 0 CA--C 1.502 -0.726 0 N-CA-C 110.185 -1.166 . . . . 65.030000000000001 110.185 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.59 149.19 23.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.276 -0.962 . . . . 65.430000000000007 109.529 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.7 p -73.18 127.07 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.175 -1.046 . . . . 74.549999999999997 108.175 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.6 m -73.5 -25.75 60.58 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.208 -1.36 . . . . 74.530000000000001 109.841 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.18 20.36 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 110.767 -0.933 . . . . 50.520000000000003 110.767 175.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -120.27 159.4 25.05 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.147 -1.427 . . . . 44.450000000000003 107.147 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.558 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -63.05 -54.54 45.28 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 119.942 -0.703 . . . . 70.040000000000006 110.56 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.4 Cg_endo -93.07 134.05 1.06 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.225 1.283 . . . . 72.340000000000003 109.665 171.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.7 Cg_exo -72.91 164.0 36.8 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.717 2.278 . . . . 64.239999999999995 113.429 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -54.1 145.07 17.88 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-N 115.486 -0.779 . . . . 61.310000000000002 109.372 173.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.62 34.01 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.832 -1.707 . . . . 64.319999999999993 108.832 -172.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 497' ' ' ILE . 23.0 m -88.62 119.85 29.47 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.816 -0.809 . . . . 65.430000000000007 108.816 173.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 86.5 m -101.77 127.43 48.56 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.147 -0.686 . . . . 74.430000000000007 109.147 176.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.84 160.21 64.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.647 -0.871 . . . . 72.0 108.647 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 494' ' ' THR . 42.9 Cg_exo -58.46 152.74 52.5 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.394 2.062 . . . . 55.119999999999997 111.773 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.684 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.9 m -65.98 -20.78 27.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.239 0.543 . . . . 73.030000000000001 112.39 -177.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.14 3.73 54.87 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.645 -0.707 . . . . 40.240000000000002 110.83 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.7 t -79.67 167.95 20.0 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.939 -0.393 . . . . 74.420000000000002 109.939 -177.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.19 120.64 62.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 109.757 -0.46 . . . . 62.43 109.757 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.4 tt -92.52 138.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.962 -0.385 . . . . 75.329999999999998 109.962 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.405 ' HG2' ' NE2' ' A' ' 554' ' ' GLN . 45.5 tt0 -101.82 121.76 42.71 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 121.479 0.656 . . . . 74.150000000000006 110.654 -176.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.94 134.91 41.12 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.98 1.312 . . . . 75.099999999999994 109.24 -177.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.405 ' NE2' ' HG2' ' A' ' 552' ' ' GLU . 26.8 mm-40 -101.27 108.68 20.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.625 -0.716 . . . . 73.409999999999997 110.017 -176.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 505' ' ' VAL . 64.1 t -96.9 131.76 42.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 124.066 0.946 . . . . 64.349999999999994 110.008 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 45.6 p -69.05 125.01 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.289 0.566 . . . . 74.140000000000001 110.769 175.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 1.0 OUTLIER . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 105.875 -1.898 . . . . 74.519999999999996 105.875 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 108.961 -0.755 . . . . 62.009999999999998 108.961 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 478' ' ' SER . 21.0 mp0 -82.67 125.21 30.96 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.266 -0.879 . . . . 63.450000000000003 109.979 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.531 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 18.9 tpp180 -120.7 155.87 32.96 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.68 -0.859 . . . . 73.409999999999997 108.68 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 142.02 28.83 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.207 1.003 . . . . 74.400000000000006 111.691 -174.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -86.0 128.7 57.0 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 109.524 -0.547 . . . . 73.310000000000002 109.524 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.72 160.1 47.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.161 2.574 . . . . 73.310000000000002 112.332 176.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.52 24.68 9.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.945 0.498 . . . . 71.510000000000005 111.257 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 439' ' ' GLU . 14.7 t -76.4 -2.98 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.8 1.286 . . . . 54.219999999999999 109.281 -176.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.573 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 3.1 m -52.37 -34.27 46.96 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.444 2.298 . . . . 65.129999999999995 111.323 177.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.9 t -60.97 -28.01 68.69 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.851 -0.613 . . . . 73.219999999999999 112.014 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.4 -47.51 8.72 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 118.874 -1.13 . . . . 60.450000000000003 111.836 -172.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 18.9 m -172.1 154.11 3.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.071 -1.085 . . . . 71.109999999999999 108.071 -178.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -51.91 -54.82 24.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 75.450000000000003 110.463 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.04 73.05 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 123.467 0.479 . . . . 70.25 111.91 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' A' ' 432' ' ' VAL . 10.2 mm-40 -61.04 -45.84 93.12 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.722 0.639 . . . . 50.109999999999999 111.327 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -71.27 -43.75 66.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.016 -0.538 . . . . 52.299999999999997 110.774 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.23 -48.36 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.965 -0.561 . . . . 51.140000000000001 111.985 -178.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.94 -40.1 96.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 70.239999999999995 110.344 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -66.57 -43.06 86.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.075 -0.512 . . . . 52.350000000000001 111.005 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 22.8 tp -68.69 -33.41 73.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.396 0.617 . . . . 74.439999999999998 109.611 179.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.3 m -62.42 -41.29 98.58 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.485 -0.78 . . . . 70.540000000000006 109.212 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.02 63.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.75 -0.659 . . . . 54.130000000000003 110.991 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.18 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.193 0.521 . . . . 45.140000000000001 110.02 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.98 -6.88 17.31 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.78 -0.724 . . . . 43.310000000000002 113.423 175.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 85.7 m-85 -75.28 136.8 40.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.084 0.772 . . . . 64.040000000000006 113.084 -176.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.57 25.93 3.73 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.169 -1.172 . . . . 71.510000000000005 110.169 175.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -132.61 115.19 15.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.821 -1.178 . . . . 75.340000000000003 107.821 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 67.8 m-85 -140.18 150.06 43.73 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.894 -0.41 . . . . 72.310000000000002 109.894 -175.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.471 ' HB3' HG13 ' A' ' 485' ' ' ILE . 15.1 tppt? -133.67 122.91 24.11 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 106.42 -1.696 . . . . 70.310000000000002 106.42 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -95.31 123.6 38.91 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 110.278 -0.267 . . . . 74.329999999999998 110.278 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.26 151.67 51.71 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.542 -1.281 . . . . 73.400000000000006 107.542 176.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.14 143.64 40.42 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.085 -0.646 . . . . 73.329999999999998 110.232 178.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.3 m -124.04 149.32 59.87 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 109.242 -0.651 . . . . 64.349999999999994 109.242 -178.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 490' ' ' SER . 20.9 Cg_exo -66.03 122.88 10.52 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.171 1.914 . . . . 74.439999999999998 110.238 176.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 t -134.2 179.81 6.03 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.601 -0.889 . . . . 74.109999999999999 108.601 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.1 t -65.56 141.43 97.91 Favored Pre-proline 0 N--CA 1.423 -1.825 0 C-N-CA 123.74 0.816 . . . . 74.310000000000002 110.793 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.5 Cg_exo -51.72 -29.23 32.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.389 3.393 . . . . 72.310000000000002 112.62 177.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.48 -23.92 61.9 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.626 -0.716 . . . . 74.299999999999997 112.049 -177.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 11.2 mp -108.49 8.7 27.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.449 0.537 . . . . 72.420000000000002 112.449 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 461' ' ' PRO . 93.2 t -60.7 133.4 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.967 0.413 . . . . 74.409999999999997 110.963 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.57 -16.21 57.94 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 120.9 -0.666 . . . . 44.409999999999997 113.438 175.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 463' ' ' LEU . 0.2 OUTLIER -103.82 166.22 10.55 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.538 -0.865 . . . . 73.549999999999997 109.588 178.671 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 59.3 t -82.13 130.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.429 -1.322 . . . . 72.409999999999997 107.429 176.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.1 pt -98.43 -0.87 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.17 -0.612 . . . . 63.409999999999997 110.937 -178.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 157.0 162.84 11.83 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 115.621 -0.718 . . . . 52.009999999999998 112.069 174.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.5 p -116.47 149.77 38.95 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.679 -1.23 . . . . 63.32 107.679 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.444 HD22 HD13 ' A' ' 485' ' ' ILE . 61.7 t30 -64.47 -52.02 55.91 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 120.298 -0.561 . . . . 72.409999999999997 110.874 177.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 57.7 Cg_endo -73.88 136.46 22.94 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 119.912 1.004 . . . . 71.209999999999994 109.854 172.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 22.9 Cg_exo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.505 2.136 . . . . 64.129999999999995 112.165 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -85.92 0.15 53.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.398 1.095 . . . . 43.439999999999998 109.053 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -91.07 -32.07 16.02 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.67 -1.605 . . . . 73.239999999999995 110.358 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.06 168.52 9.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.446 -0.501 . . . . 73.150000000000006 110.575 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 25.0 p -98.69 137.15 37.73 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.345 -0.389 . . . . 51.100000000000001 111.047 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.5 m -116.36 148.82 40.23 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.406 -0.59 . . . . 72.019999999999996 109.406 179.141 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.561 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -69.64 157.63 36.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.742 0.246 . . . . 54.149999999999999 111.32 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.7 mm -70.35 -25.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.896 0.855 . . . . 75.230000000000004 110.199 -175.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.9 t -95.62 2.21 54.03 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.347 -0.842 . . . . 74.040000000000006 110.337 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -80.82 139.59 35.91 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 108.267 -1.012 . . . . 73.340000000000003 108.267 176.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.34 111.99 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.006 -0.739 . . . . 64.400000000000006 109.006 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.57 118.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.865 -1.161 . . . . 63.409999999999997 107.865 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -93.87 122.05 45.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.777 -1.194 . . . . 71.549999999999997 107.777 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.19 126.0 68.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.232 -1.025 . . . . 74.209999999999994 108.232 -179.11 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.4 mp -104.09 120.93 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.392 0.615 . . . . 32.409999999999997 110.125 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.09 145.34 8.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.646 -0.706 . . . . 73.310000000000002 109.281 -177.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.6 106.73 3.29 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.83 -0.908 . . . . 72.450000000000003 110.83 176.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 64.0 m -108.2 138.56 44.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.149 -1.056 . . . . 61.439999999999998 108.149 177.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.124 0 C-N-CA 119.875 -1.155 . . . . 51.119999999999997 111.705 -177.587 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.273 0 N-CA-C 107.67 -1.233 . . . . 42.43 107.67 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 546' ' ' PRO . 43.4 p -134.89 162.78 31.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.012 -0.995 . . . . 71.439999999999998 110.766 -173.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 495' ' ' LYS . 0.3 OUTLIER -142.83 132.0 23.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.21 -1.033 . . . . 71.219999999999999 108.21 178.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.9 p-10 -80.73 138.33 36.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.436 -0.949 . . . . 61.100000000000001 108.436 173.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 42.8 pt -98.61 137.58 20.65 Favored Pre-proline 0 C--N 1.292 -1.902 0 C-N-CA 120.433 -0.507 . . . . 73.030000000000001 111.742 -177.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.69 -176.97 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.472 2.115 . . . . 73.239999999999995 110.11 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -77.02 125.95 30.17 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.402 -0.962 . . . . 73.450000000000003 108.402 176.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 7.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.139 0.971 . . . . 74.040000000000006 110.264 -177.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -93.05 160.44 14.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.628 -0.714 . . . . 71.030000000000001 110.844 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 94.96 -7.98 70.18 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 109.691 -1.364 . . . . 63.32 109.691 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -102.04 -180.0 4.16 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.32 -0.94 . . . . 75.439999999999998 108.665 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 38.4 m -88.2 155.64 19.65 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.909 -1.145 . . . . 52.409999999999997 107.909 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.79 -42.78 53.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 122.879 0.472 . . . . 62.439999999999998 112.15 -177.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.09 -42.04 85.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.857 -0.611 . . . . 73.319999999999993 111.287 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.0 p -76.6 -35.65 26.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.401 -0.92 . . . . 70.310000000000002 110.798 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.31 -48.51 77.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.184 -0.916 . . . . 71.219999999999999 111.186 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.12 -35.69 81.59 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 123.039 0.212 . . . . 75.340000000000003 110.973 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -64.65 -53.24 50.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.592 0.558 . . . . 65.129999999999995 109.882 179.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.92 -42.94 99.96 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.007 -0.542 . . . . 52.399999999999999 110.525 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.33 -37.99 89.47 Favored 'General case' 0 C--O 1.184 -2.362 0 CA-C-N 116.061 -0.518 . . . . 45.439999999999998 110.638 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.96 -46.57 89.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.842 0.353 . . . . 73.099999999999994 110.791 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -27.63 37.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 73.25 111.422 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -120.16 24.4 10.46 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.078 -0.649 . . . . 75.310000000000002 109.956 -175.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 495' ' ' LYS . . . -164.51 -110.26 0.23 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 118.507 -1.806 . . . . 54.240000000000002 116.244 -173.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.4 m-85 -116.15 176.73 4.97 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.039 0.447 . . . . 62.340000000000003 111.243 -164.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.7 m -118.63 -17.42 9.27 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.562 -0.745 . . . . 64.310000000000002 110.495 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.84 115.64 30.51 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.758 -0.777 . . . . 70.030000000000001 110.968 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -120.77 135.28 55.19 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.436 -1.257 . . . . 74.340000000000003 108.676 -177.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.0 t -115.86 152.39 33.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.9 -2.259 . . . . 72.549999999999997 104.9 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -121.46 128.72 52.42 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.996 -0.682 . . . . 73.049999999999997 110.809 -175.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.172 -1.418 . . . . 55.530000000000001 107.172 177.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 41.0 m -88.75 125.91 35.09 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.821 -0.627 . . . . 61.140000000000001 109.784 -177.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.88 156.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 176.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -79.55 118.35 21.32 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 113.588 0.959 . . . . 65.519999999999996 113.588 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 12.7 m -60.75 136.56 92.96 Favored Pre-proline 0 N--CA 1.427 -1.606 0 CA-C-N 113.288 -1.778 . . . . 62.340000000000003 110.631 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -78.08 -88.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 108.505 -1.383 . . . . 50.539999999999999 108.505 172.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 92.7 mtt180 -102.54 -55.99 0.11 Allowed Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 118.788 -0.625 . . . . 62.439999999999998 111.548 171.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 4.3 Cg_exo -75.81 149.96 34.16 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.376 1.384 . . . . 70.400000000000006 110.967 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.61 128.24 38.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.139 -1.06 . . . . 61.520000000000003 108.139 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.95 -7.31 17.11 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 110.705 -0.958 . . . . 73.400000000000006 110.705 -178.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.68 147.1 27.11 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.067 -0.716 . . . . 75.120000000000005 109.067 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.26 115.63 20.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.567 -1.642 . . . . 73.420000000000002 106.567 173.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 31.4 m -89.65 -27.45 20.14 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 115.634 -0.712 . . . . 73.409999999999997 109.775 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -177.2 -173.99 43.21 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.959 -1.115 . . . . 72.430000000000007 111.766 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.3 p -134.81 160.32 38.57 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.657 -1.238 . . . . 74.510000000000005 107.657 176.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -63.53 -54.55 42.34 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.22 0.325 . . . . 74.040000000000006 110.608 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 72.9 Cg_endo -83.64 138.45 8.37 Favored 'Trans proline' 0 C--N 1.365 1.403 0 N-CA-C 109.314 -1.071 . . . . 75.219999999999999 109.314 169.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 159.48 46.6 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 121.766 1.644 . . . . 55.140000000000001 111.82 178.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -60.76 135.1 57.67 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.436 -0.347 . . . . 71.239999999999995 110.27 177.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.65 -29.05 10.91 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 111.038 -0.825 . . . . 65.439999999999998 111.038 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.6 m -73.28 136.84 44.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.048 0.451 . . . . 70.420000000000002 110.863 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -100.78 122.36 43.26 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.478 -0.783 . . . . 72.25 109.265 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.06 157.59 69.05 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.585 -0.28 . . . . 65.349999999999994 110.474 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.514 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.9 Cg_exo -63.92 134.21 42.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.936 2.424 . . . . 70.340000000000003 113.488 -178.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.418 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.7 m -68.06 -21.29 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.554 -0.748 . . . . 73.239999999999995 111.434 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.22 0.57 51.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.393 -0.821 . . . . 75.420000000000002 110.738 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.4 t -103.52 161.84 13.54 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.45 130.54 44.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.062 -1.088 . . . . 73.209999999999994 108.062 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -95.04 145.95 7.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 110.023 -0.362 . . . . 74.340000000000003 110.023 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -102.64 116.54 32.79 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.57 -0.53 . . . . 75.219999999999999 109.57 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 25.4 tp -95.74 125.04 40.04 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.74 -1.578 . . . . 62.030000000000001 106.74 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -103.94 102.53 12.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.076 0.941 . . . . 74.140000000000001 108.507 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.0 138.19 30.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 114.418 -1.264 . . . . 74.010000000000005 110.368 -173.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 30.2 p -61.88 118.33 7.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.625 -0.88 . . . . 75.540000000000006 108.625 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 107.809 -1.182 . . . . 44.109999999999999 107.809 -176.409 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 121.628 0.728 . . . . 73.430000000000007 109.675 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -82.8 145.45 29.51 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 114.901 -1.045 . . . . 75.549999999999997 109.577 -172.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.426 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 2.7 tpt180 -131.23 153.24 49.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.38 -0.97 . . . . 74.450000000000003 108.38 -177.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.28 141.27 28.77 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 123.079 0.552 . . . . 63.520000000000003 111.153 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.8 mp -81.12 130.39 63.16 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.728 -0.841 . . . . 71.340000000000003 108.728 175.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.46 ' HB2' HG22 ' A' ' 432' ' ' VAL . 66.3 Cg_endo -71.45 160.43 48.59 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.644 2.229 . . . . 74.030000000000001 113.89 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -102.02 0.22 34.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.013 -0.994 . . . . 73.510000000000005 109.971 -179.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 430' ' ' PRO . 35.7 m -80.05 1.51 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.775 0.797 . . . . 34.539999999999999 110.665 -179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.8 m -63.93 -30.31 71.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.793 -1.094 . . . . 62.020000000000003 109.455 177.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.9 t -62.21 -26.57 68.44 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.064 -0.971 . . . . 45.32 110.316 176.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.18 -46.29 20.92 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.926 -0.71 . . . . 71.049999999999997 109.998 -175.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 22.7 m -165.59 147.37 7.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.855 -0.794 . . . . 71.209999999999994 108.855 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -50.62 -49.06 57.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.17 0.988 . . . . 74.209999999999994 111.44 174.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.43 -43.9 75.78 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 123.407 0.442 . . . . 74.25 111.363 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 16.2 mm-40 -61.57 -41.38 97.31 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.143 -0.48 . . . . 74.129999999999995 111.766 -178.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.66 -51.58 68.79 Favored 'General case' 0 CA--C 1.508 -0.662 0 O-C-N 123.898 0.749 . . . . 55.149999999999999 110.216 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.75 -48.36 86.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 114.65 -1.159 . . . . 74.310000000000002 112.087 -175.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.6 mmtp -60.42 -45.43 93.63 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 117.874 0.306 . . . . 72.439999999999998 110.726 -176.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -66.51 -46.23 76.91 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.695 -0.684 . . . . 72.310000000000002 110.502 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.2 tp -69.21 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.22 0.533 . . . . 65.0 111.476 -177.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.61 -42.89 98.19 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.131 -0.692 . . . . 64.430000000000007 109.131 176.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -18.25 62.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 40.310000000000002 110.801 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.43 -13.24 59.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.222 0.534 . . . . 55.130000000000003 110.145 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.48 -9.16 15.03 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 120.142 -1.028 . . . . 51.030000000000001 113.702 174.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -77.56 131.78 38.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.898 0.38 . . . . 75.519999999999996 111.169 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.87 12.6 5.34 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.713 -0.955 . . . . 53.240000000000002 110.713 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -118.65 115.97 25.62 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.709 -1.219 . . . . 74.239999999999995 107.709 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -134.91 154.3 51.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.494 0.664 . . . . 75.140000000000001 111.557 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 485' ' ' ILE . 63.5 tttp -143.04 123.03 13.55 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 106.447 -1.686 . . . . 63.240000000000002 106.447 170.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.441 HE21 HG21 ' A' ' 488' ' ' VAL . 63.2 tt0 -91.62 132.79 36.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.545 -0.462 . . . . 71.120000000000005 110.319 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.33 143.84 50.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.674 -0.862 . . . . 62.530000000000001 108.674 176.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -119.79 144.18 47.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.264 -0.643 . . . . 71.120000000000005 109.264 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -141.34 134.97 14.65 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 107.133 -1.432 . . . . 73.030000000000001 107.133 177.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_endo -65.53 122.19 9.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.758 1.639 . . . . 72.439999999999998 109.715 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.4 m -124.72 174.63 7.76 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 116.064 -0.516 . . . . 61.109999999999999 110.269 -176.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -62.81 142.85 97.17 Favored Pre-proline 0 N--CA 1.416 -2.171 0 N-CA-C 107.801 -1.185 . . . . 64.430000000000007 107.801 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.42 -30.93 28.71 Favored 'Trans proline' 0 N--CA 1.473 0.295 0 C-N-CA 123.85 3.033 . . . . 64.209999999999994 113.377 -176.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.8 -27.01 65.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.586 -0.279 . . . . 71.200000000000003 111.429 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.78 -0.53 29.18 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.613 0.598 . . . . 74.329999999999998 112.613 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -61.37 127.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 109.96 -0.385 . . . . 74.430000000000007 109.96 176.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.85 -4.36 71.81 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 112.019 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -114.46 154.21 28.59 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.57 -0.9 . . . . 72.420000000000002 108.57 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 486' ' ' ILE . 53.2 t -82.11 134.3 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.122 -0.696 . . . . 55.229999999999997 109.122 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.3 pt -98.08 -20.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.55 -0.46 . . . . 73.439999999999998 110.538 -178.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 166.17 28.76 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.666 -0.778 . . . . 74.329999999999998 111.676 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 37.6 p -120.94 156.23 32.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.716 -0.475 . . . . 74.230000000000004 109.716 178.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -71.59 -48.35 12.12 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.303 -0.408 . . . . 33.409999999999997 111.326 175.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.3 Cg_exo -71.59 140.26 35.72 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 109.04 -1.177 . . . . 72.420000000000002 109.04 170.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.81 142.92 90.68 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.02 2.48 . . . . 61.030000000000001 114.294 -174.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.43 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -91.16 -6.97 52.75 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 74.340000000000003 109.386 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -99.52 -27.98 13.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.578 -0.737 . . . . 61.32 111.41 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.48 151.33 38.75 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.744 0.306 . . . . 71.409999999999997 110.358 -179.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 55.3 p -74.83 131.48 40.8 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.683 -0.69 . . . . 62.420000000000002 110.538 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.2 m -106.87 151.31 25.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.139 -0.689 . . . . 62.119999999999997 109.139 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.84 152.58 40.2 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.0 -0.741 . . . . 62.109999999999999 109.0 -175.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.52 -17.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.888 0.851 . . . . 55.340000000000003 110.563 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -93.11 7.03 45.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.553 -0.749 . . . . 75.099999999999994 110.008 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.45 140.21 32.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.681 -0.859 . . . . 63.200000000000003 108.681 176.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.03 121.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.895 -1.52 . . . . 40.329999999999998 106.895 176.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.46 117.92 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 C-N-CA 118.976 -1.09 . . . . 63.530000000000001 109.37 -179.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.478 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.7 mp -96.49 111.81 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 106.091 -1.818 . . . . 75.030000000000001 106.091 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.34 123.56 59.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 109.041 -0.725 . . . . 74.120000000000005 109.041 -177.41 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.19 115.98 46.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.582 -0.736 . . . . 55.210000000000001 109.946 -173.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.441 HG21 HE21 ' A' ' 454' ' ' GLN . 30.0 t -96.86 137.98 23.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.659 -0.701 . . . . 72.010000000000005 109.547 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.23 107.6 2.22 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 107.685 -2.166 . . . . 61.25 107.685 172.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -111.39 150.97 29.03 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.219 0.533 . . . . 63.130000000000003 110.797 -172.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.263 0 N-CA-C 110.146 -1.182 . . . . 75.510000000000005 110.146 177.673 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 121.255 0.55 . . . . 75.239999999999995 109.992 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.1 p -124.89 155.99 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.813 -0.631 . . . . 74.310000000000002 109.808 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -140.89 148.95 41.27 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.09 0.556 . . . . 72.450000000000003 109.805 176.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.62 125.01 29.47 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.944 -1.502 . . . . 53.210000000000001 106.944 178.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.0 pt -79.46 132.37 62.36 Favored Pre-proline 0 C--N 1.301 -1.501 0 C-N-CA 120.182 -0.607 . . . . 62.439999999999998 110.738 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -87.22 -171.27 0.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 122.13 1.887 . . . . 71.430000000000007 111.448 177.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.92 99.39 11.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.519 -0.919 . . . . 71.329999999999998 108.519 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.4 t -99.51 -5.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.906 0.86 . . . . 44.240000000000002 108.752 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -70.84 146.51 49.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.83 -1.077 . . . . 73.510000000000005 110.779 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.5 -20.07 23.35 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 119.888 -1.149 . . . . 72.409999999999997 112.08 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.436 ' O ' HG12 ' A' ' 534' ' ' VAL . 25.0 mt-30 -92.09 -171.44 2.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.456 -0.942 . . . . 74.219999999999999 108.456 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 m -84.95 155.22 21.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.124 -1.806 . . . . 73.430000000000007 106.124 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 10.1 p -64.11 -40.77 90.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 118.514 0.597 . . . . 64.0 110.984 -177.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 9.4 t70 -64.08 -43.19 96.15 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.403 -0.817 . . . . 65.430000000000007 111.611 178.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.94 -34.98 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.634 -0.826 . . . . 61.200000000000003 111.03 -178.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.62 76.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 64.239999999999995 111.256 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -65.41 -36.77 84.94 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 116.096 -0.502 . . . . 72.129999999999995 110.638 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.5 mptp? -62.7 -49.24 75.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.264 0.352 . . . . 65.200000000000003 111.946 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -63.67 -47.96 79.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.718 -0.393 . . . . 73.549999999999997 110.413 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.447 HD21 HD13 ' A' ' 551' ' ' ILE . 34.8 tp -62.27 -37.05 83.99 Favored 'General case' 0 C--O 1.192 -1.96 0 CA-C-N 115.759 -0.655 . . . . 64.010000000000005 111.313 -176.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.3 t-20 -59.01 -41.26 87.28 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.516 0.726 . . . . 61.409999999999997 110.294 177.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.1 -32.09 31.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.802 -0.635 . . . . 74.219999999999999 111.347 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.08 12.11 25.32 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.006 -0.678 . . . . 71.540000000000006 109.949 -174.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.33 -98.52 0.13 Allowed Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 117.735 -2.174 . . . . 71.239999999999995 117.29 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 67.2 m-85 -103.13 155.32 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 112.716 0.636 . . . . 74.030000000000001 112.716 -161.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 15.3 p -99.65 -36.19 9.58 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.991 -1.004 . . . . 72.120000000000005 112.151 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -108.22 131.93 54.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.269 0.557 . . . . 75.040000000000006 110.365 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.7 147.88 51.53 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.596 -0.729 . . . . 61.509999999999998 110.405 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.86 158.79 43.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.886 -1.153 . . . . 62.240000000000002 107.886 171.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.02 150.23 42.39 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.295 0.569 . . . . 72.200000000000003 111.48 -174.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.59 135.91 53.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.441 -1.689 . . . . 62.439999999999998 106.441 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 1.6 p -88.39 126.8 35.39 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 120.927 0.394 . . . . 72.549999999999997 111.369 -175.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.62 160.92 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 109.934 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.86 113.52 19.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.921 0.867 . . . . 63.530000000000001 112.892 -175.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.8 m -114.54 117.39 42.75 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.386 -1.338 . . . . 74.329999999999998 107.386 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.93 -39.05 15.03 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.96 2.44 . . . . 73.430000000000007 115.331 -171.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.525 ' HG3' ' HD3' ' A' ' 530' ' ' PRO 0.446 7.4 ptm180 -122.19 -88.22 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 115.095 1.516 . . . . 75.349999999999994 115.095 -175.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.525 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 10.9 Cg_exo -75.22 153.51 40.78 Favored 'Trans proline' 0 C--N 1.372 1.768 0 CA-C-N 123.123 2.151 . . . . 63.399999999999999 111.072 173.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -134.94 159.41 41.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 61.149999999999999 108.073 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.33 -17.46 7.01 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.962 -0.855 . . . . 74.109999999999999 110.962 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.51 ' OE2' ' HB3' ' A' ' 556' ' ' SER . 4.3 pm0 -81.95 147.44 29.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 110.1 -0.333 . . . . 71.340000000000003 110.1 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.2 p -77.07 115.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 106.839 -1.541 . . . . 75.530000000000001 106.839 173.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.1 m -79.71 -21.21 44.88 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.243 -0.89 . . . . 74.109999999999999 110.529 -174.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.83 -168.69 34.48 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.856 -0.687 . . . . 72.319999999999993 112.101 177.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.442 HG22 HD13 ' A' ' 553' ' ' LEU . 12.1 p -117.85 160.31 21.62 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.372 -0.974 . . . . 71.040000000000006 108.372 176.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -61.82 -52.91 65.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 121.058 -0.257 . . . . 60.450000000000003 111.404 177.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.5 Cg_exo -83.95 152.75 12.85 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.077 1.185 . . . . 74.510000000000005 109.023 173.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.8 158.55 46.55 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.115 1.877 . . . . 73.349999999999994 112.417 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.41 130.52 46.62 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.131 0.491 . . . . 50.140000000000001 110.243 176.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -14.68 37.55 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 115.92 -0.582 . . . . 72.25 112.063 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 89.8 m -80.6 131.26 35.48 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.606 -0.349 . . . . 65.200000000000003 110.434 177.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.1 t -98.33 127.87 44.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.386 -0.598 . . . . 62.140000000000001 109.386 178.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' A' ' 517' ' ' PHE . 7.9 m -135.2 158.45 74.66 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.759 -0.83 . . . . 73.209999999999994 108.759 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 494' ' ' THR . 22.6 Cg_exo -65.1 133.15 34.41 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.819 1.679 . . . . 75.439999999999998 112.41 -177.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 21.6 m -68.57 -25.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.783 -1.099 . . . . 72.439999999999998 112.306 -176.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.06 -6.35 59.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.926 -1.034 . . . . 74.510000000000005 109.882 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.8 t -92.95 -172.84 3.11 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.673 -0.694 . . . . 73.439999999999998 110.267 -175.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.02 113.23 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.668 -0.696 . . . . 75.319999999999993 110.513 -174.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 512' ' ' LEU . 13.7 tt -96.2 142.61 13.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.748 -0.834 . . . . 71.140000000000001 108.748 176.097 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 34.7 tt0 -104.01 124.17 48.54 Favored 'General case' 0 N--CA 1.399 -2.986 0 CA-C-O 121.125 0.488 . . . . 74.299999999999997 110.929 -175.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -97.66 136.03 38.61 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.054 -0.975 . . . . 74.430000000000007 111.719 176.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -91.62 109.41 20.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.599 -1.63 . . . . 73.150000000000006 106.599 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.89 135.6 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.399 0.619 . . . . 74.040000000000006 111.295 -174.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.51 ' HB3' ' OE2' ' A' ' 533' ' ' GLU . 1.8 p -62.58 117.97 6.96 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 124.792 1.237 . . . . 62.420000000000002 112.388 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.427 -1.622 0 N-CA-C 108.746 -0.835 . . . . 74.219999999999999 108.746 178.473 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 480' ' ' ILE . 9.7 pt-20 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.998 0.428 . . . . 50.350000000000001 111.829 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -96.91 122.94 40.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.97 0.414 . . . . 65.400000000000006 110.813 -176.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -120.89 146.85 46.17 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.87 -0.605 . . . . 74.439999999999998 111.97 -179.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.1 141.76 28.31 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.86 -1.064 . . . . 74.010000000000005 109.791 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.35 119.64 77.71 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.414 -0.587 . . . . 74.25 109.414 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.69 142.48 35.94 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.917 2.412 . . . . 71.430000000000007 111.522 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -88.81 78.47 7.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.811 1.291 . . . . 52.240000000000002 113.494 -176.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 440' ' ' ALA . 16.5 m -115.55 4.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.469 -2.048 . . . . 50.530000000000001 105.469 167.361 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.0 m -62.16 -41.3 98.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 112.355 -2.202 . . . . 71.150000000000006 109.057 178.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 42.4 m -58.07 -27.01 63.25 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.407 -1.27 . . . . 74.230000000000004 111.243 176.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.09 -46.31 11.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.233 -0.587 . . . . 74.319999999999993 111.035 -174.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.7 m -170.16 154.17 4.87 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.926 -0.768 . . . . 63.439999999999998 108.926 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -51.82 -49.84 62.01 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.255 1.022 . . . . 73.099999999999994 110.05 169.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.97 84.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.288 -0.869 . . . . 44.539999999999999 111.772 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 17.5 mm-40 -61.28 -46.09 91.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.993 -177.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -68.0 -49.47 61.4 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.765 -0.652 . . . . 75.310000000000002 111.34 -178.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.15 -48.2 90.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 123.537 0.523 . . . . 63.409999999999997 111.779 -176.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.14 -45.88 89.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.747 0.308 . . . . 73.109999999999999 111.023 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -67.22 -40.55 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.388 -0.369 . . . . 72.329999999999998 111.364 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.81 -33.03 73.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.189 0.519 . . . . 64.420000000000002 109.876 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 41.1 m -60.12 -44.17 95.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.56 -0.746 . . . . 73.0 109.232 173.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.11 64.4 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.602 -0.726 . . . . 75.439999999999998 111.298 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.15 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.241 0.543 . . . . 74.140000000000001 110.219 178.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.78 -18.66 5.94 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.748 -0.739 . . . . 51.0 113.308 176.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 445' ' ' THR . 96.3 m-85 -74.35 136.11 42.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 110.584 -177.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.19 -12.61 1.24 Allowed Glycine 0 C--N 1.296 -1.68 0 CA-C-N 115.754 -0.657 . . . . 74.219999999999999 112.356 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -102.51 115.38 30.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.351 -0.611 . . . . 75.329999999999998 109.351 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -128.0 165.18 20.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.703 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 1.9 tmtp? -146.68 124.99 12.24 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.884 -2.265 . . . . 74.540000000000006 104.884 172.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -94.54 128.75 41.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.433 0.635 . . . . 70.319999999999993 111.173 -177.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.78 154.29 45.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.225 -1.028 . . . . 74.439999999999998 108.225 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.31 151.29 47.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.968 -0.382 . . . . 70.319999999999993 109.968 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 54.5 m -140.56 148.41 53.2 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.62 -0.882 . . . . 61.140000000000001 108.62 174.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.8 Cg_endo -65.74 129.32 21.92 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.209 1.94 . . . . 62.0 111.346 178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.8 t -141.46 173.48 11.45 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.74 -0.837 . . . . 64.329999999999998 108.74 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.4 t -66.34 146.64 99.05 Favored Pre-proline 0 N--CA 1.412 -2.332 0 C-N-CA 123.757 0.823 . . . . 74.420000000000002 109.141 177.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.23 -28.88 21.32 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.497 3.465 . . . . 72.340000000000003 113.061 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.854 -0.612 . . . . 74.319999999999993 111.176 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.35 -3.17 29.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.255 0.465 . . . . 74.319999999999993 112.255 -176.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 93.9 t -61.11 127.68 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 177.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.93 -12.0 68.99 Favored Glycine 0 C--N 1.314 -0.681 0 N-CA-C 111.49 -0.644 . . . . 73.019999999999996 111.49 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -101.74 159.5 15.27 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.644 -0.873 . . . . 64.439999999999998 108.644 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 54.6 t -82.32 132.11 32.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 64.219999999999999 108.812 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.9 pt -102.95 -23.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.966 -0.693 . . . . 73.450000000000003 111.69 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.89 157.54 22.74 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 111.564 -0.614 . . . . 61.439999999999998 111.564 178.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.2 p -124.62 147.82 48.27 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.646 -0.501 . . . . 62.43 109.646 177.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 24.6 t-20 -64.48 -50.15 67.52 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.054 -0.498 . . . . 61.299999999999997 110.56 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.0 Cg_exo -72.63 124.99 10.2 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.198 -1.501 . . . . 75.239999999999995 108.198 170.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.423 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 40.9 Cg_endo -64.21 139.32 65.61 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.646 2.231 . . . . 64.140000000000001 112.874 -175.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.06 -16.26 41.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.857 0.837 . . . . 50.009999999999998 109.508 177.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -78.74 -31.97 46.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.325 -1.307 . . . . 72.430000000000007 109.358 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.423 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.9 mp0 -108.98 172.44 6.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.536 -0.913 . . . . 64.340000000000003 108.536 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.6 p -98.54 133.72 42.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.85 -0.796 . . . . 71.420000000000002 108.85 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.2 m -116.16 140.87 48.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.38 -0.6 . . . . 64.120000000000005 109.38 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.07 145.39 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 74.230000000000004 111.659 -178.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -58.52 -31.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 124.18 0.992 . . . . 63.439999999999998 110.643 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.5 t -77.44 8.85 3.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 111.705 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.54 144.64 25.42 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 122.058 -0.401 . . . . 65.040000000000006 110.16 178.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.55 122.32 35.55 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 N-CA-C 108.367 -0.975 . . . . 71.329999999999998 108.367 175.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.4 t -87.87 117.52 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 C-N-CA 119.277 -0.969 . . . . 75.129999999999995 108.722 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 54.4 mt -99.38 111.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.595 -2.002 . . . . 64.140000000000001 105.595 175.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 125.34 58.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 109.099 -0.704 . . . . 60.530000000000001 109.099 -175.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.5 mp -99.86 116.91 44.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 N-CA-C 109.187 -0.672 . . . . 71.150000000000006 109.187 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.18 143.15 12.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 64.319999999999993 109.061 -177.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.8 114.01 3.96 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.163 -1.975 . . . . 42.420000000000002 108.163 172.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t -116.11 153.49 31.66 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.69 -0.855 . . . . 75.310000000000002 108.69 -176.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.218 0 C-N-CA 120.485 -0.864 . . . . 65.019999999999996 111.215 -179.08 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.129 0 CA-C-O 122.002 0.905 . . . . 74.400000000000006 110.691 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.3 p -131.79 159.81 37.42 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.602 -1.258 . . . . 51.130000000000003 107.602 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -147.61 145.04 28.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.834 -0.747 . . . . 75.340000000000003 110.837 177.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.64 113.11 19.42 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.035 -1.468 . . . . 74.400000000000006 107.035 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 30.7 pt -75.83 127.91 84.55 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 113.112 0.782 . . . . 74.540000000000006 113.112 -173.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 25.5 Cg_endo -101.21 112.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 122.982 2.455 . . . . 60.539999999999999 111.324 171.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.69 132.11 34.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.219 -0.659 . . . . 64.040000000000006 109.219 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.04 59.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 107.582 -1.266 . . . . 72.349999999999994 107.582 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -57.51 140.6 50.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.156 -1.838 . . . . 72.030000000000001 110.616 176.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.48 -11.29 30.68 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.673 -0.775 . . . . 24.25 111.264 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 534' ' ' VAL . 26.6 mt-30 -97.5 -171.15 2.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.103 -0.332 . . . . 65.349999999999994 110.103 177.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 12.1 m -84.86 156.75 21.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.842 -1.169 . . . . 71.540000000000006 107.842 -177.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -41.97 93.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.78 0.324 . . . . 64.430000000000007 110.608 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.49 -42.04 95.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.707 -0.679 . . . . 71.400000000000006 110.821 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.88 -34.98 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 119.638 -0.825 . . . . 63.530000000000001 110.721 -177.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.76 85.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 111.029 178.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -62.76 -45.95 90.29 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.487 0.492 . . . . 62.119999999999997 109.916 178.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -61.9 -54.03 47.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.603 -0.726 . . . . 65.25 112.053 -173.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.88 -38.33 88.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.544 -0.463 . . . . 52.539999999999999 110.919 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.71 -43.22 72.86 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 109.422 -0.584 . . . . 63.219999999999999 109.422 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.92 -45.8 89.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.351 0.661 . . . . 74.219999999999999 111.815 -178.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.72 -30.85 49.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 71.140000000000001 111.418 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.26 22.44 12.88 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 122.059 -0.401 . . . . 74.239999999999995 110.415 -174.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.74 -101.82 0.17 Allowed Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 117.165 -2.445 . . . . 72.030000000000001 116.514 -172.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 23.3 m-85 -109.6 156.37 20.26 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.513 -0.844 . . . . 71.540000000000006 110.601 -165.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.5 m -107.92 -24.27 11.7 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.762 -0.654 . . . . 71.400000000000006 111.426 -174.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -107.93 115.55 30.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.841 0.353 . . . . 71.400000000000006 110.143 -176.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -117.04 154.54 30.77 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.745 -0.661 . . . . 74.409999999999997 110.383 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.29 155.58 45.96 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.481 -1.674 . . . . 61.130000000000003 106.481 171.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.509 HE22 HD23 ' A' ' 553' ' ' LEU . 11.7 mm100 -119.96 148.3 43.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.294 -1.002 . . . . 74.209999999999994 108.294 -174.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.12 128.5 30.23 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.223 -0.658 . . . . 74.420000000000002 109.223 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -88.02 122.44 31.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.444 -1.317 . . . . 74.209999999999994 107.444 176.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.72 153.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 109.169 -175.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.34 114.59 18.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.436 1.112 . . . . 74.409999999999997 110.883 -175.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.9 p -117.17 120.52 33.51 Favored Pre-proline 0 N--CA 1.408 -2.535 0 CA-C-N 113.799 -1.546 . . . . 63.229999999999997 109.769 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.95 -55.12 3.18 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.766 2.311 . . . . 61.329999999999998 112.818 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.46 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 23.8 mtp180 -99.92 -54.4 0.17 Allowed Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 114.081 1.141 . . . . 73.010000000000005 114.081 177.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 32.1 Cg_exo -60.21 153.27 60.28 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.138 1.892 . . . . 74.329999999999998 113.798 -176.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.05 133.74 9.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.604 -1.258 . . . . 62.229999999999997 107.604 176.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 84.23 -45.16 3.44 Favored Glycine 0 C--N 1.312 -0.754 0 C-N-CA 121.258 -0.496 . . . . 75.450000000000003 113.516 177.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.22 149.68 48.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.248 1.019 . . . . 75.140000000000001 111.406 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 503' ' ' GLN . 9.3 p -75.17 127.35 36.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.193 0.52 . . . . 62.130000000000003 111.073 -174.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -82.19 -22.21 36.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.518 -0.765 . . . . 73.420000000000002 109.226 -178.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 140.67 -149.5 20.99 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.901 -1.28 . . . . 63.119999999999997 109.901 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.0 p -116.94 157.26 26.02 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.766 -1.198 . . . . 62.140000000000001 107.766 176.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 52.1 t30 -59.44 -53.48 65.48 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.39 -0.338 . . . . 75.140000000000001 111.734 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.9 Cg_exo -77.19 138.84 18.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 108.386 -1.428 . . . . 75.340000000000003 108.386 172.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.07 155.43 69.68 Favored 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 121.958 1.772 . . . . 53.210000000000001 111.948 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -59.09 143.42 48.67 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 110.695 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 94.02 -9.27 72.89 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 120.944 -0.646 . . . . 75.430000000000007 111.853 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 29.5 m -80.16 128.22 33.26 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.218 -0.66 . . . . 75.010000000000005 109.218 177.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 1.8 m -84.88 122.68 29.53 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.712 -1.218 . . . . 61.219999999999999 107.712 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.11 154.72 81.76 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.626 -0.509 . . . . 42.409999999999997 109.626 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 494' ' ' THR . 21.4 Cg_exo -67.42 133.95 31.79 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.428 2.085 . . . . 75.209999999999994 111.813 -178.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.578 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 19.5 m -67.69 -20.48 26.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.166 0.507 . . . . 72.319999999999993 112.08 -177.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.67 -3.04 55.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.83 -0.623 . . . . 73.329999999999998 110.444 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.7 t -95.19 164.99 12.62 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.361 -0.607 . . . . 73.150000000000006 109.361 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.73 136.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.604 -0.517 . . . . 72.099999999999994 109.604 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.5 tt -110.65 138.47 38.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 120.936 0.398 . . . . 64.510000000000005 109.937 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -103.4 127.43 50.76 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 122.771 0.428 . . . . 65.219999999999999 109.85 -178.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.509 HD23 HE22 ' A' ' 522' ' ' GLN . 18.4 tp -100.63 132.96 45.75 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.485 -0.78 . . . . 63.149999999999999 108.899 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -88.88 113.66 24.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.115 -0.698 . . . . 74.319999999999993 109.115 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 47.8 t -103.96 124.16 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 108.542 -0.91 . . . . 52.049999999999997 108.542 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 16.0 m -61.58 121.84 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.302 -0.999 . . . . 54.530000000000001 108.302 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 60.2 tttm . . . . . 0 N--CA 1.42 -1.96 0 CA-C-O 118.462 -0.78 . . . . 72.209999999999994 110.745 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.5 pt-20 . . . . . 0 N--CA 1.442 -0.838 0 CA-C-O 122.116 0.96 . . . . 72.450000000000003 108.641 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -83.53 121.88 27.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.802 -1.09 . . . . 74.109999999999999 109.946 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -121.07 156.92 31.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.096 -1.076 . . . . 71.230000000000004 108.096 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -83.43 140.84 32.13 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 109.844 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -84.71 127.88 63.36 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.318 -0.993 . . . . 70.510000000000005 108.318 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.3 141.59 63.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.887 1.724 . . . . 63.240000000000002 111.93 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -111.31 70.22 0.71 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 122.669 1.224 . . . . 73.230000000000004 108.781 -177.124 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.96 5.92 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 113.779 -1.555 . . . . 65.329999999999998 107.812 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.56 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.3 m -57.34 -34.62 68.97 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.872 -1.967 . . . . 53.509999999999998 112.428 -177.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.0 t -60.3 -27.06 67.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.156 0.582 . . . . 64.230000000000004 111.557 178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.45 -45.97 18.39 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 120.127 -0.629 . . . . 71.099999999999994 110.21 -172.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.4 m -170.3 149.08 3.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.494 -1.298 . . . . 73.25 107.494 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 42.2 t80 -53.22 -45.86 68.84 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.555 0.535 . . . . 74.019999999999996 110.389 171.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.13 74.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.52 -0.764 . . . . 71.040000000000006 111.867 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 30.2 mm-40 -61.35 -44.87 96.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.269 -0.423 . . . . 72.420000000000002 111.048 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -62.79 -51.05 68.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.831 -0.622 . . . . 54.100000000000001 110.766 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -62.95 -48.86 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.662 -0.699 . . . . 61.539999999999999 111.97 -175.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.06 -41.49 90.7 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 121.107 -0.237 . . . . 75.420000000000002 111.353 -177.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.12 88.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.244 0.545 . . . . 72.239999999999995 109.887 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.51 -40.32 80.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.671 -0.695 . . . . 74.319999999999993 109.904 177.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.4 m -59.47 -46.5 88.62 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.637 -0.71 . . . . 55.439999999999998 109.107 176.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.34 65.9 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.443 -0.799 . . . . 64.400000000000006 111.437 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.61 -14.01 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 74.439999999999998 111.023 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.03 -14.92 21.3 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.108 -1.044 . . . . 64.430000000000007 113.046 175.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -69.81 130.15 41.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.608 -0.516 . . . . 74.420000000000002 109.608 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.19 -23.92 6.48 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.894 -0.669 . . . . 51.219999999999999 111.704 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -103.01 115.79 31.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.831 0.824 . . . . 72.299999999999997 112.458 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 3.4 p90 -146.83 141.74 26.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.405 -1.27 . . . . 64.340000000000003 110.112 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -131.39 123.22 27.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.548 -0.751 . . . . 55.439999999999998 109.089 -174.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -85.78 135.35 33.76 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.003 -0.544 . . . . 74.239999999999995 110.576 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.68 147.7 52.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.396 -1.705 . . . . 64.040000000000006 106.396 171.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -114.4 149.2 36.53 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.438 -0.505 . . . . 70.349999999999994 109.808 -178.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 10.2 t -140.63 133.49 14.63 Favored Pre-proline 0 N--CA 1.422 -1.862 0 N-CA-C 108.01 -1.107 . . . . 72.310000000000002 108.01 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.2 Cg_exo -65.0 125.09 14.06 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.656 2.237 . . . . 63.049999999999997 111.93 -179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 31.4 t -139.26 179.5 6.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 -178.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.4 t -57.64 140.37 80.59 Favored Pre-proline 0 N--CA 1.432 -1.336 0 C-N-CA 123.213 0.605 . . . . 52.520000000000003 110.327 177.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 76.7 Cg_exo -50.58 -29.61 25.57 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 124.312 3.342 . . . . 74.310000000000002 113.573 -178.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.58 -10.59 59.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.58 0.585 . . . . 70.049999999999997 112.58 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.6 8.11 35.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.525 0.565 . . . . 74.319999999999993 112.525 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.4 p -60.68 128.1 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.796 0.331 . . . . 70.409999999999997 110.453 179.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.54 87.62 Favored Glycine 0 C--O 1.252 1.26 0 C-N-CA 120.847 -0.692 . . . . 73.409999999999997 112.214 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -113.61 146.06 40.31 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.19 -1.041 . . . . 65.420000000000002 108.19 177.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 45.8 t -81.94 144.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.943 -0.391 . . . . 64.120000000000005 109.943 -176.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.6 pt -98.21 -19.0 6.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.142 0.496 . . . . 60.340000000000003 110.503 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.24 178.36 37.67 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 111.191 -0.764 . . . . 72.219999999999999 111.191 177.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 27.8 p -119.59 145.99 45.91 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.415 -0.587 . . . . 73.409999999999997 109.415 178.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.88 -52.1 74.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 123.266 0.353 . . . . 70.519999999999996 111.103 178.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.68 143.41 23.9 Favored 'Trans proline' 0 C--N 1.366 1.493 0 N-CA-C 108.89 -1.235 . . . . 73.319999999999993 108.89 170.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 56.4 Cg_endo -65.94 153.11 79.49 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 122.459 2.106 . . . . 61.450000000000003 112.355 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -87.15 -20.07 27.55 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.424 -0.807 . . . . 72.340000000000003 110.262 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 -32.12 15.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.089 -0.959 . . . . 74.519999999999996 112.117 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 1.3 mp0 -94.57 145.57 24.72 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.234 -0.986 . . . . 70.340000000000003 108.613 178.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 28.6 p -83.87 128.71 34.74 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 116.327 -0.397 . . . . 71.209999999999994 110.513 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 m -114.03 145.11 42.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.073 -1.084 . . . . 63.340000000000003 108.073 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.413 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.46 142.0 58.31 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.663 0.268 . . . . 55.450000000000003 111.542 -176.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 425' ' ' GLU . 50.2 mm -57.75 -25.84 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.779 0.832 . . . . 73.040000000000006 110.578 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -79.56 3.61 18.33 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.971 -0.559 . . . . 74.439999999999998 111.226 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -95.52 157.77 15.75 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.975 -0.453 . . . . 74.409999999999997 110.241 179.272 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.39 122.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.962 -1.125 . . . . 71.540000000000006 107.962 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 93.3 t -89.25 119.38 36.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.616 -0.512 . . . . 71.349999999999994 109.616 179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.31 121.81 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.588 -1.264 . . . . 72.239999999999995 107.588 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.95 121.29 66.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 115.626 -0.715 . . . . 75.450000000000003 109.277 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.73 118.36 49.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 121.808 0.813 . . . . 72.439999999999998 112.511 -178.283 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 15.4 t -96.77 145.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.883 -1.053 . . . . 72.129999999999995 109.1 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.77 117.31 4.63 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 110.477 -1.049 . . . . 71.129999999999995 110.477 176.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 7.3 p -99.57 128.66 45.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 107.486 -1.302 . . . . 63.420000000000002 107.486 174.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . . . . . . 0 N--CA 1.43 -1.729 0 C-N-CA 120.213 -0.994 . . . . 71.519999999999996 112.057 -174.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.827 0 N-CA-C 107.44 -1.318 . . . . 64.209999999999994 107.44 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 546' ' ' PRO . 21.9 p -122.61 158.77 29.23 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 115.538 -0.755 . . . . 55.329999999999998 109.847 -178.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -135.65 141.63 45.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.323 -0.398 . . . . 75.349999999999994 110.76 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.07 127.1 32.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.723 -1.214 . . . . 75.209999999999994 107.723 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.97 129.79 80.0 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 115.87 -0.605 . . . . 54.149999999999999 111.863 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -94.26 124.28 0.43 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.769 2.313 . . . . 42.109999999999999 112.471 173.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.18 135.43 36.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 174.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 t -125.28 33.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.754 0.787 . . . . 75.510000000000005 108.928 -176.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -61.28 116.16 4.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 70.109999999999999 110.771 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.57 -23.92 5.01 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.651 -0.785 . . . . 60.210000000000001 112.244 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.31 -179.17 3.87 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.712 -0.847 . . . . 65.540000000000006 108.712 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 25.7 m -84.09 155.7 22.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 119.928 -0.709 . . . . 71.230000000000004 109.652 -172.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.06 -41.31 68.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.787 0.435 . . . . 72.549999999999997 111.199 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.64 -42.06 87.3 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.535 -0.757 . . . . 75.349999999999994 111.59 -178.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.06 -36.37 56.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 118.952 -1.099 . . . . 74.329999999999998 110.631 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.16 74.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.942 -1.026 . . . . 74.120000000000005 111.56 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.35 -35.24 79.74 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 123.116 0.26 . . . . 63.109999999999999 110.676 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -63.54 -49.15 74.61 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.332 0.395 . . . . 61.409999999999997 111.918 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -68.88 -38.27 79.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.897 0.379 . . . . 72.140000000000001 110.472 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 551' ' ' ILE . 48.1 tp -62.4 -44.67 95.89 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 115.84 -0.618 . . . . 53.420000000000002 110.065 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.0 t-20 -59.54 -47.69 84.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.413 0.685 . . . . 62.420000000000002 111.989 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.69 -20.0 17.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.169 -0.469 . . . . 31.23 112.04 -175.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -116.61 4.02 13.14 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 120.034 -0.666 . . . . 70.439999999999998 111.13 -178.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.73 -96.64 0.2 Allowed Glycine 0 N--CA 1.41 -3.089 0 C-N-CA 118.806 -1.664 . . . . 64.310000000000002 115.763 -169.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 9.6 m-85 -129.74 158.4 39.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.278 -0.461 . . . . 65.450000000000003 110.292 -165.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -104.95 -2.21 24.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.609 -0.885 . . . . 64.540000000000006 108.609 177.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 550' ' ' VAL . 75.5 mmtt -108.73 115.61 30.41 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 72.040000000000006 109.462 -175.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -126.24 152.42 46.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.603 0.716 . . . . 72.230000000000004 111.786 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -133.59 148.82 51.62 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.629 -1.619 . . . . 75.319999999999993 106.629 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.6 mm-40 -120.27 123.25 42.72 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.691 -1.226 . . . . 72.420000000000002 107.691 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -114.86 126.53 54.92 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.78 -1.192 . . . . 74.219999999999999 107.78 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 19.4 m -91.92 120.45 32.6 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.019 -0.734 . . . . 74.150000000000006 109.019 -178.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.39 151.51 24.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.568 -1.271 . . . . 74.319999999999993 107.568 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.476 ' HA ' ' OXT' ' A' ' 557' ' ' LYS . 12.6 m-20 -79.05 128.22 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.024 0.916 . . . . 70.310000000000002 113.411 -170.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.4 m -143.4 111.7 5.47 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.84 -1.541 . . . . 42.350000000000001 106.84 177.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -56.17 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.048 2.498 . . . . 54.219999999999999 114.568 -174.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -82.34 -44.78 0.98 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 114.715 1.376 . . . . 73.140000000000001 114.715 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 533' ' ' GLU . 72.6 Cg_exo -57.07 133.76 59.94 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.352 1.368 . . . . 71.200000000000003 110.803 174.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -143.09 127.21 17.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.587 -0.279 . . . . 74.129999999999995 110.652 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.0 -11.28 55.2 Favored Glycine 0 N--CA 1.469 0.858 0 CA-C-O 121.372 0.429 . . . . 62.450000000000003 113.024 175.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 530' ' ' PRO . 11.4 pt-20 -86.78 150.89 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.505 0.722 . . . . 74.319999999999993 110.976 178.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 47.8 t -74.71 124.64 32.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.226 -1.028 . . . . 60.130000000000003 108.226 178.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 28.8 m -83.38 -33.64 25.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 71.519999999999996 108.44 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.05 -167.12 39.92 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.834 -0.621 . . . . 65.120000000000005 111.655 177.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.5 p -118.97 160.38 22.1 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.579 -0.897 . . . . 72.219999999999999 108.579 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.9 t-20 -57.8 -56.77 31.13 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 119.274 -0.394 . . . . 73.129999999999995 111.95 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.3 Cg_endo -89.38 166.05 5.37 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.833 1.688 . . . . 52.25 109.506 174.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.28 152.55 55.75 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.295 1.996 . . . . 64.230000000000004 111.974 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.14 135.94 57.73 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.862 0.465 . . . . 65.230000000000004 110.351 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.47 37.16 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.99 -0.624 . . . . 63.439999999999998 111.564 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.6 m -67.89 131.56 45.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.483 -0.562 . . . . 74.230000000000004 109.483 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.3 t -100.02 123.72 44.58 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.994 0.902 . . . . 72.219999999999999 110.971 -177.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.69 158.93 60.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 71.319999999999993 108.465 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 494' ' ' THR . 44.1 Cg_exo -58.62 143.78 98.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.237 1.958 . . . . 74.439999999999998 110.894 179.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.32 -21.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.246 0.461 . . . . 65.329999999999998 112.246 -176.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.97 -2.77 58.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.325 -0.398 . . . . 75.329999999999998 111.034 178.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -81.21 152.58 27.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.18 -0.674 . . . . 51.030000000000001 109.18 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.9 t -90.06 125.5 42.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.312 -0.625 . . . . 61.109999999999999 109.312 -179.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.435 HD13 HD21 ' A' ' 512' ' ' LEU . 14.2 tt -97.25 139.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.122 -0.325 . . . . 61.020000000000003 110.122 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -102.85 120.27 40.3 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 120.902 0.382 . . . . 61.119999999999997 110.119 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 534' ' ' VAL . 6.3 tt -100.89 130.18 46.86 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.423 -1.325 . . . . 72.439999999999998 107.423 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.8 mt-30 -101.21 109.51 21.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.661 0.743 . . . . 71.049999999999997 110.186 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.18 139.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.448 -1.251 . . . . 75.120000000000005 111.598 -175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -57.14 121.05 9.13 Favored 'General case' 0 C--O 1.25 1.108 0 C-N-CA 123.825 0.85 . . . . 64.430000000000007 112.973 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.476 ' OXT' ' HA ' ' A' ' 526' ' ' ASP . 28.4 ttpp . . . . . 0 N--CA 1.432 -1.367 0 C-N-CA 124.951 1.301 . . . . 72.5 108.362 175.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 107.866 -1.161 . . . . 63.229999999999997 107.866 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 96.6 mt-30 -83.47 149.09 26.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.649 -1.614 . . . . 74.409999999999997 108.396 178.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 17.6 tpp180 -120.92 155.33 34.44 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.528 -1.286 . . . . 62.109999999999999 107.528 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.39 141.48 31.7 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.49 -0.93 . . . . 72.239999999999995 108.49 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -80.07 127.4 77.03 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.018 -1.475 . . . . 64.140000000000001 107.018 177.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.27 139.93 32.99 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 109.431 -1.027 . . . . 53.450000000000003 109.431 175.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -115.28 72.04 0.78 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.889 1.328 . . . . 73.319999999999993 109.93 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.14 14.68 7.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 113.552 -1.658 . . . . 61.450000000000003 107.1 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.624 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.3 m -52.39 -41.29 63.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 127.637 2.375 . . . . 63.509999999999998 110.395 178.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.3 t -56.43 -26.71 54.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.003 1.321 . . . . 64.200000000000003 112.017 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.4 mt -85.85 -46.92 10.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.118 -1.033 . . . . 63.200000000000003 111.048 -174.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 20.1 m -174.23 153.7 2.05 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.535 -0.913 . . . . 72.340000000000003 108.535 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.497 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 40.3 t80 -50.55 -50.68 52.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.142 0.977 . . . . 74.340000000000003 111.009 171.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.48 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.757 0.661 . . . . 64.420000000000002 111.461 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.413 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 50.0 mm-40 -61.49 -45.98 91.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.317 -0.402 . . . . 62.350000000000001 111.463 -178.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -63.38 -48.36 78.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.87 -0.605 . . . . 61.140000000000001 110.967 -178.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.18 -46.59 90.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.894 -0.594 . . . . 64.519999999999996 112.238 -176.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -66.55 -41.55 88.49 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.488 0.181 . . . . 71.400000000000006 111.488 -178.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.08 -38.99 86.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.458 -0.497 . . . . 70.430000000000007 111.179 176.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 452' ' ' PHE . 33.5 tp -67.11 -36.61 82.29 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.251 0.548 . . . . 52.329999999999998 110.041 178.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.2 m -59.49 -44.72 93.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.459 -0.791 . . . . 45.020000000000003 109.582 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.68 -18.65 62.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.44 -0.8 . . . . 73.329999999999998 111.181 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.16 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.228 0.537 . . . . 72.439999999999998 110.903 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.06 -25.77 9.74 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.813 -0.708 . . . . 60.009999999999998 113.454 174.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 96.2 m-85 -57.42 130.7 47.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.038 0.535 . . . . 61.340000000000003 112.0 -176.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.0 26.29 4.79 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.398 -0.906 . . . . 53.130000000000003 112.849 -178.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -132.91 115.59 15.43 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.235 -1.024 . . . . 75.010000000000005 108.235 178.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.6 m-85 -128.93 150.11 50.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.575 0.702 . . . . 71.420000000000002 111.731 -174.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.573 ' HB2' HG13 ' A' ' 485' ' ' ILE . 36.3 mmtm -136.24 130.62 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.646 -1.983 . . . . 75.540000000000006 105.646 169.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -108.26 124.72 50.74 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.703 -0.799 . . . . 74.519999999999996 110.83 -175.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.05 145.01 48.56 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.934 -0.575 . . . . 63.119999999999997 109.547 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -118.88 134.54 55.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.436 -1.32 . . . . 70.540000000000006 107.436 175.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.1 t -122.29 137.23 27.3 Favored Pre-proline 0 C--N 1.283 -2.284 0 N-CA-C 108.479 -0.934 . . . . 75.409999999999997 108.479 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.11 122.17 9.86 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.847 1.698 . . . . 54.049999999999997 110.801 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 40.5 m -134.07 178.7 6.76 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.353 -0.98 . . . . 54.329999999999998 108.353 -177.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.7 t -74.0 151.26 88.39 Favored Pre-proline 0 N--CA 1.403 -2.804 0 N-CA-C 107.651 -1.24 . . . . 74.329999999999998 107.651 176.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.498 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -50.42 -28.91 22.44 Favored 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 124.121 3.214 . . . . 63.030000000000001 112.718 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.97 -26.25 68.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.121 -0.49 . . . . 74.049999999999997 111.344 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.34 -0.42 35.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.81 1.041 . . . . 63.420000000000002 113.81 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -60.81 128.13 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 119.962 -0.695 . . . . 74.140000000000001 110.696 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.24 -12.77 67.8 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 121.12 -0.562 . . . . 74.400000000000006 112.654 177.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.27 139.72 38.35 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.732 -0.47 . . . . 72.450000000000003 109.732 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 61.6 t -82.49 128.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.767 -0.651 . . . . 75.219999999999999 109.628 -178.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.47 -6.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.937 0.399 . . . . 74.450000000000003 112.019 -176.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.29 160.92 15.43 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.939 -1.125 . . . . 75.400000000000006 112.829 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.0 p -118.95 142.29 47.91 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.255 -1.017 . . . . 71.519999999999996 108.255 176.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.527 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.7 t-20 -54.74 -51.58 77.68 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 112.387 0.514 . . . . 72.129999999999995 112.387 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.5 Cg_exo -77.2 124.13 7.05 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 N-CA-C 108.158 -1.516 . . . . 75.140000000000001 108.158 169.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.32 142.17 65.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.326 2.017 . . . . 75.120000000000005 112.037 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.55 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.21 -14.65 61.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.144 0.973 . . . . 40.43 110.697 -177.152 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.27 -9.98 55.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.731 -1.577 . . . . 64.450000000000003 111.33 -176.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -120.84 151.06 40.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.945 -0.761 . . . . 64.230000000000004 108.945 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 10.7 p -84.44 132.7 34.54 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 108.807 -0.812 . . . . 73.109999999999999 108.807 176.513 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.6 m -122.2 145.71 47.94 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.358 -0.608 . . . . 53.340000000000003 109.358 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -59.55 154.64 16.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.439 . . . . 54.520000000000003 111.001 179.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.1 -25.42 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.796 0.807 . . . . 63.43 110.603 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.4 t -94.54 11.48 30.79 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.014 -0.994 . . . . 62.5 110.921 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.74 141.35 39.34 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 121.697 -0.627 . . . . 72.530000000000001 109.853 176.47 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.57 117.33 25.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.609 0.719 . . . . 73.0 110.075 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.44 118.61 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.734 -0.839 . . . . 72.340000000000003 108.734 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.573 HG13 ' HB2' ' A' ' 453' ' ' LYS . 2.5 mp -96.5 117.83 41.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 105.411 -2.07 . . . . 71.129999999999995 105.411 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.72 119.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 109.068 -0.715 . . . . 73.540000000000006 109.068 -176.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.53 114.26 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.942 -0.572 . . . . 74.209999999999994 110.528 -175.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 17.5 t -95.99 136.59 26.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.688 -0.856 . . . . 63.539999999999999 108.688 -178.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.44 125.08 6.8 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.815 -1.714 . . . . 73.150000000000006 108.815 175.072 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -128.63 129.84 46.44 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 109.12 -0.696 . . . . 71.430000000000007 109.12 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.85 0 N-CA-C 109.104 -1.598 . . . . 44.240000000000002 109.104 178.361 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.165 0 CA-C-O 122.147 0.975 . . . . 70.129999999999995 109.591 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.9 p -137.1 154.11 50.38 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.644 -1.243 . . . . 74.340000000000003 107.644 -176.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -138.64 150.0 45.78 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.807 0.337 . . . . 71.140000000000001 110.562 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.0 t70 -100.36 113.73 26.7 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.02 -1.104 . . . . 74.109999999999999 108.02 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.559 ' H ' HD13 ' A' ' 497' ' ' ILE . 0.2 OUTLIER -98.6 134.84 21.37 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 113.443 0.905 . . . . 71.239999999999995 113.443 -174.153 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.4 -178.15 1.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.767 2.311 . . . . 55.119999999999997 109.04 170.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.69 153.64 18.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.091 -0.707 . . . . 70.150000000000006 109.091 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.65 33.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 104.937 -2.246 . . . . 54.399999999999999 104.937 175.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.89 147.45 33.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.794 -1.548 . . . . 63.399999999999999 111.327 -173.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 103.65 -12.98 53.96 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.64 -0.984 . . . . 43.539999999999999 110.64 -177.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.12 179.92 4.08 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.72 156.15 26.4 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.647 -0.421 . . . . 64.219999999999999 109.941 -170.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.1 p -54.3 -43.7 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.383 0.512 . . . . 72.310000000000002 112.383 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.64 -41.91 78.74 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.332 0.493 . . . . 63.119999999999997 112.332 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.83 -38.9 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 119.47 -0.892 . . . . 72.349999999999994 111.524 -174.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.38 80.93 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.61 -0.723 . . . . 71.530000000000001 111.39 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -64.82 -34.68 78.93 Favored 'General case' 0 C--O 1.205 -1.282 0 O-C-N 123.214 0.321 . . . . 64.120000000000005 110.394 -177.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -59.5 -52.48 65.4 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.495 -0.557 . . . . 74.299999999999997 109.495 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -66.86 -44.72 80.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.457 -0.792 . . . . 72.099999999999994 110.704 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.47 -37.0 82.03 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 115.915 -0.584 . . . . 62.350000000000001 110.531 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.81 -38.15 77.98 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.552 0.741 . . . . 74.5 110.942 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -37.62 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.718 -0.674 . . . . 74.430000000000007 111.267 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -122.74 33.83 5.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.713 0.768 . . . . 72.430000000000007 111.455 -176.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -153.39 -128.52 1.29 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.98 -1.009 . . . . 62.240000000000002 111.553 -178.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 44.7 m-85 -105.66 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.053 0.454 . . . . 65.450000000000003 110.319 -173.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.6 p -110.03 -3.63 16.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.577 -0.738 . . . . 71.439999999999998 110.902 178.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 550' ' ' VAL . 28.2 mtpp -113.77 115.73 28.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.84 -0.8 . . . . 74.239999999999995 108.84 -177.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.83 156.46 43.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.152 0.501 . . . . 74.209999999999994 111.456 -175.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -140.99 156.62 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.017 -1.475 . . . . 75.219999999999999 107.017 171.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -121.75 124.87 45.24 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.385 -0.598 . . . . 74.409999999999997 109.385 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.82 140.63 48.78 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.529 -0.915 . . . . 75.230000000000004 108.529 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 20.0 m -88.18 124.81 34.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.974 -0.557 . . . . 52.530000000000001 110.704 -176.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 33.2 m -121.17 156.8 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.954 -1.128 . . . . 73.430000000000007 107.954 176.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.88 142.4 38.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.999 0.904 . . . . 72.209999999999994 112.048 -170.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 p -118.17 135.29 23.43 Favored Pre-proline 0 N--CA 1.413 -2.294 0 CA-C-N 114.264 -1.334 . . . . 51.109999999999999 110.187 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.55 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.275 0 N-CA-C 109.075 -1.163 . . . . 43.140000000000001 109.075 171.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.559 ' HG3' ' HD3' ' A' ' 530' ' ' PRO . 23.2 ptt180 -127.43 -47.07 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 114.72 1.378 . . . . 74.349999999999994 114.72 176.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.559 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 84.7 Cg_endo -76.54 135.89 16.8 Favored 'Trans proline' 0 C--N 1.385 2.45 0 CA-C-N 121.763 1.665 . . . . 71.409999999999997 112.107 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -137.32 145.44 43.41 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.955 -0.387 . . . . 73.519999999999996 109.955 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 100.21 -18.83 54.97 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.899 -0.48 . . . . 62.450000000000003 111.899 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.43 148.4 24.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.638 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.73 122.45 28.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.289 -0.869 . . . . 75.340000000000003 109.472 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.3 m -92.68 -10.01 38.78 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.788 -1.096 . . . . 62.5 109.348 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -159.12 27.98 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 110.774 -0.931 . . . . 75.430000000000007 110.774 177.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -134.36 157.75 45.59 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.698 -1.223 . . . . 71.5 107.698 177.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 552' ' ' GLU . 25.2 t-20 -52.68 -58.72 10.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.861 -0.59 . . . . 51.0 110.908 -179.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.51 140.53 15.13 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 120.464 1.202 . . . . 63.100000000000001 109.063 170.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.47 155.8 65.9 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 121.935 1.757 . . . . 71.409999999999997 112.193 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.53 136.14 57.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.944 -0.571 . . . . 73.340000000000003 109.914 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -5.36 57.04 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.088 -1.053 . . . . 62.299999999999997 111.815 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 16.7 m -89.2 137.72 32.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.446 -0.575 . . . . 73.120000000000005 109.446 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.7 m -98.8 123.04 42.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.244 -1.021 . . . . 42.420000000000002 108.244 175.084 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.74 161.96 57.97 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 110.054 -0.351 . . . . 71.519999999999996 110.054 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 494' ' ' THR . 20.7 Cg_exo -66.33 137.79 48.57 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.02 2.48 . . . . 60.229999999999997 113.995 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.553 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 15.0 m -67.86 -20.45 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.005 0.907 . . . . 72.040000000000006 111.248 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.45 -5.15 58.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.446 -1.252 . . . . 63.229999999999997 110.456 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -103.72 152.25 22.05 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.69 -1.226 . . . . 74.049999999999997 107.69 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 519' ' ' LYS . 38.8 t -88.71 136.2 23.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.859 -0.423 . . . . 64.319999999999993 109.859 -177.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.0 tt -95.88 135.49 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.352 0.596 . . . . 70.109999999999999 109.408 176.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -101.59 120.61 40.59 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.379 -0.971 . . . . 72.430000000000007 108.379 -177.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.0 tp -95.5 126.58 40.89 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.811 -1.086 . . . . 71.439999999999998 108.472 -177.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -89.53 105.64 17.93 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.632 -0.877 . . . . 75.310000000000002 108.632 -177.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.48 134.49 47.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 120.789 0.328 . . . . 64.310000000000002 110.667 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.7 p -66.35 121.46 15.3 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.044 -0.525 . . . . 75.310000000000002 109.743 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 20.6 pttp . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 115.557 -0.747 . . . . 75.510000000000005 110.626 -177.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.775 0.797 . . . . 61.340000000000003 109.521 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -101.39 147.89 25.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.162 -1.051 . . . . 54.229999999999997 108.162 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 18.4 tpt180 -120.72 158.82 26.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.966 0.413 . . . . 73.430000000000007 110.166 -175.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.3 141.47 29.22 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.149 0.979 . . . . 74.519999999999996 110.41 -176.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.0 mp -87.85 121.49 70.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.617 -1.623 . . . . 60.009999999999998 106.617 173.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.74 141.83 55.86 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.091 1.861 . . . . 34.219999999999999 112.898 -175.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.58 11.64 23.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.74 -0.663 . . . . 73.120000000000005 110.767 -178.192 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 443' ' ' LYS . 21.5 m -73.27 -9.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.701 -0.851 . . . . 64.450000000000003 108.701 176.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.0 m -57.23 -38.2 73.44 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.329 -1.305 . . . . 71.140000000000001 109.866 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.1 m -60.02 -27.56 67.0 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.779 -1.1 . . . . 70.239999999999995 110.647 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.8 mt -79.85 -47.63 14.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.382 -0.927 . . . . 73.010000000000005 109.975 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.529 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 49.8 m -166.01 145.77 6.27 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.682 -0.858 . . . . 73.140000000000001 108.682 177.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -55.29 -44.5 75.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.468 0.707 . . . . 72.439999999999998 111.914 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.19 -43.29 78.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.447 . . . . 70.510000000000005 110.881 177.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.9 mm-40 -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 71.439999999999998 110.534 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.54 -51.39 70.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.98 -1.009 . . . . 54.149999999999999 110.95 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.31 -48.52 88.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 114.851 -1.068 . . . . 70.420000000000002 111.784 -176.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.16 -46.11 90.43 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.154 0.428 . . . . 43.420000000000002 112.154 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.528 ' HG3' HG21 ' A' ' 432' ' ' VAL . 74.5 mmtt -66.98 -42.71 84.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.847 0.356 . . . . 75.129999999999995 111.267 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.81 80.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 72.530000000000001 111.026 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 49.2 m -62.35 -45.57 92.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.204 -0.665 . . . . 64.010000000000005 109.204 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.88 62.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.593 -0.73 . . . . 14.109999999999999 111.054 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -79.33 -13.8 59.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 120.796 0.331 . . . . 51.450000000000003 110.2 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.91 -9.82 15.84 Favored Glycine 0 CA--C 1.494 -1.229 0 C-N-CA 120.072 -1.061 . . . . 75.049999999999997 113.209 173.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -80.35 136.6 36.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.58 -0.526 . . . . 73.340000000000003 109.58 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.04 -1.82 6.71 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 120.405 -0.903 . . . . 51.350000000000001 112.603 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -112.65 115.96 29.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.523 -0.918 . . . . 64.540000000000006 108.523 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -131.0 152.08 50.7 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.319 -0.4 . . . . 74.230000000000004 110.173 -174.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -135.8 122.59 21.11 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.457 -1.312 . . . . 71.310000000000002 107.457 170.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -97.68 133.37 42.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.151 0.501 . . . . 70.430000000000007 110.21 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.31 138.96 54.33 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.264 -1.384 . . . . 44.030000000000001 107.264 175.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.09 136.64 53.16 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.695 -0.854 . . . . 63.43 108.695 177.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.1 p -128.2 144.49 51.93 Favored Pre-proline 0 C--N 1.289 -2.048 0 N-CA-C 109.779 -0.452 . . . . 60.210000000000001 109.779 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -64.93 123.46 11.65 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.12 1.88 . . . . 75.239999999999995 109.85 175.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.7 m -142.06 178.16 7.72 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.5 -0.926 . . . . 54.229999999999997 108.5 -177.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -58.76 141.71 84.74 Favored Pre-proline 0 C--O 1.253 1.272 0 C-N-CA 123.295 0.638 . . . . 75.519999999999996 111.431 178.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.46 -28.58 28.4 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.982 3.788 . . . . 73.129999999999995 113.382 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -75.39 -11.26 60.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.785 0.661 . . . . 73.25 112.785 -178.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 83.4 mt -111.0 6.36 20.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.978 0.362 . . . . 71.329999999999998 111.978 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 49.1 t -61.21 127.34 20.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 121.125 -0.23 . . . . 74.099999999999994 110.804 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.24 87.75 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 116.11 -0.496 . . . . 73.030000000000001 112.467 176.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 28.4 mtpp -106.75 142.13 36.89 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.113 -1.069 . . . . 72.099999999999994 108.113 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -81.76 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.408 -0.59 . . . . 62.409999999999997 109.408 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 20.2 pt -98.25 -10.08 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.085 -0.507 . . . . 75.040000000000006 111.652 -176.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 162.15 21.34 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.64 -0.79 . . . . 75.049999999999997 112.153 177.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 25.4 p -130.09 150.31 51.41 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.021 -1.103 . . . . 65.049999999999997 108.021 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.61 -52.9 61.6 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 119.325 -0.369 . . . . 74.310000000000002 111.855 176.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.99 140.81 38.85 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 120.836 1.024 . . . . 61.539999999999999 110.073 173.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.02 145.69 85.81 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.253 2.636 . . . . 51.329999999999998 113.248 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -90.95 -17.39 26.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.331 1.062 . . . . 44.149999999999999 109.122 178.15 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -92.92 -19.14 21.94 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.616 -1.175 . . . . 55.009999999999998 110.114 -176.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -118.97 150.94 39.07 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.14 -0.482 . . . . 64.340000000000003 110.378 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.7 p -85.99 127.2 34.59 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.513 -0.312 . . . . 74.420000000000002 111.226 -178.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.0 m -111.27 151.24 28.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.475 0.71 . . . . 72.430000000000007 109.777 -176.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.496 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -60.43 142.92 54.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 61.299999999999997 111.811 -178.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.89 -30.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.765 1.226 . . . . 73.049999999999997 111.275 -176.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -83.95 0.75 46.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.073 -0.512 . . . . 74.329999999999998 111.604 -175.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -73.44 145.08 46.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 112.465 0.543 . . . . 74.430000000000007 112.465 -177.843 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.7 p -84.46 125.78 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.627 -0.879 . . . . 61.039999999999999 108.627 172.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.0 118.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 109.032 -0.729 . . . . 74.510000000000005 109.032 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.72 115.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 105.804 -1.924 . . . . 75.230000000000004 105.804 174.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.39 125.46 70.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.408 -0.815 . . . . 55.119999999999997 109.932 -174.234 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.33 120.75 55.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.083 0.468 . . . . 54.420000000000002 110.107 -177.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.8 t -102.84 140.39 21.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 CA-C-N 115.642 -0.708 . . . . 70.019999999999996 109.67 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.0 122.73 5.84 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 109.238 -1.545 . . . . 51.329999999999998 109.238 173.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.4 p -122.29 137.27 54.91 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.109 -0.7 . . . . 44.240000000000002 109.109 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 464' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.803 0 C-N-CA 120.141 -1.028 . . . . 45.100000000000001 111.464 -176.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.695 0 N-CA-C 107.939 -1.134 . . . . 71.530000000000001 107.939 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 546' ' ' PRO . 22.5 p -125.33 166.05 17.26 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.335 -0.848 . . . . 61.329999999999998 111.242 -175.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -149.57 147.13 27.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.741 0.817 . . . . 72.109999999999999 110.191 176.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 30.4 t70 -96.08 127.05 41.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.137 -1.06 . . . . 72.310000000000002 108.137 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.49 121.81 83.14 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 112.231 0.456 . . . . 73.209999999999994 112.231 -175.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.19 146.29 14.1 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.995 1.797 . . . . 54.219999999999999 110.437 175.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.81 121.01 17.25 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.362 -0.607 . . . . 72.310000000000002 109.362 179.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.01 19.09 3.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.68 1.228 . . . . 72.140000000000001 108.249 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.21 112.25 19.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.421 -1.263 . . . . 63.409999999999997 109.525 -176.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.98 -28.39 1.71 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.66 -0.976 . . . . 54.43 110.66 -178.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 507' ' ' VAL . 21.3 mt-30 -86.46 178.57 7.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.425 -0.954 . . . . 71.450000000000003 108.425 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 155.95 28.55 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.154 -1.054 . . . . 55.119999999999997 108.154 -174.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.8 p -51.76 -45.9 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.608 0.595 . . . . 60.350000000000001 112.608 -176.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.57 -42.76 82.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.22 0.325 . . . . 65.140000000000001 111.545 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 503' ' ' GLN . 13.2 p -76.92 -39.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 119.537 -0.865 . . . . 74.019999999999996 111.678 -175.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.3 71.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.465 -0.789 . . . . 41.229999999999997 112.284 179.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.02 -35.6 81.71 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 120.138 -0.625 . . . . 73.120000000000005 110.333 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 510' ' ' LYS . 33.1 ttmt -60.67 -48.15 83.07 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.951 0.782 . . . . 75.349999999999994 109.331 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -62.62 -43.7 98.14 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.438 -0.801 . . . . 72.530000000000001 110.689 178.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.25 -43.06 92.54 Favored 'General case' 0 C--O 1.188 -2.16 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 109.45 -178.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -58.74 -37.71 76.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.037 0.935 . . . . 72.510000000000005 111.76 -178.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.0 t -66.05 -37.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 112.512 0.56 . . . . 53.109999999999999 112.512 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -112.19 -15.4 13.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.24 -0.584 . . . . 74.25 111.896 -173.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -106.14 -110.31 3.48 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 115.541 -0.754 . . . . 74.040000000000006 113.324 -175.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.544 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 21.0 m-85 -123.94 175.43 6.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.092 0.472 . . . . 71.439999999999998 110.992 -172.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.9 p -109.42 -3.45 17.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.362 -0.835 . . . . 62.200000000000003 110.477 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.42 115.72 30.64 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.008 -0.738 . . . . 72.329999999999998 109.008 -176.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.78 149.28 50.79 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 123.576 0.547 . . . . 62.219999999999999 110.846 -176.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.6 m -136.36 143.54 44.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.21 -1.774 . . . . 73.310000000000002 106.21 171.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -121.78 136.78 54.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 118.019 0.372 . . . . 65.510000000000005 110.157 -177.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.419 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -126.48 131.02 51.73 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.445 -0.946 . . . . 64.510000000000005 108.445 177.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 6.3 p -88.88 133.6 34.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.094 0.473 . . . . 72.030000000000001 112.167 -176.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.16 163.1 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.95 -1.5 . . . . 72.010000000000005 106.95 175.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 10.9 p-10 -78.29 137.32 38.02 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.047 0.451 . . . . 70.439999999999998 109.829 -175.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 8.2 m -97.94 108.23 45.14 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.157 -172.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 30.0 Cg_endo -90.92 -90.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 122.449 2.099 . . . . 72.409999999999997 110.332 172.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -84.18 -48.63 0.68 Allowed Pre-proline 0 N--CA 1.439 -1.008 0 C-N-CA 120.177 -0.609 . . . . 74.030000000000001 111.518 171.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.542 ' HA ' ' OE2' ' A' ' 533' ' ' GLU . 78.4 Cg_exo -58.74 134.1 58.36 Favored 'Trans proline' 0 C--N 1.374 1.918 0 CA-C-N 120.19 1.104 . . . . 63.409999999999997 110.488 169.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.46 116.26 3.87 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 123.192 0.308 . . . . 72.340000000000003 110.796 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.17 -15.16 35.03 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 121.997 0.776 . . . . 73.219999999999999 111.64 178.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.542 ' OE2' ' HA ' ' A' ' 530' ' ' PRO . 13.9 pt-20 -87.55 150.04 23.96 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 125.315 1.446 . . . . 74.430000000000007 110.939 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 553' ' ' LEU . 79.2 t -73.15 122.4 25.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 107.68 -1.23 . . . . 62.100000000000001 107.68 178.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.8 m -87.8 -24.68 23.67 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.007 -0.997 . . . . 74.439999999999998 110.593 -174.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.01 -163.28 37.02 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.906 -0.878 . . . . 64.420000000000002 110.906 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.9 p -140.7 160.22 40.51 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 72.519999999999996 107.964 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.45 -60.27 11.11 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 119.243 -0.408 . . . . 75.510000000000005 110.786 178.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.13 139.86 19.39 Favored 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 120.189 1.103 . . . . 72.540000000000006 109.265 172.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.12 153.94 52.0 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.976 1.784 . . . . 74.120000000000005 112.229 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.71 131.77 51.28 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.475 -0.565 . . . . 74.200000000000003 109.475 176.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.25 -5.77 36.12 Favored Glycine 0 C--N 1.299 -1.49 0 N-CA-C 110.464 -1.054 . . . . 45.140000000000001 110.464 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -88.41 125.33 34.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.517 -0.549 . . . . 54.399999999999999 109.517 174.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.1 m -101.6 123.49 45.69 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.426 -0.953 . . . . 74.219999999999999 108.426 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.31 164.49 42.95 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.636 -0.505 . . . . 62.030000000000001 109.636 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.5 Cg_exo -58.65 147.84 85.31 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.605 2.203 . . . . 75.299999999999997 111.436 176.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.544 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.2 m -66.86 -19.19 25.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.624 0.601 . . . . 61.530000000000001 112.624 -178.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.67 3.51 44.4 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.899 -0.591 . . . . 73.120000000000005 110.968 176.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.0 t -80.89 139.65 35.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.965 -0.754 . . . . 71.219999999999999 108.965 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.77 115.93 29.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.138 -0.689 . . . . 73.140000000000001 109.138 -179.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.4 tt -88.0 134.53 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.61 0.719 . . . . 64.129999999999995 111.039 -177.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.72 122.12 43.32 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 107.43 -1.322 . . . . 64.040000000000006 107.43 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 534' ' ' VAL . 7.6 tt -111.18 127.42 55.58 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.636 -1.165 . . . . 75.25 108.648 -175.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 5.7 mm-40 -92.41 109.53 20.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.963 -0.754 . . . . 73.329999999999998 108.963 -174.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.95 138.38 26.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 64.400000000000006 111.572 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 p -71.53 125.25 26.57 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.935 -1.505 . . . . 73.540000000000006 106.935 171.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 524' ' ' SER . 62.3 pttt . . . . . 0 C--O 1.264 1.867 0 CA-C-N 115.646 -0.706 . . . . 73.299999999999997 111.246 -172.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 480' ' ' ILE . 11.1 pt-20 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 122.014 0.912 . . . . 73.310000000000002 109.657 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -121.12 134.73 55.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.548 -1.279 . . . . 73.239999999999995 107.548 175.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -125.15 158.93 32.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.353 -0.61 . . . . 63.43 109.353 -176.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.64 142.49 30.76 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 123.715 0.806 . . . . 72.25 109.581 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -79.59 130.06 69.28 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 107.876 -1.157 . . . . 70.209999999999994 107.876 178.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 149.52 49.87 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.912 1.742 . . . . 73.030000000000001 111.967 178.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -114.9 72.96 0.81 Allowed 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 122.054 0.93 . . . . 74.549999999999997 110.355 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.6 4.67 5.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.119 -1.808 . . . . 73.409999999999997 106.119 175.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.01 -32.89 74.35 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 112.754 -2.021 . . . . 53.119999999999997 110.93 -176.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 t -61.44 -27.23 68.41 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.415 -0.812 . . . . 14.4 111.122 176.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.13 -46.32 15.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.159 -1.416 . . . . 72.420000000000002 110.416 -174.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 9.5 m -166.01 147.36 6.83 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.662 -0.866 . . . . 74.239999999999995 108.662 177.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.25 -45.54 65.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.954 0.902 . . . . 74.310000000000002 111.154 172.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.0 74.6 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.909 0.484 . . . . 73.209999999999994 110.869 178.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.568 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 12.2 mm-40 -66.29 -41.19 90.15 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.511 -0.768 . . . . 54.340000000000003 110.611 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.561 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.61 -50.12 75.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.913 -0.585 . . . . 64.310000000000002 110.407 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.56 -48.21 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.541 -0.754 . . . . 62.520000000000003 111.554 -176.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -60.95 -46.67 89.76 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.473 0.546 . . . . 74.230000000000004 112.473 -177.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.6 mptp? -67.38 -38.92 85.48 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 121.029 -0.269 . . . . 61.219999999999999 111.489 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -39.74 86.59 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.244 0.545 . . . . 74.150000000000006 109.889 178.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -59.4 -45.76 90.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.286 -0.87 . . . . 73.25 109.41 176.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.28 62.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.76 -0.654 . . . . 64.109999999999999 111.689 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -13.08 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 71.420000000000002 110.265 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.14 -16.1 25.22 Favored Glycine 0 CA--C 1.494 -1.253 0 C-N-CA 120.842 -0.694 . . . . 52.009999999999998 113.039 173.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.97 121.18 14.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.156 0.503 . . . . 74.340000000000003 111.035 -177.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.401 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -105.6 -2.73 40.48 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.411 -0.813 . . . . 44.329999999999998 111.6 178.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 9.4 mpt_? -120.85 114.93 22.31 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.202 0.525 . . . . 75.109999999999999 110.176 178.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -148.26 148.36 30.38 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.321 -0.854 . . . . 34.130000000000003 111.083 178.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -131.09 129.18 41.57 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.326 -0.99 . . . . 63.409999999999997 108.326 -178.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -93.33 124.82 37.58 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.417 0.448 . . . . 72.310000000000002 110.656 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 150.56 42.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.465 -1.309 . . . . 53.409999999999997 107.465 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.87 141.17 49.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.508 -0.923 . . . . 75.349999999999994 108.508 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 13.4 t -127.96 137.67 31.3 Favored Pre-proline 0 N--CA 1.416 -2.158 0 N-CA-C 109.007 -0.738 . . . . 32.340000000000003 109.007 -179.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 33.2 Cg_exo -64.97 123.66 11.93 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.488 2.125 . . . . 72.519999999999996 111.045 179.078 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 m -138.94 179.47 6.47 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.846 -1.539 . . . . 75.230000000000004 106.846 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 15.4 t -60.53 141.81 91.57 Favored Pre-proline 0 N--CA 1.422 -1.85 0 N-CA-C 108.385 -0.969 . . . . 51.509999999999998 108.385 175.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.85 -29.29 26.12 Favored 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 124.176 3.251 . . . . 72.209999999999994 113.721 -176.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -75.5 -13.97 60.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.708 0.632 . . . . 74.329999999999998 112.708 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.42 2.38 55.69 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 122.157 -0.34 . . . . 64.409999999999997 111.845 179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -60.75 128.43 21.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.258 0.551 . . . . 72.239999999999995 110.436 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.26 -12.94 67.61 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 120.834 -0.698 . . . . 75.329999999999998 111.774 178.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -98.76 139.97 33.65 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.369 -0.974 . . . . 65.310000000000002 108.369 177.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 60.7 t -82.27 138.89 18.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.119 -1.067 . . . . 64.140000000000001 108.119 176.406 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 32.3 pt -98.38 -29.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 120.033 -0.667 . . . . 74.340000000000003 111.227 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.82 168.76 40.89 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.345 -1.407 . . . . 62.020000000000003 112.502 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 34.2 p -117.64 143.32 46.26 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.27 -0.641 . . . . 63.399999999999999 109.27 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.3 t-20 -60.16 -49.77 89.28 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.578 0.584 . . . . 71.239999999999995 112.578 177.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.4 Cg_exo -81.97 144.59 13.61 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.03 1.153 . . . . 73.099999999999994 109.203 172.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 89.0 Cg_endo -72.55 145.01 41.32 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.34 2.026 . . . . 74.219999999999999 111.237 -179.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -79.86 -18.25 51.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.522 -0.763 . . . . 75.109999999999999 110.09 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -77.4 -27.44 52.42 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.931 -1.031 . . . . 75.150000000000006 113.019 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.0 mp0 -100.76 160.89 13.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.222 -1.029 . . . . 72.219999999999999 108.222 175.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.2 p -97.94 126.04 43.15 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 109.414 -0.587 . . . . 65.329999999999998 109.414 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 142.82 34.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.491 -0.929 . . . . 62.109999999999999 108.491 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -56.49 153.22 10.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.568 0.581 . . . . 65.030000000000001 112.568 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.2 mm -61.51 -30.02 47.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.434 0.635 . . . . 33.43 110.149 178.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 8.31 39.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 45.439999999999998 111.128 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.09 149.4 26.93 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.148 -1.056 . . . . 71.450000000000003 108.148 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.38 117.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.845 0.831 . . . . 71.209999999999994 111.382 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.1 t -92.44 119.92 40.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.359 -0.837 . . . . 52.030000000000001 109.545 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.61 116.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.766 -1.568 . . . . 74.129999999999995 106.766 175.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 126.16 58.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.715 -0.675 . . . . 63.450000000000003 109.327 -176.549 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 26.7 mt -104.49 115.61 46.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.776 -0.647 . . . . 74.420000000000002 110.224 -173.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.14 136.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.231 -0.655 . . . . 73.310000000000002 109.231 -177.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.43 124.67 6.56 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 109.096 -1.602 . . . . 72.439999999999998 109.096 175.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.5 m -135.31 140.78 45.39 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.138 -0.69 . . . . 62.539999999999999 109.138 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.866 0 C-N-CA 120.162 -1.018 . . . . 35.140000000000001 110.651 179.261 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.252 0 CA-C-O 122.081 0.944 . . . . 71.120000000000005 109.493 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.6 p -136.02 152.93 51.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.705 -1.134 . . . . 74.120000000000005 108.165 -177.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -141.22 153.4 45.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.085 -0.339 . . . . 74.25 110.085 177.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -93.91 138.54 31.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.123 -0.489 . . . . 63.299999999999997 110.128 179.083 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 31.0 pt -94.79 129.19 36.82 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 116.123 -0.49 . . . . 64.230000000000004 111.049 -179.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 5.3 Cg_exo -77.1 174.12 13.33 Favored 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.355 2.037 . . . . 73.540000000000006 110.779 172.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.97 128.86 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 70.430000000000007 111.123 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.45 -9.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.502 0.668 . . . . 71.200000000000003 110.275 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.56 136.23 47.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.514 -0.766 . . . . 72.25 112.142 -174.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.5 -16.1 29.33 Favored Glycine 0 CA--C 1.492 -1.363 0 C-N-CA 120.784 -0.722 . . . . 53.109999999999999 111.578 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.459 ' HB3' HG13 ' A' ' 507' ' ' VAL . 23.1 mt-30 -87.16 177.99 7.02 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 110.149 -0.315 . . . . 65.5 110.149 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.1 155.84 18.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.709 -1.219 . . . . 74.209999999999994 107.709 -177.068 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.69 -46.69 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.086 0.773 . . . . 64.120000000000005 113.086 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.85 -41.82 74.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.28 0.474 . . . . 74.299999999999997 112.28 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 503' ' ' GLN . 10.1 p -75.52 -34.4 29.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.608 -0.837 . . . . 74.329999999999998 110.737 -175.053 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.62 85.06 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.928 -1.033 . . . . 51.020000000000003 110.134 177.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.37 -35.99 82.68 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.084 -0.507 . . . . 71.400000000000006 111.456 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.76 -51.54 61.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.834 -0.346 . . . . 75.340000000000003 110.776 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.428 ' O ' HG12 ' A' ' 514' ' ' VAL . 62.2 m-20 -68.3 -39.7 81.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 109.978 -177.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.59 -37.31 87.13 Favored 'General case' 0 C--O 1.181 -2.527 0 CA-C-N 116.277 -0.42 . . . . 75.109999999999999 110.142 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -58.94 -39.85 82.85 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.039 0.536 . . . . 62.520000000000003 111.535 -178.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 511' ' ' ASN . 7.7 p -74.18 -31.28 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 120.149 -0.62 . . . . 50.420000000000002 112.197 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.73 -33.76 9.72 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.982 0.896 . . . . 74.409999999999997 110.897 -175.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -92.74 -112.74 2.07 Favored Glycine 0 N--CA 1.416 -2.645 0 CA-C-N 114.301 -1.318 . . . . 61.399999999999999 113.933 -172.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 57.5 m-85 -130.61 175.97 8.57 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.759 -0.46 . . . . 74.099999999999994 109.759 -170.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 m -98.03 -25.71 14.86 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.233 -0.439 . . . . 72.209999999999994 112.076 -173.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.66 123.16 48.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.871 -0.732 . . . . 72.310000000000002 110.839 -177.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.74 146.09 34.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.153 -0.931 . . . . 63.420000000000002 109.867 -176.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.5 m -126.88 149.5 49.73 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.323 -1.732 . . . . 52.340000000000003 106.323 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.51 131.37 54.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.623 -0.51 . . . . 73.420000000000002 109.623 -174.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.3 52.27 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.969 -1.123 . . . . 71.329999999999998 107.969 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.7 m -103.45 129.35 50.56 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.854 0.359 . . . . 63.509999999999998 110.708 -176.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.0 m -122.47 156.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 110.145 178.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.95 142.48 27.76 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.755 . . . . 55.409999999999997 109.422 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 37.9 t -137.13 140.34 30.91 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 106.556 -1.646 . . . . 74.340000000000003 106.556 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.12 -72.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.815 2.343 . . . . 75.310000000000002 113.167 -176.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 529' ' ' ARG 0.285 30.9 mmt180 -116.47 -54.97 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.653 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 178.19 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.59 133.84 56.97 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.174 1.249 . . . . 61.450000000000003 110.855 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.93 4.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.698 -0.482 . . . . 71.439999999999998 109.698 -178.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.48 -25.52 2.98 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.439 -1.064 . . . . 74.099999999999994 110.439 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.63 150.27 23.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.633 0.773 . . . . 73.409999999999997 110.454 177.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.13 120.0 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 106.879 -1.526 . . . . 51.200000000000003 106.879 175.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 21.2 m -70.04 -27.59 64.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.976 -1.011 . . . . 75.019999999999996 109.851 -175.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.68 24.88 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 110.297 -1.121 . . . . 73.310000000000002 110.297 177.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.2 p -129.87 161.33 31.05 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 107.753 -1.203 . . . . 74.219999999999999 107.753 178.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.1 t-20 -61.64 -52.58 68.34 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 120.654 -0.418 . . . . 75.120000000000005 110.131 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_exo -79.85 127.35 6.99 Favored 'Trans proline' 0 C--N 1.364 1.351 0 N-CA-C 108.459 -1.4 . . . . 72.0 108.459 170.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.06 154.45 73.99 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.151 1.901 . . . . 65.120000000000005 112.229 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -52.03 132.6 32.85 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.078 0.551 . . . . 73.030000000000001 111.282 179.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.85 -25.29 21.24 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 111.05 -0.82 . . . . 74.299999999999997 111.05 -176.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.1 m -65.7 135.59 55.17 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.21 0.528 . . . . 72.219999999999999 110.73 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.7 m -94.97 123.61 38.54 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.239 -1.393 . . . . 65.120000000000005 107.239 177.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 517' ' ' PHE . 20.5 t -123.22 152.21 63.49 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 107.012 -1.477 . . . . 72.129999999999995 107.012 -176.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.9 Cg_exo -59.87 140.03 91.11 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 73.430000000000007 112.077 174.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 23.8 m -67.62 -21.34 27.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.397 0.617 . . . . 51.350000000000001 111.685 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -88.89 3.59 50.81 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.027 -0.988 . . . . 73.109999999999999 110.756 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -97.25 154.23 17.53 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.267 -0.642 . . . . 75.430000000000007 109.267 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.77 137.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.838 -0.801 . . . . 63.43 108.838 177.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.7 tp -93.16 129.89 43.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.48 -0.563 . . . . 73.049999999999997 109.48 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -103.0 116.57 32.8 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 122.798 0.439 . . . . 74.420000000000002 110.712 -176.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.31 134.28 39.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.323 -0.853 . . . . 65.349999999999994 111.111 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -96.97 108.51 21.25 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 63.140000000000001 107.529 178.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.67 138.37 29.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 120.428 0.156 . . . . 74.319999999999993 111.223 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.7 p -72.64 119.8 17.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.338 -0.615 . . . . 65.439999999999998 109.338 179.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 C--N 1.294 -1.836 0 CA-C-N 115.87 -0.605 . . . . 64.549999999999997 109.539 -177.033 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 122.032 0.92 . . . . 75.019999999999996 109.042 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.417 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 92.5 mt-30 -83.11 152.08 25.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.546 -1.206 . . . . 75.400000000000006 110.734 -176.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.496 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 13.7 tpp180 -127.56 157.62 39.66 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.458 -1.312 . . . . 54.109999999999999 107.458 177.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.45 141.55 31.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 123.588 0.555 . . . . 64.230000000000004 110.13 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.9 mp -79.66 130.83 66.3 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.097 -1.075 . . . . 75.450000000000003 108.097 177.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 30.5 Cg_exo -64.61 141.0 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.833 1.688 . . . . 74.349999999999994 112.314 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.59 9.01 43.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.583 -0.735 . . . . 75.349999999999994 110.362 -177.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.41 7.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.016 0.913 . . . . 74.25 110.656 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 3.2 p -60.72 -38.7 85.96 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 125.324 1.45 . . . . 64.319999999999993 110.514 177.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.1 t -60.7 -26.66 67.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.124 -0.943 . . . . 72.310000000000002 111.278 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 51.8 mt -81.88 -46.42 14.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.11 -0.636 . . . . 72.200000000000003 110.224 -174.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 21.0 m -167.94 150.21 5.56 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.819 -1.178 . . . . 74.129999999999995 107.819 177.514 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.37 -48.71 68.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 64.0 110.139 173.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.61 71.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.626 0.77 . . . . 75.120000000000005 112.094 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.4 mm-40 -61.68 -45.72 92.79 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.297 -0.411 . . . . 63.329999999999998 111.584 -178.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -66.62 -45.74 78.13 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.92 -47.53 89.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.832 0 O-C-N 123.822 0.701 . . . . 55.43 112.388 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.09 -47.42 86.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.617 0.246 . . . . 73.209999999999994 111.661 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.62 -42.31 86.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.408 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.65 -38.38 80.42 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 72.439999999999998 110.562 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 46.8 m -63.26 -42.5 99.17 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.865 -0.607 . . . . 72.540000000000006 109.578 175.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.11 -18.48 64.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.044 -0.526 . . . . 63.439999999999998 110.561 177.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.92 -13.96 58.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.04 0.448 . . . . 70.109999999999999 110.1 178.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.99 -14.05 26.46 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.851 -0.69 . . . . 64.109999999999999 112.991 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.59 130.08 41.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.71 0.291 . . . . 53.439999999999998 110.525 -178.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.38 11.11 6.81 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.236 -0.746 . . . . 42.119999999999997 111.236 178.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 451' ' ' ARG . 0.6 OUTLIER -111.04 115.43 29.44 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.052 -1.462 . . . . 52.450000000000003 107.052 -178.512 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -136.76 147.49 46.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.662 -0.415 . . . . 62.200000000000003 111.043 -174.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.401 ' HB2' HG13 ' A' ' 485' ' ' ILE . 14.6 mmmm -132.14 122.75 25.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.254 -1.387 . . . . 75.329999999999998 107.254 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -103.72 128.94 51.03 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.866 -0.42 . . . . 63.100000000000001 109.866 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -129.86 144.04 51.11 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.187 -1.412 . . . . 54.520000000000003 107.187 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.03 135.79 53.63 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.447 -0.946 . . . . 73.109999999999999 108.447 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.3 m -116.44 138.57 24.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.669 -0.863 . . . . 53.539999999999999 108.669 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.9 122.31 10.09 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.063 1.842 . . . . 61.520000000000003 110.416 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.473 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 25.1 t -143.66 -179.18 6.29 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 105.914 -1.884 . . . . 71.099999999999994 105.914 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.1 t -66.07 132.99 94.66 Favored Pre-proline 0 N--CA 1.416 -2.175 0 CA-C-O 121.071 0.462 . . . . 64.129999999999995 109.886 176.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.73 -28.51 30.29 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.917 3.078 . . . . 71.340000000000003 112.039 176.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.87 -17.33 63.06 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.738 -0.665 . . . . 71.129999999999995 112.103 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.65 13.39 19.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.177 -0.327 . . . . 73.510000000000005 111.698 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.9 p -57.47 128.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 42.439999999999998 111.572 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.47 -12.92 59.92 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.626 -0.797 . . . . 44.43 112.131 177.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -92.84 139.78 30.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.179 -0.675 . . . . 61.020000000000003 109.179 176.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 486' ' ' ILE . 61.5 t -82.47 134.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.992 -0.744 . . . . 72.019999999999996 108.992 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.0 pt -97.31 -7.41 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.251 -0.58 . . . . 73.510000000000005 110.73 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.72 167.81 25.86 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.656 -0.783 . . . . 53.32 111.651 175.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.5 p -120.43 149.47 42.33 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.893 -1.151 . . . . 74.109999999999999 107.893 176.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.8 t-20 -65.05 -52.94 45.3 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-O 119.248 -0.406 . . . . 73.230000000000004 111.079 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.6 Cg_exo -73.93 139.58 27.52 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 108.8 -1.269 . . . . 71.099999999999994 108.8 172.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.47 141.31 66.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.578 2.185 . . . . 65.0 112.63 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.32 -11.86 55.63 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.204 -0.907 . . . . 54.140000000000001 110.164 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -94.56 -24.77 17.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.934 -0.575 . . . . 63.340000000000003 111.458 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.86 174.16 5.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.08 -0.648 . . . . 73.230000000000004 109.538 177.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.417 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 19.1 p -101.18 144.33 30.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.967 -0.561 . . . . 55.149999999999999 109.776 178.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.3 m -127.85 148.8 50.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.708 -0.849 . . . . 73.049999999999997 108.708 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 152.29 42.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 110.061 -0.348 . . . . 70.430000000000007 110.061 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.03 -12.74 16.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.859 0.838 . . . . 74.219999999999999 111.213 -173.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -90.18 1.12 56.79 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.844 -0.616 . . . . 72.420000000000002 110.923 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.52 141.76 41.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.01 0.433 . . . . 71.019999999999996 111.977 -177.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.76 115.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.79 -1.189 . . . . 61.119999999999997 107.79 176.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.48 119.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.587 -0.845 . . . . 75.420000000000002 108.931 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.5 mp -99.4 123.23 51.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.239 -1.763 . . . . 71.030000000000001 106.239 175.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -115.38 123.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 109.327 -0.62 . . . . 74.450000000000003 109.327 -177.709 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -103.52 117.54 49.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 CA-C-O 121.76 0.79 . . . . 70.120000000000005 111.802 178.749 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 20.1 t -96.61 140.47 17.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.872 -1.058 . . . . 72.140000000000001 109.335 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.42 116.8 4.38 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.29 -1.524 . . . . 70.420000000000002 109.29 174.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -126.64 129.95 49.5 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 107.36 -1.348 . . . . 73.129999999999995 107.36 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.418 -2.526 0 C-N-CA 119.464 -1.35 . . . . 65.400000000000006 111.373 -178.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.874 0.845 . . . . 52.219999999999999 109.545 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 546' ' ' PRO . 14.5 p -137.94 157.55 46.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.693 -1.14 . . . . 64.400000000000006 108.735 -177.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.25 147.48 32.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.652 178.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.6 p-10 -84.71 131.82 34.53 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.161 -0.927 . . . . 74.439999999999998 108.54 175.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.9 pt -76.47 134.7 69.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.712 -0.676 . . . . 73.140000000000001 110.843 -177.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.13 167.43 9.38 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.565 2.177 . . . . 74.420000000000002 109.778 173.088 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.02 141.88 28.34 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.631 -1.248 . . . . 74.340000000000003 107.631 176.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.62 13.84 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-O 121.986 0.898 . . . . 65.439999999999998 110.492 -174.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.58 147.52 29.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.398 -0.819 . . . . 71.209999999999994 111.649 -175.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 91.48 11.81 60.41 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 111.099 -0.8 . . . . 25.219999999999999 111.099 177.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.49 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 22.5 mt-30 -119.89 178.42 4.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.8 0.334 . . . . 75.209999999999994 111.831 -176.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.679 -1.23 . . . . 72.140000000000001 107.679 -176.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.05 -41.65 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 117.833 0.288 . . . . 54.229999999999997 111.381 -177.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.04 -42.51 80.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.549 0.574 . . . . 65.400000000000006 112.549 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 11.2 p -73.67 -34.94 42.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 118.98 -1.088 . . . . 72.439999999999998 110.16 -176.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.36 -49.9 72.06 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.941 -1.027 . . . . 51.399999999999999 111.157 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -65.13 -37.5 87.63 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.642 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -65.59 -53.6 39.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.107 0.41 . . . . 74.450000000000003 112.107 178.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -62.42 -39.0 91.86 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.078 0.466 . . . . 62.43 110.596 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.59 -47.66 62.77 Favored 'General case' 0 C--O 1.187 -2.192 0 CA-C-N 115.884 -0.598 . . . . 63.329999999999998 110.575 178.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.38 -41.19 98.79 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.448 0.536 . . . . 74.040000000000006 112.448 -176.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.05 -29.11 43.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.335 0.495 . . . . 52.219999999999999 112.335 -177.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.88 -26.37 6.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.204 -0.998 . . . . 73.019999999999996 111.798 -174.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.65 -98.92 2.38 Favored Glycine 0 N--CA 1.41 -3.065 0 CA-C-N 115.26 -0.882 . . . . 70.209999999999994 114.533 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 50.1 m-85 -133.68 160.11 38.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.761 0.315 . . . . 61.119999999999997 110.487 -167.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 p -103.63 -7.9 20.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.586 -0.734 . . . . 73.129999999999995 112.004 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.48 119.92 40.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.725 -0.472 . . . . 75.329999999999998 109.725 -176.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -126.3 153.47 44.77 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.595 0.712 . . . . 60.030000000000001 111.533 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.5 m -141.16 153.71 45.49 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.928 -1.508 . . . . 53.43 106.928 169.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -121.65 132.31 54.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 118.28 0.491 . . . . 74.409999999999997 110.956 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.14 136.14 53.44 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.068 -1.456 . . . . 63.509999999999998 107.068 174.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 25.9 m -98.53 133.49 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.948 0.404 . . . . 62.219999999999999 110.491 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.13 163.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.42 -0.955 . . . . 52.43 108.42 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.17 140.08 38.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.262 0.553 . . . . 70.239999999999995 110.213 -174.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.0 p -103.17 118.23 58.43 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.402 -0.817 . . . . 50.439999999999998 113.015 -172.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -80.62 -75.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.829 1.686 . . . . 74.540000000000006 109.226 172.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.549 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 28.7 mmm180 -107.79 -52.73 0.07 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.751 -0.642 . . . . 73.049999999999997 112.472 171.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.549 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 19.4 Cg_endo -62.81 134.21 45.74 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 120.644 1.266 . . . . 73.430000000000007 111.355 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.62 126.53 7.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.066 -1.087 . . . . 71.209999999999994 108.066 178.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.21 -29.33 7.72 Favored Glycine 0 C--N 1.308 -0.979 0 N-CA-C 111.372 -0.691 . . . . 55.140000000000001 111.372 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.93 149.78 26.84 Favored 'General case' 0 C--O 1.255 1.361 0 C-N-CA 123.232 0.613 . . . . 74.310000000000002 110.044 176.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.434 HG21 ' CB ' ' A' ' 508' ' ' ALA . 80.4 t -74.31 126.92 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.891 0 CA-C-O 121.527 0.68 . . . . 73.010000000000005 109.554 -173.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.6 m -92.15 -12.65 32.28 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 110.136 -175.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.73 -150.77 19.99 Favored Glycine 0 N--CA 1.425 -2.069 0 C-N-CA 120.1 -1.048 . . . . 65.150000000000006 112.815 174.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 17.9 p -118.16 161.5 19.77 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 124.591 1.156 . . . . 43.450000000000003 109.254 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.9 t-20 -61.33 -57.12 27.69 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 119.298 -0.382 . . . . 72.510000000000005 111.094 176.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.2 Cg_exo -83.41 156.29 14.38 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.224 1.282 . . . . 74.209999999999994 109.852 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.14 158.83 48.61 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.042 1.828 . . . . 71.109999999999999 112.196 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.89 133.81 54.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.204 0.601 . . . . 75.230000000000004 111.045 178.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.98 -19.64 32.4 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.805 -0.712 . . . . 51.119999999999997 111.676 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.0 m -65.56 123.84 20.76 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.676 -0.49 . . . . 53.409999999999997 109.676 177.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 41.6 m -94.03 123.81 37.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 109.944 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.8 157.01 72.84 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 70.129999999999995 108.978 177.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.535 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.4 Cg_exo -58.7 146.01 93.71 Favored 'Trans proline' 0 CA--C 1.519 -0.24 0 C-N-CA 122.929 2.419 . . . . 64.049999999999997 111.619 177.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 32.4 m -66.75 -20.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.434 0.635 . . . . 75.209999999999994 111.767 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -91.11 3.85 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.345 -0.843 . . . . 61.200000000000003 111.38 176.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -83.06 152.06 25.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.939 -0.763 . . . . 74.109999999999999 108.939 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.58 119.2 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.02 -1.104 . . . . 71.319999999999993 108.02 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -89.83 141.64 14.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.189 0.518 . . . . 74.329999999999998 110.139 -177.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.0 121.78 43.25 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 121.618 0.723 . . . . 75.319999999999993 110.228 -176.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.7 134.54 39.83 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.207 1.403 . . . . 65.239999999999995 108.954 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -103.83 115.91 31.32 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.246 -0.888 . . . . 62.009999999999998 109.244 -177.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.18 129.83 75.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 116.107 -0.497 . . . . 72.400000000000006 111.061 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 68.2 m -74.52 116.67 15.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.347 -0.983 . . . . 62.039999999999999 108.347 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.446 -0.797 . . . . 64.230000000000004 108.955 -175.988 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.599 0.714 . . . . 74.439999999999998 110.023 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 78.2 mt-30 -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 114.95 -1.023 . . . . 74.209999999999994 110.577 -177.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -129.88 156.76 43.87 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.078 -1.082 . . . . 74.430000000000007 108.078 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.43 143.16 27.37 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.167 0.432 . . . . 72.310000000000002 112.167 -178.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 1.8 mp -77.53 130.67 73.38 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.875 -0.602 . . . . 65.319999999999993 111.413 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 75.0 Cg_exo -54.1 148.95 37.57 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.887 3.724 . . . . 73.209999999999994 115.524 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -94.64 -5.24 46.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.437 -0.801 . . . . 63.530000000000001 110.125 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.5 p -74.95 -5.99 7.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.256 1.027 . . . . 73.209999999999994 109.679 -176.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.61 -26.69 68.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.409 -1.268 . . . . 71.439999999999998 109.119 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.1 p -58.51 -27.67 64.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.816 -1.083 . . . . 64.349999999999994 111.341 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.6 mt -86.75 -47.35 9.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.709 -0.796 . . . . 74.230000000000004 110.978 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 25.6 m -167.01 150.17 6.5 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 109.533 -0.543 . . . . 74.140000000000001 109.533 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -51.63 -46.56 63.7 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.116 1.366 . . . . 73.030000000000001 111.199 174.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.21 85.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.998 -0.546 . . . . 64.040000000000006 111.277 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.69 -44.11 97.58 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.668 -0.696 . . . . 73.299999999999997 110.827 178.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -50.79 72.35 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.093 -0.958 . . . . 63.549999999999997 110.399 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -46.58 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.799 -0.637 . . . . 74.099999999999994 112.129 -176.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -63.31 -48.01 79.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.476 0.179 . . . . 60.119999999999997 110.984 -177.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -68.25 -39.47 82.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.071 -0.513 . . . . 74.329999999999998 111.63 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.524 HD23 ' CE2' ' A' ' 452' ' ' PHE . 28.9 tp -67.44 -37.49 83.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.223 0.535 . . . . 74.030000000000001 109.686 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 -44.13 95.94 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.326 -0.852 . . . . 71.340000000000003 109.722 175.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.76 62.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.606 -0.725 . . . . 72.239999999999995 111.442 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.91 -12.96 54.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 22.440000000000001 111.047 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.61 -18.74 10.74 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.536 -0.84 . . . . 73.200000000000003 112.693 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.506 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 81.5 m-85 -75.69 136.51 40.37 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.663 0.268 . . . . 75.409999999999997 110.301 -176.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -137.99 26.0 2.89 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.721 -0.951 . . . . 70.450000000000003 110.721 177.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -124.52 116.03 21.82 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.374 -1.343 . . . . 72.409999999999997 107.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.524 ' CE2' HD23 ' A' ' 444' ' ' LEU . 64.0 m-85 -130.18 146.5 51.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.301 0.572 . . . . 53.310000000000002 110.903 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.405 ' HB3' HG12 ' A' ' 485' ' ' ILE . 63.6 tttp -140.86 123.29 15.92 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.807 -1.553 . . . . 75.230000000000004 106.807 169.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.443 HE21 HG21 ' A' ' 488' ' ' VAL . 58.5 tt0 -91.93 130.07 37.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.16 0.505 . . . . 74.409999999999997 111.306 -177.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -130.03 141.94 50.68 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.37 -1.344 . . . . 51.329999999999998 107.37 175.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.15 149.09 45.01 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.199 -0.601 . . . . 53.329999999999998 110.791 -177.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 56.0 m -132.49 134.27 24.62 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-N 115.475 -0.784 . . . . 62.229999999999997 108.889 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_exo -65.58 127.51 18.18 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.627 2.218 . . . . 73.310000000000002 112.243 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 38.6 m -146.94 -179.94 7.16 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 125.498 1.519 . . . . 72.230000000000004 107.077 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.4 t -50.51 114.56 4.67 Favored Pre-proline 0 CA--C 1.584 2.269 0 C-N-CA 124.135 0.974 . . . . 64.109999999999999 110.14 177.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.11 -28.91 34.8 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.736 3.624 . . . . 63.509999999999998 116.425 -171.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.97 -20.83 64.2 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.956 -0.698 . . . . 72.109999999999999 112.077 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -95.37 14.37 22.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.485 0.55 . . . . 73.109999999999999 112.485 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.09 128.09 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.386 0.613 . . . . 75.0 110.697 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.3 1.77 55.72 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.677 -0.692 . . . . 54.32 112.783 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.483 ' HD2' HD12 ' A' ' 463' ' ' LEU . 57.8 tttp -91.79 138.49 31.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.623 -1.251 . . . . 72.140000000000001 107.623 176.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 486' ' ' ILE . 50.7 t -82.96 124.82 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.212 -0.995 . . . . 73.219999999999999 108.39 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -99.51 -14.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 120.221 -0.592 . . . . 72.400000000000006 111.272 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.04 39.17 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.602 -0.809 . . . . 63.240000000000002 111.203 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.6 p -132.19 147.78 52.43 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.683 -0.858 . . . . 74.310000000000002 108.683 177.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.7 t-20 -64.02 -51.93 59.71 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 119.167 -0.444 . . . . 72.420000000000002 111.272 176.002 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.2 Cg_exo -74.12 145.18 34.76 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.334 1.356 . . . . 61.43 109.74 173.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.78 146.01 58.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.696 2.264 . . . . 65.439999999999998 112.995 -177.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -101.77 -9.7 20.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.544 -0.753 . . . . 72.510000000000005 110.196 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.475 -0.935 . . . . 70.420000000000002 108.475 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -117.77 175.56 5.6 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.164 -0.926 . . . . 71.439999999999998 108.531 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 27.4 p -88.3 148.74 24.15 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 116.648 -0.251 . . . . 62.25 111.592 -177.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.6 m -126.05 148.61 49.28 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.781 -1.192 . . . . 65.230000000000004 107.781 175.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 147.13 53.52 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-O 120.611 0.243 . . . . 34.32 111.331 -177.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.01 -28.14 41.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 75.5 111.311 179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.0 t -85.48 7.48 22.66 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.717 -0.674 . . . . 75.420000000000002 110.399 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.97 144.68 27.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.346 -0.613 . . . . 64.209999999999994 109.346 -177.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.68 111.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.346 -0.983 . . . . 74.439999999999998 108.346 179.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.22 118.23 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 C-N-CA 118.925 -1.11 . . . . 34.310000000000002 108.424 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.443 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 58.5 mt -100.43 113.94 37.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.345 -1.724 . . . . 70.409999999999997 106.345 176.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.46 128.12 52.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 CA-C-N 115.652 -0.703 . . . . 52.539999999999999 109.458 -174.706 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 30.9 mm -97.59 109.9 24.34 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-O 121.361 0.6 . . . . 71.420000000000002 109.484 -176.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.443 HG21 HE21 ' A' ' 454' ' ' GLN . 15.9 t -96.69 133.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.543 -0.753 . . . . 61.43 110.143 -177.215 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.71 115.91 4.91 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.146 -1.982 . . . . 65.540000000000006 108.146 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.0 m -127.44 160.39 31.61 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.084 -1.08 . . . . 63.329999999999998 108.084 -176.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.783 0 C-N-CA 119.207 -1.473 . . . . 70.299999999999997 111.064 -178.073 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.259 0 CA-C-O 121.938 0.875 . . . . 74.129999999999995 109.042 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -136.45 166.35 23.7 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.909 -1.041 . . . . 65.129999999999995 110.009 -174.064 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -150.6 151.05 31.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.142 0.977 . . . . 63.329999999999998 108.908 175.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -95.65 133.11 40.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.399 -1.334 . . . . 71.219999999999999 107.399 173.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 43.6 pt -84.32 134.84 42.27 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 120.534 -0.466 . . . . 73.400000000000006 111.638 -175.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.04 170.37 7.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.621 2.214 . . . . 75.409999999999997 111.509 175.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -85.61 133.13 34.06 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.933 -0.576 . . . . 75.310000000000002 110.638 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.71 13.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.63 -0.714 . . . . 61.310000000000002 110.526 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.76 137.47 40.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.099 -0.5 . . . . 43.329999999999998 110.703 -177.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.05 50.44 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.491 -1.044 . . . . 75.329999999999998 110.491 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.496 ' HB3' HG13 ' A' ' 507' ' ' VAL . 17.8 mt-30 -97.59 169.59 9.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 72.129999999999995 108.24 178.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 28.2 m -82.98 155.35 24.02 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.183 -1.043 . . . . 74.239999999999995 108.183 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 13.5 p -52.63 -41.38 37.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 123.488 0.715 . . . . 60.32 111.973 -177.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.19 -43.98 76.88 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.531 -0.468 . . . . 73.230000000000004 112.144 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 503' ' ' GLN . 12.6 p -77.08 -34.96 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 119.848 -0.741 . . . . 74.450000000000003 111.684 -176.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.22 84.57 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.033 -0.985 . . . . 52.299999999999997 111.205 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -63.73 -36.19 83.05 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.225 0.328 . . . . 70.219999999999999 110.502 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 91.1 mttt -65.02 -49.91 68.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.934 -0.575 . . . . 70.109999999999999 111.794 177.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.01 -41.45 86.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.468 -0.493 . . . . 70.530000000000001 110.328 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.85 -44.27 94.2 Favored 'General case' 0 C--O 1.195 -1.765 0 CA-C-N 115.839 -0.618 . . . . 74.099999999999994 110.124 -179.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.07 -37.83 78.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.54 0.57 . . . . 70.129999999999995 112.54 -178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 66.8 t -59.09 -36.78 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.442 0.464 . . . . 52.32 111.195 -178.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.05 -34.75 8.33 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.809 -0.756 . . . . 75.239999999999995 110.495 -177.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -94.99 -122.84 3.87 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.707 -1.133 . . . . 70.420000000000002 115.869 -170.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 19.0 m-85 -122.58 178.13 5.13 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.92 0.391 . . . . 65.329999999999998 110.07 -168.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.8 m -116.44 8.9 14.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.217 1.008 . . . . 71.310000000000002 109.301 178.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.86 115.27 29.77 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.99 -1.115 . . . . 75.400000000000006 107.99 178.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -125.96 151.72 46.63 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.215 0.531 . . . . 64.0 110.956 -175.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.0 m -141.55 153.39 44.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.537 -1.653 . . . . 52.409999999999997 106.537 170.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.46 135.78 52.69 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 118.268 0.485 . . . . 52.32 110.412 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.574 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -130.08 145.08 51.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.239 -0.652 . . . . 61.020000000000003 109.239 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 21.2 m -87.83 124.97 34.18 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.833 0.349 . . . . 73.239999999999995 111.394 -175.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.3 163.16 30.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.579 -0.897 . . . . 62.329999999999998 108.579 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.42 137.32 37.93 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.682 0.993 . . . . 61.439999999999998 113.682 -172.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.3 t -162.01 115.1 1.2 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.598 1.559 . . . . 75.450000000000003 106.852 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.03 -89.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.378 2.719 . . . . 44.32 115.793 -172.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 530' ' ' PRO . 57.3 mtt180 -86.33 -42.56 0.58 Allowed Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 113.547 0.943 . . . . 73.129999999999995 113.547 178.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 11.1 Cg_endo -57.17 133.91 60.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 120.502 1.215 . . . . 61.310000000000002 109.524 173.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.96 140.74 21.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.041 0.448 . . . . 74.409999999999997 110.704 -172.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.06 77.22 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.629 -0.714 . . . . 61.409999999999997 111.368 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 11.2 pt-20 -87.47 148.78 24.79 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.317 0.579 . . . . 64.120000000000005 110.94 177.418 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 76.9 t -75.2 122.18 28.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.33 -1.359 . . . . 75.129999999999995 107.33 176.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.4 m -98.33 -1.35 41.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.242 -0.89 . . . . 62.130000000000003 110.148 -174.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.69 -169.24 32.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.659 -0.576 . . . . 70.219999999999999 111.659 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.7 p -137.27 160.65 38.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.407 -0.96 . . . . 75.219999999999999 108.407 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.3 t30 -58.48 -56.87 31.0 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.429 -0.32 . . . . 70.209999999999994 111.45 177.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.7 Cg_endo -84.19 151.3 12.26 Favored 'Trans proline' 0 C--N 1.365 1.433 0 N-CA-C 108.954 -1.21 . . . . 71.329999999999998 108.954 174.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.63 148.76 53.94 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.644 1.563 . . . . 73.319999999999993 111.658 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.08 129.48 41.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.262 -0.426 . . . . 71.340000000000003 110.061 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -15.12 37.33 Favored Glycine 0 C--N 1.301 -1.375 0 C-N-CA 120.884 -0.674 . . . . 45.530000000000001 112.05 -177.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.5 m -81.08 134.82 35.72 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 110.036 -0.357 . . . . 43.229999999999997 110.036 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 85.3 m -90.65 123.32 34.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.879 -0.6 . . . . 74.299999999999997 109.799 177.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.69 158.7 67.1 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.793 -0.817 . . . . 74.430000000000007 108.793 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.49 ' HA ' HG22 ' A' ' 494' ' ' THR . 24.5 Cg_exo -65.33 146.63 86.32 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.514 2.143 . . . . 75.120000000000005 112.118 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 19.1 m -67.7 -19.89 25.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.379 1.085 . . . . 72.299999999999997 110.027 177.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.32 -17.26 60.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.918 -1.492 . . . . 72.239999999999995 109.481 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.5 t -86.61 142.11 28.5 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.412 -0.813 . . . . 50.219999999999999 108.93 -176.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.36 126.28 44.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.506 -1.294 . . . . 73.540000000000006 107.506 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.87 137.95 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.266 0.555 . . . . 72.200000000000003 111.121 -176.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.74 119.93 39.55 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 108.91 -0.774 . . . . 72.120000000000005 108.91 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -99.32 124.1 44.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.985 -1.461 . . . . 72.140000000000001 107.936 -177.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.574 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 4.1 mm-40 -90.13 108.51 19.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.505 0.669 . . . . 73.120000000000005 110.128 -175.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.99 140.56 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.737 -1.12 . . . . 72.329999999999998 111.856 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 40.1 m -56.24 127.89 33.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.666 0.746 . . . . 72.120000000000005 112.521 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 77.6 tttt . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.959 -1.126 . . . . 74.420000000000002 107.959 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.4 0 N-CA-C 110.82 -0.912 . . . . 43.049999999999997 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.45 168.46 24.24 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.96 2.44 . . . . 55.229999999999997 112.008 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.1 OUTLIER -83.41 -7.75 59.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.69 1.233 . . . . 73.400000000000006 108.637 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 54.3 mt-30 -94.48 140.11 30.26 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.33 -1.759 . . . . 72.420000000000002 108.949 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpp180 -120.87 152.35 38.55 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.827 -1.175 . . . . 73.120000000000005 107.827 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.36 140.88 32.16 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 124.091 0.87 . . . . 64.129999999999995 109.775 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -89.98 122.76 67.46 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 109.33 -0.619 . . . . 54.009999999999998 109.33 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.45 141.14 94.94 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.597 2.198 . . . . 70.120000000000005 112.581 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.41 24.13 4.12 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.35 -0.841 . . . . 73.099999999999994 110.891 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.5 -7.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.047 0.927 . . . . 74.329999999999998 109.024 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 13.2 m -62.74 -36.32 82.66 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.472 -1.24 . . . . 73.120000000000005 110.097 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 18.1 p -62.11 -26.6 68.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.25 -1.341 . . . . 70.109999999999999 110.839 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.9 mt -83.71 -44.62 14.29 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.041 -0.527 . . . . 63.210000000000001 110.586 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 438' ' ' ALA . 22.3 m -160.87 145.61 14.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.671 -0.492 . . . . 74.409999999999997 109.671 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -54.92 -42.37 72.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.478 0.711 . . . . 71.409999999999997 110.92 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 436' ' ' THR . . . -57.55 -44.39 85.16 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.888 -0.596 . . . . 63.210000000000001 110.579 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.66 -43.61 98.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.369 -0.832 . . . . 55.399999999999999 111.256 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.76 -51.73 68.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.443 -0.799 . . . . 62.119999999999997 110.978 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.1 -47.55 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.869 -0.605 . . . . 60.039999999999999 112.333 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -64.78 -47.15 79.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.7 -0.4 . . . . 61.43 111.65 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.89 -40.33 83.51 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.633 -0.427 . . . . 71.140000000000001 111.984 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.508 HD23 ' CE2' ' A' ' 452' ' ' PHE . 19.4 tp -68.89 -33.64 74.11 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.363 0.601 . . . . 73.299999999999997 110.261 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.6 m -64.06 -41.63 97.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.62 -0.718 . . . . 72.329999999999998 109.59 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -16.57 62.79 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.798 -0.637 . . . . 74.099999999999994 110.82 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.4 -13.47 52.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.063 0.459 . . . . 74.129999999999995 110.077 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.77 -2.36 27.43 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.567 -0.825 . . . . 75.129999999999995 113.844 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 95.6 m-85 -83.56 136.49 34.23 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 117.303 0.552 . . . . 62.420000000000002 111.671 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.21 4.82 4.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.549 -0.751 . . . . 73.120000000000005 112.451 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.436 ' NE ' ' HB ' ' A' ' 483' ' ' VAL . 77.2 ttt180 -111.29 115.56 29.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.702 -0.851 . . . . 75.340000000000003 108.702 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.508 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.2 m-85 -130.82 156.9 44.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.024 -0.534 . . . . 74.430000000000007 111.12 -173.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 485' ' ' ILE . 27.5 tptp -139.41 121.82 16.09 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 104.615 -2.365 . . . . 74.010000000000005 104.615 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -110.65 135.19 51.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.744 0.307 . . . . 71.409999999999997 111.397 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.3 156.56 46.4 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.987 -1.116 . . . . 65.230000000000004 107.987 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -136.09 143.06 44.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.219999999999999 107.732 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 27.8 m -130.99 139.19 34.83 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 109.501 -0.555 . . . . 63.520000000000003 109.501 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 35.8 Cg_exo -64.41 123.07 11.21 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.292 1.995 . . . . 74.439999999999998 110.326 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 68.0 m -151.81 -179.51 7.52 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.087 -1.079 . . . . 53.539999999999999 108.087 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.475 ' HA ' ' HD2' ' A' ' 461' ' ' PRO . 2.8 t -33.97 108.53 0.32 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 125.787 1.635 . . . . 61.030000000000001 112.625 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 460' ' ' THR . 16.3 Cg_endo -56.33 -29.75 78.06 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 124.139 3.226 . . . . 52.140000000000001 115.274 -173.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -71.98 -6.91 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.583 0.586 . . . . 75.030000000000001 112.583 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 78.8 mt -111.3 13.81 21.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.006 0.432 . . . . 60.409999999999997 110.936 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.82 133.62 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.826 -0.625 . . . . 55.210000000000001 112.008 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.86 79.55 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 121.037 -0.602 . . . . 70.329999999999998 113.793 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 434' ' ' THR . 11.1 pttp -101.67 162.26 13.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.761 -1.2 . . . . 73.409999999999997 107.761 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 53.3 t -81.46 133.21 29.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.851 -1.166 . . . . 71.140000000000001 107.851 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.6 pt -102.11 -6.73 9.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.593 -0.443 . . . . 65.129999999999995 110.819 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.5 143.69 4.05 Favored Glycine 0 N--CA 1.423 -2.224 0 C-N-CA 120.237 -0.983 . . . . 74.409999999999997 112.864 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.4 p -119.35 147.46 44.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.837 -1.171 . . . . 73.329999999999998 107.837 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 4.7 m-20 -66.49 -51.38 42.2 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 119.394 -0.336 . . . . 73.219999999999999 111.595 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 24.4 Cg_exo -71.12 127.81 13.99 Favored 'Trans proline' 0 C--N 1.361 1.223 0 N-CA-C 108.012 -1.572 . . . . 64.340000000000003 108.012 169.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 6.1 Cg_exo -75.27 158.22 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.893 1.729 . . . . 55.439999999999998 113.102 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.08 -17.0 51.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.842 0.829 . . . . 43.219999999999999 109.981 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -96.87 -25.92 15.27 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.389 -0.823 . . . . 64.530000000000001 111.537 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.11 156.68 17.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.889 -0.411 . . . . 73.349999999999994 109.889 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.5 p -90.57 140.83 29.38 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.183 -0.673 . . . . 70.019999999999996 109.183 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.1 m -126.7 142.6 51.49 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.752 -0.832 . . . . 60.439999999999998 108.752 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.427 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -60.43 140.17 57.35 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.226 -0.657 . . . . 53.030000000000001 109.226 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 427' ' ' ARG . 59.6 mt -72.21 -9.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.98 0.895 . . . . 70.030000000000001 111.616 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -81.94 -3.29 53.96 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.613 -0.721 . . . . 73.140000000000001 109.185 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.43 147.38 28.78 Favored 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 121.983 -0.448 . . . . 73.040000000000006 110.644 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.436 ' HB ' ' NE ' ' A' ' 451' ' ' ARG . 5.1 p -85.66 124.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.837 -1.171 . . . . 73.319999999999993 107.837 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 444' ' ' LEU . 60.1 t -87.94 118.12 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.285 -0.966 . . . . 75.140000000000001 108.588 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -94.65 115.11 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.785 -1.561 . . . . 75.310000000000002 106.785 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.06 124.18 69.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.24 -0.891 . . . . 52.509999999999998 109.377 -176.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.59 123.17 61.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.303 -0.628 . . . . 73.329999999999998 109.303 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.21 141.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.314 -0.624 . . . . 42.350000000000001 109.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -76.92 113.51 3.8 Favored Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.526 -1.429 . . . . 75.010000000000005 109.526 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -102.19 130.04 48.73 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.618 -0.512 . . . . 71.030000000000001 109.618 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -114.59 99.73 0.96 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 109.024 -1.63 . . . . 50.240000000000002 109.024 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.41 156.87 32.83 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.488 2.125 . . . . 45.229999999999997 112.427 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.03 109.95 21.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.171 -1.418 . . . . 65.420000000000002 107.171 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.8 p -119.89 151.26 39.16 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.167 -0.924 . . . . 71.439999999999998 109.738 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 495' ' ' LYS . 21.8 mmmt -146.65 149.47 33.56 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.114 0.483 . . . . 64.329999999999998 111.432 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 543' ' ' THR . 9.1 p-10 -82.6 134.48 35.18 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.381 -1.281 . . . . 74.340000000000003 107.602 173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 540' ' ' PRO . 0.2 OUTLIER -75.62 122.73 87.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 119.622 -0.831 . . . . 62.299999999999997 109.091 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.9 170.53 9.87 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.403 2.069 . . . . 53.240000000000002 112.712 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.02 116.62 29.08 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.817 -0.629 . . . . 65.109999999999999 109.948 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.84 17.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 122.621 1.2 . . . . 60.420000000000002 107.942 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 147.55 48.57 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.325 -1.307 . . . . 63.299999999999997 109.45 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.13 -6.48 53.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 111.363 -0.695 . . . . 34.009999999999998 111.363 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.47 177.28 4.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.3 m -77.47 156.35 31.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.248 -0.649 . . . . 72.219999999999999 109.248 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.62 -44.03 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 123.448 0.468 . . . . 72.540000000000006 111.598 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.3 -42.68 79.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.031 0.382 . . . . 72.439999999999998 112.031 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.07 -35.07 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.651 -0.819 . . . . 40.520000000000003 111.121 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.45 81.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.698 -0.683 . . . . 61.100000000000001 111.094 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.66 -38.22 84.15 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.395 0.434 . . . . 74.409999999999997 110.538 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.1 tttm -63.7 -52.01 62.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.654 -0.703 . . . . 61.43 110.27 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -65.02 -41.61 95.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.899 0.38 . . . . 62.43 110.969 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.25 -39.39 89.47 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.616 -0.72 . . . . 64.310000000000002 109.762 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -59.02 -41.57 88.07 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.186 0.594 . . . . 71.230000000000004 112.427 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.1 t -59.02 -35.35 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 55.25 111.088 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -112.28 4.31 17.64 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.024 -0.67 . . . . 74.340000000000003 111.398 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.93 -100.25 0.29 Allowed Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 118.036 -2.031 . . . . 61.219999999999999 117.625 -168.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 60.9 m-85 -120.08 161.47 20.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.404 -0.398 . . . . 72.120000000000005 111.295 -164.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 m -119.01 -13.96 9.39 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.527 0.68 . . . . 64.319999999999993 110.782 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -107.97 115.49 30.23 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.422 -0.955 . . . . 54.25 108.422 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -120.97 156.64 31.67 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.542 0.687 . . . . 71.239999999999995 111.318 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.7 m -139.99 155.75 46.96 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.518 -1.66 . . . . 75.219999999999999 106.518 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -121.28 138.46 54.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.038 0.447 . . . . 74.120000000000005 110.007 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.94 131.75 56.05 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.545 -0.909 . . . . 43.450000000000003 108.545 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 36.1 m -88.61 123.17 32.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.572 0.545 . . . . 73.230000000000004 109.677 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 35.3 m -121.61 162.64 20.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.768 -1.197 . . . . 73.230000000000004 107.768 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 11.1 m-20 -78.06 133.3 37.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.095 0.474 . . . . 75.150000000000006 110.79 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 11.0 m -95.95 105.42 21.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.732 -1.122 . . . . 54.049999999999997 111.563 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 2.4 Cg_endo -81.16 -77.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 121.701 1.6 . . . . 61.420000000000002 109.506 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.447 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 48.8 mmm-85 -95.24 -58.47 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 120.325 -0.55 . . . . 75.439999999999998 109.892 173.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 527' ' ' SER . 36.6 Cg_endo -65.34 144.62 80.97 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.945 1.763 . . . . 72.340000000000003 112.309 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -151.37 132.73 14.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.837 -0.801 . . . . 63.240000000000002 108.837 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.86 -24.66 5.79 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-O 121.922 0.735 . . . . 65.519999999999996 112.075 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.15 150.38 24.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 C-N-CA 124.372 1.069 . . . . 73.340000000000003 111.492 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 97.6 t -73.18 128.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.081 -0.963 . . . . 74.230000000000004 110.018 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -92.25 -22.23 19.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.255 -1.339 . . . . 61.039999999999999 109.733 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.96 33.67 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.156 -0.777 . . . . 61.020000000000003 111.156 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.9 p -117.94 160.33 21.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.643 -0.873 . . . . 61.140000000000001 108.643 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -64.13 -58.5 14.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.338 -0.363 . . . . 41.030000000000001 111.035 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.49 148.81 43.32 Favored 'Trans proline' 0 C--N 1.373 1.862 0 N-CA-C 109.17 -1.127 . . . . 62.229999999999997 109.17 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.471 ' O ' HD11 ' A' ' 497' ' ' ILE . 32.1 Cg_exo -60.46 140.06 89.58 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.069 1.846 . . . . 54.200000000000003 110.661 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.39 131.94 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.618 0.367 . . . . 73.109999999999999 110.847 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.22 40.7 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.363 -0.922 . . . . 74.25 112.274 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 60.3 m -67.44 126.47 29.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.144 -0.687 . . . . 74.310000000000002 109.144 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.2 m -94.33 122.86 37.32 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.942 -0.762 . . . . 63.539999999999999 108.942 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.03 161.0 66.37 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.282 -0.636 . . . . 75.219999999999999 109.282 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 494' ' ' THR . 49.7 Cg_exo -58.83 134.93 63.59 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.468 2.112 . . . . 62.399999999999999 111.355 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.517 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 20.0 m -65.94 -19.85 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.244 0.545 . . . . 62.140000000000001 111.263 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -77.67 -10.27 59.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.647 -0.706 . . . . 62.219999999999999 111.516 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.0 t -85.39 161.13 19.58 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 64.409999999999997 108.922 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.32 130.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.012 0.434 . . . . 74.049999999999997 111.278 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.9 tt -101.6 132.84 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.071 0.462 . . . . 45.399999999999999 110.011 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.59 127.45 51.01 Favored 'General case' 0 N--CA 1.399 -2.999 0 N-CA-C 108.73 -0.841 . . . . 51.100000000000001 108.73 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.5 tp -104.19 133.58 48.88 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.944 -1.025 . . . . 74.510000000000005 108.854 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -94.46 109.23 21.12 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.708 -1.219 . . . . 72.010000000000005 107.708 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.71 138.51 44.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 121.177 0.513 . . . . 54.219999999999999 112.187 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -68.09 114.95 7.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.722 -0.844 . . . . 43.539999999999999 108.722 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 61.9 pttt . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 115.802 -0.636 . . . . 62.229999999999997 110.702 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 110.338 -1.105 . . . . 43.049999999999997 110.338 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -71.12 152.19 61.99 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.455 2.103 . . . . 70.239999999999995 111.222 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 480' ' ' ILE . 12.4 pt-20 -87.93 14.46 8.85 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.77 0.319 . . . . 73.299999999999997 111.491 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 478' ' ' SER . 68.6 mt-30 -90.84 119.14 30.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.291 -0.564 . . . . 65.530000000000001 110.018 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -120.18 160.24 23.3 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.462 -1.31 . . . . 71.540000000000006 107.462 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -86.09 141.39 29.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 123.385 0.428 . . . . 61.210000000000001 111.4 -177.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.1 130.72 68.63 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.597 -0.89 . . . . 72.310000000000002 108.597 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.34 142.93 78.54 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.319 2.68 . . . . 74.319999999999993 114.426 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.46 -7.5 50.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.314 -0.857 . . . . 75.549999999999997 111.091 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 32.4 m -80.38 1.05 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.6 0.714 . . . . 60.119999999999997 110.801 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.3 m -63.77 -28.05 69.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.091 -0.959 . . . . 42.240000000000002 109.476 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -62.07 -28.4 69.58 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.587 -1.188 . . . . 72.519999999999996 111.186 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 63.9 mt -83.37 -45.27 13.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.089 -0.505 . . . . 53.329999999999998 110.572 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.521 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.5 m -165.69 149.06 7.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.655 -0.869 . . . . 65.129999999999995 108.655 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.08 -45.41 75.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.407 0.683 . . . . 71.209999999999994 110.655 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 442' ' ' LYS . . . -55.41 -44.7 76.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.038 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.521 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 31.2 mm-40 -64.32 -37.89 89.1 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.014 -0.539 . . . . 74.420000000000002 110.935 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.79 -51.33 68.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 73.310000000000002 110.477 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.41 -46.03 97.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.221 -0.9 . . . . 73.310000000000002 112.309 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 438' ' ' ALA . 15.8 ptpt -63.03 -44.55 95.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.561 0.22 . . . . 74.25 111.319 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.34 -38.44 84.85 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.04 0.385 . . . . 72.010000000000005 112.04 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.1 tp -68.53 -34.26 75.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.516 0.674 . . . . 74.040000000000006 109.938 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.2 m -65.66 -40.74 92.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.418 -0.81 . . . . 73.040000000000006 109.305 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -16.57 62.71 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.315 0.578 . . . . 72.010000000000005 110.419 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.78 -14.14 49.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.222 0.534 . . . . 61.329999999999998 109.589 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.39 50.16 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.884 -0.674 . . . . 64.25 113.616 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.0 m-85 -92.29 121.36 33.72 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.177 0.489 . . . . 62.210000000000001 110.123 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.21 5.02 21.87 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 111.197 -0.761 . . . . 73.099999999999994 111.197 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -102.86 116.46 32.6 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.326 -0.62 . . . . 74.510000000000005 109.326 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.439 ' CE2' HD23 ' A' ' 444' ' ' LEU . 73.8 m-85 -130.4 144.79 51.61 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.281 0.563 . . . . 73.120000000000005 111.075 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.489 ' HB3' HG13 ' A' ' 485' ' ' ILE . 22.3 tptm -131.02 121.84 25.75 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.897 -2.26 . . . . 73.319999999999993 104.897 167.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -105.32 134.99 47.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.695 -0.483 . . . . 63.340000000000003 109.695 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.93 150.32 44.4 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.695 -0.854 . . . . 71.120000000000005 108.695 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -125.73 148.74 48.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.762 -1.199 . . . . 73.109999999999999 107.762 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.2 m -143.17 144.79 30.0 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 109.115 -0.698 . . . . 74.239999999999995 109.115 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.4 Cg_exo -65.44 123.05 10.91 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.608 2.206 . . . . 51.039999999999999 112.571 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.8 t -137.17 -179.13 5.54 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.699 -1.963 . . . . 74.129999999999995 105.699 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.46 ' CG2' HD23 ' A' ' 463' ' ' LEU . 6.9 t -61.88 141.64 95.3 Favored Pre-proline 0 N--CA 1.423 -1.791 0 N-CA-C 109.944 -0.391 . . . . 53.299999999999997 109.944 178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.76 -29.66 34.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.108 3.205 . . . . 74.140000000000001 112.32 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.05 -20.65 65.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.999 0.74 . . . . 73.299999999999997 112.999 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.46 HD23 ' CG2' ' A' ' 460' ' ' THR . 4.5 mm? -106.33 11.47 30.97 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.107 -0.371 . . . . 75.120000000000005 111.964 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.92 128.99 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.156 0.503 . . . . 74.329999999999998 111.419 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.29 -9.58 77.01 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.655 -0.783 . . . . 73.430000000000007 112.49 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.423 ' HD2' HD13 ' A' ' 463' ' ' LEU . 68.1 mttm -100.55 155.35 17.9 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.175 -1.046 . . . . 74.310000000000002 108.175 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.577 HG22 HD11 ' A' ' 486' ' ' ILE . 53.7 t -81.96 129.75 36.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.901 -1.148 . . . . 70.230000000000004 107.901 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.2 pt -98.55 -16.04 7.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.42 -0.512 . . . . 74.519999999999996 110.799 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 176.32 149.1 7.36 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.675 -0.693 . . . . 73.310000000000002 111.738 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.3 p -116.82 152.85 33.56 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.606 -1.257 . . . . 73.349999999999994 107.606 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.1 t-20 -68.03 -51.94 25.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 C-N-CA 120.502 -0.479 . . . . 74.010000000000005 110.714 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.9 Cg_exo -79.13 130.59 9.38 Favored 'Trans proline' 0 C--N 1.371 1.751 0 N-CA-C 107.952 -1.595 . . . . 52.299999999999997 107.952 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 7.2 Cg_exo -69.88 157.15 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.791 1.661 . . . . 62.420000000000002 112.845 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.19 -6.75 57.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.358 1.075 . . . . 72.150000000000006 109.109 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 -40.32 14.29 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.14 -1.391 . . . . 75.239999999999995 111.048 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.77 167.13 10.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 71.0 110.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 p -101.57 133.56 46.06 Favored 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 108.708 -0.849 . . . . 74.230000000000004 108.708 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.2 m -118.9 148.6 42.75 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.379 -0.6 . . . . 65.329999999999998 109.379 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.25 51.78 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.282 0.364 . . . . 63.329999999999998 111.403 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.8 mm -57.7 -28.51 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.708 1.203 . . . . 74.409999999999997 111.147 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.1 t -76.56 -7.36 55.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.73 -0.668 . . . . 62.240000000000002 110.876 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.99 142.22 28.1 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 122.074 -0.391 . . . . 54.240000000000002 110.435 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.96 126.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.786 -0.82 . . . . 74.219999999999999 108.786 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.19 119.37 36.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.137 -0.69 . . . . 43.240000000000002 109.137 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.9 mp -92.94 119.65 40.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.182 -1.414 . . . . 72.140000000000001 107.182 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.577 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -117.06 125.91 74.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 109.53 -0.545 . . . . 74.099999999999994 109.53 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.43 119.18 52.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.538 -0.542 . . . . 71.239999999999995 109.538 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.21 144.12 10.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.98 -0.748 . . . . 60.329999999999998 108.98 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -77.71 122.21 6.0 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 111.823 -0.511 . . . . 55.340000000000003 111.823 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.9 t -118.45 131.93 56.25 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.16 -1.793 . . . . 63.219999999999999 106.16 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -115.08 136.08 12.84 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.672 -1.251 . . . . 72.349999999999994 111.12 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.9 122.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.318 2.012 . . . . 55.229999999999997 111.247 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.86 102.4 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.864 -1.532 . . . . 71.430000000000007 106.864 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.6 p -125.21 152.79 44.07 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.88 -0.6 . . . . 75.239999999999995 110.119 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -133.67 135.6 44.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.31 -0.405 . . . . 44.32 109.939 -177.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.7 p-10 -83.28 130.54 35.08 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.454 -0.943 . . . . 34.549999999999997 108.454 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.8 pt -81.52 131.99 56.62 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 115.991 -0.55 . . . . 62.310000000000002 110.423 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -84.36 152.62 12.16 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.518 2.145 . . . . 72.530000000000001 112.111 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.56 101.22 2.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.533 0.683 . . . . 73.340000000000003 109.95 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.06 1.81 8.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.278 -0.874 . . . . 71.329999999999998 109.484 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -67.85 122.95 19.25 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.999 -1.0 . . . . 64.349999999999994 110.679 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.94 -29.73 3.87 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.607 -0.597 . . . . 60.450000000000003 111.607 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -88.87 -175.48 4.88 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.109 -0.701 . . . . 73.450000000000003 109.109 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 70.0 p -80.49 157.38 26.17 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.637 -0.825 . . . . 43.32 110.644 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.01 -41.6 80.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.452 0.644 . . . . 53.210000000000001 109.333 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.71 -43.28 89.57 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.259 -0.882 . . . . 64.049999999999997 112.504 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.58 -34.68 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 119.945 -0.702 . . . . 45.210000000000001 110.585 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.12 77.94 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.803 -0.635 . . . . 75.140000000000001 110.834 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.24 -41.74 97.41 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.638 0.586 . . . . 63.450000000000003 110.203 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 514' ' ' VAL . 56.0 mtmt -65.16 -51.73 59.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 113.203 0.816 . . . . 62.020000000000003 113.203 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -63.48 -40.93 98.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.912 0.386 . . . . 73.040000000000006 110.725 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 551' ' ' ILE . 59.0 tp -66.53 -39.51 88.64 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 115.626 -0.716 . . . . 64.209999999999994 110.796 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.77 -37.66 87.51 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.891 0.377 . . . . 73.239999999999995 110.654 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 510' ' ' LYS . 47.7 t -69.16 -30.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.965 -0.561 . . . . 51.340000000000003 111.476 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.92 18.83 7.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 120.201 -0.6 . . . . 71.319999999999993 111.748 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -150.06 -110.75 0.53 Allowed Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 118.869 -1.634 . . . . 72.319999999999993 115.135 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -114.27 164.25 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.373 -0.414 . . . . 71.030000000000001 110.214 -168.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -105.57 -7.98 18.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.426 -0.806 . . . . 75.230000000000004 109.916 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.71 119.27 33.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 74.209999999999994 111.544 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.79 155.95 42.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.149 -0.932 . . . . 71.109999999999999 109.711 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 72.7 m -135.03 148.18 49.86 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.135 -1.432 . . . . 65.099999999999994 107.135 170.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -122.23 128.2 50.87 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.264 -0.643 . . . . 53.119999999999997 109.264 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -119.75 131.48 55.37 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.319 -0.993 . . . . 54.210000000000001 108.319 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -88.69 126.69 35.43 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.447 0.641 . . . . 52.119999999999997 111.425 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.02 162.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.228 -1.397 . . . . 72.329999999999998 107.228 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 557' ' ' LYS . 5.9 p-10 -79.36 129.26 34.29 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.795 0.807 . . . . 71.299999999999997 112.426 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 556' ' ' SER . 10.9 p -92.94 122.25 64.11 Favored Pre-proline 0 N--CA 1.416 -2.152 0 CA-C-N 114.272 -1.331 . . . . 75.150000000000006 108.712 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.82 -67.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.472 2.114 . . . . 64.099999999999994 111.882 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -136.1 -52.08 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 123.704 0.802 . . . . 74.420000000000002 109.473 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 20.4 Cg_endo -63.6 150.14 89.21 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.215 1.276 . . . . 75.140000000000001 110.196 168.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.62 139.89 16.63 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.469 -0.567 . . . . 61.200000000000003 109.469 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.64 10.92 Favored Glycine 0 C--O 1.242 0.607 0 C-N-CA 120.905 -0.665 . . . . 52.25 111.775 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 533' ' ' GLU . 0.4 OUTLIER -87.14 147.02 25.81 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.933 0.397 . . . . 63.009999999999998 110.626 177.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 501' ' ' ALA . 7.9 p -77.62 122.71 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 108.219 -1.03 . . . . 74.409999999999997 108.219 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.41 -25.59 59.56 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.296 -0.865 . . . . 54.140000000000001 109.571 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.79 -156.3 26.8 Favored Glycine 0 N--CA 1.424 -2.115 0 N-CA-C 110.299 -1.12 . . . . 73.129999999999995 110.299 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.0 p -130.0 160.54 33.32 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.379 -0.971 . . . . 72.439999999999998 108.379 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.58 -56.35 36.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 123.461 0.476 . . . . 74.209999999999994 110.751 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.26 146.92 28.82 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.009 1.139 . . . . 71.319999999999993 109.96 170.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -73.3 156.07 50.98 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.363 2.042 . . . . 44.310000000000002 112.465 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.8 136.99 58.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.075 0.55 . . . . 74.209999999999994 111.351 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -17.45 56.52 Favored Glycine 0 C--N 1.312 -0.765 0 C-N-CA 120.85 -0.69 . . . . 32.039999999999999 112.004 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.5 m -71.54 132.48 44.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.397 -0.594 . . . . 71.140000000000001 109.397 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -99.25 122.77 42.88 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.023 -1.103 . . . . 71.530000000000001 108.023 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.85 154.95 73.53 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.486 -0.931 . . . . 74.109999999999999 108.486 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.492 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.8 Cg_exo -59.91 141.99 97.65 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.229 1.952 . . . . 73.099999999999994 111.621 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.8 -19.28 25.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 121.797 0.808 . . . . 60.420000000000002 111.575 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -87.31 2.73 49.34 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.982 -1.008 . . . . 74.120000000000005 109.541 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -103.45 149.06 25.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.351 -0.84 . . . . 33.32 108.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.36 130.13 42.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.008 0.433 . . . . 72.140000000000001 110.721 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.444 HD13 HD21 ' A' ' 512' ' ' LEU . 12.1 tt -95.38 130.84 43.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 74.120000000000005 110.6 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.99 121.7 43.1 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.209 0.528 . . . . 70.239999999999995 110.581 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.04 133.76 39.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.824 -1.08 . . . . 53.539999999999999 110.087 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.407 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 12.4 mm-40 -90.18 109.57 20.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.523 -1.658 . . . . 75.329999999999998 106.523 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.47 133.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.119 0.414 . . . . 74.150000000000006 112.119 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 527' ' ' SER . 14.5 m -70.47 114.48 8.62 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.247 -1.39 . . . . 71.540000000000006 107.247 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 526' ' ' ASP 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 117.903 -1.519 . . . . 71.219999999999999 111.77 -176.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.255 0 N-CA-C 110.232 -1.147 . . . . 44.520000000000003 110.232 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.88 148.94 25.63 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.722 1.615 . . . . 64.340000000000003 111.693 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.97 11.1 14.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 73.129999999999995 110.379 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 91.9 mt-30 -83.37 126.92 33.23 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.463 -1.31 . . . . 64.439999999999998 107.463 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -130.05 162.32 29.02 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.845 -1.169 . . . . 64.349999999999994 107.845 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.32 141.53 29.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.257 0.465 . . . . 62.020000000000003 112.257 -173.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -82.39 129.2 64.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 107.285 -1.376 . . . . 65.120000000000005 107.285 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.34 141.19 96.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.056 1.837 . . . . 75.129999999999995 112.685 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -94.24 4.17 54.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.862 -0.608 . . . . 73.120000000000005 109.809 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.529 HG21 ' HD2' ' A' ' 443' ' ' LYS . 35.2 m -75.96 -2.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.201 -0.909 . . . . 70.5 109.955 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 15.1 m -60.52 -33.64 72.93 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.441 -1.254 . . . . 73.540000000000006 110.181 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.407 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.3 t -64.91 -25.61 67.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.051 -0.977 . . . . 72.420000000000002 110.607 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.8 mt -81.4 -45.74 15.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.691 -0.404 . . . . 75.409999999999997 110.279 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 438' ' ' ALA . 58.9 m -163.37 142.33 8.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.707 -0.849 . . . . 72.439999999999998 108.707 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.417 ' HA ' HG23 ' A' ' 467' ' ' VAL . 25.9 t80 -54.75 -45.11 74.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.045 0.538 . . . . 73.400000000000006 110.898 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.448 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.91 -42.95 76.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.067 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.35 -42.91 99.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 116.031 -0.532 . . . . 75.519999999999996 111.782 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.63 -51.73 68.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.516 -0.765 . . . . 73.430000000000007 111.324 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.35 -47.58 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.368 -0.833 . . . . 65.319999999999993 111.956 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.34 -46.21 81.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.975 0.417 . . . . 74.340000000000003 110.948 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.529 ' HD2' HG21 ' A' ' 432' ' ' VAL 0.251 59.5 mttp -67.28 -37.9 84.17 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 113.08 0.77 . . . . 72.349999999999994 113.08 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 41.5 tp -67.77 -36.78 81.11 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.143 0.497 . . . . 74.349999999999994 109.728 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.3 m -60.65 -42.69 97.5 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 51.439999999999998 109.294 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.7 -19.65 62.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.414 -0.812 . . . . 74.0 111.336 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.21 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.275 0.56 . . . . 60.210000000000001 110.218 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.32 29.36 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.767 -0.73 . . . . 72.129999999999995 113.437 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.93 130.96 35.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.883 0.341 . . . . 74.209999999999994 110.597 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 30.4 4.27 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.11 -0.796 . . . . 33.210000000000001 111.11 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.408 ' HB3' HG22 ' A' ' 483' ' ' VAL . 3.0 mmp_? -132.58 115.9 16.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.551 -0.907 . . . . 54.130000000000003 108.551 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 65.9 m-85 -133.39 148.09 51.8 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.177 -0.919 . . . . 63.399999999999999 110.306 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.527 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.2 tppp? -138.97 122.64 17.49 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.202 -1.777 . . . . 73.439999999999998 106.202 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -103.1 135.22 45.17 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.874 0.369 . . . . 74.099999999999994 111.321 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.91 152.34 43.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.696 -1.594 . . . . 70.129999999999995 106.696 172.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.67 150.74 48.82 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.879 -0.786 . . . . 60.140000000000001 108.879 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.4 m -140.22 150.25 60.86 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 109.11 -0.7 . . . . 74.510000000000005 109.11 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.2 Cg_exo -65.39 132.44 31.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.325 2.017 . . . . 71.129999999999995 111.218 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.2 m -146.8 177.12 9.35 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.181 -0.463 . . . . 62.539999999999999 110.229 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.0 t -62.54 144.49 95.69 Favored Pre-proline 0 N--CA 1.432 -1.347 0 C-N-CA 123.852 0.861 . . . . 61.200000000000003 110.015 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.9 Cg_exo -51.15 -31.72 37.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.966 3.111 . . . . 73.239999999999995 113.067 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.99 -12.04 60.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 120.027 -0.669 . . . . 75.019999999999996 111.754 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.5 mt -109.61 -4.45 16.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.7 -0.227 . . . . 62.100000000000001 111.528 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.8 t -61.2 127.5 20.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.567 -0.531 . . . . 72.310000000000002 109.567 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.42 75.33 Favored Glycine 0 C--O 1.25 1.101 0 C-N-CA 121.082 -0.58 . . . . 53.439999999999998 111.738 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 95.5 mttt -125.27 159.22 32.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.405 -0.961 . . . . 61.25 108.405 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.642 HG22 HD11 ' A' ' 486' ' ' ILE . 39.1 t -82.75 133.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 109.329 -0.619 . . . . 75.219999999999999 109.329 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.72 -7.59 9.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 120.462 -0.495 . . . . 74.219999999999999 110.342 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.495 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 162.16 165.08 18.48 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.995 -0.842 . . . . 63.420000000000002 110.995 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.1 p -120.0 145.45 46.79 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.25 -0.648 . . . . 42.43 109.25 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.49 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.1 t-20 -57.4 -50.58 87.37 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 118.981 -0.533 . . . . 64.450000000000003 111.886 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.3 Cg_exo -76.7 131.82 12.69 Favored 'Trans proline' 0 C--N 1.37 1.709 0 N-CA-C 108.377 -1.432 . . . . 75.549999999999997 108.377 171.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.65 138.56 70.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.429 2.086 . . . . 72.239999999999995 112.037 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.49 1.77 50.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.133 0.968 . . . . 54.32 110.484 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.03 -27.78 15.45 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.798 -1.092 . . . . 73.340000000000003 109.639 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -109.89 164.85 12.19 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.848 -0.614 . . . . 71.319999999999993 109.455 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 15.5 p -90.61 136.86 32.79 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 120.736 0.303 . . . . 64.340000000000003 111.247 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.7 m -120.1 142.03 49.26 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.69 -0.856 . . . . 71.319999999999993 108.69 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.97 39.35 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.932 0.345 . . . . 74.329999999999998 111.932 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.81 -23.54 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.044 0.937 . . . . 74.219999999999999 111.282 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -80.67 -8.94 59.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.549 -0.75 . . . . 74.430000000000007 110.9 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 140.63 43.3 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.921 0.391 . . . . 52.439999999999998 112.04 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 451' ' ' ARG . 99.4 t -85.3 122.89 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.942 -1.133 . . . . 74.0 107.942 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.95 118.84 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.223 -1.029 . . . . 74.409999999999997 108.223 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.527 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.6 mp -92.74 117.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.064 -1.828 . . . . 74.219999999999999 106.064 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.642 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.56 120.57 62.36 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 CA-C-N 115.566 -0.743 . . . . 73.409999999999997 109.429 -174.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.66 121.45 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.645 0.736 . . . . 60.329999999999998 111.242 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 142.72 13.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.778 -1.101 . . . . 72.040000000000006 109.386 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.38 118.99 4.9 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 109.024 -1.63 . . . . 63.420000000000002 109.024 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.6 t -122.79 155.6 36.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.557 -0.905 . . . . 65.010000000000005 108.557 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -114.21 123.2 5.97 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 109.602 -1.399 . . . . 62.32 109.602 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.2 112.43 2.07 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.978 1.785 . . . . 73.549999999999997 110.316 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -71.21 95.52 1.28 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.123 0.963 . . . . 61.299999999999997 110.448 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 8.9 p -140.41 153.86 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.735 -1.12 . . . . 65.409999999999997 109.053 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.96 146.96 36.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.328 -0.249 . . . . 74.239999999999995 110.328 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.0 p-10 -100.41 135.53 41.71 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.613 -0.884 . . . . 75.140000000000001 108.613 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 32.7 pt -89.99 137.7 28.01 Favored Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 115.919 -0.582 . . . . 72.319999999999993 111.526 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.6 Cg_endo -83.19 -172.09 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.224 1.949 . . . . 73.25 110.25 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.1 128.58 35.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.169 0.509 . . . . 72.25 110.487 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.39 4.16 2.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.845 0.831 . . . . 62.009999999999998 109.435 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.67 144.06 26.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.489 -0.778 . . . . 62.039999999999999 110.279 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 95.3 13.09 53.25 Favored Glycine 0 CA--C 1.498 -1.007 0 N-CA-C 111.081 -0.808 . . . . 61.240000000000002 111.081 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 507' ' ' VAL . 19.8 mt-30 -118.88 176.18 5.4 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.056 -1.09 . . . . 75.230000000000004 108.056 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 m -86.58 155.41 20.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.715 -1.217 . . . . 52.520000000000003 107.715 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 10.3 p -54.87 -41.51 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 123.383 0.427 . . . . 71.25 111.968 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.25 -42.53 83.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.138 0.422 . . . . 52.399999999999999 112.138 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.3 p -76.52 -34.38 24.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 119.884 -0.726 . . . . 55.509999999999998 110.646 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.446 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -61.14 -47.66 85.2 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.078 -0.964 . . . . 74.209999999999994 111.017 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.2 mt-30 -62.75 -38.3 89.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 123.631 0.582 . . . . 73.549999999999997 110.002 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 514' ' ' VAL . 44.7 mmtm -63.03 -52.82 61.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.529 0.518 . . . . 64.239999999999995 111.911 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.57 -42.78 99.76 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 110.939 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.09 -43.33 95.72 Favored 'General case' 0 C--O 1.197 -1.698 0 CA-C-N 115.641 -0.709 . . . . 72.400000000000006 109.939 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.99 -38.61 79.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.41 0.684 . . . . 70.340000000000003 111.383 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.8 t -62.03 -40.52 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.291 -0.413 . . . . 41.539999999999999 111.63 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -101.29 -36.4 8.91 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.505 -0.878 . . . . 72.200000000000003 110.863 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -89.6 -115.77 1.55 Allowed Glycine 0 N--CA 1.415 -2.739 0 CA-C-N 114.435 -1.257 . . . . 74.209999999999994 115.783 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 17.3 m-85 -125.15 -175.29 3.26 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.194 -0.503 . . . . 73.409999999999997 110.235 -167.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.3 p -113.2 -7.71 13.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.305 0.483 . . . . 74.219999999999999 112.305 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.65 120.86 43.69 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 120.617 -0.433 . . . . 63.5 110.147 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -125.67 155.97 40.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.42 -0.809 . . . . 71.099999999999994 109.284 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 154.82 45.61 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.842 -1.54 . . . . 75.450000000000003 106.842 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -120.97 128.42 52.71 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.229 -0.588 . . . . 72.239999999999995 110.193 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.07 131.19 57.01 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.086 -1.079 . . . . 61.409999999999997 108.086 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.3 p -88.78 131.41 35.07 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.745 -0.661 . . . . 70.420000000000002 111.184 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.4 m -121.96 162.0 21.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.803 -1.184 . . . . 75.439999999999998 107.803 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -79.8 123.75 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.254 0.549 . . . . 75.140000000000001 111.733 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 556' ' ' SER . 7.2 m -85.15 149.75 53.44 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.203 -0.908 . . . . 63.200000000000003 108.567 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.599 1.532 . . . . 75.450000000000003 109.285 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.487 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.4 mtt180 -122.97 -58.46 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.802 -0.618 . . . . 74.400000000000006 111.003 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 57.2 Cg_endo -71.34 148.4 54.96 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.823 1.33 . . . . 32.039999999999999 111.522 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.71 175.68 9.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.045 -0.724 . . . . 51.030000000000001 109.045 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 86.51 -15.85 48.51 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 121.256 -0.497 . . . . 54.229999999999997 111.927 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.92 147.83 25.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.657 0.741 . . . . 65.239999999999995 111.598 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 508' ' ' ALA . 69.7 t -81.46 123.7 38.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 114.991 -1.004 . . . . 71.140000000000001 109.614 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.9 m -86.13 -26.45 25.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.733 -1.122 . . . . 70.109999999999999 109.242 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.13 -153.27 23.72 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 111.019 -0.832 . . . . 74.310000000000002 111.019 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -134.81 161.29 35.63 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.954 -0.758 . . . . 74.340000000000003 108.954 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.6 t-20 -54.69 -54.44 49.08 Favored Pre-proline 0 CA--C 1.561 1.374 0 O-C-N 123.291 0.369 . . . . 70.319999999999993 110.615 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 79.4 Cg_endo -82.35 149.4 14.96 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.103 1.202 . . . . 63.43 110.191 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 21.6 Cg_exo -67.64 154.13 74.26 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.317 2.011 . . . . 62.119999999999997 113.024 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.78 129.56 40.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.18 -0.674 . . . . 43.350000000000001 109.18 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.59 46.46 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 111.862 -0.495 . . . . 34.299999999999997 111.862 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 93.2 m -78.06 137.36 38.2 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.986 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -94.56 123.89 38.26 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.727 -0.669 . . . . 74.439999999999998 109.77 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.9 155.0 78.27 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 110.092 -0.336 . . . . 75.200000000000003 110.092 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.4 Cg_exo -64.03 139.72 68.75 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.242 2.628 . . . . 71.400000000000006 112.482 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.556 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 16.3 m -67.75 -21.19 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.785 0.803 . . . . 64.140000000000001 111.114 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.12 -10.92 59.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.646 -1.161 . . . . 75.230000000000004 110.349 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.8 t -93.24 155.1 17.64 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.927 -0.768 . . . . 71.030000000000001 108.927 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.68 130.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.937 -0.764 . . . . 60.109999999999999 108.937 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 18.7 tt -93.64 135.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.539 0.685 . . . . 64.5 111.377 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -102.74 124.49 48.37 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 109.485 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 28.4 tp -96.72 132.78 42.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.893 -1.048 . . . . 72.140000000000001 109.204 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -96.33 106.66 18.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.414 -1.328 . . . . 71.219999999999999 107.414 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.62 137.0 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 111.125 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.471 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 50.2 m -65.83 115.65 6.17 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.025 -1.102 . . . . 51.119999999999997 108.025 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 C--N 1.314 -0.955 0 O-C-N 123.643 0.589 . . . . 71.209999999999994 109.773 -176.345 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.495 0 N-CA-C 110.343 -1.103 . . . . 75.129999999999995 110.343 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.88 150.2 88.46 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.484 2.123 . . . . 71.230000000000004 112.147 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.88 23.27 8.68 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.516 -0.55 . . . . 74.340000000000003 109.516 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.524 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 66.2 mt-30 -83.83 138.74 33.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.842 -0.617 . . . . 62.539999999999999 112.435 -171.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -130.18 154.73 47.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.852 -1.907 . . . . 75.239999999999995 105.852 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.15 28.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 117.737 0.244 . . . . 74.329999999999998 110.727 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.2 mp -79.69 129.98 69.25 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 108.493 -0.928 . . . . 74.030000000000001 108.493 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.61 141.14 54.05 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.938 1.759 . . . . 75.510000000000005 111.062 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.39 67.23 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.267 1.032 . . . . 74.209999999999994 109.844 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.422 HG13 HD12 ' A' ' 435' ' ' LEU . 43.6 t -117.39 -2.55 9.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.556 -1.646 . . . . 72.510000000000005 106.556 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.674 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.2 m -60.96 -41.22 95.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.394 -1.73 . . . . 74.200000000000003 111.373 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 13.9 t -58.15 -26.29 62.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.6 -0.727 . . . . 74.239999999999995 111.623 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 432' ' ' VAL . 78.4 mt -80.93 -44.53 18.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.318 -0.553 . . . . 72.329999999999998 110.916 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.5 m -164.64 145.2 7.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.695 -0.854 . . . . 74.519999999999996 108.695 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.38 -43.65 79.45 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.787 0.835 . . . . 72.310000000000002 110.77 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.17 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.695 0.76 . . . . 74.209999999999994 110.704 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.535 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.9 mm-40 -70.42 -38.78 74.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.663 -0.699 . . . . 72.430000000000007 110.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.674 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.84 -50.95 71.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.472 -0.786 . . . . 44.32 111.036 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.4 t -59.37 -46.32 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 111.571 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -65.13 -44.79 87.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.744 -0.383 . . . . 75.200000000000003 111.139 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -63.4 -44.69 93.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.259 -0.428 . . . . 75.209999999999994 111.821 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.601 HD23 ' CE2' ' A' ' 452' ' ' PHE . 29.4 tp -67.26 -40.11 86.17 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.329 -0.396 . . . . 73.219999999999999 110.295 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.2 m -60.44 -44.15 96.12 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 110.468 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.08 -18.05 62.56 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.784 -0.644 . . . . 71.25 111.431 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.62 57.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.092 0.472 . . . . 41.210000000000001 110.825 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.9 -6.03 37.17 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.368 -0.92 . . . . 72.430000000000007 112.675 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.6 m-85 -81.7 130.84 35.2 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.098 -0.704 . . . . 71.409999999999997 109.098 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.62 2.03 6.47 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.47 -0.872 . . . . 71.439999999999998 113.129 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HG3' HG23 ' A' ' 483' ' ' VAL . 9.1 tpp180 -104.37 115.35 30.22 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.126 -1.065 . . . . 71.140000000000001 108.126 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.601 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.0 m-85 -123.28 144.89 49.12 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.318 0.58 . . . . 75.439999999999998 110.8 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -135.26 122.62 21.79 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.77 -1.567 . . . . 63.439999999999998 106.77 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -93.89 121.75 35.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.045 0.45 . . . . 53.119999999999997 109.881 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.02 151.68 45.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.929 -1.138 . . . . 75.030000000000001 107.929 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -132.03 134.35 45.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.331 -0.618 . . . . 74.329999999999998 109.331 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.4 m -119.04 137.53 25.2 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 107.979 -1.119 . . . . 72.140000000000001 107.979 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.07 121.63 9.17 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.458 1.438 . . . . 53.340000000000003 109.606 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 492' ' ' PRO . 15.3 m -138.93 179.22 6.62 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.121 -1.437 . . . . 72.120000000000005 107.121 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.3 t -56.43 126.24 68.65 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-O 121.659 0.742 . . . . 72.409999999999997 110.164 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.51 -28.91 29.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 125.25 3.966 . . . . 62.299999999999997 115.739 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.69 -15.96 62.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.66 0.615 . . . . 73.510000000000005 112.66 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 73.3 mt -87.69 4.74 42.89 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 64.230000000000004 112.149 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.5 p -60.25 130.08 23.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 121.023 0.439 . . . . 55.539999999999999 110.172 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.51 68.54 Favored Glycine 0 C--N 1.307 -1.04 0 C-N-CA 120.631 -0.795 . . . . 52.140000000000001 111.656 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.88 144.33 42.62 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.138 0.494 . . . . 53.200000000000003 109.914 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.629 HG22 HD11 ' A' ' 486' ' ' ILE . 46.0 t -82.13 135.82 24.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.376 -0.972 . . . . 73.219999999999999 108.376 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.3 pt -97.96 -29.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 119.84 -0.744 . . . . 64.129999999999995 110.417 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -174.28 161.17 31.11 Favored Glycine 0 N--CA 1.424 -2.162 0 C-N-CA 120.395 -0.907 . . . . 61.310000000000002 111.639 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.0 p -118.7 152.81 35.44 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.194 -0.669 . . . . 54.539999999999999 109.194 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 16.7 t-20 -62.76 -54.56 46.34 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-O 119.156 -0.45 . . . . 72.329999999999998 111.416 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -75.81 134.16 16.2 Favored 'Trans proline' 0 C--N 1.366 1.477 0 N-CA-C 108.529 -1.374 . . . . 63.43 108.529 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.89 143.65 73.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.854 2.37 . . . . 72.439999999999998 113.206 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -88.89 -7.57 55.86 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.442 1.115 . . . . 60.32 109.437 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.91 -33.01 17.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.449 -1.25 . . . . 73.329999999999998 110.06 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -114.91 175.67 5.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.597 -0.729 . . . . 75.150000000000006 110.681 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 18.0 p -92.42 139.98 30.04 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 116.338 -0.392 . . . . 72.0 109.99 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 53.4 m -130.1 147.07 51.8 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.883 -0.784 . . . . 74.420000000000002 108.883 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.485 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.98 150.37 48.76 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.012 0.434 . . . . 73.420000000000002 111.521 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.38 -24.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.626 -0.715 . . . . 72.319999999999993 110.025 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -81.14 2.27 28.24 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.807 -0.633 . . . . 64.519999999999996 111.085 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.37 145.66 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.924 -0.398 . . . . 71.5 109.924 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 451' ' ' ARG . 3.4 p -86.35 120.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.265 -1.013 . . . . 64.420000000000002 108.265 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.44 117.23 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 C-N-CA 118.233 -1.387 . . . . 71.540000000000006 107.456 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 64.4 mt -97.97 112.21 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 105.438 -2.06 . . . . 74.109999999999999 105.438 175.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.629 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.85 120.4 51.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 N-CA-C 108.346 -0.983 . . . . 65.409999999999997 108.346 -175.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.18 120.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.328 0.585 . . . . 74.049999999999997 110.124 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.72 138.83 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.887 -1.153 . . . . 70.409999999999997 107.887 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.9 104.66 2.23 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 108.753 -1.739 . . . . 71.439999999999998 108.753 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.5 t -105.63 139.73 39.78 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.815 -1.18 . . . . 72.150000000000006 107.815 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -72.2 139.31 27.92 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 108.902 -1.679 . . . . 74.230000000000004 108.902 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 459' ' ' SER . 12.1 Cg_exo -66.89 105.76 1.01 Allowed 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.796 1.664 . . . . 72.109999999999999 111.404 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -79.3 104.51 9.97 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.483 -1.235 . . . . 70.430000000000007 108.965 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.1 p -121.68 158.96 27.56 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.813 -1.085 . . . . 74.310000000000002 108.379 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -150.0 148.53 29.17 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.087 -0.338 . . . . 70.340000000000003 110.087 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.5 p-10 -80.36 131.6 35.65 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.45 0.643 . . . . 60.0 110.322 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.3 pt -75.4 131.29 77.98 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.177 -0.919 . . . . 75.230000000000004 111.461 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -92.14 119.64 0.5 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 122.639 2.226 . . . . 74.409999999999997 111.753 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.75 122.28 28.89 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.675 -1.232 . . . . 75.010000000000005 107.675 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.44 43.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.829 1.299 . . . . 63.229999999999997 110.631 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -59.72 145.97 43.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.358 -1.292 . . . . 72.340000000000003 112.242 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.0 -12.64 31.83 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.134 -0.555 . . . . 73.109999999999999 113.012 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.528 ' O ' HG12 ' A' ' 534' ' ' VAL . 25.5 mt-30 -108.17 -170.9 1.76 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 121.048 -0.261 . . . . 75.319999999999993 111.311 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.1 m -85.07 156.36 21.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.498 -1.297 . . . . 73.109999999999999 107.498 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.99 -41.19 90.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.576 0.626 . . . . 70.109999999999999 111.232 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.82 -42.06 97.73 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 116.492 -0.322 . . . . 65.319999999999993 111.424 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.8 -34.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 119.194 -1.003 . . . . 63.340000000000003 111.018 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.78 86.66 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.873 -0.603 . . . . 72.510000000000005 110.247 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -61.91 -42.27 98.89 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 123.255 0.347 . . . . 62.009999999999998 110.097 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.25 -48.36 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.342 -0.614 . . . . 72.030000000000001 109.342 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.89 -38.9 92.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.540000000000006 110.771 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.29 -43.68 73.34 Favored 'General case' 0 C--O 1.186 -2.263 0 CA-C-N 115.352 -0.84 . . . . 64.439999999999998 110.185 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.36 -46.55 86.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.433 0.635 . . . . 74.329999999999998 111.435 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.04 -18.65 21.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 62.32 111.316 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -129.87 18.41 5.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.932 -0.766 . . . . 73.150000000000006 108.932 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -162.61 -110.74 0.25 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.111 -1.042 . . . . 44.539999999999999 114.691 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -123.31 167.74 13.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.856 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 9.3 p -104.68 7.03 34.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.829 0.678 . . . . 73.310000000000002 112.829 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 550' ' ' VAL . 0.0 OUTLIER -131.04 123.01 27.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.775 0.321 . . . . 73.230000000000004 110.781 -178.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.76 152.15 48.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 74.099999999999994 110.528 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 47.8 t -127.51 147.83 50.32 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.818 -1.919 . . . . 70.0 105.818 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -121.53 127.51 51.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 110.258 -0.275 . . . . 74.439999999999998 110.258 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 135.29 48.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.8 -0.637 . . . . 73.409999999999997 109.741 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 2.7 p -88.47 130.1 35.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.71 -0.677 . . . . 74.140000000000001 109.551 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.44 159.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.639 -0.504 . . . . 71.010000000000005 109.639 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.32 115.95 17.53 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.962 0.887 . . . . 73.400000000000006 109.795 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 2.9 m -95.26 157.3 36.61 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.883 -1.508 . . . . 71.230000000000004 110.68 -171.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 6.1 Cg_exo -80.72 -142.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.641 2.227 . . . . 73.439999999999998 108.817 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.601 ' HA ' ' NE ' ' A' ' 529' ' ' ARG . 4.3 mmp_? -58.35 -49.78 91.69 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 113.481 0.919 . . . . 73.510000000000005 113.481 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.82 149.0 47.17 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.269 1.313 . . . . 73.109999999999999 111.455 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.86 145.97 26.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.254 -1.017 . . . . 62.109999999999999 108.254 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.48 -53.07 0.74 Allowed Glycine 0 N--CA 1.437 -1.274 0 C-N-CA 120.683 -0.77 . . . . 74.299999999999997 112.431 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.06 149.56 48.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.127 0.571 . . . . 52.109999999999999 111.965 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -73.49 127.65 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 121.486 0.66 . . . . 72.430000000000007 109.584 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -24.65 44.55 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.717 -1.128 . . . . 64.510000000000005 109.642 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.09 -146.38 16.63 Favored Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 111.311 -0.716 . . . . 61.439999999999998 111.311 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -116.19 160.07 20.91 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.487 -0.931 . . . . 72.439999999999998 108.487 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -53.74 -54.24 48.56 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 111.813 0.301 . . . . 71.319999999999993 111.813 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.4 Cg_endo -92.56 167.67 2.73 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.253 1.969 . . . . 64.230000000000004 110.179 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.95 155.6 57.35 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.466 2.11 . . . . 71.450000000000003 111.538 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 137.88 58.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.757 -0.46 . . . . 45.210000000000001 109.757 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.43 -19.11 34.62 Favored Glycine 0 C--N 1.294 -1.751 0 C-N-CA 120.023 -1.084 . . . . 72.25 111.717 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -65.64 123.14 18.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.484 -0.932 . . . . 61.109999999999999 108.484 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 16.8 m -94.87 122.48 37.55 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.703 -0.48 . . . . 73.450000000000003 109.703 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.74 159.19 69.48 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.662 -0.866 . . . . 63.420000000000002 108.662 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.2 Cg_exo -61.39 139.25 81.47 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.074 1.849 . . . . 52.43 111.339 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.63 -18.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.302 -0.863 . . . . 72.299999999999997 112.481 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.58 -9.55 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.16 -0.927 . . . . 63.399999999999999 109.78 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 45.1 m -92.34 152.1 19.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.217 -0.901 . . . . 51.340000000000003 110.795 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.463 ' HA ' ' HG2' ' A' ' 519' ' ' LYS . 39.5 t -88.38 133.53 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.261 -0.427 . . . . 70.109999999999999 110.869 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.2 tt -98.49 139.27 20.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.513 -0.551 . . . . 61.420000000000002 109.513 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.82 125.83 49.71 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 109.902 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.82 133.7 42.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.453 -0.943 . . . . 71.25 108.453 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -97.51 111.19 23.56 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.035 -1.098 . . . . 72.439999999999998 108.035 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.21 137.71 41.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 C-N-CA 120.532 -0.467 . . . . 75.430000000000007 111.996 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.2 m -68.02 117.67 10.18 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.353 -1.351 . . . . 54.200000000000003 107.353 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 8.1 ptmm? . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 118.516 -0.754 . . . . 72.209999999999994 112.341 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.756 0 N-CA-C 109.965 -1.254 . . . . 54.350000000000001 109.965 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.71 132.72 38.8 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.796 2.331 . . . . 74.439999999999998 111.866 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.15 31.06 6.32 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.164 0.507 . . . . 72.049999999999997 110.112 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 18.7 mp0 -83.9 147.21 27.64 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 119.683 -0.807 . . . . 74.430000000000007 109.384 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 7.9 tpp85 -143.26 161.16 39.03 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.137 -1.06 . . . . 63.310000000000002 108.137 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 9.5 pt-20 -82.23 140.29 33.76 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 123.582 0.753 . . . . 62.039999999999999 112.018 -172.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -96.67 126.89 41.47 Favored Pre-proline 0 N--CA 1.424 -1.735 0 N-CA-C 104.607 -2.368 . . . . 64.319999999999993 104.607 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.62 141.34 90.82 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.35 2.034 . . . . 73.209999999999994 114.381 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -100.76 -5.22 26.67 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.845 -1.07 . . . . 51.520000000000003 108.492 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.43 -4.68 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 122.542 1.163 . . . . 63.310000000000002 108.524 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.0 m -58.51 -31.98 68.4 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.922 -1.49 . . . . 72.109999999999999 109.283 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -57.14 -27.51 61.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.538 -1.21 . . . . 70.099999999999994 110.642 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.1 mt -89.99 -44.47 9.84 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.008 -0.677 . . . . 71.430000000000007 111.724 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.552 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 24.5 m -158.34 143.55 16.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.326 -0.859 . . . . 74.519999999999996 109.947 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.27 -45.92 79.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.848 0.459 . . . . 63.420000000000002 110.006 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.45 ' H ' HG22 ' A' ' 436' ' ' THR . . . -55.73 -35.27 65.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.901 -0.591 . . . . 75.349999999999994 111.782 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.552 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.0 mm-40 -70.79 -43.59 68.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.412 -0.358 . . . . 72.329999999999998 111.154 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.07 -51.22 70.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.363 -0.835 . . . . 71.450000000000003 110.554 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.87 -47.62 88.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 115.493 -0.776 . . . . 64.209999999999994 112.125 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -64.81 -42.91 94.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.677 -0.409 . . . . 73.420000000000002 111.629 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -66.44 -45.49 79.65 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.096 0.474 . . . . 74.299999999999997 110.176 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 34.6 tp -68.58 -37.35 79.78 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.767 -0.651 . . . . 73.329999999999998 111.065 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.9 m -64.62 -42.27 95.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 109.846 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.9 -15.45 62.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.967 -0.56 . . . . 52.130000000000003 110.921 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.574 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -81.14 -14.83 57.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.211 0.529 . . . . 64.209999999999994 110.098 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.31 58.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.298 -0.954 . . . . 73.400000000000006 113.652 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 90.6 m-85 -72.58 146.02 46.98 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.911 -0.774 . . . . 74.310000000000002 108.911 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.25 -7.01 2.31 Favored Glycine 0 C--N 1.303 -1.275 0 C-N-CA 120.006 -1.092 . . . . 73.120000000000005 112.656 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 483' ' ' VAL . 0.0 OUTLIER -102.5 115.42 30.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.859 -1.534 . . . . 61.310000000000002 106.859 -178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.08 149.37 50.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.175 0.512 . . . . 75.150000000000006 110.722 -173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.459 ' HB3' HG13 ' A' ' 485' ' ' ILE . 17.6 tppt? -138.64 123.02 18.3 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.537 -1.283 . . . . 73.25 107.537 169.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -102.74 134.85 45.45 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.331 0.586 . . . . 75.129999999999995 111.114 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.14 158.42 44.49 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.183 -1.043 . . . . 64.430000000000007 108.183 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -135.2 146.91 49.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.231 -1.026 . . . . 74.019999999999996 108.231 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 35.1 t -133.6 131.3 21.23 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.352 -0.981 . . . . 55.340000000000003 108.352 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.8 Cg_exo -65.87 120.89 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.775 1.65 . . . . 72.319999999999993 109.989 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.0 m -140.79 179.48 6.68 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 106.735 -1.58 . . . . 74.319999999999993 106.735 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -52.49 133.82 44.18 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.341 0.401 . . . . 65.219999999999999 111.581 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.481 ' O ' HG12 ' A' ' 464' ' ' VAL . 86.9 Cg_exo -50.45 -26.51 16.45 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 125.071 3.847 . . . . 72.319999999999993 113.05 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -57.27 -33.22 67.39 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.304 0.642 . . . . 53.520000000000003 110.568 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 93.9 mt -103.83 11.07 36.17 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.567 0.58 . . . . 74.120000000000005 112.567 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.3 p -61.21 128.15 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 119.927 -0.709 . . . . 74.140000000000001 110.595 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.13 77.69 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 120.887 -0.673 . . . . 52.039999999999999 112.163 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.7 mptp? -100.31 148.69 24.4 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.685 -0.857 . . . . 74.120000000000005 108.685 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 486' ' ' ILE . 58.5 t -81.93 125.35 39.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.758 -1.201 . . . . 70.129999999999995 107.758 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.92 -10.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 120.852 0.358 . . . . 74.200000000000003 111.386 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.22 149.04 8.06 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.176 -1.012 . . . . 71.239999999999995 112.193 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -119.03 140.48 49.97 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.494 -1.299 . . . . 73.430000000000007 107.494 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.514 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.6 t-20 -62.59 -53.83 53.56 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-O 118.963 -0.541 . . . . 75.420000000000002 111.765 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.1 Cg_exo -74.34 146.0 34.99 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 108.583 -1.353 . . . . 74.519999999999996 108.583 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.7 134.28 46.45 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.415 2.077 . . . . 72.200000000000003 112.918 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.63 6.44 47.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.481 1.134 . . . . 74.409999999999997 109.529 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.37 -21.87 13.75 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.279 -1.328 . . . . 63.020000000000003 109.278 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.7 155.54 39.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.225 -0.443 . . . . 64.439999999999998 111.413 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.7 p -83.99 123.91 30.49 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.653 -0.703 . . . . 74.140000000000001 109.516 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.8 m -115.59 150.74 36.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.716 -0.846 . . . . 60.520000000000003 108.716 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.99 151.21 46.51 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.24 0.216 . . . . 62.109999999999999 111.338 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.96 -17.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.83 0.852 . . . . 72.209999999999994 112.215 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.4 t -72.04 -6.05 39.55 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 116.44 -0.345 . . . . 72.519999999999996 110.851 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.95 131.1 35.75 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 122.633 0.373 . . . . 63.130000000000003 111.996 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 451' ' ' ARG . 6.6 p -83.79 123.57 38.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.867 -1.16 . . . . 61.240000000000002 107.867 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.34 118.18 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 C-N-CA 119.067 -1.053 . . . . 74.510000000000005 109.322 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.514 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -97.21 112.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.685 -1.969 . . . . 73.129999999999995 105.685 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.42 121.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 115.908 -0.587 . . . . 65.140000000000001 109.559 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.97 120.45 52.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.183 0.516 . . . . 75.400000000000006 109.894 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.0 t -96.05 140.32 17.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-N 115.694 -0.684 . . . . 72.25 109.19 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.31 114.03 3.85 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.368 -1.093 . . . . 72.049999999999997 110.368 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 40.6 t -98.84 133.56 42.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.013 -1.106 . . . . 43.299999999999997 108.013 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -105.48 118.61 5.86 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.915 -0.874 . . . . 75.400000000000006 110.915 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.67 142.52 29.06 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.383 2.055 . . . . 70.400000000000006 110.505 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -97.67 100.25 11.63 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.259 -1.015 . . . . 64.510000000000005 108.259 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 546' ' ' PRO . 33.7 p -131.55 143.9 50.71 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.429 -0.35 . . . . 71.310000000000002 110.534 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.84 164.59 27.23 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.07 -0.715 . . . . 63.030000000000001 109.07 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.17 134.02 35.77 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.06 -1.459 . . . . 73.340000000000003 107.06 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 517' ' ' PHE . 32.5 pt -76.65 132.49 71.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.67 -0.412 . . . . 74.109999999999999 110.251 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -91.42 178.46 1.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.763 2.309 . . . . 75.329999999999998 113.217 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.68 135.95 36.71 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.928 -1.138 . . . . 71.150000000000006 107.928 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.85 16.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.991 0.9 . . . . 42.439999999999998 109.407 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.48 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -68.06 132.43 47.24 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.899 -1.046 . . . . 41.140000000000001 111.801 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 117.91 -24.65 8.8 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.429 -0.891 . . . . 72.400000000000006 112.023 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.57 173.75 7.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.945 -0.761 . . . . 74.049999999999997 108.945 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 9.8 p -80.01 156.94 26.92 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.486 -0.486 . . . . 55.009999999999998 111.504 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.76 -42.26 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 O-C-N 123.838 0.712 . . . . 71.209999999999994 112.181 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.64 -39.44 80.71 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 121.017 -0.273 . . . . 64.099999999999994 111.592 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 83.8 t -71.1 -44.04 75.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.442 0.639 . . . . 63.520000000000003 110.827 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.08 -47.83 81.23 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 74.209999999999994 111.628 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.81 -35.62 81.68 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 121.042 -0.263 . . . . 71.310000000000002 110.579 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.7 OUTLIER -65.14 -51.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.206 -0.664 . . . . 52.149999999999999 109.206 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.7 -37.8 87.92 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.96 -0.564 . . . . 65.239999999999995 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.67 -45.47 71.64 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.818 -0.628 . . . . 74.420000000000002 109.451 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.29 -41.27 88.53 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.033 0.753 . . . . 72.530000000000001 113.033 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.3 t -64.23 -31.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 111.655 -177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.81 15.91 11.8 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.993 -0.283 . . . . 74.230000000000004 110.72 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.8 -98.08 0.2 Allowed Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 117.281 -2.39 . . . . 42.119999999999997 117.426 -169.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.667 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 78.1 m-85 -121.89 152.83 39.19 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.145 0.497 . . . . 74.549999999999997 111.791 -164.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.9 m -96.19 -27.48 15.01 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.02 -0.991 . . . . 62.420000000000002 111.871 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.75 134.66 51.16 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.156 -0.34 . . . . 64.200000000000003 110.09 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.77 145.53 51.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.347 0.594 . . . . 75.329999999999998 111.009 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.3 m -141.11 144.6 34.98 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.873 -1.529 . . . . 71.450000000000003 106.873 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 553' ' ' LEU . 13.2 mm-40 -121.26 127.41 51.36 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.119 -1.067 . . . . 72.400000000000006 108.119 -172.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.436 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -114.28 133.45 55.64 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.991 -1.114 . . . . 64.209999999999994 107.991 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.7 m -88.55 130.81 35.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.165 0.507 . . . . 22.210000000000001 110.718 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.25 162.82 21.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 105.033 -2.21 . . . . 72.409999999999997 105.033 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.75 131.9 36.04 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 118.872 0.76 . . . . 61.149999999999999 111.991 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 66.4 p -77.04 150.38 80.88 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.946 -1.025 . . . . 75.400000000000006 109.215 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.52 -47.4 7.52 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.021 1.814 . . . . 71.5 110.512 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 20.4 mmt180 -163.2 -58.83 0.01 OUTLIER Pre-proline 0 C--O 1.222 -0.348 0 C-N-CA 127.316 2.246 . . . . 74.209999999999994 109.411 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 527' ' ' SER . 30.5 Cg_endo -66.85 135.96 39.99 Favored 'Trans proline' 0 C--N 1.36 1.137 0 N-CA-C 109.091 -1.157 . . . . 62.409999999999997 109.091 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.34 157.85 38.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.297 0.373 . . . . 54.219999999999999 110.145 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 115.13 -18.67 15.89 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 121.131 -0.557 . . . . 61.119999999999997 112.192 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 0.3 OUTLIER -87.36 148.46 25.02 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.253 0.549 . . . . 74.329999999999998 111.336 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 501' ' ' ALA . 11.4 p -81.26 128.87 38.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.822 -0.807 . . . . 73.430000000000007 108.822 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -78.44 -31.2 47.95 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.775 -0.824 . . . . 65.239999999999995 108.775 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.09 -157.29 28.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.16 -1.176 . . . . 52.329999999999998 110.16 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.4 p -117.56 160.77 20.7 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.154 -1.054 . . . . 70.420000000000002 108.154 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 64.4 t30 -58.67 -51.26 83.09 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 119.979 -0.688 . . . . 71.109999999999999 111.167 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.3 Cg_exo -81.53 155.73 18.68 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 121.33 1.353 . . . . 53.340000000000003 109.835 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.64 149.98 56.05 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.373 2.049 . . . . 65.140000000000001 112.025 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.18 129.89 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.353 0.661 . . . . 72.25 110.045 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -7.06 36.33 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.573 -0.822 . . . . 63.299999999999997 111.834 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.1 m -77.13 133.92 38.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.451 -0.574 . . . . 71.420000000000002 109.451 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.9 t -100.81 127.33 47.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.251 0.548 . . . . 73.430000000000007 110.312 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 517' ' ' PHE . 11.2 m -138.76 162.08 54.84 Favored Pre-proline 0 C--O 1.248 1.018 0 N-CA-C 109.331 -0.618 . . . . 72.140000000000001 109.331 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.4 Cg_exo -63.84 135.03 46.23 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.483 2.122 . . . . 72.239999999999995 112.373 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.667 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 11.3 m -67.29 -21.12 27.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.699 0.762 . . . . 64.099999999999994 112.381 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.27 -7.96 55.95 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.602 -1.181 . . . . 64.010000000000005 109.324 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -92.14 179.0 5.69 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.432 -0.804 . . . . 70.209999999999994 110.764 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.31 124.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.84 -0.618 . . . . 64.340000000000003 112.365 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.3 tp -94.1 123.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 106.476 -1.676 . . . . 72.310000000000002 106.476 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.64 116.74 32.91 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-O 120.894 0.378 . . . . 72.430000000000007 110.082 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.614 ' HB2' ' OE1' ' A' ' 522' ' ' GLN . 6.1 mp -98.72 134.37 41.73 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.169 -0.923 . . . . 70.239999999999995 110.621 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 9.0 mm-40 -92.06 109.84 21.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.66 -1.978 . . . . 73.450000000000003 105.66 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.3 m -105.73 137.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 112.515 0.561 . . . . 71.310000000000002 112.515 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 49.5 m -72.72 114.53 10.96 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.577 0.703 . . . . 61.310000000000002 110.312 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 557' ' ' LYS . 7.3 tmtm? . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.046 -1.464 . . . . 71.420000000000002 107.046 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.3 0 N-CA-C 110.108 -1.197 . . . . 63.520000000000003 110.108 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 156.24 65.62 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.649 2.233 . . . . 62.200000000000003 111.959 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -107.55 20.7 18.52 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.992 0.901 . . . . 64.340000000000003 108.724 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.3 mt-30 -87.53 120.97 29.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.111 -0.95 . . . . 64.140000000000001 110.862 -174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -120.66 166.38 13.76 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.698 0.761 . . . . 65.530000000000001 110.536 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -84.38 140.3 31.66 Favored 'General case' 0 C--N 1.266 -3.053 0 CA-C-N 113.628 -1.623 . . . . 74.329999999999998 109.421 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.22 126.81 78.38 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 106.791 -1.559 . . . . 54.530000000000001 106.791 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.13 141.74 70.97 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.493 2.129 . . . . 71.219999999999999 112.399 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -112.41 70.64 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.532 1.158 . . . . 63.439999999999998 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.51 6.74 4.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 123.886 1.803 . . . . 65.5 106.226 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 0.7 OUTLIER -62.71 -30.97 71.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.32 -2.218 . . . . 73.109999999999999 109.308 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.0 m -58.37 -28.24 64.96 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 125.821 1.649 . . . . 64.25 110.642 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.5 -45.3 9.04 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.449 -0.501 . . . . 71.219999999999999 112.107 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.7 m -163.65 150.66 12.23 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.754 -0.832 . . . . 72.0 108.754 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 441' ' ' VAL . 32.7 t80 -53.08 -54.89 28.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.539 0.524 . . . . 74.230000000000004 110.704 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.7 -36.57 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 112.117 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -61.48 -45.77 92.83 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 112.313 0.486 . . . . 64.400000000000006 112.313 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -65.3 -44.58 87.49 Favored 'General case' 0 CA--C 1.498 -1.049 0 O-C-N 123.68 0.613 . . . . 71.319999999999993 109.727 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.422 HG21 ' CZ ' ' A' ' 437' ' ' TYR . 90.8 t -59.02 -46.82 91.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.436 0 CA-C-N 115.368 -0.833 . . . . 53.219999999999999 111.629 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.9 mmpt? -60.28 -47.03 87.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.824 0.284 . . . . 74.030000000000001 110.966 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.72 -38.95 87.71 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.937 -0.305 . . . . 63.549999999999997 111.244 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 25.8 tp -67.04 -41.27 86.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.16 0.505 . . . . 75.519999999999996 110.092 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.9 m -61.07 -45.27 95.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.998 -1.001 . . . . 64.109999999999999 109.022 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.96 62.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.68 -0.691 . . . . 74.129999999999995 111.718 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.28 -13.12 57.49 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.193 0.521 . . . . 74.530000000000001 110.724 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.93 20.35 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 120.665 -0.779 . . . . 64.239999999999995 112.3 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.4 m-85 -69.23 118.08 11.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.53 -0.545 . . . . 74.239999999999995 109.53 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -106.72 -15.71 16.09 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.63 -0.714 . . . . 74.230000000000004 111.483 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -109.45 114.01 27.29 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.954 0.883 . . . . 73.049999999999997 110.344 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.7 154.46 40.6 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.665 -1.152 . . . . 54.149999999999999 111.208 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -131.33 125.45 32.76 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.16 -0.681 . . . . 72.209999999999994 109.16 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -88.69 121.02 30.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.981 0.419 . . . . 72.230000000000004 110.744 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.39 153.5 32.95 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 71.549999999999997 107.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.48 147.62 49.8 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.775 -0.824 . . . . 75.219999999999999 108.775 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.4 t -137.21 138.24 24.79 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 108.816 -0.809 . . . . 74.519999999999996 108.816 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 490' ' ' SER . 25.9 Cg_exo -64.81 122.16 9.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 72.120000000000005 110.182 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -137.52 179.75 6.22 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.929 -1.137 . . . . 63.149999999999999 107.929 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.6 t -65.27 144.03 98.92 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.047 -0.723 . . . . 75.409999999999997 109.047 174.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.36 -28.03 25.82 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.571 3.514 . . . . 75.450000000000003 112.464 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -59.01 -34.44 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 123.393 0.677 . . . . 73.420000000000002 111.442 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.98 4.75 49.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.066 1.135 . . . . 63.329999999999998 114.066 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 79.5 t -60.5 130.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.152 0.501 . . . . 54.420000000000002 112.325 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.94 84.72 Favored Glycine 0 CA--C 1.504 -0.644 0 CA-C-N 115.252 -0.886 . . . . 72.129999999999995 112.646 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.07 151.62 38.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.838 -0.43 . . . . 62.340000000000003 109.838 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 486' ' ' ILE . 46.7 t -81.93 134.25 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.687 -0.857 . . . . 71.230000000000004 108.687 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.46 -24.36 4.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.59 -0.444 . . . . 62.039999999999999 111.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.85 168.05 38.17 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.684 -0.77 . . . . 51.450000000000003 111.952 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.3 p -121.03 153.13 37.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.668 -0.493 . . . . 72.209999999999994 109.668 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 23.2 t-20 -68.49 -52.74 19.17 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 119.299 -0.381 . . . . 72.340000000000003 111.272 174.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.76 129.64 10.08 Favored 'Trans proline' 0 C--N 1.365 1.418 0 CA-C-N 120.202 1.108 . . . . 54.32 109.605 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.437 ' HB2' ' NE2' ' A' ' 476' ' ' GLN . 28.9 Cg_endo -64.67 129.89 24.83 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.323 2.015 . . . . 75.230000000000004 112.25 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 0.71 30.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.755 0.788 . . . . 51.140000000000001 111.605 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.99 -1.004 . . . . 52.219999999999999 109.165 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.607 ' N ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -129.79 157.84 41.08 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.109 -1.071 . . . . 71.430000000000007 108.109 177.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 37.4 p -86.72 123.67 32.13 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.997 -0.371 . . . . 73.519999999999996 109.997 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 50.4 m -108.58 145.18 35.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.395 -0.594 . . . . 71.439999999999998 109.395 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.26 153.2 43.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.152 -0.477 . . . . 70.400000000000006 110.781 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.87 -21.83 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.729 0.811 . . . . 73.450000000000003 110.7 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -76.66 9.09 3.0 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 116.037 -0.529 . . . . 74.209999999999994 111.944 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -98.6 145.83 26.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.378 0.271 . . . . 61.119999999999997 111.151 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.52 119.52 35.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.876 -1.157 . . . . 71.25 107.876 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 71.0 t -87.62 118.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 118.992 -1.083 . . . . 62.43 108.617 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 66.0 mt -94.86 114.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.795 -1.557 . . . . 72.209999999999994 106.795 176.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.27 128.36 59.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 115.656 -0.702 . . . . 72.230000000000004 109.488 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 38.1 mt -106.53 118.97 55.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 116.08 -0.509 . . . . 65.439999999999998 110.549 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.63 145.87 8.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.752 -0.658 . . . . 73.010000000000005 109.548 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -87.76 123.49 6.68 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.069 -0.812 . . . . 72.0 111.069 176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.8 m -123.6 137.61 54.71 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.414 -0.958 . . . . 55.299999999999997 108.414 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -100.78 144.49 16.7 Favored Glycine 0 C--N 1.314 -0.681 0 C-N-CA 120.541 -0.838 . . . . 70.209999999999994 112.827 -175.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.84 116.2 4.46 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.01 2.473 . . . . 72.340000000000003 111.744 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -72.25 95.49 1.7 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.851 0.834 . . . . 63.240000000000002 111.483 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -134.67 154.39 51.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.206 -0.906 . . . . 74.409999999999997 110.85 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.49 149.6 30.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.869 -0.419 . . . . 71.239999999999995 109.869 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -90.58 139.14 30.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -96.19 138.44 21.59 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.777 -0.647 . . . . 65.239999999999995 112.019 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.25 171.26 11.46 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.522 2.148 . . . . 55.009999999999998 111.037 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -85.53 132.99 34.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.202 0.525 . . . . 73.129999999999995 110.174 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.73 11.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.962 0.887 . . . . 74.230000000000004 109.182 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.37 155.24 22.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.786 -0.643 . . . . 64.239999999999995 110.192 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 97.71 -13.26 64.08 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.539 -1.425 . . . . 63.140000000000001 109.539 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -94.53 179.65 5.2 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.438 -1.319 . . . . 74.430000000000007 107.438 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.0 m -83.67 155.28 23.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.718 -1.216 . . . . 61.229999999999997 107.718 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.8 -42.95 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.24 -42.55 75.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.058 0.392 . . . . 70.129999999999995 112.058 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -75.08 -35.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.551 -0.86 . . . . 72.400000000000006 111.036 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.437 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.85 -48.18 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.273 -0.876 . . . . 73.340000000000003 111.354 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.44 -34.74 78.89 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 121.249 -0.18 . . . . 75.0 110.969 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -64.67 -49.1 72.31 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.111 -0.329 . . . . 74.319999999999993 110.111 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.77 -46.52 81.79 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.242 0.544 . . . . 62.219999999999999 110.377 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.8 -36.58 81.53 Favored 'General case' 0 C--O 1.181 -2.551 0 CA-C-N 115.113 -0.949 . . . . 72.5 110.855 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.98 -39.28 81.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.246 0.546 . . . . 73.219999999999999 110.4 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.33 -34.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.496 -0.775 . . . . 65.420000000000002 111.336 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -111.27 11.3 21.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.566 0.698 . . . . 73.319999999999993 111.802 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.87 -111.97 1.33 Allowed Glycine 0 N--CA 1.417 -2.593 0 CA-C-N 115.412 -0.813 . . . . 41.130000000000003 111.893 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 37.1 m-85 -133.16 -177.15 4.39 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.542 -0.54 . . . . 72.439999999999998 109.542 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -106.98 -7.95 16.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.647 0.737 . . . . 62.43 109.729 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -108.11 115.99 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.863 -0.608 . . . . 63.329999999999998 110.061 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -126.25 151.49 47.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.785 0.802 . . . . 75.239999999999995 112.366 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.8 m -136.87 151.67 49.36 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.202 -1.407 . . . . 51.299999999999997 107.202 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.538 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.7 mm-40 -121.33 131.14 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.38 -0.6 . . . . 74.010000000000005 109.38 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.5 130.96 56.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.374 -0.602 . . . . 72.430000000000007 109.374 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 15.3 m -93.55 120.82 34.29 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.99 -0.745 . . . . 60.530000000000001 108.99 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.5 m -122.01 162.29 21.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 74.129999999999995 108.157 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . 0.262 13.8 m-20 -82.39 141.85 32.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.943 1.46 . . . . 74.439999999999998 114.943 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 2.7 m -97.55 144.03 27.24 Favored Pre-proline 0 C--N 1.28 -2.45 0 CA-C-N 113.425 -1.716 . . . . 63.219999999999999 109.016 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.94 -69.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 107.939 -1.6 . . . . 65.200000000000003 107.939 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.475 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 36.5 mmt180 -118.39 -59.4 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 118.494 -0.765 . . . . 75.329999999999998 112.291 170.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 527' ' ' SER . 54.7 Cg_endo -69.15 136.79 35.56 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 121.454 1.436 . . . . 71.439999999999998 111.811 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.08 123.03 16.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.861 -0.792 . . . . 65.319999999999993 108.861 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.08 -18.45 6.58 Favored Glycine 0 C--N 1.296 -1.662 0 N-CA-C 109.388 -1.485 . . . . 55.140000000000001 109.388 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -79.09 147.42 32.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.245 -0.977 . . . . 72.329999999999998 109.542 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 553' ' ' LEU . 58.7 t -76.16 115.54 17.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 107.971 -1.122 . . . . 72.200000000000003 107.971 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 16.9 m -78.26 -24.83 46.68 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.65 -0.704 . . . . 75.409999999999997 109.544 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.54 -175.39 43.16 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.84 -0.904 . . . . 51.229999999999997 110.84 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.3 p -119.69 158.55 26.24 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.013 -1.477 . . . . 73.439999999999998 107.013 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.2 t-20 -59.43 -53.14 68.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 120.292 -0.563 . . . . 73.450000000000003 111.609 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.6 Cg_endo -86.81 147.71 8.25 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 121.21 1.273 . . . . 61.0 109.172 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.63 153.01 65.2 Favored 'Trans proline' 0 C--O 1.245 0.825 0 C-N-CA 122.022 1.815 . . . . 73.129999999999995 112.279 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 129.49 40.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.87 -0.605 . . . . 72.319999999999993 109.488 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.34 -19.08 37.73 Favored Glycine 0 C--N 1.304 -1.225 0 C-N-CA 121.122 -0.561 . . . . 75.420000000000002 111.744 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 87.5 m -75.03 132.42 41.31 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.915 0.388 . . . . 54.140000000000001 110.386 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 29.1 m -91.05 123.72 34.73 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.79 -0.819 . . . . 64.349999999999994 108.79 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.67 160.98 63.76 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.159 -0.682 . . . . 74.530000000000001 109.159 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.39 134.69 49.64 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.275 1.983 . . . . 63.409999999999997 112.356 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.6 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 15.7 m -67.56 -19.87 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 122.434 1.111 . . . . 53.200000000000003 110.56 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.76 -13.71 58.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.599 -1.637 . . . . 54.340000000000003 109.307 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 64.1 m -93.25 169.43 10.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.074 -0.966 . . . . 73.319999999999993 111.865 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.35 133.48 44.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.964 -0.562 . . . . 62.130000000000003 110.188 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.8 tt -102.87 137.25 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.208 0.528 . . . . 64.409999999999997 110.015 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 24.9 tt0 -103.79 129.71 51.24 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 116.076 -0.511 . . . . 72.129999999999995 110.355 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.538 ' HB3' ' OE1' ' A' ' 522' ' ' GLN . 6.4 tt -102.41 127.09 49.58 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.255 -1.387 . . . . 75.420000000000002 107.255 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -104.07 106.98 17.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.778 0.799 . . . . 71.299999999999997 109.28 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.62 138.02 37.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 114.831 -1.077 . . . . 64.430000000000007 111.793 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.497 ' HB2' ' OG ' ' A' ' 527' ' ' SER . 13.5 p -65.03 122.56 17.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 62.340000000000003 109.997 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 524' ' ' SER . 22.6 pttp . . . . . 0 C--O 1.259 1.564 0 CA-C-N 116.466 -0.334 . . . . 72.310000000000002 111.779 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.98 0 N-CA-C 109.7 -1.36 . . . . 44.509999999999998 109.7 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.54 132.98 30.59 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.159 1.906 . . . . 51.140000000000001 111.325 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 10.6 pt-20 -93.9 -4.92 49.05 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 60.039999999999999 109.935 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -114.28 133.04 55.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.552 -1.204 . . . . 74.109999999999999 109.022 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.597 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -120.51 161.51 21.17 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 108.109 -1.071 . . . . 73.319999999999993 108.109 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.84 141.6 32.15 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.369 0.668 . . . . 73.540000000000006 110.301 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.586 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.68 130.9 66.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 106.825 -1.546 . . . . 71.200000000000003 106.825 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.408 ' HB3' ' HD3' ' A' ' 443' ' ' LYS . 85.5 Cg_exo -53.47 140.95 63.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.097 2.531 . . . . 61.43 113.931 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.53 -2.78 57.91 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.021 -0.99 . . . . 73.230000000000004 110.258 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.84 8.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.766 0.793 . . . . 72.209999999999994 110.832 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.3 p -61.39 -42.23 98.39 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.536 1.534 . . . . 75.140000000000001 110.832 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 7.1 p -66.34 -25.59 66.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.742 -1.117 . . . . 54.219999999999999 111.867 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.37 -46.31 17.86 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.26 -0.576 . . . . 64.420000000000002 110.297 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.9 m -169.59 147.15 3.47 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.058 -1.09 . . . . 74.140000000000001 108.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 441' ' ' VAL . 25.5 t80 -50.75 -49.13 58.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.657 0.783 . . . . 74.230000000000004 110.296 171.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -57.53 -35.86 70.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.652 -0.704 . . . . 41.399999999999999 111.871 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.544 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.6 mm-40 -70.66 -40.38 73.04 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.095 0.474 . . . . 75.420000000000002 110.857 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -46.38 90.09 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.169 -0.923 . . . . 70.230000000000004 110.364 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 437' ' ' TYR . 90.1 t -58.64 -47.41 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.45 -0.796 . . . . 63.100000000000001 111.961 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 61.7 mttp -62.91 -48.84 77.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.822 0.344 . . . . 70.510000000000005 110.439 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 430' ' ' PRO . 49.2 tttp -68.27 -38.44 81.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.579 -0.737 . . . . 53.130000000000003 111.259 -176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 35.4 tp -68.47 -40.33 81.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.15 0.5 . . . . 74.329999999999998 109.983 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 38.6 m -60.93 -45.81 93.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.442 -0.799 . . . . 71.319999999999993 109.884 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.97 62.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.712 -0.676 . . . . 72.129999999999995 111.226 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.401 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -80.18 -13.75 59.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.648 0.261 . . . . 64.120000000000005 110.358 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.25 -5.29 49.03 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.347 -0.93 . . . . 65.329999999999998 114.203 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 76.7 m-85 -62.96 139.12 58.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.866 0.333 . . . . 72.299999999999997 111.226 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.45 -2.93 9.66 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.39 -0.91 . . . . 72.109999999999999 113.37 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -119.31 115.63 24.54 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.527 -0.916 . . . . 74.349999999999994 108.527 -177.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -132.45 151.12 52.01 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.943 0.401 . . . . 74.129999999999995 110.161 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 485' ' ' ILE . 61.8 tttp -139.6 122.62 16.75 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.251 -1.759 . . . . 74.209999999999994 106.251 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.84 135.08 42.85 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.88 -0.328 . . . . 64.329999999999998 110.244 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.95 155.17 50.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.494 -0.928 . . . . 54.039999999999999 108.494 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.431 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.5 p30 -133.9 138.53 45.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.679 -1.23 . . . . 73.219999999999999 107.679 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 t -134.98 143.54 46.56 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 108.849 -0.797 . . . . 73.030000000000001 108.849 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.68 122.19 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.142 1.895 . . . . 71.409999999999997 109.114 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.4 m -133.3 179.64 6.07 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.309 -0.86 . . . . 53.200000000000003 109.491 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -61.07 135.16 93.21 Favored Pre-proline 0 N--CA 1.417 -2.117 0 C-N-CA 123.755 0.822 . . . . 73.099999999999994 108.935 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 89.3 Cg_exo -50.64 -29.98 27.11 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.097 3.198 . . . . 65.209999999999994 115.123 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -75.76 -22.8 56.13 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.728 -0.789 . . . . 73.340000000000003 112.501 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.14 4.89 51.04 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.598 0.592 . . . . 65.310000000000002 112.598 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 15.0 p -61.2 127.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 C-N-CA 120.097 -0.641 . . . . 43.43 109.874 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.52 -6.05 77.53 Favored Glycine 0 C--N 1.308 -0.989 0 CA-C-N 115.595 -0.729 . . . . 51.109999999999999 113.169 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -110.0 157.14 19.61 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.61 -0.885 . . . . 75.209999999999994 108.61 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 486' ' ' ILE . 48.9 t -82.26 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.844 -1.169 . . . . 52.020000000000003 107.844 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 34.9 pt -97.74 -20.41 5.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.21 -0.596 . . . . 63.439999999999998 109.688 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.54 155.24 14.64 Favored Glycine 0 N--CA 1.409 -3.132 0 C-N-CA 120.015 -1.088 . . . . 74.0 112.425 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.9 p -119.56 154.28 34.13 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.263 -1.754 . . . . 71.430000000000007 106.263 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 41.7 t-20 -65.12 -55.0 29.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 C-N-CA 119.975 -0.69 . . . . 62.140000000000001 110.625 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.73 126.94 9.21 Favored 'Trans proline' 0 C--N 1.365 1.428 0 N-CA-C 108.947 -1.213 . . . . 51.43 108.947 173.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.46 143.46 76.05 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.464 2.109 . . . . 62.229999999999997 112.264 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.27 4.58 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.183 0.992 . . . . 73.25 110.692 -176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -101.4 -9.28 21.27 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.456 -1.247 . . . . 72.129999999999995 109.471 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -122.27 167.48 13.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.517 -0.92 . . . . 74.409999999999997 108.517 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 30.6 p -98.03 143.43 28.59 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 109.619 -0.511 . . . . 71.409999999999997 109.619 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.6 m -128.98 147.41 50.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.016 -0.735 . . . . 73.349999999999994 109.016 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -54.52 153.39 5.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.586 0.958 . . . . 71.109999999999999 113.586 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.59 -32.29 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 110.241 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 36.39 4.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.779 1.276 . . . . 72.430000000000007 110.222 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 19.2 t-20 -88.33 145.63 25.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 105.028 -2.212 . . . . 71.140000000000001 105.028 173.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.88 111.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.55 -1.26 . . . . 73.510000000000005 111.074 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.45 118.51 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.993 -1.114 . . . . 73.0 107.993 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.5 mp -95.23 112.69 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 72.140000000000001 106.286 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.79 118.39 50.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 109.481 -0.562 . . . . 73.549999999999997 109.481 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -100.07 121.68 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.393 -0.595 . . . . 62.030000000000001 109.393 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 134.02 35.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.36 115.73 5.21 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 109.82 -1.312 . . . . 71.099999999999994 109.82 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 456' ' ' ASN . 12.1 m -113.07 130.2 56.24 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.208 -0.664 . . . . 75.319999999999993 109.208 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 492' ' ' PRO . . . -89.36 131.5 10.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 119.198 -0.779 . . . . 23.329999999999998 111.398 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 25.5 Cg_exo -65.34 122.87 10.69 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.835 2.356 . . . . 75.519999999999996 112.394 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 547' ' ' VAL . . . -75.43 95.82 3.33 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.254 1.026 . . . . 63.049999999999997 108.696 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 546' ' ' PRO . 7.5 p -132.58 157.33 45.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.815 -1.084 . . . . 71.420000000000002 109.901 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 140.1 22.86 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.336 -0.987 . . . . 73.230000000000004 108.336 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.3 p-10 -89.78 136.08 33.25 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.305 -1.368 . . . . 72.099999999999994 107.305 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 541' ' ' ALA . 29.2 pt -81.97 134.99 48.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 116.071 -0.513 . . . . 73.219999999999999 112.367 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.54 -175.39 1.26 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.965 2.443 . . . . 74.420000000000002 112.08 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -91.22 95.39 10.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.289 0.566 . . . . 70.510000000000005 109.895 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.26 -3.86 10.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.828 0.823 . . . . 62.100000000000001 108.996 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.56 55.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.162 -1.381 . . . . 71.319999999999993 110.036 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.22 -16.72 38.29 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 111.001 -0.84 . . . . 53.140000000000001 111.001 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -97.92 -175.35 3.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.557 -0.905 . . . . 75.25 108.557 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.9 m -79.17 155.01 28.84 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.724 -0.843 . . . . 63.240000000000002 108.724 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.534 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 6.9 p -53.71 -45.65 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 123.608 0.568 . . . . 71.329999999999998 112.116 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.9 -41.96 77.54 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.76 0.652 . . . . 73.219999999999999 112.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.7 -37.41 35.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 119.946 -0.702 . . . . 61.310000000000002 111.788 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.05 91.25 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.082 -0.508 . . . . 71.299999999999997 111.202 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -65.26 -35.51 81.25 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.795 -0.362 . . . . 71.340000000000003 110.68 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 514' ' ' VAL . 19.5 mmtp -59.83 -50.49 73.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.165 0.432 . . . . 73.120000000000005 112.165 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -62.37 -38.66 90.42 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.915 0.388 . . . . 63.210000000000001 110.91 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.09 -46.28 71.42 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.632 -0.713 . . . . 74.310000000000002 109.906 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.3 t-20 -59.15 -48.03 83.1 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 124.025 0.93 . . . . 70.209999999999994 112.066 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.3 t -60.89 -28.67 43.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.822 -0.626 . . . . 73.530000000000001 112.031 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.72 13.15 9.96 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.477 -0.889 . . . . 73.239999999999995 111.366 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -154.01 -88.78 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.44 0 C-N-CA 117.581 -2.247 . . . . 72.120000000000005 117.276 -170.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 55.7 m-85 -117.96 151.27 37.77 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.494 -0.353 . . . . 74.540000000000006 111.008 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 8.6 m -107.52 -25.72 11.25 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.081 -0.509 . . . . 74.230000000000004 110.673 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.3 126.29 52.66 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.32 -0.622 . . . . 75.349999999999994 109.32 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -128.4 144.11 51.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 110.853 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.4 m -121.79 153.59 38.1 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.005 -1.48 . . . . 74.450000000000003 107.005 172.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -127.2 129.36 47.67 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.116 -0.634 . . . . 63.020000000000003 110.833 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -117.57 144.03 45.52 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.225 -1.398 . . . . 74.230000000000004 107.225 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -101.86 135.36 43.54 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.971 0.415 . . . . 72.0 111.379 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 18.5 m -121.94 149.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.71 -1.219 . . . . 75.439999999999998 107.71 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.25 118.5 20.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.42 -0.585 . . . . 73.239999999999995 109.42 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 556' ' ' SER . 82.7 p -90.98 162.85 31.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 113.58 0.956 . . . . 51.119999999999997 113.58 -170.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -71.8 -138.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.548 2.832 . . . . 71.319999999999993 109.468 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -68.87 -53.45 14.85 Favored Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 113.082 0.771 . . . . 75.129999999999995 113.082 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.6 150.88 36.22 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 121.451 1.434 . . . . 73.530000000000001 112.062 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -149.9 145.69 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.682 -0.858 . . . . 50.409999999999997 108.682 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.11 -20.77 5.89 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 111.28 -0.728 . . . . 74.340000000000003 111.28 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 148.75 25.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.069 -0.345 . . . . 52.450000000000003 110.069 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.7 t -74.57 115.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.596 -1.631 . . . . 74.129999999999995 106.596 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.2 m -72.0 -33.27 67.96 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 109.824 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.93 -165.04 36.62 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 110.59 -1.004 . . . . 74.010000000000005 110.59 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.9 p -125.0 160.83 28.08 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 107.777 -1.194 . . . . 60.420000000000002 107.777 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 63.8 t30 -59.82 -51.13 82.96 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 119.757 -0.777 . . . . 74.129999999999995 111.27 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.1 Cg_exo -77.52 145.2 23.27 Favored 'Trans proline' 0 C--N 1.367 1.512 0 N-CA-C 108.832 -1.257 . . . . 71.209999999999994 108.832 171.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.2 Cg_exo -70.54 152.09 65.05 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.188 1.925 . . . . 63.520000000000003 111.9 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -55.38 137.07 48.78 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.028 0.531 . . . . 71.329999999999998 110.765 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.68 -20.34 46.63 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 121.102 -0.57 . . . . 32.350000000000001 112.023 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 29.6 m -73.44 135.4 44.14 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.841 -0.211 . . . . 52.100000000000001 110.566 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 35.5 m -96.98 123.36 40.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.581 -0.525 . . . . 63.25 109.581 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.4 164.17 43.01 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 109.209 -0.663 . . . . 74.209999999999994 109.209 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.495 ' HA ' HG22 ' A' ' 494' ' ' THR . 7.4 Cg_exo -71.92 133.55 21.89 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 73.310000000000002 111.27 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.6 m -68.8 -20.88 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 70.519999999999996 111.141 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.8 -16.72 60.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.408 -1.269 . . . . 64.200000000000003 110.501 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.2 t -97.08 161.17 13.94 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.005 -0.739 . . . . 72.109999999999999 109.005 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.47 134.89 26.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.259 -0.645 . . . . 50.0 109.259 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -105.19 141.01 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.011 0.434 . . . . 51.219999999999999 110.577 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -103.08 121.56 42.86 Favored 'General case' 0 N--CA 1.406 -2.63 0 C-N-CA 123.525 0.73 . . . . 72.120000000000005 110.433 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.01 134.27 42.09 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 124.211 1.004 . . . . 52.340000000000003 110.015 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -92.27 108.25 19.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.859 -1.163 . . . . 71.209999999999994 107.859 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.82 138.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.798 -0.637 . . . . 71.340000000000003 110.33 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 527' ' ' SER . 6.2 p -65.91 119.55 11.5 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.129 0.966 . . . . 74.049999999999997 113.585 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 29.1 tttm . . . . . 0 C--O 1.262 1.763 0 C-N-CA 125.691 1.596 . . . . 74.209999999999994 108.431 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.655 0 N-CA-C 110.281 -1.128 . . . . 72.219999999999999 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.15 155.93 66.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.502 2.135 . . . . 34.229999999999997 111.502 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.0 OUTLIER -101.63 4.0 40.4 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.271 1.034 . . . . 63.030000000000001 108.443 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -107.69 137.92 44.84 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.986 -1.461 . . . . 73.219999999999999 109.662 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.15 156.12 40.62 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.947 -1.131 . . . . 63.039999999999999 107.947 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.6 OUTLIER -83.08 141.89 31.68 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 123.524 0.73 . . . . 55.119999999999997 111.393 -176.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -85.2 121.17 73.95 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.431 -0.951 . . . . 64.299999999999997 108.431 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.22 143.36 39.51 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.033 1.822 . . . . 72.019999999999996 112.253 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.66 32.24 0.59 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.778 0.799 . . . . 63.549999999999997 111.851 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.06 -12.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.863 -1.162 . . . . 74.120000000000005 107.863 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 11.6 m -60.49 -36.66 78.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.168 -1.378 . . . . 62.420000000000002 109.265 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -57.03 -27.74 61.9 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.217 -1.356 . . . . 75.209999999999994 110.465 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.59 -46.64 12.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.626 -0.43 . . . . 73.150000000000006 110.688 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 438' ' ' ALA . 40.5 m -166.47 149.05 6.81 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.201 -0.666 . . . . 63.539999999999999 109.201 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.54 -46.88 63.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.217 1.007 . . . . 73.219999999999999 110.374 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.513 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 73.340000000000003 111.365 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.49 -36.92 74.09 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.99 -0.55 . . . . 75.150000000000006 111.764 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.45 -52.37 64.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 124.342 1.026 . . . . 72.510000000000005 110.435 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 67.3 t -66.8 -50.64 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 115.129 -0.942 . . . . 65.030000000000001 111.808 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -62.49 -45.37 93.34 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.767 0.654 . . . . 71.340000000000003 112.767 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -68.5 -40.81 80.74 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.873 -0.731 . . . . 64.340000000000003 110.933 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.51 -33.87 74.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.055 0.455 . . . . 44.009999999999998 109.813 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 37.1 m -59.68 -45.04 93.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.465 -0.789 . . . . 75.420000000000002 109.215 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.07 -16.81 62.61 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.726 -0.67 . . . . 63.219999999999999 111.159 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.16 -13.78 54.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 110.452 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -18.18 9.1 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 120.308 -0.949 . . . . 61.149999999999999 113.178 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.95 130.59 42.61 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.889 -0.411 . . . . 75.540000000000006 109.889 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -118.92 -1.31 14.68 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.285 -0.959 . . . . 55.420000000000002 112.879 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.42 115.34 20.78 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.367 0.603 . . . . 74.140000000000001 109.961 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -125.62 154.87 41.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.895 -1.15 . . . . 74.129999999999995 107.895 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 485' ' ' ILE . 28.0 tptp -133.98 122.97 23.83 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.569 -1.271 . . . . 73.25 107.569 174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -91.18 120.84 32.45 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.472 0.654 . . . . 50.200000000000003 110.662 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.08 155.62 28.96 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.212 -1.773 . . . . 63.130000000000003 106.212 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 9.8 p30 -138.15 144.3 40.71 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.288 -0.634 . . . . 75.409999999999997 109.288 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 t -134.59 140.32 35.19 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 107.616 -1.253 . . . . 64.219999999999999 107.616 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_exo -65.13 122.63 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.045 1.83 . . . . 64.230000000000004 110.634 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.6 t -144.05 179.91 6.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.587 -1.635 . . . . 52.219999999999999 106.587 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -63.55 145.32 97.41 Favored Pre-proline 0 N--CA 1.414 -2.262 0 O-C-N 123.316 0.385 . . . . 73.430000000000007 110.026 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 464' ' ' VAL . 4.7 Cg_endo -50.61 -28.07 21.17 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.734 3.623 . . . . 55.310000000000002 112.236 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.75 -24.1 65.46 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.923 0.889 . . . . 74.109999999999999 112.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.9 5.7 33.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.852 0.686 . . . . 64.109999999999999 112.852 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.8 t -61.06 128.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.975 0.416 . . . . 75.400000000000006 111.269 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.47 84.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.499 -0.773 . . . . 75.099999999999994 111.91 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -111.19 146.79 36.28 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.234 -1.025 . . . . 74.340000000000003 108.234 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.8 t -81.39 129.37 37.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.101 -1.074 . . . . 64.400000000000006 108.101 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.7 pt -98.75 -9.8 8.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.349999999999994 111.418 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.33 163.02 24.62 Favored Glycine 0 CA--C 1.482 -2.005 0 C-N-CA 119.547 -1.311 . . . . 73.299999999999997 110.863 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.8 p -116.73 146.13 43.0 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.779 -0.822 . . . . 63.049999999999997 108.779 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.5 t30 -57.72 -50.04 90.34 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 123.315 0.384 . . . . 73.319999999999993 110.531 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_endo -85.01 137.91 6.54 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 N-CA-C 107.838 -1.639 . . . . 71.310000000000002 107.838 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 476' ' ' GLN . 6.3 Cg_exo -61.27 141.01 91.62 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.343 1.362 . . . . 73.239999999999995 111.029 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -81.66 10.72 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.377 1.084 . . . . 72.340000000000003 109.905 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -95.12 -29.91 14.32 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 113.84 -1.527 . . . . 65.450000000000003 108.398 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 473' ' ' PRO . 3.4 pt20 -98.86 170.78 8.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.779 -0.646 . . . . 62.310000000000002 109.93 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.7 p -98.49 134.02 42.05 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 116.036 -0.529 . . . . 50.149999999999999 109.886 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.0 m -114.0 145.53 41.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.462 -0.57 . . . . 72.219999999999999 109.462 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -59.39 148.11 33.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.974 0.416 . . . . 72.319999999999993 111.992 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.51 -30.74 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 123.537 0.735 . . . . 74.340000000000003 111.514 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -101.39 17.24 23.17 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.284 0.564 . . . . 65.510000000000005 110.549 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -88.56 139.3 30.62 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.785 -1.191 . . . . 65.150000000000006 107.785 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.95 111.08 16.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.642 0.734 . . . . 55.210000000000001 109.363 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.89 118.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.515 -0.92 . . . . 73.430000000000007 108.515 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 453' ' ' LYS . 46.8 mt -99.25 111.55 29.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.501 -1.296 . . . . 74.239999999999995 107.501 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 486' ' ' ILE . 0.0 OUTLIER -103.7 129.97 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-O 121.075 0.464 . . . . 61.109999999999999 110.16 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.71 116.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.233 -1.025 . . . . 64.409999999999997 108.233 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.42 140.07 18.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.966 -0.561 . . . . 73.25 109.568 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.71 118.15 6.93 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.454 -1.058 . . . . 74.349999999999994 110.454 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.3 m -119.96 132.72 55.6 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.846 -0.798 . . . . 73.209999999999994 108.846 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -136.27 103.18 0.43 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.991 -1.243 . . . . 72.150000000000006 109.991 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.18 118.97 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.039 1.826 . . . . 72.409999999999997 111.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -74.79 99.84 3.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.12 -1.067 . . . . 75.120000000000005 108.12 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 546' ' ' PRO . 35.6 p -124.66 156.92 36.75 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.077 -0.965 . . . . 63.43 108.956 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.05 150.29 31.53 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 70.049999999999997 107.779 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 544' ' ' THR . 6.7 p-10 -99.46 138.22 36.86 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 120.948 0.404 . . . . 74.530000000000001 110.282 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 541' ' ' ALA . 31.5 pt -88.15 133.91 36.02 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.556 -0.747 . . . . 74.120000000000005 111.985 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.3 177.0 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.603 2.202 . . . . 63.32 110.877 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.07 115.45 27.34 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.635 -0.426 . . . . 74.209999999999994 110.295 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.2 14.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.514 1.15 . . . . 63.109999999999999 108.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.49 143.23 46.68 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.09 -0.959 . . . . 61.210000000000001 110.48 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.7 -24.71 10.09 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.056 -0.592 . . . . 64.219999999999999 111.631 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -91.89 177.62 6.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.183 -0.673 . . . . 74.340000000000003 109.183 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.6 m -75.85 155.47 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.628 -0.508 . . . . 74.219999999999999 109.628 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.51 -49.1 14.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 123.719 0.637 . . . . 73.140000000000001 112.614 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.42 -42.51 74.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.259 0.466 . . . . 64.319999999999993 112.259 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -39.48 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 119.786 -0.766 . . . . 74.450000000000003 111.861 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.56 83.66 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.785 -0.643 . . . . 65.319999999999993 111.365 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.75 -35.52 80.96 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 120.219 -0.592 . . . . 70.239999999999995 110.5 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 513' ' ' ASN . 59.9 tttp -63.11 -48.9 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.462 0.648 . . . . 73.099999999999994 110.139 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -68.84 -38.24 79.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.264 -0.88 . . . . 63.240000000000002 111.453 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.03 -35.94 81.01 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 108.969 -0.752 . . . . 70.129999999999995 108.969 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 510' ' ' LYS . 2.5 t-20 -57.28 -38.8 74.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 75.430000000000007 110.115 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.06 -44.28 97.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.223 0.535 . . . . 54.009999999999998 110.632 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -103.23 16.46 26.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.037 0.446 . . . . 65.209999999999994 111.235 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.1 -117.9 1.28 Allowed Glycine 0 N--CA 1.414 -2.792 0 C-N-CA 120.766 -0.731 . . . . 44.409999999999997 112.421 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 16.7 m-85 -122.01 173.4 7.56 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 110.263 -0.273 . . . . 72.0 110.263 -171.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 19.5 p -96.23 -14.26 22.83 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.752 -0.658 . . . . 75.209999999999994 111.409 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.18 115.69 29.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.559 -0.291 . . . . 64.329999999999998 111.448 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -120.98 151.34 39.85 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.278 0.561 . . . . 74.319999999999993 111.095 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.2 m -135.64 152.21 51.0 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.892 -1.892 . . . . 75.209999999999994 105.892 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -119.39 123.55 44.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.634 -0.876 . . . . 54.299999999999997 108.634 -170.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.84 121.24 42.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.451 -0.574 . . . . 72.209999999999994 109.451 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 557' ' ' LYS . 19.4 p -87.88 116.27 25.92 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.115 0.484 . . . . 51.420000000000002 110.099 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.53 162.14 21.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 115.533 -0.758 . . . . 73.010000000000005 110.16 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.69 121.44 24.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.152 0.977 . . . . 72.430000000000007 109.967 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 556' ' ' SER . 2.6 p -144.9 101.77 4.52 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 114.189 -1.369 . . . . 72.450000000000003 109.967 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.61 -57.35 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.559 2.839 . . . . 54.340000000000003 114.481 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 57.1 mtt180 -80.04 -49.43 1.27 Allowed Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 113.06 0.763 . . . . 72.310000000000002 113.06 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 39.6 Cg_exo -62.03 134.94 52.2 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.739 1.626 . . . . 72.25 112.306 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.07 74.36 0.97 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.89 3.68 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 110.747 -0.941 . . . . 73.5 110.747 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -86.19 149.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.256 0.55 . . . . 75.030000000000001 111.147 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 553' ' ' LEU . 87.7 t -73.71 124.7 31.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.345 -0.843 . . . . 64.25 109.079 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.6 m -76.23 -28.95 57.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.592 -1.185 . . . . 52.310000000000002 110.252 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 160.77 -159.66 31.2 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.03 -1.228 . . . . 73.219999999999999 110.03 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.5 p -127.18 157.38 39.92 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.261 -1.015 . . . . 62.229999999999997 108.261 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.5 t30 -66.81 -54.65 20.56 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.086 -0.645 . . . . 74.310000000000002 110.613 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.5 Cg_exo -71.7 131.59 18.82 Favored 'Trans proline' 0 C--N 1.377 2.033 0 N-CA-C 108.113 -1.534 . . . . 64.129999999999995 108.113 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.4 147.46 90.69 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.463 2.108 . . . . 64.430000000000007 113.075 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -63.26 142.82 58.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.988 -0.551 . . . . 53.299999999999997 110.56 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.99 64.0 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.519 -0.632 . . . . 61.210000000000001 111.519 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.1 m -79.65 132.39 36.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.582 -0.525 . . . . 71.510000000000005 109.582 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 496' ' ' ASP . 41.2 m -97.91 122.23 40.77 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.308 -0.997 . . . . 73.329999999999998 108.308 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.52 165.25 37.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.472 -0.936 . . . . 74.030000000000001 108.472 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.486 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.3 Cg_exo -59.5 137.58 78.7 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.493 2.129 . . . . 63.329999999999998 113.69 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.665 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -67.3 -19.69 25.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.157 -0.929 . . . . 71.540000000000006 112.259 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.76 -3.67 58.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.674 -1.148 . . . . 64.549999999999997 109.667 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.7 m -95.7 152.24 18.64 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 115.371 -0.831 . . . . 53.109999999999999 110.559 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.9 t -88.71 134.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.688 -0.687 . . . . 73.25 110.433 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 497' ' ' ILE . 9.3 tt -102.53 141.96 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 109.551 -0.537 . . . . 75.409999999999997 109.551 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -103.02 122.37 44.49 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.814 -0.809 . . . . 72.420000000000002 108.814 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 534' ' ' VAL . 20.0 tp -98.22 128.85 44.9 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.031 -0.986 . . . . 74.129999999999995 108.751 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -88.2 106.31 18.11 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.82 -0.807 . . . . 71.230000000000004 108.82 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 524' ' ' SER . 29.7 m -105.56 139.11 27.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 115.662 -0.699 . . . . 33.420000000000002 110.429 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.411 ' HA ' ' OG ' ' A' ' 527' ' ' SER . 22.3 p -57.16 120.76 8.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.537 -0.756 . . . . 73.109999999999999 112.139 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 524' ' ' SER . 57.4 tttm . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 109.31 -0.626 . . . . 74.310000000000002 109.31 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.631 0 N-CA-C 110.408 -1.077 . . . . 62.109999999999999 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.8 141.28 96.51 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.699 2.266 . . . . 62.210000000000001 111.045 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER -92.7 -1.01 57.19 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.504 0.668 . . . . 71.420000000000002 109.552 -179.174 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 60.0 mt-30 -109.69 125.54 52.74 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.561 -1.2 . . . . 74.230000000000004 108.926 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -123.12 160.44 26.44 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.169 -1.048 . . . . 73.430000000000007 108.169 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.97 141.64 28.46 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.635 -0.505 . . . . 73.099999999999994 109.635 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.59 119.41 76.76 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.73 -0.841 . . . . 74.209999999999994 108.73 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.94 144.51 43.19 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.275 1.983 . . . . 65.209999999999994 111.99 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.97 59.44 5.63 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.164 1.459 . . . . 72.519999999999996 109.17 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 439' ' ' GLU . 11.3 p -108.14 -5.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 106.333 -1.728 . . . . 64.209999999999994 106.333 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 1.3 p -63.25 -32.37 73.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.864 -1.971 . . . . 71.209999999999994 109.704 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.416 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 12.6 t -63.02 -26.79 69.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.332 -1.304 . . . . 63.109999999999999 111.103 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 432' ' ' VAL . 80.4 mt -85.54 -46.7 10.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.02 -1.072 . . . . 52.43 111.488 -173.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 1.8 m -171.88 150.6 2.63 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.172 -1.047 . . . . 72.0 108.172 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -52.63 -48.27 66.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.224 0.61 . . . . 74.420000000000002 110.631 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.78 66.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.731 -0.668 . . . . 54.210000000000001 111.968 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.503 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.4 mm-40 -70.98 -42.85 69.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.285 -0.416 . . . . 75.439999999999998 111.126 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.457 ' HA ' HG13 ' A' ' 432' ' ' VAL . . . -60.6 -47.06 87.89 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.199 -0.909 . . . . 73.409999999999997 110.75 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.54 -48.78 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.663 -0.699 . . . . 51.520000000000003 111.227 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -62.29 -44.65 96.02 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.024 0.379 . . . . 54.350000000000001 112.024 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 443' ' ' LYS . 6.5 mmpt? -66.56 -42.68 86.72 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.76 -0.376 . . . . 43.439999999999998 111.673 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.431 HD23 ' CE1' ' A' ' 452' ' ' PHE . 10.3 tp -69.41 -32.97 72.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.274 0.559 . . . . 71.219999999999999 110.106 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.6 m -64.45 -41.55 96.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.847 -0.615 . . . . 64.540000000000006 109.405 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.23 -16.22 63.02 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.168 0.508 . . . . 64.120000000000005 110.942 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.65 -13.06 46.66 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.099 -0.5 . . . . 63.039999999999999 110.086 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.54 -9.31 24.08 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.002 -0.618 . . . . 72.319999999999993 113.95 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -71.85 143.72 49.32 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.889 0.344 . . . . 73.299999999999997 111.194 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -149.0 16.54 1.19 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.69 -0.767 . . . . 64.310000000000002 112.319 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -120.97 115.77 23.82 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.987 -1.486 . . . . 71.319999999999993 106.987 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.431 ' CE1' HD23 ' A' ' 444' ' ' LEU . 96.5 m-85 -141.36 160.64 39.7 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 113.514 0.931 . . . . 72.409999999999997 113.514 -171.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -142.33 134.08 26.93 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.197 1.799 . . . . 74.140000000000001 107.012 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -103.65 132.03 50.27 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.62 -0.511 . . . . 73.420000000000002 109.62 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.53 139.24 53.37 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.767 -0.827 . . . . 75.409999999999997 108.767 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -114.17 130.19 56.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.607 -0.886 . . . . 62.350000000000001 108.607 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 50.1 m -120.63 138.17 27.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.517 -0.311 . . . . 74.349999999999994 110.433 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 14.9 Cg_exo -69.85 122.61 9.26 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.357 2.038 . . . . 74.319999999999993 111.007 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -144.75 179.07 7.55 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.039 -1.467 . . . . 41.310000000000002 107.039 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.532 ' OG1' ' HD2' ' A' ' 461' ' ' PRO . 6.6 t -70.76 144.2 90.56 Favored Pre-proline 0 N--CA 1.433 -1.322 0 N-CA-C 109.039 -0.726 . . . . 74.299999999999997 109.039 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 464' ' ' VAL . 2.0 Cg_endo -48.8 -27.88 12.0 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 125.165 3.91 . . . . 61.149999999999999 115.476 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.72 -13.22 61.98 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.29 -1.364 . . . . 54.420000000000002 112.343 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.424 HD12 ' HD3' ' A' ' 466' ' ' LYS . 2.8 mm? -98.23 -0.14 44.64 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.831 -0.543 . . . . 71.129999999999995 111.364 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 461' ' ' PRO . 84.9 t -61.51 128.14 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.799 -0.445 . . . . 71.420000000000002 109.799 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.79 -16.73 60.15 Favored Glycine 0 C--O 1.244 0.773 0 C-N-CA 121.099 -0.572 . . . . 73.109999999999999 111.996 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 463' ' ' LEU . 78.5 tttt -92.77 142.66 27.1 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.894 -0.78 . . . . 74.150000000000006 108.894 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.595 HG22 HD11 ' A' ' 486' ' ' ILE . 60.2 t -82.85 124.85 39.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.628 -1.619 . . . . 75.150000000000006 106.628 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.46 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -105.16 -5.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 118.667 -1.213 . . . . 74.0 111.803 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.14 160.14 27.84 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 119.775 -1.202 . . . . 55.119999999999997 112.666 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.4 p -134.42 145.33 48.79 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.196 -1.409 . . . . 71.510000000000005 107.196 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.41 ' OD1' ' HB ' ' A' ' 485' ' ' ILE . 12.5 m120 -64.4 -51.08 63.11 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 120.364 -0.534 . . . . 75.129999999999995 112.202 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.55 123.38 11.35 Favored 'Trans proline' 0 C--O 1.253 1.252 0 N-CA-C 108.716 -1.302 . . . . 70.420000000000002 108.716 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.38 139.19 37.52 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.217 1.945 . . . . 55.109999999999999 112.185 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.24 2.14 37.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.724 0.773 . . . . 54.130000000000003 110.608 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.24 -32.92 24.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.877 -1.056 . . . . 55.140000000000001 110.094 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.67 178.37 4.42 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.155 -1.054 . . . . 44.409999999999997 108.155 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 32.5 p -97.04 126.54 42.26 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-O 121.277 0.561 . . . . 61.509999999999998 110.547 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -106.77 147.05 30.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.479 -0.934 . . . . 52.450000000000003 108.479 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -74.5 147.58 41.75 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 120.9 0.381 . . . . 60.329999999999998 111.584 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.85 -21.9 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.31 1.044 . . . . 75.5 111.26 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -94.85 1.78 55.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.417 -0.811 . . . . 71.329999999999998 110.103 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -78.83 144.6 34.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.971 -0.751 . . . . 74.030000000000001 108.971 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 38.7 t -82.13 112.49 20.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.558 -1.275 . . . . 62.310000000000002 107.558 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.69 119.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 N-CA-C 109.176 -0.676 . . . . 63.119999999999997 109.176 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.41 ' HB ' ' OD1' ' A' ' 471' ' ' ASN . 3.3 mp -97.68 119.48 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.463 -2.051 . . . . 44.350000000000001 105.463 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.595 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -109.19 128.43 65.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.95 -0.568 . . . . 72.439999999999998 109.981 -175.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 58.5 mt -103.65 112.51 37.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-N 115.299 -0.864 . . . . 73.25 110.52 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.16 140.57 17.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 115.517 -0.765 . . . . 73.530000000000001 109.585 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.68 129.3 9.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.237 -1.145 . . . . 30.109999999999999 110.237 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.5 p -135.58 152.03 50.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.842 -0.429 . . . . 62.520000000000003 109.842 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -108.38 156.3 15.8 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.986 -1.245 . . . . 54.119999999999997 109.986 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.53 120.18 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.1 1.867 . . . . 72.209999999999994 110.399 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -73.42 90.35 1.69 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.743 0.783 . . . . 54.009999999999998 109.512 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.7 p -138.72 162.81 33.76 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.197 -0.911 . . . . 70.230000000000004 110.476 -172.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 517' ' ' PHE . 48.0 tptt -146.61 139.85 25.63 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.267 -0.424 . . . . 73.439999999999998 110.318 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -80.61 137.73 36.39 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.214 1.005 . . . . 63.329999999999998 109.023 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.6 pt -97.34 133.29 24.04 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 120.041 -0.663 . . . . 74.150000000000006 110.674 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.22 178.22 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.512 2.141 . . . . 72.140000000000001 110.296 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.0 122.53 38.92 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.153 -0.619 . . . . 73.239999999999995 110.045 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.36 6.02 5.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.652 -0.704 . . . . 72.230000000000004 110.102 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.561 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -74.01 147.2 43.15 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.553 -0.749 . . . . 73.019999999999996 110.712 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.46 -14.23 56.63 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.051 -0.82 . . . . 63.420000000000002 111.051 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -99.58 -170.04 1.84 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.583 -0.525 . . . . 61.130000000000003 109.583 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.1 m -82.08 155.77 24.91 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.667 -1.234 . . . . 74.430000000000007 107.667 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.76 -42.09 76.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.712 0.292 . . . . 74.409999999999997 111.537 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 31.9 t70 -68.19 -43.46 78.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.197 0.443 . . . . 55.219999999999999 112.197 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.26 -34.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.77 -0.772 . . . . 70.219999999999999 110.839 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.73 -49.18 78.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.728 . . . . 74.319999999999993 110.752 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.61 -34.66 78.76 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 120.669 -0.412 . . . . 73.129999999999995 111.009 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 12.7 mmmm -57.36 -53.16 61.29 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.166 0.291 . . . . 71.010000000000005 111.148 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -62.84 -40.63 98.04 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.38 0.61 . . . . 65.409999999999997 110.285 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 551' ' ' ILE . 46.7 tp -64.91 -38.51 91.21 Favored 'General case' 0 C--O 1.191 -2.02 0 CA-C-N 115.081 -0.963 . . . . 71.010000000000005 110.928 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.13 -37.96 84.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.163 0.585 . . . . 70.349999999999994 111.54 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.24 -29.8 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 64.230000000000004 110.697 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.66 31.21 6.36 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.166 -0.334 . . . . 72.120000000000005 110.363 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -160.39 -108.7 0.24 Allowed Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 119.009 -1.567 . . . . 51.420000000000002 113.759 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 495' ' ' LYS . 18.3 m-85 -137.69 177.26 8.01 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.876 -0.787 . . . . 75.129999999999995 108.876 -172.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 m -112.13 6.5 19.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 122.296 1.046 . . . . 61.520000000000003 108.725 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -108.52 115.75 30.69 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.647 -0.872 . . . . 72.219999999999999 108.647 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -128.16 150.87 49.81 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.293 0.371 . . . . 72.420000000000002 110.222 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 74.8 m -130.8 155.7 46.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.572 -1.27 . . . . 63.210000000000001 107.572 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -121.91 122.25 38.96 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.998 0.428 . . . . 74.129999999999995 110.001 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.47 56.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.777 -0.823 . . . . 60.340000000000003 108.777 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -90.07 118.9 29.96 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.575 -0.898 . . . . 74.530000000000001 108.575 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.6 152.23 25.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.584 -0.895 . . . . 70.230000000000004 108.584 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.64 123.04 25.53 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.606 1.193 . . . . 54.329999999999998 111.098 -169.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.5 m -128.49 101.04 21.63 Favored Pre-proline 0 N--CA 1.416 -2.138 0 CA-C-N 113.795 -1.548 . . . . 65.010000000000005 109.102 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.26 -57.15 1.19 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.032 2.488 . . . . 74.040000000000006 112.538 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -88.33 -49.41 0.43 Allowed Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 113.349 0.87 . . . . 73.329999999999998 113.349 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.59 146.52 95.38 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 121.883 1.722 . . . . 44.310000000000002 112.701 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.11 85.04 0.32 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.395 1.078 . . . . 72.329999999999998 108.381 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.0 -35.05 2.44 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 110.543 -1.023 . . . . 72.319999999999993 110.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -85.31 147.21 26.65 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.155 0.502 . . . . 65.120000000000005 109.91 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.4 p -75.07 126.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.499 -0.926 . . . . 74.030000000000001 108.499 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.2 m -72.11 -36.57 69.48 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.331 -0.85 . . . . 61.109999999999999 109.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 172.46 -167.44 40.35 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.258 -0.972 . . . . 60.039999999999999 111.728 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.1 p -118.71 160.62 21.53 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.525 -0.917 . . . . 71.099999999999994 108.525 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.6 t-20 -61.58 -53.39 61.91 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.93 -0.308 . . . . 74.030000000000001 111.33 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -87.81 144.93 6.5 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 108.912 -1.226 . . . . 73.239999999999995 108.912 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.3 Cg_exo -69.13 150.83 72.52 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 121.816 1.677 . . . . 64.530000000000001 111.447 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.09 135.83 36.72 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.674 0.79 . . . . 61.43 111.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.98 -26.51 20.52 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.228 -0.749 . . . . 61.439999999999998 111.228 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 88.2 m -65.68 133.69 51.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.501 . . . . 72.439999999999998 111.184 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.3 m -101.99 122.87 44.88 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.271 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.44 155.55 71.65 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.639 -0.504 . . . . 73.010000000000005 109.639 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 494' ' ' THR . 11.6 Cg_endo -58.86 138.98 88.82 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.664 2.243 . . . . 70.450000000000003 112.944 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.492 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 21.4 m -67.04 -19.7 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 122.344 1.069 . . . . 71.420000000000002 110.344 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.31 -2.67 39.14 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.956 -1.475 . . . . 72.530000000000001 110.453 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -108.43 172.38 6.87 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.751 -0.833 . . . . 74.25 108.751 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.58 136.34 50.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.872 -0.788 . . . . 74.519999999999996 108.872 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 512' ' ' LEU . 16.7 tt -94.51 138.88 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 120.063 -0.655 . . . . 72.530000000000001 110.531 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -102.17 124.01 47.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-O 121.241 0.543 . . . . 74.310000000000002 110.032 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.98 131.2 46.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.233 -1.765 . . . . 73.099999999999994 106.233 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -107.12 105.95 16.2 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.717 0.77 . . . . 63.210000000000001 110.234 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.03 139.83 16.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.134 -1.394 . . . . 75.420000000000002 111.487 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.1 p -56.33 114.71 2.1 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 63.200000000000003 112.903 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.358 -1.719 . . . . 52.310000000000002 106.358 174.129 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 110.428 -1.069 . . . . 53.420000000000002 110.428 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.49 163.15 27.26 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.922 1.748 . . . . 53.310000000000002 113.073 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.2 OUTLIER -100.45 33.53 2.68 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.829 1.252 . . . . 75.299999999999997 107.79 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 478' ' ' SER . 96.0 mt-30 -110.1 135.67 50.54 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.004 -1.453 . . . . 73.219999999999999 109.962 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -126.29 158.53 35.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.036 0.446 . . . . 64.450000000000003 111.436 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.92 141.99 30.0 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.789 -1.096 . . . . 75.430000000000007 110.532 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -79.27 129.93 70.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.721 -0.844 . . . . 63.43 108.721 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.89 141.8 65.6 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.671 2.914 . . . . 72.319999999999993 114.792 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.26 -3.05 48.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.918 -1.037 . . . . 74.150000000000006 111.271 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.8 m -85.68 3.39 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.603 0.716 . . . . 61.32 110.812 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 14.8 m -61.48 -29.57 70.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.823 -1.08 . . . . 71.319999999999993 110.196 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.494 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 18.2 p -62.44 -27.87 69.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.102 -0.953 . . . . 75.409999999999997 111.524 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.6 -45.44 21.63 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.925 -0.398 . . . . 74.549999999999997 109.925 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 16.1 m -166.79 148.27 6.13 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.717 -0.846 . . . . 71.540000000000006 108.717 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 441' ' ' VAL . 53.1 t80 -53.27 -43.01 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.925 0.89 . . . . 74.239999999999995 111.301 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.75 -41.16 85.88 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.483 -0.326 . . . . 53.119999999999997 111.24 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 15.5 mm-40 -63.69 -40.61 97.23 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.248 0.547 . . . . 74.519999999999996 110.099 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -50.96 71.54 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.982 -1.008 . . . . 73.010000000000005 110.595 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 437' ' ' TYR . 92.7 t -59.42 -45.84 93.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.37 -0.832 . . . . 71.230000000000004 111.819 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 67.7 mttm -63.05 -47.28 83.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.695 0.283 . . . . 72.230000000000004 111.591 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -67.78 -38.81 83.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.312 -0.404 . . . . 74.25 111.399 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.55 -37.98 83.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.235 0.54 . . . . 74.230000000000004 109.88 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.2 m -59.47 -47.87 83.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.425 -0.807 . . . . 73.109999999999999 109.784 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.45 -15.83 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.011 -0.541 . . . . 62.530000000000001 111.933 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.0 -13.73 59.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.242 0.544 . . . . 74.409999999999997 110.433 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.88 -17.62 24.88 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.421 -0.895 . . . . 53.32 113.11 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -64.05 126.95 29.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.109 0.481 . . . . 55.43 111.082 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -110.12 -1.89 29.91 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.385 -0.825 . . . . 73.109999999999999 111.277 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 3.0 mpt_? -123.73 114.87 20.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.227 0.536 . . . . 71.519999999999996 110.187 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -147.68 146.81 29.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.429 -0.805 . . . . 61.140000000000001 110.361 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -131.13 126.51 35.9 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.363 -0.606 . . . . 72.439999999999998 109.363 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -84.0 122.35 28.64 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.613 -0.721 . . . . 72.439999999999998 111.191 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.36 149.86 41.12 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.069 -1.456 . . . . 40.210000000000001 107.069 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -127.92 146.82 50.51 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.785 -0.45 . . . . 50.219999999999999 109.785 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 44.5 m -124.57 131.45 24.16 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.791 -0.818 . . . . 75.120000000000005 108.791 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.51 123.81 11.61 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.461 2.107 . . . . 71.510000000000005 111.056 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 49.7 m -147.02 -179.72 7.01 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.444 -0.947 . . . . 65.450000000000003 108.444 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -49.75 136.35 19.24 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.896 0.878 . . . . 73.310000000000002 110.66 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.599 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 9.1 Cg_endo -50.66 -36.5 50.83 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.666 3.578 . . . . 75.349999999999994 114.786 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -77.58 -8.75 58.32 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.261 0.837 . . . . 73.230000000000004 113.261 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 18.0 tp -84.39 -11.82 55.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.003 0.43 . . . . 71.25 110.433 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.3 p -56.72 135.91 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.443 -0.799 . . . . 72.329999999999998 112.028 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.04 55.21 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 121.06 -0.59 . . . . 74.420000000000002 114.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 434' ' ' THR . 14.3 ptmm? -107.85 148.18 29.92 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.919 -1.112 . . . . 74.450000000000003 110.396 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.593 HG22 HD11 ' A' ' 486' ' ' ILE . 61.0 t -81.39 131.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.719 -0.474 . . . . 50.25 109.719 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 33.8 pt -101.04 -10.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.992 -0.549 . . . . 73.120000000000005 111.529 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.98 172.42 33.31 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.213 -0.755 . . . . 74.340000000000003 111.213 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 159.07 37.63 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.099 -0.704 . . . . 44.340000000000003 109.099 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 24.3 t-20 -60.6 -56.17 37.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 119.16 -0.448 . . . . 72.310000000000002 111.58 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.7 Cg_endo -85.88 146.15 9.05 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 121.192 1.261 . . . . 73.319999999999993 109.486 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.618 ' HG2' ' HG2' ' A' ' 476' ' ' GLN . 14.2 Cg_exo -62.88 149.8 90.33 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.693 1.595 . . . . 73.319999999999993 111.637 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.7 -11.66 60.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.654 0.74 . . . . 72.319999999999993 109.798 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -96.2 -12.19 25.0 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.222 -0.899 . . . . 71.129999999999995 112.012 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.618 ' HG2' ' HG2' ' A' ' 473' ' ' PRO . 0.0 OUTLIER -96.11 155.07 16.91 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 119.435 -0.906 . . . . 63.340000000000003 108.845 176.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.416 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 34.7 p -101.2 120.68 40.6 Favored 'General case' 0 N--CA 1.395 -3.185 0 N-CA-C 108.372 -0.974 . . . . 74.540000000000006 108.372 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 24.6 m -105.1 140.05 38.86 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.203 -0.666 . . . . 33.009999999999998 109.203 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -61.63 146.78 47.94 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.953 -0.388 . . . . 73.319999999999993 109.953 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.39 -23.0 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 123.597 0.759 . . . . 70.340000000000003 111.965 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.6 t -77.84 -8.02 57.47 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.355 -0.384 . . . . 62.43 111.299 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -74.87 136.2 41.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 120.909 0.385 . . . . 72.010000000000005 110.833 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.66 113.85 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 0 N-CA-C 106.588 -1.634 . . . . 74.209999999999994 106.588 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 63.0 t -86.63 119.93 35.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.136 -0.69 . . . . 71.430000000000007 109.136 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.84 111.86 24.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.885 -1.524 . . . . 75.319999999999993 106.885 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.593 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.68 128.11 55.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.68 -1.146 . . . . 74.439999999999998 108.719 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 54.8 mt -104.52 114.04 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.614 0.721 . . . . 75.140000000000001 110.988 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.55 130.33 45.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.471 -0.786 . . . . 62.420000000000002 109.421 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.31 114.51 4.98 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 107.81 -2.116 . . . . 30.300000000000001 107.81 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.1 m -120.54 129.37 53.77 Favored 'General case' 0 N--CA 1.412 -2.347 0 C-N-CA 120.163 -0.615 . . . . 74.409999999999997 109.525 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -101.22 115.22 5.22 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 110.218 -1.153 . . . . 60.340000000000003 110.218 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.5 129.97 33.49 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.285 1.99 . . . . 72.230000000000004 111.195 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -70.69 97.17 1.31 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 546' ' ' PRO . 6.9 p -133.5 152.26 51.88 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.678 -1.147 . . . . 73.319999999999993 109.467 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.82 143.75 27.69 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.717 -0.475 . . . . 75.030000000000001 109.717 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 543' ' ' THR . 7.3 p-10 -93.0 138.32 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.681 -0.859 . . . . 65.519999999999996 108.681 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 497' ' ' ILE . 0.2 OUTLIER -93.82 121.04 65.29 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 114.849 1.426 . . . . 62.109999999999999 114.849 -176.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.75 136.27 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 106.294 -2.233 . . . . 73.109999999999999 106.294 164.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.37 139.86 56.64 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.796 0.807 . . . . 74.439999999999998 111.866 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.27 27.88 3.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.854 -1.535 . . . . 72.439999999999998 106.854 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.87 137.63 33.59 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.963 -1.471 . . . . 61.439999999999998 110.583 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.07 -48.23 0.93 Allowed Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.572 -0.823 . . . . 53.020000000000003 112.612 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.6 -168.69 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 111.877 0.325 . . . . 74.510000000000005 111.877 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.9 p -82.58 162.24 22.01 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 112.898 0.703 . . . . 73.340000000000003 112.898 -170.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.8 t -48.11 -52.5 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 O-C-N 124.839 1.337 . . . . 74.420000000000002 110.16 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 1.8 m-20 -68.04 -42.18 80.98 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.855 -1.066 . . . . 70.209999999999994 112.753 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.28 -35.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 119.214 -0.994 . . . . 73.329999999999998 111.497 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.444 ' HB3' HG21 ' A' ' 534' ' ' VAL . . . -64.06 -42.58 96.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.754 -0.657 . . . . 71.209999999999994 111.021 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 79.4 mt-30 -61.4 -43.36 98.99 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.989 -0.375 . . . . 75.010000000000005 109.989 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.8 mptp? -61.74 -49.31 76.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.79 -0.641 . . . . 62.149999999999999 111.883 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -62.58 -47.78 82.3 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 123.205 0.315 . . . . 75.329999999999998 110.66 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.11 -43.29 99.1 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.938 -0.574 . . . . 73.150000000000006 110.719 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.38 -37.22 74.82 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.717 0.807 . . . . 71.140000000000001 111.75 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.1 t -63.44 -42.48 96.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 116.282 -0.417 . . . . 73.109999999999999 111.869 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -108.21 -18.45 13.77 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.944 -1.102 . . . . 73.430000000000007 111.856 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -102.98 -100.47 2.57 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 115.079 0.792 . . . . 43.119999999999997 115.079 -171.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.568 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 49.0 m-85 -127.56 172.69 10.51 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.916 0.389 . . . . 73.319999999999993 111.183 -168.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.8 p -106.27 -25.73 11.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.485 -0.78 . . . . 65.319999999999993 111.047 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.73 121.65 45.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.871 -0.604 . . . . 64.109999999999999 109.72 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -128.46 143.4 50.98 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.591 . . . . 72.329999999999998 112.204 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.8 m -115.15 152.48 32.51 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.732 -1.951 . . . . 54.329999999999998 105.732 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -123.39 134.06 54.02 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.175 -0.61 . . . . 73.120000000000005 111.586 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.71 121.89 39.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.81 -0.811 . . . . 54.439999999999998 108.81 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.5 m -88.24 118.05 27.57 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.626 -1.62 . . . . 74.200000000000003 106.626 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 34.0 m -119.97 149.5 22.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.263 -1.384 . . . . 74.129999999999995 107.263 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.33 133.75 37.57 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.39 1.091 . . . . 73.219999999999999 112.579 -167.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 5.8 m -94.61 129.08 37.52 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 112.962 -1.926 . . . . 71.409999999999997 109.165 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.13 -71.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 121.073 1.182 . . . . 71.409999999999997 109.072 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.429 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 24.5 mmm180 -111.57 -55.05 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.036 -0.507 . . . . 74.310000000000002 112.165 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 527' ' ' SER . 10.7 Cg_exo -73.18 134.48 21.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.306 1.338 . . . . 74.319999999999993 111.339 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.51 159.46 43.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.436 -0.95 . . . . 65.299999999999997 108.436 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.91 -21.81 25.28 Favored Glycine 0 C--N 1.319 -0.402 0 CA-C-O 121.611 0.562 . . . . 65.019999999999996 111.862 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.52 147.77 25.2 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.245 0.545 . . . . 51.350000000000001 110.728 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 508' ' ' ALA . 64.5 t -75.88 124.88 34.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.975 -0.75 . . . . 74.239999999999995 108.975 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -33.21 52.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.315 -0.857 . . . . 70.120000000000005 109.44 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.78 -147.18 15.19 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.333 -0.707 . . . . 72.340000000000003 111.333 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.0 p -121.79 160.41 24.68 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.955 -0.757 . . . . 62.299999999999997 108.955 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -62.55 -52.61 64.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 121.007 -0.277 . . . . 74.040000000000006 110.368 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 57.8 Cg_endo -74.41 146.2 34.96 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 120.919 1.079 . . . . 75.340000000000003 109.791 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.2 Cg_exo -63.67 154.25 70.35 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.197 1.931 . . . . 73.439999999999998 111.9 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.45 132.88 53.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.024 -0.535 . . . . 74.25 109.964 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.49 -10.84 56.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.113 -0.565 . . . . 63.299999999999997 111.824 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 71.5 m -77.46 129.3 35.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.616 -0.513 . . . . 65.219999999999999 109.616 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.0 t -93.85 122.6 36.5 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.476 0.655 . . . . 63.210000000000001 110.148 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.27 158.81 70.13 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.685 -0.857 . . . . 54.439999999999998 108.685 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.418 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.7 Cg_exo -63.86 134.29 42.8 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.032 1.821 . . . . 75.230000000000004 112.081 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.568 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 17.2 m -67.61 -22.61 28.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.886 0.851 . . . . 73.540000000000006 110.849 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.15 0.73 52.89 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.353 -1.294 . . . . 75.319999999999993 111.685 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.8 t -98.02 -177.55 3.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.971 -0.751 . . . . 74.439999999999998 108.971 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 22.8 t -109.41 134.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.857 -1.164 . . . . 73.109999999999999 107.857 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.1 tt -115.08 146.0 20.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.498 -0.556 . . . . 75.310000000000002 109.498 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.43 130.96 49.36 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-O 121.46 0.647 . . . . 72.209999999999994 110.454 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.7 tp -101.75 130.96 48.27 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.68 -1.145 . . . . 71.349999999999994 108.624 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -94.8 115.33 27.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.959 -1.497 . . . . 73.25 106.959 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.74 135.2 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-N 116.525 -0.307 . . . . 72.310000000000002 111.089 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.5 m -74.23 114.39 12.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 109.04 -0.726 . . . . 72.549999999999997 109.04 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 11.5 ptmm? . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 114.795 -1.093 . . . . 72.439999999999998 110.919 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.82 0 N-CA-C 109.681 -1.367 . . . . 43.049999999999997 109.681 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.02 133.18 19.33 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 122.306 2.004 . . . . 63.25 109.22 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.4 pt-20 -85.91 57.79 4.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.411 1.1 . . . . 74.439999999999998 111.041 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 95.7 mt-30 -111.02 130.18 55.67 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.315 -1.311 . . . . 62.039999999999999 108.774 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -125.06 150.44 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.322 -0.854 . . . . 70.450000000000003 110.354 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 140.7 32.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 111.575 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -84.26 126.63 69.13 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 108.244 -1.021 . . . . 74.25 108.244 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.8 140.85 36.18 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.311 1.34 . . . . 63.350000000000001 110.517 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -105.81 69.37 0.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.457 1.122 . . . . 63.229999999999997 109.973 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.483 HG11 ' HD2' ' A' ' 443' ' ' LYS . 14.5 p -113.11 6.32 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 105.937 -1.875 . . . . 75.329999999999998 105.937 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.645 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.2 m -57.92 -30.05 65.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.031 -2.35 . . . . 60.5 110.399 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 3.2 m -61.76 -27.83 69.01 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.852 1.261 . . . . 72.150000000000006 110.856 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.0 -46.34 9.92 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 118.763 -1.175 . . . . 54.549999999999997 111.323 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.569 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.8 m -167.88 151.97 6.34 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -52.14 -49.29 64.02 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.266 1.026 . . . . 74.140000000000001 109.507 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.97 76.7 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.256 -0.883 . . . . 71.239999999999995 111.412 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.569 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 26.3 mm-40 -61.85 -46.06 91.07 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.239 0.337 . . . . 71.310000000000002 110.95 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -63.15 -47.25 83.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.629 -0.714 . . . . 62.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.25 -45.37 98.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.658 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -60.8 -47.58 85.67 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 122.197 0.199 . . . . 72.209999999999994 111.453 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 432' ' ' VAL . 65.0 mttm -67.79 -39.14 84.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.381 -0.527 . . . . 71.120000000000005 112.34 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.4 tp -68.05 -37.06 80.88 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.319 0.58 . . . . 72.450000000000003 109.898 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -65.13 -41.81 94.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.509 -0.769 . . . . 75.319999999999993 109.4 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.75 -21.44 63.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.845 -0.616 . . . . 70.319999999999993 110.768 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.86 -13.33 59.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.335 0.588 . . . . 64.450000000000003 109.767 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.98 16.07 61.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.693 -0.685 . . . . 72.129999999999995 113.61 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.24 133.39 52.7 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.123 0.487 . . . . 72.209999999999994 111.141 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -90.39 -48.93 3.37 Favored Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.505 -0.771 . . . . 74.299999999999997 113.059 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -110.38 116.0 30.66 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.306 -0.958 . . . . 73.129999999999995 111.905 -172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 39.7 p90 -146.66 146.36 30.35 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.891 -0.595 . . . . 73.019999999999996 110.448 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -131.75 131.83 43.32 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.281 -0.637 . . . . 71.310000000000002 109.281 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -89.25 129.82 35.75 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.752 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.99 144.68 48.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.432 -1.321 . . . . 72.109999999999999 107.432 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -123.09 144.56 49.23 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.906 -0.718 . . . . 63.030000000000001 110.258 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.9 m -137.75 131.28 16.98 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.114 -0.494 . . . . 63.509999999999998 110.211 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.47 123.41 11.1 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.6 2.2 . . . . 72.239999999999995 111.218 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.5 p -142.78 179.25 7.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.991 -0.55 . . . . 52.240000000000002 110.476 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.2 t -56.38 143.38 66.0 Favored Pre-proline 0 N--CA 1.429 -1.485 0 C-N-CA 124.116 0.967 . . . . 63.140000000000001 109.987 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 464' ' ' VAL . 85.5 Cg_exo -50.58 -29.23 24.33 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.047 3.164 . . . . 75.409999999999997 113.01 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.06 -35.7 81.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.568 0.581 . . . . 74.049999999999997 112.568 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.87 -9.38 46.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 111.584 0.216 . . . . 42.020000000000003 111.584 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 61.4 t -61.5 127.02 20.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 109.88 -0.415 . . . . 75.420000000000002 109.88 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.3 71.4 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.562 -0.745 . . . . 33.049999999999997 111.798 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 434' ' ' THR . 4.3 mptp? -98.88 145.49 26.95 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.344 0.658 . . . . 75.409999999999997 109.475 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 94.9 t -82.12 126.61 39.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.378 -1.712 . . . . 74.340000000000003 106.378 173.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.24 -5.39 9.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.815 -0.754 . . . . 72.120000000000005 111.641 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.04 13.33 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.103 -1.046 . . . . 54.240000000000002 112.997 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 31.7 p -116.91 141.46 48.2 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.607 -1.257 . . . . 70.349999999999994 107.607 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.461 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 28.1 t-20 -57.16 -53.52 64.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-O 119.105 -0.474 . . . . 73.540000000000006 111.914 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.67 144.54 17.6 Favored 'Trans proline' 0 C--N 1.36 1.143 0 CA-C-N 120.459 1.2 . . . . 74.230000000000004 109.087 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.26 147.85 93.49 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.536 2.158 . . . . 75.129999999999995 111.536 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.85 -21.56 26.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.026 0.441 . . . . 42.539999999999999 111.625 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.85 -30.72 59.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.7 0.762 . . . . 35.299999999999997 109.717 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.25 152.93 17.94 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.539 -0.755 . . . . 74.420000000000002 110.036 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 34.2 p -85.19 117.68 24.28 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 115.945 -0.571 . . . . 71.329999999999998 110.593 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.2 m -100.79 146.63 27.03 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.573 -1.269 . . . . 73.150000000000006 107.573 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -71.31 150.79 44.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 118.078 0.399 . . . . 62.539999999999999 110.502 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.56 -25.06 23.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 124.316 1.046 . . . . 75.030000000000001 110.83 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -100.55 0.17 38.92 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.514 -0.766 . . . . 72.310000000000002 111.278 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -77.35 151.81 34.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.205 -1.406 . . . . 73.230000000000004 107.205 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.34 111.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 119.211 -0.995 . . . . 70.549999999999997 110.495 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 75.0 t -90.31 118.72 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.235 -1.024 . . . . 75.400000000000006 108.235 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 69.2 mt -95.18 119.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.345 -1.354 . . . . 72.319999999999993 107.345 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.99 119.67 55.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 109.361 -0.607 . . . . 64.299999999999997 109.361 -177.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 487' ' ' ILE . 3.2 mp -99.03 119.67 47.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 109.68 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.65 136.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.299 -0.864 . . . . 54.119999999999997 109.995 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -73.97 112.47 3.81 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 107.595 -2.202 . . . . 63.539999999999999 107.595 172.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.5 m -114.27 158.41 21.44 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.705 -0.48 . . . . 74.010000000000005 109.705 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -91.24 136.58 13.41 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.673 -0.775 . . . . 64.019999999999996 111.345 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.08 121.31 7.16 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.865 1.71 . . . . 54.140000000000001 108.365 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -82.75 80.9 8.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.12 0.962 . . . . 74.439999999999998 110.131 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -137.31 156.31 48.4 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.756 -1.201 . . . . 64.230000000000004 107.756 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -149.85 157.04 42.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.632 0.604 . . . . 73.420000000000002 112.632 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.42 130.6 34.61 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 125.344 1.458 . . . . 75.519999999999996 110.219 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -87.27 129.23 52.33 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.397 -0.521 . . . . 54.100000000000001 111.402 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.04 162.34 23.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.66 2.24 . . . . 64.340000000000003 111.552 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.27 114.55 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.047 -0.524 . . . . 74.329999999999998 110.041 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.41 ' HA ' HE21 ' A' ' 503' ' ' GLN . 27.7 m -122.84 -0.02 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 112.305 0.483 . . . . 72.129999999999995 112.305 -177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -68.87 143.21 54.58 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.407 0.442 . . . . 74.209999999999994 110.398 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 90.38 11.61 62.4 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.406 -0.902 . . . . 75.150000000000006 111.027 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 500' ' ' VAL . 42.1 mt-30 -122.43 -170.16 2.03 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.841 -0.8 . . . . 75.019999999999996 108.841 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.8 m -91.21 155.44 18.58 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.366 -1.346 . . . . 74.329999999999998 107.366 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.22 -41.35 80.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.266 0.354 . . . . 73.010000000000005 111.606 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.5 m-20 -66.08 -42.98 88.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 111.463 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.5 -36.38 28.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 119.757 -0.777 . . . . 64.329999999999998 110.988 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.53 -46.4 86.21 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.477 -0.783 . . . . 75.329999999999998 111.382 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.8 -35.72 82.02 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 120.447 -0.501 . . . . 52.210000000000001 110.084 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 mmtp -65.52 -50.69 64.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.552 -0.295 . . . . 73.239999999999995 111.516 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.24 -40.51 96.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.289 -0.414 . . . . 71.540000000000006 110.936 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.3 -42.61 75.21 Favored 'General case' 0 C--O 1.183 -2.441 0 N-CA-C 109.225 -0.658 . . . . 72.420000000000002 109.225 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.18 -40.01 84.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.943 0.497 . . . . 63.009999999999998 111.607 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.6 t -67.01 -29.66 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 112.455 0.539 . . . . 73.109999999999999 112.455 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -118.55 -5.11 10.76 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.406 -0.918 . . . . 70.219999999999999 111.699 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -108.71 1.94 Allowed Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 115.402 -0.817 . . . . 61.119999999999997 113.497 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 31.3 m-85 -130.3 174.41 9.87 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.461 -0.495 . . . . 61.329999999999998 111.279 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -103.82 -5.13 22.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.403 -0.817 . . . . 54.210000000000001 111.096 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 550' ' ' VAL . 14.8 ptpt -113.82 121.04 42.82 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.029 -0.532 . . . . 72.140000000000001 110.782 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -126.27 148.54 49.49 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.681 0.753 . . . . 74.239999999999995 111.766 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.9 m -127.81 154.94 44.85 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.851 -1.907 . . . . 64.340000000000003 105.851 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -121.81 143.21 49.54 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.722 -0.791 . . . . 74.299999999999997 109.848 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 554' ' ' GLN . . . -113.73 123.0 48.83 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.933 -1.506 . . . . 70.329999999999998 106.933 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.3 m -88.76 116.45 27.03 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.437 -0.801 . . . . 62.210000000000001 109.779 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 29.9 m -121.14 156.92 24.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.179 -1.415 . . . . 62.409999999999997 107.179 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.39 124.04 27.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.252 0.549 . . . . 74.439999999999998 110.438 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 18.3 m -72.15 151.69 92.48 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.631 -1.168 . . . . 75.329999999999998 112.626 -173.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 4.5 Cg_exo -80.62 -144.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.848 2.366 . . . . 65.340000000000003 107.441 168.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.83 -49.57 68.15 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 121.554 -0.716 . . . . 72.109999999999999 111.926 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.95 152.25 36.25 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 121.168 1.245 . . . . 54.399999999999999 111.111 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -140.13 149.66 43.3 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 101.03 -10.45 58.49 Favored Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.97 -0.633 . . . . 62.539999999999999 111.907 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.32 148.81 24.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.315 0.579 . . . . 74.200000000000003 111.701 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.536 HG21 ' CB ' ' A' ' 508' ' ' ALA . 95.5 t -75.75 120.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.271 -0.877 . . . . 72.420000000000002 109.133 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.1 m -82.1 -31.39 30.74 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.121 -0.945 . . . . 74.5 108.751 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 170.62 -169.64 42.5 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.284 -0.726 . . . . 71.349999999999994 111.284 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 32.7 p -123.69 149.46 45.46 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.221 -1.77 . . . . 64.099999999999994 106.221 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.6 t-20 -56.21 -58.32 17.25 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.978 -0.534 . . . . 61.450000000000003 112.069 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.8 Cg_exo -80.5 145.16 16.4 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.343 1.362 . . . . 74.230000000000004 108.784 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.1 147.56 73.56 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.898 1.732 . . . . 63.229999999999997 112.226 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -53.51 129.57 32.88 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.728 0.811 . . . . 44.329999999999998 110.267 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.68 -7.79 36.58 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.624 -0.798 . . . . 54.509999999999998 111.51 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.8 m -82.73 126.87 32.86 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.791 -0.448 . . . . 70.409999999999997 109.791 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 87.9 m -93.3 123.18 36.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.037 -1.098 . . . . 63.310000000000002 108.037 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.97 158.55 68.38 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 109.113 -0.699 . . . . 52.5 109.113 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 494' ' ' THR . 34.6 Cg_exo -61.09 145.66 98.63 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 122.664 2.242 . . . . 71.510000000000005 112.129 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.439 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 18.5 m -67.4 -19.24 25.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 122.144 0.974 . . . . 72.329999999999998 109.221 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.13 3.78 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 63.0 109.998 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 36.3 t -112.71 141.83 46.04 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.783 -1.192 . . . . 70.040000000000006 107.783 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.471 ' HA ' ' HG3' ' A' ' 519' ' ' LYS . 21.9 t -91.34 136.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.306 -0.627 . . . . 72.430000000000007 109.306 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.1 tp -91.32 135.02 28.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 110.078 -0.341 . . . . 62.329999999999998 110.078 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -102.86 117.64 35.08 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-O 121.573 0.701 . . . . 72.299999999999997 110.7 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.51 118.88 33.95 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.897 -1.52 . . . . 74.129999999999995 106.897 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 523' ' ' ALA . 8.9 mt-30 -94.56 106.67 18.66 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.616 -1.253 . . . . 63.340000000000003 107.616 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.23 138.56 46.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-N 114.957 -1.02 . . . . 75.329999999999998 112.029 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.463 ' HB3' ' OG ' ' A' ' 527' ' ' SER . 31.8 m -61.02 121.1 11.59 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.037 -0.983 . . . . 54.539999999999999 109.392 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 22.5 pttp . . . . . 0 C--O 1.254 1.305 0 CA-C-N 115.754 -0.657 . . . . 62.310000000000002 110.588 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.163 0 N-CA-C 109.001 -1.64 . . . . 53.450000000000003 109.001 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.3 132.16 25.14 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 CA-C-N 119.399 1.6 . . . . 52.25 109.419 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.1 pt-20 -96.34 17.57 15.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.808 0.813 . . . . 73.239999999999995 109.588 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -83.61 123.57 29.91 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.319 -0.855 . . . . 54.149999999999999 109.571 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -120.26 164.45 16.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.788 -1.189 . . . . 71.519999999999996 107.788 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.42 141.61 32.62 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 123.247 0.619 . . . . 64.230000000000004 112.323 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -85.06 131.46 48.6 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 105.33 -2.1 . . . . 55.229999999999997 105.33 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.34 141.5 97.78 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.994 1.796 . . . . 71.409999999999997 113.041 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -102.34 -13.03 17.49 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.411 -0.813 . . . . 64.239999999999995 108.913 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.61 8.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.046 -0.979 . . . . 62.130000000000003 110.331 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.1 m -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.798 -1.092 . . . . 74.430000000000007 108.865 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 p -59.29 -27.62 66.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.133 -1.394 . . . . 75.049999999999997 111.115 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.42 -45.08 23.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.609 -0.515 . . . . 71.25 109.609 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 19.7 m -163.69 144.49 8.85 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.148 -1.056 . . . . 51.329999999999998 108.148 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 441' ' ' VAL . 30.1 t80 -59.29 -41.38 88.8 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.75 0.42 . . . . 73.140000000000001 110.465 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.42 ' H ' HG22 ' A' ' 436' ' ' THR . . . -56.16 -40.69 74.27 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.19 0.306 . . . . 64.329999999999998 111.176 175.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.456 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 40.7 mm-40 -61.87 -44.43 96.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 116.237 -0.438 . . . . 70.439999999999998 110.31 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.23 -47.71 84.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.351 -0.84 . . . . 51.409999999999997 110.708 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.7 t -58.7 -50.55 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 O-C-N 123.704 0.628 . . . . 74.049999999999997 110.79 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -38.0 84.7 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.789 0.662 . . . . 75.439999999999998 112.789 -177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -66.47 -43.29 85.89 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 120.739 0.305 . . . . 72.409999999999997 110.719 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.79 -36.88 78.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 74.430000000000007 110.313 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 60.4 m -63.63 -41.28 98.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.995 -0.743 . . . . 74.109999999999999 108.995 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.16 -18.67 62.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.987 -0.551 . . . . 63.32 111.239 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.47 -14.65 51.99 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.677 -0.49 . . . . 74.349999999999994 109.677 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 85.98 8.73 78.62 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.953 -0.567 . . . . 63.149999999999999 114.33 172.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.49 124.54 20.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.213 0.506 . . . . 74.420000000000002 111.834 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -63.4 -55.41 25.79 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.054 -0.975 . . . . 21.100000000000001 114.285 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 0.4 OUTLIER -121.81 130.95 53.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.282 -0.567 . . . . 74.209999999999994 110.761 -174.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.77 144.59 31.25 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.805 -0.634 . . . . 75.140000000000001 109.304 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -131.34 141.5 49.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.456 -0.572 . . . . 63.100000000000001 109.456 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.63 136.4 34.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.878 0.736 . . . . 64.129999999999995 110.813 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.63 52.44 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.55 -2.018 . . . . 72.120000000000005 105.55 171.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -138.59 150.47 46.34 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 119.012 0.823 . . . . 72.310000000000002 110.138 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 25.6 m -131.94 145.7 58.56 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 108.627 -0.879 . . . . 55.409999999999997 108.627 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.63 134.8 26.93 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.505 2.137 . . . . 71.120000000000005 112.04 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.3 p -152.15 179.74 8.24 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.866 0.866 . . . . 64.099999999999994 109.207 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -59.68 142.3 87.98 Favored Pre-proline 0 N--CA 1.432 -1.339 0 C-N-CA 123.741 0.817 . . . . 44.450000000000003 111.411 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 464' ' ' VAL . 54.0 Cg_exo -52.57 -28.13 35.43 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.421 3.414 . . . . 73.129999999999995 113.428 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.98 -10.34 59.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.344 0.498 . . . . 64.010000000000005 112.344 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 9.5 mp -107.29 0.73 23.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.446 0.535 . . . . 75.5 112.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 461' ' ' PRO . 12.1 p -61.29 128.81 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.286 0.565 . . . . 55.310000000000002 112.191 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.82 69.7 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 120.896 -0.669 . . . . 74.030000000000001 112.427 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 23.5 mtpp -109.91 146.17 35.62 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.318 -0.993 . . . . 72.510000000000005 108.318 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 486' ' ' ILE . 63.1 t -81.86 124.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.29 -0.633 . . . . 73.230000000000004 109.29 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.1 pt -101.68 -2.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.923 -0.58 . . . . 62.140000000000001 111.639 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.99 156.67 11.79 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.119 -0.562 . . . . 50.43 112.324 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 35.0 p -128.5 148.73 50.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.415 -0.957 . . . . 64.120000000000005 108.415 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -65.52 -56.18 20.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.273 -0.394 . . . . 61.229999999999997 110.477 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 57.3 Cg_endo -82.2 131.37 6.72 Favored 'Trans proline' 0 C--N 1.364 1.369 0 CA-C-N 120.152 1.09 . . . . 74.049999999999997 109.473 170.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -72.69 152.61 53.49 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.976 1.784 . . . . 42.530000000000001 113.119 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.11 6.35 11.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.395 1.078 . . . . 72.409999999999997 111.232 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.23 -28.64 13.99 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.796 -0.638 . . . . 73.319999999999993 111.108 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -115.45 161.47 18.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.211 -0.663 . . . . 73.239999999999995 109.211 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 33.3 p -95.35 140.8 29.72 Favored 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 120.483 -0.487 . . . . 71.219999999999999 109.875 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 482' ' ' ASN . 23.4 m -120.88 147.94 44.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.452 -0.573 . . . . 62.219999999999999 109.452 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 482' ' ' ASN . . . -57.12 151.32 15.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.352 0.871 . . . . 64.129999999999995 113.352 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 448' ' ' GLY . 45.1 mm -58.07 -32.98 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.049 0.939 . . . . 74.140000000000001 110.368 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.2 t -81.4 3.25 25.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.251 -0.886 . . . . 64.510000000000005 111.979 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 478' ' ' SER . 0.8 OUTLIER -74.33 158.42 34.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.275 0.559 . . . . 70.010000000000005 112.349 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 451' ' ' ARG . 60.4 t -106.97 114.31 45.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.027 -1.101 . . . . 73.519999999999996 108.027 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 88.6 t -94.61 119.91 43.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.237 0.541 . . . . 73.25 110.439 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 71.9 mt -96.31 112.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.484 -1.673 . . . . 74.040000000000006 106.484 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -106.19 128.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 116.167 -0.47 . . . . 71.099999999999994 110.533 -176.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.93 115.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.599 0.714 . . . . 75.239999999999995 111.069 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.53 142.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.547 -0.752 . . . . 72.140000000000001 109.55 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.27 113.71 3.77 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.091 -1.204 . . . . 62.25 110.091 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 35.1 t -95.8 129.81 42.92 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 106.748 -1.575 . . . . 61.420000000000002 106.748 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -116.61 99.71 0.87 Allowed Glycine 0 C--N 1.297 -1.593 0 C-N-CA 119.754 -1.212 . . . . 73.420000000000002 112.029 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.8 114.52 3.98 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.147 1.898 . . . . 73.409999999999997 109.911 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.34 106.69 17.57 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.027 -0.731 . . . . 60.100000000000001 109.027 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 546' ' ' PRO . 66.6 p -124.92 164.93 19.02 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.25 -0.887 . . . . 74.319999999999993 109.123 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 495' ' ' LYS . 6.4 mmpt? -139.62 144.18 37.57 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.686 -0.857 . . . . 72.109999999999999 108.686 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 27.6 t70 -90.59 130.34 36.63 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.788 -0.819 . . . . 54.420000000000002 108.788 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 20.4 pt -96.12 121.39 60.77 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.268 -0.573 . . . . 71.340000000000003 112.525 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.23 169.96 4.93 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.915 1.743 . . . . 65.310000000000002 109.316 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.88 129.71 34.84 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.491 -0.884 . . . . 75.439999999999998 109.574 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.35 14.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 123.278 1.513 . . . . 62.109999999999999 107.093 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -71.61 138.57 48.82 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.546 -1.661 . . . . 60.409999999999997 110.293 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.09 -4.57 41.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.648 -0.787 . . . . 72.510000000000005 111.822 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -106.09 176.63 5.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.844 -1.539 . . . . 73.340000000000003 106.844 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 71.1 p -80.41 157.87 26.13 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.448 -0.901 . . . . 72.349999999999994 108.963 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.46 -43.14 86.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.495 0.664 . . . . 62.240000000000002 110.19 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.86 -42.8 85.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.77 -1.105 . . . . 73.310000000000002 111.812 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.18 -36.84 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 119.431 -0.908 . . . . 73.430000000000007 111.243 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.49 73.4 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.908 -0.587 . . . . 71.439999999999998 111.282 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.3 -35.97 82.62 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 120.318 -0.553 . . . . 65.25 110.614 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -61.37 -53.69 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.505 0.503 . . . . 75.239999999999995 110.775 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.11 -41.85 94.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.788 -0.642 . . . . 73.420000000000002 110.673 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 551' ' ' ILE . 4.9 tt -66.36 -40.66 89.91 Favored 'General case' 0 C--O 1.186 -2.257 0 CA-C-N 115.404 -0.816 . . . . 75.510000000000005 109.246 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.1 t-20 -58.54 -38.29 77.46 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.387 0.675 . . . . 60.229999999999997 111.621 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.57 -40.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.726 -0.67 . . . . 72.129999999999995 112.032 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -107.4 -23.28 12.26 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.037 -0.665 . . . . 70.230000000000004 112.197 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -103.59 -100.16 2.58 Favored Glycine 0 N--CA 1.413 -2.861 0 CA-C-N 115.262 -0.881 . . . . 34.420000000000002 113.683 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 46.0 m-85 -131.23 166.86 20.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.331 0.586 . . . . 64.450000000000003 111.185 -171.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.443 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 4.7 p -102.8 -4.12 25.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.943 -1.026 . . . . 74.400000000000006 110.295 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -109.95 116.29 31.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.705 . . . . 72.239999999999995 109.763 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -128.94 145.84 51.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 110.911 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 59.2 m -135.64 145.63 47.02 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.988 -1.486 . . . . 73.510000000000005 106.988 172.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -125.55 143.25 51.09 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.393 -0.523 . . . . 72.439999999999998 111.95 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.45 129.23 52.85 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.596 -1.261 . . . . 65.439999999999998 107.596 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -88.35 127.74 35.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.207 0.527 . . . . 73.209999999999994 110.422 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.1 m -121.54 162.53 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.287 -1.005 . . . . 75.420000000000002 108.287 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.78 140.51 38.23 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.937 -0.705 . . . . 73.409999999999997 110.065 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 530' ' ' PRO . 8.3 m -90.08 114.17 59.9 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.377 -1.283 . . . . 62.240000000000002 110.825 -174.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.85 -83.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.729 1.619 . . . . 52.520000000000003 109.661 173.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 97.3 mtt180 -90.9 -54.8 0.27 Allowed Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-O 118.805 -0.616 . . . . 64.530000000000001 111.14 172.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.66 ' O ' ' HB3' ' A' ' 527' ' ' SER . 21.9 Cg_endo -61.61 153.26 68.2 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.99 1.794 . . . . 64.409999999999997 111.359 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.46 82.43 0.27 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.853 0.861 . . . . 71.310000000000002 108.993 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.31 -31.12 2.64 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.482 -1.047 . . . . 75.5 110.482 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -86.12 149.55 25.05 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.259 -0.471 . . . . 72.209999999999994 110.17 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 501' ' ' ALA . 5.3 p -73.85 123.11 28.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.318 -0.993 . . . . 64.530000000000001 108.318 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -71.87 -41.58 67.86 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.872 -1.058 . . . . 60.109999999999999 110.874 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -174.26 -160.35 22.3 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.407 -0.902 . . . . 71.120000000000005 111.189 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.0 p -131.74 159.98 36.86 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.66 -0.867 . . . . 73.420000000000002 108.66 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.473 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 48.8 t30 -69.02 -55.36 10.53 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-O 118.937 -0.554 . . . . 72.530000000000001 110.512 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.0 Cg_endo -81.48 146.94 15.59 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.05 1.167 . . . . 74.329999999999998 109.533 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.04 147.73 43.66 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.943 1.762 . . . . 74.340000000000003 112.444 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.11 138.23 58.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.824 -0.626 . . . . 53.229999999999997 110.017 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.74 -5.75 60.16 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 111.173 -0.771 . . . . 65.430000000000007 111.173 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -88.78 126.04 35.16 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.593 -0.521 . . . . 62.32 109.593 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.1 m -90.51 123.13 33.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.802 -1.184 . . . . 63.530000000000001 107.802 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.74 154.74 75.8 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.82 -0.437 . . . . 52.439999999999998 109.82 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.533 ' HA ' HG22 ' A' ' 494' ' ' THR . 27.0 Cg_exo -64.72 147.71 89.91 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.945 2.43 . . . . 73.510000000000005 113.55 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.534 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.6 m -67.05 -19.42 25.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.163 0.982 . . . . 70.040000000000006 111.995 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.62 -8.03 59.03 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.688 -1.142 . . . . 34.049999999999997 109.365 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 41.4 m -97.44 149.91 21.62 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 115.165 -0.925 . . . . 62.399999999999999 109.204 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.87 136.57 26.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.94 -0.573 . . . . 73.299999999999997 110.309 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 512' ' ' LEU . 15.5 tt -98.93 129.01 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.665 0.745 . . . . 74.430000000000007 109.963 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 521' ' ' SER . 31.8 tt0 -103.74 129.67 51.15 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 115.696 -0.684 . . . . 50.109999999999999 110.379 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.72 134.5 48.74 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.419 1.088 . . . . 71.420000000000002 110.672 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.06 108.53 19.79 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.276 -1.75 . . . . 61.329999999999998 106.276 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.09 137.62 38.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 112.089 0.403 . . . . 75.200000000000003 112.089 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.7 m -60.42 122.02 13.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.668 -1.604 . . . . 73.010000000000005 106.668 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.836 -0.602 . . . . 70.140000000000001 111.863 -172.789 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.903 0 N-CA-C 109.993 -1.243 . . . . 43.32 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.58 152.29 70.22 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.298 1.999 . . . . 62.210000000000001 110.858 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.3 OUTLIER -82.59 49.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.041 0.924 . . . . 74.409999999999997 111.319 -177.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 96.2 mt-30 -102.93 130.22 49.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.81 -1.086 . . . . 72.329999999999998 108.758 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -128.23 158.85 36.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.206 -1.035 . . . . 73.329999999999998 108.206 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -82.66 141.5 32.43 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 123.254 0.622 . . . . 72.510000000000005 110.365 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -85.09 130.01 53.79 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.052 -0.721 . . . . 70.209999999999994 109.052 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.01 145.19 99.42 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.979 2.453 . . . . 71.319999999999993 112.333 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.24 11.72 35.44 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.433 1.111 . . . . 74.439999999999998 110.14 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.91 -9.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.581 1.182 . . . . 73.310000000000002 108.562 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.8 m -59.26 -33.75 71.41 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.916 -1.493 . . . . 65.299999999999997 110.292 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 4.2 m -60.68 -27.34 67.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.505 -1.225 . . . . 65.530000000000001 110.375 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.79 -44.25 17.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 119.991 -0.683 . . . . 74.510000000000005 110.959 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.614 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 91.5 m -162.0 144.61 11.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 109.394 -0.595 . . . . 61.25 109.394 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -52.68 -49.42 65.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.016 0.926 . . . . 73.510000000000005 111.227 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.69 -40.77 80.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 43.329999999999998 111.22 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 19.9 mm-40 -61.42 -41.42 97.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.827 -0.624 . . . . 73.450000000000003 111.101 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -61.05 -51.82 67.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 123.915 0.759 . . . . 53.109999999999999 110.718 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.77 -46.68 95.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 CA-C-N 115.114 -0.948 . . . . 75.019999999999996 111.994 -174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 75.6 mmtt -60.84 -47.89 84.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 110.028 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -68.26 -45.29 73.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.351 -0.84 . . . . 74.510000000000005 111.431 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 452' ' ' PHE . 21.8 tp -69.07 -38.53 79.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.063 0.459 . . . . 63.409999999999997 110.845 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.6 m -64.16 -39.66 94.48 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.838 -0.619 . . . . 73.239999999999995 109.459 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -18.98 62.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.932 -0.577 . . . . 64.319999999999993 110.442 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.16 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.087 0.47 . . . . 61.020000000000003 110.124 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.84 -23.71 9.93 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.617 -0.802 . . . . 43.25 113.175 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.69 134.29 56.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.741 0.305 . . . . 74.439999999999998 110.783 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -130.13 -8.17 3.41 Favored Glycine 0 N--CA 1.428 -1.886 0 C-N-CA 119.811 -1.185 . . . . 61.039999999999999 112.898 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -102.69 115.4 30.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.548 -0.908 . . . . 71.209999999999994 108.548 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 444' ' ' LEU . 42.3 m-85 -129.19 154.88 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.294 -0.866 . . . . 74.230000000000004 110.394 -175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.468 ' HB3' HG12 ' A' ' 485' ' ' ILE . 0.7 OUTLIER -138.86 122.92 17.93 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.37 -2.455 . . . . 75.420000000000002 104.37 169.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -105.17 134.61 47.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 110.904 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.13 153.3 47.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.497 -0.927 . . . . 52.240000000000002 108.497 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.35 146.49 50.02 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 62.109999999999999 109.396 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 53.4 m -139.89 135.21 16.37 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 116.555 -0.293 . . . . 65.340000000000003 110.373 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 26.6 Cg_exo -64.72 122.39 10.23 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.386 2.057 . . . . 62.219999999999999 111.374 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.7 m -140.54 -179.91 6.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.81 -1.181 . . . . 71.409999999999997 107.81 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.406 ' CG2' HD23 ' A' ' 463' ' ' LEU . 10.8 t -50.2 142.99 13.46 Favored Pre-proline 0 C--O 1.25 1.131 0 C-N-CA 123.168 0.587 . . . . 73.349999999999994 110.795 176.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.12 -29.32 28.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.088 3.192 . . . . 72.129999999999995 112.986 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.52 -18.86 63.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.467 0.543 . . . . 54.240000000000002 112.467 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -100.97 6.8 43.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.978 0.732 . . . . 75.230000000000004 112.978 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.6 p -61.01 127.69 21.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.406 -0.518 . . . . 55.119999999999997 110.546 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.48 12.73 84.26 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.801 -0.714 . . . . 60.539999999999999 112.439 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 94.6 mttt -121.18 154.87 35.68 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.693 -0.854 . . . . 71.140000000000001 108.693 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.645 HG22 HD11 ' A' ' 486' ' ' ILE . 40.5 t -82.06 126.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.174 -0.676 . . . . 64.230000000000004 109.174 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.4 pt -98.17 -13.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.462 -0.495 . . . . 60.240000000000002 110.358 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.45 160.82 19.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.595 -0.812 . . . . 73.319999999999993 111.684 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.5 p -120.86 146.72 46.28 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.546 -0.909 . . . . 71.329999999999998 108.546 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.561 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 26.3 t-20 -58.49 -57.93 22.81 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-O 119.128 -0.463 . . . . 73.310000000000002 111.042 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.34 129.55 14.04 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 108.737 -1.294 . . . . 73.450000000000003 108.737 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.7 133.08 37.72 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 74.209999999999994 112.254 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.6 -5.7 46.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.939 0.876 . . . . 63.32 110.673 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.81 -28.44 28.08 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.224 -1.353 . . . . 73.109999999999999 109.4 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.91 165.21 11.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.041 -0.726 . . . . 74.109999999999999 109.041 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 21.5 p -87.84 120.83 29.56 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 109.094 -0.706 . . . . 75.150000000000006 109.094 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 19.8 m -104.39 147.98 26.93 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.359 -0.978 . . . . 73.420000000000002 108.359 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.81 148.58 44.38 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.752 0.31 . . . . 71.430000000000007 110.94 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.36 -21.9 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.869 0.842 . . . . 64.310000000000002 110.549 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 t -94.32 -0.56 54.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.228 -0.896 . . . . 71.219999999999999 110.566 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.9 142.13 38.63 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.345 -0.983 . . . . 71.430000000000007 108.345 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.63 112.0 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.702 -0.851 . . . . 63.520000000000003 108.702 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.77 118.41 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 108.389 -0.967 . . . . 52.140000000000001 108.389 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.4 mt -92.44 112.01 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 106.018 -1.845 . . . . 75.450000000000003 106.018 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.55 121.56 56.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.121 -0.945 . . . . 73.310000000000002 108.633 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.93 118.85 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.748 -0.66 . . . . 71.200000000000003 109.608 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.25 139.16 19.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.011 -1.107 . . . . 62.119999999999997 108.011 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.02 127.08 7.79 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 109.975 -1.25 . . . . 54.439999999999998 109.975 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 24.6 p -108.38 131.72 54.47 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.749 -0.834 . . . . 70.230000000000004 108.749 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -90.88 163.75 29.64 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.939 -1.264 . . . . 74.209999999999994 109.939 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.68 121.78 10.06 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.153 1.902 . . . . 73.409999999999997 112.016 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -112.57 70.12 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.353 -1.351 . . . . 74.319999999999993 107.353 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 41.5 p -135.51 166.36 23.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.854 -1.066 . . . . 62.420000000000002 109.583 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 27.6 mmtm -140.13 137.63 34.61 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.052 0.453 . . . . 65.109999999999999 111.802 173.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.78 126.46 31.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.626 -1.17 . . . . 72.519999999999996 108.058 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.9 pt -96.34 131.01 29.39 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.73 -0.788 . . . . 75.439999999999998 110.619 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.76 -177.95 1.03 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.356 2.037 . . . . 71.219999999999999 110.472 174.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.91 93.8 3.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.07 0.462 . . . . 74.349999999999994 110.232 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.19 -0.6 10.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.84 -1.541 . . . . 60.219999999999999 106.84 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -70.46 143.69 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.459 -1.7 . . . . 73.409999999999997 109.565 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.22 -15.45 25.36 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.477 -0.868 . . . . 45.100000000000001 111.52 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.64 -170.15 1.95 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.28 -0.568 . . . . 74.430000000000007 110.249 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.5 157.52 21.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.894 -1.15 . . . . 74.239999999999995 107.894 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 42.4 t -56.62 -49.62 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.416 0.627 . . . . 43.5 111.14 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.27 -41.96 80.3 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.282 -0.872 . . . . 74.299999999999997 111.129 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.32 -44.67 94.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.828 -1.078 . . . . 45.43 110.632 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.05 96.47 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.003 -0.544 . . . . 61.329999999999998 110.957 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.21 -40.17 95.19 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.89 -0.411 . . . . 73.450000000000003 109.89 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -44.03 89.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.832 -0.622 . . . . 75.140000000000001 110.6 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.65 -44.51 73.98 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.039 0.447 . . . . 73.140000000000001 110.519 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.15 -36.8 85.37 Favored 'General case' 0 C--O 1.191 -2.004 0 CA-C-N 115.565 -0.743 . . . . 71.409999999999997 109.54 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 26.2 t-20 -57.85 -37.96 74.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.263 0.625 . . . . 61.039999999999999 111.597 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.46 -43.16 91.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.585 -0.734 . . . . 55.299999999999997 111.675 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -110.85 13.29 22.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.521 -0.472 . . . . 71.450000000000003 110.549 -171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -147.9 -103.01 0.31 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.408 -1.377 . . . . 44.5 115.108 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 46.9 m-85 -127.04 177.56 6.56 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.005 0.431 . . . . 74.109999999999999 112.143 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 m -120.74 -14.52 8.54 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.739 -0.664 . . . . 64.540000000000006 110.949 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.438 ' HB3' HG12 ' A' ' 550' ' ' VAL . 31.5 mmmt -108.23 119.68 40.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.431 -0.581 . . . . 75.239999999999995 109.431 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.72 147.57 44.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.714 -0.675 . . . . 73.010000000000005 111.001 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 44.3 m -137.5 151.64 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.756 -1.572 . . . . 65.019999999999996 106.756 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -121.53 137.83 54.56 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 118.339 0.518 . . . . 71.230000000000004 111.381 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -126.17 122.62 36.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.353 -1.351 . . . . 70.299999999999997 107.353 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 5.2 p -89.33 132.7 34.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.777 0.322 . . . . 52.130000000000003 111.5 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.76 149.31 24.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.183 -1.414 . . . . 72.109999999999999 107.183 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.88 136.3 37.25 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.133 -0.627 . . . . 64.319999999999993 110.972 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.1 m -133.64 160.5 68.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.065 -0.97 . . . . 73.549999999999997 109.982 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -70.19 -142.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.38 2.72 . . . . 63.439999999999998 111.964 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -51.39 81.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 113.888 1.07 . . . . 73.040000000000006 113.888 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.24 133.02 31.38 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 121.043 1.408 . . . . 72.109999999999999 109.799 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -168.78 125.49 0.98 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.303 0.641 . . . . 74.109999999999999 109.518 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.9 -23.53 1.45 Allowed Glycine 0 C--N 1.301 -1.413 0 N-CA-C 109.841 -1.304 . . . . 63.130000000000003 109.841 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.55 29.92 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.447 -0.946 . . . . 74.019999999999996 108.447 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 75.0 t -74.05 119.39 21.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.6 -0.889 . . . . 61.0 108.6 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 3.0 m -68.5 -40.36 80.89 Favored 'General case' 0 N--CA 1.427 -1.595 0 O-C-N 124.529 1.143 . . . . 71.319999999999993 109.642 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 169.61 -152.87 20.63 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.506 -0.854 . . . . 42.229999999999997 111.541 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -134.04 161.76 33.96 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.744 -1.206 . . . . 61.329999999999998 107.744 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -56.32 -65.3 1.67 Allowed Pre-proline 0 N--CA 1.474 0.76 0 CA-C-O 118.891 -0.576 . . . . 63.409999999999997 110.65 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 60.2 Cg_endo -76.88 147.92 27.66 Favored 'Trans proline' 0 C--N 1.367 1.509 0 CA-C-N 120.633 1.262 . . . . 74.25 109.248 173.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.86 163.05 40.08 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.927 1.751 . . . . 71.109999999999999 111.528 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.76 58.66 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.187 -0.46 . . . . 61.200000000000003 110.21 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.49 -12.76 61.51 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.936 -0.865 . . . . 65.420000000000002 110.936 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.7 m -86.04 124.22 32.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 109.07 -0.715 . . . . 73.25 109.07 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.1 t -90.6 123.38 34.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.96 -1.126 . . . . 74.209999999999994 107.96 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 517' ' ' PHE . 19.4 m -123.64 156.27 64.93 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 109.671 -0.492 . . . . 55.030000000000001 109.671 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 135.08 65.29 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.213 2.609 . . . . 71.329999999999998 114.23 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.5 m -67.28 -20.78 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.274 -0.876 . . . . 63.549999999999997 111.518 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.11 -0.23 55.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 111.12 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 17.4 t -100.42 151.04 22.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.236 -1.024 . . . . 63.149999999999999 108.236 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 519' ' ' LYS . 5.7 m -88.58 136.41 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 N-CA-C 108.022 -1.103 . . . . 73.409999999999997 108.022 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.6 tt -97.52 143.28 12.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 120.036 -0.665 . . . . 74.099999999999994 110.858 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -102.45 118.37 36.72 Favored 'General case' 0 N--CA 1.408 -2.547 0 C-N-CA 123.471 0.709 . . . . 64.239999999999995 109.404 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.0 tp -97.05 129.25 44.51 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.729 -1.123 . . . . 50.200000000000003 108.689 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -90.05 112.95 24.56 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.364 -0.976 . . . . 71.329999999999998 108.364 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.8 137.88 33.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.006 -0.543 . . . . 65.310000000000002 111.955 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.5 m -68.76 126.08 28.61 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 115.64 -0.709 . . . . 73.349999999999994 111.65 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 115.308 -0.86 . . . . 52.240000000000002 108.803 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.033 0 N-CA-C 110.443 -1.063 . . . . 51.219999999999999 110.443 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.06 144.05 23.39 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.224 1.95 . . . . 54.409999999999997 112.338 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.3 OUTLIER -86.25 64.15 8.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.559 1.171 . . . . 64.219999999999999 110.191 178.203 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.435 ' C ' ' HB ' ' A' ' 477' ' ' THR . 26.7 mt-30 -101.64 125.7 48.35 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.006 -1.452 . . . . 55.140000000000001 108.755 175.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -121.04 153.44 37.38 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.407 -0.36 . . . . 62.329999999999998 110.341 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.02 141.39 28.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 110.889 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.4 mp -85.09 128.33 60.53 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 107.47 -1.307 . . . . 73.140000000000001 107.47 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.414 ' HG3' ' HD2' ' A' ' 443' ' ' LYS . 61.9 Cg_endo -69.8 147.05 61.78 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.561 2.174 . . . . 65.439999999999998 112.55 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -83.54 29.31 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.956 -0.565 . . . . 72.439999999999998 110.762 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 440' ' ' ALA . 35.9 m -85.84 7.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.001 0.905 . . . . 72.019999999999996 109.784 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 2.3 p -58.0 -35.02 70.62 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 125.999 1.719 . . . . 72.209999999999994 109.982 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 466' ' ' LYS . 14.6 t -60.47 -26.04 66.48 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.718 -1.583 . . . . 74.129999999999995 111.496 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.81 -47.81 10.01 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 118.953 -1.099 . . . . 73.099999999999994 111.05 -174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.4 m -174.41 153.99 2.03 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.736 -1.209 . . . . 73.209999999999994 107.736 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 467' ' ' VAL . 29.2 t80 -50.37 -54.72 19.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.293 1.037 . . . . 64.109999999999999 110.656 171.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.18 -41.23 75.18 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.912 -0.586 . . . . 63.340000000000003 111.936 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 443' ' ' LYS . 66.2 mm-40 -61.51 -46.56 89.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.156 0.428 . . . . 74.129999999999995 112.156 -178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.433 ' HA ' HG23 ' A' ' 432' ' ' VAL . . . -72.22 -45.83 58.64 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.603 0.594 . . . . 63.409999999999997 112.603 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.74 -47.6 88.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 53.350000000000001 110.958 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.62 -35.21 79.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.304 0.242 . . . . 50.149999999999999 110.973 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 439' ' ' GLU . 2.6 tmtm? -66.26 -47.61 73.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.155 -1.054 . . . . 62.420000000000002 108.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.1 tp -68.86 -32.66 72.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.723 -0.671 . . . . 72.209999999999994 110.519 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 96.9 m -60.89 -43.99 97.72 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.51 -0.768 . . . . 64.239999999999995 109.308 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.01 -20.02 62.45 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.077 -0.51 . . . . 71.340000000000003 111.148 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.54 -10.9 59.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.997 -0.547 . . . . 71.310000000000002 110.414 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.51 -8.43 8.33 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 119.927 -1.13 . . . . 74.120000000000005 113.956 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 445' ' ' THR . 92.5 m-85 -86.17 133.37 33.86 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 117.306 0.553 . . . . 73.319999999999993 110.773 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.41 -13.96 3.04 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.886 -0.673 . . . . 53.229999999999997 112.692 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 483' ' ' VAL . 14.3 ttm180 -103.06 116.29 32.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.41 0.605 . . . . 71.040000000000006 110.87 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.04 158.03 40.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.826 -0.625 . . . . 75.010000000000005 111.231 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 485' ' ' ILE . 5.4 tppp? -134.61 135.7 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.042 -2.207 . . . . 61.439999999999998 105.042 172.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -115.95 135.09 54.3 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.535 0.607 . . . . 73.319999999999993 111.236 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.24 140.86 45.58 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.348 -0.982 . . . . 64.299999999999997 108.348 175.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.86 142.12 46.5 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.862 -0.792 . . . . 74.140000000000001 108.862 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.5 t -140.58 146.74 46.19 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 108.605 -0.887 . . . . 54.149999999999999 108.605 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.2 Cg_exo -65.08 140.17 64.31 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.846 1.698 . . . . 70.299999999999997 109.926 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 71.1 m -150.72 179.77 7.93 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.747 -0.835 . . . . 60.200000000000003 108.747 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.1 t -56.09 133.67 74.5 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.94 -0.763 . . . . 75.450000000000003 108.94 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 79.3 Cg_exo -50.1 -29.59 22.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.142 3.228 . . . . 62.409999999999997 115.117 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.81 -10.31 59.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.234 0.828 . . . . 54.229999999999997 113.234 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 74.8 mt -102.53 11.61 37.61 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.784 -0.366 . . . . 64.239999999999995 111.731 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -61.14 128.05 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.999 0.428 . . . . 73.540000000000006 110.737 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.8 3.99 90.39 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.996 -0.547 . . . . 73.329999999999998 112.292 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 434' ' ' THR . 93.5 mttt -112.23 159.69 18.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.371 -0.974 . . . . 71.299999999999997 108.371 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 46.0 t -82.67 129.07 38.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.557 -0.905 . . . . 52.409999999999997 108.557 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.33 -20.52 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.361 0.601 . . . . 63.299999999999997 109.764 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.75 170.2 33.09 Favored Glycine 0 N--CA 1.416 -2.688 0 N-CA-C 110.471 -1.052 . . . . 53.530000000000001 110.471 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.2 p -120.02 157.62 28.49 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.452 -0.573 . . . . 72.349999999999994 109.452 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.577 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 25.6 t-20 -60.21 -49.28 91.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 119.238 -0.41 . . . . 51.340000000000003 111.49 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.0 Cg_exo -83.14 155.88 14.82 Favored 'Trans proline' 0 C--N 1.365 1.402 0 N-CA-C 107.821 -1.646 . . . . 73.25 107.821 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 68.4 Cg_endo -66.36 146.65 81.26 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 121.697 1.598 . . . . 60.509999999999998 109.887 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.94 -37.4 29.56 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 121.059 0.457 . . . . 73.219999999999999 111.166 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . 0.271 18.8 m-80 -85.41 -8.33 58.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.719 1.377 . . . . 41.039999999999999 114.719 -172.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.8 mp0 -95.39 152.28 18.54 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.773 -1.195 . . . . 74.120000000000005 107.773 174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.435 ' HB ' ' C ' ' A' ' 426' ' ' GLN . 33.1 p -79.51 121.63 25.46 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.272 0.558 . . . . 62.140000000000001 110.738 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.6 m -104.59 140.83 37.43 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.357 -0.979 . . . . 65.25 108.357 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.73 145.67 52.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.733 0.302 . . . . 64.129999999999995 111.635 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.0 mm -59.59 -21.89 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.472 0.709 . . . . 71.109999999999999 111.27 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.8 t -83.49 0.08 47.94 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.924 -0.485 . . . . 72.25 111.473 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.08 154.77 20.49 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.967 0.413 . . . . 74.129999999999995 110.605 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 451' ' ' ARG . 2.6 p -98.25 124.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.17 -1.418 . . . . 42.240000000000002 107.17 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.41 118.7 37.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 C-N-CA 119.19 -1.004 . . . . 75.040000000000006 109.405 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.577 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.96 113.15 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.029 -1.841 . . . . 74.109999999999999 106.029 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.34 128.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 115.923 -0.58 . . . . 75.530000000000001 109.595 -175.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 31.5 mt -104.5 119.96 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.277 -0.874 . . . . 64.010000000000005 109.286 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.59 137.76 23.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.279 -0.873 . . . . 73.0 108.885 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -85.05 123.49 6.32 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 110.943 -0.863 . . . . 62.350000000000001 110.943 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 27.4 t -111.07 129.46 55.91 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.67 -1.604 . . . . 62.200000000000003 106.67 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -80.15 146.8 28.19 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 109.291 -1.523 . . . . 63.229999999999997 109.291 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.08 110.99 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.85 1.7 . . . . 75.040000000000006 111.819 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -98.73 61.27 1.32 Allowed 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.69 -1.226 . . . . 64.430000000000007 107.69 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 23.8 p -134.76 160.71 37.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.348 -0.842 . . . . 74.319999999999993 110.66 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -150.45 142.24 23.74 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.714 0.806 . . . . 63.439999999999998 109.052 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.6 p-10 -88.75 134.01 34.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.479 . . . . 72.349999999999994 107.008 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.95 124.92 88.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 CA-C-N 115.489 -0.778 . . . . 63.409999999999997 111.867 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.06 150.15 1.65 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.533 2.155 . . . . 60.25 111.212 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -87.64 107.55 18.66 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.345 1.069 . . . . 63.539999999999999 110.053 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.489 HG12 HE21 ' A' ' 503' ' ' GLN . 5.1 t -105.53 42.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 106.925 -1.509 . . . . 64.010000000000005 106.925 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -80.42 159.89 25.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.406 -1.27 . . . . 64.510000000000005 112.629 -173.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 105.15 -16.09 46.37 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.216 -0.753 . . . . 72.319999999999993 111.216 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.489 HE21 HG12 ' A' ' 500' ' ' VAL . 39.0 mt-30 -89.93 -173.08 3.75 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.195 0.522 . . . . 74.239999999999995 111.696 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.6 m -90.85 156.56 17.93 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.403 -1.332 . . . . 63.32 107.403 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 19.2 t -55.05 -48.97 75.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 123.721 0.638 . . . . 64.439999999999998 111.08 -172.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.34 -41.62 80.46 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.619 0.6 . . . . 75.120000000000005 112.619 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 503' ' ' GLN . 7.9 p -73.88 -34.86 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.507 -0.877 . . . . 75.540000000000006 111.234 -174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.78 89.22 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.727 -0.67 . . . . 73.150000000000006 110.216 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 47.1 mt-30 -62.73 -42.74 99.81 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 123.448 0.467 . . . . 73.109999999999999 110.481 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 0.0 OUTLIER -62.08 -42.67 99.44 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 112.897 0.703 . . . . 73.299999999999997 112.897 178.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -66.99 -48.11 69.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.53 -0.468 . . . . 65.400000000000006 110.094 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 551' ' ' ILE . 41.8 tp -60.2 -41.17 92.44 Favored 'General case' 0 C--O 1.198 -1.614 0 CA-C-N 115.512 -0.767 . . . . 63.030000000000001 110.144 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.8 t-20 -59.21 -48.05 83.05 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.856 0.862 . . . . 74.200000000000003 111.29 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.88 -18.89 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.318 0.488 . . . . 75.150000000000006 112.318 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -118.96 8.66 11.7 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.778 -0.769 . . . . 64.0 110.229 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -149.84 -95.83 0.14 Allowed Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.02 -1.562 . . . . 65.530000000000001 115.836 -170.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 59.6 m-85 -123.11 170.18 10.47 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.221 0.534 . . . . 74.430000000000007 111.736 -165.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 20.4 p -97.11 -35.9 10.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.276 -0.874 . . . . 54.219999999999999 112.352 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -117.77 142.61 47.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.127 0.489 . . . . 71.530000000000001 112.075 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -127.6 156.99 41.4 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.735 -1.12 . . . . 74.120000000000005 110.404 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 40.4 t -129.73 141.99 50.79 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.845 -2.28 . . . . 71.129999999999995 104.845 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -121.28 129.78 53.31 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.944 -0.761 . . . . 72.340000000000003 108.944 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.411 ' HB3' HE22 ' A' ' 554' ' ' GLN . . . -129.03 136.96 51.0 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 123.601 0.563 . . . . 61.329999999999998 109.736 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 51.9 m -88.56 131.61 34.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.31 -0.859 . . . . 63.130000000000003 109.491 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.434 ' O ' ' HG3' ' A' ' 557' ' ' LYS . 34.4 m -122.24 149.53 25.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.734 -0.469 . . . . 70.120000000000005 109.734 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.93 111.45 16.27 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.74 0.781 . . . . 73.040000000000006 110.195 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 528' ' ' PRO . 7.2 p -107.58 119.81 49.37 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.615 -1.175 . . . . 52.039999999999999 109.818 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 527' ' ' SER . 26.9 Cg_exo -65.13 -51.49 1.54 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.449 2.099 . . . . 65.549999999999997 111.527 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 529' ' ' ARG . 14.9 mmm180 -102.78 -50.93 0.15 Allowed Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 114.186 1.18 . . . . 74.319999999999993 114.186 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.75 153.45 36.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.904 1.736 . . . . 74.420000000000002 112.373 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.89 108.01 0.86 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 122.918 0.487 . . . . 70.329999999999998 110.968 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.75 -24.08 33.19 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 120.935 -0.65 . . . . 74.420000000000002 114.336 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.24 23.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.7 p -73.68 120.16 22.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.945 -0.761 . . . . 64.010000000000005 108.945 176.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.8 m -71.73 -40.39 69.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.991 -1.004 . . . . 74.230000000000004 110.174 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.84 -149.81 13.81 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.488 -0.645 . . . . 71.299999999999997 111.488 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.5 p -117.9 160.03 22.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.277 -1.008 . . . . 72.120000000000005 108.277 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -74.3 -56.05 2.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.018 -1.073 . . . . 71.329999999999998 110.181 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.4 Cg_endo -64.87 149.33 89.71 Favored 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 120.741 0.961 . . . . 63.039999999999999 109.614 170.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 18.9 Cg_exo -66.8 152.36 80.66 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.525 2.15 . . . . 71.25 112.549 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.38 132.64 52.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.795 -0.817 . . . . 74.530000000000001 108.795 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.63 40.83 Favored Glycine 0 C--N 1.298 -1.574 0 C-N-CA 120.272 -0.966 . . . . 42.240000000000002 111.958 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.8 m -67.44 120.96 14.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.871 -0.789 . . . . 42.100000000000001 108.871 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.4 m -90.18 122.75 33.41 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.556 -0.905 . . . . 74.109999999999999 108.556 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.01 157.63 77.7 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 108.095 -1.076 . . . . 63.200000000000003 108.095 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.81 144.3 98.53 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.182 1.922 . . . . 73.439999999999998 111.577 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -65.03 -18.55 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.18 0.991 . . . . 71.450000000000003 110.786 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.32 -17.73 53.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.883 -1.508 . . . . 74.030000000000001 109.83 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.5 m -80.97 172.4 13.79 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.985 -1.007 . . . . 61.420000000000002 113.644 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.03 124.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.358 -1.292 . . . . 75.150000000000006 109.42 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.538 HD13 HD21 ' A' ' 512' ' ' LEU . 13.1 tt -100.46 136.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.558 -0.534 . . . . 62.240000000000002 109.558 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.29 122.6 45.13 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-O 121.435 0.636 . . . . 72.120000000000005 111.126 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 12.7 tp -101.39 133.83 45.4 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.203 1.401 . . . . 70.430000000000007 109.356 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.411 HE22 ' HB3' ' A' ' 523' ' ' ALA . 25.0 mm-40 -104.01 114.56 28.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.157 -0.682 . . . . 73.129999999999995 109.157 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 137.84 34.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 111.496 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 10.4 m -64.11 115.06 4.6 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 106.94 -1.504 . . . . 65.549999999999997 106.94 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 524' ' ' SER 0.306 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 N-CA-C 114.828 1.418 . . . . 62.43 114.828 -172.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.749 0 N-CA-C 110.487 -1.045 . . . . 63.140000000000001 110.487 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.37 132.48 31.53 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.613 2.209 . . . . 71.549999999999997 110.72 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -89.14 50.48 1.95 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.894 0.854 . . . . 65.219999999999999 110.445 -176.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.8 mt-30 -83.43 137.69 33.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.355 -0.839 . . . . 64.230000000000004 111.87 -174.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 21.6 tpp180 -129.51 157.38 42.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.351 -0.981 . . . . 65.439999999999998 108.351 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.43 141.92 28.79 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 123.332 0.653 . . . . 72.120000000000005 111.279 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -85.15 130.49 51.79 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 108.109 -1.071 . . . . 73.310000000000002 108.109 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HB3' ' HG2' ' A' ' 443' ' ' LYS . 22.3 Cg_endo -60.97 158.38 34.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.546 2.83 . . . . 65.040000000000006 115.393 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -113.3 16.32 19.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.917 -1.038 . . . . 65.549999999999997 110.309 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.98 -2.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.244 1.021 . . . . 64.299999999999997 109.224 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.1 m -61.22 -38.87 88.17 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.977 -1.465 . . . . 54.130000000000003 110.828 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 9.4 t -59.03 -26.82 64.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.607 -0.724 . . . . 74.540000000000006 111.672 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.4 mt -76.9 -45.54 27.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 120.063 -0.655 . . . . 74.340000000000003 110.097 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 14.3 m -168.82 147.49 4.06 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.301 -1.0 . . . . 53.109999999999999 108.301 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -51.64 -44.47 62.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.607 0.763 . . . . 73.109999999999999 111.112 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.75 -35.41 66.16 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.984 0.514 . . . . 74.010000000000005 111.6 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 10.7 mm-40 -70.52 -42.29 71.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.796 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.34 -50.77 72.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.358 -0.837 . . . . 63.119999999999997 110.113 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.0 t -58.55 -49.19 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.214 -0.903 . . . . 75.439999999999998 112.015 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.66 -46.83 83.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.839 -0.344 . . . . 71.519999999999996 111.622 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 430' ' ' PRO . 26.6 tptp -66.78 -41.62 87.35 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 75.420000000000002 110.122 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 28.3 tp -68.48 -43.21 77.43 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.916 -0.584 . . . . 55.32 110.155 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 39.5 m -59.51 -44.68 93.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.676 -0.693 . . . . 75.420000000000002 109.804 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.69 62.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.906 -0.588 . . . . 62.25 111.395 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -80.93 -13.72 58.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.132 0.492 . . . . 51.25 110.152 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.65 -5.78 26.15 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.126 -1.035 . . . . 32.43 112.794 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.439 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 97.3 m-85 -82.65 111.54 18.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.576 -0.527 . . . . 73.129999999999995 109.576 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.25 41.32 Favored Glycine 0 N--CA 1.427 -1.918 0 CA-C-N 115.476 -0.784 . . . . 75.019999999999996 111.836 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.51 114.63 26.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.264 0.554 . . . . 71.109999999999999 111.239 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.82 156.83 43.14 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.322 -0.854 . . . . 72.530000000000001 112.366 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 123.06 29.31 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.176 -1.416 . . . . 65.140000000000001 107.176 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -94.0 125.71 38.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.858 -0.61 . . . . 73.450000000000003 109.873 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.04 147.15 50.5 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.327 -1.36 . . . . 40.439999999999998 107.327 176.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -122.57 139.88 53.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.344 -0.543 . . . . 73.010000000000005 109.652 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.4 m -126.44 140.85 38.35 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 109.259 -0.645 . . . . 74.420000000000002 109.259 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -64.77 121.91 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.597 1.531 . . . . 72.400000000000006 109.842 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 492' ' ' PRO . 13.5 m -133.67 179.99 5.88 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.761 -1.57 . . . . 70.549999999999997 106.761 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 461' ' ' PRO . 5.0 t -60.56 136.98 92.56 Favored Pre-proline 0 N--CA 1.419 -2.003 0 N-CA-C 109.136 -0.69 . . . . 65.420000000000002 109.136 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 460' ' ' THR . 85.2 Cg_exo -49.86 -28.96 19.38 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.464 3.443 . . . . 73.150000000000006 114.829 -173.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.18 -18.43 61.86 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.07 0.767 . . . . 74.129999999999995 113.07 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.28 7.96 44.59 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.934 -0.479 . . . . 61.299999999999997 111.983 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -60.96 128.36 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 120.968 0.414 . . . . 73.209999999999994 110.505 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.13 89.31 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.77 -0.728 . . . . 73.510000000000005 111.97 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -113.65 148.22 36.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.646 -1.242 . . . . 42.299999999999997 107.646 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.484 HG22 HD11 ' A' ' 486' ' ' ILE . 44.8 t -82.36 140.43 16.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.534 -0.913 . . . . 74.239999999999995 108.534 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 31.8 pt -96.96 -23.37 4.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.448 0.642 . . . . 54.030000000000001 109.402 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.39 175.48 38.62 Favored Glycine 0 N--CA 1.416 -2.681 0 N-CA-C 109.062 -1.615 . . . . 75.030000000000001 109.062 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 472' ' ' PRO . 2.6 p -116.49 154.36 30.51 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.879 -0.785 . . . . 74.010000000000005 108.879 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.7 t30 -61.09 -46.65 96.23 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 123.56 0.537 . . . . 73.5 110.165 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.4 Cg_exo -83.36 137.07 7.97 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.036 1.158 . . . . 55.119999999999997 109.391 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 476' ' ' GLN . 9.8 Cg_endo -62.56 140.19 80.08 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.266 1.977 . . . . 73.140000000000001 112.051 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.567 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.53 -8.08 55.17 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 122.134 0.969 . . . . 75.109999999999999 111.153 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -94.65 -3.98 48.47 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.603 -1.18 . . . . 70.140000000000001 110.399 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.449 ' CG ' ' HG2' ' A' ' 473' ' ' PRO . 31.3 mm-40 -109.94 159.98 16.8 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 109.081 -0.711 . . . . 73.109999999999999 109.081 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.4 ' C ' ' HB3' ' A' ' 426' ' ' GLN . 24.1 p -101.8 115.21 30.03 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.34 -1.356 . . . . 53.240000000000002 107.34 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 48.8 m -100.59 140.97 34.1 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.795 -0.446 . . . . 53.219999999999999 109.795 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.58 145.66 54.65 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.036 -0.529 . . . . 62.200000000000003 110.61 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 425' ' ' GLU . 49.1 mm -67.24 -9.16 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 122.085 0.945 . . . . 72.010000000000005 110.752 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.8 t -77.51 -5.91 51.7 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.613 -0.679 . . . . 70.209999999999994 109.894 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.05 158.09 16.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.706 -0.621 . . . . 72.209999999999994 111.742 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.98 125.77 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.013 -1.847 . . . . 71.209999999999994 106.013 169.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.71 120.53 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.813 -0.755 . . . . 75.540000000000006 110.609 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.81 114.84 29.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.098 -1.445 . . . . 74.219999999999999 107.098 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.63 121.52 61.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 109.016 -178.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.11 120.26 51.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.9 0.857 . . . . 73.230000000000004 112.446 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.0 t -96.56 146.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.588 -1.187 . . . . 73.319999999999993 108.955 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -82.83 123.41 6.09 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.026 -1.23 . . . . 50.420000000000002 110.026 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 28.8 t -110.95 143.83 40.99 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.167 -1.42 . . . . 75.400000000000006 107.167 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -96.66 137.5 13.38 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.33 -0.938 . . . . 41.420000000000002 111.308 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 459' ' ' SER . 12.9 Cg_exo -70.39 115.44 4.18 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.955 1.77 . . . . 72.409999999999997 109.156 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -83.75 87.02 7.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.915 0.864 . . . . 62.310000000000002 109.813 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 546' ' ' PRO . 32.6 p -137.32 160.06 40.15 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.75 -1.114 . . . . 74.150000000000006 108.957 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.402 ' CD ' ' HA2' ' A' ' 516' ' ' GLY . 50.7 mttm -141.47 143.06 33.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.33 0.394 . . . . 73.25 110.371 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.1 t70 -89.96 119.2 30.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.231 -1.396 . . . . 61.420000000000002 107.231 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 21.4 pt -81.9 123.42 80.1 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 112.473 0.546 . . . . 75.010000000000005 112.473 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.96 177.44 2.07 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.381 2.054 . . . . 72.519999999999996 109.287 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -85.57 138.12 32.4 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.026 -1.07 . . . . 73.409999999999997 109.526 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.67 19.01 4.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.561 -1.644 . . . . 53.109999999999999 106.561 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.592 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -77.01 153.37 34.56 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.167 -1.833 . . . . 75.129999999999995 111.657 -174.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.08 58.71 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.91 -0.662 . . . . 71.540000000000006 111.79 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.526 ' O ' HG12 ' A' ' 534' ' ' VAL . 21.0 mt-30 -121.47 -176.26 3.26 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 72.0 108.877 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.3 m -81.18 155.7 26.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 119.386 -0.925 . . . . 73.219999999999999 108.576 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.16 -41.45 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 111.619 0.229 . . . . 71.519999999999996 111.619 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.93 -42.25 85.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.378 -0.374 . . . . 64.200000000000003 111.46 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.7 p -76.04 -35.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.646 -0.822 . . . . 72.040000000000006 111.501 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.02 76.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.582 -0.736 . . . . 52.43 111.106 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.09 -38.52 91.02 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.959 -0.564 . . . . 74.329999999999998 110.355 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 514' ' ' VAL . 39.5 ttmt -63.53 -52.37 61.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 123.509 0.506 . . . . 64.439999999999998 110.866 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -62.9 -44.92 94.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 123.209 0.318 . . . . 65.239999999999995 110.302 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 31.0 tp -64.89 -36.88 85.79 Favored 'General case' 0 C--O 1.188 -2.149 0 CA-C-N 116.08 -0.509 . . . . 72.319999999999993 110.542 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 2.9 t-20 -59.61 -42.92 93.73 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.198 0.599 . . . . 74.409999999999997 110.492 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.9 t -67.7 -30.31 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.799 . . . . 70.329999999999998 111.443 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.18 15.09 14.05 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 121.679 -0.638 . . . . 74.140000000000001 110.785 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.402 ' HA2' ' CD ' ' A' ' 495' ' ' LYS . . . -155.12 -99.9 0.17 Allowed Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 118.248 -1.93 . . . . 64.310000000000002 116.637 -169.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 51.2 m-85 -115.31 161.84 17.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.264 . . . . 70.430000000000007 110.633 -168.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.2 p -102.51 -27.88 12.52 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.482 0.549 . . . . 62.439999999999998 112.482 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 9.3 mmpt? -108.79 128.46 54.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 120.589 0.233 . . . . 70.349999999999994 110.722 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 93.9 m-85 -125.18 145.21 50.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.512 -0.767 . . . . 74.400000000000006 110.375 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.1 t -115.71 159.57 21.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.137 -1.431 . . . . 60.399999999999999 107.137 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -121.18 129.09 53.07 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.744 -0.465 . . . . 72.019999999999996 109.744 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.55 129.75 44.85 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.221 -1.029 . . . . 23.350000000000001 108.221 175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 9.2 m -89.21 130.68 35.58 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.041 -0.726 . . . . 70.530000000000001 109.041 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.37 157.57 26.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.339 -0.986 . . . . 74.040000000000006 108.339 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -79.69 142.21 35.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.229 0.537 . . . . 75.420000000000002 110.984 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 22.2 p -102.35 110.22 62.27 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.992 -1.004 . . . . 72.409999999999997 112.649 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -76.95 -51.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 121.644 1.562 . . . . 71.209999999999994 110.155 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.6 -64.25 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 112.38 0.511 . . . . 73.409999999999997 112.38 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.47 149.06 34.33 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.671 1.58 . . . . 63.229999999999997 112.969 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -145.93 138.81 25.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.575 -0.528 . . . . 62.420000000000002 109.575 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 87.79 -26.69 7.19 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 122.004 0.78 . . . . 50.130000000000003 111.816 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.57 150.0 23.98 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.614 -0.793 . . . . 72.0 111.826 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 501' ' ' ALA . 2.8 p -74.41 125.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.433 -0.803 . . . . 41.100000000000001 110.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 14.3 p -88.97 -22.0 23.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.799 -0.637 . . . . 55.210000000000001 109.899 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.44 -159.13 30.95 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.205 -0.758 . . . . 74.439999999999998 111.205 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -118.39 161.04 20.62 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.27 -1.011 . . . . 75.140000000000001 108.27 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 15.1 t-20 -54.94 -55.3 40.27 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 119.216 -0.421 . . . . 72.409999999999997 111.877 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 5.8 Cg_exo -80.47 143.58 15.42 Favored 'Trans proline' 0 C--N 1.366 1.499 0 N-CA-C 108.374 -1.433 . . . . 65.329999999999998 108.374 170.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.71 157.36 52.24 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.306 2.004 . . . . 73.019999999999996 113.405 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.41 131.33 50.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.329 -0.85 . . . . 73.299999999999997 109.541 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.52 -6.95 36.32 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 110.765 -0.934 . . . . 53.409999999999997 110.765 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 36.0 m -88.45 129.33 35.46 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.543 -0.54 . . . . 73.239999999999995 109.543 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.0 m -96.75 123.22 40.38 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.195 -1.039 . . . . 54.219999999999999 108.195 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.62 158.37 72.17 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 110.179 -0.304 . . . . 74.319999999999993 110.179 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.421 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.6 Cg_exo -64.7 137.2 53.06 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.823 2.349 . . . . 74.120000000000005 111.654 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.508 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 22.5 m -67.48 -20.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.469 0.652 . . . . 52.509999999999998 111.808 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.69 2.1 46.69 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 74.040000000000006 111.319 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -93.09 167.78 11.55 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.292 -1.003 . . . . 42.340000000000003 108.292 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.43 116.61 44.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.133 -0.692 . . . . 74.450000000000003 109.133 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 15.4 tt -88.71 132.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.191 0.52 . . . . 64.140000000000001 109.99 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -102.91 131.07 50.1 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-O 121.489 0.661 . . . . 71.010000000000005 111.747 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.426 HD13 ' N ' ' A' ' 554' ' ' GLN . 1.8 tm? -99.78 135.3 41.41 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.951 1.3 . . . . 72.540000000000006 109.304 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.426 ' N ' HD13 ' A' ' 553' ' ' LEU . 25.9 mm-40 -94.69 106.44 18.42 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.489 -0.778 . . . . 64.030000000000001 108.91 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.07 122.33 47.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 109.427 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 25.6 p -76.52 115.35 16.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 108.779 -0.822 . . . . 74.140000000000001 108.779 -176.468 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.763 0 N-CA-C 110.319 -1.112 . . . . 63.140000000000001 110.319 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.91 154.7 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.206 1.938 . . . . 72.25 111.125 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.82 25.68 10.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.56 -0.533 . . . . 75.010000000000005 109.56 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 478' ' ' SER . 61.1 mt-30 -90.15 119.51 30.53 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.321 -0.4 . . . . 74.010000000000005 109.933 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.6 mmp_? -121.27 156.21 33.0 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.189 -0.46 . . . . 65.030000000000001 110.932 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.17 141.79 28.39 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.387 -0.824 . . . . 73.049999999999997 109.917 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -84.9 119.36 72.56 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.856 -1.164 . . . . 71.150000000000006 107.856 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.445 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 25.8 Cg_exo -68.47 142.28 53.6 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.265 1.977 . . . . 41.549999999999997 112.197 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 434' ' ' THR . 10.6 m-20 -84.95 37.57 0.67 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.696 0.76 . . . . 73.109999999999999 111.458 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 439' ' ' GLU . 10.9 p -87.26 -6.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.609 1.195 . . . . 52.109999999999999 108.086 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 467' ' ' VAL . 3.3 p -59.02 -36.47 75.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.664 1.586 . . . . 73.430000000000007 110.47 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 431' ' ' ASP . 14.7 t -61.69 -26.71 68.21 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.0 -1.0 . . . . 65.099999999999994 110.789 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.47 -46.5 13.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.31 -0.956 . . . . 74.120000000000005 111.407 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.554 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 85.7 m -169.73 149.72 3.86 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.788 -0.819 . . . . 52.229999999999997 108.788 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 441' ' ' VAL . 54.4 t80 -52.75 -49.4 65.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.928 0.491 . . . . 72.349999999999994 111.309 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.19 -39.87 73.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 61.200000000000003 111.589 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.554 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.7 mm-40 -62.97 -43.78 97.85 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.935 -0.575 . . . . 65.310000000000002 111.01 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.11 -44.06 95.13 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.269 -0.878 . . . . 72.420000000000002 109.932 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.5 t -60.01 -49.53 83.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 115.999 -0.546 . . . . 64.209999999999994 111.142 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.0 mmtp -60.62 -47.67 85.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.045 0.45 . . . . 74.400000000000006 110.485 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.445 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 30.6 mmmt -67.93 -41.39 82.66 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.798 0.666 . . . . 62.329999999999998 112.798 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 22.4 tp -68.48 -38.8 81.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 60.009999999999998 109.736 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.2 m -59.28 -46.04 89.62 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.266 -0.879 . . . . 70.209999999999994 109.278 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.28 -20.17 63.91 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.522 -0.763 . . . . 54.219999999999999 111.692 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.4 -13.61 59.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.306 0.574 . . . . 51.329999999999998 109.986 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.23 -9.13 42.21 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.983 -0.627 . . . . 64.340000000000003 113.232 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 95.8 m-85 -67.38 115.59 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.941 0.371 . . . . 73.409999999999997 110.011 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -105.09 2.06 40.81 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.467 -0.873 . . . . 44.020000000000003 111.619 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -126.75 113.19 16.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.3 0.572 . . . . 75.129999999999995 109.553 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -148.73 165.15 32.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.539 -0.755 . . . . 72.319999999999993 112.188 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -140.4 131.7 26.68 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.828 -0.804 . . . . 73.140000000000001 108.828 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -93.21 135.31 34.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 123.425 0.453 . . . . 75.549999999999997 110.053 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -142.7 162.47 35.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.336 -1.357 . . . . 50.530000000000001 107.336 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.84 150.68 51.89 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 118.146 0.43 . . . . 74.030000000000001 110.636 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.0 m -138.03 146.75 53.49 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 107.963 -1.125 . . . . 71.310000000000002 107.963 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.98 130.01 22.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.733 1.622 . . . . 54.210000000000001 111.143 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -143.66 -179.72 6.62 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.579 -1.637 . . . . 61.039999999999999 106.579 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.06 142.61 85.37 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 123.004 0.522 . . . . 42.439999999999998 111.32 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 75.9 Cg_exo -51.68 -29.13 32.12 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.259 3.306 . . . . 75.129999999999995 111.66 174.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.1 -29.36 67.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.512 -0.767 . . . . 71.530000000000001 111.054 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.46 13.42 24.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.409 0.522 . . . . 71.120000000000005 112.409 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 15.0 p -60.47 128.02 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.075 -0.65 . . . . 73.310000000000002 110.468 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.18 11.46 83.53 Favored Glycine 0 C--O 1.249 1.069 0 C-N-CA 120.941 -0.647 . . . . 52.119999999999997 111.789 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -122.97 154.44 38.41 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.083 -1.08 . . . . 73.25 108.083 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 486' ' ' ILE . 46.2 t -82.43 141.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.275 -0.639 . . . . 74.200000000000003 109.275 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.2 pt -97.49 -29.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.456 -0.498 . . . . 73.510000000000005 110.339 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.62 -179.01 47.05 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.531 -1.028 . . . . 62.509999999999998 110.531 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.0 p -124.23 152.17 43.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.512 -0.551 . . . . 34.420000000000002 109.512 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 24.0 t-20 -60.91 -49.95 86.99 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 112.285 0.476 . . . . 74.010000000000005 112.285 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.1 Cg_exo -78.16 142.69 19.48 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.154 1.236 . . . . 72.0 109.361 171.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.49 132.98 40.53 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.697 2.265 . . . . 63.140000000000001 111.897 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.72 -12.73 59.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.025 0.917 . . . . 65.140000000000001 110.706 -175.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.93 11.55 37.06 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.902 -1.045 . . . . 64.109999999999999 109.713 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -125.57 169.96 11.94 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 106.527 -1.657 . . . . 74.439999999999998 106.527 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.2 p -107.11 115.3 29.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 N-CA-C 108.031 -1.099 . . . . 74.310000000000002 108.031 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 30.3 m -102.03 138.81 38.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.407 -0.59 . . . . 74.150000000000006 109.407 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -66.67 137.16 56.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.614 -0.513 . . . . 64.349999999999994 109.614 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.23 -25.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 124.543 1.137 . . . . 44.240000000000002 113.074 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.3 t -71.44 -7.01 44.59 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 120.996 0.427 . . . . 71.140000000000001 111.76 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 32.7 m-80 -90.11 145.5 25.01 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 116.519 -0.309 . . . . 65.329999999999998 110.966 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.08 117.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.347 0.594 . . . . 70.109999999999999 109.759 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.79 118.86 34.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.707 -0.849 . . . . 75.530000000000001 108.707 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.3 mp -92.63 113.23 27.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.247 -1.39 . . . . 53.219999999999999 107.247 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.51 119.82 53.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.337 -0.847 . . . . 73.25 109.397 -178.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -104.11 123.79 58.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.718 0.77 . . . . 72.299999999999997 112.252 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.18 144.29 10.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 114.802 -1.09 . . . . 72.010000000000005 108.724 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.74 120.72 5.54 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 111.345 -0.702 . . . . 70.030000000000001 111.345 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.8 t -101.46 129.49 47.51 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.909 -1.885 . . . . 73.340000000000003 105.909 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -112.16 121.28 5.61 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.271 -0.966 . . . . 63.210000000000001 113.089 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 3.2 Cg_exo -77.98 112.37 3.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.735 2.29 . . . . 64.519999999999996 111.786 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.18 87.76 2.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.503 -0.925 . . . . 73.439999999999998 108.503 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 546' ' ' PRO . 16.6 p -136.99 154.67 50.35 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.821 -1.081 . . . . 71.299999999999997 109.232 -176.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.01 142.49 36.27 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.368 0.418 . . . . 72.340000000000003 109.982 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -80.82 132.2 35.46 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.262 -1.385 . . . . 72.409999999999997 107.262 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.69 129.88 80.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.998 -0.546 . . . . 75.420000000000002 110.059 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -87.07 160.79 8.67 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.565 2.177 . . . . 62.420000000000002 110.948 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.69 135.69 33.55 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.588 -0.845 . . . . 52.329999999999998 109.434 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.6 16.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 122.507 1.146 . . . . 63.219999999999999 108.416 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.63 40.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.726 -1.125 . . . . 54.109999999999999 109.719 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.68 -26.9 11.06 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.973 -1.251 . . . . 70.409999999999997 109.973 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -91.01 176.36 6.62 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.668 -1.234 . . . . 72.310000000000002 107.668 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 36.3 p -81.57 157.24 24.84 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.167 -0.613 . . . . 74.310000000000002 110.15 -175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 555' ' ' VAL . 9.9 p -52.61 -41.73 38.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.601 0.563 . . . . 72.230000000000004 112.28 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.25 -43.08 78.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.574 0.583 . . . . 73.540000000000006 112.574 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.29 -36.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 118.837 -1.145 . . . . 75.150000000000006 111.519 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.36 77.48 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.136 -0.938 . . . . 71.209999999999994 111.39 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.94 -35.01 79.8 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 123.238 0.336 . . . . 71.329999999999998 110.513 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 53.4 tttp -60.98 -51.61 68.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 123.244 0.34 . . . . 61.310000000000002 110.13 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.66 -44.77 95.42 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.726 -0.67 . . . . 54.43 110.376 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.08 -43.21 95.67 Favored 'General case' 0 C--O 1.179 -2.606 0 CA-C-N 115.404 -0.816 . . . . 70.150000000000006 109.999 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 24.6 t-20 -59.05 -39.54 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.508 0.723 . . . . 73.420000000000002 112.146 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.94 -0.573 . . . . 52.420000000000002 111.626 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.75 -39.28 7.91 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.311 -0.956 . . . . 74.349999999999994 110.165 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -95.09 -101.19 1.79 Allowed Glycine 0 N--CA 1.412 -2.945 0 CA-C-N 113.954 -1.475 . . . . 52.229999999999997 115.3 -170.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 16.9 m-85 -133.53 172.17 13.09 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.911 -167.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 18.7 m -109.84 -1.95 17.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.593 -0.73 . . . . 72.120000000000005 110.073 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -108.36 116.39 31.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.125 -0.488 . . . . 72.25 109.899 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.35 151.27 49.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.005 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -140.98 158.53 43.8 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.142 -1.429 . . . . 34.439999999999998 107.142 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -121.77 152.11 39.83 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.416 0.627 . . . . 71.040000000000006 111.818 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.487 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -134.29 125.74 28.31 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.747 -1.205 . . . . 40.530000000000001 107.747 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.9 m -88.68 131.36 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.33 -1.359 . . . . 62.439999999999998 107.33 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.3 150.52 24.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.236 -0.586 . . . . 72.430000000000007 109.921 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.07 133.6 36.78 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.014 -0.735 . . . . 70.450000000000003 109.014 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.6 m -143.59 138.85 15.71 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.049 -0.722 . . . . 73.540000000000006 109.049 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.12 -58.51 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.2 . . . . 74.340000000000003 113.178 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.417 ' H ' ' CD ' ' A' ' 530' ' ' PRO . 0.5 OUTLIER -115.26 -41.26 0.07 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-O 118.586 -0.721 . . . . 74.420000000000002 112.943 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.417 ' CD ' ' H ' ' A' ' 529' ' ' ARG . 80.8 Cg_exo -55.83 149.73 49.38 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 121.688 1.592 . . . . 73.239999999999995 112.972 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.95 113.16 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.813 -1.18 . . . . 55.439999999999998 107.813 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.04 -34.05 4.63 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.385 -0.912 . . . . 54.520000000000003 112.192 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 2.5 pm0 -85.17 147.96 26.35 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-O 121.579 0.704 . . . . 74.319999999999993 111.813 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.23 125.51 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.877 -1.157 . . . . 71.129999999999995 107.877 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.2 m -86.18 -33.95 20.65 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.677 -0.692 . . . . 72.010000000000005 109.596 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -179.94 -176.63 47.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.78 -0.928 . . . . 63.109999999999999 110.78 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.7 p -117.88 160.12 21.95 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 107.585 -1.265 . . . . 64.239999999999995 107.585 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.477 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.2 t-20 -60.23 -53.84 61.01 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.532 -0.467 . . . . 51.119999999999997 111.348 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 75.2 Cg_endo -88.41 146.73 6.2 Favored 'Trans proline' 0 C--N 1.369 1.613 0 CA-C-N 120.103 1.072 . . . . 71.439999999999998 110.116 171.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.39 159.53 52.63 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.174 1.916 . . . . 72.519999999999996 111.335 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.99 135.02 57.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.625 0.37 . . . . 73.420000000000002 110.729 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.88 48.62 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.678 -0.772 . . . . 63.5 111.933 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.7 m -71.39 121.7 19.03 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.442 -0.577 . . . . 72.430000000000007 109.442 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.4 t -83.61 126.7 33.11 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.5 0.5 . . . . 71.200000000000003 109.825 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.91 156.57 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.801 -0.814 . . . . 63.229999999999997 108.801 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 494' ' ' THR . 32.4 Cg_exo -59.47 144.71 99.34 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.436 2.09 . . . . 71.409999999999997 111.741 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.9 m -66.15 -20.54 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.327 0.492 . . . . 71.099999999999994 112.327 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.81 3.51 54.23 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.067 -0.515 . . . . 74.019999999999996 111.196 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 16.8 t -84.68 146.14 27.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.57 -0.529 . . . . 65.329999999999998 109.57 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.83 118.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.057 -1.09 . . . . 74.120000000000005 108.057 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.1 tt -94.32 145.91 7.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 120.962 0.411 . . . . 54.119999999999997 110.398 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 27.1 tt0 -102.62 127.91 49.52 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-O 121.203 0.525 . . . . 75.200000000000003 109.932 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.05 115.19 29.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.49 -1.232 . . . . 62.350000000000001 107.867 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.487 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 77.3 mt-30 -92.48 108.01 19.65 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.456 0.646 . . . . 74.319999999999993 109.468 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.483 HG21 ' HB ' ' A' ' 505' ' ' VAL . 8.0 p -113.78 139.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.056 -0.974 . . . . 75.239999999999995 111.368 -174.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 m -57.81 128.66 38.2 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.928 -1.138 . . . . 50.219999999999999 107.928 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 65.8 pttt . . . . . 0 C--O 1.264 1.868 0 N-CA-C 113.619 0.97 . . . . 74.340000000000003 113.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.726 0 N-CA-C 111.635 -0.586 . . . . 43.049999999999997 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.4 132.85 26.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.946 2.431 . . . . 75.510000000000005 112.149 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -92.33 63.59 4.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 123.143 1.449 . . . . 73.400000000000006 109.059 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 86.4 mt-30 -111.09 153.88 25.05 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.48 -1.691 . . . . 72.230000000000004 111.886 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.05 149.74 52.16 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.365 -0.834 . . . . 73.230000000000004 110.364 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -95.14 140.57 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 72.230000000000004 108.129 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.47 122.0 82.06 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 122.912 0.133 . . . . 53.310000000000002 110.69 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 142.49 33.43 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.014 2.476 . . . . 73.099999999999994 111.908 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -99.46 78.03 2.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.425 1.107 . . . . 70.019999999999996 110.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.1 m -112.44 5.34 8.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 N-CA-C 106.061 -1.829 . . . . 74.140000000000001 106.061 171.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.466 ' CB ' ' HB ' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -59.62 -38.69 82.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.684 -2.053 . . . . 64.239999999999995 110.611 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -26.34 68.46 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.283 -1.326 . . . . 61.25 112.166 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.22 -46.01 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.847 -0.427 . . . . 65.209999999999994 109.847 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 175.49 158.3 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.671 1.188 . . . . 63.43 111.335 175.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 441' ' ' VAL . 58.1 t80 -51.54 -43.69 62.43 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.91 1.284 . . . . 74.109999999999999 110.78 172.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.88 83.03 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.743 0.652 . . . . 33.439999999999998 111.036 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 19.4 mm-40 -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.692 -0.686 . . . . 64.450000000000003 109.903 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.55 -47.53 85.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.197 -0.91 . . . . 72.450000000000003 111.352 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 437' ' ' TYR . 98.8 t -59.37 -48.47 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 123.433 0.458 . . . . 72.409999999999997 111.371 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.5 mmpt? -63.86 -47.11 82.01 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.09 0.244 . . . . 54.43 111.283 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.7 mptp? -67.29 -38.52 85.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.488 0.551 . . . . 74.049999999999997 112.488 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 tp -68.02 -39.62 83.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.459 0.647 . . . . 51.509999999999998 109.44 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.24 -41.16 99.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.522 -0.763 . . . . 75.25 109.376 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.42 62.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.475 -0.784 . . . . 63.109999999999999 111.216 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.46 -13.81 53.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 74.239999999999995 109.431 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.92 56.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-N 115.702 -0.681 . . . . 75.430000000000007 113.862 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.93 133.04 46.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.157 0.503 . . . . 74.030000000000001 111.893 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.98 18.34 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.409 -0.814 . . . . 74.129999999999995 112.109 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -123.92 116.36 22.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.74 0.781 . . . . 73.200000000000003 112.044 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -143.06 147.19 34.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.225 -0.898 . . . . 74.519999999999996 110.181 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -131.02 133.9 46.17 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.688 -1.227 . . . . 73.099999999999994 107.688 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -95.47 121.43 37.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.204 0.526 . . . . 71.239999999999995 110.779 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.23 141.45 48.28 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.386 -0.968 . . . . 74.329999999999998 108.386 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -126.72 144.15 51.02 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.535 -0.543 . . . . 72.040000000000006 109.535 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.8 p -144.52 149.9 45.6 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.988 -0.551 . . . . 43.049999999999997 109.997 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.3 Cg_exo -65.54 140.55 63.32 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.258 1.972 . . . . 72.510000000000005 111.114 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.2 t -152.27 179.39 8.57 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.765 -1.198 . . . . 73.109999999999999 107.765 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.4 t -66.65 144.55 98.67 Favored Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 123.705 0.802 . . . . 63.409999999999997 110.589 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.464 ' HA ' HG23 ' A' ' 464' ' ' VAL . 88.9 Cg_exo -51.42 -29.34 30.7 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.41 3.407 . . . . 73.340000000000003 112.623 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -68.51 -32.13 71.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.804 -0.634 . . . . 75.140000000000001 111.823 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.91 9.01 39.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.551 0.575 . . . . 73.420000000000002 112.551 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 461' ' ' PRO . 92.6 t -60.76 127.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.822 -0.436 . . . . 70.420000000000002 109.822 177.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.45 -12.28 64.91 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.627 -0.797 . . . . 64.349999999999994 111.946 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.2 146.73 23.48 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.313 -0.625 . . . . 74.230000000000004 109.313 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 433' ' ' SER . 64.9 t -82.67 124.79 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 N-CA-C 106.649 -1.611 . . . . 75.340000000000003 106.649 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 25.5 pt -97.85 -2.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 120.9 0.381 . . . . 64.319999999999993 111.579 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.96 164.93 20.26 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 120.236 -0.983 . . . . 63.140000000000001 111.788 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.4 p -120.77 142.71 49.32 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.725 -1.583 . . . . 73.239999999999995 106.725 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.475 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 6.1 t30 -63.97 -45.01 80.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 123.544 0.527 . . . . 73.439999999999998 110.494 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.99 139.8 12.23 Favored 'Trans proline' 0 C--N 1.375 1.938 0 CA-C-N 120.347 1.16 . . . . 71.209999999999994 109.912 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.9 144.08 63.24 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.697 2.264 . . . . 62.229999999999997 112.338 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.94 15.9 4.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.069 0.938 . . . . 52.420000000000002 110.483 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.02 -28.74 12.56 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.863 -1.062 . . . . 74.409999999999997 111.576 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.02 154.09 31.53 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.118 -0.697 . . . . 73.439999999999998 109.118 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 16.3 p -81.59 135.27 35.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.973 -0.558 . . . . 73.439999999999998 110.566 -177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.3 m -111.9 138.24 48.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.832 -0.803 . . . . 72.310000000000002 108.832 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -61.02 150.41 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.272 0.358 . . . . 60.439999999999998 110.824 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.58 -28.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.449 0.7 . . . . 72.209999999999994 111.041 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -88.07 0.87 55.46 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.686 -0.688 . . . . 70.230000000000004 111.439 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.08 148.99 27.18 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.002 -0.74 . . . . 75.120000000000005 109.002 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 30.9 t -92.14 111.49 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.746 -0.835 . . . . 74.540000000000006 108.746 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 86.0 t -91.0 118.82 37.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.131 -0.692 . . . . 61.119999999999997 109.131 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.475 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 64.8 mt -93.8 114.25 30.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.745 -0.835 . . . . 61.409999999999997 108.745 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.6 124.97 54.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.271 -0.64 . . . . 63.25 109.271 -178.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.48 116.25 49.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.354 0.597 . . . . 73.129999999999995 111.073 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.98 140.72 16.91 Favored 'Isoleucine or valine' 0 C--O 1.252 1.225 0 CA-C-N 115.824 -0.626 . . . . 74.340000000000003 110.288 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.69 117.23 4.6 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.546 -1.422 . . . . 61.439999999999998 109.546 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.8 m -125.03 135.68 52.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.684 -0.488 . . . . 64.540000000000006 109.684 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -133.07 123.92 3.6 Favored Glycine 0 C--N 1.295 -1.739 0 N-CA-C 110.006 -1.238 . . . . 75.109999999999999 110.006 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.03 125.28 11.33 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.001 1.801 . . . . 63.219999999999999 111.47 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -69.33 96.01 0.83 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.279 -1.008 . . . . 74.430000000000007 108.279 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.2 p -128.29 155.29 44.84 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.79 -1.095 . . . . 64.120000000000005 109.842 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -142.65 149.98 39.63 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 71.150000000000006 109.35 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -85.35 138.07 32.53 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.47 -1.307 . . . . 72.120000000000005 107.47 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.6 pt -83.1 120.39 75.87 Favored Pre-proline 0 C--N 1.291 -1.937 0 C-N-CA 119.808 -0.757 . . . . 73.120000000000005 110.028 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.76 158.48 21.49 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.737 1.625 . . . . 73.209999999999994 109.431 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.42 101.91 2.07 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.064 0.935 . . . . 75.319999999999993 110.977 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.36 -1.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.666 -1.235 . . . . 70.230000000000004 107.666 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.72 119.91 15.56 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 113.822 -1.536 . . . . 63.130000000000003 107.962 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.37 -27.65 5.74 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.439 -1.464 . . . . 61.409999999999997 109.439 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -83.94 178.41 7.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.021 -0.733 . . . . 75.400000000000006 109.021 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.3 m -91.12 155.87 18.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.978 . . . . 72.219999999999999 108.361 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 -47.85 56.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 112.55 0.574 . . . . 72.319999999999993 112.55 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 20.6 m-20 -69.46 -41.38 76.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.538 0.57 . . . . 63.140000000000001 112.538 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.26 -35.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.445 -0.902 . . . . 63.509999999999998 111.55 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.67 -48.95 77.09 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.44 -0.8 . . . . 63.149999999999999 111.322 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.42 -37.02 85.7 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 120.194 -0.602 . . . . 62.119999999999997 110.608 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 2.1 mptm? -65.94 -52.13 52.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.136 0.791 . . . . 73.219999999999999 113.136 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . 0.253 33.3 p30 -69.08 -37.59 78.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.761 0.652 . . . . 72.519999999999996 112.761 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.28 -36.8 83.89 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-O 120.516 0.198 . . . . 74.219999999999999 110.742 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.5 t-20 -58.28 -37.53 75.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.59 0.756 . . . . 75.010000000000005 111.724 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.88 -38.72 83.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.717 -0.674 . . . . 65.329999999999998 111.53 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -105.51 -13.86 15.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.764 -0.774 . . . . 64.140000000000001 110.695 -174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -125.12 -97.74 1.15 Allowed Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 117.067 1.587 . . . . 51.140000000000001 117.067 -166.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 2.7 m-85 -127.59 153.69 46.1 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.04 0.448 . . . . 72.450000000000003 110.161 -163.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.4 m -106.31 -6.43 18.37 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.196 -0.911 . . . . 71.209999999999994 109.436 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -108.23 115.02 29.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.838 -0.619 . . . . 53.0 109.973 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.42 156.25 37.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.212 -0.904 . . . . 73.420000000000002 111.482 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 65.7 m -138.09 152.94 49.25 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.036 -1.839 . . . . 43.329999999999998 106.036 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -119.77 131.19 55.27 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.829 -0.804 . . . . 75.040000000000006 108.829 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -115.48 140.43 49.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.442 -0.947 . . . . 70.329999999999998 108.442 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.1 m -104.36 119.47 39.03 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.165 -0.68 . . . . 70.219999999999999 109.165 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.4 153.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.968 -0.753 . . . . 74.319999999999993 108.968 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.7 135.4 36.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.039 -0.664 . . . . 74.400000000000006 110.041 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 m -146.26 136.31 11.94 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 107.242 -1.392 . . . . 51.149999999999999 107.242 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.12 150.97 66.76 Favored 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.365 2.043 . . . . 73.129999999999995 112.156 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 530' ' ' PRO 0.406 75.8 mtm180 37.64 -89.49 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 118.166 2.654 . . . . 71.140000000000001 118.166 179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 50.7 Cg_exo -57.56 148.53 72.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.15 1.9 . . . . 54.539999999999999 113.743 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -139.05 160.09 40.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.906 -0.776 . . . . 71.120000000000005 108.906 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 105.3 -21.28 35.66 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 120.523 -0.846 . . . . 33.310000000000002 112.695 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.65 148.29 25.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.282 0.563 . . . . 73.340000000000003 111.215 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.53 119.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 63.219999999999999 108.676 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.0 m -88.21 -25.52 22.86 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.58 0.705 . . . . 65.420000000000002 109.836 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.24 178.66 47.09 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.212 -0.755 . . . . 61.329999999999998 111.212 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.2 p -118.57 160.4 21.85 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.123 -1.065 . . . . 73.230000000000004 108.123 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.4 t-20 -60.49 -54.67 52.62 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-O 119.146 -0.454 . . . . 72.510000000000005 112.057 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.2 Cg_endo -86.17 153.0 9.53 Favored 'Trans proline' 0 C--N 1.365 1.413 0 CA-C-N 120.461 1.2 . . . . 70.439999999999998 109.549 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.68 150.87 85.9 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.032 1.822 . . . . 73.219999999999999 111.577 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.64 58.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.604 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.99 54.1 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 121.095 -0.574 . . . . 51.439999999999998 112.0 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.8 m -69.55 129.17 38.93 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.776 -0.25 . . . . 74.150000000000006 110.332 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.6 m -93.86 122.95 36.87 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.652 -0.499 . . . . 64.409999999999997 109.652 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.5 161.42 60.82 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.449 -0.796 . . . . 51.039999999999999 109.07 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.518 ' HA ' HG22 ' A' ' 494' ' ' THR . 33.4 Cg_exo -60.61 136.25 65.85 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.569 2.18 . . . . 73.109999999999999 111.381 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 29.2 m -67.07 -21.36 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 70.400000000000006 111.494 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -86.34 -1.81 57.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.762 -0.654 . . . . 72.310000000000002 110.863 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.1 t -85.85 168.38 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.322 0.582 . . . . 51.130000000000003 110.419 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.9 t -97.61 136.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.34 -0.846 . . . . 74.319999999999993 108.804 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.0 tt -112.84 144.26 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.723 -0.473 . . . . 75.109999999999999 109.723 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 26.6 tt0 -103.53 122.71 45.5 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 108.815 -0.809 . . . . 72.120000000000005 108.815 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.4 tp -100.68 117.82 35.56 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.045 -1.094 . . . . 72.430000000000007 108.045 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.501 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 78.3 mt-30 -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.987 0.899 . . . . 74.409999999999997 110.325 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.33 141.21 23.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.085 -1.416 . . . . 64.409999999999997 111.872 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.2 m -55.78 122.84 12.37 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.618 -0.719 . . . . 73.0 110.208 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.147 -1.057 . . . . 61.43 108.147 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.457 0 N-CA-C 111.285 -0.726 . . . . 75.030000000000001 111.285 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.34 151.73 84.28 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.9 2.4 . . . . 72.510000000000005 112.113 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.12 1.11 56.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.142 0.496 . . . . 74.450000000000003 110.808 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 58.9 mt-30 -115.85 156.33 26.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.057 . . . . 75.510000000000005 108.145 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -150.95 155.41 39.04 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.404 -1.332 . . . . 74.510000000000005 107.404 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.36 141.1 28.89 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 110.061 -0.348 . . . . 73.439999999999998 110.061 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -78.39 130.21 72.35 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.005 -1.109 . . . . 73.340000000000003 108.005 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.64 144.19 93.75 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.572 2.182 . . . . 74.239999999999995 112.839 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.16 20.4 11.43 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.238 0.542 . . . . 65.120000000000005 111.342 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.405 HG11 ' HG3' ' A' ' 443' ' ' LYS . 8.7 p -83.29 -1.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.408 1.099 . . . . 71.310000000000002 108.435 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.8 p -60.09 -34.23 73.19 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.178 1.391 . . . . 41.399999999999999 110.097 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.7 m -59.33 -27.84 66.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.253 -1.339 . . . . 65.230000000000004 111.27 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 70.5 mt -90.77 -47.19 7.78 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 119.204 -0.998 . . . . 43.350000000000001 112.041 -175.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 6.4 m -159.9 148.28 17.21 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.386 -0.598 . . . . 73.200000000000003 109.386 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 441' ' ' VAL . 26.7 t80 -56.42 -47.85 78.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.022 0.529 . . . . 71.010000000000005 110.396 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -56.81 -44.28 81.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.944 -0.571 . . . . 65.430000000000007 111.165 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.524 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 12.6 mm-40 -63.82 -41.6 97.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.929 -0.578 . . . . 71.430000000000007 110.945 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.92 -46.33 89.7 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.361 -0.836 . . . . 65.519999999999996 110.673 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 437' ' ' TYR . 87.4 t -60.95 -46.31 96.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 O-C-N 123.792 0.683 . . . . 71.439999999999998 111.361 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 66.7 mttm -60.62 -48.53 81.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.06 0.457 . . . . 74.140000000000001 110.38 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.405 ' HG3' HG11 ' A' ' 432' ' ' VAL . 46.7 mmtm -67.65 -38.94 84.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.676 -0.693 . . . . 61.509999999999998 112.85 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.5 tp -68.54 -38.48 80.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.284 0.564 . . . . 72.219999999999999 109.574 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.4 m -61.82 -43.38 98.97 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.354 -0.839 . . . . 63.340000000000003 109.226 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.3 -16.0 62.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.73 -0.668 . . . . 71.540000000000006 111.736 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.84 -14.16 51.93 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 121.328 0.585 . . . . 71.109999999999999 109.539 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.93 55.88 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.616 -0.72 . . . . 71.25 113.891 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -59.62 131.1 49.9 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.391 0.595 . . . . 65.310000000000002 112.419 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -80.28 -43.77 9.3 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.214 -0.903 . . . . 72.510000000000005 114.183 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.406 ' HG3' HG13 ' A' ' 483' ' ' VAL . 30.7 tpt180 -129.62 132.77 46.84 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.793 0.806 . . . . 73.219999999999999 112.531 -175.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -140.73 150.38 43.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.814 -1.084 . . . . 61.0 109.991 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -130.31 130.69 44.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.059 -0.719 . . . . 60.210000000000001 109.059 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.418 HE21 HG21 ' A' ' 488' ' ' VAL . 57.7 tt0 -92.92 132.42 37.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.274 0.559 . . . . 71.409999999999997 111.321 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.48 148.94 50.31 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.946 -1.501 . . . . 62.100000000000001 106.946 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.6 148.07 48.09 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.174 -0.611 . . . . 71.420000000000002 110.091 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 28.6 m -142.75 142.55 22.95 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.988 -0.745 . . . . 74.450000000000003 108.988 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.5 Cg_exo -67.06 128.57 18.87 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.436 2.091 . . . . 72.019999999999996 111.57 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.9 m -140.28 179.22 6.77 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.757 -0.46 . . . . 70.030000000000001 109.757 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.8 t -54.88 139.87 61.61 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 123.885 0.874 . . . . 73.030000000000001 111.439 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.412 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.6 Cg_endo -52.01 -31.28 43.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.112 3.208 . . . . 63.020000000000003 113.387 -178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.34 -12.7 60.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.039 0.447 . . . . 73.319999999999993 111.847 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 30.8 tp -113.17 1.27 15.2 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.227 0.537 . . . . 71.120000000000005 110.29 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 461' ' ' PRO . 98.1 t -61.35 127.23 20.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.102 0.477 . . . . 34.530000000000001 110.722 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.18 -6.86 66.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 116.011 -0.54 . . . . 65.430000000000007 112.281 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.5 mptp? -99.87 157.3 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.786 -0.82 . . . . 73.030000000000001 108.786 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.578 HG22 HD11 ' A' ' 486' ' ' ILE . 59.0 t -81.94 131.5 33.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 73.310000000000002 107.944 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.4 pt -98.57 -4.53 9.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.43 -0.508 . . . . 64.439999999999998 111.425 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.92 154.18 7.29 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.461 -0.791 . . . . 55.409999999999997 111.493 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 18.4 p -116.76 146.37 42.87 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.135 -0.691 . . . . 64.200000000000003 109.135 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -59.1 -49.66 91.92 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.086 -0.483 . . . . 75.519999999999996 111.654 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.9 Cg_exo -82.86 144.07 12.03 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.443 1.429 . . . . 75.140000000000001 110.305 172.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 9.5 Cg_endo -75.65 135.92 18.49 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.325 2.016 . . . . 75.319999999999993 111.871 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.96 -0.29 27.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.837 0.827 . . . . 65.319999999999993 111.058 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.61 -27.01 34.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.64 -1.164 . . . . 65.340000000000003 110.418 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -113.88 175.03 5.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.291 -0.413 . . . . 74.530000000000001 110.578 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 17.2 p -98.68 115.37 28.54 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 108.534 -0.913 . . . . 73.349999999999994 108.534 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.2 m -100.44 144.19 29.72 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.906 -0.775 . . . . 61.539999999999999 108.906 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -62.11 135.08 57.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 61.350000000000001 111.388 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.4 mm -57.11 -27.09 26.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.062 1.745 . . . . 74.019999999999996 112.524 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -75.27 -11.01 59.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.969 -0.56 . . . . 60.130000000000003 111.046 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 43.9 m-80 -78.08 150.24 33.77 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 112.797 0.666 . . . . 64.519999999999996 112.797 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 451' ' ' ARG . 77.4 t -86.36 114.93 26.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.632 -1.247 . . . . 72.510000000000005 107.632 175.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.0 119.4 35.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.879 -0.785 . . . . 62.509999999999998 108.879 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -92.86 118.75 39.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.413 -1.328 . . . . 53.030000000000001 107.413 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.29 123.27 68.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.725 -0.67 . . . . 54.049999999999997 109.544 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 487' ' ' ILE . 3.1 mp -104.87 124.53 59.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.137 0.494 . . . . 73.230000000000004 110.005 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.418 HG21 HE21 ' A' ' 454' ' ' GLN . 21.7 t -103.21 140.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.728 -0.669 . . . . 71.230000000000004 110.064 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 120.51 5.17 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.521 -1.432 . . . . 74.319999999999993 109.521 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.0 t -118.33 160.45 21.63 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.411 -0.959 . . . . 73.319999999999993 108.411 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -87.6 137.36 14.52 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.418 -0.896 . . . . 61.43 111.796 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.33 132.08 26.58 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.126 1.884 . . . . 55.210000000000001 109.141 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.66 74.88 8.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.066 0.936 . . . . 72.030000000000001 110.382 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 546' ' ' PRO . 10.4 p -135.26 159.21 42.28 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.872 -1.058 . . . . 74.340000000000003 109.498 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -146.28 141.79 27.69 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.352 -0.61 . . . . 75.310000000000002 109.352 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.8 p-10 -89.14 138.13 31.7 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.961 -0.755 . . . . 74.099999999999994 108.961 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.3 pt -93.86 137.54 23.07 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 116.197 -0.456 . . . . 72.519999999999996 111.93 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.53 171.83 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.935 2.423 . . . . 74.219999999999999 112.112 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -82.84 110.57 17.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.588 0.709 . . . . 71.540000000000006 111.115 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.55 8.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.389 -0.823 . . . . 64.400000000000006 110.053 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.02 140.27 32.81 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.044 -0.525 . . . . 74.010000000000005 109.744 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.09 -13.44 58.8 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.126 -1.19 . . . . 71.010000000000005 110.126 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.477 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 17.2 mt-30 -93.96 178.3 5.7 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.264 -1.013 . . . . 73.430000000000007 108.264 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.2 p -85.54 157.5 20.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.145 -0.687 . . . . 74.540000000000006 109.145 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.41 -42.21 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.481 0.488 . . . . 65.420000000000002 112.092 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.01 -41.99 81.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.128 -0.629 . . . . 74.209999999999994 111.354 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 7.1 p -76.9 -36.42 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 118.577 -1.249 . . . . 52.030000000000001 111.125 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.84 -48.77 75.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.874 -0.603 . . . . 74.109999999999999 111.315 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.51 -35.15 80.02 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 123.293 0.37 . . . . 64.25 110.072 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 514' ' ' VAL . 50.4 tptt -63.49 -51.72 64.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.342 0.401 . . . . 54.219999999999999 110.248 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -61.89 -41.53 98.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.164 0.506 . . . . 75.430000000000007 110.126 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.408 HD21 HD13 ' A' ' 551' ' ' ILE . 37.2 tp -64.35 -47.77 78.07 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 110.171 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.87 -41.21 91.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.811 0.444 . . . . 53.329999999999998 111.919 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.3 t -63.87 -34.09 66.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.326 0.491 . . . . 63.200000000000003 112.326 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.27 -19.23 11.37 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.003 -1.079 . . . . 75.519999999999996 112.274 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -99.93 -103.5 2.52 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.71 -0.677 . . . . 61.409999999999997 114.541 -173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 11.5 m-85 -135.77 -178.59 5.2 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 110.265 -0.272 . . . . 64.25 110.265 -169.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -115.56 3.95 14.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.135 0.493 . . . . 55.200000000000003 111.106 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -108.12 115.54 30.31 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.658 -0.867 . . . . 74.510000000000005 108.658 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.63 151.5 50.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.757 0.789 . . . . 74.409999999999997 111.518 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.0 m -134.69 151.08 50.74 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.623 -1.621 . . . . 61.240000000000002 106.623 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -120.77 122.6 40.71 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.582 -1.266 . . . . 62.539999999999999 107.582 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.97 117.15 30.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.748 -1.204 . . . . 73.329999999999998 107.748 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 4.9 p -88.75 124.52 34.21 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 108.304 -0.999 . . . . 71.329999999999998 108.304 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.98 153.53 26.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.857 -0.794 . . . . 73.010000000000005 108.857 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.8 115.63 17.7 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.631 -1.248 . . . . 64.420000000000002 107.631 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 19.2 m -119.89 168.77 9.59 Favored Pre-proline 0 C--N 1.282 -2.356 0 CA-C-N 114.515 -1.22 . . . . 70.430000000000007 110.663 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 25.4 Cg_endo -61.9 -166.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 123.031 2.487 . . . . 75.340000000000003 112.165 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -50.67 -51.86 61.64 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 115.272 1.582 . . . . 73.439999999999998 115.272 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.24 133.71 36.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 CA-C-N 120.706 1.288 . . . . 64.209999999999994 111.495 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.424 ' HA ' ' OG ' ' A' ' 556' ' ' SER . . . -142.61 157.79 44.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.32 -0.622 . . . . 32.200000000000003 109.32 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 99.86 -24.89 30.39 Favored Glycine 0 C--N 1.313 -0.696 0 N-CA-C 110.389 -1.084 . . . . 51.329999999999998 110.389 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.95 148.04 25.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.346 -0.927 . . . . 75.140000000000001 110.154 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.83 119.12 23.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.109 -0.496 . . . . 72.129999999999995 111.038 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 24.0 m -73.16 -35.1 66.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.942 -1.026 . . . . 73.019999999999996 109.046 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.46 -161.58 35.31 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 111.084 -0.807 . . . . 74.319999999999993 111.084 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -130.34 160.8 32.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.524 -0.917 . . . . 61.140000000000001 108.524 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.5 t-20 -53.22 -57.87 14.88 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.493 0.496 . . . . 73.310000000000002 111.398 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.3 Cg_endo -89.2 147.42 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 CA-C-N 120.797 1.32 . . . . 73.5 109.11 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.75 155.64 69.61 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.692 1.595 . . . . 54.149999999999999 111.811 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.6 137.46 58.17 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 122.62 0.368 . . . . 65.140000000000001 110.118 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.26 -6.0 61.28 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.988 -0.625 . . . . 53.109999999999999 111.834 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.9 m -86.79 134.56 33.55 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.67 -0.312 . . . . 43.43 110.863 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 25.7 m -92.49 123.78 36.05 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.5 -0.926 . . . . 75.420000000000002 108.5 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.03 158.2 75.86 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.452 -0.573 . . . . 75.019999999999996 109.452 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 494' ' ' THR . 47.2 Cg_exo -58.74 144.33 98.19 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.825 2.35 . . . . 41.240000000000002 112.162 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 34.4 m -67.48 -20.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.664 0.616 . . . . 62.109999999999999 112.664 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.23 4.41 54.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.209 -0.451 . . . . 73.209999999999994 110.683 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.9 t -77.33 140.97 40.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.08 -1.081 . . . . 60.340000000000003 108.08 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.5 t -88.31 112.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.488 -1.301 . . . . 62.5 107.488 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 512' ' ' LEU . 19.8 tt -86.57 133.73 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.743 0.782 . . . . 72.450000000000003 111.399 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 21.0 tt0 -102.81 125.67 49.65 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.145 -0.934 . . . . 71.129999999999995 109.437 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.59 131.82 44.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.901 -1.148 . . . . 74.310000000000002 107.901 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -92.67 105.02 17.25 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 107.74 -1.207 . . . . 62.240000000000002 107.74 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 12.8 p -100.29 132.81 45.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.31 0.576 . . . . 70.439999999999998 110.145 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 531' ' ' ALA . 26.7 p -66.87 128.02 34.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.441 -0.8 . . . . 52.340000000000003 111.895 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 108.036 -1.098 . . . . 73.140000000000001 108.036 176.836 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 109.546 -1.421 . . . . 61.149999999999999 109.546 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.07 132.41 34.22 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 121.974 1.782 . . . . 72.439999999999998 111.28 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 0.1 OUTLIER -105.39 12.35 31.68 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.633 0.73 . . . . 71.519999999999996 109.658 -179.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 77.0 mt-30 -101.22 130.98 47.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.076 -0.965 . . . . 74.439999999999998 110.298 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.3 mmp_? -123.92 155.59 37.85 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.678 0.791 . . . . 64.030000000000001 110.955 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -84.77 141.55 30.44 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.782 -0.645 . . . . 62.32 111.596 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -79.25 131.18 66.64 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.626 -0.716 . . . . 74.319999999999993 109.551 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.43 152.32 65.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.962 2.441 . . . . 75.120000000000005 112.774 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -95.85 8.38 43.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.427 0.632 . . . . 65.129999999999995 110.142 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 439' ' ' GLU . 21.4 t -74.7 -12.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 122.542 1.163 . . . . 74.120000000000005 108.293 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 10.5 m -58.79 -38.39 78.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.855 -1.52 . . . . 25.129999999999999 110.804 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.2 m -60.21 -26.5 66.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.696 -1.138 . . . . 71.549999999999997 111.167 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.35 -45.45 12.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.812 -0.355 . . . . 70.140000000000001 111.108 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 28.3 m -161.86 143.78 11.34 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.031 -0.729 . . . . 72.450000000000003 109.031 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -52.51 -44.72 65.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.792 0.837 . . . . 73.120000000000005 111.455 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 436' ' ' THR . . . -62.77 -38.37 90.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.159 -0.473 . . . . 44.130000000000003 111.19 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 8.4 mm-40 -69.2 -37.34 78.06 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.731 -0.668 . . . . 73.420000000000002 110.202 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.91 -51.92 67.62 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.092 -0.958 . . . . 64.530000000000001 111.349 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.84 -40.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.425 -0.807 . . . . 74.129999999999995 111.777 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -66.08 -44.86 83.21 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.768 -0.373 . . . . 70.430000000000007 111.08 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.52 -40.57 89.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.643 0.259 . . . . 60.350000000000001 111.624 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 449' ' ' PHE . 30.3 tp -68.94 -34.75 75.87 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.25 0.548 . . . . 44.229999999999997 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.1 m -64.48 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.381 -0.6 . . . . 74.430000000000007 109.381 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.07 62.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.72 -0.673 . . . . 71.409999999999997 110.398 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.8 -13.63 53.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.724 -0.472 . . . . 63.310000000000002 109.724 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.32 -13.11 18.91 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.785 -0.643 . . . . 73.530000000000001 113.831 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 66.6 m-85 -71.09 138.94 50.16 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 111.143 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -138.38 10.63 3.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.156 -1.021 . . . . 64.040000000000006 113.149 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 483' ' ' VAL . 32.6 tpt180 -120.74 115.01 22.47 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.278 -1.008 . . . . 73.439999999999998 108.278 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.17 153.83 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.847 0.356 . . . . 73.420000000000002 110.559 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -131.42 122.35 26.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.002 -1.481 . . . . 75.200000000000003 107.002 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.41 HE21 HG21 ' A' ' 488' ' ' VAL . 59.0 tt0 -94.36 115.78 28.05 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.177 0.513 . . . . 64.219999999999999 110.193 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -118.53 154.61 32.28 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.997 -1.112 . . . . 70.239999999999995 107.997 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.21 148.22 52.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.365 -0.606 . . . . 54.109999999999999 109.365 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.6 m -135.63 147.21 60.57 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 109.06 -0.718 . . . . 54.32 109.06 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.9 Cg_exo -65.07 122.72 10.58 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.428 2.086 . . . . 74.219999999999999 110.933 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.9 t -148.88 179.4 7.89 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.017 -1.105 . . . . 74.540000000000006 108.017 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -59.84 139.83 90.1 Favored Pre-proline 0 N--CA 1.427 -1.593 0 C-N-CA 124.333 1.053 . . . . 64.329999999999998 110.662 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 82.4 Cg_exo -50.87 -29.87 28.19 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.311 3.341 . . . . 61.109999999999999 113.141 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.78 -29.73 69.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.097 -0.502 . . . . 74.25 111.818 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.31 -2.13 49.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.033 -0.531 . . . . 71.409999999999997 111.68 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 92.7 t -61.28 127.04 20.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.23 -0.656 . . . . 75.329999999999998 109.23 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.93 -3.54 82.87 Favored Glycine 0 C--N 1.307 -1.065 0 C-N-CA 121.067 -0.587 . . . . 71.120000000000005 112.121 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.7 154.29 26.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.545 -0.909 . . . . 74.400000000000006 108.545 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.661 HG22 HD11 ' A' ' 486' ' ' ILE . 43.3 t -82.12 125.36 39.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.844 -0.798 . . . . 75.219999999999999 108.844 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.8 pt -98.45 -7.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.141 0.496 . . . . 44.210000000000001 110.415 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.46 150.2 5.92 Favored Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.631 -0.713 . . . . 74.340000000000003 111.487 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 10.4 p -116.47 158.32 23.77 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 107.481 -1.303 . . . . 74.030000000000001 107.481 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.9 m120 -67.94 -55.11 14.22 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 119.059 -1.056 . . . . 63.32 110.609 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -69.26 116.33 4.46 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 108.574 -1.356 . . . . 64.129999999999995 108.574 170.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 158.79 41.56 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.566 2.177 . . . . 73.230000000000004 113.413 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.33 7.25 9.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.307 -0.86 . . . . 62.539999999999999 110.401 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.16 -40.8 11.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.356 -0.838 . . . . 73.549999999999997 110.802 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -118.73 165.27 14.21 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.589 -0.523 . . . . 73.239999999999995 109.589 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 23.9 p -84.06 142.79 30.17 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.459 -0.337 . . . . 72.310000000000002 110.682 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.3 m -124.3 150.77 45.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.883 -1.154 . . . . 52.350000000000001 107.883 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -74.63 146.22 42.61 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.534 0.606 . . . . 74.409999999999997 111.328 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.71 -23.09 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.44 1.096 . . . . 60.25 111.014 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 t -95.5 1.18 53.86 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.784 -1.098 . . . . 60.409999999999997 110.428 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -80.67 155.45 26.8 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 451' ' ' ARG . 7.7 p -88.13 121.23 38.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.889 -0.782 . . . . 64.230000000000004 108.889 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.85 118.89 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.926 -0.768 . . . . 75.219999999999999 108.926 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.44 117.43 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 106.157 -1.794 . . . . 63.530000000000001 106.157 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -108.92 124.24 65.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.701 -0.851 . . . . 61.009999999999998 108.701 -176.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.14 118.53 49.12 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 CA-C-O 121.396 0.617 . . . . 44.43 109.608 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.41 HG21 HE21 ' A' ' 454' ' ' GLN . 27.1 t -96.54 141.49 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.294 -0.866 . . . . 73.349999999999994 108.915 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -72.98 128.48 11.95 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 108.516 -1.833 . . . . 64.420000000000002 108.516 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.8 m -140.91 150.72 43.53 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.141 -0.623 . . . . 63.340000000000003 109.513 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -135.38 130.75 5.52 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.689 -1.364 . . . . 73.310000000000002 109.689 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.17 123.23 12.46 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.472 2.115 . . . . 44.109999999999999 111.618 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -83.81 92.45 7.76 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.788 0.804 . . . . 72.319999999999993 109.084 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 546' ' ' PRO . 47.0 p -131.87 160.58 35.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.356 -0.979 . . . . 72.129999999999995 108.356 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 544' ' ' THR . 67.8 mttm -135.59 147.22 48.61 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.215 -0.291 . . . . 63.420000000000002 110.215 177.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.28 126.51 36.39 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.593 -0.892 . . . . 74.150000000000006 108.593 175.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 541' ' ' ALA . 38.1 pt -81.95 137.41 46.76 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.524 -0.762 . . . . 63.539999999999999 112.358 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.43 175.47 6.25 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.563 2.175 . . . . 75.140000000000001 111.224 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.45 121.61 31.85 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 75.030000000000001 110.27 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.66 9.8 6.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.35 -0.841 . . . . 64.209999999999994 109.378 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.474 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -75.17 147.6 40.29 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.342 -0.844 . . . . 62.229999999999997 112.191 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.64 69.46 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.178 -0.769 . . . . 64.239999999999995 111.178 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.413 ' O ' HG12 ' A' ' 534' ' ' VAL . 43.6 mt-30 -117.32 -167.82 1.38 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.984 -0.747 . . . . 74.530000000000001 108.984 177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.4 m -90.67 155.66 18.68 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.299 -0.961 . . . . 72.319999999999993 109.608 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.76 -43.93 57.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.196 0.598 . . . . 72.439999999999998 112.141 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.15 -42.2 80.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 111.906 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.59 -34.23 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.894 -0.722 . . . . 65.319999999999993 111.09 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.47 -47.28 86.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.534 -0.757 . . . . 70.019999999999996 110.736 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.89 -37.37 87.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 123.257 0.348 . . . . 64.219999999999999 110.632 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 60.4 tttp -62.39 -53.67 51.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.64 -0.709 . . . . 71.040000000000006 110.062 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.07 -42.76 96.87 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.344 -0.844 . . . . 74.019999999999996 110.676 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.6 -41.12 96.98 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 115.592 -0.731 . . . . 74.150000000000006 109.715 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.18 -40.08 84.59 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.82 0.448 . . . . 74.430000000000007 110.708 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.2 t -67.18 -36.88 78.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.848 -0.615 . . . . 72.299999999999997 111.71 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -113.84 9.17 17.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.135 -0.626 . . . . 71.400000000000006 111.025 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -140.38 -107.5 0.7 Allowed Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.156 -1.497 . . . . 73.439999999999998 115.198 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.7 m-85 -127.6 -176.59 3.8 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.06 0.392 . . . . 74.239999999999995 112.06 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.87 -14.34 10.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.623 0.725 . . . . 74.120000000000005 110.559 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -108.14 115.72 30.65 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.246 -0.65 . . . . 73.409999999999997 109.246 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -124.29 155.59 38.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.298 -0.41 . . . . 75.25 110.347 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.3 m -140.86 158.29 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.447 -1.686 . . . . 71.019999999999996 106.447 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -121.95 144.12 49.06 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.735 -0.468 . . . . 73.129999999999995 109.735 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.31 134.91 54.65 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.208 -0.664 . . . . 73.329999999999998 109.208 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.4 m -90.26 119.9 30.96 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.606 -0.887 . . . . 63.240000000000002 108.606 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.51 163.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.626 -1.25 . . . . 71.439999999999998 107.626 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.43 129.18 35.42 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.642 0.734 . . . . 71.430000000000007 109.488 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 11.2 p -77.27 132.48 69.92 Favored Pre-proline 0 N--CA 1.419 -2.015 0 CA-C-N 114.682 -1.144 . . . . 72.349999999999994 110.576 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.453 ' O ' ' HD2' ' A' ' 529' ' ' ARG . 11.9 Cg_endo -63.69 -75.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.524 1.482 . . . . 72.329999999999998 109.579 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.548 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 10.9 mmm180 -121.17 -57.7 0.03 OUTLIER Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.663 -0.495 . . . . 65.200000000000003 109.663 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 2.7 Cg_exo -77.36 153.15 31.01 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.305 2.004 . . . . 65.420000000000002 111.609 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.98 149.28 52.47 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.785 -0.82 . . . . 54.329999999999998 108.785 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 103.82 -22.08 36.49 Favored Glycine 0 C--O 1.249 1.035 0 N-CA-C 111.156 -0.778 . . . . 55.340000000000003 111.156 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.09 148.09 25.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.579 0.704 . . . . 55.140000000000001 111.674 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 501' ' ' ALA . 3.8 p -75.8 125.16 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.977 -1.011 . . . . 74.239999999999995 110.15 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 8.4 m -77.45 -37.08 52.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.262 -1.014 . . . . 62.43 108.262 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.43 35.2 Favored Glycine 0 N--CA 1.417 -2.603 0 N-CA-C 109.665 -1.374 . . . . 73.140000000000001 109.665 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.3 p -117.74 159.88 22.27 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.209 -1.404 . . . . 62.32 107.209 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -56.75 -57.15 25.81 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 123.489 0.493 . . . . 73.129999999999995 110.716 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 59.8 Cg_endo -77.26 142.84 21.77 Favored 'Trans proline' 0 C--N 1.368 1.588 0 N-CA-C 109.125 -1.144 . . . . 74.239999999999995 109.125 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -65.22 151.02 86.78 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.282 1.988 . . . . 74.409999999999997 111.804 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -58.92 138.45 57.38 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.747 0.308 . . . . 34.520000000000003 110.196 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.78 -21.13 43.36 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 111.309 -0.716 . . . . 74.239999999999995 111.309 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 46.2 m -70.75 132.35 45.22 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.105 0.478 . . . . 72.230000000000004 110.394 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 m -96.67 122.66 39.86 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.397 -0.819 . . . . 74.400000000000006 108.82 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.16 159.63 71.35 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.398 -0.593 . . . . 62.299999999999997 109.398 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.583 ' HA ' HG22 ' A' ' 494' ' ' THR . 39.2 Cg_exo -61.03 142.26 96.84 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.217 2.611 . . . . 73.230000000000004 114.584 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.499 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 30.9 m -67.43 -19.32 25.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.95 0.881 . . . . 73.510000000000005 111.146 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.9 -10.12 55.79 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.22 -1.354 . . . . 63.229999999999997 109.747 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 59.9 p -92.3 171.76 8.85 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.866 -0.606 . . . . 62.420000000000002 112.03 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.25 136.39 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.261 -1.014 . . . . 74.310000000000002 108.261 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 16.0 tt -113.76 142.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 120.895 0.379 . . . . 74.420000000000002 110.538 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -102.99 128.3 49.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 122.968 0.507 . . . . 75.200000000000003 111.606 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.3 122.01 42.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.135 -1.431 . . . . 75.510000000000005 107.135 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -104.32 110.13 22.25 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.606 -0.887 . . . . 70.140000000000001 108.606 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.36 139.13 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.461 -0.791 . . . . 73.519999999999996 112.944 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 69.6 m -64.76 115.05 4.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.484 -0.78 . . . . 71.340000000000003 109.581 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 106.46 -1.682 . . . . 73.219999999999999 106.46 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.772 0 N-CA-C 110.376 -1.09 . . . . 43.049999999999997 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.69 145.06 86.01 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.172 1.914 . . . . 72.030000000000001 110.635 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 56.89 1.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.296 1.046 . . . . 72.219999999999999 111.617 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 91.7 mt-30 -121.75 131.03 53.85 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.222 -1.354 . . . . 72.219999999999999 108.122 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -122.72 151.56 41.44 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.154 -0.684 . . . . 75.450000000000003 109.154 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -93.74 142.16 27.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.266 -0.879 . . . . 74.239999999999995 110.082 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.497 ' O ' ' HB1' ' A' ' 474' ' ' ALA . 2.9 mp -79.13 125.11 84.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.858 -0.793 . . . . 73.340000000000003 108.858 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.43 141.79 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.727 1.618 . . . . 74.219999999999999 111.332 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.65 52.19 1.85 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.728 0.775 . . . . 65.349999999999994 110.652 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 440' ' ' ALA . 14.8 p -102.39 -2.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.018 -1.475 . . . . 72.120000000000005 107.018 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 1.7 p -59.11 -41.44 88.16 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.998 -1.91 . . . . 72.030000000000001 110.703 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.3 p -61.71 -26.37 68.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.9 -1.045 . . . . 72.140000000000001 112.807 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.3 -46.48 13.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 119.077 -1.049 . . . . 64.420000000000002 111.575 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 12.6 m -170.39 147.36 3.0 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.942 -0.762 . . . . 75.319999999999993 108.942 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -50.82 -48.91 59.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.507 1.123 . . . . 71.200000000000003 110.581 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 436' ' ' THR . . . -58.31 -37.76 75.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 111.579 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.511 ' HB3' HG22 ' A' ' 432' ' ' VAL . 25.0 mm-40 -69.59 -44.68 70.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.088 0.47 . . . . 65.439999999999998 110.363 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.44 -51.18 70.55 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.045 -0.979 . . . . 54.549999999999997 111.704 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.01 -45.95 89.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 CA-C-N 115.737 -0.665 . . . . 75.549999999999997 111.511 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.19 -47.91 80.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.018 0.377 . . . . 71.540000000000006 112.018 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -67.79 -39.52 84.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.31 -0.556 . . . . 63.119999999999997 110.668 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 452' ' ' PHE . 20.9 tp -69.7 -34.78 74.37 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.252 0.548 . . . . 75.409999999999997 110.716 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 27.1 m -62.06 -43.31 99.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.651 -0.704 . . . . 71.329999999999998 109.64 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.87 62.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.626 -0.715 . . . . 72.329999999999998 110.836 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.65 59.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.049 0.452 . . . . 72.200000000000003 110.454 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.92 6.95 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.329 -0.938 . . . . 75.340000000000003 113.171 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 445' ' ' THR . 97.1 m-85 -80.85 130.93 35.31 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.69 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -136.22 14.74 4.0 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.184 -1.166 . . . . 60.109999999999999 110.184 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -116.95 115.3 25.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 444' ' ' LEU . 87.7 m-85 -139.04 156.43 47.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.301 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.466 ' HB2' HG13 ' A' ' 485' ' ' ILE . 68.8 mttm -133.55 122.97 24.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.114 -1.809 . . . . 61.119999999999997 106.114 167.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -93.79 120.02 33.51 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.763 -0.775 . . . . 75.040000000000006 112.027 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.31 43.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.232 -1.025 . . . . 74.129999999999995 108.232 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.89 150.75 33.19 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.915 -1.143 . . . . 63.409999999999997 107.915 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 37.1 p -134.6 138.21 29.4 Favored Pre-proline 0 C--N 1.277 -2.575 0 N-CA-C 108.964 -0.754 . . . . 61.43 108.964 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 22.8 Cg_exo -65.57 123.6 11.64 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.086 1.857 . . . . 74.409999999999997 110.042 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 179.31 7.55 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 108.43 -0.952 . . . . 54.219999999999999 108.43 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.1 t -67.92 137.89 92.54 Favored Pre-proline 0 N--CA 1.418 -2.065 0 C-N-CA 123.467 0.707 . . . . 71.140000000000001 110.461 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 464' ' ' VAL . 98.2 Cg_exo -50.78 -29.21 25.45 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 124.669 3.579 . . . . 61.420000000000002 113.596 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.65 -21.53 61.81 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 111.401 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 466' ' ' LYS . 23.0 tp -105.15 2.92 29.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 64.310000000000002 110.683 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 461' ' ' PRO . 65.2 t -60.46 128.03 20.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-N 116.156 -0.475 . . . . 64.400000000000006 111.013 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.31 -2.55 56.37 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.717 -0.674 . . . . 64.129999999999995 111.676 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.489 ' HD2' HD12 ' A' ' 463' ' ' LEU . 96.6 mttt -112.21 145.05 40.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.38 -0.6 . . . . 64.109999999999999 109.38 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 433' ' ' SER . 47.1 t -82.75 134.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.193 -0.669 . . . . 74.310000000000002 109.193 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.7 pt -98.28 -20.09 5.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.484 -0.886 . . . . 71.219999999999999 110.08 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.927 -0.654 . . . . 54.210000000000001 111.565 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 21.2 p -116.77 161.0 19.95 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.518 -0.919 . . . . 65.349999999999994 108.518 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.543 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.4 t-20 -65.69 -52.43 43.06 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-O 119.012 -0.518 . . . . 73.140000000000001 111.568 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.5 Cg_exo -75.02 135.81 19.52 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 120.359 1.164 . . . . 52.420000000000002 109.116 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.57 136.26 53.42 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.614 2.209 . . . . 75.030000000000001 111.351 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 429' ' ' ILE . . . -77.0 -17.68 58.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.822 -0.626 . . . . 72.239999999999995 111.964 -172.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -76.49 -31.87 58.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.386 0.612 . . . . 72.049999999999997 109.71 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -95.34 164.87 12.64 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.456 -0.793 . . . . 64.540000000000006 110.836 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 p -97.63 127.1 43.33 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.525 -0.761 . . . . 62.439999999999998 110.449 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.4 m -110.06 139.68 44.92 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.283 -1.006 . . . . 61.340000000000003 108.283 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -57.89 150.39 20.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.075 0.398 . . . . 74.120000000000005 112.075 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.1 -25.71 38.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.847 -0.615 . . . . 62.420000000000002 110.82 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -86.71 5.29 36.95 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 116.146 -0.479 . . . . 75.239999999999995 111.363 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -82.13 157.52 24.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 120.909 0.385 . . . . 64.450000000000003 111.031 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 453' ' ' LYS . 22.3 t -100.05 123.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.034 -1.099 . . . . 53.240000000000002 108.034 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.18 119.01 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 C-N-CA 119.069 -1.053 . . . . 63.310000000000002 108.844 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.543 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.1 mp -92.65 118.35 38.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 105.308 -2.108 . . . . 71.310000000000002 105.308 174.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 tt -102.13 124.35 55.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 116.347 -0.388 . . . . 74.409999999999997 109.967 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.95 108.46 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.395 -0.965 . . . . 75.439999999999998 108.395 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.67 139.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.005 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.07 123.89 6.53 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.484 -1.446 . . . . 53.109999999999999 109.484 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 20.3 m -135.85 149.74 49.15 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 31.32 108.286 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -153.62 168.93 32.27 Favored Glycine 0 N--CA 1.424 -2.164 0 C-N-CA 119.746 -1.216 . . . . 73.099999999999994 110.768 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.58 124.29 6.91 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.251 1.967 . . . . 71.540000000000006 112.334 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.67 80.6 8.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.471 -1.678 . . . . 51.119999999999997 106.471 173.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 546' ' ' PRO . 37.2 p -127.96 161.29 29.47 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 114.519 -1.218 . . . . 74.420000000000002 109.858 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 544' ' ' THR . 96.0 mttt -143.31 156.33 44.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.835 -0.431 . . . . 74.319999999999993 109.835 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.8 p-10 -92.78 135.87 33.74 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.952 -0.758 . . . . 74.120000000000005 108.952 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 23.2 pt -78.14 136.67 61.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.998 -0.546 . . . . 73.530000000000001 110.926 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.83 -172.49 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.577 2.184 . . . . 74.219999999999999 110.339 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -99.41 136.35 39.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.454 -0.943 . . . . 52.229999999999997 108.454 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 m -128.66 16.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 120.887 0.375 . . . . 62.229999999999997 110.835 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -72.0 116.45 12.42 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.915 -0.584 . . . . 65.109999999999999 111.367 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 116.69 -19.33 12.57 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.811 -0.709 . . . . 62.420000000000002 112.103 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 507' ' ' VAL . 25.5 mt-30 -81.76 177.7 8.74 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.845 -0.342 . . . . 52.310000000000002 110.153 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.3 m -91.4 156.29 17.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.553 -1.277 . . . . 74.329999999999998 107.553 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.96 -43.47 75.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.921 0.391 . . . . 73.109999999999999 112.054 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 5.9 p-10 -68.51 -42.08 79.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 111.897 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 503' ' ' GLN . 8.9 p -75.94 -34.63 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.142 -1.023 . . . . 55.109999999999999 111.141 -175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.417 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -62.0 -48.89 78.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.448 -0.796 . . . . 34.340000000000003 111.364 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.4 -36.77 84.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.404 0.44 . . . . 71.030000000000001 110.746 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.6 mptp? -64.01 -47.58 79.72 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.123 0.264 . . . . 61.130000000000003 111.56 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -65.13 -42.91 93.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.975 0.417 . . . . 73.549999999999997 110.318 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.74 -37.26 85.88 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 115.762 -0.653 . . . . 73.219999999999999 109.655 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -62.25 -37.9 87.21 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 122.762 0.425 . . . . 70.239999999999995 110.714 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 510' ' ' LYS . 61.0 t -72.44 -27.21 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.089 0.471 . . . . 74.329999999999998 110.637 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.77 36.54 4.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.552 -0.295 . . . . 62.229999999999997 110.23 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -169.33 -100.92 0.14 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 117.106 -2.473 . . . . 75.25 116.613 -173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.588 ' CE2' HG23 ' A' ' 545' ' ' VAL . 61.3 m-85 -127.63 162.36 26.69 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 115.212 -0.494 . . . . 62.130000000000003 111.312 -162.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.2 m -104.37 -17.37 14.82 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.225 -0.898 . . . . 65.319999999999993 110.869 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 550' ' ' VAL . 35.3 mmtp -109.98 123.93 50.52 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.92 -0.488 . . . . 70.439999999999998 109.804 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.97 151.28 45.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.473 0.654 . . . . 73.329999999999998 111.666 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -141.6 152.03 43.67 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.121 -1.437 . . . . 74.409999999999997 107.121 169.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.23 128.12 50.77 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 110.233 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.58 127.34 52.04 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.878 -0.786 . . . . 65.209999999999994 108.878 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.438 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 20.1 m -91.29 143.07 27.03 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.117 -0.697 . . . . 62.43 109.117 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.87 159.45 26.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.375 -0.972 . . . . 73.299999999999997 108.375 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.32 134.43 36.61 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.362 0.601 . . . . 65.150000000000006 109.432 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 8.1 t -129.81 162.3 54.28 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 108.021 -1.103 . . . . 63.509999999999998 108.021 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 122.519 2.146 . . . . 65.349999999999994 110.079 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.17 -46.52 62.19 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 118.986 -1.086 . . . . 64.140000000000001 113.315 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.67 134.65 38.75 Favored 'Trans proline' 0 C--N 1.365 1.401 0 CA-C-N 120.383 1.172 . . . . 52.210000000000001 109.897 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -153.71 176.33 12.23 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.682 -0.859 . . . . 73.230000000000004 108.682 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.93 7.15 62.88 Favored Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 111.049 -0.82 . . . . 55.210000000000001 111.049 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.9 141.1 28.99 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 107.633 -1.247 . . . . 74.299999999999997 107.633 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 95.8 t -77.12 115.76 19.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 104.781 -2.303 . . . . 70.109999999999999 104.781 165.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.8 m -76.1 -26.73 56.72 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.739 -0.837 . . . . 73.140000000000001 108.739 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.43 -149.43 21.2 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.291 -0.868 . . . . 61.329999999999998 111.023 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.5 p -118.09 161.67 19.46 Favored 'General case' 0 C--N 1.279 -2.498 0 C-N-CA 123.522 0.729 . . . . 63.200000000000003 109.108 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.6 t-20 -52.33 -51.96 67.42 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 123.427 0.454 . . . . 63.350000000000001 111.636 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.3 Cg_endo -91.6 161.16 3.53 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.473 1.449 . . . . 73.430000000000007 109.845 171.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.95 150.58 61.19 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.154 1.902 . . . . 72.120000000000005 112.194 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -50.94 131.02 26.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.102 0.961 . . . . 33.200000000000003 111.422 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.55 -17.29 36.69 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.773 -0.648 . . . . 51.310000000000002 112.099 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 48.6 m -67.86 128.01 34.93 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.567 -0.372 . . . . 70.439999999999998 110.301 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 27.8 m -97.59 123.36 41.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.761 -0.459 . . . . 51.039999999999999 109.761 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' A' ' 517' ' ' PHE . 9.5 m -134.14 162.26 58.76 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.264 -0.643 . . . . 71.209999999999994 109.264 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.593 ' HA ' HG22 ' A' ' 494' ' ' THR . 31.2 Cg_exo -61.93 136.21 60.06 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.104 2.536 . . . . 75.420000000000002 113.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 33.2 m -66.73 -22.82 30.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.663 -0.699 . . . . 62.119999999999997 112.343 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.97 -2.13 57.74 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.134 -0.939 . . . . 73.120000000000005 110.011 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -93.97 173.19 7.79 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.087 -0.709 . . . . 65.530000000000001 109.087 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 519' ' ' LYS . 60.2 t -91.99 127.65 44.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 111.827 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.15 130.13 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.825 -1.176 . . . . 53.420000000000002 107.825 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 32.7 tt0 -103.04 127.19 50.38 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-O 121.268 0.556 . . . . 63.100000000000001 110.111 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 20.6 tp -95.28 132.58 40.13 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.979 -1.009 . . . . 61.130000000000003 109.06 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -100.18 113.34 25.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.425 -0.954 . . . . 74.230000000000004 108.425 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.81 137.67 44.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-O 120.627 0.251 . . . . 75.329999999999998 111.24 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 58.6 p -83.39 124.49 30.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 109.785 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 524' ' ' SER . 14.9 ttpp . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 108.829 -0.804 . . . . 74.109999999999999 108.829 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 N-CA-C 110.987 -0.845 . . . . 43.049999999999997 110.987 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.05 133.06 12.05 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 121.713 1.609 . . . . 74.310000000000002 111.746 -178.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.2 OUTLIER -87.0 -0.27 56.34 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.908 0.861 . . . . 73.129999999999995 109.916 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 77.1 mt-30 -118.57 153.5 34.13 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.222 -1.399 . . . . 63.329999999999998 107.222 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -145.85 152.62 39.79 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.292 -1.744 . . . . 72.209999999999994 106.292 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.41 140.94 30.34 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.503 0.668 . . . . 73.430000000000007 112.503 -177.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.49 131.04 69.44 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 107.51 -1.293 . . . . 73.409999999999997 107.51 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.0 140.6 94.54 Favored 'Trans proline' 0 C--O 1.243 0.734 0 C-N-CA 122.664 2.242 . . . . 73.439999999999998 113.346 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -96.47 -5.25 40.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.025 -0.989 . . . . 43.109999999999999 109.84 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.18 5.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.947 0.879 . . . . 53.219999999999999 110.703 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 2.5 p -62.63 -30.45 71.37 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.869 1.268 . . . . 60.240000000000002 109.918 177.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.5 t -57.65 -26.76 62.1 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.42 -1.263 . . . . 75.25 111.077 176.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.57 -44.96 15.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 120.788 -0.365 . . . . 62.5 110.422 -175.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.575 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 3.7 m -164.1 149.44 10.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.702 -0.851 . . . . 42.329999999999998 108.702 175.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -54.71 -44.02 73.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.783 0.833 . . . . 71.340000000000003 110.768 174.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.63 -43.56 76.26 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.305 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.575 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 5.0 mm-40 -61.67 -42.43 98.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 123.514 0.509 . . . . 74.409999999999997 110.44 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.1 -49.47 77.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.157 -0.929 . . . . 71.5 110.097 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.96 -47.61 92.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 CA-C-N 115.788 -0.642 . . . . 73.120000000000005 112.101 -177.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 35.5 mmtp -60.96 -48.6 81.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.035 0.445 . . . . 61.520000000000003 110.452 -176.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 443' ' ' LYS . 10.3 mmpt? -68.2 -39.19 82.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.899 -0.591 . . . . 75.409999999999997 111.843 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 23.4 tp -68.54 -40.25 80.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.195 0.521 . . . . 64.439999999999998 110.044 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 42.8 m -59.41 -45.85 90.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.249 -0.887 . . . . 64.150000000000006 109.461 176.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.85 -17.28 62.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.63 -0.714 . . . . 60.32 111.473 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.59 -13.92 57.4 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 110.861 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 113.9 -11.81 22.67 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.15 -1.024 . . . . 64.409999999999997 113.519 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.417 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 96.8 m-85 -72.5 138.55 47.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.976 0.417 . . . . 70.150000000000006 110.857 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -126.45 -12.74 3.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.591 -0.814 . . . . 75.340000000000003 113.599 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 451' ' ' ARG . 2.1 tpm_? -103.38 114.99 29.7 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.095 -0.706 . . . . 74.219999999999999 109.095 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 37.1 m-85 -120.03 153.27 36.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.369 -0.832 . . . . 72.340000000000003 109.696 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.521 ' HB3' HG13 ' A' ' 485' ' ' ILE . 16.3 tppt? -143.73 122.33 12.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 105.566 -2.013 . . . . 72.230000000000004 105.566 170.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -104.2 125.4 50.46 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 120.862 0.363 . . . . 71.239999999999995 110.732 -176.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.93 49.04 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.231 -1.026 . . . . 74.409999999999997 108.231 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -124.02 149.35 46.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.543 -0.91 . . . . 63.009999999999998 108.543 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.2 m -140.42 140.65 23.4 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 108.97 -0.752 . . . . 55.299999999999997 108.97 176.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.7 Cg_exo -65.76 122.0 9.51 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.965 1.777 . . . . 75.129999999999995 109.946 177.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.4 m -151.99 -179.54 7.57 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.756 -1.201 . . . . 71.040000000000006 107.756 -178.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 463' ' ' LEU . 6.9 t -24.98 100.24 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.51 0 C-N-CA 126.563 1.945 . . . . 73.239999999999995 112.83 177.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 73.8 Cg_exo -51.53 -38.09 63.89 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 124.499 3.466 . . . . 62.32 115.973 -170.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.45 -11.33 59.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.191 0.811 . . . . 74.209999999999994 113.191 -176.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.494 ' HB2' HG23 ' A' ' 460' ' ' THR . 3.9 mm? -103.65 14.15 31.71 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.692 0.282 . . . . 71.219999999999999 111.186 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.1 p -52.86 128.73 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 116.159 -0.473 . . . . 72.5 110.335 176.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.49 -3.06 56.27 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.826 -0.702 . . . . 63.25 111.506 -179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -103.48 146.01 29.15 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.316 -0.624 . . . . 73.519999999999996 109.316 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.644 HG22 HD11 ' A' ' 486' ' ' ILE . 46.9 t -81.78 132.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.477 -0.564 . . . . 72.219999999999999 109.477 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.5 -21.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.624 -0.43 . . . . 72.150000000000006 110.625 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.96 159.92 23.54 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 111.106 -0.798 . . . . 73.510000000000005 111.106 177.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -122.63 152.32 40.6 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.326 -0.99 . . . . 65.310000000000002 108.326 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.468 HD22 HD13 ' A' ' 485' ' ' ILE . 66.0 t30 -64.44 -50.59 65.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.499 -0.481 . . . . 75.540000000000006 111.058 177.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.3 Cg_exo -79.59 147.83 20.06 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 120.371 1.168 . . . . 64.530000000000001 109.104 172.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 3.7 Cg_exo -71.37 140.89 37.71 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.142 1.894 . . . . 43.140000000000001 113.463 -175.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.11 6.67 28.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.115 0.96 . . . . 73.420000000000002 109.183 176.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.1 -26.83 13.55 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.667 -1.151 . . . . 73.420000000000002 111.988 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -137.85 174.96 10.01 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.279 -0.569 . . . . 75.150000000000006 110.263 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 41.7 p -86.94 147.71 25.64 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.238 0.542 . . . . 64.439999999999998 112.368 -176.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.4 m -133.83 150.1 51.39 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.393 -1.336 . . . . 62.049999999999997 107.393 174.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.534 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -55.48 142.24 33.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.617 0.599 . . . . 65.230000000000004 112.617 -176.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.8 mm -57.02 -29.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.563 1.145 . . . . 63.299999999999997 111.532 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -94.08 12.26 27.02 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.527 -0.469 . . . . 74.120000000000005 111.577 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.95 146.32 35.55 Favored 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 122.14 -0.35 . . . . 70.140000000000001 110.365 176.652 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.2 122.98 36.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.632 -0.877 . . . . 71.200000000000003 108.632 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.82 118.51 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 108.039 -1.097 . . . . 75.200000000000003 108.039 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.0 mp -96.99 114.47 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 106.194 -1.78 . . . . 54.299999999999997 106.194 175.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.644 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.88 125.68 59.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 108.901 -0.777 . . . . 64.299999999999997 108.901 -177.713 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.46 116.47 49.31 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 CA-C-O 121.693 0.758 . . . . 53.119999999999997 109.988 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.41 136.83 25.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.22 -0.9 . . . . 71.299999999999997 109.461 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -83.91 112.1 3.53 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.783 -2.127 . . . . 54.219999999999999 107.783 174.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.4 t -115.3 145.37 42.54 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 119.873 -0.731 . . . . 74.430000000000007 109.787 -176.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -111.98 113.07 3.22 Favored Glycine 0 N--CA 1.406 -3.301 0 N-CA-C 107.965 -2.054 . . . . 71.430000000000007 107.965 176.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 115.68 2.73 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.115 1.876 . . . . 53.32 111.106 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -65.57 96.83 0.28 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.081 -0.963 . . . . 75.299999999999997 108.503 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.6 p -136.27 157.56 46.51 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.543 -1.208 . . . . 62.43 108.268 -175.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 517' ' ' PHE . 28.9 mtpp -143.94 157.36 44.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.666 -0.864 . . . . 75.129999999999995 108.666 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.0 t70 -91.36 130.92 37.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.677 -1.231 . . . . 75.120000000000005 107.677 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 23.8 pt -77.15 126.11 85.73 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 112.366 0.506 . . . . 64.400000000000006 112.366 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 55.2 Cg_endo -94.07 114.46 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.32 2.013 . . . . 71.519999999999996 112.886 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.67 124.36 29.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.422 -0.955 . . . . 64.319999999999993 108.422 175.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.4 t -114.53 45.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.154 -1.054 . . . . 75.109999999999999 108.154 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -63.29 130.73 45.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.848 -1.069 . . . . 65.150000000000006 111.381 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 129.99 -32.04 3.22 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.316 -0.945 . . . . 72.540000000000006 113.29 176.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 534' ' ' VAL . 23.7 mt-30 -94.7 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.691 -0.485 . . . . 64.140000000000001 109.691 -177.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 157.38 19.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.178 -1.009 . . . . 74.150000000000006 109.564 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.454 HG21 HG13 ' A' ' 555' ' ' VAL . 89.5 t -55.92 -44.14 77.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.593 0.558 . . . . 63.329999999999998 111.151 -176.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.61 -41.75 83.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.693 -0.685 . . . . 74.219999999999999 111.921 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.52 -36.26 27.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 118.884 -1.126 . . . . 64.409999999999997 110.654 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.58 87.25 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.53 -0.759 . . . . 61.409999999999997 110.959 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -64.82 -35.17 80.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 123.307 0.38 . . . . 70.430000000000007 110.041 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -61.42 -47.48 85.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 123.127 0.267 . . . . 73.329999999999998 111.517 176.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -68.84 -43.12 76.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.376 -0.375 . . . . 71.510000000000005 111.006 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 520' ' ' PHE . 5.8 tt -64.27 -37.54 87.86 Favored 'General case' 0 C--O 1.173 -2.947 0 CA-C-N 115.928 -0.578 . . . . 62.350000000000001 109.537 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.33 -37.44 75.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.929 0.491 . . . . 71.420000000000002 110.362 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.88 -39.86 75.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.73 -0.668 . . . . 74.340000000000003 111.122 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -94.99 -10.83 29.76 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.431 0.634 . . . . 71.200000000000003 110.384 -174.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -117.25 -117.54 2.9 Favored Glycine 0 N--CA 1.411 -2.978 0 CA-C-N 115.243 -0.889 . . . . 73.319999999999993 113.139 -172.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.684 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 35.9 m-85 -136.46 -175.41 4.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.459 -0.571 . . . . 74.319999999999993 109.459 -169.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 m -99.37 -18.5 17.48 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.719 -0.673 . . . . 40.240000000000002 111.811 -178.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -107.29 115.87 30.93 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.876 -0.729 . . . . 71.109999999999999 111.54 -175.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.471 ' CE2' HD22 ' A' ' 512' ' ' LEU . 19.7 m-85 -120.84 142.57 49.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.578 -1.192 . . . . 74.140000000000001 108.543 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.5 p -115.62 145.28 42.84 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 104.936 -2.246 . . . . 64.430000000000007 104.936 171.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -121.82 138.3 54.43 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.829 -1.148 . . . . 73.040000000000006 111.09 -174.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.6 139.91 52.92 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.782 -0.822 . . . . 54.039999999999999 108.782 178.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 40.0 m -101.75 125.18 48.37 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.998 -1.112 . . . . 75.140000000000001 107.998 177.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.15 160.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.972 -0.751 . . . . 73.310000000000002 108.972 -176.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 8.4 p-10 -78.55 132.68 37.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.445 0.641 . . . . 65.430000000000007 109.901 -175.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 p -95.51 106.12 24.72 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 114.568 -1.197 . . . . 72.129999999999995 111.963 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 4.3 Cg_exo -76.55 -66.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.34 2.027 . . . . 73.219999999999999 110.986 177.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -108.72 -52.19 0.07 OUTLIER Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-O 118.977 -0.535 . . . . 75.450000000000003 111.879 178.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.96 134.19 17.57 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 120.4 1.178 . . . . 70.439999999999998 110.635 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.76 128.54 14.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.259 -0.274 . . . . 61.009999999999998 110.259 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.42 23.38 Favored Glycine 0 CA--C 1.502 -0.726 0 N-CA-C 110.185 -1.166 . . . . 65.030000000000001 110.185 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.59 149.19 23.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.276 -0.962 . . . . 65.430000000000007 109.529 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.7 p -73.18 127.07 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.175 -1.046 . . . . 74.549999999999997 108.175 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.6 m -73.5 -25.75 60.58 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.208 -1.36 . . . . 74.530000000000001 109.841 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.18 20.36 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 110.767 -0.933 . . . . 50.520000000000003 110.767 175.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -120.27 159.4 25.05 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.147 -1.427 . . . . 44.450000000000003 107.147 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.558 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -63.05 -54.54 45.28 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 119.942 -0.703 . . . . 70.040000000000006 110.56 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.4 Cg_endo -93.07 134.05 1.06 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.225 1.283 . . . . 72.340000000000003 109.665 171.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 16.7 Cg_exo -72.91 164.0 36.8 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.717 2.278 . . . . 64.239999999999995 113.429 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -54.1 145.07 17.88 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-N 115.486 -0.779 . . . . 61.310000000000002 109.372 173.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.62 34.01 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.832 -1.707 . . . . 64.319999999999993 108.832 -172.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 497' ' ' ILE . 23.0 m -88.62 119.85 29.47 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.816 -0.809 . . . . 65.430000000000007 108.816 173.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 86.5 m -101.77 127.43 48.56 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.147 -0.686 . . . . 74.430000000000007 109.147 176.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.84 160.21 64.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.647 -0.871 . . . . 72.0 108.647 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 494' ' ' THR . 42.9 Cg_exo -58.46 152.74 52.5 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.394 2.062 . . . . 55.119999999999997 111.773 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.684 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.9 m -65.98 -20.78 27.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.239 0.543 . . . . 73.030000000000001 112.39 -177.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.14 3.73 54.87 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.645 -0.707 . . . . 40.240000000000002 110.83 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.7 t -79.67 167.95 20.0 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.939 -0.393 . . . . 74.420000000000002 109.939 -177.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.19 120.64 62.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 109.757 -0.46 . . . . 62.43 109.757 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 12.4 tt -92.52 138.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.962 -0.385 . . . . 75.329999999999998 109.962 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.405 ' HG2' ' NE2' ' A' ' 554' ' ' GLN . 45.5 tt0 -101.82 121.76 42.71 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 121.479 0.656 . . . . 74.150000000000006 110.654 -176.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.94 134.91 41.12 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.98 1.312 . . . . 75.099999999999994 109.24 -177.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.405 ' NE2' ' HG2' ' A' ' 552' ' ' GLU . 26.8 mm-40 -101.27 108.68 20.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.625 -0.716 . . . . 73.409999999999997 110.017 -176.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.454 HG13 HG21 ' A' ' 505' ' ' VAL . 64.1 t -96.9 131.76 42.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 124.066 0.946 . . . . 64.349999999999994 110.008 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 45.6 p -69.05 125.01 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.289 0.566 . . . . 74.140000000000001 110.769 175.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 1.0 OUTLIER . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 105.875 -1.898 . . . . 74.519999999999996 105.875 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.833 0 N-CA-C 110.093 -1.203 . . . . 52.219999999999999 110.093 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.46 142.18 44.22 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.622 2.214 . . . . 54.420000000000002 111.272 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.1 5.01 23.65 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.961 -0.755 . . . . 62.009999999999998 108.961 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 478' ' ' SER . 21.0 mp0 -82.67 125.21 30.96 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.266 -0.879 . . . . 63.450000000000003 109.979 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.531 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 18.9 tpp180 -120.7 155.87 32.96 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.68 -0.859 . . . . 73.409999999999997 108.68 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 142.02 28.83 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.207 1.003 . . . . 74.400000000000006 111.691 -174.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -86.0 128.7 57.0 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 109.524 -0.547 . . . . 73.310000000000002 109.524 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.72 160.1 47.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.161 2.574 . . . . 73.310000000000002 112.332 176.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.52 24.68 9.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.945 0.498 . . . . 71.510000000000005 111.257 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 439' ' ' GLU . 14.7 t -76.4 -2.98 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.8 1.286 . . . . 54.219999999999999 109.281 -176.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.573 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 3.1 m -52.37 -34.27 46.96 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.444 2.298 . . . . 65.129999999999995 111.323 177.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.9 t -60.97 -28.01 68.69 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.851 -0.613 . . . . 73.219999999999999 112.014 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.4 -47.51 8.72 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 118.874 -1.13 . . . . 60.450000000000003 111.836 -172.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 18.9 m -172.1 154.11 3.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.071 -1.085 . . . . 71.109999999999999 108.071 -178.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -51.91 -54.82 24.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 75.450000000000003 110.463 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.04 73.05 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 123.467 0.479 . . . . 70.25 111.91 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' A' ' 432' ' ' VAL . 10.2 mm-40 -61.04 -45.84 93.12 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.722 0.639 . . . . 50.109999999999999 111.327 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -71.27 -43.75 66.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.016 -0.538 . . . . 52.299999999999997 110.774 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.23 -48.36 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.965 -0.561 . . . . 51.140000000000001 111.985 -178.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.94 -40.1 96.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 70.239999999999995 110.344 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -66.57 -43.06 86.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.075 -0.512 . . . . 52.350000000000001 111.005 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.54 HD23 ' CE2' ' A' ' 452' ' ' PHE . 22.8 tp -68.69 -33.41 73.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.396 0.617 . . . . 74.439999999999998 109.611 179.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.3 m -62.42 -41.29 98.58 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.485 -0.78 . . . . 70.540000000000006 109.212 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.02 63.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.75 -0.659 . . . . 54.130000000000003 110.991 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.18 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.193 0.521 . . . . 45.140000000000001 110.02 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.98 -6.88 17.31 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.78 -0.724 . . . . 43.310000000000002 113.423 175.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 85.7 m-85 -75.28 136.8 40.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.084 0.772 . . . . 64.040000000000006 113.084 -176.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.57 25.93 3.73 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.169 -1.172 . . . . 71.510000000000005 110.169 175.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 451' ' ' ARG . 1.0 OUTLIER -132.61 115.19 15.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.821 -1.178 . . . . 75.340000000000003 107.821 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.54 ' CE2' HD23 ' A' ' 444' ' ' LEU . 67.8 m-85 -140.18 150.06 43.73 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.894 -0.41 . . . . 72.310000000000002 109.894 -175.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.471 ' HB3' HG13 ' A' ' 485' ' ' ILE . 15.1 tppt? -133.67 122.91 24.11 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 106.42 -1.696 . . . . 70.310000000000002 106.42 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -95.31 123.6 38.91 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 110.278 -0.267 . . . . 74.329999999999998 110.278 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.26 151.67 51.71 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.542 -1.281 . . . . 73.400000000000006 107.542 176.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.14 143.64 40.42 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.085 -0.646 . . . . 73.329999999999998 110.232 178.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 42.3 m -124.04 149.32 59.87 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 109.242 -0.651 . . . . 64.349999999999994 109.242 -178.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 490' ' ' SER . 20.9 Cg_exo -66.03 122.88 10.52 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.171 1.914 . . . . 74.439999999999998 110.238 176.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 t -134.2 179.81 6.03 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.601 -0.889 . . . . 74.109999999999999 108.601 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.1 t -65.56 141.43 97.91 Favored Pre-proline 0 N--CA 1.423 -1.825 0 C-N-CA 123.74 0.816 . . . . 74.310000000000002 110.793 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 464' ' ' VAL . 79.5 Cg_exo -51.72 -29.23 32.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.389 3.393 . . . . 72.310000000000002 112.62 177.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.48 -23.92 61.9 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.626 -0.716 . . . . 74.299999999999997 112.049 -177.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 466' ' ' LYS . 11.2 mp -108.49 8.7 27.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.449 0.537 . . . . 72.420000000000002 112.449 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 461' ' ' PRO . 93.2 t -60.7 133.4 26.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.967 0.413 . . . . 74.409999999999997 110.963 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.57 -16.21 57.94 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 120.9 -0.666 . . . . 44.409999999999997 113.438 175.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 463' ' ' LEU . 0.2 OUTLIER -103.82 166.22 10.55 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.538 -0.865 . . . . 73.549999999999997 109.588 178.671 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 59.3 t -82.13 130.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.429 -1.322 . . . . 72.409999999999997 107.429 176.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 26.1 pt -98.43 -0.87 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.17 -0.612 . . . . 63.409999999999997 110.937 -178.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 157.0 162.84 11.83 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 115.621 -0.718 . . . . 52.009999999999998 112.069 174.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.5 p -116.47 149.77 38.95 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.679 -1.23 . . . . 63.32 107.679 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.444 HD22 HD13 ' A' ' 485' ' ' ILE . 61.7 t30 -64.47 -52.02 55.91 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 120.298 -0.561 . . . . 72.409999999999997 110.874 177.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 57.7 Cg_endo -73.88 136.46 22.94 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 119.912 1.004 . . . . 71.209999999999994 109.854 172.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 22.9 Cg_exo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.505 2.136 . . . . 64.129999999999995 112.165 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -85.92 0.15 53.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.398 1.095 . . . . 43.439999999999998 109.053 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -91.07 -32.07 16.02 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.67 -1.605 . . . . 73.239999999999995 110.358 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.06 168.52 9.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.446 -0.501 . . . . 73.150000000000006 110.575 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 25.0 p -98.69 137.15 37.73 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.345 -0.389 . . . . 51.100000000000001 111.047 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 426' ' ' GLN . 21.5 m -116.36 148.82 40.23 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.406 -0.59 . . . . 72.019999999999996 109.406 179.141 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.561 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -69.64 157.63 36.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.742 0.246 . . . . 54.149999999999999 111.32 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.7 mm -70.35 -25.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.896 0.855 . . . . 75.230000000000004 110.199 -175.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.9 t -95.62 2.21 54.03 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.347 -0.842 . . . . 74.040000000000006 110.337 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -80.82 139.59 35.91 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 108.267 -1.012 . . . . 73.340000000000003 108.267 176.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.34 111.99 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.006 -0.739 . . . . 64.400000000000006 109.006 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.57 118.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.865 -1.161 . . . . 63.409999999999997 107.865 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 453' ' ' LYS . 4.2 mp -93.87 122.05 45.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.777 -1.194 . . . . 71.549999999999997 107.777 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -111.19 126.0 68.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.232 -1.025 . . . . 74.209999999999994 108.232 -179.11 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.4 mp -104.09 120.93 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.392 0.615 . . . . 32.409999999999997 110.125 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.09 145.34 8.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.646 -0.706 . . . . 73.310000000000002 109.281 -177.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.6 106.73 3.29 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.83 -0.908 . . . . 72.450000000000003 110.83 176.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 64.0 m -108.2 138.56 44.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.149 -1.056 . . . . 61.439999999999998 108.149 177.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -107.8 170.97 15.75 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.875 -1.155 . . . . 51.119999999999997 111.705 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.08 120.47 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.129 1.886 . . . . 41.229999999999997 110.633 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -82.11 79.18 8.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.67 -1.233 . . . . 42.43 107.67 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 546' ' ' PRO . 43.4 p -134.89 162.78 31.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.012 -0.995 . . . . 71.439999999999998 110.766 -173.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 495' ' ' LYS . 0.3 OUTLIER -142.83 132.0 23.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.21 -1.033 . . . . 71.219999999999999 108.21 178.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.9 p-10 -80.73 138.33 36.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.436 -0.949 . . . . 61.100000000000001 108.436 173.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 541' ' ' ALA . 42.8 pt -98.61 137.58 20.65 Favored Pre-proline 0 C--N 1.292 -1.902 0 C-N-CA 120.433 -0.507 . . . . 73.030000000000001 111.742 -177.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.69 -176.97 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.472 2.115 . . . . 73.239999999999995 110.11 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -77.02 125.95 30.17 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.402 -0.962 . . . . 73.450000000000003 108.402 176.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 7.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.139 0.971 . . . . 74.040000000000006 110.264 -177.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -93.05 160.44 14.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.628 -0.714 . . . . 71.030000000000001 110.844 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 94.96 -7.98 70.18 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 109.691 -1.364 . . . . 63.32 109.691 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -102.04 -180.0 4.16 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.32 -0.94 . . . . 75.439999999999998 108.665 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 38.4 m -88.2 155.64 19.65 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.909 -1.145 . . . . 52.409999999999997 107.909 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.79 -42.78 53.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 122.879 0.472 . . . . 62.439999999999998 112.15 -177.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.09 -42.04 85.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.857 -0.611 . . . . 73.319999999999993 111.287 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 13.0 p -76.6 -35.65 26.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.401 -0.92 . . . . 70.310000000000002 110.798 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.31 -48.51 77.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.184 -0.916 . . . . 71.219999999999999 111.186 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.12 -35.69 81.59 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 123.039 0.212 . . . . 75.340000000000003 110.973 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -64.65 -53.24 50.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.592 0.558 . . . . 65.129999999999995 109.882 179.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.92 -42.94 99.96 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.007 -0.542 . . . . 52.399999999999999 110.525 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.33 -37.99 89.47 Favored 'General case' 0 C--O 1.184 -2.362 0 CA-C-N 116.061 -0.518 . . . . 45.439999999999998 110.638 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.96 -46.57 89.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.842 0.353 . . . . 73.099999999999994 110.791 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -27.63 37.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 73.25 111.422 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -120.16 24.4 10.46 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.078 -0.649 . . . . 75.310000000000002 109.956 -175.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 495' ' ' LYS . . . -164.51 -110.26 0.23 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 118.507 -1.806 . . . . 54.240000000000002 116.244 -173.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 45.4 m-85 -116.15 176.73 4.97 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.039 0.447 . . . . 62.340000000000003 111.243 -164.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.7 m -118.63 -17.42 9.27 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.562 -0.745 . . . . 64.310000000000002 110.495 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.84 115.64 30.51 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.758 -0.777 . . . . 70.030000000000001 110.968 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -120.77 135.28 55.19 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.436 -1.257 . . . . 74.340000000000003 108.676 -177.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 9.0 t -115.86 152.39 33.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.9 -2.259 . . . . 72.549999999999997 104.9 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -121.46 128.72 52.42 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.996 -0.682 . . . . 73.049999999999997 110.809 -175.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.172 -1.418 . . . . 55.530000000000001 107.172 177.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 41.0 m -88.75 125.91 35.09 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.821 -0.627 . . . . 61.140000000000001 109.784 -177.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.88 156.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 176.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -79.55 118.35 21.32 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 113.588 0.959 . . . . 65.519999999999996 113.588 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 12.7 m -60.75 136.56 92.96 Favored Pre-proline 0 N--CA 1.427 -1.606 0 CA-C-N 113.288 -1.778 . . . . 62.340000000000003 110.631 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -78.08 -88.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 108.505 -1.383 . . . . 50.539999999999999 108.505 172.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 92.7 mtt180 -102.54 -55.99 0.11 Allowed Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 118.788 -0.625 . . . . 62.439999999999998 111.548 171.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 4.3 Cg_exo -75.81 149.96 34.16 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.376 1.384 . . . . 70.400000000000006 110.967 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.61 128.24 38.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.139 -1.06 . . . . 61.520000000000003 108.139 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.95 -7.31 17.11 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 110.705 -0.958 . . . . 73.400000000000006 110.705 -178.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.68 147.1 27.11 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.067 -0.716 . . . . 75.120000000000005 109.067 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.26 115.63 20.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.567 -1.642 . . . . 73.420000000000002 106.567 173.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 31.4 m -89.65 -27.45 20.14 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 115.634 -0.712 . . . . 73.409999999999997 109.775 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -177.2 -173.99 43.21 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.959 -1.115 . . . . 72.430000000000007 111.766 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.3 p -134.81 160.32 38.57 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.657 -1.238 . . . . 74.510000000000005 107.657 176.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -63.53 -54.55 42.34 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.22 0.325 . . . . 74.040000000000006 110.608 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 72.9 Cg_endo -83.64 138.45 8.37 Favored 'Trans proline' 0 C--N 1.365 1.403 0 N-CA-C 109.314 -1.071 . . . . 75.219999999999999 109.314 169.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 159.48 46.6 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 121.766 1.644 . . . . 55.140000000000001 111.82 178.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 497' ' ' ILE . . . -60.76 135.1 57.67 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.436 -0.347 . . . . 71.239999999999995 110.27 177.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.65 -29.05 10.91 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 111.038 -0.825 . . . . 65.439999999999998 111.038 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.6 m -73.28 136.84 44.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.048 0.451 . . . . 70.420000000000002 110.863 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -100.78 122.36 43.26 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.478 -0.783 . . . . 72.25 109.265 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.06 157.59 69.05 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.585 -0.28 . . . . 65.349999999999994 110.474 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.514 ' HA ' HG22 ' A' ' 494' ' ' THR . 26.9 Cg_exo -63.92 134.21 42.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.936 2.424 . . . . 70.340000000000003 113.488 -178.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.418 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.7 m -68.06 -21.29 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.554 -0.748 . . . . 73.239999999999995 111.434 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.22 0.57 51.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.393 -0.821 . . . . 75.420000000000002 110.738 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.4 t -103.52 161.84 13.54 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.45 130.54 44.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.062 -1.088 . . . . 73.209999999999994 108.062 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -95.04 145.95 7.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 110.023 -0.362 . . . . 74.340000000000003 110.023 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -102.64 116.54 32.79 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.57 -0.53 . . . . 75.219999999999999 109.57 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 25.4 tp -95.74 125.04 40.04 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.74 -1.578 . . . . 62.030000000000001 106.74 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -103.94 102.53 12.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.076 0.941 . . . . 74.140000000000001 108.507 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.0 138.19 30.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 114.418 -1.264 . . . . 74.010000000000005 110.368 -173.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 30.2 p -61.88 118.33 7.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.625 -0.88 . . . . 75.540000000000006 108.625 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 107.809 -1.182 . . . . 44.109999999999999 107.809 -176.409 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.219 0 N-CA-C 110.862 -0.895 . . . . 43.049999999999997 110.862 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.8 131.81 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.077 1.851 . . . . 74.120000000000005 112.716 -176.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.13 8.74 4.76 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.54 -0.755 . . . . 73.430000000000007 109.675 175.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -82.8 145.45 29.51 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 114.901 -1.045 . . . . 75.549999999999997 109.577 -172.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.426 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 2.7 tpt180 -131.23 153.24 49.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.38 -0.97 . . . . 74.450000000000003 108.38 -177.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.28 141.27 28.77 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 123.079 0.552 . . . . 63.520000000000003 111.153 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.8 mp -81.12 130.39 63.16 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.728 -0.841 . . . . 71.340000000000003 108.728 175.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.46 ' HB2' HG22 ' A' ' 432' ' ' VAL . 66.3 Cg_endo -71.45 160.43 48.59 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.644 2.229 . . . . 74.030000000000001 113.89 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -102.02 0.22 34.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.013 -0.994 . . . . 73.510000000000005 109.971 -179.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 430' ' ' PRO . 35.7 m -80.05 1.51 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.775 0.797 . . . . 34.539999999999999 110.665 -179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.8 m -63.93 -30.31 71.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.793 -1.094 . . . . 62.020000000000003 109.455 177.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.9 t -62.21 -26.57 68.44 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.064 -0.971 . . . . 45.32 110.316 176.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.18 -46.29 20.92 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.926 -0.71 . . . . 71.049999999999997 109.998 -175.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 22.7 m -165.59 147.37 7.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.855 -0.794 . . . . 71.209999999999994 108.855 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -50.62 -49.06 57.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.17 0.988 . . . . 74.209999999999994 111.44 174.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -55.43 -43.9 75.78 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 123.407 0.442 . . . . 74.25 111.363 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 16.2 mm-40 -61.57 -41.38 97.31 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.143 -0.48 . . . . 74.129999999999995 111.766 -178.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.66 -51.58 68.79 Favored 'General case' 0 CA--C 1.508 -0.662 0 O-C-N 123.898 0.749 . . . . 55.149999999999999 110.216 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.75 -48.36 86.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 114.65 -1.159 . . . . 74.310000000000002 112.087 -175.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.6 mmtp -60.42 -45.43 93.63 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 117.874 0.306 . . . . 72.439999999999998 110.726 -176.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -66.51 -46.23 76.91 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.695 -0.684 . . . . 72.310000000000002 110.502 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.2 tp -69.21 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.22 0.533 . . . . 65.0 111.476 -177.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.7 m -63.61 -42.89 98.19 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.131 -0.692 . . . . 64.430000000000007 109.131 176.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.72 -18.25 62.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 40.310000000000002 110.801 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.43 -13.24 59.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.222 0.534 . . . . 55.130000000000003 110.145 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.48 -9.16 15.03 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 120.142 -1.028 . . . . 51.030000000000001 113.702 174.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -77.56 131.78 38.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.898 0.38 . . . . 75.519999999999996 111.169 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.87 12.6 5.34 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.713 -0.955 . . . . 53.240000000000002 110.713 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -118.65 115.97 25.62 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.709 -1.219 . . . . 74.239999999999995 107.709 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -134.91 154.3 51.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.494 0.664 . . . . 75.140000000000001 111.557 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 485' ' ' ILE . 63.5 tttp -143.04 123.03 13.55 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 106.447 -1.686 . . . . 63.240000000000002 106.447 170.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.441 HE21 HG21 ' A' ' 488' ' ' VAL . 63.2 tt0 -91.62 132.79 36.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.545 -0.462 . . . . 71.120000000000005 110.319 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.33 143.84 50.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.674 -0.862 . . . . 62.530000000000001 108.674 176.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -119.79 144.18 47.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.264 -0.643 . . . . 71.120000000000005 109.264 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -141.34 134.97 14.65 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 107.133 -1.432 . . . . 73.030000000000001 107.133 177.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_endo -65.53 122.19 9.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.758 1.639 . . . . 72.439999999999998 109.715 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.4 m -124.72 174.63 7.76 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 116.064 -0.516 . . . . 61.109999999999999 110.269 -176.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -62.81 142.85 97.17 Favored Pre-proline 0 N--CA 1.416 -2.171 0 N-CA-C 107.801 -1.185 . . . . 64.430000000000007 107.801 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.42 -30.93 28.71 Favored 'Trans proline' 0 N--CA 1.473 0.295 0 C-N-CA 123.85 3.033 . . . . 64.209999999999994 113.377 -176.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.8 -27.01 65.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.586 -0.279 . . . . 71.200000000000003 111.429 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.78 -0.53 29.18 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.613 0.598 . . . . 74.329999999999998 112.613 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -61.37 127.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 109.96 -0.385 . . . . 74.430000000000007 109.96 176.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.85 -4.36 71.81 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 112.019 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -114.46 154.21 28.59 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.57 -0.9 . . . . 72.420000000000002 108.57 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 486' ' ' ILE . 53.2 t -82.11 134.3 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.122 -0.696 . . . . 55.229999999999997 109.122 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 36.3 pt -98.08 -20.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.55 -0.46 . . . . 73.439999999999998 110.538 -178.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 166.17 28.76 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.666 -0.778 . . . . 74.329999999999998 111.676 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 37.6 p -120.94 156.23 32.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.716 -0.475 . . . . 74.230000000000004 109.716 178.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 27.8 t-20 -71.59 -48.35 12.12 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.303 -0.408 . . . . 33.409999999999997 111.326 175.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.3 Cg_exo -71.59 140.26 35.72 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 109.04 -1.177 . . . . 72.420000000000002 109.04 170.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.81 142.92 90.68 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.02 2.48 . . . . 61.030000000000001 114.294 -174.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.43 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -91.16 -6.97 52.75 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 74.340000000000003 109.386 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -99.52 -27.98 13.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.578 -0.737 . . . . 61.32 111.41 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.48 151.33 38.75 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.744 0.306 . . . . 71.409999999999997 110.358 -179.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 55.3 p -74.83 131.48 40.8 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.683 -0.69 . . . . 62.420000000000002 110.538 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.2 m -106.87 151.31 25.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.139 -0.689 . . . . 62.119999999999997 109.139 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.84 152.58 40.2 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.0 -0.741 . . . . 62.109999999999999 109.0 -175.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.52 -17.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.888 0.851 . . . . 55.340000000000003 110.563 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -93.11 7.03 45.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.553 -0.749 . . . . 75.099999999999994 110.008 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.45 140.21 32.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.681 -0.859 . . . . 63.200000000000003 108.681 176.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.03 121.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.895 -1.52 . . . . 40.329999999999998 106.895 176.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.46 117.92 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 C-N-CA 118.976 -1.09 . . . . 63.530000000000001 109.37 -179.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.478 HG13 ' HB3' ' A' ' 453' ' ' LYS . 3.7 mp -96.49 111.81 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 106.091 -1.818 . . . . 75.030000000000001 106.091 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.34 123.56 59.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 109.041 -0.725 . . . . 74.120000000000005 109.041 -177.41 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.19 115.98 46.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.582 -0.736 . . . . 55.210000000000001 109.946 -173.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.441 HG21 HE21 ' A' ' 454' ' ' GLN . 30.0 t -96.86 137.98 23.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.659 -0.701 . . . . 72.010000000000005 109.547 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.23 107.6 2.22 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 107.685 -2.166 . . . . 61.25 107.685 172.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -111.39 150.97 29.03 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.219 0.533 . . . . 63.130000000000003 110.797 -172.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -147.77 124.44 1.91 Allowed Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.146 -1.182 . . . . 75.510000000000005 110.146 177.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.28 156.71 58.54 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.228 1.952 . . . . 72.099999999999994 110.528 177.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.88 86.77 6.44 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.255 0.55 . . . . 75.239999999999995 109.992 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 546' ' ' PRO . 40.1 p -124.89 155.99 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.813 -0.631 . . . . 74.310000000000002 109.808 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -140.89 148.95 41.27 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.09 0.556 . . . . 72.450000000000003 109.805 176.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.62 125.01 29.47 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.944 -1.502 . . . . 53.210000000000001 106.944 178.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.0 pt -79.46 132.37 62.36 Favored Pre-proline 0 C--N 1.301 -1.501 0 C-N-CA 120.182 -0.607 . . . . 62.439999999999998 110.738 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -87.22 -171.27 0.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 122.13 1.887 . . . . 71.430000000000007 111.448 177.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.92 99.39 11.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.519 -0.919 . . . . 71.329999999999998 108.519 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.4 t -99.51 -5.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.906 0.86 . . . . 44.240000000000002 108.752 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -70.84 146.51 49.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.83 -1.077 . . . . 73.510000000000005 110.779 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.5 -20.07 23.35 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 119.888 -1.149 . . . . 72.409999999999997 112.08 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.436 ' O ' HG12 ' A' ' 534' ' ' VAL . 25.0 mt-30 -92.09 -171.44 2.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.456 -0.942 . . . . 74.219999999999999 108.456 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 m -84.95 155.22 21.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.124 -1.806 . . . . 73.430000000000007 106.124 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 10.1 p -64.11 -40.77 90.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 118.514 0.597 . . . . 64.0 110.984 -177.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 9.4 t70 -64.08 -43.19 96.15 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.403 -0.817 . . . . 65.430000000000007 111.611 178.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.94 -34.98 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.634 -0.826 . . . . 61.200000000000003 111.03 -178.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.62 76.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 64.239999999999995 111.256 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -65.41 -36.77 84.94 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 116.096 -0.502 . . . . 72.129999999999995 110.638 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 5.5 mptp? -62.7 -49.24 75.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.264 0.352 . . . . 65.200000000000003 111.946 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -63.67 -47.96 79.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.718 -0.393 . . . . 73.549999999999997 110.413 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.447 HD21 HD13 ' A' ' 551' ' ' ILE . 34.8 tp -62.27 -37.05 83.99 Favored 'General case' 0 C--O 1.192 -1.96 0 CA-C-N 115.759 -0.655 . . . . 64.010000000000005 111.313 -176.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 3.3 t-20 -59.01 -41.26 87.28 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.516 0.726 . . . . 61.409999999999997 110.294 177.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.1 -32.09 31.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.802 -0.635 . . . . 74.219999999999999 111.347 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.08 12.11 25.32 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.006 -0.678 . . . . 71.540000000000006 109.949 -174.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.33 -98.52 0.13 Allowed Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 117.735 -2.174 . . . . 71.239999999999995 117.29 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 67.2 m-85 -103.13 155.32 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 112.716 0.636 . . . . 74.030000000000001 112.716 -161.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 15.3 p -99.65 -36.19 9.58 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.991 -1.004 . . . . 72.120000000000005 112.151 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -108.22 131.93 54.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.269 0.557 . . . . 75.040000000000006 110.365 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.7 147.88 51.53 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.596 -0.729 . . . . 61.509999999999998 110.405 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.86 158.79 43.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.886 -1.153 . . . . 62.240000000000002 107.886 171.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.02 150.23 42.39 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.295 0.569 . . . . 72.200000000000003 111.48 -174.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.59 135.91 53.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.441 -1.689 . . . . 62.439999999999998 106.441 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 1.6 p -88.39 126.8 35.39 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 120.927 0.394 . . . . 72.549999999999997 111.369 -175.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.62 160.92 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 109.934 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -81.86 113.52 19.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.921 0.867 . . . . 63.530000000000001 112.892 -175.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.8 m -114.54 117.39 42.75 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.386 -1.338 . . . . 74.329999999999998 107.386 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.93 -39.05 15.03 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.96 2.44 . . . . 73.430000000000007 115.331 -171.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.525 ' HG3' ' HD3' ' A' ' 530' ' ' PRO 0.446 7.4 ptm180 -122.19 -88.22 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 115.095 1.516 . . . . 75.349999999999994 115.095 -175.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.525 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 10.9 Cg_exo -75.22 153.51 40.78 Favored 'Trans proline' 0 C--N 1.372 1.768 0 CA-C-N 123.123 2.151 . . . . 63.399999999999999 111.072 173.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -134.94 159.41 41.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 61.149999999999999 108.073 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.33 -17.46 7.01 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.962 -0.855 . . . . 74.109999999999999 110.962 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.51 ' OE2' ' HB3' ' A' ' 556' ' ' SER . 4.3 pm0 -81.95 147.44 29.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 110.1 -0.333 . . . . 71.340000000000003 110.1 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 501' ' ' ALA . 4.2 p -77.07 115.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 106.839 -1.541 . . . . 75.530000000000001 106.839 173.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.1 m -79.71 -21.21 44.88 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.243 -0.89 . . . . 74.109999999999999 110.529 -174.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.83 -168.69 34.48 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.856 -0.687 . . . . 72.319999999999993 112.101 177.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.442 HG22 HD13 ' A' ' 553' ' ' LEU . 12.1 p -117.85 160.31 21.62 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.372 -0.974 . . . . 71.040000000000006 108.372 176.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.1 t-20 -61.82 -52.91 65.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 121.058 -0.257 . . . . 60.450000000000003 111.404 177.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.5 Cg_exo -83.95 152.75 12.85 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.077 1.185 . . . . 74.510000000000005 109.023 173.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.8 158.55 46.55 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.115 1.877 . . . . 73.349999999999994 112.417 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.41 130.52 46.62 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.131 0.491 . . . . 50.140000000000001 110.243 176.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -14.68 37.55 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 115.92 -0.582 . . . . 72.25 112.063 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 89.8 m -80.6 131.26 35.48 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.606 -0.349 . . . . 65.200000000000003 110.434 177.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.1 t -98.33 127.87 44.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.386 -0.598 . . . . 62.140000000000001 109.386 178.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' A' ' 517' ' ' PHE . 7.9 m -135.2 158.45 74.66 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.759 -0.83 . . . . 73.209999999999994 108.759 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 494' ' ' THR . 22.6 Cg_exo -65.1 133.15 34.41 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.819 1.679 . . . . 75.439999999999998 112.41 -177.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 21.6 m -68.57 -25.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.783 -1.099 . . . . 72.439999999999998 112.306 -176.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.06 -6.35 59.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.926 -1.034 . . . . 74.510000000000005 109.882 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.8 t -92.95 -172.84 3.11 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.673 -0.694 . . . . 73.439999999999998 110.267 -175.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.02 113.23 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.668 -0.696 . . . . 75.319999999999993 110.513 -174.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 512' ' ' LEU . 13.7 tt -96.2 142.61 13.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.748 -0.834 . . . . 71.140000000000001 108.748 176.097 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 34.7 tt0 -104.01 124.17 48.54 Favored 'General case' 0 N--CA 1.399 -2.986 0 CA-C-O 121.125 0.488 . . . . 74.299999999999997 110.929 -175.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -97.66 136.03 38.61 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.054 -0.975 . . . . 74.430000000000007 111.719 176.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -91.62 109.41 20.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.599 -1.63 . . . . 73.150000000000006 106.599 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.89 135.6 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.399 0.619 . . . . 74.040000000000006 111.295 -174.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.51 ' HB3' ' OE2' ' A' ' 533' ' ' GLU . 1.8 p -62.58 117.97 6.96 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 124.792 1.237 . . . . 62.420000000000002 112.388 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.427 -1.622 0 N-CA-C 108.746 -0.835 . . . . 74.219999999999999 108.746 178.473 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.758 0 N-CA-C 110.532 -1.027 . . . . 55.350000000000001 110.532 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.15 154.05 65.36 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.02 2.48 . . . . 65.129999999999995 112.162 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 480' ' ' ILE . 9.7 pt-20 -83.0 37.26 0.53 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.24 0.616 . . . . 50.350000000000001 111.829 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -96.91 122.94 40.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.97 0.414 . . . . 65.400000000000006 110.813 -176.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -120.89 146.85 46.17 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.87 -0.605 . . . . 74.439999999999998 111.97 -179.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.1 141.76 28.31 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.86 -1.064 . . . . 74.010000000000005 109.791 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.35 119.64 77.71 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.414 -0.587 . . . . 74.25 109.414 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.69 142.48 35.94 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.917 2.412 . . . . 71.430000000000007 111.522 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -88.81 78.47 7.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.811 1.291 . . . . 52.240000000000002 113.494 -176.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 440' ' ' ALA . 16.5 m -115.55 4.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.469 -2.048 . . . . 50.530000000000001 105.469 167.361 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.0 m -62.16 -41.3 98.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 112.355 -2.202 . . . . 71.150000000000006 109.057 178.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 42.4 m -58.07 -27.01 63.25 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.407 -1.27 . . . . 74.230000000000004 111.243 176.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.09 -46.31 11.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.233 -0.587 . . . . 74.319999999999993 111.035 -174.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 2.7 m -170.16 154.17 4.87 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.926 -0.768 . . . . 63.439999999999998 108.926 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -51.82 -49.84 62.01 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.255 1.022 . . . . 73.099999999999994 110.05 169.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.97 84.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.288 -0.869 . . . . 44.539999999999999 111.772 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 17.5 mm-40 -61.28 -46.09 91.77 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.993 -177.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -68.0 -49.47 61.4 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.765 -0.652 . . . . 75.310000000000002 111.34 -178.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.15 -48.2 90.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 123.537 0.523 . . . . 63.409999999999997 111.779 -176.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.14 -45.88 89.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.747 0.308 . . . . 73.109999999999999 111.023 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -67.22 -40.55 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.388 -0.369 . . . . 72.329999999999998 111.364 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.81 -33.03 73.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.189 0.519 . . . . 64.420000000000002 109.876 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 41.1 m -60.12 -44.17 95.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.56 -0.746 . . . . 73.0 109.232 173.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.11 64.4 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.602 -0.726 . . . . 75.439999999999998 111.298 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.15 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.241 0.543 . . . . 74.140000000000001 110.219 178.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.78 -18.66 5.94 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.748 -0.739 . . . . 51.0 113.308 176.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 445' ' ' THR . 96.3 m-85 -74.35 136.11 42.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 110.584 -177.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -135.19 -12.61 1.24 Allowed Glycine 0 C--N 1.296 -1.68 0 CA-C-N 115.754 -0.657 . . . . 74.219999999999999 112.356 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -102.51 115.38 30.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.351 -0.611 . . . . 75.329999999999998 109.351 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -128.0 165.18 20.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.703 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 1.9 tmtp? -146.68 124.99 12.24 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.884 -2.265 . . . . 74.540000000000006 104.884 172.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -94.54 128.75 41.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.433 0.635 . . . . 70.319999999999993 111.173 -177.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.78 154.29 45.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.225 -1.028 . . . . 74.439999999999998 108.225 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.31 151.29 47.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.968 -0.382 . . . . 70.319999999999993 109.968 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 54.5 m -140.56 148.41 53.2 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.62 -0.882 . . . . 61.140000000000001 108.62 174.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.8 Cg_endo -65.74 129.32 21.92 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.209 1.94 . . . . 62.0 111.346 178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.8 t -141.46 173.48 11.45 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.74 -0.837 . . . . 64.329999999999998 108.74 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.4 t -66.34 146.64 99.05 Favored Pre-proline 0 N--CA 1.412 -2.332 0 C-N-CA 123.757 0.823 . . . . 74.420000000000002 109.141 177.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.23 -28.88 21.32 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.497 3.465 . . . . 72.340000000000003 113.061 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.854 -0.612 . . . . 74.319999999999993 111.176 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.35 -3.17 29.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.255 0.465 . . . . 74.319999999999993 112.255 -176.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 93.9 t -61.11 127.68 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 177.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.93 -12.0 68.99 Favored Glycine 0 C--N 1.314 -0.681 0 N-CA-C 111.49 -0.644 . . . . 73.019999999999996 111.49 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -101.74 159.5 15.27 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.644 -0.873 . . . . 64.439999999999998 108.644 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 54.6 t -82.32 132.11 32.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 64.219999999999999 108.812 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 30.9 pt -102.95 -23.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.966 -0.693 . . . . 73.450000000000003 111.69 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.89 157.54 22.74 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 111.564 -0.614 . . . . 61.439999999999998 111.564 178.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 32.2 p -124.62 147.82 48.27 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.646 -0.501 . . . . 62.43 109.646 177.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 24.6 t-20 -64.48 -50.15 67.52 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.054 -0.498 . . . . 61.299999999999997 110.56 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.0 Cg_exo -72.63 124.99 10.2 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.198 -1.501 . . . . 75.239999999999995 108.198 170.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.423 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 40.9 Cg_endo -64.21 139.32 65.61 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.646 2.231 . . . . 64.140000000000001 112.874 -175.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.06 -16.26 41.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.857 0.837 . . . . 50.009999999999998 109.508 177.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -78.74 -31.97 46.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.325 -1.307 . . . . 72.430000000000007 109.358 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.423 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.9 mp0 -108.98 172.44 6.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.536 -0.913 . . . . 64.340000000000003 108.536 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 18.6 p -98.54 133.72 42.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.85 -0.796 . . . . 71.420000000000002 108.85 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.2 m -116.16 140.87 48.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.38 -0.6 . . . . 64.120000000000005 109.38 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.07 145.39 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 74.230000000000004 111.659 -178.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -58.52 -31.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 124.18 0.992 . . . . 63.439999999999998 110.643 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.5 t -77.44 8.85 3.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 111.705 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.54 144.64 25.42 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 122.058 -0.401 . . . . 65.040000000000006 110.16 178.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.55 122.32 35.55 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 N-CA-C 108.367 -0.975 . . . . 71.329999999999998 108.367 175.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.4 t -87.87 117.52 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 C-N-CA 119.277 -0.969 . . . . 75.129999999999995 108.722 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 54.4 mt -99.38 111.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.595 -2.002 . . . . 64.140000000000001 105.595 175.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 125.34 58.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 109.099 -0.704 . . . . 60.530000000000001 109.099 -175.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 2.5 mp -99.86 116.91 44.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 N-CA-C 109.187 -0.672 . . . . 71.150000000000006 109.187 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 13.4 t -96.18 143.15 12.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 64.319999999999993 109.061 -177.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.8 114.01 3.96 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.163 -1.975 . . . . 42.420000000000002 108.163 172.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t -116.11 153.49 31.66 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.69 -0.855 . . . . 75.310000000000002 108.69 -176.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -130.69 110.73 1.03 Allowed Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.485 -0.864 . . . . 65.019999999999996 111.215 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.31 120.84 8.27 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.318 2.012 . . . . 74.299999999999997 110.524 176.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.48 91.37 7.82 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.002 0.905 . . . . 74.400000000000006 110.691 -176.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.3 p -131.79 159.81 37.42 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.602 -1.258 . . . . 51.130000000000003 107.602 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -147.61 145.04 28.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.834 -0.747 . . . . 75.340000000000003 110.837 177.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.64 113.11 19.42 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.035 -1.468 . . . . 74.400000000000006 107.035 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 541' ' ' ALA . 30.7 pt -75.83 127.91 84.55 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 113.112 0.782 . . . . 74.540000000000006 113.112 -173.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 25.5 Cg_endo -101.21 112.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 122.982 2.455 . . . . 60.539999999999999 111.324 171.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.69 132.11 34.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.219 -0.659 . . . . 64.040000000000006 109.219 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.04 59.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 107.582 -1.266 . . . . 72.349999999999994 107.582 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 534' ' ' VAL . . . -57.51 140.6 50.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.156 -1.838 . . . . 72.030000000000001 110.616 176.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.48 -11.29 30.68 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.673 -0.775 . . . . 24.25 111.264 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 534' ' ' VAL . 26.6 mt-30 -97.5 -171.15 2.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.103 -0.332 . . . . 65.349999999999994 110.103 177.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 12.1 m -84.86 156.75 21.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.842 -1.169 . . . . 71.540000000000006 107.842 -177.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -41.97 93.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.78 0.324 . . . . 64.430000000000007 110.608 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.49 -42.04 95.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.707 -0.679 . . . . 71.400000000000006 110.821 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.88 -34.98 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 119.638 -0.825 . . . . 63.530000000000001 110.721 -177.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.76 85.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.367 -0.833 . . . . 64.439999999999998 111.029 178.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -62.76 -45.95 90.29 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.487 0.492 . . . . 62.119999999999997 109.916 178.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -61.9 -54.03 47.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.603 -0.726 . . . . 65.25 112.053 -173.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.88 -38.33 88.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.544 -0.463 . . . . 52.539999999999999 110.919 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.71 -43.22 72.86 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 109.422 -0.584 . . . . 63.219999999999999 109.422 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.92 -45.8 89.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.351 0.661 . . . . 74.219999999999999 111.815 -178.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.72 -30.85 49.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 71.140000000000001 111.418 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.26 22.44 12.88 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 122.059 -0.401 . . . . 74.239999999999995 110.415 -174.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -161.74 -101.82 0.17 Allowed Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 117.165 -2.445 . . . . 72.030000000000001 116.514 -172.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 547' ' ' VAL . 23.3 m-85 -109.6 156.37 20.26 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.513 -0.844 . . . . 71.540000000000006 110.601 -165.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.5 m -107.92 -24.27 11.7 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.762 -0.654 . . . . 71.400000000000006 111.426 -174.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -107.93 115.55 30.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.841 0.353 . . . . 71.400000000000006 110.143 -176.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -117.04 154.54 30.77 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.745 -0.661 . . . . 74.409999999999997 110.383 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.29 155.58 45.96 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.481 -1.674 . . . . 61.130000000000003 106.481 171.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.509 HE22 HD23 ' A' ' 553' ' ' LEU . 11.7 mm100 -119.96 148.3 43.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.294 -1.002 . . . . 74.209999999999994 108.294 -174.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.12 128.5 30.23 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.223 -0.658 . . . . 74.420000000000002 109.223 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 39.7 m -88.02 122.44 31.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.444 -1.317 . . . . 74.209999999999994 107.444 176.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.72 153.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 109.169 -175.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.34 114.59 18.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.436 1.112 . . . . 74.409999999999997 110.883 -175.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.9 p -117.17 120.52 33.51 Favored Pre-proline 0 N--CA 1.408 -2.535 0 CA-C-N 113.799 -1.546 . . . . 63.229999999999997 109.769 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.95 -55.12 3.18 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.766 2.311 . . . . 61.329999999999998 112.818 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.46 ' HB2' ' HD3' ' A' ' 530' ' ' PRO . 23.8 mtp180 -99.92 -54.4 0.17 Allowed Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 114.081 1.141 . . . . 73.010000000000005 114.081 177.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 529' ' ' ARG . 32.1 Cg_exo -60.21 153.27 60.28 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.138 1.892 . . . . 74.329999999999998 113.798 -176.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.05 133.74 9.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.604 -1.258 . . . . 62.229999999999997 107.604 176.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 84.23 -45.16 3.44 Favored Glycine 0 C--N 1.312 -0.754 0 C-N-CA 121.258 -0.496 . . . . 75.450000000000003 113.516 177.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.22 149.68 48.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.248 1.019 . . . . 75.140000000000001 111.406 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 503' ' ' GLN . 9.3 p -75.17 127.35 36.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.193 0.52 . . . . 62.130000000000003 111.073 -174.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -82.19 -22.21 36.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.518 -0.765 . . . . 73.420000000000002 109.226 -178.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 140.67 -149.5 20.99 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.901 -1.28 . . . . 63.119999999999997 109.901 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.0 p -116.94 157.26 26.02 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.766 -1.198 . . . . 62.140000000000001 107.766 176.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 52.1 t30 -59.44 -53.48 65.48 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.39 -0.338 . . . . 75.140000000000001 111.734 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.9 Cg_exo -77.19 138.84 18.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 108.386 -1.428 . . . . 75.340000000000003 108.386 172.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.07 155.43 69.68 Favored 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 121.958 1.772 . . . . 53.210000000000001 111.948 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 497' ' ' ILE . . . -59.09 143.42 48.67 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 110.695 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 94.02 -9.27 72.89 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 120.944 -0.646 . . . . 75.430000000000007 111.853 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 29.5 m -80.16 128.22 33.26 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.218 -0.66 . . . . 75.010000000000005 109.218 177.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 1.8 m -84.88 122.68 29.53 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.712 -1.218 . . . . 61.219999999999999 107.712 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.11 154.72 81.76 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.626 -0.509 . . . . 42.409999999999997 109.626 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 494' ' ' THR . 21.4 Cg_exo -67.42 133.95 31.79 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.428 2.085 . . . . 75.209999999999994 111.813 -178.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.578 ' HA ' ' CE2' ' A' ' 517' ' ' PHE . 19.5 m -67.69 -20.48 26.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.166 0.507 . . . . 72.319999999999993 112.08 -177.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.67 -3.04 55.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.83 -0.623 . . . . 73.329999999999998 110.444 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.7 t -95.19 164.99 12.62 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.361 -0.607 . . . . 73.150000000000006 109.361 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.73 136.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.604 -0.517 . . . . 72.099999999999994 109.604 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.5 tt -110.65 138.47 38.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 120.936 0.398 . . . . 64.510000000000005 109.937 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -103.4 127.43 50.76 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 122.771 0.428 . . . . 65.219999999999999 109.85 -178.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.509 HD23 HE22 ' A' ' 522' ' ' GLN . 18.4 tp -100.63 132.96 45.75 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.485 -0.78 . . . . 63.149999999999999 108.899 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -88.88 113.66 24.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.115 -0.698 . . . . 74.319999999999993 109.115 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 47.8 t -103.96 124.16 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 108.542 -0.91 . . . . 52.049999999999997 108.542 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 16.0 m -61.58 121.84 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.302 -0.999 . . . . 54.530000000000001 108.302 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 60.2 tttm . . . . . 0 N--CA 1.42 -1.96 0 CA-C-O 118.462 -0.78 . . . . 72.209999999999994 110.745 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.928 0 N-CA-C 110.348 -1.101 . . . . 71.109999999999999 110.348 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.0 156.06 56.58 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.282 1.988 . . . . 64.400000000000006 111.479 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 480' ' ' ILE . 10.5 pt-20 -125.08 40.12 3.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.116 0.96 . . . . 72.450000000000003 108.641 -178.287 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -83.53 121.88 27.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.802 -1.09 . . . . 74.109999999999999 109.946 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -121.07 156.92 31.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.096 -1.076 . . . . 71.230000000000004 108.096 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -83.43 140.84 32.13 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 109.844 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.1 mp -84.71 127.88 63.36 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.318 -0.993 . . . . 70.510000000000005 108.318 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.3 141.59 63.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.887 1.724 . . . . 63.240000000000002 111.93 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -111.31 70.22 0.71 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 122.669 1.224 . . . . 73.230000000000004 108.781 -177.124 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.96 5.92 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 113.779 -1.555 . . . . 65.329999999999998 107.812 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.56 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 2.3 m -57.34 -34.62 68.97 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.872 -1.967 . . . . 53.509999999999998 112.428 -177.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 12.0 t -60.3 -27.06 67.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.156 0.582 . . . . 64.230000000000004 111.557 178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.45 -45.97 18.39 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 120.127 -0.629 . . . . 71.099999999999994 110.21 -172.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 8.4 m -170.3 149.08 3.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.494 -1.298 . . . . 73.25 107.494 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 42.2 t80 -53.22 -45.86 68.84 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.555 0.535 . . . . 74.019999999999996 110.389 171.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.13 74.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.52 -0.764 . . . . 71.040000000000006 111.867 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 30.2 mm-40 -61.35 -44.87 96.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.269 -0.423 . . . . 72.420000000000002 111.048 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -62.79 -51.05 68.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.831 -0.622 . . . . 54.100000000000001 110.766 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -62.95 -48.86 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.662 -0.699 . . . . 61.539999999999999 111.97 -175.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.06 -41.49 90.7 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 121.107 -0.237 . . . . 75.420000000000002 111.353 -177.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.12 88.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.244 0.545 . . . . 72.239999999999995 109.887 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.51 -40.32 80.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.671 -0.695 . . . . 74.319999999999993 109.904 177.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.4 m -59.47 -46.5 88.62 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.637 -0.71 . . . . 55.439999999999998 109.107 176.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.34 65.9 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.443 -0.799 . . . . 64.400000000000006 111.437 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.61 -14.01 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.35 . . . . 74.439999999999998 111.023 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.03 -14.92 21.3 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.108 -1.044 . . . . 64.430000000000007 113.046 175.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -69.81 130.15 41.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.608 -0.516 . . . . 74.420000000000002 109.608 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.19 -23.92 6.48 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.894 -0.669 . . . . 51.219999999999999 111.704 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -103.01 115.79 31.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.831 0.824 . . . . 72.299999999999997 112.458 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 3.4 p90 -146.83 141.74 26.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.405 -1.27 . . . . 64.340000000000003 110.112 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -131.39 123.22 27.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.548 -0.751 . . . . 55.439999999999998 109.089 -174.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -85.78 135.35 33.76 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.003 -0.544 . . . . 74.239999999999995 110.576 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.68 147.7 52.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.396 -1.705 . . . . 64.040000000000006 106.396 171.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -114.4 149.2 36.53 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.438 -0.505 . . . . 70.349999999999994 109.808 -178.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 10.2 t -140.63 133.49 14.63 Favored Pre-proline 0 N--CA 1.422 -1.862 0 N-CA-C 108.01 -1.107 . . . . 72.310000000000002 108.01 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 24.2 Cg_exo -65.0 125.09 14.06 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.656 2.237 . . . . 63.049999999999997 111.93 -179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 31.4 t -139.26 179.5 6.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 -178.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.4 t -57.64 140.37 80.59 Favored Pre-proline 0 N--CA 1.432 -1.336 0 C-N-CA 123.213 0.605 . . . . 52.520000000000003 110.327 177.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 491' ' ' GLY . 76.7 Cg_exo -50.58 -29.61 25.57 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 124.312 3.342 . . . . 74.310000000000002 113.573 -178.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.58 -10.59 59.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.58 0.585 . . . . 70.049999999999997 112.58 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.6 8.11 35.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.525 0.565 . . . . 74.319999999999993 112.525 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 12.4 p -60.68 128.1 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.796 0.331 . . . . 70.409999999999997 110.453 179.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.54 87.62 Favored Glycine 0 C--O 1.252 1.26 0 C-N-CA 120.847 -0.692 . . . . 73.409999999999997 112.214 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -113.61 146.06 40.31 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.19 -1.041 . . . . 65.420000000000002 108.19 177.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 45.8 t -81.94 144.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.943 -0.391 . . . . 64.120000000000005 109.943 -176.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 27.6 pt -98.21 -19.0 6.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.142 0.496 . . . . 60.340000000000003 110.503 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.24 178.36 37.67 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 111.191 -0.764 . . . . 72.219999999999999 111.191 177.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 27.8 p -119.59 145.99 45.91 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.415 -0.587 . . . . 73.409999999999997 109.415 178.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.88 -52.1 74.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 123.266 0.353 . . . . 70.519999999999996 111.103 178.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.68 143.41 23.9 Favored 'Trans proline' 0 C--N 1.366 1.493 0 N-CA-C 108.89 -1.235 . . . . 73.319999999999993 108.89 170.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 56.4 Cg_endo -65.94 153.11 79.49 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 122.459 2.106 . . . . 61.450000000000003 112.355 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -87.15 -20.07 27.55 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.424 -0.807 . . . . 72.340000000000003 110.262 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 -32.12 15.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.089 -0.959 . . . . 74.519999999999996 112.117 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 1.3 mp0 -94.57 145.57 24.72 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.234 -0.986 . . . . 70.340000000000003 108.613 178.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 28.6 p -83.87 128.71 34.74 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 116.327 -0.397 . . . . 71.209999999999994 110.513 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 m -114.03 145.11 42.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.073 -1.084 . . . . 63.340000000000003 108.073 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.413 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -65.46 142.0 58.31 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.663 0.268 . . . . 55.450000000000003 111.542 -176.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 425' ' ' GLU . 50.2 mm -57.75 -25.84 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.779 0.832 . . . . 73.040000000000006 110.578 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.9 t -79.56 3.61 18.33 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.971 -0.559 . . . . 74.439999999999998 111.226 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -95.52 157.77 15.75 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.975 -0.453 . . . . 74.409999999999997 110.241 179.272 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.39 122.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.962 -1.125 . . . . 71.540000000000006 107.962 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 93.3 t -89.25 119.38 36.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.616 -0.512 . . . . 71.349999999999994 109.616 179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.31 121.81 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.588 -1.264 . . . . 72.239999999999995 107.588 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.95 121.29 66.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 115.626 -0.715 . . . . 75.450000000000003 109.277 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -102.73 118.36 49.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 121.808 0.813 . . . . 72.439999999999998 112.511 -178.283 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 15.4 t -96.77 145.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.883 -1.053 . . . . 72.129999999999995 109.1 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.77 117.31 4.63 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 110.477 -1.049 . . . . 71.129999999999995 110.477 176.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 7.3 p -99.57 128.66 45.69 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 107.486 -1.302 . . . . 63.420000000000002 107.486 174.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 461' ' ' PRO . . . -108.76 119.43 5.61 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.213 -0.994 . . . . 71.519999999999996 112.057 -174.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.74 116.96 4.89 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.393 2.062 . . . . 74.109999999999999 111.15 177.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.58 109.1 20.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 64.209999999999994 107.44 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 546' ' ' PRO . 21.9 p -122.61 158.77 29.23 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 115.538 -0.755 . . . . 55.329999999999998 109.847 -178.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -135.65 141.63 45.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.323 -0.398 . . . . 75.349999999999994 110.76 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.07 127.1 32.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.723 -1.214 . . . . 75.209999999999994 107.723 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.97 129.79 80.0 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 115.87 -0.605 . . . . 54.149999999999999 111.863 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -94.26 124.28 0.43 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.769 2.313 . . . . 42.109999999999999 112.471 173.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.18 135.43 36.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 174.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 t -125.28 33.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.754 0.787 . . . . 75.510000000000005 108.928 -176.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -61.28 116.16 4.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 70.109999999999999 110.771 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 128.57 -23.92 5.01 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.651 -0.785 . . . . 60.210000000000001 112.244 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.31 -179.17 3.87 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.712 -0.847 . . . . 65.540000000000006 108.712 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 25.7 m -84.09 155.7 22.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 119.928 -0.709 . . . . 71.230000000000004 109.652 -172.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.06 -41.31 68.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.787 0.435 . . . . 72.549999999999997 111.199 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.64 -42.06 87.3 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.535 -0.757 . . . . 75.349999999999994 111.59 -178.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.06 -36.37 56.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 118.952 -1.099 . . . . 74.329999999999998 110.631 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.16 74.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.942 -1.026 . . . . 74.120000000000005 111.56 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.35 -35.24 79.74 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 123.116 0.26 . . . . 63.109999999999999 110.676 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -63.54 -49.15 74.61 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.332 0.395 . . . . 61.409999999999997 111.918 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -68.88 -38.27 79.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.897 0.379 . . . . 72.140000000000001 110.472 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 551' ' ' ILE . 48.1 tp -62.4 -44.67 95.89 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 115.84 -0.618 . . . . 53.420000000000002 110.065 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 27.0 t-20 -59.54 -47.69 84.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.413 0.685 . . . . 62.420000000000002 111.989 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.69 -20.0 17.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.169 -0.469 . . . . 31.23 112.04 -175.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -116.61 4.02 13.14 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 120.034 -0.666 . . . . 70.439999999999998 111.13 -178.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.73 -96.64 0.2 Allowed Glycine 0 N--CA 1.41 -3.089 0 C-N-CA 118.806 -1.664 . . . . 64.310000000000002 115.763 -169.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 9.6 m-85 -129.74 158.4 39.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.278 -0.461 . . . . 65.450000000000003 110.292 -165.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -104.95 -2.21 24.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.609 -0.885 . . . . 64.540000000000006 108.609 177.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 550' ' ' VAL . 75.5 mmtt -108.73 115.61 30.41 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 72.040000000000006 109.462 -175.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -126.24 152.42 46.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.603 0.716 . . . . 72.230000000000004 111.786 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -133.59 148.82 51.62 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.629 -1.619 . . . . 75.319999999999993 106.629 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 553' ' ' LEU . 15.6 mm-40 -120.27 123.25 42.72 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.691 -1.226 . . . . 72.420000000000002 107.691 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -114.86 126.53 54.92 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.78 -1.192 . . . . 74.219999999999999 107.78 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 19.4 m -91.92 120.45 32.6 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.019 -0.734 . . . . 74.150000000000006 109.019 -178.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.39 151.51 24.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.568 -1.271 . . . . 74.319999999999993 107.568 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.476 ' HA ' ' OXT' ' A' ' 557' ' ' LYS . 12.6 m-20 -79.05 128.22 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.024 0.916 . . . . 70.310000000000002 113.411 -170.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.4 m -143.4 111.7 5.47 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.84 -1.541 . . . . 42.350000000000001 106.84 177.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -56.17 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.048 2.498 . . . . 54.219999999999999 114.568 -174.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -82.34 -44.78 0.98 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 114.715 1.376 . . . . 73.140000000000001 114.715 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 533' ' ' GLU . 72.6 Cg_exo -57.07 133.76 59.94 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.352 1.368 . . . . 71.200000000000003 110.803 174.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -143.09 127.21 17.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.587 -0.279 . . . . 74.129999999999995 110.652 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.0 -11.28 55.2 Favored Glycine 0 N--CA 1.469 0.858 0 CA-C-O 121.372 0.429 . . . . 62.450000000000003 113.024 175.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 530' ' ' PRO . 11.4 pt-20 -86.78 150.89 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.505 0.722 . . . . 74.319999999999993 110.976 178.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 47.8 t -74.71 124.64 32.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.226 -1.028 . . . . 60.130000000000003 108.226 178.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 28.8 m -83.38 -33.64 25.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 71.519999999999996 108.44 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.05 -167.12 39.92 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.834 -0.621 . . . . 65.120000000000005 111.655 177.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.5 p -118.97 160.38 22.1 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.579 -0.897 . . . . 72.219999999999999 108.579 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.9 t-20 -57.8 -56.77 31.13 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 119.274 -0.394 . . . . 73.129999999999995 111.95 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.3 Cg_endo -89.38 166.05 5.37 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.833 1.688 . . . . 52.25 109.506 174.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.28 152.55 55.75 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.295 1.996 . . . . 64.230000000000004 111.974 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.14 135.94 57.73 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.862 0.465 . . . . 65.230000000000004 110.351 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.47 37.16 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.99 -0.624 . . . . 63.439999999999998 111.564 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.6 m -67.89 131.56 45.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.483 -0.562 . . . . 74.230000000000004 109.483 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.3 t -100.02 123.72 44.58 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.994 0.902 . . . . 72.219999999999999 110.971 -177.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.69 158.93 60.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.465 -0.939 . . . . 71.319999999999993 108.465 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 494' ' ' THR . 44.1 Cg_exo -58.62 143.78 98.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.237 1.958 . . . . 74.439999999999998 110.894 179.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.32 -21.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.246 0.461 . . . . 65.329999999999998 112.246 -176.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.97 -2.77 58.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.325 -0.398 . . . . 75.329999999999998 111.034 178.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -81.21 152.58 27.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.18 -0.674 . . . . 51.030000000000001 109.18 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.9 t -90.06 125.5 42.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.312 -0.625 . . . . 61.109999999999999 109.312 -179.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.435 HD13 HD21 ' A' ' 512' ' ' LEU . 14.2 tt -97.25 139.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.122 -0.325 . . . . 61.020000000000003 110.122 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -102.85 120.27 40.3 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 120.902 0.382 . . . . 61.119999999999997 110.119 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 534' ' ' VAL . 6.3 tt -100.89 130.18 46.86 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.423 -1.325 . . . . 72.439999999999998 107.423 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 538' ' ' ASN . 78.8 mt-30 -101.21 109.51 21.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.661 0.743 . . . . 71.049999999999997 110.186 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.18 139.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.448 -1.251 . . . . 75.120000000000005 111.598 -175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -57.14 121.05 9.13 Favored 'General case' 0 C--O 1.25 1.108 0 C-N-CA 123.825 0.85 . . . . 64.430000000000007 112.973 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.476 ' OXT' ' HA ' ' A' ' 526' ' ' ASP . 28.4 ttpp . . . . . 0 N--CA 1.432 -1.367 0 C-N-CA 124.951 1.301 . . . . 72.5 108.362 175.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.186 0 N-CA-C 109.753 -1.339 . . . . 43.049999999999997 109.753 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.51 147.39 70.68 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.022 1.815 . . . . 71.030000000000001 112.496 -177.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 425' ' ' GLU . 0.1 OUTLIER -95.48 4.3 53.39 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.866 -1.161 . . . . 63.229999999999997 107.866 177.677 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 96.6 mt-30 -83.47 149.09 26.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.649 -1.614 . . . . 74.409999999999997 108.396 178.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 449' ' ' PHE . 17.6 tpp180 -120.92 155.33 34.44 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.528 -1.286 . . . . 62.109999999999999 107.528 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.39 141.48 31.7 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.49 -0.93 . . . . 72.239999999999995 108.49 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.6 mp -80.07 127.4 77.03 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.018 -1.475 . . . . 64.140000000000001 107.018 177.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.27 139.93 32.99 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 109.431 -1.027 . . . . 53.450000000000003 109.431 175.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -115.28 72.04 0.78 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.889 1.328 . . . . 73.319999999999993 109.93 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.14 14.68 7.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 113.552 -1.658 . . . . 61.450000000000003 107.1 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.624 ' HB3' ' HB ' ' A' ' 467' ' ' VAL . 1.3 m -52.39 -41.29 63.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 127.637 2.375 . . . . 63.509999999999998 110.395 178.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.3 t -56.43 -26.71 54.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.003 1.321 . . . . 64.200000000000003 112.017 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.4 mt -85.85 -46.92 10.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.118 -1.033 . . . . 63.200000000000003 111.048 -174.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 20.1 m -174.23 153.7 2.05 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.535 -0.913 . . . . 72.340000000000003 108.535 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.497 ' HA ' ' CG2' ' A' ' 467' ' ' VAL . 40.3 t80 -50.55 -50.68 52.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.142 0.977 . . . . 74.340000000000003 111.009 171.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.48 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.757 0.661 . . . . 64.420000000000002 111.461 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.413 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 50.0 mm-40 -61.49 -45.98 91.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.317 -0.402 . . . . 62.350000000000001 111.463 -178.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -63.38 -48.36 78.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.87 -0.605 . . . . 61.140000000000001 110.967 -178.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.18 -46.59 90.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.894 -0.594 . . . . 64.519999999999996 112.238 -176.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -66.55 -41.55 88.49 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.488 0.181 . . . . 71.400000000000006 111.488 -178.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.08 -38.99 86.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.458 -0.497 . . . . 70.430000000000007 111.179 176.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 452' ' ' PHE . 33.5 tp -67.11 -36.61 82.29 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.251 0.548 . . . . 52.329999999999998 110.041 178.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.2 m -59.49 -44.72 93.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.459 -0.791 . . . . 45.020000000000003 109.582 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.68 -18.65 62.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.44 -0.8 . . . . 73.329999999999998 111.181 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.63 59.16 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.228 0.537 . . . . 72.439999999999998 110.903 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.06 -25.77 9.74 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.813 -0.708 . . . . 60.009999999999998 113.454 174.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 427' ' ' ARG . 96.2 m-85 -57.42 130.7 47.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.038 0.535 . . . . 61.340000000000003 112.0 -176.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -128.0 26.29 4.79 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.398 -0.906 . . . . 53.130000000000003 112.849 -178.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -132.91 115.59 15.43 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.235 -1.024 . . . . 75.010000000000005 108.235 178.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 444' ' ' LEU . 27.6 m-85 -128.93 150.11 50.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.575 0.702 . . . . 71.420000000000002 111.731 -174.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.573 ' HB2' HG13 ' A' ' 485' ' ' ILE . 36.3 mmtm -136.24 130.62 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.646 -1.983 . . . . 75.540000000000006 105.646 169.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -108.26 124.72 50.74 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.703 -0.799 . . . . 74.519999999999996 110.83 -175.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.05 145.01 48.56 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.934 -0.575 . . . . 63.119999999999997 109.547 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -118.88 134.54 55.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.436 -1.32 . . . . 70.540000000000006 107.436 175.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.1 t -122.29 137.23 27.3 Favored Pre-proline 0 C--N 1.283 -2.284 0 N-CA-C 108.479 -0.934 . . . . 75.409999999999997 108.479 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.11 122.17 9.86 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.847 1.698 . . . . 54.049999999999997 110.801 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 40.5 m -134.07 178.7 6.76 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.353 -0.98 . . . . 54.329999999999998 108.353 -177.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.7 t -74.0 151.26 88.39 Favored Pre-proline 0 N--CA 1.403 -2.804 0 N-CA-C 107.651 -1.24 . . . . 74.329999999999998 107.651 176.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.498 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -50.42 -28.91 22.44 Favored 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 124.121 3.214 . . . . 63.030000000000001 112.718 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.97 -26.25 68.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.121 -0.49 . . . . 74.049999999999997 111.344 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.34 -0.42 35.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.81 1.041 . . . . 63.420000000000002 113.81 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -60.81 128.13 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 119.962 -0.695 . . . . 74.140000000000001 110.696 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.24 -12.77 67.8 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 121.12 -0.562 . . . . 74.400000000000006 112.654 177.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.27 139.72 38.35 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.732 -0.47 . . . . 72.450000000000003 109.732 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 61.6 t -82.49 128.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.767 -0.651 . . . . 75.219999999999999 109.628 -178.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 28.5 pt -98.47 -6.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.937 0.399 . . . . 74.450000000000003 112.019 -176.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.29 160.92 15.43 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.939 -1.125 . . . . 75.400000000000006 112.829 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 23.0 p -118.95 142.29 47.91 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.255 -1.017 . . . . 71.519999999999996 108.255 176.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.527 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.7 t-20 -54.74 -51.58 77.68 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 112.387 0.514 . . . . 72.129999999999995 112.387 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.5 Cg_exo -77.2 124.13 7.05 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 N-CA-C 108.158 -1.516 . . . . 75.140000000000001 108.158 169.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.32 142.17 65.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.326 2.017 . . . . 75.120000000000005 112.037 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.55 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.21 -14.65 61.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.144 0.973 . . . . 40.43 110.697 -177.152 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.27 -9.98 55.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.731 -1.577 . . . . 64.450000000000003 111.33 -176.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -120.84 151.06 40.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.945 -0.761 . . . . 64.230000000000004 108.945 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 10.7 p -84.44 132.7 34.54 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 108.807 -0.812 . . . . 73.109999999999999 108.807 176.513 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.6 m -122.2 145.71 47.94 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.358 -0.608 . . . . 53.340000000000003 109.358 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -59.55 154.64 16.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.439 . . . . 54.520000000000003 111.001 179.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.1 -25.42 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.796 0.807 . . . . 63.43 110.603 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.4 t -94.54 11.48 30.79 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.014 -0.994 . . . . 62.5 110.921 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -77.74 141.35 39.34 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 121.697 -0.627 . . . . 72.530000000000001 109.853 176.47 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.57 117.33 25.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.609 0.719 . . . . 73.0 110.075 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.44 118.61 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.734 -0.839 . . . . 72.340000000000003 108.734 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.573 HG13 ' HB2' ' A' ' 453' ' ' LYS . 2.5 mp -96.5 117.83 41.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 105.411 -2.07 . . . . 71.129999999999995 105.411 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.72 119.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 109.068 -0.715 . . . . 73.540000000000006 109.068 -176.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.53 114.26 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.942 -0.572 . . . . 74.209999999999994 110.528 -175.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 17.5 t -95.99 136.59 26.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.688 -0.856 . . . . 63.539999999999999 108.688 -178.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.44 125.08 6.8 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.815 -1.714 . . . . 73.150000000000006 108.815 175.072 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -128.63 129.84 46.44 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 109.12 -0.696 . . . . 71.430000000000007 109.12 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 492' ' ' PRO . . . -88.99 131.7 10.84 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.104 -1.598 . . . . 44.240000000000002 109.104 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 32.5 Cg_exo -61.59 118.27 5.13 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.375 2.05 . . . . 54.109999999999999 111.482 -178.662 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -71.45 91.78 1.05 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.147 0.975 . . . . 70.129999999999995 109.591 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.9 p -137.1 154.11 50.38 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.644 -1.243 . . . . 74.340000000000003 107.644 -176.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -138.64 150.0 45.78 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.807 0.337 . . . . 71.140000000000001 110.562 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 16.0 t70 -100.36 113.73 26.7 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.02 -1.104 . . . . 74.109999999999999 108.02 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.559 ' H ' HD13 ' A' ' 497' ' ' ILE . 0.2 OUTLIER -98.6 134.84 21.37 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 113.443 0.905 . . . . 71.239999999999995 113.443 -174.153 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.4 -178.15 1.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.767 2.311 . . . . 55.119999999999997 109.04 170.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.69 153.64 18.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.091 -0.707 . . . . 70.150000000000006 109.091 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.65 33.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 104.937 -2.246 . . . . 54.399999999999999 104.937 175.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.89 147.45 33.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.794 -1.548 . . . . 63.399999999999999 111.327 -173.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 103.65 -12.98 53.96 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.64 -0.984 . . . . 43.539999999999999 110.64 -177.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.12 179.92 4.08 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.098 -0.704 . . . . 74.129999999999995 109.098 177.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.72 156.15 26.4 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.647 -0.421 . . . . 64.219999999999999 109.941 -170.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.1 p -54.3 -43.7 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.383 0.512 . . . . 72.310000000000002 112.383 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.64 -41.91 78.74 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.332 0.493 . . . . 63.119999999999997 112.332 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.83 -38.9 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 119.47 -0.892 . . . . 72.349999999999994 111.524 -174.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.38 80.93 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.61 -0.723 . . . . 71.530000000000001 111.39 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -64.82 -34.68 78.93 Favored 'General case' 0 C--O 1.205 -1.282 0 O-C-N 123.214 0.321 . . . . 64.120000000000005 110.394 -177.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -59.5 -52.48 65.4 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.495 -0.557 . . . . 74.299999999999997 109.495 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -66.86 -44.72 80.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.457 -0.792 . . . . 72.099999999999994 110.704 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.47 -37.0 82.03 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 115.915 -0.584 . . . . 62.350000000000001 110.531 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.81 -38.15 77.98 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.552 0.741 . . . . 74.5 110.942 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -37.62 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.718 -0.674 . . . . 74.430000000000007 111.267 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -122.74 33.83 5.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.713 0.768 . . . . 72.430000000000007 111.455 -176.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -153.39 -128.52 1.29 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.98 -1.009 . . . . 62.240000000000002 111.553 -178.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 44.7 m-85 -105.66 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.053 0.454 . . . . 65.450000000000003 110.319 -173.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.6 p -110.03 -3.63 16.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.577 -0.738 . . . . 71.439999999999998 110.902 178.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 550' ' ' VAL . 28.2 mtpp -113.77 115.73 28.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.84 -0.8 . . . . 74.239999999999995 108.84 -177.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.83 156.46 43.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.152 0.501 . . . . 74.209999999999994 111.456 -175.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -140.99 156.62 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.017 -1.475 . . . . 75.219999999999999 107.017 171.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -121.75 124.87 45.24 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.385 -0.598 . . . . 74.409999999999997 109.385 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -114.82 140.63 48.78 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.529 -0.915 . . . . 75.230000000000004 108.529 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 557' ' ' LYS . 20.0 m -88.18 124.81 34.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.974 -0.557 . . . . 52.530000000000001 110.704 -176.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 33.2 m -121.17 156.8 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.954 -1.128 . . . . 73.430000000000007 107.954 176.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.88 142.4 38.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.999 0.904 . . . . 72.209999999999994 112.048 -170.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 p -118.17 135.29 23.43 Favored Pre-proline 0 N--CA 1.413 -2.294 0 CA-C-N 114.264 -1.334 . . . . 51.109999999999999 110.187 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.55 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.275 0 N-CA-C 109.075 -1.163 . . . . 43.140000000000001 109.075 171.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.559 ' HG3' ' HD3' ' A' ' 530' ' ' PRO . 23.2 ptt180 -127.43 -47.07 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 114.72 1.378 . . . . 74.349999999999994 114.72 176.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.559 ' HD3' ' HG3' ' A' ' 529' ' ' ARG . 84.7 Cg_endo -76.54 135.89 16.8 Favored 'Trans proline' 0 C--N 1.385 2.45 0 CA-C-N 121.763 1.665 . . . . 71.409999999999997 112.107 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -137.32 145.44 43.41 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.955 -0.387 . . . . 73.519999999999996 109.955 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 100.21 -18.83 54.97 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.899 -0.48 . . . . 62.450000000000003 111.899 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.43 148.4 24.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.638 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.73 122.45 28.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.289 -0.869 . . . . 75.340000000000003 109.472 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 7.3 m -92.68 -10.01 38.78 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.788 -1.096 . . . . 62.5 109.348 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -159.12 27.98 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 110.774 -0.931 . . . . 75.430000000000007 110.774 177.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -134.36 157.75 45.59 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.698 -1.223 . . . . 71.5 107.698 177.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 552' ' ' GLU . 25.2 t-20 -52.68 -58.72 10.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.861 -0.59 . . . . 51.0 110.908 -179.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.51 140.53 15.13 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 120.464 1.202 . . . . 63.100000000000001 109.063 170.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.47 155.8 65.9 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 121.935 1.757 . . . . 71.409999999999997 112.193 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.53 136.14 57.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.944 -0.571 . . . . 73.340000000000003 109.914 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -5.36 57.04 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.088 -1.053 . . . . 62.299999999999997 111.815 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 16.7 m -89.2 137.72 32.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.446 -0.575 . . . . 73.120000000000005 109.446 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.7 m -98.8 123.04 42.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.244 -1.021 . . . . 42.420000000000002 108.244 175.084 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.74 161.96 57.97 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 110.054 -0.351 . . . . 71.519999999999996 110.054 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 494' ' ' THR . 20.7 Cg_exo -66.33 137.79 48.57 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.02 2.48 . . . . 60.229999999999997 113.995 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.553 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 15.0 m -67.86 -20.45 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.005 0.907 . . . . 72.040000000000006 111.248 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.45 -5.15 58.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.446 -1.252 . . . . 63.229999999999997 110.456 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -103.72 152.25 22.05 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.69 -1.226 . . . . 74.049999999999997 107.69 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 519' ' ' LYS . 38.8 t -88.71 136.2 23.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.859 -0.423 . . . . 64.319999999999993 109.859 -177.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.0 tt -95.88 135.49 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.352 0.596 . . . . 70.109999999999999 109.408 176.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 538' ' ' ASN . 30.2 tt0 -101.59 120.61 40.59 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.379 -0.971 . . . . 72.430000000000007 108.379 -177.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.0 tp -95.5 126.58 40.89 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.811 -1.086 . . . . 71.439999999999998 108.472 -177.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -89.53 105.64 17.93 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.632 -0.877 . . . . 75.310000000000002 108.632 -177.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.48 134.49 47.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 120.789 0.328 . . . . 64.310000000000002 110.667 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.7 p -66.35 121.46 15.3 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.044 -0.525 . . . . 75.310000000000002 109.743 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 20.6 pttp . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 115.557 -0.747 . . . . 75.510000000000005 110.626 -177.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.288 0 N-CA-C 110.537 -1.025 . . . . 43.049999999999997 110.537 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.91 132.61 45.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.798 2.332 . . . . 73.209999999999994 111.079 178.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.29 27.0 4.16 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.775 0.797 . . . . 61.340000000000003 109.521 -177.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -101.39 147.89 25.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.162 -1.051 . . . . 54.229999999999997 108.162 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 447' ' ' ALA . 18.4 tpt180 -120.72 158.82 26.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.966 0.413 . . . . 73.430000000000007 110.166 -175.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.3 141.47 29.22 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.149 0.979 . . . . 74.519999999999996 110.41 -176.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.0 mp -87.85 121.49 70.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.617 -1.623 . . . . 60.009999999999998 106.617 173.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.74 141.83 55.86 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.091 1.861 . . . . 34.219999999999999 112.898 -175.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.58 11.64 23.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.74 -0.663 . . . . 73.120000000000005 110.767 -178.192 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 443' ' ' LYS . 21.5 m -73.27 -9.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.701 -0.851 . . . . 64.450000000000003 108.701 176.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.0 m -57.23 -38.2 73.44 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.329 -1.305 . . . . 71.140000000000001 109.866 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.1 m -60.02 -27.56 67.0 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 114.779 -1.1 . . . . 70.239999999999995 110.647 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.8 mt -79.85 -47.63 14.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.382 -0.927 . . . . 73.010000000000005 109.975 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.529 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 49.8 m -166.01 145.77 6.27 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.682 -0.858 . . . . 73.140000000000001 108.682 177.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -55.29 -44.5 75.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.468 0.707 . . . . 72.439999999999998 111.914 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.19 -43.29 78.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.447 . . . . 70.510000000000005 110.881 177.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 18.9 mm-40 -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 71.439999999999998 110.534 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.54 -51.39 70.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.98 -1.009 . . . . 54.149999999999999 110.95 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.31 -48.52 88.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 114.851 -1.068 . . . . 70.420000000000002 111.784 -176.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.16 -46.11 90.43 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.154 0.428 . . . . 43.420000000000002 112.154 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.528 ' HG3' HG21 ' A' ' 432' ' ' VAL . 74.5 mmtt -66.98 -42.71 84.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.847 0.356 . . . . 75.129999999999995 111.267 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.81 80.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 72.530000000000001 111.026 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 49.2 m -62.35 -45.57 92.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.204 -0.665 . . . . 64.010000000000005 109.204 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.88 62.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.593 -0.73 . . . . 14.109999999999999 111.054 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 427' ' ' ARG . . . -79.33 -13.8 59.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 120.796 0.331 . . . . 51.450000000000003 110.2 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.91 -9.82 15.84 Favored Glycine 0 CA--C 1.494 -1.229 0 C-N-CA 120.072 -1.061 . . . . 75.049999999999997 113.209 173.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -80.35 136.6 36.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.58 -0.526 . . . . 73.340000000000003 109.58 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.04 -1.82 6.71 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 120.405 -0.903 . . . . 51.350000000000001 112.603 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -112.65 115.96 29.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.523 -0.918 . . . . 64.540000000000006 108.523 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -131.0 152.08 50.7 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.319 -0.4 . . . . 74.230000000000004 110.173 -174.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -135.8 122.59 21.11 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.457 -1.312 . . . . 71.310000000000002 107.457 170.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -97.68 133.37 42.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.151 0.501 . . . . 70.430000000000007 110.21 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.31 138.96 54.33 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.264 -1.384 . . . . 44.030000000000001 107.264 175.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.09 136.64 53.16 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.695 -0.854 . . . . 63.43 108.695 177.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.1 p -128.2 144.49 51.93 Favored Pre-proline 0 C--N 1.289 -2.048 0 N-CA-C 109.779 -0.452 . . . . 60.210000000000001 109.779 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -64.93 123.46 11.65 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.12 1.88 . . . . 75.239999999999995 109.85 175.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.7 m -142.06 178.16 7.72 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.5 -0.926 . . . . 54.229999999999997 108.5 -177.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -58.76 141.71 84.74 Favored Pre-proline 0 C--O 1.253 1.272 0 C-N-CA 123.295 0.638 . . . . 75.519999999999996 111.431 178.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.46 -28.58 28.4 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.982 3.788 . . . . 73.129999999999995 113.382 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -75.39 -11.26 60.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.785 0.661 . . . . 73.25 112.785 -178.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 466' ' ' LYS . 83.4 mt -111.0 6.36 20.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.978 0.362 . . . . 71.329999999999998 111.978 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 49.1 t -61.21 127.34 20.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 121.125 -0.23 . . . . 74.099999999999994 110.804 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.87 -0.24 87.75 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 116.11 -0.496 . . . . 73.030000000000001 112.467 176.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 463' ' ' LEU . 28.4 mtpp -106.75 142.13 36.89 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.113 -1.069 . . . . 72.099999999999994 108.113 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -81.76 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.408 -0.59 . . . . 62.409999999999997 109.408 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 20.2 pt -98.25 -10.08 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.085 -0.507 . . . . 75.040000000000006 111.652 -176.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 162.15 21.34 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.64 -0.79 . . . . 75.049999999999997 112.153 177.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 25.4 p -130.09 150.31 51.41 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.021 -1.103 . . . . 65.049999999999997 108.021 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.61 -52.9 61.6 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 119.325 -0.369 . . . . 74.310000000000002 111.855 176.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.99 140.81 38.85 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 120.836 1.024 . . . . 61.539999999999999 110.073 173.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.02 145.69 85.81 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.253 2.636 . . . . 51.329999999999998 113.248 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -90.95 -17.39 26.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.331 1.062 . . . . 44.149999999999999 109.122 178.15 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -92.92 -19.14 21.94 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.616 -1.175 . . . . 55.009999999999998 110.114 -176.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -118.97 150.94 39.07 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.14 -0.482 . . . . 64.340000000000003 110.378 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 16.7 p -85.99 127.2 34.59 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.513 -0.312 . . . . 74.420000000000002 111.226 -178.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.0 m -111.27 151.24 28.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.475 0.71 . . . . 72.430000000000007 109.777 -176.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.496 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -60.43 142.92 54.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 61.299999999999997 111.811 -178.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.89 -30.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.765 1.226 . . . . 73.049999999999997 111.275 -176.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -83.95 0.75 46.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.073 -0.512 . . . . 74.329999999999998 111.604 -175.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -73.44 145.08 46.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 112.465 0.543 . . . . 74.430000000000007 112.465 -177.843 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.7 p -84.46 125.78 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.627 -0.879 . . . . 61.039999999999999 108.627 172.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.0 118.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 109.032 -0.729 . . . . 74.510000000000005 109.032 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.72 115.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 105.804 -1.924 . . . . 75.230000000000004 105.804 174.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -113.39 125.46 70.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.408 -0.815 . . . . 55.119999999999997 109.932 -174.234 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.33 120.75 55.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.083 0.468 . . . . 54.420000000000002 110.107 -177.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 23.8 t -102.84 140.39 21.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 CA-C-N 115.642 -0.708 . . . . 70.019999999999996 109.67 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.0 122.73 5.84 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 109.238 -1.545 . . . . 51.329999999999998 109.238 173.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.4 p -122.29 137.27 54.91 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.109 -0.7 . . . . 44.240000000000002 109.109 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 464' ' ' VAL . . . -103.56 130.67 10.33 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 120.141 -1.028 . . . . 45.100000000000001 111.464 -176.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.14 122.56 10.59 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.181 1.921 . . . . 55.329999999999998 109.625 175.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.5 104.24 14.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.939 -1.134 . . . . 71.530000000000001 107.939 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 546' ' ' PRO . 22.5 p -125.33 166.05 17.26 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.335 -0.848 . . . . 61.329999999999998 111.242 -175.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -149.57 147.13 27.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.741 0.817 . . . . 72.109999999999999 110.191 176.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 30.4 t70 -96.08 127.05 41.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.137 -1.06 . . . . 72.310000000000002 108.137 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.4 pt -79.49 121.81 83.14 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 112.231 0.456 . . . . 73.209999999999994 112.231 -175.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.19 146.29 14.1 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.995 1.797 . . . . 54.219999999999999 110.437 175.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.81 121.01 17.25 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.362 -0.607 . . . . 72.310000000000002 109.362 179.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.01 19.09 3.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.68 1.228 . . . . 72.140000000000001 108.249 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.21 112.25 19.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.421 -1.263 . . . . 63.409999999999997 109.525 -176.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.98 -28.39 1.71 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.66 -0.976 . . . . 54.43 110.66 -178.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 507' ' ' VAL . 21.3 mt-30 -86.46 178.57 7.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.425 -0.954 . . . . 71.450000000000003 108.425 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 155.95 28.55 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.154 -1.054 . . . . 55.119999999999997 108.154 -174.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.8 p -51.76 -45.9 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.608 0.595 . . . . 60.350000000000001 112.608 -176.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.57 -42.76 82.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.22 0.325 . . . . 65.140000000000001 111.545 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 503' ' ' GLN . 13.2 p -76.92 -39.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 119.537 -0.865 . . . . 74.019999999999996 111.678 -175.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.3 71.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.465 -0.789 . . . . 41.229999999999997 112.284 179.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.02 -35.6 81.71 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 120.138 -0.625 . . . . 73.120000000000005 110.333 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 510' ' ' LYS . 33.1 ttmt -60.67 -48.15 83.07 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.951 0.782 . . . . 75.349999999999994 109.331 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -62.62 -43.7 98.14 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.438 -0.801 . . . . 72.530000000000001 110.689 178.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.25 -43.06 92.54 Favored 'General case' 0 C--O 1.188 -2.16 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 109.45 -178.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -58.74 -37.71 76.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.037 0.935 . . . . 72.510000000000005 111.76 -178.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.0 t -66.05 -37.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 112.512 0.56 . . . . 53.109999999999999 112.512 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -112.19 -15.4 13.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.24 -0.584 . . . . 74.25 111.896 -173.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -106.14 -110.31 3.48 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 115.541 -0.754 . . . . 74.040000000000006 113.324 -175.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.544 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 21.0 m-85 -123.94 175.43 6.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.092 0.472 . . . . 71.439999999999998 110.992 -172.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.9 p -109.42 -3.45 17.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.362 -0.835 . . . . 62.200000000000003 110.477 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.42 115.72 30.64 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.008 -0.738 . . . . 72.329999999999998 109.008 -176.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.78 149.28 50.79 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 123.576 0.547 . . . . 62.219999999999999 110.846 -176.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.6 m -136.36 143.54 44.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.21 -1.774 . . . . 73.310000000000002 106.21 171.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -121.78 136.78 54.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 118.019 0.372 . . . . 65.510000000000005 110.157 -177.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.419 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -126.48 131.02 51.73 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.445 -0.946 . . . . 64.510000000000005 108.445 177.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 557' ' ' LYS . 6.3 p -88.88 133.6 34.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.094 0.473 . . . . 72.030000000000001 112.167 -176.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.16 163.1 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.95 -1.5 . . . . 72.010000000000005 106.95 175.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 528' ' ' PRO . 10.9 p-10 -78.29 137.32 38.02 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.047 0.451 . . . . 70.439999999999998 109.829 -175.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 8.2 m -97.94 108.23 45.14 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.157 -172.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 526' ' ' ASP . 30.0 Cg_endo -90.92 -90.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 122.449 2.099 . . . . 72.409999999999997 110.332 172.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -84.18 -48.63 0.68 Allowed Pre-proline 0 N--CA 1.439 -1.008 0 C-N-CA 120.177 -0.609 . . . . 74.030000000000001 111.518 171.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.542 ' HA ' ' OE2' ' A' ' 533' ' ' GLU . 78.4 Cg_exo -58.74 134.1 58.36 Favored 'Trans proline' 0 C--N 1.374 1.918 0 CA-C-N 120.19 1.104 . . . . 63.409999999999997 110.488 169.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.46 116.26 3.87 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 123.192 0.308 . . . . 72.340000000000003 110.796 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 83.17 -15.16 35.03 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 121.997 0.776 . . . . 73.219999999999999 111.64 178.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.542 ' OE2' ' HA ' ' A' ' 530' ' ' PRO . 13.9 pt-20 -87.55 150.04 23.96 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 125.315 1.446 . . . . 74.430000000000007 110.939 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 553' ' ' LEU . 79.2 t -73.15 122.4 25.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 107.68 -1.23 . . . . 62.100000000000001 107.68 178.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.8 m -87.8 -24.68 23.67 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.007 -0.997 . . . . 74.439999999999998 110.593 -174.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 168.01 -163.28 37.02 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.906 -0.878 . . . . 64.420000000000002 110.906 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.9 p -140.7 160.22 40.51 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 72.519999999999996 107.964 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.45 -60.27 11.11 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 119.243 -0.408 . . . . 75.510000000000005 110.786 178.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.13 139.86 19.39 Favored 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 120.189 1.103 . . . . 72.540000000000006 109.265 172.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.12 153.94 52.0 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.976 1.784 . . . . 74.120000000000005 112.229 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.71 131.77 51.28 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.475 -0.565 . . . . 74.200000000000003 109.475 176.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.25 -5.77 36.12 Favored Glycine 0 C--N 1.299 -1.49 0 N-CA-C 110.464 -1.054 . . . . 45.140000000000001 110.464 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.9 m -88.41 125.33 34.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.517 -0.549 . . . . 54.399999999999999 109.517 174.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 26.1 m -101.6 123.49 45.69 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.426 -0.953 . . . . 74.219999999999999 108.426 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.31 164.49 42.95 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.636 -0.505 . . . . 62.030000000000001 109.636 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.5 Cg_exo -58.65 147.84 85.31 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.605 2.203 . . . . 75.299999999999997 111.436 176.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.544 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 35.2 m -66.86 -19.19 25.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.624 0.601 . . . . 61.530000000000001 112.624 -178.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.67 3.51 44.4 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.899 -0.591 . . . . 73.120000000000005 110.968 176.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 19.0 t -80.89 139.65 35.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.965 -0.754 . . . . 71.219999999999999 108.965 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.77 115.93 29.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.138 -0.689 . . . . 73.140000000000001 109.138 -179.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 14.4 tt -88.0 134.53 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.61 0.719 . . . . 64.129999999999995 111.039 -177.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.72 122.12 43.32 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 107.43 -1.322 . . . . 64.040000000000006 107.43 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 534' ' ' VAL . 7.6 tt -111.18 127.42 55.58 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.636 -1.165 . . . . 75.25 108.648 -175.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 5.7 mm-40 -92.41 109.53 20.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.963 -0.754 . . . . 73.329999999999998 108.963 -174.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.95 138.38 26.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 64.400000000000006 111.572 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 p -71.53 125.25 26.57 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.935 -1.505 . . . . 73.540000000000006 106.935 171.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 524' ' ' SER . 62.3 pttt . . . . . 0 C--O 1.264 1.867 0 CA-C-N 115.646 -0.706 . . . . 73.299999999999997 111.246 -172.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.349 0 N-CA-C 110.493 -1.043 . . . . 73.25 110.493 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 132.03 14.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.45 1.625 . . . . 74.439999999999998 110.985 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 480' ' ' ILE . 11.1 pt-20 -110.45 16.13 21.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.014 0.912 . . . . 73.310000000000002 109.657 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -121.12 134.73 55.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.548 -1.279 . . . . 73.239999999999995 107.548 175.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -125.15 158.93 32.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.353 -0.61 . . . . 63.43 109.353 -176.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.64 142.49 30.76 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 123.715 0.806 . . . . 72.25 109.581 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.5 mp -79.59 130.06 69.28 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 107.876 -1.157 . . . . 70.209999999999994 107.876 178.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 149.52 49.87 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.912 1.742 . . . . 73.030000000000001 111.967 178.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -114.9 72.96 0.81 Allowed 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 122.054 0.93 . . . . 74.549999999999997 110.355 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.6 4.67 5.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.119 -1.808 . . . . 73.409999999999997 106.119 175.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.01 -32.89 74.35 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 112.754 -2.021 . . . . 53.119999999999997 110.93 -176.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 t -61.44 -27.23 68.41 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.415 -0.812 . . . . 14.4 111.122 176.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.13 -46.32 15.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.159 -1.416 . . . . 72.420000000000002 110.416 -174.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 9.5 m -166.01 147.36 6.83 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.662 -0.866 . . . . 74.239999999999995 108.662 177.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.25 -45.54 65.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.954 0.902 . . . . 74.310000000000002 111.154 172.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.0 74.6 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.909 0.484 . . . . 73.209999999999994 110.869 178.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.568 ' O ' ' HD3' ' A' ' 443' ' ' LYS . 12.2 mm-40 -66.29 -41.19 90.15 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.511 -0.768 . . . . 54.340000000000003 110.611 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.561 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.61 -50.12 75.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.913 -0.585 . . . . 64.310000000000002 110.407 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.56 -48.21 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.541 -0.754 . . . . 62.520000000000003 111.554 -176.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -60.95 -46.67 89.76 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.473 0.546 . . . . 74.230000000000004 112.473 -177.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 439' ' ' GLU . 4.6 mptp? -67.38 -38.92 85.48 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 121.029 -0.269 . . . . 61.219999999999999 111.489 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -39.74 86.59 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.244 0.545 . . . . 74.150000000000006 109.889 178.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -59.4 -45.76 90.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.286 -0.87 . . . . 73.25 109.41 176.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.28 62.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.76 -0.654 . . . . 64.109999999999999 111.689 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -13.08 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 71.420000000000002 110.265 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.14 -16.1 25.22 Favored Glycine 0 CA--C 1.494 -1.253 0 C-N-CA 120.842 -0.694 . . . . 52.009999999999998 113.039 173.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.97 121.18 14.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.156 0.503 . . . . 74.340000000000003 111.035 -177.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.401 ' C ' ' HD2' ' A' ' 451' ' ' ARG . . . -105.6 -2.73 40.48 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.411 -0.813 . . . . 44.329999999999998 111.6 178.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 450' ' ' GLY . 9.4 mpt_? -120.85 114.93 22.31 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.202 0.525 . . . . 75.109999999999999 110.176 178.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -148.26 148.36 30.38 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.321 -0.854 . . . . 34.130000000000003 111.083 178.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -131.09 129.18 41.57 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.326 -0.99 . . . . 63.409999999999997 108.326 -178.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -93.33 124.82 37.58 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.417 0.448 . . . . 72.310000000000002 110.656 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 150.56 42.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.465 -1.309 . . . . 53.409999999999997 107.465 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.87 141.17 49.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.508 -0.923 . . . . 75.349999999999994 108.508 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 13.4 t -127.96 137.67 31.3 Favored Pre-proline 0 N--CA 1.416 -2.158 0 N-CA-C 109.007 -0.738 . . . . 32.340000000000003 109.007 -179.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 33.2 Cg_exo -64.97 123.66 11.93 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.488 2.125 . . . . 72.519999999999996 111.045 179.078 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.0 m -138.94 179.47 6.47 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.846 -1.539 . . . . 75.230000000000004 106.846 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 15.4 t -60.53 141.81 91.57 Favored Pre-proline 0 N--CA 1.422 -1.85 0 N-CA-C 108.385 -0.969 . . . . 51.509999999999998 108.385 175.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.85 -29.29 26.12 Favored 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 124.176 3.251 . . . . 72.209999999999994 113.721 -176.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -75.5 -13.97 60.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.708 0.632 . . . . 74.329999999999998 112.708 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.42 2.38 55.69 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 122.157 -0.34 . . . . 64.409999999999997 111.845 179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.6 p -60.75 128.43 21.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.258 0.551 . . . . 72.239999999999995 110.436 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.26 -12.94 67.61 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 120.834 -0.698 . . . . 75.329999999999998 111.774 178.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -98.76 139.97 33.65 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.369 -0.974 . . . . 65.310000000000002 108.369 177.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 433' ' ' SER . 60.7 t -82.27 138.89 18.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.119 -1.067 . . . . 64.140000000000001 108.119 176.406 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 32.3 pt -98.38 -29.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 120.033 -0.667 . . . . 74.340000000000003 111.227 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -176.82 168.76 40.89 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.345 -1.407 . . . . 62.020000000000003 112.502 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 34.2 p -117.64 143.32 46.26 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.27 -0.641 . . . . 63.399999999999999 109.27 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.3 t-20 -60.16 -49.77 89.28 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.578 0.584 . . . . 71.239999999999995 112.578 177.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.4 Cg_exo -81.97 144.59 13.61 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.03 1.153 . . . . 73.099999999999994 109.203 172.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 89.0 Cg_endo -72.55 145.01 41.32 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.34 2.026 . . . . 74.219999999999999 111.237 -179.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -79.86 -18.25 51.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.522 -0.763 . . . . 75.109999999999999 110.09 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -77.4 -27.44 52.42 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.931 -1.031 . . . . 75.150000000000006 113.019 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 2.0 mp0 -100.76 160.89 13.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.222 -1.029 . . . . 72.219999999999999 108.222 175.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 41.2 p -97.94 126.04 43.15 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 109.414 -0.587 . . . . 65.329999999999998 109.414 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 142.82 34.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.491 -0.929 . . . . 62.109999999999999 108.491 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -56.49 153.22 10.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.568 0.581 . . . . 65.030000000000001 112.568 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 425' ' ' GLU . 45.2 mm -61.51 -30.02 47.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.434 0.635 . . . . 33.43 110.149 178.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 8.31 39.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 45.439999999999998 111.128 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.09 149.4 26.93 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.148 -1.056 . . . . 71.450000000000003 108.148 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.38 117.93 44.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.845 0.831 . . . . 71.209999999999994 111.382 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.1 t -92.44 119.92 40.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.359 -0.837 . . . . 52.030000000000001 109.545 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.2 mp -92.61 116.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.766 -1.568 . . . . 74.129999999999995 106.766 175.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.13 126.16 58.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.715 -0.675 . . . . 63.450000000000003 109.327 -176.549 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 26.7 mt -104.49 115.61 46.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.776 -0.647 . . . . 74.420000000000002 110.224 -173.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.14 136.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.231 -0.655 . . . . 73.310000000000002 109.231 -177.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -80.43 124.67 6.56 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 109.096 -1.602 . . . . 72.439999999999998 109.096 175.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 44.5 m -135.31 140.78 45.39 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.138 -0.69 . . . . 62.539999999999999 109.138 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -93.1 160.34 24.88 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.162 -1.018 . . . . 35.140000000000001 110.651 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.07 126.37 17.08 Favored 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 122.759 2.306 . . . . 71.430000000000007 111.334 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -80.67 81.62 6.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.081 0.944 . . . . 71.120000000000005 109.493 177.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 546' ' ' PRO . 46.6 p -136.02 152.93 51.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.705 -1.134 . . . . 74.120000000000005 108.165 -177.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -141.22 153.4 45.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.085 -0.339 . . . . 74.25 110.085 177.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.9 p-10 -93.91 138.54 31.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.123 -0.489 . . . . 63.299999999999997 110.128 179.083 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 31.0 pt -94.79 129.19 36.82 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 116.123 -0.49 . . . . 64.230000000000004 111.049 -179.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 5.3 Cg_exo -77.1 174.12 13.33 Favored 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.355 2.037 . . . . 73.540000000000006 110.779 172.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.97 128.86 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 70.430000000000007 111.123 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.45 -9.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.502 0.668 . . . . 71.200000000000003 110.275 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.56 136.23 47.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.514 -0.766 . . . . 72.25 112.142 -174.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.5 -16.1 29.33 Favored Glycine 0 CA--C 1.492 -1.363 0 C-N-CA 120.784 -0.722 . . . . 53.109999999999999 111.578 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.459 ' HB3' HG13 ' A' ' 507' ' ' VAL . 23.1 mt-30 -87.16 177.99 7.02 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 110.149 -0.315 . . . . 65.5 110.149 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.1 155.84 18.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.709 -1.219 . . . . 74.209999999999994 107.709 -177.068 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.69 -46.69 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.086 0.773 . . . . 64.120000000000005 113.086 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.85 -41.82 74.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.28 0.474 . . . . 74.299999999999997 112.28 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 503' ' ' GLN . 10.1 p -75.52 -34.4 29.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.608 -0.837 . . . . 74.329999999999998 110.737 -175.053 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.62 85.06 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.928 -1.033 . . . . 51.020000000000003 110.134 177.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.37 -35.99 82.68 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.084 -0.507 . . . . 71.400000000000006 111.456 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.76 -51.54 61.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.834 -0.346 . . . . 75.340000000000003 110.776 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.428 ' O ' HG12 ' A' ' 514' ' ' VAL . 62.2 m-20 -68.3 -39.7 81.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 109.978 -177.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.59 -37.31 87.13 Favored 'General case' 0 C--O 1.181 -2.527 0 CA-C-N 116.277 -0.42 . . . . 75.109999999999999 110.142 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -58.94 -39.85 82.85 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.039 0.536 . . . . 62.520000000000003 111.535 -178.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 511' ' ' ASN . 7.7 p -74.18 -31.28 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 120.149 -0.62 . . . . 50.420000000000002 112.197 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.73 -33.76 9.72 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.982 0.896 . . . . 74.409999999999997 110.897 -175.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -92.74 -112.74 2.07 Favored Glycine 0 N--CA 1.416 -2.645 0 CA-C-N 114.301 -1.318 . . . . 61.399999999999999 113.933 -172.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 57.5 m-85 -130.61 175.97 8.57 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.759 -0.46 . . . . 74.099999999999994 109.759 -170.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 m -98.03 -25.71 14.86 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 116.233 -0.439 . . . . 72.209999999999994 112.076 -173.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -108.66 123.16 48.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.871 -0.732 . . . . 72.310000000000002 110.839 -177.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.74 146.09 34.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.153 -0.931 . . . . 63.420000000000002 109.867 -176.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.5 m -126.88 149.5 49.73 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.323 -1.732 . . . . 52.340000000000003 106.323 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.51 131.37 54.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.623 -0.51 . . . . 73.420000000000002 109.623 -174.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.3 52.27 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.969 -1.123 . . . . 71.329999999999998 107.969 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.7 m -103.45 129.35 50.56 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.854 0.359 . . . . 63.509999999999998 110.708 -176.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.0 m -122.47 156.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 110.145 178.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.95 142.48 27.76 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.755 . . . . 55.409999999999997 109.422 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 37.9 t -137.13 140.34 30.91 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 106.556 -1.646 . . . . 74.340000000000003 106.556 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.12 -72.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.815 2.343 . . . . 75.310000000000002 113.167 -176.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 529' ' ' ARG 0.285 30.9 mmt180 -116.47 -54.97 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.653 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 178.19 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.59 133.84 56.97 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.174 1.249 . . . . 61.450000000000003 110.855 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.93 4.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.698 -0.482 . . . . 71.439999999999998 109.698 -178.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.48 -25.52 2.98 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.439 -1.064 . . . . 74.099999999999994 110.439 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.63 150.27 23.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.633 0.773 . . . . 73.409999999999997 110.454 177.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.13 120.0 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 106.879 -1.526 . . . . 51.200000000000003 106.879 175.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 21.2 m -70.04 -27.59 64.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.976 -1.011 . . . . 75.019999999999996 109.851 -175.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.68 24.88 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 110.297 -1.121 . . . . 73.310000000000002 110.297 177.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.2 p -129.87 161.33 31.05 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 107.753 -1.203 . . . . 74.219999999999999 107.753 178.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 41.1 t-20 -61.64 -52.58 68.34 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 120.654 -0.418 . . . . 75.120000000000005 110.131 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_exo -79.85 127.35 6.99 Favored 'Trans proline' 0 C--N 1.364 1.351 0 N-CA-C 108.459 -1.4 . . . . 72.0 108.459 170.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.06 154.45 73.99 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.151 1.901 . . . . 65.120000000000005 112.229 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -52.03 132.6 32.85 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.078 0.551 . . . . 73.030000000000001 111.282 179.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.85 -25.29 21.24 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 111.05 -0.82 . . . . 74.299999999999997 111.05 -176.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 90.1 m -65.7 135.59 55.17 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.21 0.528 . . . . 72.219999999999999 110.73 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.7 m -94.97 123.61 38.54 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.239 -1.393 . . . . 65.120000000000005 107.239 177.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 517' ' ' PHE . 20.5 t -123.22 152.21 63.49 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 107.012 -1.477 . . . . 72.129999999999995 107.012 -176.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.9 Cg_exo -59.87 140.03 91.11 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 73.430000000000007 112.077 174.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 23.8 m -67.62 -21.34 27.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.397 0.617 . . . . 51.350000000000001 111.685 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -88.89 3.59 50.81 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.027 -0.988 . . . . 73.109999999999999 110.756 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -97.25 154.23 17.53 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.267 -0.642 . . . . 75.430000000000007 109.267 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.77 137.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.838 -0.801 . . . . 63.43 108.838 177.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 7.7 tp -93.16 129.89 43.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.48 -0.563 . . . . 73.049999999999997 109.48 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -103.0 116.57 32.8 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 122.798 0.439 . . . . 74.420000000000002 110.712 -176.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.31 134.28 39.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.323 -0.853 . . . . 65.349999999999994 111.111 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -96.97 108.51 21.25 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 63.140000000000001 107.529 178.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.67 138.37 29.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 120.428 0.156 . . . . 74.319999999999993 111.223 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.7 p -72.64 119.8 17.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.338 -0.615 . . . . 65.439999999999998 109.338 179.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 C--N 1.294 -1.836 0 CA-C-N 115.87 -0.605 . . . . 64.549999999999997 109.539 -177.033 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.964 0 N-CA-C 110.411 -1.076 . . . . 43.109999999999999 110.411 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.58 142.26 76.86 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.92 2.413 . . . . 62.539999999999999 112.379 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.85 3.89 53.29 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.032 0.92 . . . . 75.019999999999996 109.042 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.417 ' CB ' ' HB ' ' A' ' 477' ' ' THR . 92.5 mt-30 -83.11 152.08 25.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.546 -1.206 . . . . 75.400000000000006 110.734 -176.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.496 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 13.7 tpp180 -127.56 157.62 39.66 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.458 -1.312 . . . . 54.109999999999999 107.458 177.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.45 141.55 31.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 123.588 0.555 . . . . 64.230000000000004 110.13 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 1.9 mp -79.66 130.83 66.3 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.097 -1.075 . . . . 75.450000000000003 108.097 177.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 30.5 Cg_exo -64.61 141.0 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.833 1.688 . . . . 74.349999999999994 112.314 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.59 9.01 43.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.583 -0.735 . . . . 75.349999999999994 110.362 -177.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.41 7.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.016 0.913 . . . . 74.25 110.656 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 3.2 p -60.72 -38.7 85.96 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 125.324 1.45 . . . . 64.319999999999993 110.514 177.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.1 t -60.7 -26.66 67.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.124 -0.943 . . . . 72.310000000000002 111.278 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 51.8 mt -81.88 -46.42 14.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.11 -0.636 . . . . 72.200000000000003 110.224 -174.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 21.0 m -167.94 150.21 5.56 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.819 -1.178 . . . . 74.129999999999995 107.819 177.514 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.37 -48.71 68.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 64.0 110.139 173.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.61 71.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.626 0.77 . . . . 75.120000000000005 112.094 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.4 mm-40 -61.68 -45.72 92.79 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.297 -0.411 . . . . 63.329999999999998 111.584 -178.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -66.62 -45.74 78.13 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.92 -47.53 89.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.832 0 O-C-N 123.822 0.701 . . . . 55.43 112.388 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.09 -47.42 86.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.617 0.246 . . . . 73.209999999999994 111.661 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.62 -42.31 86.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.408 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.65 -38.38 80.42 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 72.439999999999998 110.562 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 46.8 m -63.26 -42.5 99.17 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.865 -0.607 . . . . 72.540000000000006 109.578 175.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.11 -18.48 64.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.044 -0.526 . . . . 63.439999999999998 110.561 177.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.92 -13.96 58.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.04 0.448 . . . . 70.109999999999999 110.1 178.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.99 -14.05 26.46 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.851 -0.69 . . . . 64.109999999999999 112.991 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.59 130.08 41.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.71 0.291 . . . . 53.439999999999998 110.525 -178.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -127.38 11.11 6.81 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.236 -0.746 . . . . 42.119999999999997 111.236 178.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 451' ' ' ARG . 0.6 OUTLIER -111.04 115.43 29.44 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.052 -1.462 . . . . 52.450000000000003 107.052 -178.512 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -136.76 147.49 46.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.662 -0.415 . . . . 62.200000000000003 111.043 -174.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.401 ' HB2' HG13 ' A' ' 485' ' ' ILE . 14.6 mmmm -132.14 122.75 25.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.254 -1.387 . . . . 75.329999999999998 107.254 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -103.72 128.94 51.03 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.866 -0.42 . . . . 63.100000000000001 109.866 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -129.86 144.04 51.11 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.187 -1.412 . . . . 54.520000000000003 107.187 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.03 135.79 53.63 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.447 -0.946 . . . . 73.109999999999999 108.447 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.3 m -116.44 138.57 24.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.669 -0.863 . . . . 53.539999999999999 108.669 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.9 122.31 10.09 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.063 1.842 . . . . 61.520000000000003 110.416 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.473 ' O ' ' HA2' ' A' ' 491' ' ' GLY . 25.1 t -143.66 -179.18 6.29 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 105.914 -1.884 . . . . 71.099999999999994 105.914 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.1 t -66.07 132.99 94.66 Favored Pre-proline 0 N--CA 1.416 -2.175 0 CA-C-O 121.071 0.462 . . . . 64.129999999999995 109.886 176.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.73 -28.51 30.29 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.917 3.078 . . . . 71.340000000000003 112.039 176.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.87 -17.33 63.06 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.738 -0.665 . . . . 71.129999999999995 112.103 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.65 13.39 19.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.177 -0.327 . . . . 73.510000000000005 111.698 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.9 p -57.47 128.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 42.439999999999998 111.572 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.47 -12.92 59.92 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.626 -0.797 . . . . 44.43 112.131 177.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -92.84 139.78 30.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.179 -0.675 . . . . 61.020000000000003 109.179 176.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 486' ' ' ILE . 61.5 t -82.47 134.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.992 -0.744 . . . . 72.019999999999996 108.992 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 37.0 pt -97.31 -7.41 9.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.251 -0.58 . . . . 73.510000000000005 110.73 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 164.72 167.81 25.86 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.656 -0.783 . . . . 53.32 111.651 175.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.5 p -120.43 149.47 42.33 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.893 -1.151 . . . . 74.109999999999999 107.893 176.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.8 t-20 -65.05 -52.94 45.3 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-O 119.248 -0.406 . . . . 73.230000000000004 111.079 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.6 Cg_exo -73.93 139.58 27.52 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 108.8 -1.269 . . . . 71.099999999999994 108.8 172.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.47 141.31 66.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.578 2.185 . . . . 65.0 112.63 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.32 -11.86 55.63 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.204 -0.907 . . . . 54.140000000000001 110.164 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -94.56 -24.77 17.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.934 -0.575 . . . . 63.340000000000003 111.458 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.86 174.16 5.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.08 -0.648 . . . . 73.230000000000004 109.538 177.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.417 ' HB ' ' CB ' ' A' ' 426' ' ' GLN . 19.1 p -101.18 144.33 30.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.967 -0.561 . . . . 55.149999999999999 109.776 178.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.3 m -127.85 148.8 50.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.708 -0.849 . . . . 73.049999999999997 108.708 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 152.29 42.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 110.061 -0.348 . . . . 70.430000000000007 110.061 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.03 -12.74 16.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.859 0.838 . . . . 74.219999999999999 111.213 -173.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.6 t -90.18 1.12 56.79 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.844 -0.616 . . . . 72.420000000000002 110.923 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.52 141.76 41.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.01 0.433 . . . . 71.019999999999996 111.977 -177.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.76 115.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.79 -1.189 . . . . 61.119999999999997 107.79 176.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.48 119.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.587 -0.845 . . . . 75.420000000000002 108.931 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.5 mp -99.4 123.23 51.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.239 -1.763 . . . . 71.030000000000001 106.239 175.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -115.38 123.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 109.327 -0.62 . . . . 74.450000000000003 109.327 -177.709 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -103.52 117.54 49.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 CA-C-O 121.76 0.79 . . . . 70.120000000000005 111.802 178.749 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 20.1 t -96.61 140.47 17.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.872 -1.058 . . . . 72.140000000000001 109.335 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.42 116.8 4.38 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.29 -1.524 . . . . 70.420000000000002 109.29 174.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 22.8 t -126.64 129.95 49.5 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 107.36 -1.348 . . . . 73.129999999999995 107.36 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 459' ' ' SER . . . -96.15 144.08 17.07 Favored Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 119.464 -1.35 . . . . 65.400000000000006 111.373 -178.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.88 119.76 6.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.374 2.05 . . . . 75.519999999999996 110.088 176.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -86.12 79.68 9.05 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.874 0.845 . . . . 52.219999999999999 109.545 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 546' ' ' PRO . 14.5 p -137.94 157.55 46.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.693 -1.14 . . . . 64.400000000000006 108.735 -177.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.25 147.48 32.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.652 178.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.6 p-10 -84.71 131.82 34.53 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.161 -0.927 . . . . 74.439999999999998 108.54 175.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.9 pt -76.47 134.7 69.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.712 -0.676 . . . . 73.140000000000001 110.843 -177.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.13 167.43 9.38 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.565 2.177 . . . . 74.420000000000002 109.778 173.088 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.02 141.88 28.34 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.631 -1.248 . . . . 74.340000000000003 107.631 176.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.62 13.84 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-O 121.986 0.898 . . . . 65.439999999999998 110.492 -174.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.58 147.52 29.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.398 -0.819 . . . . 71.209999999999994 111.649 -175.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 91.48 11.81 60.41 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 111.099 -0.8 . . . . 25.219999999999999 111.099 177.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.49 ' HB3' ' CG1' ' A' ' 507' ' ' VAL . 22.5 mt-30 -119.89 178.42 4.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.8 0.334 . . . . 75.209999999999994 111.831 -176.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.679 -1.23 . . . . 72.140000000000001 107.679 -176.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.05 -41.65 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 117.833 0.288 . . . . 54.229999999999997 111.381 -177.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.04 -42.51 80.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.549 0.574 . . . . 65.400000000000006 112.549 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 503' ' ' GLN . 11.2 p -73.67 -34.94 42.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 118.98 -1.088 . . . . 72.439999999999998 110.16 -176.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' HG21 ' A' ' 534' ' ' VAL . . . -63.36 -49.9 72.06 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.941 -1.027 . . . . 51.399999999999999 111.157 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -65.13 -37.5 87.63 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.642 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -65.59 -53.6 39.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.107 0.41 . . . . 74.450000000000003 112.107 178.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -62.42 -39.0 91.86 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.078 0.466 . . . . 62.43 110.596 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.59 -47.66 62.77 Favored 'General case' 0 C--O 1.187 -2.192 0 CA-C-N 115.884 -0.598 . . . . 63.329999999999998 110.575 178.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.38 -41.19 98.79 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.448 0.536 . . . . 74.040000000000006 112.448 -176.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.05 -29.11 43.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.335 0.495 . . . . 52.219999999999999 112.335 -177.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.88 -26.37 6.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.204 -0.998 . . . . 73.019999999999996 111.798 -174.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.65 -98.92 2.38 Favored Glycine 0 N--CA 1.41 -3.065 0 CA-C-N 115.26 -0.882 . . . . 70.209999999999994 114.533 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' A' ' 547' ' ' VAL . 50.1 m-85 -133.68 160.11 38.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.761 0.315 . . . . 61.119999999999997 110.487 -167.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.1 p -103.63 -7.9 20.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.586 -0.734 . . . . 73.129999999999995 112.004 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.48 119.92 40.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.725 -0.472 . . . . 75.329999999999998 109.725 -176.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -126.3 153.47 44.77 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.595 0.712 . . . . 60.030000000000001 111.533 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.5 m -141.16 153.71 45.49 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.928 -1.508 . . . . 53.43 106.928 169.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -121.65 132.31 54.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 118.28 0.491 . . . . 74.409999999999997 110.956 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.14 136.14 53.44 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.068 -1.456 . . . . 63.509999999999998 107.068 174.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 25.9 m -98.53 133.49 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.948 0.404 . . . . 62.219999999999999 110.491 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.13 163.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.42 -0.955 . . . . 52.43 108.42 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.17 140.08 38.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.262 0.553 . . . . 70.239999999999995 110.213 -174.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.0 p -103.17 118.23 58.43 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.402 -0.817 . . . . 50.439999999999998 113.015 -172.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -80.62 -75.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.829 1.686 . . . . 74.540000000000006 109.226 172.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.549 ' H ' ' HD2' ' A' ' 530' ' ' PRO . 28.7 mmm180 -107.79 -52.73 0.07 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.751 -0.642 . . . . 73.049999999999997 112.472 171.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.549 ' HD2' ' H ' ' A' ' 529' ' ' ARG . 19.4 Cg_endo -62.81 134.21 45.74 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 120.644 1.266 . . . . 73.430000000000007 111.355 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -154.62 126.53 7.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.066 -1.087 . . . . 71.209999999999994 108.066 178.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 92.21 -29.33 7.72 Favored Glycine 0 C--N 1.308 -0.979 0 N-CA-C 111.372 -0.691 . . . . 55.140000000000001 111.372 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.93 149.78 26.84 Favored 'General case' 0 C--O 1.255 1.361 0 C-N-CA 123.232 0.613 . . . . 74.310000000000002 110.044 176.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.434 HG21 ' CB ' ' A' ' 508' ' ' ALA . 80.4 t -74.31 126.92 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.891 0 CA-C-O 121.527 0.68 . . . . 73.010000000000005 109.554 -173.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 5.6 m -92.15 -12.65 32.28 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.41 -1.268 . . . . 65.120000000000005 110.136 -175.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.73 -150.77 19.99 Favored Glycine 0 N--CA 1.425 -2.069 0 C-N-CA 120.1 -1.048 . . . . 65.150000000000006 112.815 174.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 17.9 p -118.16 161.5 19.77 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 124.591 1.156 . . . . 43.450000000000003 109.254 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 18.9 t-20 -61.33 -57.12 27.69 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 119.298 -0.382 . . . . 72.510000000000005 111.094 176.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.2 Cg_exo -83.41 156.29 14.38 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.224 1.282 . . . . 74.209999999999994 109.852 176.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.14 158.83 48.61 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.042 1.828 . . . . 71.109999999999999 112.196 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.89 133.81 54.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.204 0.601 . . . . 75.230000000000004 111.045 178.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.98 -19.64 32.4 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.805 -0.712 . . . . 51.119999999999997 111.676 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 39.0 m -65.56 123.84 20.76 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.676 -0.49 . . . . 53.409999999999997 109.676 177.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 41.6 m -94.03 123.81 37.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 109.944 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.8 157.01 72.84 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 70.129999999999995 108.978 177.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.535 ' HA ' HG22 ' A' ' 494' ' ' THR . 51.4 Cg_exo -58.7 146.01 93.71 Favored 'Trans proline' 0 CA--C 1.519 -0.24 0 C-N-CA 122.929 2.419 . . . . 64.049999999999997 111.619 177.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 517' ' ' PHE . 32.4 m -66.75 -20.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.434 0.635 . . . . 75.209999999999994 111.767 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -91.11 3.85 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.345 -0.843 . . . . 61.200000000000003 111.38 176.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -83.06 152.06 25.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.939 -0.763 . . . . 74.109999999999999 108.939 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.58 119.2 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.02 -1.104 . . . . 71.319999999999993 108.02 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 15.4 tt -89.83 141.64 14.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.189 0.518 . . . . 74.329999999999998 110.139 -177.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.0 121.78 43.25 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 121.618 0.723 . . . . 75.319999999999993 110.228 -176.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.7 134.54 39.83 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.207 1.403 . . . . 65.239999999999995 108.954 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -103.83 115.91 31.32 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.246 -0.888 . . . . 62.009999999999998 109.244 -177.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.18 129.83 75.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 116.107 -0.497 . . . . 72.400000000000006 111.061 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 68.2 m -74.52 116.67 15.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.347 -0.983 . . . . 62.039999999999999 108.347 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.446 -0.797 . . . . 64.230000000000004 108.955 -175.988 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 N-CA-C 110.479 -1.049 . . . . 45.439999999999998 110.479 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.19 132.98 17.25 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.635 2.224 . . . . 73.010000000000005 110.633 179.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -90.26 6.76 41.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.599 0.714 . . . . 74.439999999999998 110.023 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 477' ' ' THR . 78.2 mt-30 -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 114.95 -1.023 . . . . 74.209999999999994 110.577 -177.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -129.88 156.76 43.87 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.078 -1.082 . . . . 74.430000000000007 108.078 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.43 143.16 27.37 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.167 0.432 . . . . 72.310000000000002 112.167 -178.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 1.8 mp -77.53 130.67 73.38 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.875 -0.602 . . . . 65.319999999999993 111.413 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 75.0 Cg_exo -54.1 148.95 37.57 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.887 3.724 . . . . 73.209999999999994 115.524 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -94.64 -5.24 46.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.437 -0.801 . . . . 63.530000000000001 110.125 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.5 p -74.95 -5.99 7.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.256 1.027 . . . . 73.209999999999994 109.679 -176.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.5 m -63.61 -26.69 68.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.409 -1.268 . . . . 71.439999999999998 109.119 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.1 p -58.51 -27.67 64.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.816 -1.083 . . . . 64.349999999999994 111.341 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 67.6 mt -86.75 -47.35 9.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.709 -0.796 . . . . 74.230000000000004 110.978 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 25.6 m -167.01 150.17 6.5 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 109.533 -0.543 . . . . 74.140000000000001 109.533 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -51.63 -46.56 63.7 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.116 1.366 . . . . 73.030000000000001 111.199 174.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.21 85.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.998 -0.546 . . . . 64.040000000000006 111.277 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.69 -44.11 97.58 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.668 -0.696 . . . . 73.299999999999997 110.827 178.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -50.79 72.35 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.093 -0.958 . . . . 63.549999999999997 110.399 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -46.58 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.799 -0.637 . . . . 74.099999999999994 112.129 -176.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -63.31 -48.01 79.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.476 0.179 . . . . 60.119999999999997 110.984 -177.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -68.25 -39.47 82.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.071 -0.513 . . . . 74.329999999999998 111.63 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.524 HD23 ' CE2' ' A' ' 452' ' ' PHE . 28.9 tp -67.44 -37.49 83.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.223 0.535 . . . . 74.030000000000001 109.686 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 -44.13 95.94 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.326 -0.852 . . . . 71.340000000000003 109.722 175.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.76 62.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.606 -0.725 . . . . 72.239999999999995 111.442 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.91 -12.96 54.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 22.440000000000001 111.047 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.61 -18.74 10.74 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.536 -0.84 . . . . 73.200000000000003 112.693 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.506 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 81.5 m-85 -75.69 136.51 40.37 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.663 0.268 . . . . 75.409999999999997 110.301 -176.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -137.99 26.0 2.89 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.721 -0.951 . . . . 70.450000000000003 110.721 177.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -124.52 116.03 21.82 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.374 -1.343 . . . . 72.409999999999997 107.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.524 ' CE2' HD23 ' A' ' 444' ' ' LEU . 64.0 m-85 -130.18 146.5 51.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.301 0.572 . . . . 53.310000000000002 110.903 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.405 ' HB3' HG12 ' A' ' 485' ' ' ILE . 63.6 tttp -140.86 123.29 15.92 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.807 -1.553 . . . . 75.230000000000004 106.807 169.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.443 HE21 HG21 ' A' ' 488' ' ' VAL . 58.5 tt0 -91.93 130.07 37.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.16 0.505 . . . . 74.409999999999997 111.306 -177.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -130.03 141.94 50.68 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.37 -1.344 . . . . 51.329999999999998 107.37 175.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.15 149.09 45.01 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.199 -0.601 . . . . 53.329999999999998 110.791 -177.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 56.0 m -132.49 134.27 24.62 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-N 115.475 -0.784 . . . . 62.229999999999997 108.889 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_exo -65.58 127.51 18.18 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.627 2.218 . . . . 73.310000000000002 112.243 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 38.6 m -146.94 -179.94 7.16 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 125.498 1.519 . . . . 72.230000000000004 107.077 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.4 t -50.51 114.56 4.67 Favored Pre-proline 0 CA--C 1.584 2.269 0 C-N-CA 124.135 0.974 . . . . 64.109999999999999 110.14 177.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.11 -28.91 34.8 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.736 3.624 . . . . 63.509999999999998 116.425 -171.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.97 -20.83 64.2 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.956 -0.698 . . . . 72.109999999999999 112.077 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 466' ' ' LYS . 4.3 mm? -95.37 14.37 22.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.485 0.55 . . . . 73.109999999999999 112.485 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.09 128.09 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.386 0.613 . . . . 75.0 110.697 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.3 1.77 55.72 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.677 -0.692 . . . . 54.32 112.783 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.483 ' HD2' HD12 ' A' ' 463' ' ' LEU . 57.8 tttp -91.79 138.49 31.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.623 -1.251 . . . . 72.140000000000001 107.623 176.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 486' ' ' ILE . 50.7 t -82.96 124.82 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.212 -0.995 . . . . 73.219999999999999 108.39 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 35.6 pt -99.51 -14.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 120.221 -0.592 . . . . 72.400000000000006 111.272 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.04 39.17 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.602 -0.809 . . . . 63.240000000000002 111.203 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 29.6 p -132.19 147.78 52.43 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.683 -0.858 . . . . 74.310000000000002 108.683 177.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.7 t-20 -64.02 -51.93 59.71 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 119.167 -0.444 . . . . 72.420000000000002 111.272 176.002 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.2 Cg_exo -74.12 145.18 34.76 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.334 1.356 . . . . 61.43 109.74 173.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.78 146.01 58.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.696 2.264 . . . . 65.439999999999998 112.995 -177.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -101.77 -9.7 20.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.544 -0.753 . . . . 72.510000000000005 110.196 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.475 -0.935 . . . . 70.420000000000002 108.475 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -117.77 175.56 5.6 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.164 -0.926 . . . . 71.439999999999998 108.531 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 426' ' ' GLN . 27.4 p -88.3 148.74 24.15 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 116.648 -0.251 . . . . 62.25 111.592 -177.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.6 m -126.05 148.61 49.28 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.781 -1.192 . . . . 65.230000000000004 107.781 175.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.57 147.13 53.52 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-O 120.611 0.243 . . . . 34.32 111.331 -177.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.01 -28.14 41.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 75.5 111.311 179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.0 t -85.48 7.48 22.66 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.717 -0.674 . . . . 75.420000000000002 110.399 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.97 144.68 27.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.346 -0.613 . . . . 64.209999999999994 109.346 -177.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.68 111.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.346 -0.983 . . . . 74.439999999999998 108.346 179.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.22 118.23 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 C-N-CA 118.925 -1.11 . . . . 34.310000000000002 108.424 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.443 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 58.5 mt -100.43 113.94 37.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.345 -1.724 . . . . 70.409999999999997 106.345 176.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.46 128.12 52.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 CA-C-N 115.652 -0.703 . . . . 52.539999999999999 109.458 -174.706 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 30.9 mm -97.59 109.9 24.34 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-O 121.361 0.6 . . . . 71.420000000000002 109.484 -176.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.443 HG21 HE21 ' A' ' 454' ' ' GLN . 15.9 t -96.69 133.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.543 -0.753 . . . . 61.43 110.143 -177.215 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.71 115.91 4.91 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.146 -1.982 . . . . 65.540000000000006 108.146 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.0 m -127.44 160.39 31.61 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.084 -1.08 . . . . 63.329999999999998 108.084 -176.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -135.5 145.26 17.3 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.207 -1.473 . . . . 70.299999999999997 111.064 -178.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.32 114.53 2.25 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.579 2.186 . . . . 71.140000000000001 110.802 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -70.43 96.09 1.12 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.938 0.875 . . . . 74.129999999999995 109.042 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -136.45 166.35 23.7 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.909 -1.041 . . . . 65.129999999999995 110.009 -174.064 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -150.6 151.05 31.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.142 0.977 . . . . 63.329999999999998 108.908 175.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -95.65 133.11 40.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.399 -1.334 . . . . 71.219999999999999 107.399 173.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 43.6 pt -84.32 134.84 42.27 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 120.534 -0.466 . . . . 73.400000000000006 111.638 -175.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.04 170.37 7.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.621 2.214 . . . . 75.409999999999997 111.509 175.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -85.61 133.13 34.06 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.933 -0.576 . . . . 75.310000000000002 110.638 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.71 13.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.63 -0.714 . . . . 61.310000000000002 110.526 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -75.76 137.47 40.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.099 -0.5 . . . . 43.329999999999998 110.703 -177.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.05 50.44 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.491 -1.044 . . . . 75.329999999999998 110.491 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.496 ' HB3' HG13 ' A' ' 507' ' ' VAL . 17.8 mt-30 -97.59 169.59 9.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 72.129999999999995 108.24 178.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 28.2 m -82.98 155.35 24.02 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.183 -1.043 . . . . 74.239999999999995 108.183 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 13.5 p -52.63 -41.38 37.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 123.488 0.715 . . . . 60.32 111.973 -177.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.19 -43.98 76.88 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.531 -0.468 . . . . 73.230000000000004 112.144 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 503' ' ' GLN . 12.6 p -77.08 -34.96 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 119.848 -0.741 . . . . 74.450000000000003 111.684 -176.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.22 84.57 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.033 -0.985 . . . . 52.299999999999997 111.205 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -63.73 -36.19 83.05 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.225 0.328 . . . . 70.219999999999999 110.502 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 91.1 mttt -65.02 -49.91 68.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.934 -0.575 . . . . 70.109999999999999 111.794 177.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.01 -41.45 86.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 120.468 -0.493 . . . . 70.530000000000001 110.328 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.85 -44.27 94.2 Favored 'General case' 0 C--O 1.195 -1.765 0 CA-C-N 115.839 -0.618 . . . . 74.099999999999994 110.124 -179.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.07 -37.83 78.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.54 0.57 . . . . 70.129999999999995 112.54 -178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 66.8 t -59.09 -36.78 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.442 0.464 . . . . 52.32 111.195 -178.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.05 -34.75 8.33 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.809 -0.756 . . . . 75.239999999999995 110.495 -177.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -94.99 -122.84 3.87 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.707 -1.133 . . . . 70.420000000000002 115.869 -170.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 19.0 m-85 -122.58 178.13 5.13 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.92 0.391 . . . . 65.329999999999998 110.07 -168.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.8 m -116.44 8.9 14.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.217 1.008 . . . . 71.310000000000002 109.301 178.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.86 115.27 29.77 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.99 -1.115 . . . . 75.400000000000006 107.99 178.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -125.96 151.72 46.63 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.215 0.531 . . . . 64.0 110.956 -175.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.0 m -141.55 153.39 44.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.537 -1.653 . . . . 52.409999999999997 106.537 170.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.46 135.78 52.69 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 118.268 0.485 . . . . 52.32 110.412 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.574 ' HB3' ' OE1' ' A' ' 554' ' ' GLN . . . -130.08 145.08 51.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.239 -0.652 . . . . 61.020000000000003 109.239 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 557' ' ' LYS . 21.2 m -87.83 124.97 34.18 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.833 0.349 . . . . 73.239999999999995 111.394 -175.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.3 163.16 30.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.579 -0.897 . . . . 62.329999999999998 108.579 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.42 137.32 37.93 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.682 0.993 . . . . 61.439999999999998 113.682 -172.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 47.3 t -162.01 115.1 1.2 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.598 1.559 . . . . 75.450000000000003 106.852 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.03 -89.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.378 2.719 . . . . 44.32 115.793 -172.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 530' ' ' PRO . 57.3 mtt180 -86.33 -42.56 0.58 Allowed Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 113.547 0.943 . . . . 73.129999999999995 113.547 178.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 11.1 Cg_endo -57.17 133.91 60.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 120.502 1.215 . . . . 61.310000000000002 109.524 173.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.96 140.74 21.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.041 0.448 . . . . 74.409999999999997 110.704 -172.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.06 77.22 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.629 -0.714 . . . . 61.409999999999997 111.368 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 504' ' ' THR . 11.2 pt-20 -87.47 148.78 24.79 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.317 0.579 . . . . 64.120000000000005 110.94 177.418 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 76.9 t -75.2 122.18 28.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.33 -1.359 . . . . 75.129999999999995 107.33 176.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.4 m -98.33 -1.35 41.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.242 -0.89 . . . . 62.130000000000003 110.148 -174.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.69 -169.24 32.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.659 -0.576 . . . . 70.219999999999999 111.659 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 16.7 p -137.27 160.65 38.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.407 -0.96 . . . . 75.219999999999999 108.407 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.3 t30 -58.48 -56.87 31.0 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.429 -0.32 . . . . 70.209999999999994 111.45 177.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.7 Cg_endo -84.19 151.3 12.26 Favored 'Trans proline' 0 C--N 1.365 1.433 0 N-CA-C 108.954 -1.21 . . . . 71.329999999999998 108.954 174.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.63 148.76 53.94 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.644 1.563 . . . . 73.319999999999993 111.658 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.08 129.48 41.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.262 -0.426 . . . . 71.340000000000003 110.061 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.93 -15.12 37.33 Favored Glycine 0 C--N 1.301 -1.375 0 C-N-CA 120.884 -0.674 . . . . 45.530000000000001 112.05 -177.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 85.5 m -81.08 134.82 35.72 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 110.036 -0.357 . . . . 43.229999999999997 110.036 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 85.3 m -90.65 123.32 34.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.879 -0.6 . . . . 74.299999999999997 109.799 177.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.69 158.7 67.1 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.793 -0.817 . . . . 74.430000000000007 108.793 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.49 ' HA ' HG22 ' A' ' 494' ' ' THR . 24.5 Cg_exo -65.33 146.63 86.32 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.514 2.143 . . . . 75.120000000000005 112.118 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 19.1 m -67.7 -19.89 25.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.379 1.085 . . . . 72.299999999999997 110.027 177.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.32 -17.26 60.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.918 -1.492 . . . . 72.239999999999995 109.481 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.5 t -86.61 142.11 28.5 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.412 -0.813 . . . . 50.219999999999999 108.93 -176.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.36 126.28 44.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.506 -1.294 . . . . 73.540000000000006 107.506 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.87 137.95 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.266 0.555 . . . . 72.200000000000003 111.121 -176.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.74 119.93 39.55 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 108.91 -0.774 . . . . 72.120000000000005 108.91 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 18.6 tp -99.32 124.1 44.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.985 -1.461 . . . . 72.140000000000001 107.936 -177.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.574 ' OE1' ' HB3' ' A' ' 523' ' ' ALA . 4.1 mm-40 -90.13 108.51 19.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.505 0.669 . . . . 73.120000000000005 110.128 -175.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.99 140.56 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.737 -1.12 . . . . 72.329999999999998 111.856 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 40.1 m -56.24 127.89 33.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.666 0.746 . . . . 72.120000000000005 112.521 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 524' ' ' SER . 77.6 tttt . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.959 -1.126 . . . . 74.420000000000002 107.959 174.316 . . . . . . . . 1 1 . 1 stop_ save_